Citrus Sinensis ID: 002069
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 973 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LP24 | 1120 | Probable leucine-rich rep | yes | no | 0.980 | 0.851 | 0.449 | 0.0 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.916 | 0.853 | 0.446 | 0.0 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.984 | 0.870 | 0.366 | 1e-155 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.983 | 0.868 | 0.372 | 1e-153 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.988 | 0.768 | 0.357 | 1e-150 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.993 | 0.860 | 0.362 | 1e-150 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.985 | 0.767 | 0.348 | 1e-149 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.973 | 0.834 | 0.358 | 1e-146 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.950 | 0.810 | 0.350 | 1e-145 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.985 | 0.804 | 0.343 | 1e-137 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 770 bits (1989), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/992 (44%), Positives = 625/992 (63%), Gaps = 38/992 (3%)
Query: 7 LSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPP 66
LS N +G I P +G+L +L +L +N L+ +IP E+G + S+ L+L N L GSIP
Sbjct: 133 LSTNHLTGEISPSLGNLKNLTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKLTGSIPS 192
Query: 67 SLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLY 126
SLGNL +L+ + + N L+G IP E+G+++S++DL LS N L GSIPS+LGNL NL+ LY
Sbjct: 193 SLGNLKNLMVLYLYENYLTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLY 252
Query: 127 LHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPN 186
L+ N L+G IP EIGN++ +++L +S N L+G+IP SLGNL NL L + N L+G IP
Sbjct: 253 LYENYLTGVIPPEIGNMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPP 312
Query: 187 EIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQ 246
++GN++S+ DL L N L+GSI S GNL L ILYL N L+G+IP E+GN++S++ LQ
Sbjct: 313 KLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQ 372
Query: 247 LNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPL 306
LN N L+GSIP SFGNL L L N L+ I +E+GN++S+++L L+ N L+GS+P
Sbjct: 373 LNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPD 432
Query: 307 SLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLD 366
S G+ T L +LY N LSG+IP + N L+ L L N G P + KL ++
Sbjct: 433 SFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNIS 492
Query: 367 LSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNK------- 419
L N L G IP S SL N I + G L+ +D S NK
Sbjct: 493 LDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISS 552
Query: 420 -----------------LNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQL 462
+ G+IP + N+T L L LS+N++ GE+P G ++L +L
Sbjct: 553 NWEKSPKLGALIMSNNNITGAIPTEIWNMT-QLVELDLSTNNLFGELPEAIGNLTNLSRL 611
Query: 463 ILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIP 522
LN N+LSG++ L L LE LDLS+N F + IP++ + +KLH +NLS N+F IP
Sbjct: 612 RLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP 671
Query: 523 NPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCI 582
+ KL L++LDLS+ EIPSQ+ S+QSL+KL+LSHNNLSG I FE M L+ +
Sbjct: 672 R-LSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNV 730
Query: 583 DISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDI--KRLPPCKAFKSHKQSLK-KIWIV 639
DIS N L+G +P++ FR A AL+ N LC +I +RL PC+ K K++ +WI+
Sbjct: 731 DISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWIL 790
Query: 640 IVFPLLGTVALLISLIGLFFNFRQRKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRA 699
+ P+LG V +++S+ F + RK LQ +++ T +S+ + DGK +++II +
Sbjct: 791 V--PILG-VLVILSICANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDIIES 847
Query: 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMA---CQQEFLNEGNALTK 756
T FD H IG GG VY+A L I+AVK+ H + E++ +QEFLNE ALT+
Sbjct: 848 TNEFDPTHLIGTGGYSKVYRANL-QDTIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTE 906
Query: 757 IRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADAL 816
IRHRN+VK +GFCSH H+F++YEY+E GSL +L+ND A+ WTKR+N +KGVA AL
Sbjct: 907 IRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHAL 966
Query: 817 LYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPE 876
YMH + PIVHRDISS N+LL+ +Y A +SDFG +K LK SN + +AGT+GY+APE
Sbjct: 967 SYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPE 1026
Query: 877 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936
AYTMKVTEKCDVYSFGVL LE+I GKHP D +SS+ SS L +L + D R+ P
Sbjct: 1027 FAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEAL--SLRSISDERVLEPR 1084
Query: 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVS 968
++KL+ ++E+++ CL +P SRPTM +S
Sbjct: 1085 GQNREKLLKMVEMALLCLQANPESRPTMLSIS 1116
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 726 bits (1874), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/931 (44%), Positives = 571/931 (61%), Gaps = 39/931 (4%)
Query: 71 LTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMN 130
L +L ++D+ N SG+I G L LS N L G IP LG+L+NL TL+L N
Sbjct: 117 LPNLTFVDLSMNRFSGTISPLWGRFSKLEYFDLSINQLVGEIPPELGDLSNLDTLHLVEN 176
Query: 131 ALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGN 190
L+GSIP EIG L ++++ + N L+G IP S GNLT LV LY+ IN+LSGSIP+EIGN
Sbjct: 177 KLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGN 236
Query: 191 LKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYN 250
L +L +L LD N L+G I SFGNL + +L + N LSG IP EIGN+ +L L L+ N
Sbjct: 237 LPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTN 296
Query: 251 TLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGS 310
L+G IP + GN+ L + L N L+ SI E+G ++S++ L+++ N L+G +P S G
Sbjct: 297 KLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGK 356
Query: 311 LTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSIN 370
LT L L+ N LSG IP I N L+ LQL N G +P + KL +L L N
Sbjct: 357 LTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDN 416
Query: 371 KLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILD---------------- 414
G +P S SL + NS I + G +L+ +D
Sbjct: 417 HFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQ 476
Query: 415 --------LSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNN 466
LS+N + G+IP + N+T L L LSSN I GE+P + + +L LN
Sbjct: 477 SQKLVAFILSNNSITGAIPPEIWNMT-QLSQLDLSSNRITGELPESISNINRISKLQLNG 535
Query: 467 NELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIE 526
N LSG++ + L LEYLDLS+N F + IP +L NL +L+Y+NLS N Q IP +
Sbjct: 536 NRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLT 595
Query: 527 KLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISY 586
KL L LDLSY EI SQ S+Q+LE+L+LSHNNLSG I F++M L+ +D+S+
Sbjct: 596 KLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSH 655
Query: 587 NALQGLIPNSTAFRDAPMLALQGNKRLCGDI---KRLPPC---KAFKSHKQSLKKIWIVI 640
N LQG IP++ AFR+AP A +GNK LCG + + L PC + KSHK + + I I
Sbjct: 656 NNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKD--RNLIIYI 713
Query: 641 VFPLLGTVALLISLIGLFFNFRQRKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRAT 700
+ P++G + +L G+F FR+R ++ S LS+ +FDGK+ ++EII+AT
Sbjct: 714 LVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGG-ETLSIFSFDGKVRYQEIIKAT 772
Query: 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEM---ACQQEFLNEGNALTKI 757
FD ++ IG GG G VYKA+LP I+AVKK + + + +QEFLNE ALT+I
Sbjct: 773 GEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEI 831
Query: 758 RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL 817
RHRN+VK +GFCSH ++F+VYEY+E GSL +L ND A++ W KR+N +KGVA AL
Sbjct: 832 RHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALS 891
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL 877
YMH + P IVHRDISS N+LL +YEA +SDFG +K LK SN + +AGT+GY+APEL
Sbjct: 892 YMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPEL 951
Query: 878 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937
AY MKVTEKCDVYSFGVL LEVIKG+HP D +S++ SS + ++L + D RLP P
Sbjct: 952 AYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSS-PPDATLSLKSISDHRLPEPTP 1010
Query: 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVS 968
++++++ I++V++ CL P +RPTM +S
Sbjct: 1011 EIKEEVLEILKVALLCLHSDPQARPTMLSIS 1041
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 548 bits (1412), Expect = e-155, Method: Compositional matrix adjust.
Identities = 364/992 (36%), Positives = 532/992 (53%), Gaps = 34/992 (3%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L+ L +S N SG IP ++ L++L N+ G+IP ++ + +L L L N+L
Sbjct: 93 LRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLKKLYLCENYLF 152
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
GSIP +GNL+SL + I +N L+G IP + L+ L +R N +G IPS + +
Sbjct: 153 GSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCES 212
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L L L N L GS+P ++ L+ L+DL + N LSG IP S+GN++ L L + N +
Sbjct: 213 LKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFT 272
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
GSIP EIG L + L L N L+G I GNL + N L+G IP E G++ +
Sbjct: 273 GSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILN 332
Query: 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLS 301
L L L N L G IP G LT L L N L+ +I +E+ L L+ LQL N L
Sbjct: 333 LKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLE 392
Query: 302 GSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTK 361
G IP +G +N + L S N+LSG IP ++L L L N L+G+IP L
Sbjct: 393 GKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKS 452
Query: 362 LVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
L L L N+L+GS+P+ +L +LT L L++N L +I ++G +K+L L L++N
Sbjct: 453 LTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFT 512
Query: 422 GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLN 481
G IP + NLT + +SSN + G IP G ++ +L L+ N+ SG ++ ELG L
Sbjct: 513 GEIPPEIGNLTKIVG-FNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLV 571
Query: 482 QLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLS-ELDLSYKI 540
LE L LS N IP S G+L +L L L N S+ IP + KL L L++S+
Sbjct: 572 YLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNN 631
Query: 541 FGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFR 600
IP + ++Q LE L L+ N LSG I + L +IS N L G +P++ F+
Sbjct: 632 LSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQ 691
Query: 601 DAPMLALQGNKRLCGDIKRLPPCKAFKSHKQSLKKIWIV----------IVFPLLGTVAL 650
GN LC + C+ H S K W++ I ++G+V
Sbjct: 692 RMDSSNFAGNHGLCNSQR--SHCQPLVPHSDS-KLNWLINGSQRQKILTITCIVIGSV-F 747
Query: 651 LISLIGLFFNFRQRKNGLQT--QQSSPRNTLGLLSVLTFDGK-IVHEEIIRATKNFDDEH 707
LI+ +GL + ++R+ Q+ P ++ F K ++ ++ AT+NF ++
Sbjct: 748 LITFLGLCWTIKRREPAFVALEDQTKP----DVMDSYYFPKKGFTYQGLVDATRNFSEDV 803
Query: 708 CIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G G+VYKAE+ GE++AVKK +S G + F E + L KIRHRNIVK YG
Sbjct: 804 VLGRGACGTVYKAEMSGGEVIAVKKLNSRGEG-ASSDNSFRAEISTLGKIRHRNIVKLYG 862
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
FC H + ++YEY+ GSL L W R G A+ L Y+H +C P I
Sbjct: 863 FCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQI 922
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR-TELAGTFGYIAPELAYTMKVTEK 886
VHRDI S N+LL+ ++AHV DFG++K + L S + +AG++GYIAPE AYTMKVTEK
Sbjct: 923 VHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEK 982
Query: 887 CDVYSFGVLALEVIKGKHP-------RDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939
CD+YSFGV+ LE+I GK P D ++ + S+ + I EM D RL T +
Sbjct: 983 CDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRN--MIPTIEMFDARLDTNDKRT 1040
Query: 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
++ ++++++ C SP SRPTM++V ++
Sbjct: 1041 VHEMSLVLKIALFCTSNSPASRPTMREVVAMI 1072
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 542 bits (1397), Expect = e-153, Method: Compositional matrix adjust.
Identities = 370/993 (37%), Positives = 540/993 (54%), Gaps = 36/993 (3%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
LK L LS+N SG IP EIG+ + L++L + NQ G IP EIG+L SL L +Y+N +
Sbjct: 99 LKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRIS 158
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
GS+P +GNL SL + +N +SG +P +G+LK L+ R N ++GS+PS +G +
Sbjct: 159 GSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCES 218
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
LV L L N LSG +P EIG LK LS + + N SG IP + N T+L TL + N L
Sbjct: 219 LVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLV 278
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
G IP E+G+L+SL L L N L+G+I GNL+ + NAL+G IP E+GN++
Sbjct: 279 GPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEG 338
Query: 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLS 301
L L L N L+G+IP L L L NAL+ I L+ L LQL N+LS
Sbjct: 339 LELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLS 398
Query: 302 GSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTK 361
G+IP LG ++L L S N LSG IP+ + ++ L L N L+G+IP +
Sbjct: 399 GTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKT 458
Query: 362 LVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
LV L L+ N L G P + ++T + L +N SIP+E+G+ +L L L+ N
Sbjct: 459 LVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFT 518
Query: 422 GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLN 481
G +P + L+ L L +SSN + GE+P L +L + N SG L E+GSL
Sbjct: 519 GELPREIGMLS-QLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLY 577
Query: 482 QLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLS-ELDLSYKI 540
QLE L LS N +IP +LGNL +L L + N F+ IP + L L L+LSY
Sbjct: 578 QLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNK 637
Query: 541 FGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFR 600
EIP ++ ++ LE L L++NNLSG I F + L + SYN+L G IP R
Sbjct: 638 LTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLR 694
Query: 601 DAPMLALQGNKRLCG-------DIKRLPPCKAFKSHKQSLKKIWIVIVFPLLGTVALLIS 653
+ M + GN+ LCG + P ++ I I ++G V+L++
Sbjct: 695 NISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLI 754
Query: 654 LIGLFFNFRQRKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATKNFDDEHCIGNGG 713
+ ++ R + + Q + + L ++++ AT NFD+ +G G
Sbjct: 755 ALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGA 814
Query: 714 QGSVYKAELPTGEIVAVKKFHSPLPG------EMACQQEFLNEGNALTKIRHRNIVKFYG 767
G+VYKA LP G +AVKK S G + + + E L GN IRHRNIVK +G
Sbjct: 815 CGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGN----IRHRNIVKLHG 870
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
FC+H + ++YEY+ GSL IL + + W+KR G A L Y+H +C P I
Sbjct: 871 FCNHQGSNLLLYEYMPKGSLGEILHDPSC--NLDWSKRFKIALGAAQGLAYLHHDCKPRI 928
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR-TELAGTFGYIAPELAYTMKVTEK 886
HRDI S N+LL+ ++EAHV DFG++K + + S + +AG++GYIAPE AYTMKVTEK
Sbjct: 929 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEK 988
Query: 887 CDVYSFGVLALEVIKGKHP-------RDFISSICSSLSSNLNIALDE-MLDPRLPTPLRN 938
D+YS+GV+ LE++ GK P D ++ + S + + AL +LD RL
Sbjct: 989 SDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRD---ALSSGVLDARLTLEDER 1045
Query: 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
+ +++++++++ C SP +RP+M++V +L
Sbjct: 1046 IVSHMLTVLKIALLCTSVSPVARPSMRQVVLML 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 533 bits (1372), Expect = e-150, Method: Compositional matrix adjust.
Identities = 366/1023 (35%), Positives = 537/1023 (52%), Gaps = 61/1023 (5%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L + +FN+ +GS+P E+ L +L+ L+ N SG IP ++G L S+ L+L N L+
Sbjct: 218 LALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQ 277
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSL-GNLT 120
G IP L L +L +D+ +N L+G I E + L L L+ N L+GS+P ++ N T
Sbjct: 278 GLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNT 337
Query: 121 NLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINAL 180
+L L+L LSG IP EI N + L L +S NTL+G IP SL L L LY+ N+L
Sbjct: 338 SLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSL 397
Query: 181 SGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLK 240
G++ + I NL +L + L +N L G + G L KLEI+YL N SG +P EIGN
Sbjct: 398 EGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCT 457
Query: 241 SLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTL 300
L + N LSG IP S G L L L N L +I +GN + + L N L
Sbjct: 458 RLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQL 517
Query: 301 SGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLT 360
SGSIP S G LT L N+L G++P+ + NL++L+ + S N NGSI G+ +
Sbjct: 518 SGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGS-S 576
Query: 361 KLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKL 420
+S D++ N G IPL T+L L L +N IP+ G + LS+LD+S N L
Sbjct: 577 SYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSL 636
Query: 421 NGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSL 480
+G IP+ L L L + L++N++ G IP GK L +L L++N+ G L E+ SL
Sbjct: 637 SGIIPVELG-LCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSL 695
Query: 481 NQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHL--------- 531
+ L L N+ + SIP+ +GNL L+ LNL NQ S +P+ I KL L
Sbjct: 696 TNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNA 755
Query: 532 ----------------SELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEE 575
S LDLSY F IPS + ++ LE L+LSHN L G + +
Sbjct: 756 LTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGD 815
Query: 576 MHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPC-KAFKSHKQSLK 634
M L +++SYN L+G + + A A GN LCG L C +A +++SL
Sbjct: 816 MKSLGYLNLSYNNLEGKLKKQFSRWQAD--AFVGNAGLCG--SPLSHCNRAGSKNQRSLS 871
Query: 635 KIWIVIVFPL--LGTVALLISLIGLFFN-----FRQRKNGLQTQQSSPRNTLG-LLSVLT 686
+VI+ + L +AL++ +I LFF F++ + G S+ ++ L S
Sbjct: 872 PKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGG 931
Query: 687 FDGKIVHEEIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQE 746
I ++I+ AT ++E IG+GG G VYKAEL GE +AVKK ++ +
Sbjct: 932 AKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKIL--WKDDLMSNKS 989
Query: 747 FLNEGNALTKIRHRNIVKFYGFCSHALH--SFVVYEYLEMGSLAMIL---SNDAAAEEFG 801
F E L IRHR++VK G+CS + ++YEY+ GS+ L N E G
Sbjct: 990 FNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLG 1049
Query: 802 WTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS 861
W R+ G+A + Y+H +C PPIVHRDI S NVLL+ EAH+ DFG++K L
Sbjct: 1050 WETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYD 1109
Query: 862 NRTE----LAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLS 917
TE AG++GYIAPE AY++K TEK DVYS G++ +E++ GK P + + + +
Sbjct: 1110 TNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMV 1169
Query: 918 SNLNIALD---------EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVS 968
+ LD +++D L + L ++ ++E+++ C P RP+ ++ S
Sbjct: 1170 RWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQAS 1229
Query: 969 QLL 971
+ L
Sbjct: 1230 EYL 1232
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 532 bits (1370), Expect = e-150, Method: Compositional matrix adjust.
Identities = 360/992 (36%), Positives = 534/992 (53%), Gaps = 25/992 (2%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L L L++N +G IP EIG+ + L+++ + NQ G IP EI +LS L ++ +N L
Sbjct: 111 LVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLS 170
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
G +P +G+L +L + N L+G +P +G+L L+ R N +G+IP+ +G N
Sbjct: 171 GPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLN 230
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L L L N +SG +P EIG L L ++ + N SG IP +GNLT+L TL + N+L
Sbjct: 231 LKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLV 290
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
G IP+EIGN+KSL L L N L+G+I G L+K+ + N LSG IP E+ +
Sbjct: 291 GPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISE 350
Query: 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLS 301
L L L N L+G IP L L L N+L+ I NL S+ LQL +N+LS
Sbjct: 351 LRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLS 410
Query: 302 GSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTK 361
G IP LG + L + FS N LSG IP I +L L L N + G+IP +
Sbjct: 411 GVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKS 470
Query: 362 LVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
L+ L + N+L+G P L +L+ + L +N +P EIG + L L L++N+ +
Sbjct: 471 LLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFS 530
Query: 422 GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLN 481
++P ++ L+N L +SSN + G IP L +L L+ N G L PELGSL+
Sbjct: 531 SNLPNEISKLSN-LVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLH 589
Query: 482 QLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLS-ELDLSYKI 540
QLE L LS N F +IP ++GNL L L + N FS IP + L L ++LSY
Sbjct: 590 QLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYND 649
Query: 541 FGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFR 600
F EIP ++ ++ L L+L++N+LSG I FE + L + SYN L G +P++ F+
Sbjct: 650 FSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQ 709
Query: 601 DAPMLALQGNKRLC-GDIKRLPPCKAFKSHKQSLK-------KIWIVIVFPLLGTVALLI 652
+ + + GNK LC G ++ P + H SLK +I I++ + G LLI
Sbjct: 710 NMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLI 769
Query: 653 SLIGLFFNFRQRKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATKNFDDEHCIGNG 712
+++ F P + + + + ++I+ ATK F D + +G G
Sbjct: 770 AIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKE-RFTVKDILEATKGFHDSYIVGRG 828
Query: 713 GQGSVYKAELPTGEIVAVKKFH----SPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGF 768
G+VYKA +P+G+ +AVKK F E L KIRHRNIV+ Y F
Sbjct: 829 ACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSF 888
Query: 769 CSH--ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP 826
C H + + ++YEY+ GSL +L + + W R G A+ L Y+H +C P
Sbjct: 889 CYHQGSNSNLLLYEYMSRGSLGELL-HGGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPR 947
Query: 827 IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR-TELAGTFGYIAPELAYTMKVTE 885
I+HRDI S N+L++ +EAHV DFG++K + + LS + +AG++GYIAPE AYTMKVTE
Sbjct: 948 IIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTE 1007
Query: 886 KCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALD-----EMLDPRLPTPLRNV- 939
KCD+YSFGV+ LE++ GK P + + N D E+LDP L +V
Sbjct: 1008 KCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDDVI 1067
Query: 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
+ +I++ ++++ C SP+ RPTM++V +L
Sbjct: 1068 LNHMITVTKIAVLCTKSSPSDRPTMREVVLML 1099
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 531 bits (1368), Expect = e-149, Method: Compositional matrix adjust.
Identities = 390/1118 (34%), Positives = 553/1118 (49%), Gaps = 159/1118 (14%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L+ L L NQ +G IP ++G L +++ L N+L G IP +G L +L L+L S L
Sbjct: 121 LESLFLFSNQLTGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLT 180
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
G IP LG L + + + +N L G IP E+G+ L+ + N LNG+IP+ LG L N
Sbjct: 181 GPIPSQLGRLVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLEN 240
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L L L N+L+G IP ++G + L L + N L G IP SL +L NL TL + N L+
Sbjct: 241 LEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLT 300
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSF-GNLTKLEILYLDVNALSGLIPNEIGNLK 240
G IP E N+ L DL L N LSGS+ S N T LE L L LSG IP E+ +
Sbjct: 301 GEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQ 360
Query: 241 SLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTL 300
SL L L+ N+L+GSIP + L +L L N L ++ I NL +L L L +N L
Sbjct: 361 SLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNL 420
Query: 301 SGSIPLSLGSLTNLATLYFSTNALSGSIPNEITN------------------------LR 336
G +P + +L L L+ N SG IP EI N L+
Sbjct: 421 EGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLK 480
Query: 337 SLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSL 396
L+ L L +N L G +P +LGN +L LDL+ N+LSGSIP SF L L L LY NSL
Sbjct: 481 ELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSL 540
Query: 397 CDSIPKEIGDMKSLSILDLSSNKLNGS-----------------------IPLSLANLTN 433
++P + +++L+ ++LS N+LNG+ IPL L N N
Sbjct: 541 QGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQN 600
Query: 434 SLKVLYLSSNHIVGEIPLGHGKFSSL---------------IQLI---------LNNNEL 469
L L L N + G+IP GK L +QL+ LNNN L
Sbjct: 601 -LDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFL 659
Query: 470 SGQLSPELGSLNQLEYLDLSANTF------------------------HNSIPESLGNLV 505
SG + P LG L+QL L LS+N F + SIP+ +GNL
Sbjct: 660 SGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLG 719
Query: 506 KLHYLNLSNNQFSQKIPNPIEKLIHLSE-------------------------LDLSYKI 540
L+ LNL NQFS +P + KL L E LDLSY
Sbjct: 720 ALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNN 779
Query: 541 FGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFR 600
F +IPS + ++ LE L+LSHN L+G + +M L +++S+N L G + F
Sbjct: 780 FTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKL--KKQFS 837
Query: 601 DAPMLALQGNKRLCGDIKRLPPCKAFKSHKQ----SLKKIWIVIVFPLLGTVALLISLIG 656
P + GN LCG L C +S+ + S + + I+ L + L+I +I
Sbjct: 838 RWPADSFLGNTGLCG--SPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIA 895
Query: 657 LFFN-----FRQRKNGLQTQQSSPRNTLGLLSVLTFDG----KIVHEEIIRATKNFDDEH 707
LFF F++ +G SS ++ L +G I E+I+ AT N +E
Sbjct: 896 LFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEF 955
Query: 708 CIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
IG+GG G VYKAEL GE VAVKK ++ + F E L +IRHR++VK G
Sbjct: 956 MIGSGGSGKVYKAELENGETVAVKKIL--WKDDLMSNKSFSREVKTLGRIRHRHLVKLMG 1013
Query: 768 FCSHALH--SFVVYEYLEMGSLAMILSNDAAAEE-----FGWTKRMNAIKGVADALLYMH 820
+CS + ++YEY++ GS+ L D E W R+ G+A + Y+H
Sbjct: 1014 YCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLH 1073
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTE----LAGTFGYIAPE 876
+C PPIVHRDI S NVLL+ EAH+ DFG++K L T+ A ++GYIAPE
Sbjct: 1074 HDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPE 1133
Query: 877 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFI----SSICSSLSSNLNI---ALDEMLD 929
AY++K TEK DVYS G++ +E++ GK P D + + + ++L + A D+++D
Sbjct: 1134 YAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLID 1193
Query: 930 PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
P+L L +D ++E+++ C SP RP+ ++
Sbjct: 1194 PKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQA 1231
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 520 bits (1340), Expect = e-146, Method: Compositional matrix adjust.
Identities = 353/985 (35%), Positives = 528/985 (53%), Gaps = 38/985 (3%)
Query: 11 QFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGN 70
Q + PP I T L+ L S L+G I EIG S L + L SN L G IP SLG
Sbjct: 93 QLALPFPPNISSFTSLQKLVISNTNLTGAISSEIGDCSELIVIDLSSNSLVGEIPSSLGK 152
Query: 71 LTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMN 130
L +L + + +N L+G IP E+G SL +L + +N L+ ++P LG ++ L ++ N
Sbjct: 153 LKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGN 212
Query: 131 A-LSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIG 189
+ LSG IP+EIGN + L L ++ +SG++P SLG L+ L +L + LSG IP E+G
Sbjct: 213 SELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELG 272
Query: 190 NLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNY 249
N L +L L N LSG++ G L LE + L N L G IP EIG +KSL A+ L+
Sbjct: 273 NCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSM 332
Query: 250 NTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLG 309
N SG+IP SFGNL+ L L +N ++ SI + N L+ Q++ N +SG IP +G
Sbjct: 333 NYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIG 392
Query: 310 SLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSI 369
L L N L G+IP+E+ ++L L LS+N L GS+P L L L L L
Sbjct: 393 LLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLIS 452
Query: 370 NKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLA 429
N +SG IPL + TSL L L N + IPK IG +++LS LDLS N L+G +PL ++
Sbjct: 453 NAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEIS 512
Query: 430 NLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLS 489
N L++L LS+N + G +PL + L L +++N+L+G++ LG L L L LS
Sbjct: 513 N-CRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILS 571
Query: 490 ANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELD----LSYKIFGEEI 545
N+F+ IP SLG+ L L+LS+N S IP E+L + +LD LS+ I
Sbjct: 572 KNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIP---EELFDIQDLDIALNLSWNSLDGFI 628
Query: 546 PSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPML 605
P ++ ++ L L++SHN LSG +S + L ++IS+N G +P+S FR
Sbjct: 629 PERISALNRLSVLDISHNMLSGDLS-ALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGA 687
Query: 606 ALQGNKRLCGDIKR---------LPPCKAFKSHKQSLKKIWIVIVFPLLGTVALLISLIG 656
++GN LC R L + SH+ + I LL +V +++++G
Sbjct: 688 EMEGNNGLCSKGFRSCFVSNSSQLTTQRGVHSHR-------LRIAIGLLISVTAVLAVLG 740
Query: 657 LFFNFRQRKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATKNFDDEHCIGNGGQGS 716
+ R ++ S L F + ++ + K + + IG G G
Sbjct: 741 VLAVIRAKQMIRDDNDSETGENLWTWQFTPF--QKLNFTVEHVLKCLVEGNVIGKGCSGI 798
Query: 717 VYKAELPTGEIVAVKK-FHSPLPG------EMACQQEFLNEGNALTKIRHRNIVKFYGFC 769
VYKAE+P E++AVKK + +P + F E L IRH+NIV+F G C
Sbjct: 799 VYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCC 858
Query: 770 SHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVH 829
+ ++Y+Y+ GSL +L + GW R I G A L Y+H +C PPIVH
Sbjct: 859 WNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVH 918
Query: 830 RDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTE--LAGTFGYIAPELAYTMKVTEKC 887
RDI + N+L+ ++E ++ DFG++K + G R+ +AG++GYIAPE Y+MK+TEK
Sbjct: 919 RDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKS 978
Query: 888 DVYSFGVLALEVIKGKHPRD-FISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISI 946
DVYS+GV+ LEV+ GK P D I + I +++D L + ++++
Sbjct: 979 DVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWVKKIRDIQVIDQGLQARPESEVEEMMQT 1038
Query: 947 MEVSISCLDESPTSRPTMQKVSQLL 971
+ V++ C++ P RPTM+ V+ +L
Sbjct: 1039 LGVALLCINPIPEDRPTMKDVAAML 1063
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 517 bits (1332), Expect = e-145, Method: Compositional matrix adjust.
Identities = 352/1004 (35%), Positives = 523/1004 (52%), Gaps = 79/1004 (7%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L+ L +S +G++P +G LK+L S N L G IP + +L +L L L SN L
Sbjct: 107 LQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLT 166
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRL-SNNSLNGSIPSSLGNLT 120
G IPP + + L + + +NLL+GSIP E+G L L +R+ N ++G IPS +G+ +
Sbjct: 167 GKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCS 226
Query: 121 NLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINAL 180
NL L L ++SG++P +G LK L L + +SG IP LGN + LV L++ N+L
Sbjct: 227 NLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSL 286
Query: 181 SGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLK 240
SGSIP EIG L L L L N+L G I GN + L+++ L +N LSG IP+ IG L
Sbjct: 287 SGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLS 346
Query: 241 SLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTL 300
L ++ N SGSIP + N + LV L N +S I E+G L L N L
Sbjct: 347 FLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQL 406
Query: 301 SGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLT 360
GSIP L T+L L S N+L+G+IP+ + LR+L+ L L N+L+G IP +GN +
Sbjct: 407 EGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCS 466
Query: 361 KLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKL 420
LV L L N+++G IP SL + L N L +P EIG L ++DLS+N L
Sbjct: 467 SLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSL 526
Query: 421 NGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSL 480
GS+P +++L+ L+VL +S+N G+IP G+ SL +LIL+ N SG + LG
Sbjct: 527 EGSLPNPVSSLS-GLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMC 585
Query: 481 NQLEYLDLSANTFHNSIPESLGNLVKLHY-LNLSNNQFSQKIPNPIEKLIHLSELDLSYK 539
+ L+ LDL +N IP LG++ L LNLS+N+ + KIP
Sbjct: 586 SGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIP----------------- 628
Query: 540 IFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAF 599
S++ S+ L L+LSHN L G ++ + L ++ISYN+ G +P++ F
Sbjct: 629 -------SKIASLNKLSILDLSHNMLEGDLAP-LANIENLVSLNISYNSFSGYLPDNKLF 680
Query: 600 RDAPMLALQGNKRLC--------------------GDIKRLPPCKAFKSHKQSLKKIWIV 639
R L+GNK+LC GD R K I +
Sbjct: 681 RQLSPQDLEGNKKLCSSTQDSCFLTYRKGNGLGDDGDASR-----TRKLRLTLALLITLT 735
Query: 640 IVFPLLGTVALLISLIGLFFNFRQRKNGLQTQQSSPRNTLGLLSVLTFDG-KIVHEEIIR 698
+V +LG VA++ R R+N + ++ S F ++IIR
Sbjct: 736 VVLMILGAVAVI----------RARRN-IDNERDSELGETYKWQFTPFQKLNFSVDQIIR 784
Query: 699 ATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPL------PGEMACQQEFLNEGN 752
+ + IG G G VY+A++ GE++AVKK + + F E
Sbjct: 785 C---LVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVK 841
Query: 753 ALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGV 812
L IRH+NIV+F G C + ++Y+Y+ GSL +L ++ W R + G
Sbjct: 842 TLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL-HERRGSSLDWDLRYRILLGA 900
Query: 813 ADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTE--LAGTF 870
A L Y+H +C PPIVHRDI + N+L+ L++E +++DFG++K + G R +AG++
Sbjct: 901 AQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSY 960
Query: 871 GYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNL--NIALDEML 928
GYIAPE Y+MK+TEK DVYS+GV+ LEV+ GK P D L + N E+L
Sbjct: 961 GYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNRGSLEVL 1020
Query: 929 DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
D L + D+++ ++ ++ C++ SP RPTM+ V+ +LK
Sbjct: 1021 DSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLK 1064
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 489 bits (1259), Expect = e-137, Method: Compositional matrix adjust.
Identities = 382/1112 (34%), Positives = 546/1112 (49%), Gaps = 153/1112 (13%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L+ L L+ NQFSG IPPEI +L HL+ L S N L+GL+P + L L L L N
Sbjct: 91 LRELCLAGNQFSGKIPPEIWNLKHLQTLDLSGNSLTGLLPRLLSELPQLLYLDLSDNHFS 150
Query: 62 GSIPPSLG-NLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLT 120
GS+PPS +L +L +D+ NN LSG IP E+G L +LS+L + NS +G IPS +GN++
Sbjct: 151 GSLPPSFFISLPALSSLDVSNNSLSGEIPPEIGKLSNLSNLYMGLNSFSGQIPSEIGNIS 210
Query: 121 NLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINAL 180
L +G +P EI LK L+ L +SYN L +IP S G L NL L + L
Sbjct: 211 LLKNFAAPSCFFNGPLPKEISKLKHLAKLDLSYNPLKCSIPKSFGELHNLSILNLVSAEL 270
Query: 181 SGSIPNEIGNLKSLSDLRLDYNTLSGSI--------LYSF---------------GNLTK 217
G IP E+GN KSL L L +N+LSG + L +F G
Sbjct: 271 IGLIPPELGNCKSLKSLMLSFNSLSGPLPLELSEIPLLTFSAERNQLSGSLPSWMGKWKV 330
Query: 218 LEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIP---CSFGNLTKLVIS----- 269
L+ L L N SG IP+EI + L L L N LSGSIP C G+L + +S
Sbjct: 331 LDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLS 390
Query: 270 ---------C-------LGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTN 313
C L N ++ SI E++ L L+ L L+ N +G IP SL TN
Sbjct: 391 GTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKL-PLMALDLDSNNFTGEIPKSLWKSTN 449
Query: 314 LATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLS 373
L S N L G +P EI N SL L LS+N L G IP +G LT L L+L+ N
Sbjct: 450 LMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLTSLSVLNLNANMFQ 509
Query: 374 GSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTN 433
G IP+ TSLTTL L N+L IP +I + L L LS N L+GSIP + +
Sbjct: 510 GKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGSIPSKPSAYFH 569
Query: 434 SLK-----------VLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQ 482
++ + LS N + G IP G+ L+++ L+NN LSG++ L L
Sbjct: 570 QIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTN 629
Query: 483 LEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPN------------------- 523
L LDLS N SIP+ +GN +KL LNL+NNQ + IP
Sbjct: 630 LTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLD 689
Query: 524 -PIEK----LIHLSELDLSY------------------------KIFGEEIPSQVCSMQS 554
P+ L L+ +DLS+ F EIPS++ ++
Sbjct: 690 GPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQ 749
Query: 555 LEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLC 614
LE L++S N LSG I + L ++++ N L+G +P+ +D L GNK LC
Sbjct: 750 LEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELC 809
Query: 615 GDIKRLPPCKAFKSHKQSLKKIWIVIVFPLLGTVALLISLIGLFF-----NFRQRKNGLQ 669
G + CK L+ W + L T+ + + + L +QR + +
Sbjct: 810 GRVVG-SDCKI---EGTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPER 865
Query: 670 TQQSSPRNTLGL---------------LSVLTFDG---KIVHEEIIRATKNFDDEHCIGN 711
++S + + +++ F+ K+ +I+ AT +F ++ IG+
Sbjct: 866 MEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGD 925
Query: 712 GGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH 771
GG G+VYKA LP + VAVKK + +EF+ E L K++H N+V G+CS
Sbjct: 926 GGFGTVYKACLPGEKTVAVKKLSE---AKTQGNREFMAEMETLGKVKHPNLVSLLGYCSF 982
Query: 772 ALHSFVVYEYLEMGSLAMILSNDAAA-EEFGWTKRMNAIKGVADALLYMHTNCFPPIVHR 830
+ +VYEY+ GSL L N E W+KR+ G A L ++H P I+HR
Sbjct: 983 SEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHR 1042
Query: 831 DISSKNVLLNLEYEAHVSDFGISKFLKLGLSN-RTELAGTFGYIAPELAYTMKVTEKCDV 889
DI + N+LL+ ++E V+DFG+++ + S+ T +AGTFGYI PE + + T K DV
Sbjct: 1043 DIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYIPPEYGQSARATTKGDV 1102
Query: 890 YSFGVLALEVIKGKHPR--DFISSICSSLSS------NLNIALDEMLDPRL-PTPLRNVQ 940
YSFGV+ LE++ GK P DF S +L N A+D ++DP L L+N Q
Sbjct: 1103 YSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVD-VIDPLLVSVALKNSQ 1161
Query: 941 DKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ ++++++ CL E+P RP M V + LK
Sbjct: 1162 ---LRLLQIAMLCLAETPAKRPNMLDVLKALK 1190
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 973 | ||||||
| 225456159 | 1038 | PREDICTED: probable LRR receptor-like se | 0.923 | 0.866 | 0.524 | 0.0 | |
| 147767326 | 1032 | hypothetical protein VITISV_008862 [Viti | 0.924 | 0.872 | 0.517 | 0.0 | |
| 359491509 | 1032 | PREDICTED: probable LRR receptor-like se | 0.924 | 0.872 | 0.515 | 0.0 | |
| 359491512 | 1078 | PREDICTED: probable LRR receptor-like se | 0.917 | 0.828 | 0.505 | 0.0 | |
| 147772402 | 996 | hypothetical protein VITISV_022117 [Viti | 0.934 | 0.912 | 0.490 | 0.0 | |
| 297846638 | 1123 | hypothetical protein ARALYDRAFT_473694 [ | 0.982 | 0.851 | 0.450 | 0.0 | |
| 357439013 | 1131 | Receptor protein kinase-like protein [Me | 0.991 | 0.853 | 0.463 | 0.0 | |
| 225456161 | 1037 | PREDICTED: probable LRR receptor-like se | 0.955 | 0.896 | 0.477 | 0.0 | |
| 359484864 | 1091 | PREDICTED: probable LRR receptor-like se | 0.968 | 0.863 | 0.481 | 0.0 | |
| 356577797 | 1204 | PREDICTED: probable LRR receptor-like se | 0.992 | 0.802 | 0.468 | 0.0 |
| >gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 861 bits (2225), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/933 (52%), Positives = 623/933 (66%), Gaps = 34/933 (3%)
Query: 67 SLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLY 126
S + +L Y+DI N LSG IP ++G L L L LS N +G IPS +G LTNL L+
Sbjct: 108 SFSSFPNLAYVDISMNNLSGPIPPQIGLLFELKYLDLSINQFSGGIPSEIGLLTNLEVLH 167
Query: 127 LHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPN 186
L N L+GSIP EIG L L +L + N L G+IP SLGNL+NL +LY+ N LSGSIP
Sbjct: 168 LVQNQLNGSIPHEIGQLASLYELALYTNQLEGSIPASLGNLSNLASLYLYENQLSGSIPP 227
Query: 187 EIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQ 246
E+GNL +L ++ + N L+G I +FGNL +L +LYL N+LSG IP EIGNLKSL L
Sbjct: 228 EMGNLTNLVEIYSNNNNLTGPIPSTFGNLKRLTVLYLFNNSLSGPIPPEIGNLKSLQELS 287
Query: 247 LNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPL 306
L N LSG IP S +L+ L + L N LS I +EIGNLKSL+ L+L+ N L+GSIP
Sbjct: 288 LYENNLSGPIPVSLCDLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPT 347
Query: 307 SLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLD 366
SLG+LTNL L+ N LSG IP EI L L L++ N L GS+P + LV
Sbjct: 348 SLGNLTNLEILFLRDNQLSGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGICQAGSLVRFA 407
Query: 367 LSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN----- 421
+S N LSG IP S + +LT N L +I + +GD +L +DLS N+ +
Sbjct: 408 VSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGNISEVVGDCPNLEFIDLSYNRFHGELSH 467
Query: 422 -------------------GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQL 462
GSIP TN L +L LSSNH+VGEIP G +SL+ L
Sbjct: 468 NWGRCPQLQRLEIAGNNITGSIPEDFGISTN-LTLLDLSSNHLVGEIPKKMGSLTSLLGL 526
Query: 463 ILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIP 522
ILN+N+LSG + PELGSL+ LEYLDLSAN + SIPE LG+ + LHYLNLSNN+ S IP
Sbjct: 527 ILNDNQLSGSIPPELGSLSHLEYLDLSANRLNGSIPEHLGDCLDLHYLNLSNNKLSHGIP 586
Query: 523 NPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCI 582
+ KL HLS+LDLS+ + IP Q+ +QSLE L+LSHNNL G I + FE+M LS +
Sbjct: 587 VQMGKLSHLSQLDLSHNLLAGGIPPQIQGLQSLEMLDLSHNNLCGFIPKAFEDMPALSYV 646
Query: 583 DISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPCK-AFKSHKQSLK---KIWI 638
DISYN LQG IP+S AFR+A + L+GNK LCG++K L PCK F +Q +K K+
Sbjct: 647 DISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGNVKGLQPCKYGFGVDQQPVKKSHKVVF 706
Query: 639 VIVFPLLGTVALLISLIGLFFNFRQRKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIR 698
+I+FPLLG + LL + IG+F +R+ + ++ +N L S+ FDG+ ++EEII+
Sbjct: 707 IIIFPLLGALVLLFAFIGIFLIAERRERTPEIEEGDVQND--LFSISNFDGRTMYEEIIK 764
Query: 699 ATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
ATK+FD +CIG GG GSVYKAELP+ IVAVKK H P EMA Q++FLNE ALT+I+
Sbjct: 765 ATKDFDPMYCIGKGGHGSVYKAELPSSNIVAVKKLH-PSDTEMANQKDFLNEIRALTEIK 823
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLY 818
HRNIVK GFCSH H F+VYEYLE GSLA ILS + A++ GW R+N IKGVA AL Y
Sbjct: 824 HRNIVKLLGFCSHPRHKFLVYEYLERGSLATILSRE-EAKKLGWATRVNIIKGVAHALAY 882
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELA 878
MH +C PPIVHRD+SS N+LL+ +YEAH+SDFG +K LKL SN++ LAGTFGY+APELA
Sbjct: 883 MHHDCSPPIVHRDVSSNNILLDSQYEAHISDFGTAKLLKLDSSNQSILAGTFGYLAPELA 942
Query: 879 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938
YTMKVTEK DV+SFGV+ALEVIKG+HP D I S+ S + NIAL++MLDPRLP
Sbjct: 943 YTMKVTEKTDVFSFGVIALEVIKGRHPGDQILSLSVSPEKD-NIALEDMLDPRLPPLTPQ 1001
Query: 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
+ ++I+I++ +I CL +P SRPTMQ VSQ+L
Sbjct: 1002 DEGEVIAILKQAIECLKANPQSRPTMQTVSQML 1034
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2153), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 481/929 (51%), Positives = 611/929 (65%), Gaps = 29/929 (3%)
Query: 67 SLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLY 126
S + +L Y DI N LSG IP ++G L L L LS N +G IPS +G LTNL L+
Sbjct: 105 SFSSFPNLAYFDINMNKLSGPIPPQIGFLSKLKYLDLSTNQFSGRIPSEIGLLTNLEVLH 164
Query: 127 LHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPN 186
L N L+GSIP EIG LK L DL + N L G+IP SLGNL+NL LY+ N LSG IP
Sbjct: 165 LVENQLNGSIPHEIGQLKSLCDLSLYTNKLEGSIPASLGNLSNLTNLYLDENKLSGLIPP 224
Query: 187 EIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQ 246
E+GNL L +L L+ N L+G I + GNL L +L L N LSG IP EIGNLK L L
Sbjct: 225 EMGNLTKLVELCLNANNLTGPIPSTLGNLKSLTLLRLYNNQLSGPIPTEIGNLKHLRNLS 284
Query: 247 LNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPL 306
L+ N LSG IP S G+L+ L L N LS I +E+GNL+SL+ L+++ N L+GSIP
Sbjct: 285 LSSNYLSGPIPMSLGDLSGLKSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPT 344
Query: 307 SLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLN----------------- 349
SLG+L NL LY N LS SIP EI L L +L++ N L+
Sbjct: 345 SLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLENFT 404
Query: 350 -------GSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPK 402
G IP +L N L L N+L+G+I +F +L + L N + +
Sbjct: 405 VFDNFLIGPIPESLKNCPSLARARLQRNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQ 464
Query: 403 EIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQL 462
G L LD++ N + GSIP ++ L VL LSSNH+VGEIP G SSL +L
Sbjct: 465 NWGRCHKLQWLDIAGNNITGSIPADFG-ISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKL 523
Query: 463 ILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIP 522
ILN+N LSG + PELGSL L YLDLS N + SIPE LGN + L+YLNLSNN+ S IP
Sbjct: 524 ILNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIP 583
Query: 523 NPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCI 582
+ KL HLS LDLS+ + EIPSQ+ +QSLEKLNLSHNNLSG I + FE+MH L +
Sbjct: 584 VQMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLWQV 643
Query: 583 DISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPCKAFKSHKQSLKKIWIVIVF 642
DISYN LQG IPNS AF++ + LQGNK LCG +K L PC+ + K + K ++I I+F
Sbjct: 644 DISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGLQPCENRSATKGTHKAVFI-IIF 702
Query: 643 PLLGTVALLISLIGLFFNFRQRKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATKN 702
LLG + +L + IG+ + R+N + +++ T L S+ TFDG+ +E II ATK+
Sbjct: 703 SLLGALLILSAFIGISLISQGRRNA-KMEKAGDVQTENLFSISTFDGRTTYEAIIEATKD 761
Query: 703 FDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
FD +CIG GG GSVYKAELP+G IVAVKK H +MA Q++F+NE ALT+I+HRNI
Sbjct: 762 FDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHR-FDIDMAHQKDFMNEIRALTEIKHRNI 820
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTN 822
VK GFCSH+ HSF+VYEYLE GSL ILS + A+E GW R+N IKGVA AL Y+H +
Sbjct: 821 VKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWGTRVNIIKGVAHALSYLHHD 880
Query: 823 CFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMK 882
C PPIVHRDISS NVLL+ +YEAHVSDFG +KFLKL SN + LAGT+GY+APELAYTMK
Sbjct: 881 CVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNWSTLAGTYGYVAPELAYTMK 940
Query: 883 VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDK 942
VTEKCDVYSFGVLALEV++G+HP D ISS+ +S + N+ L ++LDPRLP P + +
Sbjct: 941 VTEKCDVYSFGVLALEVMRGRHPGDLISSLSASPGKD-NVVLKDVLDPRLPPPTLRDEAE 999
Query: 943 LISIMEVSISCLDESPTSRPTMQKVSQLL 971
++S+++++ +CL+ SP SRPTMQ VSQ+L
Sbjct: 1000 VMSVIQLATACLNGSPQSRPTMQMVSQML 1028
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 826 bits (2133), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/929 (51%), Positives = 607/929 (65%), Gaps = 29/929 (3%)
Query: 67 SLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLY 126
S + +L Y DI N LSG IP ++G L L L LS N +G IPS +G LTNL L+
Sbjct: 105 SFSSFPNLAYFDINMNKLSGPIPPQIGFLSKLKYLDLSTNQFSGRIPSEIGLLTNLEVLH 164
Query: 127 LHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPN 186
L N L+GSIP EIG LK L DL + N L G IP SLGNL+NL LY+ N LSG IP
Sbjct: 165 LVENQLNGSIPHEIGQLKSLCDLSLYTNKLEGTIPASLGNLSNLTNLYLDENKLSGLIPP 224
Query: 187 EIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQ 246
E+GNL L +L L+ N L+G I + GNL L +L L N LSG IP EIGNLK L L
Sbjct: 225 EMGNLTKLVELCLNANNLTGPIPSTLGNLKSLTLLRLYNNQLSGPIPTEIGNLKHLRNLS 284
Query: 247 LNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPL 306
L+ N LSG IP S G+L+ L L N LS I +E+GNL+SL+ L+++ N L+GSIP
Sbjct: 285 LSSNYLSGPIPMSLGDLSGLKSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPT 344
Query: 307 SLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLN----------------- 349
LG+L NL LY N LS SIP EI L L +L++ N L+
Sbjct: 345 LLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLENFT 404
Query: 350 -------GSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPK 402
G IP +L N L L N+L+G+I +F +L + L N + +
Sbjct: 405 VFDNFLIGPIPESLKNCPSLARARLQGNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQ 464
Query: 403 EIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQL 462
G L LD++ N + GSIP ++ L VL LSSNH+VGEIP G SSL +L
Sbjct: 465 NWGRCHKLQWLDIAGNNITGSIPADFG-ISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKL 523
Query: 463 ILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIP 522
ILN+N LSG + PELGSL L YLDLS N + SIPE LGN + L+YLNLSNN+ S IP
Sbjct: 524 ILNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIP 583
Query: 523 NPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCI 582
+ KL HLS LDLS+ + EIPSQ+ +QSLEKLNLSHNNLSG I + FE+MH L +
Sbjct: 584 VQMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLWQV 643
Query: 583 DISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPCKAFKSHKQSLKKIWIVIVF 642
DISYN LQG IPNS AF++ + LQGNK LCG +K L PC+ + K + K ++I I+F
Sbjct: 644 DISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGLQPCENRSATKGTHKAVFI-IIF 702
Query: 643 PLLGTVALLISLIGLFFNFRQRKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATKN 702
LLG + +L + IG+ + R+N + +++ T L S+ TFDG+ +E II ATK+
Sbjct: 703 SLLGALLILSAFIGISLISQGRRNA-KMEKAGDVQTENLFSISTFDGRTTYEAIIEATKD 761
Query: 703 FDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
FD +CIG GG GSVYKAELP+G IVAVKK H +MA Q++F+NE ALT+I+HRNI
Sbjct: 762 FDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHR-FDIDMAHQKDFVNEIRALTEIKHRNI 820
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTN 822
VK GFCSH+ HSF+VYEYLE GSL ILS + A+E GW R+N IKGV+ AL Y+H +
Sbjct: 821 VKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWGTRVNIIKGVSHALSYLHHD 880
Query: 823 CFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMK 882
C PPIVHRDISS NVLL+ +YEAHVSDFG +KFLKL SN + LAGT+GY+APELAYTMK
Sbjct: 881 CVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNWSTLAGTYGYVAPELAYTMK 940
Query: 883 VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDK 942
VTEKCDVYSFGVLALEV++G+HP D ISS+ S + N+ L ++LDPRLP P + +
Sbjct: 941 VTEKCDVYSFGVLALEVMRGRHPGDLISSLSDSPGKD-NVVLKDVLDPRLPPPTFRDEAE 999
Query: 943 LISIMEVSISCLDESPTSRPTMQKVSQLL 971
+ S+++++ +CL+ SP SRPTMQ VSQ+L
Sbjct: 1000 VTSVIQLATACLNGSPQSRPTMQMVSQML 1028
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491512|ref|XP_002278614.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 805 bits (2079), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 471/931 (50%), Positives = 606/931 (65%), Gaps = 38/931 (4%)
Query: 73 SLIYIDIGNNLLSGSIPN-EVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNA 131
S+I I++ + L G++ S +L+ + + N+L+G IP +G L+ L L L N
Sbjct: 117 SVIRINLTESGLRGTLQAFSFSSFPNLAYVDVCINNLSGPIPPQIGLLSKLKYLDLSTNQ 176
Query: 132 LSGSIPDEIG---NLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEI 188
SG IP EIG NL+ L L + N L G+IP SLGNL+NL +LY+ N LSGSIP E+
Sbjct: 177 FSGGIPPEIGLLTNLEVLHLLALYTNQLEGSIPASLGNLSNLASLYLYENQLSGSIPPEM 236
Query: 189 GNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLN 248
GNL +L ++ D N L+G I +FGNL +L LYL N LSG IP EIGNL SL + L
Sbjct: 237 GNLANLVEIYSDTNNLTGLIPSTFGNLKRLTTLYLFNNQLSGHIPPEIGNLTSLQGISLY 296
Query: 249 YNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSL 308
N LSG IP S G+L+ L + L N LS I EIGNLKSL+ L+L+ N L+GSIP SL
Sbjct: 297 ANNLSGPIPASLGDLSGLTLLHLYANQLSGPIPPEIGNLKSLVDLELSENQLNGSIPTSL 356
Query: 309 GSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLS 368
G+LTNL L+ N LSG P EI L L L++ N L+GS+P + LV +S
Sbjct: 357 GNLTNLEILFLRDNHLSGYFPKEIGKLHKLVVLEIDTNRLSGSLPEGICQGGSLVRFTVS 416
Query: 369 INKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNG------ 422
N LSG IP S + +LT N L +I + +GD +L +DLS N+ +G
Sbjct: 417 DNLLSGPIPKSMKNCRNLTRALFGGNQLTGNISEVVGDCPNLEYIDLSYNRFHGELSHNW 476
Query: 423 ------------------SIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLIL 464
SIP TN L +L LSSNH+VGEIP G +SL++L L
Sbjct: 477 GRCPQLQRLEMAGNDITGSIPEDFGISTN-LTLLDLSSNHLVGEIPKKMGSLTSLLELKL 535
Query: 465 NNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNP 524
N+N+LSG + PELGSL L +LDLSAN + SI E+LG + LHYLNLSNN+ S +IP
Sbjct: 536 NDNQLSGSIPPELGSLFSLAHLDLSANRLNGSITENLGACLNLHYLNLSNNKLSNRIPAQ 595
Query: 525 IEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDI 584
+ KL HLS+LDLS+ + EIP Q+ ++SLE LNLSHNNLSG I + FEEM LS IDI
Sbjct: 596 MGKLSHLSQLDLSHNLLSGEIPPQIEGLESLENLNLSHNNLSGFIPKAFEEMRGLSDIDI 655
Query: 585 SYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPCK----AFKSHKQSLKKIWIVI 640
SYN LQG IPNS AFRDA + L+GNK LCG++K L PCK A + + KI +I
Sbjct: 656 SYNQLQGPIPNSKAFRDATIELLKGNKDLCGNVKGLQPCKNDSGAGQQPVKKGHKIVFII 715
Query: 641 VFPLLGTVALLISLIGLFFNFRQRKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRAT 700
VFPLLG + LL + IG+F + K + ++ +N L S+ TFDG+ ++EEII+AT
Sbjct: 716 VFPLLGALVLLFAFIGIFLIAERTKRTPEIEEGDVQND--LFSISTFDGRAMYEEIIKAT 773
Query: 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
K+FD +CIG GG GSVYKAEL +G IVAVKK ++ +MA Q++F NE ALT+I+HR
Sbjct: 774 KDFDPMYCIGKGGHGSVYKAELSSGNIVAVKKLYAS-DIDMANQRDFFNEVRALTEIKHR 832
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMH 820
NIVK GFCSH HSF+VYEYLE GSLA +LS + A++ GW R+N IKGVA AL YMH
Sbjct: 833 NIVKLLGFCSHPRHSFLVYEYLERGSLAAMLSRE-EAKKLGWATRINIIKGVAHALSYMH 891
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYT 880
+C PPIVHRDISS N+LL+ +YE H+SDFG +K LKL SN++ LAGTFGY+APE AYT
Sbjct: 892 HDCSPPIVHRDISSNNILLDSQYEPHISDFGTAKLLKLDSSNQSALAGTFGYVAPEHAYT 951
Query: 881 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940
MKVTEK DVYSFGV+ LEVIKG+HP D I S+ S NI L++MLDPRLP +
Sbjct: 952 MKVTEKTDVYSFGVITLEVIKGRHPGDQILSLSVSPEKE-NIVLEDMLDPRLPPLTAQDE 1010
Query: 941 DKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
++ISI+ ++ +CL +P SRPTM+ +SQ+L
Sbjct: 1011 GEVISIINLATACLSVNPESRPTMKIISQML 1041
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147772402|emb|CAN73988.1| hypothetical protein VITISV_022117 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 798 bits (2060), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 474/967 (49%), Positives = 603/967 (62%), Gaps = 58/967 (5%)
Query: 9 FNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSL 68
N SG IPP+IG L+ LK L S NQ SG IP EIG L++L L L N
Sbjct: 80 MNNLSGPIPPQIGLLSELKYLDLSINQFSGGIPSEIGLLTNLEVLHLVQN---------- 129
Query: 69 GNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLH 128
L+GSIP+E+G L SL +L L N L GSIP+SLGNL+NL LYL+
Sbjct: 130 --------------QLNGSIPHEIGQLASLYELALYTNQLEGSIPASLGNLSNLAYLYLY 175
Query: 129 MNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEI 188
N LS SIP E+GNL L ++ N L G IP + GNL L LY+ N LSG IP EI
Sbjct: 176 ENQLSDSIPPEMGNLTNLVEIYSDTNNLIGPIPSTFGNLKRLTVLYLFNNRLSGHIPPEI 235
Query: 189 GNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLN 248
GNLKSL L L N LSG I S G+L+ L +L+L N LSG IP EIGNLKSL+ L+L+
Sbjct: 236 GNLKSLQGLSLYENNLSGPIPASLGDLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELS 295
Query: 249 YNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSL 308
N L+GSIP S GNLT L L N LS I +EIG L L+ L+++ N L GS+P +
Sbjct: 296 ENQLNGSIPTSLGNLTNLETLFLRDNQLSGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGI 355
Query: 309 GSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLS 368
+L S N LSG IP + N ++L+ N L G+I +G+ L +++S
Sbjct: 356 CQGGSLERFTVSDNHLSGPIPKSLKNCKNLTRALFGGNQLTGNISEVVGDCPNLEYINVS 415
Query: 369 INKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSL 428
N G + ++ L L + N++ SIP++ G L++LDLSSN L G IP +
Sbjct: 416 YNSFHGELSHNWGRYPRLQRLEMAWNNITGSIPEDFGISTDLTLLDLSSNHLFGEIPKKM 475
Query: 429 ANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDL 488
++T SL L L+ N + G IP G + L L L+ N L+G + LG L YL+L
Sbjct: 476 GSVT-SLWKLILNDNQLSGNIPPELGSLADLGYLDLSANRLNGSIPEHLGDCLGLNYLNL 534
Query: 489 SANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQ 548
S N + IP +G L L L+LS+N + IP IE L
Sbjct: 535 SNNKLSHGIPVQMGKLGHLSQLDLSHNLLTGDIPPQIEGL-------------------- 574
Query: 549 VCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQ 608
QSLE LNLSHNNLSG I + FEEM LS +DISYN LQG IPNS AFRDA + AL+
Sbjct: 575 ----QSLENLNLSHNNLSGFIPKAFEEMLGLSDVDISYNQLQGPIPNSKAFRDATIEALK 630
Query: 609 GNKRLCGDIKRLPPCKAFKS-HKQSLK---KIWIVIVFPLLGTVALLISLIGLFFNFRQR 664
GNK LCG++KRL PCK +Q +K K+ +I+FPLLG + LL + IG+F +R
Sbjct: 631 GNKGLCGNVKRLRPCKYGSGVDQQPVKKSHKVVFIIIFPLLGALVLLFAFIGIFLIAARR 690
Query: 665 KNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATKNFDDEHCIGNGGQGSVYKAELPT 724
+ + ++ +N L S+ TFDG+ ++EEII+ATK+FD +CIG GG GSVYKAELP+
Sbjct: 691 ERTPEIKEGEVQND--LFSISTFDGRTMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPS 748
Query: 725 GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 784
IVAVKK H P EMA Q++FLNE ALT+I+HRNIVK GFCSH H F+VYEYLE
Sbjct: 749 SNIVAVKKLH-PSDTEMANQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLER 807
Query: 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYE 844
GSLA ILS + A++ GW R+N IKGVA AL YMH +C PPIVHRDISS N+LL+ +YE
Sbjct: 808 GSLATILSRE-EAKKLGWATRVNIIKGVAHALAYMHHDCSPPIVHRDISSNNILLDSQYE 866
Query: 845 AHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 904
AH+SDFG +K LKL SN++ LAGTFGY+APELAYTMKVTEK DV+SFGV+ALEVIKG+H
Sbjct: 867 AHISDFGTAKLLKLDSSNQSILAGTFGYLAPELAYTMKVTEKTDVFSFGVIALEVIKGRH 926
Query: 905 PRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTM 964
P D I S+ S + NIAL++MLDPRLP + ++I+I++ + CL +P SRPTM
Sbjct: 927 PGDQILSLSVSPEKD-NIALEDMLDPRLPPLTPQDEGEVIAIIKQATECLKANPQSRPTM 985
Query: 965 QKVSQLL 971
Q VSQ+L
Sbjct: 986 QTVSQML 992
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297846638|ref|XP_002891200.1| hypothetical protein ARALYDRAFT_473694 [Arabidopsis lyrata subsp. lyrata] gi|297337042|gb|EFH67459.1| hypothetical protein ARALYDRAFT_473694 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 797 bits (2059), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/1024 (45%), Positives = 633/1024 (61%), Gaps = 68/1024 (6%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L + LS N+FSG+IPP+ G+L+ L S N L+ IP +G L +L L L+ N+L
Sbjct: 107 LASIDLSMNRFSGTIPPQFGNLSKLIYFDLSTNHLTREIPPSLGNLKNLTVLDLHHNYLT 166
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLS---------------------- 99
G IPP LGN+ S+ Y+++ +N L+GSIP+ +G+LK+L+
Sbjct: 167 GVIPPDLGNMESMTYLELSHNKLTGSIPSSLGNLKNLTVLYLYQNYLTGVIPPELGNMES 226
Query: 100 --DLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLS 157
DL LS N L GSIPSSLGNL NL LYLH N L+G IP E+GN++ + DL++S N L+
Sbjct: 227 MIDLELSTNKLTGSIPSSLGNLKNLTVLYLHHNYLTGVIPPELGNMESMIDLELSDNKLT 286
Query: 158 GAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTK 217
G+IP SLGNL NL LY+ N L+G IP E+GN++S++ L L N L+GSI S GNL
Sbjct: 287 GSIPSSLGNLKNLTVLYLYKNYLTGVIPPELGNMESMTYLDLSENKLTGSIPSSLGNLKN 346
Query: 218 LEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALS 277
L +LYL N L+G+IP E+GNL+S++ L+L+ N L+GSIP S GNL L + L N L+
Sbjct: 347 LTVLYLHHNYLTGVIPPELGNLESMIDLELSDNKLTGSIPSSLGNLKNLTVLYLHHNYLT 406
Query: 278 SSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRS 337
I E+GN++S++ L L+ N L+GSIP S G+ T L +LY N LSG+IP + N
Sbjct: 407 GVIPPELGNMESMIDLALSQNNLTGSIPSSFGNFTKLESLYLRDNHLSGTIPRGVANSSE 466
Query: 338 LSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLC 397
L++L L N G +P + KL + L N L G IP S SL N
Sbjct: 467 LTELLLDINNFTGFLPENICKGGKLQNFSLDYNHLEGHIPKSLRDCKSLIRAKFVGNKFI 526
Query: 398 DSIPKEIGDMKSLSILDLSSNKLNG------------------------SIPLSLANLTN 433
+I + G L +DLS NK NG +IP + N+
Sbjct: 527 GNISEAFGVYPDLDFIDLSHNKFNGEISSNWQKSPKLGALIMSNNNITGAIPPEIWNM-K 585
Query: 434 SLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTF 493
L L LS+N++ GE+P G + L +L+LN N+LSG++ L L LE LDLS+N F
Sbjct: 586 QLGELDLSTNNLTGELPEAIGNLTGLSKLLLNGNKLSGRVPTGLSFLTNLESLDLSSNRF 645
Query: 494 HNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQ 553
+ IP++ + +KLH +NLS N F +IP + KL L+ LDLS+ EIPSQ+ S+Q
Sbjct: 646 SSQIPQTFDSFLKLHEMNLSKNNFDGRIPG-LTKLTQLTHLDLSHNQLDGEIPSQLSSLQ 704
Query: 554 SLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRL 613
SL+KLNLSHNNLSG I FE M L+ IDIS N L+G +P++ AF++A AL+GN+ L
Sbjct: 705 SLDKLNLSHNNLSGFIPTTFESMKALTFIDISNNKLEGPLPDNPAFQNATSDALEGNRGL 764
Query: 614 CGDI--KRLPPCKAFKSHKQSLKK-IWIVIVFPLLGTVALLISLIGLF-FNFRQRK--NG 667
C +I +RL C+ F+ K++ +WI++ P+LG + +L G F + R+RK NG
Sbjct: 765 CSNIPKQRLKSCRGFQKPKKNGNLLVWILV--PILGALVILSICAGAFTYYIRKRKPHNG 822
Query: 668 LQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATKNFDDEHCIGNGGQGSVYKAELPTGEI 727
T + N +S+ + DGK +++II +T FD + IG+GG VYKA LP I
Sbjct: 823 RNTDSETGEN----MSIFSVDGKFKYQDIIESTNEFDQRYLIGSGGYSKVYKANLPDA-I 877
Query: 728 VAVKKFHSPLPGEMA---CQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 784
VAVK+ H + E++ +QEFLNE ALT+IRHRN+VK +GFCSH H+F++YEY+E
Sbjct: 878 VAVKRLHDTIDEEISKPVVKQEFLNEVRALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEK 937
Query: 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYE 844
GSL +L+N+ A+ WTKR+N +KGVA AL YMH + PIVHRDISS N+LL+ +Y
Sbjct: 938 GSLNKLLANEEEAKRLTWTKRINIVKGVAHALSYMHHDRSTPIVHRDISSGNILLDNDYT 997
Query: 845 AHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 904
A +SDFG +K LK SN + +AGT+GY+APE AYTMKVTEKCDVYSFGVL LEVI GKH
Sbjct: 998 AKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILEVIMGKH 1057
Query: 905 PRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTM 964
P D ++S+ SS L +L + D R+ P ++KLI ++EV++SCL P SRPTM
Sbjct: 1058 PGDLVASLSSSPGETL--SLRSISDERILEPRGQNREKLIKMVEVALSCLQADPQSRPTM 1115
Query: 965 QKVS 968
+S
Sbjct: 1116 LSIS 1119
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357439013|ref|XP_003589783.1| Receptor protein kinase-like protein [Medicago truncatula] gi|355478831|gb|AES60034.1| Receptor protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 788 bits (2036), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/1002 (46%), Positives = 630/1002 (62%), Gaps = 37/1002 (3%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
LK L LS N SG+IP IG+L+ + L S N L+G+IP EI +L SL LS+ +N L
Sbjct: 128 LKTLDLSVNNLSGTIPNSIGNLSKISYLDLSFNYLTGIIPFEITQLVSLYFLSMATNQLI 187
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
G IP +GNL +L +DI N L+GS+P E+G L L++L LS N L+G+IPS++GNL+N
Sbjct: 188 GHIPREIGNLVNLERLDIQLNNLTGSVPQEIGFLTKLAELDLSANYLSGTIPSTIGNLSN 247
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L LYL+ N L GSIP E+GNL L +Q+ N LSG IP S+GNL NL ++ + N LS
Sbjct: 248 LHWLYLYQNHLMGSIPSEVGNLYSLFTIQLLGNHLSGPIPSSIGNLVNLNSIRLDHNDLS 307
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
G IP IG L +L + L N +SG + + GNLTKL +LYL NAL+G IP IGNL +
Sbjct: 308 GEIPISIGKLVNLDTIDLSDNKISGPLPSTIGNLTKLTVLYLSSNALTGQIPPSIGNLVN 367
Query: 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLS 301
L + L+ N LS IP + GNLTK+ I L +NAL+ + IGN+ +L + L+ N LS
Sbjct: 368 LDTIDLSENKLSRPIPSTVGNLTKVSILSLHSNALTGQLPPSIGNMVNLDTIYLSENKLS 427
Query: 302 GSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTK 361
G IP ++G+LT L +L +N+L+G+IP + N+ +L LQL+ N G +PL + K
Sbjct: 428 GPIPSTIGNLTKLNSLSLFSNSLTGNIPKVMNNIANLESLQLASNNFTGHLPLNICAGRK 487
Query: 362 LVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEI----------------- 404
L S N+ +G IP S +SL + L +N + D+I
Sbjct: 488 LTKFSASNNQFTGPIPKSLKKCSSLIRVRLQQNQITDNITDAFGVYPNLDYMELSDNNFY 547
Query: 405 -------GDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFS 457
G K+L+ L +S+N L GSIP L T L+ L LSSNH+ G+IP G S
Sbjct: 548 GHISPNWGKCKNLTSLQISNNNLTGSIPQELGGAT-QLQELNLSSNHLTGKIPEELGNLS 606
Query: 458 SLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQF 517
LI+L ++NN L G++ ++ SL L L+L N IP LG L +L +LNLS N+F
Sbjct: 607 LLIKLSISNNNLLGEVPVQIASLQALTALELEKNNLSGFIPRRLGRLSELIHLNLSQNKF 666
Query: 518 SQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMH 577
IP ++L + +LDLS + IPS + + L+ LNLSHNNLSG+I + EM
Sbjct: 667 EGNIPVEFDQLKVIEDLDLSENVMSGTIPSMLGQLNHLQTLNLSHNNLSGTIPLSYGEML 726
Query: 578 WLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPCKA----FKSHKQSL 633
L+ +DISYN L+G IP+ TAF+ AP+ AL+ NK LCG++ L C F SHK S
Sbjct: 727 SLTIVDISYNQLEGPIPSITAFQKAPIEALRNNKGLCGNVSGLVCCSTSGGNFHSHKTS- 785
Query: 634 KKIWIVIVFPLLGTVALLISLIGLFFNFRQRKNGLQTQQSSPRNTLGLLSVLTFDGKIVH 693
I ++++ LGT+ L G+ + F Q + + + T L ++ +FDGK+V+
Sbjct: 786 -NILVLVLPLTLGTLLLAFFAYGISYLFCQTSSTKEDNHAEEFQTENLFAIWSFDGKMVY 844
Query: 694 EEIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNA 753
E II AT++FD++H IG GG GSVYKAELPTG++VAVKK HS EM+ + F NE +A
Sbjct: 845 ETIIEATEDFDNKHLIGVGGHGSVYKAELPTGQVVAVKKLHSLQNEEMSNLKAFTNEIHA 904
Query: 754 LTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVA 813
L +IRHRNIVK YGFCSH LHSF+VYE+LE GS+ IL ++ A EF W +R+N IK +A
Sbjct: 905 LKEIRHRNIVKLYGFCSHRLHSFLVYEFLEKGSMDNILKDNEQAAEFDWNRRVNVIKDIA 964
Query: 814 DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI 873
+AL Y+H +C PPIVHRDISSKNV+L+LEY AHVSDFG SKFL SN T AGTFGY
Sbjct: 965 NALCYLHHDCSPPIVHRDISSKNVILDLEYVAHVSDFGTSKFLNPNSSNMTSFAGTFGYA 1024
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLS-SNLNIALDEM----- 927
APELAYTM+V EKCDVYSFG+L LE++ GKHP D ++S+ S S +++ LD M
Sbjct: 1025 APELAYTMEVNEKCDVYSFGILTLEILFGKHPGDVVTSLWKQPSQSVIDVTLDTMPLIER 1084
Query: 928 LDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969
LD RLP P + ++ S++ ++++CL ES SRPTM+ V +
Sbjct: 1085 LDQRLPHPTNTIVQEVASVVRIAVACLAESLRSRPTMEHVCK 1126
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456161|ref|XP_002278590.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 786 bits (2029), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/971 (47%), Positives = 616/971 (63%), Gaps = 41/971 (4%)
Query: 5 LGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSI 64
LG + FS S P + ++ S N LSG IP +IG LS L L L N G I
Sbjct: 100 LGGTLQAFSFSSFPNLAYV------DISMNNLSGPIPPQIGLLSKLKYLDLSINQFSGGI 153
Query: 65 PPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVT 124
PP +G LT+L + + N L+GSIP+E+G L SL +L L N L GSIP+SLGNL+NL +
Sbjct: 154 PPEIGLLTNLEVLHLVQNQLNGSIPHEIGQLTSLYELALYTNQLEGSIPASLGNLSNLAS 213
Query: 125 LYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSI 184
LYL+ N LSGSIP E+GNL L L N L+G IP + GNL +L LY+ N+LSG I
Sbjct: 214 LYLYENQLSGSIPPEMGNLTNLVQLYSDTNNLTGPIPSTFGNLKHLTVLYLFNNSLSGPI 273
Query: 185 PNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLA 244
P EIGNLKSL L L N LSG I S +L+ L +L+L N LSG IP EIGNLKSL+
Sbjct: 274 PPEIGNLKSLQGLSLYGNNLSGPIPVSLCDLSGLTLLHLYANQLSGPIPQEIGNLKSLVD 333
Query: 245 LQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSI 304
L+L+ N L+GSIP S GNLT L I L N LS +EIG L L+ L+++ N L GS+
Sbjct: 334 LELSENQLNGSIPTSLGNLTNLEILFLRDNRLSGYFPQEIGKLHKLVVLEIDTNQLFGSL 393
Query: 305 PLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVS 364
P + +L S N LSG IP + N R+L+ N L G++ +G+ L
Sbjct: 394 PEGICQGGSLERFTVSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGNVSEVVGDCPNLEF 453
Query: 365 LDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSI 424
+DLS N+ G + ++ L L + N++ SIP++ G +L +LDLSSN L G I
Sbjct: 454 IDLSYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPEDFGISTNLILLDLSSNHLVGEI 513
Query: 425 PLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLE 484
P + +LT SL L L+ N + G IP G S L L L+ N L+G + LG L
Sbjct: 514 PKKMGSLT-SLLGLILNDNQLSGSIPPELGSLSHLEYLDLSANRLNGSIPEHLGDCLDLH 572
Query: 485 YLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEE 544
YL+LS N + IP +G L L L+LS+N + IP
Sbjct: 573 YLNLSNNKLSHGIPVQMGKLSHLSQLDLSHNLLTGGIP---------------------- 610
Query: 545 IPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPM 604
+Q+ ++SLE L+LSHNNL G I + FE+M LS +DISYN LQG IP+S AFR+A +
Sbjct: 611 --AQIQGLESLEMLDLSHNNLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNAFRNATI 668
Query: 605 LALQGNKRLCGDIKRLPPCK-AFKSHKQSLK---KIWIVIVFPLLGTVALLISLIGLFFN 660
L+GNK LCG++K L PCK F +Q +K K+ +I+FPLLG + LL + IG+F
Sbjct: 669 EVLKGNKDLCGNVKGLQPCKYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLSAFIGIFLI 728
Query: 661 FRQRKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATKNFDDEHCIGNGGQGSVYKA 720
+R+ + ++ +N LLS+ TFDG+ ++EEII+ATK+FD +CIG GG GSVYKA
Sbjct: 729 AERRERTPEIEEGDVQNN--LLSISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGSVYKA 786
Query: 721 ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780
ELP+G IVAVKK H P +MA Q++FLN+ A+T+I+HRNIV+ GFCS+ HSF+VYE
Sbjct: 787 ELPSGNIVAVKKLH-PSDMDMANQKDFLNKVRAMTEIKHRNIVRLLGFCSYPRHSFLVYE 845
Query: 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLN 840
YLE GSLA ILS + A++ GW R+ IKGVA AL YMH +C PPIVHRDISS N+LL+
Sbjct: 846 YLERGSLATILSRE-EAKKLGWATRVKIIKGVAHALSYMHHDCSPPIVHRDISSNNILLD 904
Query: 841 LEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVI 900
+YEAH+S+ G +K LK+ SN+++LAGT GY+APE AYTMKVTEK DVYSFGV+ALEVI
Sbjct: 905 SQYEAHISNLGTAKLLKVDSSNQSKLAGTVGYVAPEHAYTMKVTEKTDVYSFGVIALEVI 964
Query: 901 KGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTS 960
KG+HP D I SI S+S NI L +MLDPRLP + ++++I++++ +CL+ +P S
Sbjct: 965 KGRHPGDQILSI--SVSPEKNIVLKDMLDPRLPPLTPQDEGEVVAIIKLATACLNANPQS 1022
Query: 961 RPTMQKVSQLL 971
RPTM+ +SQ+L
Sbjct: 1023 RPTMEIISQML 1033
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484864|ref|XP_002273966.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 781 bits (2018), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/956 (48%), Positives = 601/956 (62%), Gaps = 14/956 (1%)
Query: 23 LTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNN 82
L +L L N LSG IP EIG L SLN L L +N L G IPPS+GNL +L + + N
Sbjct: 121 LPNLVTLDLYNNSLSGSIPQEIGLLRSLNNLKLSTNNLSGPIPPSIGNLRNLTTLYLHTN 180
Query: 83 LLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGN 142
LSGSIP E+G L+SL+DL LS N+L+G IP S+GNL NL TLYLH N LSGSIP EIG
Sbjct: 181 KLSGSIPQEIGLLRSLNDLELSANNLSGPIPPSIGNLRNLTTLYLHTNKLSGSIPQEIGL 240
Query: 143 LKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYN 202
L+ L+DL++S N L+G IP S+GNL NL TLY+ N LSGSIP EIG L+SL+DL L N
Sbjct: 241 LRSLNDLELSTNNLNGPIPPSIGNLRNLTTLYLHTNKLSGSIPKEIGMLRSLNDLELSTN 300
Query: 203 TLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGN 262
L+G I S G L L LYL N LSG IP EIG L+SL L L+ N LSG IP GN
Sbjct: 301 NLNGPIPPSIGKLRNLTTLYLHNNKLSGSIPLEIGLLRSLFNLSLSTNNLSGPIPPFIGN 360
Query: 263 LTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTN 322
L L L N S SI EIG L+SL L L N LSG IP + +L +L +L+ N
Sbjct: 361 LRNLTKLYLDNNRFSGSIPREIGLLRSLHDLALATNKLSGPIPQEIDNLIHLKSLHLEEN 420
Query: 323 ALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFAS 382
+G +P ++ +L + N G IP++L N T L + L N+L G+I F
Sbjct: 421 NFTGHLPQQMCLGGALENFTAMGNHFTGPIPMSLRNCTSLFRVRLERNQLEGNITEVFGV 480
Query: 383 LTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSS 442
+L + L N+L + + G SL+ L++S N L+G IP L L L LSS
Sbjct: 481 YPNLNFMDLSSNNLYGELSHKWGQCGSLTSLNISHNNLSGIIPPQLGEAI-QLHRLDLSS 539
Query: 443 NHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLG 502
NH++G+IP GK +S+ L+L+NN+LSG + E+G+L LE+L L++N SIP+ LG
Sbjct: 540 NHLLGKIPRELGKLTSMFHLVLSNNQLSGNIPLEVGNLFNLEHLSLTSNNLSGSIPKQLG 599
Query: 503 NLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSH 562
L KL +LNLS N+F + IP+ I + L LDLS + +IP Q+ +Q LE LNLSH
Sbjct: 600 MLSKLFFLNLSKNKFGESIPDEIGNMHSLQNLDLSQNMLNGKIPQQLGELQRLETLNLSH 659
Query: 563 NNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPP 622
N LSGSI FE+M L+ +DIS N L+G +P+ AF++AP A N LCG+ L P
Sbjct: 660 NELSGSIPSTFEDMLSLTSVDISSNQLEGPLPDIKAFQEAPFEAFMSNGGLCGNATGLKP 719
Query: 623 CKAFKSHKQSLKKIWIVIVFPLLGTVALLISLIGLFFNFRQRKNGLQTQQSSPRNTLGLL 682
C F K I I+ TV LL +G++F R + +SS L
Sbjct: 720 CIPFTQKKNKRSMILIIS-----STVFLLCISMGIYFTLYWRARN-RKGKSSETPCEDLF 773
Query: 683 SVLTFDGKIVHEEIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMA 742
++ DG I++++II T+ F+ ++CIG+GGQG+VYKAELPTG +VAVKK H P GEM+
Sbjct: 774 AIWDHDGGILYQDIIEVTEEFNSKYCIGSGGQGTVYKAELPTGRVVAVKKLHPPQDGEMS 833
Query: 743 CQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGW 802
+ F +E ALT+IRHRNIVKFYG+CSHA HSF+VY+ +E GSL ILSN+ A W
Sbjct: 834 SLKAFTSEIRALTEIRHRNIVKFYGYCSHARHSFLVYKLMEKGSLRNILSNEEEAIGLDW 893
Query: 803 TKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL-GLS 861
+R+N +KGVA+AL YMH +C PPI+HRDISS NVLL+ EYEAHVSDFG ++ LK S
Sbjct: 894 IRRLNIVKGVAEALSYMHHDCSPPIIHRDISSNNVLLDSEYEAHVSDFGTARLLKPDSSS 953
Query: 862 NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLN 921
N T AGTFGY APELAYT +V K DVYS+GV+ LEVI GKHP D ISS+ S+ SS+
Sbjct: 954 NWTSFAGTFGYSAPELAYTTQVNNKTDVYSYGVVTLEVIMGKHPGDLISSLSSASSSSSV 1013
Query: 922 IA------LDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
A L + +D RL P+ + +++ ++++ +C +P RPTM++VSQ L
Sbjct: 1014 TAVADSLLLKDAIDQRLSPPIHQISEEVAFAVKLAFACQHVNPHCRPTMRQVSQAL 1069
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356577797|ref|XP_003557009.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 776 bits (2003), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/1002 (46%), Positives = 620/1002 (61%), Gaps = 36/1002 (3%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L VL + N+ +G IP IG+L ++ L +N+LSG IP IG LS L+GL + N L
Sbjct: 198 LSVLSIYSNELTGPIPTSIGNLVNMDSLLLYENKLSGSIPFTIGNLSKLSGLYISLNELT 257
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
G IP S+GNL +L + + N LSGSIP +G+L LS L + +N L G IP+S+GNL N
Sbjct: 258 GPIPASIGNLVNLEAMRLFKNKLSGSIPFNIGNLSKLSKLSIHSNELTGPIPASIGNLVN 317
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L ++ LH N LSGSIP IGNL S L +S+N L+G IP S+GNL +L +L + N LS
Sbjct: 318 LDSMILHKNKLSGSIPFIIGNLSKFSVLSISFNELTGPIPASIGNLVHLDSLLLEENKLS 377
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
GSIP IGNL LS L + N L+G I S GNL LE + L N LSG IP IGNL
Sbjct: 378 GSIPFTIGNLSKLSGLYISLNELTGPIPASIGNLVNLEAMRLFKNKLSGSIPFTIGNLSK 437
Query: 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLS 301
L L ++ N L+G IP S GNL L L N LS SI IGNL L L ++ N L+
Sbjct: 438 LSKLSIHSNELTGPIPASIGNLVHLDSLLLEENKLSGSIPFTIGNLSKLSVLSISLNELT 497
Query: 302 GSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSEN--------------T 347
GSIP ++G+L+N+ L+F N L G IP E++ L +L LQL++N T
Sbjct: 498 GSIPSTIGNLSNVRELFFIGNELGGKIPIEMSMLTALESLQLADNNFIGHLPQNICIGGT 557
Query: 348 LN----------GSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLC 397
L G IP++L N + L+ + L N+L+G I +F L +L + L +N+
Sbjct: 558 LKNFTAGDNNFIGPIPVSLKNCSSLIRVRLQRNQLTGDITDAFGVLPNLDYIELSDNNFY 617
Query: 398 DSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFS 457
+ G +SL+ L +S+N L+G IP LA T L+ L LSSNH+ G IP
Sbjct: 618 GQLSPNWGKFRSLTSLRISNNNLSGVIPPELAGAT-KLQRLQLSSNHLTGNIPHDLCNLP 676
Query: 458 SLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQF 517
L L L+NN L+G + E+ S+ +L+ L L +N IP+ LGNL+ L ++LS N F
Sbjct: 677 -LFDLSLDNNNLTGNVPKEIASMQKLQILKLGSNKLSGLIPKQLGNLLNLWNMSLSQNNF 735
Query: 518 SQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMH 577
IP+ + KL L+ LDL IPS ++SLE LNLSHNNLSG++S F++M
Sbjct: 736 QGNIPSELGKLKSLTSLDLGGNSLRGTIPSMFGELKSLETLNLSHNNLSGNLSS-FDDMT 794
Query: 578 WLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPCK--AFKSHKQSLKK 635
L+ IDISYN +G +PN AF +A + AL+ NK LCG++ L PC + KSH KK
Sbjct: 795 SLTSIDISYNQFEGPLPNILAFHNAKIEALRNNKGLCGNVTGLEPCSTSSGKSHNHMRKK 854
Query: 636 IWIVIVFPLLGTVALLISLIGLFFNFRQRKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEE 695
+ IVI+ LG + L + G++++ Q + Q +S + T + ++ +FDGK+V E
Sbjct: 855 VMIVILPLTLGILILALFAFGVWYHLCQTSTNKEDQATSIQ-TPNIFAIWSFDGKMVFEN 913
Query: 696 IIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALT 755
II AT++FDD+H IG GGQG VYKA LPTG++VAVKK HS GEM + F E ALT
Sbjct: 914 IIEATEDFDDKHLIGVGGQGCVYKAVLPTGQVVAVKKLHSVPNGEMLNLKAFTCEIQALT 973
Query: 756 KIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADA 815
+IRHRNIVK YGFCSH+ SF+V E+LE GS+ L +D A F W KR+N +K VA+A
Sbjct: 974 EIRHRNIVKLYGFCSHSQFSFLVCEFLENGSVEKTLKDDGQAMAFDWYKRVNVVKDVANA 1033
Query: 816 LLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAP 875
L YMH C P IVHRDISSKNVLL+ EY AHVSDFG +KFL SN T GTFGY AP
Sbjct: 1034 LCYMHHECSPRIVHRDISSKNVLLDSEYVAHVSDFGTAKFLNPDSSNWTSFVGTFGYAAP 1093
Query: 876 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNL------NIALDEMLD 929
ELAYTM+V EKCDVYSFGVLA E++ GKHP D ISS+ S S L ++AL + LD
Sbjct: 1094 ELAYTMEVNEKCDVYSFGVLAWEILVGKHPGDDISSLLGSSPSTLVASTLDHMALMDKLD 1153
Query: 930 PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
PRLP P + + ++ SI +++++CL ESP SRPTM++V+ L
Sbjct: 1154 PRLPHPTKPIGKEVASIAKIAMACLTESPRSRPTMEQVANEL 1195
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 973 | ||||||
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.985 | 0.856 | 0.401 | 2.7e-180 | |
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.926 | 0.862 | 0.413 | 2.5e-177 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.988 | 0.872 | 0.357 | 1.3e-137 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.992 | 0.773 | 0.344 | 1.2e-134 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.988 | 0.873 | 0.343 | 2e-134 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.923 | 0.799 | 0.356 | 8.8e-134 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.988 | 0.768 | 0.339 | 3e-133 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.978 | 0.838 | 0.336 | 9.1e-132 | |
| TAIR|locus:2161825 | 1090 | AT5G56040 [Arabidopsis thalian | 0.965 | 0.861 | 0.346 | 3.1e-131 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.976 | 0.832 | 0.337 | 9.3e-130 |
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1750 (621.1 bits), Expect = 2.7e-180, P = 2.7e-180
Identities = 391/973 (40%), Positives = 560/973 (57%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRXXXXXXXXXXXXXXK 61
L VL L N + IP E+G++ + L+ S+N+L+G IP +G
Sbjct: 152 LTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKLTGSIPSSLGNLKNLMVLYLYENYLT 211
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGXXXXXXXXXXXXXXXXXXIPSSLGNLTN 121
G IPP LGN+ S+ + + N L+GSIP+ +G IP +GN+ +
Sbjct: 212 GVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIGNMES 271
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
+ L L N L+GSIP +GNLK L+ L + N L+G IP LGN+ +++ L + N L+
Sbjct: 272 MTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLT 331
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
GSIP+ +GNLK+L+ L L N L+G I GN+ + L L+ N L+G IP+ GNLK+
Sbjct: 332 GSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNLKN 391
Query: 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTXX 301
L L L N L+G IP GN+ ++ L N L+ S+ + GN L L L N
Sbjct: 392 LTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLS 451
Query: 302 XXXXXXXXXXTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTK 361
++L TL TN +G P + R L ++ L N L G IP +L +
Sbjct: 452 GAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKS 511
Query: 362 LVSLDLSINKLSGSIPLSFAXXXXXXXXXXXENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
L+ NK +G I +F N I L L +S+N +
Sbjct: 512 LIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNIT 571
Query: 422 GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLN 481
G+IP + N+T ++ L LS+N++ GE+P G ++L +L LN N+LSG++ L L
Sbjct: 572 GAIPTEIWNMTQLVE-LDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLT 630
Query: 482 QLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIF 541
LE LDLS+N F + IP++ + +KLH +NLS N+F IP + KL L++LDLS+
Sbjct: 631 NLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIPR-LSKLTQLTQLDLSHNQL 689
Query: 542 GEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRD 601
EIPSQ+ S+QSL+KL+LSHNNLSG I FE M L+ +DIS N L+G +P++ FR
Sbjct: 690 DGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRK 749
Query: 602 APMLALQGNKRLCGDI--KRLPPCKAFKSHKQSLKKI-WIVIVFPLLGTVALLISLIGLF 658
A AL+ N LC +I +RL PC+ K K++ + WI++ P+LG V +++S+
Sbjct: 750 ATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILV--PILG-VLVILSICANT 806
Query: 659 FNFRQRKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATKNFDDEHCIGNGGQGSVY 718
F + RK LQ +++ T +S+ + DGK +++II +T FD H IG GG VY
Sbjct: 807 FTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVY 866
Query: 719 KAELPTGEIVAVKKFHSPLPGEMA---CQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775
+A L I+AVK+ H + E++ +QEFLNE ALT+IRHRN+VK +GFCSH H+
Sbjct: 867 RANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHT 925
Query: 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSK 835
F++YEY+E GSL +L+ND A+ WTKR+N +KGVA AL YMH + PIVHRDISS
Sbjct: 926 FLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSG 985
Query: 836 NVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVL 895
N+LL+ +Y A +SDFG +K LK SN + +AGT+GY+APE AYTMKVTEKCDVYSFGVL
Sbjct: 986 NILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVL 1045
Query: 896 ALEVIKGKHPRDFXXXXXXXXXXXXXXALDEMLDPRLPTPLRNVQDKLISIMEVSISCLD 955
LE+I GKHP D +L + D R+ P ++KL+ ++E+++ CL
Sbjct: 1046 ILELIIGKHPGDLVSSLSSSPGEAL--SLRSISDERVLEPRGQNREKLLKMVEMALLCLQ 1103
Query: 956 ESPTSRPTMQKVS 968
+P SRPTM +S
Sbjct: 1104 ANPESRPTMLSIS 1116
|
|
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1722 (611.2 bits), Expect = 2.5e-177, P = 2.5e-177
Identities = 379/916 (41%), Positives = 527/916 (57%)
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGXXXXXXXXXXXXXXXXXXIPSSLGNLTN 121
G+I P G + L Y D+ N L G IP E+G IPS +G LT
Sbjct: 132 GTISPLWGRFSKLEYFDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTK 191
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
+ + ++ N L+G IP GNL L +L + N+LSG+IP +GNL NL L + N L+
Sbjct: 192 VTEIAIYDNLLTGPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLT 251
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
G IP+ GNLK+++ L + N LSG I GN+T L+ L L N L+G IP+ +GN+K+
Sbjct: 252 GKIPSSFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKT 311
Query: 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTXX 301
L L L N L+GSIP G + ++ + N L+ + + G L +L L L N
Sbjct: 312 LAVLHLYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLS 371
Query: 302 XXXXXXXXXXTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTK 361
T L L TN +G +P+ I L +L L +N G +P +L +
Sbjct: 372 GPIPPGIANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKS 431
Query: 362 LVSLDLSINKLSGSIPLSFAXXXXXXXXXXXENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
L+ + N SG I +F N+ + + L LS+N +
Sbjct: 432 LIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSIT 491
Query: 422 GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLN 481
G+IP + N+T L L LSSN I GE+P + + +L LN N LSG++ + L
Sbjct: 492 GAIPPEIWNMTQ-LSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLT 550
Query: 482 QLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIF 541
LEYLDLS+N F + IP +L NL +L+Y+NLS N Q IP + KL L LDLSY
Sbjct: 551 NLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQL 610
Query: 542 GEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRD 601
EI SQ S+Q+LE+L+LSHNNLSG I F++M L+ +D+S+N LQG IP++ AFR+
Sbjct: 611 DGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRN 670
Query: 602 APMLALQGNKRLCGDIKR---LPPCK---AFKSHKQSLKKIWIVIVFPLLGTVALLISLI 655
AP A +GNK LCG + L PC + KSHK + + I I+ P++G + +L
Sbjct: 671 APPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKD--RNLIIYILVPIIGAIIILSVCA 728
Query: 656 GLFFNFRQRKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATKNFDDEHCIGNGGQG 715
G+F FR+R ++ S LS+ +FDGK+ ++EII+AT FD ++ IG GG G
Sbjct: 729 GIFICFRKRTKQIEEHTDSESGG-ETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHG 787
Query: 716 SVYKAELPTGEIVAVKKFHSPLPGEMA---CQQEFLNEGNALTKIRHRNIVKFYGFCSHA 772
VYKA+LP I+AVKK + ++ +QEFLNE ALT+IRHRN+VK +GFCSH
Sbjct: 788 KVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHR 846
Query: 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDI 832
++F+VYEY+E GSL +L ND A++ W KR+N +KGVA AL YMH + P IVHRDI
Sbjct: 847 RNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDI 906
Query: 833 SSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSF 892
SS N+LL +YEA +SDFG +K LK SN + +AGT+GY+APELAY MKVTEKCDVYSF
Sbjct: 907 SSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSF 966
Query: 893 GVLALEVIKGKHPRDFXXXXXXXXXXXXXXALDEMLDPRLPTPLRNVQDKLISIMEVSIS 952
GVL LEVIKG+HP D +L + D RLP P ++++++ I++V++
Sbjct: 967 GVLTLEVIKGEHPGDLVSTLSSSPPDATL-SLKSISDHRLPEPTPEIKEEVLEILKVALL 1025
Query: 953 CLDESPTSRPTMQKVS 968
CL P +RPTM +S
Sbjct: 1026 CLHSDPQARPTMLSIS 1041
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1347 (479.2 bits), Expect = 1.3e-137, P = 1.3e-137
Identities = 353/988 (35%), Positives = 507/988 (51%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRXXXXXXXXXXXXXXK 61
LK L LS+N SG IP EIG+ + L++L + NQ G IP EIG+
Sbjct: 99 LKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRIS 158
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGXXXXXXXXXXXXXXXXXXIPSSLGNLTN 121
GS+P +GNL SL + +N +SG +P +G +PS +G +
Sbjct: 159 GSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCES 218
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
LV L L N LSG +P EIG LK LS + + N SG IP + N T+L TL + N L
Sbjct: 219 LVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLV 278
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLT-KLEILYLDVNALSGLIPNEIGNLK 240
G IP E+G+L+SL L L N L+G+I GNL+ +EI + + NAL+G IP E+GN++
Sbjct: 279 GPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSE-NALTGEIPLELGNIE 337
Query: 241 SLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTX 300
L L L N L+G+IP L L L NAL+ I L+ L LQL N+
Sbjct: 338 GLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSL 397
Query: 301 XXXXXXXXXXXTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLT 360
++L L S N LSG IP+ + ++ L L N L+G+IP +
Sbjct: 398 SGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCK 457
Query: 361 KLVSLDLSINKLSGSIPLSFAXXXXXXXXXXXENSLCDSIPKEIGDMKSLSILDLSSNKL 420
LV L L+ N L G P + +N SIP+E+G+ +L L L+ N
Sbjct: 458 TLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGF 517
Query: 421 NGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSL 480
G +P + L+ L L +SSN + GE+P L +L + N SG L E+GSL
Sbjct: 518 TGELPREIGMLSQ-LGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSL 576
Query: 481 NQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLS-ELDLSYK 539
QLE L LS N +IP +LGNL +L L + N F+ IP + L L L+LSY
Sbjct: 577 YQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYN 636
Query: 540 IFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAF 599
EIP ++ ++ LE L L++NNLSG I F + L + SYN+L G IP
Sbjct: 637 KLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LL 693
Query: 600 RDAPMLALQGNKRLCGD-----IKRLP--PCKAF-KSHKQSLKKIWIVIVFPLLGTVALL 651
R+ M + GN+ LCG I+ P P ++ K KI I I ++G V+L+
Sbjct: 694 RNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKI-IAITAAVIGGVSLM 752
Query: 652 ISLIGLFFNFRQRKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATKNFDDEHCIGN 711
+ + ++ R + + Q + + L ++++ AT NFD+ +G
Sbjct: 753 LIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGR 812
Query: 712 GGQGSVYKAELPTGEIVAVKKFHSPLPG--EMACQQEFLNEGNALTKIRHRNIVKFYGFC 769
G G+VYKA LP G +AVKK S G F E L IRHRNIVK +GFC
Sbjct: 813 GACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFC 872
Query: 770 SHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVH 829
+H + ++YEY+ GSL IL + + W+KR G A L Y+H +C P I H
Sbjct: 873 NHQGSNLLLYEYMPKGSLGEILHDPSC--NLDWSKRFKIALGAAQGLAYLHHDCKPRIFH 930
Query: 830 RDISSKNVLLNLEYEAHVSDFGISKFLKLGLS-NRTELAGTFGYIAPELAYTMKVTEKCD 888
RDI S N+LL+ ++EAHV DFG++K + + S + + +AG++GYIAPE AYTMKVTEK D
Sbjct: 931 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSD 990
Query: 889 VYSFGVLALEVIKGK---HPRDFXXXXXX-XXXXXXXXALDE-MLDPRLPTPLRNVQDKL 943
+YS+GV+ LE++ GK P D AL +LD RL + +
Sbjct: 991 IYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSGVLDARLTLEDERIVSHM 1050
Query: 944 ISIMEVSISCLDESPTSRPTMQKVSQLL 971
++++++++ C SP +RP+M++V +L
Sbjct: 1051 LTVLKIALLCTSVSPVARPSMRQVVLML 1078
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1319 (469.4 bits), Expect = 1.2e-134, P = 1.2e-134
Identities = 346/1004 (34%), Positives = 496/1004 (49%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRXXXXXXXXXXXXXXK 61
L++L L+ N +G IP ++G ++ L+ LS NQL GLIP +
Sbjct: 241 LEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLT 300
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEV-GXXXXXXXXXXXXXXXXXXIPSSLGNLT 120
G IP N++ L+ + + NN LSGS+P + IP L
Sbjct: 301 GEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQ 360
Query: 121 NLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINAL 180
+L L L N+L+GSIP+ + L L+DL + NTL G + S+ NLTNL L + N L
Sbjct: 361 SLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNL 420
Query: 181 SGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLK 240
G +P EI L+ L L L N SG I GN T L+++ + N G IP IG LK
Sbjct: 421 EGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLK 480
Query: 241 SLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTX 300
L L L N L G +P S GN +L I L N LS SI G LK L L L N+
Sbjct: 481 ELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSL 540
Query: 301 XXXXXXXXXXXTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLT 360
NL + S N L+G+I + + S ++ N IPL LGN
Sbjct: 541 QGNLPDSLISLRNLTRINLSHNRLNGTI-HPLCGSSSYLSFDVTNNGFEDEIPLELGNSQ 599
Query: 361 KLVSLDLSINKLSGSIPLSFAXXXXXXXXXXXENSLCDSIPKEIGDMKSLSILDLSSNKL 420
L L L N+L+G IP + N+L +IP ++ K L+ +DL++N L
Sbjct: 600 NLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFL 659
Query: 421 NGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSL 480
+G IP L L+ L L LSSN V +P + L+ L L+ N L+G + E+G+L
Sbjct: 660 SGPIPPWLGKLSQ-LGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNL 718
Query: 481 NQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHL-SELDLSYK 539
L L+L N F S+P+++G L KL+ L LS N + +IP I +L L S LDLSY
Sbjct: 719 GALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYN 778
Query: 540 IFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAF 599
F +IPS + ++ LE L+LSHN L+G + +M L +++S+N L G + F
Sbjct: 779 NFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQ--F 836
Query: 600 RDAPMLALQGNKRLCGD-IKRLPPCKAF-KSHKQSLKKIWIVIVFPLLGTVALLISLIGL 657
P + GN LCG + R ++ K S + + I+ L + L+I +I L
Sbjct: 837 SRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIAL 896
Query: 658 FFN-----FRQRKNGLQTQQSSPRNTLGLLSVLTFDGK----IVHEEIIRATKNFDDEHC 708
FF F++ +G SS ++ L +G I E+I+ AT N +E
Sbjct: 897 FFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFM 956
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGF 768
IG+GG G VYKAEL GE VAVKK ++ + F E L +IRHR++VK G+
Sbjct: 957 IGSGGSGKVYKAELENGETVAVKKIL--WKDDLMSNKSFSREVKTLGRIRHRHLVKLMGY 1014
Query: 769 CSHALH--SFVVYEYLEMGSLAMILSNDAAAEE-----FGWTKRMNAIKGVADALLYMHT 821
CS + ++YEY++ GS+ L D E W R+ G+A + Y+H
Sbjct: 1015 CSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHH 1074
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTE----LAGTFGYIAPEL 877
+C PPIVHRDI S NVLL+ EAH+ DFG++K L T+ A ++GYIAPE
Sbjct: 1075 DCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEY 1134
Query: 878 AYTMKVTEKCDVYSFGVLALEVIKGKHPRD--FXXXXXX-----XXXXXXXXALDEMLDP 930
AY++K TEK DVYS G++ +E++ GK P D F A D+++DP
Sbjct: 1135 AYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDP 1194
Query: 931 RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTM-QKVSQLLKI 973
+L L +D ++E+++ C SP RP+ Q LL +
Sbjct: 1195 KLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSLLHV 1238
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1317 (468.7 bits), Expect = 2.0e-134, P = 2.0e-134
Identities = 339/988 (34%), Positives = 495/988 (50%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRXXXXXXXXXXXXXXK 61
L+ L +S N SG IP ++ L++L N+ G+IP ++
Sbjct: 93 LRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLKKLYLCENYLF 152
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGXXXXXXXXXXXXXXXXXXIPSSLGNLTN 121
GSIP +GNL+SL + I +N L+G IP + IPS + +
Sbjct: 153 GSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCES 212
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L L L N L GS+P ++ L+ L+DL + N LSG IP S+GN++ L L + N +
Sbjct: 213 LKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFT 272
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
GSIP EIG L + L L N L+G I GNL + N L+G IP E G++ +
Sbjct: 273 GSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILN 332
Query: 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTXX 301
L L L N L G IP G LT L L N L+ +I +E+ L L+ LQL N
Sbjct: 333 LKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLE 392
Query: 302 XXXXXXXXXXTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTK 361
+N + L S N+LSG IP ++L L L N L+G+IP L
Sbjct: 393 GKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKS 452
Query: 362 LVSLDLSINKLSGSIPLSFAXXXXXXXXXXXENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
L L L N+L+GS+P+ +N L +I ++G +K+L L L++N
Sbjct: 453 LTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFT 512
Query: 422 GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLN 481
G IP + NLT + +SSN + G IP G ++ +L L+ N+ SG ++ ELG L
Sbjct: 513 GEIPPEIGNLTKIVG-FNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLV 571
Query: 482 QLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLS-ELDLSYKI 540
LE L LS N IP S G+L +L L L N S+ IP + KL L L++S+
Sbjct: 572 YLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNN 631
Query: 541 FGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFR 600
IP + ++Q LE L L+ N LSG I + L +IS N L G +P++ F+
Sbjct: 632 LSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQ 691
Query: 601 DAPMLALQGNKRLCGDIKRLPPCKAFKSHKQSLKKIWIV----------IVFPLLGTVAL 650
GN LC + C+ H S K W++ I ++G+V
Sbjct: 692 RMDSSNFAGNHGLCNSQRS--HCQPLVPHSDS-KLNWLINGSQRQKILTITCIVIGSV-F 747
Query: 651 LISLIGLFFNFRQRKNGLQTQQSSPRNTLGLLSVLTFDGK-IVHEEIIRATKNFDDEHCI 709
LI+ +GL + ++R+ + + + + F K ++ ++ AT+NF ++ +
Sbjct: 748 LITFLGLCWTIKRREPAFVALEDQTKPDV--MDSYYFPKKGFTYQGLVDATRNFSEDVVL 805
Query: 710 GNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFC 769
G G G+VYKAE+ GE++AVKK +S G + F E + L KIRHRNIVK YGFC
Sbjct: 806 GRGACGTVYKAEMSGGEVIAVKKLNSRGEGASS-DNSFRAEISTLGKIRHRNIVKLYGFC 864
Query: 770 SHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVH 829
H + ++YEY+ GSL L W R G A+ L Y+H +C P IVH
Sbjct: 865 YHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVH 924
Query: 830 RDISSKNVLLNLEYEAHVSDFGISKFLKLGLS-NRTELAGTFGYIAPELAYTMKVTEKCD 888
RDI S N+LL+ ++AHV DFG++K + L S + + +AG++GYIAPE AYTMKVTEKCD
Sbjct: 925 RDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCD 984
Query: 889 VYSFGVLALEVIKGKHP-----RDFXXXXXXXXXXXXXXALDEMLDPRLPTPLRNVQDKL 943
+YSFGV+ LE+I GK P + EM D RL T + ++
Sbjct: 985 IYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPTIEMFDARLDTNDKRTVHEM 1044
Query: 944 ISIMEVSISCLDESPTSRPTMQKVSQLL 971
++++++ C SP SRPTM++V ++
Sbjct: 1045 SLVLKIALFCTSNSPASRPTMREVVAMI 1072
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1311 (466.6 bits), Expect = 8.8e-134, P = 8.8e-134
Identities = 329/922 (35%), Positives = 476/922 (51%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRXXXXXXXXXXXXXXK 61
L L L++N +G IP EIG+ + L+++ + NQ G IP EI +
Sbjct: 111 LVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLS 170
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGXXXXXXXXXXXXXXXXXXIPSSLGNLTN 121
G +P +G+L +L + N L+G +P +G IP+ +G N
Sbjct: 171 GPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLN 230
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L L L N +SG +P EIG L L ++ + N SG IP +GNLT+L TL + N+L
Sbjct: 231 LKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLV 290
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
G IP+EIGN+KSL L L N L+G+I G L+K+ + N LSG IP E+ +
Sbjct: 291 GPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISE 350
Query: 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTXX 301
L L L N L+G IP L L L N+L+ I NL S+ LQL +N+
Sbjct: 351 LRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLS 410
Query: 302 XXXXXXXXXXTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTK 361
+ L + FS N LSG IP I +L L L N + G+IP +
Sbjct: 411 GVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKS 470
Query: 362 LVSLDLSINKLSGSIPLSFAXXXXXXXXXXXENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
L+ L + N+L+G P +N +P EIG + L L L++N+ +
Sbjct: 471 LLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFS 530
Query: 422 GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLN 481
++P ++ L+N L +SSN + G IP L +L L+ N G L PELGSL+
Sbjct: 531 SNLPNEISKLSN-LVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLH 589
Query: 482 QLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLS-ELDLSYKI 540
QLE L LS N F +IP ++GNL L L + N FS IP + L L ++LSY
Sbjct: 590 QLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYND 649
Query: 541 FGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFR 600
F EIP ++ ++ L L+L++N+LSG I FE + L + SYN L G +P++ F+
Sbjct: 650 FSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQ 709
Query: 601 DAPMLALQGNKRLCGD-IKRLPPCKAFKSHKQSLK-------KIWIVIVFPLLGTVALLI 652
+ + + GNK LCG ++ P + H SLK +I I+IV ++G ++LL
Sbjct: 710 NMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISSLKAGSARRGRI-IIIVSSVIGGISLL- 767
Query: 653 SLIGLFFNFRQRKNGLQTQQSSPRNTLGLLSVLTFDGK--IVHEEIIRATKNFDDEHCIG 710
LI + +F + + S + F K ++I+ ATK F D + +G
Sbjct: 768 -LIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVG 826
Query: 711 NGGQGSVYKAELPTGEIVAVKKFHSPLPGEMA----CQQEFLNEGNALTKIRHRNIVKFY 766
G G+VYKA +P+G+ +AVKK S G F E L KIRHRNIV+ Y
Sbjct: 827 RGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLY 886
Query: 767 GFCSH--ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
FC H + + ++YEY+ GSL +L + + W R G A+ L Y+H +C
Sbjct: 887 SFCYHQGSNSNLLLYEYMSRGSLGELL-HGGKSHSMDWPTRFAIALGAAEGLAYLHHDCK 945
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTE-LAGTFGYIAPELAYTMKV 883
P I+HRDI S N+L++ +EAHV DFG++K + + LS +AG++GYIAPE AYTMKV
Sbjct: 946 PRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKV 1005
Query: 884 TEKCDVYSFGVLALEVIKGKHP 905
TEKCD+YSFGV+ LE++ GK P
Sbjct: 1006 TEKCDIYSFGVVLLELLTGKAP 1027
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1306 (464.8 bits), Expect = 3.0e-133, P = 3.0e-133
Identities = 339/999 (33%), Positives = 493/999 (49%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRXXXXXXXXXXXXXXK 61
L+ L L N FSG IP ++G L ++ L+ NQL GLIP +
Sbjct: 242 LQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLT 301
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEV-GXXXXXXXXXXXXXXXXXXIPSSLGNLT 120
G I + L ++ + N LSGS+P + IP+ + N
Sbjct: 302 GVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQ 361
Query: 121 NLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINAL 180
+L L L N L+G IPD + L L++L ++ N+L G + S+ NLTNL + N L
Sbjct: 362 SLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNL 421
Query: 181 SGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLK 240
G +P EIG L L + L N SG + GN T+L+ + N LSG IP+ IG LK
Sbjct: 422 EGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLK 481
Query: 241 SLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTX 300
L L L N L G+IP S GN ++ + L N LS SI G L +L + N+
Sbjct: 482 DLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSL 541
Query: 301 XXXXXXXXXXXTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLT 360
NL + FS+N +GSI + + S ++EN G IPL LG T
Sbjct: 542 QGNLPDSLINLKNLTRINFSSNKFNGSI-SPLCGSSSYLSFDVTENGFEGDIPLELGKST 600
Query: 361 KLVSLDLSINKLSGSIPLSFAXXXXXXXXXXXENSLCDSIPKEIGDMKSLSILDLSSNKL 420
L L L N+ +G IP +F NSL IP E+G K L+ +DL++N L
Sbjct: 601 NLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYL 660
Query: 421 NGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSL 480
+G IP L L L L LSSN VG +P ++++ L L+ N L+G + E+G+L
Sbjct: 661 SGVIPTWLGKLP-LLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNL 719
Query: 481 NQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHL-SELDLSYK 539
L L+L N +P ++G L KL L LS N + +IP I +L L S LDLSY
Sbjct: 720 QALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYN 779
Query: 540 IFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAF 599
F IPS + ++ LE L+LSHN L G + +M L +++SYN L+G + +
Sbjct: 780 NFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSR 839
Query: 600 RDAPMLALQGNKRLCGDIKRLPPC-KAFKSHKQSLKKIWIVIVFPL--LGTVALLISLIG 656
A A GN LCG L C +A +++SL +VI+ + L +AL++ +I
Sbjct: 840 WQAD--AFVGNAGLCGS--PLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVII 895
Query: 657 LFFN-----FRQRKNGLQTQQSSPRNTLG-LLSVLTFDGKIVHEEIIRATKNFDDEHCIG 710
LFF F++ + G S+ ++ L S I ++I+ AT ++E IG
Sbjct: 896 LFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIG 955
Query: 711 NGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCS 770
+GG G VYKAEL GE +AVKK ++ + F E L IRHR++VK G+CS
Sbjct: 956 SGGSGKVYKAELKNGETIAVKKIL--WKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCS 1013
Query: 771 HALH--SFVVYEYLEMGSLAMIL---SNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFP 825
+ ++YEY+ GS+ L N E GW R+ G+A + Y+H +C P
Sbjct: 1014 SKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVP 1073
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTE----LAGTFGYIAPELAYTM 881
PIVHRDI S NVLL+ EAH+ DFG++K L TE AG++GYIAPE AY++
Sbjct: 1074 PIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSL 1133
Query: 882 KVTEKCDVYSFGVLALEVIKGKHPRDFXXXXXXXXXXXXXXALD---------EMLDPRL 932
K TEK DVYS G++ +E++ GK P + LD +++D L
Sbjct: 1134 KATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSEL 1193
Query: 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
+ L ++ ++E+++ C P RP+ ++ S+ L
Sbjct: 1194 KSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQASEYL 1232
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1292 (459.9 bits), Expect = 9.1e-132, P = 9.1e-132
Identities = 330/980 (33%), Positives = 496/980 (50%)
Query: 11 QFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRXXXXXXXXXXXXXXKGSIPPSLGN 70
Q + PP I T L+ L S L+G I EIG G IP SLG
Sbjct: 93 QLALPFPPNISSFTSLQKLVISNTNLTGAISSEIGDCSELIVIDLSSNSLVGEIPSSLGK 152
Query: 71 LTSLIYIDIGNNLLSGSIPNEVGXXXXXXXXXXXXXXXXXXIPSSLGNLTNLVTLYLHMN 130
L +L + + +N L+G IP E+G +P LG ++ L ++ N
Sbjct: 153 LKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGN 212
Query: 131 A-LSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIG 189
+ LSG IP+EIGN + L L ++ +SG++P SLG L+ L +L + LSG IP E+G
Sbjct: 213 SELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELG 272
Query: 190 NLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNY 249
N L +L L N LSG++ G L LE + L N L G IP EIG +KSL A+ L+
Sbjct: 273 NCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSM 332
Query: 250 NTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTXXXXXXXXXX 309
N SG+IP SFGNL+ L L +N ++ SI + N L+ Q++ N
Sbjct: 333 NYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIG 392
Query: 310 XXTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSI 369
L N L G+IP+E+ ++L L LS+N L GS+P L L L L L
Sbjct: 393 LLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLIS 452
Query: 370 NKLSGSIPLSFAXXXXXXXXXXXENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLA 429
N +SG IPL N + IPK IG +++LS LDLS N L+G +PL ++
Sbjct: 453 NAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEIS 512
Query: 430 NLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLS 489
N L++L LS+N + G +PL + L L +++N+L+G++ LG L L L LS
Sbjct: 513 NC-RQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILS 571
Query: 490 ANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELD----LSYKIFGEEI 545
N+F+ IP SLG+ L L+LS+N S IP E+L + +LD LS+ I
Sbjct: 572 KNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIP---EELFDIQDLDIALNLSWNSLDGFI 628
Query: 546 PSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPML 605
P ++ ++ L L++SHN LSG +S + L ++IS+N G +P+S FR
Sbjct: 629 PERISALNRLSVLDISHNMLSGDLS-ALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGA 687
Query: 606 ALQGNKRLCGDIKRLPPCKAFKSHKQSLKK-IW---IVIVFPLLGTVALLISLIGLFFNF 661
++GN LC K C S + + ++ + + I LL +V +++++G+
Sbjct: 688 EMEGNNGLCS--KGFRSCFVSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVI 745
Query: 662 RQRKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATKNFDDEHCIGNGGQGSVYKAE 721
R ++ S L F K+ + + K + + IG G G VYKAE
Sbjct: 746 RAKQMIRDDNDSETGENLWTWQFTPFQ-KL-NFTVEHVLKCLVEGNVIGKGCSGIVYKAE 803
Query: 722 LPTGEIVAVKKFHS-PLPG------EMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH 774
+P E++AVKK +P + F E L IRH+NIV+F G C +
Sbjct: 804 MPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNT 863
Query: 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISS 834
++Y+Y+ GSL +L + GW R I G A L Y+H +C PPIVHRDI +
Sbjct: 864 RLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKA 923
Query: 835 KNVLLNLEYEAHVSDFGISKFLKLGLSNRTE--LAGTFGYIAPELAYTMKVTEKCDVYSF 892
N+L+ ++E ++ DFG++K + G R+ +AG++GYIAPE Y+MK+TEK DVYS+
Sbjct: 924 NNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSY 983
Query: 893 GVLALEVIKGKHPRDFXXXXXXXXXXXXXXALD-EMLDPRLPTPLRNVQDKLISIMEVSI 951
GV+ LEV+ GK P D D +++D L + ++++ + V++
Sbjct: 984 GVVVLEVLTGKQPIDPTIPDGLHIVDWVKKIRDIQVIDQGLQARPESEVEEMMQTLGVAL 1043
Query: 952 SCLDESPTSRPTMQKVSQLL 971
C++ P RPTM+ V+ +L
Sbjct: 1044 LCINPIPEDRPTMKDVAAML 1063
|
|
| TAIR|locus:2161825 AT5G56040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1287 (458.1 bits), Expect = 3.1e-131, P = 3.1e-131
Identities = 342/988 (34%), Positives = 506/988 (51%)
Query: 7 LSFNQFSGSIPP-EIGHLTHLKLLSFSKNQLSGLIPHEIGRXXXXXXXXXXXXXXKGSIP 65
L F G +P + + L LLS + L+G IP E+G G IP
Sbjct: 78 LQVMDFQGPLPATNLRQIKSLTLLSLTSVNLTGSIPKELGDLSELEVLDLADNSLSGEIP 137
Query: 66 PSLGNLTSLIYIDIGNNLLSGSIPNEVGXXXXXXXXXXXXXXXXXXIPSSLGNLTNLVTL 125
+ L L + + N L G IP+E+G IP ++G L NL
Sbjct: 138 VDIFKLKKLKILSLNTNNLEGVIPSELGNLVNLIELTLFDNKLAGEIPRTIGELKNLEIF 197
Query: 126 YLHMNA-LSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSI 184
N L G +P EIGN + L L ++ +LSG +P S+GNL + T+ + + LSG I
Sbjct: 198 RAGGNKNLRGELPWEIGNCESLVTLGLAETSLSGRLPASIGNLKKVQTIALYTSLLSGPI 257
Query: 185 PNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLA 244
P+EIGN L +L L N++SGSI S G L KL+ L L N L G IP E+G L
Sbjct: 258 PDEIGNCTELQNLYLYQNSISGSIPVSMGRLKKLQSLLLWQNNLVGKIPTELGTCPELFL 317
Query: 245 LQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTXXXXX 304
+ L+ N L+G+IP SFGNL L L N LS +I EE+ N L HL+++ N
Sbjct: 318 VDLSENLLTGNIPRSFGNLPNLQELQLSVNQLSGTIPEELANCTKLTHLEIDNNQISGEI 377
Query: 305 XXXXXXXTNLATLYFS-TNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLV 363
T+L T++F+ N L+G IP ++ + L + LS N L+GSIP + + L
Sbjct: 378 PPLIGKLTSL-TMFFAWQNQLTGIIPESLSQCQELQAIDLSYNNLSGSIPNGIFEIRNLT 436
Query: 364 SLDLSINKLSGSIPLSFAXXXXXXXXXXXENSLCDSIPKEIGDMKSLSILDLSSNKLNGS 423
L L N LSG IP N L +IP EIG++K+L+ +D+S N+L G+
Sbjct: 437 KLLLLSNYLSGFIPPDIGNCTNLYRLRLNGNRLAGNIPAEIGNLKNLNFIDISENRLIGN 496
Query: 424 IPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLI-LNNNELSGQLSPELGSLNQ 482
IP ++ T SL+ + L SN + G +P G +Q I L++N L+G L +GSL +
Sbjct: 497 IPPEISGCT-SLEFVDLHSNGLTGGLP---GTLPKSLQFIDLSDNSLTGSLPTGIGSLTE 552
Query: 483 LEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLS-ELDLSYKIF 541
L L+L+ N F IP + + L LNL +N F+ +IPN + ++ L+ L+LS F
Sbjct: 553 LTKLNLAKNRFSGEIPREISSCRSLQLLNLGDNGFTGEIPNELGRIPSLAISLNLSCNHF 612
Query: 542 GEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRD 601
EIPS+ S+ +L L++SHN L+G+++ ++ L ++IS+N G +PN+ FR
Sbjct: 613 TGEIPSRFSSLTNLGTLDVSHNKLAGNLN-VLADLQNLVSLNISFNEFSGELPNTLFFRK 671
Query: 602 APMLALQGNKRLCGDIKRLPPCKAFKSHKQSLKKIWIVIVFPLLGTVALLISLIGLFFNF 661
P+ L+ NK L I P H+ ++K ++V +V L++ +
Sbjct: 672 LPLSVLESNKGLF--ISTRPENGIQTRHRSAVKVTMSILV---AASVVLVLMAVYTLVK- 725
Query: 662 RQRKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATKNFDDEHCIGNGGQGSVYKAE 721
QR G Q + S TL D I ++I+ KN + IG G G VY+
Sbjct: 726 AQRITGKQEELDSWEVTL----YQKLDFSI--DDIV---KNLTSANVIGTGSSGVVYRVT 776
Query: 722 LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEY 781
+P+GE +AVKK S + F +E N L IRHRNI++ G+CS+ + Y+Y
Sbjct: 777 IPSGETLAVKKMWSKEEN-----RAFNSEINTLGSIRHRNIIRLLGWCSNRNLKLLFYDY 831
Query: 782 LEMGSLAMILSNDAAAEEFG--WTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL 839
L GSL+ +L + A G W R + + GVA AL Y+H +C PPI+H D+ + NVLL
Sbjct: 832 LPNGSLSSLL-HGAGKGSGGADWEARYDVVLGVAHALAYLHHDCLPPILHGDVKAMNVLL 890
Query: 840 NLEYEAHVSDFGISKFLK-LG--------LSNRTELAGTFGYIAPELAYTMKVTEKCDVY 890
+E++++DFG++K + G LSNR LAG++GY+APE A +TEK DVY
Sbjct: 891 GSRFESYLADFGLAKIVSGEGVTDGDSSKLSNRPPLAGSYGYMAPEHASMQHITEKSDVY 950
Query: 891 SFGVLALEVIKGKHPRDFXXXXXXXXXXXXXXAL----D--EMLDPRLPTPLRNVQDKLI 944
S+GV+ LEV+ GKHP D L D E+LDPRL + +++
Sbjct: 951 SYGVVLLEVLTGKHPLDPDLPGGAHLVQWVRDHLAGKKDPREILDPRLRGRADPIMHEML 1010
Query: 945 SIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ VS C+ + RP M+ + +LK
Sbjct: 1011 QTLAVSFLCVSNKASDRPMMKDIVAMLK 1038
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1273 (453.2 bits), Expect = 9.3e-130, P = 9.3e-130
Identities = 330/977 (33%), Positives = 495/977 (50%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRXXXXXXXXXXXXXXKGSIPPSLGNLTSL 74
S+P + L+ L+ S L+G +P +G G IP SL L +L
Sbjct: 96 SLPKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNL 155
Query: 75 IYIDIGNNLLSGSIPNEVGXXXXXXXXXXXXXXXXXXIPSSLGNLTNLVTLYLHMNA-LS 133
+ + +N L+G IP ++ IP+ LG L+ L + + N +S
Sbjct: 156 ETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEIS 215
Query: 134 GSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKS 193
G IP EIG+ L+ L ++ ++SG +P SLG L L TL I +SG IP+++GN
Sbjct: 216 GQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSE 275
Query: 194 LSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLS 253
L DL L N+LSGSI G LTKLE L+L N+L G IP EIGN +L + L+ N LS
Sbjct: 276 LVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLS 335
Query: 254 GSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTXXXXXXXXXXXXTN 313
GSIP S G L+ L + N S SI I N SL+ LQL+ N T
Sbjct: 336 GSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTK 395
Query: 314 LATLYFS-TNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKL 372
L TL+F+ +N L GSIP + + L L LS N+L G+IP L L L L L N L
Sbjct: 396 L-TLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSL 454
Query: 373 SGSIPLSFAXXXXXXXXXXXENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLT 432
SG IP N + IP IG +K ++ LD SSN+L+G +P + + +
Sbjct: 455 SGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCS 514
Query: 433 NSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANT 492
L+++ LS+N + G +P S L L ++ N+ SG++ LG L L L LS N
Sbjct: 515 E-LQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNL 573
Query: 493 FHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLS-ELDLSYKIFGEEIPSQVCS 551
F SIP SLG L L+L +N+ S +IP+ + + +L L+LS +IPS++ S
Sbjct: 574 FSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIAS 633
Query: 552 MQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNK 611
+ L L+LSHN L G ++ + L ++ISYN+ G +P++ FR L+GNK
Sbjct: 634 LNKLSILDLSHNMLEGDLAP-LANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNK 692
Query: 612 RLCGDIKR---LPPCKA--FKSHKQSLKKIWIVIVFPLLGTVALLISLIGLFFNFRQRKN 666
+LC + L K + + + + LL T+ +++ ++G R R+N
Sbjct: 693 KLCSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRN 752
Query: 667 GLQTQQSSPRNTLGLLSVLTFDG-KIVHEEIIRATKNFDDEHCIGNGGQGSVYKAELPTG 725
+ ++ S F ++IIR + + IG G G VY+A++ G
Sbjct: 753 -IDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLV---EPNVIGKGCSGVVYRADVDNG 808
Query: 726 EIVAVKKFHSPLPG----EMA--CQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779
E++AVKK + E + F E L IRH+NIV+F G C + ++Y
Sbjct: 809 EVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMY 868
Query: 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL 839
+Y+ GSL +L ++ W R + G A L Y+H +C PPIVHRDI + N+L+
Sbjct: 869 DYMPNGSLGSLL-HERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILI 927
Query: 840 NLEYEAHVSDFGISKFLKLGLSNRTE--LAGTFGYIAPELAYTMKVTEKCDVYSFGVLAL 897
L++E +++DFG++K + G R +AG++GYIAPE Y+MK+TEK DVYS+GV+ L
Sbjct: 928 GLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVL 987
Query: 898 EVIKGKHPRD--FXXXXXXXXXXXXXXALDEMLDPRLPTPLRNVQDKLISIMEVSISCLD 955
EV+ GK P D E+LD L + D+++ ++ ++ C++
Sbjct: 988 EVLTGKQPIDPTVPEGIHLVDWVRQNRGSLEVLDSTLRSRTEAEADEMMQVLGTALLCVN 1047
Query: 956 ESPTSRPTMQKVSQLLK 972
SP RPTM+ V+ +LK
Sbjct: 1048 SSPDERPTMKDVAAMLK 1064
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LP24 | Y1571_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4495 | 0.9804 | 0.8517 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 973 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-134 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-62 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-41 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-40 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-40 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-38 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-35 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-35 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-13 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-09 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-08 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-07 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-05 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 5e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 4e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 0.001 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 0.001 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.002 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 0.002 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.002 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.002 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 0.002 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 0.002 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.003 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.003 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 427 bits (1099), Expect = e-134
Identities = 314/986 (31%), Positives = 473/986 (47%), Gaps = 122/986 (12%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
+ + LS SG I I L +++ ++ S NQLSG IP +I SS
Sbjct: 71 VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSS------------ 118
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
SL Y+++ NN +GSIP GS+ +L L LSNN L+G IP+ +G+ ++
Sbjct: 119 -----------SLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSS 165
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L L L N L G IP+ + NL L L ++ N L G IP LG + +L +Y+G N LS
Sbjct: 166 LKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
G IP EIG L SL+ L L YN L+G I S GNL L+ L+L N LSG IP I +L+
Sbjct: 226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQK 285
Query: 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLS 301
L++L L+ N+LSG IP +LVI
Sbjct: 286 LISLDLSDNSLSGEIP-------ELVI--------------------------------- 305
Query: 302 GSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTK 361
L NL L+ +N +G IP +T+L L LQL N +G IP LG
Sbjct: 306 --------QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNN 357
Query: 362 LVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
L LDLS N L+G IP S +L L L+ NSL IPK +G +SL + L N +
Sbjct: 358 LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417
Query: 422 GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLN 481
G +P L + L +S+N++ G I SL L L N+ G L GS
Sbjct: 418 GELPSEFTKLP-LVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-K 475
Query: 482 QLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIF 541
+LE LDLS N F ++P LG+L +L L LS N+ S +IP+ + L LDLS+
Sbjct: 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535
Query: 542 GEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRD 601
+IP+ M L +L+LS N LSG I + + L ++IS+N L G +P++ AF
Sbjct: 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLA 595
Query: 602 APMLALQGNKRLCGDIKR--LPPCKAFKSHKQSLKKIWIVIVFPLLGTVALLISLIGLFF 659
A+ GN LCG LPPCK + W + LG L+++L+ F
Sbjct: 596 INASAVAGNIDLCGGDTTSGLPPCKRVRK-----TPSWWFYITCTLG-AFLVLALVAFGF 649
Query: 660 NFRQRKNGLQTQQSSPRNTLGLLSVLTFDGK----IVHEEIIRATKNFDDEHCIGNGGQG 715
F + +N L+ ++ N G + FD K I +I+ + K +E+ I G +G
Sbjct: 650 VFIRGRNNLELKRV--ENEDGTWELQFFDSKVSKSITINDILSSLK---EENVISRGKKG 704
Query: 716 SVYKAELPTGEI----VAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH 771
+ YK + + + +S E+A + K++H NIVK G C
Sbjct: 705 ASYKGKSIKNGMQFVVKEINDVNSIPSSEIA----------DMGKLQHPNIVKLIGLCRS 754
Query: 772 ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRD 831
+++++EY+E +L+ +L N W +R G+A AL ++H C P +V +
Sbjct: 755 EKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGN 808
Query: 832 ISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYS 891
+S + ++++ + E H + L L T+ + Y+APE T +TEK D+Y
Sbjct: 809 LSPEKIIIDGKDEPH-----LRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYG 863
Query: 892 FGVLALEVIKGKHPRDFISSICSSLS-----SNLNIALDEMLDPRLPTPLRNVQDKLISI 946
FG++ +E++ GK P D + S+ + LD +DP + + Q++++ +
Sbjct: 864 FGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEV 923
Query: 947 MEVSISCLDESPTSRPTMQKVSQLLK 972
M +++ C PT+RP V + L+
Sbjct: 924 MNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 228 bits (582), Expect = 4e-62
Identities = 166/460 (36%), Positives = 226/460 (49%), Gaps = 28/460 (6%)
Query: 190 NLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEI------------- 236
N + + L +SG I + L ++ + L N LSG IP++I
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 237 ----------GNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGN 286
G++ +L L L+ N LSG IP G+ + L + LG N L I + N
Sbjct: 127 NNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTN 186
Query: 287 LKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSEN 346
L SL L L N L G IP LG + +L +Y N LSG IP EI L SL+ L L N
Sbjct: 187 LTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYN 246
Query: 347 TLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGD 406
L G IP +LGNL L L L NKLSG IP S SL L +L L +NSL IP+ +
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 407 MKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNN 466
+++L IL L SN G IP++L +L L+VL L SN GEIP GK ++L L L+
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPR-LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLST 365
Query: 467 NELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIE 526
N L+G++ L S L L L +N+ IP+SLG L + L +N FS ++P+
Sbjct: 366 NNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFT 425
Query: 527 KLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISY 586
KL + LD+S I S+ M SL+ L+L+ N G + F L +D+S
Sbjct: 426 KLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKR-LENLDLSR 484
Query: 587 NALQGLIPNS-TAFRDAPMLALQGNKRLCGDIKR-LPPCK 624
N G +P + + L L NK L G+I L CK
Sbjct: 485 NQFSGAVPRKLGSLSELMQLKLSENK-LSGEIPDELSSCK 523
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 9e-41
Identities = 79/276 (28%), Positives = 122/276 (44%), Gaps = 26/276 (9%)
Query: 703 FDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN 761
++ +G+G G+VYKA TG+IVAVK Q E L ++ H N
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSK-KDQTARREIRILRRLSHPN 59
Query: 762 IVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT 821
IV+ H ++V EY E G L LS + + L Y+H+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHS 116
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPE-LAYT 880
N I+HRD+ +N+LL+ ++DFG++K L S+ T GT Y+APE L
Sbjct: 117 N---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 881 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940
K DV+S GV+ E++ GK P S + +++ L PL +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPP----------FSGENILDQLQLIRRILGPPLEFDE 223
Query: 941 DKLISIMEVSIS----CLDESPTSRPTMQKVSQLLK 972
K S E + CL++ P+ RPT + ++L+
Sbjct: 224 PKWSSGSEEAKDLIKKCLNKDPSKRPTAE---EILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 65/193 (33%), Positives = 99/193 (51%), Gaps = 10/193 (5%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G GG G+VY A TG+ VA+K + +E L E L K+ H NIVK YG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--EELLREIEILKKLNHPNIVKLYG 58
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
H ++V EY E GSL +L + + + + + + + L Y+H+N I
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 828 VHRDISSKNVLL-NLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPE-LAYTMKVTE 885
+HRD+ +N+LL + + ++DFG+SK L S + GT Y+APE L +E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 886 KCDVYSFGVLALE 898
K D++S GV+ E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 3e-40
Identities = 70/270 (25%), Positives = 120/270 (44%), Gaps = 23/270 (8%)
Query: 703 FDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN 761
++ +G G G VY A + TG++VA+K ++ L E L K++H N
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIK--KKKIKKDRERILREIKILKKLKHPN 58
Query: 762 IVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT 821
IV+ Y ++V EY E G L +L E + ++ + AL Y+H+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE-DEARFY--LRQILSALEYLHS 115
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTM 881
IVHRD+ +N+LL+ + ++DFG+++ L G T GT Y+APE+
Sbjct: 116 KG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFVGTPEYMAPEVLLGK 171
Query: 882 KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR--NV 939
+ D++S GV+ E++ GK P F L ++ P+ P P ++
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPP--FPG------DDQLLELFKKIGKPKPPFPPPEWDI 223
Query: 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQ 969
+ ++ L + P R T ++ Q
Sbjct: 224 SPEAKDLIR---KLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 4e-40
Identities = 107/285 (37%), Positives = 140/285 (49%), Gaps = 24/285 (8%)
Query: 333 TNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIP--------------- 377
N + + LS ++G I A+ L + +++LS N+LSG IP
Sbjct: 66 NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125
Query: 378 --------LSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLA 429
+ S+ +L TL L N L IP +IG SL +LDL N L G IP SL
Sbjct: 126 SNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT 185
Query: 430 NLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLS 489
NLT SL+ L L+SN +VG+IP G+ SL + L N LSG++ E+G L L +LDL
Sbjct: 186 NLT-SLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLV 244
Query: 490 ANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQV 549
N IP SLGNL L YL L N+ S IP I L L LDLS EIP V
Sbjct: 245 YNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV 304
Query: 550 CSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIP 594
+Q+LE L+L NN +G I + L + + N G IP
Sbjct: 305 IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIP 349
|
Length = 968 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 83/286 (29%), Positives = 125/286 (43%), Gaps = 53/286 (18%)
Query: 703 FDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN 761
F+ IG GG G VYKA TG+ VA+K +++ +NE L K +H N
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE---SKEKKEKIINEIQILKKCKHPN 58
Query: 762 IVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMN------AIKGVADA 815
IVK+YG ++V E+ GSL +L + + + K +
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKS--------TNQTLTESQIAYVCKELLKG 110
Query: 816 LLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAP 875
L Y+H+N I+HRDI + N+LL + E + DFG+S L + R + GT ++AP
Sbjct: 111 LEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAP 166
Query: 876 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNI--ALDEMLDPRLP 933
E+ K D++S G+ A+E+ +GK P S L AL ++
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKPPY-----------SELPPMKALFKI--ATNG 213
Query: 934 TPLRNVQDKLISIMEVSIS-------CLDESPTSRPTMQKVSQLLK 972
P L + + S CL ++P RPT QLLK
Sbjct: 214 PP------GLRNPEKWSDEFKDFLKKCLQKNPEKRPT---AEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 2e-35
Identities = 75/275 (27%), Positives = 117/275 (42%), Gaps = 35/275 (12%)
Query: 709 IGNGGQGSVYKAEL-----PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIV 763
+G G G VYK L VAVK + +EFL E + K+ H NIV
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNIV 64
Query: 764 KFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC 823
K G C+ +V EY+ G L L +E + ++ +A + Y+ +
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSFALQIARGMEYLESK- 122
Query: 824 FPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA-GTFGYIAPELAYTMK 882
+HRD++++N L+ +SDFG+S+ L + + ++APE K
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 883 VTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLD-----PRLPTPL 936
T K DV+SFGVL E+ G+ P ++ E+L+ RLP P
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYP-------------GMSNAEVLEYLKKGYRLPKP- 226
Query: 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
N +L +M C E P RPT ++ ++L
Sbjct: 227 PNCPPELYKLML---QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 76/277 (27%), Positives = 114/277 (41%), Gaps = 39/277 (14%)
Query: 709 IGNGGQGSVYKAEL-----PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIV 763
+G G G VYK L T VAVK E ++EFL E + + K+ H NIV
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEE--REEFLEEASIMKKLSHPNIV 64
Query: 764 KFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC 823
+ G C+ ++V EY+ G L L +M +A + Y+ +
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQM--ALQIAKGMEYLESKN 122
Query: 824 FPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF--GYIAPELAYTM 881
F VHRD++++N L+ +SDFG+S+ + R G ++APE
Sbjct: 123 F---VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 882 KVTEKCDVYSFGVLALEVI-------KGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934
K T K DV+SFGVL E+ G + + + RLP
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED--------------GYRLPR 225
Query: 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
P N D+L +M + C P RPT ++ + L
Sbjct: 226 P-ENCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 77/272 (28%), Positives = 118/272 (43%), Gaps = 30/272 (11%)
Query: 709 IGNGGQGSVYKAEL-----PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIV 763
+G G G VYK +L VAVK + +EFL E + K+ H N+V
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNVV 64
Query: 764 KFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC 823
K G C+ ++V EY+E G L L + + ++ +A + Y+ +
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 824 FPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA-GTFGYIAPELAYTMK 882
+HRD++++N L+ +SDFG+S+ L R ++APE K
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 883 VTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPLRNV 939
T K DV+SFGVL E+ G+ P +S N + E L RLP P N
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMS----------NEEVLEYLKNGYRLPQP-PNC 228
Query: 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
+L +M C E P RPT ++ ++L
Sbjct: 229 PPELYDLML---QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 73/282 (25%), Positives = 120/282 (42%), Gaps = 40/282 (14%)
Query: 709 IGNGGQGSVYKAEL----PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
+G G G VYK +L VAVK E +++FL E + K+ H N+V+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE--RKDFLKEARVMKKLGHPNVVR 60
Query: 765 FYGFCSHALHSFVVYEYLEMGSL------AMILSNDAAAEEFGWTKRMNAIKGVADALLY 818
G C+ ++V EY+E G L + + ++ +A + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF--GYIAPE 876
+ + VHRD++++N L+ + +SDFG+S+ + R + G ++APE
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 877 LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP----- 930
T K DV+SFGVL E+ G P ++ +E+L+
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP-------------GLSNEEVLEYLRKGY 224
Query: 931 RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
RLP P D+L +M SC P RPT ++ + L+
Sbjct: 225 RLPKP-EYCPDELYELML---SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 71/274 (25%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 707 HCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
+G G GSVY A TGE++AVK E + E L+ ++H NIV++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSE-EELEALEREIRILSSLQHPNIVRY 64
Query: 766 YGFCSHALHSF--VVYEYLEMGSLAMILSNDAAAEEF---GWTKRMNAIKGVADALLYMH 820
YG + + EY+ GSL+ +L E +T++ + + L Y+H
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ------ILEGLAYLH 118
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN--RTELAGTFGYIAPELA 878
+N IVHRDI N+L++ + ++DFG +K L + + GT ++APE+
Sbjct: 119 SNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 879 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938
+ D++S G +E+ GK P S + + L P +P +
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPW----SELGNPMAALYKIGSSGEPPEIPE---H 228
Query: 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ ++ + CL P RPT +LL+
Sbjct: 229 LSEEAKDFLR---KCLRRDPKKRPT---ADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 78/283 (27%), Positives = 120/283 (42%), Gaps = 43/283 (15%)
Query: 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
+ + +G G G VYK PTG+I A+KK H + G+ +++ L E L
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH--VDGDEEFRKQLLRELKTLRSCESP 59
Query: 761 NIVKFYGFCSHALHS----FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI--KGVAD 814
+VK YG A + +V EY++ GSLA D + + + A + +
Sbjct: 60 YVVKCYG----AFYKEGEISIVLEYMDGGSLA-----DLLKKVGKIPEPVLAYIARQILK 110
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIA 874
L Y+HT I+HRDI N+L+N + E ++DFGISK L+ L GT Y++
Sbjct: 111 GLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMS 168
Query: 875 PELAYTMKVTEKCDVYSFGVLALEVIKGKHP------RDFISSICSSLSSNLNIALDEML 928
PE + D++S G+ LE GK P F + I
Sbjct: 169 PERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ-------AICDGP-- 219
Query: 929 DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
P LP + + +CL + P RP+ ++LL
Sbjct: 220 PPSLPA--EEFSPEFRDFIS---ACLQKDPKKRPS---AAELL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 76/285 (26%), Positives = 128/285 (44%), Gaps = 45/285 (15%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQE--FLNEGNALTK 756
+ + + IG G G VYKA + TG+ VA+KK + Q + +NE +
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR------LRKQNKELIINEILIMKD 71
Query: 757 IRHRNIVKFYGFCSHAL--HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMN------A 808
+H NIV +Y S+ + +VV EY++ GSL I++ + RMN
Sbjct: 72 CKHPNIVDYYD--SYLVGDELWVVMEYMDGGSLTDIITQN--------FVRMNEPQIAYV 121
Query: 809 IKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAG 868
+ V L Y+H+ ++HRDI S N+LL+ + ++DFG + L S R + G
Sbjct: 122 CREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVG 178
Query: 869 TFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPR-DFISSICSSLSSNLNIALDEM 927
T ++APE+ K D++S G++ +E+ +G+ P L + I +
Sbjct: 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-----PPLRALFLITTKGI 233
Query: 928 LDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
P L P + + CL + P RP+ + +LL+
Sbjct: 234 --PPLKNP-EKWSPEFKDFLN---KCLVKDPEKRPSAE---ELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 71/275 (25%), Positives = 116/275 (42%), Gaps = 41/275 (14%)
Query: 708 CIGNGGQGSVYKAE-LPTGEIVAVKKF--HSPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
IG G G VYK L TG+ VA+K+ + + + E + L ++H NIVK
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEAL---KSIMQEIDLLKNLKHPNIVK 63
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
+ G + +++ EY E GSL I+ F + + V L Y+H
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQ-- 118
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVT 884
++HRDI + N+L + ++DFG++ L + + GT ++APE+ +
Sbjct: 119 -GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 885 EKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLN-------IALDEMLDPRLPTPLR 937
D++S G +E++ G P +LN I D+ P LP
Sbjct: 178 TASDIWSLGCTVIELLTGNPP-----------YYDLNPMAALFRIVQDDH--PPLPE--- 221
Query: 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ +L + C + P RPT + QLLK
Sbjct: 222 GISPELKDFLM---QCFQKDPNLRPTAK---QLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 74/277 (26%), Positives = 120/277 (43%), Gaps = 40/277 (14%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGF 768
IG G G VYK L VAVK S LP ++ +++FL E L + H NIVK G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDL--KRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 769 CSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADA---LLYMHT-NCF 824
C ++V E + GSL L ++ DA + Y+ + NC
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNR-----LTVKKLLQMSLDAAAGMEYLESKNC- 114
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI-----APELAY 879
+HRD++++N L+ +SDFG+S+ + G+ ++ I APE
Sbjct: 115 ---IHRDLAARNCLVGENNVLKISDFGMSREEEGGI---YTVSDGLKQIPIKWTAPEALN 168
Query: 880 TMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPL 936
+ T + DV+S+G+L E G P +S N E ++ R+P P
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPYPGMS----------NQQTRERIESGYRMPAP- 217
Query: 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLKI 973
+ +++ +M C P +RP+ ++ L+I
Sbjct: 218 QLCPEEIYRLML---QCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 69/210 (32%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQE------FLNEGNALTKIRHRN 761
IG+G GSVY +GE++AVK+ P + ++ E L +++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 762 IVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT 821
IV++ G A H + EY+ GS+A +L+N A EE T N ++ + L Y+H
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE---TLVRNFVRQILKGLNYLHN 124
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL------SNRTELAGTFGYIAP 875
I+HRDI N+L++ + +SDFGISK L+ R L G+ ++AP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 876 ELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
E+ T K D++S G L +E++ GKHP
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 75/281 (26%), Positives = 125/281 (44%), Gaps = 42/281 (14%)
Query: 706 EHCIGNGGQGSVYKAELPTG----EIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN 761
E IG G G V + L VA+K + + +FL E + + + H N
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL--DFLTEASIMGQFDHPN 66
Query: 762 IVKFYGFCSHALHSFVVYEYLEMGSLAMIL-SNDAAAEEFGWTKRMNAIKGVADALLYMH 820
I++ G + + ++ EY+E GSL L ND +F + + ++G+A + Y+
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLS 123
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFG--YIAPE-L 877
+ VHRD++++N+L+N VSDFG+S+ L+ + T G + APE +
Sbjct: 124 EMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI 180
Query: 878 AYTMKVTEKCDVYSFGVLALEVIK-GKHP------RDFISSICSSLSSNLNIALDEMLDP 930
AY K T DV+SFG++ EV+ G+ P +D I ++
Sbjct: 181 AYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV--------------EDGY 225
Query: 931 RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
RLP P + L +M + C + RPT ++ L
Sbjct: 226 RLPPP-MDCPSALYQLM---LDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 70/207 (33%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 703 FDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN 761
FD +G G GSVYKA TG++VA+K P+ ++ QE + E + L +
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDL---QEIIKEISILKQCDSPY 59
Query: 762 IVKFYGFCSHALHSFVVYEYLEMGSL--AMILSNDAAAEEFGWTKRMNAIKGVADALLYM 819
IVK+YG ++V EY GS+ M ++N EE +KG L Y+
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKG----LEYL 115
Query: 820 HTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAY 879
H+N +HRDI + N+LLN E +A ++DFG+S L ++ R + GT ++APE+
Sbjct: 116 HSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ 172
Query: 880 TMKVTEKCDVYSFGVLALEVIKGKHPR 906
+ K D++S G+ A+E+ +GK P
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPPY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 83/283 (29%), Positives = 124/283 (43%), Gaps = 49/283 (17%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVK--KFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
IG G G VY A L TGE++AVK + + +E +E L ++H N+VK+
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQ---DNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 766 YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL----YMHT 821
YG H ++ EY G+L +L E G + I+ LL Y+H+
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELL-------EHGRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT-------ELAGTFGYIA 874
+ IVHRDI N+ L+ + DFG + LK +N T LAGT Y+A
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK---NNTTTMGEEVQSLAGTPAYMA 171
Query: 875 PELAYTMKVTEK---CDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIA--LDEMLD 929
PE+ K D++S G + LE+ GK P S L + I +
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP-------WSELDNEFQIMFHVGAGHK 224
Query: 930 PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
P +P L+ + + ++ CL+ P RPT S+LL+
Sbjct: 225 PPIPDSLQ-LSPEGKDFLD---RCLESDPKKRPT---ASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 102 bits (253), Expect = 5e-23
Identities = 65/267 (24%), Positives = 114/267 (42%), Gaps = 16/267 (5%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH-RNIVKFYG 767
+G G G VY A ++VA+K L + + FL E L + H NIVK Y
Sbjct: 8 LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
F ++V EY++ GSL +L ++ + + + AL Y+H+ I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---I 122
Query: 828 VHRDISSKNVLLNLEY-EAHVSDFGISKFLKLGLSNR------TELAGTFGYIAPELAYT 880
+HRDI +N+LL+ + + DFG++K L S + GT GY+APE+
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 881 M---KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937
+ + D++S G+ E++ G P + + ++ + I P
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 938 NVQDKLISIMEVSISCLDESPTSRPTM 964
N + + ++ L + P +R +
Sbjct: 243 NPELISKAASDLLKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 75/270 (27%), Positives = 123/270 (45%), Gaps = 33/270 (12%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGF 768
+G+G G V+ + VA+K G M+ + +F+ E + K+ H N+V+ YG
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE---GAMS-EDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 769 CSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIV 828
C+ F+V EY+ G L L W ++ V +A+ Y+ +N F +
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNGF---I 122
Query: 829 HRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR-TELAGT---FGYIAPELAYTMKVT 884
HRD++++N L+ + VSDFG+++++ L ++ T GT + PE+ + +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYV---LDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 885 EKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKL 943
K DV+SFGVL EV +GK P + SN + RL P KL
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERF--------SNSEVVESVSAGYRLYRP------KL 225
Query: 944 IS--IMEVSISCLDESPTSRPTMQKVSQLL 971
+ + SC E P RP +K+ L
Sbjct: 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 75/280 (26%), Positives = 119/280 (42%), Gaps = 55/280 (19%)
Query: 708 CIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
IG G G V + G+ VAVK L + Q FL E + +T +RH N+V+ G
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKC----LKDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
++V EY+ GSL L + A + A+ V + + Y+ F
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD-VCEGMEYLEEKNF--- 123
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF--GYIAPELAYTMKVTE 885
VHRD++++NVL++ + A VSDFG++K G +G + APE K +
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFST 178
Query: 886 KCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLI 944
K DV+SFG+L E+ G+ P PR+ PL++V +
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPY-----------------------PRI--PLKDVVPHVE 213
Query: 945 S-------------IMEVSISCLDESPTSRPTMQKVSQLL 971
+ +V C + P RPT +++ + L
Sbjct: 214 KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (240), Expect = 6e-22
Identities = 74/278 (26%), Positives = 121/278 (43%), Gaps = 29/278 (10%)
Query: 702 NFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
++ IG G G VY G++ +K+ E +++ LNE L K+ H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE-KEREDALNEVKILKKLNHP 59
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAA-EEFGWTKRMNAIKGVADALLYM 819
NI+K+Y +V EY + G L+ + + F + ++ + AL Y+
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 820 HTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF-G---YIAP 875
H+ I+HRDI +N+ L + DFGISK LS+ +LA T G Y++P
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV----LSSTVDLAKTVVGTPYYLSP 172
Query: 876 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935
EL K D++S G + E+ KHP F L+ + + + +
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHP--FEGENLLELALKILKGQYPPIPSQYSSE 230
Query: 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLKI 973
LRN L+S S L + P RP+ ++Q+L+
Sbjct: 231 LRN----LVS------SLLQKDPEERPS---IAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 68/210 (32%), Positives = 102/210 (48%), Gaps = 28/210 (13%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPL-PGE--MACQQEFLNEGNALTKIRHRNIVK 764
IG+G G VYKA ++ TGE+VA+K L PG+ QQE L + RH NIV
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVI--KLEPGDDFEIIQQEIS----MLKECRHPNIVA 64
Query: 765 FYG--FCSHALHSFVVYEYLEMGSLAMILS-NDAAAEE--FGWTKRMNAIKGVADALLYM 819
++G L ++V EY GSL I E + R +KG L Y+
Sbjct: 65 YFGSYLRRDKL--WIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-ETLKG----LAYL 117
Query: 820 HTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELA- 878
H +HRDI N+LL + + ++DFG+S L ++ R GT ++APE+A
Sbjct: 118 HET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 879 --YTMKVTEKCDVYSFGVLALEVIKGKHPR 906
KCD+++ G+ A+E+ + + P
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 81/287 (28%), Positives = 120/287 (41%), Gaps = 55/287 (19%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFH-SPLPGEMACQQEFLNEGNALTKIRHRNIVKFY 766
IG G VY A LP E VA+K+ + E E A+++ H N+VK+Y
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV---DELRKEVQAMSQCNHPNVVKYY 65
Query: 767 GFCSHALHSFV-------VYEYLEMGSLAMIL----SNDAAAEEFGWTKRMNAIKGVADA 815
SFV V YL GSL I+ E T +K V
Sbjct: 66 T-------SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT----VLKEVLKG 114
Query: 816 LLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN----RTELAGTFG 871
L Y+H+N +HRDI + N+LL + ++DFG+S L G R GT
Sbjct: 115 LEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171
Query: 872 YIAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHP-RDF--ISSICSSLSSNLNIALDEM 927
++APE+ + K D++SFG+ A+E+ G P + + + +L ++
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-------- 223
Query: 928 LDPRLPTPLRNVQDKLIS--IMEVSISCLDESPTSRPTMQKVSQLLK 972
P L T K S ++ CL + P+ RPT +LLK
Sbjct: 224 -PPSLET---GADYKKYSKSFRKMISLCLQKDPSKRPT---AEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 74/272 (27%), Positives = 125/272 (45%), Gaps = 37/272 (13%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGF 768
+G+G G V+ + VA+K + G M +++F+ E + K+ H +V+ YG
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE---GAM-SEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 769 CSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIV 828
C+ ++V E++E G L L + ++ + V + + Y+ N F +
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNSF---I 122
Query: 829 HRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFG------YIAPELAYTMK 882
HRD++++N L++ VSDFG+++++ L + E + G + PE+ K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYV---LDD--EYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 883 VTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQD 941
+ K DV+SFGVL EV +GK P F SN + RL P
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMP--FEK------KSNYEVVEMISRGFRLYRP------ 223
Query: 942 KLIS--IMEVSISCLDESPTSRPTMQKVSQLL 971
KL S + EV SC E P RPT ++ + +
Sbjct: 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 7e-21
Identities = 74/273 (27%), Positives = 120/273 (43%), Gaps = 36/273 (13%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH---RNIVK 764
IG G G+VY+ +PTG +VA+K + P + + E L+++R NI K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV--SDIQREVALLSQLRQSQPPNITK 66
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
+YG +++ EY E GS+ ++ AE++ I+ V AL Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV----IIREVLVALKYIHKV-- 120
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL-----AY 879
++HRDI + N+L+ + DFG++ L S R+ GT ++APE+ Y
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 880 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939
K D++S G+ E+ G P S+++ ML P+ P
Sbjct: 180 DTKA----DIWSLGITIYEMATGNPPY-----------SDVDAFRAMMLIPKSKPPRLED 224
Query: 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ E +CLDE P R + +LLK
Sbjct: 225 NGYSKLLREFVAACLDEEPKERLS---AEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 74/281 (26%), Positives = 116/281 (41%), Gaps = 42/281 (14%)
Query: 708 CIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQ--QEFLNEGNALTKIRHRNIVK 764
IG G G+V K G+I+ K+ G M + Q+ ++E N L +++H NIV+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDY---GNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 765 FYGFCSHALHS------FVVYEYLEMGSLAMILS-----NDAAAEEFGWTKRMNAIKGVA 813
+Y + ++V EY E G LA ++ EEF W + +
Sbjct: 64 YY----DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQLL 115
Query: 814 DALLYMHTNCFPP--IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFG 871
AL H P ++HRD+ N+ L+ + DFG++K L S GT
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPY 175
Query: 872 YIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPR 931
Y++PE M EK D++S G L E+ P F + L+S + + R
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP--FTARNQLQLASKIKEGKFRRIPYR 233
Query: 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ L V I S L+ P RP+ +LL+
Sbjct: 234 YSSELNEV----IK------SMLNVDPDKRPS---TEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 67/243 (27%), Positives = 113/243 (46%), Gaps = 25/243 (10%)
Query: 728 VAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 787
VA+K G M+ + EF+ E + K+ H +V+ YG C+ ++V EY+ G L
Sbjct: 31 VAIKMIKE---GSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86
Query: 788 AMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV 847
L + F ++ + K V + + Y+ + F +HRD++++N L++ + V
Sbjct: 87 LNYLRE--HGKRFQPSQLLEMCKDVCEGMAYLESKQF---IHRDLAARNCLVDDQGCVKV 141
Query: 848 SDFGISKFLKLGLSNRTELAGTF--GYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKH 904
SDFG+S+++ L + + F + PE+ K + K DV++FGVL EV GK
Sbjct: 142 SDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKM 200
Query: 905 PRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTM 964
P + +N RL P +K+ +IM SC E RPT
Sbjct: 201 PYE--------RFNNSETVEKVSQGLRLYRP-HLASEKVYAIM---YSCWHEKAEERPTF 248
Query: 965 QKV 967
Q++
Sbjct: 249 QQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 73/275 (26%), Positives = 127/275 (46%), Gaps = 29/275 (10%)
Query: 706 EHCIGNGGQGSVYKAELPTG----EIVAVKKFHSPLPGEMACQ-QEFLNEGNALTKIRHR 760
+ IG G G V++ L VA+K PG Q Q+FL+E + + + H
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK---PGYTEKQRQDFLSEASIMGQFSHH 66
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMH 820
NI++ G + + ++ EY+E G+L L + EF + + ++G+A + Y+
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLS 124
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAG---TFGYIAPEL 877
+ VHRD++++N+L+N E VSDFG+S+ L+ +G + APE
Sbjct: 125 DMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 878 AYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936
K T DV+SFG++ EV+ G+ P +S+ + +N RLP P+
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKAINDGF------RLPAPM 233
Query: 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
D ++ ++ + C + RP + LL
Sbjct: 234 ----DCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 33/221 (14%)
Query: 709 IGNGGQGSVYKAEL----PTGE--IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
+G G G V+ E P + +VAVK + +++F E LT +H NI
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA--RKDFEREAELLTNFQHENI 70
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSLAMIL-----------SNDAAAEEFGWTKRMNAIKG 811
VKFYG C+ +V+EY+E G L L S D+ E ++ +
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 812 VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK------FLKLGLSNRTE 865
+A ++Y+ + F VHRD++++N L+ + + DFG+S+ + ++G T
Sbjct: 131 IASGMVYLASQHF---VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVG--GHTM 185
Query: 866 LAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 905
L ++ PE K T + DV+SFGV+ E+ GK P
Sbjct: 186 LP--IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 79/286 (27%), Positives = 136/286 (47%), Gaps = 44/286 (15%)
Query: 706 EHCIGNGGQGSVYKAEL-PTGE---IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN 761
E IG G G V + L G+ VA+K S + +++FL+E + + + H N
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ--RRDFLSEASIMGQFDHPN 66
Query: 762 IVKFYGFCSHALHSFVVYEYLEMGSLAMILS-NDAAAEEFGWTKRMNAIKGVADALLYMH 820
I+ G + + ++ E++E G+L L ND +F + + ++G+A + Y+
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLS 123
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI-----AP 875
+ VHRD++++N+L+N VSDFG+S+FL+ S+ T + G I AP
Sbjct: 124 EMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 876 ELAYTMKVTEKCDVYSFGVLALEVIK-GKHP------RDFISSICSSLSSNLNIALDEML 928
E K T DV+S+G++ EV+ G+ P +D I++I
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-------------- 226
Query: 929 DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTM-QKVSQLLKI 973
D RLP P+ D ++ ++ + C + +RP Q VS L K+
Sbjct: 227 DYRLPPPM----DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 70/264 (26%), Positives = 116/264 (43%), Gaps = 28/264 (10%)
Query: 709 IGNGGQGSVYKAEL--PTGEI--VAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
+G+G G V + E G++ VAVK S + +FL E + + H N+++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD--IMDDFLKEAAIMHSLDHENLIR 60
Query: 765 FYGFC-SHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC 823
YG +H L +V E +GSL L DA F + + +A+ + Y+ +
Sbjct: 61 LYGVVLTHPL--MMVTELAPLGSLLDRLRKDALG-HFLISTLCDYAVQIANGMRYLESKR 117
Query: 824 FPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN-RTE--LAGTFGYIAPELAYT 880
F +HRD++++N+LL + + + DFG+ + L + E L F + APE T
Sbjct: 118 F---IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 881 MKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939
+ DV+ FGV E+ G+ P + S + ++ + RL P
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP--WAGLSGSQILKKIDKEGE-----RLERPEACP 227
Query: 940 QDKLISIMEVSISCLDESPTSRPT 963
QD I V + C +P RPT
Sbjct: 228 QD----IYNVMLQCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 9e-20
Identities = 72/260 (27%), Positives = 124/260 (47%), Gaps = 29/260 (11%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGF 768
IG+G G V+ VA+K G M+ +++F+ E + K+ H +V+ YG
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE---GAMS-EEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 769 CSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIV 828
C+ +V+E++E G L+ L A +F + V + + Y+ ++ +
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLESSNV---I 122
Query: 829 HRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR-TELAGT---FGYIAPELAYTMKVT 884
HRD++++N L+ VSDFG+++F+ L ++ T GT + +PE+ K +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFV---LDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179
Query: 885 EKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKL 943
K DV+SFGVL EV +GK P + S+ S + +N + PRL +
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSN--SEVVETINAGF-RLYKPRLASQ-------- 228
Query: 944 ISIMEVSISCLDESPTSRPT 963
S+ E+ C E P RP+
Sbjct: 229 -SVYELMQHCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-19
Identities = 61/204 (29%), Positives = 106/204 (51%), Gaps = 23/204 (11%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQE-----FLNEGNALTKIRHRNI 762
IG G G+VY A ++ TG+ VA+K +M QQ+ +NE + + +H NI
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIK--------QMNLQQQPKKELIINEILVMRENKHPNI 78
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI-KGVADALLYMHT 821
V + +VV EYL GSL +++ E ++ A+ + AL ++H+
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE-----GQIAAVCRECLQALEFLHS 133
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTM 881
N ++HRDI S N+LL ++ ++DFG + S R+ + GT ++APE+
Sbjct: 134 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 190
Query: 882 KVTEKCDVYSFGVLALEVIKGKHP 905
K D++S G++A+E+++G+ P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 68/223 (30%), Positives = 110/223 (49%), Gaps = 36/223 (16%)
Query: 709 IGNGGQGSVYKAEL----PTGE--IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
+G G G V+ AE PT + +VAVK P +A +++F E LT ++H +I
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHI 69
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSL----------AMILSND---AAAEEFGWTKRMNAI 809
VKFYG C +V+EY++ G L AMIL + A E G ++ ++
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 810 KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK------FLKLGLSNR 863
+A ++Y+ + F VHRD++++N L+ + DFG+S+ + ++G
Sbjct: 130 SQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG--GH 184
Query: 864 TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 905
T L ++ PE K T + DV+SFGV+ E+ GK P
Sbjct: 185 TMLP--IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 69/267 (25%), Positives = 120/267 (44%), Gaps = 42/267 (15%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGF 768
+G G G V+ VAVK PG M+ + FL E + K+RH +V+ Y
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMS-PEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 769 CSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKG----VADALLYMHTNCF 824
CS ++V EY+ GSL L + G R+ + +A+ + Y+ + +
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGE-----GKKLRLPQLVDMAAQIAEGMAYLESRNY 124
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG-LSNRTELAGTFGYIAPELAYTMKV 883
+HRD++++N+L+ ++DFG+++ ++ + R + APE A +
Sbjct: 125 ---IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRF 181
Query: 884 TEKCDVYSFGVLALEVI-KGKHP------RDFISSICSSLSSNLNIALDEMLDPRLPTPL 936
T K DV+SFG+L E++ G+ P R+ + + R+P P
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV--------------ERGYRMPRP- 226
Query: 937 RNVQDKLISIMEVSISCLDESPTSRPT 963
N ++L +M + C D+ P RPT
Sbjct: 227 PNCPEELYDLM---LQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 69/261 (26%), Positives = 119/261 (45%), Gaps = 26/261 (9%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGF 768
+G G G V++ VAVK PG M ++FL E + K+RH +++ Y
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK---PGTMD-PKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 769 CSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIV 828
C+ ++V E ++ GSL L A + ++ VA + Y+ + +
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQNY---I 125
Query: 829 HRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN-RTELAGTFGYIAPELAYTMKVTEKC 887
HRD++++NVL+ V+DFG+++ +K + R + APE A + + K
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 888 DVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPLRNVQDKLI 944
DV+SFG+L E++ G+ P ++ N + + +D R+P P +L
Sbjct: 186 DVWSFGILLTEIVTYGRMPYPGMT----------NAEVLQQVDQGYRMPCP-PGCPKELY 234
Query: 945 SIMEVSISCLDESPTSRPTMQ 965
IM + C E P RPT +
Sbjct: 235 DIM---LDCWKEDPDDRPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 75/265 (28%), Positives = 115/265 (43%), Gaps = 27/265 (10%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G G V K PTG+I+AVK L A Q++ L E + L K IV FYG
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWT-----KRMNAIKGVADALLYMHTN 822
+ + EY++ GSL IL E G ++ V L Y+H
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILK-----EVQGRIPERILGKI--AVAVLKGLTYLHEK 119
Query: 823 CFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMK 882
I+HRD+ N+L+N + + DFG+S L L+ GT Y+APE
Sbjct: 120 H--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGND 175
Query: 883 VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDK 942
+ K D++S G+ +E+ G+ P + + L ++E PRLP K
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-PPRLP------SGK 228
Query: 943 LISIMEVSIS-CLDESPTSRPTMQK 966
+ ++ CL + P RP+ ++
Sbjct: 229 FSPDFQDFVNLCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 67/229 (29%), Positives = 108/229 (47%), Gaps = 31/229 (13%)
Query: 693 HEEIIRATK----------NFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEM 741
HE+ A + D+ IG G G V A + TG VAVKK ++
Sbjct: 1 HEQFRAALQLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM------DL 54
Query: 742 ACQQ--EFL-NEGNALTKIRHRNIVKFYGFCSHALHS--FVVYEYLEMGSLAMILSNDAA 796
QQ E L NE + +H NIV+ Y S+ + +VV E+LE G+L I+++
Sbjct: 55 RKQQRRELLFNEVVIMRDYQHPNIVEMYS--SYLVGDELWVVMEFLEGGALTDIVTHTRM 112
Query: 797 AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856
EE + V AL ++H ++HRDI S ++LL + +SDFG +
Sbjct: 113 NEE----QIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165
Query: 857 KLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
+ R L GT ++APE+ + + D++S G++ +E++ G+ P
Sbjct: 166 SKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 81/277 (29%), Positives = 122/277 (44%), Gaps = 39/277 (14%)
Query: 709 IGNGGQGSVYKA--ELPTG-EI-VAVKKFHSPLPGEMACQ-QEFLNEGNALTKIRHRNIV 763
+G+G GSV K + +G E+ VAVK +A +EFL E + + ++ H IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK---QEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 764 KFYGFC-SHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTN 822
+ G C L +V E +G L L E + VA + Y+ +
Sbjct: 60 RLIGVCKGEPL--MLVMELAPLGPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESK 114
Query: 823 CFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN--RTELAGTF--GYIAPELA 878
F VHRD++++NVLL ++A +SDFG+S+ L G S+ R AG + + APE
Sbjct: 115 HF---VHRDLAARNVLLVNRHQAKISDFGMSRALGAG-SDYYRATTAGRWPLKWYAPECI 170
Query: 879 YTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTP 935
K + K DV+S+GV E G P + + ML+ RLP P
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK----------GAEVIAMLESGERLPRP 220
Query: 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
++ SIM SC P RPT ++ +
Sbjct: 221 -EECPQEIYSIML---SCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 9e-19
Identities = 80/280 (28%), Positives = 122/280 (43%), Gaps = 42/280 (15%)
Query: 703 FDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKF---HSPLPGEMACQQEFLNEGNALTKIR 758
F CIG G G VYKA + T ++VA+K + E QQE L++ R
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED-IQQEI----QFLSQCR 57
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLY 818
I K+YG +++ EY GS +L + T ++ V L Y
Sbjct: 58 SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK----PGKLDETYIAFILREVLLGLEY 113
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELA 878
+H +HRDI + N+LL+ E + ++DFG+S L +S R GT ++APE+
Sbjct: 114 LHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI 170
Query: 879 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEM----LDPRLPT 934
EK D++S G+ A+E+ KG+ P LS L M L P+
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPP----------LSD-----LHPMRVLFLIPKNNP 215
Query: 935 PLRNVQDKLIS--IMEVSISCLDESPTSRPTMQKVSQLLK 972
P ++ S + CL++ P RP+ +LLK
Sbjct: 216 PS--LEGNKFSKPFKDFVSLCLNKDPKERPS---AKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 67/269 (24%), Positives = 126/269 (46%), Gaps = 24/269 (8%)
Query: 698 RATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI 757
R + F E +G+G G V++ VA+K S ++ QQ+F E AL ++
Sbjct: 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS---DDLLKQQDFQKEVQALKRL 59
Query: 758 RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL 817
RH++++ + CS +++ E +E GSL L + ++ VA+ +
Sbjct: 60 RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMA 118
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK--LGLSNRTELAGTFGYIAP 875
Y+ +HRD++++N+L+ + V+DFG+++ +K + LS+ ++ + + AP
Sbjct: 119 YLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAP 173
Query: 876 ELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934
E A + K DV+SFG+L E+ G+ P + +N + R+P
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM--------NNHEVYDQITAGYRMPC 225
Query: 935 PLRNVQDKLISIMEVSISCLDESPTSRPT 963
P + Q+ + IM + C P RP+
Sbjct: 226 PAKCPQE-IYKIM---LECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 27/268 (10%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGF 768
+GNG G V+ VAVK PG M+ + FL E + K+RH +V+ Y
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK---PGTMS-PESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 769 CSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIV 828
S ++V EY+ GSL L D ++ VA + Y+ + +
Sbjct: 70 VSEE-PIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIERMNY---I 124
Query: 829 HRDISSKNVLLNLEYEAHVSDFGISKFLKLG-LSNRTELAGTFGYIAPELAYTMKVTEKC 887
HRD+ S N+L+ ++DFG+++ ++ + R + APE A + T K
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 888 DVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPLRNVQDKLI 944
DV+SFG+L E++ KG+ P ++ N + E ++ R+P P QD I
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMN----------NREVLEQVERGYRMPCP----QDCPI 230
Query: 945 SIMEVSISCLDESPTSRPTMQKVSQLLK 972
S+ E+ + C + P RPT + + L+
Sbjct: 231 SLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVK--KFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
I G G V+ A+ TG+I A+K K + + + L E + L++ + +VK
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD-MIRKNQ-VDQVLTERDILSQAQSPYVVKL 58
Query: 766 YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFP 825
Y + ++V EYL G LA +L N + +E + I + AL Y+H+N
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE-DVAR--IYIAEIVLALEYLHSN--- 112
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT-----------ELAGTFGYIA 874
I+HRD+ N+L++ ++DFG+SK GL R + GT YIA
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKV---GLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 875 PELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
PE+ ++ D +S G + E + G P
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 64/222 (28%), Positives = 106/222 (47%), Gaps = 35/222 (15%)
Query: 709 IGNGGQGSVYKAE----LPTGE--IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
+G G G V+ AE LP + +VAVK + +Q+F E LT ++H++I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTVLQHQHI 69
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSL----------AMIL--SNDAAAEEFGWTKRMNAIK 810
V+FYG C+ +V+EY+ G L A IL D A + + +
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 811 GVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK------FLKLGLSNRT 864
+A ++Y+ + F VHRD++++N L+ + DFG+S+ + ++G RT
Sbjct: 130 QIASGMVYLASLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG--GRT 184
Query: 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 905
L ++ PE K T + D++SFGV+ E+ GK P
Sbjct: 185 MLP--IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 76/282 (26%), Positives = 117/282 (41%), Gaps = 44/282 (15%)
Query: 709 IGNGGQGSVYKAELP-----TGEIVAVKKF-HSPLPGEMACQQEFLNEGNALTKIRHRNI 762
+G G G V TGE VAVK HS GE + +F E L + H NI
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS---GEEQHRSDFEREIEILRTLDHENI 68
Query: 763 VKFYGFC--SHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIK------GVAD 814
VK+ G C ++ EYL GSL L ++N + +
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD--------QINLKRLLLFSSQICK 120
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG----LSNRTELAGTF 870
+ Y+ + +HRD++++N+L+ E +SDFG++K L + F
Sbjct: 121 GMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 871 GYIAPELAYTMKVTEKCDVYSFGVLALEVI----KGKHP-RDFISSICSSLSSNLNIALD 925
Y APE T K + DV+SFGV E+ + P +F+ I + + L
Sbjct: 178 WY-APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236
Query: 926 EMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQ 965
E+L RLP P + D++ +M+ C + P RP+
Sbjct: 237 ELLKEGERLPRP-PSCPDEVYDLMK---LCWEAEPQDRPSFA 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 5e-18
Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 23/204 (11%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQE-----FLNEGNALTKIRHRNI 762
IG G G+VY A ++ TG+ VA++ +M QQ+ +NE + + ++ NI
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI-KGVADALLYMHT 821
V + +VV EYL GSL +++ E ++ A+ + AL ++H+
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE-----GQIAAVCRECLQALEFLHS 134
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTM 881
N ++HRDI S N+LL ++ ++DFG + S R+ + GT ++APE+
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 882 KVTEKCDVYSFGVLALEVIKGKHP 905
K D++S G++A+E+I+G+ P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 5e-18
Identities = 58/198 (29%), Positives = 103/198 (52%), Gaps = 11/198 (5%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
IG G G+V+ A ++ TG+ VA+K+ + + ++ +NE + ++++ NIV F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQ---KQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
FVV EYL GSL +++ E + + AL ++H N +
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTETCMDE----AQIAAVCRECLQALEFLHAN---QV 136
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKC 887
+HRDI S NVLL ++ ++DFG + S R+ + GT ++APE+ K
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 888 DVYSFGVLALEVIKGKHP 905
D++S G++A+E+++G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 72/265 (27%), Positives = 121/265 (45%), Gaps = 22/265 (8%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGF 768
+G G G V+ VAVK PG M+ Q FL E N + ++H +V+ Y
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK---PGTMSVQA-FLEEANLMKTLQHDKLVRLYAV 69
Query: 769 CSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIV 828
+ +++ EY+ GSL L +D + K ++ +A+ + Y+ + +
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSDEGG-KVLLPKLIDFSAQIAEGMAYIERKNY---I 125
Query: 829 HRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAG-TFGYIAPELAYTMKVTEKC 887
HRD+ + NVL++ ++DFG+++ ++ E A + APE T K
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 888 DVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISI 946
DV+SFG+L E++ GK P +S +S++ AL R+P N D+L I
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMS------NSDVMSALQRGY--RMPRM-ENCPDELYDI 236
Query: 947 MEVSISCLDESPTSRPTMQKVSQLL 971
M+ +C E RPT + +L
Sbjct: 237 MK---TCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 7e-18
Identities = 83/280 (29%), Positives = 116/280 (41%), Gaps = 48/280 (17%)
Query: 709 IGNGGQGSVYKAELP-TGEIVAVKKFH-SPLPGEMACQQEFLNEGNALTKIRHRNIVKFY 766
+G G GSV K L TG I A+K P P Q++ L E + IVK+Y
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNP---DLQKQILRELEINKSCKSPYIVKYY 65
Query: 767 G-FCSHALHSF-VVYEYLEMGSLAMI----LSNDAAAEEFGWTKRMNAIKGVADALLYMH 820
G F + S + EY E GSL I E K V L Y+H
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAE---SVLKGLSYLH 122
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFG----YIAPE 876
+ I+HRDI N+LL + + + DFG+S +L S LAGTF Y+APE
Sbjct: 123 SR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNS----LAGTFTGTSFYMAPE 173
Query: 877 ----LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS------LSSNLNIALDE 926
Y++ DV+S G+ LEV + + P F LS +N+ E
Sbjct: 174 RIQGKPYSI----TSDVWSLGLTLLEVAQNRFP--FPPEGEPPLGPIELLSYIVNMPNPE 227
Query: 927 MLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQK 966
+ D P ++ ++ CL++ PT RPT
Sbjct: 228 LKDE--PGNGIKWSEEFKDFIKQ---CLEKDPTRRPTPWD 262
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 72/268 (26%), Positives = 126/268 (47%), Gaps = 33/268 (12%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGF 768
IG G G+V + E TG+ VAVK + Q FL E +TK+ H+N+V+ G
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA-----QAFLEETAVMTKLHHKNLVRLLGV 67
Query: 769 CSH-ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
H L+ +V E + G+L L A + + VA+ + Y+ + +
Sbjct: 68 ILHNGLY--IVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESK---KL 121
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKC 887
VHRD++++N+L++ + A VSDFG+++ +G+ N ++L + APE K + K
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN-SKLP--VKWTAPEALKHKKFSSKS 178
Query: 888 DVYSFGVLALEVI---KGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLI 944
DV+S+GVL EV + +P+ + + + ++P P +
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR------MEPPEGCP-----ADVY 227
Query: 945 SIMEVSISCLDESPTSRPTMQKVSQLLK 972
+M SC + P RP+ K+ + L+
Sbjct: 228 VLMT---SCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-17
Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 23/204 (11%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQE-----FLNEGNALTKIRHRNI 762
IG G G+VY A ++ TG+ VA+K +M QQ+ +NE + + ++ NI
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIK--------QMNLQQQPKKELIINEILVMRENKNPNI 78
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI-KGVADALLYMHT 821
V + +VV EYL GSL +++ E ++ A+ + AL ++H+
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE-----GQIAAVCRECLQALDFLHS 133
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTM 881
N ++HRDI S N+LL ++ ++DFG + S R+ + GT ++APE+
Sbjct: 134 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 190
Query: 882 KVTEKCDVYSFGVLALEVIKGKHP 905
K D++S G++A+E+++G+ P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 78/307 (25%), Positives = 130/307 (42%), Gaps = 55/307 (17%)
Query: 695 EIIRATKNFDDEHCIGNGGQGSVYKAEL--PTGE-------IVAVKKFHSPLPGEMACQQ 745
EI + F +E +G G G VYK EL P I +K+ P QQ
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-----KVQQ 53
Query: 746 EFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKR 805
EF E ++ ++H NIV G C+ + +++EYL G L L ++ + G
Sbjct: 54 EFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113
Query: 806 MNAIKG-------------VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852
+K +A + Y+ ++ F VHRD++++N L+ +SDFG+
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHHF---VHRDLAARNCLVGEGLTVKISDFGL 170
Query: 853 SKFLKLG----LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRD 907
S+ + + +++ L ++ PE K T + D++SFGV+ E+ G P
Sbjct: 171 SRDIYSADYYRVQSKSLLP--VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228
Query: 908 FISSICSSLSSNLNIALDEMLDPR--LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQ 965
S N + EM+ R LP P +D + + I C +E P RP +
Sbjct: 229 GFS----------NQEVIEMIRSRQLLPCP----EDCPARVYALMIECWNEIPARRPRFK 274
Query: 966 KVSQLLK 972
+ L+
Sbjct: 275 DIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 78/288 (27%), Positives = 118/288 (40%), Gaps = 54/288 (18%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFY 766
IG G G VYKA TG++VA+K + + ++E E N L K H NI FY
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMD--IIEDE--EEEIKEEYNILRKYSNHPNIATFY 69
Query: 767 GFCSHALHS------FVVYEYLEMGSL-----AMILSNDAAAEEFGWTKRMNAIKGVADA 815
G ++V E GS+ + EE W + ++
Sbjct: 70 GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEE--WIAYI--LRETLRG 125
Query: 816 LLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAP 875
L Y+H N ++HRDI +N+LL E + DFG+S L L R GT ++AP
Sbjct: 126 LAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAP 182
Query: 876 ELAYTMKVTE-----KCDVYSFGVLALEVIKGK------HPRDFISSICSSLSSNLNIAL 924
E+ + + + DV+S G+ A+E+ GK HP + I +
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP------- 235
Query: 925 DEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
P L +P N K + CL ++ RP M+ +LL+
Sbjct: 236 -----PTLKSP-ENWSKKFNDFIS---ECLIKNYEQRPFME---ELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-17
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQE---FLNEGNALTKIRHRNIVK 764
IG G G V A E +G VAVK ++ QQ NE + +H+N+V+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMM------DLRKQQRRELLFNEVVIMRDYQHQNVVE 82
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
Y +V+ E+L+ G+L I+S EE + + V AL Y+H+
Sbjct: 83 MYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEE----QIATVCESVLQALCYLHSQ-- 136
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVT 884
++HRDI S ++LL L+ +SDFG + + R L GT ++APE+
Sbjct: 137 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 885 EKCDVYSFGVLALEVIKGKHP 905
+ D++S G++ +E++ G+ P
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 72/274 (26%), Positives = 119/274 (43%), Gaps = 37/274 (13%)
Query: 709 IGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
IG G G V+ L VAVK LP ++ + +FL E L + H NIV+ G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIG 60
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
C+ ++V E ++ G L + + +M ++ A + Y+ +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM--VENAAAGMEYLESKH---C 115
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFG-------YIAPELAYT 880
+HRD++++N L+ + +SDFG+S+ + G+ A T G + APE
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGV-----YASTGGMKQIPVKWTAPEALNY 170
Query: 881 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNL-NIALDEMLDP--RLPTPLR 937
+ + + DV+SFG+L E S+ + +NL N E ++ RLP P
Sbjct: 171 GRYSSESDVWSFGILLWEAF----------SLGAVPYANLSNQQTREAIEQGVRLPCP-E 219
Query: 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
D + +ME C + P RP+ V Q L
Sbjct: 220 LCPDAVYRLME---RCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 68/273 (24%), Positives = 120/273 (43%), Gaps = 26/273 (9%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVK--KFHSPLPGEM-ACQQEFLNEGNALTKIRHRNIVK 764
+G G S Y+A ++ TG ++AVK + E + E + ++ H +I++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
G H + E++ GS++ +LS A +E +N + + L Y+H N
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AVIINYTEQLLRGLSYLHEN-- 122
Query: 825 PPIVHRDISSKNVLLNLE-YEAHVSDFGISKFLKLGLSNRTE----LAGTFGYIAPELAY 879
I+HRD+ N+L++ ++DFG + L + E L GT ++APE+
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 880 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939
+ CDV+S G + +E+ K P + + L+ IA P +P L
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWN-AEKHSNHLALIFKIA-SATTAPSIPEHLSP- 238
Query: 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ +V++ CL+ P RP +LLK
Sbjct: 239 -----GLRDVTLRCLELQPEDRP---PSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 8e-17
Identities = 40/85 (47%), Positives = 59/85 (69%), Gaps = 1/85 (1%)
Query: 34 NQ-LSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEV 92
NQ L G IP++I +L L ++L N ++G+IPPSLG++TSL +D+ N +GSIP +
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 93 GSLKSLSDLRLSNNSLNGSIPSSLG 117
G L SL L L+ NSL+G +P++LG
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 70/275 (25%), Positives = 120/275 (43%), Gaps = 39/275 (14%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMA--CQQEFLNEGNALTKIRHRNIVKF 765
+G+G GSVY+ L G+ AVK+ G+ ++ E L+K++H NIV++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 766 YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKR---MNAIKGVADALLYMHTN 822
G + ++ E + GSLA +L +++G + + L Y+H
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLL------KKYGSFPEPVIRLYTRQILLGLEYLHDR 121
Query: 823 CFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL----- 877
VHRDI N+L++ ++DFG++K + S G+ ++APE+
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 878 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937
Y + D++S G LE+ GK P S +++ I + L P +P L
Sbjct: 178 GYGLAA----DIWSLGCTVLEMATGKPP----WSQLEGVAAVFKIGRSKEL-PPIPDHLS 228
Query: 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ I CL P+ RPT ++LL+
Sbjct: 229 DEAKDFILK------CLQRDPSLRPT---AAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 79/281 (28%), Positives = 129/281 (45%), Gaps = 34/281 (12%)
Query: 710 GNGGQGSVYK---AELPTGEIVAVKKFHSPLPGEMACQQE--FLNEGNALTKIRHRNIVK 764
G+ G+ S+Y A TGE+VAVK L E Q + E N L + H NIVK
Sbjct: 15 GHFGKVSLYCYDPANDGTGEMVAVKT----LKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 765 FYGFCSHALHSFV--VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTN 822
+ G CS + + EY+ +GSL L + + + + + + + Y+H+
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 823 CFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG-LSNRTELAG---TFGYIAPELA 878
+ +HRD++++NVLL+ + + DFG++K + G R G F Y A E
Sbjct: 127 HY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECL 182
Query: 879 YTMKVTEKCDVYSFGVLALEVI-----KGKHPRDFISSICSSLSSNLNIALDEMLD--PR 931
K + DV+SFGV E++ K P+ F I + L E+L+ R
Sbjct: 183 KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242
Query: 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
LP P +N ++ +M+ +C + RPT + + +LK
Sbjct: 243 LPCP-KNCPQEVYILMK---NCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 71/288 (24%), Positives = 116/288 (40%), Gaps = 39/288 (13%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
IG G G VYKA + TGEIVA+KK E + L E L ++ H NI+K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA-LREIKLLKELNHPNIIKLLD 65
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
H ++V+E+++ +I + + + + L + H++ I
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYKLI---KDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR--TELAGTFGYIAPELAYTMKV-T 884
+HRD+ +N+L+N E ++DFG+++ G R T T Y APEL K +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLAR--SFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 885 EKCDVYSFGVLALEVIK------GKHPRDFISSIC--------------SSLSSNLNIAL 924
D++S G + E++ GK D + I +SL+ N +
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237
Query: 925 DEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ LP N + + ++ L P R T Q L
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLS---QMLHYDPHKRIT---AEQALA 279
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 77/286 (26%), Positives = 132/286 (46%), Gaps = 51/286 (17%)
Query: 706 EHCIGNGGQGSVYKAELPTG---EI-VAVKKFHSPLPGEMACQQ-EFLNEGNALTKIRHR 760
E IG G G V L EI VA+K + G Q+ +FL+E + + + H
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKA---GYTEKQRRDFLSEASIMGQFDHP 65
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSL-AMILSNDAAAEEFGWTKRMNAIKGVADALLYM 819
NI+ G + + +V EY+E GSL A + +D +F + + ++G+A + Y+
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYL 122
Query: 820 HTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGT-------FGY 872
+ VHRD++++N+L+N VSDFG+S+ L+ + E A T +
Sbjct: 123 SDMGY---VHRDLAARNILVNSNLVCKVSDFGLSRVLE----DDPEAAYTTRGGKIPIRW 175
Query: 873 IAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP------RDFISSICSSLSSNLNIALD 925
APE K T DV+S+G++ EV+ G+ P +D I +I +
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI------------E 223
Query: 926 EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
E RLP P+ D ++ ++ + C + RP +++ +L
Sbjct: 224 EGY--RLPAPM----DCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-16
Identities = 40/82 (48%), Positives = 52/82 (63%)
Query: 324 LSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASL 383
L G IPN+I+ LR L + LS N++ G+IP +LG++T L LDLS N +GSIP S L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 384 TSLTTLYLYENSLCDSIPKEIG 405
TSL L L NSL +P +G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 706 EHCIGNGGQGSVYKAELPT-GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
+H +G G G VY+ VAVK L + +EFL E + +I+H N+V+
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKT----LKEDTMEVEEFLKEAAVMKEIKHPNLVQ 66
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
G C+ +++ E++ G+L L + +E + ++ A+ Y+ F
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGT---FGYIAPE-LAYT 880
+HRD++++N L+ + V+DFG+S+ + T AG + APE LAY
Sbjct: 126 ---IHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLAYN 180
Query: 881 MKVTEKCDVYSFGVLALEV 899
K + K DV++FGVL E+
Sbjct: 181 -KFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQE---FLNEGNALTKIRHRNIVK 764
IG G G V A E TG+ VAVKK ++ QQ NE + H N+V
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM------DLRKQQRRELLFNEVVIMRDYHHENVVD 83
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
Y +VV E+LE G+L I+++ EE T ++ ++ AL Y+H
Sbjct: 84 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLR----ALSYLHNQ-- 137
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVT 884
++HRDI S ++LL + +SDFG + + R L GT ++APE+ +
Sbjct: 138 -GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196
Query: 885 EKCDVYSFGVLALEVIKGKHP 905
+ D++S G++ +E+I G+ P
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 61/195 (31%), Positives = 93/195 (47%), Gaps = 14/195 (7%)
Query: 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
IG G G V + G VAVK + A Q FL E + +T++RH N+V+
Sbjct: 11 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQL 64
Query: 766 YGFCSHALHS-FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
G ++V EY+ GSL L + + G + V +A+ Y+ N F
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANNF 123
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVT 884
VHRD++++NVL++ + A VSDFG++K S + + APE K +
Sbjct: 124 ---VHRDLAARNVLVSEDNVAKVSDFGLTKEAS---STQDTGKLPVKWTAPEALREKKFS 177
Query: 885 EKCDVYSFGVLALEV 899
K DV+SFG+L E+
Sbjct: 178 TKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 74/265 (27%), Positives = 116/265 (43%), Gaps = 24/265 (9%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G GSV K + +PTG ++A K H + + + +++ L E + + R IV FYG
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVH--IGAKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
+ + + E+++ GSL I K A+ L +H I
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR-----I 125
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKC 887
+HRDI N+L+N + + DFG+S L +++ GT Y++PE K T K
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD--TFVGTSTYMSPERIQGGKYTVKS 183
Query: 888 DVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLD------PRLPTPLRNVQD 941
DV+S G+ +E+ GK P F + + I LD + PRLP
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI-LDLLQQIVQEPPPRLP------SS 236
Query: 942 KLISIMEVSIS-CLDESPTSRPTMQ 965
+ + CL + PT RPT Q
Sbjct: 237 DFPEDLRDFVDACLLKDPTERPTPQ 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-16
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 709 IGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQE---FLNEGNALTKIRHRNIVK 764
IG G G V A + +G++VAVKK ++ QQ NE + +H N+V+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM------DLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
Y +VV E+LE G+L I+++ EE + +K AL +H
Sbjct: 82 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLK----ALSVLHAQ-- 135
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVT 884
++HRDI S ++LL + +SDFG + + R L GT ++APEL +
Sbjct: 136 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 885 EKCDVYSFGVLALEVIKGKHP 905
+ D++S G++ +E++ G+ P
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 21/222 (9%)
Query: 693 HEEIIRATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEG 751
H E++R IG G G V + T ++ A+K + E + LNE
Sbjct: 1 HFELLRV---------IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNER 51
Query: 752 NALTKIRHRNIVKF-YGFCSHALHSFVVYEYLEMGSLAM-ILSNDAAAEEFGWTKRMNAI 809
L ++ H +V Y F + ++V + L G L + +EE +
Sbjct: 52 RILQELNHPFLVNLWYSFQDEE-NMYLVVDLLLGGDLRYHLSQKVKFSEE---QVKFWIC 107
Query: 810 KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGT 869
+ + AL Y+H+ I+HRDI N+LL+ + H++DF I+ + + T +GT
Sbjct: 108 E-IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTSGT 162
Query: 870 FGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS 911
GY+APE+ + D +S GV A E ++GK P S
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 70/265 (26%), Positives = 121/265 (45%), Gaps = 25/265 (9%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
IG G G V+K + T ++VA+K L ++ E L++ + K+YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
+++ EYL GS A+ L +EF + +K + L Y+H+
Sbjct: 70 SYLKGTKLWIIMEYLGGGS-ALDLLRAGPFDEF---QIATMLKEILKGLDYLHSE---KK 122
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKC 887
+HRDI + NVLL+ + + ++DFG++ L R GT ++APE+ K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 182
Query: 888 DVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIM 947
D++S G+ A+E+ KG+ P +S+++ L P+ P +
Sbjct: 183 DIWSLGITAIELAKGEPP-----------NSDMHPMRVLFLIPKNNPPTL-TGEFSKPFK 230
Query: 948 EVSISCLDESPTSRPTMQKVSQLLK 972
E +CL++ P+ RPT + +LLK
Sbjct: 231 EFIDACLNKDPSFRPTAK---ELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 78/274 (28%), Positives = 122/274 (44%), Gaps = 30/274 (10%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEF--LNEGNALTK-IRHRNIVKF 765
+G G G+VY G+++AVK+ +A ++E+ L E L K ++H NIV++
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 766 YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI-KGVADALLYMHTNCF 824
G C + E++ GS++ IL+ E + K I GVA Y+H NC
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNNC- 122
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTE------LAGTFGYIAPELA 878
+VHRDI NV+L + DFG ++ L + T + GT ++APE+
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 879 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938
K D++S G E+ GK P ++S+ L++ I L PRLP
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPP---LASM-DRLAAMFYIGAHRGLMPRLPDSFSA 236
Query: 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
++ SCL RP+ QLL+
Sbjct: 237 AAIDFVT------SCLTRDQHERPS---ALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 6e-16
Identities = 67/268 (25%), Positives = 118/268 (44%), Gaps = 27/268 (10%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGF 768
+G G G V+ VA+K PG M + FL E + K+RH +V Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMM-PEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 769 CSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIV 828
S ++V E++ GSL L + + + ++ +AD + Y+ + +
Sbjct: 70 VSEE-PIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIERMNY---I 124
Query: 829 HRDISSKNVLLNLEYEAHVSDFGISKFLKLG-LSNRTELAGTFGYIAPELAYTMKVTEKC 887
HRD+ + N+L+ ++DFG+++ ++ + R + APE A + T K
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 888 DVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPLRNVQDKLI 944
DV+SFG+L E++ KG+ P +N + E ++ R+P P Q
Sbjct: 185 DVWSFGILLTELVTKGRVP----------YPGMVNREVLEQVERGYRMPCP----QGCPE 230
Query: 945 SIMEVSISCLDESPTSRPTMQKVSQLLK 972
S+ E+ C + P RPT + + L+
Sbjct: 231 SLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 6e-16
Identities = 71/275 (25%), Positives = 117/275 (42%), Gaps = 41/275 (14%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGF 768
+G G G V+ VA+K PG M+ + FL E + K+RH +V+ Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 769 CSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI----KGVADALLYMHTNCF 824
S ++V EY+ GSL L E G R+ + +A + Y+ +
Sbjct: 70 VSEE-PIYIVTEYMSKGSLLDFLKG-----EMGKYLRLPQLVDMAAQIASGMAYVERMNY 123
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG-LSNRTELAGTFGYIAPELAYTMKV 883
VHRD+ + N+L+ V+DFG+++ ++ + R + APE A +
Sbjct: 124 ---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 884 TEKCDVYSFGVLALEV-IKGKHPRDFISSICSSLSSNLNIALDEMLDP-----RLPTPLR 937
T K DV+SFG+L E+ KG+ P + E+LD R+P P
Sbjct: 181 TIKSDVWSFGILLTELTTKGRVPYP-------------GMVNREVLDQVERGYRMPCPPE 227
Query: 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ S+ ++ C + P RPT + + L+
Sbjct: 228 CPE----SLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-16
Identities = 69/267 (25%), Positives = 110/267 (41%), Gaps = 28/267 (10%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G GSVYK + L + A+K+ + +++ +NE L + H NI+ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKE 66
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAA-----EEFGWTKRMNAIKGVADALLYMHTN 822
+V EY G L+ +S E+ W + ++G L +H
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG----LQALHEQ 122
Query: 823 CFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMK 882
I+HRD+ S N+LL + D GISK LK ++ +T++ GT Y+APE+
Sbjct: 123 ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA-KTQI-GTPHYMAPEVWKGRP 177
Query: 883 VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDK 942
+ K D++S G L E+ P + S +L + P +P QD
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFEARS------MQDLRYKVQRGKYPPIPP--IYSQDL 229
Query: 943 LISIMEVSISCLDESPTSRPTMQKVSQ 969
I S L P RP K+
Sbjct: 230 QNFIR----SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 8e-16
Identities = 38/89 (42%), Positives = 58/89 (65%)
Query: 77 IDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSI 136
+ + N L G IPN++ L+ L + LS NS+ G+IP SLG++T+L L L N+ +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 137 PDEIGNLKFLSDLQVSYNTLSGAIPFSLG 165
P+ +G L L L ++ N+LSG +P +LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 8e-16
Identities = 62/194 (31%), Positives = 88/194 (45%), Gaps = 23/194 (11%)
Query: 724 TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFY--GFCSHALHSFVVYEY 781
TG VA+K + P E + F E ++ H NIV G L F V+EY
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEY 60
Query: 782 LEMGSLAMILSNDAA--AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL 839
+ +L +L+ D A A E T R+ V DAL H IVHRD+ +N+++
Sbjct: 61 VPGRTLREVLAADGALPAGE---TGRLML--QVLDALACAHNQ---GIVHRDLKPQNIMV 112
Query: 840 ---NLEYEAHVSDFGISKFL-------KLGLSNRTELAGTFGYIAPELAYTMKVTEKCDV 889
+ A V DFGI L L+ TE+ GT Y APE VT D+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 890 YSFGVLALEVIKGK 903
Y++G++ LE + G+
Sbjct: 173 YAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 71/278 (25%), Positives = 130/278 (46%), Gaps = 43/278 (15%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G+G G VYKA+ TG A K E+ ++F+ E + L++ +H NIV Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL---EDFMVEIDILSECKHPNIVGLYE 69
Query: 768 FCSHALHSFVVYEYLEMGSL-AMILSNDAAAEEFGWTKRMNAI-KGVADALLYMHTNCFP 825
+ +++ E+ + G+L +++L + E ++ + + + +AL ++H++
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELERGLTE----PQIRYVCRQMLEALNFLHSH--- 122
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAY--TMKV 883
++HRD+ + N+LL L+ + ++DFG+S K L R GT ++APE+ T K
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKD 182
Query: 884 TE---KCDVYSFGVLALEVIKGK------HPRDFISSICSSLSSNLNIALDEMLDPRLPT 934
K D++S G+ +E+ + + +P + I S L P +
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-------DQPSKWS 235
Query: 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ D L SCL + P RPT ++LLK
Sbjct: 236 --SSFNDFL-------KSCLVKDPDDRPT---AAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK-FY 766
+G G G V + TG++ A+K + + L E N L++I H IVK Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 767 GFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP 826
F + ++V EY G L LS + E + A + AL Y+H+
Sbjct: 61 AFQTE-EKLYLVLEYAPGGELFSHLSKEGRFSE-ERARFYAA--EIVLALEYLHSL---G 113
Query: 827 IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL----AYTMK 882
I++RD+ +N+LL+ + ++DFG++K L S GT Y+APE+ Y
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173
Query: 883 VTEKCDVYSFGVLALEVIKGKHP 905
V D +S GVL E++ GK P
Sbjct: 174 V----DWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 80/289 (27%), Positives = 129/289 (44%), Gaps = 47/289 (16%)
Query: 703 FDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHR 760
F+ +GNG G VYK + TG++ A+K E + E N L K HR
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEI----NMLKKYSHHR 73
Query: 761 NIVKFYGF------CSHALHSFVVYEYLEMGSLAMILSN---DAAAEEFGWTKRMNAIKG 811
NI +YG H ++V E+ GS+ ++ N +A E++ ++G
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 812 VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFG 871
+A L+ H ++HRDI +NVLL E + DFG+S L + R GT
Sbjct: 134 LAH--LHAHK-----VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 186
Query: 872 YIAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDE 926
++APE+ + + + D++S G+ A+E+ +G P +C +++
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP------LC-----DMHPMRAL 235
Query: 927 MLDPRLPTPL---RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
L PR P P + K I +E CL ++ SRP+ + QLLK
Sbjct: 236 FLIPRNPPPKLKSKKWSKKFIDFIE---GCLVKNYLSRPSTE---QLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 22/211 (10%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFL---------NEGNALTKIR 758
IG G G VY A + TGE++AVK+ LP +A + + +E L +
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVE--LPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLY 818
H NIV++ GF + + + EY+ GS+ L EE + + V + L Y
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-QLVRFFT--EQVLEGLAY 123
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN--RTELAGTFGYIAPE 876
+H+ I+HRD+ + N+L++ + +SDFGISK N + G+ ++APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 877 L--AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
+ +Y+ + K D++S G + LE+ G+ P
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 70/293 (23%), Positives = 119/293 (40%), Gaps = 50/293 (17%)
Query: 708 CIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKF 765
+G+G GSVY A TGE+VA+KK C L E +L K+ H NIVK
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNEHPNIVKL 63
Query: 766 YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFP 825
+ V+EY+E ++ F + + I + L ++H + F
Sbjct: 64 KEVFRENDELYFVFEYMEGNLYQLMKDRKGKP--FSESVIRSIIYQILQGLAHIHKHGF- 120
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR---TELAGTFGYIAPEL----- 877
HRD+ +N+L++ ++DFG+++ ++ +R T+ T Y APE+
Sbjct: 121 --FHRDLKPENLLVSGPEVVKIADFGLAREIR----SRPPYTDYVSTRWYRAPEILLRST 174
Query: 878 AYTMKVTEKCDVYSFGVLALEVIKGKHP-------RDFISSICS--------------SL 916
+Y+ V D+++ G + E+ + P D + ICS L
Sbjct: 175 SYSSPV----DIWALGCIMAELYTLR-PLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229
Query: 917 SSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969
+S L + L + N + I +++ L P RPT + Q
Sbjct: 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIK---DMLRWDPKKRPTASQALQ 279
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 10/209 (4%)
Query: 702 NFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN 761
+F+ + IG G G V+K + V K ++E ++E L K+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 762 IVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAA---AEEFGWTKRMNAIKGVADALLY 818
I+++Y +V EY E G L +L E+ W + + G+A +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELA 878
+H+ I+HRDI S N+ L+ + D G++K L + + GT Y++PEL
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC 173
Query: 879 YTMKVTEKCDVYSFGVLALEVIKGKHPRD 907
EK DV++ GV+ E GKHP D
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 72/288 (25%), Positives = 119/288 (41%), Gaps = 52/288 (18%)
Query: 709 IGNGGQGSVYKAELPTGE------IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
+G G G V+ A+ E +V VK + Q EF E + K+ H+N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNV 70
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADA------L 816
V+ G C A +++ EY ++G L L + +E ++ + VA +
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 817 LYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK------FLKLGLSNRTELAGTF 870
++ F VHRD++++N L++ + E VS +SK + KL R L
Sbjct: 131 DHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKL----RNALI-PL 182
Query: 871 GYIAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEML- 928
++APE + K DV+SFGVL EV +G+ P +S +E+L
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-------------EEVLN 229
Query: 929 -----DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
LP P +L +M C +P RP+ ++ L
Sbjct: 230 RLQAGKLELPVP-EGCPSRLYKLMT---RCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 68/269 (25%), Positives = 114/269 (42%), Gaps = 25/269 (9%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGF 768
+G G G V+K L VAVK LP E+ + FL+E L + H NIVK G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK--FLSEARILKQYDHPNIVKLIGV 60
Query: 769 CSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT-NCFPPI 827
C+ ++V E + G L +E + + A + Y+ + NC
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKK--KDELKTKQLVKFALDAAAGMAYLESKNC---- 114
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGT-FGYIAPELAYTMKVTEK 886
+HRD++++N L+ +SDFG+S+ G+ + + L + APE + + +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 887 CDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPLRNVQDKLI 944
DV+S+G+L E F +C N E ++ R+ P + D
Sbjct: 175 SDVWSYGILLWET--------FSLGVC-PYPGMTNQQAREQVEKGYRMSCPQKCPDD--- 222
Query: 945 SIMEVSISCLDESPTSRPTMQKVSQLLKI 973
+ +V C D P +RP ++ + L
Sbjct: 223 -VYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 4e-15
Identities = 81/289 (28%), Positives = 130/289 (44%), Gaps = 47/289 (16%)
Query: 703 FDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHR 760
F+ +GNG G VYK + TG++ A+K E +QE N L K HR
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEI----NMLKKYSHHR 63
Query: 761 NIVKFYG-FCSHAL-----HSFVVYEYLEMGSLAMILSN---DAAAEEFGWTKRMNAIKG 811
NI +YG F ++V E+ GS+ ++ N + EE W + +
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE--WIAYI--CRE 119
Query: 812 VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFG 871
+ L ++H + ++HRDI +NVLL E + DFG+S L + R GT
Sbjct: 120 ILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 176
Query: 872 YIAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDE 926
++APE+ + + K D++S G+ A+E+ +G P +C +++
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP------LC-----DMHPMRAL 225
Query: 927 MLDPRLPTPL---RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
L PR P P + K S +E SCL ++ + RPT + QL+K
Sbjct: 226 FLIPRNPAPRLKSKKWSKKFQSFIE---SCLVKNHSQRPTTE---QLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-15
Identities = 46/110 (41%), Positives = 66/110 (60%), Gaps = 1/110 (0%)
Query: 221 LYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSI 280
L LD L G IPN+I L+ L ++ L+ N++ G+IP S G++T L + L N+ + SI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 281 LEEIGNLKSLLHLQLNYNTLSGSIPLSLGS-LTNLATLYFSTNALSGSIP 329
E +G L SL L LN N+LSG +P +LG L + A+ F+ NA IP
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 79/285 (27%), Positives = 122/285 (42%), Gaps = 37/285 (12%)
Query: 703 FDDEHCI-----GNGGQGSVYKAELP-----TGEIVAVKKFHSPLPGEMACQQEFLNEGN 752
F++ H G G GSV TGE+VAVKK + ++F E
Sbjct: 1 FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL---RDFEREIE 57
Query: 753 ALTKIRHRNIVKFYGFCSHA--LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIK 810
L ++H NIVK+ G C A + +V EYL GSL L E K +
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYAS 115
Query: 811 GVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS-NRTELAG- 868
+ + Y+ + + VHRD++++N+L+ E + DFG++K L + G
Sbjct: 116 QICKGMEYLGSKRY---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGE 172
Query: 869 --TFGYIAPELAYTMKVTEKCDVYSFGVLALEVI----KGKHP-RDFISSI-CSSLSSNL 920
F Y APE K + DV+SFGV+ E+ K P +F+ + +
Sbjct: 173 SPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMI 231
Query: 921 NIALDEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPT 963
L E+L RLP P ++ +IM+ C + P+ RP+
Sbjct: 232 VYHLIELLKNNGRLPAPP-GCPAEIYAIMK---ECWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 8e-15
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 35/211 (16%)
Query: 708 CIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEG---------NALTKI 757
+G G G VYKA + TGEIVA+KK + EG + L ++
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIR----------LDNEEEGIPSTALREISLLKEL 55
Query: 758 RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL 817
+H NIVK ++V+EY +M L L K + + + L
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSI--MYQLLRGLA 112
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL 877
Y H++ I+HRD+ +N+L+N + ++DFG+++ + L T T Y APE+
Sbjct: 113 YCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169
Query: 878 -----AYTMKVTEKCDVYSFGVLALEVIKGK 903
Y+ V D++S G + E+I GK
Sbjct: 170 LLGSKHYSTAV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 69/287 (24%), Positives = 129/287 (44%), Gaps = 45/287 (15%)
Query: 709 IGNGGQGSVYKAEL----PTGE--IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
+G G G V+ AE P + +VAVK +++F E LT ++H +I
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD---ASDNARKDFHREAELLTNLQHEHI 69
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSL----------AMILSNDAAAEEFGWTKRMNAIKGV 812
VKFYG C +V+EY++ G L A++++ E ++ ++ + +
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 813 ADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK------FLKLGLSNRTEL 866
A ++Y+ + F VHRD++++N L+ + DFG+S+ + ++G T L
Sbjct: 130 AAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG--GHTML 184
Query: 867 AGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALD 925
++ PE K T + DV+S GV+ E+ GK P +S+ N ++
Sbjct: 185 P--IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---------NEVIE 233
Query: 926 EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ R+ R ++ +M + C P R ++++ LL+
Sbjct: 234 CITQGRVLQRPRTCPKEVYDLM---LGCWQREPHMRLNIKEIHSLLQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 69/263 (26%), Positives = 112/263 (42%), Gaps = 25/263 (9%)
Query: 708 CIGNGGQGSVYKA-ELPTGEIVAVKKFH-SPLPGEMACQQEFL-NEGNALTKIRHRNIVK 764
+G G G VY ++ TG +AVK+ P E + L E L ++H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
+YG + EY+ GS+ L A E K I + + Y+H+N
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI---LEGVEYLHSN-- 123
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA---GTFGYIAPELAYTM 881
IVHRDI N+L + + DFG SK L+ S+ T + GT +++PE+
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 882 KVTEKCDVYSFGVLALEVIKGKHP-RDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940
K DV+S G +E++ K P +F ++++ IA +P+LP+ +
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPPWAEF-----EAMAAIFKIATQPT-NPQLPSHVSPDA 236
Query: 941 DKLISIMEVSISCLDESPTSRPT 963
+ E+ RP+
Sbjct: 237 RNFLRR------TFVENAKKRPS 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 79/277 (28%), Positives = 124/277 (44%), Gaps = 41/277 (14%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTK-IRHRNIVKFY 766
+G G G VY A +L T +A+K+ +P + + L+E AL ++HRNIV++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKE----IPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 767 GFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP 826
G S + E + GSL+ +L + + + K + + L Y+H N
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---Q 128
Query: 827 IVHRDISSKNVLLNLEYEA--HVSDFGISKFLKLGLSNRTE-LAGTFGYIAPELAYTMKV 883
IVHRDI NVL+N Y +SDFG SK L G++ TE GT Y+APE V
Sbjct: 129 IVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLA-GINPCTETFTGTLQYMAPE------V 180
Query: 884 TEK--------CDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935
+K D++S G +E+ GK P FI + ++ + + ++ P +P
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGKPP--FI-ELGEPQAAMFKVGMFKI-HPEIPES 236
Query: 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
L I + C + P R + LL+
Sbjct: 237 LSAEAKNFI------LRCFEPDPDKRAS---AHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 63/217 (29%), Positives = 95/217 (43%), Gaps = 25/217 (11%)
Query: 698 RATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHS-------PLPGEMACQQEFLN 749
R+ F+ + IG G G VY+A + +GEIVA+KK P+ L
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--------LR 55
Query: 750 EGNALTKIRHRNIVKFYGFC--SHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMN 807
E L +RH NIV+ H F+V EY E LA +L N F ++
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTP--FSESQVKC 112
Query: 808 AIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA 867
+ + L Y+H N I+HRD+ N+LL + ++DFG+++ L T
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169
Query: 868 GTFGYIAPELAYTMKV-TEKCDVYSFGVLALEVIKGK 903
T Y APEL T D+++ G + E++ K
Sbjct: 170 VTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 67/274 (24%), Positives = 110/274 (40%), Gaps = 50/274 (18%)
Query: 709 IGNGGQGSVYKAE-LPTGE----IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIV 763
+G+G G+VYK +P GE VA+K + +E L+E + + H ++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPK--ANKEILDEAYVMASVDHPHVV 72
Query: 764 KFYGFC---SHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMH 820
+ G C L + + + +G L + N G +N +A + Y+
Sbjct: 73 RLLGICLSSQVQL----ITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLE 126
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFG-----YIAP 875
+VHRD++++NVL+ ++DFG++K L + E G ++A
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD---VDEKEYHAEGGKVPIKWMAL 180
Query: 876 ELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLD----- 929
E T K DV+S+GV E++ G P + I E+ D
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-------------GIPAVEIPDLLEKG 227
Query: 930 PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPT 963
RLP P I + V + C SRPT
Sbjct: 228 ERLPQP----PICTIDVYMVLVKCWMIDAESRPT 257
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 64/282 (22%), Positives = 126/282 (44%), Gaps = 29/282 (10%)
Query: 695 EIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNAL 754
EI R + + + +G G G V+ A VAVK PG M+ + FL E N +
Sbjct: 2 EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEA-FLAEANVM 55
Query: 755 TKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVAD 814
++H +VK + + +++ E++ GSL L +D +++ K ++ +A+
Sbjct: 56 KTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAE 113
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAG-TFGYI 873
+ ++ + +HRD+ + N+L++ ++DFG+++ ++ E A +
Sbjct: 114 GMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT 170
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISS--ICSSLSSNLNIALDEMLDP 930
APE T K DV+SFG+L +E++ G+ P +S+ + +L + P
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-------P 223
Query: 931 RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
R + + + + C P RPT + + +L
Sbjct: 224 RPENCPEELYN-------IMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 79/275 (28%), Positives = 136/275 (49%), Gaps = 35/275 (12%)
Query: 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQ--QEFLNEGNALTKI 757
K F D IG+G G+VY A ++ T E+VA+KK G+ + + Q+ + E L ++
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQQL 72
Query: 758 RHRNIVKFYGFCSHALHS-FVVYEYLEMGSLAMILS-NDAAAEEFGWTKRMNAI-KGVAD 814
RH N +++ G C H+ ++V EY +GS + IL + +E + AI G
Sbjct: 73 RHPNTIEYKG-CYLREHTAWLVMEYC-LGSASDILEVHKKPLQEV----EIAAICHGALQ 126
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIA 874
L Y+H++ +HRDI + N+LL ++DFG + +S GT ++A
Sbjct: 127 GLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASL----VSPANSFVGTPYWMA 179
Query: 875 PELAYTM---KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPR 931
PE+ M + K DV+S G+ +E+ + K P F + S+L +IA ++ P
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSAL---YHIAQND--SPT 233
Query: 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQK 966
L + + D + ++ SCL + P RP+ ++
Sbjct: 234 LSS--NDWSDYFRNFVD---SCLQKIPQDRPSSEE 263
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 58/199 (29%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
IG G G V+KA + TGE VA+KK E + L E AL +H +VK
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRR-LEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKR--MNAIKGVADALLYMHTNCFP 825
H +V EY+ L+ +L ++ K +KGVA YMH N
Sbjct: 67 VFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVA----YMHAN--- 118
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR-TELAGTFGYIAPELAY-TMKV 883
I+HRD+ N+L++ + ++DFG+++ + T Y APEL Y K
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178
Query: 884 TEKCDVYSFGVLALEVIKG 902
D+++ G + E++ G
Sbjct: 179 DPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 75/272 (27%), Positives = 130/272 (47%), Gaps = 31/272 (11%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G+G G VYKA+ TG + A K + E+ ++++ E L H IVK G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYMVEIEILATCNHPYIVKLLG 76
Query: 768 FCSHALHSFVVYEYLEMGSL-AMILSNDAAAEEFGWTKRMNAI-KGVADALLYMHTNCFP 825
+++ E+ G++ A++L D E ++ I + + +AL Y+H+
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTE----PQIQVICRQMLEALQYLHSM--- 129
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAY--TMKV 883
I+HRD+ + NVLL L+ + ++DFG+S L R GT ++APE+ TMK
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 884 TE---KCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940
T K D++S G+ +E+ + + P + + + L IA E P L P +
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHEL----NPMRVLLKIAKSE--PPTLSQPSKWSM 243
Query: 941 DKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ + + LD+ P +RP+ +QLL+
Sbjct: 244 E----FRDFLKTALDKHPETRPS---AAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 18/198 (9%)
Query: 709 IGNGGQGSVYKA---ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
+G+G G+V K + + VAVK + + A + E L E N + ++ + IV+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKND-NNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 766 YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFP 825
G C A +V E E+G L L + E T+ + V+ + Y+ F
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITE---LVHQVSMGMKYLEETNF- 116
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFG-----YIAPELAYT 880
VHRD++++NVLL ++ A +SDFG+SK LG A T G + APE
Sbjct: 117 --VHRDLAARNVLLVTQHYAKISDFGLSK--ALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 881 MKVTEKCDVYSFGVLALE 898
K + K DV+SFGVL E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 75/266 (28%), Positives = 119/266 (44%), Gaps = 27/266 (10%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
IG G G VYK + T E+VA+K L ++ E L++ I ++YG
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
+++ EYL GS +L E + T +KG L Y+H+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKG----LDYLHSE---RK 122
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKC 887
+HRDI + NVLL+ + + ++DFG++ L R GT ++APE+ K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182
Query: 888 DVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPR-LPTPLRNVQDKLISI 946
D++S G+ A+E+ KG+ P +S+L+ L P+ P L K
Sbjct: 183 DIWSLGITAIELAKGEPP-----------NSDLHPMRVLFLIPKNSPPTLEGQYSK--PF 229
Query: 947 MEVSISCLDESPTSRPTMQKVSQLLK 972
E +CL++ P RPT + +LLK
Sbjct: 230 KEFVEACLNKDPRFRPTAK---ELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 5e-14
Identities = 74/276 (26%), Positives = 128/276 (46%), Gaps = 35/276 (12%)
Query: 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
K F D IG+G G+VY A ++ T E+VA+KK Q+ + E L +I+H
Sbjct: 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYM 819
N +++ G +++V EY +GS + +L + + + G L Y+
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYL 141
Query: 820 HTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAY 879
H++ ++HRDI + N+LL + ++DFG + S GT ++APE+
Sbjct: 142 HSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI----ASPANSFVGTPYWMAPEVIL 194
Query: 880 TMKVTE---KCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP- 935
M + K DV+S G+ +E+ + K P + +++S+ +IA +E P L +
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSALYHIAQNE--SPTLQSNE 248
Query: 936 ----LRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
RN D SCL + P RPT +++
Sbjct: 249 WSDYFRNFVD----------SCLQKIPQDRPTSEEL 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-14
Identities = 36/82 (43%), Positives = 51/82 (62%)
Query: 180 LSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNL 239
L G IPN+I L+ L + L N++ G+I S G++T LE+L L N+ +G IP +G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 240 KSLLALQLNYNTLSGSIPCSFG 261
SL L LN N+LSG +P + G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 70/279 (25%), Positives = 132/279 (47%), Gaps = 30/279 (10%)
Query: 706 EHCIGNGGQGSVYKAELPTG--EIVAVKK--FHSPLPGEMACQQE-----FLNEGNALTK 756
EH +G+G G VYK ++A+K+ H+P G+ +++ ++E + +
Sbjct: 6 EH-LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 757 -IRHRNIVKFYGFCSHALHSFVVYEYLEMGSLA-MILSNDAAAEEFGWTKRMNAIKGVAD 814
+RH NIV++Y ++V + +E L S + F + N +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIA 874
AL Y+H IVHRD++ N++L + + ++DFG++K K S T + GT Y
Sbjct: 125 ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVGTILYSC 181
Query: 875 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934
PE+ EK DV++FG + ++ + P F S+ SL++ + ++ + +P
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPP--FYSTNMLSLATKI---VEAVYEP---- 232
Query: 935 PLRNVQDKLIS--IMEVSISCLDESPTSRPTMQKVSQLL 971
+ + + S + +V SCL +RP + +VS ++
Sbjct: 233 ----LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGE--MACQQEFLNEGNALTKIRHRNIVKF 765
IG+G G VYKA + TGE+ A+K PGE QQE + + +H NIV +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLE-PGEDFAVVQQEII----MMKDCKHSNIVAY 71
Query: 766 YGFCSHALHSFVVYEYLEMGSLAMI--LSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC 823
+G ++ E+ GSL I ++ + + + R ++G L Y+H+
Sbjct: 72 FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR-ETLQG----LYYLHSK- 125
Query: 824 FPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMK- 882
+HRDI N+LL ++DFG+S + ++ R GT ++APE+A +
Sbjct: 126 --GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 883 --VTEKCDVYSFGVLALEVIKGKHP 905
+ CD+++ G+ A+E+ + + P
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 8e-14
Identities = 70/260 (26%), Positives = 117/260 (45%), Gaps = 22/260 (8%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
IG G G V+K + T ++VA+K L ++ E L++ + K+YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
+++ EYL GS +L E T+ ++ + L Y+H+
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDE----TQIATILREILKGLDYLHSE---KK 122
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKC 887
+HRDI + NVLL+ E ++DFG++ L R GT ++APE+ K
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 888 DVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIM 947
D++S G+ A+E+ KG+ P S L + L +P PT N L +
Sbjct: 183 DIWSLGITAIELAKGEPPH-------SELHPMKVLFLIPKNNP--PTLEGNYSKPLKEFV 233
Query: 948 EVSISCLDESPTSRPTMQKV 967
E +CL++ P+ RPT +++
Sbjct: 234 E---ACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 64/223 (28%), Positives = 109/223 (48%), Gaps = 27/223 (12%)
Query: 695 EIIRATKNFDDE--HCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGE--MACQQEFLN 749
+I+R D E +G+G G VYKA L TGE+ AVK PG+ QQE
Sbjct: 1 DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE-PGDDFSLIQQEIF- 58
Query: 750 EGNALTKIRHRNIVKFYG--FCSHALHSFVVYEYLEMGSLAMI--LSNDAAAEEFGWTKR 805
+ + +H NIV ++G L ++ EY GSL I ++ + + + R
Sbjct: 59 ---MVKECKHCNIVAYFGSYLSREKL--WICMEYCGGGSLQDIYHVTGPLSELQIAYVCR 113
Query: 806 MNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTE 865
++G+A Y+H+ +HRDI N+LL + ++DFG++ + ++ R
Sbjct: 114 -ETLQGLA----YLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS 165
Query: 866 LAGTFGYIAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHP 905
GT ++APE+A K + CD+++ G+ A+E+ + + P
Sbjct: 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-13
Identities = 38/91 (41%), Positives = 51/91 (56%)
Query: 5 LGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSI 64
LGL G IP +I L HL+ ++ S N + G IP +G ++SL L L N GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 65 PPSLGNLTSLIYIDIGNNLLSGSIPNEVGSL 95
P SLG LTSL +++ N LSG +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 72/271 (26%), Positives = 122/271 (45%), Gaps = 40/271 (14%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G GSVYK PTG +A+K+ L + + + + E + L K IV FYG
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP- 826
++ EY++ GSL + + A E + ++ + A++
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATE----GIPEDVLRRITYAVV-KGLKFLKEE 121
Query: 827 --IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPE-------- 876
I+HRD+ NVL+N + + DFG+S L L+ +T + G Y+APE
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA-KTNI-GCQSYMAPERIKSGGPN 179
Query: 877 --LAYTMKVTEKCDVYSFGVLALEVIKGKHPR--DFISSICSSLSSNLNIALDEMLDPRL 932
YT+ + DV+S G+ LE+ G++P + ++I + LS A+ + P L
Sbjct: 180 QNPTYTV----QSDVWSLGLSILEMALGRYPYPPETYANIFAQLS-----AIVDGDPPTL 230
Query: 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPT 963
P+ + ++ CL++ P RPT
Sbjct: 231 PSGYSDDAQDFVA------KCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 54/286 (18%)
Query: 709 IGNGGQGSVYKAELPTGEI---VAVKKFHSPLPGEMACQ---QEFLNEGNALTKI-RHRN 761
IG G G V KA + + A+K+ E A + ++F E L K+ H N
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMK-----EYASKDDHRDFAGELEVLCKLGHHPN 69
Query: 762 IVKFYGFCSHALHSFVVYEYLEMGSL------AMILSNDAA-------AEEFGWTKRMNA 808
I+ G C H + ++ EY G+L + +L D A A + ++
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 809 IKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAG 868
VA + Y+ F +HRD++++N+L+ Y A ++DFG+S+ +
Sbjct: 130 AADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKK 180
Query: 869 TFG-----YIAPE-LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLN 921
T G ++A E L Y++ T DV+S+GVL E++ G P + C+ L L
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTP--YCGMTCAELYEKLP 237
Query: 922 IALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
RL PL N D++ +M C E P RP+ ++
Sbjct: 238 QGY------RLEKPL-NCDDEVYDLMR---QCWREKPYERPSFAQI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 71/282 (25%), Positives = 113/282 (40%), Gaps = 36/282 (12%)
Query: 709 IGNGGQGSVYKAELPTGEIVA---VKKFH-SPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
IGNG G V E G A VK+ S P E Q FL E ++ H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDE---QLLFLQEVQPYRELNHPNVLQ 59
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRM--NAIKGVADALLYMHTN 822
G C ++ +V E+ +G L L ++ K + VA LL++H
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 823 CFPPIVHRDISSKNVLLNLEYEAHVSDFGI--SKFLKLGLSNRTELAGTFGYIAPELA-- 878
F +H D++ +N L + + D+G+ ++ + + A ++APEL
Sbjct: 120 DF---IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 879 -----YTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSN--LNIALDEMLDP 930
T+K +++S GV E+ P LS L + E D
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY-------PDLSDEQVLKQVVREQ-DI 228
Query: 931 RLPTPLRNVQDKLIS-IMEVSISCLDESPTSRPTMQKVSQLL 971
+LP P + K EV C P +RPT ++V +LL
Sbjct: 229 KLPKP--QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 53/237 (22%), Positives = 88/237 (37%), Gaps = 48/237 (20%)
Query: 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-R 758
+F IG G +V A E T + A+K + + E LT++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLE----------MGSLAMILSNDAAAEEFGWTKRMNA 808
H I+K Y + + V EY GSL + AAE
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAE---------- 110
Query: 809 IKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL------------ 856
+ AL Y+H+ I+HRD+ +N+LL+ + ++DFG +K L
Sbjct: 111 ---ILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164
Query: 857 --------KLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
+ GT Y++PEL + D+++ G + +++ GK P
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 52/189 (27%), Positives = 79/189 (41%), Gaps = 29/189 (15%)
Query: 728 VAVKKFHSPLPGE-MACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGS 786
VAVK P +++FL E L+++ NI + G C+ ++ EY+E G
Sbjct: 49 VAVKV---LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105
Query: 787 LAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT------------NCFPPIVHRDISS 834
L L A N+ LLYM T N VHRD+++
Sbjct: 106 LNQFLQKHVAETS---GLACNSKSLSFSTLLYMATQIASGMRYLESLN----FVHRDLAT 158
Query: 835 KNVLLNLEYEAHVSDFGISKFLKLG----LSNRTELAGTFGYIAPELAYTMKVTEKCDVY 890
+N L+ Y ++DFG+S+ L + R L ++A E K T K DV+
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLP--IRWMAWESVLLGKFTTKSDVW 216
Query: 891 SFGVLALEV 899
+FGV E+
Sbjct: 217 AFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 70/266 (26%), Positives = 114/266 (42%), Gaps = 39/266 (14%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G+G G+VYKA L T I+AVK PL + Q++ ++E L K I+ FYG
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVI--PLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 768 --FCSHALHSFVVYEYLEMGSLAM-------ILSNDAAAEEFGWTKRMNAIKGVADALLY 818
F + + + E+++ GSL + +L A A V L Y
Sbjct: 67 AFFVENRIS--ICTEFMDGGSLDVYRKIPEHVLGRIAVA--------------VVKGLTY 110
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELA 878
+ + I+HRD+ N+L+N + + DFG+S +L S GT Y+APE
Sbjct: 111 LWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVST--QLVNSIAKTYVGTNAYMAPERI 165
Query: 879 YTMKVTEKCDVYSFGVLALEVIKGKHPR-DFISSICSSLSSNLNIALDEMLDPRLPTPLR 937
+ DV+S G+ +E+ G+ P + S + L + + P LP
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ- 224
Query: 938 NVQDKLISIMEVSISCLDESPTSRPT 963
+K + + C+ + P RP
Sbjct: 225 -FSEKFVHFI---TQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 3e-13
Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 36/212 (16%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEF----LNEGNALTKIRHRNIV 763
IG G G VYKA TGE+VA+KK + E ++ F + E L K+RH NIV
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKK----IRMENE-KEGFPITAIREIKLLQKLRHPNIV 61
Query: 764 KFYGFC-SHALHS-FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL---- 817
+ S S ++V+EY++ L +L + +F + IK LL
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDS--PEVKFT----ESQIKCYMKQLLEGLQ 114
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL-KLGLSNRTELAGTFGYIAPE 876
Y+H+N I+HRDI N+L+N + ++DFG+++ K ++ T T Y PE
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171
Query: 877 L-----AYTMKVTEKCDVYSFGVLALEVIKGK 903
L Y +V D++S G + E+ GK
Sbjct: 172 LLLGATRYGPEV----DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 48/287 (16%)
Query: 706 EHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-R 758
E IG G G V +A + I +K+F S ++F E L K+
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEND-----HRDFAGELEVLCKLGH 61
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSL------AMILSNDAA-AEEFGWTKRMNA--- 808
H NI+ G C + + ++ EY G+L + +L D A A+E G + +
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 809 IKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAG 868
++ +D M +HRD++++NVL+ + ++DFG+S+ +
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR------GEEVYVKK 175
Query: 869 TFG-----YIAPE-LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLN 921
T G ++A E L Y++ T K DV+SFGVL E++ G P + C+ L L
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTT-KSDVWSFGVLLWEIVSLGGTP--YCGMTCAELYEKLP 232
Query: 922 IALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVS 968
R+ P RN D++ +M C + P RP ++S
Sbjct: 233 QGY------RMEKP-RNCDDEVYELMR---QCWRDRPYERPPFAQIS 269
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 30/209 (14%)
Query: 707 HCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
+G G G V K TGEIVA+KKF E ++ L E L ++RH NIV
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDV-KKTALREVKVLRQLRHENIVNL 65
Query: 766 YGFCSHALHSFVVYEYLEMGSLAMI------LSNDAAAEEFGWTKRMNAIKGVADALLYM 819
++V+EY+E L ++ L DA + I + A+ Y
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDA-------VRSY--IWQLLQAIAYC 116
Query: 820 HTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG-LSNRTELAGTFGYIAPEL- 877
H++ I+HRDI +N+L++ + DFG ++ L+ S T+ T Y APEL
Sbjct: 117 HSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELL 173
Query: 878 ----AYTMKVTEKCDVYSFGVLALEVIKG 902
Y V DV++ G + E++ G
Sbjct: 174 VGDTNYGKPV----DVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 70/294 (23%), Positives = 117/294 (39%), Gaps = 61/294 (20%)
Query: 709 IGNGGQGSVYK---AELPTGEI---VAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
+G G G VY+ + GE VA+K + M + EFLNE + + + ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN--ASMRERIEFLNEASVMKEFNCHHV 71
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEF-------GWTKRMNAIKGVADA 815
V+ G S + VV E + G L L + E K + +AD
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 816 LLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK-------FLKLG---LSNRTE 865
+ Y+ F VHRD++++N ++ + + DFG+++ + K G L R
Sbjct: 132 MAYLAAKKF---VHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 186
Query: 866 LAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVI-------KGKHPRDFISSICSSLSS 918
++APE T K DV+SFGV+ E+ +G + + +
Sbjct: 187 ------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG--- 237
Query: 919 NLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ LP N DKL+ +M + C +P RPT ++ LK
Sbjct: 238 ------GHL---DLPE---NCPDKLLELMRM---CWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 709 IGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G GG G V ++ A+K E Q+ +E L + H IVK Y
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
+ +++ EY G L IL + +E +T R I V A Y+H I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE--YTARF-YIACVVLAFEYLHNR---GI 114
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT-ELAGTFGYIAPEL----AYTMK 882
++RD+ +N+LL+ + DFG +K KL +T GT Y+APE+ Y
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAK--KLKSGQKTWTFCGTPEYVAPEIILNKGYDFS 172
Query: 883 VTEKCDVYSFGVLALEVIKGKHP 905
V D +S G+L E++ G+ P
Sbjct: 173 V----DYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 34/213 (15%)
Query: 709 IGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQ---EFLNEGNALTKIRH 759
+G+G G VY+ VAVK LP E +Q +FL E ++K H
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKT----LP-ESCSEQDESDFLMEALIMSKFNH 68
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRM----NAIKGVADA 815
+NIV+ G L F++ E + G L L + E + M + VA
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 816 LLYMHTNCFPPIVHRDISSKNVLLNLEYE---AHVSDFGISK------FLKLGLSNRTEL 866
Y+ N F +HRDI+++N LL + A ++DFG+++ + + G R L
Sbjct: 129 CKYLEENHF---IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG--GRAML 183
Query: 867 AGTFGYIAPELAYTMKVTEKCDVYSFGVLALEV 899
++ PE T K DV+SFGVL E+
Sbjct: 184 P--IKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 74/274 (27%), Positives = 127/274 (46%), Gaps = 39/274 (14%)
Query: 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
K F D IG+G G+VY A ++ E+VA+KK Q+ + E L K+RH
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMILS-NDAAAEEFGWTKRMNAIK-GVADALL 817
N +++ G +++V EY +GS + +L + +E + A+ G L
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEV----EIAAVTHGALQGLA 129
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL 877
Y+H++ ++HRD+ + N+LL+ + DFG + ++ GT ++APE+
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAPEV 182
Query: 878 AYTMKVTE---KCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934
M + K DV+S G+ +E+ + K P + +++S+ +IA +E P L +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSALYHIAQNE--SPALQS 236
Query: 935 -----PLRNVQDKLISIMEVSISCLDESPTSRPT 963
RN D SCL + P RPT
Sbjct: 237 GHWSEYFRNFVD----------SCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 64/266 (24%), Positives = 120/266 (45%), Gaps = 23/266 (8%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGF 768
+G G G V+ VA+K G M+ + FL E N + +++H +V+ Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK---QGSMS-PEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 769 CSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIV 828
+ +++ EY+E GSL L + K ++ +A+ + ++ + +
Sbjct: 70 VTQE-PIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIERKNY---I 124
Query: 829 HRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAG-TFGYIAPELAYTMKVTEKC 887
HRD+ + N+L++ ++DFG+++ ++ E A + APE T K
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 888 DVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISI 946
DV+SFG+L E++ G+ P +++ + NL R+P P N ++L +
Sbjct: 185 DVWSFGILLTEIVTYGRIPYPGMTN--PEVIQNLERGY------RMPRP-DNCPEELYEL 235
Query: 947 MEVSISCLDESPTSRPTMQKVSQLLK 972
M C E P RPT + + +L+
Sbjct: 236 M---RLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 8e-13
Identities = 65/235 (27%), Positives = 106/235 (45%), Gaps = 29/235 (12%)
Query: 698 RATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVK--KFHSPLPGEMACQQEF----LNE 750
R+ ++ + I G G VY+A + TGEIVA+K K G F L E
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG-------FPITSLRE 54
Query: 751 GNALTKIRHRNIV--KFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNA 808
N L K++H NIV K S+ ++V EY+E L ++ + F ++
Sbjct: 55 INILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMET--MKQPFLQSEVKCL 111
Query: 809 IKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAG 868
+ + + ++H N I+HRD+ + N+LLN + DFG+++ L T+L
Sbjct: 112 MLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV 168
Query: 869 TFGYIAPELAY-TMKVTEKCDVYSFGVLALEVI------KGKHPRDFISSICSSL 916
T Y APEL + + D++S G + E++ GK D ++ I L
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLL 223
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 9e-13
Identities = 38/91 (41%), Positives = 53/91 (58%)
Query: 338 LSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLC 397
+ L L L G IP + L L S++LS N + G+IP S S+TSL L L NS
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 398 DSIPKEIGDMKSLSILDLSSNKLNGSIPLSL 428
SIP+ +G + SL IL+L+ N L+G +P +L
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 78/297 (26%), Positives = 119/297 (40%), Gaps = 58/297 (19%)
Query: 700 TKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKK---FHSPLPGEMA---CQQEFLNEGN 752
NF E IG G VYKA L G +VA+KK F EM +Q+ L E +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIF------EMMDAKARQDCLKEID 54
Query: 753 ALTKIRHRNIVKFYGFCSHALHSFV-------VYEYLEMGSLAMILSNDAAA-----EEF 800
L ++ H N++K+ SF+ V E + G L+ ++ + E
Sbjct: 55 LLKQLDHPNVIKYLA-------SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 107
Query: 801 GWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860
W + + AL +MH+ I+HRDI NV + + D G+ +F
Sbjct: 108 IWKYFVQ----LCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160
Query: 861 SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNL 920
+ L GT Y++PE + K D++S G L E+ + P F + S
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCK 218
Query: 921 NIALDEMLDPRLP-----TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
I + P LP LR+ L+S C++ P RP + V Q+ K
Sbjct: 219 KIEKCDY--PPLPADHYSEELRD----LVSR------CINPDPEKRPDISYVLQVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-12
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 703 FDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN 761
F H IG+G G+VY A T E+VAVKK Q+ + E L +++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 762 IVKFYGFCSHALHS-FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMH 820
+++ G C H+ ++V EY +GS + +L + + + G L Y+H
Sbjct: 83 TIEYKG-CYLKEHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLH 138
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYT 880
++ ++HRDI + N+LL + ++DFG + S GT ++APE+
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANSFVGTPYWMAPEVILA 191
Query: 881 MKVTE---KCDVYSFGVLALEVIKGKHP 905
M + K DV+S G+ +E+ + K P
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 59/224 (26%), Positives = 95/224 (42%), Gaps = 24/224 (10%)
Query: 748 LNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAA----AEEFGWT 803
LNE L+ ++H NI+ +Y + EY G+L + E W
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 804 KRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR 863
+ + A+ Y+H I+HRDI + N+ L + DFGISK L S
Sbjct: 107 -----LFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158
Query: 864 TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIA 923
+ GT Y++PEL +K K D+++ G + E++ K R F ++ LN+
Sbjct: 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK--RTF------DATNPLNLV 210
Query: 924 LDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
+ + P + LIS++ S L + P RPT +V
Sbjct: 211 VKIVQGNYTPVVSVYSSE-LISLVH---SLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 12/206 (5%)
Query: 702 NFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
+ + +G G G V+ + + A+K P + +Q NE L ++ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMH 820
I++ + +++ EY+ G L L N + F + + + AL Y+H
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLH 118
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT-ELAGTFGYIAPELAY 879
+ IV+RD+ +N+LL+ E ++DFG +K L +RT L GT Y+APE+
Sbjct: 119 SK---EIVYRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWTLCGTPEYLAPEVIQ 171
Query: 880 TMKVTEKCDVYSFGVLALEVIKGKHP 905
+ + D ++ G+L E++ G P
Sbjct: 172 SKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-12
Identities = 36/89 (40%), Positives = 54/89 (60%)
Query: 125 LYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSI 184
L L L G IP++I L+ L + +S N++ G IP SLG++T+L L + N+ +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 185 PNEIGNLKSLSDLRLDYNTLSGSILYSFG 213
P +G L SL L L+ N+LSG + + G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 55/181 (30%), Positives = 86/181 (47%), Gaps = 24/181 (13%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR---HRNIVK 764
IG G G+VYKA +L TG VA+KK PL E L E L ++ H NIV+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPL-SEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 765 FYGFC-----SHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL-- 817
C L +V+E+++ LA LS + G IK + LL
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSK---CPKPGLPPE--TIKDLMRQLLRG 119
Query: 818 --YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAP 875
++H++ IVHRD+ +N+L+ + + ++DFG+++ ++ T + T Y AP
Sbjct: 120 VDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAP 175
Query: 876 E 876
E
Sbjct: 176 E 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 78/283 (27%), Positives = 129/283 (45%), Gaps = 38/283 (13%)
Query: 709 IGNGGQGSVYKAELP------TGEI-VAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN 761
+G+G G VY+ +G I VAVK + ++EFL E + ++ H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNHPN 60
Query: 762 IVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFG-----WTKRMNAIKGVADAL 816
IVK G C +++ E +E G L L DA E FG + ++ VA
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 817 LYMHTNCFPPIVHRDISSKNVLLNLE-YEA----HVSDFGISKFLKLGLSNRTELAGTFG 871
+Y+ F +HRD++++N L++ + Y+A + DFG+++ + R E G
Sbjct: 120 VYLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 872 --YIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEML 928
++APE K T + DV+SFGVL E++ G+ P +N +
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP--------YPALNNQEVLQHVTA 228
Query: 929 DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
RL P N DK+ +M +C + P+ RPT ++ ++L
Sbjct: 229 GGRLQKP-ENCPDKIYQLMT---NCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 72/288 (25%), Positives = 121/288 (42%), Gaps = 53/288 (18%)
Query: 713 GQGSVYKAEL--------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
G+G K EL TGE VAVK G + E L + H NIVK
Sbjct: 13 GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHENIVK 70
Query: 765 FYGFCSHALHSFV--VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTN 822
+ G C+ + + + E+L GSL L + + +++ + + Y+ +
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSR 128
Query: 823 CFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT---ELAGTFGYIAPELAY 879
+ VHRD++++NVL+ E++ + DFG++K ++ T +L + APE
Sbjct: 129 QY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 880 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDP--------- 930
K DV+SFGV E++ + C S SS + + L +M+ P
Sbjct: 186 QSKFYIASDVWSFGVTLYELL----------TYCDSESSPMTLFL-KMIGPTHGQMTVTR 234
Query: 931 ---------RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969
RLP P N +++ +M C + P+ R T Q + +
Sbjct: 235 LVRVLEEGKRLPRP-PNCPEEVYQLMR---KCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-12
Identities = 37/86 (43%), Positives = 50/86 (58%), Gaps = 1/86 (1%)
Query: 365 LDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSI 424
L L L G IP + L L ++ L NS+ +IP +G + SL +LDLS N NGSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 425 PLSLANLTNSLKVLYLSSNHIVGEIP 450
P SL LT SL++L L+ N + G +P
Sbjct: 483 PESLGQLT-SLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-12
Identities = 86/256 (33%), Positives = 122/256 (47%), Gaps = 9/256 (3%)
Query: 310 SLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSI 369
S L + S + NL L L L+ N L +I L LT L SLDL
Sbjct: 67 SRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDN 125
Query: 370 NKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLA 429
N ++ PL ++L L L +N + +P + ++ +L LDLS N L+ +P L+
Sbjct: 126 NNITDIPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLS-DLPKLLS 183
Query: 430 NLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLS 489
NL+N L L LS N I ++P S+L +L L+NN + +L L +L L L+LS
Sbjct: 184 NLSN-LNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELS 240
Query: 490 ANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQV 549
N +PES+GNL L L+LSNNQ S + + L +L ELDLS +P
Sbjct: 241 NNKL-EDLPESIGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDLSGNSLSNALPLIA 297
Query: 550 CSMQSLEKLNLSHNNL 565
+ LE L L
Sbjct: 298 LLLLLLELLLNLLLTL 313
|
Length = 394 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-12
Identities = 102/319 (31%), Positives = 152/319 (47%), Gaps = 15/319 (4%)
Query: 32 SKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNE 91
+ L+P + RL SL+ LS S +L NL L +D+ N L +I +E
Sbjct: 54 LSSNTLLLLPSSLSRLLSLDLLSP-SGISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SE 111
Query: 92 VGSLKSLSDLRLSNNSLNGSIPSSLGNLT-NLVTLYLHMNALSGSIPDEIGNLKFLSDLQ 150
+ L +L+ L L NN++ IP +G L NL L L N + S+P + NL L +L
Sbjct: 112 LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLD 169
Query: 151 VSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILY 210
+S+N LS +P L NL+NL L + N +S +P EI L +L +L L N++ +L
Sbjct: 170 LSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLS 226
Query: 211 SFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISC 270
S NL L L L N L +P IGNL +L L L+ N +S SI S G+LT L
Sbjct: 227 SLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SIS-SLGSLTNLRELD 283
Query: 271 LGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPN 330
L N S+ + + LL L L ++ L ++ + S P
Sbjct: 284 LSGN----SLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPE 339
Query: 331 EITNLRSLSDLQLSENTLN 349
++ L SL++L +N L+
Sbjct: 340 ALSILESLNNLWTLDNALD 358
|
Length = 394 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 70/284 (24%), Positives = 119/284 (41%), Gaps = 36/284 (12%)
Query: 702 NFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
NF E IG G VY+A L G VA+KK + + + + E + L ++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGV-------A 813
N++K+Y +V E + G L+ ++ + F KR+ K V
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMI------KHFKKQKRLIPEKTVWKYFVQLC 116
Query: 814 DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI 873
AL +MH+ ++HRDI NV + + D G+ +F + L GT Y+
Sbjct: 117 SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVIKGKHP----RDFISSICSSLSSNLNIALDEMLD 929
+PE + K D++S G L E+ + P + + S+C + E D
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI---------EQCD 224
Query: 930 -PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
P P P + ++L ++ + C++ P RP + V + K
Sbjct: 225 YP--PLPSDHYSEELRQLVNM---CINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 6e-12
Identities = 71/273 (26%), Positives = 111/273 (40%), Gaps = 39/273 (14%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
IG+G G+VYK PTG + A+K + E +++ E L + H N+VK +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGN--HEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
H V+ E+++ GSL A E+F + G+A Y+H I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLE---GTHIADEQFLADVARQILSGIA----YLHRR---HI 189
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPE-----LAYTMK 882
VHRDI N+L+N ++DFG+S+ L + GT Y++PE L +
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAY 249
Query: 883 VTEKCDVYSFGVLALEVIKGKHP------RDFISSICSSLSSNLNIALDEMLDPRLPTPL 936
D++S GV LE G+ P D+ S +C+ M P P
Sbjct: 250 DGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC----------MSQP--PEAP 297
Query: 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969
+ + CL P R + ++ Q
Sbjct: 298 ATASREFRHFISC---CLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 8e-12
Identities = 41/103 (39%), Positives = 59/103 (57%), Gaps = 3/103 (2%)
Query: 258 CSFGNLT-KLVISCLGTN--ALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNL 314
C F + K I LG + L I +I L+ L + L+ N++ G+IP SLGS+T+L
Sbjct: 409 CQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSL 468
Query: 315 ATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALG 357
L S N+ +GSIP + L SL L L+ N+L+G +P ALG
Sbjct: 469 EVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-12
Identities = 36/85 (42%), Positives = 52/85 (61%)
Query: 293 LQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSI 352
L L+ L G IP + L +L ++ S N++ G+IP + ++ SL L LS N+ NGSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 353 PLALGNLTKLVSLDLSINKLSGSIP 377
P +LG LT L L+L+ N LSG +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G+G G VYKA+ TG + A K + E+ ++++ E + L H NIVK
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEEL---EDYMVEIDILASCDHPNIVKLLD 69
Query: 768 FCSHALHSFVVYEYLEMGSL-AMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP 826
+ + +++ E+ G++ A++L + E + K +AL Y+H N
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTE---PQIRVVCKQTLEALNYLHEN---K 123
Query: 827 IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTE- 885
I+HRD+ + N+L L+ + ++DFG+S + R GT ++APE+ +
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 886 ----KCDVYSFGVLALEVIKGKHP 905
K DV+S G+ +E+ + + P
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-11
Identities = 88/303 (29%), Positives = 144/303 (47%), Gaps = 14/303 (4%)
Query: 310 SLTNLATLYFSTNALSGSIPNEIT---NLRSLSDLQLSENTLNGSIPLALGNLTKLVSLD 366
S T L +T + N NL S++ +L+ N + ++ L +L++L+SLD
Sbjct: 14 SNTLREVLSSNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLD 73
Query: 367 LSINKL--SGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSI 424
L S + +L L +L L N L +I E+ ++ +L+ LDL +N + I
Sbjct: 74 LLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNIT-DI 131
Query: 425 PLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLE 484
P + L ++LK L LS N I +P +L L L+ N+LS L L +L+ L
Sbjct: 132 PPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLN 189
Query: 485 YLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEE 544
LDLS N +P + L L L+LSNN ++ + + L +LS L+LS E+
Sbjct: 190 NLDLSGNKIS-DLPPEIELLSALEELDLSNNS-IIELLSSLSNLKNLSGLELS-NNKLED 246
Query: 545 IPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPM 604
+P + ++ +LE L+LS+N + S + L +D+S N+L +P
Sbjct: 247 LPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLE 304
Query: 605 LAL 607
L L
Sbjct: 305 LLL 307
|
Length = 394 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 73/277 (26%), Positives = 115/277 (41%), Gaps = 48/277 (17%)
Query: 708 CIGNGGQGSVYKA--ELPTGEI--VAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIV 763
CIG G G VY+ P E VAVK + + ++FL E + + H +IV
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQEAYIMRQFDHPHIV 70
Query: 764 KFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIK---GVADALLYMH 820
K G + ++V E +G L L + I ++ AL Y+
Sbjct: 71 KLIGVITEN-PVWIVMELAPLGELRSYLQ-----VNKYSLDLASLILYSYQLSTALAYLE 124
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK---LGLSNRTELAGTFGYIAPEL 877
+ F VHRDI+++NVL++ + DFG+S++L+ +++ +L ++APE
Sbjct: 125 SKRF---VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP--IKWMAPES 179
Query: 878 AYTMKVTEKCDVYSFGVLALEVIK-GKHP------RDFISSICSSLSSNLNIALDEMLDP 930
+ T DV+ FGV E++ G P D I I E +
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI-------------ENGE- 225
Query: 931 RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
RLP P N L S+M C P+ RP ++
Sbjct: 226 RLPMP-PNCPPTLYSLMT---KCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 66/232 (28%), Positives = 94/232 (40%), Gaps = 34/232 (14%)
Query: 694 EEIIRATKNFDDEHCIGNGGQGSVYK-AELPTGEIVAVKKFHSPLPGEMACQQEFLNEGN 752
E + T ++ IG G G VYK G + AVK P+ +E E N
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-DPISD---VDEEIEAEYN 70
Query: 753 ALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILS--NDAAAEEF--GWTKRMN 807
L + H N+VKFYG F + L G L ++L N + E G
Sbjct: 71 ILQSLPNHPNVVKFYGM-------FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123
Query: 808 AIK---------GVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858
+ G L ++H N I+HRD+ N+LL E + DFG+S L
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
Query: 859 GLSNRTELAGTFGYIAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
R GT ++APE+ Y +CDV+S G+ A+E+ G P
Sbjct: 181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 66/260 (25%), Positives = 112/260 (43%), Gaps = 28/260 (10%)
Query: 709 IGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK-FY 766
+G GG G V+ A+ TGEIVA+K+ L ++ + L E + LT + +VK Y
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 767 GFCSHALHSFVVYEYLEMGSLAMILSNDAAAEE----FGWTKRMNAIKGVADALLYMHTN 822
F + ++ EY+ G +L+N E F + A+ DAL +
Sbjct: 69 AF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV----DALHELG-- 121
Query: 823 CFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMK 882
+HRD+ +N L++ ++DFG+SK ++ + G+ Y+APE+
Sbjct: 122 ----YIHRDLKPENFLIDASGHIKLTDFGLSKG---IVTYANSVVGSPDYMAPEVLRGKG 174
Query: 883 VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLD-PRLPTPLRNVQD 941
D +S G + E + G P F S + NL E L P P N+ D
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPP--FSGSTPNETWENL-KYWKETLQRPVYDDPRFNLSD 231
Query: 942 KLISIMEVSISCLDESPTSR 961
+ ++ +++ P+ R
Sbjct: 232 EAWDLIT---KLIND-PSRR 247
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 67/292 (22%), Positives = 117/292 (40%), Gaps = 64/292 (21%)
Query: 707 HCIGNGGQGSVYKAEL-----PTGEI-VAVKKFHSPLPGEMACQQE---FLNEGNALTKI 757
+G G G V KAE P VAVK + A +++ ++E + I
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK-----DDATEKDLSDLVSEMEMMKMI 72
Query: 758 -RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMIL-SNDAAAEEFGWTKRMNAIKG---- 811
+H+NI+ G C+ +VV EY G+L L + E +
Sbjct: 73 GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 812 --------VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK------FLK 857
VA + ++ + +HRD++++NVL+ ++ ++DFG+++ + +
Sbjct: 133 DLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR 189
Query: 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSL 916
+ R + ++APE + T + DV+SFGVL E+ G P
Sbjct: 190 KTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP--------- 236
Query: 917 SSNLNIALDEMLD-----PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPT 963
I ++E+ R+ P N +L +M C E P+ RPT
Sbjct: 237 ----GIPVEELFKLLKEGYRMEKPQ-NCTQELYHLM---RDCWHEVPSQRPT 280
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-11
Identities = 35/76 (46%), Positives = 45/76 (59%)
Query: 447 GEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVK 506
G IP K L + L+ N + G + P LGS+ LE LDLS N+F+ SIPESLG L
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 507 LHYLNLSNNQFSQKIP 522
L LNL+ N S ++P
Sbjct: 492 LRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 62/243 (25%), Positives = 104/243 (42%), Gaps = 37/243 (15%)
Query: 744 QQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEMGSL------AMILSNDAA 796
++F E L K+ H NI+ G C H + ++ EY G+L + +L D A
Sbjct: 39 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 98
Query: 797 -AEEFGWTKRMNA---IKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852
A +++ + AD M +HRD++++N+L+ Y A ++DFG+
Sbjct: 99 FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158
Query: 853 SKFLKLGLSNRTELAGTFG-----YIAPE-LAYTMKVTEKCDVYSFGVLALEVIK-GKHP 905
S+ + T G ++A E L Y++ T DV+S+GVL E++ G P
Sbjct: 159 SR------GQEVYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTP 211
Query: 906 RDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQ 965
+ C+ L L RL P N D++ +M C E P RP+
Sbjct: 212 --YCGMTCAELYEKLPQGY------RLEKP-LNCDDEVYDLMR---QCWREKPYERPSFA 259
Query: 966 KVS 968
++
Sbjct: 260 QIL 262
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 709 IGNGGQGSVYKA--ELPTGEI-VAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
+G+G G V K ++ +I VA+K + E + + E + E + ++ + IV+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 766 YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFP 825
G C A +V E G L LS +E + + + V+ + Y+ F
Sbjct: 61 IGVC-EAEALMLVMEMASGGPLNKFLS--GKKDEITVSNVVELMHQVSMGMKYLEGKNF- 116
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFG-----YIAPELAYT 880
VHRD++++NVLL ++ A +SDFG+SK LG + A + G + APE
Sbjct: 117 --VHRDLAARNVLLVNQHYAKISDFGLSK--ALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 881 MKVTEKCDVYSFGVLALEVIK-GKHP 905
K + + DV+S+G+ E G+ P
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 707 HCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
+G+G GSV A + TGE VA+KK P E+ ++ + E L ++H N++
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENVIGL 79
Query: 766 YG-FCS----HALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMH 820
F S F YL M + L K + + L Y+H
Sbjct: 80 LDVFTSAVSGDEFQDF----YLVMPYMQTDLQK-IMGHPLSEDKVQYLVYQMLCGLKYIH 134
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAG---TFGYIAPEL 877
+ I+HRD+ N+ +N + E + DFG+++ E+ G T Y APE+
Sbjct: 135 SA---GIIHRDLKPGNLAVNEDCELKILDFGLAR------HADAEMTGYVVTRWYRAPEV 185
Query: 878 AYT-MKVTEKCDVYSFGVLALEVIKGK 903
M + D++S G + E++ GK
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 7e-11
Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFH-SPLPGEMACQQEFLN-EGNALTKIRHRNIVKF 765
+G G G VY ++ TG +A K+ P E + + L E L ++H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 766 YGFC--SHALHSFVVY-EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTN 822
YG C A + ++ EY+ GS+ L A E T++ + + + + Y+H+N
Sbjct: 70 YG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE-SVTRKYT--RQILEGMSYLHSN 125
Query: 823 CFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL----GLSNRTELAGTFGYIAPELA 878
IVHRDI N+L + + DFG SK L+ G R+ + GT +++PE+
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPEVI 181
Query: 879 YTMKVTEKCDVYSFGVLALEVIKGKHP 905
K DV+S G +E++ K P
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 9e-11
Identities = 57/215 (26%), Positives = 87/215 (40%), Gaps = 54/215 (25%)
Query: 462 LILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKI 521
L L+N L G + ++ L L+ ++LS N+ +IP SLG++ L L+LS N F+ I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 522 PNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSC 581
P + +L SL LNL+ N+LSG +
Sbjct: 483 PESLGQL------------------------TSLRILNLNGNSLSGRVP----------- 507
Query: 582 IDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPCKAFKSHKQSLKKIWIVIV 641
AL G + + +F N LCG I L C H KI I
Sbjct: 508 -----AALGGRLLHRASFN------FTDNAGLCG-IPGLRAC---GPHLSVGAKIGIA-- 550
Query: 642 FPLLGTVALLISLIGLFFNFRQRKNGLQTQQSSPR 676
+VA L +I +++R+N L+ Q+ + R
Sbjct: 551 --FGVSVAFLFLVICAMCWWKRRQNILRAQRIAAR 583
|
Length = 623 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 9e-11
Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 14/202 (6%)
Query: 709 IGNGGQGSVYKAELP-TGEIVAVKKFHSP---LPGEMACQQEFLNEGNALT-KIRHRNIV 763
+G G G V+ AEL T + A+K + ++ C + E L+ H +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECT---MVEKRVLSLAWEHPFLT 59
Query: 764 KFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC 823
Y + F V EYL G L + + +F + + L ++H+
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSK- 115
Query: 824 FPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKV 883
IV+RD+ N+LL+ + ++DFG+ K LG + GT YIAPE+ K
Sbjct: 116 --GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY 173
Query: 884 TEKCDVYSFGVLALEVIKGKHP 905
D +SFGVL E++ G+ P
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 9e-11
Identities = 74/305 (24%), Positives = 124/305 (40%), Gaps = 69/305 (22%)
Query: 709 IGNGGQGSVYKAE------LPTGEIVAVKKFHSPLPGEMACQQEF---LNEGNALTKIRH 759
+G G G V KA VAVK E A E L+E N L ++ H
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-----ENASSSELRDLLSEFNLLKQVNH 62
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMIL--------------------SNDAAAEE 799
+++K YG CS ++ EY + GSL L D E
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 800 ---------FGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDF 850
F W ++ + Y+ +VHRD++++NVL+ + +SDF
Sbjct: 123 ALTMGDLISFAWQ--------ISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDF 171
Query: 851 GISK--FLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRD 907
G+S+ + + R++ ++A E + T + DV+SFGVL E++ G +P
Sbjct: 172 GLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231
Query: 908 FISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
I+ L + L R+ P N +++ ++M ++C + P RPT +
Sbjct: 232 GIAP--ERLFNLLKTGY------RMERP-ENCSEEMYNLM---LTCWKQEPDKRPTFADI 279
Query: 968 SQLLK 972
S+ L+
Sbjct: 280 SKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 9e-11
Identities = 60/274 (21%), Positives = 112/274 (40%), Gaps = 39/274 (14%)
Query: 703 FDDEHCIGNGGQGSV-YKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN 761
+ D +G+G G+V + TG VA+KK + P E+ ++ + E L ++H N
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMKHEN 75
Query: 762 IVKFYGFCS--HALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYM 819
++ + +L F + YL M + L E+ + + + L Y+
Sbjct: 76 VIGLLDVFTPDLSLDRFHDF-YLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYI 134
Query: 820 HTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAG---TFGYIAPE 876
H I+HRD+ N+ +N + E + DFG+++ +E+ G T Y APE
Sbjct: 135 HA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR------QTDSEMTGYVVTRWYRAPE 185
Query: 877 LAYT-MKVTEKCDVYSFGVLALEVIKGK-------H--------------PRDFISSICS 914
+ M T+ D++S G + E++ GK H ++F+ + S
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245
Query: 915 SLSSNLNIALDEMLDPRLPTPLRNVQDKLISIME 948
+ N L + L N ++++E
Sbjct: 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLE 279
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 29/68 (42%), Positives = 43/68 (63%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L+ + LS N G+IPP +G +T L++L S N +G IP +G+L+SL L+L N L
Sbjct: 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS 503
Query: 62 GSIPPSLG 69
G +P +LG
Sbjct: 504 GRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 29/216 (13%)
Query: 705 DEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH-RNI 762
D IG G G+V K P+G I+AVK+ S + + Q+ L + + + + I
Sbjct: 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE--QKRLLMDLDVVMRSSDCPYI 65
Query: 763 VKFYGFCSHALHSFVVYEYLE--MGSLAMIL---SNDAAAEEFGWTKRMNAIK-GVADAL 816
VKFYG ++ E ++ + + EE + I AL
Sbjct: 66 VKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEI-----LGKIAVATVKAL 120
Query: 817 LYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPE 876
Y+ I+HRD+ N+LL+ + DFGIS L ++ +T AG Y+APE
Sbjct: 121 NYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA-KTRDAGCRPYMAPE 177
Query: 877 L-------AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
Y + + DV+S G+ EV GK P
Sbjct: 178 RIDPSARDGYDV----RSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 21/213 (9%)
Query: 702 NFDDEHCIGNGGQGSVY----KAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI 757
++ IG G G +Y K++ I + P+ + A ++E + L K+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVI----LLAKM 56
Query: 758 RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL 817
+H NIV F+ F+V EY + G L M N F + ++ ++ L
Sbjct: 57 KHPNIVTFFASFQENGRLFIVMEYCDGGDL-MKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLE-YEAHVSDFGISKFLKLGLSNRTELA----GTFGY 872
++H I+HRDI S+N+ L+ A + DFGI++ L ++ ELA GT Y
Sbjct: 116 HIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL----NDSMELAYTCVGTPYY 168
Query: 873 IAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
++PE+ K D++S G + E+ KHP
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 709 IGNGGQGSVYKAELPTGEIVA---VKKFH-SPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
IGNG G V +E+ T VA VK+ + E Q EFL +G+ ++H NI++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE---QNEFLQQGDPYRILQHPNILQ 59
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIK---GVADALLYMHT 821
G C A+ +V+EY E+G L LS + ++ + + +A + +MH
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQE--QWHRRNSQLLLLQRMACEIAAGVTHMHK 117
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAHVSDFGI--SKFLKLGLSNRTELAGTFGYIAPELA- 878
+ F +H D++ +N L + V D+GI S++ + + + ++APEL
Sbjct: 118 HNF---LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 879 ------YTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPR 931
T + T+ +V++ GV E+ + P +S L+ + ++ P+
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIKDQQVKLFKPQ 233
Query: 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
L P ++ +++ C SP R T ++V +LL
Sbjct: 234 LELPY---SERWYEVLQF---CW-LSPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 45/140 (32%), Positives = 67/140 (47%), Gaps = 8/140 (5%)
Query: 768 FCSHAL--HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFP 825
FC+ H F V EYL G L + + +E R A + + L ++H
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA--RARFYAAEIIC-GLQFLHKK--- 115
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTE 885
I++RD+ NVLL+ + ++DFG+ K G + GT YIAPE+ K E
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175
Query: 886 KCDVYSFGVLALEVIKGKHP 905
D +SFGVL E++ G+ P
Sbjct: 176 SVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 72/286 (25%), Positives = 122/286 (42%), Gaps = 40/286 (13%)
Query: 702 NFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
NF E IG G VY+A L + VA+KK + +Q+ + E + L ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 761 NIVKFYGFCSHALHSFV-------VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGV- 812
N++K+ L SF+ V E + G L+ ++ + F KR+ + V
Sbjct: 63 NVIKY-------LDSFIEDNELNIVLELADAGDLSQMI------KYFKKQKRLIPERTVW 109
Query: 813 ------ADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTEL 866
A+ +MH+ ++HRDI NV + + D G+ +F + L
Sbjct: 110 KYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 166
Query: 867 AGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDE 926
GT Y++PE + K D++S G L E+ + P F + S L +++
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLFS--LCQKIEQ 222
Query: 927 MLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
P LPT + +KL ++ + C+ P RP + V Q+ K
Sbjct: 223 CDYPPLPT--EHYSEKLRELVSM---CIYPDPDQRPDIGYVHQIAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 51/184 (27%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 727 IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGS 786
+VAVK + + + +FL E ++++++ NI++ G C ++ EY+E G
Sbjct: 46 LVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 787 LAMILSNDAAAEEFGWTKRMNAIKGVADA-LLYMHTNCFPPI--------VHRDISSKNV 837
L LS F N I V+ A LLYM + VHRD++++N
Sbjct: 104 LNQFLSQREIESTF---THANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160
Query: 838 LLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFG--YIAPELAYTMKVTEKCDVYSFGVL 895
L+ Y ++DFG+S+ L G R + ++A E K T DV++FGV
Sbjct: 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVT 220
Query: 896 ALEV 899
E+
Sbjct: 221 LWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFH-SPLPGEMACQQEFLN-EGNALTKIRHRNIVKF 765
+G G G VY + TG +AVK+ P E + + L E L + H IV++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 766 YGFCSHALHSF--VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC 823
YG + + E++ GS+ L + A E T++ + + + + Y+H+N
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE-NVTRKYT--RQILEGVSYLHSNM 126
Query: 824 FPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK---LGLSNRTELAGTFGYIAPELAYT 880
IVHRDI N+L + + DFG SK L+ L + + GT +++PE+
Sbjct: 127 ---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 881 MKVTEKCDVYSFGVLALEVIKGKHP 905
K D++S G +E++ K P
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 2e-10
Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 38/220 (17%)
Query: 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
+F+ +G G G V +G+ A+K ++ + LNE L IRH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKG-------- 811
+V YG + ++V EY+ G L F ++
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGEL------------FSHLRKSGRFPEPVARFYAA 108
Query: 812 -VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT-ELAGT 869
V AL Y+H+ IV+RD+ +N+LL+ + ++DFG +K +K RT L GT
Sbjct: 109 QVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK----GRTYTLCGT 161
Query: 870 FGYIAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
Y+APE+ Y V D ++ G+L E++ G P
Sbjct: 162 PEYLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 16/211 (7%)
Query: 713 GQGSVYKAEL----PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGF 768
G+GS +A L + + A+K+ LP + ++ E L K++H NIV F
Sbjct: 9 GEGSFGRALLVQHVNSDQKYAMKEIR--LPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 769 CSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIV 828
H ++V EY + G L M + F + + + ++H ++
Sbjct: 67 FEADGHLYIVMEYCDGGDL-MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVL 122
Query: 829 HRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCD 888
HRDI SKN+ L + + DFG ++ L + GT Y+ PE+ M K D
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSD 182
Query: 889 VYSFGVLALEVIKGKHP------RDFISSIC 913
++S G + E+ KHP ++ I +C
Sbjct: 183 IWSLGCILYELCTLKHPFQANSWKNLILKVC 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH-RNIVKFY 766
+G G G V K +PTG I+AVK+ + + Q+ L + + + V FY
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATV--NSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 767 G---------FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL 817
G C + + + Y ++ + + D + + AL
Sbjct: 67 GALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK---------IAVSIVKALE 117
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL 877
Y+H+ ++HRD+ NVL+N + + DFGIS +L ++ +T AG Y+APE
Sbjct: 118 YLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA-KTIDAGCKPYMAPER 174
Query: 878 --------AYTMKVTEKCDVYSFGVLALEVIKGKHPRD 907
Y + K DV+S G+ +E+ G+ P D
Sbjct: 175 INPELNQKGYDV----KSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 72/284 (25%), Positives = 119/284 (41%), Gaps = 47/284 (16%)
Query: 709 IGNGGQGSVYKAELPTGE----IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
IG G G VY L + AVK + ++ ++FL EG + H N++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 765 FYGFCSHALHS-FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKG-------VADAL 816
G C + S VV Y++ G L + ++ +K VA +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSE---------THNPTVKDLIGFGLQVAKGM 111
Query: 817 LYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK--FLKLGLSNRTELAGTF--GY 872
Y+ + F VHRD++++N +L+ + V+DFG+++ + K S +
Sbjct: 112 EYLASKKF---VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW 168
Query: 873 IAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDPR 931
+A E T K T K DV+SFGVL E++ +G P + S +I + + R
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--------FDITVYLLQGRR 220
Query: 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPT----MQKVSQLL 971
L P D L +M +SC P RPT + ++ Q+
Sbjct: 221 LLQP-EYCPDPLYEVM---LSCWHPKPEMRPTFSELVSRIEQIF 260
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-10
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G G V K + P+G I+A K H L + A + + + E L + IV FYG
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIH--LEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 768 -FCSHALHSFVVYEYLEMGSLAMILSN-DAAAEEFGWTKRMNAIKGVADALLYMHTNCFP 825
F S S + E+++ GSL +L EE + ++G+A Y+
Sbjct: 71 AFYSDGEIS-ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA----YLREK--H 123
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTE 885
I+HRD+ N+L+N E + DFG+S L ++N GT Y++PE +
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSV 181
Query: 886 KCDVYSFGVLALEVIKGKHP 905
+ D++S G+ +E+ G++P
Sbjct: 182 QSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 40/132 (30%), Positives = 65/132 (49%), Gaps = 6/132 (4%)
Query: 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDIS 833
H F V E+L G L + + + + T I L ++H+ I++RD+
Sbjct: 70 HLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEI---VCGLQFLHSK---GIIYRDLK 123
Query: 834 SKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFG 893
NV+L+ + ++DFG+ K G + + GT YIAPE+ +K T D +SFG
Sbjct: 124 LDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFG 183
Query: 894 VLALEVIKGKHP 905
VL E++ G+ P
Sbjct: 184 VLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNAL-------TKIRHR 760
+G G G VY + TG +AVK+ +P + Q E E NAL +RH
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQ----VPFDPDSQ-ETSKEVNALECEIQLLKNLRHD 64
Query: 761 NIVKFYGFC-----SHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADA 815
IV++YG C L FV EY+ GS+ L A E T+R + +
Sbjct: 65 RIVQYYG-CLRDPEEKKLSIFV--EYMPGGSIKDQLKAYGALTE-NVTRRYT--RQILQG 118
Query: 816 LLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT---ELAGTFGY 872
+ Y+H+N IVHRDI N+L + + DFG SK ++ + T + GT +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 873 IAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
++PE+ K DV+S +E++ K P
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 30/208 (14%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G G V K P+G I+A K H L + A + + + E L + IV FYG
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIH--LEIKPAIRNQIIRELKVLHECNSPYIVGFYG 66
Query: 768 -FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI---------KGVADALL 817
F S S + E+++ GSL +L K+ I V L
Sbjct: 67 AFYSDGEIS-ICMEHMDGGSLDQVL------------KKAGRIPENILGKISIAVLRGLT 113
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL 877
Y+ I+HRD+ N+L+N E + DFG+S L ++N GT Y++PE
Sbjct: 114 YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 169
Query: 878 AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
T + D++S G+ +E+ G++P
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 6/157 (3%)
Query: 744 QQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWT 803
+ NE L + H NI+++Y +V EY G+LA +
Sbjct: 43 RLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYI-QKRCNSLLDED 101
Query: 804 KRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYE-AHVSDFGISKFLKLGLSN 862
++ + AL ++HT I+HRD+ ++N+LL+ + DFGISK L S
Sbjct: 102 TILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSK 157
Query: 863 RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEV 899
+ GT YI+PEL +K D+++ G + E+
Sbjct: 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 40/222 (18%)
Query: 709 IGNGGQGSVYKAE----LPTGE--IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
IG G G V++A LP +VAVK +M Q +F E + + H NI
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALMAEFDHPNI 70
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSLAMIL------------SNDAAAEEFGW-------T 803
VK G C+ +++EY+ G L L + ++A + G T
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 804 KRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK------FLK 857
+++ K VA + Y+ F VHRD++++N L+ ++DFG+S+ + K
Sbjct: 131 EQLCIAKQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEV 899
++ A ++ PE + + T + DV+++GV+ E+
Sbjct: 188 ASEND----AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 702 NFDDEHCIGNGGQGSVYK-AELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
+F+ +G G G V+K + P+G I+A K H L + A + + + E L +
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIH--LEIKPAIRNQIIRELQVLHECNSP 63
Query: 761 NIVKFYG-FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTK-RMNAIKGVADALLY 818
IV FYG F S S + E+++ GSL +L E K + IKG L Y
Sbjct: 64 YIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTY 118
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELA 878
+ I+HRD+ N+L+N E + DFG+S L ++N GT Y++PE
Sbjct: 119 LREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERL 174
Query: 879 YTMKVTEKCDVYSFGVLALEVIKGKHP 905
+ + D++S G+ +E+ G++P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 77/299 (25%), Positives = 121/299 (40%), Gaps = 60/299 (20%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKF----HSPLPGEMACQQEFLNEGNALTKIRHRNIV 763
IG G G V+K TG+IVA+KKF P+ ++A L E L +++H N+V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA-----LREIRMLKQLKHPNLV 63
Query: 764 KFYGFC--SHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT 821
LH +V+EY + L + N E I A+ + H
Sbjct: 64 NLIEVFRRKRKLH--LVFEYCDHTVLNELEKNPRGVPE---HLIKKIIWQTLQAVNFCHK 118
Query: 822 -NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL--- 877
NC +HRD+ +N+L+ + + + DFG ++ L + T+ T Y APEL
Sbjct: 119 HNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG 174
Query: 878 --AYTMKVTEKCDVYSFGVLALEVIKG-----------------KHPRDFISSICSSLSS 918
Y V DV++ G + E++ G K D I S+
Sbjct: 175 DTQYGPPV----DVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST 230
Query: 919 N-----LNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
N L+I E +P L + N+ +S ++ CL PT R + +LL+
Sbjct: 231 NQFFKGLSIPEPETREP-LESKFPNISSPALSFLK---GCLQMDPTERLS---CEELLE 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 33/213 (15%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
IG G G V A + TGE VA+KK + ++ L E L +RH +IV+
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEI-- 64
Query: 768 FCSHAL---------HSFVVYEYLEMGSLAMILSNDAAAEE---FGWTKRMNAIKGVADA 815
H + +VV+E +E +I +ND E F + + A+K
Sbjct: 65 --KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALK----- 117
Query: 816 LLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK--FLKLGLSN-RTELAGTFGY 872
Y+HT + HRD+ KN+L N + + + DFG+++ F + T+ T Y
Sbjct: 118 --YIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172
Query: 873 IAPEL--AYTMKVTEKCDVYSFGVLALEVIKGK 903
APEL ++ K T D++S G + EV+ GK
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 8e-10
Identities = 71/277 (25%), Positives = 116/277 (41%), Gaps = 44/277 (15%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
T + D +G G G V A + TG+ VA+KK P + ++ + E L +R
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLR 67
Query: 759 HRNIVKFYG-FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL 817
H NI+ F S + V E L L +L++ ++F ++G L
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILRG----LK 122
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL 877
Y+H+ +VHRD+ N+L+N + + DFG+++ T T Y APE+
Sbjct: 123 YVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQD---PQMTGYVSTRYYRAPEI 176
Query: 878 AYT-MKVTEKCDVYSFGVLALEVIKGK-------H--------------PRDFISSICSS 915
T K + D++S G + E+++GK H P D I++ICS
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS- 235
Query: 916 LSSNLNIALDEMLDPRLPTPL----RNVQDKLISIME 948
+ L + L R P P +N I ++E
Sbjct: 236 -ENTLRFV--QSLPKREPVPFSEKFKNADPSAIDLLE 269
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 1e-09
Identities = 64/269 (23%), Positives = 117/269 (43%), Gaps = 30/269 (11%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
+G+G G+VYK +P GE V + K + G A EF++E + + H ++V+
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA-NVEFMDEALIMASMDHPHLVR 73
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
G C V + + G L + + G +N +A ++Y+
Sbjct: 74 LLGVCLSPTIQLVT-QLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER-- 128
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF--GYIAPELAYTMK 882
+VHRD++++NVL+ ++DFG+++ L+ G ++A E + K
Sbjct: 129 -RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187
Query: 883 VTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPLRNV 939
T + DV+S+GV E++ G P D I + + ++L+ RLP P
Sbjct: 188 FTHQSDVWSYGVTIWELMTFGGKPYDGIPT----------REIPDLLEKGERLPQPPICT 237
Query: 940 QDKLISIMEVSISCLDESPTSRPTMQKVS 968
I + V + C SRP ++++
Sbjct: 238 ----IDVYMVMVKCWMIDADSRPKFKELA 262
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 66/280 (23%), Positives = 119/280 (42%), Gaps = 33/280 (11%)
Query: 709 IGNGGQGSVYKA---ELPTGEI---VAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
+G G G VY+ ++ GE VAVK + + + EFLNE + + ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 71
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSLAMIL------SNDAAAEEFGWTKRMNAIKG-VADA 815
V+ G S + VV E + G L L + + + M + +AD
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 816 LLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF--GYI 873
+ Y++ F VHRD++++N ++ ++ + DFG+++ + R G ++
Sbjct: 132 MAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRL 932
APE T D++SFGV+ E+ + P +S+ L +D L
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQVLKFVMD---GGYL 240
Query: 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
P N +++ +M + C +P RPT ++ LLK
Sbjct: 241 DQP-DNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 67/263 (25%), Positives = 97/263 (36%), Gaps = 40/263 (15%)
Query: 338 LSDLQLSENTLN-GSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTL---YLYE 393
LS + S+ L L LDLS N L SL ++L L
Sbjct: 58 LSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNN 117
Query: 394 NSLCDSIPKEIGD-----MKSLSILDLSSNKLNGSIPLSLANL---TNSLKVLYLSSNHI 445
N L D + + +L L L N+L G+ +LA LK L L++N I
Sbjct: 118 NGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGI 177
Query: 446 VGE--IPLGHG--KFSSLIQLILNNNEL----SGQLSPELGSLNQLEYLDLSAN------ 491
L G +L L LNNN L + L+ L SL LE L+L N
Sbjct: 178 GDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAG 237
Query: 492 --TFHNSIPESLGNLVKLHYLNLSNNQF----SQKIPNPIEKLIHLSELDLSYKIFGEEI 545
+++ +L+ L+LS N ++ + + + L ELDL FGEE
Sbjct: 238 AAALASALLSPNISLLT---LSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEG 294
Query: 546 PSQVCSMQ-----SLEKLNLSHN 563
+ LE L + +
Sbjct: 295 AQLLAESLLEPGNELESLWVKDD 317
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 67/281 (23%), Positives = 121/281 (43%), Gaps = 35/281 (12%)
Query: 709 IGNGGQGSVYKAELPTGEI-------VAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN 761
+G G G VY+ + G + VA+K + M + EFLNE + + + +
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 70
Query: 762 IVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWT------KRMNAIKG-VAD 814
+V+ G S + V+ E + G L L + E K+M + G +AD
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFG--Y 872
+ Y++ N F VHRD++++N ++ ++ + DFG+++ + R G +
Sbjct: 131 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 873 IAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPR 931
++PE T DV+SFGV+ E+ + P +S+ L ++ L
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----EQVLRFVMEGGL--- 239
Query: 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
L P N D L +M + C +P RP+ ++ +K
Sbjct: 240 LDKP-DNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G G V K T EIVA+KKF E ++ L E L ++ NIV+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQENIVELKE 67
Query: 768 FCSHALHSFVVYEYLEMGSLAMI--LSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFP 825
++V+EY+E L ++ + N E K + I + A+ + H N
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE-----KVRSYIYQLIKAIHWCHKN--- 119
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL-SNRTELAGTFGYIAPELAYTMKVT 884
IVHRDI +N+L++ + DFG ++ L G +N TE T Y +PEL
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 885 EKCDVYSFGVLALEVIKGK 903
+ D++S G + E+ G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 18/202 (8%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLN----EGNALTKIRHRNIV 763
I G GSVY A+ TG+ A+K +M + + N + + +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKK---SDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 764 KFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC 823
K Y + ++V EYL G A ++ E W K I V + +H
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE-DWAK--QYIAEVVLGVEDLHQR- 116
Query: 824 FPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKV 883
I+HRDI +N+L++ ++DFG+S+ GL N+ + GT Y+APE +
Sbjct: 117 --GIIHRDIKPENLLIDQTGHLKLTDFGLSR---NGLENK-KFVGTPDYLAPETILGVGD 170
Query: 884 TEKCDVYSFGVLALEVIKGKHP 905
+ D +S G + E + G P
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 8/199 (4%)
Query: 709 IGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF-Y 766
+G GG G V ++ TG++ A KK + +Q LNE L K+ R IV Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 767 GFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP 826
F + V+ + G L + N F + + + L ++H
Sbjct: 61 AFETKDDLCLVM-TLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLHQR---R 115
Query: 827 IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEK 886
IV+RD+ +NVLL+ +SD G++ LK G AGT GY+APE+
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 887 CDVYSFGVLALEVIKGKHP 905
D ++ G E+I G+ P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-09
Identities = 60/217 (27%), Positives = 88/217 (40%), Gaps = 36/217 (16%)
Query: 709 IGNGGQGSVYKAELPT-GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
IG GG G VY A P VA+KK L ++ FL E + H IV Y
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL---------- 817
CS + Y+E +L +L + E + A K A L
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL---SKELAEKTSVGAFLSIFHKICATI 126
Query: 818 -YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL---------------GLS 861
Y+H+ ++HRD+ N+LL L E + D+G + F KL S
Sbjct: 127 EYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 862 NRT---ELAGTFGYIAPELAYTMKVTEKCDVYSFGVL 895
+ T ++ GT Y+APE + +E D+Y+ GV+
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220
|
Length = 932 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 24/219 (10%)
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIK-GVADALL 817
H NIV G C+ V+ EY G L L E F + + + VA +
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMA 155
Query: 818 YMHT-NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF---GYI 873
++ + NC +HRD++++NVLL + DFG+++ + SN ++
Sbjct: 156 FLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMND-SNYVVKGNARLPVKWM 210
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRL 932
APE + T + DV+S+G+L E+ G +P + S L M P
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM--PVDSKFYKLIKEGYRMAQPEH 268
Query: 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
++ IM+ +C D P RPT +++ QL+
Sbjct: 269 AP------AEIYDIMK---TCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 74/301 (24%), Positives = 117/301 (38%), Gaps = 76/301 (25%)
Query: 709 IGNGGQGSVYKAEL--PTGEI--VAVKKF------HSPLPGEMACQQEFLNEGNALTKIR 758
+G G GSV + +L G VAVK +S + +EFL+E +
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEI-------EEFLSEAACMKDFD 59
Query: 759 HRNIVKFYGFCSHA--------------------LHSFVVYEYLEMGSLAMILSNDAAAE 798
H N++K G C A LHSF++Y L E
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLP-----------E 108
Query: 799 EFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858
+ + + +A + Y+ F +HRD++++N +L + V+DFG+SK +
Sbjct: 109 KLPLQTLLKFMVDIALGMEYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSKKIYS 165
Query: 859 GLSNRTELAGTF--GYIAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSS 915
G R +IA E T K DV++FGV E+ +G+ P + +
Sbjct: 166 GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---- 221
Query: 916 LSSNLNIALDEMLD-----PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970
E+ D RL P + D+L +M SC P RPT K+ ++
Sbjct: 222 ---------HEIYDYLRHGNRLKQP-EDCLDELYDLM---YSCWRADPKDRPTFTKLREV 268
Query: 971 L 971
L
Sbjct: 269 L 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 55/212 (25%), Positives = 83/212 (39%), Gaps = 34/212 (16%)
Query: 709 IGNGGQGSVYKAELP-TGEIVAVKKFHSPL---PGEMACQQEFLNEGNAL-TKIRHRNIV 763
+G G G V AEL T E+ AVK + ++ C E L +H +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTM---TEKRVLALAGKHPFLT 59
Query: 764 KFYGFCSHALHSFVVYEYLEMGSLAMILSNDA----------AAEEFGWTKRMNAIKGVA 813
+ + F V EY+ G L + AAE +
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAE-------------IV 106
Query: 814 DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI 873
L ++H I++RD+ NVLL+ E ++DFG+ K LG + GT YI
Sbjct: 107 LGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYI 163
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
APE+ D ++ GVL E++ G+ P
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 50/197 (25%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G G V K + TG+IVA+KKF + ++ + E L ++RH N+V
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLES-EDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRM-NAIKGVADALLYMHTNCFPP 826
++V+E+++ L + +E K + ++G+ + H++
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIE----FCHSH---N 120
Query: 827 IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAY-TMKVTE 885
I+HRDI +N+L++ + DFG ++ L T+ T Y APEL K
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGR 180
Query: 886 KCDVYSFGVLALEVIKG 902
D+++ G L E++ G
Sbjct: 181 AVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 50/218 (22%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR--------- 758
IG G G VYKA + TGEIVA+KK L E +EG T IR
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIR--LETE--------DEGVPSTAIREISLLKELN 56
Query: 759 HRNIVKFYGFCSHALHS----FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKG--- 811
H NIV+ +HS ++V+E+L++ L + ++ G + IK
Sbjct: 57 HPNIVRLL----DVVHSENKLYLVFEFLDL-DLKKYMD---SSPLTGLDPPL--IKSYLY 106
Query: 812 -VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF 870
+ + Y H++ ++HRD+ +N+L++ E ++DFG+++ + + T T
Sbjct: 107 QLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTL 163
Query: 871 GYIAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 903
Y APE+ Y+ V D++S G + E++ +
Sbjct: 164 WYRAPEILLGSRQYSTPV----DIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 5e-09
Identities = 65/239 (27%), Positives = 97/239 (40%), Gaps = 48/239 (20%)
Query: 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
+ + IG G G V A PTG VA+KK SP + CQ+ L E L + +H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-SPFEHQTFCQRT-LREIKILRRFKH 62
Query: 760 RNIVKFYGF-CSHALHSF----VVYEYLEMGSLAMI----LSNDAAAEEFGWTKRMNAIK 810
NI+ + SF +V E +E +I LSND R
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILR----- 117
Query: 811 GVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK----------FLKLGL 860
L Y+H+ ++HRD+ N+LLN + + DFG+++ FL
Sbjct: 118 ----GLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL---- 166
Query: 861 SNRTELAGTFGYIAPELAYTMK-VTEKCDVYSFGVLALEVIK------GKHPRDFISSI 912
TE T Y APE+ K T+ D++S G + E++ GK ++ I
Sbjct: 167 ---TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI 222
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 744 QQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWT 803
++E E L+ ++H NIV++ + ++V +Y E G L + N F
Sbjct: 43 REESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPED 101
Query: 804 KRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR 863
+ ++ + AL ++H I+HRDI S+N+ L + + DFGI++ L++
Sbjct: 102 QILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV----LNST 154
Query: 864 TELA----GTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 904
ELA GT Y++PE+ K D+++ G + E+ KH
Sbjct: 155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKH 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 16/205 (7%)
Query: 702 NFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
NF IG G G VYKA TGE+VA+KK E + E + L ++ H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 59
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL--- 817
NIVK ++V+E+L L + + + IK LL
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSG-----IPLPLIKSYLFQLLQGL 113
Query: 818 -YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPE 876
+ H++ ++HRD+ +N+L+N E ++DFG+++ + + T T Y APE
Sbjct: 114 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 170
Query: 877 LAYTMKV-TEKCDVYSFGVLALEVI 900
+ K + D++S G + E++
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-09
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 709 IGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G G V AEL T E+ A+K L ++ Q + ++ +T+ R + +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKV----LKKDVILQDDDVD--CTMTEKRILALAAKHP 56
Query: 768 FCSHALHS--------FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYM 819
F + ALH F V EY+ G L + + +F + V AL+++
Sbjct: 57 FLT-ALHCCFQTKDRLFFVMEYVNGGDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFL 112
Query: 820 HTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAY 879
H + +++RD+ N+LL+ E ++DFG+ K L T GT YIAPE+
Sbjct: 113 HRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQ 169
Query: 880 TMKVTEKCDVYSFGVLALEVIKGKHP 905
++ D ++ GVL E++ G+ P
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 68/282 (24%), Positives = 118/282 (41%), Gaps = 37/282 (13%)
Query: 709 IGNGGQGSVYKAELPTGEI---VAVKKFHSPL--PGEMACQQEFLNEGNALTKIRHRNIV 763
+G G GSV + +L + VAVK + EM ++FL+E + + H N++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEM---EDFLSEAVCMKEFDHPNVM 63
Query: 764 KFYGFCSHALHS------FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVAD--- 814
+ G C + S V+ +++ G L L + + +K + D
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF--GY 872
+ Y+ + F +HRD++++N +LN V+DFG+SK + G R +
Sbjct: 124 GMEYLSSKSF---IHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 873 IAPELAYTMKVTEKCDVYSFGVLALEV-IKGKHPRDFISSICSSLSSNLNIALDEMLD-P 930
IA E T K DV+SFGV E+ +G+ P + + E+ D
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-------------SEIYDYL 227
Query: 931 RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
R L+ D L + + SC +P RP+ + + L+
Sbjct: 228 RQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 70/305 (22%), Positives = 129/305 (42%), Gaps = 51/305 (16%)
Query: 695 EIIRATKNFDDEHCIGNGGQGSVYKAEL-------PTGEIVAVKKFHSPLPGEMACQQEF 747
EI +T F +E +G G VYK L T + VA+K E ++EF
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQT-QAVAIKTLKDKA--EGPLREEF 55
Query: 748 LNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMN 807
+E ++++H NIV G + +++ Y L L + + G T
Sbjct: 56 KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115
Query: 808 AIKG-------------VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854
+K +A + ++ ++ +VH+D++++NVL+ + +SD G+
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGL-- 170
Query: 855 FLKLGLSNRTELAGT----FGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFI 909
F ++ ++ +L G +++PE K + D++S+GV+ EV G P
Sbjct: 171 FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP---- 226
Query: 910 SSICSSLSSNLNIALDEMLDPR--LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
C SN ++ EM+ R LP P D + + + C +E P+ RP + +
Sbjct: 227 --YCG--YSNQDVI--EMIRNRQVLPCP----DDCPAWVYTLMLECWNEFPSRRPRFKDI 276
Query: 968 SQLLK 972
L+
Sbjct: 277 HSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSP-----LPGEMACQQEFLNEGNALTKIRHRNI 762
IG G G+VYKA + +G VA+K LP + L L H NI
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKR---LEAFDHPNI 64
Query: 763 VKFYGFCSHA-----LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL 817
V+ C+ + +V+E+++ L L + ++ L
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDK-VPPPGLPAETIKDLMRQFLRGLD 122
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL 877
++H NC IVHRD+ +N+L+ + ++DFG+++ ++ T + T Y APE+
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPEV 178
Query: 878 AYTMKVTEKCDVYSFGVLALEVIKGK 903
D++S G + E+ + K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 73/280 (26%), Positives = 124/280 (44%), Gaps = 32/280 (11%)
Query: 709 IGNGGQGSVYKAELPTG---EIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
IGNG G V E+ +G V VK+ + Q +FL E ++H N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVS--ASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 766 YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAE----EFGWTKRMNAIKGVADALLYMHT 821
G C+ +V E+ +G L L + AE + +RM +A LL++H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHLHK 118
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS--KFLKLGLSNRTELAGTFGYIAPELA- 878
N F +H D++ +N LL + + D+G+S K+ + +L +IAPEL
Sbjct: 119 NNF---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 879 ------YTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPR 931
+ T++ +V+S GV E+ + G P +S L+ + ++ PR
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE-QVLTYTVREQQLKLPKPR 234
Query: 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
L PL D+ +M+ C + P RP+ ++V LL
Sbjct: 235 LKLPL---SDRWYEVMQ---FCWLQ-PEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 71/289 (24%), Positives = 124/289 (42%), Gaps = 45/289 (15%)
Query: 696 IIRATKNFDDEHCIGNGGQGSVYKA-ELPTGE----IVAVKKFH---SPLPGEMACQQEF 747
I++ T+ F +G+G G+VYK +P GE VA+K+ SP +E
Sbjct: 3 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-----KANKEI 56
Query: 748 LNEGNALTKIRHRNIVKFYGFCSHALHSFV--VYEYLEMGSLAMILSNDAAAEEFGWTKR 805
L+E + + + ++ + G C L S V + + + G L + + G
Sbjct: 57 LDEAYVMASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHK--DNIGSQYL 111
Query: 806 MNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTE 865
+N +A + Y+ +VHRD++++NVL+ ++DFG++K L ++ E
Sbjct: 112 LNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG---ADEKE 165
Query: 866 LAGTFG-----YIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSN 919
G ++A E T + DV+S+GV E++ G P D I + S +SS
Sbjct: 166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSI 223
Query: 920 LNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVS 968
L RLP P I + + + C SRP +++
Sbjct: 224 LEKG------ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 47/217 (21%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR--------- 758
IG G G VYKA + T E +A+KK + +QE +EG T IR
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKK--------IRLEQE--DEGVPSTAIREISLLKEMQ 59
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLE------MGSLAMILSNDAAAEEFGWTKRMNAIKGV 812
H NIV+ ++V+EYL+ M S N + + + ++G+
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY----QILRGI 115
Query: 813 ADALLYMHTNCFPPIVHRDISSKNVLLNLEYEA-HVSDFGISKFLKLGLSNRTELAGTFG 871
A Y H++ ++HRD+ +N+L++ A ++DFG+++ + + T T
Sbjct: 116 A----YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLW 168
Query: 872 YIAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 903
Y APE+ Y+ V D++S G + E++ K
Sbjct: 169 YRAPEILLGSRHYSTPV----DIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-08
Identities = 77/224 (34%), Positives = 112/224 (50%), Gaps = 12/224 (5%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
LK L LS N+ S+P + +L +LK L S N LS L + LS+LN L L N +
Sbjct: 142 LKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPK-LLSNLSNLNNLDLSGNKIS 199
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
+PP + L++L +D+ NN + + + + +LK+LS L LSNN L +P S+GNL+N
Sbjct: 200 -DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSN 256
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L TL L N + S +G+L L +L +S N+LS A+P L L L +N L
Sbjct: 257 LETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELL---LNLLL 311
Query: 182 GSIPNEIGNLKSLSDLRLDYN--TLSGSILYSFGNLTKLEILYL 223
E+ L + + N T S L +L L L
Sbjct: 312 TLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDN 355
|
Length = 394 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 2e-08
Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 702 NFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLN-----EGNALT 755
++ +G G VYKA TG IVA+KK GE ++ +N E L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIK---LGERKEAKDGINFTALREIKLLQ 57
Query: 756 KIRHRNIVKFYGFCSHALHSFV--VYEYLEMGSLAMILSND----AAAEEFGWTKRMNAI 809
+++H NI+ H S + V+E++E L ++ + A+ + +
Sbjct: 58 ELKHPNIIGLLDVFGH--KSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT--L 112
Query: 810 KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR--TELA 867
+G+ Y+H+N I+HRD+ N+L+ + ++DFG+++ G NR T
Sbjct: 113 RGLE----YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS--FGSPNRKMTHQV 163
Query: 868 GTFGYIAPELAY-TMKVTEKCDVYSFGVLALEVIKGK 903
T Y APEL + D++S G + E++
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 54/242 (22%), Positives = 100/242 (41%), Gaps = 51/242 (21%)
Query: 758 RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILS-------------NDAAAEEFGWTK 804
+H+NI+ G C+ +V+ EY G+L L E+ +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 805 RMNAIKGVADALLYMHTN-CFPPIVHRDISSKNVLLNLEYEAHVSDFGISK------FLK 857
++ VA + Y+ + C +HRD++++NVL+ + ++DFG+++ + K
Sbjct: 136 LVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSL 916
+ R + ++APE + T + DV+SFG+L E+ G P
Sbjct: 192 KTSNGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP--------- 238
Query: 917 SSNLNIALDEMLD-----PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
I ++E+ R+ P N +L +M C PT RPT +++ + L
Sbjct: 239 ----GIPVEELFKLLREGHRMDKP-SNCTHELYMLMR---ECWHAVPTQRPTFKQLVEAL 290
Query: 972 KI 973
Sbjct: 291 DK 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 55/188 (29%), Positives = 86/188 (45%), Gaps = 32/188 (17%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQE-F----LNEGNALTKIRHRNI 762
IG G G V+KA T +IVA+KK M ++E F L E L ++H N+
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV------LMENEKEGFPITALREIKILQLLKHENV 73
Query: 763 VKFYGFCSHALHS---------FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVA 813
V C + ++V+E+ E LA +LSN K++ +K +
Sbjct: 74 VNLIEIC-RTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV--MKMLL 129
Query: 814 DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL---KLGLSNR-TELAGT 869
+ L Y+H N I+HRD+ + N+L+ + ++DFG+++ K NR T T
Sbjct: 130 NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 870 FGYIAPEL 877
Y PEL
Sbjct: 187 LWYRPPEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 44/148 (29%), Positives = 72/148 (48%), Gaps = 22/148 (14%)
Query: 772 ALHS--------FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI---KGVADALLYMH 820
LHS + V EY+ G L + ++ G K +A+ +A L ++H
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYHI------QQVGKFKEPHAVFYAAEIAIGLFFLH 118
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK-FLKLGLSNRTELAGTFGYIAPELAY 879
+ I++RD+ NV+L+ E ++DFG+ K + G + RT GT YIAPE+
Sbjct: 119 SK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYIAPEIIA 174
Query: 880 TMKVTEKCDVYSFGVLALEVIKGKHPRD 907
+ D ++FGVL E++ G+ P D
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 62/268 (23%), Positives = 106/268 (39%), Gaps = 51/268 (19%)
Query: 719 KAELPTGEIVAVKKFHSPLPGEMACQQE-FLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777
K ELP VA+ + G Q+ FL E L + H NIV+ G + +
Sbjct: 31 KRELP----VAIHTLRA---GCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83
Query: 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNV 837
V EY+ G+L L + + M + G+A + Y+ + VH+ +++ V
Sbjct: 84 VTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEMGY---VHKGLAAHKV 138
Query: 838 LLNLEYEAHVSDFGISKFLKLGLSNRTE-LAGTFG------YIAPELAYTMKVTEKCDVY 890
L+N + +S F +++E + T + APE + DV+
Sbjct: 139 LVNSDLVCKISGFR------RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVW 192
Query: 891 SFGVLALEVIK-GKHP------RDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKL 943
SFG++ EV+ G+ P +D I ++ RLP P RN + L
Sbjct: 193 SFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF--------------RLPAP-RNCPNLL 237
Query: 944 ISIMEVSISCLDESPTSRPTMQKVSQLL 971
+M + C + RP ++ +L
Sbjct: 238 HQLM---LDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 71/288 (24%), Positives = 123/288 (42%), Gaps = 48/288 (16%)
Query: 709 IGNGGQGSVYKAELP----TGEIVAVKKFHSPLPGEMACQ---QEFLNEGNALTKIRHRN 761
+G G GSV +A+L + + VAVK L ++ +EFL E + + H N
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKM----LKADIFSSSDIEEFLREAACMKEFDHPN 62
Query: 762 IVKFYGFCSHALHS---------FVVYEYLEMGSL-AMILSNDAAAEEFGWTKR--MNAI 809
++K G +L S V+ +++ G L +L + E F + + +
Sbjct: 63 VIKLIGV---SLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 810 KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGT 869
+A + Y+ + F +HRD++++N +LN V+DFG+SK + G R A
Sbjct: 120 IDIASGMEYLSSKNF---IHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 870 F--GYIAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFI--SSICSSLSSNLNIAL 924
++A E T DV++FGV E++ +G+ P + S I + L
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG----- 231
Query: 925 DEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
RL P ++D + E+ C P RP+ Q + L+
Sbjct: 232 -----NRLKQPPDCLED----VYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 22/212 (10%)
Query: 703 FDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN 761
F +G GG G V ++ TG++ A KK + + LNE L K+ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 762 IVKFYGFCSHALHSFVVYEYLEMGSLAMILS-NDAAAEEFGWTKRMNAIKGVADALLYMH 820
+V + Y Y +L ++L+ + +F A A+ Y
Sbjct: 62 VVS------------LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 821 TNCF-------PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI 873
C IV+RD+ +N+LL+ +SD G++ + G + + + GT GY+
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYM 168
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
APE+ + T D ++ G L E+I G+ P
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 68/290 (23%), Positives = 122/290 (42%), Gaps = 47/290 (16%)
Query: 709 IGNGGQGSVYKAEL-----PTGEIVAVKKFHSPLPGEMACQQ--EFLNEGNALTKIRHRN 761
+G G +YK L ++VA+K L QQ EF E + + ++ H N
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKT----LKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 762 IVKFYGFCSHALHSFVVYEYLEMGSLAMIL-----SNDA--AAEEFGWTKR-------MN 807
IV G + +++EYL G L L +D +++E G K ++
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 808 AIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA 867
+A + Y+ ++ F VH+D++++N+L+ + +SD G+S+ + R +
Sbjct: 129 IAIQIAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 868 GTFG--YIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIAL 924
++ PE K + D++SFGV+ E+ G P S N +
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS----------NQEV 235
Query: 925 DEMLDPR--LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
EM+ R LP + ++ S+M C E P+ RP + + L+
Sbjct: 236 IEMVRKRQLLPCS-EDCPPRMYSLM---TECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 35/227 (15%)
Query: 703 FDDEHCIGNGGQGSVYKA---ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
++ E CIG G G VYKA G+ A+KKF Q E L +++H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 760 RNIVKFYG-FCSHALHS-FVVYEYLEMGSLAMILSNDAAAEEFGWTKRM--NAIKGVADA 815
N+V F HA S +++++Y E L I+ A+ M + + + +
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 816 LLYMHTNCFPPIVHRDISSKNVLLNLEYEAH----VSDFGISKF----LKLGLSNRTELA 867
+ Y+H+N ++HRD+ N+L+ E + D G+++ LK L++ +
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP-LADLDPVV 176
Query: 868 GTFGYIAPELA-----YTMKVTEKCDVYSFG-----VLALEVI-KGK 903
T Y APEL YT + D+++ G +L LE I KG+
Sbjct: 177 VTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTLEPIFKGR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 53/239 (22%), Positives = 99/239 (41%), Gaps = 49/239 (20%)
Query: 758 RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILS-------------NDAAAEEFGWTK 804
+H+NI+ G C+ +V+ EY G+L L E+ +
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 805 RMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK------FLKL 858
++ VA + Y+ + +HRD++++NVL+ ++DFG+++ + K
Sbjct: 139 LVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLS 917
+ R + ++APE + T + DV+SFGVL E+ G P
Sbjct: 196 TTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP---------- 241
Query: 918 SNLNIALDEMLD-----PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
I ++E+ R+ P N ++L +M C P+ RPT +++ + L
Sbjct: 242 ---GIPVEELFKLLKEGHRMDKP-ANCTNELYMMMR---DCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 22/216 (10%)
Query: 702 NFDDEHCIGNGGQGSVYKAELPTGE-IVAVK---KFHSPLPGEMACQQEFLNEGNALTKI 757
+F+ IG G G V ++ E I A+K K+ E AC F E N L
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETAC---FREERNVLVNG 58
Query: 758 RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSN--DAAAEEFGWTKRMNAIKGVADA 815
+ I + + ++V +Y G L +LS D E+ A +A+
Sbjct: 59 DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDM-------ARFYIAEM 111
Query: 816 LLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS-KFLKLGLSNRTELAGTFGYIA 874
+L +H+ VHRDI NVLL++ ++DFG K + G + GT YI+
Sbjct: 112 VLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYIS 171
Query: 875 PELAYTM-----KVTEKCDVYSFGVLALEVIKGKHP 905
PE+ M K +CD +S GV E++ G+ P
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 31/97 (31%), Positives = 54/97 (55%), Gaps = 5/97 (5%)
Query: 812 VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK-FLKLGLSNRTELAGTF 870
++ L ++H I++RD+ NV+L+ E ++DFG+ K + G++ RT GT
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-FCGTP 165
Query: 871 GYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD 907
YIAPE+ + D +++GVL E++ G+ P D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 7/200 (3%)
Query: 709 IGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF-Y 766
+G GG G V ++ TG++ A KK + + + + E L K+ R IV Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 767 GFCSHALHSFVVYEYLEMGSLAMILSN-DAAAEEFGWTKRMNAIKGVADALLYMHTNCFP 825
F + +V + G L + N D F + + L ++H
Sbjct: 61 AFQTKT-DLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTE 885
I++RD+ +NVLL+ + +SD G++ LK G S AGT G++APEL +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 886 KCDVYSFGVLALEVIKGKHP 905
D ++ GV E+I + P
Sbjct: 177 SVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 50/219 (22%), Positives = 98/219 (44%), Gaps = 17/219 (7%)
Query: 750 EGNALTKIRHRNIVKFY-GFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNA 808
E L++++H NIV + + ++V + E G L L + + + +
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEW 107
Query: 809 IKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAG 868
+A AL Y+H I+HRD+ ++NV L V D GI++ L+ + L G
Sbjct: 108 FVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIG 164
Query: 869 TFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML 928
T Y++PEL K DV++ G E+ KH + + ++N + ++
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN---------AKDMNSLVYRII 215
Query: 929 DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
+ +LP ++ +L ++ + L + P RP+++ +
Sbjct: 216 EGKLPPMPKDYSPELGELIA---TMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 22/206 (10%)
Query: 709 IGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G GG G V ++ TG++ A KK + + LNE L K+ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS--- 64
Query: 768 FCSHALHSFVVYEYLEMGSLAMILS-NDAAAEEFGWTKRMNAIKGVADALLYMHTNCF-- 824
+ Y Y +L ++L+ + +F N A+ Y C
Sbjct: 65 ---------LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGL 115
Query: 825 -----PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAY 879
IV+RD+ +N+LL+ +SD G++ + G + R + GT GY+APE+
Sbjct: 116 EDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-GTVGYMAPEVIN 174
Query: 880 TMKVTEKCDVYSFGVLALEVIKGKHP 905
K T D + G L E+I+G+ P
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 16/205 (7%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQ--QEFLNEGNALTKIRHRNIVKF 765
+G+G G+V+K +P G+ + + + Q QE + A+ + H IV+
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 766 YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFP 825
G C A V + +GSL + + + +N +A + Y+ +
Sbjct: 75 LGICPGASLQLVT-QLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLEEHR-- 129
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFL----KLGLSNRTELAGTFGYIAPELAYTM 881
+VHR+++++N+LL + ++DFG++ L K + E ++A E
Sbjct: 130 -MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYS--EHKTPIKWMALESILFG 186
Query: 882 KVTEKCDVYSFGVLALEVIK-GKHP 905
+ T + DV+S+GV E++ G P
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 73/292 (25%), Positives = 104/292 (35%), Gaps = 70/292 (23%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR--------- 758
IG+G G VYK TG ++AVK+ GN R
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMR--------------RTGNKEENKRILMDLDVVL 68
Query: 759 --HR--NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMN-----AI 809
H IVK YG+ F+ E M + L KR+ I
Sbjct: 69 KSHDCPYIVKCYGYFITDSDVFICMEL--MSTCLDKLL-----------KRIQGPIPEDI 115
Query: 810 KG-----VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864
G + AL Y+ ++HRD+ N+LL+ + DFGIS L + +T
Sbjct: 116 LGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-KT 172
Query: 865 ELAGTFGYIAPELAYTMKVTEK----CDVYSFGVLALEVIKGKHPRDFISSICSSLSSNL 920
AG Y+APE K DV+S G+ +E+ G+ P C + L
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK----NCKTEFEVL 228
Query: 921 NIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
L E +P P S ++ CL + RP K +LL+
Sbjct: 229 TKILQE--EPPSLPPNEGFSPDFCSFVD---LCLTKDHRKRP---KYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 69/243 (28%), Positives = 101/243 (41%), Gaps = 57/243 (23%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR--------- 758
IG G G VYKA + TGE+VA+KK L E EG +T IR
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVR--LDNE--------KEGFPITAIREIKILRQLN 64
Query: 759 HRNIVKFYGFCSHALHS----------FVVYEYLE---MGSLAMILSNDAAAEEFGWTKR 805
HRNIV + + ++V+EY++ MG L L + F
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH------FSEDHI 118
Query: 806 MNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR-- 863
+ +K + + L Y H F +HRDI N+LLN + + ++DFG+++ +R
Sbjct: 119 KSFMKQLLEGLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSE-ESRPY 174
Query: 864 TELAGTFGYIAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHP----------RDFISSI 912
T T Y PEL + DV+S G + E+ K P + IS +
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQELAQLELISRL 233
Query: 913 CSS 915
C S
Sbjct: 234 CGS 236
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G +VYK TGEIVA+K+ H L E + E + + +++H NIV+ +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIH--LDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 768 FCSHALHSFVVYEYLEMGSLA--MILSNDAAAEEFGWTKRM--NAIKGVADALLYMHTNC 823
+V+EY++ L M A + K +KG+A + H N
Sbjct: 66 VIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA----FCHEN- 119
Query: 824 FPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKV 883
++HRD+ +N+L+N E ++DFG+++ + ++ + T Y AP++ +
Sbjct: 120 --RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 884 -TEKCDVYSFGVLALEVIKGK 903
+ D++S G + E+I G+
Sbjct: 178 YSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 77/286 (26%), Positives = 112/286 (39%), Gaps = 74/286 (25%)
Query: 709 IGNGGQGSVY-----KA----------ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNA 753
+G G G+VY KA E+P GE+ + + E
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ------------EAQL 55
Query: 754 LTKIRHRNIVKFYG-------FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRM 806
L+K+ H IVKF+ FC ++ EY E L D EE T +
Sbjct: 56 LSKLDHPAIVKFHASFLERDAFC-------IITEYCEGRDL------DCKLEELKHTGKT 102
Query: 807 NAIKGVADALL-------YMHTNCFPPIVHRDISSKNVLL--NLEYEAHVSDFGISKFLK 857
+ V + + YMH I+HRD+ +KN+ L NL + DFG+S+ L
Sbjct: 103 LSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKNNL---LKIGDFGVSRLLM 156
Query: 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLS 917
T GT Y++PE K D++S G + E+ H F + LS
Sbjct: 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHA--FEGQ--NFLS 212
Query: 918 SNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPT 963
L I E P LP +L SIM+ S L++ P+ RP+
Sbjct: 213 VVLRIV--EGPTPSLP---ETYSRQLNSIMQ---SMLNKDPSLRPS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 49/237 (20%)
Query: 758 RHRNIVKFYGFCSHALHSFVVYEYLEMGSL----------AMILSNDAAA---EEFGWTK 804
+H+NI+ G C+ +V+ EY G+L M S D E+ +
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 805 RMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK------FLKL 858
++ VA + Y+ + +HRD++++NVL+ + ++DFG+++ + K
Sbjct: 136 LVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192
Query: 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLS 917
+ R + ++APE + T + DV+SFGVL E+ G P
Sbjct: 193 TTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP---------- 238
Query: 918 SNLNIALDEMLD-----PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969
I ++E+ R+ P N +L IM C P+ RPT +++ +
Sbjct: 239 ---GIPVEELFKLLKEGHRMDKP-ANCTHELYMIMR---ECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 42/151 (27%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 812 VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK-FLKLGLSNRTELAGTF 870
++ AL Y+H I++RD+ NVLL+ E ++D+G+ K L+ G + GT
Sbjct: 105 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTP 160
Query: 871 GYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDP 930
YIAPE+ D ++ GVL E++ G+ P D + S + + + +L+
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 220
Query: 931 RLPTPLRNVQDKLISIMEVSISCLDESPTSR 961
++ P R++ K S+++ S L++ P R
Sbjct: 221 QIRIP-RSLSVKAASVLK---SFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-07
Identities = 43/144 (29%), Positives = 67/144 (46%), Gaps = 16/144 (11%)
Query: 827 IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN---RTELAGTFGYIAPELAYTMKV 883
++HRDI S N+LL + DFG SK +S+ RT GT Y+APE+
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTPYYVAPEIWRRKPY 222
Query: 884 TEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKL 943
++K D++S GVL E++ K P D ++ ++ L DP P+ +Q
Sbjct: 223 SKKADMFSLGVLLYELLTLKRPFD-----GENMEEVMHKTLAGRYDPLPPSISPEMQ--- 274
Query: 944 ISIMEVSISCLDESPTSRPTMQKV 967
E+ + L P RP+ K+
Sbjct: 275 ----EIVTALLSSDPKRRPSSSKL 294
|
Length = 496 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 2e-07
Identities = 57/235 (24%), Positives = 98/235 (41%), Gaps = 34/235 (14%)
Query: 703 FDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN 761
++ IG+G G V A TG VA+KK + + ++ L E L +RH N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR-ILREIKLLRHLRHEN 60
Query: 762 IVKFYG-FCSHALHSF----VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADAL 816
I+ + F +V E +E +I S ++ ++G L
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRG----L 116
Query: 817 LYMHT-NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL---KLGLSNRTELAGTFGY 872
Y+H+ N ++HRD+ N+L+N + + DFG+++ + + TE T Y
Sbjct: 117 KYLHSAN----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWY 172
Query: 873 IAPEL-----AYTMKVTEKCDVYSFGVLALEVI------KGKHPRDFISSICSSL 916
APEL YT + D++S G + E++ G+ D ++ I L
Sbjct: 173 RAPELLLSSSRYTKAI----DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVL 223
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 34/226 (15%)
Query: 702 NFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSP-LPGEMACQQEFLNEGNALTKIRH 759
+F+ I NG G+VY T + A+KK + L QQ F+ E + LT +
Sbjct: 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAEN 60
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAA--AEEFGWTKRMNAIKGVADALL 817
+V + H +V EY+E G A +L N A + RM + V AL
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVD----MARMYFAETVL-ALE 115
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT------------- 864
Y+H IVHRD+ N+L+ ++DFG+S K+GL + T
Sbjct: 116 YLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLS---KIGLMSLTTNLYEGHIEKDTR 169
Query: 865 -----ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
++ GT YIAPE+ + D ++ G++ E + G P
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 57/212 (26%), Positives = 86/212 (40%), Gaps = 33/212 (15%)
Query: 709 IGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGN-------------AL 754
+G G G V AE TGE+ A+K A ++ + +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIK----------ALKKGDIIARDEVESLMCEKRIFETA 56
Query: 755 TKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVAD 814
RH +V + H V EY G L M + D F + + V
Sbjct: 57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDV----FSEPRAVFYAACVVL 112
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTE-LAGTFGYI 873
L Y+H N IV+RD+ N+LL+ E ++DFG+ K +G +RT GT ++
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFL 168
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
APE+ T D + GVL E++ G+ P
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 57/214 (26%), Positives = 83/214 (38%), Gaps = 28/214 (13%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYG 767
IG G G V+K A K P+ +E E N L + H N+VKFYG
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 768 F-----CSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNA------IKGVADAL 816
+ ++V E GS+ D +RM + L
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVT-----DLVKGFLKRGERMEEPIIAYILHEALMGL 137
Query: 817 LYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPE 876
++H N +HRD+ N+LL E + DFG+S L R GT ++APE
Sbjct: 138 QHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 194
Query: 877 L-----AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
+ +CDV+S G+ A+E+ G P
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 22/212 (10%)
Query: 703 FDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN 761
F +G GG G V ++ TG++ A K+ + + LNE L K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 762 IVKFYGFCSHALHSFVVYEYLEMGSLAMILS-NDAAAEEFGWTKRMNAIKGVADALLYMH 820
+V + Y Y +L ++L+ + +F N AL Y
Sbjct: 62 VVN------------LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 821 TNCF-------PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI 873
V+RD+ +N+LL+ +SD G++ + G S R + GT GY+
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-GTVGYM 168
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
APE+ + T D + G L E+I+G+ P
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 39/136 (28%), Positives = 69/136 (50%), Gaps = 14/136 (10%)
Query: 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI---KGVADALLYMHTNCFPPIVHRDI 832
+ V EY+ G L + ++ G K +A+ +A L ++H+ I++RD+
Sbjct: 77 YFVMEYVNGGDLMYQI------QQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDL 127
Query: 833 SSKNVLLNLEYEAHVSDFGISKFLKL-GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYS 891
NV+L+ E ++DFG+ K G++ +T GT YIAPE+ + D ++
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWA 186
Query: 892 FGVLALEVIKGKHPRD 907
FGVL E++ G+ P +
Sbjct: 187 FGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 24/228 (10%)
Query: 693 HEEIIRATK-------NFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQ 745
+E+I+R + ++D IG G G V + + V K S EM +
Sbjct: 28 YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF--EMIKRS 85
Query: 746 E---FLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGW 802
+ F E + + +V+ + + ++V EY+ G L ++SN E+ W
Sbjct: 86 DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK--W 143
Query: 803 TKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS-KFLKLGLS 861
K A V AL +H+ ++HRD+ N+LL+ ++DFG K + G+
Sbjct: 144 AKFYTA--EVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198
Query: 862 NRTELAGTFGYIAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHP 905
GT YI+PE+ + +CD +S GV E++ G P
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 749 NEGNALTKIRHRNIVKF-YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMN 807
E + L ++ H IVK Y F + +++ ++L G L LS + E
Sbjct: 47 MERDILAEVNHPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTE-------E 98
Query: 808 AIK----GVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR 863
+K +A AL ++H+ I++RD+ +N+LL+ E ++DFG+SK
Sbjct: 99 DVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155
Query: 864 TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
GT Y+APE+ T+ D +SFGVL E++ G P
Sbjct: 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 22/206 (10%)
Query: 709 IGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G GG G V ++ TG++ A KK + + LNE L K+ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS--- 64
Query: 768 FCSHALHSFVVYEYLEMGSLAMILS-NDAAAEEFGWTKRMNAIKGVADALLYMHTNCF-- 824
+ Y Y +L ++L+ + +F N A+ Y
Sbjct: 65 ---------LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGL 115
Query: 825 -----PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAY 879
IV+RD+ +N+LL+ +SD G++ + G + R + GT GY+APE+
Sbjct: 116 EDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-GTVGYMAPEVVK 174
Query: 880 TMKVTEKCDVYSFGVLALEVIKGKHP 905
+ T D + G L E+I+GK P
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 9/203 (4%)
Query: 709 IGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF-Y 766
+G GG G V ++ TG++ A KK + + ++ L E L K+ IV Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 767 GFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP 826
F S H +V + G L + N + ++ + +L++H+
Sbjct: 61 AFESKT-HLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---MD 115
Query: 827 IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEK 886
IV+RD+ +NVLL+ + +SD G++ LK G + T+ AGT GY+APE+ +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI-TQRAGTNGYMAPEILKEEPYSYP 174
Query: 887 CDVYSFGVLALEVIKGKHP-RDF 908
D ++ G E++ G+ P +D
Sbjct: 175 VDWFAMGCSIYEMVAGRTPFKDH 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 62/266 (23%), Positives = 109/266 (40%), Gaps = 40/266 (15%)
Query: 727 IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGS 786
+VAVK + +FL E +++++ NI++ C + ++ EY+E G
Sbjct: 48 LVAVKMLRED--ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105
Query: 787 LAMILSN--------DAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVL 838
L LS A ++ + +A + Y+ + F VHRD++++N L
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF---VHRDLATRNCL 162
Query: 839 LNLEYEAHVSDFGISKFLKLGLSNRTELAGTFG--YIAPELAYTMKVTEKCDVYSFGVLA 896
+ Y ++DFG+S+ L G R + +++ E K T DV++FGV
Sbjct: 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTL 222
Query: 897 LEVIKGKHPRDFISSIC-----SSLSSNLNIA------LDEMLDPRLPTPLRNVQDKLIS 945
E++ ++C S LS I D+ LP P D L
Sbjct: 223 WEIL----------TLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPAL-CPDSLYK 271
Query: 946 IMEVSISCLDESPTSRPTMQKVSQLL 971
+M +SC + RP+ Q++ L
Sbjct: 272 LM---LSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 41/175 (23%), Positives = 77/175 (44%), Gaps = 21/175 (12%)
Query: 744 QQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSN---------- 793
+ +FL E L++++ NI++ G C ++ EY+E G L LS+
Sbjct: 63 RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENG 122
Query: 794 ------DAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV 847
++ ++ +A + Y+ + F VHRD++++N L+ +
Sbjct: 123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF---VHRDLATRNCLVGENLTIKI 179
Query: 848 SDFGISKFLKLGLSNRTELAGTFG--YIAPELAYTMKVTEKCDVYSFGVLALEVI 900
+DFG+S+ L G R + ++A E K T DV++FGV E++
Sbjct: 180 ADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 56/240 (23%), Positives = 97/240 (40%), Gaps = 43/240 (17%)
Query: 743 CQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGW 802
+ F + ++++ H+++V YG C S +V EY++ GSL L + W
Sbjct: 42 YSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW 101
Query: 803 TKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL---G 859
++ K +A AL ++ + H ++ +KNVLL E + G F+KL G
Sbjct: 102 --KLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKT---GNPPFIKLSDPG 153
Query: 860 LS----NRTELAGTFGYIAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS 914
+S + L ++ PE + ++ D +SFG E I S
Sbjct: 154 ISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWE-------------IFS 200
Query: 915 SLSSNLNIALD-----EMLDPR--LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
L+ ALD + + R LP P K + + C+D P RP+ + +
Sbjct: 201 GGDKPLS-ALDSQKKLQFYEDRHQLPAP------KWTELANLINQCMDYEPDFRPSFRAI 253
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 38/212 (17%)
Query: 709 IGNGGQGSVYKAELP-TGEIVAVK--KFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
+G G G V A+ TGE A+K K L +M Q E + L ++ H IV
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL--KMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 766 Y-GFCSHALHSFVVYEYLEMGSL------AMILSNDAA----AEEFGWTKRMNAIKGVAD 814
F + + E++ G L A ND A AE +
Sbjct: 84 MCSFQDEN-RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE-------------LVL 129
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT-ELAGTFGYI 873
A Y+H + I++RD+ +N+LL+ + V+DFG +K + +RT L GT Y+
Sbjct: 130 AFEYLH-SK--DIIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTFTLCGTPEYL 182
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
APE+ + + D ++ GVL E I G P
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 62/220 (28%), Positives = 94/220 (42%), Gaps = 30/220 (13%)
Query: 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTKI 757
+F+ IG G G V ++ TG++ A+K K+ E AC F E + L
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC---FREERDVLVNG 58
Query: 758 RHRNIVKF-YGFCSHALHSFVVYEYLEMGSLAMILSN--DAAAEE---FGWTKRMNAIKG 811
R I Y F + ++V +Y G L +LS D E+ F + + AI
Sbjct: 59 DRRWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI-- 115
Query: 812 VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS-KFLKLGLSNRTELAGTF 870
D++ + VHRDI NVLL+ ++DFG + L G GT
Sbjct: 116 --DSVHQLG------YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTP 167
Query: 871 GYIAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHP 905
YI+PE+ M + +CD +S GV E++ G+ P
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 6e-07
Identities = 47/207 (22%), Positives = 82/207 (39%), Gaps = 15/207 (7%)
Query: 708 CIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
C + + K + PT +VAVKK + + E +++H NI+ +
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKI-NLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
+VV + GS +L E +K V +AL Y+H+ F
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKGF--- 122
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGIS-KFLKLGLSNRT------ELAGTFGYIAPELAYT 880
+HR + + ++LL+ + + +S S +K G R +++PE+
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182
Query: 881 --MKVTEKCDVYSFGVLALEVIKGKHP 905
EK D+YS G+ A E+ G P
Sbjct: 183 NLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 31/222 (13%)
Query: 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
K+FD + +G G G V E TG+I A+K + F E + L+
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 760 RNIVKF-YGFCSHALHSFVVYEYLEMGSLAMILSN-----DAAAEEFGWTKRMNAIKGVA 813
I + Y F + ++V EY G L +L+ D +F + + AI V
Sbjct: 61 PWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV- 118
Query: 814 DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA----GT 869
H + VHRDI +NVL++ ++DFG + L +N+ + GT
Sbjct: 119 ------HQMGY---VHRDIKPENVLIDRTGHIKLADFGSAARLT---ANKMVNSKLPVGT 166
Query: 870 FGYIAPELAYTMKVTEK------CDVYSFGVLALEVIKGKHP 905
YIAPE+ TM K CD +S GV+A E+I G+ P
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 50/267 (18%), Positives = 100/267 (37%), Gaps = 30/267 (11%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGF 768
I Q S+YK + V ++ F G NE L +I NI+K YGF
Sbjct: 28 IKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86
Query: 769 CSHALHSF----VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
+ ++ EY G L +L + ++ + +++ L ++
Sbjct: 87 IIDIVDDLPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN 143
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTM--K 882
P +++++S + L+ Y+ + G+ K L Y + ++ + +
Sbjct: 144 KP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN---FMVYFSYKMLNDIFSE 198
Query: 883 VTEKCDVYSFGVLALEVIKGKHPRDFIS--SICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940
T K D+YS GV+ E+ GK P + ++ I + + N L P ++ +
Sbjct: 199 YTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN---SLKLPLDCPLEIKCIV 255
Query: 941 DKLISIMEVSISCLDESPTSRPTMQKV 967
+ C RP ++++
Sbjct: 256 EA----------CTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-06
Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 40/235 (17%)
Query: 708 CIGNGGQGSVYKA-ELPTGEIVAVKK----FHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
IG+G G V A + +G+ VA+KK F P + L E L +H NI
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP-----TLAKRTLRELKILRHFKHDNI 66
Query: 763 VK----FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLY 818
+ + +VV + +E +I S+ EE ++G L Y
Sbjct: 67 IAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRG----LKY 122
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR--------TELAGTF 870
+H+ ++HRD+ N+L+N + E + DFG+++ GLS+ TE T
Sbjct: 123 IHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR----GLSSSPTEHKYFMTEYVATR 175
Query: 871 GYIAPELAYTM-KVTEKCDVYSFGVLALEVI------KGKHPRDFISSICSSLSS 918
Y APEL ++ + T D++S G + E++ GK+ + I S L S
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS 230
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 38/161 (23%), Positives = 73/161 (45%), Gaps = 26/161 (16%)
Query: 758 RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMIL-SNDAAAEEFGWTKRMNAIKG----- 811
+H+NI+ G C+ +V+ EY G+L L + E+ + +
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 812 -------VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK------FLKL 858
VA + Y+ + +HRD++++NVL+ + ++DFG+++ + K
Sbjct: 142 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEV 899
+ R + ++APE + T + DV+SFGVL E+
Sbjct: 199 TTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 12/199 (6%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G+G GSV A + TG VAVKK P + ++ + E L ++H N++
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83
Query: 768 FCSHALHSFVVYE--YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFP 825
+ A S + YL + L+N ++ I + L Y+H+
Sbjct: 84 VFTPA-RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 139
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYT-MKVT 884
I+HRD+ N+ +N + E + DFG+++ T T Y APE+ M
Sbjct: 140 DIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNWMHYN 196
Query: 885 EKCDVYSFGVLALEVIKGK 903
+ D++S G + E++ G+
Sbjct: 197 QTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-06
Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 31/168 (18%)
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL--KLGLSNRTELAGTFGY 872
AL +H+ ++HRD+ S N+ L + DFG SK + L + GT Y
Sbjct: 181 ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYY 237
Query: 873 IAPELAYTMKVTEKCDVYSFGVLALEVI------KGKHPRDFISSICSSLSSNLNIALDE 926
+APEL + ++K D++S GV+ E++ KG R+ + + L
Sbjct: 238 LAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV-----------LYG 286
Query: 927 MLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV--SQLLK 972
DP P P V + ++++ L ++P RPT Q++ ++ LK
Sbjct: 287 KYDP-FPCP---VSSGMKALLD---PLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 16/208 (7%)
Query: 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
K + IG+G QG V A + G VAVKK P + ++ + E L + H
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNH 79
Query: 760 RNIVKFYGFCS--HALHSFV-VYEYLEM--GSLAMILSNDAAAEEFGWTKRMNAIKGVAD 814
+NI+ + +L F VY +E+ +L ++ + E + + +
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL-----LYQMLC 134
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIA 874
+ ++H+ I+HRD+ N+++ + + DFG+++ T T Y A
Sbjct: 135 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM-MTPYVVTRYYRA 190
Query: 875 PELAYTMKVTEKCDVYSFGVLALEVIKG 902
PE+ M E D++S G + E++KG
Sbjct: 191 PEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 14/162 (8%)
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
FY F + ++V EY+ G L ++SN E+ W + A V AL +H+ F
Sbjct: 109 FYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--WARFYTA--EVVLALDAIHSMGF 163
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGIS-KFLKLGLSNRTELAGTFGYIAPELAYTMK- 882
+HRD+ N+LL+ ++DFG K K G+ GT YI+PE+ +
Sbjct: 164 ---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 883 ---VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLN 921
+CD +S GV E++ G P + S+ + S +N
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPF-YADSLVGTYSKIMN 261
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 22/156 (14%)
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGT----FGYIAPEL 877
NC +HRD++++NVLL A + DFG+++ + + SN + G ++APE
Sbjct: 232 NC----IHRDVAARNVLLTDGRVAKICDFGLARDI-MNDSNYV-VKGNARLPVKWMAPES 285
Query: 878 AYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936
+ T + DV+S+G+L E+ GK P + + +S + +M P P
Sbjct: 286 IFDCVYTVQSDVWSYGILLWEIFSLGKSP--YPGILVNSKFYKMVKRGYQMSRPDFAPP- 342
Query: 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
++ SIM+ C + PT RPT ++SQL++
Sbjct: 343 -----EIYSIMK---MCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 9/160 (5%)
Query: 748 LNEGNALTKIRHRNIVKF-YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRM 806
L E L RH + Y F +H FV+ EY G L LS + E R
Sbjct: 43 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSED--RARF 99
Query: 807 NAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK-FLKLGLSNRTE 865
+ + AL Y+H+ +V+RD+ +N++L+ + ++DFG+ K +K G + +T
Sbjct: 100 YGAE-IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT- 155
Query: 866 LAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
GT Y+APE+ D + GV+ E++ G+ P
Sbjct: 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 22/217 (10%)
Query: 701 KNFDDEHCIGNGGQGSVYKAELPTGE-IVAVK---KFHSPLPGEMACQQEFLNEGNALTK 756
++F+ IG G G V +L + + A+K K+ E AC F E + L
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC---FREERDVLVN 57
Query: 757 IRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSN--DAAAEEFGWTKRMNAIKGVAD 814
++ I + + ++V +Y G L +LS D E+ + + D
Sbjct: 58 GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-D 116
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS-KFLKLGLSNRTELAGTFGYI 873
++ +H VHRDI N+L+++ ++DFG K ++ G + GT YI
Sbjct: 117 SVHQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 170
Query: 874 APELAYTM-----KVTEKCDVYSFGVLALEVIKGKHP 905
+PE+ M K +CD +S GV E++ G+ P
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 13/146 (8%)
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
Y F + ++V EY+ G L ++SN E+ W + A V AL +H+ F
Sbjct: 109 HYAF-QDDKYLYMVMEYMPGGDLVNLMSNYDIPEK--WARFYTA--EVVLALDAIHSMGF 163
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGIS-KFLKLGLSNRTELAGTFGYIAPELAYTMKV 883
+HRD+ N+LL+ ++DFG K G+ GT YI+PE+ +
Sbjct: 164 ---IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 884 T----EKCDVYSFGVLALEVIKGKHP 905
+CD +S GV E++ G P
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 17/161 (10%)
Query: 747 FLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRM 806
F + + ++ H++IV YG C + + +V E++E G L + + + W +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KF 108
Query: 807 NAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG------- 859
K +A AL Y+ +VH ++ +KN+L L E + G F+KL
Sbjct: 109 KVAKQLASALSYLEDK---DLVHGNVCTKNIL--LAREGIDGECG--PFIKLSDPGIPIT 161
Query: 860 LSNRTELAGTFGYIAPELAYTMKV-TEKCDVYSFGVLALEV 899
+ +R E +IAPE K + D +SFG E+
Sbjct: 162 VLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 10/198 (5%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G+G GSV A + + VAVKK P + ++ + E L ++H N++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGLLD 81
Query: 768 FCSHALHSFVVYE-YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP 826
+ A E YL + L+N ++ I + L Y+H+
Sbjct: 82 VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS---AG 138
Query: 827 IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYT-MKVTE 885
I+HRD+ NV +N + E + DFG+++ T T Y APE+ M +
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLARQAD---DEMTGYVATRWYRAPEIMLNWMHYNQ 195
Query: 886 KCDVYSFGVLALEVIKGK 903
D++S G + E++KGK
Sbjct: 196 TVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 5/95 (5%)
Query: 812 VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK-FLKLGLSNRTELAGTF 870
+ AL+++H I++RD+ NVLL+ E ++DFG+ K + G + T GT
Sbjct: 105 ITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTP 160
Query: 871 GYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
YIAPE+ M D ++ GVL E++ G P
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 62/248 (25%), Positives = 101/248 (40%), Gaps = 56/248 (22%)
Query: 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVK------KFHSPLPGEMACQQEFLNEGNA 753
++F+ IG G G V + TG + A+K G + +++ L E ++
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 754 LTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL-AMILSNDAAAEEFGWTKRMNAIKGV 812
L ++ FY F L+ +++ E+L G + +++ D EE + I
Sbjct: 61 LWVVK-----MFYSF-QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE----ETQFYIAET 110
Query: 813 ADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK----------LGLS- 861
A+ +H F +HRDI N+LL+ + +SDFG+ LK L S
Sbjct: 111 VLAIDSIHQLGF---IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167
Query: 862 --------------------NRTELA----GTFGYIAPELAYTMKVTEKCDVYSFGVLAL 897
NR +LA GT YIAPE+ + CD +S GV+
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 898 EVIKGKHP 905
E++ G P
Sbjct: 228 EMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 8/159 (5%)
Query: 748 LNEGNALTKIRHRNIVKF-YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRM 806
L E L RH + Y F + FV+ EY+ G L LS + E T+
Sbjct: 43 LTESRVLKNTRHPFLTSLKYSFQTKDRLCFVM-EYVNGGELFFHLSRERVFSE-DRTRFY 100
Query: 807 NAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTEL 866
A + AL Y+H+ IV+RD+ +N++L+ + ++DFG+ K +
Sbjct: 101 GA--EIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF 155
Query: 867 AGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
GT Y+APE+ D + GV+ E++ G+ P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 8/136 (5%)
Query: 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSK 835
F+V EY+ G L + E R A + + AL ++H I++RD+
Sbjct: 72 FLVIEYVNGGDLMFHMQRQRKLPE--EHARFYAAE-ICIALNFLHER---GIIYRDLKLD 125
Query: 836 NVLLNLEYEAHVSDFGISK-FLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGV 894
NVLL+ + ++D+G+ K L G + T GT YIAPE+ + D ++ GV
Sbjct: 126 NVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILRGEEYGFSVDWWALGV 184
Query: 895 LALEVIKGKHPRDFIS 910
L E++ G+ P D I+
Sbjct: 185 LMFEMMAGRSPFDIIT 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 65/277 (23%), Positives = 117/277 (42%), Gaps = 48/277 (17%)
Query: 709 IGNGGQGSVYKA-ELPTGE----IVAVKKFH---SPLPGEMACQQEFLNEGNALTKIRHR 760
+G+G G+VYK +P GE VA+K SP +E L+E + +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP-----KANKEILDEAYVMAGVGSP 69
Query: 761 NIVKFYGFCSHALHSFV--VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLY 818
+ + G C L S V V + + G L + + + G +N +A + Y
Sbjct: 70 YVCRLLGIC---LTSTVQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSY 124
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFG-----YI 873
+ +VHRD++++NVL+ ++DFG+++ L + + TE G ++
Sbjct: 125 LEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI---DETEYHADGGKVPIKWM 178
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDP-- 930
A E + T + DV+S+GV E++ G P D I + + ++L+
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----------REIPDLLEKGE 228
Query: 931 RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
RLP P D + + + C RP +++
Sbjct: 229 RLPQPPICTID----VYMIMVKCWMIDSECRPRFREL 261
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 40/155 (25%), Positives = 67/155 (43%), Gaps = 30/155 (19%)
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISK-------FLKLGLSNRTELAGTFGYIAPELAYT 880
+HRD++++N+LL+ + DFG+++ +++ G S R L ++APE +
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG-SARLPLK----WMAPESIFD 250
Query: 881 MKVTEKCDVYSFGVLALEVIK-GKHPRDFIS---SICSSLSSNLNIALDEMLDPRLPTPL 936
T + DV+SFGVL E+ G P + C L M P TP
Sbjct: 251 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG-----TRMRAPENATP- 304
Query: 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
I + ++C P RPT + ++L
Sbjct: 305 --------EIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 28/82 (34%), Positives = 48/82 (58%), Gaps = 6/82 (7%)
Query: 827 IVHRDISSKNVLLNLEYEAHVS--DFGISKFLKLGLSNRTE-LAGTFGYIAPELAYTMKV 883
+++RD+ +N+LL +Y+ H++ DFG+ K L + ++T GT Y+APEL
Sbjct: 114 VIYRDLKPENILL--DYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGY 170
Query: 884 TEKCDVYSFGVLALEVIKGKHP 905
T+ D ++ GVL E++ G P
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 10/214 (4%)
Query: 709 IGNGGQGSVYKAELPT-GEIVAVKKFHSPLPGEMACQQEFLNEGNALTK-IRHRNIVKFY 766
IG G G V A+ + G AVK + Q + E N L K ++H +V +
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 767 GFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP 826
A + V +Y+ G L L + E R A + VA A+ Y+H+
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP--RARFYAAE-VASAIGYLHSL---N 116
Query: 827 IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEK 886
I++RD+ +N+LL+ + ++DFG+ K + GT Y+APE+
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT 176
Query: 887 CDVYSFGVLALEVIKGKHPRDFISSICSSLSSNL 920
D + G + E++ G P F S S + N+
Sbjct: 177 VDWWCLGAVLYEMLYGLPP--FYSRDVSQMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 748 LNEGNALTKIRHRNIVKF-YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRM 806
+ E L RH + Y F +H FV+ EY G L LS + +T+
Sbjct: 43 VTESRVLQNTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERV-----FTEER 96
Query: 807 NAIKG--VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864
G + AL Y+H+ +V+RDI +N++L+ + ++DFG+ K G+S+
Sbjct: 97 ARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLC---KEGISDGA 150
Query: 865 EL---AGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
+ GT Y+APE+ D + GV+ E++ G+ P
Sbjct: 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 9e-06
Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 3/82 (3%)
Query: 827 IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT-ELAGTFGYIAPELAYTMKV-- 883
I++RDI +N+LL+ E ++DFG+SK R GT Y+APE+
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185
Query: 884 TEKCDVYSFGVLALEVIKGKHP 905
+ D +S GVL E++ G P
Sbjct: 186 DKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 9e-06
Identities = 50/224 (22%), Positives = 87/224 (38%), Gaps = 38/224 (16%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFH-SPLPGEMACQQEF----------LNEGNALTK 756
+G G G V KA TG+IVA+KK + ++ ++ L E + +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 757 IRHRNIVKFYG-FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI-KGVAD 814
I+H NI+ + + +V + + L ++ E + I G+
Sbjct: 77 IKHENIMGLVDVYVEGDFIN-LVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNV 134
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS----------KFLKLGLSNRT 864
+H + +HRD+S N+ +N + ++DFG++ K R
Sbjct: 135 ----LH-KWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 865 ELAG----TFGYIAPELAY-TMKVTEKCDVYSFGVLALEVIKGK 903
E T Y APEL K D++S G + E++ GK
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 26/92 (28%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 809 IKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAG 868
K + + L Y+H I+HRD+ ++N+ +N + + D G ++F + LAG
Sbjct: 163 EKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLGLAG 218
Query: 869 TFGYIAPELAYTMKVTEKCDVYSFGVLALEVI 900
T APE+ K K D++S G++ E++
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 5/98 (5%)
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK-FLKLGLSNRTELAGTFGYI 873
AL ++H I++RD+ NVLL+ E ++D+G+ K ++ G + T GT YI
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYI 163
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS 911
APE+ D ++ GVL E++ G+ P D +
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGM 201
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 26/153 (16%)
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISK-------FLKLGLSNRTELAGTFGYIAPELAYT 880
+HRD++++N+LL+ + DFG+++ +++ G R L ++APE +
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG-DARLPLK----WMAPESIFD 249
Query: 881 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP--TPLRN 938
T + DV+SFGVL E I S+ +S + I DE RL T +R
Sbjct: 250 KVYTTQSDVWSFGVLLWE----------IFSLGASPYPGVQI--DEEFCRRLKEGTRMRA 297
Query: 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
+ I + + C +P RPT ++ ++L
Sbjct: 298 PEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 49/201 (24%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
IG G G VYK TG+IVA+KK E + E + L +++H NIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-GVPSTAIREISLLKELQHPNIVCLQD 66
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
++++E+L M L L + + + + + +L+ H+ +
Sbjct: 67 VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RV 122
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL-----AYTMK 882
+HRD+ +N+L++ + ++DFG+++ + + T T Y APE+ Y+
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTP 182
Query: 883 VTEKCDVYSFGVLALEVIKGK 903
V D++S G + E+ K
Sbjct: 183 V----DIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 30/81 (37%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 827 IVHRDISSKNVLLNLEYEAHVSDFGISK-FLKLGLSNRTELAGTFGYIAPELAYTMKVTE 885
IV+RDI +N+LL+ E ++DFG+SK FL GT Y+APE+
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHG 185
Query: 886 KC-DVYSFGVLALEVIKGKHP 905
K D +S G+L E++ G P
Sbjct: 186 KAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 62/239 (25%), Positives = 103/239 (43%), Gaps = 13/239 (5%)
Query: 709 IGNGGQGSVYKAELPTGEIV-AVKKFHSPLPGEMACQQEFLNEGNALTK-IRHRNIVKFY 766
IG G G V A E AVK + ++ ++E N L K ++H +V +
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 767 GFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP 826
A + V +Y+ G L L + E R A + +A AL Y+H+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP--RARFYAAE-IASALGYLHS---LN 116
Query: 827 IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEK 886
IV+RD+ +N+LL+ + ++DFG+ K + GT Y+APE+ +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176
Query: 887 CDVYSFGVLALEVIKGKHPRDFISSICSSLSSN-LNIALDEMLDPRLPTPLRNVQDKLI 944
D + G + E++ G P F S + + N LN L L P + R++ + L+
Sbjct: 177 VDWWCLGAVLYEMLYGLPP--FYSRNTAEMYDNILNKPLQ--LKPNITNSARHLLEGLL 231
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-05
Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 6/152 (3%)
Query: 463 ILNNNELSGQLSPELGSLNQLEYLDL--SANTFHNSIPESLGNLVKLHYLNLSNNQFSQK 520
+L+ EL LS + + L+YL S+ + N ++ ++LS S K
Sbjct: 25 MLHAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGK 84
Query: 521 IPNPIEKLIHLSELDLSYKIFGEEIPSQV-CSMQSLEKLNLSHNNLSGSISRCFEEMHWL 579
I + I +L ++ ++LS IP + + SL LNLS+NN +GSI R + L
Sbjct: 85 ISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGS--IPNL 142
Query: 580 SCIDISYNALQGLIPNSTA-FRDAPMLALQGN 610
+D+S N L G IPN F +L L GN
Sbjct: 143 ETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGN 174
|
Length = 968 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 59/232 (25%), Positives = 95/232 (40%), Gaps = 44/232 (18%)
Query: 746 EFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKR 805
F + ++++ H+++VK YG C + +V EY++ G L + L + W +
Sbjct: 47 AFFETASLMSQLSHKHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--K 103
Query: 806 MNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL-----NLEYE--AHVSDFGISKFLKL 858
++ K +A AL Y+ +VH ++ KN+L+ N Y +SD GI +
Sbjct: 104 LDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP----I 156
Query: 859 GLSNRTELAGTFGYIAPELAY--TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL 916
+ +R E +IAPE +T D +SFG LE ICS+
Sbjct: 157 TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLE-------------ICSNG 203
Query: 917 SSNLN-IALDEMLD-----PRLPTPLRNVQDKLISIMEVSISCLDESPTSRP 962
L+ ++ E RLP P LI+ C PT RP
Sbjct: 204 EEPLSTLSSSEKERFYQDQHRLPMPDCAELANLIN------QCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 17/161 (10%)
Query: 747 FLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRM 806
F + ++++ H ++ +G C + +V E++E G L + L + W ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 807 NAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL---GLS-- 861
+ +A AL Y+ +VH ++ +KN+LL A G S F+KL G+S
Sbjct: 121 TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE----GTSPFIKLSDPGVSFT 173
Query: 862 --NRTELAGTFGYIAPE-LAYTMKVTEKCDVYSFGVLALEV 899
+R E +IAPE + ++ D +SFG LE+
Sbjct: 174 ALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 37/140 (26%), Positives = 62/140 (44%), Gaps = 19/140 (13%)
Query: 816 LLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA--GTFGYI 873
L +MH N F +V+RD+ N+LL+ +SD G L S + A GT GY+
Sbjct: 110 LEHMH-NRF--VVYRDLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGTHGYM 162
Query: 874 APE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP----RDFISSICSSLSSNLNIALDEML 928
APE L + D +S G + ++++G P + ++ + + L +
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 222
Query: 929 DPRLPTPL-----RNVQDKL 943
P L + L R+V +L
Sbjct: 223 SPELRSLLEGLLQRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 62/245 (25%), Positives = 95/245 (38%), Gaps = 52/245 (21%)
Query: 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
+F+ IG G G V + TG I A+K E E + L +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 761 NIVK-FYGFCSHALHSFVVYEYLEMGSL-AMILSNDAAAEE---FGWTKRMNAIKGVADA 815
+VK FY F + +++ E+L G + +++ D +EE F + + AI +
Sbjct: 62 WVVKMFYSF-QDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI--- 117
Query: 816 LLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG---------------- 859
H F +HRDI N+LL+ + +SDFG+ LK
Sbjct: 118 ----HQLGF---IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170
Query: 860 ---------------LSNRTELA----GTFGYIAPELAYTMKVTEKCDVYSFGVLALEVI 900
NR +LA GT YIAPE+ + CD +S GV+ E++
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 901 KGKHP 905
G P
Sbjct: 231 IGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 10/200 (5%)
Query: 709 IGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTK-IRHRNIVKF- 765
IG G G V A+ G+ AVK + Q+ + E N L K ++H +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 766 YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFP 825
Y F + FV+ +++ G L L + + E + +A AL Y+H+
Sbjct: 63 YSFQTTEKLYFVL-DFVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLHS---I 115
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTE 885
IV+RD+ +N+LL+ + ++DFG+ K T GT Y+APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 886 KCDVYSFGVLALEVIKGKHP 905
D + G + E++ G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 48/208 (23%), Positives = 86/208 (41%), Gaps = 13/208 (6%)
Query: 701 KNFDDEHCIGNGGQGSVYKAELPTGEI--VAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
++F+ +G G G V A + VA+K+F + +E L I
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLY 818
H V YG + ++V E++ G L + + + L++
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR-----FPNDVGCFYAAQIVLIF 144
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT-ELAGTFGYIAPEL 877
+ IV+RD+ +N+LL+ + ++DFG +K + RT L GT YIAPE+
Sbjct: 145 EYLQSLN-IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----TRTYTLCGTPEYIAPEI 199
Query: 878 AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
+ + D ++ G+ E++ G P
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 40/134 (29%), Positives = 61/134 (45%), Gaps = 13/134 (9%)
Query: 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMN-AIKGVADALLYMHTNCFPPIVHRDISS 834
++V +Y+ G L L + E R I + AL ++H IV+RD+
Sbjct: 72 YLVTDYMSGGELFWHLQKEGRFSE----DRAKFYIAELVLALEHLHKY---DIVYRDLKP 124
Query: 835 KNVLLNLEYEAHVSDFGISK--FLKLGLSNRTELAGTFGYIAPELAYTMK-VTEKCDVYS 891
+N+LL+ + DFG+SK +N GT Y+APE+ K T+ D +S
Sbjct: 125 ENILLDATGHIALCDFGLSKANLTDNKTTN--TFCGTTEYLAPEVLLDEKGYTKHVDFWS 182
Query: 892 FGVLALEVIKGKHP 905
GVL E+ G P
Sbjct: 183 LGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 701 KNFDDEHCIGNGGQGSV---YKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI 757
K + + IG+G QG V Y A L VA+KK P + ++ + E + +
Sbjct: 24 KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCV 80
Query: 758 RHRNIVKFYGFCS--HALHSFV-VYEYLEM--GSLAMILSNDAAAEEFGWT--KRMNAIK 810
H+NI+ + +L F VY +E+ +L ++ + E + + + IK
Sbjct: 81 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 811 GVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF 870
++H+ I+HRD+ N+++ + + DFG+++ + +
Sbjct: 141 -------HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 871 GYIAPELAYTMKVTEKCDVYSFGVLALEVIKGK 903
Y APE+ M E D++S G + E+IKG
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 5e-05
Identities = 71/240 (29%), Positives = 111/240 (46%), Gaps = 20/240 (8%)
Query: 304 IPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLV 363
IP L TNL TL S + +P+ I L L DL +S +P + NL L
Sbjct: 650 IP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLY 707
Query: 364 SLDLS-INKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKE--IGDMKSLSILDLSSNKL 420
L+LS ++L +S T+++ L L E ++ + P + ++ L + ++ S KL
Sbjct: 708 RLNLSGCSRLKSFPDIS----TNISWLDLDETAI-EEFPSNLRLENLDELILCEMKSEKL 762
Query: 421 NGSI-PLS--LANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQL-ILNNNELSGQLSPE 476
+ PL+ + L+ SL L+LS + E+P L L I N L + P
Sbjct: 763 WERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINL--ETLPT 820
Query: 477 LGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDL 536
+L LE LDLS + + P+ N+ LNLS +++P IEK +LS LD+
Sbjct: 821 GINLESLESLDLSGCSRLRTFPDISTNISD---LNLSRTGI-EEVPWWIEKFSNLSFLDM 876
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 6e-05
Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 50/218 (22%)
Query: 709 IGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G+G G V A TG VA+KK P + ++ + E L + H N++
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHENVIG--- 78
Query: 768 FCSHALHSFVVYEYLE-----------MGS-LAMILSNDAAAEEFGWTKRMNA------I 809
L F LE MG+ L I+ ++++ +
Sbjct: 79 ----LLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK----------CQKLSDDHIQFLV 124
Query: 810 KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAG- 868
+ L Y+H+ I+HRD+ N+ +N + E + DFG+++ E+ G
Sbjct: 125 YQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR------HTDDEMTGY 175
Query: 869 --TFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 903
T Y APE+ M + D++S G + E++ GK
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 7e-05
Identities = 57/230 (24%), Positives = 92/230 (40%), Gaps = 56/230 (24%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKF--HSPLPGEMACQQEF----LNEGNALTKIRHRN 761
+G G G VYKA ++ TG +VA+KK H+ G F L E L K++H N
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-------FPITALREIKILKKLKHPN 68
Query: 762 IVK----FYGFCSHALHS----FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVA 813
+V + ++V Y++ L+ +L N + + IK
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLT------ESQIKCYM 121
Query: 814 DALL----YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS--------KFLKLGLS 861
LL Y+H N I+HRDI + N+L++ + ++DFG++ G
Sbjct: 122 LQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 862 NRTELAG---TFGYIAPELA-----YTMKVTEKCDVYSFGVLALEVIKGK 903
+ T Y PEL YT V D++ G + E+ +
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 7e-05
Identities = 30/110 (27%), Positives = 51/110 (46%), Gaps = 7/110 (6%)
Query: 810 KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF-LKLGLSNRTELAG 868
+ V A+ Y+H N I+HRDI ++N+ +N + + DFG + F + + + AG
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245
Query: 869 TFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP---RDFISSICSS 915
T APEL D++S G++ E+ +D + C S
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDS 295
|
Length = 391 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 7e-05
Identities = 62/236 (26%), Positives = 102/236 (43%), Gaps = 65/236 (27%)
Query: 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKK----FHSPLPG-----EMACQQEFLNE 750
+ ++ +G G G V+KA + T E+VA+KK F + E+ QE +
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD- 65
Query: 751 GNALTKIRHRNIVKFYGFCSHALHS-------FVVYEYLEMGSLAMILSNDAAAEEFGWT 803
H NIVK + ++V+EY+E A+I +N E+
Sbjct: 66 --------HPNIVKLL-----NVIKAENDKDIYLVFEYMETDLHAVIRAN--ILEDV--H 108
Query: 804 KR------MNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857
KR + A+K Y+H+ ++HRD+ N+LLN + ++DFG+++ L
Sbjct: 109 KRYIMYQLLKALK-------YIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158
Query: 858 LGLSNR-----TELAGTFGYIAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 903
N T+ T Y APE+ YT V D++S G + E++ GK
Sbjct: 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 26/82 (31%), Positives = 43/82 (52%), Gaps = 3/82 (3%)
Query: 827 IVHRDISSKNVLLNLEYEAHVSDFGISK-FLKLGLSNRTELAGTFGYIAPELAYTMKV-- 883
I++RDI +N+LL+ ++DFG+SK F + + GT Y+AP++
Sbjct: 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGH 185
Query: 884 TEKCDVYSFGVLALEVIKGKHP 905
+ D +S GVL E++ G P
Sbjct: 186 DKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 1e-04
Identities = 54/222 (24%), Positives = 98/222 (44%), Gaps = 27/222 (12%)
Query: 701 KNFDDEHCIGNGGQGSV---YKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI 757
K + + IG+G QG V Y A L VA+KK P + ++ + E + +
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCV 73
Query: 758 RHRNIVKFYGFCS--HALHSFV-VYEYLEM--GSLAMILSNDAAAEEFGWT--KRMNAIK 810
H+NI+ + +L F VY +E+ +L ++ + E + + + IK
Sbjct: 74 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 133
Query: 811 GVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF 870
++H+ I+HRD+ N+++ + + DFG+++ T T
Sbjct: 134 -------HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTPYVVTR 182
Query: 871 GYIAPELAYTMKVTEKCDVYSFGVLALEVIKGK--HP-RDFI 909
Y APE+ M E D++S G + E+++ K P RD+I
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-04
Identities = 58/244 (23%), Positives = 92/244 (37%), Gaps = 35/244 (14%)
Query: 308 LGSLTNLATLYFSTNALSGSIPNEITNLR---SLSDLQLSENTLNGSI-PLALGNLT--- 360
L L L S NAL + +L SL +L+L+ N L L L
Sbjct: 77 LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLP 136
Query: 361 -KLVSLDLSINKLS--GSIPLS--FASLTSLTTLYLYENSLCD----SIPKEIGDMKSLS 411
L L L N+L L+ + L L L N + D ++ + + +L
Sbjct: 137 PALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLE 196
Query: 412 ILDLSSNKLN--GSIPLSLANLTN-SLKVLYLSSNHIVGEIPLGH------GKFSSLIQL 462
+LDL++N L G+ L+ + SL+VL L N++ + SL+ L
Sbjct: 197 VLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNL-TDAGAAALASALLSPNISLLTL 255
Query: 463 ILNNNEL----SGQLSPELGSLNQLEYLDLSANTF-----HNSIPESLGNLVKLHYLNLS 513
L+ N++ + L+ L L LDL N F L +L L +
Sbjct: 256 SLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVK 315
Query: 514 NNQF 517
++ F
Sbjct: 316 DDSF 319
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 39/153 (25%), Positives = 70/153 (45%), Gaps = 26/153 (16%)
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISK-------FLKLGLSNRTELAGTFGYIAPELAYT 880
+HRD++++N+LL+ + DFG+++ +++ G R L ++APE +
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG-DARLPLK----WMAPETIFD 255
Query: 881 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP--TPLRN 938
T + DV+SFGVL E+ S+ +S + I DE RL T +R
Sbjct: 256 RVYTIQSDVWSFGVLLWEIF----------SLGASPYPGVKI--DEEFCRRLKEGTRMRA 303
Query: 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
+ + + C P+ RPT ++ + L
Sbjct: 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 10/160 (6%)
Query: 748 LNEGNALTKIRHRNIVKF-YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRM 806
L E L RH + Y F +H FV+ EY G L LS + E +
Sbjct: 43 LTESRVLQNTRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSE-DRARFY 100
Query: 807 NAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF-LKLGLSNRTE 865
A + AL Y+H+ +V+RD+ +N++L+ + ++DFG+ K + G + +T
Sbjct: 101 GA--EIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 154
Query: 866 LAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
GT Y+APE+ D + GV+ E++ G+ P
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 23/207 (11%)
Query: 708 CIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFY 766
IG G G V A T E VA+KK + + ++ L E L + H N++
Sbjct: 12 PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLDHENVIAIK 70
Query: 767 GFCSHALHS-----FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT 821
++VYE ++ +I S+ +++ ++G L Y+H+
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRG----LKYIHS 126
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL---- 877
++HRD+ N+LLN + + DFG+++ TE T Y APEL
Sbjct: 127 ---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNC 183
Query: 878 -AYTMKVTEKCDVYSFGVLALEVIKGK 903
YT + DV+S G + E++ K
Sbjct: 184 SEYTTAI----DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 46/202 (22%), Positives = 90/202 (44%), Gaps = 28/202 (13%)
Query: 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT-NCFPPIVHRDISSKNV 837
Y+ + +LS+D + E ++ VA + ++ + NC VHRD++++NV
Sbjct: 214 YKGSNDSEVKNLLSDDGS-EGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNV 268
Query: 838 LLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF---GYIAPELAYTMKVTEKCDVYSFGV 894
LL + DFG+++ + + SN TF ++APE + T DV+S+G+
Sbjct: 269 LLAQGKIVKICDFGLARDI-MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 895 LALEVIK-GKHPRDFI---SSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVS 950
L E+ G P + S+ + + S R+ P Q+ + ++
Sbjct: 328 LLWEIFSLGGTPYPGMIVDSTFYNKIKSGY----------RMAKPDHATQE----VYDIM 373
Query: 951 ISCLDESPTSRPTMQKVSQLLK 972
+ C + P RP+ +S +++
Sbjct: 374 VKCWNSEPEKRPSFLHLSDIVE 395
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 43/216 (19%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEG---NALTKI------R 758
IG G G+V+KA T EIVA+K+ + + +EG +AL +I +
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV----------RLDDDDEGVPSSALREICLLKELK 57
Query: 759 HRNIVKFYGFCSHALHS----FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVAD 814
H+NIV+ Y LHS +V+EY + L + +K
Sbjct: 58 HKNIVRLY----DVLHSDKKLTLVFEYCDQ-DLKKYFDS------CNGDIDPEIVKSFMF 106
Query: 815 ALL----YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF 870
LL + H++ ++HRD+ +N+L+N E ++DFG+++ + + + T
Sbjct: 107 QLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTL 163
Query: 871 GYIAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHP 905
Y P++ + K+ + D++S G + E+ P
Sbjct: 164 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-04
Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 19/207 (9%)
Query: 709 IGNGGQG---SVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVK 764
+G G G S AE E VA+KK + ++ ++ L E L R H+NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRA-LRELKLLRHFRGHKNITC 66
Query: 765 FYGF---CSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT 821
Y + +YE L L I+ + + + + I + L Y+H+
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHF---QSFIYQILCGLKYIHS 123
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR----TELAGTFGYIAPEL 877
++HRD+ N+L+N + E + DFG+++ TE T Y APE+
Sbjct: 124 ---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180
Query: 878 AYTMK-VTEKCDVYSFGVLALEVIKGK 903
+ + T+ DV+S G + E++ K
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 3e-04
Identities = 64/240 (26%), Positives = 95/240 (39%), Gaps = 52/240 (21%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
IG G G V+ + TG++ A+K K ++A E + L IVK
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH---VRAERDILADADSPWIVK 65
Query: 765 -FYGFCSHALHSFVVYEYLEMGSLAMILSN-DAAAEEFGWTKRMNAIKGVADALLYMHTN 822
+Y F H ++V EY+ G L +L D EE + I + AL +H
Sbjct: 66 LYYSFQDEE-HLYLVMEYMPGGDLMNLLIRKDVFPEE--TARFY--IAELVLALDSVHKL 120
Query: 823 CFPPIVHRDISSKNVLLNLEYEAHV--SDFGISK-------------------FLKLGLS 861
F +HRDI N+L++ + H+ +DFG+ K F L
Sbjct: 121 GF---IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 862 NRTEL----------AGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS 911
R + GT YIAPE+ +CD +S GV+ E++ G P F S
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP--FYSD 233
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 61/199 (30%), Positives = 82/199 (41%), Gaps = 33/199 (16%)
Query: 397 CDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANL------TNSLKVLYLSSNHIVGEIP 450
++ + SL L LS N+ G IP L +L L+ L LS N + P
Sbjct: 40 AKALASALRPQPSLKELCLSLNET-GRIPRGLQSLLQGLTKGCGLQELDLSDNALG---P 95
Query: 451 LGHGKFSSLIQ------LILNNNELSGQ----LSPELGSLN-QLEYLDLSANTFHNSIPE 499
G G SL++ L LNNN L + L+ L L LE L L N + E
Sbjct: 96 DGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE 155
Query: 500 SLGNLV----KLHYLNLSNNQFS-QKIPNPIEKLIHLSEL---DLSYKIFGEEIPSQVC- 550
+L + L LNL+NN I E L L DL+ +E S +
Sbjct: 156 ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAE 215
Query: 551 ---SMQSLEKLNLSHNNLS 566
S++SLE LNL NNL+
Sbjct: 216 TLASLKSLEVLNLGDNNLT 234
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 4e-04
Identities = 41/158 (25%), Positives = 72/158 (45%), Gaps = 26/158 (16%)
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGT---FGYIAPELA 878
NC +HRD++++N+LL + DFG+++ ++ SN ++APE
Sbjct: 234 NC----IHRDLAARNILLTHGRITKICDFGLARDIRND-SNYVVKGNARLPVKWMAPESI 288
Query: 879 YTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDE---MLDPRLPT 934
+ T + DV+S+G+L E+ G P + + S + E ML P
Sbjct: 289 FNCVYTFESDVWSYGILLWEIFSLGSSPYPGM-----PVDSKFYKMIKEGYRMLSPECAP 343
Query: 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
++ IM+ SC D P RPT +++ QL++
Sbjct: 344 S------EMYDIMK---SCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-04
Identities = 50/227 (22%), Positives = 93/227 (40%), Gaps = 29/227 (12%)
Query: 749 NEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNA 808
NE AL ++ H NI+K +++++ + + + + ++ K+ A
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRA 271
Query: 809 I-KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFG-ISKFLKLGLSNRTEL 866
I K + A+ Y+H ++HRDI +N+ LN + + + DFG F K +
Sbjct: 272 IMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGW 328
Query: 867 AGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK---------GKHPRDFISSICSSLS 917
GT +PE+ E D++S G++ L+++ G P + I SLS
Sbjct: 329 VGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLS 388
Query: 918 SNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTM 964
+ D P P + D + S + +D + S P +
Sbjct: 389 ---------VCDEEFPDPPCKLFDYIDS------AEIDHAGHSVPPL 420
|
Length = 501 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 6e-04
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 32/217 (14%)
Query: 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
K + + IG+G QG V A + TG+ VA+KK P ++ + E + + H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNH 74
Query: 760 RNIVKFYGFCS--HALHSFV-VYEYLEM--GSLAMILSNDAAAEEFGWTKRMN------- 807
+NI+ + +L F VY +E+ +L ++ D E RM+
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHE------RMSYLLYQML 128
Query: 808 -AIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTEL 866
IK ++H+ I+HRD+ N+++ + + DFG+++ T
Sbjct: 129 CGIK-------HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTPY 177
Query: 867 AGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGK 903
T Y APE+ M E D++S G + E+I+G
Sbjct: 178 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 7e-04
Identities = 62/259 (23%), Positives = 102/259 (39%), Gaps = 68/259 (26%)
Query: 702 NFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLN---EGNALTKI 757
+F IG G G V + TG+I A+K + L EM + + + E + L +
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMK---TLLKSEMFKKDQLAHVKAERDVLAES 58
Query: 758 RHRNIVKFYGFCSHALHSFVVYEYLEMGSL-AMILSNDAAAEE---FGWTKRMNAIKGVA 813
+V Y A + +++ E+L G L M++ D +E+ F + + AI+ V
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV- 117
Query: 814 DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK-FLK--------------- 857
H F +HRDI N+L++ +SDFG+S F K
Sbjct: 118 ------HKLGF---IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168
Query: 858 -----------------LGLSNRTELA--------------GTFGYIAPELAYTMKVTEK 886
L +S++ ++A GT YIAPE+ ++
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228
Query: 887 CDVYSFGVLALEVIKGKHP 905
CD +S G + E + G P
Sbjct: 229 CDWWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-04
Identities = 51/225 (22%), Positives = 94/225 (41%), Gaps = 56/225 (24%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
IG G G VYKA + TG++VA+KK E EG T +R ++++
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRL----------EMDEEGIPPTALREISLLQMLS 58
Query: 768 FCSHAL------HS---------FVVYEYLEMGSLAMILSN---------DAAAEEFGWT 803
+ + H ++V+EYL+ + SN + F +
Sbjct: 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMY- 117
Query: 804 KRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEA-HVSDFGISKFLKLGLSN 862
+KGVA + H + ++HRD+ +N+L++ + ++D G+ + + + +
Sbjct: 118 ---QLLKGVA----HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS 167
Query: 863 RTELAGTFGYIAPEL-----AYTMKVTEKCDVYSFGVLALEVIKG 902
T T Y APE+ Y+ V D++S G + E+ +
Sbjct: 168 YTHEIVTLWYRAPEVLLGSTHYSTPV----DIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 31/125 (24%), Positives = 49/125 (39%), Gaps = 47/125 (37%)
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGI---------SKFLKLGLSNRTE------------- 865
+HRDI N+L++L+ ++DFG+ SK+ + G R +
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 866 -------------------------LAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVI 900
L GT YIAPE+ T+ CD +S GV+ E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 901 KGKHP 905
G+ P
Sbjct: 243 VGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 8e-04
Identities = 24/60 (40%), Positives = 30/60 (50%)
Query: 337 SLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSL 396
+L L LS N L A L L LDLS N L+ P +F+ L SL +L L N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 0.001
Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 809 IKGVADALL----YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864
+ VA LL Y+H I+HRDI ++NVL+N + + DFG + F + S
Sbjct: 262 VTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 865 E--LAGTFGYIAPELAYTMKVTEKCDVYSFGVLALE 898
+AGT APE+ T D++S G++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 51/215 (23%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 709 IGNGGQGSVYKA-ELPTG-EIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-------- 758
IG G G V+KA +L G VA+K+ + Q EG L+ IR
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKR--------VRVQTG--EEGMPLSTIREVAVLRHL 58
Query: 759 ----HRNIVKFYGFCS-----HALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRM-NA 808
H N+V+ + C+ +V+E+++ L L D E T+ + +
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDM 115
Query: 809 IKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAG 868
+ + L ++H++ +VHRD+ +N+L+ + ++DFG+++ ++ T +
Sbjct: 116 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVV 171
Query: 869 TFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGK 903
T Y APE+ D++S G + E+ + K
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 10/158 (6%)
Query: 750 EGNALTKIRHRNIVKF-YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNA 808
E N L ++H IV Y F + +++ EYL G L M L + E ++
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQTGG-KLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE 108
Query: 809 IKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK-FLKLGLSNRTELA 867
I + AL ++H I++RD+ +N+LL+ + ++DFG+ K + G T
Sbjct: 109 I---SLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FC 161
Query: 868 GTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
GT Y+APE+ + D +S G L +++ G P
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 0.001
Identities = 46/191 (24%), Positives = 87/191 (45%), Gaps = 33/191 (17%)
Query: 744 QQEFLNEGNALTKIRHRNIVKFYG-FCSHALHS-FVVYEYLEMGSLAMILSNDAAAEEFG 801
+ + + E N + +++H+NIV++ F + A +++ E+ + G L+ + + FG
Sbjct: 56 KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQK--CYKMFG 113
Query: 802 WTKR---MNAIKGVADALLYMHTNCFPP----IVHRDISSKNVLL--------------- 839
+ ++ + + AL Y H P ++HRD+ +N+ L
Sbjct: 114 KIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173
Query: 840 NLEYE--AHVSDFGISKFLKLGLSNRTE-LAGTFGYIAPELAY--TMKVTEKCDVYSFGV 894
NL A + DFG+SK +G+ + GT Y +PEL T +K D+++ G
Sbjct: 174 NLNGRPIAKIGDFGLSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGC 231
Query: 895 LALEVIKGKHP 905
+ E+ GK P
Sbjct: 232 IIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 25/208 (12%)
Query: 709 IGNGGQGSVY---KAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
IG GG G VY KA+ TG++ A+K + LNE L+ + + F
Sbjct: 2 IGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPF 58
Query: 766 YGFCSHALHS----FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKG-VADALLYMH 820
++A H+ + + + G L LS E K M + L +MH
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSE----KEMRFYATEIILGLEHMH 114
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA--GTFGYIAPE-L 877
N F +V+RD+ N+LL+ +SD G L S + A GT GY+APE L
Sbjct: 115 -NRF--VVYRDLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGTHGYMAPEVL 167
Query: 878 AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
D +S G + ++++G P
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 34/140 (24%), Positives = 56/140 (40%), Gaps = 46/140 (32%)
Query: 809 IKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI---------SKFLKLG 859
I + A+ +H F +HRDI N+L++ + ++DFG+ SK+ + G
Sbjct: 107 IAELTCAIESVHKMGF---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKG 163
Query: 860 LSNRTE----------------------------------LAGTFGYIAPELAYTMKVTE 885
+R + L GT YIAPE+ T+
Sbjct: 164 DHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 223
Query: 886 KCDVYSFGVLALEVIKGKHP 905
CD +S GV+ E++ G+ P
Sbjct: 224 LCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 48/198 (24%), Positives = 87/198 (43%), Gaps = 12/198 (6%)
Query: 709 IGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G +V+K T +VA+K+ L E + E + L ++H NIV +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFP-P 826
+V+EYL+ L L N G M+ +K LL + C
Sbjct: 71 IIHTERCLTLVFEYLD-SDLKQYLDN------CGNLMSMHNVKIFMFQLLRGLSYCHKRK 123
Query: 827 IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPE-LAYTMKVTE 885
I+HRD+ +N+L+N + E ++DFG+++ + + T Y P+ L + + +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 886 KCDVYSFGVLALEVIKGK 903
D++ G + E+ G+
Sbjct: 184 PIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 59/251 (23%), Positives = 101/251 (40%), Gaps = 58/251 (23%)
Query: 747 FLNEGNALTKIRHRNIVKFYGFCSHALHS-FVVYEYLEMGSLAMILSNDAAAEEFGWTKR 805
L E L + H+NI+ C FV+Y Y+ G+L + L E
Sbjct: 55 LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114
Query: 806 MN------AIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL--- 856
AI+ +A + Y+H ++H+DI+++N +++ E + ++D +S+ L
Sbjct: 115 STQQLVHMAIQ-IACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPM 170
Query: 857 ---KLGLS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISS 911
LG + NR ++A E + + DV+SFGVL E++ G+ P
Sbjct: 171 DYHCLGDNENR-----PVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY----- 220
Query: 912 ICSSLSSNLNIALDEMLDP-----------RLPTPLRNVQDKLISIMEVSISCLDESPTS 960
+DP RL P+ N D+L ++M C P
Sbjct: 221 --------------VEIDPFEMAAYLKDGYRLAQPI-NCPDELFAVMAC---CWALDPEE 262
Query: 961 RPTMQKVSQLL 971
RP+ ++ Q L
Sbjct: 263 RPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 703 FDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN 761
+ D +G G G V+ A + + VAVKK P + + L E + ++ H N
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV---KHALREIKIIRRLDHDN 63
Query: 762 IVKFY---GFCSHALHS-----------FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMN 807
IVK Y G L ++V EY+E LA +L +EE
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQ 122
Query: 808 AIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE-YEAHVSDFGISKFLKLGLSNR--- 863
++G L Y+H+ ++HRD+ NV +N E + DFG+++ + S++
Sbjct: 123 LLRG----LKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYL 175
Query: 864 TELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 903
+E T Y +P L + T+ D+++ G + E++ GK
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 47/201 (23%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 709 IGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G +VYK T +VA+K+ L E + E + L ++H NIV +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIK----GVADALLYMHTNC 823
+V+EYL+ L L ++ G + M+ +K + L Y H
Sbjct: 72 IIHTEKSLTLVFEYLDK-DLKQYL------DDCGNSINMHNVKLFLFQLLRGLNYCHRR- 123
Query: 824 FPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPE-LAYTMK 882
++HRD+ +N+L+N E ++DFG+++ + + T Y P+ L +
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTD 181
Query: 883 VTEKCDVYSFGVLALEVIKGK 903
+ + D++ G + E+ G+
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 23/232 (9%)
Query: 709 IGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTK-IRHRNIVKF- 765
IG G G V A+ G+ AVK + Q+ + E N L K ++H +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 766 YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFP 825
Y F + FV+ +Y+ G L L + + E R A + +A AL Y+H+
Sbjct: 63 YSFQTADKLYFVL-DYVNGGELFFHLQRERSFPEP--RARFYAAE-IASALGYLHSL--- 115
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTE 885
I++RD+ +N+LL+ + ++DFG+ K + GT Y+APE+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175
Query: 886 KCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937
D + G + E++ G P F S + EM D L PLR
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP--FYSRDTA-----------EMYDNILNKPLR 214
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 62/250 (24%), Positives = 98/250 (39%), Gaps = 65/250 (26%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLN---EGNALTKIRHRNIVK 764
IG G G V + TG I A+KK EM +++ + E + L + + +VK
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKL---RKSEMLEKEQVAHVRAERDILAEADNPWVVK 65
Query: 765 FYGFCSHALHSFVVYEYL---EMGSLAM---ILSNDAAAEEFGWTKRMNAIKGVADALLY 818
Y + +++ EYL +M +L M + + F + + AI +
Sbjct: 66 LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET--RFYIAETILAIDSI------ 117
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL-KLGLS---------------- 861
H + +HRDI N+LL+ + +SDFG+ L K +
Sbjct: 118 -HKLGY---IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 862 -----------------NRTELA----GTFGYIAPELAYTMKVTEKCDVYSFGVLALEVI 900
NR LA GT YIAPE+ ++CD +S GV+ E++
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
Query: 901 KGKHPRDFIS 910
G P F S
Sbjct: 234 VGYPP--FCS 241
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 812 VADALLYMHT-NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF 870
VA+ + ++ + NC VHRD++++NVL+ + DFG+++ + + SN TF
Sbjct: 248 VANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDI-MRDSNYISKGSTF 302
Query: 871 ---GYIAPELAYTMKVTEKCDVYSFGVLALEV 899
++APE + T DV+SFG+L E+
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.004
Identities = 31/125 (24%), Positives = 48/125 (38%), Gaps = 47/125 (37%)
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGI---------SKFLKLG---------LSNRTE---- 865
+HRDI N+L++ + ++DFG+ SK+ + G SN
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 866 -------------------------LAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVI 900
L GT YIAPE+ T+ CD +S GV+ E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 901 KGKHP 905
G+ P
Sbjct: 243 VGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 973 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.95 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.56 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.55 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.53 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.5 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.48 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.32 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.26 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.22 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.21 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.2 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.2 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.19 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.18 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.18 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.1 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.1 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.01 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.96 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.87 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.83 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.77 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.76 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.75 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.7 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.67 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.67 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.66 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.62 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.58 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.53 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-105 Score=1012.43 Aligned_cols=870 Identities=35% Similarity=0.533 Sum_probs=535.7
Q ss_pred CCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCcccc-CccccceeeccCCcCCCCCCCccccCCccceeec
Q 002069 49 SLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVG-SLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYL 127 (973)
Q Consensus 49 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 127 (973)
+++.|+|++|.+.+.+|..|..+++|++|+|++|++++.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+|
T Consensus 70 ~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~L 147 (968)
T PLN00113 70 RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDL 147 (968)
T ss_pred cEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEEC
Confidence 344444444444444444444444444444444444444443332 444444444444444443332 23344444444
Q ss_pred ccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeeccccccccc
Q 002069 128 HMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGS 207 (973)
Q Consensus 128 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 207 (973)
++|.+++.+|..|+++++|++|++++|.+.+.+|..++++++|++|++++|.+.+.+|..++++++|++|+|++|++.+.
T Consensus 148 s~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~ 227 (968)
T PLN00113 148 SNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGE 227 (968)
T ss_pred cCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCc
Confidence 44444444444444444444444444444444444444444444444444444444444444444444444444444444
Q ss_pred cccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccc
Q 002069 208 ILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNL 287 (973)
Q Consensus 208 ~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l 287 (973)
.+..|+++++|++|++++|.+++..|..|+++++|+.|++++|++++..|.. +.++
T Consensus 228 ~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~------------------------l~~l 283 (968)
T PLN00113 228 IPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS------------------------IFSL 283 (968)
T ss_pred CChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchh------------------------Hhhc
Confidence 4444444444444444444444444444444555555555554444333322 2233
Q ss_pred cccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEc
Q 002069 288 KSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDL 367 (973)
Q Consensus 288 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 367 (973)
++|++|++++|.+.+.+|..+..+++|+.|++++|.+.+..|..+..+++|+.|++++|.+++..|..++.+++|+.|++
T Consensus 284 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~L 363 (968)
T PLN00113 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDL 363 (968)
T ss_pred cCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEEC
Confidence 34444444444444444444444444444444444444444444444445555555555544444444455555555555
Q ss_pred cCCcccCCCCcccccccccchhcccccccccCCCcccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCccccc
Q 002069 368 SINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVG 447 (973)
Q Consensus 368 s~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~ 447 (973)
++|++++..|..+..+++|+.|++++|++.+..|..+..+++|+.|++++|++++.+|..+..+. +|+.|++++|.+++
T Consensus 364 s~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~ 442 (968)
T PLN00113 364 STNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLP-LVYFLDISNNNLQG 442 (968)
T ss_pred CCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCC-CCCEEECcCCcccC
Confidence 55555544454454455555555555555544555555555555555555555554554444433 45555555555555
Q ss_pred ccCCCCCCCcccceeeccCCccCCCCCcccccccccccccccccccccccCccccccccccEEeecCccCCCCCCccccc
Q 002069 448 EIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEK 527 (973)
Q Consensus 448 ~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 527 (973)
.++..+..+++|+.|++++|++.+..|..+ ..++|+.||+++|++++..|..+..+++|++|+|++|++++.+|..+..
T Consensus 443 ~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 521 (968)
T PLN00113 443 RINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSS 521 (968)
T ss_pred ccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcC
Confidence 555555555666666666666665555444 3467888888888888777888888888888888888888888888888
Q ss_pred ccccCeecccccccCCCcchhhcccccccccccccccccCccchhhhccccccEEeCcCCCCCCCCCCCccCCCCCcchh
Q 002069 528 LIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLAL 607 (973)
Q Consensus 528 l~~L~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~ 607 (973)
+.+|++|++++|.+++..|..+..+++|+.|+|++|++++..|..+..++.|+.+++++|++++..|...++..+....+
T Consensus 522 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~ 601 (968)
T PLN00113 522 CKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAV 601 (968)
T ss_pred ccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhh
Confidence 88888888888888888899999999999999999999999999999999999999999999999998888888889999
Q ss_pred cCCCCccCCCcc--CCCCcccccCCcccceEEEEeehhHHHHHHHHHHHHhhheeeeeecccccccCCCCccccCccccc
Q 002069 608 QGNKRLCGDIKR--LPPCKAFKSHKQSLKKIWIVIVFPLLGTVALLISLIGLFFNFRQRKNGLQTQQSSPRNTLGLLSVL 685 (973)
Q Consensus 608 ~~N~~~c~~~~~--l~~~~~~~~~~~~~~~~~~~ii~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (973)
.|||.+|+.... .++|.... +....++ ++++++++++++++++++++++|+|+....++.+............
T Consensus 602 ~~n~~lc~~~~~~~~~~c~~~~----~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (968)
T PLN00113 602 AGNIDLCGGDTTSGLPPCKRVR----KTPSWWF-YITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD 676 (968)
T ss_pred cCCccccCCccccCCCCCcccc----ccceeee-ehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccc
Confidence 999999986543 56674321 1122233 3333333333333333333333332221111111111100000000
Q ss_pred -ccCccccHHHHHHHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCcee
Q 002069 686 -TFDGKIVHEEIIRATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIV 763 (973)
Q Consensus 686 -~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 763 (973)
.....+..++ ....|...+.||+|+||.||+|.. .+++.||||++...... ...|++.+++++|||||
T Consensus 677 ~~~~~~~~~~~---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv 746 (968)
T PLN00113 677 SKVSKSITIND---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIV 746 (968)
T ss_pred cccchhhhHHH---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcc
Confidence 0011123333 345677888999999999999965 58899999998643221 12457889999999999
Q ss_pred eeceeeeccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC
Q 002069 764 KFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY 843 (973)
Q Consensus 764 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~ 843 (973)
+++|+|.+++..++||||+++|+|.++++ .++|.++.+++.|+|+|++|||..+.++|+|||+||+||+++.++
T Consensus 747 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~ 820 (968)
T PLN00113 747 KLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD 820 (968)
T ss_pred eEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC
Confidence 99999999999999999999999999995 378999999999999999999966555999999999999999998
Q ss_pred ceEEecccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhh----hhhhhhhh
Q 002069 844 EAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS----ICSSLSSN 919 (973)
Q Consensus 844 ~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~----~~~~~~~~ 919 (973)
.+++. ||.+..... .....+++.|+|||++.+..++.++|||||||++|||+||+.||+.... ...+....
T Consensus 821 ~~~~~-~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~ 895 (968)
T PLN00113 821 EPHLR-LSLPGLLCT----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYC 895 (968)
T ss_pred ceEEE-ecccccccc----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHh
Confidence 88875 665543321 1234688999999999999999999999999999999999999863321 11111111
Q ss_pred h-hhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 920 L-NIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 920 ~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
. ......++++.+........+....+.+++.+||+.||++||||+||++.|+
T Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 949 (968)
T PLN00113 896 YSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949 (968)
T ss_pred cCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHH
Confidence 1 1122334455443333333456667889999999999999999999999885
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-63 Score=623.99 Aligned_cols=537 Identities=38% Similarity=0.564 Sum_probs=407.3
Q ss_pred CCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCccc-CCCCCcEEEccCCcCcccCCccccCcccccee
Q 002069 23 LTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLG-NLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDL 101 (973)
Q Consensus 23 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~-~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L 101 (973)
..+++.|||++|.+++.+|..|..+++|+.|+|++|++.+.+|..+. .+++|++|+|++|.+++.+|. +.+++|++|
T Consensus 68 ~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L 145 (968)
T PLN00113 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETL 145 (968)
T ss_pred CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEE
Confidence 35789999999999998898999999999999999999888888765 899999999999999887775 568899999
Q ss_pred eccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccC
Q 002069 102 RLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181 (973)
Q Consensus 102 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~ 181 (973)
+|++|.+.+.+|..++++++|++|+|++|.+.+.+|..|+++++|++|++++|.+++.+|..++++++|+.|++++|.+.
T Consensus 146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 225 (968)
T PLN00113 146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225 (968)
T ss_pred ECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence 99999998889999999999999999999998889999999999999999999999889999999999999999999999
Q ss_pred CCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccC
Q 002069 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFG 261 (973)
Q Consensus 182 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 261 (973)
+.+|..++++++|++|++++|.+.+..+..|+++++|+.|++++|.+++..|..+.++++|+.|++++|.+++..|..+.
T Consensus 226 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~ 305 (968)
T PLN00113 226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305 (968)
T ss_pred CcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHc
Confidence 88999999999999999999999988888999999999999999999988899999999999999999998877666555
Q ss_pred CcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcE
Q 002069 262 NLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDL 341 (973)
Q Consensus 262 ~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 341 (973)
+++ +|+.|++++|.+++..|..+..+++|+.|++++|.+++..|..+..+++|+.|
T Consensus 306 ~l~------------------------~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L 361 (968)
T PLN00113 306 QLQ------------------------NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVL 361 (968)
T ss_pred CCC------------------------CCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEE
Confidence 444 45555555555555555555555555555555555555555555555555555
Q ss_pred EcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCCCCEEEccCCCCC
Q 002069 342 QLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421 (973)
Q Consensus 342 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 421 (973)
++++|.+++..|..+..+++|+.|++++|++.+..|..+..+++|+.|++++|++++..|..|..+++|+.|++++|.++
T Consensus 362 ~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 441 (968)
T PLN00113 362 DLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQ 441 (968)
T ss_pred ECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCccc
Confidence 55555555555555555555666666666665555555555566666666666665555555666666666666666666
Q ss_pred CCcchhhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCCcccccccccccccccccccccccCccc
Q 002069 422 GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESL 501 (973)
Q Consensus 422 ~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~~~~l 501 (973)
+.+|..+..+. +|++|++++|++.+..|..+ ..++|+.|++++|++++..|..+..+++|++|+|++|.+.+.+|+.+
T Consensus 442 ~~~~~~~~~l~-~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 519 (968)
T PLN00113 442 GRINSRKWDMP-SLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDEL 519 (968)
T ss_pred CccChhhccCC-CCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHH
Confidence 55555544443 56666666666655555443 23567777777777777777777777777777777777777777777
Q ss_pred cccccccEEeecCccCCCCCCcccccccccCeecccccccCCCcchhhcccccccccccccccccCccchhhhccccccE
Q 002069 502 GNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSC 581 (973)
Q Consensus 502 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 581 (973)
..+++|++|+|++|++++.+|..+..+++|+.||+++|.+.+..|..+..+++|++|++++|++++..|.. ..+..+..
T Consensus 520 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~ 598 (968)
T PLN00113 520 SSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST-GAFLAINA 598 (968)
T ss_pred cCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCc-chhcccCh
Confidence 77777777777777777777777777777777888877777777877777888888888888887766643 22333444
Q ss_pred EeCcCCC
Q 002069 582 IDISYNA 588 (973)
Q Consensus 582 l~l~~N~ 588 (973)
..+.+|+
T Consensus 599 ~~~~~n~ 605 (968)
T PLN00113 599 SAVAGNI 605 (968)
T ss_pred hhhcCCc
Confidence 5556665
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=416.43 Aligned_cols=281 Identities=40% Similarity=0.685 Sum_probs=238.5
Q ss_pred cCccccHHHHHHHhcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeec
Q 002069 687 FDGKIVHEEIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFY 766 (973)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~ 766 (973)
....++++++..+|++|...+.||+|+||.||+|...+|+.||||++....... .++|.+|+.++.+++|||+|+++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEE
Confidence 445689999999999999999999999999999999899999999887654332 35699999999999999999999
Q ss_pred eeeeccc-eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCce
Q 002069 767 GFCSHAL-HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEA 845 (973)
Q Consensus 767 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~ 845 (973)
|||.+.+ +.++|||||++|+|.++++..... +++|.+|++||.++|+||+|||+.+.++|+||||||+|||+|+++++
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 9999988 599999999999999999876544 78999999999999999999999988889999999999999999999
Q ss_pred EEecccccccccCCCCccccc-ccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchh-----hhhhhhhhh
Q 002069 846 HVSDFGISKFLKLGLSNRTEL-AGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS-----SICSSLSSN 919 (973)
Q Consensus 846 kl~Dfg~a~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~-----~~~~~~~~~ 919 (973)
||+|||+|+............ .||.+|+|||++..+..+.|+|||||||++.|++||+.|.+... ....|....
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 999999996654311222222 89999999999999999999999999999999999999887432 233443333
Q ss_pred hhh-hhhhhcCCCCCC-CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 920 LNI-ALDEMLDPRLPT-PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 920 ~~~-~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
... ...+++|+++.. .... ......+.+++.+|++.+|++||+|.+|+++|+
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~-~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~ 350 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPD-EKEVKKLAELALRCLRPDPKERPTMSQVVKELE 350 (361)
T ss_pred HHCcchhheeCCCccCCCCCh-HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence 333 578888988763 2221 156777899999999999999999999999874
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=395.27 Aligned_cols=256 Identities=29% Similarity=0.527 Sum_probs=212.7
Q ss_pred cCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc-eeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL-HSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~ 779 (973)
....+.+.+|+|+||+||+|.+.....||||++......... .++|.+|+.++.+++|||||+++|+|.++. ..++||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 344455669999999999999955555999999876555444 789999999999999999999999999887 789999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCC-eEeecCCCCCeeecCCC-ceEEeccccccccc
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP-IVHRDISSKNVLLNLEY-EAHVSDFGISKFLK 857 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~ 857 (973)
||+++|+|.+++++. ....+++..+++++.|||+|+.|||+. + ||||||||+|||++.++ ++||+|||+++...
T Consensus 120 Ey~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999999999875 346799999999999999999999999 7 99999999999999997 99999999998766
Q ss_pred CCCCcccccccccCcccccccc--cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 858 LGLSNRTELAGTFGYIAPELAY--TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
......+...||+.|||||++. ...|+.|+||||||+++|||+||+.||...... +.. ........++.++..
T Consensus 196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-~~~----~~v~~~~~Rp~~p~~ 270 (362)
T KOG0192|consen 196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-QVA----SAVVVGGLRPPIPKE 270 (362)
T ss_pred cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-HHH----HHHHhcCCCCCCCcc
Confidence 4333444478999999999999 669999999999999999999999999865541 111 112222233333332
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+...+..++.+||+.||.+||++.+++..|+
T Consensus 271 ------~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~ 301 (362)
T KOG0192|consen 271 ------CPPHLSSLMERCWLVDPSRRPSFLEIVSRLE 301 (362)
T ss_pred ------CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence 3445778888999999999999999999885
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=375.56 Aligned_cols=254 Identities=27% Similarity=0.369 Sum_probs=212.3
Q ss_pred CCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc-eeEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL-HSFVVY 779 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~ 779 (973)
+.+..+.||+|..|+||++.++ +++.+|+|++... .+.+.++++.+|++++++.+||+||.+||+|..++ ...|+|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 4556788999999999999765 7899999999654 33455899999999999999999999999999888 599999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
|||++|+|+++++.. +++++...-+|+.++++||.|||+.. +||||||||+|||++..|+|||+|||.++.....
T Consensus 158 EYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999999999765 46899999999999999999999742 9999999999999999999999999999877654
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
...+++||..|||||.+.+..|+.++||||||+.++|+.+|+.||..... -...+.+.+..+.+...+.....
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~----~~~~~~~Ll~~Iv~~ppP~lP~~- 305 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP----PYLDIFELLCAIVDEPPPRLPEG- 305 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC----CCCCHHHHHHHHhcCCCCCCCcc-
Confidence 55678999999999999999999999999999999999999999874310 01122334444444333222221
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..+.++..++..|+++||.+||++.|++++
T Consensus 306 -~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 -EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 345568899999999999999999999864
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=400.74 Aligned_cols=491 Identities=30% Similarity=0.422 Sum_probs=391.9
Q ss_pred CcEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccC
Q 002069 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGN 81 (973)
Q Consensus 2 l~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~ 81 (973)
++.|++++|.++ .+-+.+..|..|++|++++|++. .+|++++.+..++.|+.++|++. .+|+.++.+.+|+.|++++
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 467889999987 78888899999999999999998 67888999999999999999998 8999999999999999999
Q ss_pred CcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCC
Q 002069 82 NLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIP 161 (973)
Q Consensus 82 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 161 (973)
|.+. .+|++++.+..|+.|+..+|++. .+|+.++++.+|..|++.+|+++ ..|+..-+++.|++||+-.|.++ .+|
T Consensus 124 n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~-tlP 199 (565)
T KOG0472|consen 124 NELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLE-TLP 199 (565)
T ss_pred ccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhh-cCC
Confidence 9998 88889999999999999999998 78889999999999999999998 45555555999999999999988 788
Q ss_pred ccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCcccccccc
Q 002069 162 FSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241 (973)
Q Consensus 162 ~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~ 241 (973)
..+++|.+|..||+..|+|. .+| .|.+++.|.+|+++.|+|+.++.+...++++|.+|||.+|++++. |+.+.-+.+
T Consensus 200 ~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~-Pde~clLrs 276 (565)
T KOG0472|consen 200 PELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEV-PDEICLLRS 276 (565)
T ss_pred hhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccC-chHHHHhhh
Confidence 88999999999999999998 677 889999999999999999977777777899999999999999875 888888999
Q ss_pred ccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhcccc--ccceEEcccccccCCcCchhhcCCccceeec
Q 002069 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLK--SLLHLQLNYNTLSGSIPLSLGSLTNLATLYF 319 (973)
Q Consensus 242 L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~--~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 319 (973)
|.+||+|+|.|+ ..|.+++++ .|+.|-+.+|.+.++-.+.+.+-+ -|++|.= .++...+..-. -.+-..-+.
T Consensus 277 L~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs---~~~~dglS~se-~~~e~~~t~ 350 (565)
T KOG0472|consen 277 LERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRS---KIKDDGLSQSE-GGTETAMTL 350 (565)
T ss_pred hhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHH---hhccCCCCCCc-ccccccCCC
Confidence 999999999998 466678888 888888888887766555443321 1222210 11111000000 000000000
Q ss_pred cccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCC--CCcEEEccCCcccCCCCcccccccccch-hccccccc
Q 002069 320 STNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLT--KLVSLDLSINKLSGSIPLSFASLTSLTT-LYLYENSL 396 (973)
Q Consensus 320 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~i~~~~~~~~~~l~~L~~-L~L~~N~l 396 (973)
.. ........+.+.+.|+++.-+++.++...|..-. -....+++.|++. ..|..+..+..+.+ +.+++|.+
T Consensus 351 ----~~-~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i 424 (565)
T KOG0472|consen 351 ----PS-ESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI 424 (565)
T ss_pred ----CC-CcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc
Confidence 01 1111234466788999999999855444454322 3788999999998 78888888876654 55555555
Q ss_pred ccCCCcccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCCcc
Q 002069 397 CDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPE 476 (973)
Q Consensus 397 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~ 476 (973)
+..|..++.+++|..|+|++|.+. .+|..++.+. .|+.|++++|++. ..|.....+..|+.+-.++|++....+..
T Consensus 425 -sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv-~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~ 500 (565)
T KOG0472|consen 425 -SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLV-RLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSG 500 (565)
T ss_pred -ccchHHHHhhhcceeeecccchhh-hcchhhhhhh-hhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHH
Confidence 668888999999999999999998 8999999887 5999999999888 66777777778888888999999888888
Q ss_pred cccccccccccccccccccccCccccccccccEEeecCccCCC
Q 002069 477 LGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQ 519 (973)
Q Consensus 477 l~~l~~L~~L~Ls~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~ 519 (973)
+..+.+|..|||.+|.+. .+|..++++++|++|.|++|+|+.
T Consensus 501 l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr~ 542 (565)
T KOG0472|consen 501 LKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFRQ 542 (565)
T ss_pred hhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccCC
Confidence 999999999999999997 788999999999999999999983
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=374.74 Aligned_cols=257 Identities=26% Similarity=0.325 Sum_probs=215.9
Q ss_pred HhcCCcccccccCCCceeEEEE-EcCCCCEEEEEEcCCCCCcc----hhhHHHHHHHHHHhhcCCCCceeeeceeeeccc
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGE----MACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL 773 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 773 (973)
..+.|.+.+.+|+|+||.|-+| +.++|+.||||+++...... .+....+.+|+++|+++.||+||++++++..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4567889999999999999999 55699999999998654322 112344679999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC---CceEEecc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE---YEAHVSDF 850 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~---~~~kl~Df 850 (973)
..|+||||++||.|.+++-.+. .+.+.....+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999986654 456677889999999999999999 99999999999999766 77999999
Q ss_pred cccccccCCCCcccccccccCcccccccccCCC---CCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhh
Q 002069 851 GISKFLKLGLSNRTELAGTFGYIAPELAYTMKV---TEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEM 927 (973)
Q Consensus 851 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 927 (973)
|+|+..+.+ ..+.+..|||.|.|||++.++.+ ..++|+||+||++|-+++|.+||..... .....+++
T Consensus 324 GlAK~~g~~-sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~--------~~sl~eQI 394 (475)
T KOG0615|consen 324 GLAKVSGEG-SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT--------DPSLKEQI 394 (475)
T ss_pred chhhccccc-eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC--------CccHHHHH
Confidence 999988743 66778999999999999986643 3478999999999999999999973221 01134455
Q ss_pred cCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 928 LDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..+++......+.+..++..++|.+|+..||++|||++|+++.
T Consensus 395 ~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 395 LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 5667666666677788889999999999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=387.74 Aligned_cols=251 Identities=25% Similarity=0.426 Sum_probs=219.2
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.+|...+.||+|||+.||.++. .+|+.||+|++.+........++.+.+|+++.++++|||||+++++|++....|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999966 799999999998766666666889999999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
|+|+.++|..++++. +++++.+++.+++||+.|+.|||++ +|+|||+|..|++++++.+|||+|||+|.....+
T Consensus 98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999999843 5799999999999999999999999 9999999999999999999999999999999988
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
.+...+..|||-|.|||++.....+..+||||+||++|.|+.|++||+... +.+....+....+..+.
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~---------vkety~~Ik~~~Y~~P~--- 239 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT---------VKETYNKIKLNEYSMPS--- 239 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch---------HHHHHHHHHhcCccccc---
Confidence 888889999999999999999999999999999999999999999998321 22222222222222111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..+.+..+||.++|+.||.+|||+++|++.
T Consensus 240 -~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 240 -HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 223345789999999999999999999863
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=355.07 Aligned_cols=257 Identities=24% Similarity=0.327 Sum_probs=213.0
Q ss_pred hcCCcccccccCCCceeEEEE-EcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeece-eeeccce-eE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG-FCSHALH-SF 776 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~ 776 (973)
...|++.++||.|.||+||++ +..+|..||.|.++-... ....+++...|+.++++++|||||++++ .+.++.+ .+
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 356888999999999999999 567999999999984433 3445788999999999999999999998 4444444 79
Q ss_pred EEEEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEeecCCCCCeeecCCCceEEeccccc
Q 002069 777 VVYEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCFPP--IVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
||||||..|+|..+++... ..+.+++..+|+++.|++.|++++|.+. +. |+||||||.||+++.+|.||++|||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhH
Confidence 9999999999999997544 3457899999999999999999999942 24 899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 854 KFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 854 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
+.+..........+|||.||+||.+.+.+|+.||||||+||++|||+.-++||.+.. .......+-+...+
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---------~~~L~~KI~qgd~~ 246 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---------LLSLCKKIEQGDYP 246 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---------HHHHHHHHHcCCCC
Confidence 999877777778999999999999999999999999999999999999999998442 22222233333333
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
.-+. ..++.++.++|..|+.+||+.||+...+++
T Consensus 247 ~~p~--~~YS~~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 247 PLPD--EHYSTDLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred CCcH--HHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence 2221 456778999999999999999998544443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=383.89 Aligned_cols=251 Identities=27% Similarity=0.467 Sum_probs=209.9
Q ss_pred cCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+.+..++.||+|.||+||.|.+.....||+|.++..... .++|.+|+++|++++|++||+++|+|..++..+||||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 345667889999999999999987789999999865322 4789999999999999999999999999889999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
||+.|+|.+|++. .....+...+.+.++.|||+|++||+++ ++|||||.++||||+++..|||+|||+|+...++.
T Consensus 282 ~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 282 YMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred ecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 9999999999986 2345688999999999999999999999 99999999999999999999999999999665554
Q ss_pred Ccc-cccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCC-CCCCCch
Q 002069 861 SNR-TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDP-RLPTPLR 937 (973)
Q Consensus 861 ~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 937 (973)
+.. ....-+..|.|||.+....++.|||||||||+||||+| |+.||..+.. .+.+..+..+ +++.+
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn---------~ev~~~le~GyRlp~P-- 426 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN---------EEVLELLERGYRLPRP-- 426 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH---------HHHHHHHhccCcCCCC--
Confidence 432 23345779999999999999999999999999999998 9999875543 1122222221 22322
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..++..+++++..||+.+|++|||++.+...++
T Consensus 427 --~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~ 459 (468)
T KOG0197|consen 427 --EGCPDEVYELMKSCWHEDPEDRPTFETLREVLE 459 (468)
T ss_pred --CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHH
Confidence 234556889999999999999999999887764
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=387.79 Aligned_cols=517 Identities=30% Similarity=0.410 Sum_probs=390.8
Q ss_pred EEeCCCCCCCCCCCcccCCC-------------CCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccC
Q 002069 4 VLGLSFNQFSGSIPPEIGHL-------------THLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGN 70 (973)
Q Consensus 4 ~L~l~~~~l~~~~p~~~~~l-------------~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~ 70 (973)
.|++|++.+. .+|.++..+ ..|+.|++++|.++ .+-+.+.+|..|.+|++++|++. .+|++++.
T Consensus 13 ~lnlsnr~l~-~vp~~vyq~~~t~~e~e~wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~ 89 (565)
T KOG0472|consen 13 SLNLSNRSLK-DVPTEVYQINLTTGEGENWWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGE 89 (565)
T ss_pred ccccccchhh-hccHHHHHHHhhccchhhhhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHH
Confidence 3667777764 777765533 44788999999998 45667888999999999999998 88999999
Q ss_pred CCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCcee
Q 002069 71 LTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQ 150 (973)
Q Consensus 71 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 150 (973)
+..++.|+.++|+++ .+|+.++.+.+|..|+.++|.+. .+|++++.+-.|+.|+..+|+++ ..|++++++.+|..|+
T Consensus 90 l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~ 166 (565)
T KOG0472|consen 90 LEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLD 166 (565)
T ss_pred HHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhh
Confidence 999999999999998 89999999999999999999998 78889999999999999999998 7899999999999999
Q ss_pred cccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCC
Q 002069 151 VSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSG 230 (973)
Q Consensus 151 l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~ 230 (973)
+.+|+++ ..|...-.|+.|++|++..|-+. .+|..++.+.+|+.|+|..|+|...+ .|.++..|++|+++.|+|..
T Consensus 167 ~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP--ef~gcs~L~Elh~g~N~i~~ 242 (565)
T KOG0472|consen 167 LEGNKLK-ALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLP--EFPGCSLLKELHVGENQIEM 242 (565)
T ss_pred ccccchh-hCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCC--CCCccHHHHHHHhcccHHHh
Confidence 9999998 44444445999999999999888 78889999999999999999998544 78999999999999999987
Q ss_pred CCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhc
Q 002069 231 LIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGS 310 (973)
Q Consensus 231 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 310 (973)
++.+....+++|..|||.+|+++ ..|..+.-+ .+|.+||+++|.|+ ..|..+++
T Consensus 243 lpae~~~~L~~l~vLDLRdNklk-e~Pde~clL------------------------rsL~rLDlSNN~is-~Lp~sLgn 296 (565)
T KOG0472|consen 243 LPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLL------------------------RSLERLDLSNNDIS-SLPYSLGN 296 (565)
T ss_pred hHHHHhcccccceeeeccccccc-cCchHHHHh------------------------hhhhhhcccCCccc-cCCccccc
Confidence 75556668899999999999987 345444444 44555555555555 34445555
Q ss_pred CCccceeeccccccCCCCCccccC-----CCCCCc----EEcCCCC---C---C--CcchhccCCCCCCcEEEccCCccc
Q 002069 311 LTNLATLYFSTNALSGSIPNEITN-----LRSLSD----LQLSENT---L---N--GSIPLALGNLTKLVSLDLSINKLS 373 (973)
Q Consensus 311 l~~L~~L~L~~n~l~~~~~~~~~~-----l~~L~~----L~L~~N~---l---~--~~~~~~~~~l~~L~~L~Ls~N~i~ 373 (973)
+ .|+.|-+.+|.+..+-.+.+.. ++.|+. =.++... - + .........+.+.+.|++++-+++
T Consensus 297 l-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt 375 (565)
T KOG0472|consen 297 L-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT 375 (565)
T ss_pred c-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc
Confidence 5 5555555555544211111100 001110 0001100 0 0 011112234667899999999999
Q ss_pred CCCCcccccc--cccchhcccccccccCCCcccCCCCCC-CEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccC
Q 002069 374 GSIPLSFASL--TSLTTLYLYENSLCDSIPKEIGDMKSL-SILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIP 450 (973)
Q Consensus 374 ~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~ 450 (973)
.+....|..- .-.+..+++.|++.+ .|..+..++.+ +.+++++|.+. -+|..++.+. +|+.|+|++|-+- .+|
T Consensus 376 ~VPdEVfea~~~~~Vt~VnfskNqL~e-lPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~-kLt~L~L~NN~Ln-~LP 451 (565)
T KOG0472|consen 376 LVPDEVFEAAKSEIVTSVNFSKNQLCE-LPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQ-KLTFLDLSNNLLN-DLP 451 (565)
T ss_pred cCCHHHHHHhhhcceEEEecccchHhh-hhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhh-cceeeecccchhh-hcc
Confidence 5544455432 238899999999975 78777776655 45677777775 7888888776 7999999999888 667
Q ss_pred CCCCCCcccceeeccCCccCCCCCcccccccccccccccccccccccCccccccccccEEeecCccCCCCCCcccccccc
Q 002069 451 LGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIH 530 (973)
Q Consensus 451 ~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 530 (973)
..++.+..|+.|+++.|++. ..|+.+..+..++.+--++|+++...+..+.++.+|+.|||.+|.+. .+|..++++++
T Consensus 452 ~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~Lgnmtn 529 (565)
T KOG0472|consen 452 EEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTN 529 (565)
T ss_pred hhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccc
Confidence 77888888999999999998 78999999999999999999998776777999999999999999996 57889999999
Q ss_pred cCeecccccccCCCcchhhccccccccccccccc
Q 002069 531 LSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNN 564 (973)
Q Consensus 531 L~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~N~ 564 (973)
|++|++++|.|. ..+..+--......|..-+++
T Consensus 530 L~hLeL~gNpfr-~Pr~~iLmkgT~aiL~ylrdr 562 (565)
T KOG0472|consen 530 LRHLELDGNPFR-QPRHQILMKGTAAILSYLRDR 562 (565)
T ss_pred eeEEEecCCccC-CCHHHHhccChHHHHHHhccc
Confidence 999999999998 444444333334444433333
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=359.47 Aligned_cols=201 Identities=27% Similarity=0.454 Sum_probs=181.2
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
..+|...+.||+|+||+||+|+++ ++..||||.+..... ....++.+..|+.+++.++|||||++++++..++..|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 467889999999999999999765 789999999876532 234467789999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC------CceEEecccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE------YEAHVSDFGI 852 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~------~~~kl~Dfg~ 852 (973)
||||.||+|.+|+++.+ .+++..++.++.|+|.|+++||++ +||||||||+|||++.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999998765 688999999999999999999999 99999999999999765 4589999999
Q ss_pred cccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcc
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDF 908 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 908 (973)
|+...++ .......|+|-|||||++...+|+.|+|+||+|+++|++++|+.||+.
T Consensus 162 AR~L~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 162 ARFLQPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhhCCch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 9998765 344567899999999999999999999999999999999999999983
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=393.23 Aligned_cols=256 Identities=24% Similarity=0.434 Sum_probs=214.2
Q ss_pred hcCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 773 (973)
..+....+.||+|+||+||+|+.. +...||||.++.... ...+++|.+|++++..++|||||+++|+|.+++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~--~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE--NQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc--HHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 345667788999999999999642 456799999987643 335899999999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHhccCcc-----------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAA-----------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE 842 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~ 842 (973)
..++|+|||..|+|.+||....+ ..+++..+.+.||.|||.|++||.++ .+||||+..+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence 99999999999999999954332 23488999999999999999999999 89999999999999999
Q ss_pred CceEEecccccccccCCCCcc-c-ccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhh
Q 002069 843 YEAHVSDFGISKFLKLGLSNR-T-ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSN 919 (973)
Q Consensus 843 ~~~kl~Dfg~a~~~~~~~~~~-~-~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~ 919 (973)
..|||+|||+++.+...++.. . ...-+.+|||||.+..++|+++||||||||++||+++ |+.||.+..+
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-------- 711 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-------- 711 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--------
Confidence 999999999998765443332 1 3445789999999999999999999999999999997 9999875443
Q ss_pred hhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 920 LNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+++++.+..+++ ......++.++++++..||+..|++||+++||-..|+
T Consensus 712 -~EVIe~i~~g~l---L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~ 760 (774)
T KOG1026|consen 712 -QEVIECIRAGQL---LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQ 760 (774)
T ss_pred -HHHHHHHHcCCc---ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence 334444444444 2233456677999999999999999999999988874
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=355.23 Aligned_cols=245 Identities=26% Similarity=0.357 Sum_probs=209.9
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.++||+|+||+||.++. .+++.+|+|++++....+....+....|..++.+++||+||+++-.|++++..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46899999999999999999954 57899999999887666666678899999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
+||+.||.|...+++.+ .+++..+.-++..|+.||.|||++ +|||||+||+|||+|++|+++++|||+++..-.
T Consensus 104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999998654 688999999999999999999999 999999999999999999999999999997766
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.......++||+.|||||++.+..|+..+|.||+|+++|||++|.+||.... .....+.+...+.+.....
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~---------~~~~~~~I~~~k~~~~p~~ 248 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED---------VKKMYDKILKGKLPLPPGY 248 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc---------HHHHHHHHhcCcCCCCCcc
Confidence 6566677899999999999999999999999999999999999999998433 2233333333332221111
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCC
Q 002069 939 VQDKLISIMEVSISCLDESPTSRP 962 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RP 962 (973)
...+..+++.+.+..||++|-
T Consensus 249 ---ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 249 ---LSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---CCHHHHHHHHHHhccCHHHhc
Confidence 122456888899999999995
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=378.95 Aligned_cols=368 Identities=28% Similarity=0.259 Sum_probs=266.9
Q ss_pred ceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeecccc
Q 002069 123 VTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYN 202 (973)
Q Consensus 123 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N 202 (973)
+.|++++|+++.+-+..|.++++|+++++.+|.++ .+|...+...+|+.|+|.+|.|+..-.+.++.++.|+.||||.|
T Consensus 81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN 159 (873)
T ss_pred eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence 44677777776666666677777777777777776 55655555556777777777777666667777777777777777
Q ss_pred ccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhh
Q 002069 203 TLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILE 282 (973)
Q Consensus 203 ~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~ 282 (973)
.|+.++...|..=.++++|+|++|.|+.+..+.|.++.+|..|.|+.|.|+..++.+|.+|++|+.|.|..|+|.-...-
T Consensus 160 ~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~l 239 (873)
T KOG4194|consen 160 LISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGL 239 (873)
T ss_pred hhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhh
Confidence 77777777777777777777777777777777777777777777777777777777777777777777777777766677
Q ss_pred hhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCC
Q 002069 283 EIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKL 362 (973)
Q Consensus 283 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 362 (973)
.|.++++|+.|.|..|+|.....+.|..+.++++|+|+.|+++..-..++-+++.|+.|+|+.|.|..+.++.+...++|
T Consensus 240 tFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL 319 (873)
T KOG4194|consen 240 TFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKL 319 (873)
T ss_pred hhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccc
Confidence 78888888888888888877777778888888888888888877777777788888888888888887777777778888
Q ss_pred cEEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeC
Q 002069 363 VSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSS 442 (973)
Q Consensus 363 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~ 442 (973)
+.||||+|+|+...+.+|..+..|++|+|++|+|+.....+|..+++|++|||++|.|++.+.+.
T Consensus 320 ~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDa--------------- 384 (873)
T KOG4194|consen 320 KELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDA--------------- 384 (873)
T ss_pred eeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecc---------------
Confidence 88888888888777788888888888888888887777777888888888888888877544331
Q ss_pred cccccccCCCCCCCcccceeeccCCccCCCCCcccccccccccccccccccccccCccccccccccEEeecC
Q 002069 443 NHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSN 514 (973)
Q Consensus 443 n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~~~~l~~l~~L~~L~L~~ 514 (973)
...|.++++|+.|++.+|+|..+...+|.+++.|++|||.+|.|....+++|..+ .|+.|.+..
T Consensus 385 -------a~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 385 -------AVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS 448 (873)
T ss_pred -------hhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence 1223345555555555555555555556666666666666666665556666655 555555443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=376.87 Aligned_cols=391 Identities=24% Similarity=0.239 Sum_probs=313.8
Q ss_pred CEEECCCCcccccCCcCccC-C-CCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeecc
Q 002069 27 KLLSFSKNQLSGLIPHEIGR-L-SSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLS 104 (973)
Q Consensus 27 ~~L~l~~n~l~~~~p~~~~~-l-~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~ 104 (973)
..||.+++.+...--..+.. + +.-++|++++|++...-+..|.++++|+.+++.+|.++ .+|...+...+|+.|+|.
T Consensus 55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~ 133 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR 133 (873)
T ss_pred eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence 55777777776321111111 1 33456888888888777777888888888888888888 788777777778888888
Q ss_pred CCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCC
Q 002069 105 NNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSI 184 (973)
Q Consensus 105 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~ 184 (973)
+|.|...-.+++..++.|++|||+.|.|+.+.-..|..-.++++|+|++|+|+...-+.|.++.+|..|.|+.|+++...
T Consensus 134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp 213 (873)
T KOG4194|consen 134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLP 213 (873)
T ss_pred ccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccC
Confidence 88888666677888888888888888888555566777788888888888888777788888888888888888888666
Q ss_pred CccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcc
Q 002069 185 PNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLT 264 (973)
Q Consensus 185 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 264 (973)
+..|.+|++|+.|+|..|+|.-+..-+|.+|++|+.|.|..|.|..+-.++|..+.++++|+|+.|+++..-.+++-+|+
T Consensus 214 ~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt 293 (873)
T KOG4194|consen 214 QRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLT 293 (873)
T ss_pred HHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccc
Confidence 67777788888888888888866677888888888888888888888888888888888888888888888888888888
Q ss_pred hhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcC
Q 002069 265 KLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLS 344 (973)
Q Consensus 265 ~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 344 (973)
.|+.|+++.|.|..+..+.+...++|++|+|++|+|+...+..|..+..|++|.|++|.+..+-..+|..+++|+.|||+
T Consensus 294 ~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr 373 (873)
T KOG4194|consen 294 SLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR 373 (873)
T ss_pred hhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence 88888888888888888888888888888888888888888888888888888888888887777788888888888888
Q ss_pred CCCCCCcch---hccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCCCCEEEccCCC
Q 002069 345 ENTLNGSIP---LALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNK 419 (973)
Q Consensus 345 ~N~l~~~~~---~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 419 (973)
+|.|+..+. ..|.++++|+.|+|.+|+|..+...+|.++.+|++|||.+|.|..+.+++|..| .|+.|.++.-.
T Consensus 374 ~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSss 450 (873)
T KOG4194|consen 374 SNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSS 450 (873)
T ss_pred CCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccc
Confidence 888875443 457788888888888888887777788888888888888888888888888888 78887776543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=332.11 Aligned_cols=262 Identities=22% Similarity=0.302 Sum_probs=209.6
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|+...++|+|+||+||+++.+ +|+.||||+|..+.. +....+-.++|+.++++++|+|+|.++++|......++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 46888899999999999999775 799999999987643 3445788899999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||++..-|.+ +++.. ...+...+.+++.|++.|+.|+|++ +++||||||+|||++.+|.+|+||||+|+.....
T Consensus 81 E~~dhTvL~e-Le~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 81 EYCDHTVLHE-LERYP--NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred eecchHHHHH-HHhcc--CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9998755554 44333 3467889999999999999999999 9999999999999999999999999999988755
Q ss_pred CCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh---------hhhhhhhhh----
Q 002069 860 LSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL---------SSNLNIALD---- 925 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~---------~~~~~~~~~---- 925 (973)
....+..+.|.-|.|||.+.+ .+|...+||||+||++.||++|.+-|.+.+++..-. .+.....+.
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 566777889999999999887 679999999999999999999999998766543211 111111110
Q ss_pred --hhcCCCCCC---CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 926 --EMLDPRLPT---PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 926 --~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
.+.-|.... .....+.....+.+++..|++.||++|++-++++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111111 11112234456789999999999999999998874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=360.50 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=214.8
Q ss_pred hcCCcccccccCCCceeEEEE-EcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
...|...++||+|+.|.||.| +..+++.||||++....... ++-+.+|+.+|+..+|+|||++++.|...+..|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 456888899999999999999 55688999999998654333 47788999999999999999999999888999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
||||+||+|.|.+... .+++.++..|+.++++||+|||.+ ||+|||||.+||+++.+|.+||+|||++..+..
T Consensus 349 MEym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EeecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 9999999999998754 388999999999999999999999 999999999999999999999999999998887
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
........+|||.|||||+.....|++|.||||||++++||+.|++||=.+..+.+-+- +...-......
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL----------Ia~ng~P~lk~ 491 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----------IATNGTPKLKN 491 (550)
T ss_pred ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH----------HhhcCCCCcCC
Confidence 76677889999999999999999999999999999999999999999865443322111 11111122233
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
....+..+.+++.+|++.||++||++.|++++
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 34456678899999999999999999999874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.16 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=208.5
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhc--CCCCceeeeceeeeccc----
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTK--IRHRNIVKFYGFCSHAL---- 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~---- 773 (973)
....+..+.+|+|+||.||||.. +++.||||+|.. ..++.|.+|-++++- ++|+||++++++-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc-cCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 45567788999999999999988 569999999963 335778888777664 58999999999987665
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCC------CCeEeecCCCCCeeecCCCceEE
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF------PPIVHRDISSKNVLLNLEYEAHV 847 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~------~~i~H~Dlk~~Nill~~~~~~kl 847 (973)
++|+|+||++.|+|.+|++.+ .++|....+|+..|++||+|||+... ++|+|||||.+|||+..|+++.|
T Consensus 282 eywLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 899999999999999999865 48999999999999999999998653 68999999999999999999999
Q ss_pred ecccccccccCCCCc--ccccccccCcccccccccCC------CCCccchHHHHHHHHHHHhCCCCCc------chhhhh
Q 002069 848 SDFGISKFLKLGLSN--RTELAGTFGYIAPELAYTMK------VTEKCDVYSFGVLALEVIKGKHPRD------FISSIC 913 (973)
Q Consensus 848 ~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~slG~~l~el~tg~~p~~------~~~~~~ 913 (973)
+|||+|..+.++... ....+||.+|||||++.+.- .-.+.||||+|.|+|||++.-.-++ +.-...
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 999999988765432 33478999999999987642 2246899999999999997433221 111111
Q ss_pred hh------hhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 914 SS------LSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 914 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
+. ++......+.+..+|.++..+... ..+..+.+.+..||+.||+.|-|+.-|-+++
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~ 500 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERM 500 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence 11 222233445666677777777665 5677899999999999999999999888765
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=341.52 Aligned_cols=255 Identities=26% Similarity=0.363 Sum_probs=211.3
Q ss_pred hcCCcccccccCCCceeEEEEE-cCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.+.|++.+.||.|..++||+|+ .+.++.||||++.-...... ...+.+|+..|+.++||||++++..|..+...|+|
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 4689999999999999999994 56889999999987655443 68899999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|.||.+|++.++++...+. .+.+..+..|.+++++||.|||++ |.||||||+.|||++.+|.|||+|||.+..+..
T Consensus 103 mpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred ehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999999866543 488999999999999999999999 999999999999999999999999998765544
Q ss_pred CCCcc----cccccccCccccccccc--CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 859 GLSNR----TELAGTFGYIAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 859 ~~~~~----~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
..... ..++||+.|||||++.. ..|+.|+||||||++..|+.+|+.||...+.+.. +-..+....
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv---------Ll~tLqn~p 249 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV---------LLLTLQNDP 249 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH---------HHHHhcCCC
Confidence 33222 45689999999999653 3589999999999999999999999986654321 111112111
Q ss_pred C------CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 933 P------TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 933 ~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
+ ...+........+.+++..|+++||.+|||+++++.
T Consensus 250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1 112222334567889999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=352.91 Aligned_cols=255 Identities=24% Similarity=0.344 Sum_probs=213.3
Q ss_pred HHHhcCCcccccccCCCceeEEEE-EcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccce
Q 002069 697 IRATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALH 774 (973)
Q Consensus 697 ~~~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 774 (973)
.....+|.+.+.||+|+|++||+| +..+++.||||++.+...-.+...+-+..|-++|.++ .||.|++++-.|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 445678999999999999999999 4458999999998765544444456678899999999 89999999999999999
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.|+|+||+++|+|.+++++.+ .+++.-++.++.+|+.|++|||+. |||||||||+|||+|.||++||+|||.|+
T Consensus 149 LYFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999998764 688899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCC-------------cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhh
Q 002069 855 FLKLGLS-------------NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLN 921 (973)
Q Consensus 855 ~~~~~~~-------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 921 (973)
.+.+... ....++||..|.+||++.....++.+|+|+|||++|+|+.|++||....+ .
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---------y 293 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---------Y 293 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---------H
Confidence 8754211 11458999999999999999999999999999999999999999974332 2
Q ss_pred hhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 922 IALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..+.+++.-.+..+.. .+....+||.+.+..||.+|+|.+++.++
T Consensus 294 liFqkI~~l~y~fp~~----fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 294 LIFQKIQALDYEFPEG----FPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHHHHhcccCCCC----CCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 2333333333222211 11346788899999999999999998764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=374.30 Aligned_cols=251 Identities=26% Similarity=0.457 Sum_probs=212.0
Q ss_pred CCcccccccCCCceeEEEEEcC----CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP----TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
...+.++||.|.||+|++|+++ ....||||.++... .+..+.+|+.|+.+|.+++||||+++.|+.......+|
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 3457889999999999999764 23479999998653 34557899999999999999999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
|+|||++|+|+.||+.+. +++++.+...+.++||.|+.||.+. ++||||+.++|||++.+-.+|++|||+++...
T Consensus 708 iTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 999999999999997665 5699999999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCcc-cccc--cccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCC-CC
Q 002069 858 LGLSNR-TELA--GTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDP-RL 932 (973)
Q Consensus 858 ~~~~~~-~~~~--g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 932 (973)
++.+.. +... -+.+|.|||.+...+++.+|||||||+++||.++ |..||-.+.+ .+.+..+.+. ++
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN---------QdVIkaIe~gyRL 853 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---------QDVIKAIEQGYRL 853 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---------HHHHHHHHhccCC
Confidence 765332 2222 3679999999999999999999999999999886 9999764442 2222222222 22
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
|. +.+++..+++|+..||++|-.+||++++++..|+
T Consensus 854 Pp----PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lD 889 (996)
T KOG0196|consen 854 PP----PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLD 889 (996)
T ss_pred CC----CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHH
Confidence 32 2456778999999999999999999999999874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=354.91 Aligned_cols=261 Identities=24% Similarity=0.358 Sum_probs=211.5
Q ss_pred HHHHHHhcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc
Q 002069 694 EEIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL 773 (973)
Q Consensus 694 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 773 (973)
++++...+...+.+.||+|.||+||+|+|. ..||||++........ ..+.|.+|+.++++-+|.||+=+.|||..+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 445555667778899999999999999984 3699999987765544 6899999999999999999999999999887
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
. .||+.||+|.+|+.+++... ..+...+.+.||.|||+|+.|||.+ +|||||+|..||++.++++|||+|||++
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred e-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence 7 89999999999999997655 5688899999999999999999999 9999999999999999999999999998
Q ss_pred ccccCC--CCcccccccccCccccccccc---CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhc
Q 002069 854 KFLKLG--LSNRTELAGTFGYIAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML 928 (973)
Q Consensus 854 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 928 (973)
..-... ..+.....|...|||||+++. .+|++.+||||||+|+|||+||..||. ...- ...+..+-
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~--------dqIifmVG 606 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNR--------DQIIFMVG 606 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCCh--------hheEEEec
Confidence 654332 233445668899999999874 468999999999999999999999997 2211 11111111
Q ss_pred CCCC-CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 929 DPRL-PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 929 ~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
++.. +........+.+++.+|+..||..++++||.+.+|+..|+
T Consensus 607 rG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~ 651 (678)
T KOG0193|consen 607 RGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLE 651 (678)
T ss_pred ccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHH
Confidence 1111 1112222345667888999999999999999999999664
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=350.93 Aligned_cols=248 Identities=26% Similarity=0.363 Sum_probs=209.8
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|-+.+.||+|.||.||||+.+ +.+.||+|.+.+....+ ...+.+.+|++++++++|||||.++++|+...+.|+|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 56888899999999999999665 78999999987654333 33678999999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+.| +|..++.... .++++++..++.|++.|+.|||+. +|.|||+||+||+++..|++|++|||+|+.+...
T Consensus 81 e~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 99986 9999997654 589999999999999999999999 9999999999999999999999999999998876
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
....+...|||-|||||...+.+|+..+|.||+||++||+++|++||...+ ....++.+.......+
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---------i~~Lv~~I~~d~v~~p---- 220 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---------ITQLVKSILKDPVKPP---- 220 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---------HHHHHHHHhcCCCCCc----
Confidence 666677889999999999999999999999999999999999999996222 1111122221111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
......+..++...+.+||.+|.|..++++
T Consensus 221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 221 STASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 234455778888999999999999998875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=352.79 Aligned_cols=240 Identities=29% Similarity=0.477 Sum_probs=201.8
Q ss_pred ccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCC
Q 002069 705 DEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 705 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
..+-+|+|+.|.||.|+. .++.||||+++.- =..++..+++++||||+.|.|+|.....+|||||||..
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 356799999999999998 6789999987532 12578889999999999999999999999999999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccc
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 864 (973)
|-|..+++... .++......+.++||.|+.|||.+ .|||||+|.-||||..+..|||+|||-++...+- ..+-
T Consensus 197 GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkM 269 (904)
T KOG4721|consen 197 GQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKM 269 (904)
T ss_pred ccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhh
Confidence 99999997654 577888999999999999999999 9999999999999999999999999999877655 4556
Q ss_pred ccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHH
Q 002069 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLI 944 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (973)
.++||..|||||++...+.+.|+||||||||||||+||..||...+...-.++-. .. .+ +++- ...++.
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG--sN---sL--~Lpv----PstcP~ 338 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG--SN---SL--HLPV----PSTCPD 338 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEecc--CC---cc--cccC----cccCch
Confidence 7899999999999999999999999999999999999999998655432211110 00 01 1111 123445
Q ss_pred HHHHHHhcccCCCCCCCCCHHHHHHHhcC
Q 002069 945 SIMEVSISCLDESPTSRPTMQKVSQLLKI 973 (973)
Q Consensus 945 ~l~~li~~cl~~dP~~RPs~~ev~~~L~~ 973 (973)
.+.-|+++||+..|..||++.+++.+|+|
T Consensus 339 GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 57778889999999999999999999987
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=342.01 Aligned_cols=249 Identities=26% Similarity=0.403 Sum_probs=200.4
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc--eeE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL--HSF 776 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~ 776 (973)
..+|...+.||+|+||+||++... +|+.+|||......... .+.+.+|+.++.+++|||||+++|...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 345778899999999999999654 59999999987542211 577899999999999999999999854443 689
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC-CCceEEeccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL-EYEAHVSDFGISKF 855 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-~~~~kl~Dfg~a~~ 855 (973)
+.|||+++|+|.+++++.+. .+++..++.+++||++|++|||++ |++|+||||+|||++. ++.+||+|||.++.
T Consensus 93 i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 99999999999999987663 689999999999999999999999 9999999999999999 69999999999987
Q ss_pred ccC---CCCcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcch-hhhhhhhhhhhhhhhhhhc--
Q 002069 856 LKL---GLSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFI-SSICSSLSSNLNIALDEML-- 928 (973)
Q Consensus 856 ~~~---~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~-- 928 (973)
... .........||+.|||||++..+ ....++||||+||++.||+||+.||... ... ........
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~--------~~~~~ig~~~ 239 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA--------EALLLIGRED 239 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH--------HHHHHHhccC
Confidence 763 11223457899999999999953 3445999999999999999999999852 111 11111111
Q ss_pred -CCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 929 -DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 929 -~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
-|.++.. .+....+++.+|+..||++||||+++++.
T Consensus 240 ~~P~ip~~------ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 240 SLPEIPDS------LSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred CCCCCCcc------cCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 1222222 23346788899999999999999999875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=346.39 Aligned_cols=260 Identities=23% Similarity=0.357 Sum_probs=212.6
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.....+.++||+|-||+|..+....+..||||+++...... .+.+|.+|+.+|.+++|||||+++|+|..++..++|+
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~--~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKN--ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchh--HHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 45677889999999999999998788999999999765443 3699999999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
|||++|+|..|+.++.... .......+|+.|||.|++||.+- .+||||+.++|+|++.++++||+|||+++....+
T Consensus 615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999998775432 45566788999999999999998 8999999999999999999999999999966555
Q ss_pred CCc--ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh--CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC-C
Q 002069 860 LSN--RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFISSICSSLSSNLNIALDEMLDPRLP-T 934 (973)
Q Consensus 860 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 934 (973)
.+. ....+-+.+|||||.+.-++++.++|||+||+++||+++ ...||....+. ..-+...++++..-. .
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e------~vven~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE------QVVENAGEFFRDQGRQV 764 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH------HHHHhhhhhcCCCCcce
Confidence 433 234567899999999999999999999999999999985 88898754321 111112222221111 1
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
-...+..++..+++++.+||..|.++||+++++...|
T Consensus 765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~l 801 (807)
T KOG1094|consen 765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFL 801 (807)
T ss_pred eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHH
Confidence 1122234566789999999999999999999998766
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=311.92 Aligned_cols=263 Identities=21% Similarity=0.277 Sum_probs=211.0
Q ss_pred cCCcccccccCCCceeEEEE-EcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.+|...+++|+|.||.||+| +.++|+.||||+++.....+ .......+|+..++.++|+||+.++++|.+.+...+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 46888899999999999999 55699999999998653322 22466789999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
|||+ .+|+..+++.. ..++..++..++.++.+|++|||++ .|+|||+||.|+|++.+|.+|++|||+|+.+...
T Consensus 81 Efm~-tdLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred Eecc-ccHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9997 68999997654 4688999999999999999999999 9999999999999999999999999999999877
Q ss_pred CCcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhhhhhhhh-------
Q 002069 860 LSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSNLNIALD------- 925 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~~~~------- 925 (973)
.......+-|.-|.|||.+.+. .|+..+|+||.||++.||+.|.+-|.+..++.+ .++.-....+.
T Consensus 155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 7666667889999999988764 689999999999999999999988876554321 11111111100
Q ss_pred --hhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 926 --EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 926 --~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
++..-..+....-...+..+..+++.+|+..||.+|.|++|++++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111000011111223445566899999999999999999999864
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=382.25 Aligned_cols=463 Identities=32% Similarity=0.385 Sum_probs=315.7
Q ss_pred EEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcC-ccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCC
Q 002069 4 VLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHE-IGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNN 82 (973)
Q Consensus 4 ~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n 82 (973)
.+|+++.+++ .||..+..-..++.|++++|.+.. .|-+ +.+...|+.|++++|++. ..|..+..+.+|+.|+++.|
T Consensus 2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~-~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n 78 (1081)
T KOG0618|consen 2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLLS-RPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRN 78 (1081)
T ss_pred CcccccccCc-ccchhhccHHHHHhhhcccccccc-CchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchh
Confidence 4789999998 899999888889999999998874 3433 344556999999999998 89999999999999999999
Q ss_pred cCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCc
Q 002069 83 LLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPF 162 (973)
Q Consensus 83 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 162 (973)
.+. .+|.+..++.+|++|+|.+|++. .+|.++..+++|+.|+++.|.+. .+|..+..+..++.+..++|.....
T Consensus 79 ~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~--- 152 (1081)
T KOG0618|consen 79 YIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR--- 152 (1081)
T ss_pred hHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh---
Confidence 998 88999999999999999999998 89999999999999999999997 8999999999999999999933222
Q ss_pred cccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccc
Q 002069 163 SLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSL 242 (973)
Q Consensus 163 ~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 242 (973)
++.+. ++.+++..|.+.+.++..+..+.. .|+|.+|.+. ...+..+++|+.|....|++..+ --..++|
T Consensus 153 -lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l----~~~g~~l 221 (1081)
T KOG0618|consen 153 -LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSEL----EISGPSL 221 (1081)
T ss_pred -hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceE----EecCcch
Confidence 33333 888999999999888888887777 7999999987 34577889999999999998765 2345789
Q ss_pred cceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeecccc
Q 002069 243 LALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTN 322 (973)
Q Consensus 243 ~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 322 (973)
+.|+.++|.++...+.-.. .+|+++++++|++++ .|.+++.+.+|+.+...+|
T Consensus 222 ~~L~a~~n~l~~~~~~p~p--------------------------~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N 274 (1081)
T KOG0618|consen 222 TALYADHNPLTTLDVHPVP--------------------------LNLQYLDISHNNLSN-LPEWIGACANLEALNANHN 274 (1081)
T ss_pred heeeeccCcceeecccccc--------------------------ccceeeecchhhhhc-chHHHHhcccceEecccch
Confidence 9999999988744332211 245555555555552 3355555555555555555
Q ss_pred ccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCccccccc-ccchhcccccccccCCC
Q 002069 323 ALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLT-SLTTLYLYENSLCDSIP 401 (973)
Q Consensus 323 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~ 401 (973)
.++ .+|..+...++|+.|.+..|.+. .+|....+++.|++|||..|+|....+..|.-+. +|..|+.+.|++.....
T Consensus 275 ~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~ 352 (1081)
T KOG0618|consen 275 RLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPS 352 (1081)
T ss_pred hHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccccccc
Confidence 554 45555555555555555555555 3444455555555555555555533332333222 25555555555543221
Q ss_pred cccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCCccccccc
Q 002069 402 KEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLN 481 (973)
Q Consensus 402 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~ 481 (973)
-.=..++.|+.|.+.+|.+++..-..+.+.. .|+.|+|++|++...+...+.+++.|++|+||+|+++ .+|..+..++
T Consensus 353 ~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~-hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~ 430 (1081)
T KOG0618|consen 353 YEENNHAALQELYLANNHLTDSCFPVLVNFK-HLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLG 430 (1081)
T ss_pred ccchhhHHHHHHHHhcCcccccchhhhcccc-ceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhh
Confidence 1111234555666666666554444444433 4555555555555444444445555555555555555 4455566666
Q ss_pred ccccccccccccccccCccccccccccEEeecCccCCC
Q 002069 482 QLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQ 519 (973)
Q Consensus 482 ~L~~L~Ls~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~ 519 (973)
.|+.|...+|.+. ..| .+..++.|+.+|+|.|+++.
T Consensus 431 ~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~ 466 (1081)
T KOG0618|consen 431 RLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSE 466 (1081)
T ss_pred hhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhh
Confidence 6666666666665 344 55556666666666666654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=387.17 Aligned_cols=507 Identities=33% Similarity=0.386 Sum_probs=401.7
Q ss_pred EEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCC-CcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCC
Q 002069 28 LLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIP-PSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNN 106 (973)
Q Consensus 28 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n 106 (973)
.+|++...++ .+|..+..-..++.|++..|-+. ..| +.+.+..+|+.||+++|++. ..|..+..+.+|+.|+++.|
T Consensus 2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n 78 (1081)
T KOG0618|consen 2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRN 78 (1081)
T ss_pred CcccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchh
Confidence 4688888887 77888877777999999999877 444 44556677999999999998 88999999999999999999
Q ss_pred cCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCc
Q 002069 107 SLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPN 186 (973)
Q Consensus 107 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~ 186 (973)
.|. .+|.+..++.+|++|.|.+|++. .+|.++..+++|++|++++|++. ..|..+..++.++.+..++|.....
T Consensus 79 ~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~--- 152 (1081)
T KOG0618|consen 79 YIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR--- 152 (1081)
T ss_pred hHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh---
Confidence 998 78899999999999999999987 88999999999999999999987 7777788888888888887722212
Q ss_pred cccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcchh
Q 002069 187 EIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKL 266 (973)
Q Consensus 187 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 266 (973)
++... .+.+++..|.+.+-.+.....++. .|+|.+|.+. . -.+..+.+|+.|....|+++
T Consensus 153 -lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls------------- 212 (1081)
T KOG0618|consen 153 -LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLS------------- 212 (1081)
T ss_pred -hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccc-------------
Confidence 22222 566666666666544444444444 4666666654 1 23444555555555555543
Q ss_pred hhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCC
Q 002069 267 VISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSEN 346 (973)
Q Consensus 267 ~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 346 (973)
... -..++|+.|+.++|.++...+.. .-.+|+++++++|+++ ..|.++..+.+|+.++..+|
T Consensus 213 -----------~l~----~~g~~l~~L~a~~n~l~~~~~~p--~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N 274 (1081)
T KOG0618|consen 213 -----------ELE----ISGPSLTALYADHNPLTTLDVHP--VPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHN 274 (1081)
T ss_pred -----------eEE----ecCcchheeeeccCcceeecccc--ccccceeeecchhhhh-cchHHHHhcccceEecccch
Confidence 221 13468899999999998443322 2368999999999999 56799999999999999999
Q ss_pred CCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCC-CCEEEccCCCCCCCcc
Q 002069 347 TLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKS-LSILDLSSNKLNGSIP 425 (973)
Q Consensus 347 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~ 425 (973)
+++ .+|..+...++|+.|++..|.+. .+|....++++|++|+|..|+|....+..+.-... |+.|+.+.|++. ..|
T Consensus 275 ~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~-~lp 351 (1081)
T KOG0618|consen 275 RLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS-TLP 351 (1081)
T ss_pred hHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc-ccc
Confidence 997 78888889999999999999999 67777888999999999999997654444444443 889999999997 556
Q ss_pred hhhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCCcccccccccccccccccccccccCccccccc
Q 002069 426 LSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLV 505 (973)
Q Consensus 426 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~~~~l~~l~ 505 (973)
..-....+.|+.|++.+|.+++.....+.++..|+.|+|++|+|.......+.++..|++|+||+|+++ .+|+.+..+.
T Consensus 352 ~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~ 430 (1081)
T KOG0618|consen 352 SYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLG 430 (1081)
T ss_pred cccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhh
Confidence 444444568999999999999988888899999999999999999888888999999999999999998 7889999999
Q ss_pred cccEEeecCccCCCCCCcccccccccCeecccccccCCCcchhhcccccccccccccccccCccchhhhccccccEEeCc
Q 002069 506 KLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDIS 585 (973)
Q Consensus 506 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~ 585 (973)
.|++|...+|++.. .| .+..+.+|+.+|+|.|+++.........-++|++|||+||.-.....+.|..+..+...+++
T Consensus 431 ~L~tL~ahsN~l~~-fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~ 508 (1081)
T KOG0618|consen 431 RLHTLRAHSNQLLS-FP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDIT 508 (1081)
T ss_pred hhHHHhhcCCceee-ch-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecc
Confidence 99999999999974 44 88999999999999999985444333333899999999998655667778888888888888
Q ss_pred CC
Q 002069 586 YN 587 (973)
Q Consensus 586 ~N 587 (973)
-|
T Consensus 509 ~~ 510 (1081)
T KOG0618|consen 509 LN 510 (1081)
T ss_pred cC
Confidence 77
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=317.63 Aligned_cols=240 Identities=24% Similarity=0.326 Sum_probs=203.2
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|+..+.+|.|+||.|..++.+ +|..+|+|++......+....+...+|..+++.+.||+++++++.+.+.+..++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 357888999999999999999665 7889999999877666666677889999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||.+||-|.+++++.+ ++++..++-+|.||+.|++|||+. +|++||+||+|||+|.+|.+||+|||+|+....
T Consensus 123 meyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999997654 789999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
. .-+.+|||.|+|||.+.++++..++|.|||||++|||+.|.+||.....+ ...+.+....+..+.
T Consensus 197 r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~---------~iY~KI~~~~v~fP~-- 262 (355)
T KOG0616|consen 197 R---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI---------QIYEKILEGKVKFPS-- 262 (355)
T ss_pred c---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH---------HHHHHHHhCcccCCc--
Confidence 3 44578999999999999999999999999999999999999999743321 112222222222111
Q ss_pred hHHHHHHHHHHHhcccCCCCCCC
Q 002069 939 VQDKLISIMEVSISCLDESPTSR 961 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~R 961 (973)
.....+.+++...++.|-.+|
T Consensus 263 --~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 263 --YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --ccCHHHHHHHHHHHhhhhHhh
Confidence 112236678888999998888
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=342.19 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=212.5
Q ss_pred cCCcccccccCCCceeEEEE-EcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
..|...+.||+|.||.||+| +..+++.||+|++.-.... ...+++.+|+.++.+++++||.++|+.+-.+...|++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 45777899999999999999 5568999999999865433 34688999999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
|||.||++.+.++... .+.+..+.-|++++..|+.|+|.+ +.+|||||+.||++..+|.||++|||.+......
T Consensus 91 ey~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HHhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence 9999999999997654 236677777899999999999999 9999999999999999999999999999988777
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
......++|||.|||||++.+..|+.|+||||||++.+||++|.+|+.....+ .+...+....++....
T Consensus 165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------rvlflIpk~~PP~L~~- 233 (467)
T KOG0201|consen 165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------RVLFLIPKSAPPRLDG- 233 (467)
T ss_pred hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------eEEEeccCCCCCcccc-
Confidence 66678899999999999999889999999999999999999999998754432 1112222222333332
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+.+++..|+++||+.||+|.+++++
T Consensus 234 -~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 -DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 445568899999999999999999999864
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=349.88 Aligned_cols=253 Identities=23% Similarity=0.302 Sum_probs=207.9
Q ss_pred HhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCc-c-hhhHHHHHHHHHHhhcCC-CCceeeeceeeeccce
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPG-E-MACQQEFLNEGNALTKIR-HRNIVKFYGFCSHALH 774 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 774 (973)
....|.+.+.||+|+||+|+.|.. .+++.||+|++...... . ....+.+.+|+.++++++ ||||+++++++..+..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 457899999999999999999954 47899999977654211 1 123466778999999998 9999999999999999
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC-CceEEeccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE-YEAHVSDFGIS 853 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl~Dfg~a 853 (973)
.++||||+.+|+|.+++.+. .++.+.++..+++|++.|++|+|+. ||+||||||+||+++.+ +.+||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999763 4678899999999999999999999 99999999999999999 99999999999
Q ss_pred ccccCCCCcccccccccCcccccccccCC-CC-CccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 854 KFLKLGLSNRTELAGTFGYIAPELAYTMK-VT-EKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 854 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
..............||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+.... ......+....
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~---------~~l~~ki~~~~ 239 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV---------PNLYRKIRKGE 239 (370)
T ss_pred cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH---------HHHHHHHhcCC
Confidence 98853335667789999999999999877 76 679999999999999999999985321 11111222222
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
+..+..- . ..++..++.+|+..||.+|+|+.++++
T Consensus 240 ~~~p~~~--~-S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 240 FKIPSYL--L-SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ccCCCCc--C-CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 2211110 0 445788999999999999999999984
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=339.63 Aligned_cols=263 Identities=23% Similarity=0.318 Sum_probs=210.6
Q ss_pred HhcCCcccccccCCCceeEEEEE-cCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeeccc-ee
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHAL-HS 775 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~ 775 (973)
..++|.+.++||.|.||+||+|+ ..+|+.||||+++..... ++ .-.=.+|+..++++. ||||+++.+++.+.+ ..
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 35689999999999999999994 458999999999865433 21 233468999999997 999999999998888 89
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++|||||+ .+|++++++. .+.+++.+++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+.
T Consensus 86 ~fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 86 YFVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence 99999997 7999999876 57899999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCcccccccc-cCCCCCccchHHHHHHHHHHHhCCCCCcchhhh------hhhhhhhh------hh
Q 002069 856 LKLGLSNRTELAGTFGYIAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSI------CSSLSSNL------NI 922 (973)
Q Consensus 856 ~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~------~~~~~~~~------~~ 922 (973)
+... ...+..+.|.-|+|||++. +.-|+.+.|+||+||+++|+.+-++-|.+..++ |..++.-- ..
T Consensus 160 v~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 160 VRSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 7644 4556788999999999864 567899999999999999999988888765533 22222111 11
Q ss_pred hhhhhcCCCCCCCch-----hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 923 ALDEMLDPRLPTPLR-----NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 923 ~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.+...+.-+++.-.. -......+..+++.+|+++||.+||||++++++
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 122222222221111 112345678899999999999999999999874
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=328.49 Aligned_cols=251 Identities=21% Similarity=0.303 Sum_probs=217.8
Q ss_pred HhcCCcccccccCCCceeEEEE-EcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
...+|++.+.+|+|.||.|-+| ++..|+.||||.+++....++...-.+.+|+++|..+.||||+.+|++|+..+...|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 3467999999999999999999 557999999999998877777777789999999999999999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||||..+|.|++|+.+.+ .+++.+++++++||+.|+.|+|.+ +++|||+|.+|||+|.++.+||+|||++-.+.
T Consensus 131 vMEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999997654 689999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCcccccccccCcccccccccCCCC-CccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
.. ....++.|+|-|.+||++.+.+|. +.+|.||+||++|.++.|..||++.+ ....+.++-.+.+..+.
T Consensus 205 ~~-kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---------hk~lvrQIs~GaYrEP~ 274 (668)
T KOG0611|consen 205 DK-KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---------HKRLVRQISRGAYREPE 274 (668)
T ss_pred cc-cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---------HHHHHHHhhcccccCCC
Confidence 54 455678999999999999999985 67999999999999999999999544 23334444455444332
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
. +.+..-+|+.|+.++|++|.|+.+|...
T Consensus 275 ~-----PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 275 T-----PSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred C-----CchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 2 1224567889999999999999999765
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=354.51 Aligned_cols=258 Identities=25% Similarity=0.376 Sum_probs=206.7
Q ss_pred HhcCCcccccccCCCceeEEEEEcC--CC---CEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP--TG---EIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL 773 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 773 (973)
..++..+.++||+|+||.||+|.+. ++ ..||||..+..........++|.+|+++|+.++|||||++||++....
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 3445566689999999999999654 22 238999998654455667899999999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
..++|||+|.||+|.++++.... .++..+...++.++|.||+|||++ +++||||.++|+|++.++.+||+|||++
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccc
Confidence 99999999999999999987653 689999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 854 KFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 854 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
+.-...........-+.+|+|||.+....|++++|||||||++||+++ |..||....... ..........+...
T Consensus 310 ~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-----v~~kI~~~~~r~~~ 384 (474)
T KOG0194|consen 310 RAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-----VKAKIVKNGYRMPI 384 (474)
T ss_pred cCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-----HHHHHHhcCccCCC
Confidence 755311111112245789999999999999999999999999999998 899987554320 00111111111111
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+. ..+..+..++.+||..||++||+|.++.+.++
T Consensus 385 ~~------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~ 418 (474)
T KOG0194|consen 385 PS------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLE 418 (474)
T ss_pred CC------CCHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence 11 23345677778999999999999999999875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=339.49 Aligned_cols=254 Identities=22% Similarity=0.273 Sum_probs=205.3
Q ss_pred hcCCcccccccCCCceeEEEEE-cCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|+...+||+|+||+||.|+ ..+|..+|+|++++.........+.+..|-.+|...++|.||+++-.|.+.+..|+|
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 5789999999999999999995 458999999999987666666678889999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||++||++..+|.+.. .+++..+..++.+++-|++.+|+. |+|||||||+|+|+|..|++|++|||++.-...
T Consensus 220 MEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999997654 689999999999999999999999 999999999999999999999999999853311
Q ss_pred -----------------------CCC-----c-------------------ccccccccCcccccccccCCCCCccchHH
Q 002069 859 -----------------------GLS-----N-------------------RTELAGTFGYIAPELAYTMKVTEKCDVYS 891 (973)
Q Consensus 859 -----------------------~~~-----~-------------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s 891 (973)
+.. . ....+|||.|||||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 000 0 01368999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCC---HHHHH
Q 002069 892 FGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPT---MQKVS 968 (973)
Q Consensus 892 lG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev~ 968 (973)
+||++|||+.|-+||....... ....++..+..-.++.......+..++|.+|+. ||++|-- ++||.
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~---------T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQE---------TYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHH---------HHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 9999999999999998544321 111111111111111111222456789999998 9999964 55554
Q ss_pred H
Q 002069 969 Q 969 (973)
Q Consensus 969 ~ 969 (973)
+
T Consensus 444 ~ 444 (550)
T KOG0605|consen 444 K 444 (550)
T ss_pred c
Confidence 3
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=352.75 Aligned_cols=257 Identities=22% Similarity=0.380 Sum_probs=201.2
Q ss_pred hcCCcccccccCCCceeEEEEEc------CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeecc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHA 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 772 (973)
.++|++.+.||+|+||.||+|.+ .+++.||||++..... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 46799999999999999999953 2456899999875422 22356789999999999 899999999988764
Q ss_pred -ceeEEEEEecCCCChHHHhccCcc-------------------------------------------------------
Q 002069 773 -LHSFVVYEYLEMGSLAMILSNDAA------------------------------------------------------- 796 (973)
Q Consensus 773 -~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 796 (973)
...++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 457899999999999999965321
Q ss_pred ----ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC--ccccccccc
Q 002069 797 ----AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS--NRTELAGTF 870 (973)
Q Consensus 797 ----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~ 870 (973)
..++++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++....... ......+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 13478889999999999999999999 999999999999999999999999999986543321 122344678
Q ss_pred CcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHH
Q 002069 871 GYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEV 949 (973)
Q Consensus 871 ~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 949 (973)
.|+|||++.+..++.++|||||||++|||++ |..||........ .............+ ...+..+.++
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~------~~~~~~l~~l 309 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----FCQRLKDGTRMRAP------ENATPEIYRI 309 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-----HHHHHhcCCCCCCC------CCCCHHHHHH
Confidence 8999999999899999999999999999997 9999975321100 00111111111111 1223457899
Q ss_pred HhcccCCCCCCCCCHHHHHHHhc
Q 002069 950 SISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 950 i~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+.+||+.||.+|||+.|+++.|+
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~ 332 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILG 332 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHH
Confidence 99999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=369.54 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=209.3
Q ss_pred hcCCcccccccCCCceeEEEEEcC--CCC----EEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP--TGE----IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 773 (973)
..+.+..+.||+|+||.||.|... .|. .||||.+.+. .+.....+|.+|..+|+.++|||||+++|+|-+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 445667889999999999999553 343 4899988765 34455799999999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHhccCcc----ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEec
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAA----AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSD 849 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~D 849 (973)
..+|++|||++|+|..|+++.+. ...++..+.+.++.|||+|+.||+++ ++|||||.++|+|+++...|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999987632 34588999999999999999999999 899999999999999999999999
Q ss_pred ccccccccCCCC-ccccc-ccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhh-
Q 002069 850 FGISKFLKLGLS-NRTEL-AGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALD- 925 (973)
Q Consensus 850 fg~a~~~~~~~~-~~~~~-~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~- 925 (973)
||+|+.+....+ ..... .-+.+|||||.+..+.++.|+|||||||++||++| |..||....+. +.+.
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~---------~v~~~ 916 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF---------EVLLD 916 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH---------HHHHH
Confidence 999995544333 22222 34679999999999999999999999999999998 99998754431 1222
Q ss_pred hhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 926 EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
-....+++.+ ..++..+++++..||+.+|++||++..++++++
T Consensus 917 ~~~ggRL~~P----~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~ 959 (1025)
T KOG1095|consen 917 VLEGGRLDPP----SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDP 959 (1025)
T ss_pred HHhCCccCCC----CCCChHHHHHHHHHccCChhhCccHHHHHhhhh
Confidence 1222343333 334556889999999999999999999998764
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.76 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=211.0
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.-|++.+.||.|+-|.|-.|++ .+|+.+|||++.............+.+|+-+|+-+.|||++++|++++...++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 5688899999999999999955 599999999998764444444577889999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|-|.+++-+++ ++++.++.++++||+.|+.|+|.. +|+|||+||+|+|+|..+.+||+|||+|..-.++
T Consensus 92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999997654 688999999999999999999999 9999999999999999999999999999865544
Q ss_pred CCcccccccccCcccccccccCCCC-CccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.-..+.+|+|.|+|||++++.+|+ .++||||.||++|.++||+.||++ .+....+..+..+.+.-+
T Consensus 166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---------dNir~LLlKV~~G~f~MP--- 232 (786)
T KOG0588|consen 166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---------DNIRVLLLKVQRGVFEMP--- 232 (786)
T ss_pred -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---------ccHHHHHHHHHcCcccCC---
Confidence 444567899999999999999985 689999999999999999999982 222233333333333222
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...+.+.++|+.+|+.+||.+|.|++||.++
T Consensus 233 -s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 233 -SNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -CcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1223346788999999999999999999875
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.56 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=216.6
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccce-eEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH-SFV 777 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~l 777 (973)
.++|..++++|+|+||.++.++++ +++.|++|.+.-....... +....+|+.++++++|||||.+.+.|.+.+. .+|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 357899999999999999999665 6789999998766554443 5588999999999999999999999998888 899
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||+|++||++.+.+.+.. ...++++.+..++.|++.|+.|||++ .|+|||+|+.||+++.++.||++|||+|+...
T Consensus 82 vm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 999999999999997665 46789999999999999999999988 99999999999999999999999999999998
Q ss_pred CCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
.........+||+.||.||.+.+.+|..|+||||+||++|||++-+++|...+. .....++....+.+-
T Consensus 158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m---------~~Li~ki~~~~~~Pl-- 226 (426)
T KOG0589|consen 158 PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM---------SELILKINRGLYSPL-- 226 (426)
T ss_pred CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch---------HHHHHHHhhccCCCC--
Confidence 876677788999999999999999999999999999999999999999984331 112222222221111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...+..++..+|..|++.+|..||++.+++.+
T Consensus 227 -p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 -PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 12345568889999999999999999999864
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=303.61 Aligned_cols=260 Identities=23% Similarity=0.304 Sum_probs=210.0
Q ss_pred hcCCcccccccCCCceeEEEEE-cCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc-----c
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA-----L 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~ 773 (973)
.++|.+.+.+|+|||+-||.++ ..+++.||+|++.-.. .+..+..++|++..++++|||+++++++...+ .
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 4689999999999999999995 4588999999987543 34468899999999999999999999987433 3
Q ss_pred eeEEEEEecCCCChHHHhccCccc-cCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAA-EEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
..|++++|+..|+|.+.++..... ..+++.+++.|+.++++|+++||+.. ++++||||||.||++.+++.+++.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 589999999999999999765543 37899999999999999999999984 3599999999999999999999999999
Q ss_pred cccccCCCCc---------ccccccccCcccccccc---cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhh
Q 002069 853 SKFLKLGLSN---------RTELAGTFGYIAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNL 920 (973)
Q Consensus 853 a~~~~~~~~~---------~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 920 (973)
+....-.... +.....|..|.|||.+. +...++++|||||||++|+|+.|..||+....-...+
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl---- 251 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL---- 251 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE----
Confidence 9866543221 23456799999999886 4457889999999999999999999998554321111
Q ss_pred hhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 921 NIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.-.+..+.+..+... .+++.+.++|..|++.||.+||++.+++..++
T Consensus 252 ---aLAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d 298 (302)
T KOG2345|consen 252 ---ALAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSKLD 298 (302)
T ss_pred ---EEeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 112223333222222 26677899999999999999999999998764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=326.69 Aligned_cols=256 Identities=22% Similarity=0.295 Sum_probs=200.9
Q ss_pred HHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCc-----------chhhHHHHHHHHHHhhcCCCCceeee
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPG-----------EMACQQEFLNEGNALTKIRHRNIVKF 765 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~niv~~ 765 (973)
...++|++.+.||+|.||.|-+|+. .+++.||||++.+.... .....+...+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3457899999999999999999955 48999999998643211 01113588999999999999999999
Q ss_pred ceeeecc--ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC
Q 002069 766 YGFCSHA--LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY 843 (973)
Q Consensus 766 ~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~ 843 (973)
+++..++ +..|+|+|||..|.+... ......+++.++++++.+++.||+|||.+ ||+||||||+|+|++.+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 9998664 578999999998877633 12222389999999999999999999999 999999999999999999
Q ss_pred ceEEecccccccccCC-----CCcccccccccCcccccccccCC----CCCccchHHHHHHHHHHHhCCCCCcchhhhhh
Q 002069 844 EAHVSDFGISKFLKLG-----LSNRTELAGTFGYIAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFISSICS 914 (973)
Q Consensus 844 ~~kl~Dfg~a~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 914 (973)
+|||+|||.+.....+ .......+|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||-....
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--- 324 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--- 324 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH---
Confidence 9999999999876332 12234478999999999988743 34678999999999999999999863221
Q ss_pred hhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 915 SLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.+..+.++...+..+.. .+....+.++|.+++++||+.|.+..+|..+
T Consensus 325 ------~~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 325 ------LELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred ------HHHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 22233333333322211 2345568899999999999999999998654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.02 Aligned_cols=246 Identities=20% Similarity=0.319 Sum_probs=198.8
Q ss_pred ccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec----cceeEEEEEec
Q 002069 707 HCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH----ALHSFVVYEYL 782 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~ 782 (973)
..||+|++|.||+|.+ +|+.||||++...........+.|.+|+.++++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999988 789999999986654444445788899999999999999999999876 34678999999
Q ss_pred CCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCc
Q 002069 783 EMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN 862 (973)
Q Consensus 783 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 862 (973)
++|+|.+++... ..+++....+++.|++.|++|||+.. +++||||||+||+++.++.+|++|||+++.....
T Consensus 105 ~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--- 176 (283)
T PHA02988 105 TRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--- 176 (283)
T ss_pred CCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhccc---
Confidence 999999999754 35789999999999999999999842 7889999999999999999999999998865432
Q ss_pred ccccccccCccccccccc--CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhH
Q 002069 863 RTELAGTFGYIAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940 (973)
Q Consensus 863 ~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (973)
.....|++.|+|||++.+ ..++.++|||||||++|||++|+.||....... . ..........+..+ .
T Consensus 177 ~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~-~----~~~i~~~~~~~~~~------~ 245 (283)
T PHA02988 177 PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE-I----YDLIINKNNSLKLP------L 245 (283)
T ss_pred cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH-H----HHHHHhcCCCCCCC------C
Confidence 123468899999999876 678999999999999999999999997443110 0 00111111111111 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 941 DKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 941 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+..+.+++.+||+.||.+|||++++++.|+
T Consensus 246 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~ 277 (283)
T PHA02988 246 DCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277 (283)
T ss_pred cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 23445789999999999999999999999885
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=339.78 Aligned_cols=255 Identities=22% Similarity=0.257 Sum_probs=201.8
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
.|+..+.||+|+||+||+|.. .+|+.||||.+.............+.+|+.++++++|++++++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999965 5899999999865433322334568899999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++|+|.+++.... ...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||++......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG- 155 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-
Confidence 999999998875433 23578999999999999999999999 9999999999999999999999999999876433
Q ss_pred CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhH
Q 002069 861 SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (973)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||........ ............... ..
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~----~~ 226 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-----REEVDRRVKEDQEEY----SE 226 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-----HHHHHHHhhcccccC----Cc
Confidence 223345789999999999999999999999999999999999999974332100 000111111111110 01
Q ss_pred HHHHHHHHHHhcccCCCCCCCCC-----HHHHHHH
Q 002069 941 DKLISIMEVSISCLDESPTSRPT-----MQKVSQL 970 (973)
Q Consensus 941 ~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~ 970 (973)
.....+.+++.+||+.||.+||+ ++++++.
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 12345778999999999999997 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=323.26 Aligned_cols=261 Identities=24% Similarity=0.361 Sum_probs=207.7
Q ss_pred HhcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC--CCCceeeeceeeecc----
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI--RHRNIVKFYGFCSHA---- 772 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~---- 772 (973)
..++.++.+.||+|.||+||+|+| .|+.||||+|.... ...+.+|.++++.+ +|+||..+++.-..+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hhheeEEEEEecCccccceeeccc-cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 356788999999999999999999 78999999997431 35677888887765 999999999886432
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEeecCCCCCeeecCCCceEE
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTN-----CFPPIVHRDISSKNVLLNLEYEAHV 847 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~i~H~Dlk~~Nill~~~~~~kl 847 (973)
.+.|+|++|++.|||.||+.+. .++....++++..+|.||+|||.. +.|.|.|||||+.||++..++.+.|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 3779999999999999999864 478899999999999999999974 3478999999999999999999999
Q ss_pred ecccccccccCCC----CcccccccccCcccccccccCC------CCCccchHHHHHHHHHHHh----------CCCCCc
Q 002069 848 SDFGISKFLKLGL----SNRTELAGTFGYIAPELAYTMK------VTEKCDVYSFGVLALEVIK----------GKHPRD 907 (973)
Q Consensus 848 ~Dfg~a~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~slG~~l~el~t----------g~~p~~ 907 (973)
+|+|+|.....+. ...+..+||.+|||||++...- .-..+||||||.++||++. -+.||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 9999998776542 2356689999999999986532 1235899999999999984 246666
Q ss_pred chhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 908 FISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
........+.........+.++|.++..+... +....+.++++.||..+|..|-|+-.+...|
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~-~~l~~m~klMkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSD-PALRVMAKLMKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred cCCCCCCCHHHHhcceeecccCCCCCcccccC-HHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence 44332222233333344556677777777764 4567789999999999999999987776554
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=330.02 Aligned_cols=262 Identities=26% Similarity=0.372 Sum_probs=203.7
Q ss_pred hcCCcccccccCCCceeEEEE-EcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc--ceeE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA--LHSF 776 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 776 (973)
.+.|+.+++||+|.||.||+| +..+|+.||+|++....... ....-..+|+.++++++||||+++.+...+. ...|
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 456788899999999999999 55699999999987654322 2345667899999999999999999998776 6899
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
+|+|||++ +|.-++.... -.|++.++..+++|++.|++|+|++ ||+|||||.+|||+|.+|.+||+|||+|+++
T Consensus 195 lVFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 99999985 6766665433 4689999999999999999999999 9999999999999999999999999999988
Q ss_pred cCCCC-cccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhh---------hhhhhhhhh--
Q 002069 857 KLGLS-NRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICS---------SLSSNLNIA-- 923 (973)
Q Consensus 857 ~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~---------~~~~~~~~~-- 923 (973)
..... ..+..+-|.-|.|||.+.+. .|+.++|+||.||++.||++|++.|.+..++.+ .-...+...
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 76543 36778899999999998875 599999999999999999999999986543211 111111110
Q ss_pred --hhhhcCCCCCCCchhh----HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 924 --LDEMLDPRLPTPLRNV----QDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 924 --~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
....+.+..+- .... ...+....+|+..+|..||.+|.||.++++
T Consensus 349 LP~~~~~kp~~~y-~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPY-KRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcc-cchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00111111110 0001 112244677888999999999999999875
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=339.33 Aligned_cols=248 Identities=23% Similarity=0.300 Sum_probs=202.0
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36889999999999999999654 78999999986433222233567889999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.++++... .+++..+..++.|++.|++|||++ +++||||||+||+++.++.+|++|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999996543 578899999999999999999999 9999999999999999999999999999866432
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .............+.
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---------~~~~~i~~~~~~~~~--- 219 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---------GIYEKILAGKLEFPR--- 219 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHhCCcCCCc---
Confidence 22356899999999999888999999999999999999999999743311 111111111111110
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPT-----MQKVSQL 970 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~ 970 (973)
.....+.+++.+|++.||.+||+ ++++++.
T Consensus 220 -~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 220 -HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11335778999999999999995 8888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=339.27 Aligned_cols=263 Identities=21% Similarity=0.329 Sum_probs=201.5
Q ss_pred hcCCcccccccCCCceeEEEEEcC-----------------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCce
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-----------------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 762 (973)
..+|++.++||+|+||.||+|.++ ++..||+|.+..... .....+|.+|+.++.+++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCCCe
Confidence 357889999999999999999643 234699999875432 2346789999999999999999
Q ss_pred eeeceeeeccceeEEEEEecCCCChHHHhccCc----------------cccCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 002069 763 VKFYGFCSHALHSFVVYEYLEMGSLAMILSNDA----------------AAEEFGWTKRMNAIKGVADALLYMHTNCFPP 826 (973)
Q Consensus 763 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ 826 (973)
+++++++.+.+..++||||+++++|.+++.... ....+++.++++++.|++.|++|||+. +
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ 158 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---N 158 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence 999999999889999999999999999985432 112468889999999999999999999 9
Q ss_pred eEeecCCCCCeeecCCCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh--C
Q 002069 827 IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK--G 902 (973)
Q Consensus 827 i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t--g 902 (973)
|+||||||+||+++.++.+||+|||.++....... ......++..|+|||++.+..++.++||||||+++|||++ +
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 99999999999999999999999999986644322 1223445789999999988889999999999999999987 5
Q ss_pred CCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 903 KHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 903 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..||....... .................... ....+..+.+++.+||+.||.+|||+++|.+.|+
T Consensus 239 ~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 239 EQPYGELTDEQ--VIENAGEFFRDQGRQVYLFR---PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCCcCCHHH--HHHHHHHHhhhccccccccC---CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 67776432110 00000000000000000000 1122346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=301.74 Aligned_cols=251 Identities=26% Similarity=0.405 Sum_probs=211.9
Q ss_pred HhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
+.++|++.+.||+|.||.||.|+. +++-.||+|++.+..........++.+|+++-..++||||.++|++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 357899999999999999999965 4788999999876655455556889999999999999999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
++||.++|.+...++... ..++++.....++.|+|.|+.|+|.. .|+||||||+|+|++.++..|++|||-+....
T Consensus 100 ilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999997544 45688899999999999999999999 99999999999999999999999999987554
Q ss_pred CCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhc--CCCCCCC
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML--DPRLPTP 935 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 935 (973)
........||..|.|||+..+..++..+|+|++|++.||++.|.+||..... .+...++. +-.++.
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---------~etYkrI~k~~~~~p~- 243 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---------SETYKRIRKVDLKFPS- 243 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---------HHHHHHHHHccccCCc-
Confidence 3455668899999999999999999999999999999999999999974331 11111111 112221
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.......++|.+|+..+|.+|.+..|+++.
T Consensus 244 -----~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 244 -----TISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -----ccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 223456789999999999999999999875
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=343.20 Aligned_cols=242 Identities=21% Similarity=0.253 Sum_probs=197.8
Q ss_pred ccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCCC
Q 002069 707 HCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMG 785 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 785 (973)
+.||+|+||.||+|.. .+|+.||+|++.............+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999955 588999999987543323333567888999999999999999999999999999999999999
Q ss_pred ChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCcccc
Q 002069 786 SLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTE 865 (973)
Q Consensus 786 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 865 (973)
+|.+++... ..+++.++..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence 999998654 3578999999999999999999999 9999999999999999999999999998754333333445
Q ss_pred cccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcC--CCCCCCchhhHHHH
Q 002069 866 LAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLD--PRLPTPLRNVQDKL 943 (973)
Q Consensus 866 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 943 (973)
..||+.|+|||++.+..++.++||||+||++|||++|+.||...... ........ ..++. ...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---------~~~~~~~~~~~~~p~------~~~ 219 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---------KLFELILMEEIRFPR------TLS 219 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---------HHHHHHHcCCCCCCC------CCC
Confidence 67999999999999999999999999999999999999999643211 11111111 11221 123
Q ss_pred HHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 002069 944 ISIMEVSISCLDESPTSRP-----TMQKVSQ 969 (973)
Q Consensus 944 ~~l~~li~~cl~~dP~~RP-----s~~ev~~ 969 (973)
..+.+++.+||+.||++|| ++.++++
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 220 PEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 4577899999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=341.49 Aligned_cols=246 Identities=23% Similarity=0.303 Sum_probs=205.2
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 776 (973)
..++|.+.++||+|+||+|+.|..+ +++.+|||++++...-.....+..+.|..++... +||.++.++..|...++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3578999999999999999999665 7889999999988766666678888898887766 6999999999999999999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
+||||+.||++..+. ..+.+++..+.-+|..++.||+|||++ +|||||+|.+|||+|.+|++||+|||+++.-
T Consensus 446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999944332 235789999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 857 KLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 857 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
........++.|||.|||||++.+..|+.++|.|||||++|||+.|+.||.+.++ ++..+.++.....-+
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE---------ee~FdsI~~d~~~yP- 588 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE---------EEVFDSIVNDEVRYP- 588 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH---------HHHHHHHhcCCCCCC-
Confidence 5444567789999999999999999999999999999999999999999984432 223333322221111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTM 964 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 964 (973)
...+.+...++++++.++|++|--+
T Consensus 589 ---~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 589 ---RFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---CcccHHHHHHHHHHhccCcccccCC
Confidence 1123345677889999999999765
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=343.43 Aligned_cols=242 Identities=23% Similarity=0.289 Sum_probs=195.0
Q ss_pred ccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCCCCh
Q 002069 709 IGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 787 (973)
Q Consensus 709 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 787 (973)
||+|+||.||+|... +++.||+|++.............+.+|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999654 7889999998653322333456788999999999999999999999999999999999999999
Q ss_pred HHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCcccccc
Q 002069 788 AMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA 867 (973)
Q Consensus 788 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 867 (973)
.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||+++.............
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence 9999754 3578999999999999999999999 999999999999999999999999999986543333344567
Q ss_pred cccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHH
Q 002069 868 GTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIM 947 (973)
Q Consensus 868 g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 947 (973)
||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..............+ ......+.
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~---------~~~~~~~~~~~~~~~----~~~~~~~~ 221 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV---------NEMYRKILQEPLRFP----DGFDRDAK 221 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH---------HHHHHHHHcCCCCCC----CcCCHHHH
Confidence 99999999999999999999999999999999999999974321 111111112111111 11234577
Q ss_pred HHHhcccCCCCCCCCC---HHHHHH
Q 002069 948 EVSISCLDESPTSRPT---MQKVSQ 969 (973)
Q Consensus 948 ~li~~cl~~dP~~RPs---~~ev~~ 969 (973)
+++.+||+.||.+||+ +.+++.
T Consensus 222 ~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 222 DLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 8999999999999985 555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=344.21 Aligned_cols=256 Identities=21% Similarity=0.287 Sum_probs=204.7
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||.||+|... +++.||||++.............+..|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999664 68999999987543222334567889999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+++.... .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999996543 578899999999999999999999 999999999999999999999999999976543
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
......|++.|+|||++.+..++.++||||+||++|||++|+.||......... ............+..... .
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~---~ 226 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW--ENLKYWKETLQRPVYDDP---R 226 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH--HHHHhccccccCCCCCcc---c
Confidence 234467999999999999989999999999999999999999999743321100 000000000111111110 0
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+.+++.+|++.+|.+||+++++++.
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1234457889999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=304.70 Aligned_cols=255 Identities=21% Similarity=0.282 Sum_probs=209.3
Q ss_pred HhcCCcccccccCCCceeEEEE-EcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
..+.|++.+.||+|.|+.||++ ..++|+.+|+|++........ ..+++.+|+.+-+.++|||||++.+.....+..|+
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 4567899999999999999999 556899999998865433322 36888999999999999999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC---CCceEEecccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL---EYEAHVSDFGISK 854 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---~~~~kl~Dfg~a~ 854 (973)
|+|+|+|++|..-+-.. ..+++..+-..+.||++|+.|+|.+ +|||||+||+|+++.. ..-+|++|||+|.
T Consensus 88 vFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 99999999986544221 4577888899999999999999999 9999999999999943 3469999999999
Q ss_pred cccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCC
Q 002069 855 FLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934 (973)
Q Consensus 855 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (973)
... +...+...+|||+|||||+....+|+..+|||+.||++|-++.|.+||.+++. ....++++.+.+..
T Consensus 162 ~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---------~rlye~I~~g~yd~ 231 (355)
T KOG0033|consen 162 EVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---------HRLYEQIKAGAYDY 231 (355)
T ss_pred EeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---------HHHHHHHhccccCC
Confidence 888 44667788999999999999999999999999999999999999999975331 22233344444332
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
+...+.....+..+++++|+..||.+|.|+.|.+..
T Consensus 232 ~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 232 PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 222333444556788899999999999999998764
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=341.14 Aligned_cols=243 Identities=21% Similarity=0.258 Sum_probs=198.3
Q ss_pred ccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCCC
Q 002069 707 HCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMG 785 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 785 (973)
+.||+|+||.||++.. .+++.||+|++.............+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 478999999987543333344577889999999999999999999999999999999999999
Q ss_pred ChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCcccc
Q 002069 786 SLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTE 865 (973)
Q Consensus 786 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 865 (973)
+|.+++... ..+++.++..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 999888654 3588999999999999999999999 9999999999999999999999999998764433333345
Q ss_pred cccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcC--CCCCCCchhhHHHH
Q 002069 866 LAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLD--PRLPTPLRNVQDKL 943 (973)
Q Consensus 866 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 943 (973)
..||+.|+|||++.+..++.++||||+||++|||++|+.||...... ........ ..++.. ..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---------~~~~~~~~~~~~~p~~------~~ 219 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---------KLFELILMEDIKFPRT------LS 219 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---------HHHHHhccCCccCCCC------CC
Confidence 67999999999999889999999999999999999999999643211 11111111 112211 23
Q ss_pred HHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 002069 944 ISIMEVSISCLDESPTSRP-----TMQKVSQL 970 (973)
Q Consensus 944 ~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 970 (973)
..+.+++.+|++.||.+|| ++.++++.
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 3567899999999999997 88988764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=340.96 Aligned_cols=248 Identities=24% Similarity=0.269 Sum_probs=201.8
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.+|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57899999999999999999664 78999999987532222233567889999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999987543 578899999999999999999999 9999999999999999999999999999866432
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .............+.
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---------~~~~~i~~~~~~~p~--- 236 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---------RIYEKILAGRLKFPN--- 236 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---------HHHHHHhcCCcCCCC---
Confidence 22357899999999999999999999999999999999999999643321 111111111111110
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPT-----MQKVSQL 970 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~ 970 (973)
.....+.+++.+||+.||.+||+ +++++..
T Consensus 237 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 237 -WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01234678999999999999997 6777643
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=344.20 Aligned_cols=257 Identities=22% Similarity=0.352 Sum_probs=202.4
Q ss_pred hcCCcccccccCCCceeEEEEEc------CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeecc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHA 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 772 (973)
.++|++.+.||+|+||.||+|.+ .++..||||+++..... ...+.+.+|+.++..+ +||||+++++++.++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45789999999999999999953 24568999999754322 2356788999999999 899999999999999
Q ss_pred ceeEEEEEecCCCChHHHhccCcc--------------------------------------------------------
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAA-------------------------------------------------------- 796 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------------- 796 (973)
+..++||||+++|+|.++++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999999864321
Q ss_pred ----------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 797 ----------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 797 ----------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
...+++..+.+++.||+.|++|||+. +++||||||+||+++.++.+|++|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 12478889999999999999999999 99999999999999999999999999998664432
Q ss_pred Cc--ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 861 SN--RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 861 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
.. .....++..|+|||++.+..++.++|||||||++|||++ |..||......... .........+..+.
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~--- 340 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF-----YKMIKEGYRMLSPE--- 340 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH-----HHHHHhCccCCCCC---
Confidence 21 122345678999999999999999999999999999998 89998643211110 01111111111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+.++.+++.+||+.||++||++.||++.|+
T Consensus 341 ---~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~ 372 (375)
T cd05104 341 ---CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372 (375)
T ss_pred ---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 11335789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=337.90 Aligned_cols=242 Identities=22% Similarity=0.256 Sum_probs=196.8
Q ss_pred ccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCCC
Q 002069 707 HCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMG 785 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 785 (973)
+.||+|+||.||++.. .+|+.||+|++.............+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999965 478999999987543223334567788999999999999999999999999999999999999
Q ss_pred ChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCcccc
Q 002069 786 SLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTE 865 (973)
Q Consensus 786 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 865 (973)
+|.+++.... .+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 9998886543 578999999999999999999999 9999999999999999999999999998764333333345
Q ss_pred cccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCC--CCCCCchhhHHHH
Q 002069 866 LAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPLRNVQDKL 943 (973)
Q Consensus 866 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 943 (973)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...... ......... .++.. ..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---------~~~~~~~~~~~~~p~~------~~ 219 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---------RLFELILMEEIRFPRT------LS 219 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---------HHHHHHhcCCCCCCCC------CC
Confidence 67999999999999989999999999999999999999999643211 111111111 11211 23
Q ss_pred HHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 002069 944 ISIMEVSISCLDESPTSRP-----TMQKVSQ 969 (973)
Q Consensus 944 ~~l~~li~~cl~~dP~~RP-----s~~ev~~ 969 (973)
..+.+++.+||+.||.+|| ++.++++
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 4567899999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=344.10 Aligned_cols=258 Identities=25% Similarity=0.375 Sum_probs=202.8
Q ss_pred HhcCCcccccccCCCceeEEEEEc------CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeec
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSH 771 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 771 (973)
..++|++.+.||+|+||.||+|.+ .++..||||+++..... .....+.+|+.+++.+ +|+||+++++++..
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 356899999999999999999853 23457999999765332 2356788999999999 89999999999999
Q ss_pred cceeEEEEEecCCCChHHHhccCcc-------------------------------------------------------
Q 002069 772 ALHSFVVYEYLEMGSLAMILSNDAA------------------------------------------------------- 796 (973)
Q Consensus 772 ~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 796 (973)
.+..++||||+++|+|.++++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999999854321
Q ss_pred ------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC--c
Q 002069 797 ------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS--N 862 (973)
Q Consensus 797 ------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~ 862 (973)
..++++.++++++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 12478889999999999999999999 999999999999999999999999999986543321 1
Q ss_pred ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHH
Q 002069 863 RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQD 941 (973)
Q Consensus 863 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (973)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||........ ..........+..+. .
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~------~ 339 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-----FYKMVKRGYQMSRPD------F 339 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-----HHHHHHcccCccCCC------C
Confidence 122335678999999998899999999999999999997 9999874321110 001111111111111 1
Q ss_pred HHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 942 KLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 942 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+..+.+++.+||+.||++|||+.+|++.|+
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~ 370 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQ 370 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1345788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.69 Aligned_cols=259 Identities=23% Similarity=0.380 Sum_probs=212.7
Q ss_pred HHHHHHhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc
Q 002069 694 EEIIRATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA 772 (973)
Q Consensus 694 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 772 (973)
+.++....+....++||-|-||.||.|.|+ -.-.||||.++... ...++|+.|+.+|+.++|||+|+++|+|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 444445556777899999999999999886 45689999998642 2378999999999999999999999999999
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
..+|||+|||.+|+|.+|+++.. +..++.-..+.+|.||+.|++||..+ .+||||+.++|+|+.++..||++|||+
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence 99999999999999999997655 34567778899999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCccc-ccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCC
Q 002069 853 SKFLKLGLSNRT-ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDP 930 (973)
Q Consensus 853 a~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (973)
++.+..+.+... ...-+..|.|||.+....++.|+|||+|||++||+.| |..||.+.+- ..+..++..
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----------SqVY~LLEk 481 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------SQVYGLLEK 481 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----------HHHHHHHhc
Confidence 999876533322 1223678999999999999999999999999999998 9999876542 111222222
Q ss_pred CCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 931 RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 931 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.++- .....++..++++++.||++.|.+||++.|+-+.+|
T Consensus 482 gyRM--~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 482 GYRM--DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred cccc--cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 2211 112345567899999999999999999999998775
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=311.68 Aligned_cols=248 Identities=26% Similarity=0.430 Sum_probs=214.7
Q ss_pred CcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEe
Q 002069 703 FDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEY 781 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 781 (973)
|++++++|+|+||.||+|-+ .+|+.||||.+... ...+++..|+.+|++.+.|++|++||.+......||||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 66788999999999999944 58999999998643 2368899999999999999999999999888899999999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS 861 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 861 (973)
|.-|+..+.++... +++++.++..+++.-++|++|||.. .-+|||||+.|||++.+|.+|++|||.|....+...
T Consensus 110 CGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 110 CGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred cCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 99999999996544 5789999999999999999999998 789999999999999999999999999987766555
Q ss_pred cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHH
Q 002069 862 NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQD 941 (973)
Q Consensus 862 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (973)
......|||.|||||++..-.|+.++||||+|++..||..|++||.....+++.+ ++....++.+..+..
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF----------MIPT~PPPTF~KPE~ 254 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF----------MIPTKPPPTFKKPEE 254 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE----------eccCCCCCCCCChHh
Confidence 5667889999999999999999999999999999999999999998766554432 223334444555555
Q ss_pred HHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 942 KLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 942 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
-+.++-+++++|+-+.|++|.|+.++++.
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 56778899999999999999999998874
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=330.91 Aligned_cols=262 Identities=19% Similarity=0.248 Sum_probs=200.1
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||+|.. .+++.||+|++....... ....+.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 5699999999999999999955 478999999987543221 2356788999999999999999999999988999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++ +|.+++.... ..+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+|++|||.++.....
T Consensus 83 e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 83 EYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred eCCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 99984 8988886443 3578899999999999999999999 9999999999999999999999999999765443
Q ss_pred CCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhhhhhhh--------
Q 002069 860 LSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSNLNIAL-------- 924 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~~~-------- 924 (973)
........+++.|+|||.+.+ ..++.++||||+||++|||+||+.||........ ..........
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 333445678999999998865 5688999999999999999999999964331100 0000000000
Q ss_pred -hhhcCCCCCC-C-chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 925 -DEMLDPRLPT-P-LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 925 -~~~~~~~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+.... . .........+..+++.+|++.||.+|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0011111000 0 00001123456799999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=324.77 Aligned_cols=254 Identities=21% Similarity=0.314 Sum_probs=202.2
Q ss_pred hcCCcccccccCCCceeEEEEEcC----CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP----TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
..+|++.+.||+|+||.||+|.+. .+..||+|.++..... .....|.+|+..+++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD--KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 357899999999999999999642 4568999999865332 3356799999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+++|+|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|||.+..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 99999999999999997543 3688999999999999999999999 999999999999999999999999998765
Q ss_pred ccCCCC-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 856 LKLGLS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 856 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
...... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||...... .......+....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---------~~~~~~~~~~~~ 227 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---------DVIKAVEDGFRL 227 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---------HHHHHHHCCCCC
Confidence 432211 1112345678999999998999999999999999999775 99998743321 011111111111
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.. ....+..+.+++.+||+.+|.+||+++++.+.|+
T Consensus 228 ~~---~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~ 263 (266)
T cd05064 228 PA---PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILS 263 (266)
T ss_pred CC---CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHH
Confidence 11 1123445788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=329.80 Aligned_cols=249 Identities=22% Similarity=0.267 Sum_probs=197.4
Q ss_pred ccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCCCCh
Q 002069 709 IGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 787 (973)
Q Consensus 709 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 787 (973)
||+|+||+||++.. .+++.||+|.+...........+.+..|+.+++.++|++|+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999955 47899999998654332222346678899999999999999999999999999999999999999
Q ss_pred HHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccccc
Q 002069 788 AMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTEL 866 (973)
Q Consensus 788 ~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 866 (973)
.+++.... ....+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||.+.............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 98875432 234689999999999999999999999 99999999999999999999999999998765544444456
Q ss_pred ccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHH
Q 002069 867 AGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISI 946 (973)
Q Consensus 867 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 946 (973)
.|++.|+|||++.+..++.++|||||||++|||++|+.||........ ............... ....+..+
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~----~~~~~~~~ 228 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-----NKELKQRILNDSVTY----PDKFSPAS 228 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-----HHHHHHhhcccCCCC----cccCCHHH
Confidence 789999999999999999999999999999999999999974321100 011111111111111 11234457
Q ss_pred HHHHhcccCCCCCCCC-----CHHHHHH
Q 002069 947 MEVSISCLDESPTSRP-----TMQKVSQ 969 (973)
Q Consensus 947 ~~li~~cl~~dP~~RP-----s~~ev~~ 969 (973)
.+++.+|++.||++|| +++++++
T Consensus 229 ~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 229 KSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 8899999999999999 6777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=338.91 Aligned_cols=247 Identities=22% Similarity=0.287 Sum_probs=201.5
Q ss_pred hcCCcccccccCCCceeEEEEEcC--CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP--TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
.++|++.+.||+|+||.||+|... ++..||+|++...........+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 357999999999999999999643 336899999864332223335678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||||+++|+|.+++.+.. .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||.++...
T Consensus 109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999997543 578999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCC--CCCC
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPR--LPTP 935 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 935 (973)
.. .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......... ++..
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---------~~~~~i~~~~~~~p~~ 250 (340)
T PTZ00426 183 TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---------LIYQKILEGIIYFPKF 250 (340)
T ss_pred CC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---------HHHHHHhcCCCCCCCC
Confidence 32 23457999999999999888999999999999999999999999743321 1111111111 1211
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRP-----TMQKVSQL 970 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 970 (973)
....+.+++.+|++.||++|+ +++++++.
T Consensus 251 ------~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 251 ------LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 123467889999999999995 89988764
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=324.63 Aligned_cols=260 Identities=22% Similarity=0.267 Sum_probs=209.0
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||.||+|... +++.||||.+.............+.+|++++++++|||++++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999654 78999999876543334444677899999999999999999999999989999999
Q ss_pred EecCCCChHHHhccCcc-ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 780 EYLEMGSLAMILSNDAA-AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
||+++++|.+++..... ...+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998854322 23578899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.........+++.|+|||.+.+..++.++||||+|+++|||++|+.||....... ............+...
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~-- 229 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-------FSLCQKIEQCDYPPLP-- 229 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-------HHHHHHHhcCCCCCCC--
Confidence 4333344568899999999988889999999999999999999999985322110 0111111111111111
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.......+.+++.+||+.+|.+||++.+|++.++
T Consensus 230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~ 263 (267)
T cd08228 230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAK 263 (267)
T ss_pred hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHH
Confidence 1233456889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=345.18 Aligned_cols=254 Identities=23% Similarity=0.289 Sum_probs=204.5
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||+|... +++.||||++.............+..|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36899999999999999999654 78999999987543222233567889999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999755 4688999999999999999999998 9999999999999999999999999999866543
Q ss_pred C-----------------------------CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchh
Q 002069 860 L-----------------------------SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS 910 (973)
Q Consensus 860 ~-----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 910 (973)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 12234578999999999999999999999999999999999999997443
Q ss_pred hhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCC-HHHHHHH
Q 002069 911 SICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPT-MQKVSQL 970 (973)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ev~~~ 970 (973)
.... .............+... ..+..+.+++.+|++ ||.+||+ ++++++.
T Consensus 235 ~~~~-----~~~i~~~~~~~~~p~~~----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQET-----YNKIINWKESLRFPPDP----PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHH-----HHHHhccCCcccCCCCC----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2110 00011000001111111 134457789999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=333.46 Aligned_cols=260 Identities=23% Similarity=0.316 Sum_probs=204.1
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||++... ++..||+|.+.... .....+.+.+|++++++++||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 367999999999999999999654 78899999987542 223357899999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.++++... .+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||.+.....
T Consensus 82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 82 MEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred eecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 99999999999996543 5788999999999999999999862 699999999999999999999999999876543
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhh--hhhhhhhhhh---------------
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS--ICSSLSSNLN--------------- 921 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~--~~~~~~~~~~--------------- 921 (973)
. ......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.......
T Consensus 157 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred c--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 2 22345789999999999998999999999999999999999999964321 1111000000
Q ss_pred --------------------hhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 922 --------------------IALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 922 --------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...........+. . .......++.+++.+||+.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPK-L-PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcC-C-CCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000000 0 001234568899999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=334.99 Aligned_cols=253 Identities=23% Similarity=0.305 Sum_probs=195.6
Q ss_pred ccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEEEEEecCC
Q 002069 707 HCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
+.||+|+||.||+|.. .+++.||+|++.............+..|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999965 47889999999765333333456678888888776 899999999999999999999999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccc
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 864 (973)
++|..++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence 9999888644 3588999999999999999999999 999999999999999999999999999875433333344
Q ss_pred ccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHH
Q 002069 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLI 944 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (973)
...||+.|+|||++.+..++.++|||||||++|||++|+.||............................+ .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~ 230 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSV 230 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCH
Confidence 56799999999999999999999999999999999999999963221110000000011111111111111 11233
Q ss_pred HHHHHHhcccCCCCCCCCC------HHHHHH
Q 002069 945 SIMEVSISCLDESPTSRPT------MQKVSQ 969 (973)
Q Consensus 945 ~l~~li~~cl~~dP~~RPs------~~ev~~ 969 (973)
.+.+++.+||+.||++||+ ++++++
T Consensus 231 ~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 231 KAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred HHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 4678999999999999998 456654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=320.45 Aligned_cols=250 Identities=25% Similarity=0.432 Sum_probs=202.4
Q ss_pred cCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
.+|++.+.||+|+||.||+|+++++..||+|.+..... ...++.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 45888899999999999999888888999999864322 24678899999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++|+|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++......
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 80 FMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 999999999986543 3578999999999999999999999 99999999999999999999999999987654322
Q ss_pred C-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCC-CCCCCch
Q 002069 861 S-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDP-RLPTPLR 937 (973)
Q Consensus 861 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 937 (973)
. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ......... ....+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---------~~~~~i~~~~~~~~~-- 223 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---------EVVEMISRGFRLYRP-- 223 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---------HHHHHHHCCCCCCCC--
Confidence 2 1223345678999999988889999999999999999999 99998743321 111111111 11001
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
......+.+++.+||+.+|++||+++++++.|.
T Consensus 224 --~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 --KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112345789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=340.48 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=195.1
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.+|+..+.||+|+||.||+|.. .+++.||||++.... .......+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 4566788999999999999965 478999999986542 2234578899999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+.. ...+..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 152 e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 152 EFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred ecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 999999986432 245677889999999999999999 9999999999999999999999999999877554
Q ss_pred CCcccccccccCccccccccc-----CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCC
Q 002069 860 LSNRTELAGTFGYIAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (973)
........|+..|+|||++.. ...+.++|||||||++|||++|+.||..... ..+ ..............
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-~~~-----~~~~~~~~~~~~~~ 295 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-GDW-----ASLMCAICMSQPPE 295 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-ccH-----HHHHHHHhccCCCC
Confidence 444455679999999998743 2345689999999999999999999973211 000 01111110000000
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
........+.+++.+||+.||++||++.|+++.
T Consensus 296 ---~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 296 ---APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011233457899999999999999999999874
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=335.07 Aligned_cols=253 Identities=21% Similarity=0.292 Sum_probs=196.5
Q ss_pred ccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEEEEEecCC
Q 002069 707 HCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
+.||+|+||.||+|.. .+++.||+|+++............+..|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999965 47899999999754333333456688899999888 799999999999999999999999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccc
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 864 (973)
|+|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence 9999888643 3589999999999999999999999 999999999999999999999999999875433223344
Q ss_pred ccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHH
Q 002069 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLI 944 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (973)
...||+.|+|||++.+..++.++||||+||++|||++|+.||+...........................+. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~----~~~~ 230 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSV 230 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC----CCCH
Confidence 567999999999999999999999999999999999999999743211100000000111111111111111 1223
Q ss_pred HHHHHHhcccCCCCCCCCC------HHHHHH
Q 002069 945 SIMEVSISCLDESPTSRPT------MQKVSQ 969 (973)
Q Consensus 945 ~l~~li~~cl~~dP~~RPs------~~ev~~ 969 (973)
.+.+++.+|++.||.+||+ ++++++
T Consensus 231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 4678999999999999997 667764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=332.14 Aligned_cols=263 Identities=19% Similarity=0.285 Sum_probs=199.5
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|... +++.||||++....... ....+.+|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 367999999999999999999664 78999999987543222 235677899999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||++ +++.+++.... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++....
T Consensus 82 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 82 FEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred EECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 99996 67877775433 3578899999999999999999999 999999999999999999999999999876543
Q ss_pred CCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhh-------hhhhh----
Q 002069 859 GLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLN-------IALDE---- 926 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~---- 926 (973)
.........+++.|+|||++.+ ..++.++||||+||++|||++|+.||....+.......... .....
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 3333344678999999998865 45788999999999999999999999754332111110000 00000
Q ss_pred -hcCC-CC----CCCchhh---HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 927 -MLDP-RL----PTPLRNV---QDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 927 -~~~~-~~----~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...+ .+ +...... ......+.+++.+|++.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000 00 0000000 0012356789999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=319.34 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=213.9
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
..-|++.+.||+|.|++|-.|++- +|++||||++.+...... ....+.+|+..|+-++|||||++|++.......|+|
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 356889999999999999999654 899999999987655443 356788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC-CceEEeccccccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE-YEAHVSDFGISKFLK 857 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl~Dfg~a~~~~ 857 (973)
.|.-++|+|++|+-++. ..+.+..+.+++.||+.|+.|+|+. .+||||+||+||++-+. |-||++|||++-.+.
T Consensus 96 LELGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 99999999999997665 3578999999999999999999999 89999999999987654 899999999999888
Q ss_pred CCCCcccccccccCcccccccccCCCC-CccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
++ .......|+..|.|||++.+..|+ +++||||+||++|.+++|+.||+...+ .+.+-.+++-++.-+
T Consensus 171 PG-~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND---------SETLTmImDCKYtvP- 239 (864)
T KOG4717|consen 171 PG-KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND---------SETLTMIMDCKYTVP- 239 (864)
T ss_pred Cc-chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc---------hhhhhhhhcccccCc-
Confidence 76 455678899999999999999987 578999999999999999999984332 233444555544332
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+..++|.+|+..||++|.+.++|+..
T Consensus 240 ---shvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 240 ---SHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ---hhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 3455678899999999999999999999753
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=344.85 Aligned_cols=252 Identities=22% Similarity=0.323 Sum_probs=204.7
Q ss_pred hcCCcccccccCCCceeEEEEEcCCC-CEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeecee-eec-----
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTG-EIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGF-CSH----- 771 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~~----- 771 (973)
..++++.++|.+|||+.||.|....+ ..||+|++-.. ++...+...+|+++|+.++ |+|||.+++. ...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 35678899999999999999976554 99999998754 4455788999999999996 9999999993 211
Q ss_pred -cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecc
Q 002069 772 -ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDF 850 (973)
Q Consensus 772 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df 850 (973)
.-++++.||||.||.|.|++......+ +++.++++|+.|+++|+++||... ++|||||||-+|||+..+|..|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence 236789999999999999997655444 999999999999999999999974 57999999999999999999999999
Q ss_pred cccccccCCCCcc---------cccccccCccccccc---ccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhh
Q 002069 851 GISKFLKLGLSNR---------TELAGTFGYIAPELA---YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSS 918 (973)
Q Consensus 851 g~a~~~~~~~~~~---------~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~ 918 (973)
|.|...-...... -...-|+.|+|||++ .+.++++|+|||||||+||-++....||+.-.
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------- 262 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------- 262 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--------
Confidence 9987443322111 123568999999986 47789999999999999999999999998332
Q ss_pred hhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 919 NLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
..+++...+..+. .+.+...+..||+.||+.||.+||++.+|+..+
T Consensus 263 -----~laIlng~Y~~P~--~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 263 -----KLAILNGNYSFPP--FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred -----ceeEEeccccCCC--CccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 1223333333222 145677789999999999999999999998865
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=305.47 Aligned_cols=263 Identities=25% Similarity=0.273 Sum_probs=204.5
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec--cceeE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH--ALHSF 776 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~ 776 (973)
.+.|+..++|++|.||.||+|+. ++++.||+|+++...... ..--...+|+.++.+.+|||||.+-++... -+..|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~-GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE-GFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC-CCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 45688899999999999999955 488999999998654322 123446789999999999999999887754 45789
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
+|||||+. +|...+.... .++...++..++.|+++|++|||.+ .|+|||+|++|+|+...|.+||+|||+|+.+
T Consensus 154 ~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence 99999985 7888886544 5789999999999999999999999 9999999999999999999999999999999
Q ss_pred cCCCCcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhhhhhhhhhhcC
Q 002069 857 KLGLSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSNLNIALDEMLD 929 (973)
Q Consensus 857 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~~ 929 (973)
+......+..+-|.-|.|||.+.+. .|+++.|+||+||++.||+++++-|.+...+.+ ..+.-.+..+..+..
T Consensus 228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 8877778888999999999998765 589999999999999999999999886553321 111111111100000
Q ss_pred ------CCCCC-Cchh----hHH--HHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 930 ------PRLPT-PLRN----VQD--KLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 930 ------~~~~~-~~~~----~~~--~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
-.++. +... ... ....-++++...+..||++|.||+|.++
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00000 0000 011 1244578888999999999999999875
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.62 Aligned_cols=255 Identities=22% Similarity=0.265 Sum_probs=202.4
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
.|++.+.||+|+||+||++.. .+++.||||++.............+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999965 4789999999865433222334567889999999999999999999999899999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998886433 24589999999999999999999999 99999999999999999999999999998764332
Q ss_pred CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhH
Q 002069 861 SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (973)
......|++.|+|||++.+..++.++||||+||++|||++|+.||........ .+.....+....... ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~---~~ 226 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK------REEVERRVKEDQEEY---SE 226 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH------HHHHHHHhhhccccc---Cc
Confidence 22345789999999999988899999999999999999999999974332100 001111111111100 11
Q ss_pred HHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 002069 941 DKLISIMEVSISCLDESPTSRP-----TMQKVSQL 970 (973)
Q Consensus 941 ~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 970 (973)
..+..+.+++.+||+.||++|| +++++++.
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 2344578899999999999999 88888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=333.60 Aligned_cols=247 Identities=24% Similarity=0.304 Sum_probs=194.9
Q ss_pred CcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHh---hcCCCCceeeeceeeeccceeEEE
Q 002069 703 FDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNAL---TKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
|++.+.||+|+||.||+|.. .+++.||||+++..........+.+..|+.++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67789999999999999965 47899999998753222222345566666554 567899999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|..+++. ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999988754 3589999999999999999999999 999999999999999999999999999875443
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.........|++.|+|||++.+..++.++|||||||++|||++|+.||...... .............+
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---------~~~~~i~~~~~~~p--- 221 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---------EVFDSIVNDEVRYP--- 221 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHhCCCCCC---
Confidence 333344567999999999999989999999999999999999999999743321 11111111111111
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 002069 939 VQDKLISIMEVSISCLDESPTSRP-----TMQKVSQ 969 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~ 969 (973)
......+.+++.+||+.||.+|| ++.++++
T Consensus 222 -~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 222 -RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11234567899999999999999 5666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.28 Aligned_cols=243 Identities=22% Similarity=0.255 Sum_probs=196.8
Q ss_pred ccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCCC
Q 002069 707 HCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMG 785 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 785 (973)
+.||+|+||.||+|.. .+++.||+|++.............+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999954 588999999987543333333567788999999999999999999999999999999999999
Q ss_pred ChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccc
Q 002069 786 SLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT-NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864 (973)
Q Consensus 786 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 864 (973)
+|.+++.... .+++.++..++.|++.|++|||+ . +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 9999886543 57899999999999999999997 6 999999999999999999999999999876443333334
Q ss_pred ccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCC--CCCCCchhhHHH
Q 002069 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPLRNVQDK 942 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 942 (973)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... .++.. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---------~~~~~i~~~~~~~p~~------~ 219 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---------KLFELILMEEIRFPRT------L 219 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---------HHHHHHhcCCCCCCCC------C
Confidence 567999999999999989999999999999999999999999643211 111111111 11211 2
Q ss_pred HHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 002069 943 LISIMEVSISCLDESPTSRP-----TMQKVSQL 970 (973)
Q Consensus 943 ~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 970 (973)
...+.+++.+|++.||++|+ ++.++++.
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 220 SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 33577899999999999996 89998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=340.33 Aligned_cols=203 Identities=25% Similarity=0.330 Sum_probs=175.6
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||+|.. .+++.||+|++.............+..|+.++.+++|++|+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4688999999999999999955 478999999987533223333567888999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|+|.+++... ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 999999999999754 3588999999999999999999999 9999999999999999999999999998754321
Q ss_pred CC-----------------------------------cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCC
Q 002069 860 LS-----------------------------------NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 904 (973)
Q Consensus 860 ~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~ 904 (973)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 0123479999999999999999999999999999999999999
Q ss_pred CCcch
Q 002069 905 PRDFI 909 (973)
Q Consensus 905 p~~~~ 909 (973)
||...
T Consensus 235 Pf~~~ 239 (363)
T cd05628 235 PFCSE 239 (363)
T ss_pred CCCCC
Confidence 99743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=295.69 Aligned_cols=258 Identities=21% Similarity=0.317 Sum_probs=218.0
Q ss_pred HHHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCC-----CcchhhHHHHHHHHHHhhcC-CCCceeeeceee
Q 002069 697 IRATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPL-----PGEMACQQEFLNEGNALTKI-RHRNIVKFYGFC 769 (973)
Q Consensus 697 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 769 (973)
......|.-.+.+|.|..++|.++.+ ++|+.+|+|++.... .......+.-.+|+.+++++ .||+|+.+.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 34456788889999999999988844 588999999875322 11233456678899999998 799999999999
Q ss_pred eccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEec
Q 002069 770 SHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSD 849 (973)
Q Consensus 770 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~D 849 (973)
+.+...++|+|.|+.|-|.|++...- .++++..++|++|+.+|++|||.. .|||||+||+|||++++..+||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 99999999999999999999997544 578999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCcccccccccCcccccccccC------CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhh
Q 002069 850 FGISKFLKLGLSNRTELAGTFGYIAPELAYTM------KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIA 923 (973)
Q Consensus 850 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 923 (973)
||+|+...++ +......|||+|.|||.+... .|+..+|.||.||++|.++.|.+||..... -..
T Consensus 167 FGFa~~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---------mlM 236 (411)
T KOG0599|consen 167 FGFACQLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---------MLM 236 (411)
T ss_pred cceeeccCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---------HHH
Confidence 9999998876 455678999999999988642 467789999999999999999999864332 223
Q ss_pred hhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 924 LDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
+..++.+.+......+.+......++|.+|++.||.+|.|++|+++.
T Consensus 237 LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 237 LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 45556667766666777888888999999999999999999998863
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=327.76 Aligned_cols=263 Identities=25% Similarity=0.299 Sum_probs=202.1
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||+|... +++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 36899999999999999999664 7889999998754322 223567889999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||++++.+..+... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 80 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 80 EYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred ecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99998877655432 23578999999999999999999999 9999999999999999999999999999876543
Q ss_pred CC-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh------hhhhhhhhhh------
Q 002069 860 LS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL------SSNLNIALDE------ 926 (973)
Q Consensus 860 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~------~~~~~~~~~~------ 926 (973)
.. ......|++.|+|||++.+..++.++||||+||++|||++|+.||.......... ..........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 22 2234568999999999998889999999999999999999999997543211100 0000000000
Q ss_pred ---hcCCCCCCCc----hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 927 ---MLDPRLPTPL----RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 927 ---~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...+...... ......+..+.+++.+|++.||++|||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 0001134568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=341.83 Aligned_cols=254 Identities=21% Similarity=0.260 Sum_probs=196.7
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
.|+.++.||+|+||+||+|.. .+++.||+|++.............+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999954 5789999999875433333345678999999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++|+|.+++.+.. .+++..+..++.|++.|++|||+. +|+||||||+||+++.++++|++|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999987543 578899999999999999999999 99999999999999999999999999976432100
Q ss_pred -----------------------------------------------CcccccccccCcccccccccCCCCCccchHHHH
Q 002069 861 -----------------------------------------------SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFG 893 (973)
Q Consensus 861 -----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG 893 (973)
.......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 001234699999999999988899999999999
Q ss_pred HHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhc--ccCCCCCCCCCHHHHHHH
Q 002069 894 VLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSIS--CLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 894 ~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~ev~~~ 970 (973)
|++|||+||+.||......... ............+... ....++.+++.+ |+..+|..||+++++++.
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~-----~~i~~~~~~~~~~~~~----~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQ-----LKVINWENTLHIPPQV----KLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHH-----HHHHccccccCCCCCC----CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999999743321100 0000000011111111 122345677766 556667779999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=341.28 Aligned_cols=255 Identities=20% Similarity=0.241 Sum_probs=201.6
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|.. .+++.||+|++...........+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 46799999999999999999965 47899999998643222222345678899999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++|+|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+.....
T Consensus 122 ~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 122 MEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999998643 467888999999999999999999 999999999999999999999999999986643
Q ss_pred CCC-cccccccccCcccccccccC----CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 859 GLS-NRTELAGTFGYIAPELAYTM----KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 859 ~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ......+.....
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---------~~~~~i~~~~~~ 265 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---------GTYSKIMDHKNS 265 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---------HHHHHHHcCCCc
Confidence 322 23346799999999998653 3788999999999999999999999744321 111111111111
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCC--CCCHHHHHHH
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTS--RPTMQKVSQL 970 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~ 970 (973)
.........+..+.+++.+|++.+|.+ ||+++++++.
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 111111123456778999999999998 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=324.74 Aligned_cols=255 Identities=25% Similarity=0.426 Sum_probs=204.6
Q ss_pred cCCcccccccCCCceeEEEEEcCC------CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccce
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPT------GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH 774 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 774 (973)
.+|++.+.||+|+||.||+|.... .+.||+|.+.... .......|.+|+..+.+++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 468899999999999999996532 2579999987543 22335779999999999999999999999998889
Q ss_pred eEEEEEecCCCChHHHhccCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC
Q 002069 775 SFVVYEYLEMGSLAMILSNDAA-------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL 841 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~ 841 (973)
.+++|||+++++|.+++..... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcC
Confidence 9999999999999999965432 14578899999999999999999999 9999999999999999
Q ss_pred CCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhh
Q 002069 842 EYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSS 918 (973)
Q Consensus 842 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~ 918 (973)
++.++|+|||.++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~------ 233 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ------ 233 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH------
Confidence 99999999999976543321 2233456889999999988889999999999999999998 99998643211
Q ss_pred hhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 919 NLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.....+........ ....+..+.+++.+||+.||.+||++++|++.|+
T Consensus 234 ---~~~~~i~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05048 234 ---EVIEMIRSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281 (283)
T ss_pred ---HHHHHHHcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence 11111111111111 1234456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=310.19 Aligned_cols=254 Identities=22% Similarity=0.283 Sum_probs=208.2
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
+.|+..+.||.|.-|+||.++.. ++..+|+|++.+..........+...|.++++.++||.++.+|+.++.++..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 45777889999999999999775 45899999998765555555677888999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC-
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL- 858 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~- 858 (973)
|||+||+|....+++. .+.+++..++-+|..++-||+|||-. |||+||+||+|||+.++|++.++||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999887655 56899999999999999999999999 999999999999999999999999998643311
Q ss_pred --------------------------------CCC-----------------------cccccccccCcccccccccCCC
Q 002069 859 --------------------------------GLS-----------------------NRTELAGTFGYIAPELAYTMKV 883 (973)
Q Consensus 859 --------------------------------~~~-----------------------~~~~~~g~~~y~aPE~~~~~~~ 883 (973)
... ....++||-.|.|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 0123689999999999999999
Q ss_pred CCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCC
Q 002069 884 TEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPT 963 (973)
Q Consensus 884 ~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 963 (973)
+.++|.|+|||++|||+.|..||.+... .+.+..++......+.. ...+....+||++.+.+||.+|-.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~---------~~Tl~NIv~~~l~Fp~~--~~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNN---------KETLRNIVGQPLKFPEE--PEVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCc---------hhhHHHHhcCCCcCCCC--CcchhHHHHHHHHHhccChhhhhc
Confidence 9999999999999999999999985432 22223333222221111 234556789999999999999987
Q ss_pred ----HHHHHH
Q 002069 964 ----MQKVSQ 969 (973)
Q Consensus 964 ----~~ev~~ 969 (973)
|+||-+
T Consensus 382 ~~rGA~eIK~ 391 (459)
T KOG0610|consen 382 SKRGAAEIKR 391 (459)
T ss_pred cccchHHhhc
Confidence 777754
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=332.92 Aligned_cols=239 Identities=23% Similarity=0.333 Sum_probs=191.8
Q ss_pred ccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEEEEEecCC
Q 002069 707 HCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
+.||+|+||+||+|..+ +++.||||++...........+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999654 7899999998753222223346677888888776 799999999999999999999999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccc
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 864 (973)
|+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence 99999886543 588999999999999999999999 999999999999999999999999999876543333344
Q ss_pred ccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHH
Q 002069 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLI 944 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (973)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... .............+ .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---------~~~~~i~~~~~~~~----~~~~~ 221 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---------DLFEAILNDEVVYP----TWLSQ 221 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---------HHHHHHhcCCCCCC----CCCCH
Confidence 567999999999999889999999999999999999999999743321 11111111111111 01233
Q ss_pred HHHHHHhcccCCCCCCCCCH
Q 002069 945 SIMEVSISCLDESPTSRPTM 964 (973)
Q Consensus 945 ~l~~li~~cl~~dP~~RPs~ 964 (973)
.+.+++.+|++.||++||++
T Consensus 222 ~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHHcccCHHHCCCC
Confidence 57789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=339.76 Aligned_cols=249 Identities=25% Similarity=0.431 Sum_probs=204.0
Q ss_pred CcccccccCCCceeEEEEEc-CCCC----EEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 703 FDDEHCIGNGGQGSVYKAEL-PTGE----IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
....++||+|+||+||+|-| +.|+ +||+|++...... ....++.+|+..|.+++|||+++++|+|.... ..|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 34567899999999999944 4443 6899998765433 33588999999999999999999999998765 779
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
|++||+.|+|.+|++.++ ..+.....+.|..|||+|+.|||++ ++|||||.++|||+.....+|+.|||+++...
T Consensus 775 vtq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 999999999999998755 5688899999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCcccccc--cccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCC
Q 002069 858 LGLSNRTELA--GTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934 (973)
Q Consensus 858 ~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (973)
.+........ -.+.|||-|.+....|+.++|||||||++||++| |..|++.... +.+...+.. +.
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~----------~eI~dlle~--ge 917 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA----------EEIPDLLEK--GE 917 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH----------HHhhHHHhc--cc
Confidence 7654443333 3678999999999999999999999999999998 9999885542 111111111 11
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
..+.++-+..+++.++.+||..|++.||+++++...+
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~f 954 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEF 954 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHH
Confidence 1222344567789999999999999999999998765
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=332.77 Aligned_cols=244 Identities=24% Similarity=0.336 Sum_probs=195.8
Q ss_pred ccccCCCceeEEEEEc----CCCCEEEEEEcCCCCC-cchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEe
Q 002069 707 HCIGNGGQGSVYKAEL----PTGEIVAVKKFHSPLP-GEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEY 781 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 781 (973)
+.||+|+||.||+++. .+++.||||++..... ........+..|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999964 3678999999864321 1112245678899999999999999999999999999999999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS 861 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 861 (973)
+++++|.++++... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999986543 567888999999999999999999 999999999999999999999999999875543333
Q ss_pred cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHH
Q 002069 862 NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQD 941 (973)
Q Consensus 862 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (973)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...... .............+ ..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---------~~~~~~~~~~~~~~----~~ 222 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---------KTIDKILKGKLNLP----PY 222 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---------HHHHHHHcCCCCCC----CC
Confidence 344467999999999999888999999999999999999999999743321 11112222221111 11
Q ss_pred HHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 002069 942 KLISIMEVSISCLDESPTSRP-----TMQKVSQ 969 (973)
Q Consensus 942 ~~~~l~~li~~cl~~dP~~RP-----s~~ev~~ 969 (973)
....+.+++.+|++.||++|| +++++++
T Consensus 223 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 223 LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 223577899999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=324.08 Aligned_cols=256 Identities=25% Similarity=0.446 Sum_probs=205.7
Q ss_pred hcCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 773 (973)
.++|.+.+.||+|+||.||+|... +++.||||.+..... ....+.+.+|++++++++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 356888999999999999999653 357899999875433 223578999999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHhccCc-----------cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC
Q 002069 774 HSFVVYEYLEMGSLAMILSNDA-----------AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE 842 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~ 842 (973)
..++||||+++++|.+++.... ....+++.++..++.|++.|++|+|+. +++||||||+||+++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCC
Confidence 9999999999999999997543 134578899999999999999999999 99999999999999999
Q ss_pred CceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhh
Q 002069 843 YEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSN 919 (973)
Q Consensus 843 ~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~ 919 (973)
+.+|++|||.++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~------- 231 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE------- 231 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------
Confidence 9999999999876533221 1223446788999999999999999999999999999998 99998643211
Q ss_pred hhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 920 LNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
............... ...+..+.+++.+||+.||.+||++.||++.|+
T Consensus 232 --~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 --EVIECITQGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred --HHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111111111111111 123345789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=332.16 Aligned_cols=244 Identities=22% Similarity=0.299 Sum_probs=194.6
Q ss_pred CCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCC-CceeeeceeeeccceeEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH-RNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 779 (973)
+|++.+.||+|+||.||+|... +++.||||++...........+.+..|..++..++| ++|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4888999999999999999654 678999999875432223335678889999998866 46888999999889999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|+|.+++.... .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999986543 578899999999999999999999 9999999999999999999999999998754333
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
........||+.|+|||++.+..++.++||||+||++|||+||+.||...... .............+.
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---------~~~~~i~~~~~~~~~--- 222 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---------ELFQSIMEHNVSYPK--- 222 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---------HHHHHHHcCCCCCCC---
Confidence 33344567999999999999999999999999999999999999999743321 111111111111110
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTM 964 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~ 964 (973)
.....+.+++.+|++.||.+|++.
T Consensus 223 -~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 223 -SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 123356789999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=321.70 Aligned_cols=254 Identities=25% Similarity=0.455 Sum_probs=209.0
Q ss_pred HhcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
...+|++.+.||+|+||.||+|...+++.||+|.+..... ....++..|+.+++.++|+||+++++++.+....++|
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4567999999999999999999887899999999875422 2356788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.++++... ...+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.+|++|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 81 TELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred EeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999999997643 34689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCC-CCCCCc
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDP-RLPTPL 936 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 936 (973)
.........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...... ......... +.+.+
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---------~~~~~~~~~~~~~~~- 226 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---------EVYDQITAGYRMPCP- 226 (261)
T ss_pred ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---------HHHHHHHhCCcCCCC-
Confidence 4333334456788999999988889999999999999999998 89998643311 111111111 11111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+..+.+++.+||+.||.+|||++++++.|+
T Consensus 227 ---~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~ 259 (261)
T cd05148 227 ---AKCPQEIYKIMLECWAAEPEDRPSFKALREELD 259 (261)
T ss_pred ---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 123345789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=321.83 Aligned_cols=260 Identities=23% Similarity=0.309 Sum_probs=209.3
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||.||+|.. .+++.||||.+............++.+|+.+++.++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999999964 588999999886543334444578899999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 780 EYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
||+++++|.++++... ....+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999986432 234688999999999999999999999 999999999999999999999999999887655
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.........++..|+|||++.+..++.++||||||+++|+|++|..||.......... .........+..+
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~----- 229 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL----CKKIEQCDYPPLP----- 229 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHH----hhhhhcCCCCCCC-----
Confidence 4333444578899999999988889999999999999999999999986332110000 0111111111111
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.......+.+++.+||+.||.+|||+.+|++.++
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~ 263 (267)
T cd08229 230 SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAK 263 (267)
T ss_pred cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHh
Confidence 1123456889999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=327.37 Aligned_cols=255 Identities=23% Similarity=0.287 Sum_probs=219.5
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeeccceeE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 776 (973)
....|++.+.||+|.||.||++..+ +|+.+|+|.+...........+.+.+|+.+|+++. |||||.+++++++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3567999999999999999999665 69999999998765554445678999999999998 999999999999999999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC----CceEEecccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE----YEAHVSDFGI 852 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~----~~~kl~Dfg~ 852 (973)
+|||++.||.|.+.+... .+++.++..++.|++.|++|||+. ||+|||+||+|+++... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999755 289999999999999999999998 99999999999999543 4799999999
Q ss_pred cccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
|..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||...... .....+....+
T Consensus 186 a~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~---------~~~~~i~~~~~ 255 (382)
T KOG0032|consen 186 AKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF---------EIFLAILRGDF 255 (382)
T ss_pred ceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh---------HHHHHHHcCCC
Confidence 998887 46677889999999999999999999999999999999999999999855432 12223444444
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+......+.++|..|+..||.+|+|+.+++++
T Consensus 256 ~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 44444455666778899999999999999999999875
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=317.92 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=202.4
Q ss_pred cCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
++|++.+.||+|+||+||+|++.++..||+|.+..... ....+.+|+.++++++||||+++++++......++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 45888899999999999999887777899999874322 24678999999999999999999999998888999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.+|++|||.++......
T Consensus 80 ~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 80 YMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred cCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 999999999997543 2588999999999999999999999 99999999999999999999999999987654432
Q ss_pred Cc-ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 861 SN-RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 861 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.. .....++..|+|||+..+..++.++||||||+++|||++ |..||...... ................
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---------~~~~~~~~~~~~~~~~- 224 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---------ETVEKVSQGLRLYRPH- 224 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---------HHHHHHhcCCCCCCCC-
Confidence 21 122345678999999988889999999999999999998 99998643321 0111111111111001
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+..+.+++.+||+.+|.+||++.++++.++
T Consensus 225 --~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 --LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 12346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=319.54 Aligned_cols=253 Identities=24% Similarity=0.400 Sum_probs=205.2
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++.+....++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 46789999999999999999988788899999976432 12578899999999999999999999999988999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.++++... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|||.+......
T Consensus 81 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 81 EYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred ecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999997543 34578899999999999999999998 9999999999999999999999999999876543
Q ss_pred CCc-ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 860 LSN-RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 860 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
... .....++..|+|||++.+..++.++|||||||++|+|+| |+.||....... .......... .+..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~------~~~~~~~~~~--~~~~-- 226 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD------VMSALQRGYR--MPRM-- 226 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH------HHHHHHcCCC--CCCC--
Confidence 221 223345678999999988889999999999999999998 999986432110 0011111111 1111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+..+.+++.+|++.+|++||+++++.+.|+
T Consensus 227 --~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 259 (261)
T cd05072 227 --ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259 (261)
T ss_pred --CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 112345788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=353.84 Aligned_cols=258 Identities=26% Similarity=0.378 Sum_probs=202.1
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.++||+|+||.||+|.. .+++.||+|++...........+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999965 478999999997654444445678999999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCc--------cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccc
Q 002069 780 EYLEMGSLAMILSNDA--------AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFG 851 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg 851 (973)
||++|++|.++++... .....++..+++++.||+.|++|||+. +|+||||||+||+++.++.+|++|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986421 123456778899999999999999999 99999999999999999999999999
Q ss_pred ccccccCCC------------------CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhh
Q 002069 852 ISKFLKLGL------------------SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIC 913 (973)
Q Consensus 852 ~a~~~~~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 913 (973)
.++...... .......||+.|+|||++.+..++.++||||+||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998662110 01123468999999999999999999999999999999999999997432110
Q ss_pred hhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCC-HHHHHHHh
Q 002069 914 SSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPT-MQKVSQLL 971 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ev~~~L 971 (973)
... ......+.. .......+..+.+++.+|++.||++||+ ++++.+.|
T Consensus 239 i~~-------~~~i~~P~~---~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L 287 (932)
T PRK13184 239 ISY-------RDVILSPIE---VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL 287 (932)
T ss_pred hhh-------hhhccChhh---ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 000 001111110 0111223345778999999999999965 55565544
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=332.26 Aligned_cols=245 Identities=23% Similarity=0.315 Sum_probs=195.9
Q ss_pred ccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEEEEEecCC
Q 002069 707 HCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
+.||+|+||.||+|... +++.||+|++.............+..|.+++..+ +||+|+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999654 6889999998754322233346677888888766 899999999999999999999999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccc
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 864 (973)
++|..++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 99998886443 578899999999999999999999 999999999999999999999999999876544333444
Q ss_pred ccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHH
Q 002069 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLI 944 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (973)
...|++.|+|||++.+..++.++||||+||++|||++|+.||...... .............+. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---------~~~~~i~~~~~~~p~----~~~~ 221 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---------DLFESILHDDVLYPV----WLSK 221 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---------HHHHHHHcCCCCCCC----CCCH
Confidence 567899999999999989999999999999999999999999744321 111111111111110 1223
Q ss_pred HHHHHHhcccCCCCCCCC-------CHHHHHHH
Q 002069 945 SIMEVSISCLDESPTSRP-------TMQKVSQL 970 (973)
Q Consensus 945 ~l~~li~~cl~~dP~~RP-------s~~ev~~~ 970 (973)
.+.+++.+|++.||++|| +++++++.
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 577899999999999999 78887653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=337.13 Aligned_cols=257 Identities=21% Similarity=0.346 Sum_probs=202.4
Q ss_pred hcCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeecc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHA 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 772 (973)
.++|++.+.||+|+||.||+|... .+..||||++..... ....+.+.+|+.+++++. ||||+++++++.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 468899999999999999999642 234799999975432 233578999999999996 99999999999999
Q ss_pred ceeEEEEEecCCCChHHHhccCcc--------------------------------------------------------
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAA-------------------------------------------------------- 796 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------------- 796 (973)
+..++||||+++|+|.+++.....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999999854321
Q ss_pred -------------------------------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeee
Q 002069 797 -------------------------------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL 839 (973)
Q Consensus 797 -------------------------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill 839 (973)
...+++.++..++.|++.|++|||+. +++||||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEE
Confidence 12477888999999999999999999 99999999999999
Q ss_pred cCCCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhh
Q 002069 840 NLEYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSL 916 (973)
Q Consensus 840 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~ 916 (973)
+.++.+|++|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-- 348 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-- 348 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--
Confidence 9999999999999986643321 2223456788999999998889999999999999999997 9999864321100
Q ss_pred hhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 917 SSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.............+ ...+..+.+++.+||+.||++||++.+|.+.|+
T Consensus 349 ---~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 349 ---FYNKIKSGYRMAKP------DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred ---HHHHHhcCCCCCCC------ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 00111111111111 123446789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=341.65 Aligned_cols=254 Identities=22% Similarity=0.265 Sum_probs=198.7
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||+|.. .+++.||||++.............+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 3689999999999999999965 478999999987432222233466888999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|+|.+++.... .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||+++.....
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999986543 588999999999999999999999 9999999999999999999999999998754321
Q ss_pred CC--------------------------------------cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh
Q 002069 860 LS--------------------------------------NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK 901 (973)
Q Consensus 860 ~~--------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t 901 (973)
.. ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 10 0012468999999999999899999999999999999999
Q ss_pred CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCC---HHHHHHH
Q 002069 902 GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPT---MQKVSQL 970 (973)
Q Consensus 902 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev~~~ 970 (973)
|..||........ .............+... .....+.+++.+|+. +|.+|++ ++++++.
T Consensus 235 G~~Pf~~~~~~~~-----~~~i~~~~~~~~~~~~~----~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQET-----YRKIINWKETLQFPDEV----PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHHHH-----HHHHHcCCCccCCCCCC----CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999974432110 00000000000111111 123346788889996 8999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=334.60 Aligned_cols=260 Identities=25% Similarity=0.341 Sum_probs=196.0
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc-----cee
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA-----LHS 775 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 775 (973)
+|++.+.||+|+||.||+|.. .+++.||||++...... ......+.+|+.++++++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 588899999999999999964 47899999998743222 22245788999999999999999999987543 247
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
|+||||++ ++|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 80 YVVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 99999996 68988886443 588999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCC---cccccccccCccccccccc--CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhh-----
Q 002069 856 LKLGLS---NRTELAGTFGYIAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSN----- 919 (973)
Q Consensus 856 ~~~~~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~----- 919 (973)
...... ......|++.|+|||++.+ ..++.++|||||||++|||+||+.||........ ..+..
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 533221 1234578999999999865 5788999999999999999999999964332110 00000
Q ss_pred -------hhhhhhhhcCCCCCCCc-hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 920 -------LNIALDEMLDPRLPTPL-RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 920 -------~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
....... +....+... .........+.+++.+||+.||++|||++|+++.
T Consensus 233 ~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSS-MRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHh-hcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000011 111111110 0011123456789999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=325.73 Aligned_cols=249 Identities=34% Similarity=0.506 Sum_probs=192.3
Q ss_pred ccccccCCCceeEEEEEcC-----CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 705 DEHCIGNGGQGSVYKAELP-----TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 705 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
+.+.||.|.||.||+|.+. .+..|+||.++... .....++|.+|++.+++++||||++++|++...+..++||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeecccccccccccccccccccccccccccccc
Confidence 4578999999999999765 35689999996532 2233689999999999999999999999999888899999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|+|.++++... ...+++.++..|+.|+|+|++|||+. +++|+||+++||+++.++.+||+|||.+......
T Consensus 81 e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp E--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 9999999999998662 24689999999999999999999999 9999999999999999999999999999876322
Q ss_pred CC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 860 LS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 860 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
.. ......+...|+|||.+.+..++.++||||||+++||+++ |+.||...... .......+......+.
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~------~~~~~~~~~~~~~~~~-- 228 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE------EIIEKLKQGQRLPIPD-- 228 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH------HHHHHHHTTEETTSBT--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc------cccccccccccceecc--
Confidence 11 1233457789999999998889999999999999999999 78998643211 0011111111111111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
..+..+.+++.+||+.||++||++.++++.|
T Consensus 229 ----~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 229 ----NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1234577899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=329.29 Aligned_cols=241 Identities=26% Similarity=0.360 Sum_probs=191.3
Q ss_pred ccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhc-CCCCceeeeceeeeccceeEEEEEecCC
Q 002069 707 HCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTK-IRHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
+.||+|+||.||+|.. .+++.||+|+++..........+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999965 4688999999875432222234555666666664 4899999999999999999999999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccc
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 864 (973)
|+|.++++... .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 99999986543 578999999999999999999999 999999999999999999999999999986544334444
Q ss_pred ccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhc--CCCCCCCchhhHHH
Q 002069 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML--DPRLPTPLRNVQDK 942 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 942 (973)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... .+.++.. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---------~~~~~i~~~~~~~~~~------~ 219 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---------ELFDSILNDRPHFPRW------I 219 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHcCCCCCCCC------C
Confidence 567999999999999989999999999999999999999999744321 0111111 1112211 2
Q ss_pred HHHHHHHHhcccCCCCCCCCCHH-HHH
Q 002069 943 LISIMEVSISCLDESPTSRPTMQ-KVS 968 (973)
Q Consensus 943 ~~~l~~li~~cl~~dP~~RPs~~-ev~ 968 (973)
...+.+++.+||+.||.+||++. ++.
T Consensus 220 ~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 220 SKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 33467889999999999999875 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=338.20 Aligned_cols=255 Identities=24% Similarity=0.258 Sum_probs=201.6
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||+|.. .+++.||+|+++..........+.+.+|+.+++.++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3688999999999999999955 478999999987543333334567889999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|+|.+++++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999997542 3688999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc-ccccccccCcccccccc------cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 860 LSN-RTELAGTFGYIAPELAY------TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 860 ~~~-~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
... .....||+.|+|||++. ...++.++|||||||++|||++|+.||........ ............+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-----~~~i~~~~~~~~~ 230 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-----YNNIMNFQRFLKF 230 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-----HHHHHcCCCccCC
Confidence 222 23346899999999986 45678899999999999999999999974332110 0000000000111
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
+.. ......+.+++.+|++ +|.+||+++++++.
T Consensus 231 ~~~----~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 231 PED----PKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCC----CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 111 1223457788889998 99999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=338.73 Aligned_cols=256 Identities=20% Similarity=0.242 Sum_probs=199.7
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
..++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3578999999999999999999664 688999999864322222234568889999999999999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||||+++|+|.+++... .+++.++..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999999643 478889999999999999999999 99999999999999999999999999998764
Q ss_pred CCCC-cccccccccCcccccccccCC----CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 858 LGLS-NRTELAGTFGYIAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 858 ~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
.... ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||...... ......+....
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~---------~~~~~i~~~~~ 264 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV---------GTYSKIMDHKN 264 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH---------HHHHHHHhCCc
Confidence 3322 223567999999999987543 778999999999999999999999743321 11111221111
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCC--CCCHHHHHHH
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTS--RPTMQKVSQL 970 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~ 970 (973)
.............+.+++..|+..+|.+ ||+++|++++
T Consensus 265 ~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111111122344667888999866554 8999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=330.96 Aligned_cols=244 Identities=21% Similarity=0.288 Sum_probs=195.5
Q ss_pred CCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 779 (973)
+|++.+.||+|+||.||+|... +++.||+|++.............+..|..++... +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999654 6789999998754332233345567787887777 6899999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|+|.+++.... .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999886543 578999999999999999999999 9999999999999999999999999999765433
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
........||+.|+|||++.+..++.++|||||||++|||+||+.||...... .............+
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---------~~~~~i~~~~~~~p---- 221 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---------ELFQSIMEHNVAYP---- 221 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---------HHHHHHHhCCCCCC----
Confidence 33344567999999999999999999999999999999999999999744321 11111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTM 964 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~ 964 (973)
......+.+++.+|++.||.+|++.
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1123456789999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=322.36 Aligned_cols=257 Identities=22% Similarity=0.354 Sum_probs=202.7
Q ss_pred HhcCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA 772 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 772 (973)
..++|++.+.||+|+||.||+|... +++.||||++..... .....++.+|+.+++.++||||+++++++.++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4567999999999999999998642 356799999864322 23356789999999999999999999999998
Q ss_pred ceeEEEEEecCCCChHHHhccCcc-------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCce
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAA-------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEA 845 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~ 845 (973)
...++||||+++++|.+++++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence 999999999999999999865332 22467889999999999999999998 99999999999999999999
Q ss_pred EEecccccccccCCCCcc--cccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhh
Q 002069 846 HVSDFGISKFLKLGLSNR--TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNI 922 (973)
Q Consensus 846 kl~Dfg~a~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 922 (973)
+++|||.++......... ....+++.|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---------~ 229 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---------Q 229 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---------H
Confidence 999999987654332211 12345778999999998889999999999999999999 78898643211 1
Q ss_pred hhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 923 ALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.............. ...+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 230 ~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 230 VLRFVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11111111111111 112345788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=335.37 Aligned_cols=255 Identities=20% Similarity=0.236 Sum_probs=197.7
Q ss_pred hcCCcccccccCCCceeEEEEE-cCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
..+|++.+.||+|+||.||+|. ..+++.||+|... ...+.+|++++++++||||+++++++......++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 3579999999999999999995 4588999999743 24567899999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
+|++. ++|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|+....
T Consensus 162 ~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 162 LPRYK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred EecCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 99996 6888887543 3578999999999999999999999 999999999999999999999999999975432
Q ss_pred C-CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhh-------------hhhhh------
Q 002069 859 G-LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIC-------------SSLSS------ 918 (973)
Q Consensus 859 ~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-------------~~~~~------ 918 (973)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||-...... ...+.
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 2 122334679999999999999899999999999999999999998864221100 00000
Q ss_pred -----hhhhhhhhh-----cCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 919 -----NLNIALDEM-----LDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 919 -----~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......... ..+.....+......+.++.+++.+|++.||.+|||++|+++.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000 0011111122223345678899999999999999999999863
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=311.00 Aligned_cols=257 Identities=25% Similarity=0.307 Sum_probs=195.2
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc-----e
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL-----H 774 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~ 774 (973)
-+|...+.+|.|+||.||+|.. .+++.||||+.-...... .+|+++|+.++|||||++.-+|.... .
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 4577789999999999999954 467999999987543322 36899999999999999988875322 3
Q ss_pred eEEEEEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC-CceEEecccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE-YEAHVSDFGI 852 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl~Dfg~ 852 (973)
..+|||||| .+|.++++... ....++...+.-+.+||.+|++|||+. +|+||||||.|+|+|.+ |.+||||||.
T Consensus 97 lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 97 LNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCc
Confidence 358999998 58988886421 234577788888999999999999998 99999999999999988 9999999999
Q ss_pred cccccCCCCcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhh------hhhhhhhhhhhh
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSIC------SSLSSNLNIALD 925 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~------~~~~~~~~~~~~ 925 (973)
|+...++. .......|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+... ..++.-..+.+.
T Consensus 173 AK~L~~~e-pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 173 AKVLVKGE-PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred ceeeccCC-CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 99887763 34566788999999998865 69999999999999999999999998755321 111111111111
Q ss_pred hh-------cCCCCCCC-ch--hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 926 EM-------LDPRLPTP-LR--NVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 926 ~~-------~~~~~~~~-~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
.+ ..+.+... +. .......+..+++.++++.+|.+|.++.|+++
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11 11111111 00 11223456789999999999999999999875
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=341.39 Aligned_cols=254 Identities=20% Similarity=0.247 Sum_probs=196.6
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||+|.. .+++.||||++...........+.+.+|++++++++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688999999999999999954 588999999986432222333567889999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999998654 3578899999999999999999999 9999999999999999999999999998643211
Q ss_pred CC-----------------------------------------------cccccccccCcccccccccCCCCCccchHHH
Q 002069 860 LS-----------------------------------------------NRTELAGTFGYIAPELAYTMKVTEKCDVYSF 892 (973)
Q Consensus 860 ~~-----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~sl 892 (973)
.. ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0012468999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCC---CCHHHHHH
Q 002069 893 GVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSR---PTMQKVSQ 969 (973)
Q Consensus 893 G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ev~~ 969 (973)
||++|||++|+.||........ . ...........++.. ......+.+++.+|+. +|.+| +++.++++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~-~----~~i~~~~~~~~~p~~----~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHET-Y----RKIINWRETLYFPDD----IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHH-H----HHHHccCCccCCCCC----CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 9999999999999974332110 0 000000000111111 1123456788889997 66664 69999876
Q ss_pred H
Q 002069 970 L 970 (973)
Q Consensus 970 ~ 970 (973)
.
T Consensus 305 h 305 (377)
T cd05629 305 H 305 (377)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=316.61 Aligned_cols=253 Identities=25% Similarity=0.448 Sum_probs=204.8
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.++|++.+.||+|++|.||+|...+++.||+|.++.... ..+++.+|+.++++++||||+++++++......++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 467899999999999999999877788999999875422 2467889999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++.....
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 81 ELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred ecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 9999999999997544 34689999999999999999999999 9999999999999999999999999999877533
Q ss_pred CCcc-cccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 860 LSNR-TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 860 ~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
.... .....+..|+|||++.+..++.++||||||+++|||++ |+.||....... ......... ..+..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~--~~~~~-- 226 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE------VLQQVDQGY--RMPCP-- 226 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCC--CCCCC--
Confidence 2211 11223468999999998889999999999999999999 999986432110 000111110 11111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+..+.+++.+|++.+|.+||++.++++.|+
T Consensus 227 --~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~ 259 (261)
T cd05068 227 --PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259 (261)
T ss_pred --CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 123356889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.05 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=206.8
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|++.+.||+|++|.||+|.. .+++.|++|.+...... ......+.+|++++++++|||++++++++.+.+..++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 477889999999999999965 47899999998654322 3346789999999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++++|.+++.... ...+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.++......
T Consensus 80 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 80 YAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred eCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 999999999997542 34688999999999999999999998 99999999999999999999999999998776544
Q ss_pred CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhH
Q 002069 861 SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (973)
.......|++.|+|||+..+..++.++||||||+++|+|++|+.||...... ...........+... .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~~~~---~ 223 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---------ALILKIIRGVFPPVS---Q 223 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHcCCCCCCc---c
Confidence 4444557889999999999988999999999999999999999999744311 111111111111111 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 941 DKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 941 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=316.92 Aligned_cols=260 Identities=23% Similarity=0.292 Sum_probs=209.3
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||.||+|... +|+.||+|.++..........+.+.+|++++++++|++++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999665 89999999987543333334678999999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCcc-ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 780 EYLEMGSLAMILSNDAA-AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
||+++++|.+++..... ...+++.+++.++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999865322 34578999999999999999999999 999999999999999999999999999886654
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.........+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... ............+...
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~-- 229 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-------YSLCKKIEKCDYPPLP-- 229 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH-------HHHHhhhhcCCCCCCC--
Confidence 4333344568899999999998889999999999999999999999986332100 0011111111111100
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.......+.+++.+||+.+|++||++.+|++.++
T Consensus 230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~ 263 (267)
T cd08224 230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAK 263 (267)
T ss_pred hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHH
Confidence 1123446789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=317.29 Aligned_cols=253 Identities=26% Similarity=0.412 Sum_probs=203.3
Q ss_pred cCCcccccccCCCceeEEEEEcC----CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP----TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (973)
++|++.+.||+|+||+||+|.++ +...||||.+..... .....+|.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 56889999999999999999764 245799999875432 233578899999999999999999999999989999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
+||||+++++|.+++.... ..+++.++++++.|++.|++|||+. +|+||||||+||+++.++.++++|||.++..
T Consensus 82 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 82 IITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999997543 3688999999999999999999998 9999999999999999999999999999877
Q ss_pred cCCCCc--ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 857 KLGLSN--RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 857 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
...... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ............
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---------~~~~~~~~~~~~ 227 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---------DVIKAVEDGYRL 227 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---------HHHHHHHcCCCC
Confidence 522211 122345678999999998889999999999999999998 99998532211 011111111000
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
... ...+..+.+++.+||+.+|++||++++|++.|+
T Consensus 228 ~~~---~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~ 263 (266)
T cd05033 228 PPP---MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263 (266)
T ss_pred CCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 000 123446789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=324.82 Aligned_cols=263 Identities=20% Similarity=0.309 Sum_probs=195.2
Q ss_pred cCCcccccccCCCceeEEEEEc-C-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC---CCCceeeeceeee-----
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-P-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI---RHRNIVKFYGFCS----- 770 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~----- 770 (973)
++|++.+.||+|+||+||+|.. . +++.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 3689999999999999999965 3 56889999987543222 1234556677666655 7999999999885
Q ss_pred ccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecc
Q 002069 771 HALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDF 850 (973)
Q Consensus 771 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df 850 (973)
.....++||||++ ++|.+++.... ...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 2446899999997 68999886543 23578999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh--hhhh----hhhhh
Q 002069 851 GISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS--LSSN----LNIAL 924 (973)
Q Consensus 851 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~--~~~~----~~~~~ 924 (973)
|.++..... .......|++.|+|||.+.+..++.++|||||||++|||++|++||......... .... .....
T Consensus 155 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 155 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred cceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 999866543 2334457899999999998888999999999999999999999999754321100 0000 00000
Q ss_pred -------hhhcCCCCCCCchh-hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 925 -------DEMLDPRLPTPLRN-VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 925 -------~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+........ .......+.+++.+|++.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00000110110000 01223456789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=329.20 Aligned_cols=244 Identities=24% Similarity=0.312 Sum_probs=195.4
Q ss_pred ccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEEEEEecCC
Q 002069 707 HCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
+.||+|+||+||+|... +++.||||++.............+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999654 6889999998754322223346677888888877 799999999999999999999999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccc
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 864 (973)
++|.+++.+.. .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence 99999886543 588999999999999999999999 999999999999999999999999999875433333334
Q ss_pred ccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHH
Q 002069 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLI 944 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (973)
...|++.|+|||++.+..++.++||||+||++|||++|+.||....... ............+ .....
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---------~~~~i~~~~~~~~----~~~~~ 221 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---------LFQSILEDEVRYP----RWLSK 221 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---------HHHHHHcCCCCCC----CcCCH
Confidence 4568999999999999999999999999999999999999997443211 1111111111111 11234
Q ss_pred HHHHHHhcccCCCCCCCCCH-----HHHHH
Q 002069 945 SIMEVSISCLDESPTSRPTM-----QKVSQ 969 (973)
Q Consensus 945 ~l~~li~~cl~~dP~~RPs~-----~ev~~ 969 (973)
.+.+++.+||+.||.+||++ .++++
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 57889999999999999999 87765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=326.87 Aligned_cols=201 Identities=25% Similarity=0.362 Sum_probs=175.3
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 368999999999999999999664 788999998875422 23357789999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.++++... .+++..+..++.|++.|++|||+.. +++||||||+||+++.++.+|++|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 82 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999999997543 4788999999999999999999852 799999999999999999999999999876543
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcch
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFI 909 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 909 (973)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred h--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 2 223356899999999999888999999999999999999999998743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=334.46 Aligned_cols=240 Identities=23% Similarity=0.299 Sum_probs=189.7
Q ss_pred ccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHH-HhhcCCCCceeeeceeeeccceeEEEEEecCC
Q 002069 707 HCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGN-ALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
+.||+|+||+||+|.. .+|+.||+|++.............+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999965 478999999986432222222345555554 46788999999999999999999999999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccc
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 864 (973)
|+|.++++.. ..+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence 9999998654 3578899999999999999999999 999999999999999999999999999876443333344
Q ss_pred ccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHH
Q 002069 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLI 944 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (973)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .............. .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---------~~~~~i~~~~~~~~----~~~~~ 221 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---------EMYDNILNKPLRLK----PNISV 221 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH---------HHHHHHHcCCCCCC----CCCCH
Confidence 567999999999999999999999999999999999999999743211 11111111111111 11234
Q ss_pred HHHHHHhcccCCCCCCCCCHH
Q 002069 945 SIMEVSISCLDESPTSRPTMQ 965 (973)
Q Consensus 945 ~l~~li~~cl~~dP~~RPs~~ 965 (973)
.+.+++.+|++.||.+||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCC
Confidence 577899999999999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=343.76 Aligned_cols=251 Identities=21% Similarity=0.203 Sum_probs=201.7
Q ss_pred cCCcccccccCCCceeEEEEEcC-C-CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-T-GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
..|.+.+.||+|+||.||+|... + ++.||+|.+... .......+..|+.+++.++|||||++++++..++..++|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 34899999999999999999543 4 678899876543 223346778899999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 779 YEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
|||+++|+|.++++... ...++++.++..++.|++.||+|+|+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 99999999999886432 234688999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 858 LGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 858 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...............
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---------~~~~~~~~~~~~~~~ 291 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---------REIMQQVLYGKYDPF 291 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHhCCCCCC
Confidence 4322 23345699999999999999999999999999999999999999974321 111111111111111
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
. ...+..+.+++.+||+.||++||+++++++
T Consensus 292 ~---~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 P---CPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred C---ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1 112345788999999999999999999875
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=327.98 Aligned_cols=241 Identities=24% Similarity=0.342 Sum_probs=192.0
Q ss_pred ccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEEEEEecCC
Q 002069 707 HCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
+.||+|+||.||+|... +|+.||+|+++............+..|..++... +||+|+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999664 7899999998753221122245566777777654 899999999999999999999999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccc
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 864 (973)
|+|.+++... ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++..........
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 9999988653 3578899999999999999999999 999999999999999999999999999875433333445
Q ss_pred ccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhc--CCCCCCCchhhHHH
Q 002069 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML--DPRLPTPLRNVQDK 942 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 942 (973)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... ....... .+.++.. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---------~~~~~~~~~~~~~~~~------~ 219 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---------ELFESIRVDTPHYPRW------I 219 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---------HHHHHHHhCCCCCCCC------C
Confidence 567999999999999999999999999999999999999999743321 1111111 1122211 2
Q ss_pred HHHHHHHHhcccCCCCCCCCCHH-HHH
Q 002069 943 LISIMEVSISCLDESPTSRPTMQ-KVS 968 (973)
Q Consensus 943 ~~~l~~li~~cl~~dP~~RPs~~-ev~ 968 (973)
...+.+++.+|++.||.+||++. ++.
T Consensus 220 ~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 220 TKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 33567899999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=330.81 Aligned_cols=244 Identities=25% Similarity=0.351 Sum_probs=192.0
Q ss_pred ccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhc-CCCCceeeeceeeeccceeEEEEEecCC
Q 002069 707 HCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTK-IRHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
+.||+|+||+||+|... +++.||||+++............+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999654 688999999875322112223556677777775 4999999999999999999999999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccc
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 864 (973)
|+|.+++... ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 9999998653 3578899999999999999999999 999999999999999999999999999875433333344
Q ss_pred ccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHH
Q 002069 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLI 944 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (973)
...||+.|+|||++.+..++.++||||+||++|||++|+.||....... . .... ....+.++.. ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~----~~~i-~~~~~~~~~~------~~~ 221 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--L----FQSI-RMDNPCYPRW------LTR 221 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--H----HHHH-HhCCCCCCcc------CCH
Confidence 5678999999999999899999999999999999999999997433110 0 0000 0111122211 223
Q ss_pred HHHHHHhcccCCCCCCCCCHH-HHHH
Q 002069 945 SIMEVSISCLDESPTSRPTMQ-KVSQ 969 (973)
Q Consensus 945 ~l~~li~~cl~~dP~~RPs~~-ev~~ 969 (973)
.+.+++.+||+.||++||++. ++.+
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHHc
Confidence 467889999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=329.72 Aligned_cols=257 Identities=23% Similarity=0.386 Sum_probs=200.8
Q ss_pred hcCCcccccccCCCceeEEEEEc------CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeecc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHA 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 772 (973)
.++|++.+.||+|+||.||+|.. .+++.||+|++...... ...+.+..|+.++.++ +|+||++++++|...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA--SEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH--HHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 45799999999999999999953 23578999998754322 2346788899999999 899999999988654
Q ss_pred -ceeEEEEEecCCCChHHHhccCcc-------------------------------------------------------
Q 002069 773 -LHSFVVYEYLEMGSLAMILSNDAA------------------------------------------------------- 796 (973)
Q Consensus 773 -~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 796 (973)
...++||||+++++|.+++.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 567899999999999999854321
Q ss_pred ---ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC--cccccccccC
Q 002069 797 ---AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS--NRTELAGTFG 871 (973)
Q Consensus 797 ---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~ 871 (973)
..++++.++..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++.+..... ......++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 13678999999999999999999999 999999999999999999999999999987643322 1223456778
Q ss_pred cccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHH
Q 002069 872 YIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVS 950 (973)
Q Consensus 872 y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 950 (973)
|+|||++.+..++.++|||||||++|||++ |..||........ .............+ ......+.+++
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~------~~~~~~~~~l~ 309 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-----FCRRLKEGTRMRAP------EYATPEIYSIM 309 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-----HHHHHhccCCCCCC------ccCCHHHHHHH
Confidence 999999999999999999999999999998 9999864221100 00111111111111 11234578999
Q ss_pred hcccCCCCCCCCCHHHHHHHhc
Q 002069 951 ISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 951 ~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+||+.+|++||++.|++++|+
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~ 331 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILG 331 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.64 Aligned_cols=366 Identities=29% Similarity=0.400 Sum_probs=233.2
Q ss_pred CCCCCCCEEECCCCccc-ccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccc
Q 002069 21 GHLTHLKLLSFSKNQLS-GLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLS 99 (973)
Q Consensus 21 ~~l~~L~~L~l~~n~l~-~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 99 (973)
+-|+.++-.|+++|.++ +.+|.....++++++|.|...++. .+|+.++.|.+|++|.+++|+++ .+-..+..|+.|+
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LR 81 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLR 81 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence 34555666677777766 456777777777777777777776 67777777777777777777776 5556666677777
Q ss_pred eeeccCCcCCCC-CCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeeccc
Q 002069 100 DLRLSNNSLNGS-IPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGIN 178 (973)
Q Consensus 100 ~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n 178 (973)
.+++.+|++... +|..+..+..|..|||++|+++ ..|..+..-+++-.|+||+|+|..++..-|-+|+.|-.|+|++|
T Consensus 82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~N 160 (1255)
T KOG0444|consen 82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNN 160 (1255)
T ss_pred HHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccc
Confidence 777777776532 5666777777777777777776 67777777777777777777776444455667777777777777
Q ss_pred ccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccC-CCCCccccccccccceecccccccCCCC
Q 002069 179 ALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALS-GLIPNEIGNLKSLLALQLNYNTLSGSIP 257 (973)
Q Consensus 179 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 257 (973)
++. .+|..+..|..|++|+|++|.+.......+..+++|++|.+++.+-+ .-+|..+..+.+|..+|+|.|.+. ..|
T Consensus 161 rLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vP 238 (1255)
T KOG0444|consen 161 RLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVP 238 (1255)
T ss_pred hhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cch
Confidence 777 67777777778888888888777666666777777777777776544 225677777778888888888776 444
Q ss_pred cccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCC-CCCccccCCC
Q 002069 258 CSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSG-SIPNEITNLR 336 (973)
Q Consensus 258 ~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~ 336 (973)
..+-++.+|+.|+|++|.|+... -..+.+.+|++|+++.|+++ ..|..++.+++|+.|++.+|+++- -+|..++.+.
T Consensus 239 ecly~l~~LrrLNLS~N~iteL~-~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~ 316 (1255)
T KOG0444|consen 239 ECLYKLRNLRRLNLSGNKITELN-MTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLI 316 (1255)
T ss_pred HHHhhhhhhheeccCcCceeeee-ccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhh
Confidence 44444444444444444444321 22334445555566666555 455555555555555555555542 2455555555
Q ss_pred CCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccc
Q 002069 337 SLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENS 395 (973)
Q Consensus 337 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~ 395 (973)
+|+.+..++|.+. ..|..++.+.+|+.|.|++|++- ..|.++.-++.|+.||+.+|.
T Consensus 317 ~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 317 QLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred hhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence 5555555555554 45555555555555555555554 345555555555555555553
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=339.40 Aligned_cols=252 Identities=20% Similarity=0.256 Sum_probs=194.4
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
.|+..+.||+|+||+||+|.. .+++.||+|++.............+.+|+.++++++|+||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588999999999999999955 5788999999875322223345678899999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++|+|.+++.+.. .+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999986543 578899999999999999999999 99999999999999999999999999975331100
Q ss_pred -----------------------------------------------CcccccccccCcccccccccCCCCCccchHHHH
Q 002069 861 -----------------------------------------------SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFG 893 (973)
Q Consensus 861 -----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG 893 (973)
.......||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 001124689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCC---HHHHHH
Q 002069 894 VLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPT---MQKVSQ 969 (973)
Q Consensus 894 ~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev~~ 969 (973)
|++|||++|+.||......... ............+.. ........+++.+|+ .+|.+|++ ++++++
T Consensus 236 vil~elltG~~Pf~~~~~~~~~-----~~i~~~~~~~~~p~~----~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQ-----MKVINWQTSLHIPPQ----AKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHH-----HHHHccCCCcCCCCc----ccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 9999999999999754321110 000000001111111 112233556666665 49999987 887765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=340.88 Aligned_cols=253 Identities=20% Similarity=0.234 Sum_probs=195.5
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|++.+.||+|+||.||+|+. .+++.||||++.............+.+|++++++++|+||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 689999999999999999965 4789999999864322222234678899999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++|+|.+++.+.. .+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999996543 578889999999999999999999 99999999999999999999999999975332100
Q ss_pred -------------------------------------------CcccccccccCcccccccccCCCCCccchHHHHHHHH
Q 002069 861 -------------------------------------------SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLAL 897 (973)
Q Consensus 861 -------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 897 (973)
.......||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0011346999999999999999999999999999999
Q ss_pred HHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCC---CHHHHHHH
Q 002069 898 EVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRP---TMQKVSQL 970 (973)
Q Consensus 898 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ev~~~ 970 (973)
||++|+.||......... ...........++.. ......+.+++.+|+ .+|.+|+ ++.++++.
T Consensus 236 ell~G~~Pf~~~~~~~~~-----~~i~~~~~~~~~~~~----~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAETQ-----LKVINWETTLHIPSQ----AKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHHH-----HHHhccCccccCCCC----CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999999754321100 000000000011111 112234566777766 4999999 88988764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=319.52 Aligned_cols=248 Identities=23% Similarity=0.286 Sum_probs=194.7
Q ss_pred ccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCCCCh
Q 002069 709 IGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 787 (973)
Q Consensus 709 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 787 (973)
||+|+||+||+++. .+|+.||+|++.............+..|++++++++||||+++++++..+.+.++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999965 47899999998643322222345566799999999999999999999999999999999999999
Q ss_pred HHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCcccccc
Q 002069 788 AMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA 867 (973)
Q Consensus 788 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 867 (973)
.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+...... .......
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRA 155 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeeccC
Confidence 98886443 23478899999999999999999999 9999999999999999999999999998876543 2223456
Q ss_pred cccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHH
Q 002069 868 GTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIM 947 (973)
Q Consensus 868 g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 947 (973)
|++.|+|||++.+..++.++||||+||++|||++|+.||........ ................. ......+.
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~---~~~~~~~~ 227 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-----KEELKRRTLEDEVKFEH---QNFTEESK 227 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-----HHHHHHHhhcccccccc---ccCCHHHH
Confidence 89999999999988899999999999999999999999864321100 01111111222221111 12234578
Q ss_pred HHHhcccCCCCCCCCCHHHHHH
Q 002069 948 EVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 948 ~li~~cl~~dP~~RPs~~ev~~ 969 (973)
+++.+||+.||++||+++|+++
T Consensus 228 ~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 228 DICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHHhccCHhhCCCCccchh
Confidence 9999999999999999976554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=344.05 Aligned_cols=257 Identities=25% Similarity=0.274 Sum_probs=203.7
Q ss_pred HHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc---
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL--- 773 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--- 773 (973)
...++|++.+.||+|+||+||+|.. .+|+.||||++...... ......+.+|+..+..++|++++++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 3457999999999999999999954 58999999998754332 233567889999999999999999988764332
Q ss_pred -----eeEEEEEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEE
Q 002069 774 -----HSFVVYEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV 847 (973)
Q Consensus 774 -----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl 847 (973)
..++||||+++|+|.++++... ....+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 3579999999999999996533 234688999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCC--CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhh
Q 002069 848 SDFGISKFLKLGL--SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALD 925 (973)
Q Consensus 848 ~Dfg~a~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 925 (973)
+|||+++.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~---------~~~~~ 255 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM---------EEVMH 255 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---------HHHHH
Confidence 9999998764321 122345799999999999999999999999999999999999999974321 11111
Q ss_pred hhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 926 EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
........... ...+..+.+++.+||+.||.+||++.++++.
T Consensus 256 ~~~~~~~~~~~---~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 KTLAGRYDPLP---PSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHhcCCCCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111111111 1123457889999999999999999999764
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=332.50 Aligned_cols=240 Identities=24% Similarity=0.297 Sum_probs=193.6
Q ss_pred ccccCCCceeEEEEEc----CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEec
Q 002069 707 HCIGNGGQGSVYKAEL----PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYL 782 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 782 (973)
+.||+|+||.||+++. .+|+.||+|++...... ......+..|++++++++||||+++++++..++..|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999854 36889999998753221 122456778999999999999999999999999999999999
Q ss_pred CCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCc
Q 002069 783 EMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN 862 (973)
Q Consensus 783 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 862 (973)
++++|.+++.+. ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++........
T Consensus 81 ~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 81 RGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 999999998643 3578999999999999999999999 9999999999999999999999999999866544333
Q ss_pred ccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHH
Q 002069 863 RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDK 942 (973)
Q Consensus 863 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (973)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .............+ ...
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---------~~~~~i~~~~~~~p----~~~ 221 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---------ETMTMILKAKLGMP----QFL 221 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---------HHHHHHHcCCCCCC----CCC
Confidence 44567899999999999888999999999999999999999999743321 11111111111111 112
Q ss_pred HHHHHHHHhcccCCCCCCCCCHHH
Q 002069 943 LISIMEVSISCLDESPTSRPTMQK 966 (973)
Q Consensus 943 ~~~l~~li~~cl~~dP~~RPs~~e 966 (973)
...+.+++.+||+.||++||++.+
T Consensus 222 ~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 222 SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 335678999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=319.56 Aligned_cols=255 Identities=25% Similarity=0.434 Sum_probs=202.7
Q ss_pred hcCCcccccccCCCceeEEEEEc------CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 773 (973)
..+|.+.+.||+|+||.||++.. .++..||+|.+.... ....+.+.+|++++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 46788999999999999999963 234569999986532 233577999999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHhccCcc----------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAA----------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY 843 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~ 843 (973)
..++||||+++++|.+++..... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999999964431 23589999999999999999999999 999999999999999999
Q ss_pred ceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhh
Q 002069 844 EAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNL 920 (973)
Q Consensus 844 ~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~ 920 (973)
.+|++|||.++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-------- 229 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------- 229 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------
Confidence 999999999986543221 1223345778999999998889999999999999999998 99998643211
Q ss_pred hhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 921 NIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
................ ..+..+.+++.+||+.||.+|||+.++.+.|+
T Consensus 230 -~~~~~i~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~ 277 (288)
T cd05093 230 -EVIECITQGRVLQRPR---TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277 (288)
T ss_pred -HHHHHHHcCCcCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 1111111111111111 12345789999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=317.55 Aligned_cols=255 Identities=23% Similarity=0.353 Sum_probs=202.1
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
..+|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.++++++||||+++++++..++..++|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 35799999999999999999965 5789999999864322 2245678899999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.++++.. ..+++.++..++.|++.|++|||+. +|+|||++|+||+++.++.++++|||.+.....
T Consensus 85 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 85 MEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 9999999999998643 3578999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccCcccccccc---cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 859 GLSNRTELAGTFGYIAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
.........+++.|+|||.+. ...++.++||||+||++|||++|+.||.......... .........+..
T Consensus 159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~--- 231 (267)
T cd06646 159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF----LMSKSNFQPPKL--- 231 (267)
T ss_pred cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe----eeecCCCCCCCC---
Confidence 433334456889999999874 3457789999999999999999999985332111000 000000011111
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
......+..+.+++.+||+.+|++||+++++++.+
T Consensus 232 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 -KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11112335678999999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=315.25 Aligned_cols=252 Identities=24% Similarity=0.391 Sum_probs=202.6
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
..|++.+.||+|+||.||+|.. .+++.||+|++.... ...+++.+|++++++++|+||+++++++..+...++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 4578889999999999999955 468899999986432 22467899999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+++.... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+......
T Consensus 82 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 82 EFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999986543 24578999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcc-cccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 860 LSNR-TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 860 ~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
.... ....+++.|+|||.+.+..++.++|||||||++|||++ |..||....... . .........+..+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~-----~~~~~~~~~~~~~---- 227 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-V-----YELLEKGYRMERP---- 227 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-H-----HHHHHCCCCCCCC----
Confidence 2211 12234678999999998899999999999999999998 999986432110 0 0111111111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+..+.+++.+||+.||.+||++.++++.|+
T Consensus 228 --~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 260 (263)
T cd05052 228 --EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260 (263)
T ss_pred --CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 112345788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.98 Aligned_cols=255 Identities=21% Similarity=0.354 Sum_probs=201.3
Q ss_pred cCCcccccccCCCceeEEEEEc-----CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-----PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
..|++.+.||+|+||.||+|.. .+++.||+|.+..... ......+.+|+.++++++||||+++++++..+...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 5688889999999999999963 3567899999875322 22346788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHhccCcc--------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC
Q 002069 776 FVVYEYLEMGSLAMILSNDAA--------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL 841 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~ 841 (973)
|+||||+++++|.+++..... ...+++.+.+.++.|++.|++|||+. +++||||||+||+++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence 999999999999999853221 23478899999999999999999999 9999999999999999
Q ss_pred CCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhh
Q 002069 842 EYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSS 918 (973)
Q Consensus 842 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~ 918 (973)
++.+|++|||+++....... ......++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~------ 233 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ------ 233 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------
Confidence 99999999999986643321 1223445678999999988889999999999999999998 99998643210
Q ss_pred hhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 919 NLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
............... ...+..+.+++.+||+.||++||++.++.++|+
T Consensus 234 ---~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 234 ---EVIEMVRKRQLLPCS---EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred ---HHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 000111011111111 112345778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=335.12 Aligned_cols=259 Identities=19% Similarity=0.233 Sum_probs=200.8
Q ss_pred HHHHhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccce
Q 002069 696 IIRATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH 774 (973)
Q Consensus 696 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 774 (973)
.....++|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3445689999999999999999999664 788999999864322222334567889999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.++||||+++|+|.++++.. .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 99999999999999998643 478888999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCC-cccccccccCcccccccccCC----CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcC
Q 002069 855 FLKLGLS-NRTELAGTFGYIAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLD 929 (973)
Q Consensus 855 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 929 (973)
....... ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||...... .....++.
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---------~~~~~i~~ 261 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---------GTYSKIMN 261 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH---------HHHHHHHc
Confidence 7654322 233567999999999987543 788999999999999999999999743321 11111111
Q ss_pred CCCCCCchhhHHHHHHHHHHHhcccCCCCCC--CCCHHHHHHH
Q 002069 930 PRLPTPLRNVQDKLISIMEVSISCLDESPTS--RPTMQKVSQL 970 (973)
Q Consensus 930 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~ 970 (973)
.............+..+.+++.+|+..++.+ ||+++++++.
T Consensus 262 ~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 262 HKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1100001111123445678888999844443 7899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=313.75 Aligned_cols=252 Identities=22% Similarity=0.390 Sum_probs=203.6
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.++|++.++||+|+||.||+|..++++.||+|.+..... ...++.+|+.++++++|+|++++++++. .+..++||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 467899999999999999999888899999999875432 2467899999999999999999999875 45689999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+......
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 80 EYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 9999999999986543 34688999999999999999999998 9999999999999999999999999999776532
Q ss_pred CC-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 860 LS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 860 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
.. ......++..|+|||++.+..++.++||||||+++||+++ |+.||...... ..............+
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~~~~---- 225 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP------EVIQNLERGYRMPRP---- 225 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH------HHHHHHHcCCCCCCC----
Confidence 22 2223446778999999988889999999999999999999 99999743311 001111111111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+..+.+++.+|++.+|++||+++++.+.|+
T Consensus 226 --~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 226 --DNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred --CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence 112345889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=327.12 Aligned_cols=246 Identities=21% Similarity=0.284 Sum_probs=193.0
Q ss_pred ccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEEEEEecCC
Q 002069 707 HCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
+.||+|+||+||+|.. .+++.||+|++...........+.+..|+.++.++ +||+|+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999965 47889999999765433334456788899998888 699999999999999999999999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccc
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 864 (973)
++|.+++... ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence 9999888643 3589999999999999999999999 999999999999999999999999999875433333344
Q ss_pred ccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHH
Q 002069 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLI 944 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (973)
...||+.|+|||++.+..++.++|||||||++|||++|+.||+........ .................+ ...+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~p----~~~~~ 228 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM--NTEDYLFQVILEKPIRIP----RFLSV 228 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc--ccHHHHHHHHHhCCCCCC----CCCCH
Confidence 567999999999999999999999999999999999999999643211000 000011111111111111 11223
Q ss_pred HHHHHHhcccCCCCCCCCCH
Q 002069 945 SIMEVSISCLDESPTSRPTM 964 (973)
Q Consensus 945 ~l~~li~~cl~~dP~~RPs~ 964 (973)
.+.+++.+|++.||.+||++
T Consensus 229 ~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 229 KASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHHHHHhccCHHHcCCC
Confidence 46788999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=326.70 Aligned_cols=244 Identities=20% Similarity=0.289 Sum_probs=194.4
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeeccceeEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 779 (973)
+|+..+.||+|+||+||+|.. .+|+.||+|++...........+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999965 478999999987543222233466778888888875 577888999999888999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|+|.+++.... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999986543 588999999999999999999999 9999999999999999999999999998765433
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .............+
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---------~~~~~i~~~~~~~p---- 221 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---------ELFQSIMEHNVSYP---- 221 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---------HHHHHHHhCCCCCC----
Confidence 33344566999999999999989999999999999999999999999744321 11111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTM 964 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~ 964 (973)
......+.+++.+|++.+|.+|++.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1123356789999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=313.28 Aligned_cols=251 Identities=25% Similarity=0.407 Sum_probs=201.8
Q ss_pred cCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
.+|++.+.||+|+||.||+|.+++++.+|+|.+..... ....+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 35788999999999999999887778999999864322 13578889999999999999999999999889999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++++|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++......
T Consensus 80 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 80 YMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred cCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 999999999997543 2578999999999999999999999 99999999999999999999999999987654322
Q ss_pred Cc-ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 861 SN-RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 861 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.. .....++..|+|||.+.+..++.++||||||+++||+++ |+.||+....... ............+.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~---- 224 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV------VESVSAGYRLYRPK---- 224 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH------HHHHHcCCcCCCCC----
Confidence 11 112234567999999998889999999999999999999 8999874332110 01111111111111
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 225 --~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 225 --LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred --CCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 13446889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=325.98 Aligned_cols=252 Identities=23% Similarity=0.413 Sum_probs=199.1
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCC----EEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGE----IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
.+|+..+.||+|+||.||+|.+. +++ .||+|++..... ....+++.+|+.+++.++||||++++|++... ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 46899999999999999999653 343 489999875322 23357889999999999999999999999765 56
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++|+||+++|+|.+++.... ..+++..++.++.||+.|++|||+. +|+||||||+||+++.++.+||+|||.++.
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 79999999999999997543 3578899999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCcc--cccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 856 LKLGLSNR--TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 856 ~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
........ ....++..|+|||++.+..++.++|||||||++||+++ |+.||+...... ........ ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~--~~~ 230 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKG--ERL 230 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHhCC--CCC
Confidence 75432221 22334678999999999999999999999999999998 999987433110 01111111 111
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+.+ ..+...+.+++.+||+.+|.+||++.++++.+.
T Consensus 231 ~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~ 266 (316)
T cd05108 231 PQP----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 266 (316)
T ss_pred CCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 111 112345788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.19 Aligned_cols=266 Identities=20% Similarity=0.285 Sum_probs=204.6
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCc-eeeeceeeeccc----
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN-IVKFYGFCSHAL---- 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~---- 773 (973)
...|+.+++||+|+||+||+|+. .+|+.||+|++.-.... +..-....+|+.++++++|+| ||++++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45677888999999999999954 48899999998765432 112356689999999999999 999999997766
Q ss_pred --eeEEEEEecCCCChHHHhccCccc-cCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecc
Q 002069 774 --HSFVVYEYLEMGSLAMILSNDAAA-EEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDF 850 (973)
Q Consensus 774 --~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df 850 (973)
..++|+||++ .+|..++...... ..++...+..++.||+.|++|||++ +|+||||||+||+++.+|.+|++||
T Consensus 89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeecc
Confidence 7889999996 6899999765532 3456688999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhhhhhh
Q 002069 851 GISKFLKLGLSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSNLNIA 923 (973)
Q Consensus 851 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~~ 923 (973)
|+|+.+.-.....+..++|.-|.|||++.+. .|+...||||+||+++||++++.-|.+..+... ..+.-....
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 9999877555566777899999999998876 689999999999999999999998876543211 111100011
Q ss_pred hhhh---cCC--CCCCC-----chh-hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 924 LDEM---LDP--RLPTP-----LRN-VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 924 ~~~~---~~~--~~~~~-----~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
+... -+- .++.. ... .........+++.+|++.+|.+|.|++.++++
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0000 000 11100 000 01111357789999999999999999998874
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=321.04 Aligned_cols=252 Identities=24% Similarity=0.415 Sum_probs=204.6
Q ss_pred cCCcccccccCCCceeEEEEEcC---CCC--EEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP---TGE--IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
+.....+.||.|-||.||+|.+. .|+ .||||.-+... ..+..+.|.+|..+|+.++||||++++|+|.+. ..
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~ 465 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM 465 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence 34456678999999999999542 333 58899887643 333478999999999999999999999999876 68
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
|||||.++.|-|..|++.+. ..++......++.||+.|++|||+. ..|||||..+|||+.....||++|||+++.
T Consensus 466 WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence 99999999999999998665 4678888999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCcccc-cccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 856 LKLGLSNRTE-LAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 856 ~~~~~~~~~~-~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
+.++.+.... ..-+..|||||.+.-..++.+||||.|||++||++. |..||.+..+. .+-..++.. .++|
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs------DVI~~iEnG--eRlP 612 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS------DVIGHIENG--ERLP 612 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc------ceEEEecCC--CCCC
Confidence 9877554433 344779999999999999999999999999999986 99999855431 001111111 1222
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
. ++.++..++.++.+||..||.+||++.++...|.
T Consensus 613 ~----P~nCPp~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 613 C----PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred C----CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 2 2345556888999999999999999999987763
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=319.13 Aligned_cols=255 Identities=19% Similarity=0.310 Sum_probs=202.2
Q ss_pred cCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccce
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH 774 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 774 (973)
.+|++.+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++..++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 35778899999999999999642 357899999975432 2335778899999999999999999999999889
Q ss_pred eEEEEEecCCCChHHHhccCc-------------cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC
Q 002069 775 SFVVYEYLEMGSLAMILSNDA-------------AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL 841 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~ 841 (973)
.++++||+++++|.+++.... ....+++..+..++.|++.|++|+|+. +++||||||+||++++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFD 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecC
Confidence 999999999999999985321 123578889999999999999999999 9999999999999999
Q ss_pred CCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhh
Q 002069 842 EYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSS 918 (973)
Q Consensus 842 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~ 918 (973)
++.+|++|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------- 232 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------- 232 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence 99999999999886543321 1223456789999999988889999999999999999998 8888864321
Q ss_pred hhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 919 NLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.........+...... .+.+..+.+++.+||+.+|.+||++++|++.|+
T Consensus 233 --~~~~~~i~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 233 --QDVIEMIRNRQVLPCP---DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred --HHHHHHHHcCCcCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 1112222222211111 123445789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=332.39 Aligned_cols=252 Identities=22% Similarity=0.294 Sum_probs=197.2
Q ss_pred CCcccccccCCCceeEEEEEc----CCCCEEEEEEcCCCCC-cchhhHHHHHHHHHHhhcC-CCCceeeeceeeecccee
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL----PTGEIVAVKKFHSPLP-GEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 775 (973)
+|++.+.||+|+||.||+++. .+++.||+|++..... ......+.+..|+.+++.+ +|++|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999999854 3688999999864321 1222346678899999999 599999999999999999
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+++|+|.+++... ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999998643 3578999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCC-cccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhc--CCC
Q 002069 856 LKLGLS-NRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML--DPR 931 (973)
Q Consensus 856 ~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~ 931 (973)
+..... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||........ ......... ++.
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----~~~~~~~~~~~~~~ 229 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-----QSEVSRRILKCDPP 229 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-----HHHHHHHHhcCCCC
Confidence 543322 22345799999999998765 478899999999999999999999964321100 001111111 122
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRP-----TMQKVSQL 970 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 970 (973)
++.. ....+.+++.+|++.||++|| +++++++.
T Consensus 230 ~~~~------~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 230 FPSF------IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCC------CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 2211 233467889999999999999 67777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=313.46 Aligned_cols=251 Identities=21% Similarity=0.292 Sum_probs=203.6
Q ss_pred CCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|++.+.||+|+||.||++... +++.||+|.+..... ....+.+..|+.+++.++|+|++++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4788999999999999999654 789999999864432 2235778899999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|++++++.+++.... ...+++..++.++.|++.|++|||+. +++|+||||+||+++.++.++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 79 YCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 999999999886432 34578999999999999999999999 99999999999999999999999999998765443
Q ss_pred CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhH
Q 002069 861 SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (973)
.......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ............... .
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~~~~---~ 222 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK---------NLILKVCQGSYKPLP---S 222 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---------HHHHHHhcCCCCCCC---c
Confidence 3344567899999999999888999999999999999999999999743211 111111111111110 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 941 DKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 941 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+.+++.+||+.||++||++.+++..
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 123457789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=312.36 Aligned_cols=247 Identities=25% Similarity=0.414 Sum_probs=196.6
Q ss_pred ccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCCC
Q 002069 707 HCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMG 785 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 785 (973)
+.||+|+||.||+|.. .+++.||+|.+..... ......+.+|++++++++||||+++++++......++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 4699999999999965 4789999998865432 233577999999999999999999999999999999999999999
Q ss_pred ChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCcc--
Q 002069 786 SLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR-- 863 (973)
Q Consensus 786 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-- 863 (973)
+|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+..........
T Consensus 79 ~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 79 DFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred cHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 9999996543 3578999999999999999999999 99999999999999999999999999987654321111
Q ss_pred cccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHH
Q 002069 864 TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDK 942 (973)
Q Consensus 864 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (973)
....++..|+|||.+.+..++.++||||||+++|||++ |..||....... .............+ ...
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~------~~~~~~~~~~~~~~------~~~ 221 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ------TREAIEQGVRLPCP------ELC 221 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH------HHHHHHcCCCCCCc------ccC
Confidence 11223567999999998889999999999999999998 889986432110 01111111111111 122
Q ss_pred HHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 943 LISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 943 ~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+..+.+++.+|++.+|++|||+.++.+.|+
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 346788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=333.11 Aligned_cols=240 Identities=23% Similarity=0.291 Sum_probs=189.9
Q ss_pred ccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHH-HhhcCCCCceeeeceeeeccceeEEEEEecCC
Q 002069 707 HCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGN-ALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
+.||+|+||+||+|.. .+|+.||+|++.............+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999955 478999999986542222223455556654 46778999999999999999999999999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccc
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 864 (973)
|+|..++... ..+++.++..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 9999888643 3578999999999999999999999 999999999999999999999999999875433333444
Q ss_pred ccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHH
Q 002069 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLI 944 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (973)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...... ............... ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---------~~~~~~~~~~~~~~~----~~~~ 221 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---------EMYDNILHKPLVLRP----GASL 221 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---------HHHHHHHcCCccCCC----CCCH
Confidence 567999999999999999999999999999999999999999743211 111111111111110 1233
Q ss_pred HHHHHHhcccCCCCCCCCCHH
Q 002069 945 SIMEVSISCLDESPTSRPTMQ 965 (973)
Q Consensus 945 ~l~~li~~cl~~dP~~RPs~~ 965 (973)
.+.+++.+|++.+|.+||++.
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCC
Confidence 467889999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=330.89 Aligned_cols=240 Identities=23% Similarity=0.303 Sum_probs=188.6
Q ss_pred ccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHH-HhhcCCCCceeeeceeeeccceeEEEEEecCC
Q 002069 707 HCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGN-ALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
+.||+|+||.||+|+. .+++.||+|++.............+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999965 478999999986432222222345555554 57888999999999999999999999999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccc
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 864 (973)
++|..++... ..+++.++..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence 9999888643 3578889999999999999999998 999999999999999999999999999875433333334
Q ss_pred ccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHH
Q 002069 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLI 944 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (973)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...... .............+ .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~~~i~~~~~~~~----~~~~~ 221 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---------QMYDNILHKPLQLP----GGKTV 221 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---------HHHHHHhcCCCCCC----CCCCH
Confidence 567899999999999889999999999999999999999999743211 11111111111111 11233
Q ss_pred HHHHHHhcccCCCCCCCCCHH
Q 002069 945 SIMEVSISCLDESPTSRPTMQ 965 (973)
Q Consensus 945 ~l~~li~~cl~~dP~~RPs~~ 965 (973)
.+.+++.+|++.||.+||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCC
Confidence 577899999999999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=318.13 Aligned_cols=254 Identities=25% Similarity=0.473 Sum_probs=203.2
Q ss_pred cCCcccccccCCCceeEEEEEc------CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccce
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH 774 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 774 (973)
++|.+.+.||+|+||.||+|.. .++..|++|.+.... ....+.+.+|++++++++|+||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 5688889999999999999964 245569999986432 2334678999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHhccCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC
Q 002069 775 SFVVYEYLEMGSLAMILSNDAA-------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL 841 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~ 841 (973)
.++||||+++++|.+++..... ...+++.+++.++.|++.|++|||++ +++||||||+||+++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence 9999999999999999965432 23578999999999999999999999 9999999999999999
Q ss_pred CCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhh
Q 002069 842 EYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSS 918 (973)
Q Consensus 842 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~ 918 (973)
++.++++|||.+........ ......+++.|+|||++.+..++.++||||||+++|||+| |+.||......
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------ 232 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT------ 232 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------
Confidence 99999999999976543321 1233456788999999998889999999999999999999 99998643221
Q ss_pred hhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 919 NLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
............... ...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 233 ---~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~ 280 (291)
T cd05094 233 ---EVIECITQGRVLERP---RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280 (291)
T ss_pred ---HHHHHHhCCCCCCCC---ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 111111111111111 112345789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=331.83 Aligned_cols=241 Identities=23% Similarity=0.269 Sum_probs=188.6
Q ss_pred ccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHH-HhhcCCCCceeeeceeeeccceeEEEEEecCC
Q 002069 707 HCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGN-ALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
+.||+|+||+||+|... +++.||+|++.............+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999654 67899999986432211222334444443 56788999999999999999999999999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccc
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 864 (973)
++|.+++... ..+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 9999998653 3577888999999999999999999 999999999999999999999999999976543333344
Q ss_pred ccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHH
Q 002069 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLI 944 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (973)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... .............. .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~~~i~~~~~~~~----~~~~~ 221 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---------EMYDNILNKPLQLK----PNITN 221 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---------HHHHHHHhCCcCCC----CCCCH
Confidence 567999999999999999999999999999999999999999743321 11111111111111 11233
Q ss_pred HHHHHHhcccCCCCCCCCCHHH
Q 002069 945 SIMEVSISCLDESPTSRPTMQK 966 (973)
Q Consensus 945 ~l~~li~~cl~~dP~~RPs~~e 966 (973)
.+.+++.+|++.||.+||++.+
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCCC
Confidence 5678899999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=319.32 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=203.9
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
..+|++.+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.+++.++|+|++++++++..+...++|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 35899999999999999999964 57899999998754322 246788999999999999999999999998999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.++++.. .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+.....
T Consensus 96 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred ecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 9999999999998642 478899999999999999999999 999999999999999999999999999886654
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.........+++.|+|||.+.+..++.++|||||||++|+|++|+.||.......... .....+... ...
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~--------~~~~~~~~~--~~~ 238 (296)
T cd06654 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY--------LIATNGTPE--LQN 238 (296)
T ss_pred cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH--------HHhcCCCCC--CCC
Confidence 4333344578899999999998889999999999999999999999997443211100 000111100 011
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.......+.+++.+||..||++||++.++++.
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 12234557889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=311.46 Aligned_cols=251 Identities=27% Similarity=0.465 Sum_probs=202.6
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.++|++.+.||+|+||.||+|..+++..||+|.+...... .+.+.+|+.++++++|++++++++++.+ ...++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVT 79 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEE
Confidence 4578999999999999999998888889999998754322 3678999999999999999999998854 4678999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.++++... ...+++.+++.++.|++.|++|||+. +++||||||+||++++++.++++|||.+......
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 80 EYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 9999999999997543 24578999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc-ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCC-CCCCCc
Q 002069 860 LSN-RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDP-RLPTPL 936 (973)
Q Consensus 860 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 936 (973)
... .....++..|+|||+..+..++.++||||||+++|||++ |..||...... ......... ..+.+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---------~~~~~~~~~~~~~~~- 225 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---------EVLEQVERGYRMPCP- 225 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---------HHHHHHHcCCCCCCC-
Confidence 221 122345678999999988889999999999999999999 89998643211 111111111 11111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+..+.+++.+|++.+|.+|||+.++.+.|+
T Consensus 226 ---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 258 (260)
T cd05070 226 ---QDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258 (260)
T ss_pred ---CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 123446889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=312.61 Aligned_cols=252 Identities=25% Similarity=0.407 Sum_probs=201.8
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
..+|++.++||+|+||+||+|...++..||+|++..... ..+.+.+|++++++++|+||+++++++.+ +..++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence 356999999999999999999877767899999875322 23678999999999999999999998754 4678999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.++++... ...+++..+..++.|++.|++|+|+. +++||||||+||+++.++.++++|||.++.....
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 80 EYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999997543 23578999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc-ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 860 LSN-RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 860 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
... .....++..|+|||+..+..++.++||||||+++|||+| |+.||...... ......... .....
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---------~~~~~~~~~-~~~~~- 224 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERG-YRMPC- 224 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---------HHHHHHhcC-CCCCC-
Confidence 322 123446778999999988889999999999999999999 88888643211 001111111 00000
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
....+..+.+++.+|++.||++||+++++++.|+
T Consensus 225 -~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~ 258 (262)
T cd05071 225 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258 (262)
T ss_pred -ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 1234456789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=319.90 Aligned_cols=263 Identities=23% Similarity=0.374 Sum_probs=203.4
Q ss_pred hcCCcccccccCCCceeEEEEEcCC-----------------CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCce
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPT-----------------GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 762 (973)
..+|++.+.||+|+||.||+|.... +..||+|++...... ...+.+.+|++++++++|||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence 4679999999999999999986532 246899998754332 346789999999999999999
Q ss_pred eeeceeeeccceeEEEEEecCCCChHHHhccCcc--------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCC
Q 002069 763 VKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAA--------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISS 834 (973)
Q Consensus 763 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~ 834 (973)
+++++++..++..++||||+++++|.+++..... ...+++..++.++.|++.|++|||+. +++||||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp 158 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLAT 158 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccch
Confidence 9999999998999999999999999999965431 22578999999999999999999998 999999999
Q ss_pred CCeeecCCCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh--CCCCCcchh
Q 002069 835 KNVLLNLEYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFIS 910 (973)
Q Consensus 835 ~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t--g~~p~~~~~ 910 (973)
+||+++.++.++++|||.++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 999999999999999999876543321 1223456788999999988889999999999999999998 777876432
Q ss_pred hhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 911 SICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.... . ......................+.++.+++.+|++.||.+|||+.++++.|+
T Consensus 239 ~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 DQQV-I----ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred hHHH-H----HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1110 0 0000000000000000011122346889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=319.14 Aligned_cols=254 Identities=24% Similarity=0.366 Sum_probs=197.9
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCC--EEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGE--IVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 776 (973)
++|++.+.||+|+||.||+|... ++. .+++|.++.... ....+.+.+|+.++.++ +||||+++++++...+..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS--ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC--HHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 57899999999999999999654 333 578888874322 22356789999999999 7999999999999888999
Q ss_pred EEEEecCCCChHHHhccCc-------------cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC
Q 002069 777 VVYEYLEMGSLAMILSNDA-------------AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY 843 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~ 843 (973)
+||||+++++|.+++.... ....+++.+++.++.|++.|++|||+. +++||||||+||+++.++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCC
Confidence 9999999999999996533 113578999999999999999999998 999999999999999999
Q ss_pred ceEEecccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhh
Q 002069 844 EAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNI 922 (973)
Q Consensus 844 ~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 922 (973)
.+|++|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |..||....... ...
T Consensus 157 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-----~~~- 229 (297)
T cd05089 157 ASKIADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-----LYE- 229 (297)
T ss_pred eEEECCcCCCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHH-
Confidence 9999999998643221 11112233567999999988889999999999999999997 999986432110 000
Q ss_pred hhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 923 ALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..........+. ..+..+.+++.+||+.+|.+||+++++++.|+
T Consensus 230 ~~~~~~~~~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 273 (297)
T cd05089 230 KLPQGYRMEKPR------NCDDEVYELMRQCWRDRPYERPPFAQISVQLS 273 (297)
T ss_pred HHhcCCCCCCCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111111111111 12345789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=322.44 Aligned_cols=262 Identities=18% Similarity=0.261 Sum_probs=199.1
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|.+.+.||+|+||+||+|..+ +++.||+|++....... ....+.+|+.++++++||||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 57999999999999999999654 78899999987543222 2356778999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++ ++.+++.... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.....
T Consensus 84 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 84 EYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred eCCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 99985 8888875443 3578899999999999999999999 9999999999999999999999999999765443
Q ss_pred CCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhh------hhhhhhhhhhhh-------
Q 002069 860 LSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSIC------SSLSSNLNIALD------- 925 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~------~~~~~~~~~~~~------- 925 (973)
........+++.|+|||++.+ ..++.++||||+||++|||+||+.||....... ............
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 333344568899999998865 457899999999999999999999996432110 000000000000
Q ss_pred --hhcCCCC-CCC-chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 926 --EMLDPRL-PTP-LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 926 --~~~~~~~-~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
....+.. +.. .........++.+++.+|++.||.+|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000100 000 00111223457799999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=310.25 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=207.2
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|+..+.||+|+||.||.++. .+++.|++|.+....... ....++.+|++++++++|+||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 588899999999999999954 578999999986543222 335678899999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++++|.+++.+.. ...+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.+|++|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 80 YANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred ecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999999997553 34678999999999999999999998 99999999999999999999999999998765544
Q ss_pred CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhH
Q 002069 861 SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (973)
.......+++.|+|||+..+..++.++||||||+++|||++|+.||+.... ................ .
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~~---~ 223 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---------LNLVVKIVQGNYTPVV---S 223 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH---------HHHHHHHHcCCCCCCc---c
Confidence 334456789999999999888889999999999999999999999864221 1111112222221111 2
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 941 DKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 941 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
.....+.+++.+||+.+|.+||+++++++..
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 2344577899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.30 Aligned_cols=254 Identities=21% Similarity=0.259 Sum_probs=199.9
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
.|+..+.||+|+||+||+|.. .+++.||+|.+.............+.+|++++++++|++++++.+++..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 367778999999999999955 4789999999865433333334567889999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++|||.+......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~- 155 (285)
T cd05632 81 IMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG- 155 (285)
T ss_pred eccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC-
Confidence 999999998886433 23589999999999999999999999 9999999999999999999999999998765432
Q ss_pred CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhH
Q 002069 861 SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (973)
.......|+..|+|||++.+..++.++||||+||++|||++|..||......... .............. ..
T Consensus 156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~-----~~~~~~~~~~~~~~----~~ 226 (285)
T cd05632 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR-----EEVDRRVLETEEVY----SA 226 (285)
T ss_pred CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHHhhhcccccc----Cc
Confidence 2223457899999999999888999999999999999999999999743321100 00111111111000 01
Q ss_pred HHHHHHHHHHhcccCCCCCCCCC-----HHHHHH
Q 002069 941 DKLISIMEVSISCLDESPTSRPT-----MQKVSQ 969 (973)
Q Consensus 941 ~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~ 969 (973)
.....+.+++..|++.||++||+ +.++++
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 227 KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 12334678999999999999999 667664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=330.77 Aligned_cols=259 Identities=22% Similarity=0.344 Sum_probs=203.2
Q ss_pred HHhcCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeee
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCS 770 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~ 770 (973)
...++|.+.+.||+|+||.||+|.+. .++.||||+++..... ...+.+.+|+.++.++. ||||+++++++.
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 34457888999999999999999753 3468999999765332 22457889999999997 999999999999
Q ss_pred ccceeEEEEEecCCCChHHHhccCcc------------------------------------------------------
Q 002069 771 HALHSFVVYEYLEMGSLAMILSNDAA------------------------------------------------------ 796 (973)
Q Consensus 771 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------ 796 (973)
.++..++||||+++|+|.+++++...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 98899999999999999999965321
Q ss_pred -----------------------------------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCC
Q 002069 797 -----------------------------------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSK 835 (973)
Q Consensus 797 -----------------------------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~ 835 (973)
...+++..++.++.|++.|++|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 12367788899999999999999998 9999999999
Q ss_pred CeeecCCCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhh
Q 002069 836 NVLLNLEYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSI 912 (973)
Q Consensus 836 Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~ 912 (973)
||+++.++.+|++|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986543211 1223457889999999998889999999999999999998 89998643311
Q ss_pred hhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 913 CSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
... .........+..+. .....+.+++.+||+.+|.+||+++++++.|+
T Consensus 349 ~~~-----~~~~~~~~~~~~p~------~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 397 (401)
T cd05107 349 EQF-----YNAIKRGYRMAKPA------HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397 (401)
T ss_pred HHH-----HHHHHcCCCCCCCC------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 100 00111111111111 12345789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=319.48 Aligned_cols=263 Identities=21% Similarity=0.348 Sum_probs=200.7
Q ss_pred hcCCcccccccCCCceeEEEEEcCC---------------CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPT---------------GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK 764 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 764 (973)
..+|++.+.||+|+||.||++.... ...||+|+++.... ......|.+|++++++++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcCe
Confidence 3579999999999999999986532 23589999875432 233567999999999999999999
Q ss_pred eceeeeccceeEEEEEecCCCChHHHhccCcc---------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCC
Q 002069 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAA---------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSK 835 (973)
Q Consensus 765 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~ 835 (973)
+++++......++||||+++++|.+++..... ...+++.+++.++.|++.|++|||+. +++||||||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~ 158 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR 158 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence 99999999999999999999999999864321 12468899999999999999999999 9999999999
Q ss_pred CeeecCCCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh--CCCCCcchhh
Q 002069 836 NVLLNLEYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFISS 911 (973)
Q Consensus 836 Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t--g~~p~~~~~~ 911 (973)
||+++.++.+|++|||.+........ ......+++.|+|||+..+..++.++|||||||++|+|++ |..||.....
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 99999999999999999976543321 1122345778999999988889999999999999999998 6677764321
Q ss_pred hhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 912 ICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.. .... ................ ....+..+.+++.+||+.||++||++++|++.|+
T Consensus 239 ~~-~~~~-~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 EQ-VIEN-TGEFFRNQGRQIYLSQ---TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HH-HHHH-HHHhhhhccccccCCC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 10 0000 0000000000000000 0112346889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=318.95 Aligned_cols=262 Identities=23% Similarity=0.370 Sum_probs=201.4
Q ss_pred hcCCcccccccCCCceeEEEEEcC-----------------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCce
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-----------------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 762 (973)
.++|++.+.||+|+||.||+++.. ++..||+|++..... .....++.+|+.+++.++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN--KNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCc
Confidence 357999999999999999998532 234699999875422 2335789999999999999999
Q ss_pred eeeceeeeccceeEEEEEecCCCChHHHhccCcc--------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCC
Q 002069 763 VKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAA--------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISS 834 (973)
Q Consensus 763 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~ 834 (973)
+++++++...+..++||||+++++|.+++..... ...+++.++..++.|++.|++|||+. +++||||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp 158 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLAT 158 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCh
Confidence 9999999998999999999999999999965431 12477889999999999999999999 999999999
Q ss_pred CCeeecCCCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh--CCCCCcchh
Q 002069 835 KNVLLNLEYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFIS 910 (973)
Q Consensus 835 ~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t--g~~p~~~~~ 910 (973)
+||+++.++.++++|||.++.+..... ......+++.|+|||...+..++.++|||||||++|||++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 999999999999999999986543321 1122334678999999888889999999999999999998 778886433
Q ss_pred hhhhhhhhhhhhhhhhh-cCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 911 SICSSLSSNLNIALDEM-LDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 911 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
... ... ......... .....+.+ ...+..+.+++.+||+.||.+||++++|++.|+
T Consensus 239 ~~~-~~~-~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 239 DEQ-VIE-NTGEFFRDQGRQVYLPKP----ALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred hHH-HHH-HHHHHHhhccccccCCCC----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 211 000 000000000 00011111 112346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.36 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=203.9
Q ss_pred HHhcCCcccccccCCCceeEEEE-EcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec-----
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH----- 771 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----- 771 (973)
.....|...+.||+|+||.|+.| +..+|+.||||++...... ....++..+|+..++.++|+||+.+.+.+..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~-~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFEN-QIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhc-hHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 34456777899999999999999 4458999999999865443 3446888999999999999999999998854
Q ss_pred cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccc
Q 002069 772 ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFG 851 (973)
Q Consensus 772 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg 851 (973)
-...|+|+|+| +.+|...++... .++...+..++.|+++|+.|+|+. +|+|||+||.|++++.+...||+|||
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence 24679999999 478999997654 488899999999999999999999 99999999999999999999999999
Q ss_pred ccccccCC--CCcccccccccCcccccccc-cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhhhhh
Q 002069 852 ISKFLKLG--LSNRTELAGTFGYIAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSNLNI 922 (973)
Q Consensus 852 ~a~~~~~~--~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~ 922 (973)
+|+..... ....+..+-|.-|.|||.+. ...|+.+.||||.||++.||++|++-|.+.+...+ ..+.-..+
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 99987642 23456677899999999875 56799999999999999999999999876542210 00000000
Q ss_pred h--------hhhhc---CCCCCCCchh-hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 923 A--------LDEML---DPRLPTPLRN-VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 923 ~--------~~~~~---~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
. ....+ ....+.++.. .+.......+++.+|+..||.+|+|++|+++.
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 11111 1111111111 11223445688889999999999999999864
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=333.93 Aligned_cols=253 Identities=21% Similarity=0.265 Sum_probs=195.3
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|+..+.||+|+||+||+|.. .+++.||+|++.............+..|+.++.+++|++|+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688899999999999999965 478999999986432222333567888999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 999999999998654 3578999999999999999999999 9999999999999999999999999998754321
Q ss_pred CC-----------------------------------cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCC
Q 002069 860 LS-----------------------------------NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 904 (973)
Q Consensus 860 ~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~ 904 (973)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00 0113469999999999999999999999999999999999999
Q ss_pred CCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCC---HHHHHH
Q 002069 905 PRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPT---MQKVSQ 969 (973)
Q Consensus 905 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev~~ 969 (973)
||........ ............++... .....+.+++.+|+ .||.+|++ ++++.+
T Consensus 235 Pf~~~~~~~~-----~~~i~~~~~~~~~p~~~----~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 235 PFCSETPQET-----YRKVMNWKETLVFPPEV----PISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCHHHH-----HHHHHcCCCceecCCCC----CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 9974332110 00000000000111111 11234566777766 49999985 566654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=314.53 Aligned_cols=256 Identities=23% Similarity=0.340 Sum_probs=201.0
Q ss_pred hcCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 773 (973)
+++|++.+.||+|+||.||+|.+. .+..||+|.+.... .......|..|+.++++++|+||+++++++.+.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 567999999999999999999664 35689999886432 2233567999999999999999999999999888
Q ss_pred eeEEEEEecCCCChHHHhccCcc----ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC---ceE
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAA----AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY---EAH 846 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~---~~k 846 (973)
..++||||+++++|.+++..... ...+++.++++++.||+.|++|||+. +++||||||+||+++.++ .+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceE
Confidence 99999999999999999965542 23588999999999999999999999 999999999999998654 599
Q ss_pred EecccccccccCCCCc--ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhh
Q 002069 847 VSDFGISKFLKLGLSN--RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIA 923 (973)
Q Consensus 847 l~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 923 (973)
++|||.++........ ......+..|+|||++.+..++.++|||||||++|||++ |+.||+...... ....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------~~~~ 233 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VMEF 233 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHH
Confidence 9999999876332211 112234568999999998899999999999999999997 999987433110 0000
Q ss_pred hhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 924 LDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.........+ ...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 234 ~~~~~~~~~~------~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGGGRLDPP------KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcCCcCCCC------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1000011111 112345788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=319.17 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=203.3
Q ss_pred HhcCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeec
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSH 771 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 771 (973)
..++|++.+.||+|+||.||+|... ....||+|++...... .....+.+|+++++++ +|+||+++++++..
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3467899999999999999999653 2367999998754322 2346788999999999 89999999999999
Q ss_pred cceeEEEEEecCCCChHHHhccC-------------ccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCee
Q 002069 772 ALHSFVVYEYLEMGSLAMILSND-------------AAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVL 838 (973)
Q Consensus 772 ~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nil 838 (973)
.+..++||||+++++|.++++.. .....+++..++.++.|++.|++|||+. +++||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence 99999999999999999999643 2234688999999999999999999998 9999999999999
Q ss_pred ecCCCceEEecccccccccCCCCc--ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhh
Q 002069 839 LNLEYEAHVSDFGISKFLKLGLSN--RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSS 915 (973)
Q Consensus 839 l~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~ 915 (973)
++.++.+|++|||.++........ .....++..|+|||+..+..++.++|||||||++||+++ |..||.......
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 242 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-- 242 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--
Confidence 999999999999999876543221 122335678999999988889999999999999999997 999986432110
Q ss_pred hhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 916 LSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.............+ ......+.+++.+||+.||++|||+.++++.|+
T Consensus 243 ----~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~ 289 (293)
T cd05053 243 ----LFKLLKEGYRMEKP------QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289 (293)
T ss_pred ----HHHHHHcCCcCCCC------CCCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence 00011111111111 122345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=318.46 Aligned_cols=254 Identities=22% Similarity=0.285 Sum_probs=200.6
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
.|+..+.||+|+||.||+|.. .+++.||||.+.............+.+|+.++++++|++++++++++.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367788999999999999955 4789999999875433333334567889999999999999999999999899999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+.......
T Consensus 81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999999886433 23588999999999999999999998 99999999999999999999999999987654332
Q ss_pred CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhH
Q 002069 861 SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (973)
......|+..|+|||++.+..++.++||||+||++|+|++|+.||......... .......... ....+.
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~~~~~~~~~-~~~~~~------ 226 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKEV-QEEYSE------ 226 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HHHHhhhhhh-hhhcCc------
Confidence 223457899999999999989999999999999999999999999743211000 0000000100 111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCC-----HHHHHH
Q 002069 941 DKLISIMEVSISCLDESPTSRPT-----MQKVSQ 969 (973)
Q Consensus 941 ~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~ 969 (973)
.....+.+++.+||+.||.+||| ++|+++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 12334678999999999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=314.69 Aligned_cols=256 Identities=23% Similarity=0.325 Sum_probs=203.5
Q ss_pred hcCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 773 (973)
.++|++.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 457889999999999999999653 34689999986543 2233567889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHhccCcc-------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceE
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAA-------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAH 846 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~k 846 (973)
..++||||+++++|.+++..... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence 99999999999999999965432 22468899999999999999999998 999999999999999999999
Q ss_pred EecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhh
Q 002069 847 VSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIA 923 (973)
Q Consensus 847 l~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 923 (973)
++|||.++....... ......++..|+|||.+.+..++.++|||||||++||++| |..||....... ....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~~~ 233 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE------VLKF 233 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH------HHHH
Confidence 999999886644321 1223456789999999988889999999999999999998 999986332110 0001
Q ss_pred hhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 924 LDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.........+.. .+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 234 ~~~~~~~~~~~~------~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 234 VIDGGHLDLPEN------CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HhcCCCCCCCCC------CCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111101111111 2446789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=311.14 Aligned_cols=250 Identities=29% Similarity=0.430 Sum_probs=205.2
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|+..+.||+|+||.||+|... +++.||+|.+.... ..+++.+|++++++++|+|++++++++......++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 57899999999999999999765 48899999986431 1578999999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++|||++|+||+++.++.++++|||.+......
T Consensus 78 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 78 EYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred ecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 9999999999986433 4678999999999999999999999 9999999999999999999999999999877654
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
........++..|+|||++.+..++.++||||||+++|+|++|+.||.......... .. ...........
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~---------~~-~~~~~~~~~~~ 222 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF---------MI-PNKPPPTLSDP 222 (256)
T ss_pred ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh---------hh-ccCCCCCCCch
Confidence 333344568899999999998889999999999999999999999987433211100 00 00111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+.+++.+||+.||.+|||+.++++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 2234567899999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.16 Aligned_cols=245 Identities=26% Similarity=0.377 Sum_probs=194.2
Q ss_pred cccCCCceeEEEEEc---CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCC
Q 002069 708 CIGNGGQGSVYKAEL---PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 708 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
.||+|+||.||+|.+ .+++.||+|++..... .....+++.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 589999999999954 3678899999875432 23346789999999999999999999998864 467899999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCc--
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN-- 862 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-- 862 (973)
++|.+++.... .+++..+..++.|++.|++|+|+. +++||||||+||+++.++.+|++|||.++........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 80 GPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999996443 578999999999999999999999 9999999999999999999999999999876543221
Q ss_pred -ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhH
Q 002069 863 -RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940 (973)
Q Consensus 863 -~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (973)
.....+++.|+|||.+....++.++|||||||++|||++ |+.||...... .. .........+..+.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~----~~~i~~~~~~~~~~------ 221 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EV----TQMIESGERMECPQ------ 221 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HH----HHHHHCCCCCCCCC------
Confidence 122234678999999988888999999999999999998 99999743221 00 11111111111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 941 DKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 941 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+..+.++|.+||+.||++||++++|++.|+
T Consensus 222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~ 253 (257)
T cd05116 222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLR 253 (257)
T ss_pred CCCHHHHHHHHHHhccCchhCcCHHHHHHHHh
Confidence 12345788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=316.89 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=200.6
Q ss_pred CCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
+|++.+.||+|+||.||+|... ....||+|.+...... ....++.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH--HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 4788899999999999999542 2357999988754332 2347789999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHhccCc---------------------cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCC
Q 002069 776 FVVYEYLEMGSLAMILSNDA---------------------AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISS 834 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~ 834 (973)
++||||+++++|.+++.... ...++++.+++.++.|++.|++|||+. +++||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence 99999999999999986421 123578999999999999999999998 999999999
Q ss_pred CCeeecCCCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhh
Q 002069 835 KNVLLNLEYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISS 911 (973)
Q Consensus 835 ~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~ 911 (973)
+||++++++.+|++|||.++....... ......++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999976543222 1122345678999999988889999999999999999998 9999864321
Q ss_pred hhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 912 ICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
. ..............+ ......+.+++.+||+.+|++||+++++++.|+
T Consensus 236 ~------~~~~~~~~~~~~~~~------~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~ 284 (290)
T cd05045 236 E------RLFNLLKTGYRMERP------ENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284 (290)
T ss_pred H------HHHHHHhCCCCCCCC------CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 1 001111111111111 122346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=316.04 Aligned_cols=257 Identities=22% Similarity=0.349 Sum_probs=201.7
Q ss_pred HhcCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA 772 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 772 (973)
..++|++.+.||+|+||.||+|... .+..||+|.+..... ......+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3578999999999999999999542 245899999865432 23346788999999999999999999999988
Q ss_pred ceeEEEEEecCCCChHHHhccCcc-------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCce
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAA-------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEA 845 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~ 845 (973)
...++||||+++|+|.++++.... ....++..+..++.|++.|++|||++ +++||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 899999999999999999964321 23456788899999999999999999 99999999999999999999
Q ss_pred EEecccccccccCCCCc--ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhh
Q 002069 846 HVSDFGISKFLKLGLSN--RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNI 922 (973)
Q Consensus 846 kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 922 (973)
+++|||.++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---------~~ 229 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---------EQ 229 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---------HH
Confidence 99999998865432221 122345678999999998889999999999999999998 7889864221 11
Q ss_pred hhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 923 ALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.............. ...+..+.+++.+|++.||++|||+.++++.|+
T Consensus 230 ~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~ 276 (288)
T cd05061 230 VLKFVMDGGYLDQP---DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276 (288)
T ss_pred HHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 11111111111111 112346889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=316.64 Aligned_cols=264 Identities=20% Similarity=0.254 Sum_probs=200.5
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|++.+.||+|++|.||+|.. .+++.||+|++...... ....+.+.+|+.++++++|||++++++++.++...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 478889999999999999965 47899999998654322 2234678889999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|++ +++.+++........+++.+++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||.+.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 997 68888886555445789999999999999999999999 99999999999999999999999999998665443
Q ss_pred CcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh------hhhhhhh---------h
Q 002069 861 SNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL------SSNLNIA---------L 924 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~------~~~~~~~---------~ 924 (973)
.......+++.|+|||.+.+. .++.++|||||||++|+|+||+.||.......... ....... .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 333445678899999987654 46889999999999999999999997433211000 0000000 0
Q ss_pred hhhcCCCCCC-CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 925 DEMLDPRLPT-PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 925 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.......... ..........++.+++.+||+.||.+|||+.+|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000 000001123456789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.57 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=196.3
Q ss_pred CcccccccCCCceeEEEEEcCC-CC--EEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc------c
Q 002069 703 FDDEHCIGNGGQGSVYKAELPT-GE--IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA------L 773 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 773 (973)
|.+.+.||+|+||.||+|...+ ++ .||+|.++.... .....+.+..|+.+++.++|+||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567899999999999997643 33 699999875432 233357889999999999999999999987432 2
Q ss_pred eeEEEEEecCCCChHHHhccCc---cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDA---AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDF 850 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df 850 (973)
..++||||+++|+|.+++.... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence 4689999999999999874322 223578999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCc--ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhh
Q 002069 851 GISKFLKLGLSN--RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEM 927 (973)
Q Consensus 851 g~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 927 (973)
|.++........ .....+++.|+|||+..+..++.++||||||+++|||++ |+.||....... .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---------~~~~~ 227 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---------IYDYL 227 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---------HHHHH
Confidence 999876543221 122346778999999998889999999999999999999 889987433210 01111
Q ss_pred cCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 928 LDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
......... ...+..+.+++.+||+.||++|||++++++.|+
T Consensus 228 ~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 269 (272)
T cd05075 228 RQGNRLKQP---PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269 (272)
T ss_pred HcCCCCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 111111111 122345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.69 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=201.0
Q ss_pred cCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
++|++.+.||+|+||.||+|....+..||+|++..... ..+.+.+|+.++++++|++++++++++.. +..++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTE 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEE
Confidence 56889999999999999999887777899998764322 24678899999999999999999998754 56789999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++++|.++++... ...+++..+..++.|++.|++|||+. +++|+||||+||++++++.++++|||.++......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 81 FMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999997543 34578999999999999999999998 99999999999999999999999999998764432
Q ss_pred C-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 861 S-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 861 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
. ......++..|+|||...+..++.++||||||+++|||+| |+.||........ ............+
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~~----- 225 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV------LEQVERGYRMPCP----- 225 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcCCCCCCC-----
Confidence 2 1223346778999999988889999999999999999999 9999874332110 0011111111111
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+..+.+++.+||+.||.+||+++++++.|+
T Consensus 226 -~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 258 (260)
T cd05069 226 -QGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258 (260)
T ss_pred -cccCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 123456789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.59 Aligned_cols=247 Identities=24% Similarity=0.399 Sum_probs=198.7
Q ss_pred ccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCCCC
Q 002069 707 HCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGS 786 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 786 (973)
+.||+|+||.||+|...+++.||+|++...... .....+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ--ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCH--HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 469999999999998878999999998765332 234678899999999999999999999999999999999999999
Q ss_pred hHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCcc-cc
Q 002069 787 LAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR-TE 865 (973)
Q Consensus 787 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~ 865 (973)
|.+++.... ..+++.++..++.|++.|+.|+|+. +++||||||+||+++.++.+|++|||.+.......... ..
T Consensus 79 L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 79 FLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 999986543 3578999999999999999999998 99999999999999999999999999987654332211 12
Q ss_pred cccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHH
Q 002069 866 LAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLI 944 (973)
Q Consensus 866 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (973)
..+++.|+|||++.+..++.++||||||+++|++++ |..||........ ............+. ..+.
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~------~~~~ 221 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA------REQVEKGYRMSCPQ------KCPD 221 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH------HHHHHcCCCCCCCC------CCCH
Confidence 344678999999988889999999999999999998 9999864322110 00111111111111 1234
Q ss_pred HHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 945 SIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 945 ~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+.+++.+|++.+|++||++.++++.|.
T Consensus 222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 222 DVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 6788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.97 Aligned_cols=252 Identities=25% Similarity=0.485 Sum_probs=205.0
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.++|.+.+.||+|+||.||+|..++++.||||.+..... ..+++.+|+.++++++|+|++++++++......++||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 467999999999999999999887888999999875332 2467899999999999999999999999888999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+++.... ...+++.++..++.|++.|++|||+. +++|+||||+||+++.++.+|++|||.++.....
T Consensus 81 e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 81 EYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred eccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999999997543 24589999999999999999999999 9999999999999999999999999999876532
Q ss_pred CC-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCC-CCCCCc
Q 002069 860 LS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDP-RLPTPL 936 (973)
Q Consensus 860 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 936 (973)
.. ......++..|+|||.+.+..++.++||||+|+++||+++ |+.||...... ......... ..+.+
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---------~~~~~~~~~~~~~~~- 226 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---------EVLEQVERGYRMPRP- 226 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---------HHHHHHHcCCCCCCC-
Confidence 21 1122335678999999998889999999999999999998 99998643211 111111111 11111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+..+.+++.+|++.+|++||+++++.+.|+
T Consensus 227 ---~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 227 ---PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred ---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 112345788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.38 Aligned_cols=255 Identities=24% Similarity=0.421 Sum_probs=201.9
Q ss_pred hcCCcccccccCCCceeEEEEEc------CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 773 (973)
..+|+..++||+|+||.||+|.. .++..||+|.+... .......+.+|++++++++|+||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 35788899999999999999953 24568999987643 2233578999999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHhccCcc------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAA------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL 841 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~ 841 (973)
..++||||+++++|.+++..... ...+++..++.++.|++.|++|||+. +++||||||+||++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcC
Confidence 99999999999999999975432 13578999999999999999999999 9999999999999999
Q ss_pred CCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhh
Q 002069 842 EYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSS 918 (973)
Q Consensus 842 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~ 918 (973)
++.+|++|||.+........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----- 232 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE----- 232 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-----
Confidence 99999999999876543221 1122345788999999998889999999999999999998 999986332110
Q ss_pred hhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 919 NLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.............. ...+..+.+++.+||+.||.+||++++|.+.|+
T Consensus 233 ----~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 233 ----AIECITQGRELERP---RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----HHHHHHcCccCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 01111111100000 112345789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=312.13 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=196.6
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCC----EEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGE----IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
.+|++.+.||+|+||+||+|.+. +++ .|++|.+..... .....++..|+..+++++||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG--RQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc--hHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 46888899999999999999653 454 478888754322 2234678888889999999999999998864 456
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++|+||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++.
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 78999999999999997543 3588999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 856 LKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 856 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
...... ......++..|+|||++.+..++.++||||||+++||+++ |+.||....... .............
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~ 232 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE------VPDLLEKGERLAQ 232 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHCCCcCCC
Confidence 643322 1223456778999999998899999999999999999998 999987433210 0011111101111
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+. .....+.+++.+||+.||.+|||+.|+++.|+
T Consensus 233 ~~------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~ 266 (279)
T cd05111 233 PQ------ICTIDVYMVMVKCWMIDENVRPTFKELANEFT 266 (279)
T ss_pred CC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11 12234678899999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=318.26 Aligned_cols=255 Identities=24% Similarity=0.371 Sum_probs=198.5
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCC--EEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeecccee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGE--IVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 775 (973)
..+|++.+.||+|+||.||+|.+. ++. .+|+|.+.... .......+.+|++++.++ +|+||+++++++.+.+..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 467899999999999999999654 454 46788776432 223357788999999999 899999999999999999
Q ss_pred EEEEEecCCCChHHHhccCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC
Q 002069 776 FVVYEYLEMGSLAMILSNDAA-------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE 842 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~ 842 (973)
++||||+++++|.++++.... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC
Confidence 999999999999999965431 23578999999999999999999999 99999999999999999
Q ss_pred CceEEecccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhh
Q 002069 843 YEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLN 921 (973)
Q Consensus 843 ~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~ 921 (973)
+.+|++|||+++..... .......++..|+|||++.+..++.++|||||||++|||+| |..||....... . .
T Consensus 161 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~----~ 233 (303)
T cd05088 161 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--L----Y 233 (303)
T ss_pred CcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--H----H
Confidence 99999999998643221 11122234678999999988889999999999999999998 999986432110 0 0
Q ss_pred hhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 922 IALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...........+ ...+..+.+++.+||+.+|++||+++++++.++
T Consensus 234 ~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~ 278 (303)
T cd05088 234 EKLPQGYRLEKP------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 278 (303)
T ss_pred HHHhcCCcCCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 001110011111 112335788999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=307.57 Aligned_cols=245 Identities=23% Similarity=0.336 Sum_probs=193.0
Q ss_pred cccCCCceeEEEEEcC---CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCC
Q 002069 708 CIGNGGQGSVYKAELP---TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 708 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
.||+|+||.||+|.+. ++..||+|++..... ....+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 3899999999999653 455799999875432 2335779999999999999999999998864 477999999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCcc-
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR- 863 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~- 863 (973)
++|.+++.... ..+++.++++++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++.........
T Consensus 79 ~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 79 GPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 99999986433 3688999999999999999999999 99999999999999999999999999998654432211
Q ss_pred --cccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhH
Q 002069 864 --TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940 (973)
Q Consensus 864 --~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (973)
....+++.|+|||++....++.++|||||||++||+++ |..||....... .............+ .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~------~ 221 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------VMSFIEQGKRLDCP------A 221 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHHCCCCCCCC------C
Confidence 11233578999999988889999999999999999996 999987433210 00111111111111 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 941 DKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 941 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+.++.+++.+||+.+|++||++.+|.+.|+
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~ 253 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 22346778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=317.47 Aligned_cols=248 Identities=26% Similarity=0.376 Sum_probs=201.5
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
.|+-.+.||.|+||.||.|+. .+.+.||||++.-...+..+.-.++..|+..+.+++|||.+.+-|+|-.+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 366678899999999999954 5889999999976544444445789999999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
||- |+-.|++.-+. +++.+.++..|+.+.+.|++|||++ +.||||||+.|||+++.|.||++|||.|....+
T Consensus 107 YCl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 996 67777775443 4678889999999999999999999 999999999999999999999999999987654
Q ss_pred CcccccccccCcccccccc---cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 861 SNRTELAGTFGYIAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
...++|||.|||||++. .+.|+.|+||||+|++..|+...++|+=.+..+.+-+ .+.+.-.|.+. ..
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY------HIAQNesPtLq--s~ 248 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQNESPTLQ--SN 248 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH------HHHhcCCCCCC--Cc
Confidence 46789999999999875 5679999999999999999999999964333332211 11111122222 12
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.| +..+..++..|+++-|.+|||.++++..
T Consensus 249 eW---S~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 249 EW---SDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred hh---HHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 23 3346778889999999999999998764
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.37 Aligned_cols=254 Identities=24% Similarity=0.322 Sum_probs=203.0
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcc--hhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGE--MACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
++|++.+.||+|++|.||+|.. .+++.||+|.+....... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999954 478999999987543221 2224678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.++...
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999986543 578899999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCcc---cccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCC
Q 002069 858 LGLSNR---TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934 (973)
Q Consensus 858 ~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (973)
...... ....++..|+|||++.+..++.++||||+|+++|||++|+.||.......... ........+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~- 229 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-----KIATQPTNPQLP- 229 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-----HHhccCCCCCCC-
Confidence 322111 23457889999999999889999999999999999999999986433211110 000000111111
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
......+.+++.+||+.+|.+|||+.++++..
T Consensus 230 -----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 230 -----SHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred -----ccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 12334577899999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=317.68 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=203.0
Q ss_pred hcCCcccccccCCCceeEEEEEc------CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeecc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHA 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 772 (973)
.++|.+.+.||+|+||.||+|.. .++..||||+++.... ....+.+.+|+.+++++ +|+||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 45799999999999999999953 1345799999875432 22357789999999999 799999999999999
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
+..++||||+++++|.++++.... ..+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++++|||.
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999975432 3479999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcC
Q 002069 853 SKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLD 929 (973)
Q Consensus 853 a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 929 (973)
++....... ......++..|+|||.+.+..++.++||||+||++|||++ |..||........ ..........
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-----~~~~~~~~~~ 262 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-----FYKLIKEGYR 262 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-----HHHHHHcCCc
Confidence 986644321 1122346788999999998889999999999999999998 9999864332110 0111111111
Q ss_pred CCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 930 PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 930 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+. .....+.+++.+|++.+|++|||+.++++.|+
T Consensus 263 ~~~~~------~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~ 299 (302)
T cd05055 263 MAQPE------HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299 (302)
T ss_pred CCCCC------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 11111 12345788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=314.52 Aligned_cols=253 Identities=28% Similarity=0.406 Sum_probs=201.4
Q ss_pred CcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEe
Q 002069 703 FDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEY 781 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 781 (973)
|++.+.||+|+||+||++... +++.||+|++......... ......|+.++++++||||+++++++.+....++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 678899999999999999665 6678999999875433222 23345699999999999999999999999999999999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS 861 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 861 (973)
+++++|.+++. ....+++.++..++.|+++|+++||+. +++|+||||+||+++.++.++++|||.+........
T Consensus 80 ~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 80 CPGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp ETTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred ccccccccccc---ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999997 234678999999999999999999999 999999999999999999999999999986533334
Q ss_pred cccccccccCcccccccc-cCCCCCccchHHHHHHHHHHHhCCCCCcchh--hhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 862 NRTELAGTFGYIAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFIS--SICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 862 ~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
......+++.|+|||+.. +..++.++||||+|+++|+|++|..||.... +................ ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~---- 225 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS----SQQ---- 225 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH----TTS----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc----ccc----
Confidence 455677899999999998 7889999999999999999999999998541 11111100000000000 000
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.......+.+++.+||+.||++||++.++++.
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00112568899999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.36 Aligned_cols=248 Identities=23% Similarity=0.376 Sum_probs=203.6
Q ss_pred cccccccCCCceeEEEEEcC--CCC--EEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 704 DDEHCIGNGGQGSVYKAELP--TGE--IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 704 ~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
...+.||+|.||+||+|.|. +|+ .||||.+....... ...+|.+|+.+|.+++|+|++++||+.-+ ....+||
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 44578999999999999774 444 58999998765443 46899999999999999999999999987 4677999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
|.++.|+|.+.+++ .....+.....-.++.|||.|++||.++ ++||||+..+|+++-....|||+|||+.+..+.+
T Consensus 190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999987 4556788888999999999999999999 9999999999999999999999999999988655
Q ss_pred CCccc---ccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 860 LSNRT---ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 860 ~~~~~---~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
...+. ...-...|.|||.+...+++.++|||+|||++|||+| |+.||-+.... .+-+.++.. ..
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------qIL~~iD~~--er 333 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------QILKNIDAG--ER 333 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------HHHHhcccc--cc
Confidence 33321 1234678999999999999999999999999999998 88998744321 112222211 11
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+++++++++..||..+|++|||+..+.+.
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 12224567789999999999999999999999743
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.20 Aligned_cols=261 Identities=21% Similarity=0.281 Sum_probs=197.1
Q ss_pred HhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc----
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL---- 773 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 773 (973)
..++|++.+.||+|+||.||+|.. .+|+.||||++...... ......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 457899999999999999999955 47899999998754322 233567889999999999999999999886443
Q ss_pred --eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccc
Q 002069 774 --HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFG 851 (973)
Q Consensus 774 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg 851 (973)
..++||||+++ ++.+.+. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 46999999975 5655553 2367888999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh------hh-------
Q 002069 852 ISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL------SS------- 918 (973)
Q Consensus 852 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~------~~------- 918 (973)
+++..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||........+. ..
T Consensus 169 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 169 LARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred CccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 99765332 22334578999999999999999999999999999999999999997543211100 00
Q ss_pred hhhhhhhhhcC--CCCCC--------------CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 919 NLNIALDEMLD--PRLPT--------------PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 919 ~~~~~~~~~~~--~~~~~--------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
........... +..+. ...........+.+++.+|++.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000 00000 000001123457899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=316.79 Aligned_cols=251 Identities=25% Similarity=0.394 Sum_probs=203.7
Q ss_pred hcCCcccccccCCCceeEEEEE-cCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
..+|++.+.||.|+||.||+|. ..+++.||+|.+...... ..+.+.+|+..++.++|||++++++++..++..++|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 3579999999999999999995 458899999998653222 246788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
+||+++++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+.....
T Consensus 95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 95 MEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999999988642 478999999999999999999999 999999999999999999999999999886654
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.........+++.|+|||.+.+..++.++|||||||++|++++|+.||.......... .......+....
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~------~~~~~~~~~~~~---- 237 (296)
T cd06655 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGTPELQN---- 237 (296)
T ss_pred ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhcCCcccCC----
Confidence 4333344568899999999998889999999999999999999999997544321110 000000111111
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.......+.+++.+||+.||.+||++.++++.
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 11223457789999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.23 Aligned_cols=256 Identities=24% Similarity=0.361 Sum_probs=200.8
Q ss_pred hcCCcccccccCCCceeEEEEEcC--------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP--------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCS 770 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 770 (973)
.++|.+.+.||+|+||.||+|... +...||+|.+..... .....++..|+.+++.+ +||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 357999999999999999999642 235799999975422 22356788899999999 8999999999999
Q ss_pred ccceeEEEEEecCCCChHHHhccCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCe
Q 002069 771 HALHSFVVYEYLEMGSLAMILSNDAA-------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNV 837 (973)
Q Consensus 771 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni 837 (973)
..+..++||||+++++|.+++..... ...+++.++++++.|++.|++|||+. +++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence 99999999999999999999975432 23588999999999999999999998 999999999999
Q ss_pred eecCCCceEEecccccccccCCCCcc--cccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhh
Q 002069 838 LLNLEYEAHVSDFGISKFLKLGLSNR--TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICS 914 (973)
Q Consensus 838 ll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 914 (973)
+++.++.+|++|||.++......... ....+++.|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~-~ 250 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-E 250 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-H
Confidence 99999999999999987664322111 12234578999999988889999999999999999998 88898633210 0
Q ss_pred hhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 915 SLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.............+ ......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 251 -----~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~ 297 (307)
T cd05098 251 -----LFKLLKEGHRMDKP------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297 (307)
T ss_pred -----HHHHHHcCCCCCCC------CcCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 00011111111111 122346778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.76 Aligned_cols=256 Identities=23% Similarity=0.415 Sum_probs=202.9
Q ss_pred hcCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 773 (973)
.++|++.+.||+|+||.||+|... +++.||+|++..... .....++.+|+.++++++|||++++++++..++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 467899999999999999999653 567899999875432 233577999999999999999999999999988
Q ss_pred eeEEEEEecCCCChHHHhccCc-------------------cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCC
Q 002069 774 HSFVVYEYLEMGSLAMILSNDA-------------------AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISS 834 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~ 834 (973)
..++||||+++++|.+++.... ....+++.+++.++.|++.|++|||+. +++||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence 9999999999999999996432 113478889999999999999999999 999999999
Q ss_pred CCeeecCCCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhh
Q 002069 835 KNVLLNLEYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISS 911 (973)
Q Consensus 835 ~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~ 911 (973)
+||+++.++.++++|||.+........ .......++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999876543321 1222345678999999988889999999999999999997 8888853221
Q ss_pred hhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 912 ICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
. ............... ...+..+.+++.+|++.||.+|||+.|+++.|+
T Consensus 239 ~---------~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 239 E---------EVIYYVRDGNVLSCP---DNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred H---------HHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1 111111111111100 112345889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=311.35 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=198.5
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||.||+|.. .+++.||+|++..... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 3678889999999999999954 5889999999865422 233567999999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||++++++..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++++|||.+......
T Consensus 79 e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 79 EFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred ecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 999999997652 367888999999999999999999 9999999999999999999999999999765432
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||........... ..........+..+.. . .
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~-~ 222 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM--PLQLLQCIVDEDPPVL-P-V 222 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc--hHHHHHHHhccCCCCC-C-C
Confidence 23345789999999999988899999999999999999999999964321111000 0011111111111100 0 0
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+.+++.+|++.+|++||+++|+++.
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1123357889999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.47 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=198.2
Q ss_pred CcccccccCCCceeEEEEEc-----CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc--cee
Q 002069 703 FDDEHCIGNGGQGSVYKAEL-----PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA--LHS 775 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 775 (973)
|++.+.||+|+||+||.+.. .+++.||+|.+...... .....+.+|++++++++||||+++++++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ--QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 38889999999999988632 36789999998754321 2357788999999999999999999988653 357
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+++++|.+++... .+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|||.++.
T Consensus 84 ~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence 8999999999999998643 489999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCc---ccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhh-hhhhhhh----hhhhhhhh
Q 002069 856 LKLGLSN---RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSI-CSSLSSN----LNIALDEM 927 (973)
Q Consensus 856 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-~~~~~~~----~~~~~~~~ 927 (973)
....... .....++..|+|||.+.+..++.++||||||+++|||+||..||...... ....... ......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 6543221 11234566799999998888999999999999999999999998643211 0000000 00011111
Q ss_pred cCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 928 LDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.......+. ....+..+.+++.+||+.+|.+|||++++++.|+
T Consensus 237 ~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~ 279 (283)
T cd05080 237 LERGMRLPC--PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279 (283)
T ss_pred hhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 111111110 1123356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=312.80 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=200.7
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|.. .+++.||+|.++.... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 35788889999999999999954 5789999999865422 2245678899999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.++++... .+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.++++|||.+.....
T Consensus 85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 85 MEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred EeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 99999999999986543 578999999999999999999999 999999999999999999999999999876654
Q ss_pred CCCcccccccccCcccccccc---cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 859 GLSNRTELAGTFGYIAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
.........|++.|+|||++. ...++.++||||+||++|+|++|+.||.......... ........+ ..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~-----~~~~~~~~~---~~ 230 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-----LMTKSNFQP---PK 230 (267)
T ss_pred cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH-----hhhccCCCC---Cc
Confidence 433344567899999999874 4558889999999999999999999985332111000 000000011 00
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.......+..+.+++.+|++.+|++||+++++++.
T Consensus 231 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 11111123357789999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=308.42 Aligned_cols=254 Identities=27% Similarity=0.403 Sum_probs=205.5
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||.||+|.. .+++.+|+|.+...... ..+.+.+|++++++++|||++++++++.+.+..+++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 5789999999999999999965 46789999998754322 3578899999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.+|++|||.+......
T Consensus 80 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 80 EYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred eCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 9999999999986542 3588999999999999999999998 9999999999999999999999999999876544
Q ss_pred CCcccccccccCcccccccccC---CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 860 LSNRTELAGTFGYIAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
........++..|+|||.+.+. .++.++||||||+++|||+||+.||.......... ........+ ...
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-----~~~~~~~~~---~~~ 226 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-----LISKSNFPP---PKL 226 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhccCCC---ccc
Confidence 3333445688899999998776 78899999999999999999999987433211110 000010011 111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+..+.+++.+||+.+|.+|||+++|+..
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1123345668899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=309.84 Aligned_cols=254 Identities=25% Similarity=0.383 Sum_probs=199.4
Q ss_pred CcccccccCCCceeEEEEEcC----CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccce----
Q 002069 703 FDDEHCIGNGGQGSVYKAELP----TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH---- 774 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 774 (973)
|++.+.||+|+||.||+|... .+..||+|+++..... ......+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 567899999999999999653 2468999998754322 2335678999999999999999999998865543
Q ss_pred --eEEEEEecCCCChHHHhccCc---cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEec
Q 002069 775 --SFVVYEYLEMGSLAMILSNDA---AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSD 849 (973)
Q Consensus 775 --~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~D 849 (973)
.++||||+++++|..++.... ....+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence 789999999999999985432 224688999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCc--ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhh
Q 002069 850 FGISKFLKLGLSN--RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDE 926 (973)
Q Consensus 850 fg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 926 (973)
||.++........ .....++..|+|||++.+..++.++|||||||++|||++ |..||...... .....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---------~~~~~ 227 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---------EIYDY 227 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---------HHHHH
Confidence 9999876543322 122335678999999988889999999999999999999 89998643321 11111
Q ss_pred hcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 927 MLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.......... ...+..+.+++.+||+.||.+||++.|+++.|+
T Consensus 228 ~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~ 270 (273)
T cd05035 228 LRHGNRLKQP---EDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270 (273)
T ss_pred HHcCCCCCCC---cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111111111 123446789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=309.85 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=201.3
Q ss_pred cCCcccccccCCCceeEEEEEcC-C---CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-T---GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (973)
.+|++.+.||+|+||.||+|... + +..||+|.++.... ....+.+..|+.++++++||||+++++++..++..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 56888999999999999999653 2 33799999875432 233578999999999999999999999999989999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
+||||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 82 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999997543 3578999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCcc---cccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 857 KLGLSNR---TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 857 ~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
....... ....++..|+|||++.+..++.++||||||+++||+++ |..||....... ......+... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~------~~~~~~~~~~--~ 228 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD------VIKAIEEGYR--L 228 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH------HHHHHhCCCc--C
Confidence 5432211 11223568999999998889999999999999999886 999986432110 0001111111 1
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+.. ...+..+.+++.+|++.+|.+||++.++++.|+
T Consensus 229 ~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 264 (267)
T cd05066 229 PAP----MDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264 (267)
T ss_pred CCC----CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHH
Confidence 111 122345788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=314.54 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=199.5
Q ss_pred HhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeecc----
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHA---- 772 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~---- 772 (973)
+.+.|++.+.||+|+||.||+|.. .+++.||+|++.... .....+..|+.+++++ +|+|++++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 456788899999999999999965 478899999986432 1246788899999998 799999999998642
Q ss_pred --ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecc
Q 002069 773 --LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDF 850 (973)
Q Consensus 773 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df 850 (973)
...++||||+++++|.+++.... ...+++..+..++.|++.|++|||+. +++|+|++|+||++++++.++++||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence 46799999999999999987533 24578999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCcccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhh
Q 002069 851 GISKFLKLGLSNRTELAGTFGYIAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALD 925 (973)
Q Consensus 851 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 925 (973)
|++..............|++.|+|||++. +..++.++||||+||++|||++|+.||........... ..
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~------~~ 229 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------IP 229 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH------Hh
Confidence 99987654433444567899999999986 33578899999999999999999999964332111110 00
Q ss_pred hhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 926 EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
....+.... ...+..+.+++.+||+.||.+|||+.++++.
T Consensus 230 ~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 230 RNPAPRLKS-----KKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred cCCCCCCCC-----CCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000011110 1123457889999999999999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=308.01 Aligned_cols=249 Identities=27% Similarity=0.421 Sum_probs=202.7
Q ss_pred ccccCCCceeEEEEEcCC----CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEec
Q 002069 707 HCIGNGGQGSVYKAELPT----GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYL 782 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 782 (973)
+.||+|+||.||+|.... +..||+|.+....... ..+.+.+|++.++.++|+|++++++++......++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 469999999999996643 7899999998654433 3678999999999999999999999999988999999999
Q ss_pred CCCChHHHhccCcc------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 783 EMGSLAMILSNDAA------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 783 ~~~~L~~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
++++|.++++.... ...+++.+++.++.|++.|++|||++ +++||||+|+||+++.++.+|++|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccc
Confidence 99999999976521 25689999999999999999999998 9999999999999999999999999999877
Q ss_pred cCCC--CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 857 KLGL--SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 857 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
.... .......+++.|+|||.+....++.++||||+|+++|||++ |..||...... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---------~~~~~~~~~~~~ 226 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---------EVLEYLRKGYRL 226 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---------HHHHHHHcCCCC
Confidence 6543 22334567889999999988889999999999999999999 69998754311 011111111110
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.. ....+..+.+++.+||+.+|.+|||++|+++.|+
T Consensus 227 ~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 PK---PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CC---CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00 1122456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=334.17 Aligned_cols=259 Identities=24% Similarity=0.262 Sum_probs=190.8
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc------
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA------ 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 772 (973)
..+|++.+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 46799999999999999999965 478999999885421 2334799999999999999998876321
Q ss_pred --ceeEEEEEecCCCChHHHhccC-ccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC-ceEEe
Q 002069 773 --LHSFVVYEYLEMGSLAMILSND-AAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY-EAHVS 848 (973)
Q Consensus 773 --~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-~~kl~ 848 (973)
...++||||+++ ++.+++... .....+++..++.++.||+.||+|||+. +|+||||||+||+++.++ .+||+
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeee
Confidence 246789999984 677766432 2234688999999999999999999999 999999999999998664 79999
Q ss_pred cccccccccCCCCcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhhhh
Q 002069 849 DFGISKFLKLGLSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSNLN 921 (973)
Q Consensus 849 Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~ 921 (973)
|||+|+...... ......||+.|+|||++.+. .++.++||||+||++|||++|.+||........ ..+....
T Consensus 214 DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 214 DFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 999998765432 23345789999999998754 689999999999999999999999975432110 0000000
Q ss_pred hhhhh----hcCCCCCCC----chh--hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 922 IALDE----MLDPRLPTP----LRN--VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 922 ~~~~~----~~~~~~~~~----~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..... ..+..++.. ... ....+.++.+++.+||+.||.+|||+.|+++.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000 000001100 000 00123467899999999999999999998853
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=312.58 Aligned_cols=256 Identities=21% Similarity=0.332 Sum_probs=203.7
Q ss_pred hcCCcccccccCCCceeEEEEEcCC-----CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec-cc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPT-----GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH-AL 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~ 773 (973)
.++|++.+.||+|+||.||+|.... +..||+|++.... .....+.+.+|+.++++++|+|++++++++.. +.
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4678999999999999999997654 6889999987442 23346778999999999999999999998766 46
Q ss_pred eeEEEEEecCCCChHHHhccCccc-----cCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEe
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAA-----EEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVS 848 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~ 848 (973)
..++++||+++++|.+++...... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999999654322 4688999999999999999999998 99999999999999999999999
Q ss_pred cccccccccCCCCc--ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhh
Q 002069 849 DFGISKFLKLGLSN--RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALD 925 (973)
Q Consensus 849 Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 925 (973)
|||+++.+...... .....++..|+|||++.+..++.++||||||+++||+++ |+.||....... ......
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~ 233 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE------MAAYLK 233 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH------HHHHHH
Confidence 99999866433211 122345678999999988889999999999999999999 999997433211 011111
Q ss_pred hhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 926 EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.... .... ...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 234 ~~~~--~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 274 (280)
T cd05043 234 DGYR--LAQP----INCPDELFAVMACCWALDPEERPSFSQLVQCLT 274 (280)
T ss_pred cCCC--CCCC----CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 1111 1111 112345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.85 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=203.3
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
..+|++.+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.+++.++|+|++++++++..++..++|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 46899999999999999999964 58999999998653322 246788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.+++.+. .+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+.....
T Consensus 95 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred ecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 9999999999998642 468899999999999999999999 999999999999999999999999999887654
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.........+++.|+|||...+..++.++|||||||++|++++|+.||.......... ........ ....
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--------~~~~~~~~--~~~~ 237 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------LIATNGTP--ELQN 237 (297)
T ss_pred CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--------eeccCCCC--CCCC
Confidence 4333344578899999999998889999999999999999999999996433211000 00000100 0011
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
.......+.+++.+||+.+|++||+++++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1223345778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.38 Aligned_cols=248 Identities=27% Similarity=0.450 Sum_probs=198.3
Q ss_pred ccccCCCceeEEEEEcC--CCC--EEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEec
Q 002069 707 HCIGNGGQGSVYKAELP--TGE--IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYL 782 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 782 (973)
+.||+|++|.||+|.+. .++ .||+|.+...... ...+.+.+|+..+++++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 46899999999999653 233 6999999765443 446889999999999999999999999988 8889999999
Q ss_pred CCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCc
Q 002069 783 EMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN 862 (973)
Q Consensus 783 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 862 (973)
++++|.+++.+... ..+++..++.++.|++.|++|||+. +++|+||+|+||+++.++.+|++|||.++........
T Consensus 78 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 78 PLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99999999976543 4689999999999999999999999 9999999999999999999999999999877543221
Q ss_pred ---ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 863 ---RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 863 ---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||....... .. .. ... ........
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~----~~-~~~-~~~~~~~~--- 223 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-IL----KK-IDK-EGERLERP--- 223 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HH----HH-HHh-cCCcCCCC---
Confidence 122456788999999998889999999999999999998 999986332110 00 00 000 00111111
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 224 -~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 -EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 123346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=322.75 Aligned_cols=257 Identities=22% Similarity=0.247 Sum_probs=196.0
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||++.. .+++.||+|++...........+.+.+|..++..++|++|+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4689999999999999999965 478999999986432222233566889999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|+|.+++.+.. ..+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999996532 3578999999999999999999999 9999999999999999999999999998766543
Q ss_pred CC-cccccccccCccccccccc-----CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 860 LS-NRTELAGTFGYIAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 860 ~~-~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
.. ......||+.|+|||++.. ..++.++||||+||++|||++|+.||........ ............++
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-----~~~i~~~~~~~~~~ 230 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----YGKIMNHKEHFQFP 230 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH-----HHHHHcCCCcccCC
Confidence 22 2223468999999999863 4578899999999999999999999974321100 00111000001111
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCC--CCCCHHHHHHH
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPT--SRPTMQKVSQL 970 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~ev~~~ 970 (973)
.... ..+..+.+++.+|+..+++ .||+++++++.
T Consensus 231 ~~~~---~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 231 PDVT---DVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CccC---CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1111 1233466777787755443 37899998764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=316.31 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=202.1
Q ss_pred hcCCcccccccCCCceeEEEEEc--------CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL--------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCS 770 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 770 (973)
..+|.+.+.||+|+||.||+|.. .++..||+|.+..... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 46788999999999999999953 1345799999875422 23357789999999999 8999999999999
Q ss_pred ccceeEEEEEecCCCChHHHhccCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCe
Q 002069 771 HALHSFVVYEYLEMGSLAMILSNDAA-------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNV 837 (973)
Q Consensus 771 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni 837 (973)
.....++||||+++++|.+++..... ...+++.++..++.|++.|++|||+. +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 99999999999999999999975421 23578899999999999999999999 999999999999
Q ss_pred eecCCCceEEecccccccccCCCCc--ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhh
Q 002069 838 LLNLEYEAHVSDFGISKFLKLGLSN--RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICS 914 (973)
Q Consensus 838 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 914 (973)
+++.++.+|++|||.++........ .....+++.|+|||++.+..++.++||||||+++||+++ |..||......
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-- 246 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 246 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--
Confidence 9999999999999999876543222 222345678999999988889999999999999999998 78887643211
Q ss_pred hhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 915 SLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.............. ....+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 247 -------~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~ 294 (304)
T cd05101 247 -------ELFKLLKEGHRMDK---PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294 (304)
T ss_pred -------HHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 11111111111000 0123445788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=311.23 Aligned_cols=250 Identities=27% Similarity=0.397 Sum_probs=204.2
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||.|+||.||+|... +++.||+|++..... ......+.+|+.+++.++|+|++++++++.++...++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 36888999999999999999654 789999999875432 233467889999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+++... ++++.++..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.++.....
T Consensus 79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 79 EYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred EeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999999998753 678999999999999999999999 9999999999999999999999999999877654
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
........+++.|+|||++.+..++.++||||||+++|+|+||+.||........ .........+.....
T Consensus 152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~~---- 221 (274)
T cd06609 152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LFLIPKNNPPSLEGN---- 221 (274)
T ss_pred ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HHHhhhcCCCCCccc----
Confidence 3344456788899999999988899999999999999999999999964321100 000111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..+..+.+++.+||+.||++|||++++++.
T Consensus 222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 -KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 134457889999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=333.38 Aligned_cols=368 Identities=29% Similarity=0.389 Sum_probs=328.5
Q ss_pred CCcEEeCCCCCCC-CCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEc
Q 002069 1 MLKVLGLSFNQFS-GSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDI 79 (973)
Q Consensus 1 ~l~~L~l~~~~l~-~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l 79 (973)
|++-.|+++|.++ +.+|..+..++.++.|-|...++. .+|++++.|.+|+.|.+++|++. .+-+.+..|+.|+.+++
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 5677899999999 579999999999999999999998 78999999999999999999998 78888999999999999
Q ss_pred cCCcCc-ccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcc-cccccCCCCceecccCCCC
Q 002069 80 GNNLLS-GSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPD-EIGNLKFLSDLQVSYNTLS 157 (973)
Q Consensus 80 ~~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~l~~N~l~ 157 (973)
.+|++. .-+|..|..|..|+.||||+|+++ +.|..+..-+++-+|+|++|+|. ++|. -|-+|+.|-.||||+|++.
T Consensus 86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh
Confidence 999985 358999999999999999999999 89999999999999999999998 5664 4789999999999999998
Q ss_pred CCCCccccCccccceeeecccccCCCCCccccccCccceeeccccccc-cccccccCCCCcccEEecCCcccCCCCCccc
Q 002069 158 GAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLS-GSILYSFGNLTKLEILYLDVNALSGLIPNEI 236 (973)
Q Consensus 158 ~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~ 236 (973)
.+|..+..|.+|++|.|++|.+.-..-..+..+.+|++|.+++.+=+ .-.|.++..+.+|..++++.|.+. +.|+.+
T Consensus 164 -~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecl 241 (1255)
T KOG0444|consen 164 -MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECL 241 (1255)
T ss_pred -hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHH
Confidence 78889999999999999999887444456667888999999987644 235668899999999999999998 459999
Q ss_pred cccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccC-CcCchhhcCCccc
Q 002069 237 GNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSG-SIPLSLGSLTNLA 315 (973)
Q Consensus 237 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~ 315 (973)
.++++|+.|+||+|+|+. .....+...+|+.|++++|+++. .|+++..+++|+.|++.+|+++- -+|..++.+.+|+
T Consensus 242 y~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt~-LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Le 319 (1255)
T KOG0444|consen 242 YKLRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLTV-LPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLE 319 (1255)
T ss_pred hhhhhhheeccCcCceee-eeccHHHHhhhhhhccccchhcc-chHHHhhhHHHHHHHhccCcccccCCccchhhhhhhH
Confidence 999999999999999984 44556778899999999999985 57899999999999999999863 4789999999999
Q ss_pred eeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCc
Q 002069 316 TLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPL 378 (973)
Q Consensus 316 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~ 378 (973)
.+..++|.+. ..|..++.|..|+.|.|++|++- ..|.++.-++.|+.||+..|.--...|.
T Consensus 320 vf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 320 VFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred HHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence 9999999998 89999999999999999999998 7899999999999999999976544443
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.12 Aligned_cols=262 Identities=22% Similarity=0.294 Sum_probs=193.3
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC---CCCceeeeceeeec-----c
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI---RHRNIVKFYGFCSH-----A 772 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~ 772 (973)
+|++.+.||+|+||+||+|.. .+++.||+|.+....... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 588899999999999999955 478999999987543221 1123455666666655 79999999998754 3
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
...++||||++ +++.+++.... ...+++.++..++.|++.|++|+|+. +++||||||+||+++.++.+|++|||.
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 45789999998 58888886543 23589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhhhhhhhh-
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSNLNIALD- 925 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~~~~- 925 (973)
++..... .......|++.|+|||++.+..++.++||||+||++|||++|++||........ ...........
T Consensus 155 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 155 ARIYSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 9866533 222345689999999999988899999999999999999999999864332110 00000000000
Q ss_pred ------hhcCCCCCCC-chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 926 ------EMLDPRLPTP-LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 926 ------~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
....+..... ..........+.+++.+|++.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000 00111234557899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=307.59 Aligned_cols=252 Identities=20% Similarity=0.297 Sum_probs=204.6
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|++.+.||+|+||.||++.. .+|+.||+|++...... ....+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 588899999999999999954 47899999998653222 2235688999999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++++|.+++.... ...+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 80 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 80 YCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred cCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999986533 23578899999999999999999998 99999999999999999999999999998765543
Q ss_pred CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhH
Q 002069 861 SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (973)
.......|++.|+|||+..+..++.++|||||||++|+|++|+.||..... ............+... .
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~~---~ 223 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---------KNLVLKIIRGSYPPVS---S 223 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH---------HHHHHHHhcCCCCCCc---c
Confidence 333445688999999999988899999999999999999999999863221 1111122222211111 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 941 DKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 941 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+.+++.+||+.+|.+||++.+|++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 224457899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=325.85 Aligned_cols=243 Identities=23% Similarity=0.250 Sum_probs=187.3
Q ss_pred ccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC---CCCceeeeceeeeccceeEEEEEecCC
Q 002069 709 IGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI---RHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 709 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
||+|+||+||+|+. .+++.||||++.............+..|..++... +||+|+++++++.+....|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999965 47899999998643222222234455566666555 699999999999999999999999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccc
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 864 (973)
|+|.+++... ..+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 9999988653 3578999999999999999999999 999999999999999999999999999876543333344
Q ss_pred ccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHH
Q 002069 865 ELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKL 943 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (973)
...||+.|+|||++.+. .++.++||||+||++|||++|+.||...... .............+.. ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~---------~~~~~i~~~~~~~~~~---~~~ 222 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---------QMYRNIAFGKVRFPKN---VLS 222 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH---------HHHHHHHcCCCCCCCc---cCC
Confidence 56799999999998754 4789999999999999999999999743211 1111111111111111 123
Q ss_pred HHHHHHHhcccCCCCCCCC----CHHHHHH
Q 002069 944 ISIMEVSISCLDESPTSRP----TMQKVSQ 969 (973)
Q Consensus 944 ~~l~~li~~cl~~dP~~RP----s~~ev~~ 969 (973)
..+.+++.+||+.||.+|| ++.++++
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 3467889999999999998 5666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=305.46 Aligned_cols=245 Identities=27% Similarity=0.396 Sum_probs=194.6
Q ss_pred ccccCCCceeEEEEEcC-C---CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEec
Q 002069 707 HCIGNGGQGSVYKAELP-T---GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYL 782 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 782 (973)
++||+|+||.||+|.+. . +..||+|.+...... ...+++.+|+.++++++|+|++++++++.. ...++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence 46999999999999543 2 268999998865443 335789999999999999999999998764 4679999999
Q ss_pred CCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCc
Q 002069 783 EMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN 862 (973)
Q Consensus 783 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 862 (973)
++++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++........
T Consensus 78 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 78 PLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 9999999997544 578999999999999999999999 9999999999999999999999999999876544322
Q ss_pred cc---ccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 863 RT---ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 863 ~~---~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.. ...++..|+|||.+.+..++.++||||||+++|||++ |..||....... .............+
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~----- 220 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE------VIAMLESGERLPRP----- 220 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHHcCCcCCCC-----
Confidence 21 1223567999999998889999999999999999998 999987443210 00111111010111
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 221 -~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~ 253 (257)
T cd05060 221 -EECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253 (257)
T ss_pred -CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 122345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=311.85 Aligned_cols=253 Identities=21% Similarity=0.389 Sum_probs=199.3
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCC----EEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccce
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGE----IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH 774 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 774 (973)
..+|++.++||+|+||+||+|.+ .+++ .||+|++..... ....+.+.+|+.+++.++|+||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 35788999999999999999965 3444 489999875432 23357788999999999999999999999754 5
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.+++|||+++|++.++++... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence 679999999999999997543 3588999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCc--ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 855 FLKLGLSN--RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 855 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
........ .....+++.|+|||...+..++.++|||||||++|||++ |..||+...... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~ 231 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE------IPDLLEKGERLP 231 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHCCCcCC
Confidence 76543221 122345678999999988889999999999999999998 999987432110 001111111111
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+ ...+..+.+++.+||+.||++||++.++++.|+
T Consensus 232 ~~------~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~ 266 (279)
T cd05109 232 QP------PICTIDVYMIMVKCWMIDSECRPRFRELVDEFS 266 (279)
T ss_pred CC------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11 123345788999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=312.02 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=198.5
Q ss_pred CcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEe
Q 002069 703 FDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEY 781 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 781 (973)
|++.+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+++++.++|||++++++++..+...++||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 677889999999999999654 67889999986432 23357788999999999999999999999999999999999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS 861 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 861 (973)
++++++.+++.+.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+........
T Consensus 84 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 84 CAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred cCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 99999998875432 3688999999999999999999999 999999999999999999999999999876544333
Q ss_pred cccccccccCcccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 862 NRTELAGTFGYIAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 862 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
......+++.|+|||++. +..++.++|||||||++|||++|+.||.......... . ......+....+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-----~-~~~~~~~~~~~~- 231 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLL-----K-IAKSEPPTLAQP- 231 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHH-----H-HhhcCCCCCCCc-
Confidence 344567899999999874 3457789999999999999999999987433211000 0 000001111111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+.+++.+||+.||.+||+++++++.
T Consensus 232 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 ---SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223457899999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=306.20 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=201.8
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec-cceeEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH-ALHSFVVY 779 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 779 (973)
.|++.+.||+|++|.||++.. .+++.||+|++....... ...+.+.+|++++++++|+|++++++.+.. ....++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 488999999999999999965 467899999986533222 235678899999999999999999998764 44678999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||++++++.++++... ...+++.+++.++.|++.|++++|+. +++||||||+||+++.++.++++|||.+......
T Consensus 80 e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred cccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999997533 34589999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
........+++.|+|||+..+..++.++||||+|+++|+|++|+.||+..... ...........+.. .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---------~~~~~~~~~~~~~~---~ 223 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---------SLVYRIIEGKLPPM---P 223 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---------HHHHHHHhcCCCCC---c
Confidence 33344556899999999999998999999999999999999999998743311 11111111111111 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+.+++.+|++.+|++||++.++++.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1233467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=324.50 Aligned_cols=262 Identities=19% Similarity=0.265 Sum_probs=198.2
Q ss_pred HHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc----
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA---- 772 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---- 772 (973)
...++|++.+.||+|+||.||+|.. ..++.||||++...... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 3457899999999999999999954 47899999998764332 23356788899999999999999999988543
Q ss_pred --ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecc
Q 002069 773 --LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDF 850 (973)
Q Consensus 773 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df 850 (973)
...++||||+++ ++.+++. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+||
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence 356899999975 5666654 2478889999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh------h-------
Q 002069 851 GISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL------S------- 917 (973)
Q Consensus 851 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~------~------- 917 (973)
|+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .
T Consensus 164 g~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 164 GLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999865433 22334578999999999999899999999999999999999999997543211100 0
Q ss_pred hhhhhhhhhhcCC--C--------------CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 918 SNLNIALDEMLDP--R--------------LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 918 ~~~~~~~~~~~~~--~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
............. . .+............+.+++.+|++.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000000 0 000000011123457899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.33 Aligned_cols=257 Identities=25% Similarity=0.326 Sum_probs=199.3
Q ss_pred HHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeE
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (973)
.++..+.....||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++|+||+++++++..++..+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 3455566667899999999999964 477889999886542 223568899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC-CCceEEeccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL-EYEAHVSDFGISKF 855 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-~~~~kl~Dfg~a~~ 855 (973)
+|+||+++++|.+++.........++..+..++.|++.|++|||+. +|+||||||+||+++. ++.++++|||.+..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999997543221227888899999999999999998 9999999999999986 67999999999876
Q ss_pred ccCCCCcccccccccCcccccccccCC--CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 856 LKLGLSNRTELAGTFGYIAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 856 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
............+++.|+|||++.+.. ++.++||||||+++|+|++|+.||........... .... ....+.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~---~~~~-~~~~~~~~ 234 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF---KVGM-FKIHPEIP 234 (268)
T ss_pred cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh---hhhh-hccCCCCC
Confidence 654333334456899999999986543 78899999999999999999999863321110000 0000 00111111
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+.+++.+||+.+|.+|||+.++++.
T Consensus 235 ------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 235 ------ESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ------cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 1233457889999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=317.41 Aligned_cols=194 Identities=21% Similarity=0.328 Sum_probs=159.7
Q ss_pred cccccCCCceeEEEEEcC---CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec--cceeEEEEE
Q 002069 706 EHCIGNGGQGSVYKAELP---TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH--ALHSFVVYE 780 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 780 (973)
.++||+|+||+||+|... +++.||+|.+..... ...+.+|+.++++++||||+++++++.. ....++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999653 568899999864321 2456789999999999999999998854 456789999
Q ss_pred ecCCCChHHHhccCc------cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeee----cCCCceEEecc
Q 002069 781 YLEMGSLAMILSNDA------AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL----NLEYEAHVSDF 850 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill----~~~~~~kl~Df 850 (973)
|++ +++.+++.... ....+++..+..++.|++.|++|||+. +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 986 57887775322 123588999999999999999999999 99999999999999 45678999999
Q ss_pred cccccccCCCC---cccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcc
Q 002069 851 GISKFLKLGLS---NRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDF 908 (973)
Q Consensus 851 g~a~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~ 908 (973)
|+++.+..... ......||+.|+|||++.+. .++.++||||+||++|||++|++||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 99987654322 22346789999999998764 588999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=315.79 Aligned_cols=256 Identities=22% Similarity=0.354 Sum_probs=200.6
Q ss_pred hcCCcccccccCCCceeEEEEEcC--------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP--------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCS 770 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 770 (973)
.++|.+.+.||+|+||.||+|... ....||+|++..... ......+..|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 467889999999999999999531 345799999875432 23356788999999999 6999999999999
Q ss_pred ccceeEEEEEecCCCChHHHhccCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCe
Q 002069 771 HALHSFVVYEYLEMGSLAMILSNDAA-------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNV 837 (973)
Q Consensus 771 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni 837 (973)
+.+..++||||+++|+|.+++..... ...+++.++.+++.|++.|++|||+. +++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence 88899999999999999999965321 23588999999999999999999998 999999999999
Q ss_pred eecCCCceEEecccccccccCCCCcc--cccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhh
Q 002069 838 LLNLEYEAHVSDFGISKFLKLGLSNR--TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICS 914 (973)
Q Consensus 838 ll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 914 (973)
+++.++.+|++|||.++......... ....+++.|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-- 243 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE-- 243 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 99999999999999998665332211 12234567999999988889999999999999999999 89998643211
Q ss_pred hhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 915 SLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
............... ...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 244 -------~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 291 (314)
T cd05099 244 -------ELFKLLREGHRMDKP---SNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291 (314)
T ss_pred -------HHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 001111111100000 122335778999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=318.04 Aligned_cols=246 Identities=26% Similarity=0.339 Sum_probs=198.2
Q ss_pred cccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCCCC
Q 002069 708 CIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGS 786 (973)
Q Consensus 708 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 786 (973)
++|+|.||+||.|+.. +...+|||.+...... ..+-+..|+...++++|+|||+++|.+.++++.-|.||.++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr---~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR---EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch---hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 5999999999999665 5567999998654322 24678899999999999999999999999999999999999999
Q ss_pred hHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeec-CCCceEEecccccccccCCCCcccc
Q 002069 787 LAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLN-LEYEAHVSDFGISKFLKLGLSNRTE 865 (973)
Q Consensus 787 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~ 865 (973)
|.+.++..-..-.=.+..+-.+.+||++|+.|||++ .|||||||-+||+++ ..|.+||+|||-++....-.....+
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 999997655322226777888899999999999999 999999999999995 5699999999999988665555667
Q ss_pred cccccCcccccccccCC--CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHH
Q 002069 866 LAGTFGYIAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKL 943 (973)
Q Consensus 866 ~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (973)
+.||..|||||++..++ |..++|||||||++.||.||++||-...+..+ ..+.-.+.+.-|+ .+.+..
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-------AMFkVGmyKvHP~---iPeels 805 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-------AMFKVGMYKVHPP---IPEELS 805 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-------hhhhhcceecCCC---CcHHHH
Confidence 88999999999998664 78899999999999999999999974443211 1111111111111 123345
Q ss_pred HHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 944 ISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 944 ~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
.+...+|.+|+.+||.+||++.++++
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhcc
Confidence 56778999999999999999999875
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=321.62 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=198.7
Q ss_pred hcCCcccccccCCCceeEEEEEc------CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeecc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHA 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 772 (973)
.++|++.+.||+|+||.||+|.+ .+++.||||+++..... .....+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh--HHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 46799999999999999999953 35789999999754322 2346788999999999 689999999988654
Q ss_pred -ceeEEEEEecCCCChHHHhccCcc-------------------------------------------------------
Q 002069 773 -LHSFVVYEYLEMGSLAMILSNDAA------------------------------------------------------- 796 (973)
Q Consensus 773 -~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 796 (973)
...++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 457899999999999999864320
Q ss_pred ---------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC--cccc
Q 002069 797 ---------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS--NRTE 865 (973)
Q Consensus 797 ---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~ 865 (973)
...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||.+........ ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12468888999999999999999999 999999999999999999999999999986543221 1122
Q ss_pred cccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHH
Q 002069 866 LAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLI 944 (973)
Q Consensus 866 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (973)
..+++.|+|||.+.+..++.++||||||+++|||++ |..||........ .............+.. ...
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~------~~~ 309 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLKEGTRMRAPDY------TTP 309 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-----HHHHHhccCCCCCCCC------CCH
Confidence 345678999999988889999999999999999997 9999864321100 0011111111111111 123
Q ss_pred HHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 945 SIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 945 ~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+.+++..||+.||++|||+.++++.|+
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~ 337 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEHLG 337 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 5788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.01 Aligned_cols=264 Identities=25% Similarity=0.345 Sum_probs=204.3
Q ss_pred ccHHHHHHHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeecee
Q 002069 691 IVHEEIIRATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGF 768 (973)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 768 (973)
+..+.+..+.++|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.+++++ +||||++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 83 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGM 83 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeee
Confidence 34455666788999999999999999999955 478899999875421 1235678899999999 79999999998
Q ss_pred ee-----ccceeEEEEEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC
Q 002069 769 CS-----HALHSFVVYEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE 842 (973)
Q Consensus 769 ~~-----~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~ 842 (973)
+. .+...++||||+++++|.+++.... ....+++..+..++.|++.|+.|||+. +++|||+||+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~ 160 (286)
T cd06638 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTE 160 (286)
T ss_pred eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCC
Confidence 74 3456899999999999999886432 234678899999999999999999999 99999999999999999
Q ss_pred CceEEecccccccccCCCCcccccccccCccccccccc-----CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhh
Q 002069 843 YEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLS 917 (973)
Q Consensus 843 ~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 917 (973)
+.+|++|||.++.............|++.|+|||++.. ..++.++||||+||++|||++|+.||..........
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~- 239 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF- 239 (286)
T ss_pred CCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-
Confidence 99999999999876544333445578999999998753 447889999999999999999999987433211100
Q ss_pred hhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 918 SNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
.......+.... .......+.+++.+||+.||++|||+.|+++..
T Consensus 240 -----~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 -----KIPRNPPPTLHQ----PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred -----hccccCCCcccC----CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000000011100 011223577899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=313.35 Aligned_cols=255 Identities=26% Similarity=0.352 Sum_probs=201.9
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.++++++|+||+++++++..++..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 36888999999999999999665 78999999886532 2223577899999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+++........+++..+..++.|++.|++|||+.. +++||||||+||+++.++.+|++|||.+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999999876543446899999999999999999999742 8999999999999999999999999998765432
Q ss_pred CCcccccccccCcccccccccCC------CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 860 LSNRTELAGTFGYIAPELAYTMK------VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
......+++.|+|||.+.+.. ++.++||||+||++|+|++|+.||...... ..............+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~ 228 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA------NIFAQLSAIVDGDPP 228 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh------hHHHHHHHHhhcCCC
Confidence 223346888999999986543 478999999999999999999999643210 001111111121111
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.. .......+.+++.+||+.+|.+||+++++++.
T Consensus 229 ~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 229 TL---PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CC---CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11 11244567889999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=306.58 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=202.9
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.++|++.+.||+|+||.||+|.. .|+.||+|.+..... ..+++.+|+.++++++|+|++++++++.+....++||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 35788999999999999999987 478999999975432 3578999999999999999999999999888999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.++++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++.....
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 80 EYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 99999999999975432 3589999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
. ....++..|+|||++.+..++.++||||||+++||+++ |..||...... .. ............+
T Consensus 156 ~---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~----~~~~~~~~~~~~~----- 221 (256)
T cd05039 156 Q---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DV----VPHVEKGYRMEAP----- 221 (256)
T ss_pred c---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HH----HHHHhcCCCCCCc-----
Confidence 1 12345678999999988889999999999999999997 99998643210 00 0011111011111
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+..+.+++.+|++.+|++||++++++++|+
T Consensus 222 -~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 254 (256)
T cd05039 222 -EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254 (256)
T ss_pred -cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHh
Confidence 122346788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=324.33 Aligned_cols=261 Identities=21% Similarity=0.276 Sum_probs=196.9
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc-----ee
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL-----HS 775 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~ 775 (973)
+|+..+.||+|+||+||+|.. .+++.||||++..... .....+.+.+|+.+++.++|+||+++++++..++ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 478889999999999999965 5899999999865422 2233567889999999999999999999998766 78
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+. +++.+++... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 80 ~lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 99999997 5787777543 3588999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCC-CcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhh--------
Q 002069 856 LKLGL-SNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSN-------- 919 (973)
Q Consensus 856 ~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~-------- 919 (973)
..... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||........ ..+..
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 54332 222345678999999998774 478999999999999999999999975432110 00000
Q ss_pred hhhhhhhhcC-CCCCCCch----hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 920 LNIALDEMLD-PRLPTPLR----NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 920 ~~~~~~~~~~-~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.......... +..+.... ........+.+++.+|++.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000 00000000 001123457889999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=312.56 Aligned_cols=253 Identities=25% Similarity=0.385 Sum_probs=202.8
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+..|++++++++|||++++++++..+...++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 456899999999999999999654 7899999998643 223357789999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 81 IEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred eeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 99999999999986543 3588999999999999999999999 999999999999999999999999999876654
Q ss_pred CCCcccccccccCcccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 859 GLSNRTELAGTFGYIAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
.........+++.|+|||.+. ...++.++||||||+++|||++|+.||........ .........+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~---------~~~~~~~~~~ 226 (280)
T cd06611 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV---------LLKILKSEPP 226 (280)
T ss_pred cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH---------HHHHhcCCCC
Confidence 433344567899999999874 34567899999999999999999999874432110 0111111100
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...........+.+++.+||+.+|.+||++.++++.
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 -TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 011111233457889999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=309.67 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=204.4
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 778 (973)
...|++.++||+||.+.||++...+.+.||+|++..... +.....-|.+|+..+.++ .|.+||++++|-..++..|+|
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 467999999999999999999988889999988765433 334467899999999999 599999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||-+ .+|..+++..... ...| .++.+..||+.|+.+.|++ ||||.|+||.|+++- .|.+||+|||.|..+..
T Consensus 439 mE~Gd-~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred eeccc-ccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 99764 7999999765532 2234 7788999999999999999 999999999999886 58999999999998877
Q ss_pred CCC--cccccccccCcccccccccCC-----------CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhh
Q 002069 859 GLS--NRTELAGTFGYIAPELAYTMK-----------VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALD 925 (973)
Q Consensus 859 ~~~--~~~~~~g~~~y~aPE~~~~~~-----------~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 925 (973)
+.. .....+||+.||+||.+.... .+.++||||+||++|+|+.|+.||...... ...+.
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~--------~aKl~ 583 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ--------IAKLH 583 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH--------HHHHH
Confidence 643 345689999999999986432 557899999999999999999999744322 33345
Q ss_pred hhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 926 EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.+.+|....++..... ..++.++++.|++.||++||+..++++.
T Consensus 584 aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 584 AITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred hhcCCCccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 5566633222222211 1227788999999999999999999863
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=308.10 Aligned_cols=258 Identities=28% Similarity=0.407 Sum_probs=205.8
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||.|+||+||+|.. .++..||+|++....... ..+.+.+|+..++.++|+|++++++.+..+...++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 4688999999999999999965 478899999987543322 4578999999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.++++.......+++..+..++.|++.|++|||+. +++|||++|+||++++++.++++|||.+..+...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 9999999999997654435688999999999999999999999 9999999999999999999999999998776544
Q ss_pred CCc----ccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCC
Q 002069 860 LSN----RTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934 (973)
Q Consensus 860 ~~~----~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (973)
... .....|+..|+|||++... .++.++|||||||++|||++|+.||......... ...... ..+....
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~-----~~~~~~-~~~~~~~ 229 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL-----MLTLQN-DPPSLET 229 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH-----HHHhcC-CCCCcCC
Confidence 322 1334688999999998776 7889999999999999999999999744321100 000000 0111111
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
. ......+..+.+++.+||+.||++||+++++++.
T Consensus 230 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 230 G-ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred c-cccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1 0011334567899999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=312.38 Aligned_cols=252 Identities=23% Similarity=0.370 Sum_probs=200.4
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.+.|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++|+|++++++++..+...++|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 367899999999999999999664 6899999998753 223357788999999999999999999999988899999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||++++++..++.+.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 88 ~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 88 IEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 99999999998875433 3578999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCcccccccccCcccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 859 GLSNRTELAGTFGYIAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
.........+++.|+|||++. ...++.++|||||||++|||++|+.||....... ..........+
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---------~~~~~~~~~~~ 233 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---------VLLKIAKSEPP 233 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH---------HHHHHhcCCCc
Confidence 333334456889999999885 3456789999999999999999999986433210 11111111110
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
...........+.+++.+||+.||++||+++++++
T Consensus 234 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 -TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00111123345788999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=344.24 Aligned_cols=256 Identities=21% Similarity=0.319 Sum_probs=199.2
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec--ccee
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH--ALHS 775 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 775 (973)
...+|.+.+.||+|+||+||+|... +++.||+|.+...... ......|..|+.++++++|||||++++++.+ ....
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 4568999999999999999999654 6788999998754322 2335778999999999999999999998854 3568
Q ss_pred EEEEEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCC----CCeEeecCCCCCeeecCC--------
Q 002069 776 FVVYEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCF----PPIVHRDISSKNVLLNLE-------- 842 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~----~~i~H~Dlk~~Nill~~~-------- 842 (973)
|+||||+++++|.+++.... ....+++..++.|+.||+.||+|||+... .+|+||||||+|||++.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999996533 22468999999999999999999998521 259999999999999642
Q ss_pred ---------CceEEecccccccccCCCCcccccccccCccccccccc--CCCCCccchHHHHHHHHHHHhCCCCCcchhh
Q 002069 843 ---------YEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISS 911 (973)
Q Consensus 843 ---------~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 911 (973)
+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 358999999998764432 2234579999999999854 4588999999999999999999999974332
Q ss_pred hhhhhhhhhhhhhhhhcC-CCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 912 ICSSLSSNLNIALDEMLD-PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
.... ...+.. +.++. ...+..+.++|..||+.+|.+||++.++++
T Consensus 249 ~~ql--------i~~lk~~p~lpi-----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 249 FSQL--------ISELKRGPDLPI-----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHH--------HHHHhcCCCCCc-----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 2111 111111 11111 112345789999999999999999999985
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=311.73 Aligned_cols=249 Identities=26% Similarity=0.379 Sum_probs=201.4
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
+.|+..+.||+|+||.||+|.. .+++.||+|.+...... ...+.+.+|+.++++++||||+++++++..+...++||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch--HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 3467778899999999999954 47889999998644322 23578899999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+++.. ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+......
T Consensus 82 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 82 EYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 99999999999864 3578899999999999999999998 9999999999999999999999999999876544
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
........++..|+|||++.+..++.++|||||||++|||++|+.||........ .........+...
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~~~~~~~~~~~------ 222 (277)
T cd06642 155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LFLIPKNSPPTLE------ 222 (277)
T ss_pred chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------HhhhhcCCCCCCC------
Confidence 3333345688999999999988899999999999999999999999863321100 0000000111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...+..+.+++.+||+.+|.+||++.++++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1234457899999999999999999999874
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=313.83 Aligned_cols=259 Identities=23% Similarity=0.324 Sum_probs=201.7
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||.||+|.. .+++.||+|.++... ......++.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 3688999999999999999965 478899999987542 2233567889999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.++++.. ..+++..+..++.|+++|++|||+.. +++|+||||+||+++.++.+|++|||.+......
T Consensus 79 ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 79 EHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred eccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999999999754 35789999999999999999999842 8999999999999999999999999998765432
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhh--hhhhhhhh----------------
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIC--SSLSSNLN---------------- 921 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~---------------- 921 (973)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ........
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 2234578899999999988889999999999999999999999986332110 00000000
Q ss_pred ---------hhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 922 ---------IALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 922 ---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...........+.. ........+.+++.+||+.||++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKL--PSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccC--cCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000000 001133458899999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=304.82 Aligned_cols=251 Identities=25% Similarity=0.414 Sum_probs=201.5
Q ss_pred cCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
.+|++.+.||+|+||.||+|.+.+++.+|+|.+...... ..+|.+|++++++++||+++++++++......++|||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 468888999999999999998777889999998754322 3678899999999999999999999998889999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++++|.+++.... ..+++..++.++.|++.|++|||+. +++|+||||+||+++.++.++++|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 80 FMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 999999999986543 3578999999999999999999999 99999999999999999999999999987654332
Q ss_pred Cc-ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 861 SN-RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 861 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.. .....++..|+|||++.+..++.++||||+|+++|||++ |+.||....... . .....+......+.
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-~-----~~~~~~~~~~~~~~---- 224 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-V-----VETINAGFRLYKPR---- 224 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-H-----HHHHhCCCCCCCCC----
Confidence 11 122345678999999998889999999999999999998 999986432110 0 00011100111011
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+..+.+++.+||+.+|++||++.++++.|.
T Consensus 225 --~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 --LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 12345888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=321.45 Aligned_cols=257 Identities=20% Similarity=0.233 Sum_probs=196.8
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||++..+ +++.||+|++.............+..|+.++..++|++|+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36889999999999999999664 67889999986422222223456888999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|+|.+++++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999999997532 3578899999999999999999999 9999999999999999999999999998765433
Q ss_pred CC-cccccccccCcccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 860 LS-NRTELAGTFGYIAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 860 ~~-~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
.. ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ ............++
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~-----~~~i~~~~~~~~~p 230 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----YGKIMNHKERFQFP 230 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH-----HHHHhCCCccccCC
Confidence 22 223357999999999986 34578899999999999999999999974432111 01111111111122
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCC--CCCHHHHHHH
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTS--RPTMQKVSQL 970 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~ 970 (973)
... ......+.+++.+|+..+|.+ |++++++++.
T Consensus 231 ~~~---~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 231 AQV---TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred Ccc---ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 111 122345677888888655544 7899998764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=308.16 Aligned_cols=252 Identities=28% Similarity=0.495 Sum_probs=200.7
Q ss_pred cCCcccccccCCCceeEEEEEcC-CC---CEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TG---EIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (973)
.+|+..+.||+|+||.||+|... ++ ..||+|.+..... ....+.+..|+.++++++|+|++++.+++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 46788899999999999999654 33 3799999865422 233577899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
+||||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+...
T Consensus 83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 83 IITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999996543 4688999999999999999999999 9999999999999999999999999998766
Q ss_pred cCCCCcc---cccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCC-C
Q 002069 857 KLGLSNR---TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDP-R 931 (973)
Q Consensus 857 ~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~ 931 (973)
....... .....++.|+|||++.+..++.++|||||||++||+++ |+.||...... ......... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---------~~~~~i~~~~~ 228 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---------EVMKAINDGFR 228 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---------HHHHHHhcCCC
Confidence 4332211 11223457999999988889999999999999999997 99998633210 111111111 1
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+.. ...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 229 ~~~~----~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~ 265 (268)
T cd05063 229 LPAP----MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD 265 (268)
T ss_pred CCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1111 123456789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=304.77 Aligned_cols=240 Identities=21% Similarity=0.377 Sum_probs=188.0
Q ss_pred ccccCCCceeEEEEEcCC-------------CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc
Q 002069 707 HCIGNGGQGSVYKAELPT-------------GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL 773 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 773 (973)
+.||+|+||.||+|...+ ...||+|.+.... ......|.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999996532 2258999876532 233567889999999999999999999999888
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCc-------eE
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYE-------AH 846 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~-------~k 846 (973)
..++||||+++++|..++.... ..+++..+++++.||+.|++|||+. +|+||||||+||+++.++. ++
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence 9999999999999999886433 3588999999999999999999999 9999999999999987654 89
Q ss_pred EecccccccccCCCCcccccccccCcccccccc-cCCCCCccchHHHHHHHHHHH-hCCCCCcchhhhhhhhhhhhhhhh
Q 002069 847 VSDFGISKFLKLGLSNRTELAGTFGYIAPELAY-TMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIAL 924 (973)
Q Consensus 847 l~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~-tg~~p~~~~~~~~~~~~~~~~~~~ 924 (973)
++|||.+..... .....++..|+|||.+. +..++.++|||||||++|||+ +|..||....... .
T Consensus 153 l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----------~ 218 (262)
T cd05077 153 LSDPGIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE----------K 218 (262)
T ss_pred eCCCCCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH----------H
Confidence 999999865432 22346788999999886 466889999999999999998 5888876332110 0
Q ss_pred hhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 925 DEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
............ .....+.+++.+||+.||.+||++.++++.++
T Consensus 219 ~~~~~~~~~~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 219 ERFYEGQCMLVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHHhcCccCCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 001111111110 11235788999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=315.43 Aligned_cols=261 Identities=18% Similarity=0.233 Sum_probs=198.9
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||.||+|... +++.||+|.+....... ....+.+|+.++++++||||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 57999999999999999999654 78899999986543222 2356778999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||++ ++|.+++.... ..+++..+..++.|++.|++|||+. +++|+||||+||+++.++.+|++|||.+......
T Consensus 84 e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 84 EYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred eccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 9997 58988886543 3578899999999999999999999 9999999999999999999999999999765443
Q ss_pred CCcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhhhhhhhhhhc----
Q 002069 860 LSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSNLNIALDEML---- 928 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~---- 928 (973)
........+++.|+|||.+.+. .++.++|||||||++|||+||+.||........ .............+
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 3333445678999999988654 478899999999999999999999974331100 00000000000000
Q ss_pred --CCCCCCCch-----hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 929 --DPRLPTPLR-----NVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 929 --~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
....+.... ........+.+++.+|++.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000010000 00112345788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=308.52 Aligned_cols=251 Identities=29% Similarity=0.449 Sum_probs=201.3
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcch------hhHHHHHHHHHHhhcCCCCceeeeceeeeccce
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEM------ACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH 774 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 774 (973)
+|.+...||+|+||.||+|.. .+++.||+|.+........ ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999955 4788999998875433221 223578899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999997543 578899999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCC------cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhc
Q 002069 855 FLKLGLS------NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML 928 (973)
Q Consensus 855 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 928 (973)
....... ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.......... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~ 228 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF------KIGENA 228 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH------HHhccC
Confidence 7653211 1123457889999999998889999999999999999999999997433211100 011111
Q ss_pred CCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 929 DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.+..+. .....+.+++.+||+.||.+||++.++++.
T Consensus 229 ~~~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 229 SPEIPS------NISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CCcCCc------ccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 222221 223457789999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=321.20 Aligned_cols=257 Identities=21% Similarity=0.235 Sum_probs=197.9
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||+++.. +++.||+|++.............+.+|..++..++|++|+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46899999999999999999654 78899999986432222233456888999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|+|.+++.... ..+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999997532 3578899999999999999999999 9999999999999999999999999999876543
Q ss_pred CC-cccccccccCccccccccc-----CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 860 LS-NRTELAGTFGYIAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 860 ~~-~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
.. ......|++.|+|||++.+ ..++.++|||||||++|||++|+.||........ ............++
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-----~~~i~~~~~~~~~p 230 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----YGKIMNHEERFQFP 230 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH-----HHHHHcCCCcccCC
Confidence 22 2233569999999999875 4578899999999999999999999974332110 01111100111112
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCC--CCCHHHHHHH
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTS--RPTMQKVSQL 970 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~ 970 (973)
... ...+..+.+++.+|+..++++ |++++++.+.
T Consensus 231 ~~~---~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 231 SHI---TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred Ccc---ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 211 122345778888988866554 5688888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=311.58 Aligned_cols=262 Identities=25% Similarity=0.374 Sum_probs=198.7
Q ss_pred cCCcccccccCCCceeEEEEEc-----CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec--cc
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-----PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH--AL 773 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~ 773 (973)
.+|++.+.||+|+||+||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4788899999999999999963 367899999987542 2335678999999999999999999998743 34
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
..++||||+++++|.+++.+.. ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence 6789999999999999996543 3578999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcc---cccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhh-hhhhhhh-----hhhh
Q 002069 854 KFLKLGLSNR---TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIC-SSLSSNL-----NIAL 924 (973)
Q Consensus 854 ~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~-----~~~~ 924 (973)
+......... ....++..|+|||+..+..++.++|||||||++|||++|..|+....... ....... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 8765432211 11223456999999988889999999999999999999887754322110 0000000 0001
Q ss_pred hhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 925 DEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+.+......+ .....+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 236 ~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05081 236 IELLKNNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281 (284)
T ss_pred HHHHhcCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 11111111000 01122345889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=304.87 Aligned_cols=248 Identities=27% Similarity=0.408 Sum_probs=198.0
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeee-ccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCS-HALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|.. .|+.||+|.+.... ..+.+.+|+.++++++|++++++++++. .+...++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 35788999999999999999976 57889999986431 2467899999999999999999999764 45578999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.++++... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++....
T Consensus 79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 79 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred EECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 99999999999997543 23478999999999999999999999 999999999999999999999999999875543
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
. .....++..|+|||++.+..++.++|||||||++|||++ |+.||...... . . .........+..+
T Consensus 155 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~-~-~----~~~~~~~~~~~~~---- 221 (256)
T cd05082 155 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-D-V----VPRVEKGYKMDAP---- 221 (256)
T ss_pred c---CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-H-H----HHHHhcCCCCCCC----
Confidence 2 122345678999999998889999999999999999997 99998633210 0 0 0001110111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+..+.+++.+|++.+|++|||++++++.|+
T Consensus 222 --~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 254 (256)
T cd05082 222 --DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254 (256)
T ss_pred --CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence 122345788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=308.10 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=203.4
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
..|+..+.||+|+||.||+|.. .+++.||+|.+..... ......+.+|+.++++++|+||+++++++.++...++||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 4577889999999999999965 4688999999874422 233578899999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+++... ++++.++..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||.+......
T Consensus 82 e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 82 EYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred ecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999999998642 478899999999999999999998 9999999999999999999999999999776544
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
........++..|+|||++.+..++.++|||||||++|||+||+.||........ . .......+. ...
T Consensus 155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---------~-~~~~~~~~~--~~~ 222 (277)
T cd06640 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV---------L-FLIPKNNPP--TLT 222 (277)
T ss_pred ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH---------h-hhhhcCCCC--CCc
Confidence 3333445678899999999888899999999999999999999999874332110 0 001111111 112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...+..+.+++.+||+.+|++||+++++++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2345678899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=321.85 Aligned_cols=261 Identities=20% Similarity=0.274 Sum_probs=197.4
Q ss_pred HhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc-----
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA----- 772 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 772 (973)
..++|++.+.||+|+||.||+|.. ..++.||||++...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 457899999999999999999954 47899999998754322 23356788999999999999999999987543
Q ss_pred -ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccc
Q 002069 773 -LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFG 851 (973)
Q Consensus 773 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg 851 (973)
...++||||+++ ++.+++.. .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 356999999975 67766642 467889999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh------h-------h
Q 002069 852 ISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL------S-------S 918 (973)
Q Consensus 852 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~------~-------~ 918 (973)
+++..... .......+++.|+|||++.+..++.++|||||||++|||++|+.||.......... . .
T Consensus 172 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 172 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred CccccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 99865433 22334578999999999999999999999999999999999999997543211100 0 0
Q ss_pred hhhhhhhhhcC--CCC--------------CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 919 NLNIALDEMLD--PRL--------------PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 919 ~~~~~~~~~~~--~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
........... +.. +............+.+++.+|++.||.+|||+.++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000 000 00000001123457899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=309.57 Aligned_cols=262 Identities=21% Similarity=0.333 Sum_probs=200.6
Q ss_pred cCCcccccccCCCceeEEEEEc-----CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc--c
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-----PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA--L 773 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~ 773 (973)
+.|++.+.||+|+||.||.+.. .+++.||+|.++.... ......+.+|+.++++++|||++++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 4578899999999999999963 3678899999875432 23356899999999999999999999998764 5
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
..++||||+++++|.+++.+.. ..+++.+++.++.|++.|++|+|+. +++||||||+||+++.++.++++|||.+
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence 6789999999999999986543 3578999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCc---ccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhh-hhh----hh-hhhhhh
Q 002069 854 KFLKLGLSN---RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIC-SSL----SS-NLNIAL 924 (973)
Q Consensus 854 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-~~~----~~-~~~~~~ 924 (973)
+........ .....++..|+|||++.+..++.++||||||+++|||+|++.|+....... ... .. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 876543221 123456778999999988889999999999999999999877643211000 000 00 000011
Q ss_pred hhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 925 DEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
........... ....+..+.+++.+||+.+|++||+++++++.++
T Consensus 237 ~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 281 (284)
T cd05079 237 RVLEEGKRLPR---PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE 281 (284)
T ss_pred HHHHcCccCCC---CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 11111111110 1123456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=306.07 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=192.1
Q ss_pred ccccCCCceeEEEEEcC-CCC--EEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEEEEEec
Q 002069 707 HCIGNGGQGSVYKAELP-TGE--IVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFVVYEYL 782 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 782 (973)
+.||+|+||.||+|... ++. .+|+|.++.... ....+.+.+|++++.++ +||||+++++++......++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC--HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 46899999999999664 444 478888874322 23356788999999999 8999999999999988999999999
Q ss_pred CCCChHHHhccCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEec
Q 002069 783 EMGSLAMILSNDAA-------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSD 849 (973)
Q Consensus 783 ~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~D 849 (973)
++++|.+++..... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECC
Confidence 99999999965431 23478999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhc
Q 002069 850 FGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEML 928 (973)
Q Consensus 850 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 928 (973)
||++...... ........++.|+|||++.+..++.++|||||||++|||++ |..||...... .. .. ......
T Consensus 156 fgl~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~----~~-~~~~~~ 228 (270)
T cd05047 156 FGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-EL----YE-KLPQGY 228 (270)
T ss_pred CCCccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-HH----HH-HHhCCC
Confidence 9998633211 11112234567999999988889999999999999999997 99998643211 00 00 011100
Q ss_pred CCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 929 DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
....+ ......+.+++.+||+.+|.+|||++++++.|+
T Consensus 229 ~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 266 (270)
T cd05047 229 RLEKP------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 266 (270)
T ss_pred CCCCC------CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 11111 112335789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=303.95 Aligned_cols=252 Identities=24% Similarity=0.428 Sum_probs=202.7
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.++|++.+.||+|+||.||+|...++..||+|.+.... .....+.+|+.++++++|+|++++++++.+ ...++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 46799999999999999999987778889999887431 225678999999999999999999999887 6789999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+++.... ...+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.+|++|||.+......
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 80 EFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999999997543 34578899999999999999999998 9999999999999999999999999999766443
Q ss_pred CCc-ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 860 LSN-RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 860 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
... .....++..|+|||++....++.++|||||||++|+++| |+.||....... ......... ..+..
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~------~~~~~~~~~--~~~~~-- 225 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE------VIRALERGY--RMPRP-- 225 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCC--CCCCc--
Confidence 221 222345678999999988889999999999999999999 999987432110 000011100 11111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+..+.+++.+|++.+|++||++.++.+.|+
T Consensus 226 --~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~ 258 (260)
T cd05073 226 --ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258 (260)
T ss_pred --ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 123345789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=304.81 Aligned_cols=253 Identities=26% Similarity=0.339 Sum_probs=190.3
Q ss_pred ccccCCCceeEEEEEcC---CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecC
Q 002069 707 HCIGNGGQGSVYKAELP---TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLE 783 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 783 (973)
+.||+|+||.||+|... ++..+|+|.+...... .....+.+|+.++++++||||+++++++.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999653 3457999988754322 234678899999999999999999999998889999999999
Q ss_pred CCChHHHhccCcc--ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC
Q 002069 784 MGSLAMILSNDAA--AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS 861 (973)
Q Consensus 784 ~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 861 (973)
+|+|.++++.... ....++..+..++.|++.|++|||+. +++|+||||+||+++.++++|++|||.++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 9999999965432 23456778889999999999999999 999999999999999999999999999875443321
Q ss_pred --cccccccccCcccccccccC-------CCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 862 --NRTELAGTFGYIAPELAYTM-------KVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 862 --~~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
......+++.|+|||++.+. .++.++||||||+++|||++ |+.||.......... ............+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~ 234 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT-YTVREQQLKLPKPR 234 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH-HHhhcccCCCCCCc
Confidence 12234578889999988642 35789999999999999996 999997443211100 00000000111111
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.. ......+.+++..|| .+|++|||++||++.|.
T Consensus 235 ~~------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 235 LK------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cC------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11 012234667888999 58999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=306.16 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=201.2
Q ss_pred CCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCc---chhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPG---EMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
+|.+.+.||+|+||+||+|...+++.||||.+...... .......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47888999999999999998778999999988644221 122345688999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.+++.+.. .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999996543 478899999999999999999998 999999999999999999999999999876532
Q ss_pred C------CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 859 G------LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 859 ~------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
. ........++..|+|||++.+..++.++||||+|+++|+|++|+.||.......... .........+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~ 230 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF----YIGAHRGLMPRL 230 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH----HhhhccCCCCCC
Confidence 1 111223568899999999998889999999999999999999999997433211110 000000011111
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
+. .....+.+++.+||+.+|.+||++.++++
T Consensus 231 ~~------~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 231 PD------SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CC------CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11 12345788999999999999999999976
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=310.51 Aligned_cols=263 Identities=22% Similarity=0.295 Sum_probs=202.0
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+.++++++|+|++++++++......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 36889999999999999999665 6899999998654322 122466889999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||++++.+..+.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|||.+......
T Consensus 80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 80 EYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred eccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999999888876543 2578999999999999999999998 9999999999999999999999999999877554
Q ss_pred CCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh--hhhhhhh---h---------
Q 002069 860 LSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL--SSNLNIA---L--------- 924 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~--~~~~~~~---~--------- 924 (973)
........++..|+|||++.+ ..++.++||||||+++|||++|+.||.......... ....... .
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 333344567889999999876 457889999999999999999999997543211100 0000000 0
Q ss_pred -hhhcCCCCCCCc---hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 925 -DEMLDPRLPTPL---RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 925 -~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+...... .........+.+++.+||+.||++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000001000000 0011224567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=313.97 Aligned_cols=248 Identities=27% Similarity=0.381 Sum_probs=199.5
Q ss_pred CcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEe
Q 002069 703 FDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEY 781 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 781 (973)
|.....||+|+||.||++.. .+++.||||.+.... ....+.+.+|+..++.++|+|++++++.+..++..++||||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 44456799999999999965 478999999986432 23356788999999999999999999999999999999999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS 861 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 861 (973)
+++++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+........
T Consensus 101 ~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 101 LEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 9999999988532 478899999999999999999999 999999999999999999999999999876654433
Q ss_pred cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHH
Q 002069 862 NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQD 941 (973)
Q Consensus 862 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (973)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ . ........+.... ...
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~-----~~~~~~~~~~~~~----~~~ 243 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-M-----RRIRDNLPPRVKD----SHK 243 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H-----HHHHhcCCCcccc----ccc
Confidence 33445689999999999888899999999999999999999999874332110 0 0111111222111 112
Q ss_pred HHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 942 KLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 942 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
....+.+++.+|++.||.+|||++++++.
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 33457788999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=307.88 Aligned_cols=253 Identities=28% Similarity=0.488 Sum_probs=200.3
Q ss_pred cCCcccccccCCCceeEEEEEcC-CC---CEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TG---EIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (973)
..|++.+.||+|+||.||+|... ++ ..||||.+.... .....++|..|+.+++.++||||+++++++..+...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 35788999999999999999654 33 369999987542 2334678999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
+||||+++++|.++++... ..+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.+|++|||.+...
T Consensus 82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 82 IITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccc
Confidence 9999999999999997543 3578999999999999999999999 9999999999999999999999999998766
Q ss_pred cCCCCcc--cc-cc--cccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCC
Q 002069 857 KLGLSNR--TE-LA--GTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDP 930 (973)
Q Consensus 857 ~~~~~~~--~~-~~--g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (973)
....... .. .. .+..|+|||++.+..++.++||||+||++||+++ |..||....... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~------~~~~i~~~~-- 228 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD------VINAIEQDY-- 228 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH------HHHHHHcCC--
Confidence 4432211 11 11 2457999999998899999999999999999886 999986432110 001111111
Q ss_pred CCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 931 RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 931 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+.. .+.+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 229 ~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 266 (269)
T cd05065 229 RLPPP----MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266 (269)
T ss_pred cCCCc----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111 123445788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.85 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=201.9
Q ss_pred cCCcccccccCCCceeEEEEEcCC-CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPT-GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
+-|.++..||.|+||.||+|..++ +-..|-|++.. ...+..++|.-|++++...+||+||++++.|..++..||..
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 446677889999999999996653 44456676653 34455789999999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
|||.||-...++-.- ...+++.++.-+++|++.||.|||++ .|||||+|+.|||++-+|.++++|||.+......
T Consensus 109 EFC~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred eecCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH
Confidence 999999998887543 35789999999999999999999999 9999999999999999999999999998765555
Q ss_pred CCcccccccccCcccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCC
Q 002069 860 LSNRTELAGTFGYIAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (973)
......+.|||.|||||+.. ..+|+.++||||||+++.||..+.+|......+.- +-.+. ..-|+
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV---------llKia-KSePP 253 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---------LLKIA-KSEPP 253 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH---------HHHHh-hcCCC
Confidence 45567789999999999864 46799999999999999999999999764332211 11111 11111
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
....+..-...+.+++..|+..+|..||++++++++
T Consensus 254 TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 254 TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 111122233457788889999999999999999864
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=318.99 Aligned_cols=263 Identities=21% Similarity=0.291 Sum_probs=197.2
Q ss_pred HHHHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc--
Q 002069 696 IIRATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA-- 772 (973)
Q Consensus 696 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-- 772 (973)
.....++|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 334567899999999999999999954 57889999998754322 22346678899999999999999999987533
Q ss_pred ----ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEe
Q 002069 773 ----LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVS 848 (973)
Q Consensus 773 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~ 848 (973)
...++++|++ +++|.++++. ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 3568999987 6889888753 3588999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhhhh
Q 002069 849 DFGISKFLKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSNLN 921 (973)
Q Consensus 849 Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~ 921 (973)
|||+++..... .....|++.|+|||++.+ ..++.++||||+||++|+|++|+.||........ .......
T Consensus 161 Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 161 DFGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred CCccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999865432 234578999999999876 5688999999999999999999999974331100 0000000
Q ss_pred h--------hhhhhcC--CCCCCC-ch-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 922 I--------ALDEMLD--PRLPTP-LR-NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 922 ~--------~~~~~~~--~~~~~~-~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
. ....... +..+.. .. ........+.+++.+|++.||.+|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000000 000000 00 000112346789999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=311.97 Aligned_cols=261 Identities=26% Similarity=0.359 Sum_probs=202.9
Q ss_pred HHHHHHHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeee
Q 002069 693 HEEIIRATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCS 770 (973)
Q Consensus 693 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 770 (973)
.+++..+.++|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.++.++ +|||++++++++.
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 344555678999999999999999999965 578999999986431 1246677899999998 8999999999986
Q ss_pred cc-----ceeEEEEEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCc
Q 002069 771 HA-----LHSFVVYEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYE 844 (973)
Q Consensus 771 ~~-----~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~ 844 (973)
.. ...++||||+++++|.++++... ....+++..++.++.|++.|++|||+. +++||||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 43 35799999999999999886432 234688999999999999999999998 9999999999999999999
Q ss_pred eEEecccccccccCCCCcccccccccCcccccccccC-----CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhh
Q 002069 845 AHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSN 919 (973)
Q Consensus 845 ~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 919 (973)
+|++|||.+..............|+..|+|||.+... .++.++|||||||++|||++|+.||..........
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~--- 243 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF--- 243 (291)
T ss_pred EEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH---
Confidence 9999999988765443333445688999999987543 36789999999999999999999987433211100
Q ss_pred hhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 920 LNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
. ......+.+. ........+.+++.+||+.+|++||++.++++.
T Consensus 244 --~-~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 --K-IPRNPPPTLL----HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred --H-HhcCCCCCCC----cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 0000011111 111233458899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=313.89 Aligned_cols=254 Identities=23% Similarity=0.277 Sum_probs=204.6
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|+..+.||+|+||.||+|... +++.||+|.+...........+.+..|+++++.++|++|+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999654 68999999997654443334677899999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+.+++|.++++... ...+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++++|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999987432 34689999999999999999999999 9999999999999999999999999998755322
Q ss_pred CC-----------------------------cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchh
Q 002069 860 LS-----------------------------NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS 910 (973)
Q Consensus 860 ~~-----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 910 (973)
.. ......|+..|+|||+..+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 11 1113467889999999998889999999999999999999999997443
Q ss_pred hhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCC----HHHHHH
Q 002069 911 SICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPT----MQKVSQ 969 (973)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~ev~~ 969 (973)
.. ............... .......+.+++.+|++.||++||+ ++++++
T Consensus 237 ~~---------~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RD---------ETFSNILKKEVTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hH---------HHHHHHhcCCccCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 21 111111121111111 1114456889999999999999999 777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=284.17 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=195.9
Q ss_pred CCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 779 (973)
..+.+..+|.|..|.||+++.. +|...|||.+.+.... +..+++...++++..- ++|+||+.+|||......++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk--ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH--HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 3455677999999999999665 6899999999875433 3467788888876555 5999999999999988899999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
|.|. ...+.++++-. .++++.-+-++...+++||.||-++. +|+|||+||+|||+|+.|.+|++|||.+.++-+.
T Consensus 171 elMs-~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 171 ELMS-TCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHH-HHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 9885 45666665433 45788888899999999999999985 9999999999999999999999999999876543
Q ss_pred CCcccccccccCccccccccc---CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 860 LSNRTELAGTFGYIAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
...+..+|.+.|||||.+.. ..|+.++||||||++++|++||+.||..-.-....+. .... -..|.++..
T Consensus 246 -kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt----kvln-~ePP~L~~~- 318 (391)
T KOG0983|consen 246 -KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT----KVLN-EEPPLLPGH- 318 (391)
T ss_pred -cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH----HHHh-cCCCCCCcc-
Confidence 34456789999999998864 4688999999999999999999999975321111111 1111 111222222
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...+..+.+++..|+++|+.+||...+++++
T Consensus 319 ---~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 319 ---MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ---cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 2244567889999999999999999998864
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=315.66 Aligned_cols=255 Identities=23% Similarity=0.345 Sum_probs=200.6
Q ss_pred cCCcccccccCCCceeEEEEEcC--------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeec
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP--------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSH 771 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 771 (973)
.+|++.+.||+|+||.||+|... .+..||+|.+..... ....+++.+|+.+++++ +||||+++++++..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--DKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC--HHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 46899999999999999999542 123689998875422 22357889999999999 89999999999999
Q ss_pred cceeEEEEEecCCCChHHHhccCc-------------cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCee
Q 002069 772 ALHSFVVYEYLEMGSLAMILSNDA-------------AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVL 838 (973)
Q Consensus 772 ~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nil 838 (973)
.+..++||||+++|+|.+++.... ....+++.++..++.|++.|++|||+. +++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence 889999999999999999996532 223578899999999999999999999 9999999999999
Q ss_pred ecCCCceEEecccccccccCCCCc--ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhh
Q 002069 839 LNLEYEAHVSDFGISKFLKLGLSN--RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSS 915 (973)
Q Consensus 839 l~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~ 915 (973)
++.++.+||+|||.++........ .....++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---- 242 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---- 242 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH----
Confidence 999999999999999866543221 122234567999999999899999999999999999998 8898864321
Q ss_pred hhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 916 LSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
................ ......+.+++.+||+.+|.+||++.++++.|+
T Consensus 243 -----~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~ 291 (334)
T cd05100 243 -----EELFKLLKEGHRMDKP---ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291 (334)
T ss_pred -----HHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 1111111111111111 122345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=318.78 Aligned_cols=192 Identities=21% Similarity=0.321 Sum_probs=164.4
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
...+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++|+||+++++++..+...++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 3457999999999999999999654 6789999985422 23468899999999999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||||+. +++.+++.... ..+++.+++.++.||+.|++|||+. +|+||||||+||+++.++.+||+|||.++...
T Consensus 135 v~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 999995 68888886433 4689999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPR 906 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~ 906 (973)
.. .......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 209 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 22 2223456899999999999999999999999999999999865543
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=304.85 Aligned_cols=253 Identities=25% Similarity=0.343 Sum_probs=203.3
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec--cceeEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH--ALHSFVV 778 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv 778 (973)
+|++.+.+|+|+||.||+|.. .+++.||+|++...... ....+.+..|++++++++|+|++++++++.. +...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 478889999999999999954 57899999998754332 3335778899999999999999999998753 4467899
Q ss_pred EEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 779 YEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMH-----TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH-----~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
|||+++++|.+++.... ....+++.+++.++.|++.|++||| +. +++|+||+|+||+++.++.+|++|||.
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccc
Confidence 99999999999996532 2356899999999999999999999 66 899999999999999999999999999
Q ss_pred cccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
+..............+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~~~~ 227 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---------LQLASKIKEGKF 227 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---------HHHHHHHhcCCC
Confidence 98776554334456789999999999988899999999999999999999999974431 011111111111
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
+... ......+.+++.+|++.+|.+||++.+|++.
T Consensus 228 ~~~~---~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 RRIP---YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCc---cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111 1233467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=305.31 Aligned_cols=257 Identities=22% Similarity=0.361 Sum_probs=201.4
Q ss_pred CCcccccccCCCceeEEEEEcCC--CCEEEEEEcCCCCC-------cchhhHHHHHHHHHHhhc-CCCCceeeeceeeec
Q 002069 702 NFDDEHCIGNGGQGSVYKAELPT--GEIVAVKKFHSPLP-------GEMACQQEFLNEGNALTK-IRHRNIVKFYGFCSH 771 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~-------~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~ 771 (973)
.|++.+.||+|+||.||+|.... ++.||+|.+..... .......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999997654 78899998753221 122334567788888765 799999999999999
Q ss_pred cceeEEEEEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecc
Q 002069 772 ALHSFVVYEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDF 850 (973)
Q Consensus 772 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df 850 (973)
.+..++||||+++++|.+++.... ....+++..++.++.|++.|++|||+.. +++|+||+|+||+++.++.+|++||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999999885422 2346889999999999999999999742 8999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCC
Q 002069 851 GISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDP 930 (973)
Q Consensus 851 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (973)
|.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .........
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---------~~~~~~~~~ 228 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---------SLATKIVEA 228 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---------HHHHHHhhc
Confidence 9998765442 334456889999999999888999999999999999999999998633211 011111111
Q ss_pred CCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 931 RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 931 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
....... ......+.+++.+||+.||.+||++.|+.++++
T Consensus 229 ~~~~~~~--~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYEPLPE--GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCCcCCc--ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111000 112345788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=304.86 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=189.1
Q ss_pred ccccCCCceeEEEEEcC---CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecC
Q 002069 707 HCIGNGGQGSVYKAELP---TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLE 783 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 783 (973)
+.||+|+||+||+|... ....||+|.+.... .......+.+|+..++.++|+||+++++++.+....++||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 36999999999999543 34578889876432 22335678899999999999999999999999999999999999
Q ss_pred CCChHHHhccCcc--ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC
Q 002069 784 MGSLAMILSNDAA--AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS 861 (973)
Q Consensus 784 ~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 861 (973)
+|+|.+++..... ....++.....++.||+.|++|||+. +|+||||||+||+++.++.+|++|||.+........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 9999999976542 23356788899999999999999999 999999999999999999999999999875433221
Q ss_pred --cccccccccCccccccccc-------CCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 862 --NRTELAGTFGYIAPELAYT-------MKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 862 --~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
......+++.|+|||++.. ..++.++|||||||++|||++ |..||........ . ...... ....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~----~~~~~~-~~~~ 229 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-L----KQVVRE-QDIK 229 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-H----HHHhhc-cCcc
Confidence 1233456778999998643 356789999999999999999 7888864332110 0 000110 1111
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+.+. ........+.+++..|| .||++|||+++|++.|.
T Consensus 230 ~~~~~-~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQ-LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCc-ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11110 01122344567778898 59999999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=301.44 Aligned_cols=247 Identities=28% Similarity=0.421 Sum_probs=198.2
Q ss_pred ccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCCCC
Q 002069 707 HCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGS 786 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 786 (973)
++||+|+||.||+|...+++.||+|.+...... .....+.+|++++++++|+||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 469999999999997766999999998765333 345789999999999999999999999999999999999999999
Q ss_pred hHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCcc--c
Q 002069 787 LAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR--T 864 (973)
Q Consensus 787 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~ 864 (973)
|.+++.... ..+++..+..++.+++.|++|||++ +++||||+|+||+++.++.+|++|||.+.......... .
T Consensus 79 l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 79 LLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 999986543 3578899999999999999999999 99999999999999999999999999997654322111 1
Q ss_pred ccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHH
Q 002069 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKL 943 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (973)
...++..|+|||.+.+..++.++||||||+++|||+| |..||....... ......... .... ....+
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~------~~~~~~~~~--~~~~----~~~~~ 221 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRERIESGY--RMPA----PQLCP 221 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH------HHHHHhcCC--CCCC----CccCC
Confidence 1234567999999988889999999999999999999 888886433110 001111111 1111 11234
Q ss_pred HHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 944 ISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 944 ~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+.+++.+|++.+|++||++.|+++.|+
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 46889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=309.62 Aligned_cols=247 Identities=25% Similarity=0.324 Sum_probs=201.8
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36889999999999999999654 78999999987543333334577889999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998654 3578999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...... .............+.
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~~~~--- 219 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---------QIYEKILEGKVRFPS--- 219 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHhcCCccCCc---
Confidence 23456889999999998888899999999999999999999998743311 111111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRP-----TMQKVSQ 969 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~ 969 (973)
.....+.+++.+||+.||.+|| +++|+++
T Consensus 220 -~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 220 -FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1134577899999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=312.22 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=198.9
Q ss_pred CcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEe
Q 002069 703 FDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEY 781 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 781 (973)
|+....||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 34455799999999999955 4789999999864322 2246788999999999999999999999999999999999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS 861 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 861 (973)
+++++|.+++.. ..+++.+++.++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+........
T Consensus 100 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 100 LQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 999999998754 3478999999999999999999999 999999999999999999999999999876654433
Q ss_pred cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHH
Q 002069 862 NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQD 941 (973)
Q Consensus 862 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (973)
......|++.|+|||++.+..++.++|||||||++|||++|+.||........ .... .............
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---------~~~~-~~~~~~~~~~~~~ 242 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---------MKRL-RDSPPPKLKNAHK 242 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---------HHHH-hccCCCCccccCC
Confidence 34456789999999999988899999999999999999999999864332111 0000 0000111111112
Q ss_pred HHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 942 KLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 942 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
....+.+++.+||+.+|++||+++++++.
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 23457789999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=313.57 Aligned_cols=193 Identities=21% Similarity=0.336 Sum_probs=158.6
Q ss_pred ccccCCCceeEEEEEcC---CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec--cceeEEEEEe
Q 002069 707 HCIGNGGQGSVYKAELP---TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH--ALHSFVVYEY 781 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 781 (973)
.+||+|+||+||+|... +++.||+|.+..... ...+.+|+.++++++||||+++++++.. +...++||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 57999999999999754 457899999864321 3467789999999999999999998843 4577899999
Q ss_pred cCCCChHHHhccCc------cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeee----cCCCceEEeccc
Q 002069 782 LEMGSLAMILSNDA------AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL----NLEYEAHVSDFG 851 (973)
Q Consensus 782 ~~~~~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill----~~~~~~kl~Dfg 851 (973)
++ +++.+++.... ....+++..++.++.|++.|++|||+. +|+||||||+||++ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 87 47777764321 123578999999999999999999999 99999999999999 556799999999
Q ss_pred ccccccCCCC---cccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcc
Q 002069 852 ISKFLKLGLS---NRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDF 908 (973)
Q Consensus 852 ~a~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~ 908 (973)
+++....... ......+|+.|+|||++.+. .++.++||||+||++|||+||+.||..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 9987654322 22345689999999998764 578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=309.34 Aligned_cols=260 Identities=27% Similarity=0.363 Sum_probs=204.2
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
..+|++.+.||+|+||+||+|.. .+++.||+|++..... ....+.+.+|+++++.++||||+++++++......++|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 35788899999999999999965 4789999998865422 23367899999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.+++... ..+++..+..++.+++.|+.|||+.. +++||||+|+||+++.++.++++|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 82 MEFMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EecCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 9999999999988653 35789999999999999999999742 899999999999999999999999999875532
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh--hhhhhhhhhhhhhcCCCCCCCc
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS--SLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
. ......|+..|+|||++.+..++.++|||||||++|++++|+.||+....... ..................+...
T Consensus 157 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd06620 157 S--IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP 234 (284)
T ss_pred h--ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC
Confidence 2 12245689999999999888899999999999999999999999974332100 0000011111222211111100
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
....+..+.+++.+|++.||.+|||++|++++
T Consensus 235 --~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 235 --SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred --chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11234567899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=315.95 Aligned_cols=195 Identities=26% Similarity=0.340 Sum_probs=172.3
Q ss_pred CCcccccccCCCceeEEEE-EcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC------CCceeeeceeeeccce
Q 002069 702 NFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR------HRNIVKFYGFCSHALH 774 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~~~ 774 (973)
+|.+.+.||+|.||.|.+| +..+++.||||+++.. .....+...|+.++..++ --|+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 8999999999999999999 6678999999999853 233566778899988885 3489999999999999
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC--CceEEecccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE--YEAHVSDFGI 852 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~--~~~kl~Dfg~ 852 (973)
.|||+|.+. -+|+++++.+... .++...++.++.||+.||..||+. +|||+||||+|||+.+. ..|||+|||.
T Consensus 263 lciVfELL~-~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence 999999885 7999999987754 489999999999999999999999 99999999999999655 4799999999
Q ss_pred cccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcc
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDF 908 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 908 (973)
|.......+ ....+..|+|||++.+.+|+.+.|||||||++.||++|.+-|.+
T Consensus 338 Sc~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 338 SCFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred ccccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 988765544 45678899999999999999999999999999999999877764
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=324.70 Aligned_cols=256 Identities=20% Similarity=0.229 Sum_probs=196.1
Q ss_pred hcCCcccccccCCCceeEEEEEcC---CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP---TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (973)
..+|.+.+.||+|+||.||++... .++.||||.+... ..+.+|+.++++++||||+++++++......+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 357999999999999999999542 4678999987642 23457999999999999999999999989999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
+|||++. +++.+++... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.++|+|||+++..
T Consensus 163 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EEehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 9999986 6888888432 4689999999999999999999999 9999999999999999999999999999766
Q ss_pred cCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhh--hhhhhh-------------
Q 002069 857 KLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIC--SSLSSN------------- 919 (973)
Q Consensus 857 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~--~~~~~~------------- 919 (973)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+...
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 54322 2234679999999999999999999999999999999999999986432100 000000
Q ss_pred -----hhhhhhhh---cCCCCCCC-chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 920 -----LNIALDEM---LDPRLPTP-LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 920 -----~~~~~~~~---~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
........ ..+....+ .-........+.+++.+|++.||++|||+.|++..
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 01111000 00001123457789999999999999999999864
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=314.80 Aligned_cols=259 Identities=20% Similarity=0.255 Sum_probs=193.4
Q ss_pred ccccccCC--CceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEe
Q 002069 705 DEHCIGNG--GQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEY 781 (973)
Q Consensus 705 ~~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 781 (973)
+.++||+| +||+||++.. .+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 46789999 6889999955 58999999998754332 22346677899999999999999999999999999999999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS 861 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 861 (973)
++++++.+++.... ...+++..++.++.|++.|++|||+. +|+||||||+||+++.++.++++||+.+........
T Consensus 81 ~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 81 MAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred cCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999996543 23578999999999999999999999 999999999999999999999999987543321111
Q ss_pred -------cccccccccCccccccccc--CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhc----
Q 002069 862 -------NRTELAGTFGYIAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML---- 928 (973)
Q Consensus 862 -------~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 928 (973)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||............ .........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLDTTT 235 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-hcCCccccccccc
Confidence 1122356778999999876 45889999999999999999999999743321100000 000000000
Q ss_pred ---------------CCCC----------C-C----CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 929 ---------------DPRL----------P-T----PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 929 ---------------~~~~----------~-~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
+... + . ...........+.+++.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000 0 0 00001122346789999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=310.54 Aligned_cols=263 Identities=22% Similarity=0.268 Sum_probs=201.2
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCc--chhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPG--EMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
+|++.+.||+|+||.||+|.. .+++.||||.+...... .......+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999965 47899999999765432 122345677899999999999999999999998899999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+ +++|.+++.... ..+++..++.++.|+++|++|||+. +++|+||+|+||+++.++.++|+|||.++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999997543 3689999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhhhhhhhh------
Q 002069 859 GLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSNLNIALD------ 925 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~~~~------ 925 (973)
.........+++.|+|||.+.+ ..++.++|||||||++|||++|..||........ ...........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 4333344567888999998864 4578899999999999999999888764332110 00000000000
Q ss_pred hhcCCC--CCCC-chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 926 EMLDPR--LPTP-LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 926 ~~~~~~--~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...... .... ..........+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000 0000 00011234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=306.68 Aligned_cols=256 Identities=24% Similarity=0.388 Sum_probs=202.6
Q ss_pred cCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccce
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH 774 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 774 (973)
++|+..+.||+|+||.||+|+.+ +.+.||+|.+..... ....+.+.+|+.++++++|+|++++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 57889999999999999999753 346799998865322 2235789999999999999999999999999889
Q ss_pred eEEEEEecCCCChHHHhccCccc------cCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEe
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAA------EEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVS 848 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~ 848 (973)
.++||||+++++|.++++..... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEc
Confidence 99999999999999999755422 2589999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCC-CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhh
Q 002069 849 DFGISKFLKLG-LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDE 926 (973)
Q Consensus 849 Dfg~a~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 926 (973)
|||.+...... ........+++.|+|||.+.+..++.++||||||+++|++++ |..||....... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---------~~~~ 230 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---------VLNR 230 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---------HHHH
Confidence 99998754322 122334456788999999988888999999999999999998 888986432110 0111
Q ss_pred hcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 927 MLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.......... ....+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 231 ~~~~~~~~~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQAGKLELPV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHcCCcCCCC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111111100 0122346788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=308.35 Aligned_cols=260 Identities=24% Similarity=0.356 Sum_probs=202.7
Q ss_pred cHHHHHHHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceee
Q 002069 692 VHEEIIRATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFC 769 (973)
Q Consensus 692 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 769 (973)
+..+...+...|++.+.+|+|+||.||+|.. .+++.||+|.+... .....++..|+.+++++ +|+|++++++++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 82 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAF 82 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence 3445555678899999999999999999965 57899999998543 12246788899999998 799999999998
Q ss_pred ec------cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC
Q 002069 770 SH------ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY 843 (973)
Q Consensus 770 ~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~ 843 (973)
.. ....++||||+++++|.+++.... ...+++..+..++.|++.|++|||+. +++|+|++|+||+++.++
T Consensus 83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA 158 (282)
T ss_pred hcccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 53 457799999999999999986543 23477888999999999999999999 999999999999999999
Q ss_pred ceEEecccccccccCCCCcccccccccCcccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhh
Q 002069 844 EAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSS 918 (973)
Q Consensus 844 ~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~ 918 (973)
.++++|||.+..............|++.|+|||.+. ...++.++|||||||++|||++|+.||.........
T Consensus 159 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~--- 235 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL--- 235 (282)
T ss_pred CEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh---
Confidence 999999999876643333344567899999999875 345788999999999999999999999643221110
Q ss_pred hhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 919 NLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
........+.. .....+..+.+++.+||+.||.+||++.|+++.
T Consensus 236 ------~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 236 ------FLIPRNPPPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ------hhHhhCCCCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00111111100 011234468899999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=324.01 Aligned_cols=256 Identities=19% Similarity=0.237 Sum_probs=193.7
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
...|.+.+.||+|+||.||+|... +++.||||... ...+.+|++++++++|+|||++++++..++..++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 346999999999999999999654 68899999643 23456899999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
||++. ++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 239 ~e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 239 LPKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred EEccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 99995 78888886432 3689999999999999999999999 999999999999999999999999999986643
Q ss_pred CCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchh-h-hhhhhhhhhhhhhhh--------
Q 002069 859 GLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS-S-ICSSLSSNLNIALDE-------- 926 (973)
Q Consensus 859 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~-~-~~~~~~~~~~~~~~~-------- 926 (973)
... ......||+.|+|||++.+..++.++|||||||++|||++|..|+-... . ............+..
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 321 1223569999999999999999999999999999999999876542111 0 000000000000000
Q ss_pred ------------------hcCCCC-CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 927 ------------------MLDPRL-PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 927 ------------------~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...+.. ...+.........+.+++.+||+.||.+|||+.|+++.
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 00111111222357889999999999999999999875
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=308.56 Aligned_cols=255 Identities=28% Similarity=0.401 Sum_probs=202.2
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccc---
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHAL--- 773 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~--- 773 (973)
++++|++.+.||+|++|.||+|... +++.|++|++..... ..+++.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 4688999999999999999999664 678999999875322 246789999999999 7999999999996543
Q ss_pred ---eeEEEEEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEec
Q 002069 774 ---HSFVVYEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSD 849 (973)
Q Consensus 774 ---~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~D 849 (973)
..++||||+++++|.++++... ....+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+|++|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence 4899999999999999986533 234688999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCcccccccccCccccccccc-----CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhh
Q 002069 850 FGISKFLKLGLSNRTELAGTFGYIAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIAL 924 (973)
Q Consensus 850 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 924 (973)
||.+..............|++.|+|||++.. ..++.++|||||||++|+|++|+.||........ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---------~ 227 (275)
T cd06608 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA---------L 227 (275)
T ss_pred CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH---------H
Confidence 9998876544334445678999999998753 3467889999999999999999999964322111 1
Q ss_pred hhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 925 DEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.+..... .............+.+++.+||+.||++|||++++++.
T Consensus 228 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 228 FKIPRNP-PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred HHhhccC-CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111 11111112244568899999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=305.92 Aligned_cols=254 Identities=26% Similarity=0.357 Sum_probs=204.1
Q ss_pred CCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|+..+.||+|+||.||+|... +++.||+|++...... ...+++.+|++++++++||||+++++++......++|+|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 5788899999999999999665 7899999998764322 346788999999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT-NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
|+++++|.+++.... ..+++..+..++.|++.|++|+|+ . +++|+||+|+||+++.++.++++|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 80 YMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred ecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 999999999997543 467889999999999999999999 7 9999999999999999999999999998766433
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
... ...++..|+|||++.+..++.++||||+|+++|+|++|+.||......... .............+....
T Consensus 155 ~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~-- 226 (265)
T cd06605 155 LAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG----IFELLQYIVNEPPPRLPS-- 226 (265)
T ss_pred Hhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc----HHHHHHHHhcCCCCCCCh--
Confidence 221 267889999999999889999999999999999999999998643210000 011112222221111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+.++|.+||..||++|||+.++++.
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 227 GKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1134557899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.86 Aligned_cols=247 Identities=26% Similarity=0.384 Sum_probs=189.4
Q ss_pred ccccCCCceeEEEEEcC----CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeee-ccceeEEEEEe
Q 002069 707 HCIGNGGQGSVYKAELP----TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCS-HALHSFVVYEY 781 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~ 781 (973)
+.||+|+||.||+|... ++..||+|++.... .....+.+.+|+.+++.++|||++++++++. .++..++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 46899999999999642 34579999986432 2233578889999999999999999999775 45567899999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS 861 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 861 (973)
+++++|.+++.+.. ...++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++.......
T Consensus 79 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 79 MKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 99999999997543 2457788899999999999999998 999999999999999999999999999976543211
Q ss_pred ----cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhC-CCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 862 ----NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKG-KHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 862 ----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
......+++.|+|||+..+..++.++|||||||++|||++| ..||...... ...............
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~ 224 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---------DITVYLLQGRRLLQP 224 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---------HHHHHHhcCCCCCCC
Confidence 11233457789999999888899999999999999999995 5566532211 011111111111110
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 225 ---~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~ 257 (262)
T cd05058 225 ---EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIE 257 (262)
T ss_pred ---CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 112345788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.13 Aligned_cols=252 Identities=28% Similarity=0.412 Sum_probs=202.6
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|++.+.||+|+||.||+|.. .+++.||+|.++..... ....+.+..|++++++++|+||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 588899999999999999965 47899999998765433 3346889999999999999999999999998999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+|++|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 80 YCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred cCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999987542 468899999999999999999999 99999999999999999999999999998765443
Q ss_pred Cccc----ccccccCcccccccccCC---CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 861 SNRT----ELAGTFGYIAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 861 ~~~~----~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
.... ...+++.|+|||++.+.. ++.++||||||+++||+++|+.||.......... ........+.++
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~-----~~~~~~~~~~~~ 228 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM-----FHVGAGHKPPIP 228 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH-----HHHhcCCCCCCC
Confidence 2221 356788999999988766 8889999999999999999999997432111100 000111111222
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
. .......+.+++.+||+.+|.+||++++++.
T Consensus 229 ~----~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 D----SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred c----ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1 1122445778999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=311.53 Aligned_cols=254 Identities=23% Similarity=0.270 Sum_probs=197.8
Q ss_pred CCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|++.+.||+|+||.||++... +++.||+|.+.............+.+|+.+++.++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 6888999999999999999654 688999999875433223335678899999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++++|.++++... .+++..+..++.|++.|++|+|+. +++||||||+||+++.++.+|++|||.++......
T Consensus 82 ~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 82 YVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999996543 578999999999999999999999 99999999999999999999999999986421110
Q ss_pred C---------------cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhh
Q 002069 861 S---------------NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALD 925 (973)
Q Consensus 861 ~---------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 925 (973)
. ......++..|+|||.+.+..++.++||||||+++||+++|..||..... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---------~~~~~ 226 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---------EELFG 226 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHH
Confidence 0 11124578899999999888899999999999999999999999863321 11111
Q ss_pred hhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 926 EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
.........+.. ....+..+.+++.+||+.||++||++.++.+.+
T Consensus 227 ~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 227 QVISDDIEWPEG-DEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred HHHhcccCCCCc-cccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 111111110000 012334578999999999999999965444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=301.74 Aligned_cols=246 Identities=28% Similarity=0.464 Sum_probs=198.0
Q ss_pred cCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
++|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.++++++|||++++++++... ..++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 5688999999999999999975 77889999986431 246788999999999999999999998765 4789999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++++|.+++.... ...+++..++.++.|++.|++|+|+. +++||||||+||+++.++.+|++|||.+......
T Consensus 79 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 79 LMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG- 153 (254)
T ss_pred CCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence 999999999997543 23578999999999999999999998 9999999999999999999999999998764332
Q ss_pred CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 861 SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
......+..|+|||++.+..++.++||||||+++|||++ |+.||....... .............+
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~------ 219 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VKECVEKGYRMEPP------ 219 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------HHHHHhCCCCCCCC------
Confidence 122344678999999988889999999999999999997 999986433110 00111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+..+.+++.+||+.+|++||+++++++.|+
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 123456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=309.17 Aligned_cols=262 Identities=21% Similarity=0.296 Sum_probs=197.4
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|++.+.||+|+||.||+|.. .+|+.||+|++...... ......+.+|+.++++++|||++++++++.+....++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 478889999999999999965 47899999998653222 1223567789999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|++ +++.+++.... ..+++..++.++.||++|++|||+. +++||||||+||+++.++.+|++|||.++......
T Consensus 80 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 80 YCD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred cCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 997 57888775432 3589999999999999999999999 99999999999999999999999999998665443
Q ss_pred CcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhh-------hhh---hhhhhcC
Q 002069 861 SNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSN-------LNI---ALDEMLD 929 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~-------~~~---~~~~~~~ 929 (973)
.......+++.|+|||++.+. .++.++|||||||++|||+||+.|+............. ... ......+
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 333445678999999988764 46889999999999999999999863222111000000 000 0000000
Q ss_pred ----CCCCCCc---hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 930 ----PRLPTPL---RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 930 ----~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
+..+... .........+.+++.+||+.||.+|||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000000 0011223567789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.48 Aligned_cols=239 Identities=23% Similarity=0.366 Sum_probs=185.9
Q ss_pred cccCCCceeEEEEEcC-------------------------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCce
Q 002069 708 CIGNGGQGSVYKAELP-------------------------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762 (973)
Q Consensus 708 ~lg~G~~g~V~~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 762 (973)
.||+|+||.||+|.+. ....||+|++... .......|.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence 6999999999999531 1135889988643 22334678889999999999999
Q ss_pred eeeceeeeccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC
Q 002069 763 VKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE 842 (973)
Q Consensus 763 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~ 842 (973)
+++++++.+....++||||+++++|..++.... ..+++..+..++.|+++|++|||+. +|+||||||+||+++..
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 999999999999999999999999999986533 3578999999999999999999998 99999999999999764
Q ss_pred C-------ceEEecccccccccCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHH-hCCCCCcchhhhh
Q 002069 843 Y-------EAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVI-KGKHPRDFISSIC 913 (973)
Q Consensus 843 ~-------~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~-tg~~p~~~~~~~~ 913 (973)
+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||.......
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred CcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3 3899999988644322 23457888999998865 56889999999999999995 6999986432110
Q ss_pred hhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 914 SSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
. ...... ....+.. ....+.+++.+||+.+|++||++.++++.|.
T Consensus 230 ~------~~~~~~--~~~~~~~------~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 K------ERFYEK--KHRLPEP------SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H------HHHHHh--ccCCCCC------CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 000000 1111111 1124778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=308.09 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=203.1
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
..+|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++|||++++++++......++|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 36899999999999999999954 478899999986432 22246788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
+||+++++|.+++.+. .+++.++..++.|++.|++|||+. +++|+|++|+||+++.++.++++|||.+.....
T Consensus 95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred EecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999999998643 467889999999999999999999 999999999999999999999999999876655
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.........+++.|+|||.+....++.++||||||+++|++++|+.||.......... .....+. .....
T Consensus 168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~--------~~~~~~~--~~~~~ 237 (293)
T cd06647 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------LIATNGT--PELQN 237 (293)
T ss_pred cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--------ehhcCCC--CCCCC
Confidence 4333444568899999999988889999999999999999999999997433211100 0000111 01111
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.......+.+++.+||+.+|++||++.+++.+
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12234457889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=303.97 Aligned_cols=251 Identities=25% Similarity=0.429 Sum_probs=199.5
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCC----EEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGE----IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
.+|++.+.||+|+||.||+|.+. +|+ .||+|....... .....++.+|+..+++++|||++++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 57889999999999999999653 333 689998875533 3345788999999999999999999999987 688
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++.
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999999999997543 3488999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCcc--cccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCC-C
Q 002069 856 LKLGLSNR--TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDP-R 931 (973)
Q Consensus 856 ~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~ 931 (973)
........ ....++..|+|||.+....++.++||||||+++||+++ |+.||+..... ......... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---------~~~~~~~~~~~ 229 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---------EIPDLLEKGER 229 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---------HHHHHHhCCCC
Confidence 65432211 12224578999999988889999999999999999998 99998743211 011111111 1
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+.+. .....+.+++.+||..||.+||++.++++.|+
T Consensus 230 ~~~~~----~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~ 266 (279)
T cd05057 230 LPQPP----ICTIDVYMVLVKCWMIDAESRPTFKELINEFS 266 (279)
T ss_pred CCCCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 11111 12235778899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.02 Aligned_cols=249 Identities=27% Similarity=0.439 Sum_probs=200.6
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC---CCceeeeceeeeccceeEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR---HRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l 777 (973)
.|+..+.||+|+||.||+|.. .+++.||+|.+...... ...+++.+|+.++++++ |||++++++++..+...++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 477889999999999999965 57899999998754322 23467888999999886 9999999999999889999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||||+++++|.++++.. .+++..++.++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+....
T Consensus 80 v~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 99999999999998643 578999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 858 LGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
..........|+..|+|||++.+ ..++.++|||||||++|+|++|+.||......... ........+.++..
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~- 225 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM------MLIPKSKPPRLEDN- 225 (277)
T ss_pred CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh------hccccCCCCCCCcc-
Confidence 55444445678999999998865 44688999999999999999999999743321100 00000111111111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+.+++.+||+.||++||++.++++.
T Consensus 226 ----~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 226 ----GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ----cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 134467889999999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.80 Aligned_cols=264 Identities=20% Similarity=0.260 Sum_probs=198.1
Q ss_pred HhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
+.++|.+.+.||+|+||.||+|.. .+++.||+|++....... ....+.+|+.+++.++|+||+++++++..++..++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 356899999999999999999954 478999999986543222 23467789999999999999999999999989999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||||++ +++.+++.... ..+++.++..++.|++.|++|||+. +++|+||||+||+++.++.+|++|||.++...
T Consensus 81 v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred EEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 999996 67777765432 3467888999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhh---------------
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLN--------------- 921 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~--------------- 921 (973)
..........+++.|+|||++.+. .++.++|||||||++|||++|+.||+............+.
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 333333445678999999998754 4788999999999999999999999754321111110000
Q ss_pred --hhhhhhcCCCCCCCchh---hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 922 --IALDEMLDPRLPTPLRN---VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 922 --~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...........+..... .......+.+++.+|++.||.+|||++|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000000100000 00113457789999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=300.21 Aligned_cols=251 Identities=28% Similarity=0.428 Sum_probs=200.1
Q ss_pred CcccccccCCCceeEEEEEcCC-----CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 703 FDDEHCIGNGGQGSVYKAELPT-----GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
+++.+.||.|+||.||++.... +..||+|++....... ..+.+..|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ--QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH--HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 4567899999999999996643 4889999997553321 35789999999999999999999999999899999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||||+++++|.++++.... ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+....
T Consensus 79 i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecc
Confidence 9999999999999975432 1279999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccc-ccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 858 LGLSNRT-ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 858 ~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
....... ...+++.|+|||.+.+..++.++||||+|+++|+|++ |..||...... ..............
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---------~~~~~~~~~~~~~~ 225 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---------EVLEYLKKGYRLPK 225 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---------HHHHHHhcCCCCCC
Confidence 4422221 2347789999999988889999999999999999998 88888642210 00111111111111
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
. ...+..+.+++.+|++.||++|||+.++++.|
T Consensus 226 ~---~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 P---ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred C---CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1 11344578899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=309.48 Aligned_cols=263 Identities=22% Similarity=0.334 Sum_probs=202.1
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|+++++.++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 36889999999999999999764 68999999987543332 33567889999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||++++++.++.... ..+++.+++.++.|++.|++|||+. +++|+|++|+||+++.++.++++|||.+......
T Consensus 80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 80 EFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred ecCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999999998876543 2478999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh--h---hhhhhhhhh-------
Q 002069 860 LSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL--S---SNLNIALDE------- 926 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~--~---~~~~~~~~~------- 926 (973)
........++..|+|||++.+ ..++.++||||||+++|||++|+.||.......... . .........
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 333344568899999998875 346789999999999999999999986433211000 0 000000000
Q ss_pred ---hcCCCCCCCc---hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 927 ---MLDPRLPTPL---RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 927 ---~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...+...... ......+..+.+++.+||+.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0001100000 0011234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=301.00 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=195.3
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCC--cchhhHHHHHHHHHHhhcCCCCceeeeceeeec--ccee
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLP--GEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH--ALHS 775 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 775 (973)
.+|+..+.||+|+||.||+|.. .+++.||+|++..... ......+.+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688999999999999999955 4789999998864432 122234678899999999999999999998865 3567
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
+++|||+++++|.+++.... .+++...+.++.|++.|++|||+. +++||||+|+||+++.++.+|++|||.++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999986543 478899999999999999999998 999999999999999999999999999876
Q ss_pred ccCCC---CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 856 LKLGL---SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 856 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
..... .......++..|+|||++.+..++.++||||+||++||+++|+.||.......... ........+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~-----~~~~~~~~~~~ 230 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF-----KIATQPTNPQL 230 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH-----HHhcCCCCCCC
Confidence 54321 11223458889999999998889999999999999999999999997433211100 00001111111
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
+ ......+.+++ +||..+|++||+++||++
T Consensus 231 ~------~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 231 P------SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred c------hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1 11223455666 688899999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.63 Aligned_cols=238 Identities=26% Similarity=0.426 Sum_probs=188.4
Q ss_pred ccccCCCceeEEEEEcCC-C----------CEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 707 HCIGNGGQGSVYKAELPT-G----------EIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
+.||+|+||.||+|...+ + ..|++|.+...... ...+.+|+.++++++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 469999999999997653 3 25788877643211 5788999999999999999999999988 778
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC-------ceEEe
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY-------EAHVS 848 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-------~~kl~ 848 (973)
++||||+++++|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++ .+|++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence 999999999999999975442 578999999999999999999998 999999999999999887 79999
Q ss_pred cccccccccCCCCcccccccccCcccccccccC--CCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhh
Q 002069 849 DFGISKFLKLGLSNRTELAGTFGYIAPELAYTM--KVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALD 925 (973)
Q Consensus 849 Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 925 (973)
|||.+..... .....++..|+|||++.+. .++.++||||||+++||+++ |..||...... .. .....
T Consensus 151 Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-~~-----~~~~~ 220 (259)
T cd05037 151 DPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-EK-----ERFYQ 220 (259)
T ss_pred CCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-hH-----HHHHh
Confidence 9999986543 2234567789999998876 78899999999999999999 57777533210 00 00000
Q ss_pred hhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 926 EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.....+... ...+.+++.+||+.+|.+|||+.++++.|+
T Consensus 221 --~~~~~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 --DQHRLPMPD------CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --cCCCCCCCC------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011111111 145789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=301.46 Aligned_cols=253 Identities=28% Similarity=0.403 Sum_probs=207.1
Q ss_pred CCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|++.+.||+|++|.||+|... +++.||||++...... .....+.+|+..+.+++|+|++++++++..+...++|||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 5888999999999999999665 6999999998765332 336789999999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT-NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
|+++++|.+++... ..+++..++.++.|+++|++|+|+ . +++||||+|+||+++.++.++++|||.+......
T Consensus 80 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 80 YMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred ecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 99999999999754 457899999999999999999999 8 9999999999999999999999999999877654
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
........++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..............+....
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~-- 225 (264)
T cd06623 154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP------SFFELMQAICDGPPPSLPA-- 225 (264)
T ss_pred CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc------CHHHHHHHHhcCCCCCCCc--
Confidence 44333556889999999999888999999999999999999999998744310 0011111111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...+..+.+++.+|++.+|++||++.++++.
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 226 EEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1134568899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=299.93 Aligned_cols=251 Identities=22% Similarity=0.313 Sum_probs=201.6
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|+..+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|++++++++|||++++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 588899999999999999955 47889999998754332 2336789999999999999999999999998889999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC-CceEEecccccccccCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE-YEAHVSDFGISKFLKLG 859 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~ 859 (973)
|+++++|.+++.... ...+++..+..++.|++.|++|||++ +++|+||+|+||+++.+ +.+|++|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 80 YAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred cCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999997543 33578999999999999999999999 99999999999999865 46899999999876543
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||+..... ...............
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~--- 222 (256)
T cd08220 156 S-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---------ALVLKIMSGTFAPIS--- 222 (256)
T ss_pred c-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---------HHHHHHHhcCCCCCC---
Confidence 2 223356889999999999888899999999999999999999998743211 111111111111100
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+.+++.+||+.+|.+|||+.|+++.
T Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1133457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=330.45 Aligned_cols=262 Identities=19% Similarity=0.178 Sum_probs=189.8
Q ss_pred HHHHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC------CCceeeecee
Q 002069 696 IIRATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR------HRNIVKFYGF 768 (973)
Q Consensus 696 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~ 768 (973)
+.....+|++.+.||+|+||+||+|.. .+++.||||+++... .....+..|+.+++.++ |.++++++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 334567899999999999999999955 478899999986421 11234455666665554 4568899998
Q ss_pred eecc-ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC----
Q 002069 769 CSHA-LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY---- 843 (973)
Q Consensus 769 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~---- 843 (973)
+..+ .+.++|||++ +++|.+++.+. ..+++.++..|+.||+.||+|||++. +|+||||||+||+++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccc
Confidence 8654 5788999988 67888888654 35889999999999999999999732 899999999999998765
Q ss_pred ------------ceEEecccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhh
Q 002069 844 ------------EAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS 911 (973)
Q Consensus 844 ------------~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 911 (973)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||+....
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred cccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 49999999876432 223456799999999999999999999999999999999999999975432
Q ss_pred hhh------hhhhhhhhh--------hhhhc------CCCCCC---------CchhhHHHHHHHHHHHhcccCCCCCCCC
Q 002069 912 ICS------SLSSNLNIA--------LDEML------DPRLPT---------PLRNVQDKLISIMEVSISCLDESPTSRP 962 (973)
Q Consensus 912 ~~~------~~~~~~~~~--------~~~~~------~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RP 962 (973)
... ..+...... ..... .+.... ...........+.+++.+||+.||++||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 110 000000000 00000 000000 0000001134577999999999999999
Q ss_pred CHHHHHHH
Q 002069 963 TMQKVSQL 970 (973)
Q Consensus 963 s~~ev~~~ 970 (973)
|++|++++
T Consensus 431 ta~e~L~H 438 (467)
T PTZ00284 431 NARQMTTH 438 (467)
T ss_pred CHHHHhcC
Confidence 99999863
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.98 Aligned_cols=246 Identities=23% Similarity=0.368 Sum_probs=195.1
Q ss_pred cccccccCCCceeEEEEE-cCCCCEEE---EEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccce--eEE
Q 002069 704 DDEHCIGNGGQGSVYKAE-LPTGEIVA---VKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH--SFV 777 (973)
Q Consensus 704 ~~~~~lg~G~~g~V~~~~-~~~~~~va---vK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~l 777 (973)
....+||+|+|-+||+|. ..+|-.|| ||.-. ........++|..|+.+++.++||||+++|+++.+... ..+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d--~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~ 120 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRD--VTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF 120 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHH--hhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence 345789999999999994 44677776 33221 12233446899999999999999999999999987655 678
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC-CceEEecccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE-YEAHVSDFGISKFL 856 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl~Dfg~a~~~ 856 (973)
|+|.+..|+|..|.++.+ +.....+.+|++||++||.|||++. |+|+|||||.+||+++.+ |.|||+|.|+|...
T Consensus 121 iTEL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 999999999999998765 5678899999999999999999985 589999999999999766 99999999999987
Q ss_pred cCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 857 KLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 857 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
+.. ......|||.|||||++. ..|+..+||||||+++.||+|+.+||..-... +...+.+..+.-|..+
T Consensus 197 r~s--~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~--------AQIYKKV~SGiKP~sl 265 (632)
T KOG0584|consen 197 RKS--HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP--------AQIYKKVTSGIKPAAL 265 (632)
T ss_pred hcc--ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH--------HHHHHHHHcCCCHHHh
Confidence 653 334478999999999987 67999999999999999999999998732221 1222233333322222
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
.... ...+.++|.+|+.. ..+|||+.|++.
T Consensus 266 ~kV~--dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 266 SKVK--DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred hccC--CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 2111 23578999999999 899999999985
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.39 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=198.8
Q ss_pred cCCcccccccCCCceeEEEEEcCC----CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPT----GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (973)
.+|.+.+.||+|+||.||+|...+ ...||||....... ....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcE
Confidence 468888999999999999996532 34799999875432 23357899999999999999999999998764 578
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
+||||+++++|.+++.... ..+++.+++.++.|++.|++|+|+. +++||||||+||+++.++.+|++|||.++..
T Consensus 83 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 83 IVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 9999999999999997543 3578999999999999999999998 9999999999999999999999999998866
Q ss_pred cCCCCc-ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCC
Q 002069 857 KLGLSN-RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934 (973)
Q Consensus 857 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (973)
...... .....+++.|+|||.+....++.++||||||+++||+++ |..||........ ............+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~~~- 230 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV------IGRIENGERLPMP- 230 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHcCCcCCCC-
Confidence 443221 222334578999999988889999999999999999986 9999974432110 0011111111111
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+..+.+++.+|+..+|.+|||+.++++.|+
T Consensus 231 -----~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~ 263 (270)
T cd05056 231 -----PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263 (270)
T ss_pred -----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 122345788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.56 Aligned_cols=248 Identities=26% Similarity=0.383 Sum_probs=199.4
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
.|...+.||+|++|.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++|||++++++++..++..++|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 355567999999999999964 578999999886432 2234668899999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++++|.+++.. ..+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+.......
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 97 FLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 9999999999875 3478899999999999999999999 99999999999999999999999999887655443
Q ss_pred CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhH
Q 002069 861 SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (973)
.......|++.|+|||...+..++.++||||||+++|||++|+.||........ . ........+.... ..
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~-~-----~~~~~~~~~~~~~----~~ 239 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-M-----KRIRDNLPPKLKN----LH 239 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH-H-----HHHHhcCCCCCcc----cc
Confidence 333445689999999999888899999999999999999999999864321100 0 0011111111111 11
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 941 DKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 941 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
.....+.+++.+||+.+|++||++.++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 13346889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.66 Aligned_cols=263 Identities=24% Similarity=0.347 Sum_probs=203.6
Q ss_pred cCCcccccccCCCceeEEEEEcC-----CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec--cc
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-----TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH--AL 773 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~ 773 (973)
+.|++.+.||+|+||.||+|.+. +++.||||.+...... ...+.|.+|++.+++++|+||+++++++.. +.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 46788899999999999999643 4688999999755332 346789999999999999999999999877 55
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
..++||||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++++|||.+
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 7899999999999999997544 2588999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCcc---cccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh-hhh----hhhhhhh
Q 002069 854 KFLKLGLSNR---TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS-LSS----NLNIALD 925 (973)
Q Consensus 854 ~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~-~~~----~~~~~~~ 925 (973)
.......... ....++..|+|||...+..++.++||||||+++|||+||+.|+......... ... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 8775332211 1234566799999998888999999999999999999999998643211100 000 0011111
Q ss_pred hhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 926 EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+.+........ ....+..+.+++.+||+.+|++|||+.||+++|+
T Consensus 237 ~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05038 237 ELLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281 (284)
T ss_pred HHHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence 11111111110 1122356889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.23 Aligned_cols=263 Identities=22% Similarity=0.304 Sum_probs=198.7
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|+..+.||+|++|.||+|.. .+++.||||++....... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 478899999999999999965 478999999987543222 224678899999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+. +++.+++.... ...+++.++..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||.+.......
T Consensus 80 ~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 80 FLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred ccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 996 68888886443 34688999999999999999999999 99999999999999999999999999988665443
Q ss_pred CcccccccccCcccccccccCC-CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh------hhhhhh---h---hh--
Q 002069 861 SNRTELAGTFGYIAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL------SSNLNI---A---LD-- 925 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~------~~~~~~---~---~~-- 925 (973)
.......+++.|+|||++.+.. ++.++||||||+++|||+||+.||.......... ...... . ..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 3334456788999999887644 5888999999999999999999986433211100 000000 0 00
Q ss_pred -hhcCCCCCCCchh-hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 926 -EMLDPRLPTPLRN-VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 926 -~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
............. .......+.+++.+|++.||.+|||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000000 01123456789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=305.24 Aligned_cols=262 Identities=27% Similarity=0.330 Sum_probs=200.9
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc--ceeEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA--LHSFV 777 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 777 (973)
++|+..+.||.|++|.||+|.. .+++.||+|.+...... ....++.+|++++++++||||+++++++... ...++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 3578889999999999999965 47899999998754322 3357789999999999999999999988543 46899
Q ss_pred EEEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 778 VYEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
||||+++++|.+++.... ....+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 999999999998875322 234578899999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 857 KLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 857 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
.... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||+........ .............+.++...
T Consensus 156 ~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd06621 156 VNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PIELLSYIVNMPNPELKDEP 232 (287)
T ss_pred cccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hHHHHHHHhcCCchhhccCC
Confidence 4322 22345788999999999889999999999999999999999999754210000 00000111111111111111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.........+.+++.+||+.+|.+|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1111234567899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=301.17 Aligned_cols=252 Identities=26% Similarity=0.389 Sum_probs=187.7
Q ss_pred ccccCCCceeEEEEEcCCC---CEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecC
Q 002069 707 HCIGNGGQGSVYKAELPTG---EIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLE 783 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 783 (973)
+.||+|+||.||+|...++ ..+++|.+..... ....+.+.+|+..++.++||||+++++++.+....++||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999964333 3566777654322 2336789999999999999999999999999889999999999
Q ss_pred CCChHHHhccCcc-ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC--
Q 002069 784 MGSLAMILSNDAA-AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL-- 860 (973)
Q Consensus 784 ~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-- 860 (973)
+|+|.+++++... ....++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+.......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 9999999975432 23456778889999999999999998 99999999999999999999999999986432211
Q ss_pred CcccccccccCccccccccc-------CCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 861 SNRTELAGTFGYIAPELAYT-------MKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
.......++..|+|||++.. ..++.++|||||||++|||++ |..||...... ...............++.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIKDQQVKLFKPQL 234 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhhcccccCCCcc
Confidence 12234567889999998753 245778999999999999997 57787633221 1111111111111222222
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
... ....+.+++..|| .+|++||++++|++.|
T Consensus 235 ~~~------~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 235 ELP------YSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred CCC------CcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 222 2234677888999 6799999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.80 Aligned_cols=256 Identities=26% Similarity=0.393 Sum_probs=200.0
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCc-------chhhHHHHHHHHHHhhcCCCCceeeeceeeeccc
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPG-------EMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL 773 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 773 (973)
+|...+.||+|+||.||+|.. .+++.||+|.+...... .....+.+.+|+.++++++|||++++++++..++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999954 47899999988642211 1112356888999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
..++||||+++++|.+++.+. ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999999755 3578899999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCC--cccccccccCcccccccccCC--CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcC
Q 002069 854 KFLKLGLS--NRTELAGTFGYIAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLD 929 (973)
Q Consensus 854 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 929 (973)
+....... ......++..|+|||.+.... ++.++||||+|+++||+++|..||........... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~ 230 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK-----LGNKRSA 230 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHH-----hhccccC
Confidence 76543211 122345788999999987654 78899999999999999999999864332211110 0001111
Q ss_pred CCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 930 PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 930 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
+.++.. .....+..+.+++.+||+.||.+||++++|++.
T Consensus 231 ~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 231 PPIPPD--VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CcCCcc--ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111 112234568889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=301.89 Aligned_cols=248 Identities=25% Similarity=0.385 Sum_probs=200.7
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
-|+..+.||+|+||.||+|.. .+++.||+|.+..... ....+.+.+|+..+++++||||+++++++.+++..++|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 477888999999999999954 4789999999764322 2335788999999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++++|.+++.. ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 83 ~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 83 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 9999999999864 2478999999999999999999998 99999999999999999999999999987665433
Q ss_pred CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhH
Q 002069 861 SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (973)
.......++..|+|||.+.+..++.++|||||||++|+|++|..||........ .........+.+. .
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~------~ 223 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV------LFLIPKNNPPTLE------G 223 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH------HHHHhcCCCCCCC------c
Confidence 333345688899999999888889999999999999999999999864321100 0000000011111 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 941 DKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 941 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+.+++.+||+.+|.+||+++++++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 233457789999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=306.23 Aligned_cols=262 Identities=18% Similarity=0.291 Sum_probs=197.3
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|++|.||+|..+ +++.||+|.+....... ....+.+|++++++++|+||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 67899999999999999999654 78999999987543221 1345678999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++ +|.+++.+.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++.....
T Consensus 83 e~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 83 EYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred ecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 99984 8999886543 3678999999999999999999999 9999999999999999999999999998755332
Q ss_pred CCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhh-------hhhhhhh----
Q 002069 860 LSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNL-------NIALDEM---- 927 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~-------~~~~~~~---- 927 (973)
........++..|+|||++.+ ..++.++||||+|+++|||++|+.||.........+.... .......
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 222233456889999998875 4578899999999999999999999964431111110000 0000000
Q ss_pred --cCCCCCC--Cch---h--hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 928 --LDPRLPT--PLR---N--VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 928 --~~~~~~~--~~~---~--~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
....... ... . .......+.+++.+|++.+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000 000 0 00111456789999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=308.22 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=196.8
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCC----EEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGE----IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
.+|+..+.||+|+||.||+|.+ .+++ .||+|.+..... .....++.+|+.++++++||||+++++++..+ ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 5678889999999999999965 3444 578998865432 22245788999999999999999999998754 46
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++|+||+++|++.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++.
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 79999999999999986543 3578899999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCc--ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 856 LKLGLSN--RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 856 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
....... .....++..|+|||++.+..++.++|||||||++||+++ |+.||....... ........ ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~--~~~ 230 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE------IPDLLEKG--ERL 230 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHCC--CCC
Confidence 6543221 222345778999999998889999999999999999997 999986432100 00111110 111
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+.. ......+.+++.+||..+|++||+++++++.++
T Consensus 231 ~~~----~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~ 266 (303)
T cd05110 231 PQP----PICTIDVYMVMVKCWMIDADSRPKFKELAAEFS 266 (303)
T ss_pred CCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111 112345788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=298.95 Aligned_cols=252 Identities=22% Similarity=0.282 Sum_probs=196.9
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCC--CcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc--cee
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPL--PGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA--LHS 775 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 775 (973)
.+|++.+.||+|+||.||+|.. .+++.||+|.+.... .......+.+.+|+.++++++||||+++++++.++ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688999999999999999965 478999999875322 12223356788999999999999999999988663 467
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+++++|.+++.... .+++..+++++.|++.|++|||+. +++|+||||+||+++.++.++++|||.+..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999986543 467888999999999999999999 999999999999999999999999999876
Q ss_pred ccCCC---CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 856 LKLGL---SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 856 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
..... .......++..|+|||.+.+..++.++|||||||++|||++|+.||......... ......+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--------~~~~~~~~~ 227 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI--------FKIATQPTN 227 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH--------HHHhcCCCC
Confidence 54321 1223345888999999998888999999999999999999999999743321111 011111111
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
+.. .......+.+++.+|+. +|++||+++++++.
T Consensus 228 ~~~---~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 228 PVL---PPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCC---chhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111 12233456778889984 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.76 Aligned_cols=249 Identities=24% Similarity=0.417 Sum_probs=195.4
Q ss_pred ccccCCCceeEEEEEcCC-------CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 707 HCIGNGGQGSVYKAELPT-------GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
+.||+|+||.||+|...+ ++.||+|.+..... ......+.+|+.++++++||||+++++++...+..++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 369999999999996532 25799998864322 223578899999999999999999999999888999999
Q ss_pred EecCCCChHHHhccCc----cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC-----ceEEecc
Q 002069 780 EYLEMGSLAMILSNDA----AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY-----EAHVSDF 850 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-----~~kl~Df 850 (973)
||+++++|.+++.+.. ....+++.+++.++.|++.|++|||+. +++|+||||+||+++.++ .++++||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999999999996532 123478899999999999999999998 999999999999999877 8999999
Q ss_pred cccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhh
Q 002069 851 GISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEM 927 (973)
Q Consensus 851 g~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 927 (973)
|.++....... ......++..|+|||++.+..++.++|||||||++|||++ |+.||........ ......
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~- 228 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV------LQHVTA- 228 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH------HHHHhc-
Confidence 99876543321 1122345788999999999899999999999999999998 9999864332110 000000
Q ss_pred cCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 928 LDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...... ....+..+.+++.+||+.+|.+||++++|.+.|+
T Consensus 229 -~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 -GGRLQK----PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -CCccCC----cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 011111 1123456789999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=304.49 Aligned_cols=253 Identities=27% Similarity=0.424 Sum_probs=205.9
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
.++.|+..+.+|+|+||.||+|... +++.||+|++..... ..+.+.+|++.+++++|+|++++++++..+...++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 4567888999999999999999665 789999999875422 35778899999999999999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
|+||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++|+|++|+||+++.++.++++|||.+....
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 999999999999997654 3689999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
..........+++.|+|||++.+..++.++|||||||++|+|++|+.||........ .........+. ..
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~---------~~~~~~~~~~~-~~ 237 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA---------LFLITTKGIPP-LK 237 (286)
T ss_pred cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH---------HHHHHhcCCCC-Cc
Confidence 433333345578899999999888899999999999999999999999874332111 00111111111 11
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+..+.+++.+|++.+|.+||++.++++.
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111234568899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.74 Aligned_cols=247 Identities=24% Similarity=0.277 Sum_probs=194.2
Q ss_pred ccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCCCCh
Q 002069 709 IGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 787 (973)
Q Consensus 709 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 787 (973)
||+|+||+||+|.. .+|+.||+|.+.............+..|++++++++|||++++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999954 47899999998754322233355678899999999999999999999998999999999999999
Q ss_pred HHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCcccccc
Q 002069 788 AMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA 867 (973)
Q Consensus 788 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 867 (973)
.+++..... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.+...... .......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRA 155 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Ccccccc
Confidence 999865442 4588999999999999999999999 9999999999999999999999999998766442 2233456
Q ss_pred cccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHH
Q 002069 868 GTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIM 947 (973)
Q Consensus 868 g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 947 (973)
++..|+|||++.+..++.++||||+|+++|+|++|+.||........ .............. ........+.
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~----~~~~~~~~~~ 226 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-----KEELKRRTLEMAVE----YPDKFSPEAK 226 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-----HHHHHhcccccccc----CCccCCHHHH
Confidence 78899999999888899999999999999999999999964332100 00000111110100 0111244578
Q ss_pred HHHhcccCCCCCCCC-----CHHHHHH
Q 002069 948 EVSISCLDESPTSRP-----TMQKVSQ 969 (973)
Q Consensus 948 ~li~~cl~~dP~~RP-----s~~ev~~ 969 (973)
+++.+||+.||.+|| ++.++++
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 227 DLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHccCChhHccCCCcccHHHHHh
Confidence 999999999999999 7777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.46 Aligned_cols=240 Identities=23% Similarity=0.388 Sum_probs=187.8
Q ss_pred ccccCCCceeEEEEEcC-C-------CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 707 HCIGNGGQGSVYKAELP-T-------GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
+.||+|+||.||+|... . ...||+|.+... .....+.+.+|+.+++.++|||++++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 46999999999999553 2 234888887532 223356788999999999999999999999988899999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCc--------eEEecc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYE--------AHVSDF 850 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~--------~kl~Df 850 (973)
|||+++|+|.++++... ..+++..+..++.||+.|++|||+. +|+||||||+||+++.++. ++++||
T Consensus 78 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999999999997654 2578999999999999999999999 9999999999999987765 699999
Q ss_pred cccccccCCCCcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCC-CCCcchhhhhhhhhhhhhhhhhhhc
Q 002069 851 GISKFLKLGLSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGK-HPRDFISSICSSLSSNLNIALDEML 928 (973)
Q Consensus 851 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 928 (973)
|.+..... .....+++.|+|||++.+. .++.++||||||+++|||++|. .||...+.... ..... .
T Consensus 153 g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~------~~~~~--~ 220 (258)
T cd05078 153 GISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK------LQFYE--D 220 (258)
T ss_pred ccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH------HHHHH--c
Confidence 98865532 2234678899999998764 5788999999999999999985 56543221110 00000 0
Q ss_pred CCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 929 DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...++.. ....+.+++.+||+.||++|||++++++.|+
T Consensus 221 ~~~~~~~------~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 RHQLPAP------KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cccCCCC------CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1112211 1235789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=303.36 Aligned_cols=251 Identities=25% Similarity=0.338 Sum_probs=203.6
Q ss_pred CCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|++.+.||+|+||.||+|... +++.||+|.+...........+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4888999999999999999664 689999999875443333446789999999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++++|.+++... ..+++.++..++.|+++|++|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999999754 3678999999999999999999999 99999999999999999999999999988665432
Q ss_pred CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhH
Q 002069 861 SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (973)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||........ ......... ..+..+.
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~-~~~~~~~------ 223 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR---DQIRAKQET-ADVLYPA------ 223 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH---HHHHHHhcc-ccccCcc------
Confidence 23445688899999999888899999999999999999999999874432100 000000000 1111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCH--HHHHH
Q 002069 941 DKLISIMEVSISCLDESPTSRPTM--QKVSQ 969 (973)
Q Consensus 941 ~~~~~l~~li~~cl~~dP~~RPs~--~ev~~ 969 (973)
..+..+.+++.+||+.||.+||++ +|+.+
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 123567889999999999999999 77664
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=304.88 Aligned_cols=249 Identities=27% Similarity=0.389 Sum_probs=198.2
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
+.|+..+.||+|+||+||+|... +++.||+|.+...........+++.+|+.+++.++|||++++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56888999999999999999654 78999999986543333444567899999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||++ |++.+++.... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.+......
T Consensus 95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 57777765332 3578999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCcccccccccCcccccccc---cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 860 LSNRTELAGTFGYIAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
....+++.|+|||++. ...++.++||||||+++|||+||+.||.......... .......+...
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~------~~~~~~~~~~~--- 235 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQNDSPTLS--- 235 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH------HHhcCCCCCCC---
Confidence 2356788999999874 3568889999999999999999999986443221100 00000001111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.......+.+++.+||+.+|++||++.++++.
T Consensus 236 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 236 --SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11234568899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=304.54 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=194.0
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHH-hhcCCCCceeeeceeeeccceeEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNA-LTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
++|++.+.||+|+||.||+|... +|+.||+|++....... ...++..|... ++..+|||++++++++..++..++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 36889999999999999999654 79999999987543222 23455556654 5667999999999999998999999
Q ss_pred EEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 779 YEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
|||++ ++|.++++... ....+++..++.++.|++.|++|||++. +++||||||+||+++.++.+||+|||.+....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99997 68888875432 2356899999999999999999999863 79999999999999999999999999998664
Q ss_pred CCCCcccccccccCccccccccc----CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 858 LGLSNRTELAGTFGYIAPELAYT----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
.. .......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||.......... .... ....+..+
T Consensus 156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~ 229 (283)
T cd06617 156 DS-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL----KQVV-EEPSPQLP 229 (283)
T ss_pred cc-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHH----HHHH-hcCCCCCC
Confidence 32 12233568889999998865 446889999999999999999999986322111100 0000 11111111
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
. ...+..+.+++.+||+.+|++||+++++++
T Consensus 230 ~-----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 230 A-----EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred c-----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 123456789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=304.53 Aligned_cols=262 Identities=21% Similarity=0.283 Sum_probs=198.6
Q ss_pred CcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEe
Q 002069 703 FDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEY 781 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 781 (973)
|++.+.||.|++|.||+|.. .+|+.||+|++....... ...+.+.+|++++++++|||++++++++.++...++||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 67788999999999999965 489999999987543222 2246788899999999999999999999999999999999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS 861 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 861 (973)
++ ++|.+++..... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.++.......
T Consensus 80 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 80 LD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred cC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 95 689998865432 3588999999999999999999998 999999999999999999999999999976644333
Q ss_pred cccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhh------hhhhhh------hhh--
Q 002069 862 NRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLS------SNLNIA------LDE-- 926 (973)
Q Consensus 862 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~------~~~~~~------~~~-- 926 (973)
......+++.|+|||++.+. .++.++||||||+++|+|++|+.||........... ...... ..+
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 33344678899999987654 468899999999999999999999975432111000 000000 000
Q ss_pred --hcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 927 --MLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 927 --~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...................+.+++.+|++.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000001111223567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=298.62 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=201.1
Q ss_pred CCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCC--cchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLP--GEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
+|+..+.||+|+||.||+|... +++.||+|.+..... ......+.+.+|+.++++++|+|++++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999665 889999999864322 1223457789999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.+++.+.. .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+|++|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999996543 578999999999999999999999 999999999999999999999999999876644
Q ss_pred CCCcccccccccCcccccccccCC-CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
.. ......+++.|+|||.+.... ++.++|+||||+++|+|++|+.||.......... ........+.++.
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~-----~~~~~~~~~~~~~--- 225 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF-----KIGRSKELPPIPD--- 225 (258)
T ss_pred cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH-----HHHhcccCCCcCC---
Confidence 32 234456889999999987766 8899999999999999999999986433111100 0000000111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+.+++.+||+.+|.+||++.++++.
T Consensus 226 ---~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 226 ---HLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ---CcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 123457789999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=306.03 Aligned_cols=263 Identities=24% Similarity=0.264 Sum_probs=199.3
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc--ceeEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA--LHSFV 777 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 777 (973)
++|++.+.||+|+||.||+|..+ +++.||+|.++..... ......+.+|+.++++++||||+++++++... ...++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 57889999999999999999665 6889999998754322 22235677899999999999999999998776 78999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||||++ ++|.+++.... ..+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.+|++|||.+....
T Consensus 84 v~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 84 VMEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred EehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999997 58988886543 3589999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCcccccccccCcccccccccCC-CCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhhhhhhhh---h-
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSNLNIALD---E- 926 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~~~~---~- 926 (973)
..........+++.|+|||.+.+.. ++.++|+||+|+++|||++|+.||........ ........... .
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 5433334456788999999887644 68899999999999999999999975432110 00000000000 0
Q ss_pred -------hcCCCCCCCchhhHH--HHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 927 -------MLDPRLPTPLRNVQD--KLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 927 -------~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
............... ....+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000000011 14457789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=298.64 Aligned_cols=252 Identities=22% Similarity=0.300 Sum_probs=201.9
Q ss_pred CCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|++.+.||+|+||.||+|... +|..||+|.+....... ...+.+.+|+.+++.++|+|++++++.+......++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 4788899999999999999654 68899999986542221 234678899999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC-ceEEecccccccccCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY-EAHVSDFGISKFLKLG 859 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~ 859 (973)
|+++++|.+++.+.. ...+++..+..++.|++.|++|||+. +++|+|++|+||++++++ .+|++|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 80 YCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred cCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999986543 23578999999999999999999998 999999999999999885 4699999999877654
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
........|++.|+|||+..+..++.++||||||+++|||++|+.||...... ....+..........
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~~~~--- 223 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH---------QLVLKICQGYFAPIS--- 223 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---------HHHHHHhcccCCCCC---
Confidence 33334456899999999998888999999999999999999999998643211 111111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+.+++.+||+.+|++|||+.++++.
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 224 PNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1123457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=303.38 Aligned_cols=263 Identities=20% Similarity=0.303 Sum_probs=201.0
Q ss_pred CCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|++.+.||+|++|.||+|... +|+.||||++...... .....+.+|+.++++++|+|++++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 4888999999999999999764 7899999998754322 224667789999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++ ++.+++........+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+.......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9985 8888887655445689999999999999999999998 99999999999999999999999999997664433
Q ss_pred CcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh------hhhhhhhhhhhhc-----
Q 002069 861 SNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS------LSSNLNIALDEML----- 928 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~------~~~~~~~~~~~~~----- 928 (973)
.......+++.|+|||++.+. .++.++||||+||++|+|++|+.||......... .............
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 333345678899999988654 4688999999999999999999999754321100 0000000000000
Q ss_pred CCCCCCCchh-----hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 929 DPRLPTPLRN-----VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 929 ~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
....+..... .......+.+++.+|++.||.+||+++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0111110000 01224567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=298.86 Aligned_cols=254 Identities=22% Similarity=0.365 Sum_probs=200.7
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcc---hhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGE---MACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
+|+..+.||+|+||.||+|.. .+++.||+|.+....... ....+.+.+|+.++++++|+|++++++++.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999954 588999999987543221 2235788999999999999999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC-ceEEecccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY-EAHVSDFGISKFL 856 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-~~kl~Dfg~a~~~ 856 (973)
||||+++++|.+++++. .++++..+..++.|++.|++|||+. +++|+||+|+||+++.++ .+|++|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999999653 3578899999999999999999999 999999999999998776 5999999998776
Q ss_pred cCCCC----cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 857 KLGLS----NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 857 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
..... ......++..|+|||.+.+..++.++||||+|+++|++++|+.||...... .. .....+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~-----~~~~~~~~~~~~ 228 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-NH-----LALIFKIASATT 228 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-ch-----HHHHHHHhccCC
Confidence 54321 122346788999999998888999999999999999999999998633210 00 001111100011
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
... ........+.+++.+|++.+|.+||++.+++.
T Consensus 229 ~~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 APS--IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCC--CchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 111 11233456788999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=306.65 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=209.9
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
...|.+...||+|.|+.|..|.+. ++..||+|.+++....... ...+.+|+++|+.+.|||||+++.+...+...|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 467999999999999999999654 8999999999876554433 45599999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+.+|.+++++.++. +..+..+..++.|+++|++|||++ .|||||+|++||+++.+..+||+|||++.++..
T Consensus 134 ~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999998776 344588899999999999999999 999999999999999999999999999999875
Q ss_pred CCCcccccccccCcccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
+ .......|++.|+|||++.+.+| .+++|+||+|+++|.++.|..||++. ...+.-.+.+..++.-++.
T Consensus 208 ~-~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~---------~lk~Lr~rvl~gk~rIp~~ 277 (596)
T KOG0586|consen 208 G-LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ---------NLKELRPRVLRGKYRIPFY 277 (596)
T ss_pred c-ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc---------ccccccchheeeeecccce
Confidence 4 45567889999999999999887 47899999999999999999999832 2222233333444433322
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...+..+++++++-.+|.+|++.+++.+.
T Consensus 278 ----ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 278 ----MSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ----eechhHHHHHHhhccCccccCCHHHhhhh
Confidence 12235678889999999999999998764
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=303.14 Aligned_cols=263 Identities=24% Similarity=0.335 Sum_probs=201.8
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||.||+|... +++.||+|+++..... ....+.+.+|++++++++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 36889999999999999999664 6889999998754322 233578899999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||++++.+..+.... ..+++.++..++.|++.|++|||+. +++|+|++|+||+++.++.+|++|||.+......
T Consensus 80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 80 EYVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred ecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999987777665432 3478999999999999999999999 9999999999999999999999999999877654
Q ss_pred CC-cccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhh---------hhhhhhh--hh
Q 002069 860 LS-NRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLS---------SNLNIAL--DE 926 (973)
Q Consensus 860 ~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~---------~~~~~~~--~~ 926 (973)
.. ......++..|+|||++.+. .++.++||||||+++|+|++|+.||........... ....... ..
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 32 33345678899999999887 788999999999999999999999874432110000 0000000 00
Q ss_pred hcCC-CCCCCchh-------hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 927 MLDP-RLPTPLRN-------VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 927 ~~~~-~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.... .++..... ....+..+.+++.+||+.+|++||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000 00000000 00124668899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=302.98 Aligned_cols=262 Identities=24% Similarity=0.326 Sum_probs=201.5
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|++.+.||+|+||.||+|.. .+|+.||+|++....... ...+.+.+|+.++++++|||++++++++..+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 588899999999999999965 478999999987643222 235778999999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+ +++|.+++.... ..+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.++++|||.+.......
T Consensus 80 ~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 80 YM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred cc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 99 999999986543 4689999999999999999999999 99999999999999999999999999998765432
Q ss_pred C-cccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh--hhhhh----hhhh--------
Q 002069 861 S-NRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS--LSSNL----NIAL-------- 924 (973)
Q Consensus 861 ~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~----~~~~-------- 924 (973)
. ......++..|+|||++.+. .++.++||||+|+++|||++|.+||......... ..... ....
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 1 23345689999999998654 4688999999999999999998888643321100 00000 0000
Q ss_pred -hhhcCC-CCCCCch-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 925 -DEMLDP-RLPTPLR-NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 925 -~~~~~~-~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+ ....... ........+.+++.+|++.||.+||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 0000000 001234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=298.61 Aligned_cols=245 Identities=22% Similarity=0.248 Sum_probs=188.2
Q ss_pred ccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHH-hhcCCCCceeeeceeeeccceeEEEEEecCC
Q 002069 707 HCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNA-LTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
+.||+|+||.||+|.. .+++.||+|++.............+..|..+ ....+|+|++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999965 4789999999865432222223344555444 4455899999999999999999999999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccc
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 864 (973)
++|.++++... .+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.++.... ..
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 151 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK 151 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence 99999996543 578899999999999999999999 999999999999999999999999999875432 23
Q ss_pred ccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHH
Q 002069 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLI 944 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (973)
...+++.|+|||.+.+..++.++||||+|+++|||++|..||....... ......................
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~ 222 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---------VFDNILSRRINWPEEVKEFCSP 222 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---------HHHHHHhcccCCCCcccccCCH
Confidence 4568899999999988888999999999999999999999996432210 0111111111111111112345
Q ss_pred HHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 945 SIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 945 ~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.+.+++.+||+.+|++||++.++.+.
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHH
Confidence 67899999999999999977655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=284.19 Aligned_cols=253 Identities=26% Similarity=0.336 Sum_probs=198.1
Q ss_pred CcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhh-cCCCCceeeeceeeeccceeEEEEE
Q 002069 703 FDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALT-KIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
.+....||.|+||+|+|-.+ +.|+..|||++..... ...++++..|.+... .-++|+||++||++..++..||.||
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 34456799999999999955 4899999999987655 334788999988644 4589999999999999999999999
Q ss_pred ecCCCChHHHhccCc--cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 781 YLEMGSLAMILSNDA--AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
.|+ .++..+-+.-. ...++++.-.-+|+...+.||.||-+.. .|+|||+||+|||++..|.+|+||||.+.....
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 996 56665543211 2346788888888889999999999874 899999999999999999999999999876543
Q ss_pred CCCcccccccccCccccccccc--CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC-
Q 002069 859 GLSNRTELAGTFGYIAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP- 935 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 935 (973)
. ...+..+|...|||||.+.. ..|+.+|||||+|+++||+.||+.|+....+.. +.+.+++.+..+..
T Consensus 221 S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf--------eql~~Vv~gdpp~l~ 291 (361)
T KOG1006|consen 221 S-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF--------EQLCQVVIGDPPILL 291 (361)
T ss_pred H-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH--------HHHHHHHcCCCCeec
Confidence 3 34456689999999998864 348999999999999999999999987544322 22333333333221
Q ss_pred -chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 936 -LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 936 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
.....+....+..+|..|+.+|-..||.+.++..
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1222345667889999999999999999998865
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=325.55 Aligned_cols=254 Identities=25% Similarity=0.396 Sum_probs=194.4
Q ss_pred HHhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec-----
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH----- 771 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----- 771 (973)
+...+|+..+.||+||||.||+++.+ ||+.||||++.... .......+.+|+..+++++|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 45567888899999999999999876 99999999997654 23335778899999999999999998751100
Q ss_pred --------------------------------------------------------------------------------
Q 002069 772 -------------------------------------------------------------------------------- 771 (973)
Q Consensus 772 -------------------------------------------------------------------------------- 771 (973)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred --------------------------c--------ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHH
Q 002069 772 --------------------------A--------LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL 817 (973)
Q Consensus 772 --------------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 817 (973)
+ ...||-||||+...+.+++.++.... .....|+++.+|+.|++
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLA 711 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHH
Confidence 0 12378899999888888887654321 35788999999999999
Q ss_pred HHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc----C--------------CCCcccccccccCcccccccc
Q 002069 818 YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK----L--------------GLSNRTELAGTFGYIAPELAY 879 (973)
Q Consensus 818 ~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~----~--------------~~~~~~~~~g~~~y~aPE~~~ 879 (973)
|+|+. |||||||||.||++++++.|||+|||+|+... . .....+..+||.-|+|||++.
T Consensus 712 YIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 99999 99999999999999999999999999998722 0 011335678999999999987
Q ss_pred cC---CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCC
Q 002069 880 TM---KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDE 956 (973)
Q Consensus 880 ~~---~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 956 (973)
+. +|+.|+|+||+||+++||+ +||.-.-+ ....+....++.++.+..-.......-..+|..+++.
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsME--------Ra~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEML---YPFGTSME--------RASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSH 857 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHh---ccCCchHH--------HHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcC
Confidence 65 4999999999999999999 45641110 1223334445555555222222333346788899999
Q ss_pred CCCCCCCHHHHHH
Q 002069 957 SPTSRPTMQKVSQ 969 (973)
Q Consensus 957 dP~~RPs~~ev~~ 969 (973)
||.+||||.|++.
T Consensus 858 dP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 858 DPSKRPTATELLN 870 (1351)
T ss_pred CCccCCCHHHHhh
Confidence 9999999999975
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=300.91 Aligned_cols=245 Identities=21% Similarity=0.240 Sum_probs=186.6
Q ss_pred cccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHH---hhcCCCCceeeeceeeeccceeEEEEEecC
Q 002069 708 CIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNA---LTKIRHRNIVKFYGFCSHALHSFVVYEYLE 783 (973)
Q Consensus 708 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~---l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 783 (973)
.||+|+||.||+|.. .+++.||+|.+.............+.+|..+ +...+||+++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999965 4789999999865433222222334444433 334479999999999998889999999999
Q ss_pred CCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCcc
Q 002069 784 MGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR 863 (973)
Q Consensus 784 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 863 (973)
+++|.+++... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+...... ..
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~ 152 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KP 152 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc--Cc
Confidence 99999998654 3589999999999999999999999 9999999999999999999999999998755432 22
Q ss_pred cccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHH
Q 002069 864 TELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDK 942 (973)
Q Consensus 864 ~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (973)
....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||........ ...... .......++ ...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~-~~~~~~~~~------~~~ 222 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRM-TLTVNVELP------DSF 222 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH---HHHHHH-hhcCCcCCc------ccc
Confidence 33468999999998864 5678999999999999999999999964321000 000000 000111111 123
Q ss_pred HHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 002069 943 LISIMEVSISCLDESPTSRP-----TMQKVSQL 970 (973)
Q Consensus 943 ~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 970 (973)
...+.+++.+|++.||.+|| ++++++++
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 34578899999999999999 69998874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=303.89 Aligned_cols=265 Identities=19% Similarity=0.246 Sum_probs=197.3
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccce----
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALH---- 774 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~---- 774 (973)
++|++.+.||+|+||.||+|.. .+++.||+|++...... ......+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 3688999999999999999965 47899999998654322 12246788899999999 46999999999876555
Q ss_pred -eEEEEEecCCCChHHHhccCcc--ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC-CCceEEecc
Q 002069 775 -SFVVYEYLEMGSLAMILSNDAA--AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL-EYEAHVSDF 850 (973)
Q Consensus 775 -~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-~~~~kl~Df 850 (973)
.|+||||+++ ++.+++..... ...+++.+++.++.||+.|++|||+. +++||||+|+||+++. ++.+|++||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence 7999999985 78888754332 24689999999999999999999999 9999999999999998 889999999
Q ss_pred cccccccCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhh------hhhhh
Q 002069 851 GISKFLKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSS------NLNIA 923 (973)
Q Consensus 851 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~------~~~~~ 923 (973)
|.++.+...........+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........- .....
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 999866443333334467889999998865 45789999999999999999999999754322111000 00000
Q ss_pred hhhhc-------CCCCCC-C-chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 924 LDEML-------DPRLPT-P-LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 924 ~~~~~-------~~~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..... .+.... . ..........+.++|.+||+.||.+||+++|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 000000 0 00011234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=302.96 Aligned_cols=244 Identities=26% Similarity=0.387 Sum_probs=196.5
Q ss_pred cccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCC
Q 002069 706 EHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
..+||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.++|+|++++++++..++..++||||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 36799999999999965 478999999975432 22357789999999999999999999999999999999999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccc
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 864 (973)
++|.+++... .+++.....++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+...........
T Consensus 102 ~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~ 174 (292)
T cd06657 102 GALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174 (292)
T ss_pred CcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence 9999987532 478899999999999999999999 999999999999999999999999999876654333334
Q ss_pred ccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHH
Q 002069 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLI 944 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (973)
...|++.|+|||++.+..++.++||||+|+++|+|++|..||........ .........+... .......
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~------~~~~~~~~~~~~~----~~~~~~~ 244 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA------MKMIRDNLPPKLK----NLHKVSP 244 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhhCCcccC----CcccCCH
Confidence 45688999999999888889999999999999999999999864322110 0011111111111 1112234
Q ss_pred HHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 945 SIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 945 ~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
.+.+++.+||+.+|.+||++.++++
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhc
Confidence 5778899999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=296.49 Aligned_cols=245 Identities=24% Similarity=0.293 Sum_probs=197.3
Q ss_pred ccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCCCCh
Q 002069 709 IGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 787 (973)
Q Consensus 709 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 787 (973)
||.|+||.||+|... +++.||+|++...........+.+.+|+.++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999664 5899999998765443334467899999999999999999999999999999999999999999
Q ss_pred HHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCcccccc
Q 002069 788 AMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA 867 (973)
Q Consensus 788 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 867 (973)
.+++.+.. .+++.++..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||.+....... ......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~ 153 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC 153 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence 99997543 478899999999999999999998 99999999999999999999999999998765432 223356
Q ss_pred cccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHH
Q 002069 868 GTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIM 947 (973)
Q Consensus 868 g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 947 (973)
+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...... .................. ......+.
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~--~~~~~~~~ 224 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-------PMEIYNDILKGNGKLEFP--NYIDKAAK 224 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-------HHHHHHHHhccCCCCCCC--cccCHHHH
Confidence 889999999998888999999999999999999999999744310 011111111111000111 11144688
Q ss_pred HHHhcccCCCCCCCCC-----HHHHHH
Q 002069 948 EVSISCLDESPTSRPT-----MQKVSQ 969 (973)
Q Consensus 948 ~li~~cl~~dP~~RPs-----~~ev~~ 969 (973)
+++.+||+.+|.+||+ ++|+++
T Consensus 225 ~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 225 DLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHccCChhhCcCCcccCHHHHhc
Confidence 9999999999999999 888776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=297.20 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=195.8
Q ss_pred CcccccccCCCceeEEEEEcC----CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc-----
Q 002069 703 FDDEHCIGNGGQGSVYKAELP----TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL----- 773 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 773 (973)
|.+.+.||+|+||+||+|.+. +++.||||++....... ...+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 567889999999999999642 46889999987543332 23567889999999999999999999886432
Q ss_pred -eeEEEEEecCCCChHHHhccCc---cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEec
Q 002069 774 -HSFVVYEYLEMGSLAMILSNDA---AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSD 849 (973)
Q Consensus 774 -~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~D 849 (973)
..++++||+++|++.+++.... ....+++...+.++.|++.|++|||+. +|+||||||+||+++.++.+|++|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence 2368899999999998874322 123478899999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhh
Q 002069 850 FGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDE 926 (973)
Q Consensus 850 fg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 926 (973)
||.++....... ......+++.|++||......++.++||||||+++|||++ |+.||....... .......
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~------~~~~~~~ 230 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE------IYNYLIK 230 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH------HHHHHHc
Confidence 999986643321 1223345678999999988889999999999999999999 889986433210 0000000
Q ss_pred hcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 927 MLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
......+ ......+.+++.+||+.+|.+||++.++++.|+
T Consensus 231 ~~~~~~~------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~ 270 (273)
T cd05074 231 GNRLKQP------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270 (273)
T ss_pred CCcCCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 0011111 122346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.34 Aligned_cols=250 Identities=30% Similarity=0.439 Sum_probs=204.3
Q ss_pred CCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
.|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++.+++++|++++++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 3778899999999999999664 789999999976433 245789999999999999999999999999899999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++++|.+++.... ..+++..+..++.|++.|+++||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 78 FCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred cCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 999999999987543 4689999999999999999999998 99999999999999999999999999998776543
Q ss_pred CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhH
Q 002069 861 SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (973)
. .....++..|+|||++.+..++.++||||||+++|+|++|+.||...+...... .......+.... ..
T Consensus 153 ~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~~~~~~----~~ 221 (253)
T cd05122 153 A-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF------KIATNGPPGLRN----PE 221 (253)
T ss_pred c-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH------HHHhcCCCCcCc----cc
Confidence 2 344578899999999988889999999999999999999999987543211100 000000111111 11
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 941 DKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 941 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+.+++.+||+.||++|||+.++++.
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 123457899999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=300.27 Aligned_cols=261 Identities=18% Similarity=0.208 Sum_probs=186.5
Q ss_pred hcCCcccccccCCCceeEEEEEcCC----CCEEEEEEcCCCCCcchhh--------HHHHHHHHHHhhcCCCCceeeece
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPT----GEIVAVKKFHSPLPGEMAC--------QQEFLNEGNALTKIRHRNIVKFYG 767 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~ 767 (973)
.++|++.+.||+|+||+||+|.+.+ +..+|+|+........... ......+...+..++|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3689999999999999999997643 4567777643322111000 011223344566778999999999
Q ss_pred eeeccc----eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC
Q 002069 768 FCSHAL----HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY 843 (973)
Q Consensus 768 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~ 843 (973)
++.... ..++++|++. .++.+.++.. ...++..+..++.|++.|++|||+. +++||||||+||+++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 775443 3467888764 4666666432 2356788999999999999999999 999999999999999999
Q ss_pred ceEEecccccccccCCCC-------cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh
Q 002069 844 EAHVSDFGISKFLKLGLS-------NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL 916 (973)
Q Consensus 844 ~~kl~Dfg~a~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 916 (973)
.++++|||+|+.+..... ......||+.|+|||+..+..++.++|||||||++|||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999987643211 1223469999999999999999999999999999999999999997553211111
Q ss_pred hhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 917 SSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.............+.... ...+..+.+++..|++.+|++||+++++.+.++
T Consensus 244 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIKI-----KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHHHhhhhhhcc-----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111111112222222111 112345788999999999999999999998874
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=304.92 Aligned_cols=265 Identities=20% Similarity=0.295 Sum_probs=196.9
Q ss_pred CCcccccccCCCceeEEEEEcC---CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc--ceeE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP---TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA--LHSF 776 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 776 (973)
+|++.+.||+|+||.||+|... +++.||+|.+...........+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999654 5789999999864322222346778899999999999999999999887 7899
Q ss_pred EEEEecCCCChHHHhccCcc--ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC----CCceEEecc
Q 002069 777 VVYEYLEMGSLAMILSNDAA--AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL----EYEAHVSDF 850 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~----~~~~kl~Df 850 (973)
+||||+++ ++.+++..... ...+++..++.++.|++.|++|||+. +++||||||+||+++. ++.+|++||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 67666643332 23688999999999999999999999 9999999999999999 899999999
Q ss_pred cccccccCCCC---cccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhh----hhhh
Q 002069 851 GISKFLKLGLS---NRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSS----NLNI 922 (973)
Q Consensus 851 g~a~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~----~~~~ 922 (973)
|.+........ ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||...........+ ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987644322 22345678899999987664 5788999999999999999999999743321100000 0000
Q ss_pred hh------------------------hhhcCCCCCC-CchhhH----HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 923 AL------------------------DEMLDPRLPT-PLRNVQ----DKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 923 ~~------------------------~~~~~~~~~~-~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.+ ........+. ...... .....+.+++.+|++.||++|||+.|+++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 0000011110 000000 223467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=302.01 Aligned_cols=249 Identities=26% Similarity=0.394 Sum_probs=196.9
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
.|+..+.||+|+||.||+|.. .+++.||+|++.............+.+|++++++++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 477788999999999999965 4789999999875433333445678899999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|++ |++.+++.... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.+......
T Consensus 106 ~~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 997 57777765332 4588999999999999999999999 9999999999999999999999999998754432
Q ss_pred CcccccccccCcccccccc---cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 861 SNRTELAGTFGYIAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
....+++.|+|||++. ...++.++|||||||++|||++|+.||........ .........+..
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---------~~~~~~~~~~~~-- 244 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---------LYHIAQNESPTL-- 244 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---------HHHHHhccCCCC--
Confidence 3346888999999874 45688899999999999999999999864321110 011111111100
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
........+.+++.+||+.+|.+||++.++++..
T Consensus 245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred CCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 0112334578899999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=307.01 Aligned_cols=261 Identities=21% Similarity=0.306 Sum_probs=197.6
Q ss_pred HhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc-----
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA----- 772 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 772 (973)
..++|+..+.||+|+||.||+|.. .+++.||+|++...... ......+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN-VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC-hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 457899999999999999999954 48999999998654322 22346678899999999999999999988543
Q ss_pred -ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccc
Q 002069 773 -LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFG 851 (973)
Q Consensus 773 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg 851 (973)
...++||||++ +++.+.+.. .++..++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35699999996 588877753 278889999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh------hhh-------
Q 002069 852 ISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS------LSS------- 918 (973)
Q Consensus 852 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~------~~~------- 918 (973)
.++...... ......+++.|+|||.+.+..++.++||||+||++|+|++|+.||...+....+ ...
T Consensus 164 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 164 LARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred cceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 998764432 233456789999999999999999999999999999999999999744321100 000
Q ss_pred hhhhhhhhhcCCCC----------------CCCch-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 919 NLNIALDEMLDPRL----------------PTPLR-NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 919 ~~~~~~~~~~~~~~----------------~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
............+. +.... ........+.+++.+|++.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000000000 00000 011224457899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=283.82 Aligned_cols=242 Identities=23% Similarity=0.278 Sum_probs=201.2
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|+..+++|+|.||.|..++.+ +++.||+|++++...-.......-..|-.+++..+||.+..+--.|...++.|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467999999999999999999554 8999999999987766665566777899999999999999998889999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||..||.|.-.+.+. +.+++...+-+-..|+.|+.|||++ +||.||+|.+|.++|.||++||+|||+++.--.
T Consensus 247 MeyanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999999888654 3688888889999999999999999 999999999999999999999999999986554
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcC--CCCCCCc
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLD--PRLPTPL 936 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 936 (973)
.......+.|||.|.|||++....|+.++|.|.+||++|||++|+.||...+. ...+.-++- -++|...
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---------~kLFeLIl~ed~kFPr~l 391 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---------EKLFELILMEDLKFPRTL 391 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---------hHHHHHHHhhhccCCccC
Confidence 45566788999999999999999999999999999999999999999974331 111111111 1222222
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCC
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRP 962 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RP 962 (973)
. .+...++...+.+||++|-
T Consensus 392 s------~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 392 S------PEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred C------HHHHHHHHHHhhcChHhhc
Confidence 2 1234566789999999995
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=301.54 Aligned_cols=253 Identities=26% Similarity=0.350 Sum_probs=194.8
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeeccceeEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 779 (973)
+|+..+.||+|+||.||++.. .+++.||+|.+...... .....+.+|+.++.++. |+||+++++++..++..+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 466678899999999999955 47899999998754322 34577899999999996 999999999999888999999
Q ss_pred EecCCCChHHHhccC--ccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 780 EYLEMGSLAMILSND--AAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 780 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||++ +++.++.... .....+++..+..++.|++.|++|||+.. +++||||||+||+++.++.+|++|||+++...
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9986 4555443211 11246889999999999999999999743 89999999999999999999999999997654
Q ss_pred CCCCcccccccccCcccccccccC---CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcC---CC
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLD---PR 931 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 931 (973)
... ......|+..|+|||++.+. .++.++||||+||++|||++|+.||....... ....+... +.
T Consensus 160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~ 230 (288)
T cd06616 160 DSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF--------DQLTQVVKGDPPI 230 (288)
T ss_pred cCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH--------HHHhhhcCCCCCc
Confidence 332 22334688899999998766 68899999999999999999999987432110 11111111 11
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.... .....+..+.+++.+||+.||.+|||+++|++.
T Consensus 231 ~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 LSNS--EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCc--CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 112244568899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=293.70 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=206.3
Q ss_pred CCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|++.+.||.|+||.||++... +++.||+|++...... ....+.+.+|+++++.++|+|++++++.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 4788899999999999999654 7899999998764332 2346778899999999999999999999998899999999
Q ss_pred ecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 781 YLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
|+++++|.+++.... ....+++.++..++.+++.|++|||+. +++|+||+|+||+++.++.++++|||.+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999997543 235689999999999999999999999 9999999999999999999999999999877655
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
........|++.|+|||...+..++.++||||+|+++|+|++|+.||+..... ................
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~~~~~-- 225 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---------ELALKILKGQYPPIPS-- 225 (258)
T ss_pred cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---------HHHHHHhcCCCCCCCC--
Confidence 43344457889999999998888999999999999999999999998744311 1111111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+.+++.+||+.+|++||++.++++.
T Consensus 226 -~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 -QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 223457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=294.51 Aligned_cols=251 Identities=24% Similarity=0.278 Sum_probs=204.8
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|++.+.||+|+||.||++.. .+++.||+|.+...... ......+.+|++++++++|+||+++++++.+....++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 478899999999999999954 47889999998754332 2335678899999999999999999999999899999999
Q ss_pred ecCCCChHHHhccCcc-ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 781 YLEMGSLAMILSNDAA-AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
|+++++|.+++.+... ...+++..++.++.|++.|++|||+. +++|+||+|+||+++.++.+|++|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999999865322 34678999999999999999999999 9999999999999999999999999999877554
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
......+++.|+|||...+..++.++|+||+|+++|||++|+.||...+.. ...........+...
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~~~~--- 222 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---------DLRYKVQRGKYPPIP--- 222 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHhcCCCCCCc---
Confidence 222356889999999999988999999999999999999999999744321 111111112222111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+.+++.+|++.+|++||++.++++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1344568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=303.86 Aligned_cols=264 Identities=27% Similarity=0.313 Sum_probs=197.3
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc--ceeE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA--LHSF 776 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 776 (973)
.++|++.+.||+|+||.||+|.. .+|+.||+|++....... .....+.+|+.++++++|+|++++++++.+. +..+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 46799999999999999999965 478999999986443221 1134566899999999999999999998654 4679
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
+||||++ ++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+...
T Consensus 85 lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999997 47888886533 4689999999999999999999999 9999999999999999999999999999877
Q ss_pred cCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhhhhhhhhhhcC
Q 002069 857 KLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSNLNIALDEMLD 929 (973)
Q Consensus 857 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~~ 929 (973)
...........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||........ ...............
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 654333334456788999999865 4578999999999999999999999974432110 000000000000000
Q ss_pred ----CC--CC-CCchh----hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 930 ----PR--LP-TPLRN----VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 930 ----~~--~~-~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.. .. ..... .......+.+++.+|++.||++|||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 00 00000 01124456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=297.49 Aligned_cols=246 Identities=24% Similarity=0.340 Sum_probs=196.2
Q ss_pred ccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCCCCh
Q 002069 709 IGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 787 (973)
Q Consensus 709 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 787 (973)
||+|+||.||++... +|+.||+|++...........+.+.+|++++++++|||++++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999765 5999999998765443334567889999999999999999999999999999999999999999
Q ss_pred HHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC------
Q 002069 788 AMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS------ 861 (973)
Q Consensus 788 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------ 861 (973)
.+++++.. .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99997543 578999999999999999999999 999999999999999999999999999876543311
Q ss_pred --cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 862 --NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 862 --~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
......++..|+|||...+...+.++||||||+++|++++|+.||...... .............+. .
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~~~~--~ 223 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---------EIFQNILNGKIEWPE--D 223 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHhcCCcCCCc--c
Confidence 223456788999999998888899999999999999999999998743311 111111111111110 0
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
......+.+++.+||+.+|.+|||+.++.+.+
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 224 VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 11245578999999999999999995544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=299.86 Aligned_cols=264 Identities=20% Similarity=0.271 Sum_probs=197.1
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|++|+||+|... +++.||+|.+...... ....+.+.+|++++++++|||++++++++......++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 46889999999999999999654 7899999998654322 122467888999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC-CCceEEecccccccccC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL-EYEAHVSDFGISKFLKL 858 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-~~~~kl~Dfg~a~~~~~ 858 (973)
||++ +++.+++.... ...+++..+..++.||+.|++|||+. +++|+||+|+||+++. ++.+|++|||.+.....
T Consensus 81 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 81 EYLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred eccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 9996 57877775433 23457888999999999999999999 9999999999999985 46799999999976654
Q ss_pred CCCcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhh------hhhhhhhh------
Q 002069 859 GLSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLS------SNLNIALD------ 925 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~------~~~~~~~~------ 925 (973)
.........+++.|+|||++.+. .++.++||||+|+++|+|+||+.||........... ........
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 33333445678999999988664 578899999999999999999999974432211100 00000000
Q ss_pred --hhcCCCCCCCc--hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 926 --EMLDPRLPTPL--RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 926 --~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
....+...... .........+.+++.+|++.+|++||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000100000 0011223457889999999999999999999863
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=333.54 Aligned_cols=253 Identities=28% Similarity=0.397 Sum_probs=204.0
Q ss_pred hcCCcccccccCCCceeEEEE-EcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
+-+++....||.|.||.||-| ...+|+..|+|-++..... ....+...+|..++..+.|||+|++||+-.+.+..+|.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 457888899999999999999 5568999999988754433 34467788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
||||++|+|.+.+...+ -.++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|..+..
T Consensus 1313 MEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999987544 234566677889999999999999 999999999999999999999999999998876
Q ss_pred CCCc----ccccccccCcccccccccCC---CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 859 GLSN----RTELAGTFGYIAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 859 ~~~~----~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
.... .....||+.|||||++.+.. ...++||||+|||+.||+||+.||...++..+.+.. +...-.|.
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~-----V~~gh~Pq 1461 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH-----VAAGHKPQ 1461 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH-----HhccCCCC
Confidence 5322 23578999999999997654 456799999999999999999999865543322211 11111222
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
+|.. ...+-.+++..|++.||++|=++.|+++.
T Consensus 1462 ~P~~------ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 IPER------LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred Cchh------hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2222 34445788889999999999988888763
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=291.83 Aligned_cols=251 Identities=26% Similarity=0.362 Sum_probs=205.6
Q ss_pred CCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc--ceeEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA--LHSFVV 778 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 778 (973)
+|+..+.||+|++|.||+|... +++.|++|++...... ....+.+.+|+.++++++|+||+++++.+... ...++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 4778899999999999999665 7899999998765332 23467899999999999999999999999887 889999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
+||+++++|.+++.... .+++.+++.++.|++.|++|||+. +++|+|++|+||+++.++.++++|||.+.....
T Consensus 80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999997543 689999999999999999999998 999999999999999999999999999987765
Q ss_pred CCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcC-CCCCCC
Q 002069 859 GLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLD-PRLPTP 935 (973)
Q Consensus 859 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 935 (973)
... ......++..|+|||...+...+.++||||||+++|+|++|..||........ ....... ......
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~ 225 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--------ALYKIGSSGEPPEI 225 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--------HHHhccccCCCcCC
Confidence 432 13446788999999999888899999999999999999999999975441111 1111111 111111
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
. ......+.+++.+|++.+|.+||++.++++.
T Consensus 226 ~---~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 226 P---EHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred C---cccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1 1224568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=306.68 Aligned_cols=261 Identities=23% Similarity=0.322 Sum_probs=195.3
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc-----c
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA-----L 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~ 773 (973)
.++|++.+.||+|+||.||+|.. .+|+.||+|++..... ......+.+|+.++++++|+||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH--QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 46899999999999999999954 5789999999864322 22346788899999999999999999987543 3
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
..++|+||++ +++.+++.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 82 DVYIVQELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred eEEEEehhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 5789999997 478777753 3588999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCC---cccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhh------hhhhhhhhhh
Q 002069 854 KFLKLGLS---NRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSIC------SSLSSNLNIA 923 (973)
Q Consensus 854 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~------~~~~~~~~~~ 923 (973)
........ ......|++.|+|||.+.+ ..++.++||||+||++|+|++|+.||....... ........+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 76543221 1223567899999998754 468899999999999999999999996433110 0000000011
Q ss_pred hhhhcCCC-------CC----CCch-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 924 LDEMLDPR-------LP----TPLR-NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 924 ~~~~~~~~-------~~----~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
........ .+ .... ........+.+++.+||+.||++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11000000 00 0000 011234568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=325.26 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=206.4
Q ss_pred HHhcCCcccccccCCCceeEEEEEcC----C----CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeecee
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAELP----T----GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGF 768 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 768 (973)
...++..+.+.+|+|.||.||+|... . ...||||+++..... ...+.+..|+++|+.+ +|+||+.++|+
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 33445566779999999999999532 1 457999999877655 4478999999999999 69999999999
Q ss_pred eeccceeEEEEEecCCCChHHHhccCc-----------cc--cCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCC
Q 002069 769 CSHALHSFVVYEYLEMGSLAMILSNDA-----------AA--EEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSK 835 (973)
Q Consensus 769 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~ 835 (973)
|...+..++|+||+..|+|.+|++..+ .. ..++..+.+.++.|||.|++||++. +++|||+.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence 999889999999999999999997665 01 2388999999999999999999999 9999999999
Q ss_pred CeeecCCCceEEecccccccccCCCCcc-cccc--cccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhh
Q 002069 836 NVLLNLEYEAHVSDFGISKFLKLGLSNR-TELA--GTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISS 911 (973)
Q Consensus 836 Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~--g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~ 911 (973)
||+++.+..+||+|||+|+...+..... .... -+..|||||.+....|+.++|||||||++||++| |..||.....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 9999999999999999999765543332 2222 3567999999999999999999999999999998 9999874221
Q ss_pred hhhhhhhhhhhhhhhhcCC-CCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 912 ICSSLSSNLNIALDEMLDP-RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
. ......+.++ ++..+ ..+..+++++++.||+.+|++||++.++++.++
T Consensus 528 ~--------~~l~~~l~~G~r~~~P----~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~ 577 (609)
T KOG0200|consen 528 T--------EELLEFLKEGNRMEQP----EHCSDEIYDLMKSCWNADPEDRPTFSECVEFFE 577 (609)
T ss_pred H--------HHHHHHHhcCCCCCCC----CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence 1 1111111111 11111 223456789999999999999999999998874
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=307.74 Aligned_cols=201 Identities=30% Similarity=0.418 Sum_probs=177.2
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc------ce
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA------LH 774 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 774 (973)
.|...+.+|+|+||.||+|+. .+|+.||||.+....... .++...+|++++++++|+|||+.+++-.+. ..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r--~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR--PRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccc--hHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 345667899999999999984 589999999998754333 367888999999999999999999886543 35
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeec--CCC--ceEEecc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLN--LEY--EAHVSDF 850 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~--~~~--~~kl~Df 850 (973)
..+|||||.+|+|...+.+......+++.+.+.++.+++.|+.|||++ +|+||||||.||++- ++| ..||+||
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecc
Confidence 689999999999999999888888899999999999999999999999 999999999999984 334 3799999
Q ss_pred cccccccCCCCcccccccccCcccccccc-cCCCCCccchHHHHHHHHHHHhCCCCCcc
Q 002069 851 GISKFLKLGLSNRTELAGTFGYIAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDF 908 (973)
Q Consensus 851 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 908 (973)
|.|+...++ +.....+||..|.+||.+. .+.|+..+|.|||||++|+.+||..||-.
T Consensus 169 G~Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 169 GAARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 999988776 4677889999999999998 48889999999999999999999999864
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=289.27 Aligned_cols=249 Identities=25% Similarity=0.411 Sum_probs=204.6
Q ss_pred CCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|++.+.||+|++|.||+|... +++.||+|.+...... ....+.+.+|++++++++|++++++++++..+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 4788899999999999999554 7889999999765432 2345789999999999999999999999998889999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++++|.+++... ..+++..++.++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 80 YAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred cCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999998754 4688999999999999999999999 99999999999999999999999999998776554
Q ss_pred CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhH
Q 002069 861 SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (973)
.......++..|+|||...+..++.++||||+|+++|+|++|+.||........... ......+.++.
T Consensus 154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~------ 221 (254)
T cd06627 154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR------IVQDDHPPLPE------ 221 (254)
T ss_pred ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH------HhccCCCCCCC------
Confidence 434456788999999999888889999999999999999999999874432211110 00011111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 941 DKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 941 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
.....+.+++.+|++.+|++||++.+++.
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 12345778999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=305.22 Aligned_cols=263 Identities=22% Similarity=0.256 Sum_probs=198.5
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc-----c
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA-----L 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~ 773 (973)
..+|.+.+.||+|+||+||+|.. .+++.||||.+....... .....+.+|+.+++.++|+||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 46799999999999999999954 578999999987543222 2245677899999999999999999988644 2
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
..++||||+. ++|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 4799999996 6898888654 3588999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhh------hhhhhhhhhh---
Q 002069 854 KFLKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSIC------SSLSSNLNIA--- 923 (973)
Q Consensus 854 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~------~~~~~~~~~~--- 923 (973)
+.............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+... ...+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 876543333344567889999998765 468899999999999999999999997533110 0000000000
Q ss_pred -----hhhhc---CCCCCCC-chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 924 -----LDEML---DPRLPTP-LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 924 -----~~~~~---~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..... ....... ..........+.+++.+||+.+|++|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000 0000000 00112234567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.51 Aligned_cols=249 Identities=22% Similarity=0.237 Sum_probs=198.9
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.+.|..-++||+||||.||-+.. .+|+.||.|.+.+.............+|-.++.++..+.||.+--+|...+..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 45688889999999999998844 48999999988654444444456678899999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
+..|.||+|.-++...+. ..+++..++-++.+|+-||++||+. +||.||+||+|||+|+.|+|+|+|.|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999988877664 5689999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
+. .....+||.+|||||++....|+...|.||+||++|||+.|+.||.....-. -.+.+++..........
T Consensus 340 g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv------k~eEvdrr~~~~~~ey~-- 410 (591)
T KOG0986|consen 340 GK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV------KREEVDRRTLEDPEEYS-- 410 (591)
T ss_pred CC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh------hHHHHHHHHhcchhhcc--
Confidence 63 3345599999999999999999999999999999999999999997432110 01111111111100000
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCC
Q 002069 939 VQDKLISIMEVSISCLDESPTSRP 962 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RP 962 (973)
...+.+...+-...++.||.+|-
T Consensus 411 -~kFS~eakslc~~LL~Kdp~~RL 433 (591)
T KOG0986|consen 411 -DKFSEEAKSLCEGLLTKDPEKRL 433 (591)
T ss_pred -cccCHHHHHHHHHHHccCHHHhc
Confidence 11223344555688999999985
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=297.39 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=203.4
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeeccceeEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 778 (973)
++|.+.+.||+|+||.||+|.. .+++.||+|++...........+.+..|.+++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 3688999999999999999965 479999999987643333344577889999999998 99999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.+++.+.. .+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999997543 689999999999999999999999 999999999999999999999999999886644
Q ss_pred CCC--------------------cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhh
Q 002069 859 GLS--------------------NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSS 918 (973)
Q Consensus 859 ~~~--------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~ 918 (973)
... ......++..|+|||...+..++.++||||+|+++|++++|+.||.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----- 229 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----- 229 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-----
Confidence 321 1223457889999999988889999999999999999999999997443210
Q ss_pred hhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCH----HHHHHH
Q 002069 919 NLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTM----QKVSQL 970 (973)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~ev~~~ 970 (973)
............+ ......+.+++.+||+.+|.+||++ +++++.
T Consensus 230 ----~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 230 ----TFQKILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred ----HHHHHHhcCCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1111111111111 1113457899999999999999999 888753
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=304.57 Aligned_cols=263 Identities=23% Similarity=0.299 Sum_probs=197.2
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeecc--ce
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHA--LH 774 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~ 774 (973)
..++|++.+.||+|+||.||+|... +++.||+|++...... ......+..|+.+++++ +||||+++++++... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN-ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc-chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 4578999999999999999999654 7889999988643222 22245677899999999 999999999998643 36
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.++||||++ ++|.++++.. .+.+..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 799999997 5898888643 578889999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCC-----cccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhhhhh
Q 002069 855 FLKLGLS-----NRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSNLNI 922 (973)
Q Consensus 855 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~ 922 (973)
....... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 6644321 2233568899999998765 4578899999999999999999999964332110 00000000
Q ss_pred h--------hhhhc----CCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 923 A--------LDEML----DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 923 ~--------~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
. ....+ .................+.+++.+||+.||.+|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 00011 001000011111134568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=273.31 Aligned_cols=254 Identities=21% Similarity=0.328 Sum_probs=207.7
Q ss_pred ccccCCCceeEEEE-EcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEEEEEecCC
Q 002069 707 HCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 707 ~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
+.+|+|+||.|--+ ...+|..||||++.+. ....+.++.+|++++.+. .|+||+.++++|+++..+|+|||.|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 57999999999888 5679999999999765 223468899999999998 699999999999999999999999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC---ceEEecccccccccCC--
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY---EAHVSDFGISKFLKLG-- 859 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~---~~kl~Dfg~a~~~~~~-- 859 (973)
|+|...++++. .+++.++.+++++||.||.+||.+ ||.|||+||+|||..... -|||+||.+..-+...
T Consensus 161 GplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 161 GPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred chHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 99999987543 689999999999999999999999 999999999999996654 5899999987644322
Q ss_pred CC-----cccccccccCcccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCcchh-hhhhhhhhh-----hhhh
Q 002069 860 LS-----NRTELAGTFGYIAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFIS-SICSSLSSN-----LNIA 923 (973)
Q Consensus 860 ~~-----~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~-~~~~~~~~~-----~~~~ 923 (973)
.. ...+.+|+..|||||+.. ...|+.+.|.||+||++|-|+.|.+||.+.- ..|.|.... ....
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 11 123467899999999753 2358889999999999999999999997543 223332222 2333
Q ss_pred hhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 924 LDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
+..+.++.+..+...+...+....+++...+-.|+..|-++.+++.
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 5566677777777777778888889999999999999999998875
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=318.69 Aligned_cols=268 Identities=18% Similarity=0.196 Sum_probs=188.0
Q ss_pred HhcCCcccccccCCCceeEEEEEcC--CCCEEEEEEcC--------------CCCCcchhhHHHHHHHHHHhhcCCCCce
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP--TGEIVAVKKFH--------------SPLPGEMACQQEFLNEGNALTKIRHRNI 762 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~--------------~~~~~~~~~~~~~~~e~~~l~~l~h~ni 762 (973)
...+|++.+.||+|+||+||++..+ ++..+++|.+. ............+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999998543 22222322111 1111112234668899999999999999
Q ss_pred eeeceeeeccceeEEEEEecCCCChHHHhccCcc--ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeec
Q 002069 763 VKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAA--AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLN 840 (973)
Q Consensus 763 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~ 840 (973)
+++++++..++..|+|+|++. +++.+++..... .......++..++.|++.||+|||+. +|+||||||+||+++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999986 577777643321 12334667889999999999999999 999999999999999
Q ss_pred CCCceEEecccccccccCCCC-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCC-Ccchhh-hhhhhh
Q 002069 841 LEYEAHVSDFGISKFLKLGLS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-RDFISS-ICSSLS 917 (973)
Q Consensus 841 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p-~~~~~~-~~~~~~ 917 (973)
.++.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|..+ |..... ......
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999999987754322 22346799999999999999999999999999999999998754 321110 000000
Q ss_pred hhh---h----------hhhhhhcC-CCC---CCCchhh---HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 918 SNL---N----------IALDEMLD-PRL---PTPLRNV---QDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 918 ~~~---~----------~~~~~~~~-~~~---~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
... . ......+. ..+ +...... ......+.+++.+|++.||++|||+.|+++.
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 0 00000000 000 0000000 0112346677889999999999999999864
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=298.64 Aligned_cols=254 Identities=25% Similarity=0.355 Sum_probs=194.5
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 777 (973)
.++|++.+.||+|+||.||+|.+. +++.||||+++..... .....+..|+.++.+. .||||+++++++.+....++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 467889999999999999999775 4899999998754322 2245666777766666 59999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||||++ +++.++..... ..+++..+..++.|++.|++|||+.. +++||||+|+||+++.++.+||+|||.+..+.
T Consensus 92 v~e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred EeeccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 999985 57777765432 36889999999999999999999732 89999999999999999999999999987664
Q ss_pred CCCCcccccccccCcccccccccCC----CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
... ......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||.......... ...... ..+..+
T Consensus 167 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~-~~~~~~ 240 (296)
T cd06618 167 DSK-AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL----TKILQE-EPPSLP 240 (296)
T ss_pred CCC-cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHH----HHHhcC-CCCCCC
Confidence 332 223345788999999987554 7889999999999999999999986422111110 001100 011111
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.. ......+.+++.+||+.||.+||+++++++.
T Consensus 241 ~~----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 241 PN----EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC----CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 1233457899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=295.59 Aligned_cols=261 Identities=23% Similarity=0.290 Sum_probs=201.6
Q ss_pred CcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEe
Q 002069 703 FDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEY 781 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 781 (973)
|++.+.||+|++|.||+|... +++.||+|++....... .....+..|++++++++|++|+++++++..+...++||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 567789999999999999664 78999999987543321 2356788899999999999999999999999999999999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS 861 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 861 (973)
+++ ++.+++.... ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+........
T Consensus 80 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 80 MDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred cCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 975 8888876533 4688999999999999999999999 999999999999999999999999999987765432
Q ss_pred cccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh------hhhhhhhhhhhhcC-----
Q 002069 862 NRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS------LSSNLNIALDEMLD----- 929 (973)
Q Consensus 862 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~------~~~~~~~~~~~~~~----- 929 (973)
......++..|+|||.+.+. .++.++||||+|+++|+|+||+.||......... ..............
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 33345678899999998776 7889999999999999999999999654321110 00000000000000
Q ss_pred ------CCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 930 ------PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 930 ------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
................+.+++.+||+.||.+||++++++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000011112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=290.09 Aligned_cols=252 Identities=23% Similarity=0.277 Sum_probs=197.2
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCC--CcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc--cee
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPL--PGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA--LHS 775 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 775 (973)
.+|++.+.||+|+||.||+|.. .+++.||+|.+.... .........+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688999999999999999965 478999999875321 11223356889999999999999999999998653 467
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++|+||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++++|||.++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999986433 478899999999999999999999 999999999999999999999999999986
Q ss_pred ccCCC---CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 856 LKLGL---SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 856 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
..... .......++..|+|||++.+..++.++|||||||++|++++|+.||......... .........+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~ 230 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI-----FKIATQPTKPML 230 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH-----HHHHcCCCCCCC
Confidence 54321 1223356889999999999888999999999999999999999999743321110 000000011111
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
+ ......+.+++.+||+ +|.+||++.+++.+
T Consensus 231 p------~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 231 P------DGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred C------cccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1 1233457788999999 57999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=291.39 Aligned_cols=249 Identities=22% Similarity=0.295 Sum_probs=191.9
Q ss_pred HHHHHHhcCCcccccc--cCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceee
Q 002069 694 EEIIRATKNFDDEHCI--GNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFC 769 (973)
Q Consensus 694 ~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 769 (973)
.+.....++|++.+.+ |+|+||.||++.. .+++.+|+|.+....... .|+.....+ +|||++++++++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~ 78 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSV 78 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEE
Confidence 3444556778887777 9999999999954 478899999986432111 111121112 799999999999
Q ss_pred eccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC-ceEEe
Q 002069 770 SHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY-EAHVS 848 (973)
Q Consensus 770 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-~~kl~ 848 (973)
..++..++||||+++++|.++++... .+++.++..++.|+++|++|||+. +++||||||+||+++.++ .++++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 79 TTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred ecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEe
Confidence 99999999999999999999997543 689999999999999999999999 999999999999999998 99999
Q ss_pred cccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhc
Q 002069 849 DFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML 928 (973)
Q Consensus 849 Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 928 (973)
|||.++..... ....++..|+|||++.+..++.++||||+|+++|||++|+.||....... . .... .....
T Consensus 153 dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~--~~~~-~~~~~ 223 (267)
T PHA03390 153 DYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--L--DLES-LLKRQ 223 (267)
T ss_pred cCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--h--hHHH-HHHhh
Confidence 99998765432 23468899999999998889999999999999999999999997332110 0 0001 11111
Q ss_pred CCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCC-HHHHHH
Q 002069 929 DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPT-MQKVSQ 969 (973)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ev~~ 969 (973)
..... ........+.+++.+|++.+|.+||+ ++++++
T Consensus 224 ~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 QKKLP----FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cccCC----cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11111 11234456789999999999999996 699875
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=294.45 Aligned_cols=257 Identities=20% Similarity=0.204 Sum_probs=193.5
Q ss_pred CcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeecc--ceeEEE
Q 002069 703 FDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHA--LHSFVV 778 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv 778 (973)
|++.+.||+|+||.||+|.. .+++.||+|+++....... ......|+.++.++. |+|++++++++.++ +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch--hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 67788999999999999954 4789999999875432221 234457888888885 99999999999877 889999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||++ +++.+++.... ..+++.+++.++.|++.|++|||+. +++||||+|+||+++. +.+|++|||.++....
T Consensus 79 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 79 FELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred EecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 99997 57888776433 3689999999999999999999999 9999999999999999 9999999999987644
Q ss_pred CCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh--hh----hhhhhhhhhhhcCC-
Q 002069 859 GLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS--SL----SSNLNIALDEMLDP- 930 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~----~~~~~~~~~~~~~~- 930 (973)
.. ......+++.|+|||++.+ ..++.++||||+||++|||++|..||........ .. ....... .+....
T Consensus 152 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 229 (282)
T cd07831 152 KP-PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFRKS 229 (282)
T ss_pred CC-CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhccc
Confidence 32 2233567889999997644 5578899999999999999999999975432110 00 0000000 000000
Q ss_pred -----CCCCCc-----hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 931 -----RLPTPL-----RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 931 -----~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..+... ......+..+.+++.+||+.+|++||+++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000 0012335678999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=296.12 Aligned_cols=261 Identities=26% Similarity=0.356 Sum_probs=197.6
Q ss_pred CcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc--ceeEEEE
Q 002069 703 FDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA--LHSFVVY 779 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 779 (973)
|++.+.||+|+||.||+|... +++.||+|++.... ........+.+|++++++++|+|++++++++... +..++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 677889999999999999665 68899999998654 2223346788999999999999999999999887 7899999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++ ++.+++.... ..+++.+++.++.|++.|++|||+. +++|+||+|+||++++++.+|++|||.+......
T Consensus 80 e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 80 EYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 99984 8888886543 3688999999999999999999999 9999999999999999999999999999876543
Q ss_pred CC-cccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh--hhhh----hhhhhhh------
Q 002069 860 LS-NRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS--SLSS----NLNIALD------ 925 (973)
Q Consensus 860 ~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~~~----~~~~~~~------ 925 (973)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||+....... .... .......
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 21 1233456888999998765 4578899999999999999999999974332100 0000 0000000
Q ss_pred --hhcCCCC--CCCchhh-HH-HHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 926 --EMLDPRL--PTPLRNV-QD-KLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 926 --~~~~~~~--~~~~~~~-~~-~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
+...+.. +...... .. .+..+.+++.+||+.+|.+||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000 0000000 01 14568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=303.70 Aligned_cols=263 Identities=23% Similarity=0.298 Sum_probs=198.4
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec----cce
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH----ALH 774 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~ 774 (973)
..+|++.+.||+|+||.||+|.. .+|+.||+|++...... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 46899999999999999999954 47999999998754322 2235677889999999999999999998753 346
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.++||||+. +++.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+.
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 799999996 68998886443 488999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCC----cccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhhh---
Q 002069 855 FLKLGLS----NRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSNL--- 920 (973)
Q Consensus 855 ~~~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~--- 920 (973)
....... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.... ..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 6543221 1223568899999998765 4588999999999999999999999975432110 000000
Q ss_pred -----hhhhhhh---cCCCCCCCch-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 921 -----NIALDEM---LDPRLPTPLR-NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 921 -----~~~~~~~---~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+. ........+. .....+..+.+++.+|++.||.+||+++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000 0111111111 012235668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=296.92 Aligned_cols=266 Identities=24% Similarity=0.319 Sum_probs=197.7
Q ss_pred HHhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc---
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL--- 773 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--- 773 (973)
...++|++.+.||+|+||.||+|..+ +++.||+|+++..... ......+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 45678999999999999999999664 6899999998754322 122456778999999999999999999986654
Q ss_pred -------eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceE
Q 002069 774 -------HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAH 846 (973)
Q Consensus 774 -------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~k 846 (973)
..++|+||+++ ++.+++... ...+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999986 677776543 23689999999999999999999999 999999999999999999999
Q ss_pred EecccccccccCCCC-cccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh--hhh----
Q 002069 847 VSDFGISKFLKLGLS-NRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS--LSS---- 918 (973)
Q Consensus 847 l~Dfg~a~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~--~~~---- 918 (973)
++|||.+........ ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......... +..
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999999987654432 2223456788999998764 35688999999999999999999999743321100 000
Q ss_pred hhhhhhhhhc--------CCCC--CCC-chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 919 NLNIALDEML--------DPRL--PTP-LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 919 ~~~~~~~~~~--------~~~~--~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.......... ++.. ... .......+..+.+++.+||+.||.+||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000000 0000 000 00001124567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=296.97 Aligned_cols=249 Identities=26% Similarity=0.381 Sum_probs=195.4
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
..|+..+.||+|+||.||+|.. .+++.||+|.+............++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3477788999999999999965 478899999986433333333567889999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+. |++.+++.... ..+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+......
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 57777764332 3578999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCcccccccccCcccccccc---cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 860 LSNRTELAGTFGYIAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
....+++.|+|||.+. ...++.++|||||||++|+|++|+.||........ .........+...
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------~~~~~~~~~~~~~ 235 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---------LYHIAQNESPALQ 235 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH---------HHHHhhcCCCCcC
Confidence 2346888999999874 34578899999999999999999999864321100 0001111111100
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.......+.+++.+||+.+|.+||+++++++.
T Consensus 236 --~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 236 --SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred --cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 11234457889999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=293.05 Aligned_cols=245 Identities=21% Similarity=0.240 Sum_probs=187.1
Q ss_pred cccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHH---HHhhcCCCCceeeeceeeeccceeEEEEEecC
Q 002069 708 CIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEG---NALTKIRHRNIVKFYGFCSHALHSFVVYEYLE 783 (973)
Q Consensus 708 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 783 (973)
.||+|+||.||+|.. .+++.||+|.+.............+..|. ..++...||+|+++++++..++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999965 46899999998654322211122333443 34445689999999999999999999999999
Q ss_pred CCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCcc
Q 002069 784 MGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR 863 (973)
Q Consensus 784 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 863 (973)
+++|.+++... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+...... ..
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~ 152 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KP 152 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CC
Confidence 99999988643 3689999999999999999999998 9999999999999999999999999998765432 22
Q ss_pred cccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHH
Q 002069 864 TELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDK 942 (973)
Q Consensus 864 ~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (973)
....|+..|+|||.+.+. .++.++||||+||++|||++|+.||......... ... .........++.. .
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~---~~~-~~~~~~~~~~~~~------~ 222 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EID-RMTLTMAVELPDS------F 222 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH---HHH-HHhhccCCCCCCc------C
Confidence 345689999999998754 6889999999999999999999999743211000 000 0000111122211 2
Q ss_pred HHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 002069 943 LISIMEVSISCLDESPTSRP-----TMQKVSQL 970 (973)
Q Consensus 943 ~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 970 (973)
+..+.+++.+|++.+|.+|| ++.++++.
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 34578899999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=292.75 Aligned_cols=260 Identities=23% Similarity=0.326 Sum_probs=196.0
Q ss_pred CcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC---CCCceeeeceeeeccce----
Q 002069 703 FDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI---RHRNIVKFYGFCSHALH---- 774 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~---- 774 (973)
|++.+.||+|+||.||+|..+ +++.||+|++....... .....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 677889999999999999765 58999999997543322 2235566777776655 69999999999987766
Q ss_pred -eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 775 -SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 775 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
.+++|||++ +++.+++..... ..+++.+++.++.|++.|++|||+. +++|+|++|+||+++.++.+|++|||.+
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999997 479888865432 3589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhh--------hhh-
Q 002069 854 KFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLN--------IAL- 924 (973)
Q Consensus 854 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~--------~~~- 924 (973)
....... ......++..|+|||++.+..++.++|||||||++|||++|+.||+....... ...... ...
T Consensus 155 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 155 RIYSFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ-LDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred eeccCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH-HHHHHHHcCCCChHhcCC
Confidence 8765432 22334578899999999988899999999999999999999999875432110 000000 000
Q ss_pred -----hhhcCCCCCCC-chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 925 -----DEMLDPRLPTP-LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 925 -----~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
........... ..........+.+++.+||+.||.+||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000000111 11112334567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=290.14 Aligned_cols=253 Identities=21% Similarity=0.261 Sum_probs=197.8
Q ss_pred CCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCc--chhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPG--EMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
+|.+.+.||+|+||.||++... .+..+++|.++..... ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888999999999999999654 4455666665532211 112235677889999999999999999999988899999
Q ss_pred EEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 779 YEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
|||+++++|.+++.... ....+++.+++.++.|++.|++|||+. +++|+|++|+||+++. +.++++|||.++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999886432 235689999999999999999999999 9999999999999975 679999999998765
Q ss_pred CCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
..........|++.|+|||...+..++.++||||||+++|+|++|..||...... ...........+..
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---------~~~~~~~~~~~~~~-- 225 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL---------SVVLRIVEGPTPSL-- 225 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---------HHHHHHHcCCCCCC--
Confidence 5444444556889999999998888899999999999999999999998632211 11111111111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.......+.+++.+||+.+|++||++.++++.
T Consensus 226 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 226 -PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 12334567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-32 Score=298.03 Aligned_cols=259 Identities=21% Similarity=0.242 Sum_probs=192.2
Q ss_pred ccccCC--CceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecC
Q 002069 707 HCIGNG--GQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLE 783 (973)
Q Consensus 707 ~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 783 (973)
..||+| +||+||+|.. .+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456776 8999999965 489999999987543322 335788899999999999999999999999999999999999
Q ss_pred CCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCc-
Q 002069 784 MGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN- 862 (973)
Q Consensus 784 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 862 (973)
++++.++++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+.........
T Consensus 83 ~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 83 YGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 9999999876442 3578999999999999999999998 9999999999999999999999999865433221111
Q ss_pred ------ccccccccCcccccccccC--CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhh------------h
Q 002069 863 ------RTELAGTFGYIAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLN------------I 922 (973)
Q Consensus 863 ------~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~------------~ 922 (973)
.....++..|+|||++.+. .++.++||||+||++|||++|+.||............... .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 1112346679999998764 4788999999999999999999999743211110000000 0
Q ss_pred hhh---------------hhcCC----CC---CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 923 ALD---------------EMLDP----RL---PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 923 ~~~---------------~~~~~----~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
... ..... .+ .............+.+++.+||+.||++|||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 00000 00 00011122345678899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=296.98 Aligned_cols=264 Identities=23% Similarity=0.314 Sum_probs=193.1
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc-----
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL----- 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 773 (973)
.++|++.+.||+|+||.||+|.. .+++.||||++....... .....+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 46799999999999999999965 478999999986443221 22345678999999999999999999986543
Q ss_pred ---eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecc
Q 002069 774 ---HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDF 850 (973)
Q Consensus 774 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df 850 (973)
..++||||+. +++.+++.... ..+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.+|++||
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 4499999997 47887775432 3578999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCc----ccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh--h----hhh
Q 002069 851 GISKFLKLGLSN----RTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS--L----SSN 919 (973)
Q Consensus 851 g~a~~~~~~~~~----~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~--~----~~~ 919 (973)
|.+......... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||......... . +..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999866433211 1234578899999988664 3688999999999999999999998743321000 0 000
Q ss_pred hhhhhhhh-----cC-CCCCCCch-hhH------HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 920 LNIALDEM-----LD-PRLPTPLR-NVQ------DKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 920 ~~~~~~~~-----~~-~~~~~~~~-~~~------~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
........ .+ ...+.... ... .....+.+++.+||+.||.+|||++++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000000 00 00000000 000 012346789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=294.67 Aligned_cols=247 Identities=26% Similarity=0.371 Sum_probs=194.3
Q ss_pred CcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEe
Q 002069 703 FDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEY 781 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 781 (973)
|...+.||+|+||+||+|.. .+++.||+|++...........+.+.+|+++++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66677899999999999965 47899999998754433334456788999999999999999999999999999999999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS 861 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 861 (973)
+. +++.+++.... .++++.++..++.|++.|++|||+. +++|+||+|+||+++.++.+|++|||.+....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 96 57777775432 3578999999999999999999999 99999999999999999999999999986432
Q ss_pred cccccccccCcccccccc---cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 862 NRTELAGTFGYIAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 862 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
......|+..|+|||++. ...++.++|||||||++|||++|..||.......... .......+...
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~---------~~~~~~~~~~~-- 241 (313)
T cd06633 173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---------HIAQNDSPTLQ-- 241 (313)
T ss_pred CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH---------HHHhcCCCCCC--
Confidence 223456889999999974 4568889999999999999999999986433211110 00000111100
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 242 ~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122357789999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=298.92 Aligned_cols=262 Identities=23% Similarity=0.306 Sum_probs=197.6
Q ss_pred HHHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec-cce
Q 002069 697 IRATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH-ALH 774 (973)
Q Consensus 697 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~ 774 (973)
...+++|++.+.||.|+||.||+|.. .+++.||||++....... ...+.+..|++++++++|||++++++++.. ...
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-VLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 34678899999999999999999954 489999999886543222 234678899999999999999999998865 457
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.++||||+ +++|.++++.. .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+.
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 88999998 46898887632 467888899999999999999999 99999999999999999999999999987
Q ss_pred cccCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhh------hhhhhhhhhhhhhh
Q 002069 855 FLKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSIC------SSLSSNLNIALDEM 927 (973)
Q Consensus 855 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~------~~~~~~~~~~~~~~ 927 (973)
..... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... +..+....+.....
T Consensus 157 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 157 IQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred ccCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 55322 233467889999998765 568899999999999999999999996443210 00000000000000
Q ss_pred c-----------CCCCCCCch-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 928 L-----------DPRLPTPLR-NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 928 ~-----------~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
. ....+.+.. ........+.+++.+|++.+|++||++++++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000000000 011223568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=296.22 Aligned_cols=260 Identities=19% Similarity=0.206 Sum_probs=192.3
Q ss_pred ccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCC
Q 002069 705 DEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 705 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
+.+.+|.|+++.||++.. +++.||||++...... ....+.+.+|++++++++|+||+++++++.+.+..+++|||+++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCS-KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccc-hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 344555556666666554 7999999998754222 23457899999999999999999999999999999999999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC---
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS--- 861 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--- 861 (973)
+++.++++.... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||.+........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 999999975432 3578899999999999999999999 999999999999999999999999998875532211
Q ss_pred ----cccccccccCccccccccc--CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhh---hhhh---------
Q 002069 862 ----NRTELAGTFGYIAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSN---LNIA--------- 923 (973)
Q Consensus 862 ----~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~---~~~~--------- 923 (973)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||............. ....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 1223456788999999876 357889999999999999999999997543211110000 0000
Q ss_pred ---hhh----hcCCCC--CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 924 ---LDE----MLDPRL--PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 924 ---~~~----~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
... ...+.. .............+.+++.+||+.||++|||++++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 000000 00111112234567889999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=301.09 Aligned_cols=261 Identities=22% Similarity=0.286 Sum_probs=200.7
Q ss_pred CCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc-----ee
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL-----HS 775 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~ 775 (973)
+|++.+.||+|+||.||+|... +++.||||++..... .....+.+.+|+.+++.++|+||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5888999999999999999664 689999999876432 1233578899999999999999999999987765 78
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||++ +++.+++.+.. .+++..++.++.|++.|++|||+. +++||||||+||+++.++.++++|||.+..
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999998 58888886543 688999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCC---CcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhh------hhhhhhhhhh--
Q 002069 856 LKLGL---SNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSIC------SSLSSNLNIA-- 923 (973)
Q Consensus 856 ~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~------~~~~~~~~~~-- 923 (973)
..... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||....... ..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 76543 123345678899999999887 78999999999999999999999997443210 0000000000
Q ss_pred ------hhhhc---CCCCCCCch-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 924 ------LDEML---DPRLPTPLR-NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 924 ------~~~~~---~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..... ......... ........+.+++.+||+.+|.+||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000 000000000 011134567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-33 Score=318.13 Aligned_cols=258 Identities=21% Similarity=0.230 Sum_probs=203.4
Q ss_pred HHHHhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccce
Q 002069 696 IIRATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH 774 (973)
Q Consensus 696 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 774 (973)
+....++|.++++||+|+||.|..++++ +++.||.|++.+...-......-|..|-++|..-..+=|+.+.-+|.++.+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 3334678999999999999999999775 788999999875332333335678899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.|+|||||+||+|..++.+.. +++++.++.++..|+-||+.+|+. |+|||||||+|||+|..|++|++|||.+-
T Consensus 150 LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHH
Confidence 999999999999999997654 689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCC-CCcccccccccCccccccccc-----CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhc
Q 002069 855 FLKLG-LSNRTELAGTFGYIAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML 928 (973)
Q Consensus 855 ~~~~~-~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 928 (973)
.+..+ .-.....+|||.|.+||++.. +.|++.+|.||+||++|||+.|..||.... .... ...++
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-lveT--------Y~KIm 294 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-LVET--------YGKIM 294 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-HHHH--------HHHHh
Confidence 88744 345567899999999999852 568899999999999999999999997322 1111 11222
Q ss_pred CCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCC---HHHHHH
Q 002069 929 DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPT---MQKVSQ 969 (973)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev~~ 969 (973)
+..-...++...+.+....++|.+.+. +|+.|-. ++++..
T Consensus 295 ~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 295 NHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred chhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 221111111122344556677777665 6777776 777654
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=289.83 Aligned_cols=260 Identities=25% Similarity=0.337 Sum_probs=196.0
Q ss_pred CcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeeccceeEEEEE
Q 002069 703 FDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 780 (973)
|++.+.||+|++|+||+|... +++.||||++....... ......+|+..+++++ |+|++++++++.+++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 677889999999999999765 67899999987543321 1234557889999998 9999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+ ++++.+++.... ...+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 79 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 79 YM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred cC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 99 789998886543 24679999999999999999999999 99999999999999999999999999998665432
Q ss_pred CcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhh------hhhhhhhh------hhhhhh
Q 002069 861 SNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSIC------SSLSSNLN------IALDEM 927 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~------~~~~~~~~------~~~~~~ 927 (973)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||....... ........ ......
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 2234568889999998754 457899999999999999999999986432110 00000000 000000
Q ss_pred cCCCCCCC----chh-hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 928 LDPRLPTP----LRN-VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 928 ~~~~~~~~----~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
++..++.. ... .......+.+++.+||+.||++|||++|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 11111100 000 01113568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=284.39 Aligned_cols=242 Identities=26% Similarity=0.328 Sum_probs=197.4
Q ss_pred ccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCCCCh
Q 002069 709 IGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 787 (973)
Q Consensus 709 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 787 (973)
||+|+||.||++... +++.||+|++.............+..|+.++++++|+|++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999654 6899999998765444444467889999999999999999999999999999999999999999
Q ss_pred HHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCcccccc
Q 002069 788 AMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA 867 (973)
Q Consensus 788 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 867 (973)
.+++.... .+++..+..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||.+..............
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 99997543 578999999999999999999998 999999999999999999999999999987654433344567
Q ss_pred cccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHH
Q 002069 868 GTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIM 947 (973)
Q Consensus 868 g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 947 (973)
++..|+|||...+...+.++|+||||+++|++++|+.||...+. ..............+.. ....+.
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---------~~~~~~~~~~~~~~~~~----~~~~l~ 221 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---------KEIYEKILKDPLRFPEF----LSPEAR 221 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---------HHHHHHHhcCCCCCCCC----CCHHHH
Confidence 88999999999888889999999999999999999999974432 11111111111111111 134577
Q ss_pred HHHhcccCCCCCCCCCH---HHHHH
Q 002069 948 EVSISCLDESPTSRPTM---QKVSQ 969 (973)
Q Consensus 948 ~li~~cl~~dP~~RPs~---~ev~~ 969 (973)
+++.+||..||++||++ +++.+
T Consensus 222 ~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 222 DLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred HHHHHHhcCCHhhCCCcccHHHHHh
Confidence 89999999999999999 56554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=295.64 Aligned_cols=256 Identities=22% Similarity=0.294 Sum_probs=197.8
Q ss_pred CCcccccccCCCceeEEEEEc----CCCCEEEEEEcCCCCCc-chhhHHHHHHHHHHhhcC-CCCceeeeceeeecccee
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL----PTGEIVAVKKFHSPLPG-EMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 775 (973)
+|++.+.||+|+||.||++.. .+++.||||++...... .....+.+.+|+.++.++ +||+|+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999953 36788999998643221 122346788999999999 699999999999988899
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+++++|.+++... ..+++..+..++.|+++|++|||+. +++||||+|+||+++.++.++++|||.++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999998643 3578899999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCc-ccccccccCcccccccccCC--CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 856 LKLGLSN-RTELAGTFGYIAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 856 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
....... .....|+..|+|||...+.. .+.++||||||+++|||++|..||........ .............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~ 229 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-----QSEISRRILKSKP 229 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-----HHHHHHHHHccCC
Confidence 5443221 22345889999999987655 67899999999999999999999863221100 0011111111111
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+.+ ......+.+++.+||+.||++|||+.++.+.|+
T Consensus 230 ~~~----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 230 PFP----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred CCC----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 111 112345778999999999999999888876654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=294.29 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=195.3
Q ss_pred CCcccccccCCCceeEEEEEc----CCCCEEEEEEcCCCCCc-chhhHHHHHHHHHHhhcC-CCCceeeeceeeecccee
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL----PTGEIVAVKKFHSPLPG-EMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 775 (973)
+|++.+.||+|+||.||.|.. .+|+.||+|++...... .....+.+.+|+.+++++ +|++|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999965 37899999998753221 122346778899999999 699999999999988899
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||.+..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999998653 3578899999999999999999998 999999999999999999999999999986
Q ss_pred ccCCC-CcccccccccCcccccccccC--CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 856 LKLGL-SNRTELAGTFGYIAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 856 ~~~~~-~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
..... .......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||....... ..............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~~~~ 229 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-----SQAEISRRILKSEP 229 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-----cHHHHHHHhhccCC
Confidence 64432 122345688999999998753 46788999999999999999999986322110 00111111111111
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRP-----TMQKVSQ 969 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~ 969 (973)
+.+ ......+.+++.+|++.||.+|| +++++..
T Consensus 230 ~~~----~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 230 PYP----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CCC----ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 111 11234577889999999999997 6677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=302.64 Aligned_cols=260 Identities=25% Similarity=0.377 Sum_probs=215.0
Q ss_pred HHHHHHHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeee
Q 002069 693 HEEIIRATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCS 770 (973)
Q Consensus 693 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 770 (973)
++.....++.|++.+.||.|.+|.||+++. ++++.+|+|+....... .++...|.++++.. .|||++.++|++.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 344445567899999999999999999954 48899999998765333 46777888888887 7999999999984
Q ss_pred -----ccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCce
Q 002069 771 -----HALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEA 845 (973)
Q Consensus 771 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~ 845 (973)
.+++.|+|||||.+|+..|+++.-. ...+.|..+..|++.++.|+++||.+ .++|||||-.||+++.++.|
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence 3578999999999999999998666 67899999999999999999999999 89999999999999999999
Q ss_pred EEecccccccccCCCCcccccccccCcccccccccC-----CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhh
Q 002069 846 HVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNL 920 (973)
Q Consensus 846 kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 920 (973)
|++|||.+..............|||.|||||++... .|+.++|+||+|++..||.-|.+|+.++..+.+-+.
T Consensus 163 KLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~--- 239 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL--- 239 (953)
T ss_pred EEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc---
Confidence 999999998887666667788999999999998753 477889999999999999999999876654433221
Q ss_pred hhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 921 NIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
+.+..++....+..-.+.+.++|..|+.+|-.+||++.+++++
T Consensus 240 -------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 240 -------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1122222233344456678899999999999999999998764
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=291.35 Aligned_cols=261 Identities=25% Similarity=0.343 Sum_probs=200.8
Q ss_pred CcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEe
Q 002069 703 FDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEY 781 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 781 (973)
|+..+.||+|++|.||+|... +++.||+|++..... .....+.+..|+.++++++|++++++++++...+..++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 567788999999999999665 689999999886532 222346778899999999999999999999998999999999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS 861 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 861 (973)
++ ++|.+++.... ..+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.++.......
T Consensus 80 ~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 80 CD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred cC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 98 58999997643 3588999999999999999999999 999999999999999999999999999987655433
Q ss_pred cccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhhhhhhhh---hh--cC
Q 002069 862 NRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSNLNIALD---EM--LD 929 (973)
Q Consensus 862 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~~~~---~~--~~ 929 (973)
......++..|+|||.+.+. .++.++||||||+++||+++|+.||........ ........... .. .+
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 33445567889999998766 788999999999999999999999975432110 00000000000 00 00
Q ss_pred CCCCCC----c-hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 930 PRLPTP----L-RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 930 ~~~~~~----~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..++.. . .........+.+++.+||+.||++||++++++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 011000 0 0111224568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=298.74 Aligned_cols=258 Identities=21% Similarity=0.313 Sum_probs=192.7
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc------
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA------ 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 772 (973)
..+|...+.||+|+||.||+|.. .+|+.||||++...... ......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 47899999999999999999965 47899999998754322 22245688999999999999999999988643
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
...++|+||+. .++..+.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred ceEEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 34689999996 46766542 2578899999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh---h---hhhhhhh-
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL---S---SNLNIAL- 924 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~---~---~~~~~~~- 924 (973)
++.... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.......... . .......
T Consensus 164 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 164 ARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred CcCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 876532 2233467889999999876 468889999999999999999999997543211000 0 0000000
Q ss_pred -------hhhcC--CCCC-CCchh-hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 925 -------DEMLD--PRLP-TPLRN-VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 925 -------~~~~~--~~~~-~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..... +..+ ..... .......+.+++.+||+.||.+||+++++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0000 00000 01123457799999999999999999999853
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=270.82 Aligned_cols=207 Identities=22% Similarity=0.313 Sum_probs=171.6
Q ss_pred HhcCCcccccccCCCceeEEEEEc-C--C--CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec-c
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAEL-P--T--GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH-A 772 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~-~--~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~ 772 (973)
....|+....||+|.||.||+|.. + + .+.+|+|+++....+.. ......+|+..++.++|||++.+..++-. +
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-ISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC-cCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 346799999999999999999933 2 2 23799999987654432 24567889999999999999999998865 7
Q ss_pred ceeEEEEEecCCCChHHHhccCc--cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC----CceE
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDA--AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE----YEAH 846 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~----~~~k 846 (973)
...|+++||.+. +|...++.+. ..+.++.....+|++||+.|+.|||++ -|+|||+||.||++..+ |.||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeE
Confidence 789999999985 7777775443 345789999999999999999999999 89999999999999887 8999
Q ss_pred EecccccccccCCCCc---ccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchh
Q 002069 847 VSDFGISKFLKLGLSN---RTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFIS 910 (973)
Q Consensus 847 l~Dfg~a~~~~~~~~~---~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 910 (973)
|+|||+++.+...... ....+-|.-|.|||.+.+. .|+.+.||||.||++.||+|-++-|.+.+
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 9999999988765332 3446678999999998876 48899999999999999999877765443
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=298.44 Aligned_cols=261 Identities=21% Similarity=0.304 Sum_probs=196.4
Q ss_pred HHHhcCCcccccccCCCceeEEEEE-cCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc--
Q 002069 697 IRATKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL-- 773 (973)
Q Consensus 697 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-- 773 (973)
....++|++.+.||+|+||.||+|. ..+++.||||++..... .....+.+.+|+.++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3456789999999999999999995 45899999999865432 2223467889999999999999999999886543
Q ss_pred ----eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEec
Q 002069 774 ----HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSD 849 (973)
Q Consensus 774 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~D 849 (973)
..++||||+ ++++.+++.. ..+++..++.++.|++.|++|||+. +|+||||||+||+++.++.++++|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 458999998 6799888753 3578999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh------hhhhhh
Q 002069 850 FGISKFLKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL------SSNLNI 922 (973)
Q Consensus 850 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~------~~~~~~ 922 (973)
||.+...... .....+++.|+|||.+.+ ..++.++||||+|+++|++++|+.||.......... ......
T Consensus 162 fg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 162 FGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred cccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9999865432 233467889999998876 457889999999999999999999997433211000 000000
Q ss_pred hhh--------hhcC--CCCC-CCc-hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 923 ALD--------EMLD--PRLP-TPL-RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 923 ~~~--------~~~~--~~~~-~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
... .... +... ... .........+.+++.+|++.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 0000 0000 000 000122345789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=297.22 Aligned_cols=266 Identities=21% Similarity=0.287 Sum_probs=198.2
Q ss_pred HHHHHHHhcCCcccccccCCCceeEEEEE-cCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec
Q 002069 693 HEEIIRATKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH 771 (973)
Q Consensus 693 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 771 (973)
.+++....++|++.+.||+|+||.||+|. ..+++.||+|++...... ....+.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 45566678999999999999999999995 458899999998754322 2234668889999999999999999998754
Q ss_pred c------ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCce
Q 002069 772 A------LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEA 845 (973)
Q Consensus 772 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~ 845 (973)
. ...+++++++ +++|.++++. ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 3 3467888876 7899888753 2478999999999999999999999 99999999999999999999
Q ss_pred EEecccccccccCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhh
Q 002069 846 HVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSS 918 (973)
Q Consensus 846 kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~ 918 (973)
|++|||.++.... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||........ ....
T Consensus 160 kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 160 KILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred EEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999876532 2234567889999998766 4678899999999999999999999864321110 0000
Q ss_pred hhhhhh--------hhhcC--CCCCCC-ch-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 919 NLNIAL--------DEMLD--PRLPTP-LR-NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 919 ~~~~~~--------~~~~~--~~~~~~-~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...... ..... +..+.. .. ........+.+++.+|++.||.+||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000 00000 000000 00 000123457799999999999999999998763
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=297.88 Aligned_cols=263 Identities=21% Similarity=0.244 Sum_probs=194.4
Q ss_pred cCCcc-cccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcch-----------hhHHHHHHHHHHhhcCCCCceeeece
Q 002069 701 KNFDD-EHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEM-----------ACQQEFLNEGNALTKIRHRNIVKFYG 767 (973)
Q Consensus 701 ~~~~~-~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~~~~ 767 (973)
++|.. .+.||+|+||+||+|.. .+++.||||.+........ .....+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 56799999999999964 4789999999865422210 01125778999999999999999999
Q ss_pred eeeccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEE
Q 002069 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV 847 (973)
Q Consensus 768 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl 847 (973)
++..++..++||||++ +++.+++... ..+++.....++.|++.|++|||+. +++||||+|+||+++.++.+++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 9999999999999997 6899888643 3578999999999999999999998 9999999999999999999999
Q ss_pred ecccccccccC--------------CCCcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhh
Q 002069 848 SDFGISKFLKL--------------GLSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSI 912 (973)
Q Consensus 848 ~Dfg~a~~~~~--------------~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 912 (973)
+|||.+..... .........+++.|+|||.+.+. .++.++||||+||++|||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999976651 11112234567889999998764 4688999999999999999999999754422
Q ss_pred hhh------hhhhhhhhhhhh--------cCCCCCCCc-hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 913 CSS------LSSNLNIALDEM--------LDPRLPTPL-RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 913 ~~~------~~~~~~~~~~~~--------~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
... ............ .....+... .........+.+++.+|++.+|++||+++|++..
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 110 000000000000 000000000 0011123557899999999999999999999864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=267.10 Aligned_cols=253 Identities=21% Similarity=0.254 Sum_probs=201.1
Q ss_pred hcCCccc-ccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeec----c
Q 002069 700 TKNFDDE-HCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSH----A 772 (973)
Q Consensus 700 ~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~ 772 (973)
+++|++. ++||-|-.|.|-.+.. .+++++|+|++... ....+|++..-.. .|||||.++++|.. .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 3445443 5799999999998854 48999999998642 4556777764444 79999999999854 3
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC---CceEEec
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE---YEAHVSD 849 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~---~~~kl~D 849 (973)
....+|||.|+||.|..-+++++. ..+++.++-.|++||+.|+.|||+. .|.|||+||+|+|.... ..+|++|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 466899999999999999987663 4699999999999999999999999 99999999999999644 5689999
Q ss_pred ccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcC
Q 002069 850 FGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLD 929 (973)
Q Consensus 850 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 929 (973)
||+|+.-... ....+..-||.|.|||++...+|+...|+||+||++|-|++|-+||.-..... +. ...-.++..
T Consensus 208 fGFAK~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a--is---pgMk~rI~~ 281 (400)
T KOG0604|consen 208 FGFAKETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--IS---PGMKRRIRT 281 (400)
T ss_pred cccccccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc--CC---hhHHhHhhc
Confidence 9999865432 23345567999999999999999999999999999999999999997443210 01 111223333
Q ss_pred CCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 930 PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 930 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
+.+..+...+.+.+++..++|+.++..+|.+|-|+.++++.
T Consensus 282 gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 282 GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 44455556677778888999999999999999999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=272.35 Aligned_cols=258 Identities=21% Similarity=0.276 Sum_probs=204.6
Q ss_pred HHHHhcCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceee
Q 002069 696 IIRATKNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFC 769 (973)
Q Consensus 696 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 769 (973)
+.....+++....+.+|.||.||.|-|. +.+.|.||.++.... .-....+..|...+....|||+..+.+++
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS--~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS--QIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc--HHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3344567888888999999999999443 345678888876533 33467788999999999999999999998
Q ss_pred ec-cceeEEEEEecCCCChHHHhc-----cCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC
Q 002069 770 SH-ALHSFVVYEYLEMGSLAMILS-----NDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY 843 (973)
Q Consensus 770 ~~-~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~ 843 (973)
.+ .+..+.+|.++.-|+|..|+. +......++..+...++.|++.|++|||++ +|||.||.++|.++|+.-
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhe
Confidence 54 456789999999999999997 333445677888899999999999999999 999999999999999999
Q ss_pred ceEEecccccccccCCCCcc--cccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhh
Q 002069 844 EAHVSDFGISKFLKLGLSNR--TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNL 920 (973)
Q Consensus 844 ~~kl~Dfg~a~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~ 920 (973)
+||++|-.+++..-+.++.. ...-.+..||+||.+....|+.++|||||||++|||+| |+.|+...+....
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm------ 507 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM------ 507 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH------
Confidence 99999999998776554432 22335788999999999999999999999999999998 9999875553211
Q ss_pred hhhhhhhcCC-CCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 921 NIALDEMLDP-RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 921 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
.....++ ++.++ ..++.+++.++.-||..+|++||++++++.-|
T Consensus 508 ---~~ylkdGyRlaQP----~NCPDeLf~vMacCWallpeeRPsf~Qlv~cL 552 (563)
T KOG1024|consen 508 ---EHYLKDGYRLAQP----FNCPDELFTVMACCWALLPEERPSFSQLVICL 552 (563)
T ss_pred ---HHHHhccceecCC----CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 1111122 11122 23455688899999999999999999998865
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=318.45 Aligned_cols=149 Identities=28% Similarity=0.339 Sum_probs=133.2
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|.+.+.||+|+||.||+|... +++.||||++.............+..|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367999999999999999999664 7899999999765433444457889999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
|||+++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999996543 578899999999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=253.57 Aligned_cols=206 Identities=24% Similarity=0.351 Sum_probs=170.0
Q ss_pred HHHHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccc
Q 002069 696 IIRATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHAL 773 (973)
Q Consensus 696 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 773 (973)
+....+...-...||+|++|.|-+.++ .+|+..|||++...... ..+++..+|+++..+- .+|.+|.+||...++.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~--q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS--QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh--HHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 334445556677899999999988865 48999999999866543 2367788888876554 8999999999999999
Q ss_pred eeEEEEEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
..||.||.|+ .+|..+-++.- ....+++.-.-+||..+++|+.|||++. .++|||+||+|||++.+|+||+||||.
T Consensus 119 dvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 119 DVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred cEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccc
Confidence 9999999996 57766653322 2346788889999999999999999986 899999999999999999999999999
Q ss_pred cccccCCCCcccccccccCcccccccc----cCCCCCccchHHHHHHHHHHHhCCCCCc
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAY----TMKVTEKCDVYSFGVLALEVIKGKHPRD 907 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~Dv~slG~~l~el~tg~~p~~ 907 (973)
+....+. -..+...|...|||||.+. ...|+.|+||||+|+++.||.++++||+
T Consensus 196 sG~L~dS-iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 196 SGYLVDS-IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred ceeehhh-hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 9766543 2334467889999999875 3468999999999999999999999987
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=293.90 Aligned_cols=264 Identities=22% Similarity=0.276 Sum_probs=192.9
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc-----
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL----- 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 773 (973)
.++|++.+.||+|+||.||+|... +++.||+|++........ ....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 478999999999999999999654 789999999864432221 1345678999999999999999999875433
Q ss_pred ---eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecc
Q 002069 774 ---HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDF 850 (973)
Q Consensus 774 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df 850 (973)
..++||||+++ ++...+... ...+++.++..++.|+++|++|||+. +++|+|+||+||+++.++.++++||
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 46999999975 676666543 24689999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCc-----------ccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh---
Q 002069 851 GISKFLKLGLSN-----------RTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS--- 915 (973)
Q Consensus 851 g~a~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~--- 915 (973)
|.++........ .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999765433211 1223567889999987654 5788999999999999999999998743321100
Q ss_pred h---hhhhhhh------hhh----hcCCCCCCCch-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 916 L---SSNLNIA------LDE----MLDPRLPTPLR-NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 916 ~---~~~~~~~------~~~----~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
. ....... ... ......+.... ........+.+++.+|++.||.+|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0 0000000 000 00001110000 001122467899999999999999999999863
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=278.32 Aligned_cols=244 Identities=22% Similarity=0.300 Sum_probs=197.3
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 777 (973)
..+|.+..+||+|+||.|-.|+.+ +.+.+|||++++...-.....+--+.|-.++.-. +-|.++.+..++...+..|.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 456899999999999999999654 6678999999876543333344455666666655 67899999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||||+.||+|-..+++.+ .+.+..+.-+|..||-||-+||++ ||+.||+|.+||++|.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999988886554 567788999999999999999999 99999999999999999999999999998655
Q ss_pred CCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
.+......+.|||.|+|||++...+|+..+|.|||||++|||+.|++||+++++ .+....+++....-+.+
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE---------~elF~aI~ehnvsyPKs 572 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---------DELFQAIMEHNVSYPKS 572 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH---------HHHHHHHHHccCcCccc
Confidence 555666778999999999999999999999999999999999999999996553 23333333333322211
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCC
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRP 962 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RP 962 (973)
.+.+...+....+.+.|.+|-
T Consensus 573 ----lSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 573 ----LSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ----ccHHHHHHHHHHhhcCCcccc
Confidence 223345666788888898884
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=296.42 Aligned_cols=259 Identities=23% Similarity=0.302 Sum_probs=190.9
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc------
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA------ 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 772 (973)
..+|++.+.||.|+||.||+|.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 36899999999999999999954 5789999999865432 2346788999999999999999999876543
Q ss_pred --------ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC-CC
Q 002069 773 --------LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL-EY 843 (973)
Q Consensus 773 --------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-~~ 843 (973)
...++||||++ ++|.+++.. ..+++..++.++.|++.|++|||+. +++||||||+||+++. ++
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~ 152 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence 35789999997 588888753 2478999999999999999999999 9999999999999974 56
Q ss_pred ceEEecccccccccCCCC---cccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh---h
Q 002069 844 EAHVSDFGISKFLKLGLS---NRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS---L 916 (973)
Q Consensus 844 ~~kl~Dfg~a~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~---~ 916 (973)
.+|++|||.++....... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......... .
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 789999999976543211 1123457889999998654 55788999999999999999999999643321100 0
Q ss_pred hh---hhh-------hhhhhhcC--CCCC-CCc-hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 917 SS---NLN-------IALDEMLD--PRLP-TPL-RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 917 ~~---~~~-------~~~~~~~~--~~~~-~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
.. ... ........ .... .+. ........++.+++.+|++.||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00 000 00000000 0000 000 000112345778999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=297.15 Aligned_cols=259 Identities=20% Similarity=0.281 Sum_probs=196.3
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccce---
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH--- 774 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--- 774 (973)
..++|++.+.||+|+||.||+|... +++.||||++...... ....+.+.+|+.++++++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 4578999999999999999999664 6889999998754322 2234667889999999999999999998865544
Q ss_pred ---eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccc
Q 002069 775 ---SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFG 851 (973)
Q Consensus 775 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg 851 (973)
.++|+||+ +++|.+++.. ..+++.+++.++.|++.|++|||+. +++||||+|+||+++.++.++++|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 5799998864 3589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh------hhhhhhhhh
Q 002069 852 ISKFLKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS------LSSNLNIAL 924 (973)
Q Consensus 852 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~------~~~~~~~~~ 924 (973)
.+...... .....++..|+|||...+ ..++.++||||+||++||+++|+.||......... .........
T Consensus 164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 164 LARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred cccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 99866432 234467889999998765 36788999999999999999999999643321100 000000000
Q ss_pred --------hhhc---CCCCCCCchh-hHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 925 --------DEML---DPRLPTPLRN-VQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 925 --------~~~~---~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
...+ .......... .......+.+++.+|++.||++|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000 0000000000 0112456889999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=277.52 Aligned_cols=258 Identities=27% Similarity=0.355 Sum_probs=198.1
Q ss_pred hcCCcccccccCCCceeEEEE-EcCCCCEEEEEEcCCCCCcch----hhHHHHHHHHHHhhcCCCCceeeeceeee-ccc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEM----ACQQEFLNEGNALTKIRHRNIVKFYGFCS-HAL 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~ 773 (973)
.++|-..+.+|+|||++||+| +....+.||||+-........ ...+...+|..+.+.++||.||++|+|+. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 467888899999999999999 666788999998654432222 22455778999999999999999999996 456
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC---CCceEEecc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL---EYEAHVSDF 850 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---~~~~kl~Df 850 (973)
.+|-|.|||+|.+|.-|++.+. -+++.+++.|+.||+.||.||.+.. ++|+|-|+||.|||+-. .|.+||+||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 7899999999999999998765 5789999999999999999999985 48999999999999943 489999999
Q ss_pred cccccccCCCCc-------ccccccccCccccccccc----CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhh
Q 002069 851 GISKFLKLGLSN-------RTELAGTFGYIAPELAYT----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSN 919 (973)
Q Consensus 851 g~a~~~~~~~~~-------~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 919 (973)
|+++.+..+.+. ....+||.-|.+||.+.- .+.+.|+||||.||++|+.+.|+.||.....-...+..+
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 999998766443 344789999999998753 346789999999999999999999998544322222221
Q ss_pred hhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHH
Q 002069 920 LNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVS 968 (973)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~ 968 (973)
.-....++..|. .+ -...+...+|++|+++.-++|....++.
T Consensus 698 TIlkAtEVqFP~--KP-----vVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 698 TILKATEVQFPP--KP-----VVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred chhcceeccCCC--CC-----ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111111111111 11 1122356788899998888887776654
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=291.52 Aligned_cols=260 Identities=22% Similarity=0.277 Sum_probs=190.9
Q ss_pred CCcccccccCCCceeEEEEEcC-C--CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeec----cc
Q 002069 702 NFDDEHCIGNGGQGSVYKAELP-T--GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSH----AL 773 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~ 773 (973)
+|++.+.||+|+||.||+|... + ++.||+|++...... ....+.+.+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 4788899999999999999654 4 789999998643222 22356788899999999 59999999987532 24
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
..++++||+. ++|.+++... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 5688899886 6898888643 3578999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCC----cccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhh------hhhhhhhhh
Q 002069 854 KFLKLGLS----NRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSIC------SSLSSNLNI 922 (973)
Q Consensus 854 ~~~~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~------~~~~~~~~~ 922 (973)
+....... ......|++.|+|||+..+ ..++.++||||+||++|+|++|+.||....... ...+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 86643221 1233568999999998765 468899999999999999999999987433110 000000000
Q ss_pred hhhhh-----------cCCCCCCCch-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 923 ALDEM-----------LDPRLPTPLR-NVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 923 ~~~~~-----------~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
..... .......... ........+.+++.+|++.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 0000000000 00112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=282.73 Aligned_cols=247 Identities=25% Similarity=0.317 Sum_probs=201.5
Q ss_pred cccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCC
Q 002069 706 EHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
.+++|+|-||+||-|.+ ++|+.||||++.+....... ...+.+|+.+++.++||.||.+...|+.++..+.|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 47899999999999954 58999999998765443322 47899999999999999999999999999999999999976
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC---CceEEecccccccccCCCC
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE---YEAHVSDFGISKFLKLGLS 861 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~---~~~kl~Dfg~a~~~~~~~~ 861 (973)
.-|+-++... ..++++.....++.||+.|+.|||.+ +|+|.|+||+|||+... -++|++|||+|+.++.. .
T Consensus 648 DMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-s 721 (888)
T KOG4236|consen 648 DMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-S 721 (888)
T ss_pred hHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh-h
Confidence 6666666433 35788888899999999999999999 99999999999999654 47999999999988754 4
Q ss_pred cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHH
Q 002069 862 NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQD 941 (973)
Q Consensus 862 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (973)
.....+|||.|.|||++..+.|...-|+||.||++|.-++|..||...+++-+ ++....+.-+...+.+
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd-----------QIQNAaFMyPp~PW~e 790 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND-----------QIQNAAFMYPPNPWSE 790 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH-----------HhhccccccCCCchhh
Confidence 45567999999999999999999999999999999999999999985554322 1222222222233445
Q ss_pred HHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 942 KLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 942 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......++|...++..-.+|-|.+.-+..
T Consensus 791 is~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 791 ISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred cCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 55667788999999999999988776543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=288.10 Aligned_cols=240 Identities=23% Similarity=0.279 Sum_probs=191.5
Q ss_pred HhcCCcccccccCCCceeEEEEE-cCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 776 (973)
.++.|.....+|.|+|++|-.+. ..+++..+||++.+.... ..+|+.++... +|||+++..+.+.++.+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceee
Confidence 35678888889999999998884 458899999999765222 23456555554 7999999999999999999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeee-cCCCceEEeccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL-NLEYEAHVSDFGISKF 855 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill-~~~~~~kl~Dfg~a~~ 855 (973)
+|||++.|+-+.+-+.... .+. .++..|+.+|+.|+.|||++ |+||||+||+|||+ +.+++++++|||.++.
T Consensus 393 ~v~e~l~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred eeehhccccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhh
Confidence 9999999998877765433 223 67788999999999999999 99999999999999 6889999999999987
Q ss_pred ccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 856 LKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 856 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
.+.. ....+-|..|.|||+.....|++++|+||||++||+|++|+.||..-+.. .+....+..+.+.
T Consensus 466 ~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--------~ei~~~i~~~~~s-- 532 (612)
T KOG0603|consen 466 LERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--------IEIHTRIQMPKFS-- 532 (612)
T ss_pred Cchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--------HHHHHhhcCCccc--
Confidence 7654 23345678899999999999999999999999999999999999743321 1122222223222
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
...+....+++.+|++.||.+||+|+++..
T Consensus 533 ----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 ----ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 223445678888999999999999999865
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=271.77 Aligned_cols=260 Identities=20% Similarity=0.268 Sum_probs=199.7
Q ss_pred HhcCCcccccccCCCceeEEEE-EcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-C-C----ceeeeceeeec
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-H-R----NIVKFYGFCSH 771 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-~----niv~~~~~~~~ 771 (973)
...+|.+...+|+|.||.|-.+ +...+..||||+++.- ...++...-|+++++++. + | -+|.+.+++..
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 4789999999999999999999 5556899999999742 233567778999999983 2 1 35777888999
Q ss_pred cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC----------
Q 002069 772 ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL---------- 841 (973)
Q Consensus 772 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---------- 841 (973)
.++.+||+|.+ |.|+.++++.+.. .+++..+++.|++|+++++++||+. +++|-|+||+||++-.
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccC
Confidence 99999999987 5799999987653 5789999999999999999999999 9999999999999831
Q ss_pred ----------CCceEEecccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhh
Q 002069 842 ----------EYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS 911 (973)
Q Consensus 842 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 911 (973)
...||++|||.|+..... -...+.|..|.|||++.+-.++.++||||+||+|+|+.||..-|+.-++
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 235899999999866543 2567889999999999999999999999999999999999998874331
Q ss_pred ------hhhhhhhhhhhhhhhh-------------------------cCCCCC--CCchhhHHHHHHHHHHHhcccCCCC
Q 002069 912 ------ICSSLSSNLNIALDEM-------------------------LDPRLP--TPLRNVQDKLISIMEVSISCLDESP 958 (973)
Q Consensus 912 ------~~~~~~~~~~~~~~~~-------------------------~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP 958 (973)
+....++.....+.+. .++.-+ ........+...+.+|+.+|+..||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 1111211111111111 000000 0001113455679999999999999
Q ss_pred CCCCCHHHHHHH
Q 002069 959 TSRPTMQKVSQL 970 (973)
Q Consensus 959 ~~RPs~~ev~~~ 970 (973)
.+|+|+.|+++.
T Consensus 395 ~~RiTl~EAL~H 406 (415)
T KOG0671|consen 395 ARRITLREALSH 406 (415)
T ss_pred cccccHHHHhcC
Confidence 999999999863
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=272.22 Aligned_cols=219 Identities=21% Similarity=0.153 Sum_probs=174.7
Q ss_pred CCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCCCChHHH
Q 002069 712 GGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMI 790 (973)
Q Consensus 712 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 790 (973)
|.+|.||++.. .+++.||+|++.... .+..|...+....|||++++++++.+.+..++||||+++++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 89999999955 588999999986532 223444555566799999999999999999999999999999999
Q ss_pred hccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccccccccc
Q 002069 791 LSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF 870 (973)
Q Consensus 791 l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~ 870 (973)
+.+.. .+++..+..++.|++.|++|+|+. +++||||||+||+++.++.++++|||.+...... .....++.
T Consensus 76 l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~ 146 (237)
T cd05576 76 ISKFL---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVEN 146 (237)
T ss_pred HHHhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCc
Confidence 86543 488999999999999999999998 9999999999999999999999999987665432 22344677
Q ss_pred CcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHH
Q 002069 871 GYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVS 950 (973)
Q Consensus 871 ~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 950 (973)
.|+|||...+..++.++||||+|+++|||++|+.|++..... ........++. .....+.+++
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------~~~~~~~~~~~------~~~~~~~~li 209 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----------INTHTTLNIPE------WVSEEARSLL 209 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------cccccccCCcc------cCCHHHHHHH
Confidence 899999998888999999999999999999999887532110 00000111111 1234577899
Q ss_pred hcccCCCCCCCCCH
Q 002069 951 ISCLDESPTSRPTM 964 (973)
Q Consensus 951 ~~cl~~dP~~RPs~ 964 (973)
.+|++.||.+||++
T Consensus 210 ~~~l~~dp~~R~~~ 223 (237)
T cd05576 210 QQLLQFNPTERLGA 223 (237)
T ss_pred HHHccCCHHHhcCC
Confidence 99999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=297.98 Aligned_cols=262 Identities=19% Similarity=0.202 Sum_probs=170.8
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-C----CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeecee-----
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-T----GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGF----- 768 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~----- 768 (973)
..++|++.+.||+|+||.||+|... + ++.||||++...... +....| .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 4578999999999999999999664 5 789999997643211 111111 1112222222222221
Q ss_pred -eeccceeEEEEEecCCCChHHHhccCccc-----------------cCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEee
Q 002069 769 -CSHALHSFVVYEYLEMGSLAMILSNDAAA-----------------EEFGWTKRMNAIKGVADALLYMHTNCFPPIVHR 830 (973)
Q Consensus 769 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~ 830 (973)
+..+...++||||+++++|.++++..... .......+..++.|++.||+|||+. +|+||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHR 279 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHR 279 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 24556789999999999999998654311 0112344668999999999999999 99999
Q ss_pred cCCCCCeeecC-CCceEEecccccccccCCC-CcccccccccCcccccccccC----------------------CCCCc
Q 002069 831 DISSKNVLLNL-EYEAHVSDFGISKFLKLGL-SNRTELAGTFGYIAPELAYTM----------------------KVTEK 886 (973)
Q Consensus 831 Dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~-~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~ 886 (973)
||||+|||++. ++.+||+|||+|+...... .......+++.|+|||.+... .++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999986 5899999999998664332 233456789999999965322 23456
Q ss_pred cchHHHHHHHHHHHhCCCCCcchhh-hhhhhhhh--hhhhhhhhcCCCCCCC----chhhHHHHHHHHHHHhcccCCCCC
Q 002069 887 CDVYSFGVLALEVIKGKHPRDFISS-ICSSLSSN--LNIALDEMLDPRLPTP----LRNVQDKLISIMEVSISCLDESPT 959 (973)
Q Consensus 887 ~Dv~slG~~l~el~tg~~p~~~~~~-~~~~~~~~--~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~ 959 (973)
+||||+||++|||+++..|++.... ....+... ....+.....+..... ............+++.+|++.||.
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 7999999999999998877653211 00000000 0000111111111110 000011122345899999999999
Q ss_pred CCCCHHHHHHH
Q 002069 960 SRPTMQKVSQL 970 (973)
Q Consensus 960 ~RPs~~ev~~~ 970 (973)
+|||+++++++
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999874
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=258.25 Aligned_cols=252 Identities=22% Similarity=0.287 Sum_probs=199.2
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 777 (973)
..+|.+.++||+|+|+.|..+++. +.+.||+|++++.-..+.+....+..|-.+..+. .||.+|.+..+|..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 357999999999999999999765 7789999999876554444456667777776666 79999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
|.||++||+|--.+++++ .++++.++-+...|+-|+.|||+. ||+.||+|..||++|..|++|++|+|+++.--
T Consensus 329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999977766543 588999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
.......++.|||.|.|||++++..|...+|.|++||+++||+.|+.||+-... ...-.......+.-++...+..+.+
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm-~n~d~ntedylfqvilekqiriprs 481 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGM-DNPDMNTEDYLFQVILEKQIRIPRS 481 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecC-CCcccchhHHHHHHHhhhcccccce
Confidence 444566778999999999999999999999999999999999999999985441 1111111111122222222222222
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCC
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRP 962 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RP 962 (973)
. +.....+++.-+.+||++|-
T Consensus 482 l----svkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 482 L----SVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred e----ehhhHHHHHHhhcCCcHHhc
Confidence 1 12234556688999999984
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=235.19 Aligned_cols=262 Identities=20% Similarity=0.275 Sum_probs=196.7
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|...++||+|.||+||+|+. .+++.||+|++......+ .......+|+-+++.++|+|||+++++...+...-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 466778999999999999954 578999999987654333 234677899999999999999999999988888999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
||+ -+|..|...- .+.++.+.+.+++.|+.+|+.++|++ .+.|||+||.|.+++.+|+.|++|||+++.++-..
T Consensus 82 ~cd-qdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 82 FCD-QDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred Hhh-HHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 997 5677776433 35678899999999999999999999 99999999999999999999999999999887665
Q ss_pred CcccccccccCcccccccccCC-CCCccchHHHHHHHHHHHh-CCCCCcchhhh------hhhhhhhhhhhhh---hh--
Q 002069 861 SNRTELAGTFGYIAPELAYTMK-VTEKCDVYSFGVLALEVIK-GKHPRDFISSI------CSSLSSNLNIALD---EM-- 927 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~------~~~~~~~~~~~~~---~~-- 927 (973)
......+-|.-|.+|.++.+.+ |++..|+||.||++.|+.. |++-|.+.+-. ....+.-.+..+. ..
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 5556667889999999998865 7888999999999999996 66666543211 0001100001000 00
Q ss_pred --cCCCCCCCc--hhh-HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 928 --LDPRLPTPL--RNV-QDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 928 --~~~~~~~~~--~~~-~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..|.++... ... +.....-++++.+.+.-+|..|.+++..++.
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 011111111 110 1111223567778888899999999998764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=288.71 Aligned_cols=244 Identities=25% Similarity=0.373 Sum_probs=188.3
Q ss_pred CcccccccCCCcee-EEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEEEEE
Q 002069 703 FDDEHCIGNGGQGS-VYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 703 ~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 780 (973)
|.-.+++|.|+.|+ ||+|.. +|+.||||++... ......+|+..++.- +|||||++++.-.++.+.||..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 45557799999986 799988 7899999998642 245667899988877 79999999999999999999999
Q ss_pred ecCCCChHHHhccCcc-ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC---C--CceEEecccccc
Q 002069 781 YLEMGSLAMILSNDAA-AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL---E--YEAHVSDFGISK 854 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---~--~~~kl~Dfg~a~ 854 (973)
.|. .+|.++++.... .........+.+..|+++|+++||+- +|||||+||.||||+. + .+++|+|||+++
T Consensus 584 LC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 584 LCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred Hhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 996 799999987521 11112245678899999999999997 9999999999999976 3 478999999999
Q ss_pred cccCCCCc---ccccccccCcccccccccCCCCCccchHHHHHHHHHHHhC-CCCCcchhhhhhhhhhhhhhhhhhhcCC
Q 002069 855 FLKLGLSN---RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKG-KHPRDFISSICSSLSSNLNIALDEMLDP 930 (973)
Q Consensus 855 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (973)
....+... .....||.+|+|||++....-+.++||||+||++|+.++| .+||...-...+.+-. ..... -
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~----~~~~L--~ 733 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT----GNYTL--V 733 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc----Cccce--e
Confidence 88765432 3456799999999999988888899999999999999985 9999743221111100 00000 0
Q ss_pred CCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 931 RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 931 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
.+.. ..++ ...++|.+|+++||..||+|.+|+.
T Consensus 734 ~L~~----~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 HLEP----LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eecc----CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1111 1111 4578999999999999999999975
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=283.07 Aligned_cols=267 Identities=16% Similarity=0.202 Sum_probs=181.6
Q ss_pred HhcCCcccccccCCCceeEEEEEc-----------------CCCCEEEEEEcCCCCCcchh-----------hHHHHHHH
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAEL-----------------PTGEIVAVKKFHSPLPGEMA-----------CQQEFLNE 750 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~-----------~~~~~~~e 750 (973)
..++|++.++||+|+||+||+|.. ..++.||||++......... ..+.+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999953 24568999998653221110 01223446
Q ss_pred HHHhhcCCCCce-----eeeceeeec--------cceeEEEEEecCCCChHHHhccCcc---------------------
Q 002069 751 GNALTKIRHRNI-----VKFYGFCSH--------ALHSFVVYEYLEMGSLAMILSNDAA--------------------- 796 (973)
Q Consensus 751 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~--------------------- 796 (973)
+.++.+++|.++ ++++++|.. .+..|+||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766554 667777743 3467999999999999999864211
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCc-ccccccccCcccc
Q 002069 797 AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN-RTELAGTFGYIAP 875 (973)
Q Consensus 797 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~g~~~y~aP 875 (973)
....++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+|++|||+++........ .....+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12346778899999999999999999 9999999999999999999999999999765433211 1123357899999
Q ss_pred cccccCCC----------------------CCccchHHHHHHHHHHHhCCC-CCcchhhhhhhhhhh--hhhhhhhhcCC
Q 002069 876 ELAYTMKV----------------------TEKCDVYSFGVLALEVIKGKH-PRDFISSICSSLSSN--LNIALDEMLDP 930 (973)
Q Consensus 876 E~~~~~~~----------------------~~~~Dv~slG~~l~el~tg~~-p~~~~~~~~~~~~~~--~~~~~~~~~~~ 930 (973)
|.+..... ..+.||||+||++|+|++|.. ||............. ....+......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 98754321 124699999999999999885 665322111111100 00001111111
Q ss_pred CCCCCchhhHHHHHHHHHHHhcccCCCC---CCCCCHHHHHHH
Q 002069 931 RLPTPLRNVQDKLISIMEVSISCLDESP---TSRPTMQKVSQL 970 (973)
Q Consensus 931 ~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~ev~~~ 970 (973)
.+ .+...........+++.+++..+| .+|+|++|++++
T Consensus 460 ~~--~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 KY--DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CC--CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11 111222334556788889999766 689999999874
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-31 Score=274.20 Aligned_cols=246 Identities=21% Similarity=0.304 Sum_probs=203.5
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCC-EEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGE-IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
..+++.+..||-||||.|=.++.+..+ .+|+|++++....+....+.+..|-.+|...+.|.||++|..|.+....|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 356677788999999999999765433 4899998877666666678899999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
||-|-||.+...+++.+ .+....+.-++..+.+|++|||++ +||+||+||+|.+++.+|-+|+.|||+|+.+..
T Consensus 499 mEaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HHhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999997655 577888899999999999999999 999999999999999999999999999999987
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
+...+ ++.|||.|.|||++..+..+.++|.||+|+++||+++|.+||...+.+...- ..-..++.+- +|.
T Consensus 573 g~KTw-TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn--~ILkGid~i~---~Pr---- 642 (732)
T KOG0614|consen 573 GRKTW-TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN--LILKGIDKIE---FPR---- 642 (732)
T ss_pred CCcee-eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH--HHHhhhhhhh---ccc----
Confidence 75444 5789999999999999999999999999999999999999998766543211 0111122111 111
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCC
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPT 963 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs 963 (973)
.......++|++.+..+|.+|--
T Consensus 643 --~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 643 --RITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred --ccchhHHHHHHHHHhcCcHhhhc
Confidence 12234567888999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=263.48 Aligned_cols=239 Identities=27% Similarity=0.396 Sum_probs=192.8
Q ss_pred CceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCCCChHHHh
Q 002069 713 GQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMIL 791 (973)
Q Consensus 713 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 791 (973)
+||.||+|... +++.||+|++........ .+.+.+|++.+++++|++++++++++......++|+||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58999999765 589999999976543322 578999999999999999999999999888999999999999999998
Q ss_pred ccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCcccccccccC
Q 002069 792 SNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFG 871 (973)
Q Consensus 792 ~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~ 871 (973)
.... .+++..++.++.+++.+++|||+. +++|+||+|+||+++.++.++++|||.+....... ......++..
T Consensus 79 ~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 151 (244)
T smart00220 79 KKRG---RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPE 151 (244)
T ss_pred Hhcc---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcC
Confidence 6543 278899999999999999999999 99999999999999999999999999998775442 3344568889
Q ss_pred cccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHh
Q 002069 872 YIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSI 951 (973)
Q Consensus 872 y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 951 (973)
|+|||...+..++.++||||+|+++|++++|..||...... ............... .........+.+++.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--------~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~ 222 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--------LELFKKIGKPKPPFP-PPEWKISPEAKDLIR 222 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--------HHHHHHHhccCCCCc-cccccCCHHHHHHHH
Confidence 99999998888899999999999999999999998642211 111111111111111 000003346788999
Q ss_pred cccCCCCCCCCCHHHHHH
Q 002069 952 SCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 952 ~cl~~dP~~RPs~~ev~~ 969 (973)
+|+..+|.+||++.++++
T Consensus 223 ~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 223 KLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHccCCchhccCHHHHhh
Confidence 999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=249.55 Aligned_cols=264 Identities=25% Similarity=0.372 Sum_probs=192.4
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec-------
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH------- 771 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------- 771 (973)
...|....++|+|.||+||+|+.+ +|+.||+|+..-.... ...-....+|+.++..++|+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK-eGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc-cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 345667789999999999999664 6788999875432111 1123566789999999999999999998842
Q ss_pred -cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecc
Q 002069 772 -ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDF 850 (973)
Q Consensus 772 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df 850 (973)
....|+|+++|+. +|.-.+.... .+++..++.+++.++..|+.|+|.. .|+|||+||.|++++.+|.+|++||
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecc
Confidence 2357999999984 6777775443 3688999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCC----CcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhh---------hhhhh
Q 002069 851 GISKFLKLGL----SNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISS---------ICSSL 916 (973)
Q Consensus 851 g~a~~~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~---------~~~~~ 916 (973)
|+++.+.... ...+..+-|..|.+||.+.+ ..|+++.|||..||++.||+||.+-++...+ .|...
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 9997664321 12344567999999998876 4689999999999999999999988765332 11111
Q ss_pred hhhhhh-----hhhhhc-CCCCC-CCchhhHHHH------HHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 917 SSNLNI-----ALDEML-DPRLP-TPLRNVQDKL------ISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 917 ~~~~~~-----~~~~~~-~~~~~-~~~~~~~~~~------~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.+.+.. .+.+-+ -+.++ .......+.. ....+++..++..||.+|+++++++..
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111111 011111 01111 1111112221 145678889999999999999998754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=266.89 Aligned_cols=213 Identities=22% Similarity=0.261 Sum_probs=178.7
Q ss_pred cCccccHHHHHHHhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhH-----HHHHHHHHHhhcCC--
Q 002069 687 FDGKIVHEEIIRATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQ-----QEFLNEGNALTKIR-- 758 (973)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~-----~~~~~e~~~l~~l~-- 758 (973)
+.+.+..+.......+|...+.+|+|+||.|+.|.++ +...|+||.+.+...-...+. ..+-.|+++|..++
T Consensus 547 ~e~~~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~ 626 (772)
T KOG1152|consen 547 PEGNIGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKH 626 (772)
T ss_pred ccccccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhc
Confidence 3344444444455667999999999999999999665 567899999876543222222 23667999999997
Q ss_pred -CCceeeeceeeeccceeEEEEEec-CCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCC
Q 002069 759 -HRNIVKFYGFCSHALHSFVVYEYL-EMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKN 836 (973)
Q Consensus 759 -h~niv~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~N 836 (973)
|+||++++++|++.+.+|++||-. ++.+|.+++..+. .+++.++.-|++|++.|+++||++ ||||||||-+|
T Consensus 627 sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikden 700 (772)
T KOG1152|consen 627 SHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDEN 700 (772)
T ss_pred CccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---Cceeccccccc
Confidence 999999999999999999999965 4668999997654 688999999999999999999999 99999999999
Q ss_pred eeecCCCceEEecccccccccCCCCcccccccccCcccccccccCCCC-CccchHHHHHHHHHHHhCCCCCc
Q 002069 837 VLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPRD 907 (973)
Q Consensus 837 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~p~~ 907 (973)
|.++.+|-+|++|||.|.....+ ....++||..|+|||++.+.+|- ...|||++|+++|.++....||.
T Consensus 701 vivd~~g~~klidfgsaa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 701 VIVDSNGFVKLIDFGSAAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EEEecCCeEEEeeccchhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999999999999999876543 55678999999999999998875 55899999999999999999975
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-29 Score=265.00 Aligned_cols=203 Identities=24% Similarity=0.308 Sum_probs=171.8
Q ss_pred cCCcccccccCCCceeEEEEE-cCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.-|..++.||-|+||+|..++ ..+...||.|.+.+...-.......+..|-+++..-+.+-||++|-.|.+.+..|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 357778899999999999994 4466779999887543333333456778999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC-
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL- 858 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~- 858 (973)
||++||++-.+|-+. +.|.+..++.++..+..|+++.|.. |+|||||||+|||||.||++|++|||++.-++.
T Consensus 709 dYIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence 999999999888544 3578888999999999999999999 999999999999999999999999999864421
Q ss_pred --------CCCc---------------------------------ccccccccCcccccccccCCCCCccchHHHHHHHH
Q 002069 859 --------GLSN---------------------------------RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLAL 897 (973)
Q Consensus 859 --------~~~~---------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 897 (973)
++.. ....+||+.|+|||++....++.-+|.||.||+||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 1000 01357999999999999999999999999999999
Q ss_pred HHHhCCCCCcch
Q 002069 898 EVIKGKHPRDFI 909 (973)
Q Consensus 898 el~tg~~p~~~~ 909 (973)
||+.|+.||-..
T Consensus 863 em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 863 EMLVGQPPFLAD 874 (1034)
T ss_pred HHhhCCCCccCC
Confidence 999999999643
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=249.02 Aligned_cols=132 Identities=23% Similarity=0.369 Sum_probs=113.1
Q ss_pred cCCcccccccCCCceeEEEE-EcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC--------CCceeeeceeeec
Q 002069 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR--------HRNIVKFYGFCSH 771 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~~ 771 (973)
.+|-++++||-|.|++||.+ +..+.+.||+|+.+.. ....+....|+.++++++ ..+||+++++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 68999999999999999999 5668899999998853 233567788999999873 3589999999964
Q ss_pred ----cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeec
Q 002069 772 ----ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLN 840 (973)
Q Consensus 772 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~ 840 (973)
+.+.++|+|++ |.+|..+++.... +.++...+.+|++||+.||.|||.+| ||||-||||+|||+.
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 45889999998 6788888876554 34789999999999999999999998 999999999999993
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-29 Score=255.97 Aligned_cols=307 Identities=22% Similarity=0.210 Sum_probs=218.5
Q ss_pred EEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceeccc-C
Q 002069 76 YIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSY-N 154 (973)
Q Consensus 76 ~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~-N 154 (973)
..|.++-.++ .+|..+.. .-..++|..|+|+...|.+|..+++|+.|||++|.|+.+-|++|.++.+|.+|-+.+ |
T Consensus 50 ~VdCr~~GL~-eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N 126 (498)
T KOG4237|consen 50 IVDCRGKGLT-EVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN 126 (498)
T ss_pred eEEccCCCcc-cCcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence 3466666677 77877654 677888999999866667899999999999999999988899999999988887666 8
Q ss_pred CCCCCCCccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCc
Q 002069 155 TLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPN 234 (973)
Q Consensus 155 ~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~ 234 (973)
+|+...-..|++|..|+.|.+.-|++.....+.|..|++|..|.+.+|.+..+...+|..+..++.+.+..|.+...
T Consensus 127 kI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icd--- 203 (498)
T KOG4237|consen 127 KITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICD--- 203 (498)
T ss_pred chhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccc---
Confidence 89877677899999999999999999877778899999999999999999988888899999999999988874322
Q ss_pred cccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccc-cccceEEcccccccCC-cCchhhcCC
Q 002069 235 EIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNL-KSLLHLQLNYNTLSGS-IPLSLGSLT 312 (973)
Q Consensus 235 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l-~~L~~L~l~~n~l~~~-~~~~~~~l~ 312 (973)
.+++.+... +. ..|..+++.....-..+.++++.++....|... ..+..=..+.+...+. +...|..++
T Consensus 204 --CnL~wla~~-~a------~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~ 274 (498)
T KOG4237|consen 204 --CNLPWLADD-LA------MNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLP 274 (498)
T ss_pred --cccchhhhH-Hh------hchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcc
Confidence 222222211 11 112233333333333344444444444333321 1221111222222222 234577778
Q ss_pred ccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhccc
Q 002069 313 NLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLY 392 (973)
Q Consensus 313 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~ 392 (973)
+|++|+|++|+|+++-+.+|.+...+++|.|..|+|..+-...|.++..|+.|+|++|+|+...|.+|..+.+|.+|+|-
T Consensus 275 ~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~ 354 (498)
T KOG4237|consen 275 NLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLL 354 (498)
T ss_pred cceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehc
Confidence 88888888888887777788888888888888888876667778888888888888888887788888888888888887
Q ss_pred ccccc
Q 002069 393 ENSLC 397 (973)
Q Consensus 393 ~N~l~ 397 (973)
.|.+.
T Consensus 355 ~Np~~ 359 (498)
T KOG4237|consen 355 SNPFN 359 (498)
T ss_pred cCccc
Confidence 77653
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-30 Score=260.09 Aligned_cols=306 Identities=24% Similarity=0.252 Sum_probs=199.8
Q ss_pred eeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecc-cc
Q 002069 101 LRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGI-NA 179 (973)
Q Consensus 101 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~-n~ 179 (973)
.+-++-.++ .+|..+. ..-..++|..|+|+.+.|.+|+.+++|+.||||+|.|+.+-|++|.++.+|..|-+-+ |+
T Consensus 51 VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk 127 (498)
T KOG4237|consen 51 VDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK 127 (498)
T ss_pred EEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence 445555565 5666554 2345677777777766666677777777777777777766677777776666555544 66
Q ss_pred cCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcc
Q 002069 180 LSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCS 259 (973)
Q Consensus 180 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 259 (973)
|+...-+.|.+|.+|+.|.+.-|++.-+..++|..+++|..|.+-+|.+..+....|..+.+++.+++..|.+. .
T Consensus 128 I~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i-----c 202 (498)
T KOG4237|consen 128 ITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI-----C 202 (498)
T ss_pred hhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc-----c
Confidence 66444455666666666666666666666666666666666666666666555556666666666666666532 1
Q ss_pred cCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcC-CccceeeccccccCC-CCCccccCCCC
Q 002069 260 FGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSL-TNLATLYFSTNALSG-SIPNEITNLRS 337 (973)
Q Consensus 260 ~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~L~~n~l~~-~~~~~~~~l~~ 337 (973)
..+++.+.. +....+.+++......-..+.++++..+.+..|... ..+..-..+.+...+ -....|..+++
T Consensus 203 dCnL~wla~-------~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~ 275 (498)
T KOG4237|consen 203 DCNLPWLAD-------DLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPN 275 (498)
T ss_pred ccccchhhh-------HHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhccc
Confidence 122222221 111223345666666666777777776655555432 222222222332222 33446788888
Q ss_pred CCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCCCCEEEccC
Q 002069 338 LSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSS 417 (973)
Q Consensus 338 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 417 (973)
|+.|+|++|+|+++.+.+|.++..++.|.|..|+|..+....|.++..|++|+|++|+|+...|.+|..+.+|.+|+|-.
T Consensus 276 L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~ 355 (498)
T KOG4237|consen 276 LRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLS 355 (498)
T ss_pred ceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehcc
Confidence 88888888888888888888888888888888888877777888888888888888888888888888888888888888
Q ss_pred CCCC
Q 002069 418 NKLN 421 (973)
Q Consensus 418 N~l~ 421 (973)
|.+.
T Consensus 356 Np~~ 359 (498)
T KOG4237|consen 356 NPFN 359 (498)
T ss_pred Cccc
Confidence 8776
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=225.63 Aligned_cols=254 Identities=18% Similarity=0.267 Sum_probs=192.2
Q ss_pred hcCCcccccccCCCceeEEEEE-cCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeeccc--ee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHAL--HS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~ 775 (973)
.++|++.+++|+|.+++||.|. ..+.++++||+++. ...+.+.+|+.++..+. ||||+++++...++. .+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 4689999999999999999994 56889999999874 23578999999999996 999999999997654 56
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC-CceEEecccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE-YEAHVSDFGISK 854 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl~Dfg~a~ 854 (973)
.+|+||+.+.+....- ..++...+...+.+++.|+.|+|+. ||+|||+||+|+++|.. ...+++|+|+|.
T Consensus 111 aLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence 8999999988776554 2467778899999999999999999 99999999999999876 579999999999
Q ss_pred cccCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcch-hhh------hhhhhhh-------
Q 002069 855 FLKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFI-SSI------CSSLSSN------- 919 (973)
Q Consensus 855 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~-~~~------~~~~~~~------- 919 (973)
++.++.+ ....+.+..|..||.+-. ..|+..-|+|||||++..|+..+.||=.- ++. ....+..
T Consensus 182 FYHp~~e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 182 FYHPGKE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred hcCCCce-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 9877633 344566778899998764 45788899999999999999999997321 111 1101000
Q ss_pred -----hhhhhhhhcCCCCCCCchhh------HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 920 -----LNIALDEMLDPRLPTPLRNV------QDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 920 -----~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
.......++......++... .-...+..+++.+.+..|-++|||+.|.++
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 01111122222111111111 011244678888999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-28 Score=233.25 Aligned_cols=251 Identities=20% Similarity=0.311 Sum_probs=184.3
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeecee-eecccee
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGF-CSHALHS 775 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~ 775 (973)
..+.|.+.+.+|+|.||.+-.++++ +.+.+++|.+..+. ...++|.+|...--.+ .|.||+.-|++ |...+.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 3467999999999999999999776 67789999987653 3468899998765555 58999988865 5667788
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeec-CC-CceEEeccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLN-LE-YEAHVSDFGIS 853 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~-~~-~~~kl~Dfg~a 853 (973)
++++||+|.|+|.+-+...+ +.+....+++.|+++|+.|||++ .+||||||.+|||+- .| .+||++|||.+
T Consensus 98 vF~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred EEeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccc
Confidence 99999999999998876543 67788899999999999999999 999999999999993 33 47999999998
Q ss_pred ccccCCCCcccccccccCcccccccccC-----CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhc
Q 002069 854 KFLKLGLSNRTELAGTFGYIAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML 928 (973)
Q Consensus 854 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 928 (973)
+..+.... ..--+-.|.|||..... ...+.+|||.||+++|.++||..||+.....+... ..+.. .....
T Consensus 171 ~k~g~tV~---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y-~~~~~-w~~rk 245 (378)
T KOG1345|consen 171 RKVGTTVK---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY-WEWEQ-WLKRK 245 (378)
T ss_pred cccCceeh---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH-HHHHH-Hhccc
Confidence 86543221 12234568899976533 35677999999999999999999998433221111 11111 11222
Q ss_pred CCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHH
Q 002069 929 DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVS 968 (973)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~ 968 (973)
.++.|..+. .....++++.++-+..+|++|-...++.
T Consensus 246 ~~~~P~~F~---~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 246 NPALPKKFN---PFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred CccCchhhc---ccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 223333332 2334456777789999999995544443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-26 Score=237.15 Aligned_cols=212 Identities=33% Similarity=0.542 Sum_probs=184.7
Q ss_pred ccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCCCCh
Q 002069 709 IGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 787 (973)
Q Consensus 709 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 787 (973)
||+|++|.||++... +++.+++|++....... ..+.+.+|+..++.++|++++++++++......++++||+++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999765 48999999998653322 357899999999999999999999999998899999999999999
Q ss_pred HHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC-CCceEEecccccccccCCCCccccc
Q 002069 788 AMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL-EYEAHVSDFGISKFLKLGLSNRTEL 866 (973)
Q Consensus 788 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~ 866 (973)
.+++.... ..+++..++.++.++++++++||+. +++|+||+|.||+++. ++.++++|||.+.............
T Consensus 79 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 79 KDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 99987542 3578999999999999999999999 9999999999999999 8999999999998765543223445
Q ss_pred ccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHH
Q 002069 867 AGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLIS 945 (973)
Q Consensus 867 ~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (973)
.+...|++||..... .++.++|+|++|++++++ ..
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------~~ 189 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------PE 189 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------HH
Confidence 688899999998877 788999999999999998 34
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 946 IMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 946 l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
+.+++.+|++.+|.+||++.++++.+
T Consensus 190 ~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 190 LKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 67888999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-28 Score=238.36 Aligned_cols=260 Identities=23% Similarity=0.281 Sum_probs=189.6
Q ss_pred cccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc-----eeEE
Q 002069 704 DDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL-----HSFV 777 (973)
Q Consensus 704 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l 777 (973)
+-.+.||-|+||.||.+.. ++|+.||.|++..- .......+.+.+|+.++..++|.|+...++...-+. +.|.
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 3457899999999999955 58999999998643 234445688999999999999999999888765432 4477
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
|+|.|. .+|..++-.. ..++.+.+.-++.||.+|+.|||+. +|.||||||.|.+++.+...||+|||+++..+
T Consensus 135 ~TELmQ-SDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHH-hhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 888885 6787777543 3577888889999999999999999 99999999999999999999999999999776
Q ss_pred CCC-CcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhh------hhhhh-------hhhh
Q 002069 858 LGL-SNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSIC------SSLSS-------NLNI 922 (973)
Q Consensus 858 ~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~------~~~~~-------~~~~ 922 (973)
.+. ..++..+-|..|.|||++.+. .|+.+.||||.||++.|++..+.-|+....+. +-.+. ...+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 543 234556778899999999875 58899999999999999998887776432211 00000 0000
Q ss_pred h-hhhhcCC-----CCCCC--chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 923 A-LDEMLDP-----RLPTP--LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 923 ~-~~~~~~~-----~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
. ...+++. ..+-. .......-.+...+...++..||.+|.+.++.+...
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0 0111111 11100 011112222345667789999999999998877643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-28 Score=262.83 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=203.0
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|+..+++|+|.||.||||+. .+++..|||+++-..... ..-..+|+-+++..+|||||.++|.+-..+..|++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 46799999999999999999955 488999999998654332 46677899999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
||||.+|+|++.-+. ..++++.++..+++...+|++|||+. +-+|||||-.||++++.|.+|+.|||.+..+..
T Consensus 91 MEycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EEecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 999999999987643 34788999999999999999999999 899999999999999999999999999988776
Q ss_pred CCCcccccccccCccccccc---ccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 859 GLSNRTELAGTFGYIAPELA---YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
.......+.||+.|||||+. +.+.|...+|||+.|+...|+-.-+.|--....+.+-+ -......++. .
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~-----LmTkS~~qpp---~ 236 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF-----LMTKSGFQPP---T 236 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH-----HhhccCCCCC---c
Confidence 66666788999999999976 35568899999999999999988777733222221111 0011111111 1
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
..+...-...+.++++.|+..+|++||+++.+++
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1122223345778999999999999999988765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=233.32 Aligned_cols=259 Identities=21% Similarity=0.276 Sum_probs=196.4
Q ss_pred hcCCcccccccCCCceeEEEE-EcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc------
Q 002069 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA------ 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 772 (973)
..+|.-.+.+|.|.- .|-.| +.-.++.||+|+...+... ....++..+|...+..+.|+|+++++.++.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 356778889999998 55556 4447899999998877443 44467888999999999999999999998543
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
...|+|||+|. .++...+. -+++-..+..|..|++.|++|||+. ||+|||+||+||++..+...||.|||.
T Consensus 94 ~e~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 94 QEVYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HhHHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence 35699999996 68887775 2456678899999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhh-------------hh
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLS-------------SN 919 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~-------------~~ 919 (973)
|+..... -..+..+.+..|.|||++.+..+.+.+||||.||++.||++|+.-|.+...+..|.. ..
T Consensus 165 ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 165 ARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred hcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 9876554 345667788999999999999999999999999999999999988875443222210 00
Q ss_pred hhhh---hh------------hhc-CCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 920 LNIA---LD------------EML-DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 920 ~~~~---~~------------~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.... .. +.+ |..++.......-......+++.+|+-.||++|.++++++++
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000 00 000 001111111111122346788899999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=243.62 Aligned_cols=208 Identities=20% Similarity=0.192 Sum_probs=175.7
Q ss_pred ccHHHHHHHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC------CCcee
Q 002069 691 IVHEEIIRATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR------HRNIV 763 (973)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv 763 (973)
+.+.--+....+|.+....|+|-|++|..|.. ..|+.||||++... +...+.=..|+++++++. --|++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN----E~M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN----EVMHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc----hHHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 33333445568899999999999999999944 46889999999743 334566678999999983 45889
Q ss_pred eeceeeeccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC-
Q 002069 764 KFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE- 842 (973)
Q Consensus 764 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~- 842 (973)
+++..|.+..+.|+|+|-+. .+|.++++..+..-.+....+..++.|+.-||..|-.- +|+|.||||.|||+++.
T Consensus 498 rl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCc
Confidence 99999999999999999874 79999999888777788999999999999999999987 99999999999999987
Q ss_pred CceEEecccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcc
Q 002069 843 YEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDF 908 (973)
Q Consensus 843 ~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 908 (973)
...||||||.|....... .+...-+-.|.|||++.+.+|+...|+||.||+|||+.||+..|.+
T Consensus 574 ~iLKLCDfGSA~~~~ene--itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENE--ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred ceeeeccCcccccccccc--ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 567999999998775432 2233445679999999999999999999999999999999988864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-25 Score=230.06 Aligned_cols=199 Identities=32% Similarity=0.501 Sum_probs=172.3
Q ss_pred CcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEe
Q 002069 703 FDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEY 781 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 781 (973)
|.+.+.||+|++|.||+|... +++.||+|.+...... ...+.+.+|++.+++++|++++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 567789999999999999765 4899999999865333 2367899999999999999999999999988899999999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC-
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL- 860 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 860 (973)
+++++|.+++..... .+++.....++.+++.+++++|+. +++|+|++|+||+++.++.++++|||.+.......
T Consensus 79 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 79 CEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred cCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 999999999975432 178899999999999999999999 99999999999999999999999999998775442
Q ss_pred CcccccccccCccccccc-ccCCCCCccchHHHHHHHHHHHhCCCCCcc
Q 002069 861 SNRTELAGTFGYIAPELA-YTMKVTEKCDVYSFGVLALEVIKGKHPRDF 908 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 908 (973)
.......++..|++||.. ....++.++|||+||+++|||++|+.||+.
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122345678889999998 666778899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-24 Score=270.36 Aligned_cols=345 Identities=22% Similarity=0.251 Sum_probs=211.6
Q ss_pred cccCCCCCCCEEECCCCc------ccccCCcCccCCC-CCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCc
Q 002069 18 PEIGHLTHLKLLSFSKNQ------LSGLIPHEIGRLS-SLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPN 90 (973)
Q Consensus 18 ~~~~~l~~L~~L~l~~n~------l~~~~p~~~~~l~-~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~ 90 (973)
.+|.++++|+.|.+..+. +...+|..+..++ +|+.|++.+|.++ .+|..| ...+|++|++++|++. .+|.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 345666667766665442 2223555555553 4666666666665 666655 3566666666666666 5666
Q ss_pred cccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCcccc
Q 002069 91 EVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNL 170 (973)
Q Consensus 91 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L 170 (973)
.+..+++|++|+|+++...+.+|. ++.+++|++|+|++|.....+|..++++++|+.|++++|..-..+|..+ ++++|
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL 706 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL 706 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence 666666666666666543334553 6666666666666665444566666666666666666654333445443 56666
Q ss_pred ceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccc
Q 002069 171 VTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYN 250 (973)
Q Consensus 171 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N 250 (973)
+.|++++|.....+|.. ..+|++|++++|.+..++. .+ .+++|+.|++.++....+ ..
T Consensus 707 ~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP~-~~-~l~~L~~L~l~~~~~~~l-~~---------------- 764 (1153)
T PLN03210 707 YRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEFPS-NL-RLENLDELILCEMKSEKL-WE---------------- 764 (1153)
T ss_pred CEEeCCCCCCccccccc---cCCcCeeecCCCccccccc-cc-cccccccccccccchhhc-cc----------------
Confidence 66666665443344432 2355556666665553322 11 345555555544322111 00
Q ss_pred cccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCc
Q 002069 251 TLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPN 330 (973)
Q Consensus 251 ~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 330 (973)
.+....+..+...++|+.|++++|......+..++++++|+.|++++|...+.+|..+ .+++|+.|++++|.....+|.
T Consensus 765 ~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~ 843 (1153)
T PLN03210 765 RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPD 843 (1153)
T ss_pred cccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccc
Confidence 0011111122233455666666665444456667788888888888875444566655 688999999998865545554
Q ss_pred cccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCC-cccCCCCcccccccccchhcccccc
Q 002069 331 EITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSIN-KLSGSIPLSFASLTSLTTLYLYENS 395 (973)
Q Consensus 331 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~i~~~~~~~~~~l~~L~~L~L~~N~ 395 (973)
. .++|+.|+|++|.++ .+|.++..+++|+.|+|++| ++. .+|..+..+++|+.|++++|.
T Consensus 844 ~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 844 I---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred c---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 3 368999999999998 67888999999999999984 555 577778888999999888774
|
syringae 6; Provisional |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-25 Score=229.42 Aligned_cols=198 Identities=27% Similarity=0.366 Sum_probs=165.3
Q ss_pred HHHHhcCCcccccccCCCceeEEEEEc-C---CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeee
Q 002069 696 IIRATKNFDDEHCIGNGGQGSVYKAEL-P---TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCS 770 (973)
Q Consensus 696 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 770 (973)
+......|..+++||+|.|++||+|.. . ..+.||+|.+..... ...+.+|++++..+ .+.||+++.+++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhc
Confidence 334456799999999999999999943 2 567899999865322 36688999999999 6899999999999
Q ss_pred ccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC-CceEEec
Q 002069 771 HALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE-YEAHVSD 849 (973)
Q Consensus 771 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl~D 849 (973)
.+++..+|+||++.....++.. .++..++..+++.+..||+++|.+ |||||||||+|++.+.. +.-.|+|
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred cCCeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEe
Confidence 9999999999999999998874 466788999999999999999999 99999999999999765 7889999
Q ss_pred ccccccccCCC-------------Cc-------------------------------ccccccccCccccccccc-CCCC
Q 002069 850 FGISKFLKLGL-------------SN-------------------------------RTELAGTFGYIAPELAYT-MKVT 884 (973)
Q Consensus 850 fg~a~~~~~~~-------------~~-------------------------------~~~~~g~~~y~aPE~~~~-~~~~ 884 (973)
||+|..+.... .. ....+||++|.|||++.. ...+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 99987221100 00 012579999999999864 4578
Q ss_pred CccchHHHHHHHHHHHhCCCCCc
Q 002069 885 EKCDVYSFGVLALEVIKGKHPRD 907 (973)
Q Consensus 885 ~~~Dv~slG~~l~el~tg~~p~~ 907 (973)
+++||||.||++..++++++||-
T Consensus 257 taiDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred Cccceeeccceeehhhccccccc
Confidence 89999999999999999999984
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-24 Score=268.39 Aligned_cols=347 Identities=22% Similarity=0.220 Sum_probs=245.1
Q ss_pred CcCccCCCCCCeeeccCCc------CCCCCCCcccCCC-CCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCC
Q 002069 41 PHEIGRLSSLNGLSLYSNF------LKGSIPPSLGNLT-SLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIP 113 (973)
Q Consensus 41 p~~~~~l~~L~~L~l~~n~------~~~~~p~~~~~l~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p 113 (973)
+..|.++.+|+.|.++.+. +...+|+.|..++ +|+.|++.++.++ .+|..+ ...+|++|++++|+++ .+|
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~ 627 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW 627 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence 3456777888888776553 2234666666663 5788888887776 677766 4577888888888777 677
Q ss_pred CccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCc
Q 002069 114 SSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKS 193 (973)
Q Consensus 114 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~ 193 (973)
..+..+++|+.|+|++|.....+|+ ++.+++|++|++++|.....+|..+..+++|+.|++++|.....+|..+ ++++
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~s 705 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKS 705 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCC
Confidence 7777778888888877653335553 7777777888877776555677777777777777777754333566554 6777
Q ss_pred cceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcchhhhccCCC
Q 002069 194 LSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGT 273 (973)
Q Consensus 194 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~ 273 (973)
|+.|++++|......+. ..++|+.|++++|.+..+ |..+ .+++|+.|++.++..... ...+
T Consensus 706 L~~L~Lsgc~~L~~~p~---~~~nL~~L~L~~n~i~~l-P~~~-~l~~L~~L~l~~~~~~~l-~~~~------------- 766 (1153)
T PLN03210 706 LYRLNLSGCSRLKSFPD---ISTNISWLDLDETAIEEF-PSNL-RLENLDELILCEMKSEKL-WERV------------- 766 (1153)
T ss_pred CCEEeCCCCCCcccccc---ccCCcCeeecCCCccccc-cccc-cccccccccccccchhhc-cccc-------------
Confidence 77777777654332222 235677777777776654 3333 456666666655443211 1111
Q ss_pred cccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcch
Q 002069 274 NALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIP 353 (973)
Q Consensus 274 n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 353 (973)
....+..+...++|+.|++++|.....+|..++++++|+.|++++|...+.+|..+ ++++|+.|++++|......|
T Consensus 767 ---~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p 842 (1153)
T PLN03210 767 ---QPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFP 842 (1153)
T ss_pred ---cccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccc
Confidence 11112233445789999999998777899999999999999999986555677666 78999999999986544444
Q ss_pred hccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCCCCEEEccCCC
Q 002069 354 LALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNK 419 (973)
Q Consensus 354 ~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 419 (973)
.. .++|+.|+|++|.|+ ..|.++..+++|+.|+|++|+--..+|..+..+++|+.+++++|.
T Consensus 843 ~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 843 DI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 43 468999999999998 678899999999999999954334477788899999999999985
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-24 Score=247.13 Aligned_cols=263 Identities=26% Similarity=0.343 Sum_probs=148.1
Q ss_pred EEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCc
Q 002069 4 VLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNL 83 (973)
Q Consensus 4 ~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~ 83 (973)
.|||+.++|+ .+|+++.. +|+.|++++|+++. +|.. +++|++|++++|+++ .+|.. .++|+.|++++|.
T Consensus 205 ~LdLs~~~Lt-sLP~~l~~--~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~ 273 (788)
T PRK15387 205 VLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNP 273 (788)
T ss_pred EEEcCCCCCC-cCCcchhc--CCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccCCc
Confidence 4666666665 56665542 56666666666653 4431 355555666665555 44432 2355555555555
Q ss_pred CcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCcc
Q 002069 84 LSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFS 163 (973)
Q Consensus 84 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 163 (973)
++ .+|..+ .+|+.|++++|+++ .+|.. .++|+.|+|++|+++ .+|..+
T Consensus 274 L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~-~Lp~lp----------------------- 321 (788)
T PRK15387 274 LT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLA-SLPALP----------------------- 321 (788)
T ss_pred hh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCccc-cCCCCc-----------------------
Confidence 55 344322 34555555555555 34432 244555555555554 233211
Q ss_pred ccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCcccccccccc
Q 002069 164 LGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLL 243 (973)
Q Consensus 164 l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 243 (973)
.+|+.|++++|+++ .+|.. ..+|++|+|++|+|+.++.. .++|+.|++++|+|+.+ |.. ..+|+
T Consensus 322 ----~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls~LP~l----p~~L~~L~Ls~N~L~~L-P~l---~~~L~ 385 (788)
T PRK15387 322 ----SELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLASLPTL----PSELYKLWAYNNRLTSL-PAL---PSGLK 385 (788)
T ss_pred ----ccccccccccCccc-ccccc---ccccceEecCCCccCCCCCC----CcccceehhhccccccC-ccc---ccccc
Confidence 23444455555554 23321 13556666666666644321 24556666666666654 322 24567
Q ss_pred ceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccc
Q 002069 244 ALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNA 323 (973)
Q Consensus 244 ~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 323 (973)
.|++++|+++++ |.. .++|+.|++++|+++. +|.. ..+|+.|++++|+
T Consensus 386 ~LdLs~N~Lt~L-P~l---------------------------~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~Nq 433 (788)
T PRK15387 386 ELIVSGNRLTSL-PVL---------------------------PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQ 433 (788)
T ss_pred eEEecCCcccCC-CCc---------------------------ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCc
Confidence 777777777632 210 1356777778887774 4443 2467788888888
Q ss_pred cCCCCCccccCCCCCCcEEcCCCCCCCcchhccCC
Q 002069 324 LSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGN 358 (973)
Q Consensus 324 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 358 (973)
++ .+|..+.++++|+.|+|++|.+++..+..+..
T Consensus 434 Lt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~ 467 (788)
T PRK15387 434 LT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE 467 (788)
T ss_pred cc-ccChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence 87 57778888888888888888888777666633
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=210.35 Aligned_cols=165 Identities=22% Similarity=0.222 Sum_probs=125.1
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccc
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 864 (973)
|+|.++++... ..+++.+++.++.|++.|++|||+. + ||+||+++.++.+|+ ||.++.....
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc-----
Confidence 68899987543 4689999999999999999999998 5 999999999999999 9998866442
Q ss_pred ccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHH
Q 002069 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLI 944 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (973)
...|++.|||||++.+..++.++|||||||++|||+||+.||........... ...... .+..+...........
T Consensus 63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~ 137 (176)
T smart00750 63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILE----ILLNGM-PADDPRDRSNLESVSA 137 (176)
T ss_pred cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHH----HHHHHh-ccCCccccccHHHHHh
Confidence 12688999999999999999999999999999999999999874432211111 111111 1111111111112222
Q ss_pred --HHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 945 --SIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 945 --~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+.+++.+||+.+|.+||++.++++.+.
T Consensus 138 ~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 138 ARSFADFMRVCASRLPQRREAANHYLAHCR 167 (176)
T ss_pred hhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence 5889999999999999999999998764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=242.82 Aligned_cols=264 Identities=26% Similarity=0.295 Sum_probs=187.0
Q ss_pred CCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecc
Q 002069 49 SLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLH 128 (973)
Q Consensus 49 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 128 (973)
+-..|+|++|.++ .+|+.+. .+|+.|++++|+++ .+|.. +++|++|+|++|+|+ .+|.. .++|+.|+++
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls 270 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIF 270 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeecc
Confidence 3455666666665 5665554 35666666666666 45542 356667777777766 45543 2466667777
Q ss_pred cccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeecccccccccc
Q 002069 129 MNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSI 208 (973)
Q Consensus 129 ~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 208 (973)
+|.++ .+|..+ ++|+.|++++|+++ .+|. .+++|+.|++++|++++ +|... .+|+.|++++|++++++
T Consensus 271 ~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~---~p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~LP 338 (788)
T PRK15387 271 SNPLT-HLPALP---SGLCKLWIFGNQLT-SLPV---LPPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTSLP 338 (788)
T ss_pred CCchh-hhhhch---hhcCEEECcCCccc-cccc---cccccceeECCCCcccc-CCCCc---ccccccccccCcccccc
Confidence 77766 445432 45667777777776 4443 24678888888888884 55432 46888999999998755
Q ss_pred ccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhcccc
Q 002069 209 LYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLK 288 (973)
Q Consensus 209 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~ 288 (973)
. -..+|+.|+|++|+|+++ |.. ..+|+.|++++|+|+. +|. ...
T Consensus 339 ~----lp~~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~~-LP~---------------------------l~~ 382 (788)
T PRK15387 339 T----LPSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLTS-LPA---------------------------LPS 382 (788)
T ss_pred c----cccccceEecCCCccCCC-CCC---Ccccceehhhcccccc-Ccc---------------------------ccc
Confidence 3 125899999999999976 433 3567888899998874 221 013
Q ss_pred ccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEcc
Q 002069 289 SLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLS 368 (973)
Q Consensus 289 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 368 (973)
+|+.|++++|++++ +|.. .++|+.|++++|.++. +|... .+|+.|++++|+|+ .+|..+.++++|+.|+|+
T Consensus 383 ~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 383 GLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 453 (788)
T ss_pred ccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence 67899999999985 4543 3689999999999985 56543 47889999999999 678889999999999999
Q ss_pred CCcccCCCCccc
Q 002069 369 INKLSGSIPLSF 380 (973)
Q Consensus 369 ~N~i~~~~~~~~ 380 (973)
+|++++..+..+
T Consensus 454 ~N~Ls~~~~~~L 465 (788)
T PRK15387 454 GNPLSERTLQAL 465 (788)
T ss_pred CCCCCchHHHHH
Confidence 999997666655
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-24 Score=261.13 Aligned_cols=195 Identities=17% Similarity=0.171 Sum_probs=139.3
Q ss_pred cCCC-Cceeeeceee-------eccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 002069 756 KIRH-RNIVKFYGFC-------SHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827 (973)
Q Consensus 756 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i 827 (973)
.++| +||+++++++ .+.+..+.++||+ +++|.+++... ...+++.+++.++.||++||+|||++ +|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 4455 5888888877 2224567788887 56999999643 24589999999999999999999999 99
Q ss_pred EeecCCCCCeeecC-------------------CCceEEecccccccccCCC----------------CcccccccccCc
Q 002069 828 VHRDISSKNVLLNL-------------------EYEAHVSDFGISKFLKLGL----------------SNRTELAGTFGY 872 (973)
Q Consensus 828 ~H~Dlk~~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~----------------~~~~~~~g~~~y 872 (973)
+||||||+|||++. ++.+|++|||+++...... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4456677777765422100 001123578889
Q ss_pred ccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhc
Q 002069 873 IAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSIS 952 (973)
Q Consensus 873 ~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 952 (973)
||||++.+..++.++|||||||++|||++|..|+........ ........+.. .........++.+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~-------~~~~~~~~~~~-------~~~~~~~~~~~~~ 247 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMS-------SLRHRVLPPQI-------LLNWPKEASFCLW 247 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHH-------HHHHhhcChhh-------hhcCHHHHHHHHH
Confidence 999999999999999999999999999999988653221100 00111111111 0112234577789
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 002069 953 CLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 953 cl~~dP~~RPs~~ev~~~ 970 (973)
||+++|.+||++.|+++.
T Consensus 248 ~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 248 LLHPEPSCRPSMSELLQS 265 (793)
T ss_pred hCCCChhhCcChHHHhhc
Confidence 999999999999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=204.26 Aligned_cols=248 Identities=19% Similarity=0.315 Sum_probs=188.9
Q ss_pred CCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEe
Q 002069 702 NFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEY 781 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 781 (973)
+..+.-+|.+...|+.|+|+|+ |..+++|++...... ....++|..|.-.++-+.||||.+++|.|..+.+..++..|
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhccCCCccccccccc-Ccchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 3455667999999999999995 455666777643322 22357899999999999999999999999999999999999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe-ecCCCCCeeecCCCceEEe--cccccccccC
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVH-RDISSKNVLLNLEYEAHVS--DFGISKFLKL 858 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H-~Dlk~~Nill~~~~~~kl~--Dfg~a~~~~~ 858 (973)
|+.|+|+..++... .-..+..++.+++.+||+|++|||+.. +++- --+..+.|++|++.+++|+ |--++.
T Consensus 269 mp~gslynvlhe~t-~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsf---- 341 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSF---- 341 (448)
T ss_pred ccchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeee----
Confidence 99999999998655 335677899999999999999999974 4543 3688999999999888874 322211
Q ss_pred CCCcccccccccCcccccccccCCCC---CccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVT---EKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~---~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
+.....-.|.||+||.+..++.+ .++|+|||++++||+.|...||...+.+.-.+. ..-+-++..+++.
T Consensus 342 ---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk-----ialeglrv~ippg 413 (448)
T KOG0195|consen 342 ---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK-----IALEGLRVHIPPG 413 (448)
T ss_pred ---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh-----hhhccccccCCCC
Confidence 11123346889999999877654 468999999999999999999986665433321 1223344555544
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.. ..+.+++.-|+..||.+||.+..|+-.||
T Consensus 414 is------~hm~klm~icmnedpgkrpkfdmivpile 444 (448)
T KOG0195|consen 414 IS------RHMNKLMNICMNEDPGKRPKFDMIVPILE 444 (448)
T ss_pred cc------HHHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence 33 33567888999999999999999987775
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=194.82 Aligned_cols=257 Identities=18% Similarity=0.239 Sum_probs=194.4
Q ss_pred hcCCcccccccCCCceeEEEE-EcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeeccceeEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 777 (973)
..+|.++++||+|+||.+|.| ...+|+.||||.-..... ..++..|..+...++ ...|+.+.-|..+.+...+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 468999999999999999999 556899999999654322 366788889998886 4688888888899999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC---CceEEecccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE---YEAHVSDFGISK 854 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~---~~~kl~Dfg~a~ 854 (973)
|||.. |.+|++...-.. +.++..+.+-.|-|++.-++|+|.+ +++||||||+|+|+.-+ ..+.++|||+|+
T Consensus 89 VMdLL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeecc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 99987 689999885443 5689999999999999999999999 89999999999999755 468899999999
Q ss_pred cccCCCC-------cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhh
Q 002069 855 FLKLGLS-------NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEM 927 (973)
Q Consensus 855 ~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 927 (973)
.+.+..+ ......||.+|++-....+...+.+.|+-|+|.++.++-.|..||++..... -....+...+.-
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t--k~QKyEkI~EkK 240 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT--KKQKYEKISEKK 240 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh--HHHHHHHHHHhh
Confidence 8865422 2345789999999998888888999999999999999999999998654311 111122222222
Q ss_pred cCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 928 LDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+...+...... .+.++.-.+.-|-...-++-|...-+.+.++
T Consensus 241 ~s~~ie~LC~G---~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 241 MSTPIEVLCKG---FPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred cCCCHHHHhCC---CcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 22111111111 1223344445677777777788777776654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5e-22 Score=215.59 Aligned_cols=167 Identities=19% Similarity=0.180 Sum_probs=130.1
Q ss_pred HHHhcCCcccccccCCCceeEEEEEcC--CCCEEEEEEcCCCCC--cchhhHHHHHHHHHHhhcCCCCceee-eceeeec
Q 002069 697 IRATKNFDDEHCIGNGGQGSVYKAELP--TGEIVAVKKFHSPLP--GEMACQQEFLNEGNALTKIRHRNIVK-FYGFCSH 771 (973)
Q Consensus 697 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~ 771 (973)
.....+|++.+.||+|+||+||+|.+. +++.||||+...... ......+.|.+|++++++++|+++++ ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345678999999999999999999654 577889998753211 12233567999999999999999985 4432
Q ss_pred cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecC-CCCCeeecCCCceEEecc
Q 002069 772 ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDI-SSKNVLLNLEYEAHVSDF 850 (973)
Q Consensus 772 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dl-k~~Nill~~~~~~kl~Df 850 (973)
+..++||||++|++|... ... . ...++.|+++|++|+|+. ||+|||| ||+||+++.++.+||+||
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~~------~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RPH------G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Ccc------c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 357999999999999732 110 1 146788999999999999 9999999 999999999999999999
Q ss_pred cccccccCCCCc--------ccccccccCccccccccc
Q 002069 851 GISKFLKLGLSN--------RTELAGTFGYIAPELAYT 880 (973)
Q Consensus 851 g~a~~~~~~~~~--------~~~~~g~~~y~aPE~~~~ 880 (973)
|+|+.+...... .....+++.|+|||++..
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999977554211 124567888999998754
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-22 Score=235.28 Aligned_cols=179 Identities=27% Similarity=0.432 Sum_probs=92.6
Q ss_pred cEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCC
Q 002069 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNN 82 (973)
Q Consensus 3 ~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n 82 (973)
..|++++++++ .+|..+. .+|+.|+|++|+++ .+|..+. ++|++|++++|+++ .+|..+. .+|+.|+|++|
T Consensus 181 ~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N 251 (754)
T PRK15370 181 TELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSIN 251 (754)
T ss_pred eEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCC
Confidence 35666666665 5555543 35666666666665 3454433 35666666666665 4555443 35666666666
Q ss_pred cCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCc
Q 002069 83 LLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPF 162 (973)
Q Consensus 83 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 162 (973)
+++ .+|..+. .+|++|++++|+++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|++++|.++ .+|.
T Consensus 252 ~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt-~LP~ 321 (754)
T PRK15370 252 RIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT-ALPE 321 (754)
T ss_pred ccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc-cCCc
Confidence 665 4555443 35666666666665 4555443 35566666666555 3443332 34555555555555 2332
Q ss_pred cccCccccceeeecccccCCCCCccccccCccceeeccccccc
Q 002069 163 SLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLS 205 (973)
Q Consensus 163 ~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 205 (973)
.+. ++|+.|++++|.++ .+|..+. ++|+.|++++|+++
T Consensus 322 ~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~ 359 (754)
T PRK15370 322 TLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQIT 359 (754)
T ss_pred ccc--ccceeccccCCccc-cCChhhc--CcccEEECCCCCCC
Confidence 221 34555555555554 2343332 34444444444444
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=213.80 Aligned_cols=254 Identities=20% Similarity=0.237 Sum_probs=186.3
Q ss_pred CCcccccccCCCceeEEEEEcCC--CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC----CCceeeeceee-eccce
Q 002069 702 NFDDEHCIGNGGQGSVYKAELPT--GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR----HRNIVKFYGFC-SHALH 774 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~niv~~~~~~-~~~~~ 774 (973)
+|.+.+.||+|+||.||.|.... ...+|+|.......... ..+..|..++..+. .+++..+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 79999999999999999996544 35789998765422221 25667777777775 36899999998 57778
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC-----CceEEec
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE-----YEAHVSD 849 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-----~~~kl~D 849 (973)
.|+||+.+ |.+|.++.+... ...++..++.+|+.|++.+|+++|+. |++||||||.|+.+... ..+.+.|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred eEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 89999977 789999886555 56899999999999999999999999 99999999999999865 4699999
Q ss_pred cccccccc--CCC--------CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhh
Q 002069 850 FGISKFLK--LGL--------SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSN 919 (973)
Q Consensus 850 fg~a~~~~--~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 919 (973)
||+++.+. ... .......||..|++++...+...+.+.|+||++.++.|+..|..||......... ..
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~--~~ 248 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK--SK 248 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH--HH
Confidence 99998332 111 1123456999999999999999999999999999999999999999754422110 00
Q ss_pred hhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 920 LNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
............ .....+. .+.++...+-..+...+|....+...+
T Consensus 249 ~~~~~~~~~~~~---~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l 294 (322)
T KOG1164|consen 249 FEKDPRKLLTDR---FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELL 294 (322)
T ss_pred HHHHhhhhcccc---ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHH
Confidence 011111111110 0111122 233333444457889999988887664
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-21 Score=193.41 Aligned_cols=199 Identities=20% Similarity=0.273 Sum_probs=171.0
Q ss_pred cCCcccccccCCCceeEEEEE-cCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 778 (973)
-.|.+.++||.|.||++|.|. .-+++.||||.-... ....++..|...++.+ ..++|+.+|-+..++.+..+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 469999999999999999994 458999999985432 1246788888888888 689999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC-----ceEEeccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY-----EAHVSDFGIS 853 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-----~~kl~Dfg~a 853 (973)
+|.+ |.+|+|+..-. .+.|+.+++..||.|++.-++|+|++ .+|.|||||+|+||...+ .+.++|||+|
T Consensus 103 idLL-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhh-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 9988 68998887533 35799999999999999999999999 999999999999997654 4899999999
Q ss_pred ccccCCCCc-------ccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchh
Q 002069 854 KFLKLGLSN-------RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS 910 (973)
Q Consensus 854 ~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 910 (973)
+.+.+..+. .....||.+||+-....+.+.+.+.|.-|+|-++.+.+.|..||++..
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 988765332 234679999999999999999999999999999999999999998644
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-22 Score=232.70 Aligned_cols=255 Identities=19% Similarity=0.253 Sum_probs=189.8
Q ss_pred cccccccCCCceeEEEEE-cCCCCEEEEEEcCC---CCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 704 DDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHS---PLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 704 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~---~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
...+.+|.|++|.|+.+. ......++.|.+.. +..........+..|+.+-..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 345789999999888773 33444455554431 22222222333667888888899999999888887766666669
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++ +|..++.+. ..++..++-.+++|+..|++|+|+. ||.|||+|++|++++.+|.+||+|||.+..+..+
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 999998765 2577889999999999999999999 9999999999999999999999999999877654
Q ss_pred CC----cccccccccCcccccccccCCCCCc-cchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCC
Q 002069 860 LS----NRTELAGTFGYIAPELAYTMKVTEK-CDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934 (973)
Q Consensus 860 ~~----~~~~~~g~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (973)
.+ ......|+..|+|||.+.+..|+++ .||||.|+++..|++|+.||.................. ......
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~----~~~~~~ 549 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQ----RNIFEG 549 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccc----cccccC
Confidence 33 2456789999999999999999875 79999999999999999999754322111100000000 001112
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
........+.....++.+|+++||.+|.|+++|++
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 22233344556778889999999999999999986
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-21 Score=231.30 Aligned_cols=161 Identities=27% Similarity=0.403 Sum_probs=96.5
Q ss_pred CCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeecc
Q 002069 25 HLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLS 104 (973)
Q Consensus 25 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~ 104 (973)
+.+.|++++++++ .+|..+. +.|+.|+|++|+++ .+|..+. .+|++|++++|+++ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 4567777777776 4565553 46777777777777 5666554 46777777777776 5666553 367777777
Q ss_pred CCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCC
Q 002069 105 NNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSI 184 (973)
Q Consensus 105 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~ 184 (973)
+|++. .+|..+. ++|+.|++++|+|+ .+|+.+. ++|+.|++++|+++ .+|..+. ++|+.|++++|+++ .+
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt-~L 319 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT-AL 319 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc-cC
Confidence 77776 5666554 46777777777776 4565443 35666666666666 3333322 34555555555555 23
Q ss_pred CccccccCccceeecccccccc
Q 002069 185 PNEIGNLKSLSDLRLDYNTLSG 206 (973)
Q Consensus 185 p~~~~~l~~L~~L~L~~N~l~~ 206 (973)
|..+. ++|+.|++++|.++.
T Consensus 320 P~~l~--~sL~~L~Ls~N~Lt~ 339 (754)
T PRK15370 320 PETLP--PGLKTLEAGENALTS 339 (754)
T ss_pred Ccccc--ccceeccccCCcccc
Confidence 43322 344455555554443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-23 Score=187.64 Aligned_cols=167 Identities=33% Similarity=0.543 Sum_probs=149.7
Q ss_pred ccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCcccc
Q 002069 19 EIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSL 98 (973)
Q Consensus 19 ~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 98 (973)
.+..+.+.+.|-||+|+++ ..|+.|+.|.+|+.|++.+|+|. .+|.++..+++|+.|+++-|++. .+|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 4667788999999999998 67889999999999999999999 89999999999999999999998 899999999999
Q ss_pred ceeeccCCcCC-CCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecc
Q 002069 99 SDLRLSNNSLN-GSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGI 177 (973)
Q Consensus 99 ~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~ 177 (973)
+.|||.+|++. ..+|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+..|.+- .+|..++.++.|+.|++.+
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 99999999986 358999999999999999999997 88999999999999999999987 7888889999999999999
Q ss_pred cccCCCCCcccccc
Q 002069 178 NALSGSIPNEIGNL 191 (973)
Q Consensus 178 n~l~~~~p~~~~~l 191 (973)
|+++ .+|..++++
T Consensus 183 nrl~-vlppel~~l 195 (264)
T KOG0617|consen 183 NRLT-VLPPELANL 195 (264)
T ss_pred ceee-ecChhhhhh
Confidence 9988 667666643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-19 Score=203.07 Aligned_cols=258 Identities=26% Similarity=0.366 Sum_probs=197.8
Q ss_pred CcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCC-ceeeeceeeeccceeEEEEEe
Q 002069 703 FDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR-NIVKFYGFCSHALHSFVVYEY 781 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 781 (973)
|...+.+|.|+||.||++... ..+++|.+.............+.+|+..+..+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999775 88999999876554433468899999999999988 799999999777778999999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC-ceEEecccccccccCCC
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY-EAHVSDFGISKFLKLGL 860 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~ 860 (973)
+.++++.+++........+.......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997775443212578899999999999999999999 999999999999999988 79999999998665443
Q ss_pred C------cccccccccCccccccccc---CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCC-
Q 002069 861 S------NRTELAGTFGYIAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDP- 930 (973)
Q Consensus 861 ~------~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 930 (973)
. ......|+..|+|||...+ ..+....|+||+|++++++++|..||...... ...............+
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKIILELPTPS 234 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHHhcCCcc
Confidence 2 2356789999999999987 57888999999999999999999997644321 0000001111111111
Q ss_pred ---CCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 931 ---RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 931 ---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
....... ......+.+++..|+..+|..|.++.+...
T Consensus 235 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 235 LASPLSPSNP--ELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred cccccCcccc--chhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 1111000 122345678888999999999999887654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-20 Score=189.34 Aligned_cols=173 Identities=12% Similarity=0.101 Sum_probs=136.0
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHH------HHHHHHHhhcCCCCceeeeceeeecc-
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQE------FLNEGNALTKIRHRNIVKFYGFCSHA- 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~niv~~~~~~~~~- 772 (973)
..+|...+++|.|+||.||.++. +++.+|||.+.......+..... +.+|+..+.++.|++|+.+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 57899999999999999999876 57789999998765554443333 67899999999999999998886532
Q ss_pred -------ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCce
Q 002069 773 -------LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEA 845 (973)
Q Consensus 773 -------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~ 845 (973)
...++||||++|.+|.++.. ++. ....+++.++..+|+. |++|||++|+||+++.+| +
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-E
Confidence 35789999999999988732 222 2456999999999999 999999999999999988 9
Q ss_pred EEecccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHH
Q 002069 846 HVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVI 900 (973)
Q Consensus 846 kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 900 (973)
+++|||.+...... ... ..+.....+..++|+||||+++....
T Consensus 174 ~liDfg~~~~~~e~-~a~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQR-KAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccch-hhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999988655321 111 11344455677999999999876554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-20 Score=192.28 Aligned_cols=237 Identities=18% Similarity=0.221 Sum_probs=153.4
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCC----------Cceeeeceee
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH----------RNIVKFYGFC 769 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h----------~niv~~~~~~ 769 (973)
..+...+.||.|+++.||.+.. .+++.+|||++...........+++.+|.-....+.+ -.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 3456678899999999999955 5799999999876665555556778777766555322 1222222221
Q ss_pred e------------ccc-----eeEEEEEecCCCChHHHhcc---C-ccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 002069 770 S------------HAL-----HSFVVYEYLEMGSLAMILSN---D-AAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIV 828 (973)
Q Consensus 770 ~------------~~~-----~~~lv~e~~~~~~L~~~l~~---~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~ 828 (973)
. +.. ..+++|+-+ .++|.+++.. . ..........++.+..|+++.+++||+. |++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceE
Confidence 1 111 225678877 4788877632 1 1112234455677789999999999999 999
Q ss_pred eecCCCCCeeecCCCceEEecccccccccCCCCcccccccccCcccccccccC--------CCCCccchHHHHHHHHHHH
Q 002069 829 HRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTM--------KVTEKCDVYSFGVLALEVI 900 (973)
Q Consensus 829 H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~--------~~~~~~Dv~slG~~l~el~ 900 (973)
|+||+|+|++++.+|.+.++||+.....+.... ....+..|.+||..... .++.+.|.|++|+++|.|+
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEE---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceee---ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999998776543211 13455789999976442 4788899999999999999
Q ss_pred hCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCC
Q 002069 901 KGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSR 961 (973)
Q Consensus 901 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 961 (973)
+|+.||+......... . .+..+.+.++.+..+|..+++.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~~------~-----------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPE------W-----------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSG------G-----------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccccc------c-----------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999998543211000 0 122223556678899999999999988
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5e-22 Score=180.08 Aligned_cols=160 Identities=35% Similarity=0.566 Sum_probs=150.1
Q ss_pred CcEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccC
Q 002069 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGN 81 (973)
Q Consensus 2 l~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~ 81 (973)
++.|-||+|+++ .+||.|+.|.+|+.|++++|+++ .+|.+|+.+++|+.|++.-|++. .+|..|+.++.|+.|||.+
T Consensus 35 ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlty 111 (264)
T KOG0617|consen 35 ITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTY 111 (264)
T ss_pred hhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccc
Confidence 457889999998 99999999999999999999999 68999999999999999999999 9999999999999999999
Q ss_pred CcCc-ccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCC
Q 002069 82 NLLS-GSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAI 160 (973)
Q Consensus 82 n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 160 (973)
|.+. ..+|..|..+..|+.|+|++|.++ .+|..++++++|+.|.+..|.+- .+|..++.++.|++|.+.+|+++ .+
T Consensus 112 nnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vl 188 (264)
T KOG0617|consen 112 NNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VL 188 (264)
T ss_pred cccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ec
Confidence 9986 479999999999999999999999 89999999999999999999987 79999999999999999999999 66
Q ss_pred CccccCc
Q 002069 161 PFSLGNL 167 (973)
Q Consensus 161 p~~l~~l 167 (973)
|..++++
T Consensus 189 ppel~~l 195 (264)
T KOG0617|consen 189 PPELANL 195 (264)
T ss_pred Chhhhhh
Confidence 6666554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.6e-20 Score=182.88 Aligned_cols=143 Identities=19% Similarity=0.183 Sum_probs=109.7
Q ss_pred cccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchh-----------------------hHHHHHHHHHHhhcCCCCce
Q 002069 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMA-----------------------CQQEFLNEGNALTKIRHRNI 762 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~ni 762 (973)
...||+|+||.||+|...+|+.||||+++........ .......|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999998779999999999754321111 01223458899999988777
Q ss_pred eeeceeeeccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEeecCCCCCeeecC
Q 002069 763 VKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYM-HTNCFPPIVHRDISSKNVLLNL 841 (973)
Q Consensus 763 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~Dlk~~Nill~~ 841 (973)
.....+... ..++||||++++++....... ..++..++..++.|++.+++++ |+. ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 544433222 348999999988776543222 3578899999999999999999 687 999999999999998
Q ss_pred CCceEEeccccccccc
Q 002069 842 EYEAHVSDFGISKFLK 857 (973)
Q Consensus 842 ~~~~kl~Dfg~a~~~~ 857 (973)
++.++++|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 5789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.6e-21 Score=211.69 Aligned_cols=277 Identities=27% Similarity=0.267 Sum_probs=152.9
Q ss_pred eEEccccccc-CCcCchhhcCCccceeeccccccCCC----CCccccCCCCCCcEEcCCCCCCC------cchhccCCCC
Q 002069 292 HLQLNYNTLS-GSIPLSLGSLTNLATLYFSTNALSGS----IPNEITNLRSLSDLQLSENTLNG------SIPLALGNLT 360 (973)
Q Consensus 292 ~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~------~~~~~~~~l~ 360 (973)
.|+|..+.++ ......+..+++|+.|++++|.++.. ++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4566666665 23344556666677777777776432 33344555566666666666552 1233455556
Q ss_pred CCcEEEccCCcccCCCCcccccccc---cchhccccccccc----CCCcccCCC-CCCCEEEccCCCCCCCcchhhhhhc
Q 002069 361 KLVSLDLSINKLSGSIPLSFASLTS---LTTLYLYENSLCD----SIPKEIGDM-KSLSILDLSSNKLNGSIPLSLANLT 432 (973)
Q Consensus 361 ~L~~L~Ls~N~i~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~~~ 432 (973)
+|+.|++++|.+....+..+..+.+ |++|++++|++++ .....+..+ ++|+.|++++|.+++.....+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~---- 157 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEAL---- 157 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHH----
Confidence 6666666666665444444443333 5555555555442 111222333 445555555555443222211
Q ss_pred ccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCC----CCccccccccccccccccccccccc----Ccccccc
Q 002069 433 NSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQ----LSPELGSLNQLEYLDLSANTFHNSI----PESLGNL 504 (973)
Q Consensus 433 ~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~----~~~~l~~l~~L~~L~Ls~N~i~~~~----~~~l~~l 504 (973)
...+..+++|++|++++|.+++. ++..+..+++|++|++++|.+++.. +..+..+
T Consensus 158 -----------------~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~ 220 (319)
T cd00116 158 -----------------AKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASL 220 (319)
T ss_pred -----------------HHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhccc
Confidence 11223334555556655555531 2233444456777777777765432 2334556
Q ss_pred ccccEEeecCccCCCCCCccccc-----ccccCeecccccccCCCcc----hhhcccccccccccccccccCcc----ch
Q 002069 505 VKLHYLNLSNNQFSQKIPNPIEK-----LIHLSELDLSYKIFGEEIP----SQVCSMQSLEKLNLSHNNLSGSI----SR 571 (973)
Q Consensus 505 ~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~ls~n~i~~~~~----~~~~~l~~L~~L~L~~N~l~~~~----~~ 571 (973)
++|++|++++|++++.....+.. ...|+.|++++|.|++.+. ..+..++.|+++++++|+++... .+
T Consensus 221 ~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~ 300 (319)
T cd00116 221 KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAE 300 (319)
T ss_pred CCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHH
Confidence 67777777777776533333322 3677788888877764433 33445577888888888888664 33
Q ss_pred hhhcc-ccccEEeCcCCCC
Q 002069 572 CFEEM-HWLSCIDISYNAL 589 (973)
Q Consensus 572 ~~~~l-~~L~~l~l~~N~l 589 (973)
++... +.|+++|+.+|+|
T Consensus 301 ~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 301 SLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHhhcCCchhhcccCCCCC
Confidence 34444 6788888888864
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=170.25 Aligned_cols=186 Identities=9% Similarity=0.011 Sum_probs=139.7
Q ss_pred cccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCc-chhhHHHHHHHHHHhhcCC-CCceeeeceeeeccceeEEEEEe
Q 002069 704 DDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPG-EMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHALHSFVVYEY 781 (973)
Q Consensus 704 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 781 (973)
.+...+++|+||+||.+.. .+++++.+.+.....- .......|.+|+++++++. |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999998876 7788887777643221 1112236889999999995 5889999886 346899999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecC-CCCCeeecCCCceEEecccccccccCCC
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDI-SSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dl-k~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
++|.+|...... ....++.|++.+++++|+. ||+|||| ||+||+++.++.++|+|||+|.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999998754311 1135778999999999999 9999999 7999999999999999999998655433
Q ss_pred Cc-------------ccccccccCcccccccccC-CCC-CccchHHHHHHHHHHHhCCCCCc
Q 002069 861 SN-------------RTELAGTFGYIAPELAYTM-KVT-EKCDVYSFGVLALEVIKGKHPRD 907 (973)
Q Consensus 861 ~~-------------~~~~~g~~~y~aPE~~~~~-~~~-~~~Dv~slG~~l~el~tg~~p~~ 907 (973)
.. ......++.|++|+...-- ..+ .+.+.++-|+-+|.++|++.|+-
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 10 0112357788888754321 222 56799999999999999998853
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=174.81 Aligned_cols=143 Identities=17% Similarity=0.184 Sum_probs=111.5
Q ss_pred cccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcch-----------------------hhHHHHHHHHHHhhcCCCCce
Q 002069 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEM-----------------------ACQQEFLNEGNALTKIRHRNI 762 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~h~ni 762 (973)
...||+|+||.||+|...+|+.||||++........ .....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999877899999999876532110 001234578899999999887
Q ss_pred eeeceeeeccceeEEEEEecCCCChHHH-hccCccccCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeeec
Q 002069 763 VKFYGFCSHALHSFVVYEYLEMGSLAMI-LSNDAAAEEFGWTKRMNAIKGVADALLYMHT-NCFPPIVHRDISSKNVLLN 840 (973)
Q Consensus 763 v~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~ 840 (973)
.....+... ..++||||++++++... +.. ..++..+...++.|++.++.++|+ . ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 554444333 24899999998855433 322 246778899999999999999999 7 999999999999999
Q ss_pred CCCceEEecccccccccC
Q 002069 841 LEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 841 ~~~~~kl~Dfg~a~~~~~ 858 (973)
++.++++|||+++....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 89999999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-20 Score=207.82 Aligned_cols=277 Identities=27% Similarity=0.307 Sum_probs=180.5
Q ss_pred ccCCCcccC-chhhhhhccccccceEEcccccccCC----cCchhhcCCccceeeccccccCC------CCCccccCCCC
Q 002069 269 SCLGTNALS-SSILEEIGNLKSLLHLQLNYNTLSGS----IPLSLGSLTNLATLYFSTNALSG------SIPNEITNLRS 337 (973)
Q Consensus 269 l~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~------~~~~~~~~l~~ 337 (973)
|+|..+.++ ......+..+.+|+.|+++++.++.. ++..+...+++++++++++.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 566777776 44456778888999999999998643 45556678889999999998872 23456777899
Q ss_pred CCcEEcCCCCCCCcchhccCCCCC---CcEEEccCCcccCC----CCcccccc-cccchhcccccccccC----CCcccC
Q 002069 338 LSDLQLSENTLNGSIPLALGNLTK---LVSLDLSINKLSGS----IPLSFASL-TSLTTLYLYENSLCDS----IPKEIG 405 (973)
Q Consensus 338 L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~Ls~N~i~~~----~~~~~~~l-~~L~~L~L~~N~l~~~----~~~~~~ 405 (973)
|+.|++++|.+.+..+..+..+.+ |++|++++|++++. ....+..+ ++|+.|++++|.+++. .+..+.
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~ 162 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR 162 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHH
Confidence 999999999998666666665555 99999999999842 23345566 8999999999999842 345566
Q ss_pred CCCCCCEEEccCCCCCCCcchhhhhhc---ccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCCcccccccc
Q 002069 406 DMKSLSILDLSSNKLNGSIPLSLANLT---NSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQ 482 (973)
Q Consensus 406 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~---~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~ 482 (973)
.+++|++|++++|.+++.....+.... ++|++|++++|.+++..... .+..+..+++
T Consensus 163 ~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~--------------------l~~~~~~~~~ 222 (319)
T cd00116 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASA--------------------LAETLASLKS 222 (319)
T ss_pred hCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHH--------------------HHHHhcccCC
Confidence 778999999999999854333332222 26777777777765332211 1222334445
Q ss_pred cccccccccccccccCcccc-----ccccccEEeecCccCCCC----CCcccccccccCeecccccccCCCcchhhc---
Q 002069 483 LEYLDLSANTFHNSIPESLG-----NLVKLHYLNLSNNQFSQK----IPNPIEKLIHLSELDLSYKIFGEEIPSQVC--- 550 (973)
Q Consensus 483 L~~L~Ls~N~i~~~~~~~l~-----~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~--- 550 (973)
|++|++++|.+++.....+. ..+.|++|++++|.++.. .+..+..+++|+++++++|.+++.+...+.
T Consensus 223 L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~ 302 (319)
T cd00116 223 LEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESL 302 (319)
T ss_pred CCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHH
Confidence 55555555555432222221 124566666666666521 223344445666666666666655433333
Q ss_pred -cc-ccccccccccccc
Q 002069 551 -SM-QSLEKLNLSHNNL 565 (973)
Q Consensus 551 -~l-~~L~~L~L~~N~l 565 (973)
.. +.|+.|++.+|++
T Consensus 303 ~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 303 LEPGNELESLWVKDDSF 319 (319)
T ss_pred hhcCCchhhcccCCCCC
Confidence 23 4677777777653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.6e-19 Score=203.99 Aligned_cols=245 Identities=20% Similarity=0.192 Sum_probs=176.0
Q ss_pred CCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCc-chhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPG-EMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
.|...+.+|++.|=.|.+|+.+.|. |+||++-+..+. .....++-..|++ ...++|||.+++.-+-......|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6778899999999999999987777 899998765432 2212233333444 455699999999888777777888888
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc--C
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK--L 858 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~--~ 858 (973)
|.. -+|+|.+.... -+...+..-|+.|+..|+.-+|.. ||+|||||.+|||++.=.-+.++||..-+... .
T Consensus 102 yvk-hnLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVK-HNLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHh-hhhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 885 57887775332 345666778999999999999999 99999999999999998999999998654321 1
Q ss_pred CC-Ccc----cccccccCcccccccccC----------C-CCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhh---hh
Q 002069 859 GL-SNR----TELAGTFGYIAPELAYTM----------K-VTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSL---SS 918 (973)
Q Consensus 859 ~~-~~~----~~~~g~~~y~aPE~~~~~----------~-~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~---~~ 918 (973)
+. ... .+...-..|.|||.+... . .+++.||||+||++.|+++ |++||+.-. ..+.. ..
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-L~aYr~~~~~ 253 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-LLAYRSGNAD 253 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-HHhHhccCcc
Confidence 11 111 122233469999987541 1 4678899999999999997 788887322 11111 11
Q ss_pred hhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 919 NLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..+..++++-+ ..++.++..|++.||.+|-++++.++.
T Consensus 254 ~~e~~Le~Ied--------------~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEKIED--------------VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHhCcC--------------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11112222222 146789999999999999999999876
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-18 Score=189.28 Aligned_cols=212 Identities=24% Similarity=0.427 Sum_probs=157.7
Q ss_pred hhcCCCCceeeeceeeeccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCe-EeecC
Q 002069 754 LTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI-VHRDI 832 (973)
Q Consensus 754 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i-~H~Dl 832 (973)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.|.+.... ..+++.....++++|+.|++|+|.- +| +|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 356789999999999999999999999999999999997633 4578888999999999999999998 44 99999
Q ss_pred CCCCeeecCCCceEEecccccccccCCC--CcccccccccCcccccccccCC-------CCCccchHHHHHHHHHHHhCC
Q 002069 833 SSKNVLLNLEYEAHVSDFGISKFLKLGL--SNRTELAGTFGYIAPELAYTMK-------VTEKCDVYSFGVLALEVIKGK 903 (973)
Q Consensus 833 k~~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~-------~~~~~Dv~slG~~l~el~tg~ 903 (973)
+++|.++|....+|++|||+........ .......-..-|.|||.+.... .+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999987664311 1111223456799999987631 466799999999999999999
Q ss_pred CCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 904 HPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 904 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.||+........ ...... +...-.+.+.+......+....+..++..||..+|.+||++++|-..++
T Consensus 156 ~~~~~~~~~~~~-~eii~~-~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~ 222 (484)
T KOG1023|consen 156 GPFDLRNLVEDP-DEIILR-VKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLL 222 (484)
T ss_pred CccccccccCCh-HHHHHH-HHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence 999853321111 000001 1110111111111111133346888999999999999999999987764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.7e-19 Score=192.97 Aligned_cols=227 Identities=25% Similarity=0.298 Sum_probs=172.2
Q ss_pred cccCCCceeEEEEEc----CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeeccceeEEEEEec
Q 002069 708 CIGNGGQGSVYKAEL----PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHALHSFVVYEYL 782 (973)
Q Consensus 708 ~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 782 (973)
.+|+|.||.|+.++. ..|..+|.|..+........ +.....|..++...+ ||.+|++.-.+..+...+++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~-~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD-RTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccc-ccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 379999999998732 35677888887765433322 124556777788886 999999999999999999999999
Q ss_pred CCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCc
Q 002069 783 EMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN 862 (973)
Q Consensus 783 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 862 (973)
.+|.+...+.... .+...........+|-|++++|+. +++|||+|++||+++.+|++++.|||.++..-....
T Consensus 80 rgg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 80 RGGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred ccchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 9999987765433 456667777788899999999999 999999999999999999999999999986643322
Q ss_pred ccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHH
Q 002069 863 RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDK 942 (973)
Q Consensus 863 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (973)
..||..|||||++. ....++|.||||++.+||+||-.||.. +....+.....+.+ ...
T Consensus 153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------------~~~~~Il~~~~~~p----~~l 210 (612)
T KOG0603|consen 153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------------DTMKRILKAELEMP----REL 210 (612)
T ss_pred ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------------HHHHHHhhhccCCc----hhh
Confidence 17899999999988 567889999999999999999999974 11222222122111 223
Q ss_pred HHHHHHHHhcccCCCCCCCCCH
Q 002069 943 LISIMEVSISCLDESPTSRPTM 964 (973)
Q Consensus 943 ~~~l~~li~~cl~~dP~~RPs~ 964 (973)
......++..+...+|..|--.
T Consensus 211 ~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 211 SAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hHHHHHHHHHHHhhCHHHHhcc
Confidence 3345566667777788877543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.1e-18 Score=174.01 Aligned_cols=194 Identities=22% Similarity=0.284 Sum_probs=135.4
Q ss_pred CCCceeeeceeeec---------------------------cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHH
Q 002069 758 RHRNIVKFYGFCSH---------------------------ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIK 810 (973)
Q Consensus 758 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~ 810 (973)
+|||||++.++|.+ +...|+||..++ -+|..|+-.+. .+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 69999999886632 234588998776 58888885432 45566777889
Q ss_pred HHHHHHHHHhhCCCCCeEeecCCCCCeee--cCCC--ceEEecccccccccCC------CCcccccccccCccccccccc
Q 002069 811 GVADALLYMHTNCFPPIVHRDISSKNVLL--NLEY--EAHVSDFGISKFLKLG------LSNRTELAGTFGYIAPELAYT 880 (973)
Q Consensus 811 ~i~~~l~~LH~~~~~~i~H~Dlk~~Nill--~~~~--~~kl~Dfg~a~~~~~~------~~~~~~~~g~~~y~aPE~~~~ 880 (973)
|+.+|+.|||.+ ||.|||+|.+||++ |+|+ ...++|||++-.-+.. .+......|.-.-||||+...
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999999 99999999999999 3343 4678999987432221 112234567888999999865
Q ss_pred CCC------CCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhccc
Q 002069 881 MKV------TEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCL 954 (973)
Q Consensus 881 ~~~------~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 954 (973)
.+- -.|+|.|+.|.+.||+++...||....++.-.... ..+-.-|.++.. .+..+.+++...+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-----Yqe~qLPalp~~------vpp~~rqlV~~lL 494 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-----YQESQLPALPSR------VPPVARQLVFDLL 494 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-----hhhhhCCCCccc------CChHHHHHHHHHh
Confidence 432 34799999999999999999999854332111111 111112333322 2334678889999
Q ss_pred CCCCCCCCCHHHHHHH
Q 002069 955 DESPTSRPTMQKVSQL 970 (973)
Q Consensus 955 ~~dP~~RPs~~ev~~~ 970 (973)
+.||.+|+++.-....
T Consensus 495 ~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 495 KRDPSKRVSPNIAANV 510 (598)
T ss_pred cCCccccCCccHHHhH
Confidence 9999999986544433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-17 Score=196.42 Aligned_cols=198 Identities=23% Similarity=0.205 Sum_probs=161.5
Q ss_pred HHHHhcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC---CCceeeeceeeecc
Q 002069 696 IIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR---HRNIVKFYGFCSHA 772 (973)
Q Consensus 696 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~ 772 (973)
.+...+.|.+.+.+|+|+||+||+|...+|+.||+|+-+.+..- +|.--.+++.|++ -+.|..+..++...
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W------EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW------EFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce------eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 33446789999999999999999998878999999998766443 3333344555665 34455555666667
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC-------CCce
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL-------EYEA 845 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-------~~~~ 845 (973)
+..++|+||.+.|+|.+++. ..+.++|.....++.|+++.+++||.. +||||||||+|.++.. ..-+
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred CcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence 77899999999999999997 345688999999999999999999999 9999999999999943 2458
Q ss_pred EEecccccccccC--CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCC
Q 002069 846 HVSDFGISKFLKL--GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905 (973)
Q Consensus 846 kl~Dfg~a~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p 905 (973)
+|+|||.+-.+.. +.......++|-.+-.+|+..+.++++..|.|.++.+++.|+.|++-
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999999875542 22445667889999999999999999999999999999999998764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.8e-18 Score=181.57 Aligned_cols=174 Identities=23% Similarity=0.357 Sum_probs=136.5
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
..||.|++|...+|.+|+.+.......++.....++.|++.|++| + +.+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999888878888999999999999999999 5 8999999999999999999999999998
Q ss_pred ccccCCC------CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhh
Q 002069 854 KFLKLGL------SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDE 926 (973)
Q Consensus 854 ~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 926 (973)
....... ...+..+||..||+||.+.+..|+.|+||||+|++++|+++ -..+++.. ....+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~------------~t~~d 471 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI------------ATLTD 471 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH------------Hhhhh
Confidence 8776553 12345789999999999999999999999999999999996 33333311 11223
Q ss_pred hcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHH
Q 002069 927 MLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVS 968 (973)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~ 968 (973)
+-+..+++... .+++. =+.+..++++..|.+||++.++.
T Consensus 472 ~r~g~ip~~~~--~d~p~-e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 472 IRDGIIPPEFL--QDYPE-EYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred hhcCCCChHHh--hcCcH-HHHHHHHhcCCCcccCchHHHHh
Confidence 33344442111 11111 14667799999999999666543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.6e-17 Score=161.95 Aligned_cols=138 Identities=17% Similarity=0.245 Sum_probs=105.4
Q ss_pred CcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-----CCCceeeeceeeeccc---e
Q 002069 703 FDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-----RHRNIVKFYGFCSHAL---H 774 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~ 774 (973)
+.-.+.||+|+||.||. ++.....+||++...... ..+++.+|+.+++.+ .||||++++|++.++. .
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 34457899999999996 443333479988653222 347799999999999 5799999999998763 3
Q ss_pred -eEEEEEe--cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeEeecCCCCCeeecCC----CceE
Q 002069 775 -SFVVYEY--LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADAL-LYMHTNCFPPIVHRDISSKNVLLNLE----YEAH 846 (973)
Q Consensus 775 -~~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~i~H~Dlk~~Nill~~~----~~~k 846 (973)
+.+|+|| +++++|.+++++. .+++. ..++.+++.++ +|||++ +|+||||||+||+++.. +.++
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~ 149 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPV 149 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEE
Confidence 3478999 5589999999653 24444 35677888777 999999 99999999999999743 4799
Q ss_pred Eec-ccccc
Q 002069 847 VSD-FGISK 854 (973)
Q Consensus 847 l~D-fg~a~ 854 (973)
|+| ||.+.
T Consensus 150 LiDg~G~~~ 158 (210)
T PRK10345 150 VCDNIGEST 158 (210)
T ss_pred EEECCCCcc
Confidence 999 55443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=164.98 Aligned_cols=146 Identities=18% Similarity=0.168 Sum_probs=112.4
Q ss_pred cCCcccccccCCCceeEEEEE--cCCCCEEEEEEcCCCCCcc---------------------hhhHHHHHHHHHHhhcC
Q 002069 701 KNFDDEHCIGNGGQGSVYKAE--LPTGEIVAVKKFHSPLPGE---------------------MACQQEFLNEGNALTKI 757 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~~---------------------~~~~~~~~~e~~~l~~l 757 (973)
.-|++.+.||+|+||.||+|. ..+|+.||+|++....... ......+..|+..++++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358899999999999999997 5689999999987542110 00123467899999999
Q ss_pred CCC--ceeeeceeeeccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCC-eEeecCCC
Q 002069 758 RHR--NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP-IVHRDISS 834 (973)
Q Consensus 758 ~h~--niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~Dlk~ 834 (973)
.+. .+++++++ ...++||||++++++..+.... ......+...++.|++.+++++|+. + ++|||+||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 653 34444543 2358999999998887654222 2345566789999999999999999 8 99999999
Q ss_pred CCeeecCCCceEEeccccccccc
Q 002069 835 KNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 835 ~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
+||+++ ++.++++|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 8899999999987543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.7e-16 Score=159.74 Aligned_cols=147 Identities=18% Similarity=0.156 Sum_probs=112.8
Q ss_pred HHHHhcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcch-------------------hhHHHHHHHHHHhhc
Q 002069 696 IIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEM-------------------ACQQEFLNEGNALTK 756 (973)
Q Consensus 696 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~e~~~l~~ 756 (973)
+......|.+.+.||+|+||.||+|..++|+.||||++........ .....+..|...+..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 3344445888899999999999999888899999998764321100 012236678888888
Q ss_pred CCCC--ceeeeceeeeccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCC
Q 002069 757 IRHR--NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISS 834 (973)
Q Consensus 757 l~h~--niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~ 834 (973)
+.|+ .++..++. ...++||||++++++.+.... .....++.+++.++.++|+. +++||||+|
T Consensus 90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p 153 (198)
T cd05144 90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSE 153 (198)
T ss_pred HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCc
Confidence 8776 34444442 345899999999998765421 34567889999999999998 999999999
Q ss_pred CCeeecCCCceEEecccccccccC
Q 002069 835 KNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 835 ~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
+||++++++.++++|||.+.....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.7e-16 Score=161.08 Aligned_cols=137 Identities=16% Similarity=0.287 Sum_probs=115.3
Q ss_pred ccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcc-----hhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEe
Q 002069 707 HCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGE-----MACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEY 781 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 781 (973)
+.||+|++|.||+|.+ .|+.|++|+........ ......+.+|+..+..++|++++....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 77889999876433221 11235678899999999999988887777777788999999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++|++|.+++.... + .+..++.+++.+++++|+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999985432 2 7889999999999999999 999999999999999 78999999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.7e-16 Score=156.26 Aligned_cols=133 Identities=19% Similarity=0.320 Sum_probs=108.4
Q ss_pred cccCCCceeEEEEEcCCCCEEEEEEcCCCCCc-----chhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEec
Q 002069 708 CIGNGGQGSVYKAELPTGEIVAVKKFHSPLPG-----EMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYL 782 (973)
Q Consensus 708 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 782 (973)
.||+|+||.||+|.+ ++..|++|+....... ......++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999986 6788999986543211 1122366788999999998887666655666666779999999
Q ss_pred CCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 783 EMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 783 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
+|+++.+++..... .++.+++.+++++|+. +++|||++|.||+++ ++.++++|||.++.
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988753221 7899999999999999 999999999999999 89999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.5e-16 Score=179.96 Aligned_cols=206 Identities=24% Similarity=0.328 Sum_probs=137.4
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.+|..++.|..|+||.||.++++ +.+.+|.|+ .+. ..+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq--------~lilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQ--------NLILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-ccc--------chhhhc--cccccCCccee----------------
Confidence 56888999999999999999876 567788844 211 111111 22222334333
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
|+=...++..+ +++. +++.+++|+|+. ||+|||+||+|.+++.-|++|++|||+++..-..
T Consensus 136 -----gDc~tllk~~g---~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 -----GDCATLLKNIG---PLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred -----chhhhhcccCC---CCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 22223333222 2222 238899999999 9999999999999999999999999998644221
Q ss_pred CC---------------cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhh
Q 002069 860 LS---------------NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIAL 924 (973)
Q Consensus 860 ~~---------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 924 (973)
.. ......|||.|.|||++....|...+|.|++|+++||.+-|..||.+... ++.+
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp---------eelf 267 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---------EELF 267 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH---------HHHH
Confidence 10 11235799999999999999999999999999999999999999975421 1111
Q ss_pred hhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCC
Q 002069 925 DEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRP 962 (973)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 962 (973)
..++.-.+..... ......+.++++.+.++.+|..|-
T Consensus 268 g~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 268 GQVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhc
Confidence 1111111111111 111223456778899999999985
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.9e-15 Score=175.70 Aligned_cols=141 Identities=19% Similarity=0.268 Sum_probs=113.2
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEc-CCCCCc----chhhHHHHHHHHHHhhcCCCCceeeeceeeeccce
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKF-HSPLPG----EMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH 774 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 774 (973)
...|...+.||+|+||+||+|.+... .+++|+. ...... .....+.+.+|+++++.++|++++....++..+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 44556788999999999999987544 3444432 221111 11224668899999999999999988888877777
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.++||||+++++|.+++. ....++.+++.+++|||+. +++|||+||+||++ .++.++++|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999998874 3567899999999999999 99999999999999 57899999999987
Q ss_pred cc
Q 002069 855 FL 856 (973)
Q Consensus 855 ~~ 856 (973)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 53
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=8.9e-15 Score=147.54 Aligned_cols=139 Identities=18% Similarity=0.188 Sum_probs=97.8
Q ss_pred cccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHH---------------------HHHHHHHhhcCCCC--ce
Q 002069 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQE---------------------FLNEGNALTKIRHR--NI 762 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~---------------------~~~e~~~l~~l~h~--ni 762 (973)
.+.||+|+||+||+|...+++.||||++............. ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999988789999999987543221111111 12445555555333 23
Q ss_pred eeeceeeeccceeEEEEEecCCCChHHH-hccCccccCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeeec
Q 002069 763 VKFYGFCSHALHSFVVYEYLEMGSLAMI-LSNDAAAEEFGWTKRMNAIKGVADALLYMHT-NCFPPIVHRDISSKNVLLN 840 (973)
Q Consensus 763 v~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~ 840 (973)
++.+++ ...++||||++++.+... +.... . ..++..++.+++.++.++|+ . +++|||+||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----L-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----h-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 444433 245899999998543211 11110 0 15678899999999999999 7 999999999999999
Q ss_pred CCCceEEeccccccccc
Q 002069 841 LEYEAHVSDFGISKFLK 857 (973)
Q Consensus 841 ~~~~~kl~Dfg~a~~~~ 857 (973)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 9999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.2e-16 Score=171.52 Aligned_cols=192 Identities=33% Similarity=0.519 Sum_probs=124.2
Q ss_pred EEeCCCCCCCCCCCccc--CCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccC
Q 002069 4 VLGLSFNQFSGSIPPEI--GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGN 81 (973)
Q Consensus 4 ~L~l~~~~l~~~~p~~~--~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~ 81 (973)
+|.|++-++. .+|..= ..++.-...||+.|++. ++|.++..+..|+.+.|+.|.+. .+|.+++++..|.+|||+.
T Consensus 54 ~l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~ 130 (722)
T KOG0532|consen 54 RLLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSS 130 (722)
T ss_pred ccccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhcc
Confidence 3455665665 455322 23444566777777776 56777777777777777777777 6777777777777777777
Q ss_pred CcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCC
Q 002069 82 NLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIP 161 (973)
Q Consensus 82 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 161 (973)
|+++ .+|..+..|+ |+.|-+++|+++ .+|..++.+..|..|+.+.|.+. .+|..++++.+|+.|.+..|++. .+|
T Consensus 131 NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp 205 (722)
T KOG0532|consen 131 NQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLP 205 (722)
T ss_pred chhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCC
Confidence 7776 6676666655 777777777776 67777777777777777777766 56666777777777777777666 455
Q ss_pred ccccCccccceeeecccccCCCCCccccccCccceeeccccccc
Q 002069 162 FSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLS 205 (973)
Q Consensus 162 ~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 205 (973)
..++.| .|.+||++.|+++ .+|-.|.+|+.|++|-|.+|.+.
T Consensus 206 ~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 206 EELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred HHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 555532 2555555555555 45555555555555555555555
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.55 E-value=9.3e-17 Score=172.39 Aligned_cols=176 Identities=35% Similarity=0.504 Sum_probs=165.8
Q ss_pred EEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCc
Q 002069 4 VLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNL 83 (973)
Q Consensus 4 ~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~ 83 (973)
..||+.|++. .+|.++..+..|+.|.|.+|.+. .+|..++.|..|+.|||+.|++. .+|..++.|+ |+.|-+++|+
T Consensus 79 ~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNk 154 (722)
T KOG0532|consen 79 FADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNK 154 (722)
T ss_pred hhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCc
Confidence 5799999998 99999999999999999999998 78999999999999999999999 9999999998 9999999999
Q ss_pred CcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCcc
Q 002069 84 LSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFS 163 (973)
Q Consensus 84 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 163 (973)
++ .+|+.++.+..|..||.+.|++. .+|..++++++|+.|.+..|++. .+|..+.. -.|..||+|.|+++ .+|..
T Consensus 155 l~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lDfScNkis-~iPv~ 229 (722)
T KOG0532|consen 155 LT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLDFSCNKIS-YLPVD 229 (722)
T ss_pred cc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-CceeeeecccCcee-ecchh
Confidence 99 89999999999999999999999 79999999999999999999998 78998884 46889999999999 89999
Q ss_pred ccCccccceeeecccccCCCCCcccc
Q 002069 164 LGNLTNLVTLYIGINALSGSIPNEIG 189 (973)
Q Consensus 164 l~~l~~L~~L~l~~n~l~~~~p~~~~ 189 (973)
|.+|+.|++|-|.+|.+. ..|..+.
T Consensus 230 fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 230 FRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred hhhhhhheeeeeccCCCC-CChHHHH
Confidence 999999999999999999 6776665
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.1e-14 Score=136.84 Aligned_cols=135 Identities=16% Similarity=0.141 Sum_probs=113.6
Q ss_pred ccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCC--CceeeeceeeeccceeEEEEEec
Q 002069 705 DEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH--RNIVKFYGFCSHALHSFVVYEYL 782 (973)
Q Consensus 705 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~ 782 (973)
+.+.+|+|.++.||++...+ +.+++|....... ...+..|+..+..++| ..+++++++...++..+++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 45789999999999998744 7899999865422 3678889999999976 58999999888878899999999
Q ss_pred CCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 783 EMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 783 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
+++.+..+ +......++.+++.+++++|.....+++|+|++|+||+++..+.++++|||.+..
T Consensus 76 ~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 98777643 4567778899999999999996434799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.6e-14 Score=164.00 Aligned_cols=200 Identities=38% Similarity=0.516 Sum_probs=130.0
Q ss_pred eeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCcc-ccceeeccCCcCCCCCCCccccCCccceeecccc
Q 002069 52 GLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLK-SLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMN 130 (973)
Q Consensus 52 ~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 130 (973)
.+++..|++. ..+..+..++.++.|++.+|.++ .+|...+.+. +|+.|++++|++. .+|..++.+++|+.|+++.|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4666666664 33444555666777777777776 5666666663 6777777777776 56566677777777777777
Q ss_pred cccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeecccccccccccc
Q 002069 131 ALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILY 210 (973)
Q Consensus 131 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 210 (973)
+++ .+|...+.+++|+.|++++|+++ .+|.....+.+|++|++++|.+. ..+..+.++.++..+.+.+|++... +.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-PE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec-cc
Confidence 776 56665556677777777777776 55555555566777777777544 3556666777777777777776632 45
Q ss_pred ccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCccc
Q 002069 211 SFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSF 260 (973)
Q Consensus 211 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 260 (973)
.++.++++++|++++|.++.+.+ ++.+.+++.|++++|.++...+...
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred hhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence 56666777777777777776533 6677777777777777765555433
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.9e-14 Score=144.41 Aligned_cols=139 Identities=13% Similarity=0.179 Sum_probs=106.8
Q ss_pred ccccc-CCCceeEEEEEcCCCCEEEEEEcCCCCC----------cchhhHHHHHHHHHHhhcCCCCce--eeeceeeecc
Q 002069 706 EHCIG-NGGQGSVYKAELPTGEIVAVKKFHSPLP----------GEMACQQEFLNEGNALTKIRHRNI--VKFYGFCSHA 772 (973)
Q Consensus 706 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~ 772 (973)
...|| .||.|+||.++. .+..++||++..... ........+.+|+.++..++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 899999999987 478899998854211 011234678889999999988775 6677664332
Q ss_pred c----eeEEEEEecCC-CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEE
Q 002069 773 L----HSFVVYEYLEM-GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV 847 (973)
Q Consensus 773 ~----~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl 847 (973)
. ..++||||+++ .+|.+++... +++.. .+.+++.++++||+. ||+||||||.||+++.++.+++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 6899888542 23333 357899999999999 9999999999999999999999
Q ss_pred ecccccccc
Q 002069 848 SDFGISKFL 856 (973)
Q Consensus 848 ~Dfg~a~~~ 856 (973)
+|||.++..
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.8e-15 Score=174.35 Aligned_cols=255 Identities=20% Similarity=0.243 Sum_probs=186.6
Q ss_pred hcCCcccccccCCCceeEEEEEcC--CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeeccceeE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP--TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 776 (973)
...|.+.+.||+|+|+.|-.+... ....+|+|.+.... ......+....|..+-+.+. |+|++.+++...+++..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 356788888999999999888543 34567777766543 22333455556777777775 999999999999999999
Q ss_pred EEEEecCCCChHHHh-ccCccccCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEeecCCCCCeeecCCC-ceEEeccccc
Q 002069 777 VVYEYLEMGSLAMIL-SNDAAAEEFGWTKRMNAIKGVADALLYMH-TNCFPPIVHRDISSKNVLLNLEY-EAHVSDFGIS 853 (973)
Q Consensus 777 lv~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H~Dlk~~Nill~~~~-~~kl~Dfg~a 853 (973)
++.+|..++++.+.+ +... ...+.......+.|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||.|
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred cccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhh
Confidence 999999999998887 3222 13456677888999999999999 76 999999999999999999 9999999999
Q ss_pred ccccC-CCC--ccccccc-ccCcccccccccCC-CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhc
Q 002069 854 KFLKL-GLS--NRTELAG-TFGYIAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML 928 (973)
Q Consensus 854 ~~~~~-~~~--~~~~~~g-~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 928 (973)
..+.. ... ......| ++.|+|||...+.. ..+..|+||.|+++..+++|..||+......... ..++
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~--------~~~~ 244 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY--------SSWK 244 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc--------eeec
Confidence 88776 221 2334567 99999999988854 4567899999999999999999998544321110 0111
Q ss_pred CCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHH
Q 002069 929 DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVS 968 (973)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~ 968 (973)
..+-......+........++..+++..+|..|.+.+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 245 SNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ccccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 1110000111112222345667788989999999988764
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2e-14 Score=163.31 Aligned_cols=202 Identities=36% Similarity=0.486 Sum_probs=167.3
Q ss_pred EEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCC-CCcEEEccCCcCcccCCccccCccccceeeccCC
Q 002069 28 LLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLT-SLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNN 106 (973)
Q Consensus 28 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n 106 (973)
.|+++.|.+.. .+..+..++.++.|++.+|.++ .+|...+.+. +|++|++++|++. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 68888888752 3445677788999999999998 7888888885 8999999999998 77778888999999999999
Q ss_pred cCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCc
Q 002069 107 SLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPN 186 (973)
Q Consensus 107 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~ 186 (973)
+++ .+|...+.+++|+.|++++|+++ .+|..+..+..|++|.+++|++. ..+..+..+.++..|.+.+|++. .++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 998 77777778889999999999998 78887777888999999999654 56677888889999999999888 4578
Q ss_pred cccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccc
Q 002069 187 EIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGN 238 (973)
Q Consensus 187 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 238 (973)
.++.+++++.|++++|+++.+.. ++.+.+++.|++++|.+....+.....
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~~ 299 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIALL 299 (394)
T ss_pred hhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhcc
Confidence 88889999999999999987665 888999999999999998776554443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=5.4e-16 Score=157.82 Aligned_cols=248 Identities=28% Similarity=0.343 Sum_probs=151.7
Q ss_pred hhhcCCccceeeccccccCCC----CCccccCCCCCCcEEcCCCC---CCCcchh-------ccCCCCCCcEEEccCCcc
Q 002069 307 SLGSLTNLATLYFSTNALSGS----IPNEITNLRSLSDLQLSENT---LNGSIPL-------ALGNLTKLVSLDLSINKL 372 (973)
Q Consensus 307 ~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~---l~~~~~~-------~~~~l~~L~~L~Ls~N~i 372 (973)
....+..++.++||+|.+... +...+.+.++|+..++++=. +...+|. ++.++++|++||||+|.+
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~ 104 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAF 104 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecccccc
Confidence 344566777888888877642 33445556677777766532 1122222 334556677777777776
Q ss_pred cCCCCcccc----cccccchhcccccccccCCCcccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccc
Q 002069 373 SGSIPLSFA----SLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGE 448 (973)
Q Consensus 373 ~~~~~~~~~----~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~ 448 (973)
....+..|. ++..|++|+|.+|.+.......++. .|..|. .|+.
T Consensus 105 G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk---------------------------- 152 (382)
T KOG1909|consen 105 GPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKK---------------------------- 152 (382)
T ss_pred CccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhc----------------------------
Confidence 654444432 3455666666665553221111111 111111 1111
Q ss_pred cCCCCCCCcccceeeccCCccCC----CCCcccccccccccccccccccccc----cCccccccccccEEeecCccCCCC
Q 002069 449 IPLGHGKFSSLIQLILNNNELSG----QLSPELGSLNQLEYLDLSANTFHNS----IPESLGNLVKLHYLNLSNNQFSQK 520 (973)
Q Consensus 449 ~~~~~~~~~~L~~L~l~~N~l~~----~~~~~l~~l~~L~~L~Ls~N~i~~~----~~~~l~~l~~L~~L~L~~N~l~~~ 520 (973)
.+.-++|+.+..++|++.. .++..|...+.|+.+.++.|.|... ....|..++.|+.|||.+|-|+..
T Consensus 153 ----~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~e 228 (382)
T KOG1909|consen 153 ----AASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLE 228 (382)
T ss_pred ----cCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhH
Confidence 1122344555555555433 2345666777888888888888632 334567788888888888888754
Q ss_pred ----CCcccccccccCeecccccccCCCcchhhc-----ccccccccccccccccCc----cchhhhccccccEEeCcCC
Q 002069 521 ----IPNPIEKLIHLSELDLSYKIFGEEIPSQVC-----SMQSLEKLNLSHNNLSGS----ISRCFEEMHWLSCIDISYN 587 (973)
Q Consensus 521 ----~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~-----~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~l~l~~N 587 (973)
..+.++.+++|++|++++|.+.+.+...|. ..|+|+.|.|.+|.++-. ...+....+.|..|+|++|
T Consensus 229 gs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN 308 (382)
T KOG1909|consen 229 GSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGN 308 (382)
T ss_pred HHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcc
Confidence 335667778888888888888888877665 367899999999998743 3455666788999999999
Q ss_pred CCC
Q 002069 588 ALQ 590 (973)
Q Consensus 588 ~l~ 590 (973)
++.
T Consensus 309 ~l~ 311 (382)
T KOG1909|consen 309 RLG 311 (382)
T ss_pred ccc
Confidence 885
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=8e-15 Score=149.39 Aligned_cols=255 Identities=26% Similarity=0.244 Sum_probs=178.6
Q ss_pred hhhhccccccceEEcccccccCC----cCchhhcCCccceeecccccc---CCCCCc-------cccCCCCCCcEEcCCC
Q 002069 281 LEEIGNLKSLLHLQLNYNTLSGS----IPLSLGSLTNLATLYFSTNAL---SGSIPN-------EITNLRSLSDLQLSEN 346 (973)
Q Consensus 281 ~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l---~~~~~~-------~~~~l~~L~~L~L~~N 346 (973)
.+....+.+++.++|++|.+... +...+...++|+..++++--. ...+|. ++..++.|+.|+||+|
T Consensus 23 ~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDN 102 (382)
T KOG1909|consen 23 EEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDN 102 (382)
T ss_pred HHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecccc
Confidence 45667889999999999998642 344566788999999986322 123343 3455779999999999
Q ss_pred CCCCcchh----ccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCCCCEEEccCCCCCC
Q 002069 347 TLNGSIPL----ALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNG 422 (973)
Q Consensus 347 ~l~~~~~~----~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 422 (973)
.+.-..+. .+..+..|+.|.|.+|.+.......++ ..|..|. .|+. .++-++|+++..++|++..
T Consensus 103 A~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~--~al~~l~--~~kk-------~~~~~~Lrv~i~~rNrlen 171 (382)
T KOG1909|consen 103 AFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLG--RALFELA--VNKK-------AASKPKLRVFICGRNRLEN 171 (382)
T ss_pred ccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHH--HHHHHHH--HHhc-------cCCCcceEEEEeecccccc
Confidence 99754443 356789999999999998743333333 3456655 2322 2334789999999999986
Q ss_pred Ccchhhhhhc---ccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCCcccccccccccccccccccccc---
Q 002069 423 SIPLSLANLT---NSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNS--- 496 (973)
Q Consensus 423 ~~~~~~~~~~---~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~--- 496 (973)
.....+.... +.|+.+.++.|.|...... .+..+|..++.|+.|||.+|.++..
T Consensus 172 ~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~--------------------al~eal~~~~~LevLdl~DNtft~egs~ 231 (382)
T KOG1909|consen 172 GGATALAEAFQSHPTLEEVRLSQNGIRPEGVT--------------------ALAEALEHCPHLEVLDLRDNTFTLEGSV 231 (382)
T ss_pred ccHHHHHHHHHhccccceEEEecccccCchhH--------------------HHHHHHHhCCcceeeecccchhhhHHHH
Confidence 5554444332 4566667766666532211 3445677788888888888888742
Q ss_pred -cCccccccccccEEeecCccCCCCCCcccc-----cccccCeecccccccCCCcch----hhccccccccccccccccc
Q 002069 497 -IPESLGNLVKLHYLNLSNNQFSQKIPNPIE-----KLIHLSELDLSYKIFGEEIPS----QVCSMQSLEKLNLSHNNLS 566 (973)
Q Consensus 497 -~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~ls~n~i~~~~~~----~~~~l~~L~~L~L~~N~l~ 566 (973)
+.+.+..++.|+.|++++|.+...+..+|. ..+.|++|++.+|.|+..... .+...|.|.+|+|++|.+.
T Consensus 232 ~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 232 ALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 455667778889999999988877665442 357889999999998855443 3446789999999999994
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=2e-12 Score=146.16 Aligned_cols=144 Identities=19% Similarity=0.230 Sum_probs=100.2
Q ss_pred cccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchh-------------------------------------hHHHHH
Q 002069 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMA-------------------------------------CQQEFL 748 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-------------------------------------~~~~~~ 748 (973)
.+.||+|++|.||+|+.++|+.||||+.+........ ..-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3689999999999999999999999998654211100 001244
Q ss_pred HHHHHhhcC----C-CCceeeeceeeeccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHH-HHHHHhhC
Q 002069 749 NEGNALTKI----R-HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVAD-ALLYMHTN 822 (973)
Q Consensus 749 ~e~~~l~~l----~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~-~l~~LH~~ 822 (973)
+|+..+.++ + ++++.-..-|.......++||||++|+++.++...... .. ....++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 555555554 2 33332222222234457899999999999887643211 11 23456666666 46788988
Q ss_pred CCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 823 CFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 823 ~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
|++|+|++|.||+++.+++++++|||++..+.
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999987664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=5.8e-13 Score=157.77 Aligned_cols=117 Identities=32% Similarity=0.490 Sum_probs=65.2
Q ss_pred ccEEeecCccCCCCCCcccccccccCeecccccccCCCcchhhcccccccccccccccccCccchhhhccccccEEeCcC
Q 002069 507 LHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISY 586 (973)
Q Consensus 507 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~ 586 (973)
++.|+|++|.+++.+|..+..+.+|+.|+|++|.+.+.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|++++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 44455555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred CCCCCCCCCCc--cCCCCCcchhcCCCCccCCCccCCCCc
Q 002069 587 NALQGLIPNST--AFRDAPMLALQGNKRLCGDIKRLPPCK 624 (973)
Q Consensus 587 N~l~~~~~~~~--~~~~~~~~~~~~N~~~c~~~~~l~~~~ 624 (973)
|+++|..|... .+.....+.+.+|+.+|+.+ .+++|.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p-~l~~C~ 538 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP-GLRACG 538 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCC-CCCCCc
Confidence 55555554421 11233456788999999854 456774
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.2e-12 Score=144.69 Aligned_cols=249 Identities=24% Similarity=0.272 Sum_probs=180.6
Q ss_pred cCCcccccccC--CCceeEEEEEc---CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccce
Q 002069 701 KNFDDEHCIGN--GGQGSVYKAEL---PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALH 774 (973)
Q Consensus 701 ~~~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 774 (973)
..|...+.+|. |.+|.||.+.. .++..+|+|+-+.+...... ...=.+|+...+.+ .|++.++.+..+...+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-SKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-cccccchhhcccccCccccccccCcccccCCc
Confidence 35667788999 99999999965 47889999986554332211 22234566666666 59999999999999999
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHH----HHHHHhhCCCCCeEeecCCCCCeeecCC-CceEEec
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVAD----ALLYMHTNCFPPIVHRDISSKNVLLNLE-YEAHVSD 849 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl~D 849 (973)
.++-+|++. .++.++.+... ..++....+.+..+..+ |+.++|+. .++|.|+||.||+...+ ..++++|
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred ceeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 999999885 77877765433 23667788888888888 99999999 99999999999999999 8899999
Q ss_pred ccccccccCCCCccc-----ccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhh
Q 002069 850 FGISKFLKLGLSNRT-----ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIAL 924 (973)
Q Consensus 850 fg~a~~~~~~~~~~~-----~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 924 (973)
||....+..+.-... ...|...|++||...+ -++..+|+|++|.+..+..+|.+++..... ..+
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~----------~~W 335 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN----------SSW 335 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC----------CCc
Confidence 999988876542211 2267888999998765 478899999999999999998877542100 000
Q ss_pred hhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 925 DEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
.+.-...++.+ .......++...+..|++.+|..|++++.+..
T Consensus 336 ~~~r~~~ip~e--~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 SQLRQGYIPLE--FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccccccCchh--hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00000011111 11122334555788999999999999988764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.5e-12 Score=131.38 Aligned_cols=199 Identities=21% Similarity=0.296 Sum_probs=137.8
Q ss_pred hhcCCCCceeeeceeeecc-----ceeEEEEEecCCCChHHHhccCcc-ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 002069 754 LTKIRHRNIVKFYGFCSHA-----LHSFVVYEYLEMGSLAMILSNDAA-AEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827 (973)
Q Consensus 754 l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i 827 (973)
+-++.|.|+|+++.|+.+. ....++.|||..|++..++++-.. ...+......+++.||..||.|||+- .|.|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence 4456799999999998653 346789999999999999976443 23567778889999999999999995 5689
Q ss_pred EeecCCCCCeeecCCCceEEecccccccccCC-----CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhC
Q 002069 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLG-----LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKG 902 (973)
Q Consensus 828 ~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg 902 (973)
+|+++..+-|++..+|-+|++- +.-....+. ........+-++|.|||+-.....+.++|||+||+...||.-|
T Consensus 200 ihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999999888742 111111110 0111223467899999987777778899999999999999877
Q ss_pred CCCCc-chhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 903 KHPRD-FISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 903 ~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..--. .... ...++.....+.. ..+.. -++++.+|++..|..||+|.+++.+
T Consensus 279 Eiq~tnseS~------~~~ee~ia~~i~~-----len~l-----qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 279 EIQSTNSESK------VEVEENIANVIIG-----LENGL-----QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eeccCCCcce------eehhhhhhhheee-----ccCcc-----ccCcCcccccCCCCCCcchhhhhcC
Confidence 65421 1110 0001111111110 00001 1356779999999999999988653
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.27 E-value=8.4e-13 Score=138.34 Aligned_cols=185 Identities=28% Similarity=0.276 Sum_probs=99.8
Q ss_pred CCCCCCcEEcCCCCCCCcch-hccCCCCCCcEEEccCCcccCCCC--cccccccccchhcccccccccCCCccc-CCCCC
Q 002069 334 NLRSLSDLQLSENTLNGSIP-LALGNLTKLVSLDLSINKLSGSIP--LSFASLTSLTTLYLYENSLCDSIPKEI-GDMKS 409 (973)
Q Consensus 334 ~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~ 409 (973)
++.+|+...|++..+..... .....|++++.||||+|-+....+ .....+++|+.|+|+.|++........ ..++.
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 45556666666665542211 244556677777777776663322 223456677777777776643221111 13566
Q ss_pred CCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCC-Ccccccccccccccc
Q 002069 410 LSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQL-SPELGSLNQLEYLDL 488 (973)
Q Consensus 410 L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~-~~~l~~l~~L~~L~L 488 (973)
|+.|.|+.|.++...-..+....|+|+.|+|+.|...........-+..|++|||++|.+-+.. ....+.++.|+.|++
T Consensus 199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnl 278 (505)
T KOG3207|consen 199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNL 278 (505)
T ss_pred hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhc
Confidence 7777777777775444444444566777777777432233333344455666666666654321 133455666666666
Q ss_pred cccccccc-cCcc-----ccccccccEEeecCccCC
Q 002069 489 SANTFHNS-IPES-----LGNLVKLHYLNLSNNQFS 518 (973)
Q Consensus 489 s~N~i~~~-~~~~-----l~~l~~L~~L~L~~N~l~ 518 (973)
+.|.|... .|+. ...+++|++|+++.|+|.
T Consensus 279 s~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 279 SSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred cccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 66666532 2222 233456666666666664
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.9e-11 Score=139.32 Aligned_cols=147 Identities=14% Similarity=0.160 Sum_probs=93.9
Q ss_pred hcCCcccccccCCCceeEEEEEcCC-CCEEEEEEcCCCCCcc-------------------------------hhhHH--
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPT-GEIVAVKKFHSPLPGE-------------------------------MACQQ-- 745 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~-------------------------------~~~~~-- 745 (973)
...|+. +.+|+|++|.||+|+.++ |+.||||+.+...... .+..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345766 799999999999998876 9999999987542110 01111
Q ss_pred ----HHHHHHHHhhcC----CCCceeeeceeee-ccceeEEEEEecCCCChHHHh--ccCc-cccCCCHHHHHHHHHHHH
Q 002069 746 ----EFLNEGNALTKI----RHRNIVKFYGFCS-HALHSFVVYEYLEMGSLAMIL--SNDA-AAEEFGWTKRMNAIKGVA 813 (973)
Q Consensus 746 ----~~~~e~~~l~~l----~h~niv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l--~~~~-~~~~~~~~~~~~i~~~i~ 813 (973)
+|.+|+..+.++ .+...+.+-.++. .....++||||++|+.+.++- ...+ ....+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 234444444443 2333333333332 244568999999999998752 2211 11122222233333333
Q ss_pred HHHHHHhhCCCCCeEeecCCCCCeeecCCC----ceEEeccccccccc
Q 002069 814 DALLYMHTNCFPPIVHRDISSKNVLLNLEY----EAHVSDFGISKFLK 857 (973)
Q Consensus 814 ~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~----~~kl~Dfg~a~~~~ 857 (973)
... |++|+|++|.||+++.++ +++++|||++....
T Consensus 277 ------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 345 999999999999999988 99999999987664
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=9.6e-13 Score=149.41 Aligned_cols=197 Identities=34% Similarity=0.348 Sum_probs=136.2
Q ss_pred cCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccce
Q 002069 45 GRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVT 124 (973)
Q Consensus 45 ~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 124 (973)
..+..++.+++..|.+. .+-..+..+++|++|++.+|++. .+...+..+++|++|++++|+|+.. ..+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--cchhhccchhh
Confidence 45677777778888877 43445777888888888888887 4544477788888888888888743 35677777888
Q ss_pred eecccccccccCcccccccCCCCceecccCCCCCCCC-ccccCccccceeeecccccCCCCCccccccCccceeeccccc
Q 002069 125 LYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIP-FSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNT 203 (973)
Q Consensus 125 L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 203 (973)
|++++|.|+ -...+..++.|+.+++++|+++...+ . ...+.+++.+++++|.+.. ...+..+..+..+++..|.
T Consensus 145 L~l~~N~i~--~~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLIS--DISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcch--hccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhccccc
Confidence 888888886 23456667888888888888875444 2 5677788888888888772 3445555666666777777
Q ss_pred cccccccccCCCCc--ccEEecCCcccCCCCCccccccccccceeccccccc
Q 002069 204 LSGSILYSFGNLTK--LEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLS 253 (973)
Q Consensus 204 l~~~~~~~~~~l~~--L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (973)
++.+.. +..+.. |+.+++++|.+... +..+..+..+..|++.+|++.
T Consensus 220 i~~~~~--l~~~~~~~L~~l~l~~n~i~~~-~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 220 ISKLEG--LNELVMLHLRELYLSGNRISRS-PEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred ceeccC--cccchhHHHHHHhcccCccccc-cccccccccccccchhhcccc
Confidence 774332 223333 77778888877654 255666777777777777775
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.2e-12 Score=137.11 Aligned_cols=220 Identities=26% Similarity=0.232 Sum_probs=132.9
Q ss_pred CCCCCCcEEEccCCcccCCCC-cccccccccchhcccccccccC--CCcccCCCCCCCEEEccCCCCCCCcchhhhhhcc
Q 002069 357 GNLTKLVSLDLSINKLSGSIP-LSFASLTSLTTLYLYENSLCDS--IPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTN 433 (973)
Q Consensus 357 ~~l~~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 433 (973)
.++.+|+...|.+..+..... .....|++++.|||+.|-+... .......+++|+.|+|+.|++............+
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 467789999998888873322 3556788999999999977642 3344567889999999999887443333334445
Q ss_pred cceEEEeeCcccccc-cCCCCCCCcccceeeccCCccCCCCCccccccccccccccccccccccc-CccccccccccEEe
Q 002069 434 SLKVLYLSSNHIVGE-IPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSI-PESLGNLVKLHYLN 511 (973)
Q Consensus 434 ~L~~L~L~~n~l~~~-~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~-~~~l~~l~~L~~L~ 511 (973)
.|+.|.|+.|.++.. +......+|+|+.|+|..|.....-.....-++.|+.|||++|.+.+.. -...+.++.|+.|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 788888888887732 2223345677777777777532233333444667777777777775321 12345667777777
Q ss_pred ecCccCCCCCCcccccccccCeecccccccCCCcchhhcccccccccccccccccCcc-chhhhccccccEEeCcCCCCC
Q 002069 512 LSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSI-SRCFEEMHWLSCIDISYNALQ 590 (973)
Q Consensus 512 L~~N~l~~~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~l~l~~N~l~ 590 (973)
++.|.++..---... .-.-....++|++|+++.|++.... -+.+..+++|+.|....|.+.
T Consensus 278 ls~tgi~si~~~d~~------------------s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVE------------------SLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred ccccCcchhcCCCcc------------------chhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 777776532100000 0000113456666666666664332 234445566666666677666
Q ss_pred CCCC
Q 002069 591 GLIP 594 (973)
Q Consensus 591 ~~~~ 594 (973)
....
T Consensus 340 ~e~~ 343 (505)
T KOG3207|consen 340 KETD 343 (505)
T ss_pred cccc
Confidence 5443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.5e-12 Score=146.05 Aligned_cols=246 Identities=29% Similarity=0.319 Sum_probs=173.3
Q ss_pred CCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccce
Q 002069 21 GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSD 100 (973)
Q Consensus 21 ~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 100 (973)
..++.++.++++.|.+.. +-..+..+++|+.|++++|+|. .+...+..+++|++|++++|+|+.. ..+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--cchhhccchhh
Confidence 456777788888888874 2344778888888888888888 4544477888888888888888733 35677778888
Q ss_pred eeccCCcCCCCCCCccccCCccceeecccccccccCccc-ccccCCCCceecccCCCCCCCCccccCccccceeeecccc
Q 002069 101 LRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDE-IGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINA 179 (973)
Q Consensus 101 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~ 179 (973)
|++++|.|+. + ..+..+++|+.+++++|++....+ . ...+.+++.+++.+|.+.. ...+..+..+..+++..|+
T Consensus 145 L~l~~N~i~~-~-~~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLISD-I-SGLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcchh-c-cCCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchhc--ccchHHHHHHHHhhccccc
Confidence 8888888873 3 456678888888888888874333 2 5778888888888888853 3445566667777888888
Q ss_pred cCCCCCccccccCc--cceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccC---
Q 002069 180 LSGSIPNEIGNLKS--LSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSG--- 254 (973)
Q Consensus 180 l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~--- 254 (973)
++..- .+..+.. |+.+++++|++.... ..+..+..+..|++.+|++... ..+.....+..+.+..|++..
T Consensus 220 i~~~~--~l~~~~~~~L~~l~l~~n~i~~~~-~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 294 (414)
T KOG0531|consen 220 ISKLE--GLNELVMLHLRELYLSGNRISRSP-EGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEA 294 (414)
T ss_pred ceecc--CcccchhHHHHHHhcccCcccccc-ccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhh
Confidence 77332 2223333 788888888887432 5677788888888888888765 446666777788888887752
Q ss_pred CCCcc-cCCcchhhhccCCCcccCchh
Q 002069 255 SIPCS-FGNLTKLVISCLGTNALSSSI 280 (973)
Q Consensus 255 ~~~~~-~~~l~~L~~l~l~~n~i~~~~ 280 (973)
..... .+....+....+..|.+....
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
T KOG0531|consen 295 ISQEYITSAAPTLVTLTLELNPIRKIS 321 (414)
T ss_pred hhccccccccccccccccccCcccccc
Confidence 12222 445666777777777665543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=4.6e-11 Score=141.72 Aligned_cols=112 Identities=29% Similarity=0.420 Sum_probs=93.7
Q ss_pred ccccccccccccccccCccccccccccEEeecCccCCCCCCcccccccccCeecccccccCCCcchhhcccccccccccc
Q 002069 482 QLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLS 561 (973)
Q Consensus 482 ~L~~L~Ls~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~ 561 (973)
.++.|+|++|.+++.+|..+..+++|+.|+|++|.+++.+|..+..+.+|+.|||++|.+.+.+|..++.+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47788888888888888888888888888888888888888888888888888888888888888888889999999999
Q ss_pred cccccCccchhhhcc-ccccEEeCcCCCCCCCC
Q 002069 562 HNNLSGSISRCFEEM-HWLSCIDISYNALQGLI 593 (973)
Q Consensus 562 ~N~l~~~~~~~~~~l-~~L~~l~l~~N~l~~~~ 593 (973)
+|++++..|..+..+ ..+..+++++|...+-.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~ 531 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGI 531 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCC
Confidence 999998888877664 45678899999765543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.6e-10 Score=127.13 Aligned_cols=168 Identities=17% Similarity=0.192 Sum_probs=127.2
Q ss_pred EcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecCCCChHHHhccCccccCC
Q 002069 721 ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEF 800 (973)
Q Consensus 721 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 800 (973)
+..++.+|.|+.++.... .......+.+..++.++||+|+++++.++.++..|+|+|-+. .|..++++..
T Consensus 33 ~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----- 102 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----- 102 (690)
T ss_pred eeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----
Confidence 445788888888876533 334567778889999999999999999999999999999884 6777775433
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCcccccccccCccccccccc
Q 002069 801 GWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYT 880 (973)
Q Consensus 801 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~ 880 (973)
.....-.++||+.||.+||+.+ +++|++|...-|++++.|+.||++|..+.....-........---.|..|+.+..
T Consensus 103 -~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 103 -KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence 4455556889999999999886 8999999999999999999999999987654332211111222234566665433
Q ss_pred CCCCCccchHHHHHHHHHHHhCC
Q 002069 881 MKVTEKCDVYSFGVLALEVIKGK 903 (973)
Q Consensus 881 ~~~~~~~Dv~slG~~l~el~tg~ 903 (973)
.. -..|.|-||+++||++.|.
T Consensus 180 s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCcc
Confidence 22 3459999999999999983
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.2e-11 Score=119.60 Aligned_cols=136 Identities=29% Similarity=0.370 Sum_probs=41.5
Q ss_pred CCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCcc-CCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCc
Q 002069 7 LSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIG-RLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLS 85 (973)
Q Consensus 7 l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~-~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~ 85 (973)
|..+.++ ..|. +.+..++++|+|++|+|+.. +.++ .+.+|+.|+|++|+|+ .++ .+..++.|++|++++|+++
T Consensus 4 lt~~~i~-~~~~-~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~ 77 (175)
T PF14580_consen 4 LTANMIE-QIAQ-YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS 77 (175)
T ss_dssp ------------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---
T ss_pred ccccccc-cccc-cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC
Confidence 4444554 3333 44555678888888888743 3465 4777888888888887 454 4777788888888888887
Q ss_pred ccCCccc-cCccccceeeccCCcCCCCC-CCccccCCccceeecccccccccCcc----cccccCCCCcee
Q 002069 86 GSIPNEV-GSLKSLSDLRLSNNSLNGSI-PSSLGNLTNLVTLYLHMNALSGSIPD----EIGNLKFLSDLQ 150 (973)
Q Consensus 86 ~~~p~~~-~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~p~----~~~~l~~L~~L~ 150 (973)
.+++.+ ..+++|++|+|++|+|...- -..+..+++|++|+|.+|.++. .+. .+..+++|+.||
T Consensus 78 -~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~-~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 78 -SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE-KKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp -S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG-STTHHHHHHHH-TT-SEET
T ss_pred -ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc-hhhHHHHHHHHcChhheeC
Confidence 454444 35777888888888876311 1345667777777777777762 221 244555555555
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.19 E-value=5.4e-11 Score=117.86 Aligned_cols=130 Identities=17% Similarity=0.144 Sum_probs=95.2
Q ss_pred cccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCce-eeeceeeeccceeEEEEEecCC
Q 002069 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI-VKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~ 784 (973)
++.++.|.++.||+++. .++.|++|........ ...+..|+.+++.+.+..+ ++++.+.. ...++||||++|
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence 46789999999999987 4788999997654211 2345678888887754443 44555433 345899999999
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC--FPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.++.+. . .....++.+++++++.||+.. ..+++|||++|.||+++ ++.++++|||.+.
T Consensus 76 ~~l~~~----~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 76 SELLTE----D-------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred Cccccc----c-------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 887642 0 111345678999999999983 12359999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.5e-12 Score=126.75 Aligned_cols=132 Identities=28% Similarity=0.279 Sum_probs=61.7
Q ss_pred ccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccc
Q 002069 92 VGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLV 171 (973)
Q Consensus 92 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~ 171 (973)
+...+.|++||||+|.|+ .+.++..-+++++.|+++.|.|+. -+.+..|++|+.||||+|.++ .+.++-.++-|++
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~--v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIK 355 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT--VQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIK 355 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee--ehhhhhcccceEeecccchhH-hhhhhHhhhcCEe
Confidence 333445555555555555 455555555555555555555541 122555555555555555554 3333334444555
Q ss_pred eeeecccccCCCCCccccccCccceeecccccccccc-ccccCCCCcccEEecCCcccC
Q 002069 172 TLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSI-LYSFGNLTKLEILYLDVNALS 229 (973)
Q Consensus 172 ~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~n~i~ 229 (973)
+|.|+.|.|.. -..+.++-+|..||+++|+|.... ...++++|.|+.+.|.+|.+.
T Consensus 356 tL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 356 TLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred eeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 55555554441 123334444444444444444321 223333444444444444333
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.2e-11 Score=146.99 Aligned_cols=151 Identities=28% Similarity=0.340 Sum_probs=114.8
Q ss_pred CCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCc--CCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccc
Q 002069 22 HLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNF--LKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLS 99 (973)
Q Consensus 22 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~--~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 99 (973)
.....++..+-+|.+. .++.... .++|++|-+..|. +....++.|..++.|++|||++|.--+.+|+.|++|.+|+
T Consensus 521 ~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr 598 (889)
T KOG4658|consen 521 SWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR 598 (889)
T ss_pred chhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence 3366788889999887 4454433 3479999999996 5533444577899999999998876669999999999999
Q ss_pred eeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCC--CCCCccccCccccceeee
Q 002069 100 DLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLS--GAIPFSLGNLTNLVTLYI 175 (973)
Q Consensus 100 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~p~~l~~l~~L~~L~l 175 (973)
+|+|++..++ .+|.++++|+.|.+|++..+.-...+|.....|++|++|.+...... ...-..+..+.+|+.+..
T Consensus 599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~ 675 (889)
T KOG4658|consen 599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI 675 (889)
T ss_pred cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence 9999999998 89999999999999999988765566777888999999988776522 222233444444444444
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.18 E-value=7.1e-12 Score=124.59 Aligned_cols=134 Identities=27% Similarity=0.326 Sum_probs=69.5
Q ss_pred cccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcc
Q 002069 139 EIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKL 218 (973)
Q Consensus 139 ~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 218 (973)
.+.-++.|++||||+|.|+ .+.++..-++.++.|++++|.|. .+ +.+..+++|+.||||+|.++.+. ..-..+.+.
T Consensus 279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v-~nLa~L~~L~~LDLS~N~Ls~~~-Gwh~KLGNI 354 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TV-QNLAELPQLQLLDLSGNLLAECV-GWHLKLGNI 354 (490)
T ss_pred ecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-ee-hhhhhcccceEeecccchhHhhh-hhHhhhcCE
Confidence 3344555555555555555 44444555555555555555555 22 22555555555555555555322 122344555
Q ss_pred cEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchh-hhhhccccccceEEccc
Q 002069 219 EILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSI-LEEIGNLKSLLHLQLNY 297 (973)
Q Consensus 219 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~-~~~~~~l~~L~~L~l~~ 297 (973)
++|.|+.|.|..+ ..++.+-+|..||+++|+|. ... ...+++++.|+++.|.+
T Consensus 355 KtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie------------------------~ldeV~~IG~LPCLE~l~L~~ 408 (490)
T KOG1259|consen 355 KTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIE------------------------ELDEVNHIGNLPCLETLRLTG 408 (490)
T ss_pred eeeehhhhhHhhh--hhhHhhhhheeccccccchh------------------------hHHHhcccccccHHHHHhhcC
Confidence 5555555555433 33444555555555555553 322 23566666666777777
Q ss_pred ccccC
Q 002069 298 NTLSG 302 (973)
Q Consensus 298 n~l~~ 302 (973)
|.+.+
T Consensus 409 NPl~~ 413 (490)
T KOG1259|consen 409 NPLAG 413 (490)
T ss_pred CCccc
Confidence 76663
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=4e-10 Score=111.29 Aligned_cols=140 Identities=17% Similarity=0.204 Sum_probs=100.1
Q ss_pred cccccCCCceeEEEEEcCC-------CCEEEEEEcCCCCCc----------c---------hhhHHHHH----HHHHHhh
Q 002069 706 EHCIGNGGQGSVYKAELPT-------GEIVAVKKFHSPLPG----------E---------MACQQEFL----NEGNALT 755 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~----------~---------~~~~~~~~----~e~~~l~ 755 (973)
...||.|--+.||.|...+ +..+|||+++..... + ...++.+. +|+..++
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999996543 479999987532110 0 11123333 7888888
Q ss_pred cCCC--CceeeeceeeeccceeEEEEEecCCCChHH-HhccCccccCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEeec
Q 002069 756 KIRH--RNIVKFYGFCSHALHSFVVYEYLEMGSLAM-ILSNDAAAEEFGWTKRMNAIKGVADALLYM-HTNCFPPIVHRD 831 (973)
Q Consensus 756 ~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~D 831 (973)
++.. -.++.++++ ...++||||+.+..+.. .+++ ..++..+...+..+++.++..+ |+. ++||||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 8843 466667765 35689999998654321 2221 1234456778889999999998 777 999999
Q ss_pred CCCCCeeecCCCceEEeccccccccc
Q 002069 832 ISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 832 lk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
+++.||+++ ++.+.++|||.+....
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999997 5789999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.13 E-value=3e-11 Score=116.81 Aligned_cols=105 Identities=32% Similarity=0.402 Sum_probs=21.2
Q ss_pred CCCcEEEccCCcCcccCCcccc-CccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccc-cccCCCCce
Q 002069 72 TSLIYIDIGNNLLSGSIPNEVG-SLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEI-GNLKFLSDL 149 (973)
Q Consensus 72 ~~L~~L~l~~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~-~~l~~L~~L 149 (973)
.++++|+|++|+++ .+ +.++ .+.+|+.|+|++|+|+ .++ .+..+++|++|++++|+|+ .+++.+ ..+++|++|
T Consensus 19 ~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 19 VKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred cccccccccccccc-cc-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence 33444444444444 22 2233 2444444444444444 222 3444444444444444444 222222 234444444
Q ss_pred ecccCCCCCCC-CccccCccccceeeecccccC
Q 002069 150 QVSYNTLSGAI-PFSLGNLTNLVTLYIGINALS 181 (973)
Q Consensus 150 ~l~~N~l~~~~-p~~l~~l~~L~~L~l~~n~l~ 181 (973)
++++|+|...- -..+..+++|+.|++.+|.+.
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 44444443210 122334444455555554444
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.3e-11 Score=130.68 Aligned_cols=247 Identities=18% Similarity=0.178 Sum_probs=173.9
Q ss_pred HHhcCCcccccccCCCceeEEEEEc--CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccce
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAEL--PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALH 774 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 774 (973)
....+|..+..||.|.|+.||+... .++..|++|.......+... ...-..|+.+...+ .|.++++.+..+..-.+
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~-di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS-DIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh-hhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 3456789999999999999999843 47889999998876554432 12223455555555 58899998888887778
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC-CceEEeccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE-YEAHVSDFGIS 853 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl~Dfg~a 853 (973)
.|+--||+++++..... .....+.+..++++..|++.++.++|+. .++|+|+||+||++..+ +..+++|||.+
T Consensus 341 ~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence 88999999999887655 2223466778899999999999999998 89999999999999886 88899999998
Q ss_pred ccccCCCCcccccccccCcc--cccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 854 KFLKLGLSNRTELAGTFGYI--APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 854 ~~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
..+... . ....+..+++ +|+......+..+.|+||||..+.|.++|..--.. ......+....
T Consensus 415 t~~~~~--~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~------------~~~~~~i~~~~ 479 (524)
T KOG0601|consen 415 TRLAFS--S-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES------------GVQSLTIRSGD 479 (524)
T ss_pred ccccee--c-ccccccccccccchhhccccccccccccccccccccccccCcccCcc------------cccceeeeccc
Confidence 753221 1 1122333344 55555667788999999999999999987654210 01111122222
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.+.... ....+..+...+...|+..||.+.+....
T Consensus 480 ~p~~~~----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~ 514 (524)
T KOG0601|consen 480 TPNLPG----LKLQLQVLLKVMINPDRKRRPSAVELSLH 514 (524)
T ss_pred ccCCCc----hHHhhhhhhhhhcCCccccchhhhhhccc
Confidence 221111 11334566667889999999998887654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.3e-10 Score=105.60 Aligned_cols=134 Identities=22% Similarity=0.296 Sum_probs=102.0
Q ss_pred ccccCCCceeEEEEEcCCCCEEEEEEc-CCC----CCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEe
Q 002069 707 HCIGNGGQGSVYKAELPTGEIVAVKKF-HSP----LPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEY 781 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~----~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 781 (973)
..+++|+-+.+|.+.+. |.++++|.= .+. .....-....-.+|+.++.+++--.|...+-+..++....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35889999999999874 444666642 221 111222345677899999988766776666677777788899999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++|..+.+++... ...++..+-.-+.-||.. ||+|||+.++||.+..++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888644 244667777788899999 999999999999998655 99999999874
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.3e-09 Score=111.24 Aligned_cols=252 Identities=16% Similarity=0.196 Sum_probs=156.0
Q ss_pred ccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeecee------eecc-ceeE
Q 002069 705 DEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGF------CSHA-LHSF 776 (973)
Q Consensus 705 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~------~~~~-~~~~ 776 (973)
..+.+|+|+-+.+|-.-. -+. .+-|+++.+-.... .+ ....|... .||-+-.-+.+ ..++ ....
T Consensus 15 ~gr~LgqGgea~ly~l~e-~~d-~VAKIYh~Pppa~~---aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE-VRD-QVAKIYHAPPPAAQ---AQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCccccCCccceeeecch-hhc-hhheeecCCCchHH---HH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 456799999999997632 122 34488887644322 11 12223333 56654331211 1122 2256
Q ss_pred EEEEecCCCC-hHHHh---ccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 777 VVYEYLEMGS-LAMIL---SNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 777 lv~e~~~~~~-L~~~l---~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
+.|..+.+.- +.++. ++.+.-....|...++.++.+|.+.+.||+. |.+-||+.++|+|+.+++.|.+.|-+.
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccc
Confidence 7777776542 23332 2222334678999999999999999999999 899999999999999999999998654
Q ss_pred cccccCCCCcccccccccCcccccccc-----cCCCCCccchHHHHHHHHHHHhC-CCCCcchhhhhhhhhhhh---h--
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAY-----TMKVTEKCDVYSFGVLALEVIKG-KHPRDFISSICSSLSSNL---N-- 921 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~---~-- 921 (973)
-... .........+|.+.|.+||.-. +-..+...|-|.+||++++++.| ++||.+.......-.+.. .
T Consensus 164 fqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 164 FQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred eeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 3322 2233445678999999999754 33456679999999999999985 999986542211100000 0
Q ss_pred --hhhhhhcCCCC----CCCchhhHHHHHHHHHHHhcccCC--CCCCCCCHHHHHHHh
Q 002069 922 --IALDEMLDPRL----PTPLRNVQDKLISIMEVSISCLDE--SPTSRPTMQKVSQLL 971 (973)
Q Consensus 922 --~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~ev~~~L 971 (973)
....+.-.+.. ..++... +.++..+..+|+.. .+.-|||++-++..|
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~L---pp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl 297 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSML---PPDVQALFQQAFTESGVATPRPTAKAWVAAL 297 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhc---CHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Confidence 00011111111 1222222 33455666688874 356899999888765
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=8e-11 Score=142.14 Aligned_cols=205 Identities=27% Similarity=0.289 Sum_probs=133.6
Q ss_pred cCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCc--CcccCCccccCccccceeeccCCcCCCCCCCccccCCcc
Q 002069 45 GRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNL--LSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNL 122 (973)
Q Consensus 45 ~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~--l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 122 (973)
......+...+.+|.+. .++.+..+ ++|+.|-+..|. +....++.|..++.|++|||++|.--+.+|+++++|-+|
T Consensus 520 ~~~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L 597 (889)
T KOG4658|consen 520 KSWNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL 597 (889)
T ss_pred cchhheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence 33467788888888887 66665543 378888888886 442333447778899999999887656889999989999
Q ss_pred ceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeeccccc--CCCCCccccccCccceeecc
Q 002069 123 VTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINAL--SGSIPNEIGNLKSLSDLRLD 200 (973)
Q Consensus 123 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l--~~~~p~~~~~l~~L~~L~L~ 200 (973)
++|+|++..++ .+|..+++|+.|.+|++..+.-...+|.....|++|++|.+..... +...-..+..+..|+.+...
T Consensus 598 ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~ 676 (889)
T KOG4658|consen 598 RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSIT 676 (889)
T ss_pred hcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheee
Confidence 99999988888 7888899999999998888876555677777788888888865442 22222334455555555543
Q ss_pred ccccccccccccCCCCccc----EEecCCcccCCCCCccccccccccceecccccccCC
Q 002069 201 YNTLSGSILYSFGNLTKLE----ILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGS 255 (973)
Q Consensus 201 ~N~l~~~~~~~~~~l~~L~----~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 255 (973)
.... .....+..++.|. .+.+.++... ..+..+..+.+|+.|.+.++.+...
T Consensus 677 ~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~ 732 (889)
T KOG4658|consen 677 ISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEI 732 (889)
T ss_pred cchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchh
Confidence 3222 1112233333333 2222222222 2245566677777777777766543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.5e-09 Score=101.65 Aligned_cols=146 Identities=18% Similarity=0.274 Sum_probs=106.5
Q ss_pred ccccccCCCceeEEEEEcCCCCEEEEEE-cC----CCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 705 DEHCIGNGGQGSVYKAELPTGEIVAVKK-FH----SPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 705 ~~~~lg~G~~g~V~~~~~~~~~~vavK~-~~----~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
....+-+|+-+.|+++.+ .|+.+.||. +. -+.....-.+++..+|+..+.+++--.|....-++.+.....|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467899999999999998 677766664 22 222222334567788999988886555555555565665667999
Q ss_pred EecCC-CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC---ceEEeccccccc
Q 002069 780 EYLEM-GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY---EAHVSDFGISKF 855 (973)
Q Consensus 780 e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~---~~kl~Dfg~a~~ 855 (973)
||++| .++.+++........ ...-....+.+|-+.+.-||.. +++|||+..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 478888865443222 2222367889999999999999 999999999999997664 358999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.1e-09 Score=111.68 Aligned_cols=142 Identities=19% Similarity=0.216 Sum_probs=109.0
Q ss_pred ccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCC--Cceeeeceeeecc---ceeEEEEEe
Q 002069 707 HCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH--RNIVKFYGFCSHA---LHSFVVYEY 781 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~ 781 (973)
+.++.|.++.||++...+|+.+++|........ .....+..|.++++.+++ ..+++++.+.... +..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 578999999999998766789999997654321 124567889999999865 3457777777653 256899999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC-------------------------------------- 823 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------- 823 (973)
++|.++.+.+.. ..++..+...++.++++++++||+..
T Consensus 82 i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 82 VDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred eCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999888765421 23567778888888888888888531
Q ss_pred ---------------CCCeEeecCCCCCeeecC--CCceEEecccccc
Q 002069 824 ---------------FPPIVHRDISSKNVLLNL--EYEAHVSDFGISK 854 (973)
Q Consensus 824 ---------------~~~i~H~Dlk~~Nill~~--~~~~kl~Dfg~a~ 854 (973)
...++|+|+.+.||+++. ++.+.++||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 135799999999999998 5678999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.6e-10 Score=132.44 Aligned_cols=251 Identities=20% Similarity=0.242 Sum_probs=167.7
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
..+.+.+.+.+.+|.++.++.+.-. .|...+.|.......-.....+....+-.+.-..++|.+++..-.+......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456777888999999999988433 443444443321100000001122222223333456777766655556667899
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
|++|..++++...++..+ ..+...+......+..+.+|||.. .+.|+|++|.|.+...+++.+++|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccc
Confidence 999999999998887655 234445556667788899999997 68999999999999999999999998433221
Q ss_pred CC---------------------C----------CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 002069 858 LG---------------------L----------SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPR 906 (973)
Q Consensus 858 ~~---------------------~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~ 906 (973)
.- . .......||+.|.|||...+......+|.|+.|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0 0122356899999999999999999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHH
Q 002069 907 DFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQ 965 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 965 (973)
..... ...++.+....++.... .........+++...+..+|.+|-.|.
T Consensus 1036 na~tp---------q~~f~ni~~~~~~~p~g-~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETP---------QQIFENILNRDIPWPEG-PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcch---------hhhhhccccCCCCCCCC-ccccChhhhhhhhhhhccCchhccCcc
Confidence 74332 22233333333332221 122344566777788888888887654
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.6e-10 Score=112.27 Aligned_cols=193 Identities=24% Similarity=0.187 Sum_probs=102.8
Q ss_pred hccCCCCCCcEEEccCCcccCCCCcccc----cccccchhcccccccccCCCccc-------------CCCCCCCEEEcc
Q 002069 354 LALGNLTKLVSLDLSINKLSGSIPLSFA----SLTSLTTLYLYENSLCDSIPKEI-------------GDMKSLSILDLS 416 (973)
Q Consensus 354 ~~~~~l~~L~~L~Ls~N~i~~~~~~~~~----~l~~L~~L~L~~N~l~~~~~~~~-------------~~l~~L~~L~Ls 416 (973)
.++.+|++|+..+||+|.+....|..+. .-+.|.+|.|++|.+......-+ .+-+.|++.+..
T Consensus 86 ~aLlkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicg 165 (388)
T COG5238 86 KALLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICG 165 (388)
T ss_pred HHHhcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEec
Confidence 4556778888888888888766655443 34667777777776643222222 234566666666
Q ss_pred CCCCCCCcchhhhhhc----ccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCCcccccccccccccccccc
Q 002069 417 SNKLNGSIPLSLANLT----NSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANT 492 (973)
Q Consensus 417 ~N~l~~~~~~~~~~~~----~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~ 492 (973)
.|++. ..+....... ..|+++.+..|.|....... ..-..+..+.+|+.|||.+|.
T Consensus 166 rNRle-ngs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~-------------------L~~~gl~y~~~LevLDlqDNt 225 (388)
T COG5238 166 RNRLE-NGSKELSAALLESHENLKEVKIQQNGIRPEGVTM-------------------LAFLGLFYSHSLEVLDLQDNT 225 (388)
T ss_pred cchhc-cCcHHHHHHHHHhhcCceeEEeeecCcCcchhHH-------------------HHHHHHHHhCcceeeeccccc
Confidence 66665 3333222111 23444444444443211000 011123345677777777777
Q ss_pred cccc----cCccccccccccEEeecCccCCCCCCcccc------cccccCeecccccccCCCcchh-----h--cccccc
Q 002069 493 FHNS----IPESLGNLVKLHYLNLSNNQFSQKIPNPIE------KLIHLSELDLSYKIFGEEIPSQ-----V--CSMQSL 555 (973)
Q Consensus 493 i~~~----~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~------~l~~L~~L~ls~n~i~~~~~~~-----~--~~l~~L 555 (973)
++.. +..++..++.|+.|++.+|-++..+...+- ..++|..|-..||.+....... + ..+|-|
T Consensus 226 ft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L 305 (388)
T COG5238 226 FTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLL 305 (388)
T ss_pred hhhhhHHHHHHHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHH
Confidence 7632 334455566677777777777665554331 1345566666666554322211 1 135556
Q ss_pred ccccccccccc
Q 002069 556 EKLNLSHNNLS 566 (973)
Q Consensus 556 ~~L~L~~N~l~ 566 (973)
..|.+.||++.
T Consensus 306 ~~le~ngNr~~ 316 (388)
T COG5238 306 VDLERNGNRIK 316 (388)
T ss_pred HHHHHccCcch
Confidence 66666666654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.3e-10 Score=128.72 Aligned_cols=127 Identities=32% Similarity=0.356 Sum_probs=56.2
Q ss_pred cceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCCcccccccccccccccccccccccCccccccccccEEeec
Q 002069 434 SLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLS 513 (973)
Q Consensus 434 ~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~~~~l~~l~~L~~L~L~ 513 (973)
.|...+.+.|.++ ....++.-++.|+.|+|++|+++.. +.+..++.|++|||+.|.++...-....++ .|..|+++
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KLQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhh-hheeeeec
Confidence 3444455555544 2222333344455555555555432 244455555555555555542211122222 25555555
Q ss_pred CccCCCCCCcccccccccCeecccccccCCCcc-hhhccccccccccccccccc
Q 002069 514 NNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIP-SQVCSMQSLEKLNLSHNNLS 566 (973)
Q Consensus 514 ~N~l~~~~~~~~~~l~~L~~L~ls~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~ 566 (973)
+|.++.. ..+.+|.+|+.||+|||-|.+..- ..+..+..|+.|+|.||++-
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 5555432 234445555555555554443221 12233444555555555543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.3e-08 Score=98.63 Aligned_cols=129 Identities=23% Similarity=0.308 Sum_probs=84.7
Q ss_pred eEEEEEcCCCCEEEEEEcCCCCC-----------------------cchhhHHHHHHHHHHhhcCCCC--ceeeeceeee
Q 002069 716 SVYKAELPTGEIVAVKKFHSPLP-----------------------GEMACQQEFLNEGNALTKIRHR--NIVKFYGFCS 770 (973)
Q Consensus 716 ~V~~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~ 770 (973)
.||.|...+|..||||+...... ..........+|...|.++... ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999888999999999753211 1122345677899999999655 567777553
Q ss_pred ccceeEEEEEecC--CCChHHHhccCccccCCCHHHHHHHHHHHHHHHHH-HhhCCCCCeEeecCCCCCeeecCCCceEE
Q 002069 771 HALHSFVVYEYLE--MGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLY-MHTNCFPPIVHRDISSKNVLLNLEYEAHV 847 (973)
Q Consensus 771 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~~~i~H~Dlk~~Nill~~~~~~kl 847 (973)
..++||||++ |..+..+.... ++......++.+++..+.. +|.. |++|||+.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 3479999999 65554433221 1123456677777776655 4677 99999999999999977 9999
Q ss_pred eccccccccc
Q 002069 848 SDFGISKFLK 857 (973)
Q Consensus 848 ~Dfg~a~~~~ 857 (973)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.6e-08 Score=103.49 Aligned_cols=144 Identities=22% Similarity=0.154 Sum_probs=101.7
Q ss_pred ccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcch--------hhHHHHHHHHHHhhcCCCCce--eeeceeeec-----
Q 002069 707 HCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEM--------ACQQEFLNEGNALTKIRHRNI--VKFYGFCSH----- 771 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~----- 771 (973)
+.+-......|+++.+ +|+.|.||+......... .-...+.+|...+.++...+| ++.+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455444555777776 678999998753321100 001147788888888744333 344555533
Q ss_pred cceeEEEEEecCCC-ChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC-------CC
Q 002069 772 ALHSFVVYEYLEMG-SLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL-------EY 843 (973)
Q Consensus 772 ~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-------~~ 843 (973)
....++|||++++. +|.+++.... ..+.+......++.+++..++-||+. ||+|+|++++||+++. ++
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 23568999999986 8998885322 23445677889999999999999999 9999999999999975 46
Q ss_pred ceEEeccccccc
Q 002069 844 EAHVSDFGISKF 855 (973)
Q Consensus 844 ~~kl~Dfg~a~~ 855 (973)
.+.++||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998864
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.77 E-value=4.4e-10 Score=110.72 Aligned_cols=242 Identities=21% Similarity=0.195 Sum_probs=144.5
Q ss_pred CCCCCCcEEcCCCCCCCcchh----ccCCCCCCcEEEccCCccc---CCCCcccccccccchhcccccccccCCCcccCC
Q 002069 334 NLRSLSDLQLSENTLNGSIPL----ALGNLTKLVSLDLSINKLS---GSIPLSFASLTSLTTLYLYENSLCDSIPKEIGD 406 (973)
Q Consensus 334 ~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~Ls~N~i~---~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 406 (973)
.+..+..++||+|.|...... .+.+-.+|+..++|+--.. +..+.. |+. +..++..
T Consensus 28 ~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~------L~~-----------Ll~aLlk 90 (388)
T COG5238 28 MMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSN------LVM-----------LLKALLK 90 (388)
T ss_pred hhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHH------HHH-----------HHHHHhc
Confidence 356677777777777654333 3444556666666542211 111111 111 1234445
Q ss_pred CCCCCEEEccCCCCCCCcchhhhhhc---ccceEEEeeCcccccccCCC-------------CCCCcccceeeccCCccC
Q 002069 407 MKSLSILDLSSNKLNGSIPLSLANLT---NSLKVLYLSSNHIVGEIPLG-------------HGKFSSLIQLILNNNELS 470 (973)
Q Consensus 407 l~~L~~L~Ls~N~l~~~~~~~~~~~~---~~L~~L~L~~n~l~~~~~~~-------------~~~~~~L~~L~l~~N~l~ 470 (973)
|+.|+..+||+|.+....|..+..+. ..|++|.|++|.+....... ...-|.|+..+...|++.
T Consensus 91 cp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRle 170 (388)
T COG5238 91 CPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLE 170 (388)
T ss_pred CCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhc
Confidence 66666666666666555554443322 24666666666654221111 234467999999999986
Q ss_pred CCC----CcccccccccccccccccccccccCcc-----ccccccccEEeecCccCCCCCC----cccccccccCeeccc
Q 002069 471 GQL----SPELGSLNQLEYLDLSANTFHNSIPES-----LGNLVKLHYLNLSNNQFSQKIP----NPIEKLIHLSELDLS 537 (973)
Q Consensus 471 ~~~----~~~l~~l~~L~~L~Ls~N~i~~~~~~~-----l~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~ls 537 (973)
.-. ...+..-.+|+.+.+..|.|.-..-.. +..+.+|+.|||.+|-++.... .++..+..|++|.+.
T Consensus 171 ngs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~ln 250 (388)
T COG5238 171 NGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLN 250 (388)
T ss_pred cCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhcccc
Confidence 422 223444468999999999987432222 2345889999999999976433 455667788999999
Q ss_pred ccccCCCcchhhcc------cccccccccccccccCccch-----hh--hccccccEEeCcCCCCCCC
Q 002069 538 YKIFGEEIPSQVCS------MQSLEKLNLSHNNLSGSISR-----CF--EEMHWLSCIDISYNALQGL 592 (973)
Q Consensus 538 ~n~i~~~~~~~~~~------l~~L~~L~L~~N~l~~~~~~-----~~--~~l~~L~~l~l~~N~l~~~ 592 (973)
+|.++..+...+.. .|+|..|-..+|...+.... .+ ..++-|..|.+.+|++...
T Consensus 251 DClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~E~ 318 (388)
T COG5238 251 DCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIKEL 318 (388)
T ss_pred chhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcchhH
Confidence 99888887766542 56788888888876543211 11 2345556666666666543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.76 E-value=3.9e-09 Score=83.82 Aligned_cols=59 Identities=37% Similarity=0.461 Sum_probs=29.4
Q ss_pred ccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceeccccc
Q 002069 193 SLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNT 251 (973)
Q Consensus 193 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~ 251 (973)
+|++|++++|+++.+++..|.++++|++|++++|+++.+.+.+|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34445555555544444445555555555555555554444455555555555555544
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=6e-08 Score=97.54 Aligned_cols=139 Identities=23% Similarity=0.204 Sum_probs=99.9
Q ss_pred CcccccccCCCceeEEEEEcCCCCEEEEEEcCCCC-----------------Ccc--hhhHHHHHHHHHHhhcCCCC--c
Q 002069 703 FDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPL-----------------PGE--MACQQEFLNEGNALTKIRHR--N 761 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------------~~~--~~~~~~~~~e~~~l~~l~h~--n 761 (973)
..+..+||-|--+.||.|..+.|.++|||.=.... ..+ ...+....+|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34567899999999999999999999999622110 011 22345577899999998654 7
Q ss_pred eeeeceeeeccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC
Q 002069 762 IVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL 841 (973)
Q Consensus 762 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~ 841 (973)
+++.+++- ..++||||++|-.|...- ++.+..-.++..|..-+...-.. |+||||+++-||++++
T Consensus 173 VP~P~~~n----RHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAWN----RHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCccccc----cceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 77777754 457999999986665321 12334444555555555555555 9999999999999999
Q ss_pred CCceEEecccccccc
Q 002069 842 EYEAHVSDFGISKFL 856 (973)
Q Consensus 842 ~~~~kl~Dfg~a~~~ 856 (973)
||.+.++||-.+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999776543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.1e-08 Score=81.19 Aligned_cols=61 Identities=34% Similarity=0.416 Sum_probs=44.7
Q ss_pred cccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCccc
Q 002069 168 TNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNAL 228 (973)
Q Consensus 168 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i 228 (973)
++|++|++++|+++...+..|.++++|++|++++|+++.+.+..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4567777777777755556777777777777777777777777777777777777777764
|
... |
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.6e-09 Score=105.74 Aligned_cols=186 Identities=20% Similarity=0.222 Sum_probs=90.0
Q ss_pred CCCCCcEEcCCCCCCC--cchhccCCCCCCcEEEccCCcccCCCCcccccccccchhccccccccc-CCCcccCCCCCCC
Q 002069 335 LRSLSDLQLSENTLNG--SIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCD-SIPKEIGDMKSLS 411 (973)
Q Consensus 335 l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~ 411 (973)
++.++++||.+|.|++ .+...+.++|.|+.|+|+.|++...+...-..+.+|++|-|.+..+.- .....+..++.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 3444555555555542 122233445555555555555542111111233445555554444421 1222333445555
Q ss_pred EEEccCCCCCC--CcchhhhhhcccceEEEeeCccccc--ccCCCCCCCcccceeeccCCccCCC-CCcccccccccccc
Q 002069 412 ILDLSSNKLNG--SIPLSLANLTNSLKVLYLSSNHIVG--EIPLGHGKFSSLIQLILNNNELSGQ-LSPELGSLNQLEYL 486 (973)
Q Consensus 412 ~L~Ls~N~l~~--~~~~~~~~~~~~L~~L~L~~n~l~~--~~~~~~~~~~~L~~L~l~~N~l~~~-~~~~l~~l~~L~~L 486 (973)
+|.+|.|.+.- ..........+.+++|..-.|...- .....-.-++++..+.+..|.|.+. -.+.+..++.+-.|
T Consensus 150 elHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~L 229 (418)
T KOG2982|consen 150 ELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCL 229 (418)
T ss_pred hhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheeeecCcccchhhcccCCCCCcchhh
Confidence 55555552220 1111111122234444444443221 0011113456777788888877542 23455566777788
Q ss_pred ccccccccc-ccCccccccccccEEeecCccCCCC
Q 002069 487 DLSANTFHN-SIPESLGNLVKLHYLNLSNNQFSQK 520 (973)
Q Consensus 487 ~Ls~N~i~~-~~~~~l~~l~~L~~L~L~~N~l~~~ 520 (973)
+|+.|+|.. .--+++.+++.|..|.+++|++.+.
T Consensus 230 nL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~ 264 (418)
T KOG2982|consen 230 NLGANNIDSWASVDALNGFPQLVDLRVSENPLSDP 264 (418)
T ss_pred hhcccccccHHHHHHHcCCchhheeeccCCccccc
Confidence 888888863 2234567778888888888888654
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.2e-09 Score=105.31 Aligned_cols=213 Identities=25% Similarity=0.242 Sum_probs=116.4
Q ss_pred CCCCCCcEEcCCCCCCCcch-hcc-CCCCCCcEEEccCCcccC--CCCcccccccccchhcccccccccCCCcccCCCCC
Q 002069 334 NLRSLSDLQLSENTLNGSIP-LAL-GNLTKLVSLDLSINKLSG--SIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKS 409 (973)
Q Consensus 334 ~l~~L~~L~L~~N~l~~~~~-~~~-~~l~~L~~L~Ls~N~i~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 409 (973)
....+..|.+.++.|..... ..| ...+.++.+||.+|+|++ .+...+.+++.|++|+|+.|++...+...-....+
T Consensus 43 s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~n 122 (418)
T KOG2982|consen 43 SLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKN 122 (418)
T ss_pred cccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccc
Confidence 33445556666665543221 122 235677788888888874 23334456777777777777776433222135567
Q ss_pred CCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCCc--cccccccccccc
Q 002069 410 LSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSP--ELGSLNQLEYLD 487 (973)
Q Consensus 410 L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~--~l~~l~~L~~L~ 487 (973)
|++|-|.+..+.......+....|.+++|++|.|.+ +.+++..|.+...-+. .+..++.+..+.
T Consensus 123 l~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~--------------rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w 188 (418)
T KOG2982|consen 123 LRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSL--------------RQLNLDDNCIEDWSTEVLTLHQLPCLEQLW 188 (418)
T ss_pred eEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchh--------------hhhccccccccccchhhhhhhcCCcHHHHH
Confidence 777777777766444444444444566666666643 2334444444322111 122333444444
Q ss_pred ccccccccccCccccccccccEEeecCccCCCCC-CcccccccccCeecccccccCCCcc-hhhcccccccccccccccc
Q 002069 488 LSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKI-PNPIEKLIHLSELDLSYKIFGEEIP-SQVCSMQSLEKLNLSHNNL 565 (973)
Q Consensus 488 Ls~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~ls~n~i~~~~~-~~~~~l~~L~~L~L~~N~l 565 (973)
++-|++.. -++++..+.+..|++.... .+.+..++.+.-|+|+.|+|.+... .++..++.|..|.+++|++
T Consensus 189 ~~~~~l~r-------~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl 261 (418)
T KOG2982|consen 189 LNKNKLSR-------IFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPL 261 (418)
T ss_pred HHHHhHHh-------hcccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcc
Confidence 44444432 2356777788888875432 2344555555566666666654433 3455566666666666666
Q ss_pred cC
Q 002069 566 SG 567 (973)
Q Consensus 566 ~~ 567 (973)
..
T Consensus 262 ~d 263 (418)
T KOG2982|consen 262 SD 263 (418)
T ss_pred cc
Confidence 53
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.66 E-value=6.9e-07 Score=96.92 Aligned_cols=170 Identities=19% Similarity=0.238 Sum_probs=126.8
Q ss_pred CceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeee----ccceeEEEEEecCCC-C
Q 002069 713 GQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCS----HALHSFVVYEYLEMG-S 786 (973)
Q Consensus 713 ~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~~-~ 786 (973)
...+.|++.. .||..|+.|+++....... ..-..-+++++++.|+|+|++.+++. .....++||+|+++. +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 3457899954 4899999999965433322 12234467899999999999999885 234678999999854 5
Q ss_pred hHHHhccCc------------cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 787 LAMILSNDA------------AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 787 L~~~l~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
|.++-.... .....++...|.++.|++.||.++|+. |+.-+-+.+++|+++.+.+++|+..|...
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEeccccee
Confidence 665542221 123467889999999999999999999 99999999999999999999999888876
Q ss_pred cccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCC
Q 002069 855 FLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905 (973)
Q Consensus 855 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p 905 (973)
....+. + |.+ .--.+-|.-.||.+++.+.||..-
T Consensus 442 vl~~d~-------~-------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 442 VLQEDP-------T-------EPL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred eecCCC-------C-------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 655432 0 111 122367999999999999999544
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1e-09 Score=121.90 Aligned_cols=129 Identities=33% Similarity=0.392 Sum_probs=95.4
Q ss_pred cCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEe
Q 002069 143 LKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILY 222 (973)
Q Consensus 143 l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 222 (973)
+-.|..-+.++|++. ....++.-++.|+.|+|++|+++.. +.+..|++|+.|||++|.+..++--...++. |+.|.
T Consensus 163 Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~ 238 (1096)
T KOG1859|consen 163 WNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLN 238 (1096)
T ss_pred hhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeee
Confidence 346777788888887 6667788888888888888888843 3788888888999999988877665556666 88899
Q ss_pred cCCcccCCCCCccccccccccceecccccccCCCC-cccCCcchhhhccCCCcccC
Q 002069 223 LDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIP-CSFGNLTKLVISCLGTNALS 277 (973)
Q Consensus 223 L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~l~l~~n~i~ 277 (973)
+++|.++.+ ..+.+|.+|+.||+++|-|.+.-. .-+..|..|..|+|.+|.+-
T Consensus 239 lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 239 LRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 999988876 568888889999999988864221 12344555566666666553
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.7e-09 Score=95.65 Aligned_cols=127 Identities=21% Similarity=0.227 Sum_probs=85.3
Q ss_pred EEeCCCCCCCCCCCcccC---CCCCCCEEECCCCcccccCCcCccC-CCCCCeeeccCCcCCCCCCCcccCCCCCcEEEc
Q 002069 4 VLGLSFNQFSGSIPPEIG---HLTHLKLLSFSKNQLSGLIPHEIGR-LSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDI 79 (973)
Q Consensus 4 ~L~l~~~~l~~~~p~~~~---~l~~L~~L~l~~n~l~~~~p~~~~~-l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l 79 (973)
.+|||++.+. .+++... ...+|+..+|++|.+. .+|+.|.. .+-+++|+|++|+|+ .+|..+..++.|+.|++
T Consensus 31 ~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl 107 (177)
T KOG4579|consen 31 FLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNL 107 (177)
T ss_pred hcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhccc
Confidence 4778888774 6666544 4466666788888887 45655544 457788888888887 77877888888888888
Q ss_pred cCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeeccccccccc
Q 002069 80 GNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGS 135 (973)
Q Consensus 80 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 135 (973)
++|.+. ..|..|..|.+|-+|+..+|.+. .+|-.+.--+..-..++.++.+.+.
T Consensus 108 ~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~ 161 (177)
T KOG4579|consen 108 RFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDE 161 (177)
T ss_pred ccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCccccc
Confidence 888887 67777777888888888887776 5554432222222233444455433
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.1e-09 Score=93.32 Aligned_cols=131 Identities=24% Similarity=0.270 Sum_probs=77.0
Q ss_pred CCeeeccCCcCCCCCCCccc---CCCCCcEEEccCCcCcccCCccccC-ccccceeeccCCcCCCCCCCccccCCcccee
Q 002069 50 LNGLSLYSNFLKGSIPPSLG---NLTSLIYIDIGNNLLSGSIPNEVGS-LKSLSDLRLSNNSLNGSIPSSLGNLTNLVTL 125 (973)
Q Consensus 50 L~~L~l~~n~~~~~~p~~~~---~l~~L~~L~l~~n~l~~~~p~~~~~-l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 125 (973)
+-.++|++|++- .+++... ....|...+|++|.+. .+|+.|.. .+.+++|+|++|+|+ .+|..++.++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 445566666655 4444433 3344555577777776 55555543 346777777777777 677777777777777
Q ss_pred ecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCC
Q 002069 126 YLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIP 185 (973)
Q Consensus 126 ~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p 185 (973)
+++.|.+. ..|..|..|.++-.|+..+|.+. .+|..+-.-++.-...++++.+++.-+
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 77777776 56777767777777777777765 333333222233333335555544333
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 973 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-42 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-29 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-41 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-29 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-35 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-35 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-30 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-30 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-25 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-25 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-25 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-23 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-07 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 2e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-05 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 4e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-04 | ||
| 1xcd_A | 329 | Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo | 1e-04 | ||
| 3vq1_A | 606 | Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLE | 1e-04 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 1e-04 | ||
| 1xku_A | 330 | Crystal Structure Of The Dimeric Protein Core Of De | 1e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-04 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 1e-04 | ||
| 2z64_A | 599 | Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Comp | 1e-04 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 1e-04 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 2e-04 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 8e-04 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 2e-04 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 8e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 2e-04 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 5e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 2e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-04 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 2e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-04 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 3e-04 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 3e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-04 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 3e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-04 | ||
| 3zyo_A | 411 | Crystal Structure Of The N-Terminal Leucine Rich Re | 3e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-04 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 3e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-04 | ||
| 3zyn_A | 321 | Crystal Structure Of The N-Terminal Leucine Rich Re | 4e-04 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 4e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-04 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 5e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-04 | ||
| 2z81_A | 549 | Crystal Structure Of The Tlr1-tlr2 Heterodimer Indu | 6e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-04 | ||
| 1ziw_A | 680 | Human Toll-Like Receptor 3 Extracellular Domain Str | 8e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-04 | ||
| 3a79_A | 580 | Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Len | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329 | Back alignment and structure |
|
| >pdb|3VQ1|A Chain A, Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLEX Length = 606 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|2Z64|A Chain A, Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Complex Length = 599 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z81|A Chain A, Crystal Structure Of The Tlr1-tlr2 Heterodimer Induced By Binding Of A Tri-acylated Lipopeptide Length = 549 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1ZIW|A Chain A, Human Toll-Like Receptor 3 Extracellular Domain Structure Length = 680 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3A79|A Chain A, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Length = 580 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 538 bits (1389), Expect = e-179
Identities = 192/633 (30%), Positives = 284/633 (44%), Gaps = 23/633 (3%)
Query: 2 LKVLGLSFNQFSGSIP-PEIGHLTHLKLLSFSKNQLSGLIPHEI---GRLSSLNGLSLYS 57
LK L +S N L L++L S N +SG L L++
Sbjct: 128 LKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISG 187
Query: 58 NFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLG 117
N + G + + +L ++D+ +N S IP +G +L L +S N L+G ++
Sbjct: 188 NKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAIS 244
Query: 118 NLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSL-GNLTNLVTLYIG 176
T L L + N G IP LK L L ++ N +G IP L G L L +
Sbjct: 245 TCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLS 302
Query: 177 INALSGSIPNEIGNLKSLSDLRLDYNTLSGSI-LYSFGNLTKLEILYLDVNALSGLIPNE 235
N G++P G+ L L L N SG + + + + L++L L N SG +P
Sbjct: 303 GNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES 362
Query: 236 IGNLK-SLLALQLNYNTLSGSIPCSFGN--LTKLVISCLGTNALSSSILEEIGNLKSLLH 292
+ NL SLL L L+ N SG I + L L N + I + N L+
Sbjct: 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS 422
Query: 293 LQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSI 352
L L++N LSG+IP SLGSL+ L L N L G IP E+ +++L L L N L G I
Sbjct: 423 LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEI 482
Query: 353 PLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSI 412
P L N T L + LS N+L+G IP L +L L L NS +IP E+GD +SL
Sbjct: 483 PSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIW 542
Query: 413 LDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIP--LGHGKFSSLIQLILNNNELS 470
LDL++N NG+IP ++ + +++N I G+ + + N E
Sbjct: 543 LDLNTNLFNGTIPAAMFKQSGK-----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ 597
Query: 471 GQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIH 530
G S +L L+ ++++ + + N + +L++S N S IP I + +
Sbjct: 598 GIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPY 657
Query: 531 LSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQ 590
L L+L + IP +V ++ L L+LS N L G I + + L+ ID+S N L
Sbjct: 658 LFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717
Query: 591 GLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPC 623
G IP F P N LCG LP C
Sbjct: 718 GPIPEMGQFETFPPAKFLNNPGLCGYP--LPRC 748
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 501 bits (1293), Expect = e-165
Identities = 187/608 (30%), Positives = 280/608 (46%), Gaps = 24/608 (3%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
+ + N ++ + LT L+ L S + ++G + +SL L L N L
Sbjct: 55 IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLS 113
Query: 62 GSIPP--SLGNLTSLIYIDIGNNLLSGSIPNEVG-SLKSLSDLRLSNNSLNGSIPSSL-- 116
G + SLG+ + L ++++ +N L G L SL L LS NS++G+
Sbjct: 114 GPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVL 173
Query: 117 -GNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYI 175
L L + N +SG + + L L VS N S IP LG+ + L L I
Sbjct: 174 SDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDI 230
Query: 176 GINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNE 235
N LSG I L L + N G I L L+ L L N +G IP+
Sbjct: 231 SGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDF 288
Query: 236 I-GNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSI-LEEIGNLKSLLHL 293
+ G +L L L+ N G++P FG+ + L L +N S + ++ + ++ L L
Sbjct: 289 LSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVL 348
Query: 294 QLNYNTLSGSIPLSLGSLT-NLATLYFSTNALSGSIPNEITN--LRSLSDLQLSENTLNG 350
L++N SG +P SL +L+ +L TL S+N SG I + +L +L L N G
Sbjct: 349 DLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTG 408
Query: 351 SIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSL 410
IP L N ++LVSL LS N LSG+IP S SL+ L L L+ N L IP+E+ +K+L
Sbjct: 409 KIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTL 468
Query: 411 SILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELS 470
L L N L G IP L+N TN L + LS+N + GEIP G+ +L L L+NN S
Sbjct: 469 ETLILDFNDLTGEIPSGLSNCTN-LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS 527
Query: 471 GQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIH 530
G + ELG L +LDL+ N F+ +IP ++ ++ N + K I+
Sbjct: 528 GNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGM 583
Query: 531 LSELDLS--YKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNA 588
E + F Q+ + + N++ G S F+ + +D+SYN
Sbjct: 584 KKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNM 643
Query: 589 LQGLIPNS 596
L G IP
Sbjct: 644 LSGYIPKE 651
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 433 bits (1116), Expect = e-139
Identities = 165/541 (30%), Positives = 248/541 (45%), Gaps = 22/541 (4%)
Query: 67 SLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLY 126
+TS+ N+ ++ + + SL L L LSN+ +NGS+ +L +L
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD 106
Query: 127 LHMNALSGSIPD--EIGNLKFLSDLQVSYNTLSGAIPFSLG-NLTNLVTLYIGINALSGS 183
L N+LSG + +G+ L L VS NTL S G L +L L + N++SG+
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 184 IPNEI---GNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLK 240
L L + N +SG + LE L + N S IP +G+
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFSTGIP-FLGDCS 223
Query: 241 SLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTL 300
+L L ++ N LSG + T+L + + +N I LKSL +L L N
Sbjct: 224 ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKF 281
Query: 301 SGSIPLSL-GSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPL-ALGN 358
+G IP L G+ L L S N G++P + L L LS N +G +P+ L
Sbjct: 282 TGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341
Query: 359 LTKLVSLDLSINKLSGSIPLSFASLT-SLTTLYLYENSLCDSIPKEIGD--MKSLSILDL 415
+ L LDLS N+ SG +P S +L+ SL TL L N+ I + +L L L
Sbjct: 342 MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYL 401
Query: 416 SSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSP 475
+N G IP +L+N + L L+LS N++ G IP G S L L L N L G++
Sbjct: 402 QNNGFTGKIPPTLSNCSE-LVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460
Query: 476 ELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELD 535
EL + LE L L N IP L N L++++LSNN+ + +IP I +L +L+ L
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 520
Query: 536 LSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPN 595
LS F IP+++ +SL L+L+ N +G+I + I+ N + G
Sbjct: 521 LSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYV 576
Query: 596 S 596
Sbjct: 577 Y 577
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 413 bits (1065), Expect = e-131
Identities = 159/473 (33%), Positives = 233/473 (49%), Gaps = 36/473 (7%)
Query: 1 MLKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHE-IGRLSSLNGLSLYSNF 59
L L LS N F G++PP G + L+ L+ S N SG +P + + ++ L L L N
Sbjct: 295 TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE 354
Query: 60 LKGSIPPSLGNLT-SLIYIDIGNNLLSGSIPNEVG--SLKSLSDLRLSNNSLNGSIPSSL 116
G +P SL NL+ SL+ +D+ +N SG I + +L +L L NN G IP +L
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
Query: 117 GNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIG 176
N + LV+L+L N LSG+IP +G+L L DL++ N L G IP L + L TL +
Sbjct: 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474
Query: 177 INALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEI 236
N L+G IP+ + N +L+ + L N L+G I G L L IL L N+ SG IP E+
Sbjct: 475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534
Query: 237 GNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSL--LHLQ 294
G+ +SL+ L LN N +G+IP + + + N ++ I N H
Sbjct: 535 GDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGA 590
Query: 295 LNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPL 354
N G L L+ ++ G N S+ L +S N L+G IP
Sbjct: 591 GNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPK 650
Query: 355 ALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILD 414
+G++ L L+L N +SG SIP E+GD++ L+ILD
Sbjct: 651 EIGSMPYLFILNLGHNDISG------------------------SIPDEVGDLRGLNILD 686
Query: 415 LSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNN 467
LSSNKL+G IP +++ LT L + LS+N++ G IP G+F + NN
Sbjct: 687 LSSNKLDGRIPQAMSALT-MLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNN 737
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 1e-72
Identities = 94/348 (27%), Positives = 152/348 (43%), Gaps = 16/348 (4%)
Query: 258 CSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATL 317
C +T + +S N S++ + +L L L L+ + ++GS+ +L +L
Sbjct: 47 CRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSL 105
Query: 318 YFSTNALSGSIP--NEITNLRSLSDLQLSENTLNGSIPL-ALGNLTKLVSLDLSINKLSG 374
S N+LSG + + + L L +S NTL+ + L L LDLS N +SG
Sbjct: 106 DLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165
Query: 375 SIPLSFA---SLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANL 431
+ + + L L + N + + + +L LD+SSN + IP L +
Sbjct: 166 ANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDC 222
Query: 432 TNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSAN 491
+ L+ L +S N + G+ + L L +++N+ G + P L L+YL L+ N
Sbjct: 223 SA-LQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAEN 279
Query: 492 TFHNSIPESL-GNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQV- 549
F IP+ L G L L+LS N F +P L L LS F E+P
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339
Query: 550 CSMQSLEKLNLSHNNLSGSISRCFEEMHW-LSCIDISYNALQGLIPNS 596
M+ L+ L+LS N SG + + L +D+S N G I +
Sbjct: 340 LKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 372 bits (957), Expect = e-116
Identities = 143/639 (22%), Positives = 230/639 (35%), Gaps = 39/639 (6%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
+ VL L+ NQ + L L N +S L P +L L L+L N L
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
+ T+L + + +N + N K+L L LS+N L+ + + L N
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146
Query: 122 LVTLYLHMNALSGSIPDEIGNLKF--LSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINA 179
L L L N + +E+ L L++S N + P + L L++
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206
Query: 180 LSGSIPNEIG---NLKSLSDLRLDYNTLSGSILYSFGNL--TKLEILYLDVNALSGLIPN 234
L S+ ++ S+ +L L + LS + +F L T L +L L N L+ + +
Sbjct: 207 LGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND 266
Query: 235 EIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQ 294
L L L YN + S L + L +
Sbjct: 267 SFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS---------------FTKQS 311
Query: 295 LNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGS--I 352
++ +L S L L L N + G N T L +L L LS + +
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371
Query: 353 PLALGNL--TKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIP-KEIGDMKS 409
+L + L L+L+ NK+S +F+ L L L L N + + +E +++
Sbjct: 372 NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431
Query: 410 LSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI--VGEIPLGHGKFSSLIQLILNNN 467
+ + LS NK S A + + L+ L L + V P +L L L+NN
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPS-LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490
Query: 468 ELSGQLSPELGSLNQLEYLDLSAN--------TFHNSIPESLGNLVKLHYLNLSNNQFSQ 519
++ L L +LE LDL N L L LH LNL +N F +
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
Query: 520 KIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEE-MHW 578
+ L L +DL S + SL+ LNL N ++ + F
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610
Query: 579 LSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDI 617
L+ +D+ +N + F + L
Sbjct: 611 LTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 353 bits (907), Expect = e-109
Identities = 142/622 (22%), Positives = 233/622 (37%), Gaps = 37/622 (5%)
Query: 26 LKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLS 85
++ S +L+ +P ++ +++ L+L N L+ + + L +D+G N +S
Sbjct: 6 HEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 86 GSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKF 145
P L L L L +N L+ + TNL L+L N++ + K
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122
Query: 146 LSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLK--SLSDLRLDYNT 203
L L +S+N LS + L NL L + N + E+ SL L L N
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182
Query: 204 LSGSILYSFGNLTKLEILYLDVNALSGLIPNEIG---NLKSLLALQLNYNTLSGSIPCSF 260
+ F + +L L+L+ L + ++ S+ L L+ + LS + +F
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 261 GNL--TKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLY 318
L T L + L N L+ + L L + L YN + SL L N+ L
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLN 302
Query: 319 ---------FSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSI 369
S +L L+ L L + +N + G L L L LS
Sbjct: 303 LKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSN 362
Query: 370 NKLSGS--IPLSFASL--TSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIP 425
+ S +F SL + L L L +N + + L +LDL N++ +
Sbjct: 363 SFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422
Query: 426 LS-LANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSG--QLSPELGSLNQ 482
L N + +YLS N + SL +L+L L L
Sbjct: 423 GQEWRGLEN-IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN 481
Query: 483 LEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQ--------KIPNPIEKLIHLSEL 534
L LDLS N N + L L KL L+L +N ++ ++ L HL L
Sbjct: 482 LTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHIL 541
Query: 535 DLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIP 594
+L F E + L+ ++L NNL+ + F L +++ N + +
Sbjct: 542 NLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601
Query: 595 NS--TAFRDAPMLALQGNKRLC 614
AFR+ L ++ N C
Sbjct: 602 KVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 305 bits (782), Expect = 1e-91
Identities = 127/540 (23%), Positives = 193/540 (35%), Gaps = 29/540 (5%)
Query: 97 SLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTL 156
S S+ L +P L TN+ L L N L L+ L V +NT+
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 157 SGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLT 216
S P L L L + N LS +L++L L N++ F
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 217 KLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFG--NLTKLVISCLGTN 274
L L L N LS L++L L L+ N + + L L +N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 275 ALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLG---SLTNLATLYFSTNALSGSIPNE 331
+ + L L LN L S+ L + T++ L S + LS +
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 332 ITNLR--SLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTL 389
L+ +L+ L LS N LN + L +L L N + S L ++ L
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301
Query: 390 YLYEN---------SLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYL 440
L + SL +K L L++ N + G L N LK L L
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLIN-LKYLSL 360
Query: 441 SSNHIVGEIP----LGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNS 496
S++ S L L L N++S S L LE LDL N
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE 420
Query: 497 IP-ESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSY-KIFG-EEIPSQVCSMQ 553
+ + L + + LS N++ Q N + L L L + + PS ++
Sbjct: 421 LTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480
Query: 554 SLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRL 613
+L L+LS+NN++ E + L +D+ +N L L + A P+ L+G L
Sbjct: 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKH--ANPGGPIYFLKGLSHL 538
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 5e-58
Identities = 82/438 (18%), Positives = 140/438 (31%), Gaps = 62/438 (14%)
Query: 1 MLKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKN---------QLSGLIPHEIGRLSSLN 51
L+ L +N + L +++ L+ ++ L + L L
Sbjct: 273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLE 332
Query: 52 GLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLS-GSIPNEVGS---LKSLSDLRLSNNS 107
L++ N + G L +L Y+ + N+ S ++ NE L L L+ N
Sbjct: 333 HLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNK 392
Query: 108 LNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNL 167
++ + L +L L L +N + + L
Sbjct: 393 ISKIESDAFSWLGHLEVLDLGLNEIGQELT-----------------------GQEWRGL 429
Query: 168 TNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSG--SILYSFGNLTKLEILYLDV 225
N+ +Y+ N N + SL L L L S F L L IL L
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 226 NALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIG 285
N ++ + + + L+ L L L +N L + L +A + +
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNL----------------ARLWKHANPGGPIYFLK 533
Query: 286 NLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSE 345
L L L L N L L + N L+ + N SL L L +
Sbjct: 534 GLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQK 593
Query: 346 NTLNGSIPLALG-NLTKLVSLDLSINKLSGSIP-----LSFASLTSLTTLYLYENSLCDS 399
N + G L LD+ N + +++ + T L + LC++
Sbjct: 594 NLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNT 653
Query: 400 IPKEIGDMKSLSILDLSS 417
P G + + D SS
Sbjct: 654 PPHYHG--FPVRLFDTSS 669
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-23
Identities = 45/183 (24%), Positives = 73/183 (39%), Gaps = 6/183 (3%)
Query: 432 TNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSAN 491
T S +V S + ++P +++ L L +N+L + +QL LD+ N
Sbjct: 3 TVSHEVADCSHLKLT-QVP--DDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59
Query: 492 TFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCS 551
T PE L L LNL +N+ SQ +L+EL L + +
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 552 MQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLA---LQ 608
++L L+LSHN LS + ++ L + +S N +Q L L L
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 609 GNK 611
N+
Sbjct: 180 SNQ 182
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 341 bits (876), Expect = e-105
Identities = 101/589 (17%), Positives = 184/589 (31%), Gaps = 71/589 (12%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSG----LIPHEIGRLSSLNGLSLYS 57
+ L L SG +P IG LT L++L+ + P I S
Sbjct: 83 VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMR 142
Query: 58 NFLKGSIPPSLG--NLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSS 115
+ + + + LI I ++ SI + + +N++ + +
Sbjct: 143 MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKA 201
Query: 116 LGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYI 175
+ LT L Y+ + E + Y NL +L + +
Sbjct: 202 VMRLTKLRQFYMGNSPFVAENICEAWENENS-----EYAQQYKTEDLKWDNLKDLTDVEV 256
Query: 176 GINALSGSIPNEIGNLKSLSDLRLDYNTL--------SGSILYSFGNLTKLEILYLDVNA 227
+P + L + + + N L K++I+Y+ N
Sbjct: 257 YNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316
Query: 228 LSGL-IPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGN 286
L + + +K L L+ YN L G +P +FG+ KL L N ++ G
Sbjct: 317 LKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGF 375
Query: 287 LKSLLHLQLNYNTLSG-SIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSE 345
+ + +L +N L S++ ++ + FS N +
Sbjct: 376 TEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP----------- 424
Query: 346 NTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSL-------CD 398
+ + S++LS N++S F++ + L+++ L N L
Sbjct: 425 ------LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLK 478
Query: 399 SIPKEIGDMKSLSILDLSSNKLNGSIP-LSLANLTNSLKVLYLSSNHIVGEIPLGHGKFS 457
+ + L+ +DL NKL L L + LS N + P S
Sbjct: 479 DENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPY-LVGIDLSYNSF-SKFPTQPLNSS 536
Query: 458 SLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQF 517
+L + N D N PE + L L + +N
Sbjct: 537 TLKGFGIRNQ------------------RDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578
Query: 518 SQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLS 566
K+ I ++S LD+ S VC L ++
Sbjct: 579 R-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = 9e-97
Identities = 88/561 (15%), Positives = 168/561 (29%), Gaps = 61/561 (10%)
Query: 67 SLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNG----SIPSSLGNLTNL 122
SL + + + + SG +P+ +G L L L L ++ P + +
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 123 VTLYLHMNALSGSIPDEIGNLKF--LSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINAL 180
+ D F L ++ + +I S + N +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 181 SGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLK 240
+ + + L L + + + E + NLK
Sbjct: 196 T-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQ-----QYKTEDLKWDNLK 249
Query: 241 SLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTL 300
L +++ +P L ++ + + N S
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS----------------GEQLKD 293
Query: 301 SGSIPLSLGSLTNLATLYFSTNAL-SGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNL 359
+ +Y N L + + + ++ L L+ N L G +P A G+
Sbjct: 294 DWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSE 352
Query: 360 TKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPK--EIGDMKSLSILDLSS 417
KL SL+L+ N+++ + L N L IP + + +S +D S
Sbjct: 353 IKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSY 411
Query: 418 NKLNG-------SIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELS 470
N++ + + N + + LS+N I S L + L N L+
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGIN-VSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470
Query: 471 G-------QLSPELGSLNQLEYLDLSANTFHNSIPESL--GNLVKLHYLNLSNNQFSQKI 521
+ + L +DL N + + L L ++LS N FS K
Sbjct: 471 EIPKNSLKDENENFKNTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSFS-KF 528
Query: 522 PNPIEKLIHLSELDLSYKI------FGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEE 575
P L + + E P + SL +L + N++ +
Sbjct: 529 PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPN 588
Query: 576 MHWLSCIDISYNALQGLIPNS 596
+ L DI N + +
Sbjct: 589 ISVL---DIKDNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = 7e-90
Identities = 89/558 (15%), Positives = 179/558 (32%), Gaps = 52/558 (9%)
Query: 104 SNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSG----A 159
+ SL + + L L SG +PD IG L L L + +
Sbjct: 65 ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF 124
Query: 160 IPFSLGNLTNLVTLYIGINALSGSIPNEIGNLK--SLSDLRLDYNTLSGSILYSFGNLTK 217
P + + + + L ++ + SI S K
Sbjct: 125 GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184
Query: 218 LEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALS 277
+ N ++ + + L L + + C
Sbjct: 185 DTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN-----SEYAQQY 238
Query: 278 SSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNAL--------SGSIP 329
+ + NLK L +++ +P L +L + + + N
Sbjct: 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298
Query: 330 NEITNLRSLSDLQLSENTL-NGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTT 388
+ + + + N L + +L + KL L+ N+L G +P +F S L +
Sbjct: 299 ADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLAS 357
Query: 389 LYLYENSLCDSIPKEI-GDMKSLSILDLSSNKLNG-SIPLSLANLTNSLKVLYLSSNHIV 446
L L N + IP G + + L + NKL +++ + + S N I
Sbjct: 358 LNLAYNQI-TEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSV-MSAIDFSYNEIG 415
Query: 447 G-------EIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFH----- 494
+ K ++ + L+NN++S + + L ++L N
Sbjct: 416 SVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKN 475
Query: 495 --NSIPESLGNLVKLHYLNLSNNQFSQKIPNPIE--KLIHLSELDLSYKIFGEEIPSQVC 550
E+ N L ++L N+ + K+ + L +L +DLSY F + P+Q
Sbjct: 476 SLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSF-SKFPTQPL 533
Query: 551 SMQSLEKLNLSH------NNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPM 604
+ +L+ + + N L+ + I N ++ + + +
Sbjct: 534 NSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKI--TPNISV 591
Query: 605 LALQGNKRLCGDIKRLPP 622
L ++ N + D+ + P
Sbjct: 592 LDIKDNPNISIDLSYVCP 609
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 6e-86
Identities = 85/538 (15%), Positives = 167/538 (31%), Gaps = 86/538 (15%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L ++ + SI + N ++ + + RL+ L + ++
Sbjct: 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFV 219
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
+ Y + + +LK L+D+ + N +P+ L L
Sbjct: 220 AENICEAWENENSEY-----AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPE 274
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINAL- 180
+ + + N + +YIG N L
Sbjct: 275 MQLINVACNRGIS----------------GEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318
Query: 181 SGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLK 240
+ + + +K L L YN L G + +FG+ KL L L N ++ + N G +
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKL-PAFGSEIKLASLNLAYNQITEIPANFCGFTE 377
Query: 241 SLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTL 300
+ L +N L IP F + ++ + + +YN +
Sbjct: 378 QVENLSFAHNKLK-YIPNIF----------------------DAKSVSVMSAIDFSYNEI 414
Query: 301 SG-------SIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNG--- 350
+ + N++++ S N +S + LS + L N L
Sbjct: 415 GSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPK 474
Query: 351 ----SIPLALGNLTKLVSLDLSINKLSGSIP-LSFASLTSLTTLYLYENSLCDSIPKEIG 405
N L S+DL NKL+ +L L + L NS P +
Sbjct: 475 NSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQPL 533
Query: 406 DMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILN 465
+ +L + + N + E P G SL QL +
Sbjct: 534 NSSTLKGFGIRNQ-------------------RDAQGNRTLREWPEGITLCPSLTQLQIG 574
Query: 466 NNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPN 523
+N++ ++ ++ + LD+ N + + ++ L ++ +Q I
Sbjct: 575 SNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK-TQDIRG 628
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 5e-80
Identities = 79/502 (15%), Positives = 158/502 (31%), Gaps = 39/502 (7%)
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L ++ +N + S + + SL + + L + S
Sbjct: 35 LKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGAS 94
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSG----SILYSFGNLTKLEILYLDVNALSGLIPNEIG 237
G +P+ IG L L L L + E +
Sbjct: 95 GRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDP 154
Query: 238 NLK--SLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQL 295
L+ +N + SI S K +N + + + + + L L +
Sbjct: 155 REDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYM 213
Query: 296 NYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLA 355
+ N + + NL+ L+D+++ +P
Sbjct: 214 GNSPFVAENICEAWENENS-----EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTF 268
Query: 356 LGNLTKLVSLDLSINKL--------SGSIPLSFASLTSLTTLYLYENSLCD-SIPKEIGD 406
L L ++ ++++ N+ + +Y+ N+L + +
Sbjct: 269 LKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQK 328
Query: 407 MKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNN 466
MK L +L+ N+L G +P + + L L L+ N I G + L +
Sbjct: 329 MKKLGMLECLYNQLEGKLP-AFGSEIK-LASLNLAYNQITEIPANFCGFTEQVENLSFAH 386
Query: 467 NELSG-QLSPELGSLNQLEYLDLSANTFH-------NSIPESLGNLVKLHYLNLSNNQFS 518
N+L + S++ + +D S N + + + + + +NLSNNQ S
Sbjct: 387 NKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS 446
Query: 519 QKIPNPIEKLIHLSELDLSY-------KIFGEEIPSQVCSMQSLEKLNLSHNNLSGSI-S 570
+ LS ++L K ++ + L ++L N L+
Sbjct: 447 KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDD 506
Query: 571 RCFEEMHWLSCIDISYNALQGL 592
+ +L ID+SYN+
Sbjct: 507 FRATTLPYLVGIDLSYNSFSKF 528
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 2e-70
Identities = 69/451 (15%), Positives = 148/451 (32%), Gaps = 33/451 (7%)
Query: 170 LVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALS 229
L ++ +N + S + + + + S + ++ L L+ S
Sbjct: 35 LKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGAS 94
Query: 230 GLIPNEIGNLKSLLALQLNYNTLSG----SIPCSFGNLTKLVISCLGTNALSSSILEEIG 285
G +P+ IG L L L L + P + ++
Sbjct: 95 GRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDP 154
Query: 286 NLK--SLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQL 343
L+ +N + SI S + +N ++ + + L L +
Sbjct: 155 REDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYM 213
Query: 344 SENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKE 403
+ + + + L + +L LT + +Y +P
Sbjct: 214 GNSPFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTF 268
Query: 404 IGDMKSLSILDLSSNKL--------NGSIPLSLANLTNSLKVLYLSSNHI-VGEIPLGHG 454
+ + + +++++ N+ + ++++Y+ N++ +
Sbjct: 269 LKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK-IQIIYIGYNNLKTFPVETSLQ 327
Query: 455 KFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSN 514
K L L N+L G P GS +L L+L+ N G ++ L+ ++
Sbjct: 328 KMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAH 386
Query: 515 NQFSQKIPNPIE--KLIHLSELDLSY-------KIFGEEIPSQVCSMQSLEKLNLSHNNL 565
N+ IPN + + +S +D SY + + ++ +NLS+N +
Sbjct: 387 NKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQI 445
Query: 566 SGSISRCFEEMHWLSCIDISYNALQGLIPNS 596
S F LS I++ N L + NS
Sbjct: 446 SKFPKELFSTGSPLSSINLMGNMLTEIPKNS 476
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-19
Identities = 25/138 (18%), Positives = 49/138 (35%), Gaps = 13/138 (9%)
Query: 1 MLKVLGLSFNQFSGSIPPEI--GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSL--- 55
+L + L FN+ + + + L +L + S N S P + S+L G +
Sbjct: 489 LLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546
Query: 56 ---YSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSI 112
N P + SL + IG+N + + ++ ++S L + +N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISID 603
Query: 113 PSSLGNLTNLVTLYLHMN 130
S + L +
Sbjct: 604 LSYVCPYIEAGMYMLFYD 621
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = 1e-94
Identities = 120/537 (22%), Positives = 189/537 (35%), Gaps = 30/537 (5%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
K L LSFN L++L S+ ++ + LS L+ L L N ++
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNG-SIPSSLGNLT 120
+ L+SL + L+ +G LK+L +L +++N + +P NLT
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 121 NLVTLYLHMNALSGSIPDEIGNLKFLSDLQV----SYNTLSGAIPFSLGNLTNLVTLYIG 176
NL L L N + ++ L + L + S N ++ P + + L L +
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLR 208
Query: 177 INALSGSIPNE-IGNLKSLSDLRLDYNTLSGS------ILYSFGNLTKLEILYLDVNALS 229
N S ++ I L L RL + L L I + L
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 230 ---GLIPNEIGNLKSLLALQLNYNTLSGSIPCSF-GNLTKLVISCLGTNALSSSILEEIG 285
I + L ++ + L T+ S+ L + +
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT------L 322
Query: 286 NLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALS--GSIPNEITNLRSLSDLQL 343
LKSL L N G S L +L L S N LS G SL L L
Sbjct: 323 KLKSLKRLTFTSN--KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 344 SENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLS-FASLTSLTTLYLYENSLCDSIPK 402
S N + + L +L LD + L S F SL +L L + +
Sbjct: 381 SFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 403 EIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQL 462
+ SL +L ++ N + + +L L LS + P SSL L
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 463 ILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVK-LHYLNLSNNQFS 518
+++N + LN L+ LD S N S + L + L +LNL+ N F+
Sbjct: 500 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 308 bits (792), Expect = 7e-94
Identities = 119/569 (20%), Positives = 187/569 (32%), Gaps = 42/569 (7%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSL 74
IP + K L S N L L + L L L ++ + +L+ L
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 75 IYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNAL-S 133
+ + N + L SL L +L +G+L L L + N + S
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 134 GSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNL----VTLYIGINALSGSIPNEIG 189
+P+ NL L L +S N + L L + ++L + +N ++ P
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 190 NLKSLSDLRLDYNTLSGSILY-SFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLN 248
+ L L L N S +++ L LE+ L + N
Sbjct: 199 EI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR------------------N 239
Query: 249 YNTLSGSIPCSFGNLTKLVISCLGTNALSSS---ILEEIGNLKSLLHLQLNYNTLSGSIP 305
L + L L I L I++ L ++ L T+
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
Query: 306 LSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSL 365
S L ++ +L+ L+ G + +L L L
Sbjct: 300 FSY--NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTS-----NKGGNAFSEVDLPSLEFL 352
Query: 366 DLSINKLS--GSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGS 423
DLS N LS G S TSL L L N + ++ ++ L LD + L
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQM 411
Query: 424 IPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPE-LGSLNQ 482
S+ +L L +S H SSL L + N P+ L
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471
Query: 483 LEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFG 542
L +LDLS P + +L L LN+S+N F P + L L LD S
Sbjct: 472 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 531
Query: 543 EEIPSQVCSM-QSLEKLNLSHNNLSGSIS 570
++ SL LNL+ N+ + +
Sbjct: 532 TSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-41
Identities = 59/309 (19%), Positives = 111/309 (35%), Gaps = 21/309 (6%)
Query: 303 SIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKL 362
IP +L + L S N L + L L LS + A +L+ L
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 363 VSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNG 422
+L L+ N + +F+ L+SL L E +L IG +K+L L+++ N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 423 -SIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSL----IQLILNNNELSGQLSPEL 477
+P +NLTN L+ L LSSN I + + L L+ N ++ + P
Sbjct: 139 FKLPEYFSNLTN-LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGA 196
Query: 478 GSLNQLEYLDLSANTFHNSIPE-SLGNLVKLHYLNLSNNQFS------QKIPNPIEKLIH 530
+L L L N ++ + + L L L +F + + +E L +
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 531 LSELDLSYK---IFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYN 587
L+ + + ++I + ++ +L + + +++
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFG--WQHLELVNC 314
Query: 588 ALQGLIPNS 596
Sbjct: 315 KFGQFPTLK 323
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 6e-41
Identities = 55/270 (20%), Positives = 98/270 (36%), Gaps = 8/270 (2%)
Query: 1 MLKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLS--GLIPHEIGRLSSLNGLSLYSN 58
+ + L+F G L L+ L S+N LS G +SL L L N
Sbjct: 324 LKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 59 FLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSSLG 117
+ + + L L ++D ++ L V SL++L L +S+ +
Sbjct: 384 GVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442
Query: 118 NLTNLVTLYLHMNALSGSI-PDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIG 176
L++L L + N+ + PD L+ L+ L +S L P + +L++L L +
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 502
Query: 177 INALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNL-TKLEILYLDVNALSGLIPNE 235
N L SL L N + S + + L L L N + ++
Sbjct: 503 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562
Query: 236 --IGNLKSLLALQLNYNTLSGSIPCSFGNL 263
+ +K L + + + P +
Sbjct: 563 SFLQWIKDQRQLLVEVERMECATPSDKQGM 592
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 295 bits (756), Expect = 1e-88
Identities = 113/547 (20%), Positives = 189/547 (34%), Gaps = 18/547 (3%)
Query: 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKG 62
K + IP + + L FS N L + RL +L L L +
Sbjct: 15 KTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 63 SIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNL 122
+ + L + + N L + K+L L ++ L N L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 123 VTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS- 181
+LYL N +S + + L L N + + +L L + +N
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSIL--YSFGNLTKLEILYLDVNALSGLIPNEIGNL 239
I + L I + L + + + P L
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 240 K--SLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNY 297
S+ ++ L + +F + L L L S + + L +L L L+
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSA 310
Query: 298 NTLSGSIPLSLGSLTNLATLYFSTNALSGSI-PNEITNLRSLSDLQLSENTLNGS--IPL 354
N +S + +L L N + + NL +L +L LS + + S L
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 355 ALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEI-GDMKSLSIL 413
L NL+ L SL+LS N+ +F L L L L + ++ L +L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 414 DLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKF---SSLIQLILNNNELS 470
+LS + L+ S L L+ L L NH L L+L+ +LS
Sbjct: 431 NLSHSLLDISSEQLFDGLPA-LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
Query: 471 GQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIH 530
SL + ++DLS N +S E+L +L + YLNL++N S +P+ + L
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQ 548
Query: 531 LSELDLS 537
++L
Sbjct: 549 QRTINLR 555
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 2e-87
Identities = 115/555 (20%), Positives = 197/555 (35%), Gaps = 16/555 (2%)
Query: 27 KLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSG 86
K + L+ IP + +S L N L + L +L ++D+ +
Sbjct: 15 KTYNCENLGLNE-IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 87 SIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFL 146
+ S L L L+ N L ++L L L+ +S + N K L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 147 SDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLS- 205
L + N +S L L NA+ ++ +L+ ++L L+ N
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 206 GSILYSFGNLTKLEILYLDVNALSGLIPNEIGN--LKSLLALQLNYNTLSGSIPCSFGNL 263
I + + L +I + N ++SL P F L
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 264 TKLVISCL--GTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFST 321
++ + + + + L L L LS +P L L+ L L S
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310
Query: 322 NALSGSIPNEITNLRSLSDLQLSENTLNGSI-PLALGNLTKLVSLDLSINKL--SGSIPL 378
N +N SL+ L + NT + L NL L LDLS + + S L
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 379 SFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVL 438
+L+ L +L L N + + L +LDL+ +L S + LKVL
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 439 YLSSNHIVGEIPLGHGKFSSLIQLILNNNELSG---QLSPELGSLNQLEYLDLSANTFHN 495
LS + + +L L L N Q + L +L +LE L LS +
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
Query: 496 SIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSL 555
+ +L +++++LS+N+ + + L + L+L+ +PS + +
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQ 549
Query: 556 EKLNLSHNNLSGSIS 570
+NL N L + S
Sbjct: 550 RTINLRQNPLDCTCS 564
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 9e-84
Identities = 118/533 (22%), Positives = 205/533 (38%), Gaps = 20/533 (3%)
Query: 77 IDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSI 136
+ N L+ IP + S L S N L ++ L NL L L +
Sbjct: 17 YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 137 PDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSD 196
D + L L ++ N L +L L L+ +S + N K+L
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 197 LRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSL--LALQLNYNTLSG 254
L L N +S L KL++L NA+ L ++ +L+ L+L LN N ++
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA- 192
Query: 255 SIPCSFGNLTKLVISCLGTNALSSSILEEIGN--LKSLLHLQLNYNTLSGSIPLSLGSL- 311
I + G I + + N ++SL P L
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252
Query: 312 -TNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSIN 370
++ ++ + N L +L L+ L+ +P L L+ L L LS N
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSAN 311
Query: 371 KLSGSIPLSFASLTSLTTLYLYENSLCDSIPKE-IGDMKSLSILDLSSNKLNGS--IPLS 427
K +S ++ SLT L + N+ + + ++++L LDLS + + S L
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
Query: 428 LANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPE-LGSLNQLEYL 486
L NL++ L+ L LS N + + L L L L + + +L+ L+ L
Sbjct: 372 LRNLSH-LQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 487 DLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKI---PNPIEKLIHLSELDLSYKIFGE 543
+LS + S + L L +LNL N F + N ++ L L L LS+
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
Query: 544 EIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNS 596
S++ + ++LSHN L+ S + + ++++ N + ++P+
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSL 542
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 6e-82
Identities = 107/528 (20%), Positives = 173/528 (32%), Gaps = 37/528 (7%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L L L+ Q L L + N L + + +L L +
Sbjct: 59 LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
L N +L + +G+N +S + + L L NN+++ + +L
Sbjct: 119 SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQ 178
Query: 122 LVTLYLHMNALS-GSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGN--LTNLVTLYIGIN 178
L L++N I + L I L N + +L
Sbjct: 179 ATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 179 ALSGSIPNEIGNLKSLS--DLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEI 236
P L +S + L + +F + L+ L L LS +P+ +
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGL 297
Query: 237 GNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLN 296
L +L L L+ N S N SL HL +
Sbjct: 298 VGLSTLKKLVLSANKFENLCQISASNFP------------------------SLTHLSIK 333
Query: 297 YNTLSGSI-PLSLGSLTNLATLYFSTNAL--SGSIPNEITNLRSLSDLQLSENTLNGSIP 353
NT + L +L NL L S + + S ++ NL L L LS N
Sbjct: 334 GNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKT 393
Query: 354 LALGNLTKLVSLDLSINKLSGSIPLS-FASLTSLTTLYLYENSLCDSIPKEIGDMKSLSI 412
A +L LDL+ +L S F +L L L L + L S + + +L
Sbjct: 394 EAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQH 453
Query: 413 LDLSSNKLNGSIPLSLANLTN--SLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELS 470
L+L N +L L++L LS + + + L++N L+
Sbjct: 454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT 513
Query: 471 GQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFS 518
S E S + YL+L++N +P L L + +NL N
Sbjct: 514 S-SSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-25
Identities = 42/191 (21%), Positives = 76/191 (39%), Gaps = 5/191 (2%)
Query: 1 MLKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEI-GRLSSLNGLSLYSNF 59
L+ L LS+N+ L+LL + +L L L L+L +
Sbjct: 377 HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSL 436
Query: 60 LKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLR---LSNNSLNGSIPSSL 116
L S L +L ++++ N + SL++L L LS L+ +
Sbjct: 437 LDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAF 496
Query: 117 GNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIG 176
+L + + L N L+ S + + +LK + L ++ N +S +P L L+ T+ +
Sbjct: 497 TSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLR 555
Query: 177 INALSGSIPNE 187
N L + N
Sbjct: 556 QNPLDCTCSNI 566
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 2e-85
Identities = 102/591 (17%), Positives = 186/591 (31%), Gaps = 77/591 (13%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
+ L L+ G +P IG LT LK+LSF + + + + + ++
Sbjct: 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIR 384
Query: 62 GSIPP-SLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNG------SIPS 114
L L D+ + ++ + E+ +K S + L + + I
Sbjct: 385 MHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRITFISK 442
Query: 115 SLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLY 174
++ LT L +Y + + D Y S NL +L +
Sbjct: 443 AIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDVE 497
Query: 175 IGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPN 234
+ +P+ + +L L L + N + T+ + +
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGIS-AAQLKADWTR--------------LAD 542
Query: 235 EIGNLKSLLALQLNYNTLSG-SIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHL 293
+ + + YN L S + KL + N + LE G L L
Sbjct: 543 DEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH--LEAFGTNVKLTDL 600
Query: 294 QLNYNTLSGSIPLSLGS-LTNLATLYFSTNALSGSIPN--EITNLRSLSDLQLSENTL-- 348
+L+YN + IP + + L FS N L IPN ++ + + S N +
Sbjct: 601 KLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGS 658
Query: 349 ---NGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSL-------CD 398
N S + ++ LS N++ FA+ + ++T+ L N +
Sbjct: 659 EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLK 718
Query: 399 SIPKEIGDMKSLSILDLSSNKLNGSIP--LSLANLTNSLKVLYLSSNHIVGEIPLGHGKF 456
+ L+ +DL NKL S+ L L + +S N P
Sbjct: 719 PKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPY-LSNMDVSYNCF-SSFPTQPLNS 775
Query: 457 SSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQ 516
S L + + D N P + L L + +N
Sbjct: 776 SQLKAFGIRHQ------------------RDAEGNRILRQWPTGITTCPSLIQLQIGSND 817
Query: 517 FSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQVCSMQSLEKLNLSHNNLS 566
K+ + L LD++ ++ S VC L ++
Sbjct: 818 IR-KVDE--KLTPQLYILDIADNPNISIDVTS-VCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 275 bits (704), Expect = 4e-79
Identities = 93/583 (15%), Positives = 176/583 (30%), Gaps = 56/583 (9%)
Query: 80 GNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDE 139
G N S + + L N + L L G +PD
Sbjct: 283 GKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDA 342
Query: 140 IGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNE-IGNLKSLSDLR 198
IG L L L ++ + + + + + + L+
Sbjct: 343 IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402
Query: 199 LDYNTLSGSILYSFGNLTKLEILYLDVNALSGL------IPNEIGNLKSLLALQLNYNTL 252
L + ++ + K + L + L I I L L + +
Sbjct: 403 LLQDAINR--NPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPF 460
Query: 253 SGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLT 312
+ + NLK L ++L +P L L
Sbjct: 461 TYDNIAVDWEDAN-----SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLP 515
Query: 313 NLATLYFSTNALSG---------SIPNEITNLRSLSDLQLSENTLNG-SIPLALGNLTKL 362
L +L + N + ++ + + N L +L + KL
Sbjct: 516 ELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKL 575
Query: 363 VSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIG-DMKSLSILDLSSNKLN 421
LD NK+ + +F + LT L L N + + IP++ + L S NKL
Sbjct: 576 GLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQI-EEIPEDFCAFTDQVEGLGFSHNKLK 632
Query: 422 GSIP--LSLANLTNSLKVLYLSSNHIVGEIP-----LGHGKFSSLIQLILNNNELSGQLS 474
IP + ++ + + S N I E + K + + L+ NE+ +
Sbjct: 633 -YIPNIFNAKSVYV-MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPT 690
Query: 475 PELGSLNQLEYLDLSANTF-------HNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIE- 526
+ + + + LS N + N L ++L N+ + + +
Sbjct: 691 ELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRA 749
Query: 527 -KLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSH------NNLSGSISRCFEEMHWL 579
L +LS +D+SY F P+Q + L+ + H N + L
Sbjct: 750 TTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSL 808
Query: 580 SCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPP 622
+ I N ++ + +L + N + D+ + P
Sbjct: 809 IQLQIGSNDIRKVDEK--LTPQLYILDIADNPNISIDVTSVCP 849
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 254 bits (649), Expect = 1e-71
Identities = 81/478 (16%), Positives = 157/478 (32%), Gaps = 47/478 (9%)
Query: 1 MLKVLGLSFNQFSGSIPPEIGHLTHLKLLSF--SKNQLSGLIPHEIGRLSSLNGLSLYSN 58
+ +L + N+ P + LK N+++ I I RL+ L + ++
Sbjct: 400 LSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANS 458
Query: 59 FLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGN 118
+ Y + +LK L+D+ L N +P L +
Sbjct: 459 PFTYDNIAVDWEDANSDY-----AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD 513
Query: 119 LTNLVTLYLHMNALSG---------SIPDEIGNLKFLSDLQVSYNTLSG-AIPFSLGNLT 168
L L +L + N + D+ + + YN L SL +
Sbjct: 514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMV 573
Query: 169 NLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNAL 228
L L N + G L+DL+LDYN + ++E L N L
Sbjct: 574 KLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKL 631
Query: 229 SGLIPN-EIGNLKSLLALQLNYNTLSG-----SIPCSFGNLTKLVISCLGTNALSSSILE 282
+ ++ + ++ +YN + S L N + E
Sbjct: 632 KYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTE 691
Query: 283 EIGNLKSLLHLQLNYNTLS-------GSIPLSLGSLTNLATLYFSTNALSGSIPNEI--T 333
+ + L+ N ++ + + L T+ N L+ S+ ++ T
Sbjct: 692 LFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRAT 750
Query: 334 NLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDL------SINKLSGSIPLSFASLTSLT 387
L LS++ +S N + S P N ++L + + N++ P + SL
Sbjct: 751 TLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLI 809
Query: 388 TLYLYENSLCDSIPKEIGDMKSLSILDLSSNKL-NGSIPLSLANLTNSLKVLYLSSNH 444
L + N + + +++ L ILD++ N + + + + VL
Sbjct: 810 QLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-37
Identities = 54/286 (18%), Positives = 93/286 (32%), Gaps = 28/286 (9%)
Query: 2 LKVLGLSFNQFSGSIPPEIG-HLTHLKLLSFSKNQLSGL-IPHEIGRLSSLNGLSLYSNF 59
L L L +NQ IP + ++ L FS N+L + + + + N
Sbjct: 597 LTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNK 655
Query: 60 LKG-----SIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSL------ 108
+ S + + + N + + +S + LSNN +
Sbjct: 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPEN 715
Query: 109 -NGSIPSSLGNLTNLVTLYLHMNALSGSIPDEI--GNLKFLSDLQVSYNTLSGAIPFSLG 165
+ N L T+ L N L+ S+ D+ L +LS++ VSYN S P
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPL 773
Query: 166 NLTNLVTLYI------GINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLE 219
N + L I N + P I SL L++ N + + +L
Sbjct: 774 NSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KV--DEKLTPQLY 830
Query: 220 ILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTK 265
IL + N + + L Y+ C + +
Sbjct: 831 ILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIER 876
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 6e-82
Identities = 95/312 (30%), Positives = 156/312 (50%), Gaps = 22/312 (7%)
Query: 672 QSSPRNTLGLLSVLTFDGKIVHEEIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVK 731
+ P LG L + E+ A+ NF +++ +G GG G VYK L G +VAVK
Sbjct: 7 EEDPEVHLGQLKRFSL------RELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 732 KFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMIL 791
+ + +F E ++ HRN+++ GFC +VY Y+ GS+A L
Sbjct: 61 RLKEE--RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL 118
Query: 792 SNDAAAEE-FGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDF 850
++ W KR G A L Y+H +C P I+HRD+ + N+LL+ E+EA V DF
Sbjct: 119 RERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178
Query: 851 GISKFLKLGLSN-RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFI 909
G++K + ++ T + GT G+IAPE T K +EK DV+ +GV+ LE+I G+ D
Sbjct: 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL- 237
Query: 910 SSICSSLSSNL---------NIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTS 960
+ + + L L+ ++D L +++ +++V++ C SP
Sbjct: 238 ARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG--NYKDEEVEQLIQVALLCTQSSPME 295
Query: 961 RPTMQKVSQLLK 972
RP M +V ++L+
Sbjct: 296 RPKMSEVVRMLE 307
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 3e-81
Identities = 88/280 (31%), Positives = 134/280 (47%), Gaps = 8/280 (2%)
Query: 7 LSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSG--LIPHEIGRLSSLNGLSLYS-NFLKGS 63
+ G + + L S L IP + L LN L + N L G
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92
Query: 64 IPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLV 123
IPP++ LT L Y+ I + +SG+IP+ + +K+L L S N+L+G++P S+ +L NLV
Sbjct: 93 IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152
Query: 124 TLYLHMNALSGSIPDEIGNLKFLS-DLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSG 182
+ N +SG+IPD G+ L + +S N L+G IP + NL NL + + N L G
Sbjct: 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEG 211
Query: 183 SIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSL 242
G+ K+ + L N+L+ + G L L L N + G +P + LK L
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFL 270
Query: 243 LALQLNYNTLSGSIPCSFGNLTKLVISCLGTN-ALSSSIL 281
+L +++N L G IP GNL + +S N L S L
Sbjct: 271 HSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPL 309
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 2e-79
Identities = 101/325 (31%), Positives = 146/325 (44%), Gaps = 35/325 (10%)
Query: 63 SIPPSLGNLTSL----IYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGS--IPSSL 116
I LGN T+L D N G + + +++L LS +L IPSSL
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 117 GNLTNLVTLYLH-MNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYI 175
NL L LY+ +N L G IP I L L L +++ +SGAIP L + LVTL
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 176 GINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKL-EILYLDVNALSGLIPN 234
NALSG++P I +L +L + D N +SG+I S+G+ +KL + + N L+G IP
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
Query: 235 EIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQ 294
NL +L + L+ N L G G+ K+ +
Sbjct: 193 TFANL-NLAFVDLSRNMLEGDAS------------------------VLFGSDKNTQKIH 227
Query: 295 LNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPL 354
L N+L+ + +G NL L N + G++P +T L+ L L +S N L G IP
Sbjct: 228 LAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP- 285
Query: 355 ALGNLTKLVSLDLSINKLSGSIPLS 379
GNL + + NK PL
Sbjct: 286 QGGNLQRFDVSAYANNKCLCGSPLP 310
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 3e-79
Identities = 92/332 (27%), Positives = 139/332 (41%), Gaps = 38/332 (11%)
Query: 28 LLSFSKNQLSGLIPHEIGRLSSLN-GLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSG 86
LL K L LSS + G + + + +D+ L
Sbjct: 11 LLQI-KKDLGNP-----TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 87 S--IPNEVGSLKSLSDLRLSN-NSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNL 143
IP+ + +L L+ L + N+L G IP ++ LT L LY+ +SG+IPD + +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 144 KFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLS-DLRLDYN 202
K L L SYN LSG +P S+ +L NLV + N +SG+IP+ G+ L + + N
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 203 TLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGN 262
L+G I +F NL L + L N L G G+ K+ + L N+L+ +
Sbjct: 185 RLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG----- 238
Query: 263 LTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTN 322
++G K+L L L N + G++P L L L +L S N
Sbjct: 239 --------------------KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 323 ALSGSIPNEITNLRSLSDLQLSENTLNGSIPL 354
L G IP NL+ + N PL
Sbjct: 279 NLCGEIPQG-GNLQRFDVSAYANNKCLCGSPL 309
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 3e-78
Identities = 78/265 (29%), Positives = 125/265 (47%), Gaps = 10/265 (3%)
Query: 2 LKVLGLSFNQFSGS--IPPEIGHLTHLKLLSFSK-NQLSGLIPHEIGRLSSLNGLSLYSN 58
+ L LS IP + +L +L L N L G IP I +L+ L+ L +
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 59 FLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGN 118
+ G+IP L + +L+ +D N LSG++P + SL +L + N ++G+IP S G+
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 119 LTNLVT-LYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGI 177
+ L T + + N L+G IP NL L+ + +S N L G G+ N +++
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230
Query: 178 NALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIG 237
N+L+ + ++G K+L+ L L N + G++ L L L + N L G IP G
Sbjct: 231 NSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-G 288
Query: 238 NLKSLLALQLNYNT-LSGSI--PCS 259
NL+ N L GS C+
Sbjct: 289 NLQRFDVSAYANNKCLCGSPLPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 3e-72
Identities = 76/329 (23%), Positives = 135/329 (41%), Gaps = 55/329 (16%)
Query: 298 NTLSGSIPLSLGSLTNLATLYFSTNALSGS--IPNEITNLRSLSDLQLS-ENTLNGSIPL 354
T G + + + L S L IP+ + NL L+ L + N L G IP
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 355 ALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILD 414
A+ LT+L L ++ +SG+IP + + +L TL N+L ++P I + +L +
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 415 LSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLS 474
N+++G+IP S + + + +S N + G+IP
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP------------------------ 191
Query: 475 PELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSEL 534
P +LN L ++DLS N G+ ++L+ N + +
Sbjct: 192 PTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG------------ 238
Query: 535 DLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIP 594
+V ++L L+L +N + G++ + ++ +L +++S+N L G IP
Sbjct: 239 -------------KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 595 NSTAFRDAPMLALQGNKRLCGDIKRLPPC 623
+ + A NK LCG LP C
Sbjct: 286 QGGNLQRFDVSAYANNKCLCGSP--LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 7e-71
Identities = 81/270 (30%), Positives = 130/270 (48%), Gaps = 8/270 (2%)
Query: 226 NALSGLIPNEIGNLKSLLALQLNYNTLSGS--IPCSFGNLTKLVISCL-GTNALSSSILE 282
G++ + + L L+ L IP S NL L + G N L I
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 283 EIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQ 342
I L L +L + + +SG+IP L + L TL FS NALSG++P I++L +L +
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 343 LSENTLNGSIPLALGNLTKLV-SLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIP 401
N ++G+IP + G+ +KL S+ +S N+L+G IP +FA+L +L + L N L
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDAS 214
Query: 402 KEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQ 461
G K+ + L+ N L + + N L L L +N I G +P G + L
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKN-LNGLDLRNNRIYGTLPQGLTQLKFLHS 272
Query: 462 LILNNNELSGQLSPELGSLNQLEYLDLSAN 491
L ++ N L G++ P+ G+L + + + N
Sbjct: 273 LNVSFNNLCGEI-PQGGNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 38/137 (27%), Positives = 59/137 (43%), Gaps = 3/137 (2%)
Query: 1 MLKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
+ + +S N+ +G IPP +L L + S+N L G G + + L N L
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL 233
Query: 61 KGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLT 120
+ +G +L +D+ NN + G++P + LK L L +S N+L G IP GNL
Sbjct: 234 AFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQ 291
Query: 121 NLVTLYLHMNALSGSIP 137
N P
Sbjct: 292 RFDVSAYANNKCLCGSP 308
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 7e-80
Identities = 119/577 (20%), Positives = 190/577 (32%), Gaps = 53/577 (9%)
Query: 7 LSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPP 66
+ S +P +I + K + S N L L + S L L L ++
Sbjct: 18 CMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDK 74
Query: 67 SLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLY 126
+ L L + + N + P L SL +L L +G L L L
Sbjct: 75 AWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLN 134
Query: 127 LHMNALSG-SIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNL----VTLYIGINALS 181
+ N + +P NL L + +SYN + L L ++L + +N +
Sbjct: 135 VAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID 194
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSIL-YSFGNLTKLEILYLDVNALSGLIPNEIGNLK 240
I ++ L +L L N S +I+ NL L + L + EI
Sbjct: 195 -FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPS 253
Query: 241 --------SLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLH 292
++ +L Y F L + L ++ LE++
Sbjct: 254 IMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQS 311
Query: 293 LQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSI 352
L + L L L +L + N SI + L SLS L LS N L+ S
Sbjct: 312 LSIIRCQLKQ---FPTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSG 366
Query: 353 PLALGNL--TKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKE-IGDMKS 409
+ +L L LDLS N + +F L L L ++L ++
Sbjct: 367 CCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK 425
Query: 410 LSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNEL 469
L LD+S LT+ L L ++ N
Sbjct: 426 LLYLDISYTNTKIDFDGIFLGLTS-LNTLKMAGNSFKDNTL------------------- 465
Query: 470 SGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLI 529
S + L +LDLS L +L LN+S+N + +L
Sbjct: 466 ----SNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLY 521
Query: 530 HLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLS 566
LS LD S+ +SL NL++N+++
Sbjct: 522 SLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 5e-79
Identities = 125/551 (22%), Positives = 214/551 (38%), Gaps = 28/551 (5%)
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
GS+ P + + ++ Y + L +P+++ S S ++ LS N L S N +
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLSK--VPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L L L + L LS+L ++ N + P S LT+L L L+
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSIL-YSFGNLTKLEILYLDVNALSGLIPNEIGNLK 240
IG L +L L + +N + L F NLT L + L N + + N++ L+
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 241 ----SLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLN 296
L+L ++ N + +F + ++ G S+ + + NL L +L
Sbjct: 178 ENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237
Query: 297 YNTLSGSIPLS------LGSLTNLAT--LYFSTNALSGSIPNEITNLRSLSDLQLSENTL 348
L + L ++ + + L ++S + L+ ++
Sbjct: 238 LGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297
Query: 349 NGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMK 408
+ K SL + +L L L +L L N SI + +
Sbjct: 298 KYLEDVP--KHFKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMNKG--SISFKKVALP 350
Query: 409 SLSILDLSSNKLNGSIPLSLANL-TNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNN 467
SLS LDLS N L+ S S ++L TNSL+ L LS N + + L L ++
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHS 409
Query: 468 ELSGQLSPE-LGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPI- 525
L SL +L YLD+S L L+ L ++ N F + +
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF 469
Query: 526 EKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDIS 585
+L+ LDLS + ++ L+ LN+SHNNL S + +++ LS +D S
Sbjct: 470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCS 529
Query: 586 YNALQGLIPNS 596
+N ++
Sbjct: 530 FNRIETSKGIL 540
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 6e-79
Identities = 116/534 (21%), Positives = 183/534 (34%), Gaps = 26/534 (4%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
K + LSFN + + L+ L S+ ++ + L L+ L L N ++
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNG-SIPSSLGNLT 120
P S LTSL + L+ +G L +L L +++N ++ +P+ NLT
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 121 NLVTLYLHMNALSGSIPDEIGNLKFLSD----LQVSYNTLSGAIPFSLGNLTNLVTLYIG 176
NLV + L N + +++ L+ L +S N + I L L +
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLR 212
Query: 177 INALSGSIPNE-IGNLKSLSDLRLDYNTLSGSI------LYSFGNLTKLEILYLD--VNA 227
N S +I + NL L RL L + I
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272
Query: 228 LSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNL 287
+ L ++ A+ L ++ K + L +L
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQF---PTLDL 327
Query: 288 KSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNL--RSLSDLQLSE 345
L L L N S I +L +L+ L S NALS S ++L SL L LS
Sbjct: 328 PFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385
Query: 346 NTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLS-FASLTSLTTLYLYENSLCDSIPKEI 404
N + L +L LD + L S F SL L L + +
Sbjct: 386 NGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIF 444
Query: 405 GDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLIL 464
+ SL+ L ++ N + ++ T +L L LS + L L +
Sbjct: 445 LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM 504
Query: 465 NNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFS 518
++N L S L L LD S N S L + NL+NN +
Sbjct: 505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 6e-72
Identities = 95/296 (32%), Positives = 140/296 (47%), Gaps = 33/296 (11%)
Query: 694 EEIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNA 753
++ AT NFD + IG+G G VYK L G VA+K+ P +EF E
Sbjct: 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT---PESSQGIEEFETEIET 88
Query: 754 LTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILS-NDAAAEEFGWTKRMNAIKGV 812
L+ RH ++V GFC ++Y+Y+E G+L L +D W +R+ G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 813 ADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR-----TELA 867
A L Y+HT I+HRD+ S N+LL+ + ++DFGISK G T +
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK---KGTELDQTHLSTVVK 202
Query: 868 GTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIA---- 923
GT GYI PE ++TEK DVYSFGV+ EV+ + S +N+A
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ-----SLPREMVNLAEWAV 257
Query: 924 -------LDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
L++++DP L +R + L + ++ CL S RP+M V L+
Sbjct: 258 ESHNNGQLEQIVDPNLADKIR--PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 4e-64
Identities = 111/525 (21%), Positives = 191/525 (36%), Gaps = 35/525 (6%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSL 74
IP + K L S N L L + L L L ++ + +L+ L
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 75 IYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNAL-S 133
+ + N + L SL L +L +G+L L L + N + S
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 134 GSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNL----VTLYIGINALSGSIPNEIG 189
+P+ NL L L +S N + L L + ++L + +N ++ I
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197
Query: 190 NLKSLSDLRLDYNTLSGSIL-YSFGNLTKLEILYLDVNALSG---LIPNEIGNLKSLLAL 245
L L L N S +++ L LE+ L + L + L+ L L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 246 QLNYNTLSG------SIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNT 299
+ L+ I F LT + L + + +++ HL+L
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCK 315
Query: 300 LSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLN--GSIPLALG 357
L +L L F++N + +L SL L LS N L+ G +
Sbjct: 316 FGQ---FPTLKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 358 NLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEI--GDMKSLSILDL 415
T L LDLS N + ++ +F L L L ++L + + +++L LD+
Sbjct: 371 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDI 428
Query: 416 SSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGH-GKFSSLIQLILNNNELSGQLS 474
S + L++ L+VL ++ N + +L L L+ +L QLS
Sbjct: 429 SHTHTRVAFNGIFNGLSS-LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLS 486
Query: 475 PE-LGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFS 518
P SL+ L+ L++++N + L L + L N +
Sbjct: 487 PTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 5e-57
Identities = 123/566 (21%), Positives = 200/566 (35%), Gaps = 63/566 (11%)
Query: 48 SSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNS 107
S L L N L+ S + L +D+ + SL LS L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 108 LNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTL-SGAIPFSLGN 166
+ + L++L L L+ IG+LK L +L V++N + S +P N
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 167 LTNLVTLYIGINALSGSIPNEIGNLKSLS----DLRLDYNTLSGSILYSFGNLTKLEILY 222
LTNL L + N + ++ L + L L N ++ +F + +L L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLT 206
Query: 223 LDVNALSG-LIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSIL 281
L N S ++ I L L +L + GNL K S L
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR-----NEGNLEKF----------DKSAL 251
Query: 282 EEIGNLKSLLHLQLNYNTLSGS-IPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSD 340
E + NL ++ +L Y I LTN+++ + + + + +
Sbjct: 252 EGLCNL-TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKD-FSYNFGWQH 308
Query: 341 LQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSL--CD 398
L+L L L +L +L + NK + S L SL L L N L
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRL---TFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKG 363
Query: 399 SIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSS 458
+ SL LDLS N + ++ + L L+ L +++
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQ-LEHLDFQHSNLKQMSEFSV----- 416
Query: 459 LIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFS 518
SL L YLD+S + L L L ++ N F
Sbjct: 417 ------------------FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458
Query: 519 QKI-PNPIEKLIHLSELDLSY-KIFGEEIPSQV-CSMQSLEKLNLSHNNLSGSISRCFEE 575
+ P+ +L +L+ LDLS ++ E++ S+ SL+ LN++ N L F+
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQL--EQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDR 516
Query: 576 MHWLSCIDISYNALQGLIPNSTAFRD 601
+ L I + N P
Sbjct: 517 LTSLQKIWLHTNPWDCSCPRIDYLSR 542
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 9e-53
Identities = 103/479 (21%), Positives = 182/479 (37%), Gaps = 41/479 (8%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L L L+ N L+ L+ L + L+ L IG L +L L++ N ++
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 62 -GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLS----DLRLSNNSLNGSIPSSL 116
+P NLT+L ++D+ +N + ++ L + L LS N +N I
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA 196
Query: 117 GNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIG 176
L L L N S ++ ++ L+ L+V L +
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTC--IQGLAGLEVHRLVLG---------------EFRN 239
Query: 177 INALSGSIPNEIGNLKSLSDLRLDYNTLSGS---ILYSFGNLTKLEILYLDVNALSGLIP 233
L + + L +L+ L I+ F LT + L + +
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV-- 297
Query: 234 NEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHL 293
+ L+L +L +L + S + +L SL L
Sbjct: 298 KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV-----DLPSLEFL 352
Query: 294 QLNYNTLS--GSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGS 351
L+ N LS G S T+L L S N + ++ + L L L + L
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQM 411
Query: 352 IPL-ALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEI-GDMKS 409
+L L+ LD+S + F L+SL L + NS ++ +I ++++
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471
Query: 410 LSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGH-GKFSSLIQLILNNN 467
L+ LDLS +L P + +L++ L+VL ++SN + +P G + +SL ++ L+ N
Sbjct: 472 LTFLDLSQCQLEQLSPTAFNSLSS-LQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-38
Identities = 90/413 (21%), Positives = 137/413 (33%), Gaps = 38/413 (9%)
Query: 2 LKVLGLSFNQF-SGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNG----LSLY 56
LK L ++ N S +P +LT+L+ L S N++ + ++ L + L L
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185
Query: 57 SNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRL------SNNSLN 109
N + I P L + + NN S ++ L L RL + +L
Sbjct: 186 LNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 110 GSIPSSLGNLTNLVTLYLHMNALSGS---IPDEIGNLKFLSDLQVSYNTLSGAIPFS-LG 165
S+L L NL + L I D L +S + T+ FS
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
Query: 166 NLTNLVTLYIGINALSGSIPNEI----------------GNLKSLSDLRLDYNTLS--GS 207
+L + + +L SL L L N LS G
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGC 364
Query: 208 ILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCS-FGNLTKL 266
S T L+ L L N + + + L+ L L ++ L S F +L L
Sbjct: 365 CSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423
Query: 267 VISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSI-PLSLGSLTNLATLYFSTNALS 325
+ + + L SL L++ N+ + P L NL L S L
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 326 GSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPL 378
P +L SL L ++ N L LT L + L N S P
Sbjct: 484 QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-32
Identities = 81/393 (20%), Positives = 142/393 (36%), Gaps = 43/393 (10%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKL----LSFSKNQLSGLIPHEIGRLSSLNGLSLYS 57
L+ L LS N+ ++ L + L L S N ++ I + L+ L+L +
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRN 209
Query: 58 NFLKGSIPP-SLGNLTSLIYIDIGNNLLSGS---IPNEVGSLKSLSDLRLSNNSLNG--- 110
NF ++ + L L + + +L+ L +L + L
Sbjct: 210 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDY 269
Query: 111 ---SIPSSLGNLTNLVTLYLHMNALSGSIPDEIGN--------------------LKFLS 147
I LTN+ + L + + D N LK L
Sbjct: 270 YLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK 328
Query: 148 DLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS--GSIPNEIGNLKSLSDLRLDYNTLS 205
L + N A +L +L L + N LS G SL L L +N +
Sbjct: 329 RLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
Query: 206 GSILYSFGNLTKLEILYLDVNALSGLIPNEI-GNLKSLLALQLNYNTLSGSIPCSFGNLT 264
++ +F L +LE L + L + + +L++L+ L +++ + F L+
Sbjct: 387 -TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445
Query: 265 KLVISCLGTNALSSSILEEI-GNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNA 323
L + + N+ + L +I L++L L L+ L P + SL++L L ++N
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ 505
Query: 324 LSGSIPNEITNLRSLSDLQLSENTLNGSIPLAL 356
L L SL + L N + S P
Sbjct: 506 LKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-29
Identities = 65/322 (20%), Positives = 118/322 (36%), Gaps = 21/322 (6%)
Query: 291 LHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNG 350
+ Q IP +L + L S N L + L L LS +
Sbjct: 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 351 SIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSL 410
A +L+ L +L L+ N + +F+ L+SL L E +L IG +K+L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 411 SILDLSSNKLN-GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSL----IQLILN 465
L+++ N + +P +NLTN L+ L LSSN I + + L L+
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTN-LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185
Query: 466 NNELSGQLSPELGSLNQLEYLDLSANTFHNSIPE-SLGNLVKLHYLNL------SNNQFS 518
N ++ + P +L L L N ++ + + L L L +
Sbjct: 186 LNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 519 QKIPNPIEKLIHLS--ELDLSY-KIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEE 575
+ + +E L +L+ E L+Y + ++I + ++ +L + +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
Query: 576 -MHWLSCIDISYNALQGLIPNS 596
L ++ + L S
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKS 326
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 5e-64
Identities = 89/302 (29%), Positives = 141/302 (46%), Gaps = 40/302 (13%)
Query: 694 EEIIRATKNFDDEHC------IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQ--Q 745
E+ T NFD+ +G GG G VYK + VAVKK + + + Q
Sbjct: 18 YELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDIT-TEELKQ 75
Query: 746 EFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKR 805
+F E + K +H N+V+ GF S +VY Y+ GSL LS W R
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 806 MNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG----LS 861
+G A+ + ++H N +HRDI S N+LL+ + A +SDFG+++ + ++
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192
Query: 862 NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNL- 920
+R + GT Y+APE A ++T K D+YSFGV+ LE+I G D L
Sbjct: 193 SR--IVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE-----HREPQLLL 244
Query: 921 ---------NIALDEMLDPRLPT-PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970
+++ +D ++ +V+ ++ V+ CL E RP ++KV QL
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVE----AMYSVASQCLHEKKNKRPDIKKVQQL 300
Query: 971 LK 972
L+
Sbjct: 301 LQ 302
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 2e-63
Identities = 119/504 (23%), Positives = 209/504 (41%), Gaps = 61/504 (12%)
Query: 66 PSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTL 125
+ L + +G ++ ++ L ++ L+ + + L NL +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQI 73
Query: 126 YLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIP 185
N L+ P + NL L D+ ++ N ++ P L NLTNL L + N ++ P
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129
Query: 186 NEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLAL 245
+ NL +L+ L L NT+S + + LT L+ L N ++ L P + NL +L L
Sbjct: 130 --LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERL 182
Query: 246 QLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIP 305
++ N +S + + L +L L N +S P
Sbjct: 183 DISSNKVSD--------------------------ISVLAKLTNLESLIATNNQISDITP 216
Query: 306 LSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSL 365
L G LTNL L + N L + +L +L+DL L+ N ++ PL LTKL L
Sbjct: 217 L--GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPL--SGLTKLTEL 270
Query: 366 DLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIP 425
L N++S PL+ LT+LT L L EN L D P I ++K+L+ L L N ++ P
Sbjct: 271 KLGANQISNISPLA--GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326
Query: 426 LSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEY 485
+S +LT L+ L+ +N + L + +++ L +N++S L +L ++
Sbjct: 327 VS--SLTK-LQRLFFYNNKVSDVSSLAN--LTNINWLSAGHNQISD--LTPLANLTRITQ 379
Query: 486 LDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEI 545
L L+ + N+ N+ + + P I +E D+++ +
Sbjct: 380 LGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLP-SYT 436
Query: 546 PSQVCSMQSLEKLNLSHNNLSGSI 569
+ + SG++
Sbjct: 437 NEVSYTFSQPVTIGKGTTTFSGTV 460
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 2e-62
Identities = 124/507 (24%), Positives = 200/507 (39%), Gaps = 61/507 (12%)
Query: 20 IGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDI 79
L K ++ + L + L + L +L I+
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL--GIKSIDGVEYLNNLTQINF 75
Query: 80 GNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDE 139
NN L+ P + +L L D+ ++NN + P L NLTNL L L N ++ P
Sbjct: 76 SNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-- 129
Query: 140 IGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRL 199
+ NL L+ L++S NT+S L LT+L L G N ++ P + NL +L L +
Sbjct: 130 LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDI 184
Query: 200 DYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCS 259
N +S + LT LE L N +S + P +G L +L L LN N L
Sbjct: 185 SSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD----- 235
Query: 260 FGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYF 319
+ + +L +L L L N +S PLS LT L L
Sbjct: 236 ---------------------IGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKL 272
Query: 320 STNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLS 379
N +S P + L +L++L+L+EN L P + NL L L L N +S P+S
Sbjct: 273 GANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS 328
Query: 380 FASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLY 439
SLT L L+ Y N + S + ++ +++ L N+++ PL+ NLT + L
Sbjct: 329 --SLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTPLA--NLTR-ITQLG 381
Query: 440 LSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPE 499
L+ P+ + S+ + N + + D++ N + E
Sbjct: 382 LNDQAWTN-APVNYKANVSIPNTVKNVTGALIAPA-TISDGGSYTEPDITWNLP-SYTNE 438
Query: 500 SLGNLVKLHYLNLSNNQFSQKIPNPIE 526
+ + FS + P++
Sbjct: 439 VSYTFSQPVTIGKGTTTFSGTVTQPLK 465
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-60
Identities = 114/470 (24%), Positives = 189/470 (40%), Gaps = 37/470 (7%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L + ++ L + L + + + + L++L ++ +N L
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNNQLT 81
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
P L NLT L+ I + NN ++ P + +L +L+ L L NN + P L NLTN
Sbjct: 82 DITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTN 135
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L L L N +S + L L L L NLT L L I N +S
Sbjct: 136 LNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVS 190
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
+ + L +L L N +S G LT L+ L L+ N L + + +L +
Sbjct: 191 D--ISVLAKLTNLESLIATNNQISDIT--PLGILTNLDELSLNGNQLKDIGT--LASLTN 244
Query: 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLS 301
L L L N +S P LTKL LG N +S+ + + L +L +L+LN N L
Sbjct: 245 LTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLE 300
Query: 302 GSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTK 361
P + +L NL L N +S P +++L L L N ++ L NLT
Sbjct: 301 DISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSS--LANLTN 354
Query: 362 LVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
+ L N++S PL+ +LT +T L L + + ++ ++ + + + L
Sbjct: 355 INWLSAGHNQISDLTPLA--NLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL- 411
Query: 422 GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSG 471
P ++++ + ++ N FS + + SG
Sbjct: 412 -IAPATISDGGS-YTEPDITWNLP-SYTNEVSYTFSQPVTIGKGTTTFSG 458
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 1e-55
Identities = 109/436 (25%), Positives = 189/436 (43%), Gaps = 37/436 (8%)
Query: 162 FSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEIL 221
F+ L + +G ++ ++ +L ++ L+ D + + L L +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73
Query: 222 YLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSIL 281
N L+ + P + NL L+ + +N N ++ P NLT L L N ++ +
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD--I 127
Query: 282 EEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDL 341
+ + NL +L L+L+ NT+S LS LT+L L F ++ P + NL +L L
Sbjct: 128 DPLKNLTNLNRLELSSNTISDISALS--GLTSLQQLSFGNQ-VTDLKP--LANLTTLERL 182
Query: 342 QLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIP 401
+S N + S L LT L SL + N++S PL LT+L L L N L
Sbjct: 183 DISSNKV--SDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQL--KDI 236
Query: 402 KEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQ 461
+ + +L+ LDL++N+++ PLS LT L L L +N I PL ++L
Sbjct: 237 GTLASLTNLTDLDLANNQISNLAPLS--GLTK-LTELKLGANQISNISPLAG--LTALTN 291
Query: 462 LILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKI 521
L LN N+L + +L L YL L N + P + +L KL L NN+ S
Sbjct: 292 LELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-- 345
Query: 522 PNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSC 581
+ + L +++ L + + P + ++ + +L L+ + + + +
Sbjct: 346 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNT 403
Query: 582 IDISYNALQGLIPNST 597
+ N LI +T
Sbjct: 404 V---KNVTGALIAPAT 416
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 9e-39
Identities = 79/314 (25%), Positives = 145/314 (46%), Gaps = 26/314 (8%)
Query: 281 LEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSD 340
+ L + L ++ ++ + L + TL + + + L +L+
Sbjct: 17 IFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK--SIDGVEYLNNLTQ 72
Query: 341 LQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSI 400
+ S N L PL NLTKLV + ++ N+++ PL+ +LT+LT L L+ N + D
Sbjct: 73 INFSNNQLTDITPL--KNLTKLVDILMNNNQIADITPLA--NLTNLTGLTLFNNQITDID 128
Query: 401 PKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLI 460
P + ++ +L+ L+LSSN ++ LS LT+ L+ L N + PL + ++L
Sbjct: 129 P--LKNLTNLNRLELSSNTISDISALS--GLTS-LQQLSFG-NQVTDLKPLAN--LTTLE 180
Query: 461 QLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQK 520
+L +++N++S L L LE L + N + P LG L L L+L+ NQ
Sbjct: 181 RLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD- 235
Query: 521 IPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLS 580
+ L +L++LDL+ P + + L +L L N +S + L+
Sbjct: 236 -IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALT 290
Query: 581 CIDISYNALQGLIP 594
++++ N L+ + P
Sbjct: 291 NLELNENQLEDISP 304
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 4e-59
Identities = 103/524 (19%), Positives = 188/524 (35%), Gaps = 29/524 (5%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
V F+ SIP + +K L S N+++ + ++ ++L L L S+ +
Sbjct: 7 SGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN 63
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNG-SIPSSLGNL 119
+ +L SL ++D+ +N LS S+ + G L SL L L N + S NL
Sbjct: 64 TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 120 TNLVTLYLHMNALSGSIPDE-IGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGIN 178
TNL TL + I L L++L++ +L SL ++ ++ L + ++
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 179 ALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGN 238
+ + L S+ L L L+ + S L
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242
Query: 239 LKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYN 298
L LL L + + F + T + + ++ L +
Sbjct: 243 LLKLLRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF 296
Query: 299 TLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSEN---TLNGSIPLA 355
L + L + + + + + +L+SL L LSEN
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356
Query: 356 LGNLTKLVSLDLSINKLS--GSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSIL 413
G L +L LS N L +L +LT+L + N+ +P + + L
Sbjct: 357 KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFL 415
Query: 414 DLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQL 473
+LSS + + + +L+VL +S+N++ L L +L ++ N+L
Sbjct: 416 NLSSTGIR-VVK---TCIPQTLEVLDVSNNNL-DSFSLF---LPRLQELYISRNKLKTL- 466
Query: 474 SPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQF 517
P+ L + +S N + L L + L N +
Sbjct: 467 -PDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-53
Identities = 94/522 (18%), Positives = 175/522 (33%), Gaps = 31/522 (5%)
Query: 78 DIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIP 137
D + + SIP+ + ++ L LS N + L NL L L + ++
Sbjct: 11 DGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG 67
Query: 138 DEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSG-SIPNEIGNLKSLSD 196
D +L L L +S N LS G L++L L + N + + NL +L
Sbjct: 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127
Query: 197 LRLDYNTLSGSILY-SFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGS 255
LR+ I F LT L L + +L + +++ + L L+ + +
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187
Query: 256 IPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLA 315
+ L+ + L L+ + + ++ S S L L
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247
Query: 316 TLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGS 375
+ + + + + + L + L + L
Sbjct: 248 RYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYD 301
Query: 376 IPLSFASLTSLTTLYLYENSLCDSIPKEIGD-MKSLSILDLSSNKLNGSIPLSLANLTN- 433
+ ++ L + + + + + +P +KSL LDLS N + + A
Sbjct: 302 LSTVYSLLEKVKRITVENSKV-FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360
Query: 434 -SLKVLYLSSNHIVGEIPLGHGKFSSLIQL---ILNNNELSGQLSPELGSLNQLEYLDLS 489
SL+ L LS NH+ + +L L ++ N + ++ +L+LS
Sbjct: 361 PSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLS 418
Query: 490 ANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQ 548
+ + L L++SNN L L EL +S K+ + +P
Sbjct: 419 STGIR-VVKT--CIPQTLEVLDVSNNNLDS-FSLF---LPRLQELYISRNKL--KTLPDA 469
Query: 549 VCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQ 590
L + +S N L F+ + L I + N
Sbjct: 470 S-LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-39
Identities = 74/390 (18%), Positives = 145/390 (37%), Gaps = 14/390 (3%)
Query: 213 GNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLG 272
G ++ L L N ++ + ++ +L L L + ++ +F +L L L
Sbjct: 23 GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82
Query: 273 TNALSSSILEEIGNLKSLLHLQLNYNTLSG-SIPLSLGSLTNLATLYFSTNALSGSIPNE 331
N LSS G L SL +L L N + +LTNL TL I
Sbjct: 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI 142
Query: 332 -ITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLY 390
L SL++L++ +L +L ++ + L L +++ + + + L+S+ L
Sbjct: 143 DFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLE 202
Query: 391 LYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIP 450
L + +L + + S + + + + S L L+ + S E+
Sbjct: 203 LRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELS-----EVE 257
Query: 451 LGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYL 510
+ L + +++ +L + L + + L K+ +
Sbjct: 258 FDDCTLNGLGDFNPSESDVVSELG--KVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRI 315
Query: 511 NLSNNQFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQVC--SMQSLEKLNLSHNNLS- 566
+ N++ + + L L LDLS + E + + C + SL+ L LS N+L
Sbjct: 316 TVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS 375
Query: 567 -GSISRCFEEMHWLSCIDISYNALQGLIPN 595
+ L+ +DIS N + +
Sbjct: 376 MQKTGEILLTLKNLTSLDISRNTFHPMPDS 405
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 55/261 (21%), Positives = 101/261 (38%), Gaps = 17/261 (6%)
Query: 343 LSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPK 402
+ SIP L + SLDLS NK++ + +L L L + + ++I
Sbjct: 12 GRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-NTIEG 67
Query: 403 EI-GDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGH--GKFSSL 459
+ + SL LDLS N L+ L++ LK L L N + + ++L
Sbjct: 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSS-LKYLNLMGNPYQ-TLGVTSLFPNLTNL 125
Query: 460 IQLILNNNELSGQLSPE-LGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFS 518
L + N E ++ L L L++ A + N +SL ++ +H+L L ++ +
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
Query: 519 QKIPNPIEKLIHLSELDLSY---KIFGEEIPSQVCSMQSLEKLNLSHNNLS----GSISR 571
+ + L + L+L F ++KL + L+ + +
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 572 CFEEMHWLSCIDISYNALQGL 592
+ LS ++ L GL
Sbjct: 246 LLRYILELSEVEFDDCTLNGL 266
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-22
Identities = 46/255 (18%), Positives = 84/255 (32%), Gaps = 15/255 (5%)
Query: 1 MLKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
+ + + ++ ++ L + L + L + +++ ++ +
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
Query: 61 KGSIPPSLGNLTSLIYIDIGNNLLSGSI---PNEVGSLKSLSDLRLSNNSLN--GSIPSS 115
+L SL ++D+ NL+ G+ SL L LS N L
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI 382
Query: 116 LGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYI 175
L L NL +L + N +PD + + L +S + L L +
Sbjct: 383 LLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV---VKTCIPQTLEVLDV 438
Query: 176 GINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNE 235
N L S L L +L + N L L L ++ + N L +
Sbjct: 439 SNNNLD-SFSL---FLPRLQELYISRNKL--KTLPDASLFPVLLVMKISRNQLKSVPDGI 492
Query: 236 IGNLKSLLALQLNYN 250
L SL + L+ N
Sbjct: 493 FDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-14
Identities = 40/190 (21%), Positives = 72/190 (37%), Gaps = 30/190 (15%)
Query: 409 SLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNE 468
+ + D S SIP + LT ++K L LS N I I G
Sbjct: 6 ASGVCDGRSRSFT-SIP---SGLTAAMKSLDLSFNKIT-YIGHG---------------- 44
Query: 469 LSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKL 528
+L + L+ L L ++ + ++ +L L +L+LS+N S + L
Sbjct: 45 -------DLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPL 97
Query: 529 IHLSELDLSY-KIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISR-CFEEMHWLSCIDISY 586
L L+L + S ++ +L+ L + + I R F + L+ ++I
Sbjct: 98 SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157
Query: 587 NALQGLIPNS 596
+L+ S
Sbjct: 158 LSLRNYQSQS 167
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 6e-59
Identities = 71/312 (22%), Positives = 116/312 (37%), Gaps = 47/312 (15%)
Query: 694 EEIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGN- 752
E + + G G V+KA+L E VAVK F +Q + NE
Sbjct: 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPI------QDKQSWQNEYEV 69
Query: 753 -ALTKIRHRNIVKFYGFCSHALHS----FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMN 807
+L ++H NI++F G +++ + E GSL+ L W + +
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCH 125
Query: 808 AIKGVADALLYMHTNCF-------PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860
+ +A L Y+H + P I HRDI SKNVLL A ++DFG++ + G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 861 S--NRTELAGTFGYIAPELA-----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIC 913
S + GT Y+APE+ + + D+Y+ G++ E+ D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 914 S-----------SLSSNLNIALDEMLDPRLP--TPLRNVQDKLISIMEVSISCLDESPTS 960
SL + + + P L L +E C D +
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE---ECWDHDAEA 302
Query: 961 RPTMQKVSQLLK 972
R + V + +
Sbjct: 303 RLSAGCVGERIT 314
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-58
Identities = 71/273 (26%), Positives = 130/273 (47%), Gaps = 22/273 (8%)
Query: 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
K + E +G G G V KA+ + VA+K+ S + ++ F+ E L+++ H
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHP 61
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMH 820
NIVK YG C + + +V EY E GSL +L + M+ + + Y+H
Sbjct: 62 NIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 821 TNCFPPIVHRDISSKNVLLNLEYE-AHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAY 879
+ ++HRD+ N+LL + DFG + ++ ++ T G+ ++APE+
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVFE 176
Query: 880 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939
+EKCDV+S+G++ EVI + P D I + ++ R P +N+
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT------RPPLI-KNL 229
Query: 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ S+M C + P+ RP+M+++ +++
Sbjct: 230 PKPIESLMT---RCWSKDPSQRPSMEEIVKIMT 259
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 5e-58
Identities = 126/610 (20%), Positives = 218/610 (35%), Gaps = 64/610 (10%)
Query: 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKG 62
++ F + +P L + L S N + + L L L L S +
Sbjct: 7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 63 SIPP-SLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSI--PSSLGNL 119
+I + NL +L +D+G++ + P+ L L +LRL L+ ++ NL
Sbjct: 63 TIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL 122
Query: 120 TNLVTLYLHMNALSG-SIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLT--NLVTLYIG 176
L L L N + + G L L + S N + L L L +
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182
Query: 177 INALSGSIPNEIGN-LKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNE 235
N+L + + G + ++ L+ +S GN ++I NA+S
Sbjct: 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVS-------GNGWTVDITGNFSNAISKSQAFS 235
Query: 236 IGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQL 295
+ ++ ++ + +F L + S+ HL L
Sbjct: 236 LILAHHIMGAGFGFHNIKDPDQNTFAGLARS----------------------SVRHLDL 273
Query: 296 NYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLA 355
++ + +L +L L + N ++ L +L L LS N L
Sbjct: 274 SHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSN 333
Query: 356 LGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDL 415
L K+ +DL N ++ +F L L TL L +N+L I + S+ + L
Sbjct: 334 FYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFL 388
Query: 416 SSNKLNGSIPLSLANLTNSLKVLYLSSNHIVG-EIPLGHGKFSSLIQLILNNNELSGQLS 474
S NKL +L + + +++LS N + +I + L LILN N S
Sbjct: 389 SGNKLV-----TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSG 443
Query: 475 PEL-GSLNQLEYLDLSANTFHNSI-----PESLGNLVKLHYLNLSNNQFSQKIPNPIEKL 528
+ LE L L N + + L L L L++N + P L
Sbjct: 444 DQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHL 503
Query: 529 IHLSELDLSY-KIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYN 587
L L L+ ++ + +LE L++S N L + + LS +DI++N
Sbjct: 504 TALRGLSLNSNRL--TVLSHNDLP-ANLEILDISRNQLL-APNPDV--FVSLSVLDITHN 557
Query: 588 ALQGLIPNST 597
ST
Sbjct: 558 KFICECELST 567
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-55
Identities = 116/568 (20%), Positives = 200/568 (35%), Gaps = 40/568 (7%)
Query: 63 SIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSI-PSSLGNLTN 121
+P L L + N + + L+ L L L + +I + NL N
Sbjct: 18 QVPQVLNTTERL---LLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAI--PFSLGNLTNLVTLYIGINA 179
L L L + + PD L L +L++ + LS A+ NL L L + N
Sbjct: 75 LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQ 134
Query: 180 LSG-SIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLT--KLEILYLDVNALSGLIPNEI 236
+ + G L SL + N + + L L L N+L + +
Sbjct: 135 IRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDW 194
Query: 237 GNLKSLLA-LQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQL 295
G + + L +SG N + I+ +NA+S S + ++
Sbjct: 195 GKCMNPFRNMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGF 247
Query: 296 NYNTLSGSIPLSLGSL--TNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIP 353
++ + + L +++ L S + L+ L L L+ N +N
Sbjct: 248 GFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD 307
Query: 354 LALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSIL 413
A L L L+LS N L +F L + + L +N + + ++ L L
Sbjct: 308 EAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTL 367
Query: 414 DLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSG-Q 472
DL N L ++ + S+ ++LS N +V + + + L+ N L
Sbjct: 368 DLRDNALT-----TIHFIP-SIPDIFLSGNKLVTLPKI----NLTANLIHLSENRLENLD 417
Query: 473 LSPELGSLNQLEYLDLSANTFHNSIPESL-GNLVKLHYLNLSNNQFSQKIPNPIEK---- 527
+ L + L+ L L+ N F + + L L L N +
Sbjct: 418 ILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFE 477
Query: 528 -LIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISY 586
L HL L L++ P + +L L+L+ N L+ L +DIS
Sbjct: 478 GLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISR 535
Query: 587 NALQGLIPNSTAFRDAPMLALQGNKRLC 614
N L P+ F +L + NK +C
Sbjct: 536 NQLLAPNPDV--FVSLSVLDITHNKFIC 561
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-54
Identities = 118/538 (21%), Positives = 199/538 (36%), Gaps = 38/538 (7%)
Query: 2 LKVLGLSFNQFSGSIPPEI-GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
L++L L +I E +L +L++L +++ L P L L L LY L
Sbjct: 50 LQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGL 109
Query: 61 KGSIPPS--LGNLTSLIYIDIGNNLLSG-SIPNEVGSLKSLSDLRLSNNSLNGSIPSSLG 117
++ NL +L +D+ N + + G L SL + S+N + L
Sbjct: 110 SDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELE 169
Query: 118 NLT--NLVTLYLHMNALSGSIPDEIGN-LKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLY 174
L L L N+L + + G + ++ + +S GN +
Sbjct: 170 PLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVS-------GNGWTVDITG 222
Query: 175 IGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDV--NALSGLI 232
NA+S S + + ++ + +F L + + +LD+ + L
Sbjct: 223 NFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLN 282
Query: 233 PNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLH 292
LK L L L YN ++ +F L L + L N L L + +
Sbjct: 283 SRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY 342
Query: 293 LQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSI 352
+ L N ++ + L L TL NAL+ I + S+ D+ LS N L
Sbjct: 343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLP 397
Query: 353 PLALGNLTKLVSLDLSINKLSG-SIPLSFASLTSLTTLYLYENSLCDSIPKE--IGDMKS 409
+ L + LS N+L I + L L L +N S + + S
Sbjct: 398 KINLTANL----IHLSENRLENLDILYFLLRVPHLQILILNQNRF-SSCSGDQTPSENPS 452
Query: 410 LSILDLSSNKLNGSIPLSLANLT----NSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILN 465
L L L N L + L + L+VLYL+ N++ P ++L L LN
Sbjct: 453 LEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLN 512
Query: 466 NNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPN 523
+N L+ LE LD+S N P+ + L L++++N+F +
Sbjct: 513 SNRLTV--LSHNDLPANLEILDISRNQLLAPNPDVFVS---LSVLDITHNKFICECEL 565
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-37
Identities = 97/437 (22%), Positives = 165/437 (37%), Gaps = 31/437 (7%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKL--LSFSKNQLSGLIPHEIGR-LSSLNGLSLYSN 58
LK + S NQ E+ L L S + N L + + G+ ++ + L
Sbjct: 150 LKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEIL 209
Query: 59 FLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGN 118
+ GN ++ +N +S S + + +++ ++
Sbjct: 210 DV-------SGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAG 262
Query: 119 L--TNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIG 176
L +++ L L + LK L L ++YN ++ + L NL L +
Sbjct: 263 LARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLS 322
Query: 177 INALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEI 236
N L + L ++ + L N ++ +F L KL+ L L NAL+ I
Sbjct: 323 YNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TI 377
Query: 237 GNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLN 296
+ S+ + L+ N L ++P NLT +I + IL + + L L LN
Sbjct: 378 HFIPSIPDIFLSGNKLV-TLP--KINLTANLIHLSENRLENLDILYFLLRVPHLQILILN 434
Query: 297 YNTLSG-SIPLSLGSLTNLATLYFSTNALSGSIPNEI-----TNLRSLSDLQLSENTLNG 350
N S S + +L L+ N L + E+ L L L L+ N LN
Sbjct: 435 QNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNS 494
Query: 351 SIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSL 410
P +LT L L L+ N+L+ +L L + N L + ++ SL
Sbjct: 495 LPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQL-LAPNPDV--FVSL 549
Query: 411 SILDLSSNKLNGSIPLS 427
S+LD++ NK LS
Sbjct: 550 SVLDITHNKFICECELS 566
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-27
Identities = 78/399 (19%), Positives = 134/399 (33%), Gaps = 25/399 (6%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHL--THLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNF 59
+ G F+ L + ++ L S + L L L L+L N
Sbjct: 242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNK 301
Query: 60 LKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNL 119
+ + L +L +++ NLL + L ++ + L N + + L
Sbjct: 302 INKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFL 361
Query: 120 TNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINA 179
L TL L NAL+ I + + D+ +S N L +P + +
Sbjct: 362 EKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVT-LPKINLTANLIHLSENRLEN 415
Query: 180 LSGSIPNEIGNLKSLSDLRLDYNTLSG-SILYSFGNLTKLEILYLDVNALSGLIPNEI-- 236
L + + L L L+ N S S + LE L+L N L E+
Sbjct: 416 LDILYF--LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCW 473
Query: 237 ---GNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHL 293
L L L LN+N L+ P F +LT L L +N L+ L +L L
Sbjct: 474 DVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV--LSHNDLPANLEIL 531
Query: 294 QLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNE-ITNLRSLSDLQLSENTLN--G 350
++ N L + +L+ L + N N + +++ ++ +
Sbjct: 532 DISRNQLLA---PNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYC 588
Query: 351 SIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTL 389
P + L SL + SL + T+
Sbjct: 589 VYPDSFSG-VSLFSLSTEGCDEEEVLKSLKFSLFIVCTV 626
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 5e-56
Identities = 98/372 (26%), Positives = 163/372 (43%), Gaps = 31/372 (8%)
Query: 167 LTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVN 226
L TL IN + +L L +++ + + L + L +
Sbjct: 2 AATLATLPAPINQIF-----PDADLAEGIRAVLQKASVTDVV--TQEELESITKLVVAGE 54
Query: 227 ALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGN 286
++ + I L +L L LN N ++ P NL KL +GTN ++ + + N
Sbjct: 55 KVASI--QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQN 108
Query: 287 LKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSEN 346
L +L L LN + +S PL +LT + +L N S + ++N+ L+ L ++E+
Sbjct: 109 LTNLRELYLNEDNISDISPL--ANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTES 165
Query: 347 TLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGD 406
+ P+ NLT L SL L+ N++ PL+ SLTSL Y N + D P + +
Sbjct: 166 KVKDVTPI--ANLTDLYSLSLNYNQIEDISPLA--SLTSLHYFTAYVNQITDITP--VAN 219
Query: 407 MKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNN 466
M L+ L + +NK+ PL+ NL+ L L + +N I + + L L + +
Sbjct: 220 MTRLNSLKIGNNKITDLSPLA--NLSQ-LTWLEIGTNQISDINAVKD--LTKLKMLNVGS 274
Query: 467 NELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIE 526
N++S L +L+QL L L+ N N E +G L L L LS N + P+
Sbjct: 275 NQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIR--PLA 330
Query: 527 KLIHLSELDLSY 538
L + D +
Sbjct: 331 SLSKMDSADFAN 342
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-54
Identities = 88/374 (23%), Positives = 164/374 (43%), Gaps = 28/374 (7%)
Query: 146 LSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLS 205
+ L ++ P +L + + +++ + L+S++ L + ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 206 GSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTK 265
+ LT LE L L+ N ++ + P + NL L L + N ++ + NLT
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 266 LVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALS 325
L L + +S + + NL + L L N + L ++T L L + + +
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVK 168
Query: 326 GSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTS 385
P I NL L L L+ N + PL +LT L +N+++ P++ ++T
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISPL--ASLTSLHYFTAYVNQITDITPVA--NMTR 222
Query: 386 LTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 445
L +L + N + D P + ++ L+ L++ +N+++ I ++ +LT LK+L + SN I
Sbjct: 223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS-DIN-AVKDLTK-LKMLNVGSNQI 277
Query: 446 VGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLV 505
L + S L L LNNN+L + +G L L L LS N + P L +L
Sbjct: 278 SDISVLNN--LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLS 333
Query: 506 KLHYLNLSNNQFSQ 519
K+ + +N +
Sbjct: 334 KMDSADFANQVIKK 347
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 5e-54
Identities = 89/375 (23%), Positives = 162/375 (43%), Gaps = 31/375 (8%)
Query: 71 LTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMN 130
+L ++ P+ L L S+ + L ++ L +
Sbjct: 2 AATL---ATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE 54
Query: 131 ALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGN 190
++ SI I L L L ++ N ++ P S NL L LYIG N ++ + + N
Sbjct: 55 KVA-SIQG-IEYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKIT--DISALQN 108
Query: 191 LKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYN 250
L +L +L L+ + +S NLTK+ L L N + + N+ L L + +
Sbjct: 109 LTNLRELYLNEDNISDIS--PLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTES 165
Query: 251 TLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGS 310
+ P NLT L L N + + + +L SL + N ++ P+ +
Sbjct: 166 KVKDVTP--IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITPV--AN 219
Query: 311 LTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSIN 370
+T L +L N ++ P + NL L+ L++ N ++ I A+ +LTKL L++ N
Sbjct: 220 MTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSN 275
Query: 371 KLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLAN 430
++S L+ +L+ L +L+L N L + + IG + +L+ L LS N + PL+ +
Sbjct: 276 QISDISVLN--NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA--S 331
Query: 431 LTNSLKVLYLSSNHI 445
L+ + ++ I
Sbjct: 332 LSK-MDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 8e-54
Identities = 89/376 (23%), Positives = 166/376 (44%), Gaps = 31/376 (8%)
Query: 215 LTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTN 274
L L +N + +L + L +++ + L + +
Sbjct: 2 AATLATLPAPINQIFPD-----ADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE 54
Query: 275 ALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITN 334
++S ++ I L +L +L LN N ++ PLS +L L LY TN ++ + + N
Sbjct: 55 KVAS--IQGIEYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKIT--DISALQN 108
Query: 335 LRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYEN 394
L +L +L L+E+ ++ PL NLTK+ SL+L N + +++T L L + E+
Sbjct: 109 LTNLRELYLNEDNISDISPL--ANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTES 165
Query: 395 SLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHG 454
+ D P I ++ L L L+ N++ PL+ +LT+ L N I P+
Sbjct: 166 KVKDVTP--IANLTDLYSLSLNYNQIEDISPLA--SLTS-LHYFTAYVNQITDITPVA-- 218
Query: 455 KFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSN 514
+ L L + NN+++ L +L+QL +L++ N S ++ +L KL LN+ +
Sbjct: 219 NMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGS 274
Query: 515 NQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFE 574
NQ S + + L L+ L L+ G E + + +L L LS N+++
Sbjct: 275 NQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LA 330
Query: 575 EMHWLSCIDISYNALQ 590
+ + D + ++
Sbjct: 331 SLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 8e-54
Identities = 91/371 (24%), Positives = 161/371 (43%), Gaps = 27/371 (7%)
Query: 50 LNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLN 109
L+ + P +L I + ++ + L+S++ L ++ +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV- 56
Query: 110 GSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTN 169
+ + LTNL L L+ N ++ P + NL L++L + N ++ +L NLTN
Sbjct: 57 -ASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 170 LVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALS 229
L LY+ + +S P + NL + L L N + N+T L L + + +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVK 168
Query: 230 GLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKS 289
+ P I NL L +L LNYN + P +LT L N ++ + + N+
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTR 222
Query: 290 LLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLN 349
L L++ N ++ PL +L+ L L TN +S N + +L L L + N ++
Sbjct: 223 LNSLKIGNNKITDLSPL--ANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS 278
Query: 350 GSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKS 409
L NL++L SL L+ N+L LT+LTTL+L +N + D P + +
Sbjct: 279 DISVL--NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSK 334
Query: 410 LSILDLSSNKL 420
+ D ++ +
Sbjct: 335 MDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 144 bits (367), Expect = 5e-38
Identities = 61/252 (24%), Positives = 112/252 (44%), Gaps = 17/252 (6%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L+ L L+ + S P + +LT + L+ N + + ++ LN L++ + +K
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVK 168
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
P + NLT L + + N + P + SL SL N + P + N+T
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTR 222
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L +L + N ++ P + NL L+ L++ N +S ++ +LT L L +G N +S
Sbjct: 223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS 278
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
+ + NL L+ L L+ N L + G LT L L+L N ++ + P + +L
Sbjct: 279 D--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSK 334
Query: 242 LLALQLNYNTLS 253
+ + +
Sbjct: 335 MDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-34
Identities = 57/300 (19%), Positives = 117/300 (39%), Gaps = 46/300 (15%)
Query: 293 LQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSI 352
L ++ P + L +++ + L S++ L ++ + SI
Sbjct: 5 LATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SI 59
Query: 353 PLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSI 412
+ LT L L+L+ N+++ PLS +L LT LY+ N + + + ++ +L
Sbjct: 60 Q-GIEYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKI--TDISALQNLTNLRE 114
Query: 413 LDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQ 472
L L+ + ++ PL+ NLT + L L +NH + ++ + L L + +++
Sbjct: 115 LYLNEDNISDISPLA--NLTK-MYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKD- 169
Query: 473 LSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLS 532
+ +L L L L+ N + P L +L LHY NQ I + ++
Sbjct: 170 -VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQ--------ITDITPVA 218
Query: 533 ELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGL 592
+ L L + +N ++ + L+ ++I N + +
Sbjct: 219 NM------------------TRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI 258
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 6e-14
Identities = 28/162 (17%), Positives = 60/162 (37%), Gaps = 14/162 (8%)
Query: 435 LKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFH 494
L I P + I+ +L ++ L + L ++
Sbjct: 2 AATLATLPAPINQIFPDAD--LAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 495 NSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQVCSMQ 553
+ + + L L YLNL+ NQ + +P+ L+ L+ L + KI S + ++
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKI---TDISALQNLT 110
Query: 554 SLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPN 595
+L +L L+ +N+S + + +++ N +
Sbjct: 111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP 150
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-55
Identities = 84/277 (30%), Positives = 128/277 (46%), Gaps = 23/277 (8%)
Query: 702 NFDD---EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
+ D + IG G G+V++AE G VAVK EFL E + ++R
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAER-VNEFLREVAIMKRLR 92
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLY 818
H NIV F G + + +V EYL GSL +L A E+ +R++ VA + Y
Sbjct: 93 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELA 878
+H PPIVHR++ S N+L++ +Y V DFG+S+ + AGT ++APE+
Sbjct: 153 LHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL 211
Query: 879 YTMKVTEKCDVYSFGVLALEVIKGKHP---RDFISSICSSLSSNLNIALDEMLDPRLPTP 935
EK DVYSFGV+ E+ + P + + + RL P
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK----------RLEIP 261
Query: 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
RN+ ++ +I+E C P RP+ + LL+
Sbjct: 262 -RNLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLR 294
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 5e-54
Identities = 109/517 (21%), Positives = 182/517 (35%), Gaps = 78/517 (15%)
Query: 16 IPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLI 75
I P T L+ + L+ + P E + S + + + PP G +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLTEM-PVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 76 YIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGS 135
+ + L + +L L+N L+ S+P +L +L N+L+
Sbjct: 62 VSRLRDCLD-----------RQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-E 105
Query: 136 IPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLS 195
+P+ +LK L + LS P L L + N L +P E+ N L
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLK 156
Query: 196 DLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGS 255
+ +D N+L LE + N L L E+ NL L A+ + N+L
Sbjct: 157 IIDVDNNSLK----KLPDLPPSLEFIAAGNNQLEEL--PELQNLPFLTAIYADNNSLK-K 209
Query: 256 IPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLA 315
+P +L +V G N L L E+ NL L + + N L ++P SL L
Sbjct: 210 LPDLPLSLESIV---AGNNILEE--LPELQNLPFLTTIYADNNLLK-TLPDLPPSLEAL- 262
Query: 316 TLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIP----LALGN---------LTKL 362
N L+ +P +L L + + L+ P L + L
Sbjct: 263 --NVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSL 319
Query: 363 VSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNG 422
L++S NKL +P A L L N L +P+ +L L + N L
Sbjct: 320 EELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVPELPQ---NLKQLHVEYNPLR- 370
Query: 423 SIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQ 482
P ++ + L N + E+P +L QL + N L + S+
Sbjct: 371 EFPDIPESVED------LRMNSHLAEVP---ELPQNLKQLHVETNPLR-EFPDIPESV-- 418
Query: 483 LEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQ 519
E L +++ + + KL ++
Sbjct: 419 -EDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHHH 454
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-53
Identities = 114/528 (21%), Positives = 196/528 (37%), Gaps = 76/528 (14%)
Query: 39 LIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSL 98
I + L +S+ L +P N+ S + + P G + +
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 99 SDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSG 158
+ RL + L L+ LS S+P+ +L+ L S N+L+
Sbjct: 61 AVSRLRDCL-----------DRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT- 104
Query: 159 AIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKL 218
+P +L +L+ + ALS P L L + N L L N + L
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLEK--LPELQNSSFL 155
Query: 219 EILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSS 278
+I+ +D N+L L P+ +L+ + N L +P NL L N+L
Sbjct: 156 KIIDVDNNSLKKL-PDLPPSLEF---IAAGNNQLE-ELP-ELQNLPFLTAIYADNNSL-K 208
Query: 279 SILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSL 338
+ + +L+S + N L L +L L T+Y N L ++P+ +L +
Sbjct: 209 KLPDLPLSLES---IVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA- 261
Query: 339 SDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCD 398
L + +N L +P +LT L + + LS P +L L N +
Sbjct: 262 --LNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR- 310
Query: 399 SIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSS 458
S+ SL L++S+NKL +P L+ L S NH+ E+P +
Sbjct: 311 SLCDL---PPSLEELNVSNNKLI-ELPALPPR----LERLIASFNHLA-EVPEL---PQN 358
Query: 459 LIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFS 518
L QL + N L + S+ DL N+ +PE N L L++ N
Sbjct: 359 LKQLHVEYNPLR-EFPDIPESVE-----DLRMNSHLAEVPELPQN---LKQLHVETNPLR 409
Query: 519 QKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLS 566
+ P+ E + +L ++ + + + LE H++
Sbjct: 410 E-FPDIPES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 5e-53
Identities = 103/496 (20%), Positives = 173/496 (34%), Gaps = 82/496 (16%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L+ + + +P E ++ + ++ P G + L +
Sbjct: 13 LQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDR 71
Query: 62 G------------SIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLN 109
S+P +L SL N L+ +P SLKSL + +L+
Sbjct: 72 QAHELELNNLGLSSLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKALS 127
Query: 110 GSIPS---------------SLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYN 154
P L N + L + + N+L +PD +L+F++ N
Sbjct: 128 DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIA---AGNN 183
Query: 155 TLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGN 214
L +P L NL L +Y N+L +P+ +L+S+ N L L N
Sbjct: 184 QLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESIV---AGNNIL--EELPELQN 235
Query: 215 LTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTN 274
L L +Y D N L L P+ +L++ L + N L+ +P +LT L +S +
Sbjct: 236 LPFLTTIYADNNLLKTL-PDLPPSLEA---LNVRDNYLT-DLPELPQSLTFLDVSENIFS 290
Query: 275 ALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITN 334
LS +L +L + N + S+ +L L S N L +P
Sbjct: 291 GLSELP-------PNLYYLNASSNEIR-SLC---DLPPSLEELNVSNNKLI-ELPALPPR 338
Query: 335 LRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYEN 394
L L S N L +P NL L + N L P S+ L N
Sbjct: 339 LERLI---ASFNHLA-EVPELPQNLK---QLHVEYNPLR-EFPDIPESVED-----LRMN 385
Query: 395 SLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHG 454
S +P+ +L L + +N L P ++ + L ++S +V H
Sbjct: 386 SHLAEVPELPQ---NLKQLHVETNPLR-EFPDIPESVED----LRMNSERVVDPYEFAHE 437
Query: 455 KFSSLIQLILNNNELS 470
L + ++
Sbjct: 438 TTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-32
Identities = 67/325 (20%), Positives = 125/325 (38%), Gaps = 38/325 (11%)
Query: 280 ILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLS 339
I + L + + L+ +P+ ++ + Y + + + P R ++
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 340 DLQLSENTLNGSIPLALGN---------LTKLVSLDLSINKLSGSIPLSFASLTSLTTLY 390
+L + + L L N L SL S N L+ +P SL SL
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDN 120
Query: 391 LYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIP 450
+L D P L L +S+N+L +P L N + LK++ + +N + ++P
Sbjct: 121 NNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSF-LKIIDVDNNSLK-KLP 169
Query: 451 LGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYL 510
SL + NN+L PEL +L L + N+ +P+ + L +
Sbjct: 170 ---DLPPSLEFIAAGNNQLEEL--PELQNLPFLTAIYADNNSLK-KLPDLPLS---LESI 220
Query: 511 NLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSIS 570
NN + ++ L L+ + + + +P SLE LN+ N L+ +
Sbjct: 221 VAGNNILEE--LPELQNLPFLTTIYADNNLL-KTLPDLPP---SLEALNVRDNYLT-DLP 273
Query: 571 RCFEEMHWLSCIDISYNALQGLIPN 595
+ + +L + ++ L L PN
Sbjct: 274 ELPQSLTFLDVSENIFSGLSELPPN 298
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 8e-54
Identities = 78/286 (27%), Positives = 121/286 (42%), Gaps = 37/286 (12%)
Query: 703 FDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQ----QEFLNEGNALTKI 757
+ E IG GG G V+K + +VA+K QEF E ++ +
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 758 RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL 817
H NIVK YG + +V E++ G L L + A W+ ++ + +A +
Sbjct: 81 NHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIE 136
Query: 818 YMHTNCFPPIVHRDISSKNVLL-----NLEYEAHVSDFGISKFLKLGLSNRTELAGTFGY 872
YM N PPIVHRD+ S N+ L N A V+DFG+S+ + + L G F +
Sbjct: 137 YMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV---SGLLGNFQW 192
Query: 873 IAPEL--AYTMKVTEKCDVYSFGVLALEVIKGKHP-RDFISSICSSLSSNLNIALDEML- 928
+APE A TEK D YSF ++ ++ G+ P ++ S I M+
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY---------SYGKIKFINMIR 243
Query: 929 --DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
R P + +L +++E C P RP + + L
Sbjct: 244 EEGLRPTIP-EDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELS 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-53
Identities = 69/279 (24%), Positives = 118/279 (42%), Gaps = 33/279 (11%)
Query: 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMA-CQQEFLNEGNALTKIRHRNIVK 764
E IG GG G VY+A G+ VAVK +++ + E ++H NI+
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
G C + +V E+ G L +LS + +N +A + Y+H
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 825 PPIVHRDISSKNVLLNLEYEAH--------VSDFGISKFLKLGLSNRTELAGTFGYIAPE 876
PI+HRD+ S N+L+ + E ++DFG+++ + + AG + ++APE
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAAGAYAWMAPE 184
Query: 877 LAYTMKVTEKCDVYSFGVLALEVIKGKHP---RDFISSICSSLSSNLNIALDEMLDPRLP 933
+ ++ DV+S+GVL E++ G+ P D ++ + L LP
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL----------ALP 234
Query: 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
P + +ME C + P SRP+ + L
Sbjct: 235 IP-STCPEPFAKLME---DCWNPDPHSRPSFTNILDQLT 269
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-50
Identities = 65/338 (19%), Positives = 106/338 (31%), Gaps = 27/338 (7%)
Query: 86 GSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKF 145
GS + +L ++ L + + N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 146 LSDLQVSYNTLSGAIPFSLGNLT--NLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNT 203
+ L A L + T V L + L P++ L L + +D
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 204 LSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNL 263
L + + LE L L N L L P I +L L L + +P +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 264 TKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNA 323
E L +L L+L + + S+P S+ +L NL +L +
Sbjct: 174 ---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP 217
Query: 324 LSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASL 383
LS ++ I +L L +L L T + P G L L L ++PL L
Sbjct: 218 LS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRL 276
Query: 384 TSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
T L L L +P I + + I+ + +
Sbjct: 277 TQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-49
Identities = 62/336 (18%), Positives = 114/336 (33%), Gaps = 28/336 (8%)
Query: 110 GSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTN 169
GS + + LY + D + + + + + N N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 170 LVTLYIGINALSGSIPNEIGNLKS--LSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNA 227
AL + + + + L L L L+ L+ + +D
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 228 LSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNL 287
L L P+ + L L L N L ++P S +L +L + + + E + +
Sbjct: 116 LMEL-PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 288 KSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENT 347
L NL +L + S+P I NL++L L++ +
Sbjct: 174 ---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP 217
Query: 348 LNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDM 407
L+ ++ A+ +L KL LDL + P F L L L + S ++P +I +
Sbjct: 218 LS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRL 276
Query: 408 KSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 443
L LDL +P +A L ++ + +
Sbjct: 277 TQLEKLDLRGCVNLSRLPSLIAQLPA-NCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 5e-49
Identities = 61/329 (18%), Positives = 122/329 (37%), Gaps = 22/329 (6%)
Query: 206 GSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTK 265
GS + + + E LY + + + + N + N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 266 LVISCLGTNALSSSILEEIGNLKS--LLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNA 323
I AL + + + + + L+L L P L++L +
Sbjct: 58 PQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 324 LSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFAS- 382
L +P+ + L L L+ N L ++P ++ +L +L L + +P AS
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 383 --------LTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNS 434
L +L +L L + S+P I ++++L L + ++ L+ ++ ++ +L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPK- 230
Query: 435 LKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFH 494
L+ L L + P G + L +LIL + L ++ L QLE LDL
Sbjct: 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290
Query: 495 NSIPESLGNLVKLHYLNLSNNQFSQKIPN 523
+ +P + L + + + +Q +
Sbjct: 291 SRLPSLIAQLPANCIILVPPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 4e-47
Identities = 60/348 (17%), Positives = 105/348 (30%), Gaps = 27/348 (7%)
Query: 41 PHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSD 100
H S L + L D + N +
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNPQI 60
Query: 101 LRLSNNSLNGSIPSSLGNLT--NLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSG 158
+ +L + L + T V L L L PD+ L L + + L
Sbjct: 61 ETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM- 117
Query: 159 AIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKL 218
+P ++ L TL + N L ++P I +L L +L + + +
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD-- 174
Query: 219 EILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSS 278
E L +L +L+L + + S+P S NL L + + LS+
Sbjct: 175 -------------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA 220
Query: 279 SILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSL 338
+ I +L L L L T + P G L L + ++P +I L L
Sbjct: 221 -LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQL 279
Query: 339 SDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSL 386
L L +P + L + + + + + +
Sbjct: 280 EKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 4e-46
Identities = 61/334 (18%), Positives = 104/334 (31%), Gaps = 28/334 (8%)
Query: 235 EIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQ 294
+ L +T + + N +
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIET 62
Query: 295 LNYNTLSGSIPLSLGSLT--NLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSI 352
L + L T L + L P++ L L + + L +
Sbjct: 63 RTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 353 PLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSI 412
P + L +L L+ N L ++P S ASL L L + +P+ +
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA------- 171
Query: 413 LDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQ 472
+ L N L+ L L I +P +L L + N+ LS
Sbjct: 172 --------STDASGEHQGLVN-LQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-A 220
Query: 473 LSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLS 532
L P + L +LE LDL T + P G L L L + +P I +L L
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLE 280
Query: 533 ELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLS 566
+LDL + +PS + + + + + + +
Sbjct: 281 KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-43
Identities = 55/331 (16%), Positives = 107/331 (32%), Gaps = 26/331 (7%)
Query: 278 SSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRS 337
S + +L +T L + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRH-------YNADRNRWHSAWRQAN 54
Query: 338 LSDLQLSENTLNG--SIPLALGNLT--KLVSLDLSINKLSGSIPLSFASLTSLTTLYLYE 393
++ Q+ T + L + T V+L+L L P L+ L + +
Sbjct: 55 SNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDA 113
Query: 394 NSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIP--- 450
L +P + L L L+ N L ++P S+A+L L+ L + + + E+P
Sbjct: 114 AGL-MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNR-LRELSIRACPELTELPEPL 170
Query: 451 ------LGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNL 504
H +L L L + L + +L L+ L + + ++ ++ +L
Sbjct: 171 ASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHL 228
Query: 505 VKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNN 564
KL L+L + P L L L +P + + LEKL+L
Sbjct: 229 PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV 288
Query: 565 LSGSISRCFEEMHWLSCIDISYNALQGLIPN 595
+ ++ I + + L +
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-38
Identities = 40/213 (18%), Positives = 85/213 (39%), Gaps = 13/213 (6%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L+ + + +P + L+ L+ ++N L L P I L+ L LS+ +
Sbjct: 106 LQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRELSIRACPEL 163
Query: 62 GSIPPSLGN---------LTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSI 112
+P L + L +L + + + S+P + +L++L L++ N+ L+ ++
Sbjct: 164 TELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-AL 221
Query: 113 PSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVT 172
++ +L L L L + P G L L + + +P + LT L
Sbjct: 222 GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEK 281
Query: 173 LYIGINALSGSIPNEIGNLKSLSDLRLDYNTLS 205
L + +P+ I L + + + + +
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 6e-49
Identities = 76/320 (23%), Positives = 111/320 (34%), Gaps = 52/320 (16%)
Query: 694 EEIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGN- 752
E N IG G G+VYK L VAVK F +Q F+NE N
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA------NRQNFINEKNI 58
Query: 753 -ALTKIRHRNIVKFYGFCSHALHS-----FVVYEYLEMGSLAMILSNDAAAEEFGWTKRM 806
+ + H NI +F +V EY GSL LS W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVSSC 114
Query: 807 NAIKGVADALLYMHT------NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860
V L Y+HT + P I HRD++S+NVL+ + +SDFG+S L
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 861 SNR--------TELAGTFGYIAPE-------LAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
R GT Y+APE L ++ D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 906 RDFISSICS-------------SLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSIS 952
S+ + + E P+ P + + S+ E
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 953 CLDESPTSRPTMQKVSQLLK 972
C D+ +R T Q + +
Sbjct: 295 CWDQDAEARLTAQXAEERMA 314
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-48
Identities = 52/289 (17%), Positives = 108/289 (37%), Gaps = 35/289 (12%)
Query: 693 HEEIIRATKNFDD---EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLN 749
H I +F + G ++K G + VK ++F
Sbjct: 4 HSGI-----DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRK-SRDFNE 56
Query: 750 EGNALTKIRHRNIVKFYGFCSH--ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMN 807
E L H N++ G C A H ++ ++ GSL +L ++ ++ +
Sbjct: 57 ECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVK 115
Query: 808 AIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA 867
+A + ++H P I ++S++V+++ + A +S + +
Sbjct: 116 FALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-----SPGRM 169
Query: 868 GTFGYIAPEL---AYTMKVTEKCDVYSFGVLALEVIKGKHP-RDFISSICSSLSSNLNIA 923
++APE D++SF VL E++ + P D S++ + +A
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL-----SNMEIGMKVA 224
Query: 924 LDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
L+ + R P + + +M+ C++E P RP + +L+
Sbjct: 225 LEGL---RPTIP-PGISPHVSKLMK---ICMNEDPAKRPKFDMIVPILE 266
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-48
Identities = 66/279 (23%), Positives = 117/279 (41%), Gaps = 33/279 (11%)
Query: 709 IGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G G K TGE++ +K+ E Q+ FL E + + H N++KF G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRF--DEET-QRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
+ EY++ G+L I+ + ++ W++R++ K +A + Y+H+ I
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSM---NI 129
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN--------------RTELAGTFGYI 873
+HRD++S N L+ V+DFG+++ + + R + G ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933
APE+ EK DV+SFG++ E+I + L ++ L+
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY------LPRTMDFGLNVRGFLDRY 243
Query: 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
P N I C D P RP+ K+ L+
Sbjct: 244 CP-PNCPPSFFPITV---RCCDLDPEKRPSFVKLEHWLE 278
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 2e-46
Identities = 68/459 (14%), Positives = 142/459 (30%), Gaps = 23/459 (5%)
Query: 87 SIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFL 146
+I + +++++SL ++ S + N+ L L N LS ++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 147 SDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSG 206
L +S N L + +L+ L TL + N + E+ S+ L N +S
Sbjct: 61 ELLNLSSNVLYETLDL--ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 207 SILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSG-SIPCSFGNLTK 265
S + +YL N ++ L + G + L L N + + +
Sbjct: 114 ---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 266 LVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALS 325
L L N + ++ L L L+ N L+ + S + + N L
Sbjct: 171 LEHLNLQYNFIYD--VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 326 GSIPNEITNLRSLSDLQLSENTLN-GSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLT 384
I + ++L L N + G++ ++ ++ + + T
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECT 284
Query: 385 SLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLT---NSLKVLYLS 441
T + D + +L + + GS L + +
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDAL 344
Query: 442 SNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESL 501
I + + I L L Q+S + +L+ A + +
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHAT 403
Query: 502 GNLVKLHYLNLSNNQFSQK-IPNPIEKLIHLSELDLSYK 539
L L ++ + + + + + D+
Sbjct: 404 EEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQH 442
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 9e-46
Identities = 66/391 (16%), Positives = 135/391 (34%), Gaps = 23/391 (5%)
Query: 212 FGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCL 271
N + +I + ++L + + + ++ L L+ N LS TKL + L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 272 GTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNE 331
+N L ++ +L +L L LN N + L ++ TL+ + N +S +
Sbjct: 66 SSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS 117
Query: 332 ITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSG-SIPLSFASLTSLTTLY 390
+ ++ L+ N + L G +++ LDL +N++ + AS +L L
Sbjct: 118 R--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 391 LYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIP 450
L N + + ++ L LDLSSNKL + + + + L +N +V I
Sbjct: 176 LQYNFI-YDVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAG-VTWISLRNNKLV-LIE 230
Query: 451 LGHGKFSSLIQLILNNNELS-GQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHY 509
+L L N G L +++ + T ++
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECTVPTL 288
Query: 510 LNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFG----EEIPSQVCSMQSLEKLNLSHNNL 565
+ ++LI L + + E + + + +++
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY 348
Query: 566 SGSISRCFEEMHWLSCIDISYNALQGLIPNS 596
I + ++ AL + N
Sbjct: 349 RTVIDQVTLRKQAKITLEQKKKALDEQVSNG 379
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-44
Identities = 62/456 (13%), Positives = 136/456 (29%), Gaps = 24/456 (5%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
K+ ++ + ++ ++K L S N LS + ++ + L L+L SN L
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
L +L++L +D+ NN + E+ S+ L +NN+++ + S
Sbjct: 72 E--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS--RGQG 121
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSG-AIPFSLGNLTNLVTLYIGINAL 180
+YL N ++ + G + L + N + + L L + N +
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 181 SGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLK 240
+ ++ L L L N L+ + F + + + L N L I + +
Sbjct: 182 Y-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQ 237
Query: 241 SLLALQLNYNTLS-GSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNT 299
+L L N G++ F ++ + + +
Sbjct: 238 NLEHFDLRGNGFHCGTLRDFFSKNQRV--QTVAKQTVKKLTGQNEEECTVPTLGHYGAYC 295
Query: 300 LSGSIPLSLGSLTNLATLYFSTNALSGSIPNEIT----NLRSLSDLQLSENTLNGSIPLA 355
L L + + GS + N ++ + I
Sbjct: 296 CEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQV 355
Query: 356 LGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCD--SIPKEIGDMKSLSIL 413
++L+ L + + L + +E ++ L +
Sbjct: 356 TLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAI 415
Query: 414 DLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEI 449
++ N + + E
Sbjct: 416 VKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEEN 451
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-44
Identities = 70/434 (16%), Positives = 134/434 (30%), Gaps = 21/434 (4%)
Query: 183 SIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSL 242
+I N ++ ++L ++ + ++ L L N LS + ++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 243 LALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSG 302
L L+ N L ++ +L+ L L N + E+ S+ L N +S
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 303 SIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNG-SIPLALGNLTK 361
+S +Y + N ++ + + L L N ++ + +
Sbjct: 114 ---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 362 LVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
L L+L N + + L TL L N L + E ++ + L +NKL
Sbjct: 171 LEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV 227
Query: 422 GSIPLSLANLTNSLKVLYLSSNHIV-GEIPLGHGKFSSLIQLILN-NNELSGQLSPELGS 479
I +L N L+ L N G + K + + +L+GQ E
Sbjct: 228 -LIEKALRFSQN-LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 480 LNQLEYLDLSANTFHNSIPESLGNL--VKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLS 537
Y + L L + L+ ++ +++ E E+D
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSET-ERLECERENQARQREIDAL 344
Query: 538 YKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNST 597
+ + I Q+ L L +S L L +
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATE 404
Query: 598 AFRDAPMLALQGNK 611
+L +
Sbjct: 405 EQSPLQLLRAIVKR 418
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 5e-43
Identities = 63/460 (13%), Positives = 142/460 (30%), Gaps = 23/460 (5%)
Query: 63 SIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNL 122
+I N + ++ L ++ + S ++ +L LS N L+ + L T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 123 VTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSG 182
L L N L ++ + +L L L ++ N + L ++ TL+ N +S
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 183 SIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGL-IPNEIGNLKS 241
+ + ++ L N ++ G ++++ L L +N + + + +
Sbjct: 113 RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLS 301
L L L YN + + KL L +N L + + E + + + L N L
Sbjct: 171 LEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV 227
Query: 302 GSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTK 361
I +L NL N ++ +++ T+ T
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 362 LVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLC----DSIPKEIGDMKSLSILDLSS 417
L +L S + + E + +D
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345
Query: 418 NKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPEL 477
+ ++ + + L + ++ G + L + +L
Sbjct: 346 EQYR-TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHAT 403
Query: 478 GSLNQLEYLDLSANTF-HNSIPESLGNLVKLHYLNLSNNQ 516
+ L+ L + + + + ++ ++
Sbjct: 404 EEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHK 443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 7e-45
Identities = 64/300 (21%), Positives = 112/300 (37%), Gaps = 47/300 (15%)
Query: 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGN--ALTKIRHRNIV 763
C+G G G V++ GE VAVK F S ++ + E +RH NI+
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENIL 65
Query: 764 KFYGFCSHALHSFVVY----EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYM 819
F + HS Y EMGSL L + + +A L ++
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHL 121
Query: 820 HTNCF-----PPIVHRDISSKNVLLNLEYEAHVSDFGISKFL----KLGLSNRTELAGTF 870
H F P I HRD+ SKN+L+ + ++D G++ GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 871 GYIAPEL------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS--ICSSLSSNLNI 922
Y+APE+ ++ D+++FG++ EV + + +
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241
Query: 923 ALDEMLD--------PRLPTPLRNVQ--DKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ ++M P +P + L +M+ C ++P++R T ++ + L
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLT 298
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 7e-45
Identities = 68/272 (25%), Positives = 120/272 (44%), Gaps = 27/272 (9%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGF 768
IG+G G+VYK + G+ VAVK + P Q F NE L K RH NI+ F G+
Sbjct: 32 IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 769 CSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIV 828
+ +V ++ E SL L +F K ++ + A + Y+H I+
Sbjct: 89 STAP-QLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SII 142
Query: 829 HRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR--TELAGTFGYIAPEL---AYTMKV 883
HRD+ S N+ L+ + + DFG++ + +L+G+ ++APE+ +
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 884 TEKCDVYSFGVLALEVIKGKHP---RDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940
+ + DVY+FG++ E++ G+ P + I + L P L N
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS-------LSPDLSKVRSNCP 255
Query: 941 DKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
++ +M CL + RP+ ++ ++
Sbjct: 256 KRMKRLMA---ECLKKKRDERPSFPRILAEIE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-44
Identities = 55/280 (19%), Positives = 104/280 (37%), Gaps = 38/280 (13%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGF 768
IG G G VY GE VA++ E + F E A + RH N+V F G
Sbjct: 41 IGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQ-LKAFKREVMAYRQTRHENVVLFMGA 97
Query: 769 CSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIV 828
C H ++ + +L ++ + A K + + + Y+H I+
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHA---KGIL 152
Query: 829 HRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR-----TELAGTFGYIAPEL------ 877
H+D+ SKNV + + ++DFG+ + + R G ++APE+
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 878 ---AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS--ICSSLSSNLNIALDEMLDPRL 932
+ ++ DV++ G + E+ + P + I + + + +
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM----------KP 261
Query: 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ ++ I+ C RPT K+ +L+
Sbjct: 262 NLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDMLE 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 8e-44
Identities = 65/300 (21%), Positives = 108/300 (36%), Gaps = 47/300 (15%)
Query: 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGN--ALTKIRHRNIV 763
IG G G V+ + GE VAVK F + + + E +RH NI+
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENIL 94
Query: 764 KFYGFCSHALHS----FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYM 819
F S +++ +Y E GSL L + + L ++
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHL 150
Query: 820 HTNCF-----PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR----TELAGTF 870
HT F P I HRD+ SKN+L+ ++D G++ + GT
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 871 GYIAPEL------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS--ICSSLSSNLNI 922
Y+ PE+ + D+YSFG++ EV + + + +
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270
Query: 923 ALDEMLDP------RLPTPLRNVQD----KLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ ++M + R P R D ++ +M C +P SR T +V + L
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMT---ECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 1e-43
Identities = 60/300 (20%), Positives = 110/300 (36%), Gaps = 47/300 (15%)
Query: 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGN--ALTKIRHRNIV 763
+ IG G G V++ + GE VAVK F S ++ + E +RH NI+
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENIL 99
Query: 764 KFYGFCSHALHS----FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYM 819
F + + ++V +Y E GSL L+ + A L ++
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHL 155
Query: 820 HTNCF-----PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS----NRTELAGTF 870
H P I HRD+ SKN+L+ ++D G++ GT
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 871 GYIAPEL------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS--ICSSLSSNLNI 922
Y+APE+ + ++ D+Y+ G++ E+ + + +
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275
Query: 923 ALDEMLD--------PRLPTPLRN--VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+++EM P +P ++ + IM C + +R T ++ + L
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLS 332
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 8e-43
Identities = 62/358 (17%), Positives = 121/358 (33%), Gaps = 45/358 (12%)
Query: 183 SIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSL 242
+I N ++ ++L ++ + ++ L L N LS + ++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 243 LALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSG 302
L L+ N L ++ +L +L L LN N +
Sbjct: 61 ELLNLSSNVLYE--------------------------TLDLESLSTLRTLDLNNNYVQ- 93
Query: 303 SIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKL 362
L ++ TL+ + N +S + + ++ L+ N + L G +++
Sbjct: 94 ----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRV 146
Query: 363 VSLDLSINKLSG-SIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
LDL +N++ + AS +L L L N + + ++ L LDLSSNKL
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI-YDVKGQVV-FAKLKTLDLSSNKLA 204
Query: 422 GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELS-GQLSPELGSL 480
+ + + + L +N +V I +L L N G L
Sbjct: 205 -FMGPEFQSAAG-VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261
Query: 481 NQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPI-EKLIHLSELDLS 537
+++ + + + L + +P P ++LI L
Sbjct: 262 QRVQTVAKQTVK---KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 8e-42
Identities = 58/334 (17%), Positives = 115/334 (34%), Gaps = 23/334 (6%)
Query: 87 SIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFL 146
+I + +++++SL ++ S + N+ L L N LS ++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 147 SDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSG 206
L +S N L + +L+ L TL + N + E+ S+ L N +S
Sbjct: 61 ELLNLSSNVLYETLDL--ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 207 SILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSG-SIPCSFGNLTK 265
S + +YL N ++ L + G + L L N + + +
Sbjct: 114 V---SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 266 LVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALS 325
L L N + ++ L L L+ N L+ + S + + N L
Sbjct: 171 LEHLNLQYNFIYD--VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 326 GSIPNEITNLRSLSDLQLSENTLN-GSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLT 384
I + ++L L N + G++ ++ ++ K +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEEC 283
Query: 385 SLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSN 418
++ TL Y C+ +P D ++ L +
Sbjct: 284 TVPTLGHYGAYCCEDLPAPFAD----RLIALGHH 313
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-37
Identities = 51/321 (15%), Positives = 106/321 (33%), Gaps = 18/321 (5%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
K+ ++ + ++ ++K L S N LS + ++ + L L+L SN L
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
L +L++L +D+ NN + E+ S+ L +NN+++ + S
Sbjct: 72 E--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS--RGQG 121
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSG-AIPFSLGNLTNLVTLYIGINAL 180
+YL N ++ + G + L + N + + L L + N +
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 181 SGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLK 240
+ ++ L L L N L+ + F + + + L N L I + +
Sbjct: 182 Y-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQ 237
Query: 241 SLLALQLNYNTLS-GSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNT 299
+L L N G++ F ++ + + +
Sbjct: 238 NLEHFDLRGNGFHCGTLRDFFSKNQRV--QTVAKQTVKKLTGQNEEECTVPTLGHYGAYC 295
Query: 300 LSGSIPLSLGSLTNLATLYFS 320
L L +
Sbjct: 296 CEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 51/332 (15%), Positives = 107/332 (32%), Gaps = 18/332 (5%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSL 74
+I + K+ + + L + ++ L L N L L T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 75 IYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSG 134
+++ +N+L ++ SL +L L L+NN + L ++ TL+ N +S
Sbjct: 61 ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 135 SIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSG-SIPNEIGNLKS 193
+ + ++ ++ N ++ G + + L + +N + + + +
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 194 LSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLS 253
L L L YN + + KL+ L L N L+ + E + + + L N L
Sbjct: 171 LEHLNLQYNFI--YDVKGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227
Query: 254 GSIPCSFGNLTKLVISCLGTNALSSSILEE-IGNLKSLLHLQLNYNTLSGSIPLSLGSLT 312
I + L L N L + + + + ++
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 313 NLATLYFSTNALSGSIPNEITNLRSLSDLQLS 344
L ++ L +L
Sbjct: 287 TL--GHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 51/258 (19%), Positives = 98/258 (37%), Gaps = 26/258 (10%)
Query: 351 SIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSL 410
+I N + ++ + L ++ S ++ L L N L ++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 411 SILDLSSNKLNGSIPLS-LANLTN---------------SLKVLYLSSNHIVGEIPLGHG 454
+L+LSSN L ++ L L+ L S++ L+ ++N+I +
Sbjct: 61 ELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI-SRVSC--S 117
Query: 455 KFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHN-SIPESLGNLVKLHYLNLS 513
+ + L NN+++ + G ++++YLDL N + E + L +LNL
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 514 NNQFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRC 572
N + + L LDLS K+ + + S + ++L +N L I +
Sbjct: 178 YNFIY-DVKGQV-VFAKLKTLDLSSNKL--AFMGPEFQSAAGVTWISLRNNKLV-LIEKA 232
Query: 573 FEEMHWLSCIDISYNALQ 590
L D+ N
Sbjct: 233 LRFSQNLEHFDLRGNGFH 250
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-41
Identities = 95/456 (20%), Positives = 165/456 (36%), Gaps = 60/456 (13%)
Query: 71 LTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMN 130
+++G + L+ ++P+ + ++ L + +N+L S+P+ L L + N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELRT---LEVSGN 91
Query: 131 ALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGN 190
L+ S+P L LS L + L L+I N L+ S+P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLT-SLPVLPPG 142
Query: 191 LKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYN 250
L+ LS + N L+ S+ L KL N L+ L P L+ L ++ N
Sbjct: 143 LQELS---VSDNQLA-SLPALPSELCKLWAYN---NQLTSL-PMLPSGLQE---LSVSDN 191
Query: 251 TLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGS 310
L+ S+P L KL N L +S+ LK L ++ N L+ S+P+
Sbjct: 192 QLA-SLPTLPSELYKLWAYN---NRL-TSLPALPSGLKE---LIVSGNRLT-SLPVLPSE 242
Query: 311 LTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSIN 370
L L S N L+ S+P + L SLS + N L +P +L +L+ +++L N
Sbjct: 243 LKE---LMVSGNRLT-SLPMLPSGLLSLS---VYRNQLT-RLPESLIHLSSETTVNLEGN 294
Query: 371 KLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLAN 430
LS + +L +T+ Y + + L L++
Sbjct: 295 PLS---ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPA 351
Query: 431 LTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLI-----LNNNELSGQLSPELGSLNQLEY 485
+ + G+ L +L + + Q+S L L + E
Sbjct: 352 PADRWHMF--------GQEDNADAFSLFLDRLSETENFIKDAGFKAQISSWLAQLAEDEA 403
Query: 486 LDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKI 521
L + S + V + N Q
Sbjct: 404 LRANTFAMATEATSSCEDRVTFFLHQMKNVQLVHNA 439
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-40
Identities = 76/346 (21%), Positives = 128/346 (36%), Gaps = 45/346 (13%)
Query: 215 LTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTN 274
+L + + L+ L P+ + + L + N L+ S+P L L +S N
Sbjct: 39 NNGNAVLNVGESGLTTL-PDCLP--AHITTLVIPDNNLT-SLPALPPELRTLEVSG---N 91
Query: 275 ALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITN 334
L+S + L L L + L L+ N L+ S+P
Sbjct: 92 QLTS-LPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-SLPVLPPG 142
Query: 335 LRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYEN 394
L+ LS +S+N L S+P L KL N+L+ S+P + L L + +N
Sbjct: 143 LQELS---VSDNQLA-SLPALPSELCKL---WAYNNQLT-SLP---MLPSGLQELSVSDN 191
Query: 395 SLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHG 454
L S+P L L +N+L S+P + L L +S N + +P+
Sbjct: 192 QLA-SLPTLPS---ELYKLWAYNNRLT-SLPALPSGLK----ELIVSGNRL-TSLPVLPS 241
Query: 455 KFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSN 514
L +L+++ N L+ L L L + N +PESL +L +NL
Sbjct: 242 ---ELKELMVSGNRLT-SLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293
Query: 515 NQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNL 560
N S++ + ++ F S ++L
Sbjct: 294 NPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAA 339
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-40
Identities = 80/381 (20%), Positives = 127/381 (33%), Gaps = 51/381 (13%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
VL + + + ++P + H+ L N L+ L P L +L + N L
Sbjct: 42 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSL-PALPPELRTLE---VSGNQLT 94
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
S+P L L L L L + N L S+P L
Sbjct: 95 -SLPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLT-SLPVLPPGLQE 145
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L + N L+ S+P L L N L+ ++P L L + N L+
Sbjct: 146 ---LSVSDNQLA-SLPALPSELC---KLWAYNNQLT-SLPMLPSGLQ---ELSVSDNQLA 194
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
S+P L L +L + L+ L + N L+ L P LK
Sbjct: 195 -SLPTLPSELYKLWAYNNRLTSLPALP-------SGLKELIVSGNRLTSL-PVLPSELKE 245
Query: 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLS 301
L ++ N L+ S+P L L + N L + + E + +L S + L N LS
Sbjct: 246 ---LMVSGNRLT-SLPMLPSGLLSLSVYR---NQL-TRLPESLIHLSSETTVNLEGNPLS 297
Query: 302 GSIPLSLGSLTNLATLY---FSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPL---- 354
+L +T+ + S P E L + L P
Sbjct: 298 ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWH 357
Query: 355 ALGNLTKLVSLDLSINKLSGS 375
G + L +++LS +
Sbjct: 358 MFGQEDNADAFSLFLDRLSET 378
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-35
Identities = 79/398 (19%), Positives = 141/398 (35%), Gaps = 71/398 (17%)
Query: 167 LTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVN 226
L +G + L+ ++P+ + + L + N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP--------------------------AHITTLVIPDN 71
Query: 227 ALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGN 286
L+ L P L++L +++ N L+ S+P L +L I L +
Sbjct: 72 NLTSL-PALPPELRTL---EVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPAL------- 119
Query: 287 LKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSEN 346
L L + N L+ S+P+ L L S N L+ S+P + L L N
Sbjct: 120 PSGLCKLWIFGNQLT-SLPVLPPGLQEL---SVSDNQLA-SLPALPSELCKL---WAYNN 171
Query: 347 TLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGD 406
L S+P+ L L +S N+L+ S+P + L L+ Y N L S+P
Sbjct: 172 QLT-SLPMLPSGLQ---ELSVSDNQLA-SLP---TLPSELYKLWAYNNRL-TSLPALPS- 221
Query: 407 MKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNN 466
L L +S N+L S+P+ + L L +S N + +P+ S L+ L +
Sbjct: 222 --GLKELIVSGNRLT-SLPVLPSELKE----LMVSGNRLT-SLPML---PSGLLSLSVYR 270
Query: 467 NELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIE 526
N+L+ +L L L+ ++L N ++L + + +F +
Sbjct: 271 NQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPR 329
Query: 527 KLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNN 564
+ L + + E + N
Sbjct: 330 ETRALHLAAADWLVPARE--GEPAPADRWHMFGQEDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-33
Identities = 67/348 (19%), Positives = 131/348 (37%), Gaps = 49/348 (14%)
Query: 287 LKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSEN 346
L + + L+ ++P L ++ TL N L+ S+P LR+L +S N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTLE---VSGN 91
Query: 347 TLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGD 406
L S+P+ L +L + L A + L L+++ N L S+P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLT-SLPVLPP- 141
Query: 407 MKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNN 466
L L +S N+L S+P + L L+ +N + +P+ S L +L +++
Sbjct: 142 --GLQELSVSDNQLA-SLPALPSELCK----LWAYNNQLT-SLPML---PSGLQELSVSD 190
Query: 467 NELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIE 526
N+L+ L L +L + S+P L +L +S N+ + +P
Sbjct: 191 NQLA-SLPTLPSELYKLWAYNNR----LTSLPALPSGLKELI---VSGNRLTS-LP---V 238
Query: 527 KLIHLSELDLSY-KIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDIS 585
L EL +S ++ +P L L++ N L+ + + + +++
Sbjct: 239 LPSELKELMVSGNRL--TSLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292
Query: 586 YNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPCKAFKSHKQSL 633
N L + R+ + D+ + ++ +
Sbjct: 293 GNPLSERTLQA--LREITSAPGYSGPIIRFDMAGASAPRETRALHLAA 338
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 1e-20
Identities = 40/218 (18%), Positives = 73/218 (33%), Gaps = 29/218 (13%)
Query: 378 LSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKV 437
+ L + E+ L ++P + ++ L + N L S+P L
Sbjct: 34 MRACLNNGNAVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLT-SLPALPPELRT---- 85
Query: 438 LYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSI 497
L +S N + +P+ L L S L L + N S+
Sbjct: 86 LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQL-TSL 136
Query: 498 PESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEK 557
P L L++S+NQ + +P +L L + L++
Sbjct: 137 PVLPPG---LQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPS-------GLQE 185
Query: 558 LNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPN 595
L++S N L+ S+ E++ L + +L L
Sbjct: 186 LSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSG 222
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 48/249 (19%), Positives = 86/249 (34%), Gaps = 25/249 (10%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
LK L +S N+ + S+P L L + S N+L+ L P L SL+ +Y N L
Sbjct: 223 LKELIVSGNRLT-SLPVLPSELKELMV---SGNRLTSL-PMLPSGLLSLS---VYRNQLT 274
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDL---RLSNNSLNGSIPSSLGN 118
+P SL +L+S +++ N LS + + S + + S P
Sbjct: 275 -RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRA 333
Query: 119 LTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGIN 178
L +L P G + + + + +I
Sbjct: 334 LHLAAADWLV--------PAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIKDA 385
Query: 179 ALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGN-----LTKLEILYLDVNALSGLIP 233
I + + L LR + ++ S + L +++ + L NA G
Sbjct: 386 GFKAQISSWLAQLAEDEALRANTFAMATEATSSCEDRVTFFLHQMKNVQLVHNAEKGQYD 445
Query: 234 NEIGNLKSL 242
N++ L +
Sbjct: 446 NDLAALVAT 454
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-41
Identities = 91/442 (20%), Positives = 153/442 (34%), Gaps = 71/442 (16%)
Query: 63 SIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNL 122
I +L + I E +L + + N+++ + L + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 123 VTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSG 182
L L+ + I + LY+G NA+
Sbjct: 72 ELLNLNDLQIE-EIDTYA-----------------------FAYAHTIQKLYMGFNAIR- 106
Query: 183 SIPNEI-GNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
+P + N+ L+ L L+ N LS F N KL L + N L + + S
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS 166
Query: 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLS 301
L LQL+ N LT + ++ + SL H ++YN LS
Sbjct: 167 LQNLQLSSN-----------RLTHV----------------DLSLIPSLFHANVSYNLLS 199
Query: 302 GSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTK 361
+L + L S N+++ + + L+ L+L N L L N
Sbjct: 200 -----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPG 249
Query: 362 LVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
LV +DLS N+L + F + L LY+ N L ++ + +L +LDLS N L
Sbjct: 250 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL 308
Query: 422 GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLN 481
+ + L+ LYL N IV + L +L L L++N+ +
Sbjct: 309 -HVERNQPQFDR-LENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWDC--NSLRALFR 361
Query: 482 QLEYLDLSANTFHNSIPESLGN 503
+ + H I L +
Sbjct: 362 NVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-41
Identities = 86/400 (21%), Positives = 139/400 (34%), Gaps = 52/400 (13%)
Query: 183 SIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSL 242
I + + D+ +D T + L +I+ + + L + + + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 243 LALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSG 302
L LN + +F + +G NA+ N+ L L L N LS
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131
Query: 303 SIPLSLGSLTNLATLYFSTNALSGSIPNEI-TNLRSLSDLQLSENTLNGSIPLALGNLTK 361
+ L TL S N L I ++ SL +LQLS N L + L +
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPS 187
Query: 362 LVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
L ++S N LS + A ++ L NS+ + + + L+IL L N L
Sbjct: 188 LFHANVSYNLLS-----TLAIPIAVEELDASHNSI-NVVRGPV--NVELTILKLQHNNLT 239
Query: 422 GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGH-GKFSSLIQLILNNNELSGQLSPELGSL 480
L N L + LS N + +I K L +L ++NN L L+ +
Sbjct: 240 -DTA-WLLNYPG-LVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 294
Query: 481 NQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKI 540
L+ LDLS N + + +L L L +N + L LS
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS--------------IVTLKLS--- 336
Query: 541 FGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLS 580
+ +L+ L LSHN+ C
Sbjct: 337 ----------THHTLKNLTLSHNDWD-----CNSLRALFR 361
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-38
Identities = 71/379 (18%), Positives = 134/379 (35%), Gaps = 23/379 (6%)
Query: 40 IPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLS 99
I + + + L + + N+ + + S + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 100 DLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEI-GNLKFLSDLQVSYNTLSG 158
L L++ + + + LY+ NA+ +P + N+ L+ L + N LS
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS 131
Query: 159 AIPFSLGNLTNLVTLYIGINALSGSIPNEI-GNLKSLSDLRLDYNTLSGSILYSFGNLTK 217
N L TL + N L I ++ SL +L+L N L+ +
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPS 187
Query: 218 LEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALS 277
L + N LS + ++ L ++N+++ LT L + N L+
Sbjct: 188 LFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTILKLQ---HNNLT 239
Query: 278 SSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRS 337
+ N L+ + L+YN L + + L LY S N L ++ + +
Sbjct: 240 D--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 296
Query: 338 LSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSL- 396
L L LS N L + +L +L L N + L ++ +L L L N
Sbjct: 297 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWD 352
Query: 397 CDSIPKEIGDMKSLSILDL 415
C+S+ ++ ++ D
Sbjct: 353 CNSLRALFRNVARPAVDDA 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-37
Identities = 78/337 (23%), Positives = 134/337 (39%), Gaps = 21/337 (6%)
Query: 278 SSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRS 337
I + + ++ T +L N + F + + + + R
Sbjct: 11 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 70
Query: 338 LSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLC 397
+ L L++ + A + L + N + P F ++ LT L L N L
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL- 129
Query: 398 DSIPKEI-GDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKF 456
S+P+ I + L+ L +S+N L + T+ L+ L LSSN + + L
Sbjct: 130 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS-LQNLQLSSNRLT-HVDLSL--I 185
Query: 457 SSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQ 516
SL ++ N LS L +E LD S N+ N + + V+L L L +N
Sbjct: 186 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI-NVVRGPV--NVELTILKLQHNN 237
Query: 517 FSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQV-CSMQSLEKLNLSHNNLSGSISRCFE 574
+ + L E+DLSY ++ E+I MQ LE+L +S+N L +++ +
Sbjct: 238 LTD--TAWLLNYPGLVEVDLSYNEL--EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQ 292
Query: 575 EMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNK 611
+ L +D+S+N L + N F L L N
Sbjct: 293 PIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNS 329
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 58/299 (19%), Positives = 100/299 (33%), Gaps = 25/299 (8%)
Query: 319 FSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPL 378
I + + D+ + T + L + + +
Sbjct: 4 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA 63
Query: 379 SFASLTSLTTLYLYENSLCDSIPKEI-GDMKSLSILDLSSNKLNGSIPLSLANLTNSLKV 437
S + L L + + + I ++ L + N + P N+ L V
Sbjct: 64 LLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL-LTV 121
Query: 438 LYLSSNHIVGEIPLGH-GKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNS 496
L L N + +P G L L ++NN L + L+ L LS+N
Sbjct: 122 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-H 179
Query: 497 IPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQVCSMQSL 555
+ L + L + N+S N S + I + ELD S+ I + V L
Sbjct: 180 VD--LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSI--NVVRGPVN--VEL 228
Query: 556 EKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAP---MLALQGNK 611
L L HNNL+ + L +D+SYN L+ ++ + F L + N+
Sbjct: 229 TILKLQHNNLTDTAW--LLNYPGLVEVDLSYNELEKIMYH--PFVKMQRLERLYISNNR 283
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-41
Identities = 94/497 (18%), Positives = 176/497 (35%), Gaps = 42/497 (8%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
+L +S N S +I L+ L++L S N++ L L L L N L
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 62 GSIPPSLGNLTSLIYIDIGNNLL-SGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLT 120
I +L ++D+ N + I E G++ L L LS L S + +L
Sbjct: 83 -KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLN 139
Query: 121 NLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINAL 180
L + ++ L+ + + + + +++ + ++ +
Sbjct: 140 ISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197
Query: 181 SGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLK 240
L D + Y + L + L+ L + ++ S + ++
Sbjct: 198 KC----------VLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHT 247
Query: 241 SLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTL 300
++ ++ L G + + + +LK+L Q+ +
Sbjct: 248 TVWYFSISNVKLQGQLDFRDFDYSGT-------------------SLKALSIHQVVSDVF 288
Query: 301 SGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLT 360
+N+ F+ + + + L S N L ++ G+LT
Sbjct: 289 GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLT 348
Query: 361 KLVSLDLSINKLS--GSIPLSFASLTSLTTLYLYENSLCDSIPKEIGD-MKSLSILDLSS 417
+L +L L +N+L I + SL L + +NS+ K KSL L++SS
Sbjct: 349 ELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSS 408
Query: 418 NKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPEL 477
N L +I L +KVL L SN I IP K +L +L + +N+L
Sbjct: 409 NILTDTIFRC---LPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIF 464
Query: 478 GSLNQLEYLDLSANTFH 494
L L+ + L N +
Sbjct: 465 DRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-39
Identities = 95/539 (17%), Positives = 191/539 (35%), Gaps = 71/539 (13%)
Query: 4 VLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGS 63
++ S N +P ++ +L+ S+N +S L +I LS L L + N ++
Sbjct: 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 64 IPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSS--LGNLTN 121
L Y+D+ +N L I +L L LS N+ + ++P GN++
Sbjct: 61 DISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQ 116
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L L L L S I +L L V T L + T + I +
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPT 174
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
+ I ++ + L+ + + + + + + L N
Sbjct: 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNP-------------- 220
Query: 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLS 301
L+ L ++ + T S + ++ ++ + ++ L
Sbjct: 221 --------------------KLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQ 260
Query: 302 GSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTK 361
G + + T+L++LS Q+ + +
Sbjct: 261 GQLDFRDFDYSG-------------------TSLKALSIHQVVSDVFGFPQSYIYEIFSN 301
Query: 362 LVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
+ + +++ L + ++ L N L D++ + G + L L L N+L
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
Query: 422 --GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGH-GKFSSLIQLILNNNELSGQLSPELG 478
I + + L+ L +S N + + G SL+ L +++N L+ + L
Sbjct: 362 ELSKIAEMTTQMKS-LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL- 419
Query: 479 SLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLS 537
+++ LDL +N SIP+ + L L LN+++NQ ++L L ++ L
Sbjct: 420 -PPRIKVLDLHSNKI-KSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLH 476
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 9e-22
Identities = 66/370 (17%), Positives = 118/370 (31%), Gaps = 30/370 (8%)
Query: 240 KSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNT 299
+ L ++ N +S +L+KL I + N + + + L +L L++N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 300 LSGSIPLSLGSLTNLATLYFSTNAL-SGSIPNEITNLRSLSDLQLSENTLNGSIPLALGN 358
L +S NL L S NA + I E N+ L L LS L S L + +
Sbjct: 81 LVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 359 LTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSN 418
L L + L T L+ + I D+ ++ +L
Sbjct: 138 LNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLE-- 193
Query: 419 KLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELG 478
L+N VL + I L L LNN E + +
Sbjct: 194 ------------LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL 241
Query: 479 SL---NQLEYLDLSANTF-----HNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIH 530
L + Y +S S +L L + ++ F E +
Sbjct: 242 QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSN 301
Query: 531 LSELDLSYKIFGEEIPSQVCS-MQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNAL 589
++ + + + S + L+ S+N L+ ++ + L + + N L
Sbjct: 302 MNIKNFTV-SGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360
Query: 590 QGLIPNSTAF 599
+ L +
Sbjct: 361 KELSKIAEMT 370
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-40
Identities = 92/497 (18%), Positives = 174/497 (35%), Gaps = 59/497 (11%)
Query: 87 SIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEI-GNLKF 145
I + + D+ + + + L N + + + +P + + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76
Query: 146 LSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEI-GNLKSLSDLRLDYNTL 204
+ L ++ + ++ + LY+G NA+ +P + N+ L+ L L+ N L
Sbjct: 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 135
Query: 205 SGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLT 264
S F N KL L + N L + + SL LQL+ N L+ +
Sbjct: 136 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD------- 187
Query: 265 KLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNAL 324
+ + SL H ++YN LS +L + L S N++
Sbjct: 188 -------------------LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI 223
Query: 325 SGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLT 384
+ + + L+ L+L N L L N LV +DLS N+L + F +
Sbjct: 224 N-VVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 278
Query: 385 SLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 444
L LY+ N L ++ + +L +LDLS N L + + L+ LYL N
Sbjct: 279 RLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR-LENLYLDHNS 335
Query: 445 IVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNL 504
IV + L +L L L++N+ + + + H I L +
Sbjct: 336 IV-TLKLST--HHTLKNLTLSHNDWDC--NSLRALFRNVARPAVDDADQHCKIDYQLEHG 390
Query: 505 VKLHYLN----------LSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQS 554
+ + ++ +K+ + ++ + +Q
Sbjct: 391 LCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQG 450
Query: 555 LEKLNLSHNNLSGSISR 571
E+L N L + +
Sbjct: 451 NEQLEAEVNELRAEVQQ 467
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-39
Identities = 93/575 (16%), Positives = 191/575 (33%), Gaps = 43/575 (7%)
Query: 2 LKVLGLSFNQFSGSIPPEI-GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
K++ + +P + ++LL+ + Q+ + + ++ L + N +
Sbjct: 53 QKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI 111
Query: 61 KGSIPPS-LGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSSLGN 118
+ +PP N+ L + + N LS S+P + + L+ L +SNN+L +
Sbjct: 112 R-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA 169
Query: 119 LTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGIN 178
T+L L L N L+ + + L VSYN LS +L + L N
Sbjct: 170 TTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHN 221
Query: 179 ALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGN 238
+++ + + L+ L+L +N L+ N L + L N L ++ +
Sbjct: 222 SIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVK 276
Query: 239 LKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYN 298
++ L L ++ N L ++ + L + L N L + L +L L++N
Sbjct: 277 MQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHN 334
Query: 299 TLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGN 358
++ L L + L L S N + + R+++ + + + I L +
Sbjct: 335 SIV---TLKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 389
Query: 359 LTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSN 418
D L + +LTS+ C + + S+ L
Sbjct: 390 GLCCKESDKPYLDR----LLQYIALTSVVEKVQRAQGRCSATD----TINSVQSLSHYIT 441
Query: 419 KLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELG 478
+ G L + L + E L I N L
Sbjct: 442 QQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLA 501
Query: 479 SLNQL---------EYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLI 529
+ E E+ + L N +++ N K
Sbjct: 502 RSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQA 561
Query: 530 HLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNN 564
L + + +++ ++ +++ H++
Sbjct: 562 ELRQETSLKRQKVKQLEAKKNRNPDTRRVSHHHHH 596
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-38
Identities = 89/509 (17%), Positives = 172/509 (33%), Gaps = 35/509 (6%)
Query: 40 IPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSL 98
I + + + L + + N+ + +P + S + +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 99 SDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEI-GNLKFLSDLQVSYNTLS 157
L L++ + + + LY+ NA+ +P + N+ L+ L + N LS
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 136
Query: 158 GAIPFSLGNLTNLVTLYIGINALSGSIPNEI-GNLKSLSDLRLDYNTLSGSILYSFGNLT 216
N L TL + N L I ++ SL +L+L N L+ + +
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HV--DLSLIP 192
Query: 217 KLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNAL 276
L + N LS + ++ L ++N+++ LT L L N L
Sbjct: 193 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTILK---LQHNNL 244
Query: 277 SSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLR 336
+ + N L+ + L+YN L + + L LY S N L ++ +
Sbjct: 245 TD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 301
Query: 337 SLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSL 396
+L L LS N L + +L +L L N + L ++ +L L L N
Sbjct: 302 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDW 357
Query: 397 -CDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVL------YLSSNHIVGEI 449
C+S+ ++ ++ D + S K Y++ +V ++
Sbjct: 358 DCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKV 417
Query: 450 PLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSI----PESLGNLV 505
G+ S+ + + L E L+ N + E +
Sbjct: 418 QRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQ 477
Query: 506 KLHYLNLSNNQFSQKIPNPIEKLIHLSEL 534
L L+ + ++ P + L S+
Sbjct: 478 LLQGLHAEIDTNLRRYRLPKDGLARSSDN 506
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-34
Identities = 76/367 (20%), Positives = 139/367 (37%), Gaps = 38/367 (10%)
Query: 278 SSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEI-TNLR 336
I + + ++ T +L N + F + + +P + + R
Sbjct: 17 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFR 75
Query: 337 SLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSL 396
+ L L++ + A + L + N + P F ++ LT L L N L
Sbjct: 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 135
Query: 397 CDSIPKEI-GDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGK 455
S+P+ I + L+ L +S+N L + T+ L+ L LSSN + + L
Sbjct: 136 -SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS-LQNLQLSSNRLT-HVDLSL-- 190
Query: 456 FSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTF-----------------HNSI- 497
SL ++ N LS L +E LD S N+ HN++
Sbjct: 191 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLT 245
Query: 498 -PESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQVCSMQSL 555
L N L ++LS N+ + + +P K+ L L +S ++ + + +L
Sbjct: 246 DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL--VALNLYGQPIPTL 303
Query: 556 EKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCG 615
+ L+LSHN+L + R + L + + +N++ L + L L N C
Sbjct: 304 KVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL--KLSTHHTLKNLTLSHNDWDCN 360
Query: 616 DIKRLPP 622
++ L
Sbjct: 361 SLRALFR 367
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-25
Identities = 58/300 (19%), Positives = 103/300 (34%), Gaps = 27/300 (9%)
Query: 319 FSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPL 378
I + + D+ + T + L + + +
Sbjct: 10 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA 69
Query: 379 SFASLTSLTTLYLYENSLCDSIPKEI-GDMKSLSILDLSSNKLNGSIPLSLANLTNSLKV 437
S + L L + + + I ++ L + N + P N+ L V
Sbjct: 70 LLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL-LTV 127
Query: 438 LYLSSNHIVGEIPLGH-GKFSSLIQLILNNNELSGQLSPE-LGSLNQLEYLDLSANTFHN 495
L L N + +P G L L ++NN L ++ + + L+ L LS+N
Sbjct: 128 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT- 184
Query: 496 SIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQVCSMQS 554
+ L + L + N+S N S + I + ELD S+ I + V
Sbjct: 185 HVD--LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSI--NVVRGPVN--VE 233
Query: 555 LEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAP---MLALQGNK 611
L L L HNNL+ + L +D+SYN L+ ++ + F L + N+
Sbjct: 234 LTILKLQHNNLTDTAW--LLNYPGLVEVDLSYNELEKIMYH--PFVKMQRLERLYISNNR 289
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-37
Identities = 84/315 (26%), Positives = 134/315 (42%), Gaps = 16/315 (5%)
Query: 271 LGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPN 330
LG N + + +E + L L+LN N +S P + +L NL TL +N L IP
Sbjct: 39 LGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPL 97
Query: 331 EI-TNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTL 389
+ T L +L+ L +SEN + + +L L SL++ N L +F+ L SL L
Sbjct: 98 GVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQL 157
Query: 390 YLYENSLCDSIPKEI-GDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGE 448
L + +L SIP E + L +L L +N S L LKVL +S +
Sbjct: 158 TLEKCNL-TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYR-LKVLEISHWPYLDT 215
Query: 449 IPLGHGKFSSLIQLILNNNELSGQLSPE-LGSLNQLEYLDLSANTFHNSIPESLGNLVKL 507
+ +L L + + L+ + + L L +L+LS N L L++L
Sbjct: 216 MTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRL 274
Query: 508 HYLNLSNNQFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQVC-SMQSLEKLNLSHNNL 565
+ L Q + P L +L L++S ++ + V S+ +LE L L N L
Sbjct: 275 QEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQL--TTLEESVFHSVGNLETLILDSNPL 332
Query: 566 SGSISRCFEEMHWLS 580
C + W+
Sbjct: 333 -----ACDCRLLWVF 342
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 5e-35
Identities = 74/318 (23%), Positives = 129/318 (40%), Gaps = 15/318 (4%)
Query: 183 SIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSL 242
++P I L L N + F + LE L L+ N +S + P NL +L
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 243 LALQLNYNTLSGSIPC-SFGNLTKLVISCLGTNALSSSILEEI-GNLKSLLHLQLNYNTL 300
L L N L IP F L+ L + N + +L+ + +L +L L++ N L
Sbjct: 83 RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVI-LLDYMFQDLYNLKSLEVGDNDL 140
Query: 301 SGSIPLSLGSLTNLATLYFSTNALSGSIPNEI-TNLRSLSDLQLSENTLNGSIPLALGNL 359
+ L +L L L+ SIP E ++L L L+L +N + L
Sbjct: 141 VYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRL 199
Query: 360 TKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKE-IGDMKSLSILDLSSN 418
+L L++S ++ + +LT+L + +L ++P + + L L+LS N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPYLAVRHLVYLRFLNLSYN 258
Query: 419 KLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGH-GKFSSLIQLILNNNELSGQLSPEL 477
++ L L L+ + L + + + L L ++ N+L+ L +
Sbjct: 259 PISTIEGSMLHELLR-LQEIQLVGGQL-AVVEPYAFRGLNYLRVLNVSGNQLT-TLEESV 315
Query: 478 -GSLNQLEYLDLSANTFH 494
S+ LE L L +N
Sbjct: 316 FHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 6e-34
Identities = 70/322 (21%), Positives = 121/322 (37%), Gaps = 24/322 (7%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPP-SLGNLTS 73
++P I T +LL KN++ L E L L L N + ++ P + NL +
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFN 81
Query: 74 LIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNAL 132
L + + +N L IP V L +L+ L +S N + + +L NL +L + N L
Sbjct: 82 LRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL 140
Query: 133 SGSIPDEI-GNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNL 191
I L L L + L+ +L +L L+ L + ++ L
Sbjct: 141 V-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRL 199
Query: 192 KSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNT 251
L L + + ++ + L L + L+ + + +L L L L+YN
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNP 259
Query: 252 LSGSIPCSFGNLTKLV--------ISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGS 303
+S L +L ++ + A L L L ++ N L+
Sbjct: 260 ISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFR--------GLNYLRVLNVSGNQLTTL 311
Query: 304 IPLSLGSLTNLATLYFSTNALS 325
S+ NL TL +N L+
Sbjct: 312 EESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-31
Identities = 69/306 (22%), Positives = 121/306 (39%), Gaps = 40/306 (13%)
Query: 327 SIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSL 386
++P I L L +N + + L L+L+ N +S P +F +L +L
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 387 TTLYLYENSLCDSIPKEI-GDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 445
TL L N L IP + + +L+ LD+S NK+ + +L N LK L + N +
Sbjct: 83 RTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN-LKSLEVGDNDL 140
Query: 446 VGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLV 505
V I H FS L N LE L L + E+L +L
Sbjct: 141 V-YIS--HRAFSGL---------------------NSLEQLTLEKCNLTSIPTEALSHLH 176
Query: 506 KLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNL 565
L L L + + ++L L L++S+ + + + +L L+++H NL
Sbjct: 177 GLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL 236
Query: 566 SGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLA---LQGNKRLCGDIKRLPP 622
+ + +L +++SYN + + + + L L G + + + P
Sbjct: 237 TAVPYLAVRHLVYLRFLNLSYNPISTIEGS--MLHELLRLQEIQLVGGQ-----LAVVEP 289
Query: 623 CKAFKS 628
AF+
Sbjct: 290 -YAFRG 294
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-12
Identities = 35/134 (26%), Positives = 55/134 (41%), Gaps = 4/134 (2%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
LKVL +S + ++ P + +L LS + L+ + + L L L+L N +
Sbjct: 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS 261
Query: 62 GSIPP-SLGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSSLGNL 119
+I L L L I + L+ + L L L +S N L S ++
Sbjct: 262 -TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSV 319
Query: 120 TNLVTLYLHMNALS 133
NL TL L N L+
Sbjct: 320 GNLETLILDSNPLA 333
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 62/276 (22%), Positives = 107/276 (38%), Gaps = 37/276 (13%)
Query: 708 CIGNGGQGSVYKA-ELPTGEIVAVKKFH-SPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
IG G +VYK + T VA + L +Q F E L ++H NIV+F
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS--ERQRFKEEAEMLKGLQHPNIVRF 90
Query: 766 YGFCSHALHS----FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVA----DALL 817
Y + +V E + G+L L + F ++ ++ L
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYL------KRFK-VMKIKVLRSWCRQILKGLQ 143
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEY-EAHVSDFGISKFLKLGLSNRTELAGTFGYIAPE 876
++HT PPI+HRD+ N+ + + D G++ + S + GT ++APE
Sbjct: 144 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPE 200
Query: 877 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936
+ Y K E DVY+FG+ LE+ ++P S C + + +
Sbjct: 201 M-YEEKYDESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYRRVTSGVKPASFDKVA 255
Query: 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
++I C+ ++ R + + LL
Sbjct: 256 IPEVKEIIE------GCIRQNKDERYS---IKDLLN 282
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 9e-37
Identities = 80/421 (19%), Positives = 145/421 (34%), Gaps = 44/421 (10%)
Query: 98 LSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLS 157
+ + + + S L L +L H ++++ I L L+ L + N ++
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT 77
Query: 158 GAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTK 217
L TNL L N L+ ++ + L L+ L D N L+
Sbjct: 78 T---LDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKL---DVSQNPL 128
Query: 218 LEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALS 277
L L N L+ + ++ + L L + N + T+L N ++
Sbjct: 129 LTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
Query: 278 SSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRS 337
++ K L L + N ++ L L L L S+N L+ I +T L
Sbjct: 184 EL---DVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EID--VTPLTQ 234
Query: 338 LSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLC 397
L+ S N L L + L+KL +L L I L+ T L
Sbjct: 235 LTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-EIDLT--HNTQLIYFQAEGCRKI 288
Query: 398 DSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFS 457
+ ++ L +LD + + L L+ L LYL++ + E+ + H +
Sbjct: 289 KEL--DVTHNTQLYLLDCQAAGIT---ELDLSQNPK-LVYLYLNNTELT-ELDVSH--NT 339
Query: 458 SLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQF 517
L L N + +G + L + ++P+ L + +S +
Sbjct: 340 KLKSLSCVNAHIQD--FSSVGKIPALNNNFEAEGQTI-TMPKETLTNNSLT-IAVSPDLL 395
Query: 518 S 518
Sbjct: 396 D 396
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-35
Identities = 79/480 (16%), Positives = 159/480 (33%), Gaps = 45/480 (9%)
Query: 50 LNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLN 109
+ ++ + S L +L +D N+ ++ + + L L+ L ++N++
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77
Query: 110 GSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTN 169
++ L TNL L N L+ ++ + L L+ L N L+ +
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPL 128
Query: 170 LVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALS 229
L L N L+ I + + L++L N + T+L L N ++
Sbjct: 129 LTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKIT 183
Query: 230 GLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKS 289
L ++ K L L + N ++ + +L +N L+ ++ L
Sbjct: 184 EL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI---DVTPLTQ 234
Query: 290 LLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLN 349
L + + N L+ L + +L+ L TL+ L I +T+ L Q
Sbjct: 235 LTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGC--R 286
Query: 350 GSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKS 409
L + + T+L LD ++ L + L LYL L + +
Sbjct: 287 KIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTEL-TELD--VSHNTK 340
Query: 410 LSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNEL 469
L L + + S+ + L + + + S I + + +
Sbjct: 341 LKSLSCVNAHIQ-DFS-SVGKIPA-LNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQ 397
Query: 470 SG---QLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIE 526
G + P G + ++ P + + + P PI+
Sbjct: 398 FGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAIVGTVTTPFEAPQPIK 457
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-34
Identities = 73/408 (17%), Positives = 141/408 (34%), Gaps = 47/408 (11%)
Query: 190 NLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNY 249
N S + S L L L ++++ + I L L L
Sbjct: 19 NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTS 73
Query: 250 NTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLG 309
N ++ ++ T L +N L++ ++ L L +L + N L+ L +
Sbjct: 74 NNIT-TLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT---KLDVS 124
Query: 310 SLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSI 369
L L + N L+ I +++ L++L N + + T+L +LD S
Sbjct: 125 QNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDV--TPQTQLTTLDCSF 179
Query: 370 NKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLA 429
NK++ L + L L N++ + + L+ LD SSNKL + +
Sbjct: 180 NKITE---LDVSQNKLLNRLNCDTNNI-TKLD--LNQNIQLTFLDCSSNKLTE---IDVT 230
Query: 430 NLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLS 489
LT L S N + L S L L +L +L QL Y
Sbjct: 231 PLTQ-LTYFDCSVNPL---TELDVSTLSKLTTLHCIQTDLL---EIDLTHNTQLIYFQAE 283
Query: 490 ANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQ 548
+ + + +L+ L+ ++ + + L L L+ ++ E+
Sbjct: 284 GCRKIKELD--VTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTEL--TELD-- 334
Query: 549 VCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNS 596
V L+ L+ + ++ S ++ L+ + + +
Sbjct: 335 VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKET 380
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-33
Identities = 80/473 (16%), Positives = 161/473 (34%), Gaps = 45/473 (9%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
+ + + L L L + ++ + I +L+ L L SN +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICTSNNIT 77
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
++ L T+L Y+ +N L+ ++ V L L+ L N L +
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPL 128
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L L N L+ I + + L++L N + + T L TL N ++
Sbjct: 129 LTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDVT--PQTQLTTLDCSFNKIT 183
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
++ K L+ L D N ++ + +L L N L+ + ++ L
Sbjct: 184 EL---DVSQNKLLNRLNCDTNNIT-KL--DLNQNIQLTFLDCSSNKLTEI---DVTPLTQ 234
Query: 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLS 301
L + N L+ + LT L L ++ + L++ Q
Sbjct: 235 LTYFDCSVNPLTELDVSTLSKLTTLHCI---QTDLLEI---DLTHNTQLIYFQAEGCRKI 288
Query: 302 GSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTK 361
+ ++ T L L ++ + ++ L L L+ L + + + TK
Sbjct: 289 KELDVT--HNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTK 340
Query: 362 LVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
L SL + S + +L + E ++PKE SL+ + +S + L+
Sbjct: 341 LKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQT-ITMPKETLTNNSLT-IAVSPDLLD 396
Query: 422 GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLS 474
+ N+ +Y + + + L + N + G ++
Sbjct: 397 QFG--NPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAIVGTVT 447
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-36
Identities = 101/511 (19%), Positives = 178/511 (34%), Gaps = 54/511 (10%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSL-GNLTS 73
+P ++ K LS S+N +S L +I LS L L L N ++ S+ +
Sbjct: 45 HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101
Query: 74 LIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSS--LGNLTNLVTLYLHMNA 131
L Y+D+ +N L +I + SL L LS N + +P GNLT L L L
Sbjct: 102 LEYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAK 157
Query: 132 LSGSIPDEIGNLK-FLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGN 190
+ +L L + + G SL N L++ + S +
Sbjct: 158 FRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMS 216
Query: 191 LKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYN 250
+ +L L+L L+ + L +
Sbjct: 217 VNALGHLQLSNIKLNDENCQRLMTFLS-------------------ELTRGPTLLNVTLQ 257
Query: 251 TLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGS 310
+ + CS + + + + E + + S +
Sbjct: 258 HIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEF--------------TYSETA 303
Query: 311 LTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSIN 370
L +L + S + ++ LS + + + + L+ + N
Sbjct: 304 LKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQN 363
Query: 371 KLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIG---DMKSLSILDLSSNKLNGSIPLS 427
+ S+ ++L L TL L N L + K +M SL LD+S N LN
Sbjct: 364 VFTDSVFQGCSTLKRLQTLILQRNGL-KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDR 422
Query: 428 LANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLD 487
S+ VL LSSN + G + + L L+NN + + ++ L L+ L+
Sbjct: 423 TCAWAESILVLNLSSNMLTGSVF--RCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELN 479
Query: 488 LSANTFHNSIPE-SLGNLVKLHYLNLSNNQF 517
+++N S+P+ L L Y+ L +N +
Sbjct: 480 VASNQL-KSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-35
Identities = 93/484 (19%), Positives = 162/484 (33%), Gaps = 35/484 (7%)
Query: 103 LSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPF 162
SN +L +P L L N++S +I L L L++S+N + ++ F
Sbjct: 38 YSNRNLT-HVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDF 93
Query: 163 SL-GNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTL-SGSILYSFGNLTKLEI 220
+ +L L + N L +I + SL L L +N + FGNLTKL
Sbjct: 94 HVFLFNQDLEYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTF 150
Query: 221 LYLDVNALSGLIPNEIGNLK-SLLALQLNYNTLSGSIPCSFGNL-TKLVISCLGTNALSS 278
L L L + +L S + L L + G S T ++ N+L S
Sbjct: 151 LGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFS 210
Query: 279 SILEEIGN---LKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPN----- 330
+ N L +++LN + L + + +
Sbjct: 211 VQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLF 270
Query: 331 EITNLRSLSDLQLSENTLNGSIPLALGN-----LTKLVSLDLSINKLSGSIPLSFASLTS 385
+ R + L + T+ I L L+ + S ++
Sbjct: 271 QFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAE 330
Query: 386 LTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 445
+ L + S + L+ + N S+ + L L+ L L N +
Sbjct: 331 MNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKR-LQTLILQRNGL 389
Query: 446 VGEIPLGHGKFSSLIQLILNNNEL----SGQLSPELGSLNQLEYLDLSANTFHNSIPESL 501
++ L + L S + L+LS+N S+ L
Sbjct: 390 K-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448
Query: 502 GNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVC-SMQSLEKLNL 560
K+ L+L NN+ IP + L L EL+++ + +P V + SL+ + L
Sbjct: 449 --PPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQL-KSVPDGVFDRLTSLQYIWL 504
Query: 561 SHNN 564
N
Sbjct: 505 HDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-35
Identities = 88/458 (19%), Positives = 167/458 (36%), Gaps = 44/458 (9%)
Query: 2 LKVLGLSFNQFSGSIPPEI-GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
L+VL LS N+ S+ + L+ L S N+L + ++SL L L N
Sbjct: 78 LRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQNI---SCCPMASLRHLDLSFNDF 133
Query: 61 KGSIPPS--LGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGN 118
+P GNLT L ++ + + + LS + L S + +
Sbjct: 134 D-VLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIK-GGETES 190
Query: 119 LTNLVTLYLHMNALSGSIPDEIGNLKF-------LSDLQVSYNTLSGAIPFSLGNLTNLV 171
L T LH+ S+ N+ LS+++++ + F
Sbjct: 191 LQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPT 250
Query: 172 TLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGL 231
L + + + + + + ++Y + + + +
Sbjct: 251 LLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSET-------- 302
Query: 232 IPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLL 291
LKSL+ + S + ++ I L + + + S
Sbjct: 303 ------ALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT 356
Query: 292 HLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLN-- 349
L N + S+ +L L TL N L + +++S L+ + +LN
Sbjct: 357 FLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSL 415
Query: 350 --GSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLT-SLTTLYLYENSLCDSIPKEIGD 406
+ ++ L+LS N L+GS+ F L + L L+ N + SIPK++
Sbjct: 416 NSHAYDRTCAWAESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRI-MSIPKDVTH 471
Query: 407 MKSLSILDLSSNKLNGSIPL-SLANLTNSLKVLYLSSN 443
+++L L+++SN+L S+P LT SL+ ++L N
Sbjct: 472 LQALQELNVASNQLK-SVPDGVFDRLT-SLQYIWLHDN 507
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-36
Identities = 87/409 (21%), Positives = 145/409 (35%), Gaps = 47/409 (11%)
Query: 24 THLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPP-SLGNLTSLIYIDIGNN 82
H+ + S N ++ L RL L L + I + L+SLI + + N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 83 LLSGSIPNEV-GSLKSLSDLRLSNNSLNGSI--PSSLGNLTNLVTLYLHMNALSGSIPDE 139
+ L +L L L+ +L+G++ + LT+L L L N + P
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 140 I-GNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLR 198
N++ L +++N + L N + L S++
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL--------------RLSSITLQD 194
Query: 199 LDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSL-----LALQLNYNTLS 253
++ L + T + L L N + + + L L +YN S
Sbjct: 195 MNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGS 254
Query: 254 GSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTN 313
+F + L + + L+ + + + T+
Sbjct: 255 SFGHTNFKDPDNFTFKGLEASGVK--------------TCDLSKSKIFALLKSVFSHFTD 300
Query: 314 LATLYFSTNALSGSIPNEI-TNLRSLSDLQLSENTLNGSIP-LALGNLTKLVSLDLSINK 371
L L + N ++ I + L L L LS+N L GSI NL KL LDLS N
Sbjct: 301 LEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNH 358
Query: 372 LSGSIPL-SFASLTSLTTLYLYENSLCDSIPKEIGD-MKSLSILDLSSN 418
+ ++ SF L +L L L N L S+P I D + SL + L +N
Sbjct: 359 IR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-35
Identities = 82/433 (18%), Positives = 145/433 (33%), Gaps = 68/433 (15%)
Query: 97 SLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTL 156
++ + LS NS+ +S L +L L + I +
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNN----------------- 73
Query: 157 SGAIPFSLGNLTNLVTLYIGINALSGSIPNEI-GNLKSLSDLRLDYNTLSGSIL--YSFG 213
+ L++L+ L + N + L +L L L L G++L F
Sbjct: 74 ------TFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFK 126
Query: 214 NLTKLEILYLDVNALSGLIPNEI-GNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLG 272
LT LE+L L N + + P N++ L L +N + N + L
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL- 185
Query: 273 TNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEI 332
L S+ +N L + T++ TL S N S+
Sbjct: 186 -------------RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF 232
Query: 333 TNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASL--TSLTTLY 390
+ + + +Q + + + +F L + + T
Sbjct: 233 FDAIAGTKIQSLILSNSY-----------NMGSSFGHTNFKDPDNFTFKGLEASGVKTCD 281
Query: 391 LYENSLCDSIPKEI-GDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEI 449
L ++ + ++ K + L L L+ N++N + LT+ L L LS N + G I
Sbjct: 282 LSKSKI-FALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH-LLKLNLSQNFL-GSI 338
Query: 450 PLGHGKFSSLIQL---ILNNNELSGQLSPEL-GSLNQLEYLDLSANTFHNSIPES-LGNL 504
F +L +L L+ N + L + L L+ L L N S+P+ L
Sbjct: 339 D--SRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRL 394
Query: 505 VKLHYLNLSNNQF 517
L + L N +
Sbjct: 395 TSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-34
Identities = 85/410 (20%), Positives = 144/410 (35%), Gaps = 44/410 (10%)
Query: 2 LKVLGLSFNQFSGSIPPE-IGHLTHLKLLSFSKNQLSGLIPHEI-GRLSSLNGLSLYSNF 59
+ + LS N + + L L+ L + +I + LSSL L L N
Sbjct: 32 VNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 60 LKGSIPPS-LGNLTSLIYIDIGNNLL-SGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSSL 116
+ L +L + + L + L SL L L +N++ P+S
Sbjct: 91 FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 117 -GNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYI 175
N+ L L N + SI +E L + L+++ +
Sbjct: 150 FLNMRRFHVLDLTFNKVK-SICEED--LLNFQGKHFTLL-----------RLSSITLQDM 195
Query: 176 GINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNE 235
L S++ L L N S+ F + + + LI +
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA-------IAGTKIQSLILSN 248
Query: 236 IGNLKSLLALQLNYNTLSGSIPCSFGNL--TKLVISCLGTNALSSSILEEI-GNLKSLLH 292
N+ S + +F L + + L + + ++L+ + + L
Sbjct: 249 SYNMGS----SFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQ 303
Query: 293 LQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEI-TNLRSLSDLQLSENTLNGS 351
L L N ++ + LT+L L S N L SI + + NL L L LS N + +
Sbjct: 304 LTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI-RA 361
Query: 352 IPL-ALGNLTKLVSLDLSINKLSGSIPLS-FASLTSLTTLYLYENSL-CD 398
+ + L L L L N+L S+P F LTSL ++L+ N C
Sbjct: 362 LGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 410
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-32
Identities = 88/428 (20%), Positives = 143/428 (33%), Gaps = 50/428 (11%)
Query: 168 TNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSI-LYSFGNLTKLEILYLDVN 226
++ + + +N+++ L+ L L+++ T I +F L+ L IL LD N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 227 ALSGLIPNEIGNLKSLLALQLNYNTLSGSI--PCSFGNLTKLVISCLGTNALSSSILEEI 284
L L +L L L L G++ F LT L + L N +
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 285 -GNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQL 343
N++ L L +N + L + L S++ +
Sbjct: 150 FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL--------------RLSSITLQDM 195
Query: 344 SENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKE 403
+E L T + +LDLS N S+ F + T + S
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS------ 249
Query: 404 IGDMKSLSILDLSSNKLNGSIPLSLANLT-NSLKVLYLSSNHIVGEIPLGH-GKFSSLIQ 461
+ L + +K LS + I + F+ L Q
Sbjct: 250 -----YNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQ 303
Query: 462 LILNNNELSGQLSPE-LGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQK 520
L L NE++ ++ L L L+LS N + NL KL L+LS N
Sbjct: 304 LTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRAL 362
Query: 521 IPNPIEKLIHLSELDLSY-KIFGEEIPSQV-CSMQSLEKLNLSHNNLSGSISRCFEEMHW 578
L +L EL L ++ + +P + + SL+K+ L N C
Sbjct: 363 GDQSFLGLPNLKELALDTNQL--KSVPDGIFDRLTSLQKIWLHTNPW-----DC------ 409
Query: 579 LSCIDISY 586
SC I Y
Sbjct: 410 -SCPRIDY 416
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-31
Identities = 85/375 (22%), Positives = 132/375 (35%), Gaps = 36/375 (9%)
Query: 245 LQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEI-GNLKSLLHLQLNYNTLSGS 303
+ L+ N+++ SF L L + I L SL+ L+L+YN
Sbjct: 35 VDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQL 94
Query: 304 IPLSLGSLTNLATLYFSTNAL-SGSIPNEI-TNLRSLSDLQLSENTLNGSIPLAL-GNLT 360
+ L NL L + L + L SL L L +N + P + N+
Sbjct: 95 ETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMR 154
Query: 361 KLVSLDLSINKLSGSIPLSFASLTS--LTTLYLYENSLCDSIPKEIGD--------MKSL 410
+ LDL+ NK+ + T L L +L D +G S+
Sbjct: 155 RFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSI 214
Query: 411 SILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEI-PLGHGKF------------- 456
+ LDLS N S+ + K+ L ++ GH F
Sbjct: 215 TTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEA 274
Query: 457 SSLIQLILNNNELSGQLSPEL-GSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNN 515
S + L+ +++ L + LE L L+ N + + L L LNLS N
Sbjct: 275 SGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQN 333
Query: 516 QFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQVCS-MQSLEKLNLSHNNLSGSISR-C 572
E L L LDLSY I + Q + +L++L L N L S+
Sbjct: 334 FLGSIDSRMFENLDKLEVLDLSYNHI--RALGDQSFLGLPNLKELALDTNQLK-SVPDGI 390
Query: 573 FEEMHWLSCIDISYN 587
F+ + L I + N
Sbjct: 391 FDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-19
Identities = 60/298 (20%), Positives = 107/298 (35%), Gaps = 46/298 (15%)
Query: 360 TKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGD-MKSLSILDLSSN 418
+ +DLS+N ++ SF+ L L L + + + I + SL IL L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 419 KLNGSIPLS-LANLTNSLKVLYLSSNHIVGEIPLGHGKF---SSLIQLILNNNELSGQLS 474
+ + L N L+VL L+ ++ L F +SL L+L +N + ++
Sbjct: 90 QF-LQLETGAFNGLAN-LEVLTLTQCNL-DGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQ 145
Query: 475 PE--LGSLNQLEYLDLSANTFHNSIPESLGNLVKLH--YLNLSNNQFSQKIPNPIE---- 526
P ++ + LDL+ N + E L N H L LS+ +
Sbjct: 146 PASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKC 205
Query: 527 ----KLIHLSELDLSYKIFGEEIPSQVCSMQSLEKL-------------NLSHNNLSGSI 569
K ++ LDLS F E + + + K+ + H N
Sbjct: 206 GNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPD 265
Query: 570 SRCFEEMHW--LSCIDISYNALQGLIPNSTAFRDAPMLA---LQGNKRLCGDIKRLPP 622
+ F+ + + D+S + + L + F L L N+ I ++
Sbjct: 266 NFTFKGLEASGVKTCDLSKSKIFAL--LKSVFSHFTDLEQLTLAQNE-----INKIDD 316
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-36
Identities = 68/289 (23%), Positives = 112/289 (38%), Gaps = 36/289 (12%)
Query: 691 IVHEEIIRATKNFDDEHCIGNGGQGSVYKAELPTGEI-VAVKKFHSPLPGEMACQ-QEFL 748
+ HE+++ IG G G V+ L VAVK +FL
Sbjct: 111 LNHEDLVL-------GEQIGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFL 160
Query: 749 NEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNA 808
E L + H NIV+ G C+ ++V E ++ G L + +
Sbjct: 161 QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQM 218
Query: 809 IKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAG 868
+ A + Y+ + C +HRD++++N L+ + +SDFG+S+ G+ +
Sbjct: 219 VGDAAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLR 275
Query: 869 TFGY--IAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALD 925
APE + + + DV+SFG+L E G P +S N
Sbjct: 276 QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS----------NQQTR 325
Query: 926 EMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
E ++ RLP P D + +ME C P RP+ + Q L+
Sbjct: 326 EFVEKGGRLPCP-ELCPDAVFRLME---QCWAYEPGQRPSFSTIYQELQ 370
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 57/300 (19%), Positives = 118/300 (39%), Gaps = 47/300 (15%)
Query: 698 RATKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTK 756
R +F+ C+G GG G V++A+ A+K+ LP +++ + E AL K
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKR--IRLPNRELAREKVMREVKALAK 59
Query: 757 IRHRNIVKFYGFC------------SHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTK 804
+ H IV+++ S ++ ++ + +L ++ EE +
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 805 RMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK------- 857
++ +A+A+ ++H+ ++HRD+ N+ ++ V DFG+ +
Sbjct: 120 CLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 858 -----LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSI 912
+ T GT Y++PE + + K D++S G++ E++ +P F +
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP--FSTQ- 230
Query: 913 CSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
L + P L T + ++ L SP RP +++
Sbjct: 231 -MERVRTLTDVRNLKF-PPLFTQKYPCEYVMVQ------DMLSPSPMERPE---AINIIE 279
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 68/286 (23%), Positives = 113/286 (39%), Gaps = 39/286 (13%)
Query: 701 KNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMA--CQQEFLNEGNALTKI 757
NF E IG G VY+A L G VA+KK + M + + + E + L ++
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV--QIFDLMDAKARADCIKEIDLLKQL 89
Query: 758 RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAA-----EEFGWTKRMNAIKGV 812
H N++K+Y +V E + G L+ ++ + E W +
Sbjct: 90 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW----KYFVQL 145
Query: 813 ADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGY 872
AL +MH+ ++HRDI NV + + D G+ +F + L GT Y
Sbjct: 146 CSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 202
Query: 873 IAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932
++PE + K D++S G L E+ + P F + S I + P L
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKIEQCDY--PPL 258
Query: 933 PTP-----LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLKI 973
P+ LR L++ C++ P RP V+ + +
Sbjct: 259 PSDHYSEELRQ----LVN------MCINPDPEKRPD---VTYVYDV 291
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 70/278 (25%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
+ F IG G G V+K + T ++VA+K L ++ E L++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCD 78
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI-KGVADALL 817
+ K+YG +++ EYL GS +L E + I + + L
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-----IATILREILKGLD 133
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL 877
Y+H+ +HRDI + NVLL+ E ++DFG++ L R GT ++APE+
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 190
Query: 878 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNI--ALDEMLDPRLPTP 935
K D++S G+ A+E+ +G+ P S L+ L L P+ P
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPH-----------SELHPMKVL--FLIPKNNPP 237
Query: 936 LRNVQDKLISIMEVSIS-CLDESPTSRPTMQKVSQLLK 972
++ ++ + CL++ P+ RPT +LLK
Sbjct: 238 --TLEGNYSKPLKEFVEACLNKEPSFRPT---AKELLK 270
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 56/297 (18%), Positives = 109/297 (36%), Gaps = 59/297 (19%)
Query: 698 RATKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQ-QEFLNEGNALT 755
R +F + IG+GG G V+KA+ G+ +K + ++ E AL
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK--------RVKYNNEKAEREVKALA 59
Query: 756 KIRHRNIVKFYGF-------------CSHALHSFVVY---EYLEMGSLAMILSNDAAA-- 797
K+ H NIV + G S + ++ E+ + G+L +
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 798 -EEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856
+ + + + Y+H+ +++RD+ N+ L + + DFG+ L
Sbjct: 120 DKVLAL----ELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172
Query: 857 KLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSS 915
K RT GT Y++PE + ++ D+Y+ G++ E++ +
Sbjct: 173 K-NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-------- 223
Query: 916 LSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
S D ++ + L+ L + P RP S++L+
Sbjct: 224 TSKFFTDLRDGIISDIFDKKEKT----LLQ------KLLSKKPEDRPN---TSEILR 267
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 74/277 (26%), Positives = 129/277 (46%), Gaps = 30/277 (10%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
+ FD +G G GSVYKA TG+IVA+K+ P+ ++ QE + E + + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDL---QEIIKEISIMQQCD 82
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLY 818
++VK+YG ++V EY GS++ I+ + ++ L Y
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATI--LQSTLKGLEY 140
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELA 878
+H +HRDI + N+LLN E A ++DFG++ L ++ R + GT ++APE+
Sbjct: 141 LHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197
Query: 879 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNI--ALDEMLDPRLPTPL 936
+ D++S G+ A+E+ +GK P ++++ A+ + P P P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPY-----------ADIHPMRAI--FMIPTNPPPT 244
Query: 937 RNVQDKLISIMEVSIS-CLDESPTSRPTMQKVSQLLK 972
+ + CL +SP R T +QLL+
Sbjct: 245 FRKPELWSDNFTDFVKQCLVKSPEQRAT---ATQLLQ 278
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 73/301 (24%), Positives = 121/301 (40%), Gaps = 46/301 (15%)
Query: 689 GKIVHEEIIRA----------TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPL 737
G + HE+ A D IG G G V A E +G VAVK L
Sbjct: 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM--DL 80
Query: 738 PGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAA 797
+ ++ NE + +H N+V+ Y +V+ E+L+ G+L I+S
Sbjct: 81 RKQQR-RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLN 139
Query: 798 EEFGWTKRMNAI-KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856
EE ++ + + V AL Y+H ++HRDI S ++LL L+ +SDFG +
Sbjct: 140 EE-----QIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 191
Query: 857 KLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL 916
+ R L GT ++APE+ + D++S G++ +E++ G+ P
Sbjct: 192 SKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP----------- 240
Query: 917 SSNLNI----ALDEMLDPRLPTPLRNVQDKLISIMEVSIS-CLDESPTSRPTMQKVSQLL 971
+ A+ P P K+ ++ + L P R T +LL
Sbjct: 241 --YFSDSPVQAM--KRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT---AQELL 293
Query: 972 K 972
Sbjct: 294 D 294
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 36/280 (12%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
K + IG G G+VY A ++ TG+ VA+++ L + ++ +NE + + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPK-KELIINEILVMRENK 75
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI-KGVADALL 817
+ NIV + +VV EYL GSL +++ E ++ A+ + AL
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-----QIAAVCRECLQALE 130
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL 877
++H+N ++HRDI S N+LL ++ ++DFG + S R+ + GT ++APE+
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 878 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNI----ALDEMLDPRLP 933
K D++S G++A+E+I+G+ P LN AL L
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPP-------------YLNENPLRAL--YLIATNG 232
Query: 934 TPLRNVQDKLISIMEVSIS-CLDESPTSRPTMQKVSQLLK 972
TP +KL +I ++ CL+ R + +LL+
Sbjct: 233 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGS---AKELLQ 269
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 71/313 (22%), Positives = 126/313 (40%), Gaps = 29/313 (9%)
Query: 289 SLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTL 348
L +Q + L +P L + A L N ++ + NL++L L L N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 349 NGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEI-GDM 407
+ P A L KL L LS N+L +P +L L ++EN + + K + +
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEI-TKVRKSVFNGL 144
Query: 408 KSLSILDLSSNKLNGSI--PLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILN 465
+ +++L +N L S + + L + ++ +I IP G SL +L L+
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKK-LSYIRIADTNIT-TIPQGL--PPSLTELHLD 200
Query: 466 NNELSGQLSPE-LGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNP 524
N+++ ++ L LN L L LS N+ SL N L L+L+NN+ K+P
Sbjct: 201 GNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGG 258
Query: 525 IEKLIHLSELDLSY-KIFGEEIPSQV-------CSMQSLEKLNLSHNNLS-GSISRC-FE 574
+ ++ + L I I S S ++L N + I F
Sbjct: 259 LADHKYIQVVYLHNNNI--SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316
Query: 575 EMHWLSCIDISYN 587
++ + + +
Sbjct: 317 CVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-31
Identities = 69/312 (22%), Positives = 118/312 (37%), Gaps = 26/312 (8%)
Query: 313 NLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKL 372
+L + S L +P ++ + L L N + NL L +L L NK+
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 373 SGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLT 432
S P +FA L L LYL +N L +P+++ K+L L + N++ L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQL-KELPEKM--PKTLQELRVHENEITKVRKSVFNGLN 145
Query: 433 NSLKVLYLSSNHIVGEIPLGHGKFS---SLIQLILNNNELSGQLSPELGSLNQLEYLDLS 489
+ V+ L +N + + +G F L + + + ++ + G L L L
Sbjct: 146 Q-MIVVELGTNPL-KSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLD 200
Query: 490 ANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQ 548
N SL L L L LS N S + HL EL L+ K+ ++P
Sbjct: 201 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL--VKVPGG 258
Query: 549 VCSMQSLEKLNLSHNNLSG------SISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDA 602
+ + ++ + L +NN+S + S + + N +Q + FR
Sbjct: 259 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 318
Query: 603 P---MLALQGNK 611
+ L K
Sbjct: 319 YVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 61/317 (19%), Positives = 111/317 (35%), Gaps = 41/317 (12%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPP-SLGNLTS 73
+P ++ LL N+++ + + L +L+ L L +N + I P + L
Sbjct: 45 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVK 101
Query: 74 LIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALS 133
L + + N L +P ++ K+L +LR+ N + S L ++ + L N
Sbjct: 102 LERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNP-- 156
Query: 134 GSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKS 193
L + G + L + I ++ +IP G S
Sbjct: 157 ------------LKSSGIENGAFQG--------MKKLSYIRIADTNIT-TIPQ--GLPPS 193
Query: 194 LSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLS 253
L++L LD N ++ S L L L L N++S + + N L L LN N L
Sbjct: 194 LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253
Query: 254 GSIPCSFGNLTKLVISCLGTNALSS------SILEEIGNLKSLLHLQLNYNTLSGSI--P 305
+P + + + L N +S+ S + L N + P
Sbjct: 254 -KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 312
Query: 306 LSLGSLTNLATLYFSTN 322
+ + A +
Sbjct: 313 STFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 75/334 (22%), Positives = 129/334 (38%), Gaps = 46/334 (13%)
Query: 49 SLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSL 108
L + L+ +P L +D+ NN ++ + +LK+L L L NN +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 109 NGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLT 168
+ P + L L LYL N L +P+++ K L +L+V N ++ L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLN 145
Query: 169 NLVTLYIGINAL-SGSIPNEI-GNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVN 226
++ + +G N L S I N +K LS +R+ ++ +I G L L+LD N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TI--PQGLPPSLTELHLDGN 202
Query: 227 ALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGN 286
++ + + L +L L L++N+ IS + +L+ N
Sbjct: 203 KITKVDAASLKGLNNLAKLGLSFNS----------------ISAVDNGSLA--------N 238
Query: 287 LKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNE-------ITNLRSLS 339
L L LN N L +P L + +Y N +S +I + T S S
Sbjct: 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYS 296
Query: 340 DLQLSENTLNGSI--PLALGNLTKLVSLDLSINK 371
+ L N + P + ++ L K
Sbjct: 297 GVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 29/162 (17%), Positives = 60/162 (37%), Gaps = 14/162 (8%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L + ++ + +IP G L L N+++ + + L++L L L N +
Sbjct: 173 LSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 229
Query: 62 GSIPP-SLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNG------SIPS 114
++ SL N L + + NN L +P + K + + L NN+++ P
Sbjct: 230 -AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 287
Query: 115 SLGNLTNLVTLYLHMNALS-GSIPDEI-GNLKFLSDLQVSYN 154
+ + L N + I + + +Q+
Sbjct: 288 YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-31
Identities = 59/290 (20%), Positives = 104/290 (35%), Gaps = 36/290 (12%)
Query: 255 SIPCSFGNLTKLVISCLGTNALSS---SILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSL 311
SI N L N +S + N N + L +
Sbjct: 2 SIMLPINNNFSL-SQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--I 58
Query: 312 TNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINK 371
+ L + LS S+P+ + ++ L++++N L S+P +L L D N+
Sbjct: 59 NQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNAL-ISLPELPASLEYL---DACDNR 111
Query: 372 LSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANL 431
LS ++P SL L + N L +P+ L ++ +N+L L L
Sbjct: 112 LS-TLP---ELPASLKHLDVDNNQLT-MLPELPA---LLEYINADNNQLT-----MLPEL 158
Query: 432 TNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLE----YLD 487
SL+VL + +N + +P SL L ++ N L L + E +
Sbjct: 159 PTSLEVLSVRNNQL-TFLP---ELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFR 213
Query: 488 LSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLS 537
N IPE++ +L + L +N S +I + + +
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGP 262
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-29
Identities = 77/343 (22%), Positives = 125/343 (36%), Gaps = 38/343 (11%)
Query: 236 IGNLKSLLALQLNYNTLSG---SIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLH 292
I N SL + YNT+SG ++ K + N S + E +
Sbjct: 7 INNNFSL-SQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSE 63
Query: 293 LQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSI 352
LQLN LS S+P +L + L + NAL S+P +L L +N L+ ++
Sbjct: 64 LQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPASLEYLD---ACDNRLS-TL 115
Query: 353 PLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSI 412
P +L L D+ N+L+ +P L + N L +P+ SL +
Sbjct: 116 PELPASLKHL---DVDNNQLT-MLP---ELPALLEYINADNNQLT-MLPELPT---SLEV 164
Query: 413 LDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSL----IQLILNNNE 468
L + +N+L L L SL+ L +S+N + +P + I N
Sbjct: 165 LSVRNNQLT-----FLPELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENR 218
Query: 469 LSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKL 528
++ + + SL+ + L N + I ESL + FS +
Sbjct: 219 IT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ--QNT 275
Query: 529 IHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISR 571
+H D F E S V + + N S + R
Sbjct: 276 LHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDR 318
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 61/364 (16%), Positives = 122/364 (33%), Gaps = 40/364 (10%)
Query: 7 LSFNQFSGSIPPEI----GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKG 62
+N S + L ++N+ L+ ++ + L L L
Sbjct: 17 SFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLK--ECLINQFSELQLNRLNLS- 72
Query: 63 SIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNL 122
S+P +L + ++I N L S+P SL+ L +N L+ ++P +L +
Sbjct: 73 SLPDNLP--PQITVLEITQNALI-SLPELPASLEYLD---ACDNRLS-TLPELPASLKH- 124
Query: 123 VTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSG 182
L + N L+ +P+ L++++ N L+ +P +L L + N L+
Sbjct: 125 --LDVDNNQLT-MLPELPALLEYIN---ADNNQLT-MLPELPTSLE---VLSVRNNQLT- 173
Query: 183 SIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLE----ILYLDVNALSGLIPNEIGN 238
+P +L++L + N L S+ E N ++ + P I +
Sbjct: 174 FLPELPESLEALD---VSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITHI-PENILS 228
Query: 239 LKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYN 298
L + L N LS I S T S S ++ N
Sbjct: 229 LDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTA 286
Query: 299 TLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGN 358
+ + + + N S + + +++ S + + + L
Sbjct: 287 WFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARNTSGFREQV-AAWLEKLSA 344
Query: 359 LTKL 362
+L
Sbjct: 345 SAEL 348
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-28
Identities = 68/375 (18%), Positives = 125/375 (33%), Gaps = 38/375 (10%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
+ G + N+ S+ E + L ++ LS L P + + L + N L
Sbjct: 39 QALPGENRNEAV-SLLKEC-LINQFSELQLNRLNLSSL-PDNLP--PQITVLEITQNALI 93
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
S+P +L L D +N LS ++P SLK L + NN L +P L
Sbjct: 94 -SLPELPASLEYL---DACDNRLS-TLPELPASLKH---LDVDNNQLT-MLPELPALLE- 143
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
+ N L+ +P+ +L+ LS V N L+ +P +L L + N L
Sbjct: 144 --YINADNNQLT-MLPELPTSLEVLS---VRNNQLT-FLPELPESLE---ALDVSTNLLE 193
Query: 182 GSIPNEIGNLKSLSD----LRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIG 237
S+P + R N ++ I + +L + L+ N LS I +
Sbjct: 194 -SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLS 251
Query: 238 NLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNY 297
+ S S L + T + ++ + + +
Sbjct: 252 QQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAV--TAWFPENKQSDVSQIWHAFEHEEHA 309
Query: 298 NTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALG 357
NT S + L + + + + L + ++L+ + +
Sbjct: 310 NTFS-AFLDRLSDTVSARNT----SGFREQVAAWLEKLSASAELRQQSFAVAADATESCE 364
Query: 358 NLTKLVSLDLSINKL 372
+ L +L L
Sbjct: 365 DRVALTWNNLRKTLL 379
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-27
Identities = 70/340 (20%), Positives = 121/340 (35%), Gaps = 35/340 (10%)
Query: 40 IPHEIGRLSSLNGLSLYSN--FLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKS 97
I I SL+ S Y+ + N + +
Sbjct: 3 IMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQ 60
Query: 98 LSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLS 157
S+L+L+ +L+ S+P +L + L + NAL S+P+ +L++L N LS
Sbjct: 61 FSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLEYLD---ACDNRLS 113
Query: 158 GAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTK 217
+P +L +L + N L+ +P L+ ++ D N L+ + T
Sbjct: 114 -TLPELPASLKHL---DVDNNQLT-MLPELPALLEYIN---ADNNQLT-MLPEL---PTS 161
Query: 218 LEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISC----LGT 273
LE+L + N L+ L P +L++L ++ N L S+P +
Sbjct: 162 LEVLSVRNNQLTFL-PELPESLEAL---DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRE 216
Query: 274 NALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEIT 333
N ++ I E I +L + L N LS I SL T + S S + T
Sbjct: 217 NRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNT 275
Query: 334 NLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLS 373
R L+D + + + + N S
Sbjct: 276 LHRPLADAVT--AWFPENKQSDVSQIWHAFEHEEHANTFS 313
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-26
Identities = 66/347 (19%), Positives = 116/347 (33%), Gaps = 38/347 (10%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
+ VL ++ N S+P L +L N+LS L P L L+ + +N L
Sbjct: 82 ITVLEITQNALI-SLPELPASLEYLDA---CDNRLSTL-PELPASLKHLD---VDNNQLT 133
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
+P L + + NN L+ +P SL+ LS + NN L +P +L
Sbjct: 134 -MLPELPALLEYI---NADNNQLT-MLPELPTSLEVLS---VRNNQLT-FLPELPESLE- 183
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSD----LQVSYNTLSGAIPFSLGNLTNLVTLYIGI 177
L + N L S+P + + N ++ IP ++ +L T+ +
Sbjct: 184 --ALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILED 239
Query: 178 NALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIG 237
N LS I + + D + S+ N + +++
Sbjct: 240 NPLSSRIRESLSQQTAQPDYHG--PRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVS 297
Query: 238 NLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNY 297
+ + + NT S L+ V S T+ + + L + L+
Sbjct: 298 QIWHAFEHEEHANTFS----AFLDRLSDTV-SARNTSGFREQVAAWLEKLSASAELRQQS 352
Query: 298 NTLSGSIPLSLG-----SLTNLATLYFSTNALSGSIPNEITNLRSLS 339
++ S + NL A G N+ L SL
Sbjct: 353 FAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSLG 399
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 27/147 (18%), Positives = 49/147 (33%), Gaps = 17/147 (11%)
Query: 449 IPLGHGKFSSLIQLILNNN--ELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVK 506
I L SL Q N + + N + + E L + +
Sbjct: 3 IMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQ 60
Query: 507 LHYLNLSNNQFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQVCSMQSLEKLNLSHNNL 565
L L+ S +P+ + ++ L+++ + +P SLE L+ N L
Sbjct: 61 FSELQLNRLNLSS-LPDNLPP--QITVLEITQNAL--ISLPELPA---SLEYLDACDNRL 112
Query: 566 SGSISRCFEEMHWLSCIDISYNALQGL 592
S ++ + L D+ N L L
Sbjct: 113 S-TLPELPASLKHL---DVDNNQLTML 135
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 28/207 (13%), Positives = 60/207 (28%), Gaps = 15/207 (7%)
Query: 1 MLKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
N+ + IP I L + N LS I + + ++ +
Sbjct: 208 TEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266
Query: 61 KGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLT 120
S+ N D + ++V + + N+ + + L +
Sbjct: 267 --SMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTV 323
Query: 121 NLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGIN-- 178
+ + + + + L ++L+ ++ S + L +
Sbjct: 324 S----ARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLL 379
Query: 179 ---ALSGSIPNEIGNLKSL--SDLRLD 200
A G N+ G L SL RL+
Sbjct: 380 VHQASEGLFDNDTGALLSLGREMFRLE 406
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-31
Identities = 67/316 (21%), Positives = 113/316 (35%), Gaps = 34/316 (10%)
Query: 664 RKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATKNFDDEHCIGNGGQGSVYKA-EL 722
+ Q+ P +LT K V E + +G G G V++ +
Sbjct: 21 SSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDK 80
Query: 723 PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYL 782
TG AVK ++ + + E A + IV YG + E L
Sbjct: 81 QTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132
Query: 783 EMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE 842
E GSL ++ E + + + + L Y+HT I+H D+ + NVLL+ +
Sbjct: 133 EGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSD 186
Query: 843 -YEAHVSDFGISKFL-----KLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLA 896
A + DFG + L L + GT ++APE+ K D++S +
Sbjct: 187 GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMM 246
Query: 897 LEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDE 956
L ++ G HP + L IA + +P + + I L +
Sbjct: 247 LHMLNGCHPW----TQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQ------EGLRK 296
Query: 957 SPTSRPTMQKVSQLLK 972
P R + +L +
Sbjct: 297 EPVHRAS---AMELRR 309
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-31
Identities = 57/276 (20%), Positives = 106/276 (38%), Gaps = 27/276 (9%)
Query: 701 KNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
+ + IG G G + G +K+ + ++E E L ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKH 82
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAA---EEFGWTKRMNAIKGVADAL 816
NIV++ ++V +Y E G L ++ E+ + + AL
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL----DWFVQICLAL 138
Query: 817 LYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPE 876
++H I+HRDI S+N+ L + + DFGI++ L + GT Y++PE
Sbjct: 139 KHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 877 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936
+ K D+++ G + E+ KH F + +L + + L
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHA--FEAGSMKNLVLKIISGSFPPVSLHYSYDL 253
Query: 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
R+ L+S +P RP+ V+ +L+
Sbjct: 254 RS----LVS------QLFKRNPRDRPS---VNSILE 276
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 57/287 (19%), Positives = 108/287 (37%), Gaps = 38/287 (13%)
Query: 701 KNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
K++ +G GG V E L G A+K+ E ++E E + H
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNH 85
Query: 760 RNIVKFYGFCSHALHS----FVVYEYLEMGSLAMILSNDAAAEEFGWTKR--MNAIKGVA 813
NI++ +C + +++ + + G+L + F T+ + + G+
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGIC 144
Query: 814 DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA------ 867
L +H HRD+ N+LL E + + D G + + +
Sbjct: 145 RGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 868 ---GTFGYIAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNL 920
T Y APEL ++ + + E+ DV+S G + ++ G+ P D + S++ +
Sbjct: 202 AQRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260
Query: 921 NIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
L PR + L L++ M + P RP + +
Sbjct: 261 QNQLSIPQSPRHSSALWQ----LLNSM------MTVDPHQRPHIPLL 297
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 65/288 (22%), Positives = 120/288 (41%), Gaps = 45/288 (15%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
+ ++ +G+G G VYKA TG + A K E ++++ E L
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEE-LEDYIVEIEILATCD 74
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMN-----AI-KGV 812
H IVK G H +++ E+ G++ I+ + + + + +
Sbjct: 75 HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL--------DRGLTEPQIQVVCRQM 126
Query: 813 ADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGY 872
+AL ++H+ I+HRD+ + NVL+ LE + ++DFG+S L R GT +
Sbjct: 127 LEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYW 183
Query: 873 IAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNI--ALD 925
+APE+ + + K D++S G+ +E+ + + P LN L
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH-----------HELNPMRVL- 231
Query: 926 EMLDPRLPTPLRNVQDKLISIMEVSIS-CLDESPTSRPTMQKVSQLLK 972
+ + P K + LD++P +RP+ +QLL+
Sbjct: 232 -LKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPS---AAQLLE 275
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 68/284 (23%), Positives = 116/284 (40%), Gaps = 34/284 (11%)
Query: 701 KNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEM--ACQQEFLNEGNALTKI 757
++++ + IG G G K G+I+ K+ G M A +Q ++E N L ++
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY---GSMTEAEKQMLVSEVNLLREL 62
Query: 758 RHRNIVKFYG--FCSHALHSFVVYEYLEMGSLAMILSNDAAA-----EEFGWTKRMNAIK 810
+H NIV++Y ++V EY E G LA +++ EEF +
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL----RVMT 118
Query: 811 GVADALLYMHTNCFPP--IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAG 868
+ AL H ++HRD+ NV L+ + + DFG+++ L S G
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178
Query: 869 TFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML 928
T Y++PE M EK D++S G L E+ P F + L+ + +
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKELAGKIREGKFRRI 236
Query: 929 DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
R L +I+ L+ RP+ V ++L+
Sbjct: 237 PYRYSDELNE----IIT------RMLNLKDYHRPS---VEEILE 267
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 66/272 (24%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 706 EHCIGNGGQGSVYKAELPTGEI-VAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
+H +G G G VY+ + VAVK M +EFL E + +I+H N+V+
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTME-VEEFLKEAAVMKEIKHPNLVQ 280
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
G C+ +++ E++ G+L L +E + ++ A+ Y+ F
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNF 339
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGY--IAPELAYTMK 882
+HR+++++N L+ + V+DFG+S+ + G + F APE K
Sbjct: 340 ---IHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 883 VTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPLRNV 939
+ K DV++FGVL E+ G P I + E+L+ R+ P
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSPYPGID----------LSQVYELLEKDYRMERP-EGC 444
Query: 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
+K+ +M +C +P+ RP+ ++ Q
Sbjct: 445 PEKVYELM---RACWQWNPSDRPSFAEIHQAF 473
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 3e-30
Identities = 70/275 (25%), Positives = 116/275 (42%), Gaps = 35/275 (12%)
Query: 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
IG+G G V+ + VA+K G M+ +++F+ E + K+ H +V+
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMS-EEDFIEEAEVMMKLSHPKLVQL 68
Query: 766 YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFP 825
YG C +V E++E G L+ L F + V + + Y+ C
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEACV- 125
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI-----APELAYT 880
+HRD++++N L+ VSDFG+++F+ + + T +PE+
Sbjct: 126 --IHRDLAARNCLVGENQVIKVSDFGMTRFVL----DDQYTSSTGTKFPVKWASPEVFSF 179
Query: 881 MKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPLR 937
+ + K DV+SFGVL EV +GK P + S N + E + RL P R
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----------NSEVVEDISTGFRLYKP-R 228
Query: 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ IM C E P RP ++ + L
Sbjct: 229 LASTHVYQIM---NHCWRERPEDRPAFSRLLRQLA 260
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 73/286 (25%), Positives = 127/286 (44%), Gaps = 37/286 (12%)
Query: 695 EIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNAL 754
E+ R + +G+G G V + VAVK G M+ + EF E +
Sbjct: 4 ELKR--EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMS-EDEFFQEAQTM 57
Query: 755 TKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVAD 814
K+ H +VKFYG CS ++V EY+ G L L + + ++ + V +
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCE 115
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI- 873
+ ++ ++ F +HRD++++N L++ + VSDFG+++++ + ++
Sbjct: 116 GMAFLESHQF---IHRDLAARNCLVDRDLCVKVSDFGMTRYVL----DDQYVSSVGTKFP 168
Query: 874 ----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEML 928
APE+ + K + K DV++FG+L EV GK P D + N + +
Sbjct: 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT----------NSEVVLKV 218
Query: 929 DP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
RL P D + IM SC E P RPT Q++ ++
Sbjct: 219 SQGHRLYRP-HLASDTIYQIM---YSCWHELPEKRPTFQQLLSSIE 260
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-29
Identities = 64/283 (22%), Positives = 112/283 (39%), Gaps = 43/283 (15%)
Query: 702 NFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHR 760
+F + +G+G +G++ + VAVK+ C E L + H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP------ECFSFADREVQLLRESDEHP 78
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSLA-MILSNDAAAEEFGWTKRMNAIKGVADALLYM 819
N+++++ ++ E +L + D A + + ++ L ++
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLG---LEPITLLQQTTSGLAHL 134
Query: 820 HTNCFPPIVHRDISSKNVLL-----NLEYEAHVSDFGISKFLKLG---LSNRTELAGTFG 871
H+ IVHRD+ N+L+ + + +A +SDFG+ K L +G S R+ + GT G
Sbjct: 135 HSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 872 YIAPEL---AYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEM 927
+IAPE+ T D++S G + VI +G HP SL NI L
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG------KSLQRQANILLGAC 245
Query: 928 LDPRLPTPLRNVQDK---LISIMEVSISCLDESPTSRPTMQKV 967
P ++ LI + P RP+ + V
Sbjct: 246 -SLDCLHPEKHEDVIARELIE------KMIAMDPQKRPSAKHV 281
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 57/203 (28%), Positives = 84/203 (41%), Gaps = 12/203 (5%)
Query: 708 CIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFY 766
+G G G VY +L +A+K+ Q E ++H+NIV++
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS---QPLHEEIALHKHLKHKNIVQYL 85
Query: 767 GFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP 826
G S + E + GSL+ +L + + K + + L Y+H N
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142
Query: 827 IVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSNRTELAGTFGYIAPE--LAYTMK 882
IVHRDI NVL+N Y + SDFG SK L GT Y+APE
Sbjct: 143 IVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 883 VTEKCDVYSFGVLALEVIKGKHP 905
+ D++S G +E+ GK P
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPP 224
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 69/272 (25%), Positives = 112/272 (41%), Gaps = 31/272 (11%)
Query: 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
E +G G G V+ VA+K PG M+ + FL E + K+RH +V+
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQL 244
Query: 766 YGFCSHALHSFVVYEYLEMGSLAMIL-SNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
Y S ++V EY+ GSL L M +A + Y+ +
Sbjct: 245 YAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQIASGMAYVERMNY 301
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGY--IAPELAYTMK 882
VHRD+ + N+L+ V+DFG+++ ++ + F APE A +
Sbjct: 302 ---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYGR 357
Query: 883 VTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPLRNV 939
T K DV+SFG+L E+ KG+ P + N + + ++ R+P P
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMV----------NREVLDQVERGYRMPCP-PEC 406
Query: 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
+ L +M C + P RPT + + L
Sbjct: 407 PESLHDLM---CQCWRKEPEERPTFEYLQAFL 435
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 68/304 (22%), Positives = 114/304 (37%), Gaps = 33/304 (10%)
Query: 218 LEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALS 277
+L L N +S L ++ L+ L AL L N +S +F L KL + N L
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115
Query: 278 SSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNAL-SGSIPNEITNLR 336
I + SL+ L+++ N + L N+ + N L + +
Sbjct: 116 E-IPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL 172
Query: 337 SLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIP-LSFASLTSLTTLYLYENS 395
L+ L++SE L IP L L L L NK+ +I + L L L N
Sbjct: 173 KLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQ 228
Query: 396 LCDSIPKEI-GDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLG-- 452
+ I + +L L L +NKL+ +P L +L L+V+YL +N+I ++ +
Sbjct: 229 I-RMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKL-LQVVYLHTNNIT-KVGVNDF 284
Query: 453 HGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNL 512
+ + N L N + Y ++ TF + +
Sbjct: 285 CPVGFGVKRAYYNGISLFN---------NPVPYWEVQPATFRC--------VTDRLAIQF 327
Query: 513 SNNQ 516
N +
Sbjct: 328 GNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 66/313 (21%), Positives = 121/313 (38%), Gaps = 30/313 (9%)
Query: 289 SLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTL 348
L +Q + L ++P + + L N +S ++ L+ L L L N +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 349 NGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEI-GDM 407
+ A L KL L +S N L IP + +SL L +++N + +PK + +
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPN--LPSSLVELRIHDNRI-RKVPKGVFSGL 146
Query: 408 KSLSILDLSSNKLNGSI--PLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILN 465
++++ +++ N L S P + L L L +S + IP +L +L L+
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGL--KLNYLRISEAKLT-GIPKDL--PETLNELHLD 201
Query: 466 NNELSGQLSPE-LGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNP 524
+N++ + E L ++L L L N SL L L L+L NN+ S ++P
Sbjct: 202 HNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259
Query: 525 IEKLIHLSELDLSY-KIFGEEIPSQV-------CSMQSLEKLNLSHNNLS-GSISRC-FE 574
+ L L + L I ++ ++L +N + + F
Sbjct: 260 LPDLKLLQVVYLHTNNI--TKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317
Query: 575 EMHWLSCIDISYN 587
+ I
Sbjct: 318 CVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 66/317 (20%), Positives = 107/317 (33%), Gaps = 42/317 (13%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPP-SLGNLTS 73
++P EI LL N +S L + L L L L +N + I + L
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRK 103
Query: 74 LIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALS 133
L + I N L IP SL +LR+ +N + L N+ + + N
Sbjct: 104 LQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNP-- 158
Query: 134 GSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKS 193
L + G L L I L+ IP ++
Sbjct: 159 ------------LENSGFEPGAFDG---------LKLNYLRISEAKLT-GIPK--DLPET 194
Query: 194 LSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLS 253
L++L LD+N + L +KL L L N + + + L +L L L+ N LS
Sbjct: 195 LNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254
Query: 254 GSIPCSFGNLTKLVISCLGTNALSS------SILEEIGNLKSLLHLQLNYNTLSGSI--P 305
+P +L L + L TN ++ + + L N + P
Sbjct: 255 -RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313
Query: 306 LSLGSLTNLATLYFSTN 322
+ +T+ + F
Sbjct: 314 ATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 66/333 (19%), Positives = 115/333 (34%), Gaps = 45/333 (13%)
Query: 49 SLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSL 108
L + LK ++P + +D+ NN +S ++ L+ L L L NN +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 109 NGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLT 168
+ + L L LY+ N L IP + L +L++ N + L
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLR 147
Query: 169 NLVTLYIGINAL-SGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNA 227
N+ + +G N L + + L+ LR+ L+G L L+LD N
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG---IPKDLPETLNELHLDHNK 204
Query: 228 LSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNL 287
+ + ++ L L L +N I + +LS L
Sbjct: 205 IQAIELEDLLRYSKLYRLGLGHNQ----------------IRMIENGSLS--------FL 240
Query: 288 KSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEI-------TNLRSLSD 340
+L L L+ N LS +P L L L +Y TN ++ + +
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNG 298
Query: 341 LQLSENTLNGSI--PLALGNLTKLVSLDLSINK 371
+ L N + P +T +++ K
Sbjct: 299 ISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 60/268 (22%), Positives = 110/268 (41%), Gaps = 28/268 (10%)
Query: 362 LVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
L + S L ++P + T L L N + + + ++ L L L +NK++
Sbjct: 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 422 GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPE-LGSL 480
+ + L L+ LY+S NH+V EIP SSL++L +++N + ++ L
Sbjct: 92 KIHEKAFSPLRK-LQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGL 146
Query: 481 NQLEYLDLSANTFHNS-IPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSY- 538
+ +++ N NS + +KL+YL +S + + IP + L+EL L +
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHN 203
Query: 539 KIFGEEIPSQVCS-MQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNST 597
KI + I + L +L L HN + + + L + + N L +
Sbjct: 204 KI--QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRV---PA 258
Query: 598 AFRDAPMLA---LQGNKRLCGDIKRLPP 622
D +L L N I ++
Sbjct: 259 GLPDLKLLQVVYLHTNN-----ITKVGV 281
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 71/285 (24%), Positives = 128/285 (44%), Gaps = 44/285 (15%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQ--QEFLNEGNALTK 756
K F D IG+G G+VY A ++ E+VA+KK G+ + + Q+ + E L K
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKM--SYSGKQSNEKWQDIIKEVRFLQK 110
Query: 757 IRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI-KGVADA 815
+RH N +++ G +++V EY + ++ + +E + A+ G
Sbjct: 111 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE----VEIAAVTHGALQG 166
Query: 816 LLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAP 875
L Y+H++ ++HRD+ + N+LL+ + DFG + ++ GT ++AP
Sbjct: 167 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS----IMAPANSFVGTPYWMAP 219
Query: 876 ELAYTMKVTE---KCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNI--ALDEMLDP 930
E+ M + K DV+S G+ +E+ + K P N+N AL
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-----------FNMNAMSAL--YHIA 266
Query: 931 RLPTP-LRNVQ--DKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ +P L++ + + ++ CL + P RPT LLK
Sbjct: 267 QNESPALQSGHWSEYFRNFVDS---CLQKIPQDRPT---SEVLLK 305
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 68/274 (24%), Positives = 117/274 (42%), Gaps = 35/274 (12%)
Query: 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
+G G G V + VA+K G M+ + EF+ E + + H +V+
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMS-EDEFIEEAKVMMNLSHEKLVQL 84
Query: 766 YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFP 825
YG C+ F++ EY+ G L L F + + K V +A+ Y+ + F
Sbjct: 85 YGVCTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQF- 141
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAG-----TFGYIAPELAYT 880
+HRD++++N L+N + VSDFG+S+++ + + + PE+
Sbjct: 142 --LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMY 195
Query: 881 MKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPLR 937
K + K D+++FGVL E+ GK P + + N E + RL P
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFT----------NSETAEHIAQGLRLYRP-H 244
Query: 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
+K+ +IM SC E RPT + + +
Sbjct: 245 LASEKVYTIM---YSCWHEKADERPTFKILLSNI 275
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 77/297 (25%), Positives = 128/297 (43%), Gaps = 57/297 (19%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI- 757
F+ +GNG G VYK + TG++ A+K + G+ ++E E N L K
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDE--EEEIKQEINMLKKYS 78
Query: 758 RHRNIVKFYG------FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMN---- 807
HRNI +YG ++V E+ GS+ ++ N +
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWI 131
Query: 808 --AIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTE 865
+ + L ++H + ++HRDI +NVLL E + DFG+S L + R
Sbjct: 132 AYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 866 LAGTFGYIAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNL 920
GT ++APE+ + + K D++S G+ A+E+ +G P ++
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL-----------CDM 237
Query: 921 NI--ALDEMLDPRLPTP-LRNVQ--DKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ AL L PR P P L++ + K S +E CL ++ + RP QL+K
Sbjct: 238 HPMRAL--FLIPRNPAPRLKSKKWSKKFQSFIES---CLVKNHSQRPAT---EQLMK 286
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 75/301 (24%), Positives = 122/301 (40%), Gaps = 57/301 (18%)
Query: 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
+++ + IG+G V A P E VA+K+ L E L E A+++ H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQTSMDELLKEIQAMSQCHH 72
Query: 760 RNIVKFYG--FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMN----AI--KG 811
NIV +Y L ++V + L GS+ I+ + A+ + ++ A +
Sbjct: 73 PNIVSYYTSFVVKDEL--WLVMKLLSGGSVLDIIKH-IVAKGEHKSGVLDESTIATILRE 129
Query: 812 VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL-----KLGLSNRTEL 866
V + L Y+H N +HRD+ + N+LL + ++DFG+S FL R
Sbjct: 130 VLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 867 AGTFGYIAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLN 921
GT ++APE+ Y K D++SFG+ A+E+ G P
Sbjct: 187 VGTPCWMAPEVMEQVRGY----DFKADIWSFGITAIELATGAAPY-----------HKYP 231
Query: 922 --IALDEMLDPRLPTP-LRNVQDKLISIMEVSIS-------CLDESPTSRPTMQKVSQLL 971
L ML + P L + + S CL + P RPT ++LL
Sbjct: 232 PMKVL--MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT---AAELL 286
Query: 972 K 972
+
Sbjct: 287 R 287
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-29
Identities = 67/275 (24%), Positives = 119/275 (43%), Gaps = 35/275 (12%)
Query: 706 EHCIGNGGQGSVYKAELPTGEI-VAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
+H +G G G VY+ + VAVK M +EFL E + +I+H N+V+
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTME-VEEFLKEAAVMKEIKHPNLVQ 73
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
G C+ +++ E++ G+L L + +E + ++ A+ Y+ F
Sbjct: 74 LLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI-----APELAY 879
+HRD++++N L+ + V+DFG+S+ + T A APE
Sbjct: 133 ---IHRDLAARNCLVGENHLVKVADFGLSRLMT----GDTYTAHAGAKFPIKWTAPESLA 185
Query: 880 TMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPL 936
K + K DV++FGVL E+ G P I + E+L+ R+ P
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----------LSQVYELLEKDYRMERP- 234
Query: 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
+K+ +M +C +P+ RP+ ++ Q
Sbjct: 235 EGCPEKVYELM---RACWQWNPSDRPSFAEIHQAF 266
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 76/283 (26%), Positives = 121/283 (42%), Gaps = 45/283 (15%)
Query: 706 EHCIGNGGQGSVYKAEL---PTGEI-VAVKKFHSPLPGEMACQQ-EFLNEGNALTKIRHR 760
E IG+G G V L ++ VA+K G Q+ +FL+E + + + H
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMGQFDHP 110
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMH 820
NI++ G + + +V EY+E GSL L +F + + ++GV + Y+
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI-----AP 875
+ VHRD++++NVL++ VSDFG+S+ L+ T G I AP
Sbjct: 169 DLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLE--DDPDAAYTTTGGKIPIRWTAP 223
Query: 876 ELAYTMKVTEKCDVYSFGVLALEVI-KGKHP------RDFISSICSSLSSNLNIALDEML 928
E + DV+SFGV+ EV+ G+ P RD ISS+
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY------------ 271
Query: 929 DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
RLP P L +M + C + RP ++ +L
Sbjct: 272 --RLPAP-MGCPHALHQLM---LDCWHKDRAQRPRFSQIVSVL 308
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-29
Identities = 70/272 (25%), Positives = 113/272 (41%), Gaps = 31/272 (11%)
Query: 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
E +G G G V+ VA+K PG M+ + FL E + K+RH +V+
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQL 327
Query: 766 YGFCSHALHSFVVYEYLEMGSLAMIL-SNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
Y S ++V EY+ GSL L M A +A + Y+ +
Sbjct: 328 YAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA--QIASGMAYVERMNY 384
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGY--IAPELAYTMK 882
VHRD+ + N+L+ V+DFG+++ ++ + F APE A +
Sbjct: 385 ---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYGR 440
Query: 883 VTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPLRNV 939
T K DV+SFG+L E+ KG+ P + N + + ++ R+P P
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMV----------NREVLDQVERGYRMPCP-PEC 489
Query: 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
+ L +M C + P RPT + + L
Sbjct: 490 PESLHDLM---CQCWRKEPEERPTFEYLQAFL 518
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 65/294 (22%), Positives = 110/294 (37%), Gaps = 41/294 (13%)
Query: 698 RATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTK 756
R T F + IG+G GSV+K + G I A+K+ PL G +Q L E A
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAV 66
Query: 757 I-RHRNIVKFYGFCSHALHSFVVYEYLEMGSLA-MILSNDAAAEEFGWTKRMNAIKGVAD 814
+ +H ++V+++ + H + EY GSLA I N F + + + V
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLN-------LEYEAHVSDFGISKFL-KLG------- 859
L Y+H+ +VH DI N+ ++ E D+ +K + K+G
Sbjct: 127 GLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 860 LSNRTELAGTFGYIAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSS 918
+S+ G ++A E L K D+++ + + +
Sbjct: 184 ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQG 243
Query: 919 NLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
L PR+P L +L+ + P RP+ L+K
Sbjct: 244 RL---------PRIPQVLSQEFTELLK------VMIHPDPERRPS---AMALVK 279
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 63/257 (24%), Positives = 112/257 (43%), Gaps = 18/257 (7%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G GG +VY AE VA+K P + + F E + +++ H+NIV
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
++V EY+E +L+ + + +N + D + + H I
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM---RI 132
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA-GTFGYIAPELAYTMKVTEK 886
VHRDI +N+L++ + DFGI+K L +T GT Y +PE A E
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 887 CDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKL-IS 945
D+YS G++ E++ G+ P F + ++IA+ + D +P +V+ + S
Sbjct: 193 TDIYSIGIVLYEMLVGEPP--FNG------ETAVSIAIKHIQDS-VPNVTTDVRKDIPQS 243
Query: 946 IMEVSISCLDESPTSRP 962
+ V + ++ +R
Sbjct: 244 LSNVILRATEKDKANRY 260
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 61/234 (26%), Positives = 91/234 (38%), Gaps = 6/234 (2%)
Query: 168 TNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNA 227
+N L + N + + +L L L+L N++ + +F L L L L N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134
Query: 228 LSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEI-GN 286
L+ + L L L L N + +F + L+ LG I E
Sbjct: 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
Query: 287 LKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSEN 346
L +L +L L + +P +L L L L S N P L SL L + +
Sbjct: 195 LFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS 252
Query: 347 TLNGSIPLALGNLTKLVSLDLSINKLSGSIPLS-FASLTSLTTLYLYENSL-CD 398
++ A L LV L+L+ N LS S+P F L L L+L+ N CD
Sbjct: 253 QVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWNCD 305
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-28
Identities = 70/273 (25%), Positives = 109/273 (39%), Gaps = 20/273 (7%)
Query: 313 NLATLYFSTNALSGSIPNEI-TNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINK 371
+ + + LS +P I +N R L+ L EN + +L L L L N
Sbjct: 55 QFSKVVCTRRGLS-EVPQGIPSNTRYLN---LMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 372 LSGSIPLSFASLTSLTTLYLYENSLCDSIPKEI-GDMKSLSILDLSSNKLNGSIPLSLAN 430
+ +F L SL TL L++N L IP + L L L +N + +
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWL-TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNR 169
Query: 431 LTNSLKVLYLSSNHIVGEIPLGH-GKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLS 489
+ + L L L + I G +L L L + P L L LE L++S
Sbjct: 170 VPS-LMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD--MPNLTPLVGLEELEMS 226
Query: 490 ANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQ 548
N F P S L L L + N+Q S N + L L EL+L++ + +P
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL--SSLPHD 284
Query: 549 VC-SMQSLEKLNLSHNNLSGSISRCFEEMHWLS 580
+ ++ L +L+L HN C ++ WL+
Sbjct: 285 LFTPLRYLVELHLHHNPW-----NCDCDILWLA 312
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-27
Identities = 57/240 (23%), Positives = 96/240 (40%), Gaps = 11/240 (4%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPP-SLGNLTS 73
+P I ++ + L+ +N + + L L L L N ++ I + L S
Sbjct: 68 EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLAS 124
Query: 74 LIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYL-HMNA 131
L +++ +N L+ IP+ L L +L L NN + + + +L+ L L +
Sbjct: 125 LNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKK 183
Query: 132 LSGSIPDEI-GNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGN 190
L I + L L L + + +P +L L L L + N P
Sbjct: 184 LE-YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHG 240
Query: 191 LKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYN 250
L SL L + + +S +F L L L L N LS L + L+ L+ L L++N
Sbjct: 241 LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-26
Identities = 64/263 (24%), Positives = 105/263 (39%), Gaps = 21/263 (7%)
Query: 336 RSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENS 395
S + + L+ +P + + L+L N + +F L L L L NS
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 396 LCDSIPKEI-GDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHG 454
+ I + SL+ L+L N L + L+ L+ L+L +N I IP
Sbjct: 111 I-RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSK-LRELWLRNNPIE-SIP--SY 165
Query: 455 KFSSLIQL----ILNNNELSGQLSPE-LGSLNQLEYLDLSANTFHNSIPESLGNLVKLHY 509
F+ + L + +L +S L L+YL+L +P +L LV L
Sbjct: 166 AFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEE 222
Query: 510 LNLSNNQFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQV-CSMQSLEKLNLSHNNLSG 567
L +S N F + P L L +L + ++ I + SL +LNL+HNNLS
Sbjct: 223 LEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV--SLIERNAFDGLASLVELNLAHNNLSS 280
Query: 568 SISRCFEEMHWLSCIDISYNALQ 590
F + +L + + +N
Sbjct: 281 LPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 4e-17
Identities = 43/181 (23%), Positives = 74/181 (40%), Gaps = 5/181 (2%)
Query: 2 LKVLGLSFNQFSGSIPPEI-GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
L L L N + IP +L+ L+ L N + + + R+ SL L L
Sbjct: 125 LNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKK 183
Query: 61 KGSIPP-SLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNL 119
I + L +L Y+++G + +P + L L +L +S N P S L
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGL 241
Query: 120 TNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINA 179
++L L++ + +S + L L +L +++N LS L LV L++ N
Sbjct: 242 SSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNP 301
Query: 180 L 180
Sbjct: 302 W 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 31/110 (28%), Positives = 52/110 (47%), Gaps = 6/110 (5%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
LK L L +P + L L+ L S N + P LSSL L + ++ +
Sbjct: 198 LKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS 255
Query: 62 GSIPP-SLGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLN 109
I + L SL+ +++ +N LS S+P+++ L+ L +L L +N N
Sbjct: 256 -LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 70/281 (24%), Positives = 116/281 (41%), Gaps = 30/281 (10%)
Query: 709 IGNGGQGSVYKAELP-----TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIV 763
+G G GSV TGE+VAVKK ++F E L ++H NIV
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 764 KFYGFCSHALHS--FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT 821
K+ G C A ++ EYL GSL L E K + + + Y+ T
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT 132
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGT---FGYIAPELA 878
+ +HRD++++N+L+ E + DFG++K L + APE
Sbjct: 133 KRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 879 YTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSN-----LNIALDEMLDP-- 930
K + DV+SFGV+ E+ + + + + ++ + L E+L
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 249
Query: 931 RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
RLP P D++ IM C + + RP+ + ++ +
Sbjct: 250 RLPRP-DGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRV 286
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 62/233 (26%), Positives = 90/233 (38%), Gaps = 4/233 (1%)
Query: 168 TNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNA 227
TN L + N + N +L+ L L+L N + + +F L L L L N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 228 LSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEI-GN 286
L+ + L L L L N + +F + L LG S I E
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183
Query: 287 LKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSEN 346
L +L +L L L IP +L L L L S N LS P L L L + ++
Sbjct: 184 LSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241
Query: 347 TLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSL-CD 398
+ A NL LV ++L+ N L+ F L L ++L+ N C+
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 75/273 (27%), Positives = 114/273 (41%), Gaps = 20/273 (7%)
Query: 313 NLATLYFSTNALSGSIPNEI-TNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINK 371
+ + L +P+ I TN R L+ L EN + + +L L L LS N
Sbjct: 44 QFSKVICVRKNLR-EVPDGISTNTRLLN---LHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 372 LSGSIPLSFASLTSLTTLYLYENSLCDSIPKEI-GDMKSLSILDLSSNKLNGSIPLSLAN 430
+ +F L +L TL L++N L +IP + L L L +N + SIP N
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN 157
Query: 431 LTNSLKVLYLSSNHIVGEIPLGH-GKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLS 489
SL+ L L + I G S+L L L L P L L +L+ LDLS
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLS 215
Query: 490 ANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQ 548
N P S L+ L L + +Q N + L L E++L++ + +P
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL--TLLPHD 273
Query: 549 VC-SMQSLEKLNLSHNNLSGSISRCFEEMHWLS 580
+ + LE+++L HN C ++ WLS
Sbjct: 274 LFTPLHHLERIHLHHNPW-----NCNCDILWLS 301
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-27
Identities = 61/240 (25%), Positives = 101/240 (42%), Gaps = 11/240 (4%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPP-SLGNLTS 73
+P I T+ +LL+ +NQ+ + + L L L L N ++ +I + L +
Sbjct: 57 EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLAN 113
Query: 74 LIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYL-HMNA 131
L +++ +N L+ +IPN L L +L L NN + + + +L L L +
Sbjct: 114 LNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKR 172
Query: 132 LSGSIPDEI-GNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGN 190
LS I + L L L ++ L IP +L L L L + N LS P
Sbjct: 173 LS-YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQG 229
Query: 191 LKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYN 250
L L L + + + +F NL L + L N L+ L + L L + L++N
Sbjct: 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 59/239 (24%), Positives = 96/239 (40%), Gaps = 9/239 (3%)
Query: 63 SIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNL 122
+P + T+ +++ N + N L+ L L+LS N + + L NL
Sbjct: 57 EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 123 VTLYLHMNALSGSIPDEI-GNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIG-INAL 180
TL L N L+ +IP+ L L +L + N + ++ + +L L +G + L
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRL 173
Query: 181 SGSIPNEI-GNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNL 239
S I L +L L L L + + L KL+ L L N LS + P L
Sbjct: 174 S-YISEGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLSAIRPGSFQGL 230
Query: 240 KSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYN 298
L L + + + +F NL LV L N L+ + L L + L++N
Sbjct: 231 MHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 9e-21
Identities = 57/245 (23%), Positives = 104/245 (42%), Gaps = 23/245 (9%)
Query: 385 SLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 444
+ + +L +P I + +L+L N++ S +L + L++L LS NH
Sbjct: 44 QFSKVICVRKNL-REVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRH-LEILQLSRNH 99
Query: 445 IVGEIPLGH-GKFSSLIQLILNNNELSGQLSPE-LGSLNQLEYLDLSANTFHNSIPESLG 502
I I +G ++L L L +N L+ + L++L+ L L N + +
Sbjct: 100 I-RTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFN 157
Query: 503 NLVKLHYLNLS-NNQFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQVCSMQSLEKLNL 560
+ L L+L + S E L +L L+L+ + EIP+ + + L++L+L
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL--REIPN-LTPLIKLDELDL 214
Query: 561 SHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLA---LQGNKRLCGDI 617
S N+LS F+ + L + + + +Q + N AF + L L N +
Sbjct: 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERN--AFDNLQSLVEINLAHNN-----L 267
Query: 618 KRLPP 622
LP
Sbjct: 268 TLLPH 272
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-20
Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 11/206 (5%)
Query: 2 LKVLGLSFNQFSGSIPPEI-GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
L++L LS N +I L +L L N+L+ + LS L L L +N +
Sbjct: 90 LEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPI 148
Query: 61 KGSIPPSL-GNLTSLIYIDIG-NNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSSLG 117
+ SIP + SL +D+G LS I L +L L L+ +L IP+ L
Sbjct: 149 E-SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPN-LT 204
Query: 118 NLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGI 177
L L L L N LS P L L L + + + + NL +LV + +
Sbjct: 205 PLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAH 264
Query: 178 NALSGSIPNEI-GNLKSLSDLRLDYN 202
N L+ +P+++ L L + L +N
Sbjct: 265 NNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 43/181 (23%), Positives = 78/181 (43%), Gaps = 5/181 (2%)
Query: 2 LKVLGLSFNQFSGSIPPEI-GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
L L L N+ + +IP +L+ LK L N + + + R+ SL L L
Sbjct: 114 LNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKR 172
Query: 61 KGSIPP-SLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNL 119
I + L++L Y+++ L IP + L L +L LS N L+ P S L
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGL 230
Query: 120 TNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINA 179
+L L++ + + + NL+ L ++ +++N L+ L +L +++ N
Sbjct: 231 MHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNP 290
Query: 180 L 180
Sbjct: 291 W 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 30/110 (27%), Positives = 50/110 (45%), Gaps = 6/110 (5%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L+ L L+ IP + L L L S N LS + P L L L + + ++
Sbjct: 187 LRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ 244
Query: 62 GSIPP-SLGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLN 109
I + NL SL+ I++ +N L+ +P+++ L L + L +N N
Sbjct: 245 -VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWN 292
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 69/272 (25%), Positives = 125/272 (45%), Gaps = 31/272 (11%)
Query: 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
E +G G G V+ A VAVK PG M+ + FL E N + ++H +VK
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK---PGSMS-VEAFLAEANVMKTLQHDKLVKL 248
Query: 766 YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFP 825
+ + +++ E++ GSL L +D + K ++ +A+ + ++ +
Sbjct: 249 HAVVTKE-PIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRNY- 305
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI---APELAYTMK 882
+HRD+ + N+L++ ++DFG+++ ++ + T G I APE
Sbjct: 306 --IHRDLRAANILVSASLVCKIADFGLARVIE--DNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 883 VTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPLRNV 939
T K DV+SFG+L +E++ G+ P +S N + L+ R+P P N
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMS----------NPEVIRALERGYRMPRP-ENC 410
Query: 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
++L +IM + C P RPT + + +L
Sbjct: 411 PEELYNIM---MRCWKNRPEERPTFEYIQSVL 439
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 63/267 (23%), Positives = 104/267 (38%), Gaps = 19/267 (7%)
Query: 703 FDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN 761
F+ +G G G V+K P+G ++A K H L + A + + + E L +
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNSPY 92
Query: 762 IVKFYG--FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI-KGVADALLY 818
IV FYG + + + E+++ GSL +L E + + + V L Y
Sbjct: 93 IVGFYGAFYSDGEI--SICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIAVIKGLTY 146
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELA 878
+ I+HRD+ N+L+N E + DFG+S +L S GT Y++PE
Sbjct: 147 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERL 202
Query: 879 YTMKVTEKCDVYSFGVLALEVIKGKHP---RDFISSICSSLSSNLNIALDEMLDPRLPTP 935
+ + D++S G+ +E+ G++P D A + PR P
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 936 LRNVQDKLISIMEVSISCLDESPTSRP 962
N LD P
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPP 289
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-28
Identities = 51/265 (19%), Positives = 99/265 (37%), Gaps = 44/265 (16%)
Query: 706 EHCIGNGGQGSVYKAE---LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
+ CI +GG G +Y A + G V +K G+ Q + E L ++ H +I
Sbjct: 85 KGCIAHGGLGWIYLALDRNVN-GRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSI 141
Query: 763 VKFYGFCSHALHS-----FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL 817
V+ + F H ++V EY+ SL ++ + + + + AL
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALS 196
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL 877
Y+H+ +V+ D+ +N++L E + + D G +++ L GT G+ APE+
Sbjct: 197 YLHSI---GLVYNDLKPENIMLT-EEQLKLIDLGAVS----RINSFGYLYGTPGFQAPEI 248
Query: 878 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937
T T D+Y+ G + R+ ++ ++ +
Sbjct: 249 VRT-GPTVATDIYTVGRTLAALTLDLPTRN---------GRYVDGLPEDDPVLKTYDSYG 298
Query: 938 NVQDKLISIMEVSISCLDESPTSRP 962
+ + +D P R
Sbjct: 299 RLLRR----------AIDPDPRQRF 313
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 34/283 (12%)
Query: 709 IGNGGQGSVYKAEL-----PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIV 763
+G G G V TGE+VAVK G + + E + L + H +I+
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQH-RSGWKQEIDILRTLYHEHII 96
Query: 764 KFYGFCSHALHS--FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT 821
K+ G C A + +V EY+ +GSL L G + + + + + + Y+H
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHA 152
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI-----APE 876
+ +HRD++++NVLL+ + + DFG++K + G + G APE
Sbjct: 153 QHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG--HEYYRVREDGDSPVFWYAPE 207
Query: 877 LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSN----LNIALDEMLDP- 930
K DV+SFGV E++ + + + + L E+L+
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267
Query: 931 -RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
RLP P ++ +M+ +C + + RPT + + +LK
Sbjct: 268 ERLPRP-DKCPAEVYHLMK---NCWETEASFRPTFENLIPILK 306
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 30/284 (10%)
Query: 706 EHCIGNGGQGSVYKAELP-----TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
+G G GSV TGE+VAVKK ++F E L ++H
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSLQHD 102
Query: 761 NIVKFYGFCSHALHS--FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLY 818
NIVK+ G C A ++ EYL GSL L E K + + + Y
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEY 160
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGT---FGYIAP 875
+ T + +HRD++++N+L+ E + DFG++K L + AP
Sbjct: 161 LGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 217
Query: 876 ELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSN-----LNIALDEMLD 929
E K + DV+SFGV+ E+ + + + + ++ + L E+L
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277
Query: 930 P--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
RLP P D++ IM C + + RP+ + ++ +
Sbjct: 278 NNGRLPRP-DGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRV 317
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 66/285 (23%), Positives = 112/285 (39%), Gaps = 32/285 (11%)
Query: 706 EHCIGNGGQGSVYKAELP-----TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
+G G G V TGE VAVK P G + E L + H
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNH-IADLKKEIEILRNLYHE 83
Query: 761 NIVKFYGFCSHALHS--FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLY 818
NIVK+ G C+ + ++ E+L GSL L + + +++ + + Y
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDY 141
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI----- 873
+ + + VHRD++++NVL+ E++ + DFG++K ++ T
Sbjct: 142 LGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT--VKDDRDSPVFWY 196
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNL----NIALDEML 928
APE K DV+SFGV E++ ++ + L L
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256
Query: 929 DP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
RLP P N D++ +M C + P++R + Q + +
Sbjct: 257 KEGKRLPCP-PNCPDEVYQLM---RKCWEFQPSNRTSFQNLIEGF 297
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 61/245 (24%), Positives = 103/245 (42%), Gaps = 10/245 (4%)
Query: 183 SIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALS--GLIPNEIGNLK 240
S+P I S + L L+ N L F LT+L L L N LS G
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 241 SLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEI-GNLKSLLHLQLNYNT 299
SL L L++N + ++ +F L +L + L + +L++L++L +++
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 300 LSGSIPLSLGSLTNLATLYFSTNALSGSIPNEI-TNLRSLSDLQLSENTLNGSIPLALGN 358
+ L++L L + N+ + +I T LR+L+ L LS+ L P A +
Sbjct: 138 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 197
Query: 359 LTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEI--GDMKSLSILDLS 416
L+ L L++S N + L SL L N + + K+ SL+ L+L+
Sbjct: 198 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI-MTSKKQELQHFPSSLAFLNLT 256
Query: 417 SNKLN 421
N
Sbjct: 257 QNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 68/298 (22%), Positives = 105/298 (35%), Gaps = 41/298 (13%)
Query: 289 SLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTL 348
S ++ N L+ S+P + ++ L +N L L L+ L LS N L
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 349 N--GSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEI-G 405
+ G + T L LDLS N + ++ +F L L L ++L +
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123
Query: 406 DMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILN 465
+++L LD+S + L++ L+VL ++ N F+ L
Sbjct: 124 SLRNLIYLDISHTHTRVAFNGIFNGLSS-LEVLKMAGNSFQENFL--PDIFTEL------ 174
Query: 466 NNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPI 525
L +LDLS P + +L L LN+S+N F P
Sbjct: 175 ---------------RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY 219
Query: 526 EKLIHLSELDLSY-KIFGEEIPSQVCS--MQSLEKLNLSHNNLSGSISRCFEEMHWLS 580
+ L L LD S I Q SL LNL+ N+ C E
Sbjct: 220 KCLNSLQVLDYSLNHI--MTSKKQELQHFPSSLAFLNLTQNDF-----ACTCEHQSFL 270
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 68/262 (25%), Positives = 107/262 (40%), Gaps = 21/262 (8%)
Query: 364 SLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN-- 421
+ + L+ S+P +S T L L N L + L+ L LSSN L+
Sbjct: 11 EIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 422 GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPE--LGS 479
G S T+ LK L LS N ++ + L L ++ L Q+S S
Sbjct: 68 GCCSQSDFGTTS-LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLS 124
Query: 480 LNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKI-PNPIEKLIHLSELDLSY 538
L L YLD+S + L L L ++ N F + P+ +L +L+ LDLS
Sbjct: 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 539 -KIFGEEIPSQV-CSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNS 596
++ E++ S+ SL+ LN+SHNN + ++ ++ L +D S N +
Sbjct: 185 CQL--EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS--KK 240
Query: 597 TAFRDAP----MLALQGNKRLC 614
+ P L L N C
Sbjct: 241 QELQHFPSSLAFLNLTQNDFAC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 59/243 (24%), Positives = 96/243 (39%), Gaps = 12/243 (4%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL--KGSIPPSLGNLT 72
S+P I + L N+L L +L+ L LSL SN L KG S T
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 73 SLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSL-GNLTNLVTLYLHMNA 131
SL Y+D+ N + ++ + L+ L L +++L S+ +L NL+ L +
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 132 LSGSIPDEI-GNLKFLSDLQVSYNTLSGAI-PFSLGNLTNLVTLYIGINALSGSIPNEI- 188
+ I L L L+++ N+ P L NL L + L +
Sbjct: 138 TR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAF 195
Query: 189 GNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNL-KSLLALQL 247
+L SL L + +N + + L L++L +N + E+ + SL L L
Sbjct: 196 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 255
Query: 248 NYN 250
N
Sbjct: 256 TQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 61/242 (25%), Positives = 96/242 (39%), Gaps = 10/242 (4%)
Query: 63 SIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLN--GSIPSSLGNLT 120
S+P + +S +++ +N L L L+ L LS+N L+ G S T
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 121 NLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSL-GNLTNLVTLYIGINA 179
+L L L N + ++ L+ L L ++ L FS+ +L NL+ L I
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 180 LSGSIPNEI-GNLKSLSDLRLDYNTLSGSIL-YSFGNLTKLEILYLDVNALSGLIPNEIG 237
N I L SL L++ N+ + L F L L L L L L P
Sbjct: 138 TR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 196
Query: 238 NLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNL-KSLLHLQLN 296
+L SL L +++N + L L + N + +S +E+ + SL L L
Sbjct: 197 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 256
Query: 297 YN 298
N
Sbjct: 257 QN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 31/159 (19%), Positives = 54/159 (33%), Gaps = 9/159 (5%)
Query: 2 LKVLGLSFNQFSGSIPPE--IGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNF 59
L+ L + + L +L L S LSSL L + N
Sbjct: 103 LEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 161
Query: 60 LKGSIPP-SLGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSSLG 117
+ + P L +L ++D+ L + SL SL L +S+N+
Sbjct: 162 FQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220
Query: 118 NLTNLVTLYLHMNALSGSIPDEI--GNLKFLSDLQVSYN 154
L +L L +N + + + L+ L ++ N
Sbjct: 221 CLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 32/112 (28%), Positives = 48/112 (42%), Gaps = 6/112 (5%)
Query: 2 LKVLGLSFNQFSGSIPPEI-GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
L+VL ++ N F + P+I L +L L S+ QL L P LSSL L++ N
Sbjct: 152 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 211
Query: 61 KGSIPPS-LGNLTSLIYIDIGNNLLSGSIPNEV--GSLKSLSDLRLSNNSLN 109
S+ L SL +D N + + + SL+ L L+ N
Sbjct: 212 F-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 68/275 (24%), Positives = 109/275 (39%), Gaps = 35/275 (12%)
Query: 709 IGNGGQGSVYKAEL--PTGEI-VAVKKFHSPLPGEM--ACQQEFLNEGNALTKIRHRNIV 763
+G+G G+V K VAVK A + E L E N + ++ + IV
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILK---NEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 764 KFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC 823
+ G C +V E E+G L L + + + V+ + Y+ +
Sbjct: 82 RMIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN 137
Query: 824 FPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGT---FGYIAPELAYT 880
F VHRD++++NVLL ++ A +SDFG+SK L+ + + APE
Sbjct: 138 F---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 881 MKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPLR 937
K + K DV+SFGVL E G+ P + + ML+ R+ P
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK----------GSEVTAMLEKGERMGCP-A 243
Query: 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
++ +M C +RP V L+
Sbjct: 244 GCPREMYDLM---NLCWTYDVENRPGFAAVELRLR 275
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 58/266 (21%), Positives = 103/266 (38%), Gaps = 34/266 (12%)
Query: 709 IGNGGQGSVYKAEL----PTGEI-VAVKKFHSPLPGEMACQ-QEFLNEGNALTKIRHRNI 762
+G+G G+VYK +I VA+K+ +E L+E + + + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPHV 79
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTN 822
+ G C + ++ + + G L + + G +N +A + Y+
Sbjct: 80 CRLLGICLTS-TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 823 CFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF--GYIAPELAYT 880
VHRD++++NVL+ ++DFG++K L G ++A E
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 881 MKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPLR 937
T + DV+S+GV E++ G P D I + +L+ RLP P
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----------ASEISSILEKGERLPQP-P 242
Query: 938 NVQDKLISIMEVSISCLDESPTSRPT 963
+ IM C SRP
Sbjct: 243 ICTIDVYMIM---RKCWMIDADSRPK 265
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 64/271 (23%), Positives = 118/271 (43%), Gaps = 29/271 (10%)
Query: 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
+G G G V+ VAVK G M+ FL E N + +++H+ +V+
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMS-PDAFLAEANLMKQLQHQRLVRL 73
Query: 766 YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFP 825
Y + +++ EY+E GSL L + + K ++ +A+ + ++ +
Sbjct: 74 YAVVTQE-PIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERNY- 130
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGY--IAPELAYTMKV 883
+HRD+ + N+L++ ++DFG+++ ++ E F APE
Sbjct: 131 --IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGTF 187
Query: 884 TEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPLRNVQ 940
T K DV+SFG+L E++ G+ P ++ N + + L+ R+ P N
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMT----------NPEVIQNLERGYRMVRP-DNCP 236
Query: 941 DKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
++L +M C E P RPT + +L
Sbjct: 237 EELYQLM---RLCWKERPEDRPTFDYLRSVL 264
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-28
Identities = 67/285 (23%), Positives = 109/285 (38%), Gaps = 33/285 (11%)
Query: 706 EHCIGNGGQGSVYKAELP-----TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
+G G GSV TG +VAVK+ Q++F E L +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSD 84
Query: 761 NIVKFYGFCSHALHS--FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLY 818
IVK+ G +V EYL G L L A ++ + + + Y
Sbjct: 85 FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEY 142
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI----- 873
+ + VHRD++++N+L+ E ++DFG++K L L + G
Sbjct: 143 LGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVVREPGQSPIFWY 197
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHP----RDFISSICSSLSSNLNIALDEML 928
APE + + DV+SFGV+ E+ +F+ + L E+L
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 929 DP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
+ RLP P ++ +M+ C SP RP+ + L
Sbjct: 258 EEGQRLPAP-PACPAEVHELMK---LCWAPSPQDRPSFSALGPQL 298
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 68/277 (24%), Positives = 113/277 (40%), Gaps = 43/277 (15%)
Query: 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
IG G G V + G VAVK A Q FL E + +T++RH N+V+
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCIK---NDATA--QAFLAEASVMTQLRHSNLVQL 79
Query: 766 YGFCSHALHS-FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
G ++V EY+ GSL L + G + V +A+ Y+ N F
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNF 138
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFG------YIAPELA 878
VHRD++++NVL++ + A VSDFG++ + + + APE
Sbjct: 139 ---VHRDLAARNVLVSEDNVAKVSDFGLT---------KEASSTQDTGKLPVKWTAPEAL 186
Query: 879 YTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTP 935
K + K DV+SFG+L E+ G+ P I + ++ ++ P
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----------LKDVVPRVEKGYKMDAP 236
Query: 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ +M +C RP+ ++ + L+
Sbjct: 237 -DGCPPAVYEVM---KNCWHLDAAMRPSFLQLREQLE 269
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-28
Identities = 35/314 (11%), Positives = 77/314 (24%), Gaps = 54/314 (17%)
Query: 692 VHEEIIRATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNE 750
V + + + + G + V+ ++ E A+K F + +
Sbjct: 53 VDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEA 112
Query: 751 GNALTKIRHRNIVKFYGFCSHA--------------------------LHSFVVYEYLEM 784
A ++ + + + ++
Sbjct: 113 TFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS- 171
Query: 785 GSLAMILSNDAAAEEFGWTKRMNAIKG----VADALLYMHTNCFPPIVHRDISSKNVLLN 840
L ++ S F + + A+ + + + +VH + N+ +
Sbjct: 172 VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIM 228
Query: 841 LEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL--AYTMKVTEKCDVYSFGVLALE 898
+ + D K+G + + Y E A T T + + G+
Sbjct: 229 PDGRLMLGDVSALW--KVG-TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285
Query: 899 VIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR-----NVQDKLISIMEVSISC 953
V P F S +L L V+ LI
Sbjct: 286 VWCLFLP--FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKT-LIG------RF 336
Query: 954 LDESPTSRPTMQKV 967
L+ R +
Sbjct: 337 LNFDRRRRLLPLEA 350
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 65/280 (23%), Positives = 107/280 (38%), Gaps = 39/280 (13%)
Query: 706 EHCIGNGGQGSVYKAEL--PTGEI-VAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
+ +G G GSV + +I VA+K +E + E + ++ + I
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQIMHQLDNPYI 72
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTN 822
V+ G C +V E G L L EE + + V+ + Y+
Sbjct: 73 VRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 823 CFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGT---FGYIAPELAY 879
F VHRD++++NVLL + A +SDFG+SK L S T + + APE
Sbjct: 130 NF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 186
Query: 880 TMKVTEKCDVYSFGVLALEVI-KGKHP------RDFISSICSSLSSNLNIALDEMLDPRL 932
K + + DV+S+GV E + G+ P + ++ I R+
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--------------GKRM 232
Query: 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
P +L ++M C RP V Q ++
Sbjct: 233 ECP-PECPPELYALM---SDCWIYKWEDRPDFLTVEQRMR 268
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 61/248 (24%), Positives = 101/248 (40%), Gaps = 31/248 (12%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFY- 766
+G GG V+ A L VAVK + L + + F E + H IV Y
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 767 -GF--CSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC 823
G ++V EY++ +L I+ + + + I AL + H N
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQN- 135
Query: 824 FPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTE---LAGTFGYIAPELAYT 880
I+HRD+ N++++ V DFGI++ + ++ T+ + GT Y++PE A
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 881 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIAL----DEM-----LDPR 931
V + DVYS G + EV+ G+ P F S +++A ++
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP--FTG------DSPVSVAYQHVREDPIPPSARHEG 245
Query: 932 LPTPLRNV 939
L L V
Sbjct: 246 LSADLDAV 253
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 51/244 (20%), Positives = 91/244 (37%), Gaps = 30/244 (12%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G GG G VY+AE IVA+K L + + E +++ ++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
F +V + LA +L + + ++ + AL H
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA---GA 155
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA---GTFGYIAPELAYTMKVT 884
HRD+ +N+L++ + A++ DFGI+ T+L GT Y+APE T
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAPERFSESHAT 213
Query: 885 EKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIAL----DEM-----LDPRLPTP 935
+ D+Y+ + E + G P L++ + + P +P
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQ---------GDQLSVMGAHINQAIPRPSTVRPGIPVA 264
Query: 936 LRNV 939
V
Sbjct: 265 FDAV 268
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 71/273 (26%), Positives = 114/273 (41%), Gaps = 35/273 (12%)
Query: 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
IG G G V + G VAVK Q FL E + +T++RH N+V+
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIK---NDAT--AQAFLAEASVMTQLRHSNLVQL 251
Query: 766 YGFCSHALHSF-VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
G +V EY+ GSL L + G + V +A+ Y+ N F
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNF 310
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGY--IAPELAYTMK 882
VHRD++++NVL++ + A VSDFG++K + T+ G APE K
Sbjct: 311 ---VHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREKK 362
Query: 883 VTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPLRNV 939
+ K DV+SFG+L E+ G+ P I + ++ ++ P
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVPYPRIP----------LKDVVPRVEKGYKMDAP-DGC 411
Query: 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ +M +C +RPT ++ + L+
Sbjct: 412 PPAVYDVM---KNCWHLDAATRPTFLQLREQLE 441
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-27
Identities = 72/279 (25%), Positives = 124/279 (44%), Gaps = 37/279 (13%)
Query: 706 EHCIGNGGQGSVYKAELPT---GEI-VAVKKFHSPLPGEMACQQ-EFLNEGNALTKIRHR 760
+ +G G G V L EI VA+K G Q+ +FL E + + + H
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHP 106
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMH 820
NI++ G + + +V EY+E GSL L A +F + + ++G+A + Y+
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLS 164
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI-----AP 875
+ VHRD++++N+L+N VSDFG+ + L+ G I +P
Sbjct: 165 DMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLEDD--PEAAYTTRGGKIPIRWTSP 219
Query: 876 ELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RL 932
E K T DV+S+G++ EV+ G+ P +S N + + +D RL
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS----------NQDVIKAVDEGYRL 269
Query: 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
P P + L +M + C + +RP +++ +L
Sbjct: 270 PPP-MDCPAALYQLM---LDCWQKDRNNRPKFEQIVSIL 304
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 78/292 (26%), Positives = 127/292 (43%), Gaps = 40/292 (13%)
Query: 695 EIIRATKNFDDEHCIGNGGQGSVYKAEL--PTGEI---VAVKKFHSPLPGEMACQQ-EFL 748
EI + IG G G VYK L +G+ VA+K G Q+ +FL
Sbjct: 40 EIHPSCVTRQKV--IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFL 94
Query: 749 NEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNA 808
E + + H NI++ G S ++ EY+E G+L L EF + +
Sbjct: 95 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGM 152
Query: 809 IKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAG 868
++G+A + Y+ + VHRD++++N+L+N VSDFG+S+ L+ +G
Sbjct: 153 LRGIAAGMKYLANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 209
Query: 869 TFGYI-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNI 922
G I APE K T DV+SFG++ EV+ G+ P +S N
Sbjct: 210 --GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----------NH 257
Query: 923 ALDEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ + ++ RLPTP + + +M + C + RP + +L
Sbjct: 258 EVMKAINDGFRLPTP-MDCPSAIYQLM---MQCWQQERARRPKFADIVSILD 305
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 48/262 (18%), Positives = 96/262 (36%), Gaps = 17/262 (6%)
Query: 2 LKVLGLSFNQFSGSIPPEI-GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
+K L LS N+ + I +L+ L + N ++ + L SL L L N+L
Sbjct: 54 VKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112
Query: 61 KGSIPPSL-GNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPS-SLG 117
++ S L+SL ++++ N + L L LR+ N I
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171
Query: 118 NLTNLVTLYLHMNALSGSIPDEI-GNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIG 176
LT L L + + L S + +++ +S L + + + +++ L +
Sbjct: 172 GLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELR 230
Query: 177 INALSGSIPNEI--------GNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNAL 228
L +E+ + ++++ +L ++ ++ L L N L
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289
Query: 229 SGLIPNEIGNLKSLLALQLNYN 250
+ L SL + L+ N
Sbjct: 290 KSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 65/274 (23%), Positives = 108/274 (39%), Gaps = 21/274 (7%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPP-SLGNLTS 73
SIP + +K L S N+++ + ++ R +L L L SN + +I S +L S
Sbjct: 45 SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101
Query: 74 LIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSSL-GNLTNLVTLYLHMNA 131
L ++D+ N LS ++ + L SL+ L L N +SL +LT L L +
Sbjct: 102 LEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD 160
Query: 132 LSGSIPDEI-GNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEI-G 189
I + L FL +L++ + L P SL ++ N+ L + + +
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVD 219
Query: 190 NLKSLSDLRLDYNTLSGSIL--------YSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
S+ L L L S + + +L + + +
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQISG 278
Query: 242 LLALQLNYNTLSGSIPCS-FGNLTKLVISCLGTN 274
LL L+ + N L S+P F LT L L TN
Sbjct: 279 LLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-25
Identities = 66/308 (21%), Positives = 117/308 (37%), Gaps = 50/308 (16%)
Query: 97 SLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTL 156
++ L LSNN + S L NL L L N ++ +I
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIE------------------- 92
Query: 157 SGAIPFSLGNLTNLVTLYIGINALSGSIPNEI-GNLKSLSDLRLDYNTLSGSILYS--FG 213
S +L +L L + N LS ++ + L SL+ L L N ++ + F
Sbjct: 93 ----EDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFS 146
Query: 214 NLTKLEILYLDVNALSGLIPNEI-GNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLG 272
+LTKL+IL + I + L L L+++ + L P S ++ + L
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206
Query: 273 TNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEI 332
+ + S+ L+L L F + LS N +
Sbjct: 207 MKQHILLLEIFVDVTSSVECLELRDTDLDT----------------FHFSELSTGETNSL 250
Query: 333 TNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLS-FASLTSLTTLYL 391
+ ++++++ +L + L ++ L+ L+ S N+L S+P F LTSL ++L
Sbjct: 251 IKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWL 308
Query: 392 YENSL-CD 398
+ N C
Sbjct: 309 HTNPWDCS 316
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 58/284 (20%), Positives = 111/284 (39%), Gaps = 30/284 (10%)
Query: 289 SLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEI-TNLRSLSDLQLSENT 347
++ L L+ N ++ L NL L ++N ++ +I + ++L SL L LS N
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111
Query: 348 LNGSIPL-ALGNLTKLVSLDLSINKLSGSIPLS-FASLTSLTTLYLYENSLCDSIPKEI- 404
L ++ L+ L L+L N S F+ LT L L + I ++
Sbjct: 112 L-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 405 GDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGH-GKFSSLIQLI 463
+ L L++ ++ L P SL ++ N + L L + + SS+ L
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQN-VSHLILHMKQHI-LLLEIFVDVTSSVECLE 228
Query: 464 LNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPN 523
L + +L +LS + SL + +++ Q +
Sbjct: 229 LRDTDLDT---------FHFS--ELSTGETN-----SLIKKFTFRNVKITDESLFQ-VMK 271
Query: 524 PIEKLIHLSELDLSY-KIFGEEIPSQVC-SMQSLEKLNLSHNNL 565
+ ++ L EL+ S ++ + +P + + SL+K+ L N
Sbjct: 272 LLNQISGLLELEFSRNQL--KSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 54/265 (20%), Positives = 94/265 (35%), Gaps = 18/265 (6%)
Query: 216 TKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNA 275
++ L L N ++ + +++ +L AL L N ++ SF +L L L N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 276 LSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSL-GSLTNLATLYFSTNALSGSIPNEI-T 333
LS+ L SL L L N SL LT L L I +
Sbjct: 112 LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171
Query: 334 NLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYE 393
L L +L++ + L P +L ++ + L L + + + + +S+ L L +
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRD 231
Query: 394 NSLCDSIPKEI--------GDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 445
L E+ + + ++ L + L ++ L L S N +
Sbjct: 232 TDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG-LLELEFSRNQL 289
Query: 446 VGEIPLGHGKFSSLIQL---ILNNN 467
+ G F L L L+ N
Sbjct: 290 KS---VPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 51/254 (20%), Positives = 102/254 (40%), Gaps = 18/254 (7%)
Query: 351 SIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEI-GDMKS 409
SIP L + SLDLS N+++ +L L L N + ++I ++ + S
Sbjct: 45 SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGS 101
Query: 410 LSILDLSSNKLNGSIPLSL-ANLTNSLKVLYLSSNHIVGEIPLGH-GKFSSLIQLILNNN 467
L LDLS N L ++ S L++ L L L N + L L + N
Sbjct: 102 LEHLDLSYNYL-SNLSSSWFKPLSS-LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNM 159
Query: 468 ELSGQLSPE-LGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIE 526
+ ++ + L LE L++ A+ + P+SL ++ + +L L Q + ++
Sbjct: 160 DTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVD 219
Query: 527 KLIHLSELDLSYKIFGEEIPSQVCS--------MQSLEKLNLSHNNLSGSISRCFEEMHW 578
+ L+L S++ + + + ++ +L + + ++
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG 278
Query: 579 LSCIDISYNALQGL 592
L ++ S N L+ +
Sbjct: 279 LLELEFSRNQLKSV 292
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-27
Identities = 61/325 (18%), Positives = 102/325 (31%), Gaps = 67/325 (20%)
Query: 700 TKNFDDEHCIGNGGQ--GSVYKA-ELPTGEIVAVKKFHSPL-PGEMACQQEFLNEGNALT 755
++ IG G + +V A PTGE V V++ L E +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI--NLEACSNEMVTFLQGELHVSK 81
Query: 756 KIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMN----AI-- 809
H NIV + +VV ++ GS ++ + MN A
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT-------HFMDGMNELAIAYIL 134
Query: 810 KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT----- 864
+GV AL Y+H VHR + + ++L++++ + ++S + + +
Sbjct: 135 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 865 --ELAGTFGYIAPELAYTMKV--TEKCDVYSFGVLALEVIKGK------HP--------- 905
+++PE+ K D+YS G+ A E+ G
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251
Query: 906 -----------RDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSIS-- 952
S S N L + L P P S
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311
Query: 953 -----CLDESPTSRPTMQKVSQLLK 972
CL +P +RP+ S LL
Sbjct: 312 HFVEQCLQRNPDARPS---ASTLLN 333
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 65/277 (23%), Positives = 108/277 (38%), Gaps = 37/277 (13%)
Query: 709 IGNGGQGSVYKAEL--PTGEI--VAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
+G+G G V + E P+G+ VAVK + + +F+ E NA+ + HRN+++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
YG +V E +GSL L F VA+ + Y+ + F
Sbjct: 86 LYGVVLTP-PMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKRF 142
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGT---FGYIAPELAYTM 881
+HRD++++N+LL + DFG+ + L + F + APE T
Sbjct: 143 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 882 KVTEKCDVYSFGVLALEVI-KGKHP------RDFISSICSSLSSNLNIALDEMLDPRLPT 934
+ D + FGV E+ G+ P + I + RLP
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI-------------DKEGERLPR 246
Query: 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
P + + ++M + C P RPT + L
Sbjct: 247 P-EDCPQDIYNVM---VQCWAHKPEDRPTFVALRDFL 279
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 12/222 (5%)
Query: 183 SIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSL 242
++P I + + L N +S SF L IL+L N L+ + L L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 243 LALQLNYNTLSGSIPCS-FGNLTKLVISCLGTNALSSSILEEI-GNLKSLLHLQLNYNTL 300
L L+ N S+ + F L +L L L + + L +L +L L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNAL 141
Query: 301 SGSIP-LSLGSLTNLATLYFSTNALSGSIPNEI-TNLRSLSDLQLSENTLNGSIPLALGN 358
++P + L NL L+ N +S S+P L SL L L +N + P A +
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
Query: 359 LTKLVSLDLSINKLSGSIPLS-FASLTSLTTLYLYENSL-CD 398
L +L++L L N LS ++P A L +L L L +N CD
Sbjct: 200 LGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWVCD 240
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 61/240 (25%), Positives = 94/240 (39%), Gaps = 33/240 (13%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPP-SLGNLTS 73
++P I + + N++S + +L L L+SN L I + L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81
Query: 74 LIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPS-SLGNLTNLVTLYLHMNA 131
L +D+ +N S+ L L L L L + L L LYL NA
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140
Query: 132 LSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEI-GN 190
L ++PD+ +L NL L++ N +S S+P
Sbjct: 141 LQ-ALPDDT-----------------------FRDLGNLTHLFLHGNRIS-SVPERAFRG 175
Query: 191 LKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYN 250
L SL L L N ++ ++F +L +L LYL N LS L + L++L L+LN N
Sbjct: 176 LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 48/215 (22%), Positives = 77/215 (35%), Gaps = 10/215 (4%)
Query: 327 SIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSL 386
++P I + + L N ++ + L L L N L+ +F L L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 387 TTLYLYENSLCDSIPKEI-GDMKSLSILDLSSNKLNGSIPL-SLANLTNSLKVLYLSSNH 444
L L +N+ S+ + L L L L + L L+ LYL N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAA-LQYLYLQDNA 140
Query: 445 IVGEIPLGH-GKFSSLIQLILNNNELSGQLSPE-LGSLNQLEYLDLSANTFHNSIPESLG 502
+ +P +L L L+ N +S + L+ L+ L L N + P +
Sbjct: 141 LQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198
Query: 503 NLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLS 537
+L +L L L N S + L L L L+
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLN 233
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 56/224 (25%), Positives = 84/224 (37%), Gaps = 8/224 (3%)
Query: 104 SNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFS 163
L ++P + ++LH N +S + L+ L + N L+ +
Sbjct: 19 PQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 164 LGNLTNLVTLYIGINALSGSIPNEI-GNLKSLSDLRLDYNTLSGSI-LYSFGNLTKLEIL 221
L L L + NA S+ L L L LD L + F L L+ L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYL 134
Query: 222 YLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSIL 281
YL NAL L + +L +L L L+ N +S +F L L L N ++
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194
Query: 282 EEIGNLKSLLHLQLNYNTLSGSIPLS-LGSLTNLATLYFSTNAL 324
+L L+ L L N LS ++P L L L L + N
Sbjct: 195 HAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 51/231 (22%), Positives = 83/231 (35%), Gaps = 16/231 (6%)
Query: 387 TTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIV 446
T + L ++P I + + L N+++ S N L +L+L SN +
Sbjct: 14 VTTSCPQQGL-QAVPVGI--PAASQRIFLHGNRISHVPAASFRACRN-LTILWLHSNVL- 68
Query: 447 GEIPLGH-GKFSSLIQLILNNNELSGQLSPE-LGSLNQLEYLDLSANTFHNSIPESLGNL 504
I + L QL L++N + P L +L L L P L
Sbjct: 69 ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL 128
Query: 505 VKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQV-CSMQSLEKLNLSH 562
L YL L +N + L +L+ L L +I +P + + SL++L L
Sbjct: 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI--SSVPERAFRGLHSLDRLLLHQ 186
Query: 563 NNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAP---MLALQGN 610
N ++ F ++ L + + N L L A L L N
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE--ALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 47/184 (25%), Positives = 75/184 (40%), Gaps = 9/184 (4%)
Query: 2 LKVLGLSFNQFSGSIPPEI-GHLTHLKLLSFSKN-QLSGLIPHEIGRLSSLNGLSLYSNF 59
L +L L N + I L L+ L S N QL + P L L+ L L
Sbjct: 58 LTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116
Query: 60 LKGSIPP-SLGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSSLG 117
L+ + P L +L Y+ + +N L ++P++ L +L+ L L N ++ +
Sbjct: 117 LQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFR 174
Query: 118 NLTNLVTLYLHMNALSGSIPDEI-GNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIG 176
L +L L LH N ++ + +L L L + N LS +L L L L +
Sbjct: 175 GLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLN 233
Query: 177 INAL 180
N
Sbjct: 234 DNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 30/111 (27%), Positives = 53/111 (47%), Gaps = 6/111 (5%)
Query: 2 LKVLGLSFNQFSGSIPPEI-GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
L+ L L N ++P + L +L L N++S + L SL+ L L+ N +
Sbjct: 131 LQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189
Query: 61 KGSIPP-SLGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLN 109
+ P + +L L+ + + N LS ++P E L++L LRL++N
Sbjct: 190 A-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-26
Identities = 73/302 (24%), Positives = 118/302 (39%), Gaps = 58/302 (19%)
Query: 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RH 759
E +G G G+V G VAVK+ L E LT+ H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI------DFCDIALMEIKLLTESDDH 68
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLA-MILSNDAAAEEFGWTKRMNA---IKGVADA 815
N++++Y + ++ E +L ++ S + + E K N ++ +A
Sbjct: 69 PNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 816 LLYMHTNCFPPIVHRDISSKNVLLNLEYEAH-------------VSDFGISKFLKLG--- 859
+ ++H+ I+HRD+ +N+L++ +SDFG+ K L G
Sbjct: 128 VAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 860 -LSNRTELAGTFGYIAPEL-------AYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFIS 910
+N +GT G+ APEL ++T D++S G + ++ KGKHP
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG--- 241
Query: 911 SICSSLSSNLNI-----ALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQ 965
S NI +LDEM + + D LIS +D P RPT
Sbjct: 242 ---DKYSRESNIIRGIFSLDEMKCLHDRSLIAEATD-LIS------QMIDHDPLKRPTAM 291
Query: 966 KV 967
KV
Sbjct: 292 KV 293
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 69/305 (22%), Positives = 111/305 (36%), Gaps = 54/305 (17%)
Query: 698 RATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTK 756
R +F++ +G G G V KA A+KK + L+E L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK----IRHTEEKLSTILSEVMLLAS 58
Query: 757 IRHRNIVKFYGFCSHALHS-------------FVVYEYLEMGSLA-MILSNDAAAEEFGW 802
+ H+ +V++Y + F+ EY E G+L +I S + +
Sbjct: 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR--- 115
Query: 803 TKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL-- 860
+ + + +AL Y+H+ I+HRD+ N+ ++ + DFG++K + L
Sbjct: 116 DEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 861 ------------SNRTELAGTFGYIAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHPRD 907
N T GT Y+A E L T EK D+YS G++ E+I
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM 232
Query: 908 FISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
+I L S P V+ K+I +D P RP
Sbjct: 233 ERVNILKKLRSV-----SIEFPPDFDDNKMKVEKKIIR------LLIDHDPNKRPG---A 278
Query: 968 SQLLK 972
LL
Sbjct: 279 RTLLN 283
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 65/287 (22%), Positives = 109/287 (37%), Gaps = 32/287 (11%)
Query: 695 EIIRATKNFDDEHCIGNGGQGSVYKAEL--PTGEI-VAVKKFHSPLPGEMACQQEFLNEG 751
+ R D +G G GSV + +I VA+K +E + E
Sbjct: 331 FLKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREA 387
Query: 752 NALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKG 811
+ ++ + IV+ G C +V E G L L EE + +
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQ 444
Query: 812 VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGT-- 869
V+ + Y+ F VHR+++++NVLL + A +SDFG+SK L S T +
Sbjct: 445 VSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 501
Query: 870 -FGYIAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEM 927
+ APE K + + DV+S+GV E + G+ P + +
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK----------GPEVMAF 551
Query: 928 LDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
++ R+ P +L ++M C RP V Q ++
Sbjct: 552 IEQGKRMECP-PECPPELYALM---SDCWIYKWEDRPDFLTVEQRMR 594
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 67/289 (23%), Positives = 122/289 (42%), Gaps = 23/289 (7%)
Query: 279 SILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSL 338
+++ L + + + + ++ ++ + L + TL ++ +I + L +L
Sbjct: 10 NVIFPDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNL 65
Query: 339 SDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCD 398
L+L +N + PL NLTK+ L+LS N L ++ L S+ TL L + D
Sbjct: 66 IGLELKDNQITDLAPLK--NLTKITELELSGNPLKNVSAIA--GLQSIKTLDLTSTQITD 121
Query: 399 SIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSS 458
P + + +L +L L N++ PL+ LTN L+ L + + + PL + S
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQITNISPLA--GLTN-LQYLSIGNAQVSDLTPLAN--LSK 174
Query: 459 LIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFS 518
L L ++N++S L SL L + L N S L N L + L+N +
Sbjct: 175 LTTLKADDNKISD--ISPLASLPNLIEVHLKNN--QISDVSPLANTSNLFIVTLTNQTIT 230
Query: 519 QKIPNPIEKLIHLSELDLSYKIFGEEI-PSQVCSMQSLEKLNLSHNNLS 566
P+ +L ++ G I P+ + + NL+ N S
Sbjct: 231 N---QPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 59/279 (21%), Positives = 118/279 (42%), Gaps = 20/279 (7%)
Query: 23 LTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNN 82
L + ++ K+ ++ + L + LS + + +I + L +LI +++ +N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 83 LLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGN 142
++ + + +L +++L LS N L S++ L ++ TL L ++ P +
Sbjct: 74 QIT-DLAP-LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LAG 127
Query: 143 LKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYN 202
L L L + N ++ P L LTNL L IG +S + + NL L+ L+ D N
Sbjct: 128 LSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDN 183
Query: 203 TLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGN 262
+S + +L L ++L N +S + P + N +L + L T++ N
Sbjct: 184 KISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNN 239
Query: 263 LTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLS 301
L + + + + I + + L +N S
Sbjct: 240 LVVPNV--VKGPSGAPIAPATISDNGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 60/277 (21%), Positives = 117/277 (42%), Gaps = 21/277 (7%)
Query: 262 NLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFST 321
L + G + ++ +L + L ++ +I + L NL L
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 322 NALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFA 381
N ++ + + NL +++L+LS N L ++ A+ L + +LDL+ +++ PL+
Sbjct: 73 NQIT-DLAP-LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLA-- 126
Query: 382 SLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLS 441
L++L LYL N + + P + + +L L + + +++ PL+ NL+ L L
Sbjct: 127 GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLA--NLSK-LTTLKAD 181
Query: 442 SNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESL 501
N I PL +LI++ L NN++S L + + L + L+ T N
Sbjct: 182 DNKISDISPLAS--LPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTITNQPVFYN 237
Query: 502 GNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSY 538
NLV + + P I + +L++
Sbjct: 238 NNLVVP--NVVKGPSGAPIAPATISDNGTYASPNLTW 272
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 57/282 (20%), Positives = 116/282 (41%), Gaps = 20/282 (7%)
Query: 68 LGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYL 127
L + I I G + ++ ++ L ++ L + +I + L NL+ L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLEL 70
Query: 128 HMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNE 187
N ++ + + NL +++L++S N L ++ L ++ TL + ++ P
Sbjct: 71 KDNQIT-DLA-PLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP-- 124
Query: 188 IGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQL 247
+ L +L L LD N ++ + LT L+ L + +S L P + NL L L+
Sbjct: 125 LAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKA 180
Query: 248 NYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLS 307
+ N +S I +L L+ L N +S + + N +L + L T++
Sbjct: 181 DDNKIS-DIS-PLASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTITNQPVFY 236
Query: 308 LGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLN 349
+L + + + P I++ + + L+ N +
Sbjct: 237 NNNLVVPNVVK--GPSGAPIAPATISDNGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 69/313 (22%), Positives = 122/313 (38%), Gaps = 43/313 (13%)
Query: 162 FSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEIL 221
F L N + + G + ++ ++ +L ++ L ++ + L L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGL 68
Query: 222 YLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSIL 281
L N ++ L P + NL + L+L+ N L +
Sbjct: 69 ELKDNQITDLAP--LKNLTKITELELSGNPL--------------------------KNV 100
Query: 282 EEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDL 341
I L+S+ L L ++ PL+ L+NL LY N ++ +I + L +L L
Sbjct: 101 SAIAGLQSIKTLDLTSTQITDVTPLA--GLSNLQVLYLDLNQIT-NISP-LAGLTNLQYL 156
Query: 342 QLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIP 401
+ ++ PLA NL+KL +L NK+S PL+ SL +L ++L N + D P
Sbjct: 157 SIGNAQVSDLTPLA--NLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP 212
Query: 402 KEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQ 461
+ + +L I+ L++ + NL V S I +G ++S
Sbjct: 213 --LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASP-N 269
Query: 462 LILNNNELSGQLS 474
L N +S
Sbjct: 270 LTWNLTSFINNVS 282
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 55/251 (21%), Positives = 103/251 (41%), Gaps = 18/251 (7%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
+ + + ++ L + LS ++ + + L++L GL L N +
Sbjct: 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDNQIT 76
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
+ P L NLT + +++ N L ++ + L+S+ L L++ + P L L+N
Sbjct: 77 -DLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSN 130
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L LYL +N ++ P + L L L + +S P L NL+ L TL N +S
Sbjct: 131 LQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
I + +L +L ++ L N +S + N + L I+ L ++ NL
Sbjct: 187 -DISP-LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTITNQPVFYNNNLVV 242
Query: 242 LLALQLNYNTL 252
++
Sbjct: 243 PNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 53/308 (17%), Positives = 117/308 (37%), Gaps = 44/308 (14%)
Query: 114 SSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTL 173
L N + + + ++ ++ +L ++ L ++ + L NL+ L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG--VQYLNNLIGL 68
Query: 174 YIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIP 233
+ N ++ + + NL +++L L N L + + L ++ L L ++ + P
Sbjct: 69 ELKDNQIT-DLAP-LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 234 NEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHL 293
+ L +L L L+ N ++ + + L +L +L
Sbjct: 125 --LAGLSNLQVLYLDLNQITN--------------------------ISPLAGLTNLQYL 156
Query: 294 QLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIP 353
+ +S PL+ +L+ L TL N +S I + +L +L ++ L N ++ P
Sbjct: 157 SIGNAQVSDLTPLA--NLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP 212
Query: 354 LALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSIL 413
LA N + L + L+ ++ +L + + P I D + +
Sbjct: 213 LA--NTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIA--PATISDNGTYASP 268
Query: 414 DLSSNKLN 421
+L+ N +
Sbjct: 269 NLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 50/241 (20%), Positives = 97/241 (40%), Gaps = 21/241 (8%)
Query: 356 LGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDL 415
L + + + ++ ++ + L +TTL + + + + + +L L+L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLEL 70
Query: 416 SSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSP 475
N++ PL NLT + L LS N + + S+ L L + +++
Sbjct: 71 KDNQITDLAPLK--NLTK-ITELELSGNPLKNVSAIAG--LQSIKTLDLTSTQITDV--T 123
Query: 476 ELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELD 535
L L+ L+ L L N N L L L YL++ N Q S + P+ L L+ L
Sbjct: 124 PLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS-DLT-PLANLSKLTTLK 179
Query: 536 LSY-KIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIP 594
KI +I + S+ +L +++L +N +S +S L + ++ +
Sbjct: 180 ADDNKI--SDISP-LASLPNLIEVHLKNNQIS-DVS-PLANTSNLFIVTLTNQTITNQPV 234
Query: 595 N 595
Sbjct: 235 F 235
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 60/291 (20%), Positives = 108/291 (37%), Gaps = 42/291 (14%)
Query: 695 EIIRATKNFDDEHCIGNGGQGSVYKAELPTGEI----VAVKKFHSPLPGEMACQ-QEFLN 749
I R + +G G G VY+ + VAVK ++F++
Sbjct: 8 GIAREDVVLNRI--LGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMS 62
Query: 750 EGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI 809
E + + H +IVK G +++ E G L L + +
Sbjct: 63 EAVIMKNLDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERN--KNSLKVLTLVLYS 119
Query: 810 KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGT 869
+ A+ Y+ + VHRDI+ +N+L+ + DFG+S++++ + +
Sbjct: 120 LQICKAMAYLESINC---VHRDIAVRNILVASPECVKLGDFGLSRYIE----DEDYYKAS 172
Query: 870 FGYI-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIA 923
+ +PE + T DV+ F V E++ GK P ++ N
Sbjct: 173 VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE----------NKD 222
Query: 924 LDEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ +L+ RLP P L ++M C D P+ RP ++ L
Sbjct: 223 VIGVLEKGDRLPKP-DLCPPVLYTLM---TRCWDYDPSDRPRFTELVCSLS 269
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 56/292 (19%), Positives = 105/292 (35%), Gaps = 58/292 (19%)
Query: 706 EHCIGNGGQGSVYKAEL-------PTGEI-VAVKKFHSPLPGEMACQQEFLNEGNALTKI 757
+G G ++K E V +K + F + ++K+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD---KAHRNYSESFFEAASMMSKL 69
Query: 758 RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL 817
H+++V YG C + +V E+++ GSL L + W + K +A A+
Sbjct: 70 SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV--AKQLAAAMH 127
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEYEAH--------VSDFGISKFLKLGLSNRTELAGT 869
++ N +H ++ +KN+LL E + +SD GIS T L
Sbjct: 128 FLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS---------ITVLPKD 175
Query: 870 FGYI-----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNI 922
PE + + D +SFG E+ G P + +
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD----------SQ 225
Query: 923 ALDEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ + +LP P +L +++ +C+D P RP+ + + + L
Sbjct: 226 RKLQFYEDRHQLPAP---KAAELANLI---NNCMDYEPDHRPSFRAIIRDLN 271
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 59/283 (20%), Positives = 95/283 (33%), Gaps = 40/283 (14%)
Query: 698 RATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTK 756
++F +G+G G V+K G + AVK+ SP G + L E + K
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEK 112
Query: 757 I-RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAA--EEFGWTKRMNAIKGVA 813
+ +H V+ ++ E SL A+ E W ++
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVW----GYLRDTL 167
Query: 814 DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI 873
AL ++H+ +VH D+ N+ L + DFG+ L + + G Y+
Sbjct: 168 LALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYM 223
Query: 874 APEL---AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDP 930
APEL +Y DV+S G+ LEV L P
Sbjct: 224 APELLQGSY----GTAADVFSLGLTILEVACNMEL--------PHGGEGWQQLRQGYLPP 271
Query: 931 RLPTPL-RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
L ++ ++ L+ P R T LL
Sbjct: 272 EFTAGLSSELRS-VLV------MMLEPDPKLRAT---AEALLA 304
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 33/269 (12%), Positives = 68/269 (25%), Gaps = 44/269 (16%)
Query: 706 EHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
G ++A VA+ QE L+ L++I + +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCF 824
VV E++ GSL + + + A++ +A A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG-----AIRAMQSLAAAADAAHRA-- 148
Query: 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVT 884
+ V VS G +
Sbjct: 149 -GVALSIDHPSRVR--------VSIDGDVV------------LAYPATMPD-------AN 180
Query: 885 EKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKL- 943
+ D+ G ++ + P + + S L A + P ++ +
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLP-----EAGVRSGLAPAERDTAGQ--PIEPADIDRDIP 233
Query: 944 ISIMEVSISCLDESPTSRPTMQKVSQLLK 972
I V+ + R ++ + +
Sbjct: 234 FQISAVAARSVQGDGGIRSASTLLNLMQQ 262
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 58/266 (21%), Positives = 104/266 (39%), Gaps = 34/266 (12%)
Query: 709 IGNGGQGSVYKAEL----PTGEI-VAVKKFHSPLPGEMACQ-QEFLNEGNALTKIRHRNI 762
+G+G G+VYK +I VA+K+ +E L+E + + + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPHV 79
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTN 822
+ G C + ++ + + G L + + G +N +A + Y+
Sbjct: 80 CRLLGICLTS-TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 823 CFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF--GYIAPELAYT 880
VHRD++++NVL+ ++DFG++K L G ++A E
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 881 MKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPLR 937
T + DV+S+GV E++ G P D I + +L+ RLP P
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----------ASEISSILEKGERLPQP-P 242
Query: 938 NVQDKLISIMEVSISCLDESPTSRPT 963
+ IM + C SRP
Sbjct: 243 ICTIDVYMIM---VKCWMIDADSRPK 265
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 59/268 (22%), Positives = 108/268 (40%), Gaps = 32/268 (11%)
Query: 706 EHCIGNGGQGSVYKAEL----PTGEI-VAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
+G+G G+V+K + +I V +K G + Q + A+ + H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQS-FQAVTDHMLAIGSLDHA 75
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMH 820
+IV+ G C + +V +YL +GSL + G +N +A + Y+
Sbjct: 76 HIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLE 132
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF--GYIAPELA 878
+ VHR+++++NVLL + V+DFG++ L ++A E
Sbjct: 133 EHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189
Query: 879 YTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTP 935
+ K T + DV+S+GV E++ G P + + ++L+ RL P
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR----------LAEVPDLLEKGERLAQP 239
Query: 936 LRNVQDKLISIMEVSISCLDESPTSRPT 963
+ + +M + C RPT
Sbjct: 240 -QICTIDVYMVM---VKCWMIDENIRPT 263
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 51/316 (16%), Positives = 88/316 (27%), Gaps = 57/316 (18%)
Query: 694 EEIIRATKNFDDEHCIGNGGQGSVYKAE------LPTGEIVAVKKFHSPLPGEMACQQEF 747
E +K H +G G VY+A + +K P E
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF---YIG 114
Query: 748 LNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEE--FGWTKR 805
L +KFY S +V E G+L ++ E
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 806 MNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAH-----------VSDFGISK 854
++ + + +H I+H DI N +L + + D G S
Sbjct: 175 ISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 855 FLKLGLSNR--TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP------- 905
+KL T T G+ E+ + D + ++ G +
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291
Query: 906 -------------RDFISSICSSLSSNLNI-------ALDEMLDPRLPTPLRNVQDKLIS 945
D + + LNI +LD + ++ +K+ +
Sbjct: 292 ECKPEGLFRRLPHLDMWNEFFHVM---LNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRA 348
Query: 946 IMEVSISCLDESPTSR 961
+ I L E SR
Sbjct: 349 LRNRLIVLLLECKRSR 364
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 68/282 (24%), Positives = 115/282 (40%), Gaps = 30/282 (10%)
Query: 702 NFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTK-IRH 759
+ D IG G GSV K P+G+I+AVK+ + Q++ L + + + +
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR--STVDEKEQKQLLMDLDVVMRSSDC 80
Query: 760 RNIVKFYG--FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI--KGVADA 815
IV+FYG F ++ E + S + + + + A
Sbjct: 81 PYIVQFYGALFREGDC--WICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 816 LLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAP 875
L ++ N I+HRDI N+LL+ + DFGIS L ++ + AG Y+AP
Sbjct: 138 LNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAP 194
Query: 876 E----LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPR 931
E A + DV+S G+ E+ G+ P +S+ L+ + + P+
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ---VVKGDP--PQ 249
Query: 932 LP-TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
L + R I+ + CL + + RP +LLK
Sbjct: 250 LSNSEEREFSPSFINFVN---LCLTKDESKRPK---YKELLK 285
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 34/296 (11%), Positives = 71/296 (23%), Gaps = 57/296 (19%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR--------- 758
+G + +A TGE V + ++ E L +R
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 759 -------------HRNIVKFYGFCSHALHSFVVYEYLEM----GSLAM----ILSNDAAA 797
K +V+ + +L +LS+ +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 798 EEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL- 856
+ R+ V L +H +VH + +++L+ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 857 KLGLSNRTELAGTFGYIAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISS 911
+S A + +T D ++ G+ + P
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--NTD- 319
Query: 912 ICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
+ +P P+R L+ L R +
Sbjct: 320 --DAALGGSEWIFRS--CKNIPQPVRA----LLE------GFLRYPKEDRLLPLQA 361
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 61/211 (28%), Positives = 86/211 (40%), Gaps = 13/211 (6%)
Query: 211 SFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISC 270
+ + D L+ +P ++ K L L+ N L + T+L
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 271 LGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPN 330
L L+ L+ G L L L L++N L S+PL +L L L S N L+ S+P
Sbjct: 62 LDRAELTK--LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPL 117
Query: 331 EI-TNLRSLSDLQLSENTLNGSIPL-ALGNLTKLVSLDLSINKLSGSIPLS-FASLTSLT 387
L L +L L N L ++P L KL L L+ N L+ +P L +L
Sbjct: 118 GALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLD 175
Query: 388 TLYLYENSLCDSIPKEIGDMKSLSILDLSSN 418
TL L ENSL +IPK L L N
Sbjct: 176 TLLLQENSL-YTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 56/178 (31%), Positives = 73/178 (41%), Gaps = 11/178 (6%)
Query: 293 LQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSI 352
L L+ N L +L T L L L+ + L L L LS N L S+
Sbjct: 36 LHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SL 92
Query: 353 PLALGNLTKLVSLDLSINKLSGSIPLS-FASLTSLTTLYLYENSLCDSIPKEIGD-MKSL 410
PL L L LD+S N+L+ S+PL L L LYL N L ++P + L
Sbjct: 93 PLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNEL-KTLPPGLLTPTPKL 150
Query: 411 SILDLSSNKLNGSIPLSL-ANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNN 467
L L++N L +P L L N L L L N + IP G L L+ N
Sbjct: 151 EKLSLANNNLT-ELPAGLLNGLEN-LDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 57/232 (24%), Positives = 92/232 (39%), Gaps = 36/232 (15%)
Query: 286 NLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSE 345
+ S L + + L+ ++P L + L+ S N L + L+ L L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 346 NTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIG 405
L + G L L +LDLS N+L S+PL +L +LT L + N L S+P
Sbjct: 65 AELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL-TSLPLGAL 120
Query: 406 D-MKSLSILDLSSNKLNGSIPLSL-ANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLI 463
+ L L L N+L ++P L L+ L L++N++ E+P G +
Sbjct: 121 RGLGELQELYLKGNELK-TLPPGLLTPTPK-LEKLSLANNNLT-ELP--AGLLN------ 169
Query: 464 LNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNN 515
L L+ L L N+ + +IP+ L + L N
Sbjct: 170 ---------------GLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 52/191 (27%), Positives = 81/191 (42%), Gaps = 12/191 (6%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSL 74
++PP++ +L S+N L + + L L+L L + G L L
Sbjct: 24 ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVL 79
Query: 75 IYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSL-GNLTNLVTLYLHMNALS 133
+D+ +N L S+P +L +L+ L +S N L S+P L L LYL N L
Sbjct: 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK 137
Query: 134 GSIPDEI-GNLKFLSDLQVSYNTLSGAIPFSL-GNLTNLVTLYIGINALSGSIPNEIGNL 191
++P + L L ++ N L+ +P L L NL TL + N+L +IP
Sbjct: 138 -TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGS 194
Query: 192 KSLSDLRLDYN 202
L L N
Sbjct: 195 HLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 59/210 (28%), Positives = 77/210 (36%), Gaps = 18/210 (8%)
Query: 333 TNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLY 392
+ + S ++ + L ++P L L LS N L + T LT L L
Sbjct: 7 SKVASHLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 393 ENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLG 452
L + G + L LDLS N+L S+PL L L VL +S N + L
Sbjct: 64 RAEL-TKLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPA-LTVLDVSFNRLTS---LP 116
Query: 453 HGKFSSLIQ---LILNNNELSGQLSPEL-GSLNQLEYLDLSANTFHNSIPESL-GNLVKL 507
G L + L L NEL L P L +LE L L+ N +P L L L
Sbjct: 117 LGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENL 174
Query: 508 HYLNLSNNQFSQKIPNPIEKLIHLSELDLS 537
L L N IP L L
Sbjct: 175 DTLLLQENSL-YTIPKGFFGSHLLPFAFLH 203
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 56/206 (27%), Positives = 83/206 (40%), Gaps = 9/206 (4%)
Query: 70 NLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHM 129
+ S + ++ L+ ++P K + L LS N L ++L T L L L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 130 NALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEI- 188
L+ + G L L L +S+N L ++P L L L + N L+ S+P
Sbjct: 65 AELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGAL 120
Query: 189 GNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLN 248
L L +L L N L KLE L L N L+ L + L++L L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 249 YNTLSGSIPCSFGNLTKLVISCLGTN 274
N+L +IP F L + L N
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 43/131 (32%), Positives = 59/131 (45%), Gaps = 6/131 (4%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L L LS NQ S+P L L +L S N+L+ L + L L L L N LK
Sbjct: 79 LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK 137
Query: 62 GSIPPSL-GNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSSLGNL 119
++PP L L + + NN L+ +P + L++L L L NSL +IP
Sbjct: 138 -TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGS 194
Query: 120 TNLVTLYLHMN 130
L +LH N
Sbjct: 195 HLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 51/205 (24%), Positives = 83/205 (40%), Gaps = 13/205 (6%)
Query: 409 SLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNE 468
S ++ L ++P +L +L+LS N + ++ L QL L+ E
Sbjct: 11 SHLEVNCDKRNL-TALP---PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 469 LSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPI-EK 527
L G+L L LDLS N S+P L L L++S N+ +P
Sbjct: 67 L--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL-TSLPLGALRG 122
Query: 528 LIHLSELDLSY-KIFGEEIPSQVC-SMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDIS 585
L L EL L ++ + +P + LEKL+L++NNL+ + + L + +
Sbjct: 123 LGELQELYLKGNEL--KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 586 YNALQGLIPNSTAFRDAPMLALQGN 610
N+L + P L GN
Sbjct: 181 ENSLYTIPKGFFGSHLLPFAFLHGN 205
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 60/283 (21%), Positives = 112/283 (39%), Gaps = 39/283 (13%)
Query: 703 FDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTK-IRHR 760
++ +G+G G V+K TG ++AVK+ G + L + + + K
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR--RSGNKEENKRILMDLDVVLKSHDCP 84
Query: 761 NIVKFYG--FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI-KGVADALL 817
IV+ +G + + F+ E + + + E + + + + AL
Sbjct: 85 YIVQCFGTFITNTDV--FIAMELMGTCAEKLKKRMQGPIPE----RILGKMTVAIVKALY 138
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL 877
Y+ ++HRD+ N+LL+ + + DFGIS L + + AG Y+APE
Sbjct: 139 YLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA-KDRSAGCAAYMAPER 195
Query: 878 AYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932
T+ + DV+S G+ +E+ G+ P + L+ + +E P L
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK---VLQEEP--PLL 250
Query: 933 PTPLR---NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
P + + Q + CL + RP +LL+
Sbjct: 251 PGHMGFSGDFQS-FVK------DCLTKDHRKRPKYN---KLLE 283
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 65/271 (23%), Positives = 108/271 (39%), Gaps = 40/271 (14%)
Query: 706 EHCIGNGGQGSVYKAELPTGE----IVAVKKFHSPLPGEMACQ-QEFLNEGNALTKIRHR 760
CIG G G V++ + E VA+K ++FL E + + H
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHP 76
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMH 820
+IVK G + +++ E +G L L + ++ AL Y+
Sbjct: 77 HIVKLIGVITEN-PVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLE 133
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI-----AP 875
+ F VHRDI+++NVL++ + DFG+S++++ + T + G + AP
Sbjct: 134 SKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME----DSTYYKASKGKLPIKWMAP 186
Query: 876 ELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RL 932
E + T DV+ FGV E++ G P + N + ++ RL
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK----------NNDVIGRIENGERL 236
Query: 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPT 963
P P N L S+M C P+ RP
Sbjct: 237 PMP-PNCPPTLYSLM---TKCWAYDPSRRPR 263
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 53/296 (17%), Positives = 112/296 (37%), Gaps = 49/296 (16%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G +V++ TG++ A+K F++ + E L K+ H+NIVK +
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFA 74
Query: 768 F--CSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFP 825
+ H ++ E+ GSL +L + A ++ + ++ V + ++ N
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 826 PIVHRDISSKNVLLNLEYEAH----VSDFGISKFLKLGLSNRTELAGTFGYIAPEL---- 877
IVHR+I N++ + + ++DFG ++ L+ L GT Y+ P++
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERA 190
Query: 878 ----AYTMKVTEKCDVYSFGVLA----------------------LEVIKGKHPRDFISS 911
+ K D++S GV + I P IS
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 912 ICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
+ + + ++ + D + L L+ + +++ + L+ +
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI------LEADQEKCWGFDQF 300
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 67/286 (23%), Positives = 110/286 (38%), Gaps = 45/286 (15%)
Query: 709 IGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
+G+G G VY+ ++ P+ VAVK + + +FL E ++K H+NI
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD--ELDFLMEALIISKFNHQNI 95
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSLAMIL----SNDAAAEEFGWTKRMNAIKGVADALLY 818
V+ G +L F++ E + G L L + ++ + +A Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHV---SDFGISKFLKLGLSNRTELAGTFGYI-- 873
+ N F +HRDI+++N LL V DFG+++ + G +
Sbjct: 156 LEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY---RASYYRKGGCAMLPV 209
Query: 874 ---APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEML 928
PE T K D +SFGVL E+ G P S S N + E +
Sbjct: 210 KWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP-------YPSKS---NQEVLEFV 258
Query: 929 DP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
R+ P +N + IM C P RP + + ++
Sbjct: 259 TSGGRMDPP-KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIE 300
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 4e-24
Identities = 60/261 (22%), Positives = 105/261 (40%), Gaps = 23/261 (8%)
Query: 308 LGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDL 367
+ +++ ++ L S+ + + + + S+ + L + L L
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFL 72
Query: 368 SINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLS 427
+ NKL+ PL+ +L +L L+L EN + D + D+K L L L N ++ I
Sbjct: 73 NGNKLTDIKPLT--NLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-DIN-G 126
Query: 428 LANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLD 487
L +L L+ LYL +N I L + L L L +N++S + P L L +L+ L
Sbjct: 127 LVHLPQ-LESLYLGNNKITDITVLSR--LTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLY 181
Query: 488 LSANTFHNSIP--ESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEI 545
LS N I +L L L L L + + K N L+ + + +
Sbjct: 182 LS----KNHISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT-- 235
Query: 546 PSQVCSMQSLEKLNLSHNNLS 566
P + EK N+ +
Sbjct: 236 PEIISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-24
Identities = 57/262 (21%), Positives = 99/262 (37%), Gaps = 25/262 (9%)
Query: 338 LSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLC 397
+ + + P + + +L ++ ++ + L S+ + + +
Sbjct: 1 MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 56
Query: 398 DSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFS 457
+ I + +++ L L+ NKL I L NL N L L+L N I L
Sbjct: 57 SV--QGIQYLPNVTKLFLNGNKLT-DIK-PLTNLKN-LGWLFLDENKIKDLSSLKD--LK 109
Query: 458 SLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSI--PESLGNLVKLHYLNLSNN 515
L L L +N +S ++ L L QLE L L +N I L L KL L+L +N
Sbjct: 110 KLKSLSLEHNGIS-DING-LVHLPQLESLYLG----NNKITDITVLSRLTKLDTLSLEDN 163
Query: 516 QFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFE 574
Q S I P+ L L L LS I ++ + +++L+ L L
Sbjct: 164 QIS-DIV-PLAGLTKLQNLYLSKNHI--SDL-RALAGLKNLDVLELFSQECLNKPINHQS 218
Query: 575 EMHWLSCIDISYNALQGLIPNS 596
+ + + + +L S
Sbjct: 219 NLVVPNTVKNTDGSLVTPEIIS 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 104 bits (259), Expect = 5e-23
Identities = 54/237 (22%), Positives = 96/237 (40%), Gaps = 16/237 (6%)
Query: 23 LTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNN 82
+ K ++ + L+S++ + ++ +K S+ + L ++ + + N
Sbjct: 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGN 75
Query: 83 LLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGN 142
L+ I + +LK+L L L N + + SSL +L L +L L N +S I + +
Sbjct: 76 KLT-DIKP-LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVH 129
Query: 143 LKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYN 202
L L L + N ++ S LT L TL + N +S I + L L +L L N
Sbjct: 130 LPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKN 185
Query: 203 TLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCS 259
+S L + L L++L L N NL ++ +L S
Sbjct: 186 HIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 95.9 bits (238), Expect = 2e-20
Identities = 54/259 (20%), Positives = 99/259 (38%), Gaps = 18/259 (6%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L + ++ L + + + + + + I L ++ L L N L
Sbjct: 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLT 78
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
I P L NL +L ++ + N + + + + LK L L L +N ++ I + L +L
Sbjct: 79 -DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQ 132
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L +LYL N + + + L L L + N +S +P + LT L LY+ N +S
Sbjct: 133 LESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSKNHIS 188
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
+ + LK+L L L + NL + +L P I +
Sbjct: 189 -DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGD 244
Query: 242 LLALQLNYNTLSGSIPCSF 260
+ ++ + SF
Sbjct: 245 YEKPNVKWHLPEFTNEVSF 263
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 93.6 bits (232), Expect = 1e-19
Identities = 57/327 (17%), Positives = 114/327 (34%), Gaps = 18/327 (5%)
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
+ + PD+ + +++ A+ L ++ + + +
Sbjct: 1 MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
S+ I L +++ L L+ N L+ + NL L L+LD N + L + +LK
Sbjct: 57 -SVQG-IQYLPNVTKLFLNGNKLTD--IKPLTNLKNLGWLFLDENKIKDLSS--LKDLKK 110
Query: 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLS 301
L +L L +N +S I +L +L LG N ++ + + L L L L N +S
Sbjct: 111 LKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS 166
Query: 302 GSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTK 361
I L LT L LY S N +S + + L++L L+L NL
Sbjct: 167 -DIV-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVV 222
Query: 362 LVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
++ + L +S + + + + ++ +
Sbjct: 223 PNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRV 282
Query: 422 GSIPLSLANLTNSLKVLYLSSNHIVGE 448
+ ++ + + + G
Sbjct: 283 TQPLKEVYTVSYDVDGTVIKTKVEAGT 309
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 89.4 bits (221), Expect = 2e-18
Identities = 52/266 (19%), Positives = 100/266 (37%), Gaps = 14/266 (5%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
+ + + + S+ I +L ++ L + N+L+ + P + L +L L L N +K
Sbjct: 45 IDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK 100
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
+ L +L L + + +N +S I + L L L L NN + + + L LT
Sbjct: 101 -DLSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKI--TDITVLSRLTK 154
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L TL L N +S I + L L +L +S N +S L L NL L +
Sbjct: 155 LDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECL 210
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
N NL + ++ +L + S + + + + + +
Sbjct: 211 NKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVT 270
Query: 242 LLALQLNYNTLSGSIPCSFGNLTKLV 267
+ + ++ ++ V
Sbjct: 271 IGKAKARFHGRVTQPLKEVYTVSYDV 296
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 5e-24
Identities = 58/301 (19%), Positives = 97/301 (32%), Gaps = 23/301 (7%)
Query: 214 NLTKLEILYLDVNALSGLIPNEI-GNLKSLLALQLNYNTLSGSIPCS----FGNLTKLVI 268
N + + + G E+ G +SL L +T + + +L +L +
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75
Query: 269 SCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSI 328
+ + + L L L ++G+ P L T + +S +
Sbjct: 76 RAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135
Query: 329 PNEITN------LRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFA- 381
+ L L +++ + L +LDLS N G L A
Sbjct: 136 RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195
Query: 382 ---SLTSLTTLYLYEN---SLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSL 435
+L L L + L LDLS N L + + + L
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255
Query: 436 KVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHN 495
L LS + ++P G + L L L+ N L +P L Q+ L L N F +
Sbjct: 256 NSLNLSFTGLK-QVP--KGLPAKLSVLDLSYNRLDR--NPSPDELPQVGNLSLKGNPFLD 310
Query: 496 S 496
S
Sbjct: 311 S 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 67/281 (23%), Positives = 103/281 (36%), Gaps = 25/281 (8%)
Query: 306 LSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIP---LALGNLTKL 362
L G + L +I SL L + + I L + ++ L
Sbjct: 38 LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGL 97
Query: 363 VSLDLSINKLSGSIPLSFASLT--SLTTLYLYENSLC--DSIPKEIGD--MKSLSILDLS 416
L L +++G+ P T L L L S D+ E+ L +L ++
Sbjct: 98 QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIA 157
Query: 417 SNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGH----GKFSSLIQLILNNNE---L 469
+ + +L L LS N +GE L KF +L L L N
Sbjct: 158 QAHSL-NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216
Query: 470 SGQLSPELGSLNQLEYLDLSANTFHNSIPESL-GNLVKLHYLNLSNNQFSQKIPNPIEKL 528
SG S + QL+ LDLS N+ ++ +L+ LNLS Q +P +
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPA- 274
Query: 529 IHLSELDLSY-KIFGEEIPSQVCSMQSLEKLNLSHNNLSGS 568
LS LDLSY ++ + PS + + L+L N S
Sbjct: 275 -KLSVLDLSYNRL--DRNPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 52/293 (17%), Positives = 90/293 (30%), Gaps = 32/293 (10%)
Query: 21 GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPS---LGNLTSLIYI 77
G + LL + +I + SL L++ + + I + ++ L +
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 78 DIGNNLLSGSIPNEVGSL--KSLSDLRLSNNSLNG--SIPSSLGNL--TNLVTLYLHMNA 131
+ N ++G+ P + L+ L L N S + + L L L +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 132 LSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNL 191
+++ LS L +S N G S P + L
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLI-----------------SALCPLKFPTL 203
Query: 192 KSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEI-GNLKSLLALQLNYN 250
+ L+ T SG +L+ L L N+L L +L L++
Sbjct: 204 QVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFT 263
Query: 251 TLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGS 303
L L+ L +S N L L + +L L N S
Sbjct: 264 GLKQVPKGLPAKLSVLDLSY---NRLDR--NPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 42/220 (19%), Positives = 68/220 (30%), Gaps = 19/220 (8%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEI------GRLSSLNGLSL 55
L+ L L + +G+ PP + T L + +S L LS+
Sbjct: 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI 156
Query: 56 YSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNE----VGSLKSLSDLRLSNN---SL 108
+ +L +D+ +N G +L L L N +
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216
Query: 109 NGSIPSSLGNLTNLVTLYLHMNALSGSIPDEI-GNLKFLSDLQVSYNTLSGAIPFSLGNL 167
+G + L L L N+L + L+ L +S+ L +P L
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--P 273
Query: 168 TNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGS 207
L L + N L P L + +L L N S
Sbjct: 274 AKLSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 49/243 (20%), Positives = 75/243 (30%), Gaps = 19/243 (7%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRL--SSLNGLSLYSNF 59
L V + ++ L+ L+ +++G P + LN L+L +
Sbjct: 73 LTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVS 132
Query: 60 LKG--SIPPSLGNL--TSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSI--- 112
+ L L + I +V +LS L LS+N G
Sbjct: 133 WATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192
Query: 113 ----PSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSL-GNL 167
P L L M SG L L +S+N+L A
Sbjct: 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252
Query: 168 TNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNA 227
+ L +L + L +P + LS L L YN L S L ++ L L N
Sbjct: 253 SQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDR--NPSPDELPQVGNLSLKGNP 307
Query: 228 LSG 230
Sbjct: 308 FLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 42/227 (18%), Positives = 75/227 (33%), Gaps = 26/227 (11%)
Query: 380 FASLTSLTTLYLYENSLCDSIP-KEIGDMKSLSILDLSSNKLNGSIPLSLANLTN--SLK 436
+ SL L ++ D +I SL L + + ++ I + L+
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 437 VLYLSSNHIVGEIP--LGHGKFSSLIQLILNNNELSGQLS--PELGSLNQ--LEYLDLSA 490
L L + + G P L L L L N + + + EL + L+ L ++
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 491 NTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVC 550
N E + L L+LS+N + + P +
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERG-----------------LISALCPLKFP 201
Query: 551 SMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNST 597
++Q L N SG S L +D+S+N+L+ +
Sbjct: 202 TLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 73/291 (25%), Positives = 118/291 (40%), Gaps = 51/291 (17%)
Query: 709 IGNGGQGSVYKAELPTGE------IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
+G G G V+ AE +VAVK + +Q+F E LT ++H++I
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK---EASESARQDFQREAELLTMLQHQHI 105
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSLAMIL---SNDAAAEEFGWTKRMNAIK--------- 810
V+F+G C+ +V+EY+ G L L DA G +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 811 GVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF 870
VA ++Y+ F VHRD++++N L+ + DFG+S+ + S G
Sbjct: 166 QVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDI---YSTDYYRVGGR 219
Query: 871 GYI-----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIA 923
+ PE + Y K T + DV+SFGV+ E+ GK P +S N
Sbjct: 220 TMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLS----------NTE 268
Query: 924 LDEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ + L P R ++ +IM C P R +++ V L+
Sbjct: 269 AIDCITQGRELERP-RACPPEVYAIMR---GCWQREPQQRHSIKDVHARLQ 315
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 57/289 (19%), Positives = 113/289 (39%), Gaps = 41/289 (14%)
Query: 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFH-SPLPGEMACQQEFLNEGNALTKIRH 759
+ + IG+GG V++ +I A+K + + + NE L K++
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT--LDSYRNEIAYLNKLQQ 85
Query: 760 RN--IVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL 817
+ I++ Y + + ++V E L L + +R + K + +A+
Sbjct: 86 HSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK---KSIDPWERKSYWKNMLEAVH 141
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN--RTELAGTFGYIAP 875
+H + IVH D+ N L+ + + DFGI+ ++ ++ + GT Y+ P
Sbjct: 142 TIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 876 EL-----------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIAL 924
E K++ K DV+S G + + GK P F + + ++ L
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--F-----QQIINQIS-KL 249
Query: 925 DEMLDPRLPTPL-RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
++DP + L +++ CL P R + + +LL
Sbjct: 250 HAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRIS---IPELLA 292
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-24
Identities = 67/286 (23%), Positives = 110/286 (38%), Gaps = 45/286 (15%)
Query: 709 IGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
+G+G G VY+ ++ P+ VAVK + + +FL E ++K H+NI
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD--ELDFLMEALIISKFNHQNI 136
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSLAMIL----SNDAAAEEFGWTKRMNAIKGVADALLY 818
V+ G +L F++ E + G L L + ++ + +A Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHV---SDFGISKFLKLGLSNRTELAGTFGYI-- 873
+ N F +HRDI+++N LL V DFG+++ + G +
Sbjct: 197 LEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY---RAGYYRKGGCAMLPV 250
Query: 874 ---APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEML 928
PE T K D +SFGVL E+ G P S S N + E +
Sbjct: 251 KWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP-------YPSKS---NQEVLEFV 299
Query: 929 DP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
R+ P +N + IM C P RP + + ++
Sbjct: 300 TSGGRMDPP-KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIE 341
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 68/293 (23%), Positives = 112/293 (38%), Gaps = 35/293 (11%)
Query: 693 HEEIIRATKNFDDEHCIGNGGQGSVYKAELPTGE----IVAVKKFHSPLPGEMACQQEFL 748
H I ++ IG G G VY L + AVK + +FL
Sbjct: 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--VSQFL 74
Query: 749 NEGNALTKIRHRNIVKFYGFCSHALHS-FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMN 807
EG + H N++ G C + S VV Y++ G L + N+ +
Sbjct: 75 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIG 132
Query: 808 AIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA 867
VA + Y+ + F VHRD++++N +L+ ++ V+DFG+++ +
Sbjct: 133 FGLQVAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVH-N 188
Query: 868 GTFGYI-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLN 921
T + A E T K T K DV+SFGVL E++ +G P ++
Sbjct: 189 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----------T 238
Query: 922 IALDEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ L RL P D L +M + C RP+ ++ +
Sbjct: 239 FDITVYLLQGRRLLQP-EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 287
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 73/294 (24%), Positives = 120/294 (40%), Gaps = 56/294 (19%)
Query: 709 IGNGGQGSVYKAELPTGE------IVAVK--KFHSPLPGEMACQQEFLNEGNALTKIRHR 760
+G G G V+ AE +VAVK K +A +++F E LT ++H
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-----DPTLAARKDFQREAELLTNLQHE 77
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKG--------- 811
+IVKFYG C +V+EY++ G L L + KG
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 812 ----VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA 867
+A ++Y+ + F VHRD++++N L+ + DFG+S+ + S
Sbjct: 138 IASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDV---YSTDYYRV 191
Query: 868 GTFGYI-----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNL 920
G + PE + Y K T + DV+SFGV+ E+ GK P +S
Sbjct: 192 GGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLS---------- 240
Query: 921 NIALDEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
N + E + L P R ++ +M C P R ++++ ++L
Sbjct: 241 NTEVIECITQGRVLERP-RVCPKEVYDVML---GCWQREPQQRLNIKEIYKILH 290
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 53/296 (17%), Positives = 112/296 (37%), Gaps = 49/296 (16%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G +V++ TG++ A+K F++ + E L K+ H+NIVK +
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFA 74
Query: 768 F--CSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFP 825
+ H ++ E+ GSL +L + A ++ + ++ V + ++ N
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 826 PIVHRDISSKNVLLNLEYEAH----VSDFGISKFLKLGLSNRTELAGTFGYIAPEL---- 877
IVHR+I N++ + + ++DFG ++ L+ L GT Y+ P++
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERA 190
Query: 878 ----AYTMKVTEKCDVYSFGVLA----------------------LEVIKGKHPRDFISS 911
+ K D++S GV + I P IS
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 912 ICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
+ + + ++ + D + L L+ + +++ + L+ +
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI------LEADQEKCWGFDQF 300
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 64/282 (22%), Positives = 114/282 (40%), Gaps = 44/282 (15%)
Query: 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
+ + +G GG ++ + T E+ A K L + +++ E + + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLA-MI-----LSNDAAAEEFGWTKRMNAIKGVA 813
+++V F+GF FVV E SL + L+ A + +
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYL---------RQIV 125
Query: 814 DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI 873
Y+H N ++HRD+ N+ LN + E + DFG++ ++ + L GT YI
Sbjct: 126 LGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI 182
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNL-----NIALDEML 928
APE+ + + DV+S G + ++ GK P + +S L I +E
Sbjct: 183 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE---------TSCLKETYLRIKKNEYS 233
Query: 929 DPR-LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969
P+ + + LI M L PT+RPT+ ++
Sbjct: 234 IPKHINPVAAS----LIQKM------LQTDPTARPTINELLN 265
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 67/293 (22%), Positives = 113/293 (38%), Gaps = 35/293 (11%)
Query: 693 HEEIIRATKNFDDEHCIGNGGQGSVYKAELPTGE----IVAVKKFHSPLPGEMACQQEFL 748
H I ++ IG G G VY L + AVK + +FL
Sbjct: 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--VSQFL 138
Query: 749 NEGNALTKIRHRNIVKFYGFCSHALHS-FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMN 807
EG + H N++ G C + S VV Y++ G L + N+ +
Sbjct: 139 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIG 196
Query: 808 AIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA 867
VA + ++ + F VHRD++++N +L+ ++ V+DFG+++ + +
Sbjct: 197 FGLQVAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH-N 252
Query: 868 GTFGYI-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLN 921
T + A E T K T K DV+SFGVL E++ +G P ++
Sbjct: 253 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----------T 302
Query: 922 IALDEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ L RL P D L +M + C RP+ ++ +
Sbjct: 303 FDITVYLLQGRRLLQP-EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 351
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 2e-23
Identities = 67/299 (22%), Positives = 108/299 (36%), Gaps = 39/299 (13%)
Query: 698 RATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTK 756
+ ++ + +G GG G V + TGE VA+K+ L + ++ + E + K
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKK 68
Query: 757 IRHRNIVKFY------GFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIK 810
+ H N+V + + EY E G L L+ +
Sbjct: 69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 811 GVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAH---VSDFGISKFLKLGLSNRTELA 867
++ AL Y+H N I+HRD+ +N++L + + D G +K L G TE
Sbjct: 129 DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV 184
Query: 868 GTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-----------------RDFIS 910
GT Y+APEL K T D +SFG LA E I G P +
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244
Query: 911 SICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969
+ L+ + + L L ++ + M L R T +
Sbjct: 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM------LMWHQRQRGTDPQNPN 297
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 65/289 (22%), Positives = 117/289 (40%), Gaps = 50/289 (17%)
Query: 703 FDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTK-IRHR 760
+ +G G G V K +P+G+I+AVK+ Q+ L + + + +
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR--ATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 761 NIVKFYG--FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMN-----AI-KGV 812
V FYG F + + E ++ SL + + + I +
Sbjct: 67 FTVTFYGALFREGDVW--ICMELMD-TSLDKFY-----KQVIDKGQTIPEDILGKIAVSI 118
Query: 813 ADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGY 872
AL ++H+ ++HRD+ NVL+N + + DFGIS +L ++ + AG Y
Sbjct: 119 VKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID-AGCKPY 175
Query: 873 IAPE--------LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIAL 924
+APE Y++ K D++S G+ +E+ + P D + L +
Sbjct: 176 MAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ---VVE 228
Query: 925 DEMLDPRLPTPLRNVQDKLISIMEVSIS-CLDESPTSRPTMQKVSQLLK 972
+ P+LP DK + S CL ++ RPT +L++
Sbjct: 229 EP--SPQLP------ADKFSAEFVDFTSQCLKKNSKERPT---YPELMQ 266
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 60/290 (20%), Positives = 102/290 (35%), Gaps = 43/290 (14%)
Query: 706 EHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIV 763
+ GG VY+A+ + +G A+K+ S E + + E + K+ H NIV
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 764 KFYGFCSHALHS-------FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADAL 816
+F S F++ L G L L + + A+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 817 LYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA--------- 867
+MH PPI+HRD+ +N+LL+ + + DFG + +
Sbjct: 150 QHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 868 ---GTFGYIAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLN 921
T Y PE+ + EK D+++ G + + +HP + + L
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE--------DGAKLR 260
Query: 922 IALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
I + P T LI M L +P R ++ +V L
Sbjct: 261 IVNGKYSIPPHDTQYTVFHS-LIRAM------LQVNPEERLSIAEVVHQL 303
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 64/277 (23%), Positives = 114/277 (41%), Gaps = 34/277 (12%)
Query: 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
+ + +G GG ++ + T E+ A K L + +++ E + + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLA-MILSNDAAAEEFGWTKRMNAIKGVADALLY 818
+++V F+GF FVV E SL + A E ++ + Y
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY----LRQIVLGCQY 156
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELA 878
+H N ++HRD+ N+ LN + E + DFG++ ++ + L GT YIAPE+
Sbjct: 157 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL 213
Query: 879 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNL-----NIALDEMLDPR-L 932
+ + DV+S G + ++ GK P + +S L I +E P+ +
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPPFE---------TSCLKETYLRIKKNEYSIPKHI 264
Query: 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969
+ LI M L PT+RPT+ ++
Sbjct: 265 NPVAAS----LIQKM------LQTDPTARPTINELLN 291
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 57/285 (20%), Positives = 110/285 (38%), Gaps = 47/285 (16%)
Query: 708 CIGNGGQGSVYKAELPTGEIVAVK--KFHSPLPGEMACQQEFLNEGNALTKIRH--RNIV 763
IG+GG V++ +I A+K + + NE L K++ I+
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKII 72
Query: 764 KFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC 823
+ Y + + ++V E L L + + +R + K + +A+ +H +
Sbjct: 73 RLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQHG 128
Query: 824 FPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSN--RTELAGTFGYIAPEL-- 877
IVH D+ N L+ + + DFGI+ ++ ++ + GT Y+ PE
Sbjct: 129 ---IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 878 ---------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML 928
K++ K DV+S G + + GK P F + + ++ L ++
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--F-----QQIINQIS-KLHAII 234
Query: 929 DPRLPTPL-RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
DP + L +++ CL P R ++ +LL
Sbjct: 235 DPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIP---ELLA 273
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 62/221 (28%), Positives = 93/221 (42%), Gaps = 16/221 (7%)
Query: 183 SIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSL 242
IP+ + S +L L +N L YSF + +L++L L + + +L L
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 243 LALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEE--IGNLKSLLHLQLNYNTL 300
L L N + +F L+ L L+S LE IG+LK+L L + +N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS--LENFPIGHLKTLKELNVAHNLI 136
Query: 301 SGSIPLS--LGSLTNLATLYFSTNALSGSIPNEI----TNLRSLS-DLQLSENTLNGSIP 353
S L +LTNL L S+N + SI + L+ L LS N +N I
Sbjct: 137 Q-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQ 193
Query: 354 LALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYEN 394
+L L L N+L F LTSL ++L+ N
Sbjct: 194 PGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 56/235 (23%), Positives = 83/235 (35%), Gaps = 37/235 (15%)
Query: 289 SLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEI-TNLRSLSDLQLSENT 347
S +L L++N L S S L L S + +I + +L LS L L+ N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 348 LNGSIPL-ALGNLTKLVSLDLSINKLSGSIP-LSFASLTSLTTLYLYENSLCDSIPKEI- 404
+ S+ L A L+ L L L+ S+ L +L L + N + E
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145
Query: 405 GDMKSLSILDLSSNKLNGSIPL----SLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLI 460
++ +L LDLSSNK+ SI L + L LS N + I G F +
Sbjct: 146 SNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQ--PGAFKEI- 200
Query: 461 QLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNN 515
+L+ L L N + L L + L N
Sbjct: 201 ---------------------RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 56/244 (22%), Positives = 86/244 (35%), Gaps = 38/244 (15%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSL-GNLTS 73
IP + K L S N L L + L L L ++ +I +L+
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 74 LIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSSL-GNLTNLVTLYLHMNA 131
L + + N + S+ L SL L +L S+ + G+L L L + N
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNL 135
Query: 132 LSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEI--- 188
+ S L FS NLTNL L + N + SI
Sbjct: 136 IQ-SFK------------------LPEY--FS--NLTNLEHLDLSSNKIQ-SIYCTDLRV 171
Query: 189 -GNLKSLS-DLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQ 246
+ L+ L L N ++ +F + +L+ L LD N L + L SL +
Sbjct: 172 LHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGIFDRLTSLQKIW 230
Query: 247 LNYN 250
L+ N
Sbjct: 231 LHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 62/264 (23%), Positives = 93/264 (35%), Gaps = 53/264 (20%)
Query: 327 SIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLS-FASLTS 385
IP+ + S +L LS N L + + +L LDLS ++ +I + SL+
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 386 LTTLYLYENSLCDSIPKEI-GDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 444
L+TL L N + S+ + SL L L S+ +LK L ++ N
Sbjct: 78 LSTLILTGNPI-QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNL 135
Query: 445 IVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNL 504
I L FS+L L E+LDLS+N + L L
Sbjct: 136 IQ-SFKL-PEYFSNLTNL---------------------EHLDLSSNKIQSIYCTDLRVL 172
Query: 505 VKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQVCSMQSLEKLNLSHN 563
++ LNL LDLS + I L++L L N
Sbjct: 173 HQMPLLNL--------------------SLDLSLNPM--NFIQPGAFKEIRLKELALDTN 210
Query: 564 NLSGSISRCFEEMHWLSCIDISYN 587
L F+ + L I + N
Sbjct: 211 QLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 53/209 (25%), Positives = 78/209 (37%), Gaps = 36/209 (17%)
Query: 2 LKVLGLSFNQFSGSIPPEI-GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
L+VL LS + +I L+HL L + N + L LSSL L L
Sbjct: 54 LQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112
Query: 61 KGSIPPSL-GNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNL 119
S+ G+L +L +++ +NL+ S +P NL
Sbjct: 113 A-SLENFPIGHLKTLKELNVAHNLIQ-SFK----------------------LPEYFSNL 148
Query: 120 TNLVTLYLHMNALSGSIPDEI----GNLKFLS-DLQVSYNTLSGAIPFSLGNLTNLVTLY 174
TNL L L N + SI + L+ L +S N ++ I L L
Sbjct: 149 TNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELA 206
Query: 175 IGINALSGSIPNEI-GNLKSLSDLRLDYN 202
+ N L S+P+ I L SL + L N
Sbjct: 207 LDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 6e-07
Identities = 32/142 (22%), Positives = 56/142 (39%), Gaps = 9/142 (6%)
Query: 456 FSSLIQLILNNNELSGQLSPE-LGSLNQLEYLDLSANTFHNSIPESL-GNLVKLHYLNLS 513
S L L+ N L L S +L+ LDLS +I + +L L L L+
Sbjct: 27 PFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILT 84
Query: 514 NNQFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQV-CSMQSLEKLNLSHNNLSGSIS- 570
N L L +L + + + +++L++LN++HN +
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNL--ASLENFPIGHLKTLKELNVAHNLIQSFKLP 142
Query: 571 RCFEEMHWLSCIDISYNALQGL 592
F + L +D+S N +Q +
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSI 164
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 5e-23
Identities = 55/197 (27%), Positives = 86/197 (43%), Gaps = 29/197 (14%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G+G V+ + TG++ A+K NE L KI+H NIV
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLED 73
Query: 768 FCSHALHSFVVYEYLEMGSL-AMILS------NDAAAEEFGWTKRMNAIKGVADALLYMH 820
H ++V + + G L IL DA+ I+ V A+ Y+H
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS----------LVIQQVLSAVKYLH 123
Query: 821 TNCFPPIVHRDISSKNVLL-NLEYEAHV--SDFGISKFLKLGLSNRTELAGTFGYIAPEL 877
N IVHRD+ +N+L E + + +DFG+SK + G+ + GT GY+APE+
Sbjct: 124 ENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAPEV 178
Query: 878 AYTMKVTEKCDVYSFGV 894
++ D +S GV
Sbjct: 179 LAQKPYSKAVDCWSIGV 195
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 65/291 (22%), Positives = 107/291 (36%), Gaps = 35/291 (12%)
Query: 695 EIIRATKNFDDEHCIGNGGQGSVYKAELPTGE----IVAVKKFHSPLPGEMACQQEFLNE 750
I + IG G G VY E A+K + + FL E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS-RITEMQQ-VEAFLRE 72
Query: 751 GNALTKIRHRNIVKFYGFCSHAL-HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI 809
G + + H N++ G V+ Y+ G L + + ++
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFG 130
Query: 810 KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGT 869
VA + Y+ F VHRD++++N +L+ + V+DFG+++ + +
Sbjct: 131 LQVARGMEYLAEQKF---VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ-QHR 186
Query: 870 FGYI-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIA 923
+ A E T + T K DV+SFGVL E++ +G P I
Sbjct: 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID----------PFD 236
Query: 924 LDEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
L L RLP P D L +M+ C + P RPT + + ++
Sbjct: 237 LTHFLAQGRRLPQP-EYCPDSLYQVMQ---QCWEADPAVRPTFRVLVGEVE 283
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-23
Identities = 67/289 (23%), Positives = 111/289 (38%), Gaps = 47/289 (16%)
Query: 706 EHCIGNGGQGSVYKAELPTGE----IVAVKKFHSPLPGEMACQQE---FLNEGNALTKIR 758
+G G GSV + L + VAVK + + + Q+E FL+E +
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKT----MKLDNSSQREIEEFLSEAACMKDFS 94
Query: 759 HRNIVKFYGFCS-----HALHSFVVYEYLEMGSLAMIL-SNDAAAEEFGWTKR--MNAIK 810
H N+++ G C V+ +++ G L L + + + +
Sbjct: 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 811 GVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF 870
+A + Y+ F +HRD++++N +L + V+DFG+SK + S G
Sbjct: 155 DIALGMEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKI---YSGDYYRQGRI 208
Query: 871 GYI-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIAL 924
+ A E T K DV++FGV E+ +G P + N +
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ----------NHEM 258
Query: 925 DEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
+ L RL P + D+L IM SC P RPT + L
Sbjct: 259 YDYLLHGHRLKQP-EDCLDELYEIMY---SCWRTDPLDRPTFSVLRLQL 303
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 47/218 (21%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 690 KIVHEEIIRATKNFDD----EHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQ 744
K V + + + D +G+G G V++ E TG + K ++P P + +
Sbjct: 36 KYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---K 92
Query: 745 QEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL-AMILSNDAAAEEFGWT 803
NE + + ++ H ++ + ++ E+L G L I AE++ +
Sbjct: 93 YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA-----AEDYKMS 147
Query: 804 KR--MNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLG 859
+ +N ++ + L +MH + IVH DI +N++ + + V DFG++ L
Sbjct: 148 EAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204
Query: 860 LSNRTELAGTFGYIAPE-LAYTMKVTEKCDVYSFGVLA 896
T + APE + V D+++ GVL
Sbjct: 205 -EIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLG 240
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 36/186 (19%), Positives = 76/186 (40%), Gaps = 11/186 (5%)
Query: 286 NLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSE 345
K+ L+ L ++ + ++ + +L + + ++ + I ++ DL ++
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINN 75
Query: 346 NTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIG 405
P++ L+ L L + ++ + + LTSLT L + ++ DSI +I
Sbjct: 76 IHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 406 DMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILN 465
+ ++ +DLS N I L L LK L + + + + F L QL
Sbjct: 134 TLPKVNSIDLSYNGAITDIM-PLKTLPE-LKSLNIQFDGVHDYRGIED--FPKLNQLYAF 189
Query: 466 NNELSG 471
+ + G
Sbjct: 190 SQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-20
Identities = 32/185 (17%), Positives = 67/185 (36%), Gaps = 10/185 (5%)
Query: 214 NLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGT 273
L ++ + + ++ +L + +N L+G + +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINN 75
Query: 274 NALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEIT 333
++ I L +L L++ ++ +L LT+L L S +A SI +I
Sbjct: 76 IHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 334 NLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYE 393
L ++ + LS N I L L +L SL++ + + + L LY +
Sbjct: 134 TLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFS 190
Query: 394 NSLCD 398
++
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-19
Identities = 26/164 (15%), Positives = 62/164 (37%), Gaps = 7/164 (4%)
Query: 19 EIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYID 78
+ L ++ + ++ L I ++ L++ + P + L++L +
Sbjct: 39 TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLR 94
Query: 79 IGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPD 138
I ++ + L SL+ L +S+++ + SI + + L + ++ L N I
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M 153
Query: 139 EIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSG 182
+ L L L + ++ + + L LY + G
Sbjct: 154 PLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 28/165 (16%), Positives = 63/165 (38%), Gaps = 7/165 (4%)
Query: 67 SLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLY 126
+ + SL YI + N ++ + + ++ DL ++N + + L+NL L
Sbjct: 39 TEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNY--NPISGLSNLERLR 94
Query: 127 LHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPN 186
+ ++ + L L+ L +S++ +I + L + ++ + N I
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154
Query: 187 EIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGL 231
+ L L L + ++ + + KL LY + G
Sbjct: 155 -LKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 33/189 (17%), Positives = 68/189 (35%), Gaps = 10/189 (5%)
Query: 162 FSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEIL 221
+ +G ++ + + SL+ + L ++ L ++ L
Sbjct: 17 IPDSTFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTD--LTGIEYAHNIKDL 71
Query: 222 YLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSIL 281
++ + P I L +L L++ ++ + LT L + + +A SIL
Sbjct: 72 TINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129
Query: 282 EEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDL 341
+I L + + L+YN I L +L L +L + + I + L+ L
Sbjct: 130 TKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQL 186
Query: 342 QLSENTLNG 350
T+ G
Sbjct: 187 YAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-17
Identities = 30/176 (17%), Positives = 72/176 (40%), Gaps = 8/176 (4%)
Query: 417 SNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPE 476
+ + ++ A + + L + L++ ++ + + ++ L +NN + +P
Sbjct: 29 LLGQSSTANITEAQMNS-LTYITLANINVTDLTGIEY--AHNIKDLTINNIHATN-YNP- 83
Query: 477 LGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDL 536
+ L+ LE L + + +L L L L++S++ I I L ++ +DL
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 537 SYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGL 592
SY +I + ++ L+ LN+ + + E+ L+ + + G
Sbjct: 144 SYNGAITDI-MPLKTLPELKSLNIQFDGVH-DYR-GIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-16
Identities = 31/185 (16%), Positives = 66/185 (35%), Gaps = 10/185 (5%)
Query: 94 SLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSY 153
+ K+ + L +S + + +L + L ++ + I + DL ++
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75
Query: 154 NTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFG 213
+ P + L+NL L I ++ + L SL+ L + ++ SIL
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 214 NLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGT 273
L K+ + L N I + L L +L + ++ + + KL +
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 274 NALSS 278
+
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 24/109 (22%), Positives = 41/109 (37%), Gaps = 3/109 (2%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L+ L + + P + LT L LL S + I +I L +N + L N
Sbjct: 90 LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNG 110
I P L L L ++I + + + L+ L + ++ G
Sbjct: 150 TDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 19/141 (13%), Positives = 45/141 (31%), Gaps = 31/141 (21%)
Query: 456 FSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNN 515
F + + +L + + + +N L Y+ L+ + + + L ++N
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNI 76
Query: 516 QFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEE 575
+S L +LE+L + +++
Sbjct: 77 H--------ATNYNPISGL------------------SNLERLRIMGKDVTSDKIPNLSG 110
Query: 576 MHWLSCIDISYNALQGLIPNS 596
+ L+ +DIS++A I
Sbjct: 111 LTSLTLLDISHSAHDDSILTK 131
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 65/225 (28%), Positives = 99/225 (44%), Gaps = 30/225 (13%)
Query: 696 IIRATKNFDD----EHCIGNGGQGSVYKA-ELPTGEIVAVKKFH-SPLPGEMACQQEFLN 749
+ +T F D + +G G G V + TG+ AVK + + ++ L
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-KESLLR 75
Query: 750 EGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL--AMI----LSNDAAAEEFGWT 803
E L ++ H NI+K Y F + ++V E G L +I S AA
Sbjct: 76 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR----- 130
Query: 804 KRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL-NLEYEAHV--SDFGISKFLKLGL 860
I+ V + YMH N IVHRD+ +N+LL + +A++ DFG+S +
Sbjct: 131 ----IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS- 182
Query: 861 SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
+ GT YIAPE+ EKCDV+S GV+ ++ G P
Sbjct: 183 KKMKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 69/277 (24%), Positives = 119/277 (42%), Gaps = 40/277 (14%)
Query: 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
++F+ +G G G+VY A E + I+A+K + + + E + +RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSL------AMILSNDAAAEEFGWTKRMNAIKGVA 813
NI++ YG+ A +++ EY +G++ A +A
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---------TELA 119
Query: 814 DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI 873
+AL Y H+ ++HRDI +N+LL E ++DFG S RT+L GT Y+
Sbjct: 120 NALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--RTDLCGTLDYL 174
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML--DPR 931
PE+ EK D++S GVL E + GK P + ++ + +
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---------ANTYQETYKRISRVEFT 225
Query: 932 LPTPL-RNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
P + +D LIS + L +P+ RP +++V
Sbjct: 226 FPDFVTEGARD-LISRL------LKHNPSQRPMLREV 255
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 64/256 (25%), Positives = 102/256 (39%), Gaps = 34/256 (13%)
Query: 662 RQRKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATKNFDDEHCIGNGGQGSVYKA- 720
+ + + L G + + ++ + +G+G G V
Sbjct: 3 HHHHHSSGRENLYFQGDLQATP-----GMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCR 57
Query: 721 ELPTGEIVAVKKFH-SPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779
+ T A+K + + + L E L + H NI+K Y F + ++V
Sbjct: 58 DKVTHVERAIKIIRKTSVSTSS--NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115
Query: 780 EYLEMGSL-AMILS------NDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDI 832
E + G L I+ DAA IK V + Y+H + IVHRD+
Sbjct: 116 ECYKGGELFDEIIHRMKFNEVDAA----------VIIKQVLSGVTYLHKHN---IVHRDL 162
Query: 833 SSKNVLL-NLEYEAHV--SDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDV 889
+N+LL + E +A + DFG+S + E GT YIAPE+ K EKCDV
Sbjct: 163 KPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEV-LRKKYDEKCDV 220
Query: 890 YSFGVLALEVIKGKHP 905
+S GV+ ++ G P
Sbjct: 221 WSIGVILFILLAGYPP 236
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 65/288 (22%), Positives = 112/288 (38%), Gaps = 49/288 (17%)
Query: 709 IGNGGQGSVYKAELPTGE------IVAVKKFHSPLPGEMACQQE---FLNEGNALTKIRH 759
+G G G VY+ VA+K + E A +E FLNE + + +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-----EAASMRERIEFLNEASVMKEFNC 87
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMIL-SNDAAAEEFGWTKRMNAIK------GV 812
++V+ G S + V+ E + G L L S A + K +
Sbjct: 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 813 ADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGY 872
AD + Y++ N F VHRD++++N ++ ++ + DFG+++ + G G
Sbjct: 148 ADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY---ETDYYRKGGKGL 201
Query: 873 I-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDE 926
+ +PE T DV+SFGV+ E+ + P +S N +
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS----------NEQVLR 251
Query: 927 MLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ L P N D L +M C +P RP+ ++ +K
Sbjct: 252 FVMEGGLLDKP-DNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIK 295
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-22
Identities = 65/280 (23%), Positives = 113/280 (40%), Gaps = 40/280 (14%)
Query: 706 EHCIGNGGQGSVYKAEL---PTGEI-VAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN 761
CIG G G V++ + VA+K + + +++FL E + + H +
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV--REKFLQEALTMRQFDHPH 452
Query: 762 IVKFYGFCSHALHSFVVYEYLEMGSLAMIL-SNDAAAEEFGWTKRMNAIKGVADALLYMH 820
IVK G + +++ E +G L L + ++ AL Y+
Sbjct: 453 IVKLIGVITEN-PVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLE 508
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI-----AP 875
+ F VHRDI+++NVL++ + DFG+S++++ + T + G + AP
Sbjct: 509 SKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME----DSTYYKASKGKLPIKWMAP 561
Query: 876 ELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDP--RL 932
E + T DV+ FGV E++ G P + N + ++ RL
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK----------NNDVIGRIENGERL 611
Query: 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
P P N L S+M C P+ RP ++ L
Sbjct: 612 PMP-PNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLS 647
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 2e-22
Identities = 56/286 (19%), Positives = 109/286 (38%), Gaps = 49/286 (17%)
Query: 708 CIGNGGQGSVYKAELPTGEIVAVK--KFHSPLPGEMACQQEFLNEGNALTKIRH--RNIV 763
IG+GG V++ +I A+K + + NE L K++ I+
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKII 119
Query: 764 KFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC 823
+ Y + + ++V E L L + +R + K + +A+ +H +
Sbjct: 120 RLYDYEITDQYIYMVMECGN-IDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 824 FPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN--RTELAGTFGYIAPEL---- 877
IVH D+ N L+ + + DFGI+ ++ ++ + G Y+ PE
Sbjct: 176 ---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 878 -------AYTMKVTEKCDVYSFGVLALEVIKGK----HPRDFISSICSSLSSNLNIALDE 926
K++ K DV+S G + + GK + IS + + + N I +
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291
Query: 927 MLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ + ++QD ++ CL P R ++ +LL
Sbjct: 292 IPEK-------DLQD-VLK------CCLKRDPKQRISIP---ELLA 320
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 61/285 (21%), Positives = 108/285 (37%), Gaps = 42/285 (14%)
Query: 709 IGNGGQGSVYKAELPTGE----IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
+G G GSV +A+L + VAVK + + +EFL E + + H ++ K
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD-IEEFLREAACMKEFDHPHVAK 89
Query: 765 FYGFCS------HALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIK---GVADA 815
G V+ +++ G L L E ++ +A
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 816 LLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI-- 873
+ Y+ + F +HRD++++N +L + V+DFG+S+ + S G +
Sbjct: 150 MEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIY---SGDYYRQGCASKLPV 203
Query: 874 ---APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLD 929
A E T DV++FGV E++ +G+ P I N + L
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE----------NAEIYNYLI 253
Query: 930 P--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
RL P +++ +M C P RP+ + L+
Sbjct: 254 GGNRLKQP-PECMEEVYDLMY---QCWSADPKQRPSFTCLRMELE 294
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 59/226 (26%), Positives = 91/226 (40%), Gaps = 40/226 (17%)
Query: 696 IIRATKNFDD----EHCIGNGGQGSVYKA-ELPTGEIVAVK----------KFHSPLPGE 740
+ + + +G+G G V E A+K ++
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 741 MACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL-AMILS------N 793
+E NE + L + H NI+K + + ++V E+ E G L I++
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 794 DAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL-NLEYEAH--VSDF 850
DAA N +K + + Y+H + IVHRDI +N+LL N + + DF
Sbjct: 147 DAA----------NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDF 193
Query: 851 GISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLA 896
G+S F + GT YIAPE K EKCDV+S GV+
Sbjct: 194 GLSSFFSKD-YKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 7e-22
Identities = 52/241 (21%), Positives = 98/241 (40%), Gaps = 26/241 (10%)
Query: 669 QTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATKNFDD------EHCIGNGGQGSVYKA-E 721
+ S R + + + H + + +G G G V+K E
Sbjct: 51 RMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEE 110
Query: 722 LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEY 781
TG +A K + M ++E NE + + ++ H N+++ Y +V EY
Sbjct: 111 TATGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167
Query: 782 LEMGSL-AMILSNDAAAEEFGWTKR--MNAIKGVADALLYMHTNCFPPIVHRDISSKNVL 838
++ G L I+ E + T+ + +K + + + +MH I+H D+ +N+L
Sbjct: 168 VDGGELFDRII-----DESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENIL 219
Query: 839 LNLEYEAHV--SDFGISKFLKLGLSNRTELAGTFGYIAPE-LAYTMKVTEKCDVYSFGVL 895
+ DFG+++ K GT ++APE + Y V+ D++S GV+
Sbjct: 220 CVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVI 277
Query: 896 A 896
A
Sbjct: 278 A 278
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 76/309 (24%), Positives = 119/309 (38%), Gaps = 60/309 (19%)
Query: 692 VHEEIIRATKNFDDEHCIGNGGQGSVYKAELPTGE---IVAVKKFHSPLPGEMACQQE-- 746
++ + F D IG G G V KA + A+K+ E A + +
Sbjct: 18 IYPVLDWNDIKFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMK-----EYASKDDHR 70
Query: 747 -FLNEGNALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTK 804
F E L K+ H NI+ G C H + ++ EY G+L L E
Sbjct: 71 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 130
Query: 805 RMNAIKG-------------VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFG 851
N+ VA + Y+ F +HRD++++N+L+ Y A ++DFG
Sbjct: 131 IANSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFG 187
Query: 852 ISKFLKLGLSNRTELAGTFGYI-----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKH 904
+S+ + T G + A E L Y+ T DV+S+GVL E++ G
Sbjct: 188 LSR------GQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGT 240
Query: 905 PRDFISSICSSLSSNLNIALDEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRP 962
P ++ L E L RL P N D++ +M C E P RP
Sbjct: 241 PYCGMT----------CAELYEKLPQGYRLEKP-LNCDDEVYDLM---RQCWREKPYERP 286
Query: 963 TMQKVSQLL 971
+ ++ L
Sbjct: 287 SFAQILVSL 295
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 1e-21
Identities = 43/353 (12%), Positives = 91/353 (25%), Gaps = 72/353 (20%)
Query: 663 QRKNGLQTQQSSPRNTL---GLLSVLTFDGKI---VHEEIIRATKNFDDEHCIGNGGQGS 716
R + +S L+S ++ V E+ + +G +
Sbjct: 29 NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYA 88
Query: 717 VYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR----------------- 758
+A + TGE V + ++ E L +R
Sbjct: 89 YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148
Query: 759 -----HRNIVKFYGFCSHALHSFVVYEYLEM----GSLAM----ILSNDAAAEEFGWTKR 805
K +V+ + +L +LS+ + + R
Sbjct: 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHAR 208
Query: 806 MNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTE 865
+ V L +H +VH + +++L+ ++ F R
Sbjct: 209 LQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR----DGARVV 261
Query: 866 LAGTFGYIAPEL-----------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS 914
+ + G+ PEL +T D ++ G++ + P
Sbjct: 262 SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP--ITKD--- 316
Query: 915 SLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
++ +P P+R L+ L R +
Sbjct: 317 --AALGGSEWIFRSCKNIPQPVRA----LLE------GFLRYPKEDRLLPLQA 357
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 59/200 (29%), Positives = 86/200 (43%), Gaps = 33/200 (16%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFH-SPLPGEMACQQEFLNEGNALTKIRHRNIVKFY 766
+G G G V K + T + AVK + + + L E L K+ H NI+K +
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD--TSTILREVELLKKLDHPNIMKLF 87
Query: 767 GFCSHALHSFVVYEYLEMGSL--AMI----LSNDAAAEEFGWTKRMNAIKGVADALLYMH 820
+ ++V E G L +I S AA IK V + YMH
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---------IIKQVFSGITYMH 138
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAH---VSDFGISKFLKLGLSNRTELAGTFGYIAPEL 877
+ IVHRD+ +N+LL + + + DFG+S + + + GT YIAPE+
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEV 194
Query: 878 ---AYTMKVTEKCDVYSFGV 894
Y EKCDV+S GV
Sbjct: 195 LRGTY----DEKCDVWSAGV 210
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-21
Identities = 61/217 (28%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 694 EEIIRATKNFDD----EHCIGNGGQGSVYKA-ELPTGEIVAVKKFH-SPLPGEMACQQEF 747
E + F + +G G G V K + T + AVK + + +
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD--TSTI 68
Query: 748 LNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL-AMILS------NDAAAEEF 800
L E L K+ H NI+K + + ++V E G L I+ +DAA
Sbjct: 69 LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA---- 124
Query: 801 GWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL-NLEYEAH--VSDFGISKFLK 857
IK V + YMH + IVHRD+ +N+LL + E + + DFG+S +
Sbjct: 125 ------RIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGV 894
+ + GT YIAPE+ EKCDV+S GV
Sbjct: 176 QN-TKMKDRIGTAYYIAPEV-LRGTYDEKCDVWSAGV 210
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 62/280 (22%), Positives = 116/280 (41%), Gaps = 39/280 (13%)
Query: 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKK-FHSPLPGEMACQQEFLNEGNALTKIR 758
++F + +G G VY+A + TG VA+K + Q+ NE +++
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLK 69
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSL-------AMILSNDAAAEEFGWTKRMNAIKG 811
H +I++ Y + + + ++V E G + S + A
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFM---------HQ 120
Query: 812 VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFG 871
+ +LY+H++ I+HRD++ N+LL ++DFG++ LK+ L GT
Sbjct: 121 IITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177
Query: 872 YIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALD--EMLD 929
YI+PE+A + DV+S G + ++ G+ P D + + L+ + D
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD---------TDTVKNTLNKVVLAD 228
Query: 930 PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969
+P+ L LI + L +P R ++ V
Sbjct: 229 YEMPSFLSIEAKDLIHQL------LRRNPADRLSLSSVLD 262
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 2e-21
Identities = 52/279 (18%), Positives = 96/279 (34%), Gaps = 36/279 (12%)
Query: 289 SLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTL 348
S + ++ IP L N L F L + L +++S+N +
Sbjct: 10 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 349 NGSIPL-ALGNLTKLVSLDLS-INKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEI-G 405
I NL KL + + N L P +F +L +L L + + +P
Sbjct: 67 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKI 125
Query: 406 DMKSLSILDLSSNKLNGSIP-LSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLIL 464
+LD+ N +I S L+ +L+L+ N I EI + L +L L
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNL 184
Query: 465 NNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNP 524
++N N LE L + L++S +
Sbjct: 185 SDN-------------NNLEELP----------NDVFHGASGPVILDISRTRIHSLPSYG 221
Query: 525 IEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHN 563
+E L L +++P+ + + +L + +L++
Sbjct: 222 LENLKKLRARSTYN---LKKLPT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 4e-18
Identities = 55/258 (21%), Positives = 85/258 (32%), Gaps = 20/258 (7%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPS-LGNLTS 73
IP ++ + L F +L + L + + N + I NL
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 74 LIYIDIGN-NLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPS-SLGNLTNLVTLYLHMN 130
L I I N L I E +L +L L +SN + +P + V L + N
Sbjct: 81 LHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDN 138
Query: 131 ALSGSIPDEI--GNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEI 188
+I G L ++ N + I S N T L L + N +PN++
Sbjct: 139 INIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDV 197
Query: 189 -GNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQL 247
L + + Y NL KL L L + L +L+ L
Sbjct: 198 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLPT--LEKLVALMEASL 253
Query: 248 NYNTLSGSIPCSFGNLTK 265
Y S C+F N +
Sbjct: 254 TYP----SHCCAFANWRR 267
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 46/241 (19%), Positives = 85/241 (35%), Gaps = 12/241 (4%)
Query: 183 SIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEI-GNLKS 241
IP+++ ++ +LR L +F LE + + N + +I ++ NL
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 242 LLALQL-NYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTL 300
L +++ N L P +F NL L + + + + L + N
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 140
Query: 301 SGSIP-LSLGSLT-NLATLYFSTNALSGSIPNEITNLRSLSDLQLSE-NTLNGSIPLALG 357
+I S L+ L+ + N + I N N L +L LS+ N L
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFH 199
Query: 358 NLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSS 417
+ V LD+S ++ +L L Y +P + + +L L+
Sbjct: 200 GASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTY 255
Query: 418 N 418
Sbjct: 256 P 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 3e-16
Identities = 57/338 (16%), Positives = 93/338 (27%), Gaps = 80/338 (23%)
Query: 87 SIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFL 146
IP+++ ++ +LR L + +L + + N + I
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE--------- 71
Query: 147 SDLQVSYNTLSGAIPFSLGNLTNLVTLYI-GINALSGSIPNEIGNLKSLSDLRLDYNTLS 205
NL L + I N L I E
Sbjct: 72 --------------ADVFSNLPKLHEIRIEKANNLL-YINPEA----------------- 99
Query: 206 GSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIP-CSFGNLT 264
F NL L+ L + + L + + L + N +I SF L+
Sbjct: 100 ------FQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS 153
Query: 265 KLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNAL 324
+ L LN N + I S + T L L S N
Sbjct: 154 FE-----------------------SVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNN 189
Query: 325 SGSIPNEI-TNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASL 383
+PN++ L +S ++ L NL KL + K +P + L
Sbjct: 190 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP-TLEKL 245
Query: 384 TSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
+L L S C + + L + S
Sbjct: 246 VALMEASLTYPSHCCAFANWRRQISELHPICNKSILRQ 283
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 5e-16
Identities = 53/254 (20%), Positives = 96/254 (37%), Gaps = 26/254 (10%)
Query: 385 SLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 444
S E+ + IP ++ ++ L KL + + + L+ + +S N
Sbjct: 10 SNRVFLCQESKV-TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGD-LEKIEISQND 65
Query: 445 IVGEIPLGHGKFSSLIQL----ILNNNELSGQLSPE-LGSLNQLEYLDLSANTFHNSIPE 499
++ I FS+L +L I N L ++PE +L L+YL +S +P+
Sbjct: 66 VLEVIEAD--VFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPD 121
Query: 500 -SLGNLVKLHYLNLSNNQFSQKIP-NPIEKL-IHLSELDLSY-KIFGEEIPSQVCSMQSL 555
+ ++ L++ +N I N L L L+ I +EI + + L
Sbjct: 122 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI--QEIHNSAFNGTQL 179
Query: 556 EKLNLSHNNLSGSISR-CFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLC 614
++LNLS NN + F +DIS + L + L + L
Sbjct: 180 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY--GLENLKKLRARSTYNL- 236
Query: 615 GDIKRLPPCKAFKS 628
K+LP + +
Sbjct: 237 ---KKLPTLEKLVA 247
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 44/207 (21%), Positives = 77/207 (37%), Gaps = 12/207 (5%)
Query: 2 LKVLGLSFNQFSGSIPPEI-GHLTHLKLLSFSK-NQLSGLIPHEIGRLSSLNGLSLYSNF 59
L+ + +S N I ++ +L L + K N L + P L +L L + +
Sbjct: 56 LEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTG 115
Query: 60 LKGSIPP-SLGNLTSLIYIDIGNNLLSGSIPNEV--GSLKSLSDLRLSNNSLNGSIPSSL 116
+K +P + + +DI +N+ +I G L L+ N + I +S
Sbjct: 116 IK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSA 173
Query: 117 GNLTNLVTLYLHMNALSGSIPDEI-GNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYI 175
N T L L L N +P+++ L +S + + L NL L
Sbjct: 174 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS- 232
Query: 176 GINALSGSIPNEIGNLKSLSDLRLDYN 202
L +P + L +L + L Y
Sbjct: 233 -TYNLK-KLPT-LEKLVALMEASLTYP 256
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 58/205 (28%), Positives = 80/205 (39%), Gaps = 34/205 (16%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVK-----KFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
+G+G G V A E T + VA+K KF E E L K+ H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 763 VKFYG-FCSHALHSFVVYEYLEMGSL------AMILSNDAAAEEFGWTKRMNAIKGVADA 815
+K F + + +V E +E G L L + A
Sbjct: 78 IKIKNFFDAEDYY--IVLELMEGGELFDKVVGNKRLKEATCK---------LYFYQMLLA 126
Query: 816 LLYMHTNCFPPIVHRDISSKNVLL-NLEYEAHV--SDFGISKFLKLGLSNRTELAGTFGY 872
+ Y+H N I+HRD+ +NVLL + E + + +DFG SK L S L GT Y
Sbjct: 127 VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTY 182
Query: 873 IAPE-LAYTMKV--TEKCDVYSFGV 894
+APE L D +S GV
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGV 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-21
Identities = 46/214 (21%), Positives = 92/214 (42%), Gaps = 37/214 (17%)
Query: 700 TKNFDDE----HCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNAL 754
F +E +G G V + ++ G+ A ++ Q+ E
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTK-KLSARDHQKLEREARIC 64
Query: 755 TKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLA-MILS------NDAAAEEFGWTKRMN 807
++H NIV+ + S H +++++ + G L I++ DA+ +
Sbjct: 65 RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS----------H 114
Query: 808 AIKGVADALLYMHTNCFPPIVHRDISSKNVLL-NLEYEAHV--SDFGISKFLKLGLSNRT 864
I+ + +A+L+ H +VHR++ +N+LL + A V +DFG++ ++
Sbjct: 115 CIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 171
Query: 865 ELAGTFGYIAPEL----AYTMKVTEKCDVYSFGV 894
AGT GY++PE+ Y + D+++ GV
Sbjct: 172 GFAGTPGYLSPEVLRKDPY----GKPVDLWACGV 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 46/199 (23%), Positives = 86/199 (43%), Gaps = 21/199 (10%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
+G+G V K E TG A K K S ++E E + L ++ H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNA--IKGVADALLYMHTN 822
+ + ++ E + G L D A++ ++ IK + D + Y+HT
Sbjct: 80 LHDVYENRTDVVLILELVSGGELF-----DFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 823 CFPPIVHRDISSKNVLL-NLEYEAH---VSDFGISKFLKLGLSNRTELAGTFGYIAPE-L 877
I H D+ +N++L + + DFG++ ++ G + GT ++APE +
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIV 190
Query: 878 AYTMKVTEKCDVYSFGVLA 896
Y + + D++S GV+
Sbjct: 191 NYE-PLGLEADMWSIGVIT 208
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 3e-21
Identities = 44/193 (22%), Positives = 80/193 (41%), Gaps = 16/193 (8%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G G V++ E TG A K + + ++ E ++ +RH +V +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMT---PHESDKETVRKEIQTMSVLRHPTLVNLHD 221
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKR--MNAIKGVADALLYMHTNCFP 825
++YE++ G L A E ++ + ++ V L +MH N
Sbjct: 222 AFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN--- 274
Query: 826 PIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKV 883
VH D+ +N++ + + DFG++ L + GT + APE+A V
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPV 333
Query: 884 TEKCDVYSFGVLA 896
D++S GVL+
Sbjct: 334 GYYTDMWSVGVLS 346
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 63/295 (21%), Positives = 115/295 (38%), Gaps = 51/295 (17%)
Query: 706 EHCIGNGGQGSVYKAELPTGE------IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
+G G VYK L VA+K G + ++EF +E +++H
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL--REEFRHEAMLRARLQH 71
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKG-------- 811
N+V G + +++ Y G L L + + G T +K
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 812 -----VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTEL 866
+A + Y+ ++ VH+D++++NVL+ + +SD G+ + + +
Sbjct: 132 HLVAQIAAGMEYLSSHHV---VHKDLATRNVLVYDKLNVKISDLGLFREVY---AADYYK 185
Query: 867 AGTFGYI-----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSN 919
+ APE + Y K + D++S+GV+ EV G P S
Sbjct: 186 LLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------- 235
Query: 920 LNIALDEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
N + EM+ LP P + + ++M I C +E P+ RP + + L+
Sbjct: 236 -NQDVVEMIRNRQVLPCP-DDCPAWVYALM---IECWNEFPSRRPRFKDIHSRLR 285
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 47/219 (21%), Positives = 95/219 (43%), Gaps = 23/219 (10%)
Query: 689 GKIVHEEIIRATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVK---KFHSPLPGEMACQ 744
G + +E + + +E +G+G V K E TG A K K + +
Sbjct: 1 GTVFRQENVDDYYDTGEE--LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR 58
Query: 745 QEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTK 804
++ E + L +I+H N++ + + ++ E + G L D AE+ T+
Sbjct: 59 EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELF-----DFLAEKESLTE 113
Query: 805 RMNA--IKGVADALLYMHTNCFPPIVHRDISSKNVLL-NLEYEAH---VSDFGISKFLKL 858
+K + + + Y+H+ I H D+ +N++L + + DFG++ +
Sbjct: 114 EEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 859 GLSNRTELAGTFGYIAPE-LAYTMKVTEKCDVYSFGVLA 896
G + + GT ++APE + Y + + D++S GV+
Sbjct: 171 G-NEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 207
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 56/244 (22%), Positives = 98/244 (40%), Gaps = 34/244 (13%)
Query: 662 RQRKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATKNFDDEHCIGNGGQGSVYKA- 720
++ S+ T L+ DG + + + + E +G G VY+
Sbjct: 18 LYFQSMSSVTASAAPGTASLVPDYWIDGS--NRDALSDFFEVESE--LGRGATSIVYRCK 73
Query: 721 ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780
+ T + A+K ++ E L ++ H NI+K +V E
Sbjct: 74 QKGTQKPYALKVLKKT-----VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128
Query: 781 YLEMGSL-AMILS------NDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDIS 833
+ G L I+ DAA +A+K + +A+ Y+H N IVHRD+
Sbjct: 129 LVTGGELFDRIVEKGYYSERDAA----------DAVKQILEAVAYLHENG---IVHRDLK 175
Query: 834 SKNVLL-NLEYEAHV--SDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVY 890
+N+L +A + +DFG+SK ++ + GT GY APE+ + D++
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMW 234
Query: 891 SFGV 894
S G+
Sbjct: 235 SVGI 238
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 6e-21
Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 21/199 (10%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
+G+G V K + TG+ A K K ++E E N L +IRH NI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKR--MNAIKGVADALLYMHTN 822
+ + ++ E + G L D AE+ T+ +K + D + Y+H+
Sbjct: 73 LHDIFENKTDVVLILELVSGGELF-----DFLAEKESLTEDEATQFLKQILDGVHYLHSK 127
Query: 823 CFPPIVHRDISSKNVLL-NLEYEAH---VSDFGISKFLKLGLSNRTELAGTFGYIAPE-L 877
I H D+ +N++L + + DFGI+ ++ G + + GT ++APE +
Sbjct: 128 R---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAPEIV 183
Query: 878 AYTMKVTEKCDVYSFGVLA 896
Y + + D++S GV+
Sbjct: 184 NYE-PLGLEADMWSIGVIT 201
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 7e-21
Identities = 58/205 (28%), Positives = 82/205 (40%), Gaps = 32/205 (15%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVK-----KFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
+G+G G V A E T + VA++ KF E E L K+ H I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSL------AMILSNDAAAEEFGWTKRMNAIKGVADAL 816
+K F + ++V E +E G L L F + A+
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYF---------YQMLLAV 252
Query: 817 LYMHTNCFPPIVHRDISSKNVLLNLEYEAH---VSDFGISKFLKLGLSNRTELAGTFGYI 873
Y+H N I+HRD+ +NVLL+ + E ++DFG SK L S L GT Y+
Sbjct: 253 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYL 308
Query: 874 APE-LAYTMKV--TEKCDVYSFGVL 895
APE L D +S GV+
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVI 333
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 7e-21
Identities = 41/295 (13%), Positives = 101/295 (34%), Gaps = 41/295 (13%)
Query: 690 KIVHEEIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLN 749
K+ H I+R + + K + EI + +
Sbjct: 60 KLEHPGIVRYFNAWLETPP---------EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSV 110
Query: 750 EGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI 809
+ + +N V S ++ ++ + +L ++ + E+ ++
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170
Query: 810 KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK------------ 857
+A+A+ ++H+ ++HRD+ N+ ++ V DFG+ +
Sbjct: 171 IQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 227
Query: 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLS 917
+ T GT Y++PE + + K D++S G++ E++
Sbjct: 228 PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST-----------Q 276
Query: 918 SNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ ++ + + P + +++ L SPT RP + +++
Sbjct: 277 MERVRIITDVRNLKFPLLFTQKYPQEHMMVQ---DMLSPSPTERPE---ATDIIE 325
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 8e-21
Identities = 48/210 (22%), Positives = 86/210 (40%), Gaps = 30/210 (14%)
Query: 700 TKNFDDE----HCIGNGGQGSVYKA-ELPTGEIVAVKKFH-SPLPGEMACQQEFLNEGNA 753
+ F D +G G V + TG A K + L Q+ E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD--FQKLEREARI 58
Query: 754 LTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL------AMILSNDAAAEEFGWTKRMN 807
K++H NIV+ + ++V++ + G L S A+
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--------- 109
Query: 808 AIKGVADALLYMHTNCFPPIVHRDISSKNVLL-NLEYEAHV--SDFGISKFLKLGLSNRT 864
I+ + +++ Y H+N IVHR++ +N+LL + A V +DFG++ +
Sbjct: 110 CIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWH 165
Query: 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGV 894
AGT GY++PE+ ++ D+++ GV
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGV 195
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 48/199 (24%), Positives = 87/199 (43%), Gaps = 21/199 (10%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
+G+G V K E TG A K K S C++E E + L ++ H NI+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 765 FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNA--IKGVADALLYMHTN 822
+ + ++ E + G L D A++ ++ IK + D + Y+HT
Sbjct: 80 LHDVYENRTDVVLILELVSGGELF-----DFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 823 CFPPIVHRDISSKNVLL-NLEYEAH---VSDFGISKFLKLGLSNRTELAGTFGYIAPE-L 877
I H D+ +N++L + + DFG++ ++ G + GT ++APE +
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIV 190
Query: 878 AYTMKVTEKCDVYSFGVLA 896
Y + + D++S GV+
Sbjct: 191 NYE-PLGLEADMWSIGVIT 208
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 62/284 (21%), Positives = 113/284 (39%), Gaps = 25/284 (8%)
Query: 308 LGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDL 367
+ +++ ++ L S+ + + + + S+ + L + L L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFL 75
Query: 368 SINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLS 427
+ NKL+ PL+ +L +L L+L EN + D + D+K L L L N ++ I
Sbjct: 76 NGNKLTDIKPLA--NLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DIN-G 129
Query: 428 LANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLD 487
L +L L+ LYL +N I L + L L L +N++S + P L L +L+ L
Sbjct: 130 LVHLPQ-LESLYLGNNKITDITVLSR--LTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLY 184
Query: 488 LSANTFHNSIP--ESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEI 545
LS N I +L L L L L + + K N L+ + + +
Sbjct: 185 LS----KNHISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT-- 238
Query: 546 PSQVCSMQSLEKLNLSHNN--LSGSISRCFEEMHWLSCIDISYN 587
P + EK N+ + + +S F + + ++
Sbjct: 239 PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFH 282
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 16/231 (6%)
Query: 22 HLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGN 81
+ K ++ + L+S++ + ++ +K S+ + L ++ + +
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 77
Query: 82 NLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIG 141
N L+ I + +LK+L L L N + + SSL +L L +L L N +S I +
Sbjct: 78 NKLT-DIKP-LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LV 131
Query: 142 NLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDY 201
+L L L + N ++ S LT L TL + N +S I + L L +L L
Sbjct: 132 HLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSK 187
Query: 202 NTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTL 252
N +S L + L L++L L N NL ++ +L
Sbjct: 188 NHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 58/260 (22%), Positives = 105/260 (40%), Gaps = 18/260 (6%)
Query: 162 FSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEIL 221
FS + + +++ ++ L S+ + + + + + L + L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK--SVQGIQYLPNVTKL 73
Query: 222 YLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSIL 281
+L+ N L+ + P + NLK+L L L+ N + + S +L KL L N +S +
Sbjct: 74 FLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGISD--I 127
Query: 282 EEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDL 341
+ +L L L L N ++ LS LT L TL N +S I + L L +L
Sbjct: 128 NGLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNL 183
Query: 342 QLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIP 401
LS+N ++ + AL L L L+L + ++L T+ + SL P
Sbjct: 184 YLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--P 239
Query: 402 KEIGDMKSLSILDLSSNKLN 421
+ I D ++ +
Sbjct: 240 EIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 51/265 (19%), Positives = 96/265 (36%), Gaps = 16/265 (6%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L + ++ L + + + + + + I L ++ L L N L
Sbjct: 26 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT 81
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
I P L NL +L ++ + N + + + + LK L L L +N + S + L +L
Sbjct: 82 -DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGI--SDINGLVHLPQ 135
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L +LYL N ++ + L L L + N +S +P + LT L LY+ N +S
Sbjct: 136 LESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSKNHIS 191
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
+ + LK+L L L + NL + +L
Sbjct: 192 -DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYE 249
Query: 242 LLALQLNYNTLSGSIPCSFGNLTKL 266
++ + + + F +
Sbjct: 250 KPNVKWHLPEFTNEVSFIFYQPVTI 274
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 52/261 (19%), Positives = 103/261 (39%), Gaps = 16/261 (6%)
Query: 68 LGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYL 127
I ++ ++ ++ L S+ + +N+ + S+ + L N+ L+L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75
Query: 128 HMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNE 187
+ N L+ I + NLK L L + N + L +L L +L + N +S I
Sbjct: 76 NGNKLT-DIKP-LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DING- 129
Query: 188 IGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQL 247
+ +L L L L N + + + LTKL+ L L+ N +S ++P + L L L L
Sbjct: 130 LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 185
Query: 248 NYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLS 307
+ N +S + + L L + L + + + NL ++ +L +S
Sbjct: 186 SKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 243
Query: 308 LGSLTNLATLYFSTNALSGSI 328
+ + + +
Sbjct: 244 DDGDYEKPNVKWHLPEFTNEV 264
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-20
Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 38/220 (17%)
Query: 694 EEIIRATKNFDDE----HCIGNGGQGSVYKA-ELPTGEIVAVKKFH-SPLPGEMACQQEF 747
E ++ A+ F D +G G V + TG A K + L Q+
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKL 75
Query: 748 LNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL------AMILSNDAAAEEFG 801
E K++H NIV+ + ++V++ + G L S A+
Sbjct: 76 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--- 132
Query: 802 WTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL-NLEYEAHV--SDFGISKFLKL 858
I+ + +++ Y H+N IVHR++ +N+LL + A V +DFG++ +
Sbjct: 133 ------CIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
Query: 859 GLSNRTELAGTFGYIAPEL----AYTMKVTEKCDVYSFGV 894
AGT GY++PE+ Y ++ D+++ GV
Sbjct: 184 S-EAWHGFAGTPGYLSPEVLKKDPY----SKPVDIWACGV 218
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 45/206 (21%), Positives = 79/206 (38%), Gaps = 34/206 (16%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVK-----KFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
IG G V + TG+ AVK KF S ++ E + ++H +I
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS---PGLSTEDLKREASICHMLKHPHI 88
Query: 763 VKFYGFCSHALHSFVVYEYL----------EMGSLAMILSNDAAAEEFGWTKRMNAIKGV 812
V+ S ++V+E++ + + S A+ ++ +
Sbjct: 89 VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH---------YMRQI 139
Query: 813 ADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAH---VSDFGISKFLKLGLSNRTELAGT 869
+AL Y H N I+HRD+ VLL + + + FG++ L GT
Sbjct: 140 LEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGT 196
Query: 870 FGYIAPELAYTMKVTEKCDVYSFGVL 895
++APE+ + DV+ GV+
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 55/195 (28%), Positives = 86/195 (44%), Gaps = 20/195 (10%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
+G+G G V+ E +G +K K S +P E E L + H NI+K
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ-----IEAEIEVLKSLDHPNIIK 84
Query: 765 FYGFCSHALHSFVVYEYLEMGSL-AMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC 823
+ + ++V E E G L I+S A + +K + +AL Y H+
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ- 143
Query: 824 FPPIVHRDISSKNVLLNLEYEAH---VSDFGISKFLKLGLSNRTELAGTFGYIAPE-LAY 879
+VH+D+ +N+L + DFG+++ K + T AGT Y+APE
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFKR 200
Query: 880 TMKVTEKCDVYSFGV 894
VT KCD++S GV
Sbjct: 201 --DVTFKCDIWSAGV 213
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 5e-20
Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 31/216 (14%)
Query: 702 NFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
+FD +G G G+VY A E I+A+K + + + E + +RH
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSL------AMILSNDAAAEEFGWTKRMNAIKGVAD 814
NI++ Y + +++ E+ G L +A + +AD
Sbjct: 75 NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM---------EELAD 125
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTE-LAGTFGYI 873
AL Y H ++HRDI +N+L+ + E ++DFG S S R + GT Y+
Sbjct: 126 ALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP---SLRRRTMCGTLDYL 179
Query: 874 APEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
PE+ + KV D++ GVL E + G P
Sbjct: 180 PPEMIEGKTHDEKV----DLWCAGVLCYEFLVGMPP 211
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 6e-20
Identities = 43/195 (22%), Positives = 81/195 (41%), Gaps = 21/195 (10%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G G V++ E + + K + + Q E + L RHRNI+ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKF----VKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 768 FCSHALHSFVVYEYLEMGSL-AMILSNDAAAEEFGWTKR--MNAIKGVADALLYMHTNCF 824
+++E++ + I F +R ++ + V +AL ++H++
Sbjct: 69 SFESMEELVMIFEFISGLDIFERIN-----TSAFELNEREIVSYVHQVCEALQFLHSH-- 121
Query: 825 PPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSNRTELAGTFGYIAPE-LAYTM 881
I H DI +N++ + + +FG ++ LK G N L Y APE + +
Sbjct: 122 -NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDV 179
Query: 882 KVTEKCDVYSFGVLA 896
V+ D++S G L
Sbjct: 180 -VSTATDMWSLGTLV 193
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 9e-20
Identities = 65/297 (21%), Positives = 115/297 (38%), Gaps = 58/297 (19%)
Query: 709 IGNGGQGSVYKAELP--------TGEIVAVKKFHSPLPGEMACQQE---FLNEGNALTKI 757
+G G G V AE VAVK A +++ ++E + I
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-----SDATEKDLSDLISEMEMMKMI 131
Query: 758 -RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKG----- 811
+H+NI+ G C+ +V+ EY G+L L + +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 812 --------VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR 863
VA + Y+ + +HRD++++NVL+ + ++DFG+++ + +
Sbjct: 192 DLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 864 TELAGTFGYI-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLS 917
T G + APE + T + DV+SFGVL E+ G P +
Sbjct: 249 ---KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------- 298
Query: 918 SNLNIALDEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
L ++L R+ P N ++L +M C P+ RPT +++ + L
Sbjct: 299 ---VEELFKLLKEGHRMDKP-SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLD 348
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 65/296 (21%), Positives = 114/296 (38%), Gaps = 58/296 (19%)
Query: 709 IGNGGQGSVYKAELP--------TGEIVAVKKFHSPLPGEMACQQE---FLNEGNALTKI 757
+G G G V AE VAVK + A +++ ++E + I
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-----DDATEKDLSDLVSEMEMMKMI 97
Query: 758 -RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKG----- 811
+H+NI+ G C+ +V+ EY G+L L +
Sbjct: 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 812 --------VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR 863
+A + Y+ + +HRD++++NVL+ ++DFG+++ + +
Sbjct: 158 DLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 864 TELAGTFGYI-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLS 917
T G + APE + T + DV+SFGVL E+ G P I
Sbjct: 215 ---KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------- 264
Query: 918 SNLNIALDEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
L ++L R+ P N ++L +M C P+ RPT +++ + L
Sbjct: 265 ---VEELFKLLKEGHRMDKP-ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 313
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 51/221 (23%), Positives = 89/221 (40%), Gaps = 37/221 (16%)
Query: 698 RATKNFDDE----HCIGNGGQGSVYKA-ELPTGEIVAVK---KFHSPLPGEMACQ---QE 746
+T F + +G G V + PT + AVK Q +
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 747 FLNEGNALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEMGSL------AMILSNDAAAEE 799
L E + L K+ H NI++ F+V++ ++ G L + LS +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK- 128
Query: 800 FGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859
++ + + + +H IVHRD+ +N+LL+ + ++DFG S L G
Sbjct: 129 --------IMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 860 LSNRTELAGTFGYIAPE-LAYTMKV-----TEKCDVYSFGV 894
E+ GT Y+APE + +M ++ D++S GV
Sbjct: 178 -EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 47/199 (23%), Positives = 71/199 (35%), Gaps = 33/199 (16%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
IG G G V A + T A KK + F E + + H NI++ Y
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKY---FVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 768 FCSHALHSFVVYEYLEMGSL------AMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT 821
++V E G L + AA +K V A+ Y H
Sbjct: 74 TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---------IMKDVLSAVAYCHK 124
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAH---VSDFGISKFLKLGLSNRTELAGTFGYIAPEL- 877
+ HRD+ +N L + + DFG++ K G GT Y++P++
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVL 180
Query: 878 --AYTMKVTEKCDVYSFGV 894
Y +CD +S GV
Sbjct: 181 EGLY----GPECDEWSAGV 195
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 62/295 (21%), Positives = 107/295 (36%), Gaps = 56/295 (18%)
Query: 709 IGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQE---FLNEGNALTKI-R 758
+G G G V +A+ T VAVK E A E ++E L I
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-----EGATHSEHRALMSELKILIHIGH 89
Query: 759 HRNIVKFYGFCSHA-LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKG------ 811
H N+V G C+ V+ E+ + G+L+ L + + K
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 812 -------VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864
VA + ++ + +HRD++++N+LL+ + + DFG+++ +
Sbjct: 150 LICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV- 205
Query: 865 ELAGTFGYI-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSS 918
+ APE + T + DV+SFGVL E+ G P +
Sbjct: 206 --RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------- 256
Query: 919 NLNIALDEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
+ L R+ P ++ M C P+ RPT ++ + L
Sbjct: 257 --DEEFCRRLKEGTRMRAP-DYTTPEMYQTML---DCWHGEPSQRPTFSELVEHL 305
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 62/297 (20%), Positives = 111/297 (37%), Gaps = 57/297 (19%)
Query: 709 IGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQE---FLNEGNALTKI-R 758
+G G G V +A VAVK A E ++E L+ +
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-----PSAHLTEREALMSELKVLSYLGN 85
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKG------- 811
H NIV G C+ + V+ EY G L L + T
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 812 --------VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR 863
VA + ++ + +HRD++++N+LL + DFG+++ +K +
Sbjct: 146 DLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 864 TELAGTFGYI-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLS 917
+ APE + T + DV+S+G+ E+ G P +
Sbjct: 203 ---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV------ 253
Query: 918 SNLNIALDEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ +M+ R+ +P + ++ IM+ +C D P RPT +++ QL++
Sbjct: 254 ---DSKFYKMIKEGFRMLSP-EHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIE 303
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 38/221 (17%)
Query: 698 RATKNFDDE----HCIGNGGQGSVYKA-ELPTGEIVAVK-----KFHSPLPGEMACQQEF 747
A K F + IG G V + TG AVK ++
Sbjct: 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146
Query: 748 LNEGNALTKIR-HRNIVKFYGFCSHALHSFVVYEYLEMGSL-AMILSN------DAAAEE 799
E + L ++ H +I+ + F+V++ + G L + +
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR--- 203
Query: 800 FGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859
+ ++ + +A+ ++H N IVHRD+ +N+LL+ + +SDFG S L+ G
Sbjct: 204 -------SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253
Query: 860 LSNRTELAGTFGYIAPE-LAYTMKVTEK-----CDVYSFGV 894
EL GT GY+APE L +M T D+++ GV
Sbjct: 254 -EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 71/302 (23%), Positives = 115/302 (38%), Gaps = 65/302 (21%)
Query: 709 IGNGGQGSVYKAELPTGE------IVAVKKFHSPLPGEMACQQE---FLNEGNALTKIRH 759
+G G G V KA + VAVK L E A E L+E N L ++ H
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKM----LK-ENASPSELRDLLSEFNVLKQVNH 85
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSL---------AMILSNDAAAEEFGWTKRMNAIK 810
+++K YG CS ++ EY + GSL + + +
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 811 G------------VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858
++ + Y+ VHRD++++N+L+ + +SDFG+S+ +
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKL---VHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 859 GLSNRTELAGTFGYI-----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISS 911
S + G I A E L T + DV+SFGVL E++ G +P I
Sbjct: 203 EDSYV---KRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIP- 257
Query: 912 ICSSLSSNLNIALDEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969
L +L R+ P N +++ +M C + P RP +S+
Sbjct: 258 ---------PERLFNLLKTGHRMERP-DNCSEEMYRLML---QCWKQEPDKRPVFADISK 304
Query: 970 LL 971
L
Sbjct: 305 DL 306
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-19
Identities = 65/296 (21%), Positives = 114/296 (38%), Gaps = 58/296 (19%)
Query: 709 IGNGGQGSVYKAEL--------PTGEIVAVKKFHSPLPGEMACQQE---FLNEGNALTKI 757
+G G G V AE VAVK + A +++ ++E + I
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-----DDATEKDLSDLVSEMEMMKMI 143
Query: 758 -RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKG----- 811
+H+NI+ G C+ +V+ EY G+L L +
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 812 --------VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR 863
+A + Y+ + +HRD++++NVL+ ++DFG+++ + +
Sbjct: 204 DLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 864 TELAGTFGYI-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLS 917
T G + APE + T + DV+SFGVL E+ G P I
Sbjct: 261 ---KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------- 310
Query: 918 SNLNIALDEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
L ++L R+ P N ++L +M C P+ RPT +++ + L
Sbjct: 311 ---VEELFKLLKEGHRMDKP-ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 359
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 63/300 (21%), Positives = 115/300 (38%), Gaps = 59/300 (19%)
Query: 709 IGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
IG G G V++A +VAVK +M Q +F E + + + NI
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALMAEFDNPNI 112
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKG----------- 811
VK G C+ +++EY+ G L L + + + + +
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 812 ----------VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS 861
VA + Y+ F VHRD++++N L+ ++DFG+S+ + S
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNI---YS 226
Query: 862 NRTELAGTFGYI-----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICS 914
A I PE + Y + T + DV+++GV+ E+ G P ++
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMA---- 281
Query: 915 SLSSNLNIALDEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ + + L P N +L ++M C + P RP+ + ++L+
Sbjct: 282 ------HEEVIYYVRDGNILACP-ENCPLELYNLMR---LCWSKLPADRPSFCSIHRILQ 331
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 60/196 (30%), Positives = 89/196 (45%), Gaps = 17/196 (8%)
Query: 327 SIPNEI-TNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLS-FASLT 384
+IP+ I + + L L N L+ A LTKL L L+ NKL ++P F L
Sbjct: 30 AIPSNIPADTKKL---DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELK 85
Query: 385 SLTTLYLYENSLCDSIPKEIGD-MKSLSILDLSSNKLNGSIPLSL-ANLTNSLKVLYLSS 442
+L TL++ +N L ++P + D + +L+ L L N+L S+P + +LT L L L
Sbjct: 86 NLETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTK-LTYLSLGY 142
Query: 443 NHIVGEIPLGHGKFSSLIQL---ILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPE 499
N + +P G F L L L NN+L L +L+ L L N
Sbjct: 143 NELQ-SLP--KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEG 199
Query: 500 SLGNLVKLHYLNLSNN 515
+ +L KL L L N
Sbjct: 200 AFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-19
Identities = 61/181 (33%), Positives = 82/181 (45%), Gaps = 14/181 (7%)
Query: 245 LQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEE--IGNLKSLLHLQLNYNTLSG 302
L L N LS +F LTKL + L N L + L LK+L L + N L
Sbjct: 42 LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT--LPAGIFKELKNLETLWVTDNKLQ- 98
Query: 303 SIPLSL-GSLTNLATLYFSTNALSGSIPNEI-TNLRSLSDLQLSENTLNGSIPL-ALGNL 359
++P+ + L NLA L N L S+P + +L L+ L L N L S+P L
Sbjct: 99 ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKL 156
Query: 360 TKLVSLDLSINKLSGSIPLS-FASLTSLTTLYLYENSLCDSIPKEIGD-MKSLSILDLSS 417
T L L L N+L +P F LT L TL L N L +P+ D ++ L +L L
Sbjct: 157 TSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQL-KRVPEGAFDSLEKLKMLQLQE 214
Query: 418 N 418
N
Sbjct: 215 N 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 63/216 (29%), Positives = 92/216 (42%), Gaps = 34/216 (15%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSL-GNLTS 73
+IP I K L N+LS L RL+ L L L N L+ ++P + L +
Sbjct: 30 AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86
Query: 74 LIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSSL-GNLTNLVTLYLHMNA 131
L + + +N L ++P V L +L++LRL N L S+P + +LT L L L N
Sbjct: 87 LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNE 144
Query: 132 LSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEI-GN 190
L S+P + F LT+L L + N L +P
Sbjct: 145 LQ-SLPKGV---------------------FD--KLTSLKELRLYNNQLK-RVPEGAFDK 179
Query: 191 LKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVN 226
L L L+LD N L +F +L KL++L L N
Sbjct: 180 LTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 63/198 (31%), Positives = 86/198 (43%), Gaps = 9/198 (4%)
Query: 104 SNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFS 163
S+ L +IPS++ + L L N LS L L L ++ N L +P
Sbjct: 24 SSKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAG 79
Query: 164 L-GNLTNLVTLYIGINALSGSIPNEI-GNLKSLSDLRLDYNTLSGSILYSFGNLTKLEIL 221
+ L NL TL++ N L ++P + L +L++LRLD N L F +LTKL L
Sbjct: 80 IFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYL 138
Query: 222 YLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCS-FGNLTKLVISCLGTNALSSSI 280
L N L L L SL L+L N L +P F LT+L L N L
Sbjct: 139 SLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVP 197
Query: 281 LEEIGNLKSLLHLQLNYN 298
+L+ L LQL N
Sbjct: 198 EGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 57/185 (30%), Positives = 86/185 (46%), Gaps = 11/185 (5%)
Query: 312 TNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPL-ALGNLTKLVSLDLSIN 370
+ L +N LS L L L L++N L ++P L L +L ++ N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 371 KLSGSIPLS-FASLTSLTTLYLYENSLCDSIPKEIGD-MKSLSILDLSSNKLNGSIPLSL 428
KL ++P+ F L +L L L N L S+P + D + L+ L L N+L S+P +
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152
Query: 429 -ANLTNSLKVLYLSSNHIVGEIPLGH-GKFSSLIQLILNNNELSGQLSPELGSLNQLEYL 486
LT+ LK L L +N + +P G K + L L L+NN+L SL +L+ L
Sbjct: 153 FDKLTS-LKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKML 210
Query: 487 DLSAN 491
L N
Sbjct: 211 QLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 56/158 (35%), Positives = 81/158 (51%), Gaps = 10/158 (6%)
Query: 2 LKVLGLSFNQFSGSIPPEI-GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
L++L L+ N+ ++P I L +L+ L + N+L L +L +L L L N L
Sbjct: 63 LRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQL 121
Query: 61 KGSIPPSL-GNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSSL-G 117
K S+PP + +LT L Y+ +G N L S+P V L SL +LRL NN L +P
Sbjct: 122 K-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFD 178
Query: 118 NLTNLVTLYLHMNALSGSIPDEI-GNLKFLSDLQVSYN 154
LT L TL L N L +P+ +L+ L LQ+ N
Sbjct: 179 KLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 59/181 (32%), Positives = 81/181 (44%), Gaps = 15/181 (8%)
Query: 364 SLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEI-GDMKSLSILDLSSNKLNG 422
LDL NKLS +F LT L LYL +N L ++P I ++K+L L ++ NKL
Sbjct: 41 KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ- 98
Query: 423 SIPLSL-ANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQ---LILNNNELSGQLSPEL- 477
++P+ + L N L L L N + +P F SL + L L NEL L +
Sbjct: 99 ALPIGVFDQLVN-LAELRLDRNQLK-SLP--PRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 478 GSLNQLEYLDLSANTFHNSIPESL-GNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDL 536
L L+ L L N +PE L +L L L NNQ + + L L L L
Sbjct: 154 DKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 537 S 537
Sbjct: 213 Q 213
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 53/187 (28%), Positives = 86/187 (45%), Gaps = 20/187 (10%)
Query: 414 DLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQL---ILNNNELS 470
D SS KL +IP +N+ K L L SN + L F L +L LN+N+L
Sbjct: 22 DCSSKKLT-AIP---SNIPADTKKLDLQSNKLSS---LPSKAFHRLTKLRLLYLNDNKLQ 74
Query: 471 GQLSPEL-GSLNQLEYLDLSANTFHNSIPESL-GNLVKLHYLNLSNNQFSQKIPNPI-EK 527
L + L LE L ++ N ++P + LV L L L NQ + +P + +
Sbjct: 75 -TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDS 131
Query: 528 LIHLSELDLSY-KIFGEEIPSQVC-SMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDIS 585
L L+ L L Y ++ + +P V + SL++L L +N L F+++ L + +
Sbjct: 132 LTKLTYLSLGYNEL--QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLD 189
Query: 586 YNALQGL 592
N L+ +
Sbjct: 190 NNQLKRV 196
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 66/293 (22%), Positives = 113/293 (38%), Gaps = 53/293 (18%)
Query: 709 IGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQE---FLNEGNALTKI-R 758
+G G G V +A VAVK L A E ++E ++ + +
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKM----LK-STAHADEKEALMSELKIMSHLGQ 108
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIK-------- 810
H NIV G C+H V+ EY G L L + E +
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 811 ---GVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA 867
VA + ++ + +HRD++++NVLL + A + DFG+++ + +
Sbjct: 169 FSSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---V 222
Query: 868 GTFGYI-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLN 921
+ APE + T + DV+S+G+L E+ G +P I N
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV---------N 273
Query: 922 IALDEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+++ ++ P + SIM+ +C PT RPT Q++ L+
Sbjct: 274 SKFYKLVKDGYQMAQP-AFAPKNIYSIMQ---ACWALEPTHRPTFQQICSFLQ 322
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 34/220 (15%)
Query: 696 IIRATKNFDD-----EHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLN 749
++ +NF++ +G G V + TG+ A K G+ C+ E L+
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILH 77
Query: 750 EGNALTKIRHR-NIVKFYGFCSHALHSFVVYEYLEMGSL--------AMILSNDAAAEEF 800
E L + ++ + + ++ EY G + A ++S +
Sbjct: 78 EIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR-- 135
Query: 801 GWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAH---VSDFGISKFLK 857
IK + + + Y+H N IVH D+ +N+LL+ Y + DFG+S+ +
Sbjct: 136 -------LIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185
Query: 858 LGLSNRTELAGTFGYIAPE-LAYTMKVTEKCDVYSFGVLA 896
E+ GT Y+APE L Y +T D+++ G++A
Sbjct: 186 HA-CELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIA 223
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 9e-19
Identities = 89/438 (20%), Positives = 141/438 (32%), Gaps = 63/438 (14%)
Query: 192 KSLSDLRLDYNTLS-GSILYSFGNLTKLEILYLDVNALS----GLIPNEIGNLKSLLALQ 246
+ L + LS L + +++ LD L+ I + + +L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 247 LNYNTLSGS--------IPCSFGNLTKLVIS-CLGTNALSSSILEEIGNLKSLLHLQLNY 297
L N L + + KL + C T A + + L +L L L+
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 298 NTL--SGSIPLSLGSL---TNLATLYFSTNALS----GSIPNEITNLRSLSDLQLSENTL 348
N L +G L G L L L +LS + + + +L +S N +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 349 NGSIPLALG-----NLTKLVSLDLSINKLS----GSIPLSFASLTSLTTLYLYENSLCDS 399
N + L + +L +L L ++ + AS SL L L N L D
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
Query: 400 IPKEIGDM-----KSLSILDLSSNKL--NGSIPLSLANLTN-SLKVLYLSSNHI--VGEI 449
E+ L L + + G L SLK L L+ N + G
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302
Query: 450 PLGHG---KFSSLIQLILNNNELSGQ----LSPELGSLNQLEYLDLSANTFHNS----IP 498
L L L + + + S L L L +S N ++ +
Sbjct: 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 362
Query: 499 ESLG-NLVKLHYLNLSNNQFS----QKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSM- 552
+ LG L L L++ S + + L ELDLS G+ Q+
Sbjct: 363 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 422
Query: 553 ----QSLEKLNLSHNNLS 566
LE+L L S
Sbjct: 423 RQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-17
Identities = 88/438 (20%), Positives = 152/438 (34%), Gaps = 63/438 (14%)
Query: 146 LSDLQVSYNTLS-GAIPFSLGNLTNLVTLYIGINALS----GSIPNEIGNLKSLSDLRLD 200
+ L + LS L L + + L+ I + + +L++L L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 201 YNTLSGSILYSFGNL-----TKLEILYLDVNALS----GLIPNEIGNLKSLLALQLNYN- 250
N L ++ K++ L L L+ G++ + + L +L L L+ N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 251 -------TLSGSIPCSFGNLTKLVIS-CLGTNALSSSILEEIGNLKSLLHLQLNYNTLS- 301
L + L KL + C + A + + L ++ N ++
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 184
Query: 302 -GSIPLSLG---SLTNLATLYFSTNALS----GSIPNEITNLRSLSDLQLSENTL--NGS 351
G L G S L L + ++ + + + SL +L L N L G
Sbjct: 185 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGM 244
Query: 352 IPLALGNL---TKLVSLDLSINKLS--GSIPLSFA--SLTSLTTLYLYENSLCDSIPKEI 404
L G L ++L +L + ++ G L + SL L L N L D + +
Sbjct: 245 AELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 304
Query: 405 GDM-----KSLSILDLSSNKL--NGSIPLSLANLTN-SLKVLYLSSNHI--VGEIPLGHG 454
+ L L + S S N L L +S+N + G L G
Sbjct: 305 CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG 364
Query: 455 ---KFSSLIQLILNNNELSGQ----LSPELGSLNQLEYLDLSANTFHNSIPESLGNLVK- 506
S L L L + ++S L+ L + + L LDLS N ++ L V+
Sbjct: 365 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 424
Query: 507 ----LHYLNLSNNQFSQK 520
L L L + +S++
Sbjct: 425 PGCLLEQLVLYDIYWSEE 442
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-16
Identities = 56/295 (18%), Positives = 96/295 (32%), Gaps = 40/295 (13%)
Query: 336 RSLSDLQLSENTLN-GSIPLALGNLTKLVSLDLSINKLS--GSIPLSFA--SLTSLTTLY 390
+ L + L+ L L + + L L+ +S A +L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 391 LYENSLCDSIPKEIGDM-----KSLSILDLSSNKLN--GSIPLSLANLTN-SLKVLYLSS 442
L N L D + + L L + L G LS T +L+ L+LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 443 NHI--VGEIPLGHG---KFSSLIQLILNNNELSGQ----LSPELGSLNQLEYLDLSANTF 493
N + G L G L +L L LS L+ L + + L +S N
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 494 HNS----IPESLG-NLVKLHYLNLSNNQFS----QKIPNPIEKLIHLSELDLSYKIFGEE 544
+ + + + L + +L L L + + + + + L EL L G+
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
Query: 545 -----IPSQVCSMQSLEKLNLSHNNLS----GSISRCFEEMHWLSCIDISYNALQ 590
P + L L + ++ G + R L + ++ N L
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-15
Identities = 82/493 (16%), Positives = 154/493 (31%), Gaps = 107/493 (21%)
Query: 2 LKVLGLSFNQFSGSIPPEIGH-LTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
++ L + + S + E+ L +++ L+ +SS
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT---EARCKDISSA---------- 51
Query: 61 KGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGS-LKS----LSDLRLSNNSLN----GS 111
L +L +++ +N L + V L++ + L L N L G
Sbjct: 52 -------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGV 104
Query: 112 IPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLV 171
+ S+L L L L+L N L + L+ L + + L
Sbjct: 105 LSSTLRTLPTLQELHLSDNLLGDA------GLQLLCEGLLDPQ-------------CRLE 145
Query: 172 TLYIGINALS----GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFG-----NLTKLEILY 222
L + +LS + + + +L + N ++ + + + +LE L
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205
Query: 223 LDVNALS----GLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSS 278
L+ ++ + + + SL L L N L G L
Sbjct: 206 LESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV----------------GMAELCP 249
Query: 279 SILEEIGNLKSLLHLQLNYNTLS----GSIPLSLGSLTNLATLYFSTNALSGSIPNEI-- 332
+L L L + ++ G + L + +L L + N L +
Sbjct: 250 GLLHP---SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306
Query: 333 ---TNLRSLSDLQLSENTLNG----SIPLALGNLTKLVSLDLSINKL--SGSIPLSFA-- 381
L L + + L L+ L +S N+L +G L
Sbjct: 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLG 366
Query: 382 -SLTSLTTLYLYENSLCDSIPKEIGDM----KSLSILDLSSNKLNGS----IPLSLANLT 432
+ L L+L + + DS + SL LDLS+N L + + S+
Sbjct: 367 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 426
Query: 433 NSLKVLYLSSNHI 445
L+ L L +
Sbjct: 427 CLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 4e-08
Identities = 46/266 (17%), Positives = 96/266 (36%), Gaps = 40/266 (15%)
Query: 408 KSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI----VGEIPLGHGKFSSLIQLI 463
+ LD+ +L+ + L L +V+ L + +I +L +L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 464 LNNNELSGQ----LSPELGSLN-QLEYLDLSANTFHN----SIPESLGNLVKLHYLNLSN 514
L +NEL + L + + +++ L L + +L L L L+LS+
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 515 NQFSQKIPNPIEKLI-----HLSELDLSYKIFGEEIPSQVCSM----QSLEKLNLSHNNL 565
N + + + L +L L Y + S+ ++L +S+N++
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 566 SGS----ISRCFEEMHW-LSCIDISYN--------ALQGLIPNSTAFRDAPMLALQGNKR 612
+ + + + ++ L + + L G++ + + R+ LAL NK
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRE---LALGSNKL 239
Query: 613 LCGDIKRLPPCKAFKSHKQSLKKIWI 638
+ L C L+ +WI
Sbjct: 240 GDVGMAEL--CPGLLHPSSRLRTLWI 263
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 1e-18
Identities = 52/236 (22%), Positives = 77/236 (32%), Gaps = 51/236 (21%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKF--HSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
IG G G V A E T I A+K + + E + K+ H NI +
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 766 YGFCSHALHSFVVYEYLEMGSL---------------------------AMILSNDAAAE 798
Y + +V E G L
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 799 EFGWTKRMNA----------IKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV- 847
G+ + ++ ++ + AL Y+H I HRDI +N L + +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 848 -SDFGISKFLKLGLSNR----TELAGTFGYIAPEL--AYTMKVTEKCDVYSFGVLA 896
DFG+SK + T AGT ++APE+ KCD +S GVL
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 60/302 (19%), Positives = 110/302 (36%), Gaps = 62/302 (20%)
Query: 709 IGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQE---FLNEGNALTKI-R 758
+G+G G V A VAVK E A E ++E +T++
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-----EKADSSEREALMSELKMMTQLGS 107
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKG------- 811
H NIV G C+ + ++++EY G L L + + N +
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 812 -------------VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858
VA + ++ VHRD++++NVL+ + DFG+++ +
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSC---VHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 859 GLSNRTELAGTFGYI-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSI 912
+ + APE + T K DV+S+G+L E+ G +P I
Sbjct: 225 DSNYV---VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV- 280
Query: 913 CSSLSSNLNIALDEMLDP--RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970
+ +++ ++ P +++ IM+ SC RP+ ++
Sbjct: 281 --------DANFYKLIQNGFKMDQP-FYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSF 328
Query: 971 LK 972
L
Sbjct: 329 LG 330
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 16/216 (7%)
Query: 183 SIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSL 242
P++ L +++ + L ++ + + + + + I L ++
Sbjct: 12 IFPDDAFA--ETIKANLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNV 65
Query: 243 LALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSG 302
L L N L I + LT L L N L S L +L L L N L
Sbjct: 66 RYLALGGNKLH-DIS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ- 122
Query: 303 SIPLSL-GSLTNLATLYFSTNALSGSIPNEI-TNLRSLSDLQLSENTLNGSIPL-ALGNL 359
S+P + LTNL L + N L S+P + L +L++L LS N L S+P L
Sbjct: 123 SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKL 180
Query: 360 TKLVSLDLSINKLSGSIPL-SFASLTSLTTLYLYEN 394
T+L L L N+L S+P F LTSL ++L++N
Sbjct: 181 TQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 52/214 (24%), Positives = 83/214 (38%), Gaps = 36/214 (16%)
Query: 312 TNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINK 371
+++ + L S+ + + + + S+ + L + L L NK
Sbjct: 19 AETIKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNK 74
Query: 372 LSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGD-MKSLSILDLSSNKLNGSIPLSLAN 430
L I + LT+LT L L N L S+P + D + +L L L N+L S+P + +
Sbjct: 75 LH-DIS-ALKELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFD 130
Query: 431 LTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSA 490
+L L L+ N + L G F L L LDLS
Sbjct: 131 KLTNLTYLNLAHNQLQS---LPKGVFDKLTNL---------------------TELDLSY 166
Query: 491 NTFHNSIPESL-GNLVKLHYLNLSNNQFSQKIPN 523
N S+PE + L +L L L NQ + +P+
Sbjct: 167 NQLQ-SLPEGVFDKLTQLKDLRLYQNQL-KSVPD 198
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 56/188 (29%), Positives = 88/188 (46%), Gaps = 21/188 (11%)
Query: 289 SLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTL 348
+ L +++ + L ++ + + + + S+ I L ++ L L N L
Sbjct: 20 ETIKANLKKKSVT-DAV-TQNELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKL 75
Query: 349 NGSIPLALGNLTKLVSLDLSINKLSGSIPLS-FASLTSLTTLYLYENSLCDSIPKEIGD- 406
+ I AL LT L L L+ N+L S+P F LT+L L L EN L S+P + D
Sbjct: 76 H-DIS-ALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQL-QSLPDGVFDK 131
Query: 407 MKSLSILDLSSNKLNGSIPL----SLANLTNSLKVLYLSSNHIVGEIPLG-HGKFSSLIQ 461
+ +L+ L+L+ N+L S+P L NLT L LS N + +P G K + L
Sbjct: 132 LTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTE----LDLSYNQL-QSLPEGVFDKLTQLKD 185
Query: 462 LILNNNEL 469
L L N+L
Sbjct: 186 LRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 42/208 (20%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIG---RLSSLNGLSLYSN 58
+ + + + I +L +++ L+ N+L + L++L L L N
Sbjct: 43 IDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHDI-----SALKELTNLTYLILTGN 95
Query: 59 FLKGSIPPSL-GNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSSL 116
L+ S+P + LT+L + + N L S+P+ V L +L+ L L++N L S+P +
Sbjct: 96 QLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGV 152
Query: 117 -GNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYI 175
LTNL L L N L S+P+ + + LT L L +
Sbjct: 153 FDKLTNLTELDLSYNQLQ-SLPEGVFD-----------------------KLTQLKDLRL 188
Query: 176 GINALSGSIPNEI-GNLKSLSDLRLDYN 202
N L S+P+ + L SL + L N
Sbjct: 189 YQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 44/183 (24%), Positives = 74/183 (40%), Gaps = 18/183 (9%)
Query: 414 DLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQL 473
+S+ P + L + + + +S+ Q+I NN+++ +
Sbjct: 4 TVSTPIKQ-IFP---DDAFAETIKANLKKKSVT-DAVTQNEL-NSIDQIIANNSDI--KS 55
Query: 474 SPELGSLNQLEYLDLSANTFHNSIPESLG---NLVKLHYLNLSNNQFSQKIPNPIEKLIH 530
+ L + YL L N + L L YL L+ NQ +KL +
Sbjct: 56 VQGIQYLPNVRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTN 110
Query: 531 LSELDLSYKIFGEEIPSQVC-SMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNAL 589
L EL L + +P V + +L LNL+HN L F+++ L+ +D+SYN L
Sbjct: 111 LKELVLVENQL-QSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQL 169
Query: 590 QGL 592
Q L
Sbjct: 170 QSL 172
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 87.1 bits (215), Expect = 9e-18
Identities = 42/269 (15%), Positives = 83/269 (30%), Gaps = 13/269 (4%)
Query: 264 TKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNA 323
L + L + S L + + L S
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEK 360
Query: 324 LSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASL 383
+ + +E+ + + L +L+ +I L + L L+ ++ S +
Sbjct: 361 ST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDP--- 416
Query: 384 TSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 443
L + + + +L L+ L + L L + L LS N
Sbjct: 417 MRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLL-VTHLDLSHN 473
Query: 444 HIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHN-SIPESLG 502
+ +P L L ++N L + + +L +L+ L L N + + L
Sbjct: 474 RLR-ALPPALAALRCLEVLQASDNALE-NV-DGVANLPRLQELLLCNNRLQQSAAIQPLV 530
Query: 503 NLVKLHYLNLSNNQFSQKIPNPIEKLIHL 531
+ +L LNL N + E+L +
Sbjct: 531 SCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 85.6 bits (211), Expect = 2e-17
Identities = 51/256 (19%), Positives = 90/256 (35%), Gaps = 12/256 (4%)
Query: 312 TNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINK 371
+L + + T S + L ++ +L +LS+ K
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEK 360
Query: 372 LSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANL 431
+ + S L L +I I M++L L L L +
Sbjct: 361 ST-VLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKETLQYFSTLKAVDP 416
Query: 432 TNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSAN 491
+ + L S ++ E + +++ + L L + +L+ L L L + +LDLS N
Sbjct: 417 MRAAYLDDLRSKFLL-ENSVLKMEYADVRVLHLAHKDLT-VL-CHLEQLLLVTHLDLSHN 473
Query: 492 TFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQVC 550
++P +L L L L S+N + + L L EL L ++ +
Sbjct: 474 RLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLV 530
Query: 551 SMQSLEKLNLSHNNLS 566
S L LNL N+L
Sbjct: 531 SCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 75.2 bits (184), Expect = 5e-14
Identities = 44/239 (18%), Positives = 76/239 (31%), Gaps = 21/239 (8%)
Query: 106 NSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLG 165
L L + + + E+ + K L +L+ I +
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMR 393
Query: 166 NLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILY-----SFGNLTKLEI 220
L L+ + S LK++ +R Y S + +
Sbjct: 394 ALDPLLYEKETLQYFS--------TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRV 445
Query: 221 LYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSI 280
L+L L+ L + L + L L++N L ++P + L L + NAL +
Sbjct: 446 LHLAHKDLTVLC--HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-- 500
Query: 281 LEEIGNLKSLLHLQLNYNTLSG-SIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSL 338
++ + NL L L L N L + L S L L N+L L +
Sbjct: 501 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.4 bits (169), Expect = 3e-12
Identities = 38/238 (15%), Positives = 75/238 (31%), Gaps = 34/238 (14%)
Query: 17 PPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIY 76
+ L S + + ++ E+ L L + + +I + L L+Y
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 77 IDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSI 136
S +LK++ +R + +
Sbjct: 401 EKETLQYFS--------TLKAVDPMRAAYLDDL-------------------RSKFLLEN 433
Query: 137 PDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSD 196
+ L +++ L+ + L L + L + N L ++P + L+ L
Sbjct: 434 SVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEV 490
Query: 197 LRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGL-IPNEIGNLKSLLALQLNYNTLS 253
L+ N L + NL +L+ L L N L + + L+ L L N+L
Sbjct: 491 LQASDNAL--ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 67.5 bits (164), Expect = 1e-11
Identities = 37/179 (20%), Positives = 64/179 (35%), Gaps = 13/179 (7%)
Query: 17 PPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIY 76
+ L + K + L + P L L L N +
Sbjct: 392 MRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLEN------SVLKMEYADVRV 445
Query: 77 IDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSI 136
+ + + L+ + + + L ++ L LS+N L ++P +L L L L NAL ++
Sbjct: 446 LHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NV 501
Query: 137 PDEIGNLKFLSDLQVSYNTLSG-AIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSL 194
+ NL L +L + N L A L + LV L + N+L L +
Sbjct: 502 D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 6e-05
Identities = 33/201 (16%), Positives = 74/201 (36%), Gaps = 19/201 (9%)
Query: 440 LSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPE 499
+ L + L+ + + L EL S +L+ L+ +I
Sbjct: 332 VLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL 390
Query: 500 SLGNLVKLHYLNLSNNQFSQKIPNPIEKL--IHLSELDLSYKIFGEEIPSQVCSMQSLEK 557
+ L L Y + F + ++ + + + LD F E +
Sbjct: 391 LMRALDPLLYEKETLQYF-----STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRV 445
Query: 558 LNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDI 617
L+L+H +L+ + E++ ++ +D+S+N L+ L P A R +L N +
Sbjct: 446 LHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNA-----L 498
Query: 618 KRLPPCKAFKSHKQSLKKIWI 638
+ + ++ L+++ +
Sbjct: 499 ENVDGV----ANLPRLQELLL 515
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 48/220 (21%), Positives = 79/220 (35%), Gaps = 35/220 (15%)
Query: 692 VHEEIIRATKNFDDE----HCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQE 746
+ +++ R + F D IG G + T AVK + +E
Sbjct: 9 IVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK---SKRDPTEE 65
Query: 747 FLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL-AMILS------NDAAAEE 799
L +H NI+ + +VV E ++ G L IL +A+A
Sbjct: 66 ---IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA-- 120
Query: 800 FGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAH----VSDFGISKF 855
+ + + Y+H +VHRD+ N+L E + DFG +K
Sbjct: 121 --------VLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 856 LKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVL 895
L+ T ++APE+ CD++S GVL
Sbjct: 170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVL 209
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 49/259 (18%), Positives = 99/259 (38%), Gaps = 22/259 (8%)
Query: 332 ITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYL 391
L + L + ++ + L+ + + + + + + T+L L+L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQSLAGMQ--FFTNLKELHL 70
Query: 392 YENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPL 451
N + D P + D+ L L ++ N+L + A L+ L+L +N + L
Sbjct: 71 SHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSR----LFLDNNELRDTDSL 124
Query: 452 GHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLN 511
H +L L + NN+L + LG L++LE LDL N + L L K+++++
Sbjct: 125 IH--LKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGN--EITNTGGLTRLKKVNWID 178
Query: 512 LSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEI-PSQVCSMQSLEKLNLSHNNLS--GS 568
L+ + P++ L + G I P + + S +
Sbjct: 179 LTGQKCVN---EPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYTDE 235
Query: 569 ISRCFEEMHWLSCIDISYN 587
+S F E + + ++
Sbjct: 236 VSYKFSEYINVGETEAIFD 254
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 51/239 (21%), Positives = 91/239 (38%), Gaps = 24/239 (10%)
Query: 281 LEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSD 340
+ L + + L +++ + L+ + + + S+ + +L +
Sbjct: 12 VFPDPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKE 67
Query: 341 LQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSI 400
L LS N ++ PL +LTKL L ++ N+L L+ L+ L+L N L D
Sbjct: 68 LHLSHNQISDLSPLK--DLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRD-- 120
Query: 401 PKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLI 460
+ +K+L IL + +NKL SI L L+ L+VL L N I L +
Sbjct: 121 TDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSK-LEVLDLHGNEITNTGGLTR--LKKVN 175
Query: 461 QLILNNNELSGQ---LSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQ 516
+ L + + PEL N ++ D + P + N +
Sbjct: 176 WIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS-----PYYISNGGSYVDGCVLWEL 229
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 44/250 (17%), Positives = 92/250 (36%), Gaps = 21/250 (8%)
Query: 20 IGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDI 79
L + + K ++ L+ LS + + ++ ++ S+ + T+L + +
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHL 70
Query: 80 GNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDE 139
+N +S + + L L +L ++ N L + + + L L+L N L D
Sbjct: 71 SHNQIS-DLSP-LKDLTKLEELSVNRNRL--KNLNGIPSA-CLSRLFLDNNELRD--TDS 123
Query: 140 IGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRL 199
+ +LK L L + N L + LG L+ L L + N ++ + + LK ++ + L
Sbjct: 124 LIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWIDL 179
Query: 200 DYNTLSGSILYSFGNLTKLEILY-LDVNALSGLIPNEIGNLKSLLALQL--NYNTLSGSI 256
+ L + D +S P I N S + + + +
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKDPDGRWIS---PYYISNGGSYVDGCVLWELPVYTDEV 236
Query: 257 PCSFGNLTKL 266
F +
Sbjct: 237 SYKFSEYINV 246
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 51/219 (23%), Positives = 83/219 (37%), Gaps = 17/219 (7%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
++ + S+ + T+LK L S NQ+S L P + L+ L LS+ N LK
Sbjct: 43 VQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK 98
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
L+ L + NN L + + LK+L L + NN L SI LG L+
Sbjct: 99 NLNGIPSACLSRL---FLDNNELR-DTDS-LIHLKNLEILSIRNNKLK-SI-VMLGFLSK 151
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L L LH N ++ + + LK ++ + ++ L T+
Sbjct: 152 LEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWI 209
Query: 182 GSIPNEIGNLKSLSDLRL--DYNTLSGSILYSFGNLTKL 218
P I N S D + + + + Y F +
Sbjct: 210 S--PYYISNGGSYVDGCVLWELPVYTDEVSYKFSEYINV 246
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 43/241 (17%), Positives = 83/241 (34%), Gaps = 17/241 (7%)
Query: 140 IGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRL 199
L + +++ + L+ + + + S+ + +L +L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHL 70
Query: 200 DYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCS 259
+N +S L +LTKLE L ++ N L L L L L+ N L S
Sbjct: 71 SHNQISD--LSPLKDLTKLEELSVNRNRLKNLNGIPSACLSR---LFLDNNELRD--TDS 123
Query: 260 FGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYF 319
+L L I + N L S + +G L L L L+ N ++ + L+ L + +
Sbjct: 124 LIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITNTGGLT--RLKKVNWIDL 179
Query: 320 STNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLS 379
+ L + ++ + P + N V + + +S
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKDPDGRW--ISPYYISNGGSYVDGCVLWELPVYTDEVS 237
Query: 380 F 380
+
Sbjct: 238 Y 238
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 48/204 (23%), Positives = 73/204 (35%), Gaps = 41/204 (20%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVK-----KFHSPLPGEMACQQEFLNEGNALTKIR-HRN 761
+G G K + + AVK + E AL H N
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ-----------KEITALKLCEGHPN 67
Query: 762 IVKFYGFCSHALHSFVVYEYLEMGSL-AMILS------NDAAAEEFGWTKRMNAIKGVAD 814
IVK + LH+F+V E L G L I +A+ ++ +
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS----------YIMRKLVS 117
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLL-NLEYEAHV--SDFGISKFLKLGLSNRTELAGTFG 871
A+ +MH +VHRD+ +N+L + + DFG ++ T
Sbjct: 118 AVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH 174
Query: 872 YIAPELAYTMKVTEKCDVYSFGVL 895
Y APEL E CD++S GV+
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVI 198
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 53/230 (23%), Positives = 88/230 (38%), Gaps = 55/230 (23%)
Query: 700 TKNFDD-----EHCIGNGGQGSVYKA-ELPTGEIVAVK---KFHSPLPGEMACQQEFLNE 750
+ F+D E +G G V L T + AVK K P +E
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREV--- 61
Query: 751 GNALTKIR-HRNIVKFYGFCSHALHSFVVYEYLEMGSL-AMILSN------DAAAEEFGW 802
L + + HRN+++ F ++V+E + GS+ + I +A+
Sbjct: 62 -EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS------ 114
Query: 803 TKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVS-----DFGISKFLK 857
++ VA AL ++H I HRD+ +N+L E+ VS DF + +K
Sbjct: 115 ----VVVQDVASALDFLHNKG---IAHRDLKPENIL--CEHPNQVSPVKICDFDLGSGIK 165
Query: 858 LGLSNR-------TELAGTFGYIAPE-----LAYTMKVTEKCDVYSFGVL 895
L G+ Y+APE ++CD++S GV+
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 7e-17
Identities = 41/218 (18%), Positives = 80/218 (36%), Gaps = 26/218 (11%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVK--------------KFHSPLPGEMACQQEFLNEGNAL 754
+ G + E + A+K K ++ + +F NE +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 755 TKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNA-----I 809
T I++ + G ++ +++YEY+E S+ ++ I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 810 KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGT 869
K V ++ Y+H I HRD+ N+L++ +SDFG S+++ GT
Sbjct: 158 KSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK--IKGSRGT 213
Query: 870 FGYIAPELAYTMKVT--EKCDVYSFGVLALEVIKGKHP 905
+ ++ PE K D++S G+ + P
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 8e-17
Identities = 40/231 (17%), Positives = 84/231 (36%), Gaps = 11/231 (4%)
Query: 312 TNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINK 371
+ + IP+ + ++L L E L A NL + + +SI+
Sbjct: 11 HQEEDFRVTCKDIQ-RIPSLPPSTQTLK---LIETHLRTIPSHAFSNLPNISRIYVSIDV 66
Query: 372 LSGSIPL-SFASLTSLTTLYLYENSLCDSIPKEI-GDMKSLSILDLSSNKLNGSIPLSLA 429
+ SF +L+ +T + + I + ++ L L + + L L+
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKV 126
Query: 430 NLTNSLKVLYLSSNHIVGEIPLG--HGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLD 487
T+ +L ++ N + IP+ G + + L L NN + + + +L+ +
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVY 185
Query: 488 LSANTFHNSIPESL--GNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDL 536
L+ N + I + G L++S + +E L L +
Sbjct: 186 LNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-15
Identities = 43/237 (18%), Positives = 84/237 (35%), Gaps = 36/237 (15%)
Query: 215 LTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTN 274
+ L L L + + NL ++ + ++ + + + L ++
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSID---------------VTLQQLESH 74
Query: 275 ALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLS-LGSLTNLATLYFSTNALSGSIPNE-- 331
+ NL + H+++ I L L L L L P+
Sbjct: 75 SFY--------NLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTK 125
Query: 332 ITNLRSLSDLQLSENTLNGSIPL-ALGNLTK-LVSLDLSINKLSGSIPLSFASLTSLTTL 389
+ + L++++N SIP+ A L ++L L N + S+ + T L +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184
Query: 390 YLYENSLCDSIPKEI--GDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 444
YL +N I K+ G S+LD+S + ++P + LK L +
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALP---SKGLEHLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 36/207 (17%), Positives = 70/207 (33%), Gaps = 10/207 (4%)
Query: 23 LTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPP-SLGNLTSLIYIDIGN 81
+ L + L + H L +++ + + + + S NL+ + +I+I N
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 82 NLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIP--SSLGNLTNLVTLYLHMNALSGSIPD 138
I + L L L + N L P + + + L + N SIP
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
Query: 139 EI--GNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEI--GNLKSL 194
G L++ N + ++ N T L +Y+ N I + G
Sbjct: 149 NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 195 SDLRLDYNTLSGSILYSFGNLTKLEIL 221
S L + +++ +L +L
Sbjct: 208 SLLDVSQTSVTALPSKGLEHLKELIAR 234
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 62/319 (19%), Positives = 97/319 (30%), Gaps = 58/319 (18%)
Query: 280 ILEEIGNLKSLLHLQLNYNTLS--GSIPLS--LGSLTNLATLYFSTNALSGSIPNEITNL 335
+ + S+ + L+ NT+ + LS + S +L FS L
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83
Query: 336 RSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLS--GSIPLS--FASLTSLTTLYL 391
R L AL KL ++ LS N PL + T L LYL
Sbjct: 84 RLLLQ--------------ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 129
Query: 392 YENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI--VGEI 449
+ N L +I L A L+ + N +
Sbjct: 130 HNNGLGPQAGAKIARA------------LQELAVNKKAKNAPPLRSIICGRNRLENGSMK 177
Query: 450 PLGHG--KFSSLIQLILNNNELSGQ-----LSPELGSLNQLEYLDLSANTFHN----SIP 498
L + + N + + L L +L+ LDL NTF + ++
Sbjct: 178 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 237
Query: 499 ESLGNLVKLHYLNLSNNQFS----QKIPNPIEKLIH--LSELDLSYKIFGEE-----IPS 547
+L + L L L++ S + + KL + L L L Y +
Sbjct: 238 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 297
Query: 548 QVCSMQSLEKLNLSHNNLS 566
M L L L+ N S
Sbjct: 298 IDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 54/315 (17%), Positives = 94/315 (29%), Gaps = 65/315 (20%)
Query: 49 SLNGLSLYSNFLKG----SIPPSLGNLTSLIYIDIGNNLLSG----SIPNEVGSLKSLSD 100
S+ G SL + + S+ L S+ I + N + + + S K L
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 101 LRLSNNSLN----------GSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNL----KFL 146
S+ + +L L T+ L NA + + + + L
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 147 SDLQVSYNTLS-------------GAIPFSLGNLTNLVTLYIGINALSG----SIPNEIG 189
L + N L A+ N L ++ G N L
Sbjct: 125 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 184
Query: 190 NLKSLSDLRLDYNTL-----SGSILYSFGNLTKLEILYLDVNALSG----LIPNEIGNLK 240
+ + L +++ N + +L +L++L L N + + + +
Sbjct: 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 244
Query: 241 SLLALQLNYNTLSGS---------IPCSFGNLTKLVISC-----LGTNALSSSILEEIGN 286
+L L LN LS L L + L + I E
Sbjct: 245 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE---K 301
Query: 287 LKSLLHLQLNYNTLS 301
+ LL L+LN N S
Sbjct: 302 MPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 45/363 (12%), Positives = 103/363 (28%), Gaps = 70/363 (19%)
Query: 116 LGNLTNLVTLYLHMNALSG----SIPDEIGNLKFLSDLQVSYNTLSG----AIPFSLGNL 167
+ + + L ++A++ S+ + + ++ +S NT+ + ++ +
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 168 TNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNA 227
+L L+ L + KL + L NA
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQ--------------ALLKCPKLHTVRLSDNA 105
Query: 228 LSG----LIPNEIGNLKSLLALQLNYN--------TLSGSIPCSFGNLTKLVISCLGTNA 275
+ + + L L L+ N ++ ++ N L +
Sbjct: 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII 165
Query: 276 LSSSILEEIG---------NLKSLLHLQLNYNTL-----SGSIPLSLGSLTNLATLYFST 321
+ LE + + L +++ N + + L L L
Sbjct: 166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD 225
Query: 322 NALSG----SIPNEITNLRSLSDLQLSENTL--NGSIPLA----LGNLTKLVSLDLSINK 371
N + ++ + + +L +L L++ L G+ + L +L L N+
Sbjct: 226 NTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNE 285
Query: 372 LS--GSIPLSFA---SLTSLTTLYLYENSL------CDSIPKEIGDMKSLSILDLSSNKL 420
+ L + L L L N D I + + +L +
Sbjct: 286 IELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEE 345
Query: 421 NGS 423
Sbjct: 346 LTD 348
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 33/201 (16%), Positives = 66/201 (32%), Gaps = 41/201 (20%)
Query: 428 LANLTNSLKVLYLSSNHI--VGEIPLGHG--KFSSLIQLILNNNELSGQ----LSPELGS 479
+A S++ L + I E + + S+ +++L+ N + + LS + S
Sbjct: 1 MARF--SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIAS 58
Query: 480 LNQLEYLDLSANTFHN----------SIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLI 529
LE + S + ++L KLH + LS+N F P+ +
Sbjct: 59 KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFL 118
Query: 530 ----HLSELDLSYKIFGEE-------------IPSQVCSMQSLEKLNLSHNNLSG----S 568
L L L G + + + + L + N L
Sbjct: 119 SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE 178
Query: 569 ISRCFEEMHWLSCIDISYNAL 589
++ F+ L + + N +
Sbjct: 179 WAKTFQSHRLLHTVKMVQNGI 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 49/161 (30%), Positives = 72/161 (44%), Gaps = 15/161 (9%)
Query: 293 LQLNYNTLSGSIP--LSLGSLTNLATLYFSTNALSGSIPNEI-TNLRSLSDLQLSENTLN 349
L L++N LS + + LTNL +L S N L+ I +E + +L L LS N L+
Sbjct: 44 LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH 101
Query: 350 GSIP-LALGNLTKLVSLDLSINKLSGSIPL-SFASLTSLTTLYLYENSLCDSIPKEI--- 404
++ +L L L L N + + +F + L LYL +N + P E+
Sbjct: 102 -TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQI-SRFPVELIKD 158
Query: 405 -GDMKSLSILDLSSNKLNGSIPLSLANLTN-SLKVLYLSSN 443
+ L +LDLSSNKL L L LYL +N
Sbjct: 159 GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 8e-14
Identities = 47/191 (24%), Positives = 70/191 (36%), Gaps = 37/191 (19%)
Query: 218 LEILYLDVNALSGLIPNEI-GNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNAL 276
+L L N LS L L +L +L L++N L+ I + A
Sbjct: 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FIS---------------SEAF 84
Query: 277 SSSILEEIGNLKSLLHLQLNYNTLSGSIP-LSLGSLTNLATLYFSTNALSGSIPNEI-TN 334
+ +L +L L+ N L ++ L L L N + + +
Sbjct: 85 V--------PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFED 134
Query: 335 LRSLSDLQLSENTLNGSIP----LALGNLTKLVSLDLSINKLSGSIPLSFASLTSLT--T 388
+ L L LS+N ++ P L KL+ LDLS NKL L +
Sbjct: 135 MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193
Query: 389 LYLYENSL-CD 398
LYL+ N L CD
Sbjct: 194 LYLHNNPLECD 204
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 36/159 (22%), Positives = 58/159 (36%), Gaps = 12/159 (7%)
Query: 2 LKVLGLSFNQFSGSIPPEI--GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNF 59
+L LS N S + E LT+L L S N L+ + + +L L L SN
Sbjct: 41 TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99
Query: 60 LKGSIPP-SLGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIP---- 113
L ++ +L +L + + NN + + + L L LS N ++ P
Sbjct: 100 LH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELI 156
Query: 114 SSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVS 152
L L+ L L N L ++ L +
Sbjct: 157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 36/145 (24%), Positives = 62/145 (42%), Gaps = 13/145 (8%)
Query: 286 NLKSLLHLQLNYNTLSGSIP-LSLGSLTNLATLYFSTNALSGSIPNEI-TNLRSLSDLQL 343
L +L L L++N L+ I + + NL L S+N L ++ + ++L++L L L
Sbjct: 62 RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119
Query: 344 SENTLNGSIPL-ALGNLTKLVSLDLSINKLSGSIP----LSFASLTSLTTLYLYENSLCD 398
N + + A ++ +L L LS N++S P L L L L N L
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKK 177
Query: 399 SIPKEIGDMKSLS--ILDLSSNKLN 421
++ + + L L +N L
Sbjct: 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 8e-13
Identities = 40/139 (28%), Positives = 57/139 (41%), Gaps = 11/139 (7%)
Query: 2 LKVLGLSFNQFSGSIPPEI-GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
L L LS N + I E + +L+ L S N L L L +L L LY+N +
Sbjct: 66 LHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHI 124
Query: 61 KGSIPP-SLGNLTSLIYIDIGNNLLSGSIPNEV----GSLKSLSDLRLSNNSLNGSIPSS 115
+ + ++ L + + N +S P E+ L L L LS+N L +
Sbjct: 125 V-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTD 182
Query: 116 LGNLTNLV--TLYLHMNAL 132
L L V LYLH N L
Sbjct: 183 LQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 8/154 (5%)
Query: 149 LQVSYNTLSGAIP-FSLGNLTNLVTLYIGINALSGSIPNEI-GNLKSLSDLRLDYNTLSG 206
L +S+N LS ++ LTNL +L + N L+ I +E + +L L L N L
Sbjct: 44 LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT 102
Query: 207 SILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIP----CSFGN 262
+ F +L LE+L L N + + N ++ L L L+ N +S P
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNK 161
Query: 263 LTKLVISCLGTNALSSSILEEIGNLKSLLHLQLN 296
L KL++ L +N L L ++ L + + L
Sbjct: 162 LPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 43/162 (26%), Positives = 63/162 (38%), Gaps = 19/162 (11%)
Query: 462 LILNNNELSGQLSPE--LGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQ 519
L L++N LS +L E L L L LS N + E+ + L YL+LS+N
Sbjct: 44 LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL-H 101
Query: 520 KIPNPI-EKLIHLSELDLSY-KIFGEEIPSQV-CSMQSLEKLNLSHNNLSGSISRCFEEM 576
+ + L L L L I + M L+KL LS N +S ++
Sbjct: 102 TLDEFLFSDLQALEVLLLYNNHI--VVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDG 159
Query: 577 HWLS---CIDISYNALQGLIPNSTAFRDAP-----MLALQGN 610
+ L +D+S N L+ L + P L L N
Sbjct: 160 NKLPKLMLLDLSSNKLKKLPLT--DLQKLPAWVKNGLYLHNN 199
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 44/208 (21%), Positives = 81/208 (38%), Gaps = 39/208 (18%)
Query: 705 DEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNI 762
+ +G G G V + TG+ A+K + + E + + +I
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYD--------SPKARQEVDHHWQASGGPHI 84
Query: 763 VKFYGFCSHALHS----FVVYEYLEMGSL--------AMILSNDAAAEEFGWTKRMNAIK 810
V + H ++ E +E G L + AAE ++
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAE---------IMR 135
Query: 811 GVADALLYMHTNCFPPIVHRDISSKNVLL-NLEYEAHV--SDFGISKFLKLGLSNRTELA 867
+ A+ ++H++ I HRD+ +N+L + E +A + +DFG +K
Sbjct: 136 DIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC 190
Query: 868 GTFGYIAPELAYTMKVTEKCDVYSFGVL 895
T Y+APE+ K + CD++S GV+
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 55/154 (35%), Positives = 74/154 (48%), Gaps = 8/154 (5%)
Query: 245 LQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSI 304
L L L+ +F LTKL L N L + +L L L L N L+ S+
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SL 98
Query: 305 PLSL-GSLTNLATLYFSTNALSGSIPNEI-TNLRSLSDLQLSENTLNGSIPL-ALGNLTK 361
PL + LT L LY N L S+P+ + L L +L+L+ N L SIP A LT
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTN 156
Query: 362 LVSLDLSINKLSGSIPL-SFASLTSLTTLYLYEN 394
L +L LS N+L S+P +F L L T+ L+ N
Sbjct: 157 LQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 53/171 (30%), Positives = 73/171 (42%), Gaps = 15/171 (8%)
Query: 327 SIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLS-FASLTS 385
S+P+ I L L L LTKL L+L N+L ++ F LT
Sbjct: 28 SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84
Query: 386 LTTLYLYENSLCDSIPKEIGD-MKSLSILDLSSNKLNGSIPLSL-ANLTNSLKVLYLSSN 443
L TL L N L S+P + D + L L L N+L S+P + LT LK L L++N
Sbjct: 85 LGTLGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTK-LKELRLNTN 141
Query: 444 HIVGEIPLGHGKFSSLIQL---ILNNNELSGQLSPELGSLNQLEYLDLSAN 491
+ IP G F L L L+ N+L L +L+ + L N
Sbjct: 142 QL-QSIP--AGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 51/156 (32%), Positives = 69/156 (44%), Gaps = 8/156 (5%)
Query: 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKG 62
+ L L + LT L L+ NQL L L+ L L L +N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 63 SIPPSL-GNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSSL-GNL 119
S+P + +LT L + +G N L S+P+ V L L +LRL+ N L SIP+ L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 120 TNLVTLYLHMNALSGSIPDEI-GNLKFLSDLQVSYN 154
TNL TL L N L S+P L L + + N
Sbjct: 155 TNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 44/136 (32%), Positives = 58/136 (42%), Gaps = 14/136 (10%)
Query: 2 LKVLGLSFNQFSGSIPPEI-GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
L L L +NQ ++ + LT L L + NQL+ L L+ L+ L L N L
Sbjct: 61 LTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQL 119
Query: 61 KGSIPP----SLGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIP-S 114
K S+P L L L + N L SIP L +L L LS N L S+P
Sbjct: 120 K-SLPSGVFDRLTKLKEL---RLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHG 173
Query: 115 SLGNLTNLVTLYLHMN 130
+ L L T+ L N
Sbjct: 174 AFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 50/162 (30%), Positives = 73/162 (45%), Gaps = 13/162 (8%)
Query: 312 TNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPL-ALGNLTKLVSLDLSIN 370
+ L + L+ L L+ L L N L ++ +LT+L +L L+ N
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANN 93
Query: 371 KLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGD-MKSLSILDLSSNKLNGSIPLSL- 428
+L+ F LT L LYL N L S+P + D + L L L++N+L SIP
Sbjct: 94 QLASLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF 151
Query: 429 ANLTNSLKVLYLSSNHIVGEIPLGHGKF---SSLIQLILNNN 467
LTN L+ L LS+N + +P HG F L + L N
Sbjct: 152 DKLTN-LQTLSLSTNQLQS-VP--HGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 51/177 (28%), Positives = 69/177 (38%), Gaps = 30/177 (16%)
Query: 53 LSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGS 111
L L S L + LT L ++++ N L ++ V L L L L+NN L S
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 112 IPSSL-GNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNL 170
+P + +LT L LYL N L S+P + F LT L
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGV---------------------FD--RLTKL 133
Query: 171 VTLYIGINALSGSIPNEI-GNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVN 226
L + N L SIP L +L L L N L +F L KL+ + L N
Sbjct: 134 KELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 28/110 (25%), Positives = 52/110 (47%), Gaps = 8/110 (7%)
Query: 461 QLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESL-GNLVKLHYLNLSNNQFSQ 519
+L L + L+ L +L +L+L N ++ + +L +L L L+NNQ
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQL-A 96
Query: 520 KIPNPI-EKLIHLSELDLSY-KIFGEEIPSQVC-SMQSLEKLNLSHNNLS 566
+P + + L L +L L ++ + +PS V + L++L L+ N L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQL--KSLPSGVFDRLTKLKELRLNTNQLQ 144
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 58/281 (20%), Positives = 92/281 (32%), Gaps = 56/281 (19%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVK-------KFHSPLPGEMACQQEFLNEGNALTKIRHR 760
+G GG G+V+ L VA+K SPL + C E H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGS--LAMILSNDAAAEE-----FGWTKRMNAIKGVA 813
+++ + +V E I E F V
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF---------GQVV 149
Query: 814 DALLYMHTNCFPPIVHRDISSKNVLLNLEY-EAHVSDFGISKFLKLGLSNRTELAGTFGY 872
A+ + H+ +VHRDI +N+L++L A + DFG L GT Y
Sbjct: 150 AAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF--DGTRVY 204
Query: 873 IAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML 928
PE Y V+S G+L +++ G P + I +
Sbjct: 205 SPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIPFERDQEILEA------------- 248
Query: 929 DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969
+ P + LI CL P+SRP+++++
Sbjct: 249 ELHFPAHVSPDCCALIR------RCLAPKPSSRPSLEEILL 283
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 7e-15
Identities = 63/326 (19%), Positives = 104/326 (31%), Gaps = 52/326 (15%)
Query: 293 LQLNYNTLSGSIPLS--LGSLTNLATLYFSTNALSGSIPNEI-----TNLRSLSDLQLSE 345
+ GS P+ + +L S N L E+ S++ L LS
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 346 NTL--NGSIPLA---LGNLTKLVSLDLSINKLS--GSIPLSFA---SLTSLTTLYLYENS 395
N+L S L + SL+LS N LS S L ++T L L N
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120
Query: 396 LCDSIPKEIGDM-----KSLSILDLSSNKLN--GSIPLS--LANLTNSLKVLYLSSNHI- 445
E S++ L+L N L S L LA + ++ L L N++
Sbjct: 121 FSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180
Query: 446 -VGEIPLGHG---KFSSLIQLILNNNELSGQLSPELGSL-----NQLEYLDLSANTFHNS 496
L +S+ L L+ N L + EL + N + L+L N H
Sbjct: 181 SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP 240
Query: 497 ----IPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLI-------HLSELDLSYKIFGEEI 545
+ +L L + L + + L + +D + K
Sbjct: 241 SLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSH 300
Query: 546 PSQVCSM-----QSLEKLNLSHNNLS 566
+ ++ + +L + L
Sbjct: 301 SIPISNLIRELSGKADVPSLLNQCLI 326
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 69/338 (20%), Positives = 116/338 (34%), Gaps = 58/338 (17%)
Query: 262 NLTKLVISCLGTNALSSSILEEIG-----NLKSLLHLQLNYNTLSGSIPLSLGSL----- 311
+T L L N L S E+ S+ L L+ N+L L +
Sbjct: 23 GVTSL---DLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79
Query: 312 TNLATLYFSTNALSGSIPNEI-----TNLRSLSDLQLSENTL--NGSIPLA---LGNLTK 361
N+ +L S N LS +E+ +++ L L N S
Sbjct: 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139
Query: 362 LVSLDLSINKLS--GSIPLSFA---SLTSLTTLYLYENSLCDSIPKEIGDM-----KSLS 411
+ SL+L N L S L ++ +L L N+L E+ S++
Sbjct: 140 ITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVT 199
Query: 412 ILDLSSNKLN--GSIPLS--LANLTNSLKVLYLSSNHI----VGEIPLGHGKFSSLIQLI 463
LDLS+N L L+ +++ N + L L N + + + L L +
Sbjct: 200 SLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVY 259
Query: 464 LNNNELSGQ-------LSPELGSLNQLEYLDLSANTFHNSIPESLGNLVK-----LHYLN 511
L+ + + L ++ ++ +D + H S + NL++ +
Sbjct: 260 LDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPS 319
Query: 512 LSNN--QFSQKIPNPIEKL---IHLSELDLSYKIFGEE 544
L N F+QK IE L L E + K E
Sbjct: 320 LLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPLLEH 357
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 68/351 (19%), Positives = 119/351 (33%), Gaps = 55/351 (15%)
Query: 270 CLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSL-----TNLATLYFSTNAL 324
L + S+ + E + L L+ N L + L ++ +L S N+L
Sbjct: 4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSL 63
Query: 325 SGSIPNEI-----TNLRSLSDLQLSENTLN--GSIPLALG---NLTKLVSLDLSINKLS- 373
+E+ +++ L LS N L+ S L + LDL N S
Sbjct: 64 GFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSS 123
Query: 374 -GSIPLSFA---SLTSLTTLYLYENSLCDSIPKEIGDM-----KSLSILDLSSNKL--NG 422
S A S+T+L L N L E+ + +++ L+L N L
Sbjct: 124 KSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKN 183
Query: 423 SIPLS--LANLTNSLKVLYLSSNHI--VGEIPLGHG---KFSSLIQLILNNNELSGQ--- 472
L+ LA++ S+ L LS+N + L + + ++ L L N L G
Sbjct: 184 CAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLE 243
Query: 473 -LSPELGSLNQLEYLDLSANTFHN-------SIPESLGNLVKLHYLNLSNNQFS----QK 520
L SL L+ + L + N ++ + N+ K+ ++ + +
Sbjct: 244 NLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIP 303
Query: 521 IPNPIEKL-IHLSELDLSYKIFGEEIPSQVCSM-----QSLEKLNLSHNNL 565
I N I +L L + Q L + + L
Sbjct: 304 ISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 7e-15
Identities = 56/228 (24%), Positives = 88/228 (38%), Gaps = 50/228 (21%)
Query: 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTK 756
F +G GG G V ++ TG++ A K K A LNE L K
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA---LNEKQILEK 240
Query: 757 IRHRNIVK-FYGFCSHALHSFVVYEYLEMGSLAMILSNDA------------AAEEFGWT 803
+ R +V Y + + +V + G L + + AAE
Sbjct: 241 VNSRFVVSLAYAYETKD-ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE----- 294
Query: 804 KRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLS 861
+ L +H IV+RD+ +N+LL+ H+ SD G++ + G +
Sbjct: 295 --------ICCGLEDLHRER---IVYRDLKPENILLD--DHGHIRISDLGLAVHVPEGQT 341
Query: 862 NRTELAGTFGYIAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
+ GT GY+APE+ YT D ++ G L E+I G+ P
Sbjct: 342 IKG-RVGTVGYMAPEVVKNERYTFSP----DWWALGCLLYEMIAGQSP 384
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 9e-15
Identities = 37/131 (28%), Positives = 56/131 (42%), Gaps = 6/131 (4%)
Query: 3 KVLGLSFNQFSGSIPPEI-GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
+ L N IPP L+ + S NQ+S L P L SLN L LY N +
Sbjct: 35 TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 62 GSIPPSL-GNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSSLGNL 119
+P SL L SL + + N ++ + + L +L+ L L +N L + L
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 120 TNLVTLYLHMN 130
+ T++L N
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 32/135 (23%), Positives = 60/135 (44%), Gaps = 7/135 (5%)
Query: 312 TNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPL-ALGNLTKLVSLDLSIN 370
+ + N + P + + L + LS N ++ + A L L SL L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 371 KLSGSIPLS-FASLTSLTTLYLYENSLCDSIPKEIGD-MKSLSILDLSSNKLNGSIPLSL 428
K++ +P S F L SL L L N + + + + + +L++L L NKL +I
Sbjct: 91 KIT-ELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGT 147
Query: 429 ANLTNSLKVLYLSSN 443
+ +++ ++L+ N
Sbjct: 148 FSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 30/112 (26%), Positives = 53/112 (47%), Gaps = 6/112 (5%)
Query: 286 NLKSLLHLQLNYNTLSGSIPL-SLGSLTNLATLYFSTNALSGSIPNEI-TNLRSLSDLQL 343
K L + L+ N +S + + L +L +L N ++ +P + L SL L L
Sbjct: 54 PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLL 111
Query: 344 SENTLNGSIPL-ALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYEN 394
+ N +N + + A +L L L L NKL +F+ L ++ T++L +N
Sbjct: 112 NANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 32/155 (20%), Positives = 57/155 (36%), Gaps = 29/155 (18%)
Query: 365 LDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGD-MKSLSILDLSSNKLNGS 423
+ L N + P +F+ L + L N + + + ++SL+ L L NK+
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT-E 94
Query: 424 IPLSL-ANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQ 482
+P SL L + L++L L++N I + F L +
Sbjct: 95 LPKSLFEGLFS-LQLLLLNANKIN-CLR--VDAFQDL---------------------HN 129
Query: 483 LEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQF 517
L L L N + L + ++L+ N F
Sbjct: 130 LNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 37/154 (24%), Positives = 61/154 (39%), Gaps = 32/154 (20%)
Query: 53 LSLYSNFLKGSIPP-SLGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNG 110
+ L N +K IPP + L ID+ NN +S + + L+SL+ L L N +
Sbjct: 37 IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 111 SIPSSL-GNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTN 169
+P SL L +L L L+ N ++ + + F +L N
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRVDA---------------------FQ--DLHN 129
Query: 170 LVTLYIGINALSGSIPNEI-GNLKSLSDLRLDYN 202
L L + N L +I L+++ + L N
Sbjct: 130 LNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 26/108 (24%), Positives = 48/108 (44%), Gaps = 6/108 (5%)
Query: 2 LKVLGLSFNQFSGSIPPEI-GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
L+ + LS NQ S + P+ L L L N+++ L L SL L L +N +
Sbjct: 58 LRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKI 116
Query: 61 KGSIPP-SLGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNN 106
+ + +L +L + + +N L +I L+++ + L+ N
Sbjct: 117 N-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 30/132 (22%), Positives = 51/132 (38%), Gaps = 2/132 (1%)
Query: 168 TNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNA 227
+ + + N + P K L + L N +S +F L L L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 228 LSGLIPNEIGNLKSLLALQLNYNTLSGSIPC-SFGNLTKLVISCLGTNALSSSILEEIGN 286
++ L + L SL L LN N ++ + +F +L L + L N L +
Sbjct: 92 ITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150
Query: 287 LKSLLHLQLNYN 298
L+++ + L N
Sbjct: 151 LRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 29/127 (22%), Positives = 53/127 (41%), Gaps = 2/127 (1%)
Query: 149 LQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEI-GNLKSLSDLRLDYNTLSGS 207
+++ NT+ P + L + + N +S + + L+SL+ L L N ++
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITEL 95
Query: 208 ILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLV 267
F L L++L L+ N ++ L + +L +L L L N L +F L +
Sbjct: 96 PKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQ 155
Query: 268 ISCLGTN 274
L N
Sbjct: 156 TMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 30/113 (26%), Positives = 53/113 (46%), Gaps = 8/113 (7%)
Query: 484 EYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPI-EKLIHLSELDLSY-KIF 541
+ L NT P + KL ++LSNNQ ++ + L L+ L L KI
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKI- 92
Query: 542 GEEIPSQV-CSMQSLEKLNLSHNNLSGSISR-CFEEMHWLSCIDISYNALQGL 592
E+P + + SL+ L L+ N ++ + F+++H L+ + + N LQ +
Sbjct: 93 -TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTI 143
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 48/223 (21%)
Query: 709 IGNGGQGSVYKAEL-PTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
IG G V ++ TG++ A+K K+ GE++C F E + L R I +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC---FREERDVLVNGDRRWITQ 125
Query: 765 -FYGFCSHALHSFVVYEYLEMGSLAMILSNDA-----------AAEEFGWTKRMNAIKGV 812
+ F + ++V EY G L +LS AE +
Sbjct: 126 LHFAFQDEN-YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE-------------I 171
Query: 813 ADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSNRTELA-GT 869
A+ +H VHRDI N+LL+ H+ +DFG L+ + R+ +A GT
Sbjct: 172 VMAIDSVHRLG---YVHRDIKPDNILLD--RCGHIRLADFGSCLKLRADGTVRSLVAVGT 226
Query: 870 FGYIAPELAYTMKVTEK-------CDVYSFGVLALEVIKGKHP 905
Y++PE+ + CD ++ GV A E+ G+ P
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 48/209 (22%), Positives = 87/209 (41%), Gaps = 38/209 (18%)
Query: 709 IGNGGQGSVYKA---ELPTGEIVAVKKFHSP-LPGEMACQQEFLNEGNALTKIRHRNIVK 764
+G G G VYKA + + A+K+ + + L E ++H N++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRE------LKHPNVIS 82
Query: 765 FYG-FCSHALHS-FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNA--IKGVA----DAL 816
F SHA +++++Y E L I+ A++ ++ +K + D +
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 817 LYMHTNCFPPIVHRDISSKNVLLNLEYEAH----VSDFGISKFLKLGLSNRTELAG---T 869
Y+H N ++HRD+ N+L+ E ++D G ++ L +L T
Sbjct: 142 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 870 FGYIAPEL-----AYTMKVTEKCDVYSFG 893
F Y APEL YT + D+++ G
Sbjct: 199 FWYRAPELLLGARHYTKAI----DIWAIG 223
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 45/204 (22%), Positives = 77/204 (37%), Gaps = 38/204 (18%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFY 766
+G G G V + T E A+K + E + + +IV+
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIV 121
Query: 767 GFC----SHALHSFVVYEYLEMGSL--------AMILSNDAAAEEFGWTKRMNAIKGVAD 814
+ +V E L+ G L + A+E +K + +
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE---------IMKSIGE 172
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAH---VSDFGISKFLKLGLSNRTELAGTFG 871
A+ Y+H+ I HRD+ +N+L + ++DFG +K S T T
Sbjct: 173 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPY 228
Query: 872 YIAPELAYTMKVTEKCDVYSFGVL 895
Y+APE+ K + CD++S GV+
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVI 252
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 61/277 (22%), Positives = 98/277 (35%), Gaps = 50/277 (18%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTKIRHR--NI 762
+G+GG GSVY + VA+K K GE+ E L K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 763 VKFYGFCSHALHSFVVYEYLE-MGSL-AMILSNDAAAEEFGWTKRMNAIKG---VADALL 817
++ + ++ E E + L I A EE A V +A+
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQVLEAVR 163
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEY-EAHVSDFGISKFLKLGLSNRTELAGTFGYIAPE 876
+ H ++HRDI +N+L++L E + DFG LK + GT Y PE
Sbjct: 164 HCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF--DGTRVYSPPE 218
Query: 877 L----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932
Y + V+S G+L +++ G P + I
Sbjct: 219 WIRYHRYHGR---SAAVWSLGILLYDMVCGDIPFEHDEEIIRG-------------QVFF 262
Query: 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969
+ + LI CL P+ RPT +++
Sbjct: 263 RQRVSSECQHLIR------WCLALRPSDRPTFEEIQN 293
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 55/261 (21%), Positives = 94/261 (36%), Gaps = 54/261 (20%)
Query: 701 KNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVK-----KFHSPLPGEMACQQEFLNEGNAL 754
+ + +G+G G V+ A + V VK K E + E L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 755 TKIRHRNIVKFYGFCSHALHSFVVYEYLEMG-------SLAMILSNDAAAEEFGWTKRMN 807
+++ H NI+K + +V E G L A+ F
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF------- 136
Query: 808 AIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA 867
+ + A+ Y+ I+HRDI +N+++ ++ + DFG + +L+ G T
Sbjct: 137 --RQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FC 190
Query: 868 GTFGYIAPEL----AYTMKVTEKCDVYSFGVL--AL-----------EVIKGK-HPRDFI 909
GT Y APE+ Y + +++S GV L E ++ HP +
Sbjct: 191 GTIEYCAPEVLMGNPYRGP---ELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLV 247
Query: 910 SSICSSLSSNLNIALDEMLDP 930
S SL + +L P
Sbjct: 248 SKELMSL-------VSGLLQP 261
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 47/210 (22%), Positives = 84/210 (40%), Gaps = 35/210 (16%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR--------- 758
+G G G V K TG IVA+KKF + ++ +R
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFL----------ESDDDKMVKKIAMREIKLLKQLR 82
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLY 818
H N+V C ++V+E+++ ++ L + + + + + + +
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL- 877
H++ I+HRDI +N+L++ + DFG ++ L + T Y APEL
Sbjct: 140 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL 196
Query: 878 ----AYTMKVTEKCDVYSFGVLALEVIKGK 903
Y V DV++ G L E+ G+
Sbjct: 197 VGDVKYGKAV----DVWAIGCLVTEMFMGE 222
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 63/275 (22%), Positives = 107/275 (38%), Gaps = 47/275 (17%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
IG G V A + TG VA+K + Q+ F E + + H NIVK +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81
Query: 768 FCSHALHSFVVYEYLEMGSL-AMI-----LSNDAAAEEFGWTKRMNAIKGVADALLYMHT 821
+++ EY G + + + A +F + + A+ Y H
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF---------RQIVSAVQYCHQ 132
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL---- 877
IVHRD+ ++N+LL+ + ++DFG S +G G Y APEL
Sbjct: 133 KR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-CGAPPYAAPELFQGK 188
Query: 878 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL- 936
Y + DV+S GV+ ++ G P D NL + +L + P
Sbjct: 189 KYDGP---EVDVWSLGVILYTLVSGSLPFD---------GQNLKELRERVLRGKYRIPFY 236
Query: 937 --RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969
+ ++ L+ L +P R T++++ +
Sbjct: 237 MSTDCEN-LLKRF------LVLNPIKRGTLEQIMK 264
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 4e-13
Identities = 56/230 (24%), Positives = 89/230 (38%), Gaps = 51/230 (22%)
Query: 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTK 756
F D +G GG G V+ ++ TG++ A K K + E L K
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAK 241
Query: 757 IRHRNIVK-FYGFCSHALHSFVVYEYLEMGSLAMILSNDA--------------AAEEFG 801
+ R IV Y F + +V + G + + N A+
Sbjct: 242 VHSRFIVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ--- 297
Query: 802 WTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLG 859
+ L ++H I++RD+ +NVLL+ + +V SD G++ LK G
Sbjct: 298 ----------IVSGLEHLHQRN---IIYRDLKPENVLLD--DDGNVRISDLGLAVELKAG 342
Query: 860 LSNRTELAGTFGYIAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
+ AGT G++APEL Y V D ++ GV E+I + P
Sbjct: 343 QTKTKGYAGTPGFMAPELLLGEEYDFSV----DYFALGVTLYEMIAARGP 388
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 43/154 (27%), Positives = 62/154 (40%), Gaps = 33/154 (21%)
Query: 245 LQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSI 304
L L+ N ++ P F +L L LG+N L +
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-------------------------- 78
Query: 305 PLSLG---SLTNLATLYFSTNALSGSIPNEI-TNLRSLSDLQLSENTLNGSIPLALGNLT 360
L +G SLT L L TN L+ +P+ + L L +L + N L +P + LT
Sbjct: 79 -LPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLT 135
Query: 361 KLVSLDLSINKLSGSIPLSFASLTSLTTLYLYEN 394
L L L N+L +F L+SLT YL+ N
Sbjct: 136 HLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 37/132 (28%), Positives = 53/132 (40%), Gaps = 9/132 (6%)
Query: 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKG 62
++L L NQ + P L +LK L NQL L L+ L L L +N L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 63 SIPP----SLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGN 118
+P L +L L + N L+ +P + L L+ L L N L +
Sbjct: 102 VLPSAVFDRLVHLKEL---FMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDR 157
Query: 119 LTNLVTLYLHMN 130
L++L YL N
Sbjct: 158 LSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 43/134 (32%), Positives = 67/134 (50%), Gaps = 6/134 (4%)
Query: 312 TNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLAL-GNLTKLVSLDLSIN 370
TN LY N ++ P +L +L +L L N L ++P+ + +LT+L LDL N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98
Query: 371 KLSGSIPLS-FASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLA 429
+L+ +P + F L L L++ N L +P+ I + L+ L L N+L SIP
Sbjct: 99 QLT-VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK-SIPHGAF 155
Query: 430 NLTNSLKVLYLSSN 443
+ +SL YL N
Sbjct: 156 DRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 40/134 (29%), Positives = 54/134 (40%), Gaps = 7/134 (5%)
Query: 168 TNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYN---TLSGSILYSFGNLTKLEILYLD 224
TN LY+ N ++ P +L +L +L L N L + F +LT+L +L L
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGV---FDSLTQLTVLDLG 96
Query: 225 VNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEI 284
N L+ L L L L + N L+ +P LT L L N L S
Sbjct: 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAF 155
Query: 285 GNLKSLLHLQLNYN 298
L SL H L N
Sbjct: 156 DRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 40/152 (26%), Positives = 55/152 (36%), Gaps = 29/152 (19%)
Query: 197 LRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSI 256
L L N ++ F +L L+ LYL N L L +L L L L N L+ +
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VL 103
Query: 257 PCS-FGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLA 315
P + F L L L + N L+ +P + LT+L
Sbjct: 104 PSAVFDRLVHLK------------------------ELFMCCNKLT-ELPRGIERLTHLT 138
Query: 316 TLYFSTNALSGSIPNEI-TNLRSLSDLQLSEN 346
L N L SIP+ L SL+ L N
Sbjct: 139 HLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 38/133 (28%), Positives = 62/133 (46%), Gaps = 12/133 (9%)
Query: 364 SLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGD-MKSLSILDLSSNKLNG 422
L L N+++ P F SL +L LYL N L ++P + D + L++LDL +N+L
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 423 SIPL----SLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELG 478
+P L +L L++ N + E+P G + + L L L+ N+L
Sbjct: 102 VLPSAVFDRLVHLKE----LFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFD 156
Query: 479 SLNQLEYLDLSAN 491
L+ L + L N
Sbjct: 157 RLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 40/132 (30%), Positives = 56/132 (42%), Gaps = 13/132 (9%)
Query: 101 LRLSNNSLNGSIPSSLGNLTNLVTLYLHMN---ALSGSIPDEIGNLKFLSDLQVSYNTLS 157
L L +N + P +L NL LYL N AL + D + L L + N L+
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT---VLDLGTNQLT 101
Query: 158 GAIP---FSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGN 214
+P F L +L L++ N L+ +P I L L+ L LD N L +F
Sbjct: 102 -VLPSAVFD--RLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDR 157
Query: 215 LTKLEILYLDVN 226
L+ L YL N
Sbjct: 158 LSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 42/141 (29%), Positives = 60/141 (42%), Gaps = 5/141 (3%)
Query: 111 SIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNL 170
S+P+ G TN LYLH N ++ P +L L +L + N L +LT L
Sbjct: 33 SVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90
Query: 171 VTLYIGINALSGSIPNEI-GNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALS 229
L +G N L+ +P+ + L L +L + N L+ + LT L L LD N L
Sbjct: 91 TVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK 148
Query: 230 GLIPNEIGNLKSLLALQLNYN 250
+ L SL L N
Sbjct: 149 SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 38/125 (30%), Positives = 60/125 (48%), Gaps = 12/125 (9%)
Query: 417 SNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPE 476
+K + S+P A + + ++LYL N I P +L +L L +N+L +
Sbjct: 27 RSKRHASVP---AGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG---ALP 80
Query: 477 LG---SLNQLEYLDLSANTFHNSIPESL-GNLVKLHYLNLSNNQFSQKIPNPIEKLIHLS 532
+G SL QL LDL N +P ++ LV L L + N+ ++P IE+L HL+
Sbjct: 81 VGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLT 138
Query: 533 ELDLS 537
L L
Sbjct: 139 HLALD 143
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 37/137 (27%), Positives = 59/137 (43%), Gaps = 10/137 (7%)
Query: 384 TSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 443
T+ LYL++N + P + +L L L SN+L ++P+ + + L VL L +N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98
Query: 444 HIVGEIPLGHGKFSSLIQLI---LNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPE- 499
+ L F L+ L + N+L+ L + L L +L L N SIP
Sbjct: 99 QLTV---LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL-KSIPHG 153
Query: 500 SLGNLVKLHYLNLSNNQ 516
+ L L + L N
Sbjct: 154 AFDRLSSLTHAYLFGNP 170
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 31/135 (22%), Positives = 62/135 (45%), Gaps = 9/135 (6%)
Query: 3 KVLGLSFNQFSGSIPPEIG--HLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
L L+ N+F+ + L L+ ++FS N+++ + S +N + L SN L
Sbjct: 35 AELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL 93
Query: 61 KGSIPPSL-GNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIP-SSLG 117
+ ++ + L SL + + +N ++ + N+ L S+ L L +N + ++ +
Sbjct: 94 E-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFD 150
Query: 118 NLTNLVTLYLHMNAL 132
L +L TL L N
Sbjct: 151 TLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 33/145 (22%), Positives = 63/145 (43%), Gaps = 16/145 (11%)
Query: 328 IPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLT 387
IP LR L++ + + G L +L ++ S NK++ +F + +
Sbjct: 30 IPQYTAELR-LNNNEFTVLEATG----IFKKLPQLRKINFSNNKITDIEEGAFEGASGVN 84
Query: 388 TLYLYENSLCDSIPKEIGD-MKSLSILDLSSNKLNGSIPL-SLANLTNSLKVLYLSSNHI 445
+ L N L +++ ++ ++SL L L SN++ + S L++ +++L L N I
Sbjct: 85 EILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSS-VRLLSLYDNQI 141
Query: 446 VGEIPLGHGKFSSLIQL---ILNNN 467
+ G F +L L L N
Sbjct: 142 T-TVA--PGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 31/184 (16%), Positives = 62/184 (33%), Gaps = 54/184 (29%)
Query: 219 EILYLDVNALSGLIPNEI-GNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALS 277
L L+ N + L I L L + + N ++ +F + +
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVN---------- 84
Query: 278 SSILEEIGNLKSLLHLQLNYNTLSGSIPLSL-GSLTNLATLYFSTNALSGSIPNEITNLR 336
+ L N L ++ + L +L TL +N ++ + N+
Sbjct: 85 --------------EILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGND----- 123
Query: 337 SLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPL-SFASLTSLTTLYLYENS 395
+ L+ + L L N+++ ++ +F +L SL+TL L N
Sbjct: 124 ------------------SFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANP 164
Query: 396 L-CD 398
C+
Sbjct: 165 FNCN 168
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 25/111 (22%), Positives = 47/111 (42%), Gaps = 6/111 (5%)
Query: 2 LKVLGLSFNQFSGSIPPEI-GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
L+ + S N+ + I + + + + N+L + L SL L L SN +
Sbjct: 59 LRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRI 117
Query: 61 KGSIPP-SLGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLN 109
+ S L+S+ + + +N ++ ++ +L SLS L L N N
Sbjct: 118 T-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 28/142 (19%), Positives = 53/142 (37%), Gaps = 11/142 (7%)
Query: 64 IPPSLGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSSLGNLTNL 122
IP L + NN + + L L + SNN + + + +
Sbjct: 30 IPQYTAEL------RLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 123 VTLYLHMNALSGSIPDEI-GNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
+ L N L ++ ++ L+ L L + N ++ S L+++ L + N ++
Sbjct: 84 NEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142
Query: 182 GSIPNEI-GNLKSLSDLRLDYN 202
++ L SLS L L N
Sbjct: 143 -TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 32/175 (18%), Positives = 59/175 (33%), Gaps = 30/175 (17%)
Query: 104 SNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEI-GNLKFLSDLQVSYNTLSGAIPF 162
SN LN IP + L L+ N + I L L + S N ++
Sbjct: 19 SNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEG 75
Query: 163 SLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILY 222
+ + + + + N L ++ +++ F L L+ L
Sbjct: 76 AFEGASGVNEILLTSNRLE-NVQHKM-----------------------FKGLESLKTLM 111
Query: 223 LDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPC-SFGNLTKLVISCLGTNAL 276
L N ++ + + L S+ L L N ++ ++ +F L L L N
Sbjct: 112 LRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 31/143 (21%), Positives = 54/143 (37%), Gaps = 12/143 (8%)
Query: 399 SIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSS 458
IP+ I + + L L++N+ + L+ + S+N I + G F
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD---IEEGAFEG 79
Query: 459 LIQ---LILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPE-SLGNLVKLHYLNLSN 514
++L +N L L L+ L L +N + S L + L+L +
Sbjct: 80 ASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYD 138
Query: 515 NQFSQKIPNPI-EKLIHLSELDL 536
NQ + + L LS L+L
Sbjct: 139 NQI-TTVAPGAFDTLHSLSTLNL 160
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 8e-13
Identities = 57/229 (24%), Positives = 92/229 (40%), Gaps = 46/229 (20%)
Query: 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTK 756
++F+ IG G G V +L ++ A+K K+ E AC F E + L
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC---FREERDVLVN 130
Query: 757 IRHRNIVK-FYGFCSHALHSFVVYEYLEMGSLAMILSNDA-----------AAEEFGWTK 804
+ I Y F + ++V +Y G L +LS AE
Sbjct: 131 GDSKWITTLHYAFQDDN-NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE------ 183
Query: 805 RMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSN 862
+ A+ +H VHRDI N+L++ H+ +DFG L +
Sbjct: 184 -------MVIAIDSVHQLH---YVHRDIKPDNILMD--MNGHIRLADFGSCLKLMEDGTV 231
Query: 863 RTELA-GTFGYIAPELAYTMKVTEK-----CDVYSFGVLALEVIKGKHP 905
++ +A GT YI+PE+ M+ + CD +S GV E++ G+ P
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 9e-13
Identities = 46/210 (21%), Positives = 77/210 (36%), Gaps = 35/210 (16%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR--------- 758
IG G G V+K TG+IVA+KKF + + +R
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFL----------ESEDDPVIKKIALREIRMLKQLK 60
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLY 818
H N+V +V+EY + ++ L K + A+ +
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSI--TWQTLQAVNF 117
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL- 877
H + +HRD+ +N+L+ + DFG ++ L + T Y +PEL
Sbjct: 118 CHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELL 174
Query: 878 ----AYTMKVTEKCDVYSFGVLALEVIKGK 903
Y V DV++ G + E++ G
Sbjct: 175 VGDTQYGPPV----DVWAIGCVFAELLSGV 200
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 56/226 (24%), Positives = 90/226 (39%), Gaps = 43/226 (19%)
Query: 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTK 756
++++ IG G G V T ++ A+K KF + A F E + +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF---FWEERDIMAF 125
Query: 757 IRHRNIVK-FYGFCSHALHSFVVYEYLEMGSLAMILS------NDA---AAEEFGWTKRM 806
+V+ FY F + ++V EY+ G L ++S A AE
Sbjct: 126 ANSPWVVQLFYAFQDDR-YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAE-------- 176
Query: 807 NAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSNRT 864
V AL +H+ +HRD+ N+LL+ H+ +DFG + R
Sbjct: 177 -----VVLALDAIHSMG---FIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKEGMVRC 226
Query: 865 ELA-GTFGYIAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
+ A GT YI+PE+ +CD +S GV E++ G P
Sbjct: 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 45/215 (20%), Positives = 78/215 (36%), Gaps = 36/215 (16%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVK-------------KFHSPLPGEMACQQEFLNEGNAL 754
IG G G V A A+K P G + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 755 TKI----------RHRNIVKFYGFCSHA--LHSFVVYEYLEMGSLAMILSNDAAAEEFGW 802
++ H N+VK H ++V+E + G + + + +E+
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 803 TKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN 862
+ IKG+ Y+H I+HRDI N+L+ + ++DFG+S K +
Sbjct: 141 FYFQDLIKGIE----YLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 863 RTELAGTFGYIAPELAYTMKVT---EKCDVYSFGV 894
+ GT ++APE + + DV++ GV
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 38/118 (32%), Positives = 58/118 (49%), Gaps = 12/118 (10%)
Query: 328 IPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLT 387
IP ++T L L N +P L N L +DLS N++S SF+++T L
Sbjct: 29 IPRDVTELY------LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 388 TLYLYENSLCDSIPKEIGD-MKSLSILDLSSNKLNGSIPL-SLANLTNSLKVLYLSSN 443
TL L N L IP D +KSL +L L N ++ +P + +L+ +L L + +N
Sbjct: 82 TLILSYNRL-RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLS-ALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 8e-12
Identities = 33/106 (31%), Positives = 49/106 (46%), Gaps = 5/106 (4%)
Query: 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKG 62
L L NQF+ +P E+ + HL L+ S N++S L ++ L L L N L+
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR- 91
Query: 63 SIPPSL-GNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNN 106
IPP L SL + + N +S +P L +LS L + N
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 37/118 (31%), Positives = 56/118 (47%), Gaps = 7/118 (5%)
Query: 111 SIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNL 170
+P G ++ LYL N + +P E+ N K L+ + +S N +S S N+T L
Sbjct: 24 VLPK--GIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80
Query: 171 VTLYIGINALSGSIPNEI-GNLKSLSDLRLDYNTLSGSILY-SFGNLTKLEILYLDVN 226
+TL + N L IP LKSL L L N +S + +F +L+ L L + N
Sbjct: 81 LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 3/108 (2%)
Query: 168 TNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNA 227
++ LY+ N + +P E+ N K L+ + L N +S SF N+T+L L L N
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89
Query: 228 LSGLIPNEIGNLKSLLALQLNYNTLSGSIP-CSFGNLTKLVISCLGTN 274
L + P LKSL L L+ N +S +P +F +L+ L +G N
Sbjct: 90 LRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 34/132 (25%), Positives = 51/132 (38%), Gaps = 30/132 (22%)
Query: 271 LGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPN 330
L N + + +E+ N K L + L+ N +S S ++T L TL S N L IP
Sbjct: 38 LDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIP- 94
Query: 331 EITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPL-SFASLTSLTTL 389
P L L L L N +S +P +F L++L+ L
Sbjct: 95 ----------------------PRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHL 131
Query: 390 YLYENSL---CD 398
+ N L C+
Sbjct: 132 AIGANPLYCDCN 143
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 38/130 (29%), Positives = 53/130 (40%), Gaps = 29/130 (22%)
Query: 219 EILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSS 278
LYLD N + L+P E+ N K L + L+ N +S SF N+T+
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQ------------- 79
Query: 279 SILEEIGNLKSLLHLQLNYNTLSGSIPLSL-GSLTNLATLYFSTNALSGSIPNEI-TNLR 336
LL L L+YN L IP L +L L N +S +P +L
Sbjct: 80 -----------LLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLS 126
Query: 337 SLSDLQLSEN 346
+LS L + N
Sbjct: 127 ALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 32/127 (25%), Positives = 51/127 (40%), Gaps = 28/127 (22%)
Query: 87 SIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFL 146
+P E+ + K L+ + LSNN ++ S N+T L+TL L N L IP
Sbjct: 45 LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPPRT------ 97
Query: 147 SDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEI-GNLKSLSDLRLDYNTL- 204
F L +L L + N +S +P +L +LS L + N L
Sbjct: 98 ---------------FD--GLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLY 139
Query: 205 -SGSILY 210
++ +
Sbjct: 140 CDCNMQW 146
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 26/91 (28%), Positives = 42/91 (46%), Gaps = 8/91 (8%)
Query: 484 EYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPI-EKLIHLSELDLSY-KIF 541
L L N F +P+ L N L ++LSNN+ + N + L L LSY ++
Sbjct: 34 TELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRL- 90
Query: 542 GEEIPSQVC-SMQSLEKLNLSHNNLSGSISR 571
IP + ++SL L+L N++S +
Sbjct: 91 -RCIPPRTFDGLKSLRLLSLHGNDIS-VVPE 119
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 34/121 (28%), Positives = 48/121 (39%), Gaps = 13/121 (10%)
Query: 417 SNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPE 476
SNK +P + + LYL N +P + L + L+NN +S LS +
Sbjct: 18 SNKGLKVLP---KGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQ 72
Query: 477 L-GSLNQLEYLDLSANTFHNSIPESL-GNLVKLHYLNLSNNQFSQKIP----NPIEKLIH 530
++ QL L LS N IP L L L+L N +P N + L H
Sbjct: 73 SFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSH 130
Query: 531 L 531
L
Sbjct: 131 L 131
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 50/130 (38%), Positives = 66/130 (50%), Gaps = 8/130 (6%)
Query: 293 LQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITN-LRSLSDLQLSENTLNGS 351
L L N+L LT+L LY N L S+PN + N L SL+ L LS N L S
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-S 90
Query: 352 IPLAL-GNLTKLVSLDLSINKLSGSIPL-SFASLTSLTTLYLYENSLCDSIPKEIGD-MK 408
+P + LT+L L L+ N+L S+P F LT L L LY+N L S+P + D +
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL-KSVPDGVFDRLT 148
Query: 409 SLSILDLSSN 418
SL + L N
Sbjct: 149 SLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 43/134 (32%), Positives = 57/134 (42%), Gaps = 12/134 (8%)
Query: 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKG 62
L L N LT L L N+L L +L+SL L+L +N L+
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 63 SIPP----SLGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPS-SL 116
S+P L L L + N L S+P+ V L L DLRL N L S+P
Sbjct: 90 SLPNGVFDKLTQLKEL---ALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVF 144
Query: 117 GNLTNLVTLYLHMN 130
LT+L ++LH N
Sbjct: 145 DRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 48/166 (28%), Positives = 61/166 (36%), Gaps = 30/166 (18%)
Query: 183 SIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSL 242
S+P I + L L+ N+L F LT L LYL N L L L SL
Sbjct: 21 SVPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 243 LALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSG 302
L L+ N L F LT+L L LN N L
Sbjct: 79 TYLNLSTNQLQSLPNGVFDKLTQLK------------------------ELALNTNQLQ- 113
Query: 303 SIPLSL-GSLTNLATLYFSTNALSGSIPNEI-TNLRSLSDLQLSEN 346
S+P + LT L L N L S+P+ + L SL + L +N
Sbjct: 114 SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 41/132 (31%), Positives = 49/132 (37%), Gaps = 2/132 (1%)
Query: 168 TNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNA 227
L + N+L L SL+ L L N L F LT L L L N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87
Query: 228 LSGLIPNEIGNLKSLLALQLNYNTLSGSIPC-SFGNLTKLVISCLGTNALSSSILEEIGN 286
L L L L L LN N L S+P F LT+L L N L S
Sbjct: 88 LQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDR 146
Query: 287 LKSLLHLQLNYN 298
L SL ++ L+ N
Sbjct: 147 LTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 46/136 (33%), Positives = 62/136 (45%), Gaps = 17/136 (12%)
Query: 364 SLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGD-MKSLSILDLSSNKLNG 422
LDL N L F LTSLT LYL N L S+P + + + SL+ L+LS+N+L
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 423 SIPL----SLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQL---ILNNNELSGQLSP 475
S+P L L L L++N + +P G F L QL L N+L
Sbjct: 90 SLPNGVFDKLTQLKE----LALNTNQL-QSLP--DGVFDKLTQLKDLRLYQNQLKSVPDG 142
Query: 476 ELGSLNQLEYLDLSAN 491
L L+Y+ L N
Sbjct: 143 VFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 41/142 (28%), Positives = 59/142 (41%), Gaps = 6/142 (4%)
Query: 111 SIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNL 170
S+P+ G L L N+L L L+ L + N L LT+L
Sbjct: 21 SVPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 171 VTLYIGINALSGSIPNEI-GNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALS 229
L + N L S+PN + L L +L L+ N L F LT+L+ L L N L
Sbjct: 79 TYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK 137
Query: 230 GLIPNEI-GNLKSLLALQLNYN 250
+P+ + L SL + L+ N
Sbjct: 138 S-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 47/140 (33%), Positives = 63/140 (45%), Gaps = 13/140 (9%)
Query: 384 TSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 443
T L L NSL ++ SL+ L L NKL S+P + N SL L LS+N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86
Query: 444 HIVGEIPLGHGKFSSLIQ---LILNNNELSGQLSPE--LGSLNQLEYLDLSANTFHNSIP 498
+ L +G F L Q L LN N+L Q P+ L QL+ L L N S+P
Sbjct: 87 QLQS---LPNGVFDKLTQLKELALNTNQL--QSLPDGVFDKLTQLKDLRLYQNQLK-SVP 140
Query: 499 E-SLGNLVKLHYLNLSNNQF 517
+ L L Y+ L +N +
Sbjct: 141 DGVFDRLTSLQYIWLHDNPW 160
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 40/130 (30%), Positives = 55/130 (42%), Gaps = 8/130 (6%)
Query: 101 LRLSNNSLNGSIPSSLGNLTNLVTLYLHMN---ALSGSIPDEIGNLKFLSDLQVSYNTLS 157
L L NSL LT+L LYL N +L + +++ +L L +S N L
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLT---YLNLSTNQLQ 89
Query: 158 GAIPFSLGNLTNLVTLYIGINALSGSIPNEI-GNLKSLSDLRLDYNTLSGSILYSFGNLT 216
LT L L + N L S+P+ + L L DLRL N L F LT
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLT 148
Query: 217 KLEILYLDVN 226
L+ ++L N
Sbjct: 149 SLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 36/126 (28%), Positives = 55/126 (43%), Gaps = 13/126 (10%)
Query: 417 SNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPE 476
++ S+P + L L +N + + +SL QL L N+L S
Sbjct: 15 YSQGRTSVP---TGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ---SLP 68
Query: 477 LG---SLNQLEYLDLSANTFHNSIPESL-GNLVKLHYLNLSNNQFSQKIPNPI-EKLIHL 531
G L L YL+LS N S+P + L +L L L+ NQ Q +P+ + +KL L
Sbjct: 69 NGVFNKLTSLTYLNLSTNQL-QSLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQL 126
Query: 532 SELDLS 537
+L L
Sbjct: 127 KDLRLY 132
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 55/223 (24%), Positives = 88/223 (39%), Gaps = 41/223 (18%)
Query: 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
+F+ IG G G V + T ++ A+K + E + E + + H
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP 75
Query: 761 NIVK-FYGFCSHALHSFVVYEYLEMGSLAMILSNDA----------AAEEFGWTKRMNAI 809
+V +Y F F+V + L G L L + E
Sbjct: 76 FLVNLWYSFQDEE-DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE----------- 123
Query: 810 KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGT 869
+ AL Y+ I+HRD+ N+LL+ H++DF I+ L T +AGT
Sbjct: 124 --LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGT 177
Query: 870 FGYIAPEL-------AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
Y+APE+ Y+ V D +S GV A E+++G+ P
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 49/220 (22%), Positives = 83/220 (37%), Gaps = 33/220 (15%)
Query: 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
++F +G G +V A EL T A+K + E + ++++ H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMIL------SNDAA----AEEFGWTKRMNAI 809
VK Y + Y + G L + AE
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE----------- 138
Query: 810 KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFL-KLGLSNRTE- 865
+ AL Y+H I+HRD+ +N+LLN + H+ +DFG +K L R
Sbjct: 139 --IVSALEYLHGK---GIIHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANS 191
Query: 866 LAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
GT Y++PEL + D+++ G + +++ G P
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 4e-12
Identities = 55/227 (24%), Positives = 84/227 (37%), Gaps = 47/227 (20%)
Query: 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-- 757
+F IG GG G VY TG++ A+K + LNE L+ +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 758 -RHRNIVK-FYGFCSHALHSFVVYEYLEMGSLAMILSNDA----------AAEEFGWTKR 805
IV Y F + + + + G L LS AAE
Sbjct: 249 GDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE------- 300
Query: 806 MNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSNR 863
+ L +MH +V+RD+ N+LL+ HV SD G++ +
Sbjct: 301 ------IILGLEHMHNRF---VVYRDLKPANILLD--EHGHVRISDLGLACDFSKKKPH- 348
Query: 864 TELAGTFGYIAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
GT GY+APE+ AY D +S G + ++++G P
Sbjct: 349 -ASVGTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 60/238 (25%), Positives = 86/238 (36%), Gaps = 36/238 (15%)
Query: 686 TFDGKIVHEEIIRATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKK-FHSPLPGEMAC 743
E + F E G G G+V E TG VA+KK P
Sbjct: 8 LNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP----RFR 63
Query: 744 QQEFLNEGNALTKIRHRNIVK-FYGFCSHALHSF------VVYEYLEMGSLAMILSNDAA 796
+E L L + H NIV+ F + VV EY+ +L N
Sbjct: 64 NRE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYR 121
Query: 797 AEEFGWTKRMNAIKG----VADALLYMHTNCFPPIVHRDISSKNVLLNLE-YEAHVSDFG 851
+ IK + ++ +H + HRDI NVL+N + DFG
Sbjct: 122 RQV---APPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFG 177
Query: 852 ISKFLKLGLSNRTELAGTFGYIAPEL-----AYTMKVTEKCDVYSFG-VLALEVIKGK 903
+K L N + + Y APEL YT V D++S G + A E++ G+
Sbjct: 178 SAKKLSPSEPNVAYICSRY-YRAPELIFGNQHYTTAV----DIWSVGCIFA-EMMLGE 229
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 40/223 (17%)
Query: 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLN-EGNALTKI 757
++ D IGNG G VY+A+L +GE+VA+KK + F N E + K+
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKL 104
Query: 758 RHRNIVKFYGFCSHALHSF------VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKG 811
H NIV+ F + +V +Y+ + A + + +K
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP----VIYVKL 160
Query: 812 ----VADALLYMHTNCFPPIVHRDISSKNVLLNLE-YEAHVSDFGISKFLKLGLSNRTEL 866
+ +L Y+H+ I HRDI +N+LL+ + + DFG +K L G N + +
Sbjct: 161 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217
Query: 867 AGTFGYIAPEL-----AYTMKVTEKCDVYSFG-VLALEVIKGK 903
+ Y APEL YT + DV+S G VLA E++ G+
Sbjct: 218 C-SRYYRAPELIFGATDYTSSI----DVWSAGCVLA-ELLLGQ 254
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 5e-12
Identities = 34/106 (32%), Positives = 46/106 (43%), Gaps = 7/106 (6%)
Query: 293 LQLNYNTLSGSIPLSL-GSLTNLATLYFSTNALSGSIPNEI-TNLRSLSDLQLSENTLNG 350
L LN N L L G L +L L N L+ I + +LQL EN +
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK- 91
Query: 351 SIPL-ALGNLTKLVSLDLSINKLSGSIPL-SFASLTSLTTLYLYEN 394
I L +L +L+L N++S + SF L SLT+L L N
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 31/111 (27%), Positives = 50/111 (45%), Gaps = 7/111 (6%)
Query: 3 KVLGLSFNQFSGSIPPE--IGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
L L+ N+ I + G L HL L +NQL+G+ P+ S + L L N +
Sbjct: 32 TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI 90
Query: 61 KGSIPPSL-GNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLN 109
K I + L L +++ +N +S + L SL+ L L++N N
Sbjct: 91 K-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 36/118 (30%), Positives = 57/118 (48%), Gaps = 10/118 (8%)
Query: 328 IPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLT 387
IP T L L+D +L + +G G L LV L+L N+L+G P +F + +
Sbjct: 27 IPLHTTELL-LNDNELGRISSDG----LFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQ 81
Query: 388 TLYLYENSLCDSIPKEIGD-MKSLSILDLSSNKLNGSIPL-SLANLTNSLKVLYLSSN 443
L L EN + I ++ + L L+L N+++ + S +L SL L L+SN
Sbjct: 82 ELQLGENKI-KEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLN-SLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 36/119 (30%), Positives = 49/119 (41%), Gaps = 7/119 (5%)
Query: 183 SIPNEIGNLKSLSDLRLDYNTLSG-SILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
IP +I ++L L+ N L S FG L L L L N L+G+ PN
Sbjct: 22 EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 242 LLALQLNYNTLSGSIPC-SFGNLTKLVISCLGTNALSSSILEEI-GNLKSLLHLQLNYN 298
+ LQL N + I F L +L L N + S ++ +L SL L L N
Sbjct: 80 IQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 26/107 (24%), Positives = 44/107 (41%), Gaps = 9/107 (8%)
Query: 53 LSLYSNFLKGSIPPS--LGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLN 109
L L N L I G L L+ +++ N L+ I + +L+L N +
Sbjct: 34 LLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 110 GSIPSSL-GNLTNLVTLYLHMNALSGSIPDEI-GNLKFLSDLQVSYN 154
I + + L L TL L+ N +S + +L L+ L ++ N
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 33/119 (27%), Positives = 51/119 (42%), Gaps = 7/119 (5%)
Query: 111 SIPSSLGNLTNLVTLYLHMNALSGSIPDEI-GNLKFLSDLQVSYNTLSGAIPFSLGNLTN 169
IP + L L+ N L D + G L L L++ N L+G P + ++
Sbjct: 22 EIPR--DIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 170 LVTLYIGINALSGSIPNEI-GNLKSLSDLRLDYNTLSGSILY-SFGNLTKLEILYLDVN 226
+ L +G N + I N++ L L L L N +S ++ SF +L L L L N
Sbjct: 80 IQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 7e-05
Identities = 32/124 (25%), Positives = 52/124 (41%), Gaps = 12/124 (9%)
Query: 399 SIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSS 458
IP++I + L L+ N+L L L L L N + I F
Sbjct: 22 EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIE--PNAFEG 76
Query: 459 LIQ---LILNNNELSGQLSPEL-GSLNQLEYLDLSANTFHNSIPE-SLGNLVKLHYLNLS 513
L L N++ ++S ++ L+QL+ L+L N + + S +L L LNL+
Sbjct: 77 ASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNLA 134
Query: 514 NNQF 517
+N F
Sbjct: 135 SNPF 138
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 7e-12
Identities = 47/214 (21%), Positives = 88/214 (41%), Gaps = 24/214 (11%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
K + + IG+G QG V A + VA+KK P + ++ E + +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA-YRELVLMKCVN 119
Query: 759 HRNIVKFYGF--CSHALHSF----VVYEYLEMGSLAMI---LSNDAAAEEFGWTKRMNAI 809
H+NI+ L F +V E ++ +I L ++ + + + I
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM--SYLLYQMLCGI 177
Query: 810 KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGT 869
K ++H+ I+HRD+ N+++ + + DFG+++ T T
Sbjct: 178 K-------HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVT 226
Query: 870 FGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGK 903
Y APE+ M E D++S G + E+++ K
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 8e-12
Identities = 66/269 (24%), Positives = 101/269 (37%), Gaps = 34/269 (12%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G G V A T E VAVK + + E + H N+VKFYG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--KEICINKMLNHENVVKFYG 72
Query: 768 FCSHALHSFVVYEYLEMGSL-AMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP 826
++ EY G L I + E + GV Y+H
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG--- 125
Query: 827 IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF----GYIAPEL----A 878
I HRDI +N+LL+ +SDFG++ + NR L Y+APEL
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYN--NRERLLNKMCGTLPYVAPELLKRRE 183
Query: 879 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938
+ E DV+S G++ ++ G+ P D S C S ++ +
Sbjct: 184 FH---AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 939 VQDKLISIMEVSISCLDESPTSRPTMQKV 967
L+ + L E+P++R T+ +
Sbjct: 241 ----LLHKI------LVENPSARITIPDI 259
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 57/226 (25%), Positives = 88/226 (38%), Gaps = 48/226 (21%)
Query: 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTKI 757
F+ +G G G V + TG A+K K E+A L E L
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRVLQNS 205
Query: 758 RHRNIVK-FYGFCSHALHSFVVYEYLEMGSLAMILSNDA----------AAEEFGWTKRM 806
RH + Y F +H V EY G L LS + AE
Sbjct: 206 RHPFLTALKYSFQTHD-RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE-------- 256
Query: 807 NAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSNRT 864
+ AL Y+H+ +V+RD+ +N++L+ + H+ +DFG+ K +
Sbjct: 257 -----IVSALDYLHSEK--NVVYRDLKLENLMLD--KDGHIKITDFGLCK-EGIKDGATM 306
Query: 865 E-LAGTFGYIAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
+ GT Y+APE+ Y V D + GV+ E++ G+ P
Sbjct: 307 KTFCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 348
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 1e-11
Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 42/213 (19%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR---------H 759
IG G G VYKA+ GE A+KK E +EG T IR H
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIR----------LEKEDEGIPSTTIREISILKELKH 59
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVA----DA 815
NIVK Y +V+E+L+ L +L D K +
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLE----SVTAKSFLLQLLNG 112
Query: 816 LLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAP 875
+ Y H ++HRD+ +N+L+N E E ++DFG+++ + + T T Y AP
Sbjct: 113 IAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
Query: 876 EL-----AYTMKVTEKCDVYSFGVLALEVIKGK 903
++ Y+ + D++S G + E++ G
Sbjct: 170 DVLMGSKKYSTTI----DIWSVGCIFAEMVNGT 198
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.0 bits (165), Expect = 1e-11
Identities = 86/522 (16%), Positives = 166/522 (31%), Gaps = 150/522 (28%)
Query: 22 HLTHLKLLSFSKNQLSGLIPHE---------IGRLSSLNGLSLYSNFLKGSIPP-----S 67
+++ L+ + L L P + G+ + + S ++ + +
Sbjct: 130 NVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK-TWVALDVCLSYKVQCKMDFKIFWLN 188
Query: 68 LGNLTS--LIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTL 125
L N S + +++ LL PN S+++L +S+ L L+
Sbjct: 189 LKNCNSPETV-LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQA-------ELRRLLKS 240
Query: 126 YLHMNALSGSIPDEIGNLKFL-------------SDLQVSYNTLSGAI-----------P 161
+ N L + + N K QV+ + LS A
Sbjct: 241 KPYENCLL--VLLNVQNAKAWNAFNLSCKILLTTRFKQVT-DFLSAATTTHISLDHHSMT 297
Query: 162 FSLGNLTNLVTLYIGINALSGSIPNE-----------IGNLKSLSD--LRLDYNTLSGSI 208
+ + +L+ Y+ +P E I +S+ D D
Sbjct: 298 LTPDEVKSLLLKYLDCRP--QDLPREVLTTNPRRLSIIA--ESIRDGLATWDN------- 346
Query: 209 LYSFGNLTKL-EILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLV 267
+ N KL I+ +N L P E + L++ + IP +
Sbjct: 347 -WKHVNCDKLTTIIESSLNVLE---PAEYRKMFDRLSV-FPPSAH---IPTI-------L 391
Query: 268 ISCLGTNALSSSILEEIGNL---KSLLHLQLNYNTLSGSIP-LSLGSLTNLATLYFSTNA 323
+S + + + S + + N SL+ Q +T+S IP + L L Y A
Sbjct: 392 LSLIWFD-VIKSDVMVVVNKLHKYSLVEKQPKESTIS--IPSIYLELKVKLENEY----A 444
Query: 324 LSGSIPNEITNLRSLSDLQLSENTLNGSIPLALG------------NLTKLVSLDLSI-- 369
L SI + ++ L L+ +G L ++V LD
Sbjct: 445 LHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLE 504
Query: 370 NKL--SGSIPLSFASLTS-LTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPL 426
K+ + + S+ + L L Y+ +CD+ PK + +ILD
Sbjct: 505 QKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKY--ERLVNAILDF----------- 551
Query: 427 SLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNE 468
L +++ K++ L+++ L +
Sbjct: 552 -----------LPKIEENLI------CSKYTDLLRIALMAED 576
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 67.6 bits (164), Expect = 2e-11
Identities = 97/621 (15%), Positives = 183/621 (29%), Gaps = 185/621 (29%)
Query: 329 PNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTT 388
+ ++ L LS+ + + + L ++ L I + +T
Sbjct: 58 KDAVSGTLRLFWTLLSKQ--EEMVQKFVEEV-----LRINYKFLMSPIKTEQRQPSMMTR 110
Query: 389 LYLYE-NSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIV- 446
+Y+ + + L + K N S L +L L + N ++
Sbjct: 111 MYIEQRDRLYNDNQVFA--------------KYNVSRLQPYLKLRQALLELRPAKNVLID 156
Query: 447 GEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVK 506
G LG GK + + + + ++ + I
Sbjct: 157 G--VLGSGK-TWVALDVCLSYKVQCK--------------------MDFKI--------- 184
Query: 507 LHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKI-FGEEIPSQVCSMQS-LEKLNLSH-- 562
+LNL N + + ++KL++ + + + + I ++ S+Q+ L +L S
Sbjct: 185 -FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 563 -NNL-------SGSISRCFEEMHWLSC-I-----DIS-YNALQG-------LIPNSTAFR 600
N L + F LSC I + L L +S
Sbjct: 244 ENCLLVLLNVQNAKAWNAFN----LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT 299
Query: 601 DAPMLALQGNKRLCGDIKRLPPCKAFKSHKQSLKKIWIVIVFPLLGTVALLISLIGLFF- 659
+ +L K L + LP + L P +S+I
Sbjct: 300 PDEVKSLLL-KYLDCRPQDLPR--------EVLT------TNP------RRLSIIAESIR 338
Query: 660 -------NFRQ--RKNGLQTQQSS-----P---RNTLGLLSVLTFDGKIVHE--EIIRAT 700
N++ +SS P R LSV I +I
Sbjct: 339 DGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFD 398
Query: 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVA--VKKFHSPLPGEMACQQEFLNEGNALTKIR 758
D + N +L +V K+ +P E + +
Sbjct: 399 VIKSDVMVVVN---------KLHKYSLVEKQPKESTISIPS---IYLELKVKLENEYAL- 445
Query: 759 HRNIVKFY----GFCSHAL---------HSFVVY-----EYLEMGSLAMILSNDAAAEEF 800
HR+IV Y F S L +S + + E+ E +L ++ D F
Sbjct: 446 HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD-----F 500
Query: 801 GWTKR--------MNAIKGVADALL-------YMHTNCFPPIVHRDISS-KNVLLNLEYE 844
+ ++ NA + + L Y+ N P R +++ + L +E
Sbjct: 501 RFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDND--PKYERLVNAILDFLPKIEEN 558
Query: 845 AHVSDFGISKFLKLGLSNRTE 865
S + + L++ L E
Sbjct: 559 LICSKY--TDLLRIALMAEDE 577
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 6e-08
Identities = 92/652 (14%), Positives = 180/652 (27%), Gaps = 193/652 (29%)
Query: 390 YLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEI 449
Y Y++ L + + + D+ + L S + + +HI+
Sbjct: 16 YQYKDILSVFEDAFVDNFDCKDVQDMPKSIL-------------SKEEI----DHIIMS- 57
Query: 450 PLGHGKFSSLIQLILNNNE------LSGQLSPE---LGSLNQLEYLDLSANT-FHNSIPE 499
L +L+ E + L L S + E S T + +
Sbjct: 58 KDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRD 117
Query: 500 SLGNLVKLHYLNLSNNQFSQ---KIPNPIEKLI-HLSELDLSYKIFGEEIPSQVCSM--- 552
L N N F++ P KL L EL + + + +
Sbjct: 118 RLYN---------DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVL-------IDGVLGS 161
Query: 553 --QSLEKLNLSHNNLSGSISRCFE-EMHWLS-----CIDISYNALQGLI----PNSTAFR 600
+ S + + ++ WL+ + LQ L+ PN T+
Sbjct: 162 GKTWVALDVCL----SYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 601 DAPMLALQGNKRLCGDIK-RLPPCKAFKSHKQSL--------KKIWIVIVFPLLGTVALL 651
D K I+ L K ++ L K W
Sbjct: 218 DHS----SNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA------------ 261
Query: 652 ISLIGLFFNFRQRKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATKNFDDEHCIGN 711
FN + L + T ++ T + +H
Sbjct: 262 -------FNLSCK-------------IL----LTTRFKQVTDFLSAATTTHISLDH---- 293
Query: 712 GGQGSVYKAELPTGEIVAVKKFHSP---LPGEMACQQ---------EFLNEGNALTK-IR 758
++ E ++ K LP E E + +G A +
Sbjct: 294 -HSMTLTPDE--VKSLLL-KYLDCRPQDLPRE-VLTTNPRRLSIIAESIRDGLATWDNWK 348
Query: 759 HRNIVKFYGFCSHALHSFV----------VYEYLEM---------GSLAMILSNDAAAEE 799
H N K + + S + +++ L + L++I + ++
Sbjct: 349 HVNCDKL----TTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV 404
Query: 800 FGWTKRMN----AIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAH---VSDFGI 852
+++ K ++ + + + ++ ++ K L EY H V + I
Sbjct: 405 MVVVNKLHKYSLVEKQPKESTISIPS------IYLELKVK---LENEYALHRSIVDHYNI 455
Query: 853 SKFLKLGLSNRTELAGTFGYIAPELAYTMKV---TEKCDVYSFGVLALEVIKGKHPRDFI 909
K S+ Y + + +K E+ ++ L ++ K D
Sbjct: 456 PKTFD---SDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHD-- 510
Query: 910 SSICSSLSSNLNIALDEML--------DPRLPTPLRNVQDKLISIMEVSISC 953
S+ ++ S LN DP+ + + D L I E I
Sbjct: 511 STAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICS 562
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 8e-08
Identities = 65/504 (12%), Positives = 138/504 (27%), Gaps = 166/504 (32%)
Query: 508 HYLNLSNNQFSQK----IPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHN 563
H+++ + + + + + D +++P + S + ++ + +S +
Sbjct: 5 HHMDFETGEHQYQYKDILSVFEDAFV--DNFDCKDV---QDMPKSILSKEEIDHIIMSKD 59
Query: 564 NLSGS--------------ISRCFEEMH-----WL-SCIDISYNALQGLIPNSTAFRDAP 603
+SG+ + + EE+ +L S I + RD
Sbjct: 60 AVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRD-- 117
Query: 604 MLALQGNKRLCGDIKRLPPCKAFKSHKQSLKKIWIVIVFPLLGTVALLISLIGLFFNFRQ 663
RL D + K + L+ +
Sbjct: 118 --------RLYNDNQVFA-----KYNVSRLQPYL-------------------------K 139
Query: 664 RKNGLQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATKNFDDEHCIGNGGQGSVYKAELP 723
+ L + + ++ G G G K +
Sbjct: 140 LRQALLELRPAK-------------NVLID----------------GVLGSG---KTWV- 166
Query: 724 TGEIVAVKKFHSPLPGEMACQQEF-LNEGNALTKIRHRNIVK-FYGFCSHALHSFVVYEY 781
++ K + ++ F LN N +++ + +
Sbjct: 167 ALDVCLSYKVQCKMDFKI-----FWLNLKN---CNSPETVLEMLQKLLYQIDPN---WTS 215
Query: 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL 841
S + L + E +R+ K + LL V ++ +
Sbjct: 216 RSDHSSNIKLRIHSIQAEL---RRLLKSKPYENCLL----------VLLNVQNAKAW--- 259
Query: 842 EYEAHVSDFGIS-KFL----------KLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVY 890
A F +S K L L + T ++ + + K
Sbjct: 260 --NA----FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDC 313
Query: 891 SFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ-DKLISIMEV 949
L EV+ +PR +S I S+ L D ++V DKL +I+E
Sbjct: 314 RPQDLPREVLTT-NPR-RLSIIAESIRDGLA-----TWDN-----WKHVNCDKLTTIIES 361
Query: 950 SISCLDESPTSRPTMQKVSQLLKI 973
S++ L+ +K+ L +
Sbjct: 362 SLNVLEP-----AEYRKMFDRLSV 380
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 22/213 (10%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
K + + IG+G QG V A + VA+KK P + ++ E + +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA-YRELVLMKCVN 82
Query: 759 HRNIVKFYG-FCS-HALHSF----VVYEYLEMGSLAMILSNDAAAE--EFGWTKRMNAIK 810
H+NI+ F +L F +V E ++ +L ++ + E + + + IK
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIK 141
Query: 811 GVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF 870
++H+ I+HRD+ N+++ + + DFG+++ T T
Sbjct: 142 -------HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTR 190
Query: 871 GYIAPELAYTMKVTEKCDVYSFGVLALEVIKGK 903
Y APE+ M E D++S G + E+IKG
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 43/232 (18%), Positives = 78/232 (33%), Gaps = 33/232 (14%)
Query: 692 VHEEIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEG 751
+ E+ + + I +G G+V G VA+K+ + + +
Sbjct: 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDG-RTVNILSDSF 71
Query: 752 NA---------LTKIRHRNIVKFYG-FCSHALHSF----VVYEYLEMGSLAMILSNDAAA 797
L H NI+ F + +V E + +I
Sbjct: 72 LCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVI 131
Query: 798 EE-----FGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852
F + + + G L +H +VHRD+ N+LL + + DF +
Sbjct: 132 SPQHIQYFMY----HILLG----LHVLHEAG---VVHRDLHPGNILLADNNDITICDFNL 180
Query: 853 SKFLKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 903
++ +N+T Y APEL T+ D++S G + E+ K
Sbjct: 181 AREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 50/219 (22%), Positives = 86/219 (39%), Gaps = 49/219 (22%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR--------- 758
+G G G VYKA + T E VA+K+ E EG T IR
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIR----------LEHEEEGVPGTAIREVSLLKELQ 91
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKG----VAD 814
HRNI++ H +++EY E L + + M IK + +
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVS-------MRVIKSFLYQLIN 143
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAH-----VSDFGISKFLKLGLSNRTELAGT 869
+ + H+ +HRD+ +N+LL++ + + DFG+++ + + T T
Sbjct: 144 GVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIIT 200
Query: 870 FGYIAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 903
Y PE+ Y+ V D++S + E++
Sbjct: 201 LWYRPPEILLGSRHYSTSV----DIWSIACIWAEMLMKT 235
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 59/235 (25%), Positives = 98/235 (41%), Gaps = 51/235 (21%)
Query: 698 RATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGE------MACQQEFLNE 750
++ IG G G V+KA TG+ VA+KK + E A L E
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITA-----LRE 66
Query: 751 GNALTKIRHRNIVKFYGFCSHALHS--------FVVYEYLEMGSLAMILSNDAAAEEFGW 802
L ++H N+V C ++V+++ E LA +LSN +F
Sbjct: 67 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN--VLVKFT- 122
Query: 803 TKRMNAIKGVA----DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858
++ IK V + L Y+H N I+HRD+ + NVL+ + ++DFG+++ L
Sbjct: 123 ---LSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSL 176
Query: 859 GLSNR----TELAGTFGYIAPEL-----AYTMKVTEKCDVYSFG-VLALEVIKGK 903
+++ T T Y PEL Y + D++ G ++A E+
Sbjct: 177 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMA-EMWTRS 226
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 42/213 (19%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR---------H 759
+G G G VYKA+ G IVA+K+ + +EG T IR H
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIR----------LDAEDEGIPSTAIREISLLKELHH 78
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVA----DA 815
NIV +V+E++E L +L D + IK
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL--DENKTGLQ----DSQIKIYLYQLLRG 131
Query: 816 LLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAP 875
+ + H + I+HRD+ +N+L+N + ++DFG+++ + + + T T Y AP
Sbjct: 132 VAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188
Query: 876 EL-----AYTMKVTEKCDVYSFGVLALEVIKGK 903
++ Y+ V D++S G + E+I GK
Sbjct: 189 DVLMGSKKYSTSV----DIWSIGCIFAEMITGK 217
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 56/242 (23%), Positives = 96/242 (39%), Gaps = 68/242 (28%)
Query: 695 EIIRATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEF------ 747
++ K ++ +G G +VYKA + T +IVA+KK + + E
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK------LGHRSEAKDGINR 57
Query: 748 --LNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKR 805
L E L ++ H NI+ H + +V++++E L +I+ +
Sbjct: 58 TALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLT---- 110
Query: 806 MNAIKG----VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS 861
+ IK L Y+H + I+HRD+ N+LL+ ++DFG
Sbjct: 111 PSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFG---------- 157
Query: 862 NRTELAGTFG--------------YIAPEL-----AYTMKVTEKCDVYSFG-VLALEVIK 901
LA +FG Y APEL Y + V D+++ G +LA E++
Sbjct: 158 ----LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV----DMWAVGCILA-ELLL 208
Query: 902 GK 903
Sbjct: 209 RV 210
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 49/206 (23%), Positives = 80/206 (38%), Gaps = 37/206 (17%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVK-----KFHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
+G G G V + T AVK K GE ++E L ++RH+N+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEI----QLLRRLRHKNV 68
Query: 763 VKFYGFCSHA--LHSFVVYEYLEMGSLAMI-------LSNDAAAEEFGWTKRMNAIKGVA 813
++ + ++V EY G M+ A F +
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF---------CQLI 119
Query: 814 DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN---RTELAGTF 870
D L Y+H+ IVH+DI N+LL +S G+++ L ++ RT G+
Sbjct: 120 DGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSP 175
Query: 871 GYIAPELAYTMKVTE--KCDVYSFGV 894
+ PE+A + K D++S GV
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGV 201
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 4e-11
Identities = 47/189 (24%), Positives = 72/189 (38%), Gaps = 46/189 (24%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR--------- 758
+GNG +VYK TG VA+K+ L E EG T IR
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVK--LDSE---------EGTPSTAIREISLMKELK 61
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVA----D 814
H NIV+ Y +V+E+++ L + + +N +K
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIA 874
L + H N I+HRD+ +N+L+N + + DFG LA FG
Sbjct: 120 GLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFG--------------LARAFG--I 160
Query: 875 PELAYTMKV 883
P ++ +V
Sbjct: 161 PVNTFSSEV 169
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 66/269 (24%), Positives = 101/269 (37%), Gaps = 34/269 (12%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G G V A T E VAVK + + E + H N+VKFYG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--KEICINKMLNHENVVKFYG 72
Query: 768 FCSHALHSFVVYEYLEMGSL-AMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP 826
++ EY G L I + E + GV Y+H
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG--- 125
Query: 827 IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF----GYIAPEL----A 878
I HRDI +N+LL+ +SDFG++ + NR L Y+APEL
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYN--NRERLLNKMCGTLPYVAPELLKRRE 183
Query: 879 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938
+ E DV+S G++ ++ G+ P D S C S ++ +
Sbjct: 184 FH---AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 939 VQDKLISIMEVSISCLDESPTSRPTMQKV 967
L+ + L E+P++R T+ +
Sbjct: 241 ----LLHKI------LVENPSARITIPDI 259
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
+ D +G+G G+V A + TG VA+KK + P E+ ++ E L +R
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA-YRELRLLKHMR 82
Query: 759 HRNIVKFYGF--CSHALHSF----VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIK-- 810
H N++ L F +V ++ L ++ ++ E+ I+
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDR--------IQFL 133
Query: 811 --GVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAG 868
+ L Y+H I+HRD+ N+ +N + E + DFG+++ S T
Sbjct: 134 VYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVV 187
Query: 869 TFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 903
T Y APE+ M+ T+ D++S G + E+I GK
Sbjct: 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 56/193 (29%), Positives = 81/193 (41%), Gaps = 17/193 (8%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G G V E TG VAVK + + + E L RH +I+K Y
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 768 FCSHALHSFVVYEYLEMGSL-AMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP 826
S F+V EY+ G L I + E + V Y H +
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YCHRHM--- 131
Query: 827 IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL----AYTMK 882
+VHRD+ +NVLL+ A ++DFG+S + G RT G+ Y APE+ Y
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGRLYA-- 188
Query: 883 VTEKCDVYSFGVL 895
+ D++S GV+
Sbjct: 189 -GPEVDIWSCGVI 200
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 56/219 (25%), Positives = 85/219 (38%), Gaps = 49/219 (22%)
Query: 709 IGNGGQGSVYKAEL-PTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK 764
+G G G V TG A+K K E+A + E L RH +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTRHPFLTA 69
Query: 765 -FYGFCSHALHSFVVYEYLEMGSLAMILSNDA----------AAEEFGWTKRMNAIKGVA 813
Y F +H V EY G L LS + AE +
Sbjct: 70 LKYAFQTHD-RLCFVMEYANGGELFFHLSRERVFTEERARFYGAE-------------IV 115
Query: 814 DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSNRTE-LAGTF 870
AL Y+H+ +V+RDI +N++L+ + H+ +DFG+ K + + GT
Sbjct: 116 SALEYLHSR---DVVYRDIKLENLMLD--KDGHIKITDFGLCK-EGISDGATMKTFCGTP 169
Query: 871 GYIAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
Y+APE+ Y V D + GV+ E++ G+ P
Sbjct: 170 EYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 1e-10
Identities = 45/216 (20%), Positives = 88/216 (40%), Gaps = 43/216 (19%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR--------- 758
IG G G+V+KA T EIVA+K+ + +EG + +R
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVR----------LDDDDEGVPSSALREICLLKELK 59
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVA----D 814
H+NIV+ + +V+E+ + L D+ + +K
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLD----PEIVKSFLFQLLK 112
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIA 874
L + H+ ++HRD+ +N+L+N E +++FG+++ + + + T Y
Sbjct: 113 GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 875 PEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
P++ Y+ + D++S G + E+ P
Sbjct: 170 PDVLFGAKLYSTSI----DMWSAGCIFAELANAGRP 201
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 51/212 (24%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
K + +G+G GSV A + +GE VA+KK P E+ ++ E L ++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA-YRELLLLKHMQ 81
Query: 759 HRNIVKFYGF--CSHALHSF----VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGV 812
H N++ + +L +F +V +++ L I+ + E+ + + +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYL-----VYQM 135
Query: 813 ADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGY 872
L Y+H+ +VHRD+ N+ +N + E + DFG+++ + T T Y
Sbjct: 136 LKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM---TGYVVTRWY 189
Query: 873 IAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 903
APE+ + M + D++S G + E++ GK
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 60/199 (30%), Positives = 81/199 (40%), Gaps = 33/199 (16%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
IG+G G T E+VAVK + Q+E +N +RH NIV+F
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIIN----HRSLRHPNIVRFKE 83
Query: 768 FCSHALHSFVVYEYLEMGSL-AMI-----LSNDAAAEEFGWTKRMNAIKGVADALLYMHT 821
H ++ EY G L I S D A F + GV+ Y H+
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFF-----QQLLSGVS----YCHS 134
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAH--VSDFGISKFLKLGLSNRTELAGTFGYIAPEL-- 877
I HRD+ +N LL+ + DFG SK L ++ + GT YIAPE+
Sbjct: 135 MQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLL 190
Query: 878 --AYTMKVTEKCDVYSFGV 894
Y K DV+S GV
Sbjct: 191 RQEYDGK---IADVWSCGV 206
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 63/243 (25%), Positives = 101/243 (41%), Gaps = 45/243 (18%)
Query: 680 GLLSVLTFDGKIVHEEIIRATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLP 738
++ VL DGK + I + + IGNG G V++A + + E VA+KK
Sbjct: 23 KVIKVLASDGKTGEQREIA----YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQ--- 74
Query: 739 GEMACQQEFLN-EGNALTKIRHRNIVKFYGFCSHALHS------FVVYEYLEMGSLAMIL 791
+ F N E + ++H N+V F +V EY+
Sbjct: 75 -----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASR 129
Query: 792 SNDAAAEEFGWTKRMNAIKG----VADALLYMHTNCFPPIVHRDISSKNVLLNLE-YEAH 846
+ M IK + +L Y+H+ I HRDI +N+LL+
Sbjct: 130 HYAKLKQTMP----MLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLK 182
Query: 847 VSDFGISKFLKLGLSNRTELAGTFGYIAPEL-----AYTMKVTEKCDVYSFG-VLALEVI 900
+ DFG +K L G N + + + Y APEL YT + D++S G V+A E++
Sbjct: 183 LIDFGSAKILIAGEPNVSYIC-SRYYRAPELIFGATNYTTNI----DIWSTGCVMA-ELM 236
Query: 901 KGK 903
+G+
Sbjct: 237 QGQ 239
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 3e-10
Identities = 50/222 (22%), Positives = 86/222 (38%), Gaps = 44/222 (19%)
Query: 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR- 758
+ + +G G +VYK T +VA+K+ L E EG T IR
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR--LEHE---------EGAPCTAIRE 50
Query: 759 --------HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIK 810
H NIV + +V+EYL+ L L D M+ +K
Sbjct: 51 VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIIN----MHNVK 103
Query: 811 G----VADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTEL 866
+ L Y H ++HRD+ +N+L+N E ++DFG+++ +
Sbjct: 104 LFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE 160
Query: 867 AGTFGYIAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 903
T Y P++ Y+ ++ D++ G + E+ G+
Sbjct: 161 VVTLWYRPPDILLGSTDYSTQI----DMWGVGCIFYEMATGR 198
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 47/212 (22%), Positives = 88/212 (41%), Gaps = 20/212 (9%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
+ + + +G+G GSV A + TG VAVKK P + ++ E L ++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-YRELRLLKHMK 86
Query: 759 HRNIVKFYGFC--SHALHSF----VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGV 812
H N++ + +L F +V + ++ + + I +
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-----IYQI 141
Query: 813 ADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGY 872
L Y+H+ I+HRD+ N+ +N + E + DFG+++ T T Y
Sbjct: 142 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTA---DEMTGYVATRWY 195
Query: 873 IAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 903
APE+ M + D++S G + E++ G+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 51/231 (22%), Positives = 97/231 (41%), Gaps = 47/231 (20%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
+ +F + +G G G V A PTGEIVA+KK P + + L E L +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRT-LREIKILKHFK 67
Query: 759 HRNIVKFYG-FCSHALHSF----VVYEYLEMGSLAMILSNDAAAEEFGWTKR------MN 807
H NI+ + + +F ++ E ++ L ++S +++ + +
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDH---IQYFIYQTLR 123
Query: 808 AIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA 867
A+K +H + ++HRD+ N+L+N + V DFG+++ + ++ +E
Sbjct: 124 AVK-------VLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 868 GTFG----------YIAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 903
G Y APE+ Y+ + DV+S G + E+ +
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRR 220
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 4e-10
Identities = 61/419 (14%), Positives = 134/419 (31%), Gaps = 44/419 (10%)
Query: 190 NLKSLSDLRLDYNTLSGSILYSFG-NLTKLEILYLD-VNALSGLIPNEIG-NLKSLLALQ 246
+ L ++RL ++ L + ++L L S I ++L L
Sbjct: 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELD 162
Query: 247 LNYNTLSG-------SIPCSFGNLTKLVISCLGTNALSSSILEEIG-NLKSLLHLQLNYN 298
L + + P ++ +L L ISCL + +S S LE + +L L+LN
Sbjct: 163 LRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASE-VSFSALERLVTRCPNLKSLKLNRA 221
Query: 299 TLSGSIPLSLGSLTNLATLYFS------TNALSGSIPNEITNLRSLSDLQLSENTLNGSI 352
+ L L L + + ++ + L L + + +
Sbjct: 222 VPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYL 281
Query: 353 PLALGNLTKLVSLDLSINKLSGSIPLSFAS-LTSLTTLYLYENSLCDSIPKEIGDMKSLS 411
P ++L +L+LS + + L L++ + + K L
Sbjct: 282 PAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLR 341
Query: 412 ILDLSSNKLNGSIP---------LSLANLTNSLKVLYLSSNHI--VGEIPLGHGKFSSLI 460
L + ++ P +S++ L+ + + I + ++
Sbjct: 342 ELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARN-RPNMT 400
Query: 461 QLILNNNELSGQLSPELGSLN-----------QLEYLDLSANTFHNSIPESLGNLVKLHY 509
+ L E L L+ L L LS K+
Sbjct: 401 RFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEM 460
Query: 510 LNLSNNQFSQK-IPNPIEKLIHLSELDLSY-KIFGEEIPSQVCSMQSLEKLNLSHNNLS 566
L+++ S + + + L +L++ + + + ++++ L +S ++S
Sbjct: 461 LSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 60/438 (13%), Positives = 125/438 (28%), Gaps = 43/438 (9%)
Query: 22 HLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKG-------SIPPSLGNLTSL 74
+ L L S GL +L L L + + P + +L SL
Sbjct: 131 NFKVLVLSSCEGFSTDGLA-AIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSL 189
Query: 75 IYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHM----- 129
+ + + ++ V +L L+L+ + + L L L
Sbjct: 190 NISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEV 249
Query: 130 -NALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYI-GINALSGSIPNE 187
+ + + K L L ++ + +P + L TL + S +
Sbjct: 250 RPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKL 309
Query: 188 IGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQL 247
+ L L + + L L V + L + L
Sbjct: 310 LCQCPKLQRLWVLDYIEDAGLEVLASTCKDLR--ELRVFPSEPFVMEPNVAL-TEQGLV- 365
Query: 248 NYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLS 307
S+ L ++ C ++++ L I ++ ++
Sbjct: 366 -------SVSMGCPKLESVLYFC---RQMTNAALITIA--RNRPNMTR----------FR 403
Query: 308 LGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDL 367
L + A Y + L + + + L L LS + K+ L +
Sbjct: 404 LCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSV 463
Query: 368 SINKLSG-SIPLSFASLTSLTTLYLYENSLCD-SIPKEIGDMKSLSILDLSSNKLNGSIP 425
+ S + + SL L + + D ++ ++++ L +SS ++
Sbjct: 464 AFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGAC 523
Query: 426 LSLANLTNSLKVLYLSSN 443
L L V +
Sbjct: 524 KLLGQKMPKLNVEVIDER 541
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 47/308 (15%), Positives = 96/308 (31%), Gaps = 29/308 (9%)
Query: 306 LSLGSLTNLATLYFSTNALSGSIPNEITNLRSL--------SDLQLSENTLNGSIPLALG 357
+ + + ++ +RS+ +D L + G + +
Sbjct: 40 IERWCRRKV-FIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIE 98
Query: 358 ----NLTKLVSLDLSINKLSGSIPLSFA-SLTSLTTLYLYE-NSLCDSIPKEIGDM-KSL 410
+ T L + L ++ A S + L L I ++L
Sbjct: 99 AMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNL 158
Query: 411 SILDLSSNKLNGSIPLSLANLTN---SLKVLYLSSNH-IVGEIPLGH--GKFSSLIQLIL 464
LDL + ++ L++ + SL L +S V L + +L L L
Sbjct: 159 KELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKL 218
Query: 465 NNNELSGQLSPELGSLNQLEYLDLSA------NTFHNSIPESLGNLVKLHYLNLSNNQFS 518
N +L+ L QLE L ++ + +L +L L+ +
Sbjct: 219 NRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVP 278
Query: 519 QKIPNPIEKLIHLSELDLSY-KIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMH 577
+P L+ L+LSY + ++ +C L++L + +
Sbjct: 279 AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCK 338
Query: 578 WLSCIDIS 585
L + +
Sbjct: 339 DLRELRVF 346
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 52/349 (14%), Positives = 97/349 (27%), Gaps = 34/349 (9%)
Query: 243 LALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSG 302
+ + Y ++ F + + + A + + + G
Sbjct: 48 VFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPW----------- 96
Query: 303 SIPLSLGSLTNLATLYFS----TNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGN 358
I S T L + T+ I N + L L E +
Sbjct: 97 -IEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVL-VLSSCEGFSTDGLAAIAAT 154
Query: 359 LTKLVSLDLSINKLSGSIPLSFASL----TSLTTLYL--YENSLCDSIPKEIGD-MKSLS 411
L LDL + + + TSL +L + + + S + + +L
Sbjct: 155 CRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLK 214
Query: 412 ILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSG 471
L L+ + +L L+ L + G S + LSG
Sbjct: 215 SLKLNRAVPLEKL-ATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSG 272
Query: 472 Q-------LSPELGSLNQLEYLDLSANTFH-NSIPESLGNLVKLHYLNLSNNQFSQKIPN 523
L ++L L+LS T + + L KL L + + +
Sbjct: 273 FWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEV 332
Query: 524 PIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRC 572
L EL + P+ + Q L +++ L + C
Sbjct: 333 LASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFC 381
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 6e-10
Identities = 24/102 (23%), Positives = 43/102 (42%), Gaps = 2/102 (1%)
Query: 321 TNALSGSIPNEITNLRSLSDLQLSENTLNGSIPL-ALGNLTKLVSLDLSINKLSGSIPLS 379
T + + + +L++L + + L L L +L +L + + L P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 380 FASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
F L+ L L N+L +S+ + SL L LS N L+
Sbjct: 76 FHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 4/97 (4%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHE-IGRLSSLNGLSLYSNFLKGSIPP-SLGNLT 72
+ +L L Q + + L L L++ + L+ + P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 73 SLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLN 109
L +++ N L S+ + SL +L LS N L+
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 24/107 (22%), Positives = 37/107 (34%), Gaps = 7/107 (6%)
Query: 475 PELGSLNQLEYLDLSANTFHNSIP-ESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSE 533
L L L + + L L +L L + + P+ LS
Sbjct: 25 HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84
Query: 534 LDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLS 580
L+LS+ E + + SL++L LS N L C + WL
Sbjct: 85 LNLSFNAL-ESLSWKTVQGLSLQELVLSGNPL-----HCSCALRWLQ 125
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 21/95 (22%), Positives = 32/95 (33%), Gaps = 2/95 (2%)
Query: 63 SIPPSLGNLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
L +L + I N + L L +L + + L P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTL 156
L L L NAL S+ + L +L +S N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 18/101 (17%), Positives = 37/101 (36%), Gaps = 2/101 (1%)
Query: 177 INALSGSIPNEIGNLKSLSDLRLDYNTLSGSI-LYSFGNLTKLEILYLDVNALSGLIPNE 235
+ + + ++L++L ++ + L L +L L + + L + P+
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 236 IGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNAL 276
L L L++N L + L+ L L N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 20/98 (20%), Positives = 32/98 (32%), Gaps = 6/98 (6%)
Query: 496 SIPESLGNLVKLHYLNLSNNQFSQKIPN-PIEKLIHLSELDLSY-KIFGEEIPSQV-CSM 552
L L L + N Q Q + + L L L + + +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL--RFVAPDAFHFT 79
Query: 553 QSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQ 590
L +LNLS N L + + + L + +S N L
Sbjct: 80 PRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 22/101 (21%), Positives = 33/101 (32%), Gaps = 2/101 (1%)
Query: 105 NNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDE-IGNLKFLSDLQVSYNTLSGAIPFS 163
L NL LY+ + + L L +L + + L P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 164 LGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTL 204
L L + NAL S+ + SL +L L N L
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 18/102 (17%), Positives = 38/102 (37%), Gaps = 4/102 (3%)
Query: 81 NNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPS-SLGNLTNLVTLYLHMNALSGSIPDE 139
+ + + ++L++L + N + L L L L + + L + +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
Query: 140 I-GNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINAL 180
LS L +S+N L ++ + +L L + N L
Sbjct: 75 AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 4e-06
Identities = 18/82 (21%), Positives = 31/82 (37%), Gaps = 2/82 (2%)
Query: 2 LKVLGLSFNQFSGSIPPE-IGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
L L + Q + + L L+ L+ K+ L + P L+ L+L N L
Sbjct: 33 LTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL 92
Query: 61 KGSIPPSLGNLTSLIYIDIGNN 82
+ S+ SL + + N
Sbjct: 93 E-SLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 2e-05
Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 5/98 (5%)
Query: 399 SIPKEIGDMKSLSILDLSSNKLNGSIPL-SLANLTNSLKVLYLSSNHIVGEIPLGH-GKF 456
+ ++L+ L + + + + L L L L+ L + + + +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGE-LRNLTIVKSGLR-FVAPDAFHFT 79
Query: 457 SSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFH 494
L +L L+ N L LS + L+ L LS N H
Sbjct: 80 PRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 5e-05
Identities = 23/95 (24%), Positives = 35/95 (36%), Gaps = 2/95 (2%)
Query: 207 SILYSFGNLTKLEILYLDVNALSGLIPNE-IGNLKSLLALQLNYNTLSGSIPCSFGNLTK 265
L+ L LY++ + + L L L + + L P +F +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 266 LVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTL 300
L L NAL S + + L SL L L+ N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 3e-04
Identities = 21/96 (21%), Positives = 34/96 (35%), Gaps = 2/96 (2%)
Query: 255 SIPCSFGNLTKLVISCLGTNALSSSI-LEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTN 313
L + + L ++ L L +L + + L P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 314 LATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLN 349
L+ L S NAL S+ + SL +L LS N L+
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 6e-10
Identities = 50/222 (22%), Positives = 87/222 (39%), Gaps = 44/222 (19%)
Query: 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
FD +G G G V + +G A+K ++ + LNE L +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDA----------AAEEFGWTKRMNAIK 810
+VK + ++V EY+ G + L AA+
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ------------ 149
Query: 811 GVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSNRTE-LA 867
+ Y+H+ +++RD+ +N+L++ + ++ +DFG +K +K RT L
Sbjct: 150 -IVLTFEYLHSLD---LIYRDLKPENLLID--QQGYIQVTDFGFAKRVK----GRTWTLC 199
Query: 868 GTFGYIAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
GT +APE+ Y V D ++ GVL E+ G P
Sbjct: 200 GTPEALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP 237
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 8e-10
Identities = 53/246 (21%), Positives = 90/246 (36%), Gaps = 77/246 (31%)
Query: 698 RATKNFDDEHCIGNGGQGSVYKA--ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALT 755
RA + ++ IG G G V+KA G VA+K+ + EG L+
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTG--------EEGMPLS 57
Query: 756 KIR------------HRNIVK----FYGFCSHALHS-FVVYEYLEMGSLAMILSNDAAAE 798
IR H N+V+ + +V+E+++ L L D E
Sbjct: 58 TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPE 114
Query: 799 EFGWTKRMNAIKGVA----DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854
IK + L ++H++ +VHRD+ +N+L+ + ++DFG
Sbjct: 115 PG---VPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG--- 165
Query: 855 FLKLGLSNRTELAGTFG-------------YIAPEL----AYTMKVTEKCDVYSFGVLAL 897
LA + Y APE+ +Y V D++S G +
Sbjct: 166 -----------LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPV----DLWSVGCIFA 210
Query: 898 EVIKGK 903
E+ + K
Sbjct: 211 EMFRRK 216
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 9e-10
Identities = 33/151 (21%), Positives = 63/151 (41%), Gaps = 18/151 (11%)
Query: 827 IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF--GYIAPELAYTMKVT 884
+HRD++++N+LL+ + + DFG+++ + + ++APE + T
Sbjct: 214 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 273
Query: 885 EKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPLRNVQD 941
+ DV+SFGVL E+ G P + ++ L R+ P
Sbjct: 274 IQSDVWSFGVLLWEIFSLGASPYPGVK---------IDEEFCRRLKEGTRMRAP-DYTTP 323
Query: 942 KLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
++ M C P+ RPT ++ + L
Sbjct: 324 EMYQTML---DCWHGEPSQRPTFSELVEHLG 351
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 32/159 (20%), Positives = 53/159 (33%), Gaps = 26/159 (16%)
Query: 709 IGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQE---FLNEGNALTKI-R 758
+G G G V +A+ T VAVK E A E ++E L I
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-----EGATHSEHRALMSELKILIHIGH 84
Query: 759 HRNIVKFYGFCSHALHS-FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL 817
H N+V G C+ V+ E+ + G+L + +KR +
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNL----------STYLRSKRNEFVPYKTKGAR 134
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856
+ + + D+ + + + S F K L
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 56/227 (24%), Positives = 91/227 (40%), Gaps = 50/227 (22%)
Query: 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTKI 757
+F+ +G G G V +E T E+ AVK K ++ C + E L
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT---MVEKRVLALP 398
Query: 758 -RHRNIVK-FYGFCSHALHSFVVYEYLEMGSLAMILSNDA----------AAEEFGWTKR 805
+ + + F + + V EY+ G L + AAE
Sbjct: 399 GKPPFLTQLHSCFQTMD-RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE------- 450
Query: 806 MNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSNR 863
+A L ++ + I++RD+ NV+L+ E H+ +DFG+ K +
Sbjct: 451 ------IAIGLFFLQSK---GIIYRDLKLDNVMLD--SEGHIKIADFGMCK-ENIWDGVT 498
Query: 864 TE-LAGTFGYIAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
T+ GT YIAPE+ Y V D ++FGVL E++ G+ P
Sbjct: 499 TKTFCGTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 541
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 55/231 (23%), Positives = 90/231 (38%), Gaps = 45/231 (19%)
Query: 698 RATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEF--------- 747
AT ++ IG G G+VYKA + +G VA+K +P
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVA 63
Query: 748 -LNEGNALTKIRHRNIVKFYGFCSHALHS-----FVVYEYLEMGSLAMILSNDAAAEEFG 801
L L H N+V+ C+ + +V+E+++ L L A
Sbjct: 64 LLRR---LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK-APPPGLP 118
Query: 802 WTKRMNAIKGVA----DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857
IK + L ++H NC IVHRD+ +N+L+ ++DFG+++
Sbjct: 119 ----AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI-- 169
Query: 858 LGLSNR-TELAGTFGYIAPEL----AYTMKVTEKCDVYSFGVLALEVIKGK 903
T + T Y APE+ Y V D++S G + E+ + K
Sbjct: 170 YSYQMALTPVVVTLWYRAPEVLLQSTYATPV----DMWSVGCIFAEMFRRK 216
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 57/193 (29%), Positives = 83/193 (43%), Gaps = 17/193 (8%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G G V + TG VAVK + + + E L RH +I+K Y
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 768 FCSHALHSFVVYEYLEMGSL-AMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP 826
S F+V EY+ G L I N E+ + GV Y H +
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----YCHRHM--- 136
Query: 827 IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL----AYTMK 882
+VHRD+ +NVLL+ A ++DFG+S + G RT G+ Y APE+ Y
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGRLYA-- 193
Query: 883 VTEKCDVYSFGVL 895
+ D++S GV+
Sbjct: 194 -GPEVDIWSSGVI 205
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 52/223 (23%), Positives = 91/223 (40%), Gaps = 38/223 (17%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
+ + IG G G V A + VA+KK SP + CQ+ L E L + R
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFR 83
Query: 759 HRNIVKFYG-FCSHALHSF----VVYEYLEMGSLAMILSNDAAAEEFGW----TKRMNAI 809
H NI+ + + +V + +E ++ + + + + R
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR---- 139
Query: 810 KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR---TEL 866
L Y+H+ ++HRD+ N+LLN + + DFG+++ + TE
Sbjct: 140 -----GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 867 AGTFGYIAPEL-----AYTMKVTEKCDVYSFG-VLALEVIKGK 903
T Y APE+ YT + D++S G +LA E++ +
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSI----DIWSVGCILA-EMLSNR 229
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 41/186 (22%), Positives = 71/186 (38%), Gaps = 42/186 (22%)
Query: 361 KLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKL 420
+ V L I + + + ++L + L L N++ + I + M++L IL L N +
Sbjct: 26 EKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLI 82
Query: 421 NGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSL 480
I +L + ++L+ L++S N I LSG + L
Sbjct: 83 K-KIE-NLDAVADTLEELWISYNQI---------------------ASLSG-----IEKL 114
Query: 481 NQLEYLDLSANTFHN-SIPESLGNLVKLHYLNLSNNQFSQKIPNP----------IEKLI 529
L L +S N N + L L KL L L+ N +++L
Sbjct: 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLP 174
Query: 530 HLSELD 535
+L +LD
Sbjct: 175 NLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 37/149 (24%), Positives = 60/149 (40%), Gaps = 22/149 (14%)
Query: 280 ILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLS 339
+ + LK+ HL L+ N + I SL + NL L N + I N +L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 340 DLQLSEN---TLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSF-ASLTSLTTLYLYENS 395
+L +S N +L+G + L L L +S NK++ + A+L L L L N
Sbjct: 97 ELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP 151
Query: 396 LCDSIPKE----------IGDMKSLSILD 414
L + + + + +L LD
Sbjct: 152 LYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 26/120 (21%), Positives = 52/120 (43%), Gaps = 10/120 (8%)
Query: 476 ELGSLNQLEYLDLSANTFHN--SIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSE 533
+ + E ++L + +L L +L LS N KI + + + +L
Sbjct: 18 KSVVATEAEKVELH-GMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRI 74
Query: 534 LDLSY-KIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGL 592
L L I ++I + +LE+L +S+N ++ S+S E++ L + +S N +
Sbjct: 75 LSLGRNLI--KKIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKITNW 130
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 29/127 (22%), Positives = 47/127 (37%), Gaps = 7/127 (5%)
Query: 5 LGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSI 64
L + + L K L+ S N + + + + +L LSL N +K I
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS--LSGMENLRILSLGRNLIK-KI 85
Query: 65 PPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNG-SIPSSLGNLTNLV 123
+L + I N ++ S+ + L +L L +SNN + L L L
Sbjct: 86 ENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143
Query: 124 TLYLHMN 130
L L N
Sbjct: 144 DLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 28/131 (21%), Positives = 50/131 (38%), Gaps = 13/131 (9%)
Query: 100 DLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQV---SYNTL 156
+L + + ++L L L L N + +I +L + +L++ N +
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRILSLGRNLI 82
Query: 157 SGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSG-SILYSFGNL 215
I L L+I N ++ S+ I L +L L + N ++ + L
Sbjct: 83 K-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAAL 139
Query: 216 TKLEILYLDVN 226
KLE L L N
Sbjct: 140 DKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 24/128 (18%), Positives = 48/128 (37%), Gaps = 7/128 (5%)
Query: 196 DLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGS 255
+L + + + L + L L N + + + + +++L L L N +
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-K 84
Query: 256 IPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLS-LGSLTNL 314
I L + N ++S L I L +L L ++ N ++ + L +L L
Sbjct: 85 IENLDAVADTLEELWISYNQIAS--LSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKL 142
Query: 315 ATLYFSTN 322
L + N
Sbjct: 143 EDLLLAGN 150
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 41/120 (34%), Positives = 62/120 (51%), Gaps = 9/120 (7%)
Query: 327 SIPNEI-TNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLS-FASLT 384
S+P I ++ L +L N L LT+L L LS N++ S+P F LT
Sbjct: 21 SVPTGIPSSATRL---ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLT 76
Query: 385 SLTTLYLYENSLCDSIPKEIGD-MKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 443
LT LYL+EN L S+P + D + L L L +N+L S+P + + SL+ ++L +N
Sbjct: 77 KLTILYLHENKL-QSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 39/122 (31%), Positives = 54/122 (44%), Gaps = 14/122 (11%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPP----SLGN 70
S+P I + L N+L L +L+ L LSL N ++ S+P L
Sbjct: 21 SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77
Query: 71 LTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPS-SLGNLTNLVTLYLH 128
LT L + N L S+PN V L L +L L N L S+P LT+L ++LH
Sbjct: 78 LTIL---YLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLH 132
Query: 129 MN 130
N
Sbjct: 133 TN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 38/110 (34%), Positives = 51/110 (46%), Gaps = 6/110 (5%)
Query: 312 TNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLAL-GNLTKLVSLDLSIN 370
++ L +N L L L+ L LS+N + S+P + LTKL L L N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHEN 86
Query: 371 KLSGSIPLS-FASLTSLTTLYLYENSLCDSIPKEIGD-MKSLSILDLSSN 418
KL S+P F LT L L L N L S+P I D + SL + L +N
Sbjct: 87 KLQ-SLPNGVFDKLTQLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 39/109 (35%), Positives = 55/109 (50%), Gaps = 11/109 (10%)
Query: 364 SLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGD-MKSLSILDLSSNKLNG 422
L+L NKL F LT LT L L +N + S+P + D + L+IL L NKL
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKLQ- 89
Query: 423 SIPLSL-ANLTNSLKVLYLSSNHIVGEIPLGHGKF---SSLIQLILNNN 467
S+P + LT LK L L +N + +P G F +SL ++ L+ N
Sbjct: 90 SLPNGVFDKLTQ-LKELALDTNQLKS-VP--DGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 38/134 (28%), Positives = 49/134 (36%), Gaps = 30/134 (22%)
Query: 216 TKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCS-FGNLTKLVISCLGTN 274
+ L L+ N L L L L L L+ N + S+P F LTKL
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLT------- 79
Query: 275 ALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSL-GSLTNLATLYFSTNALSGSIPNEI- 332
L L+ N L S+P + LT L L TN L S+P+ I
Sbjct: 80 -----------------ILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIF 120
Query: 333 TNLRSLSDLQLSEN 346
L SL + L N
Sbjct: 121 DRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 37/120 (30%), Positives = 53/120 (44%), Gaps = 10/120 (8%)
Query: 111 SIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIP---FSLGNL 167
S+P+ G ++ L L N L L L+ L +S N + ++P F L
Sbjct: 21 SVPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFD--KL 75
Query: 168 TNLVTLYIGINALSGSIPNEI-GNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVN 226
T L LY+ N L S+PN + L L +L LD N L F LT L+ ++L N
Sbjct: 76 TKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 33/110 (30%), Positives = 45/110 (40%), Gaps = 16/110 (14%)
Query: 101 LRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIP----DEIGNLKFLSDLQVSYNTL 156
L L +N L LT L L L N + S+P D++ L L + N L
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLT---ILYLHENKL 88
Query: 157 SGAIP---FSLGNLTNLVTLYIGINALSGSIPNEI-GNLKSLSDLRLDYN 202
++P F LT L L + N L S+P+ I L SL + L N
Sbjct: 89 Q-SLPNGVFD--KLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 32/100 (32%), Positives = 39/100 (39%), Gaps = 2/100 (2%)
Query: 168 TNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNA 227
++ L + N L L L+ L L N + F LTKL ILYL N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87
Query: 228 LSGLIPNEIGNLKSLLALQLNYNTLSGSIP-CSFGNLTKL 266
L L L L L L+ N L S+P F LT L
Sbjct: 88 LQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSL 126
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 34/117 (29%), Positives = 49/117 (41%), Gaps = 19/117 (16%)
Query: 414 DLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLI---LNNNELS 470
+S L S+P + +S L L SN + L HG F L QL L+ N++
Sbjct: 13 RCNSKGLT-SVP---TGIPSSATRLELESNKLQS---LPHGVFDKLTQLTKLSLSQNQIQ 65
Query: 471 GQLSPELG---SLNQLEYLDLSANTFHNSIPESL-GNLVKLHYLNLSNNQFSQKIPN 523
S G L +L L L N S+P + L +L L L NQ + +P+
Sbjct: 66 ---SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQL-KSVPD 117
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 3e-09
Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 53/229 (23%)
Query: 702 NFDDEHCIGNGGQGSVYKAELP----TGEIVAVK-------KFHSPLPGEMACQQEFLNE 750
F+ +G G G V+ + ++ A+K K + E
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD--------RVRTKME 76
Query: 751 GNALTKIRHRNIVK-FYGFCSHALHSFVVYEYLEMGSLAMILSNDA----------AAEE 799
+ L ++ H IVK Y F + +++ ++L G L LS + AE
Sbjct: 77 RDILVEVNHPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE- 134
Query: 800 FGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLK 857
+A AL ++H+ I++RD+ +N+LL+ E H+ +DFG+SK
Sbjct: 135 ------------LALALDHLHSLG---IIYRDLKPENILLD--EEGHIKLTDFGLSK-ES 176
Query: 858 LGLSNRTE-LAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
+ + GT Y+APE+ T+ D +SFGVL E++ G P
Sbjct: 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 39/174 (22%), Positives = 70/174 (40%), Gaps = 42/174 (24%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVK---------KFHSPLPGEM-----ACQQEFLNEGNAL 754
IG GG G +Y A++ + E V + PL E+ A + E + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 755 TKIRHRNIVKFYGFCSHAL----HSFVVYEYLEMG-SLAMILSNDAAAEEFGWTKRMNAI 809
K+++ + K++G H + F++ + G L I + + +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKI---------YEANAKRFSR 151
Query: 810 KGVA-------DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISK 854
K V D L Y+H + + VH DI + N+LLN + V D+G++
Sbjct: 152 KTVLQLSLRILDILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 38/162 (23%), Positives = 64/162 (39%), Gaps = 22/162 (13%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
++ H IG G G V +A + +VA+KK + C++ L E L ++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI-LREIAILNRLN 110
Query: 759 HRNIVKFYG-FCSHALHSF----VVYEYLEMGSLAMILSNDAAAEE----FGWTKRMNAI 809
H ++VK + F VV E + + + E + N +
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY----NLL 166
Query: 810 KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFG 851
G + Y+H+ I+HRD+ N L+N + V DFG
Sbjct: 167 VG----VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFG 201
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 33/174 (18%), Positives = 63/174 (36%), Gaps = 42/174 (24%)
Query: 709 IGNGGQGSVYKAE---------LPTGEIVAVK--KFHSPLPGEM-----ACQQEFLNEGN 752
QG +Y+A P + ++K L E A + +N+
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 753 ALTKIRHRNIVKFYGFCSH-ALHSFVVYEYLEMG-SLAMILSNDAAAEEFGWTKRMN-AI 809
L I GF H + F+V L G SL + + +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSA---------LDVSPKHVLSE 158
Query: 810 KGVA-------DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISK 854
+ V DAL ++H N + VH +++++N+ ++ E ++ V + +G +
Sbjct: 159 RSVLQVACRLLDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 9e-09
Identities = 51/234 (21%), Positives = 91/234 (38%), Gaps = 51/234 (21%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKK--FHSPLPGEMACQQEFLNEGNALTK 756
+ D +G GG G V+ A + + VA+KK P + + L E + +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP----QSVKHA-LREIKIIRR 64
Query: 757 IRHRNIVKFY----------GFCSHALHSF----VVYEYLEMGSLAMILSNDAAAEEFGW 802
+ H NIVK + +L +V EY+E ++ E
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL 124
Query: 803 ----TKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE-YEAHVSDFGISKFLK 857
R L Y+H+ ++HRD+ N+ +N E + DFG+++ +
Sbjct: 125 FMYQLLR---------GLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 858 LGLSNR---TELAGTFGYIAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 903
S++ +E T Y +P L YT + D+++ G + E++ GK
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 40/172 (23%), Positives = 65/172 (37%), Gaps = 41/172 (23%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVK------KFHSPLPGEM-----ACQQEFLNEGNALTK 756
IG+GG G +Y A E A + + PL E+ +++ + + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 757 IRHRNIVKFYGFCSHAL----HSFVVYEYLEMG-SLAMILSNDAAAEEFGWTKRMNAIKG 811
+ + I FYG + F+V E L G L I G
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKI---------SGQNGTFK-KST 152
Query: 812 VA-------DALLYMHTNCFPPIVHRDISSKNVLLNLEYE--AHVSDFGISK 854
V D L Y+H N + VH DI + N+LL + +++D+G+S
Sbjct: 153 VLQLGIRMLDVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 60/252 (23%), Positives = 92/252 (36%), Gaps = 54/252 (21%)
Query: 709 IGNGGQGSVYKAEL-PTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTKI-RHRNIV 763
IG G V L T I A++ K ++ E + + H +V
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWV---QTEKHVFEQASNHPFLV 116
Query: 764 K-FYGFCSHALHSFVVYEYLEMGSLAMILSNDA----------AAEEFGWTKRMNAIKGV 812
F + + F V EY+ G L + +AE +
Sbjct: 117 GLHSCFQTES-RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-------------I 162
Query: 813 ADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSNRTE-LAGT 869
+ AL Y+H I++RD+ NVLL+ E H+ +D+G+ K L + T GT
Sbjct: 163 SLALNYLHER---GIIYRDLKLDNVLLD--SEGHIKLTDYGMCK-EGLRPGDTTSTFCGT 216
Query: 870 FGYIAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALD 925
YIAPE+ Y V D ++ GVL E++ G+ P F S D
Sbjct: 217 PNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP--FDIVGSSDNPDQNTE--D 268
Query: 926 EMLDPRLPTPLR 937
+ L +R
Sbjct: 269 YLFQVILEKQIR 280
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 52/193 (26%), Positives = 81/193 (41%), Gaps = 18/193 (9%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G G V A T + VA+K L + E + L +RH +I+K Y
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 768 FCSHALHSFVVYEYLEMGSL-AMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP 826
+ +V EY G L I+ E+ G I + Y H +
Sbjct: 77 VITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIE----YCHRHK--- 128
Query: 827 IVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL----AYTMK 882
IVHRD+ +N+LL+ ++DFG+S + G +T G+ Y APE+ Y
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAPEVINGKLYA-- 185
Query: 883 VTEKCDVYSFGVL 895
+ DV+S G++
Sbjct: 186 -GPEVDVWSCGIV 197
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 57/288 (19%), Positives = 100/288 (34%), Gaps = 55/288 (19%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
N+ +H IG G G VY A + T + VA+KK + + C++ L E L +++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR-ILREITILNRLK 83
Query: 759 HRNIVKFYG-FCSHALHSF----VVYEYLEMGSLAMILSNDAAAEE----FGWTKRMNAI 809
I++ Y L F +V E + + + EE + N +
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY----NLL 139
Query: 810 KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGT 869
G ++H + I+HRD+ N LLN + V DFG+++ +
Sbjct: 140 LG----ENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 870 FG----------------------YIAPEL-----AYTMKVTEKCDVYSFG-VLALEVIK 901
Y APEL YT + D++S G + A E++
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTGCIFA-ELLN 247
Query: 902 GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEV 949
+ L + ++ +D+L I +
Sbjct: 248 MLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNI 295
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 2e-08
Identities = 57/226 (25%), Positives = 94/226 (41%), Gaps = 45/226 (19%)
Query: 702 NFDDEHCIGNGGQGSVYKAELP----TGEIVAVKKFHSPL----PGEMACQQEFLNEGNA 753
F+ +G GG G V++ TG+I A+K + + A E N
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT---KAERNI 74
Query: 754 LTKIRHRNIVK-FYGFCSHALHSFVVYEYLEMGSLAMILSNDA----------AAEEFGW 802
L +++H IV Y F + +++ EYL G L M L + AE
Sbjct: 75 LEEVKHPFIVDLIYAFQTGG-KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE---- 129
Query: 803 TKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGL 860
++ AL ++H I++RD+ +N++LN ++ HV +DFG+ K +
Sbjct: 130 ---------ISMALGHLHQK---GIIYRDLKPENIMLN--HQGHVKLTDFGLCK-ESIHD 174
Query: 861 SNRTE-LAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
T GT Y+APE+ D +S G L +++ G P
Sbjct: 175 GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 48/251 (19%), Positives = 84/251 (33%), Gaps = 64/251 (25%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLN-EGNALTKI 757
+K + +G G G V + ++ +G+ A+KK + N E + + +
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ--------DPRYKNRELDIMKVL 57
Query: 758 RHRNIVK----FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVA 813
H NI+K FY + N+ + + +
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 814 D----------------------------------ALLYMHTNCFPPIVHRDISSKNVLL 839
+ A+ ++H+ I HRDI +N+L+
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLV 174
Query: 840 NLE-YEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL-----AYTMKVTEKCDVYSFG 893
N + + DFG +K L + + Y APEL YT + D++S G
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPS-VAYICSRFYRAPELMLGATEYTPSI----DLWSIG 229
Query: 894 -VLALEVIKGK 903
V E+I GK
Sbjct: 230 CVFG-ELILGK 239
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 60/354 (16%), Positives = 109/354 (30%), Gaps = 39/354 (11%)
Query: 243 LALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSG 302
L N L+ + C NL L + L + + + L HL +Y
Sbjct: 6 LLSAHNRAVLAQ-LGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEF--Q 62
Query: 303 SIPLSLGSLTNLATLYFSTNALSGSIPNEI-----TNLRSLSDLQLSENTLNGSIPLALG 357
+ S L++L L + ++ + + +L ++ L+ L+ + L
Sbjct: 63 NQRFSAEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLL 122
Query: 358 N-LTKLVSLDLSINKLS--GSIPLSFA---SLTSLTTLYLYENSLCDSIPKEIGDM---- 407
+ L L +N L L +TTL L N L + + +
Sbjct: 123 PVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGN 182
Query: 408 KSLSILDLSSNKL--NGSIPLSLANLTN-SLKVLYLSSNHI--VGEIPLGHG--KFSSLI 460
S++ L L L G L+ N L+ L ++ N + L + SL
Sbjct: 183 TSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLE 242
Query: 461 QLILNNNELS----GQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQ 516
L L NELS L G+ + +S L ++ N
Sbjct: 243 LLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEV----QRNLN 298
Query: 517 FSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSM----QSLEKLNLSHNNLS 566
+ +++ + L DL P + + + L +
Sbjct: 299 SWDR--ARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 62/252 (24%), Positives = 93/252 (36%), Gaps = 54/252 (21%)
Query: 709 IGNGGQGSVYKAEL-PTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTKI-RHRNIV 763
IG G V L T I A+K K ++ Q E + + H +V
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ---TEKHVFEQASNHPFLV 73
Query: 764 K-FYGFCSHALHSFVVYEYLEMGSLAMILSNDA----------AAEEFGWTKRMNAIKGV 812
F + + F V EY+ G L + +AE +
Sbjct: 74 GLHSCFQTES-RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-------------I 119
Query: 813 ADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSNRTE-LAGT 869
+ AL Y+H I++RD+ NVLL+ E H+ +D+G+ K L + T GT
Sbjct: 120 SLALNYLHER---GIIYRDLKLDNVLLD--SEGHIKLTDYGMCK-EGLRPGDTTSTFCGT 173
Query: 870 FGYIAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALD 925
YIAPE+ Y V D ++ GVL E++ G+ P F S D
Sbjct: 174 PNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP--FDIVGSSDNPDQNTE--D 225
Query: 926 EMLDPRLPTPLR 937
+ L +R
Sbjct: 226 YLFQVILEKQIR 237
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 3e-08
Identities = 59/220 (26%), Positives = 92/220 (41%), Gaps = 50/220 (22%)
Query: 709 IGNGGQGSVYKAEL-PTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTK-IRHRNIV 763
+G G G V+ AE T + A+K K + ++ C + E L+ H +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT---MVEKRVLSLAWEHPFLT 81
Query: 764 K-FYGFCSHALHSFVVYEYLEMGSLAMILSNDA----------AAEEFGWTKRMNAIKGV 812
F F + + F V EYL G L + + AAE +
Sbjct: 82 HMFCTFQTKE-NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE-------------I 127
Query: 813 ADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSNRTE-LAGT 869
L ++H+ IV+RD+ N+LL+ + H+ +DFG+ K + +T GT
Sbjct: 128 ILGLQFLHSK---GIVYRDLKLDNILLD--KDGHIKIADFGMCK-ENMLGDAKTNTFCGT 181
Query: 870 FGYIAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
YIAPE+ Y V D +SFGVL E++ G+ P
Sbjct: 182 PDYIAPEILLGQKYNHSV----DWWSFGVLLYEMLIGQSP 217
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 3e-08
Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 50/225 (22%)
Query: 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTKI 757
+F +G G G V+ G A+K K ++ +E L+ +
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT---NDERLMLSIV 63
Query: 758 RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDA----------AAEEFGWTKRMN 807
H I++ +G A F++ +Y+E G L +L AAE
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE--------- 114
Query: 808 AIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSNRTE 865
V AL Y+H+ I++RD+ +N+LL+ H+ +DFG +K++ + T
Sbjct: 115 ----VCLALEYLHSK---DIIYRDLKPENILLD--KNGHIKITDFGFAKYVP----DVTY 161
Query: 866 -LAGTFGYIAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
L GT YIAPE+ Y + D +SFG+L E++ G P
Sbjct: 162 TLCGTPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 5e-08
Identities = 27/118 (22%), Positives = 40/118 (33%), Gaps = 4/118 (3%)
Query: 282 EEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDL 341
+ N L L + I +L + FS N + + LR L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTL 69
Query: 342 QLSENTLNGSIPLALGNLTKLVSLDLSINKLSG-SIPLSFASLTSLTTLYLYENSLCD 398
++ N + L L L L+ N L ASL SLT L + N + +
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 127
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 24/127 (18%), Positives = 46/127 (36%), Gaps = 7/127 (5%)
Query: 412 ILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSG 471
++ L++ + + N + L L I LG + ++NE+
Sbjct: 1 MVKLTAELIEQA--AQYTNAVR-DRELDLRGYKIPVIENLGA-TLDQFDAIDFSDNEIR- 55
Query: 472 QLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQ-KIPNPIEKLIH 530
+L L +L+ L ++ N L L L L+NN + +P+ L
Sbjct: 56 KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS 114
Query: 531 LSELDLS 537
L+ L +
Sbjct: 115 LTYLCIL 121
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 23/113 (20%), Positives = 41/113 (36%), Gaps = 4/113 (3%)
Query: 307 SLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLD 366
+ L + I N L + S+N + + L +L +L
Sbjct: 14 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLL 70
Query: 367 LSINKLSGSIPLSFASLTSLTTLYLYENSLCD-SIPKEIGDMKSLSILDLSSN 418
++ N++ +L LT L L NSL + + +KSL+ L + N
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 33/144 (22%), Positives = 54/144 (37%), Gaps = 9/144 (6%)
Query: 406 DMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILN 465
+ LDL K+ I +L + + S N I ++ G L L++N
Sbjct: 17 NAVRDRELDLRGYKIP-VIE-NLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVN 72
Query: 466 NNELSGQLSPELGSLNQLEYLDLSANTFHN-SIPESLGNLVKLHYLNLSNNQFSQKI--- 521
NN + +L L L L+ N+ + L +L L YL + N + K
Sbjct: 73 NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYR 132
Query: 522 PNPIEKLIHLSELDLSYKIFGEEI 545
I K+ + LD K+ +E
Sbjct: 133 LYVIYKVPQVRVLDF-QKVKLKER 155
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 30/117 (25%), Positives = 45/117 (38%), Gaps = 11/117 (9%)
Query: 331 EITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLS---INKLSGSIPLSFASLTSLT 387
+ TN +L L + I L + ++D S I KL G F L L
Sbjct: 14 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG-----FPLLRRLK 67
Query: 388 TLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNG-SIPLSLANLTNSLKVLYLSSN 443
TL + N +C + L+ L L++N L LA+L + L L + N
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS-LTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 20/109 (18%), Positives = 41/109 (37%), Gaps = 9/109 (8%)
Query: 486 LDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEI 545
+ L+A + N V+ L+L + I N L +D S EI
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFS----DNEI 54
Query: 546 PS--QVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGL 592
++ L+ L +++N + + + L+ + ++ N+L L
Sbjct: 55 RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVEL 103
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 23/114 (20%), Positives = 41/114 (35%), Gaps = 4/114 (3%)
Query: 66 PSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTL 125
N +D+ + I N +L + S+N + + L L TL
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 126 YLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSG-AIPFSLGNLTNLVTLYIGIN 178
++ N + L L++L ++ N+L L +L +L L I N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 21/105 (20%), Positives = 33/105 (31%), Gaps = 5/105 (4%)
Query: 47 LSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNN 106
L L + I L ID +N + + L+ L L ++NN
Sbjct: 18 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNN 74
Query: 107 SLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQV 151
+ L +L L L N+L ++ L L L
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSLTY 117
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 19/105 (18%), Positives = 34/105 (32%), Gaps = 5/105 (4%)
Query: 94 SLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSY 153
+ +L L + I + L + N + + L+ L L V+
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNN 73
Query: 154 NTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLR 198
N + L +L L + N+L ++ L SL L
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSLT 116
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 7e-08
Identities = 56/227 (24%), Positives = 91/227 (40%), Gaps = 50/227 (22%)
Query: 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTKI 757
+F+ +G G G V +E T E+ AVK K ++ C + E L
Sbjct: 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT---MVEKRVLALP 77
Query: 758 -RHRNIVK-FYGFCSHALHSFVVYEYLEMGSLAMILSNDA----------AAEEFGWTKR 805
+ + + F + + V EY+ G L + AAE
Sbjct: 78 GKPPFLTQLHSCFQTMD-RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE------- 129
Query: 806 MNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSNR 863
+A L ++ + I++RD+ NV+L+ E H+ +DFG+ K +
Sbjct: 130 ------IAIGLFFLQSK---GIIYRDLKLDNVMLD--SEGHIKIADFGMCK-ENIWDGVT 177
Query: 864 TE-LAGTFGYIAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
T+ GT YIAPE+ Y V D ++FGVL E++ G+ P
Sbjct: 178 TKTFCGTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 220
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 39/207 (18%), Positives = 68/207 (32%), Gaps = 65/207 (31%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFY 766
+G G G V + T E A+K + E + + +IV+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIV 77
Query: 767 GFC----SHALHSFVVYEYLEMGSL--------AMILSNDAAAEEFGWTKRMNAIKGVAD 814
+ +V E L+ G L + A+E +K + +
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE---------IMKSIGE 128
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAH---VSDFGISKFLKLGLSNRTELAGTFG 871
A+ Y+H+ I HRD+ +N+L + ++DFG
Sbjct: 129 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG-------------------- 165
Query: 872 YIAPEL---AYTMKVTEKCDVYSFGVL 895
A E Y + CD++S GV+
Sbjct: 166 -FAKETTGEKY----DKSCDMWSLGVI 187
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 8e-08
Identities = 59/233 (25%), Positives = 92/233 (39%), Gaps = 55/233 (23%)
Query: 702 NFDDEHCIGNGGQGSVYKAELP----TGEIVAVKKFHSPLPGEMACQQEF-LNEGNALTK 756
NF+ +G G G V+ TG++ A+K + A E E L
Sbjct: 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 757 IRHRN-IVK-FYGFCSHALHSFVVYEYLEMGSLAMILSNDA----------AAEEFGWTK 804
IR +V Y F + ++ +Y+ G L LS E
Sbjct: 115 IRQSPFLVTLHYAFQTET-KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE------ 167
Query: 805 RMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSN 862
+ AL ++H I++RDI +N+LL+ HV +DFG+S K +++
Sbjct: 168 -------IVLALEHLHKL---GIIYRDIKLENILLD--SNGHVVLTDFGLS---KEFVAD 212
Query: 863 RTELAGTF-G---YIAPEL------AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
TE A F G Y+AP++ + V D +S GVL E++ G P
Sbjct: 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 50/220 (22%)
Query: 709 IGNGGQGSVYKAEL-PTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTK-IRHRNIV 763
IG G G V A AVK K E ++E N L K ++H +V
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHI---MSERNVLLKNVKHPFLV 102
Query: 764 K-FYGFCSHALHSFVVYEYLEMGSLAMILSNDA----------AAEEFGWTKRMNAIKGV 812
+ F + + V +Y+ G L L + AAE +
Sbjct: 103 GLHFSFQTAD-KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE-------------I 148
Query: 813 ADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSNRTE-LAGT 869
A AL Y+H+ IV+RD+ +N+LL+ + H+ +DFG+ K + ++ T GT
Sbjct: 149 ASALGYLHSL---NIVYRDLKPENILLD--SQGHIVLTDFGLCK-ENIEHNSTTSTFCGT 202
Query: 870 FGYIAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
Y+APE+ Y V D + G + E++ G P
Sbjct: 203 PEYLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP 238
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 66/425 (15%), Positives = 126/425 (29%), Gaps = 58/425 (13%)
Query: 196 DLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIG------------NLKSLL 243
+ L Y + F NL L++ A+ LIP G NL+ L
Sbjct: 56 TMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK 115
Query: 244 ALQLNYNTLSGS-----IPCSFGNLTKLVISCLGTNALSSSILEEIG-NLKSLLHLQLNY 297
++ +S +L L + + ++ L I + + + L +
Sbjct: 116 SVHFRRMIVSDLDLDRLAKARADDLETLKLD--KCSGFTTDGLLSIVTHCRKIKTLLMEE 173
Query: 298 NTLSGSIPLSLGSL----TNLATLYFSTNALSG----SIPNEITNLRSLSDLQLSENTL- 348
++ S L L T+L L F + + N RSL +++ + +
Sbjct: 174 SSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL 233
Query: 349 -NGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDM 407
A NL + L+ + ++ L L L + +P
Sbjct: 234 ELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFA 292
Query: 408 KSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH-IVGEIPLGHGKFSSLIQLILNN 466
+ LDL L +L +L+VL + G L L +L +
Sbjct: 293 AQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQY-CKQLKRLRIER 351
Query: 467 NELSGQLSPELGSLN------------QLEYLDLSANTFHN----SIPESLGNLVKLHYL 510
+ E G ++ +LEY+ + + N SI L NL +
Sbjct: 352 GADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLV 411
Query: 511 NLSNNQ------FSQKIPNPIEKLIHLSELDLSY---KIFGEEIPSQVCSMQSLEKLNLS 561
L + + + + L + + ++ + L
Sbjct: 412 LLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLG 471
Query: 562 HNNLS 566
+ S
Sbjct: 472 YVGES 476
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 64/423 (15%), Positives = 127/423 (30%), Gaps = 68/423 (16%)
Query: 243 LALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSG 302
+ + L Y + F NL L + A+ + I E G
Sbjct: 55 VTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGY--------------- 99
Query: 303 SIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKL 362
I N + L+S+ + + LA L
Sbjct: 100 ------------------VTPWVTEISNNLRQLKSV-HFRRMIVSDLDLDRLAKARADDL 140
Query: 363 VSLDLS-INKLSGSIPLSFAS-LTSLTTLYLYENSLCDSIPKEIGDM----KSLSILDLS 416
+L L + + LS + + TL + E+S + K + ++ SL +L+
Sbjct: 141 ETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFY 200
Query: 417 SNKLNGSIPLSLANLTN---SLKVLYLSSNHIVGEIPLGHG--KFSSLIQLILNNNELSG 471
+ P L + SL + + I+ + LN +
Sbjct: 201 MTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMP 260
Query: 472 QLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQF-SQKIPNPIEKLIH 530
+ L +L L LS N +P ++ L+L ++ I+K +
Sbjct: 261 EKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPN 319
Query: 531 LSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSG---------------SISRCFEE 575
L L+ I + + L++L + ++++ +E
Sbjct: 320 LEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQE 379
Query: 576 MHWL--SCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPCKAFKSHKQSL 633
+ ++ DI+ +L+ + D ++ L I LP +S
Sbjct: 380 LEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDR----EERITDLPLDNGVRSLLIGC 435
Query: 634 KKI 636
KK+
Sbjct: 436 KKL 438
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 60/227 (26%), Positives = 92/227 (40%), Gaps = 50/227 (22%)
Query: 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVK---KFHSPLPGEMACQQEFLNEGNALTKI 757
NF+ +G G G V A + TG++ AVK K ++ C + E L+
Sbjct: 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT---MTEKRILSLA 80
Query: 758 -RHRNIVK-FYGFCSHALHSFVVYEYLEMGSLAMILSNDA----------AAEEFGWTKR 805
H + + F F + F V E++ G L + AAE
Sbjct: 81 RNHPFLTQLFCCFQTPD-RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE------- 132
Query: 806 MNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSNR 863
+ AL+++H I++RD+ NVLL+ +E H +DFG+ K +
Sbjct: 133 ------IISALMFLHDK---GIIYRDLKLDNVLLD--HEGHCKLADFGMCK-EGICNGVT 180
Query: 864 TE-LAGTFGYIAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
T GT YIAPE+ Y V D ++ GVL E++ G P
Sbjct: 181 TATFCGTPDYIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAP 223
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 37/139 (26%), Positives = 56/139 (40%), Gaps = 7/139 (5%)
Query: 413 LDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQ 472
L L + K N L +L+ L L + ++ L K L +L L+ N + G
Sbjct: 29 LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP--KLPKLKKLELSENRIFGG 86
Query: 473 LSPELGSLNQLEYLDLSANTFHN-SIPESLGNLVKLHYLNLSNNQFSQKI---PNPIEKL 528
L L L +L+LS N + S E L L L L+L N + + + + L
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLL 146
Query: 529 IHLSELDLSYKIFGEEIPS 547
L+ LD Y +E P
Sbjct: 147 PQLTYLDG-YDREDQEAPD 164
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 7e-07
Identities = 30/115 (26%), Positives = 43/115 (37%), Gaps = 5/115 (4%)
Query: 334 NLRSLSDLQLSENTLN-GSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLY 392
++ +L L N G I L L L L S+ + L L L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELS 79
Query: 393 ENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLS-LANLTNSLKVLYLSSNHIV 446
EN + + + +L+ L+LS NKL L L L LK L L + +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLEC-LKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 9e-07
Identities = 32/107 (29%), Positives = 48/107 (44%), Gaps = 4/107 (3%)
Query: 433 NSLKVLYLSSNHI-VGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSAN 491
+++ L L + G+I +F +L L L N L +S L L +L+ L+LS N
Sbjct: 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSEN 81
Query: 492 TFHNSIPESLGNLVKLHYLNLSNNQFSQ-KIPNPIEKLIHLSELDLS 537
+ L L +LNLS N+ P++KL L LDL
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLF 128
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 29/94 (30%), Positives = 42/94 (44%), Gaps = 3/94 (3%)
Query: 326 GSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTS 385
G I +L L L L S+ L L KL L+LS N++ G + + L +
Sbjct: 39 GKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELSENRIFGGLDMLAEKLPN 96
Query: 386 LTTLYLYENSLCD-SIPKEIGDMKSLSILDLSSN 418
LT L L N L D S + + ++ L LDL +
Sbjct: 97 LTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 28/111 (25%), Positives = 41/111 (36%), Gaps = 4/111 (3%)
Query: 190 NLKSLSDLRLDYNTLS-GSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLN 248
++ +L LD + G I LE L L L + + + L L L+L+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79
Query: 249 YNTLSGSIPCSFGNLTKLVISCLGTNALSS-SILEEIGNLKSLLHLQLNYN 298
N + G + L L L N L S LE + L+ L L L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 27/107 (25%), Positives = 41/107 (38%), Gaps = 5/107 (4%)
Query: 46 RLSSLNGLSLYSNFLK-GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLS 104
+++ L L + G I +L ++ + N L S+ N + L L L LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 105 NNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQV 151
N + G + L NL L L N L + LK L L+
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKS 124
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 7e-05
Identities = 28/109 (25%), Positives = 41/109 (37%), Gaps = 5/109 (4%)
Query: 23 LTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNN 82
+ L L + N I +L LSL + L S+ L L L +++ N
Sbjct: 26 VRELVLDNCKSNDGK--IEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSEN 81
Query: 83 LLSGSIPNEVGSLKSLSDLRLSNNSLNG-SIPSSLGNLTNLVTLYLHMN 130
+ G + L +L+ L LS N L S L L L +L L
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 24/109 (22%), Positives = 43/109 (39%), Gaps = 8/109 (7%)
Query: 2 LKVLGLSFNQFS-GSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
++ L L + + G I +L+ LS L + + +L L L L N +
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN--LPKLPKLKKLELSENRI 83
Query: 61 KGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLR---LSNN 106
G + L +L ++++ N L + + LK L L+ L N
Sbjct: 84 FGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 25/106 (23%), Positives = 39/106 (36%), Gaps = 5/106 (4%)
Query: 238 NLKSLLALQL-NYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLN 296
++ L L N + G I L L L S + + L L L+L+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS--VSNLPKLPKLKKLELS 79
Query: 297 YNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQ 342
N + G + + L NL L S N L + + L+ L L+
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLK 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 30/107 (28%), Positives = 49/107 (45%), Gaps = 4/107 (3%)
Query: 433 NSLKVLYLSSNHI-VGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSAN 491
+ +K L L ++ G++ +F L L N L+ ++ L LN+L+ L+LS N
Sbjct: 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDN 74
Query: 492 TFHNSIPESLGNLVKLHYLNLSNNQFSQ-KIPNPIEKLIHLSELDLS 537
+ L +LNLS N+ P++KL +L LDL
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLF 121
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 9e-07
Identities = 28/114 (24%), Positives = 44/114 (38%), Gaps = 5/114 (4%)
Query: 334 NLRSLSDLQLSENTLN-GSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLY 392
+ +L L + N G + +L L L+ SI + L L L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72
Query: 393 ENSLCDSIPKEIGDMKSLSILDLSSNKLNG-SIPLSLANLTNSLKVLYLSSNHI 445
+N + + +L+ L+LS NK+ S L L N LK L L + +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLEN-LKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 33/134 (24%), Positives = 56/134 (41%), Gaps = 10/134 (7%)
Query: 408 KSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI--VGEIPLGHGKFSSLIQLILN 465
+ L L +++ N L + L+ L + + + +P K + L +L L+
Sbjct: 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLELS 72
Query: 466 NNELSGQLSPELGSLNQLEYLDLSANTFHN-SIPESLGNLVKLHYLNLSNNQFSQKI--- 521
+N +SG L L +L+LS N + S E L L L L+L N + +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYR 132
Query: 522 PNPIEKLIHLSELD 535
N + L L+ LD
Sbjct: 133 ENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 9e-06
Identities = 26/106 (24%), Positives = 43/106 (40%), Gaps = 5/106 (4%)
Query: 94 SLKSLSDLRLSNNSLN-GSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVS 152
+ + +L L N+ N G + L L L+ SI + + L L L++S
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 153 YNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLR 198
N +SG + NL L + N + + I LK L +L+
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLK 116
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 29/115 (25%), Positives = 49/115 (42%), Gaps = 4/115 (3%)
Query: 306 LSLGSLTNLATLYFSTNALS-GSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVS 364
L + +++ L + + G + L L L SI L L KL
Sbjct: 11 LRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKK 68
Query: 365 LDLSINKLSGSIPLSFASLTSLTTLYLYENSLCD-SIPKEIGDMKSLSILDLSSN 418
L+LS N++SG + + +LT L L N + D S + + +++L LDL +
Sbjct: 69 LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 27/110 (24%), Positives = 43/110 (39%), Gaps = 5/110 (4%)
Query: 22 HLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGN 81
+ L L + N+ + L LS + L SI +L L L +++ +
Sbjct: 18 DVKELVLDNSRSNEGK--LEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSD 73
Query: 82 NLLSGSIPNEVGSLKSLSDLRLSNNSLNG-SIPSSLGNLTNLVTLYLHMN 130
N +SG + +L+ L LS N + S L L NL +L L
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 27/107 (25%), Positives = 42/107 (39%), Gaps = 5/107 (4%)
Query: 46 RLSSLNGLSLYSNFLK-GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLS 104
S + L L ++ G + L ++ N L+ SI N + L L L LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 105 NNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQV 151
+N ++G + NL L L N + I LK L +L+
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKS 117
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 26/113 (23%), Positives = 44/113 (38%), Gaps = 5/113 (4%)
Query: 67 SLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLY 126
+ ++ L+ + +N G + + L L N L SI ++L L L L
Sbjct: 15 TPSDVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLE 70
Query: 127 LHMNALSGSIPDEIGNLKFLSDLQVSYNTLSG-AIPFSLGNLTNLVTLYIGIN 178
L N +SG + L+ L +S N + + L L NL +L +
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 46/219 (21%), Positives = 85/219 (38%), Gaps = 35/219 (15%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVK------KFHSPLPGEMACQQEFLNEGNALTKIR--H 759
+G G +V+ A+ + VA+K + E+ + +N+ + +
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLL-QRVNDADNTKEDSMGA 85
Query: 760 RNIVKFYGFCSH----ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVA-- 813
+I+K +H +H +V+E L LA+I + G + +K ++
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE----HRGIP--LIYVKQISKQ 139
Query: 814 --DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAH------VSDFGISKFLKLGLSNRTE 865
L YMH C I+H DI +NVL+ + ++D G + + + T
Sbjct: 140 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD---EHYTN 194
Query: 866 LAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 904
T Y +PE+ D++S L E+I G
Sbjct: 195 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 4e-07
Identities = 35/103 (33%), Positives = 48/103 (46%), Gaps = 26/103 (25%)
Query: 293 LQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSI 352
L LN N ++ P L NL LYF++N L+ +IP + +
Sbjct: 38 LWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFD------------------ 78
Query: 353 PLALGNLTKLVSLDLSINKLSGSIPL-SFASLTSLTTLYLYEN 394
LT+L LDL+ N L SIP +F +L SLT +YLY N
Sbjct: 79 -----KLTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 31/86 (36%), Positives = 44/86 (51%), Gaps = 5/86 (5%)
Query: 360 TKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGD-MKSLSILDLSSN 418
T L L+ N+++ P F L +L LY N L +IP + D + L+ LDL+ N
Sbjct: 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKL-TAIPTGVFDKLTQLTQLDLNDN 91
Query: 419 KLNGSIPL-SLANLTNSLKVLYLSSN 443
L SIP + NL SL +YL +N
Sbjct: 92 HLK-SIPRGAFDNLK-SLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 33/94 (35%), Positives = 47/94 (50%), Gaps = 6/94 (6%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSL-GNLTS 73
S+P I T + L + NQ++ L P L +L L SN L +IP + LT
Sbjct: 26 SVPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82
Query: 74 LIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNN 106
L +D+ +N L SIP +LKSL+ + L NN
Sbjct: 83 LTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 30/84 (35%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 216 TKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCS-FGNLTKLVISCLGTN 274
T + L+L+ N ++ L P +L +L L N N L+ +IP F LT+L L N
Sbjct: 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDN 91
Query: 275 ALSSSILEEIGNLKSLLHLQLNYN 298
L S NLKSL H+ L N
Sbjct: 92 HLKSIPRGAFDNLKSLTHIYLYNN 115
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.1 bits (121), Expect = 9e-07
Identities = 21/152 (13%), Positives = 49/152 (32%), Gaps = 21/152 (13%)
Query: 433 NSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLN--QLEYLDL-- 488
L L + + + +L L + + L + ++ + LE L L
Sbjct: 172 PLLNNLKIKGTNNLSIGKKPR---PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYV 228
Query: 489 -SANTFHNSIPESL------GNLVKLHYLNLSNNQFSQKIPNPI---EKLIHLSELDLSY 538
+ + L +L + + + + + L L +D+S
Sbjct: 229 GVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISA 288
Query: 539 KIFG----EEIPSQVCSMQSLEKLNLSHNNLS 566
+ + V ++ L+ +N+ +N LS
Sbjct: 289 GVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.7 bits (120), Expect = 1e-06
Identities = 30/177 (16%), Positives = 62/177 (35%), Gaps = 29/177 (16%)
Query: 285 GNLKSLL--HLQLNYNTLSGSIPLSLGSL--TNLATLYFSTNALSGSIPNEIT--NLRSL 338
+L +L LN + G+ LS+G NL +L + L S+ +I +L +L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221
Query: 339 SDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCD 398
L L + + L S +L L + + +
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPL---------------FSKDRFPNLKWLGIVDAEEQN 266
Query: 399 SIPKEIGD---MKSLSILDLSSNKLNGS----IPLSLANLTNSLKVLYLSSNHIVGE 448
+ + + + L +D+S+ L + + + + LK + + N++ E
Sbjct: 267 VVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH-LKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 49.2 bits (116), Expect = 4e-06
Identities = 26/185 (14%), Positives = 67/185 (36%), Gaps = 21/185 (11%)
Query: 349 NGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIG--D 406
+ L + L +L + ++ + +L +L + L DS+ ++I D
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSD 217
Query: 407 MKSLSILDLSSNKLNGSIPLSLANLTN--------SLKVLYLSSNHIVGEIPLGHGKFSS 458
+ +L L L + + +LK L + + +
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277
Query: 459 LIQLI---LNNNELSG----QLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLN 511
L QL ++ L+ L + + L+++++ N + + + L + + ++
Sbjct: 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMK-ID 336
Query: 512 LSNNQ 516
+S++Q
Sbjct: 337 VSDSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 49.2 bits (116), Expect = 4e-06
Identities = 31/212 (14%), Positives = 79/212 (37%), Gaps = 24/212 (11%)
Query: 376 IPLSFASLTSLTTLYLYENSL--CDSIPKEIGDMKSL--SILDLSSNKLNGSIPLSLANL 431
I + L+ + + E D+ + ++ L++ K+ G+ LS+
Sbjct: 131 IVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKK 190
Query: 432 TNS-LKVLYLSSNHIVGEIP--LGHGKFSSLIQLIL-------NNNELSGQLSPEL--GS 479
LK L + S + + + +L +L+L + P
Sbjct: 191 PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDR 250
Query: 480 LNQLEYLDLSANTFHNSIPESLGN---LVKLHYLNLSNNQFS----QKIPNPIEKLIHLS 532
L++L + N + E L +L +++S + + + + ++K+ HL
Sbjct: 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLK 310
Query: 533 ELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNN 564
+++ Y +E+ ++ + K+++S +
Sbjct: 311 FINMKYNYLSDEMKKELQKSLPM-KIDVSDSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 47.6 bits (112), Expect = 1e-05
Identities = 38/226 (16%), Positives = 70/226 (30%), Gaps = 36/226 (15%)
Query: 200 DYNTLSGSILYSFGNLTKLEILYLDVNALS--GLIPNEIGNLKSLLA--LQLNYNTLSGS 255
D + ++ I+ + E L+ + E +L +L LN + G+
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT 182
Query: 256 IPCSFG-----NLTKLVISCLGTNALSSSILEEIG--NLKSLLHLQLNYNTLSGSIPLSL 308
S G NL L I L S++E+I +L +L L L +
Sbjct: 183 NNLSIGKKPRPNLKSLEIIS---GGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDM 239
Query: 309 GSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGN---LTKLVSL 365
L +L L + + + L +L ++
Sbjct: 240 NVFRPLF---------------SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETM 284
Query: 366 DLSINKLSGS----IPLSFASLTSLTTLYLYENSLCDSIPKEIGDM 407
D+S L+ + + L + + N L D + KE+
Sbjct: 285 DISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 4e-04
Identities = 21/162 (12%), Positives = 47/162 (29%), Gaps = 31/162 (19%)
Query: 2 LKVLGLSFNQFSGSIPPEIG-----HLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLY 56
LK L + S+ +I +L L L ++ ++++
Sbjct: 195 LKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFD------------GDMNVF 242
Query: 57 SNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGS---LKSLSDLRLSNNSLNGS-- 111
+L ++ I + + L L + +S L
Sbjct: 243 RPLFSK------DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGA 296
Query: 112 --IPSSLGNLTNLVTLYLHMNALSGSIPDEIGN-LKFLSDLQ 150
+ + + +L + + N LS + E+ L D+
Sbjct: 297 RLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVS 338
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 28/103 (27%), Positives = 41/103 (39%), Gaps = 26/103 (25%)
Query: 293 LQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSI 352
L L N ++ P LT L L N L+ +P + +
Sbjct: 35 LYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFD------------------ 75
Query: 353 PLALGNLTKLVSLDLSINKLSGSIPL-SFASLTSLTTLYLYEN 394
LT+L L L+ N+L SIP +F +L SLT ++L N
Sbjct: 76 -----KLTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 33/95 (34%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 351 SIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGD-MKS 409
S+P G T L L N+++ P F LT LT L L N L +P + D +
Sbjct: 23 SVPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQL-TVLPAGVFDKLTQ 79
Query: 410 LSILDLSSNKLNGSIPL-SLANLTNSLKVLYLSSN 443
L+ L L+ N+L SIP + NL SL ++L +N
Sbjct: 80 LTQLSLNDNQLK-SIPRGAFDNLK-SLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 32/94 (34%), Positives = 47/94 (50%), Gaps = 6/94 (6%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSL-GNLTS 73
S+P I T ++L NQ++ L P RL+ L L L +N L +P + LT
Sbjct: 23 SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79
Query: 74 LIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNN 106
L + + +N L SIP +LKSL+ + L NN
Sbjct: 80 LTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 8e-05
Identities = 30/84 (35%), Positives = 39/84 (46%), Gaps = 2/84 (2%)
Query: 216 TKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCS-FGNLTKLVISCLGTN 274
T ++LYL N ++ L P L L L L+ N L+ +P F LT+L L N
Sbjct: 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDN 88
Query: 275 ALSSSILEEIGNLKSLLHLQLNYN 298
L S NLKSL H+ L N
Sbjct: 89 QLKSIPRGAFDNLKSLTHIWLLNN 112
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 37/168 (22%), Positives = 61/168 (36%), Gaps = 42/168 (25%)
Query: 706 EHCIGNGGQGSVYKAE-LPTGEIVAVK-----KFHSPLPGEMACQQEFLNEGNALTKIRH 759
IG G G + + L T E VA+K L E ++ +
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS---------G 64
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMG-SLAMILSNDAAAEEFGWTKRMNAIKGV---ADA 815
I + Y F ++ +V E L G SL + F R ++K V A
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL--GPSLE---------DLFDLCDRTFSLKTVLMIAIQ 113
Query: 816 LL----YMHTNCFPPIVHRDISSKNVLLNLEYEA-----HVSDFGISK 854
L+ Y+H+ ++RD+ +N L+ H+ DF ++K
Sbjct: 114 LISRMEYVHSKNL---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 50.3 bits (119), Expect = 1e-06
Identities = 45/319 (14%), Positives = 87/319 (27%), Gaps = 58/319 (18%)
Query: 697 IRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKK--FHSPLPGEMACQQ---EFLNEG 751
T+ IG G G V++ VA+K P + Q+ E L E
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 752 NALTKI---------RHRNIVKFYGF--CSHALHSFVVYEYLEMGS-------------- 786
++ R + + ++ + S
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 787 ----LAMILSNDAAAEEFGWTKRMNA------IKGVADALLYMHTNCFPPIVHRDISSKN 836
+ + E TK + + + +L + HRD+ N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGN 192
Query: 837 VLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEK--CDVYSFGV 894
VLL + K + + G + YT+ E+ V+
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTI---------PSCGLQVSIIDYTLSRLERDGIVVFCDVS 243
Query: 895 LALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCL 954
+ ++ G D+ I + N E L + DK++ M C
Sbjct: 244 MDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKC- 300
Query: 955 DESPTSRPTMQKVSQLLKI 973
+P + +K+ + +
Sbjct: 301 -NTPAMKQIKRKIQEFHRT 318
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 42/210 (20%), Positives = 78/210 (37%), Gaps = 36/210 (17%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFY 766
+G G V++A + E V VK +++ E L +R NI+
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLA 97
Query: 767 GFCSHALHSFV---VYEYLEMGSLAMILS--NDAAAEEFGWTKRMNAIKGVADALLYMHT 821
S V+E++ + D + + + AL Y H+
Sbjct: 98 D-IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFY--------MYEILKALDYCHS 148
Query: 822 NCFPPIVHRDISSKNVLLNLEY-EAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL--- 877
I+HRD+ NV+++ E+ + + D+G+++F G + + PEL
Sbjct: 149 MG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVD 204
Query: 878 --AYTMKVTEKCDVYSFGVLALEVIKGKHP 905
Y + D++S G + +I K P
Sbjct: 205 YQMYDYSL----DMWSLGCMLASMIFRKEP 230
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 48/214 (22%), Positives = 87/214 (40%), Gaps = 41/214 (19%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVK------KFHSPLPGEMACQQEFLNEGNALTKIRHR- 760
IG G G V KA + VA+K +FH ++ E L +R +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH----------RQAAEEIRILEHLRKQD 154
Query: 761 -----NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVA-- 813
N++ + H + +E L M +L ++ + + G++ + ++ A
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKN---KFQGFS--LPLVRKFAHS 208
Query: 814 --DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAH--VSDFGISKFLKLGLSNRTELAGT 869
L +H N I+H D+ +N+LL + + V DFG S + + T +
Sbjct: 209 ILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY--TYIQSR 263
Query: 870 FGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGK 903
F Y APE+ + D++S G + E++ G
Sbjct: 264 F-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 57/246 (23%), Positives = 98/246 (39%), Gaps = 67/246 (27%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
+ ++ +G G G V+K+ + TGE+VAVKK Q+ E LT++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT-FREIMILTELS 66
Query: 759 -HRNIVKFYGFCSHALHS------FVVYEYLEMGS-LAMILSNDAAAEEFGWTKR----- 805
H NIV + L + ++V++Y M + L ++ + K+
Sbjct: 67 GHENIVNLL----NVLRADNDRDVYLVFDY--METDLHAVIRANILEPVH---KQYVVYQ 117
Query: 806 -MNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864
+ IK Y+H+ ++HRD+ N+LLN E V+DFG+S+
Sbjct: 118 LIKVIK-------YLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 865 ELAGTFG---------------------YIAPEL-----AYTMKVTEKCDVYSFG-VLAL 897
+ + Y APE+ YT + D++S G +L
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWSLGCILG- 222
Query: 898 EVIKGK 903
E++ GK
Sbjct: 223 EILCGK 228
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 38/159 (23%), Positives = 65/159 (40%), Gaps = 32/159 (20%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH-RNIVKFY 766
IG+G G +Y + GE VA+K + Q E ++ I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL----ECVKTKHPQ-LHIESKIYKMMQGGVGIPTIR 71
Query: 767 GFCSHALHSFVVYEYLEMG-SLAMILSNDAAAEEFGWTKRMNAIKGV---ADALL----Y 818
+ ++ +V E L G SL + F + R ++K V AD ++ Y
Sbjct: 72 WCGAEGDYNVMVMELL--GPSLE---------DLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAH---VSDFGISK 854
+H+ F +HRD+ N L+ L + + + DFG++K
Sbjct: 121 IHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 37/165 (22%), Positives = 55/165 (33%), Gaps = 42/165 (25%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKK-----FHSPLPGEMACQQEFLNEGNALTKIRHRNI 762
IG G G +++ L + VA+K L E + I
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---------TGI 68
Query: 763 VKFYGFCSHALHSFVVYEYLEMG-SLAMILSNDAAAEEFGWTKRMNAIKGV---ADALL- 817
Y F LH+ +V + L G SL + R ++K V A +L
Sbjct: 69 PNVYYFGQEGLHNVLVIDLL--GPSL---------EDLLDLCGRKFSVKTVAMAAKQMLA 117
Query: 818 ---YMHTNCFPPIVHRDISSKNVLLNLEYEA-----HVSDFGISK 854
+H V+RDI N L+ +V DFG+ K
Sbjct: 118 RVQSIHEKSL---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 22/139 (15%), Positives = 52/139 (37%), Gaps = 18/139 (12%)
Query: 351 SIPLALGNLTKLVSLDLS-INKLSGSIPLSFASL----TSLTTLYLYENSLCDSIPKEIG 405
++ N L ++L+ I + + A T + + D + +
Sbjct: 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALA 86
Query: 406 DM----KSLSILDLSSNKL--NGSIPLSLANLTN-SLKVLYLSSNHI----VGEIPLGHG 454
+M +L L++ SN + +G + L A +N SL L + + E+ + +
Sbjct: 87 EMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANM 146
Query: 455 --KFSSLIQLILNNNELSG 471
K ++L++ + +
Sbjct: 147 LEKNTTLLKFGYHFTQQGP 165
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 17/128 (13%), Positives = 39/128 (30%), Gaps = 21/128 (16%)
Query: 355 ALGNLTKLVSLDLSINKLSGSIPLSFASL----TSLTTLYLYENSLCDSIPKEIGDM--- 407
AL T + + + + + + A + +L +L + N + S + +
Sbjct: 60 ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQS 119
Query: 408 -KSLSILDLSSNKLN----GSIPLSLANLTN-SLKVLYLSSNHIVGEIPLGHGKFSSLIQ 461
SL L + + + ++ N +L
Sbjct: 120 NTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGPR--------LRASN 171
Query: 462 LILNNNEL 469
++NNN+L
Sbjct: 172 AMMNNNDL 179
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 48/257 (18%), Positives = 84/257 (32%), Gaps = 69/257 (26%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKF-HSPLPGEMACQQEFLNEGNALTKIRHRNIV-KF 765
+G G +V+ + + + VA+K + E A L+E L +R+ +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-----LDEIRLLKSVRNSDPNDPN 99
Query: 766 YGFCSHALHSFV-----------VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVAD 814
L F V+E L L I+ ++ K++ I+ V
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKI--IQQVLQ 157
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLE-------------------------------- 842
L Y+HT C I+H DI +N+LL++
Sbjct: 158 GLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 843 ---------YEAHVSDFGISKFLKLGLS-----NRTELAGTFGYIAPELAYTMKVTEKCD 888
E ++ K LG + + TE T Y + E+ D
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 889 VYSFGVLALEVIKGKHP 905
++S +A E+ G +
Sbjct: 276 IWSTACMAFELATGDYL 292
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 32/159 (20%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFY 766
IG+G G +Y + T E VA+K + Q L E ++ I
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQ-LLYESKIYRILQGGTGIPNVR 69
Query: 767 GFCSHALHSFVVYEYLEMG-SLAMILSNDAAAEEFGWTKRMNAIKGV---ADALL----Y 818
F ++ +V + L G SL + F + R ++K V AD ++ +
Sbjct: 70 WFGVEGDYNVLVMDLL--GPSL---------EDLFNFCSRKLSLKTVLMLADQMINRVEF 118
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAH---VSDFGISK 854
+H+ F +HRDI N L+ L A+ + DFG++K
Sbjct: 119 VHSKSF---LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 8e-05
Identities = 49/214 (22%), Positives = 78/214 (36%), Gaps = 39/214 (18%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVK------KFHSPLPGEMACQQEFLNEGNALTKIRHR- 760
IG G G V KA E VA+K F Q E L +
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL---------NQA-QIEVRLLELMNKHD 111
Query: 761 -----NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVA-- 813
IV H +V+E L ++ + + G + +N + A
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTN----FRGVS--LNLTRKFAQQ 165
Query: 814 --DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAH--VSDFGISKFLKLGLSNRTELAGT 869
ALL++ T I+H D+ +N+LL + + DFG S L + +
Sbjct: 166 MCTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QYIQSR 222
Query: 870 FGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGK 903
F Y +PE+ M D++S G + +E+ G+
Sbjct: 223 F-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 43/232 (18%), Positives = 83/232 (35%), Gaps = 10/232 (4%)
Query: 292 HLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGS 351
L L L + L S +A + + + + R + +
Sbjct: 51 TLDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVST 109
Query: 352 IPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYE-NSLCDSIPKEIGD-MKS 409
+ L +KL +L L +LS I + A ++L L L + + + +
Sbjct: 110 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 169
Query: 410 LSILDLSSNKL--NGSIPLSLANLTNSLKVLYLSS-NHIVGEIPLGH--GKFSSLIQLIL 464
L L+LS + +++A+++ ++ L LS + + L + +L+ L L
Sbjct: 170 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 229
Query: 465 NN-NELSGQLSPELGSLNQLEYLDLSANT-FHNSIPESLGNLVKLHYLNLSN 514
++ L E LN L++L LS LG + L L +
Sbjct: 230 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 973 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.79 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.74 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.64 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.64 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.63 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.6 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.57 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.55 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.54 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.47 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.44 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.43 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.43 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.42 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.25 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.24 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.23 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.2 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.97 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.93 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.92 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.79 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.67 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.63 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.54 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.37 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.36 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.32 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.28 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.23 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.22 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.17 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.13 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.95 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.95 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.9 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.73 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.7 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.66 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.5 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.36 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.14 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.14 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.94 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.88 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.79 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.69 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.48 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.4 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.37 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.2 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.15 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.98 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.45 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.16 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.82 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.43 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-78 Score=746.14 Aligned_cols=616 Identities=33% Similarity=0.464 Sum_probs=462.2
Q ss_pred CcEEeCCCCCCCCC---CCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCC--cccCCCCCcE
Q 002069 2 LKVLGLSFNQFSGS---IPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPP--SLGNLTSLIY 76 (973)
Q Consensus 2 l~~L~l~~~~l~~~---~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~--~~~~l~~L~~ 76 (973)
++.|||+++.++|. +|++++.|++|+.++++.|.+. .+|..|+++++|++|+|++|.+.+.+|. .++++++|++
T Consensus 52 v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~ 130 (768)
T 3rgz_A 52 VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKF 130 (768)
T ss_dssp EEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCE
T ss_pred EEEEECCCCCcCCccCccChhHhccCcccccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCE
Confidence 46788888888877 7777777777777777777765 3566777777777777777777766776 7777777777
Q ss_pred EEccCCcCcccCCccc-cCccccceeeccCCcCCCCCCCc---cccCCccceeecccccccccCcccccccCCCCceecc
Q 002069 77 IDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNGSIPSS---LGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVS 152 (973)
Q Consensus 77 L~l~~n~l~~~~p~~~-~~l~~L~~L~L~~n~l~~~~p~~---~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~ 152 (973)
|+|++|.+++..|..+ .++++|++|+|++|++++..|.. +.++++|++|++++|.+++..|. +++++|++|+++
T Consensus 131 L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls 208 (768)
T 3rgz_A 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVS 208 (768)
T ss_dssp EECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECC
T ss_pred EECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECc
Confidence 7777777776666655 66777777777777777665555 66777777777777777654443 667777777777
Q ss_pred cCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCC
Q 002069 153 YNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLI 232 (973)
Q Consensus 153 ~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~ 232 (973)
+|.+++.+|. ++++++|++|++++|++++.+|..+.++++|++|++++|++.+..+.. .+++|++|++++|++++..
T Consensus 209 ~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~i 285 (768)
T 3rgz_A 209 SNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEI 285 (768)
T ss_dssp SSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESC
T ss_pred CCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCcc
Confidence 7777765655 777777777777777777667777777777777777777776544433 6677777777777777656
Q ss_pred Ccccccc-ccccceecccccccCCCCcccCCcchhhhccCCCcccC-chhhhhhccccccceEEcccccccCCcCchhhc
Q 002069 233 PNEIGNL-KSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALS-SSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGS 310 (973)
Q Consensus 233 ~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 310 (973)
|..+.+. ++|++|+|++|++++..|..|+++++|+.|++++|.+. .++.+.+..+++|++|++++|++++.+|..+..
T Consensus 286 p~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~ 365 (768)
T 3rgz_A 286 PDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTN 365 (768)
T ss_dssp CCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHH
T ss_pred CHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHh
Confidence 6666554 77777777777777777777777777777777777776 333444777777777777777777666777766
Q ss_pred CC-ccceeeccccccCCCCCccccC--CCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccc
Q 002069 311 LT-NLATLYFSTNALSGSIPNEITN--LRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLT 387 (973)
Q Consensus 311 l~-~L~~L~L~~n~l~~~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~ 387 (973)
++ +|++|++++|.+++..|..+.. +++|++|++++|.+++.+|..++++++|++|+|++|++++..|..|..+++|+
T Consensus 366 l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 445 (768)
T 3rgz_A 366 LSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR 445 (768)
T ss_dssp HTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCC
T ss_pred hhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCC
Confidence 65 6777777777776666666655 66677777777777666666777777777777777777766677777777777
Q ss_pred hhcccccccccCCCcccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCC
Q 002069 388 TLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNN 467 (973)
Q Consensus 388 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N 467 (973)
.|++++|++++..|..+..+++|++|++++|++++.+|..+..+. +|++|+|++|++++.+|..++.+++|++|++++|
T Consensus 446 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 524 (768)
T 3rgz_A 446 DLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCT-NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN 524 (768)
T ss_dssp EEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT-TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred EEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCC-CCCEEEccCCccCCcCChHHhcCCCCCEEECCCC
Confidence 777777777666677777777777777777777766666666554 5777777777777666666667777777777777
Q ss_pred ccCCCCCcccccccccccccccccccccccCc------------------------------------------------
Q 002069 468 ELSGQLSPELGSLNQLEYLDLSANTFHNSIPE------------------------------------------------ 499 (973)
Q Consensus 468 ~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~~~------------------------------------------------ 499 (973)
++++.+|..+..+++|++||+++|++++.+|.
T Consensus 525 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (768)
T 3rgz_A 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQL 604 (768)
T ss_dssp CCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGG
T ss_pred cccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhh
Confidence 77666667777777777777777766655443
Q ss_pred ----------------------cccccccccEEeecCccCCCCCCcccccccccCeecccccccCCCcchhhcccccccc
Q 002069 500 ----------------------SLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEK 557 (973)
Q Consensus 500 ----------------------~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~l~~L~~ 557 (973)
.+..+++|++|+|++|++++.+|..+..++.|+.|+|++|.+++.+|..++.+++|+.
T Consensus 605 ~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~ 684 (768)
T 3rgz_A 605 NRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI 684 (768)
T ss_dssp GGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCE
T ss_pred hccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCE
Confidence 4455678999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCccchhhhccccccEEeCcCCCCCCCCCCCccCCCCCcchhcCCCCccCCCccCCCCccc
Q 002069 558 LNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPCKAF 626 (973)
Q Consensus 558 L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~N~~~c~~~~~l~~~~~~ 626 (973)
|||++|+++|.+|..+..++.|++||+++|+++|.+|...+|..++..++.|||++||.+. ++|...
T Consensus 685 LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l--~~C~~~ 751 (768)
T 3rgz_A 685 LDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL--PRCDPS 751 (768)
T ss_dssp EECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS--CCCCSC
T ss_pred EECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC--cCCCCC
Confidence 9999999999999999999999999999999999999999999999999999999999874 477643
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-72 Score=687.65 Aligned_cols=579 Identities=33% Similarity=0.443 Sum_probs=460.5
Q ss_pred CcEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCc--CccCCCCCCeeeccCCcCCCCCCCcc-cCCCCCcEEE
Q 002069 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPH--EIGRLSSLNGLSLYSNFLKGSIPPSL-GNLTSLIYID 78 (973)
Q Consensus 2 l~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~--~~~~l~~L~~L~l~~n~~~~~~p~~~-~~l~~L~~L~ 78 (973)
|+.++++.+++. .+|+.++.+++|++|||++|.+++.+|. .++++++|++|+|++|.+.+.+|..+ .++++|++|+
T Consensus 79 L~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 157 (768)
T 3rgz_A 79 LESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLD 157 (768)
T ss_dssp CCEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEE
T ss_pred ccccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEE
Confidence 566677777665 5667888888888888888888877777 78888888888888888887777765 7788888888
Q ss_pred ccCCcCcccCCcc---ccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCC
Q 002069 79 IGNNLLSGSIPNE---VGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNT 155 (973)
Q Consensus 79 l~~n~l~~~~p~~---~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~ 155 (973)
|++|++++..|.. ++++++|++|++++|++.+..| +..+++|++|+|++|++++.+|. ++++++|++|++++|.
T Consensus 158 Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~ 234 (768)
T 3rgz_A 158 LSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNK 234 (768)
T ss_dssp CCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCB--CTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSC
T ss_pred CCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCC--cccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCc
Confidence 8888888777666 6778888888888888876544 37778888888888888766666 8888888888888888
Q ss_pred CCCCCCccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCC-CcccEEecCCcccCCCCCc
Q 002069 156 LSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNL-TKLEILYLDVNALSGLIPN 234 (973)
Q Consensus 156 l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~n~i~~~~~~ 234 (973)
+++..|..+..+++|++|++++|++.+.+|.. .+++|++|++++|++++..+..+..+ ++|++|++++|.+++..|.
T Consensus 235 l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~ 312 (768)
T 3rgz_A 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPP 312 (768)
T ss_dssp CCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCG
T ss_pred CCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccch
Confidence 88777788888888888888888887666654 67788888888888876666666554 7888888888888777777
Q ss_pred cccccccccceecccccccCCCCcc-cCCcchhhhccCCCcccCchhhhhhcccc-ccceEEcccccccCCcCchhhc--
Q 002069 235 EIGNLKSLLALQLNYNTLSGSIPCS-FGNLTKLVISCLGTNALSSSILEEIGNLK-SLLHLQLNYNTLSGSIPLSLGS-- 310 (973)
Q Consensus 235 ~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~l~l~~n~i~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~-- 310 (973)
.|+++++|++|++++|++++.+|.. |+++++|+.|++++|.+....+..+.+++ +|++|++++|.+++..|..+..
T Consensus 313 ~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~ 392 (768)
T 3rgz_A 313 FFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNP 392 (768)
T ss_dssp GGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCST
T ss_pred HHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcc
Confidence 8888888888888888877555544 77788888888888877766677777776 7888888888777777766665
Q ss_pred CCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhc
Q 002069 311 LTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLY 390 (973)
Q Consensus 311 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~ 390 (973)
+++|++|++++|.+++.+|..+.++++|++|+|++|.+++..|..++++++|++|++++|++++..|..|..+++|++|+
T Consensus 393 ~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 472 (768)
T 3rgz_A 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLI 472 (768)
T ss_dssp TCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEE
T ss_pred cCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEE
Confidence 67778888888877777777777777888888888877777777777777788888888877777777777777788888
Q ss_pred ccccccccCCCcccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccC
Q 002069 391 LYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELS 470 (973)
Q Consensus 391 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~ 470 (973)
+++|++++..|..+..+++|++|+|++|++++.+|..+..+. +|++|+|++|++++.+|..++.+++|+.|++++|+++
T Consensus 473 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 551 (768)
T 3rgz_A 473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLE-NLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFN 551 (768)
T ss_dssp CCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT-TCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEE
T ss_pred ecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCC-CCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccC
Confidence 888877777777777777788888888877777777777665 6788888888777777777777777888888777776
Q ss_pred CCCCcc----------------------------------------------------------------------cccc
Q 002069 471 GQLSPE----------------------------------------------------------------------LGSL 480 (973)
Q Consensus 471 ~~~~~~----------------------------------------------------------------------l~~l 480 (973)
+.+|.. +..+
T Consensus 552 g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l 631 (768)
T 3rgz_A 552 GTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNN 631 (768)
T ss_dssp SBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSS
T ss_pred CcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhcc
Confidence 555543 4446
Q ss_pred cccccccccccccccccCccccccccccEEeecCccCCCCCCcccccccccCeecccccccCCCcchhhccccccccccc
Q 002069 481 NQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNL 560 (973)
Q Consensus 481 ~~L~~L~Ls~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~l~~L~~L~L 560 (973)
++|+.|||++|++++.+|..++.+++|+.|+|++|++++.+|..+..+++|+.||||+|++++.+|..+..++.|++|++
T Consensus 632 ~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~l 711 (768)
T 3rgz_A 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDL 711 (768)
T ss_dssp BCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEEC
T ss_pred ccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEEC
Confidence 78999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCccchhhhccccccEEeCcCCC
Q 002069 561 SHNNLSGSISRCFEEMHWLSCIDISYNA 588 (973)
Q Consensus 561 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~ 588 (973)
++|+++|.+|.. ..+..+....+.+|+
T Consensus 712 s~N~l~g~iP~~-~~~~~~~~~~~~gN~ 738 (768)
T 3rgz_A 712 SNNNLSGPIPEM-GQFETFPPAKFLNNP 738 (768)
T ss_dssp CSSEEEEECCSS-SSGGGSCGGGGCSCT
T ss_pred cCCcccccCCCc-hhhccCCHHHhcCCc
Confidence 999999998854 223444555677775
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-65 Score=626.53 Aligned_cols=589 Identities=25% Similarity=0.249 Sum_probs=510.2
Q ss_pred cEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCC
Q 002069 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNN 82 (973)
Q Consensus 3 ~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n 82 (973)
+.+|.++++++ .+|..+. +++++|+|++|.+++..|..|.++++|++|+|++|++++..|.+|+++++|++|+|++|
T Consensus 7 ~~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 7 EVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp SEEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred CeeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 46899999998 8998776 89999999999999877778999999999999999999888999999999999999999
Q ss_pred cCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCc
Q 002069 83 LLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPF 162 (973)
Q Consensus 83 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 162 (973)
++++..+..|+.+++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|++++|.+++..+.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 99954444799999999999999999977778999999999999999999988889999999999999999999987777
Q ss_pred ccc--CccccceeeecccccCCCCCccccccCccceeeccccccccccccccC---CCCcccEEecCCcccCCCCCcccc
Q 002069 163 SLG--NLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFG---NLTKLEILYLDVNALSGLIPNEIG 237 (973)
Q Consensus 163 ~l~--~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~L~~n~i~~~~~~~~~ 237 (973)
.+. .+++|+.|++++|++++..|..+..+++|+.|++++|.+.......+. ..++|+.|++++|.+++..|..|.
T Consensus 164 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~ 243 (680)
T 1ziw_A 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243 (680)
T ss_dssp HHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTG
T ss_pred HhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhh
Confidence 654 568999999999999988999999999999999999987643322221 358899999999999999999999
Q ss_pred cccc--ccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccC-----CcC----c
Q 002069 238 NLKS--LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSG-----SIP----L 306 (973)
Q Consensus 238 ~l~~--L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~-----~~~----~ 306 (973)
+++. |+.|++++|++++..|..|+.+++|+.+++++|.+....+..|.++++|++|++++|...+ .+| .
T Consensus 244 ~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~ 323 (680)
T 1ziw_A 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF 323 (680)
T ss_dssp GGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTT
T ss_pred ccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChh
Confidence 9876 9999999999998889999999999999999999999888999999999999999876543 122 3
Q ss_pred hhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCc--chhccCCC--CCCcEEEccCCcccCCCCccccc
Q 002069 307 SLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGS--IPLALGNL--TKLVSLDLSINKLSGSIPLSFAS 382 (973)
Q Consensus 307 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l--~~L~~L~Ls~N~i~~~~~~~~~~ 382 (973)
.|..+++|++|++++|.+++..+..|.++++|++|++++|.++.. ....|..+ ++|+.|++++|++++..|.+|..
T Consensus 324 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~ 403 (680)
T 1ziw_A 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403 (680)
T ss_dssp TTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTT
T ss_pred hcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhC
Confidence 688899999999999999988888899999999999999975422 22334433 58999999999999888889999
Q ss_pred ccccchhcccccccccCCC-cccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccc--cccCCCCCCCccc
Q 002069 383 LTSLTTLYLYENSLCDSIP-KEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIV--GEIPLGHGKFSSL 459 (973)
Q Consensus 383 l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~--~~~~~~~~~~~~L 459 (973)
+++|+.|++++|++++..+ ..|.++++|++|++++|++++..+..+...+ +|++|++++|.++ +..|..+..+++|
T Consensus 404 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~-~L~~L~l~~n~l~~~~~~p~~~~~l~~L 482 (680)
T 1ziw_A 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVP-SLQRLMLRRVALKNVDSSPSPFQPLRNL 482 (680)
T ss_dssp CTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCT-TCCEEECTTSCCBCTTCSSCTTTTCTTC
T ss_pred CCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCc-ccccchhccccccccccCCcccccCCCC
Confidence 9999999999999976554 7888999999999999998866666666554 7999999999887 4677888889999
Q ss_pred ceeeccCCccCCCCCcccccccccccccccccccccccC--------ccccccccccEEeecCccCCCCCCccccccccc
Q 002069 460 IQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIP--------ESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHL 531 (973)
Q Consensus 460 ~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~~--------~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 531 (973)
+.|++++|++++..+..|..+++|++|++++|.+++..+ ..|.++++|++|+|++|+++...+..|.++++|
T Consensus 483 ~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L 562 (680)
T 1ziw_A 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL 562 (680)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCc
Confidence 999999999998888888999999999999999886422 237788999999999999987776788999999
Q ss_pred CeecccccccCCCcchhhcccccccccccccccccCccchhhh-ccccccEEeCcCCCCCCCCCC
Q 002069 532 SELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFE-EMHWLSCIDISYNALQGLIPN 595 (973)
Q Consensus 532 ~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~l~l~~N~l~~~~~~ 595 (973)
++|++++|.++...+..|..+++|+.|+|++|++++..+..+. .++.|+.|++++|+|.+.++.
T Consensus 563 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 563 KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred ceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 9999999999988888888899999999999999988888887 788999999999999998874
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-65 Score=621.26 Aligned_cols=585 Identities=24% Similarity=0.255 Sum_probs=523.0
Q ss_pred CEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCC
Q 002069 27 KLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNN 106 (973)
Q Consensus 27 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n 106 (973)
+.+|.++++++ .+|..+. +++++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 7 ~~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 7 EVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp SEEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred CeeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 67999999998 6787776 79999999999999777778999999999999999999888999999999999999999
Q ss_pred cCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCc
Q 002069 107 SLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPN 186 (973)
Q Consensus 107 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~ 186 (973)
++++..+..|+++++|++|+|++|++++..|..|+++++|++|++++|.+++..|..++++++|++|++++|.+++..+.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 99955455799999999999999999977778999999999999999999989999999999999999999999977776
Q ss_pred ccc--ccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCcccc---ccccccceecccccccCCCCcccC
Q 002069 187 EIG--NLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIG---NLKSLLALQLNYNTLSGSIPCSFG 261 (973)
Q Consensus 187 ~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~ 261 (973)
.+. .+++|++|++++|+++++.+..|..+++|+.|++++|.+.......+. ..++|+.|++++|.+++..|.+|.
T Consensus 164 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~ 243 (680)
T 1ziw_A 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243 (680)
T ss_dssp HHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTG
T ss_pred HhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhh
Confidence 654 568999999999999999999999999999999999987532111111 237899999999999999999999
Q ss_pred Ccch--hhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCC-----CCC----c
Q 002069 262 NLTK--LVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSG-----SIP----N 330 (973)
Q Consensus 262 ~l~~--L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-----~~~----~ 330 (973)
+++. |+.|++++|.+....+..|+.+++|++|++++|.+++..|..|..+++|+.|++++|...+ .+| .
T Consensus 244 ~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~ 323 (680)
T 1ziw_A 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF 323 (680)
T ss_dssp GGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTT
T ss_pred ccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChh
Confidence 9876 9999999999999999999999999999999999999999999999999999999876543 223 2
Q ss_pred cccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCccc--CCCCcccccc--cccchhcccccccccCCCcccCC
Q 002069 331 EITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLS--GSIPLSFASL--TSLTTLYLYENSLCDSIPKEIGD 406 (973)
Q Consensus 331 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~--~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~ 406 (973)
.|..+++|++|++++|.+++..+..|.++++|++|++++|.+. ......|..+ ++|+.|++++|++++..|.+|..
T Consensus 324 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~ 403 (680)
T 1ziw_A 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403 (680)
T ss_dssp TTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTT
T ss_pred hcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhC
Confidence 7889999999999999999999999999999999999999864 2334455544 58999999999999999999999
Q ss_pred CCCCCEEEccCCCCCCCcch-hhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccC--CCCCccccccccc
Q 002069 407 MKSLSILDLSSNKLNGSIPL-SLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELS--GQLSPELGSLNQL 483 (973)
Q Consensus 407 l~~L~~L~Ls~N~l~~~~~~-~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~--~~~~~~l~~l~~L 483 (973)
+++|++|+|++|++++.+|. .+.++ ++|++|++++|++++..+..+..+++|+.|++++|.++ +..|..|..+++|
T Consensus 404 l~~L~~L~L~~N~l~~~~~~~~~~~l-~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L 482 (680)
T 1ziw_A 404 LGHLEVLDLGLNEIGQELTGQEWRGL-ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482 (680)
T ss_dssp CTTCCEEECCSSCCEEECCSGGGTTC-TTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTC
T ss_pred CCCCCEEeCCCCcCccccCcccccCc-ccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCC
Confidence 99999999999999876764 45444 48999999999999999999999999999999999997 5678899999999
Q ss_pred ccccccccccccccCccccccccccEEeecCccCCCCCC--------cccccccccCeecccccccCCCcchhhcccccc
Q 002069 484 EYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIP--------NPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSL 555 (973)
Q Consensus 484 ~~L~Ls~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~--------~~~~~l~~L~~L~ls~n~i~~~~~~~~~~l~~L 555 (973)
++|++++|.+++..+..|.++++|++|+|++|++++..+ ..+..+++|++|++++|.++...+..|..+++|
T Consensus 483 ~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L 562 (680)
T 1ziw_A 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL 562 (680)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCc
Confidence 999999999998888889999999999999999986422 347899999999999999997777789999999
Q ss_pred cccccccccccCccchhhhccccccEEeCcCCCCCCCCCCCc--cCCCCCcchhcCCCCccC
Q 002069 556 EKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNST--AFRDAPMLALQGNKRLCG 615 (973)
Q Consensus 556 ~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~--~~~~~~~~~~~~N~~~c~ 615 (973)
++|+|++|++++..+..|..++.|+.|++++|++++.++... .+..+..+.+.+|||.|+
T Consensus 563 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~ 624 (680)
T 1ziw_A 563 KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624 (680)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred ceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence 999999999999999999999999999999999999987632 577899999999999997
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-59 Score=561.54 Aligned_cols=539 Identities=19% Similarity=0.162 Sum_probs=361.8
Q ss_pred EEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCc
Q 002069 4 VLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNL 83 (973)
Q Consensus 4 ~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~ 83 (973)
.+|.++.+++ .+|..+.. ++++|+|++|.+++..|..|+++++|++|+|++|++.+..|.+|+++++|++|+|++|+
T Consensus 16 ~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 16 TYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp EEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 3455555554 55554432 45555555555555445555555555555555555554445555555555555555555
Q ss_pred CcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCcc
Q 002069 84 LSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFS 163 (973)
Q Consensus 84 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 163 (973)
+++..|..|+.+++|++|++++|++++..|..++++++|++|++++|+++ +..+..
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~------------------------~~~~~~ 148 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS------------------------SIKLPK 148 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCC------------------------CCCCCT
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCccc------------------------ccCccc
Confidence 55444555555555555555555555333444455555555555555544 322222
Q ss_pred ccCccccceeeecccccCCCCCccccccCccc--eeeccccccccccccccCCCCcccEEecCCcccCCCCCcccccccc
Q 002069 164 LGNLTNLVTLYIGINALSGSIPNEIGNLKSLS--DLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241 (973)
Q Consensus 164 l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~--~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~ 241 (973)
+..+++|++|++++|.+++..|..++.+++|+ .|++++|++.++.+..|.. .+|+.|++++|. ..+..+.++.+
T Consensus 149 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~ 224 (606)
T 3t6q_A 149 GFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKN 224 (606)
T ss_dssp TCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTT
T ss_pred ccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhccc
Confidence 22344455555555544444444455555555 4555555555544444433 355555555554 12333444433
Q ss_pred ccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhcccc--ccceEEcccccccCCcCchhhcCCccceeec
Q 002069 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLK--SLLHLQLNYNTLSGSIPLSLGSLTNLATLYF 319 (973)
Q Consensus 242 L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~--~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 319 (973)
+....+..+.+.... .. .+....|..+. +|+.|++++|.+++..+..|+.+++|++|++
T Consensus 225 ~~l~~l~~~~~~~~~----------------~~---~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 285 (606)
T 3t6q_A 225 STIQSLWLGTFEDMD----------------DE---DISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDL 285 (606)
T ss_dssp CEEEEEECCCCTTSC----------------CC---CCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEEC
T ss_pred cchhheechhhcccc----------------cc---ccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEec
Confidence 333332222221100 01 11122333332 6788888888888777777888888888888
Q ss_pred cccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCC-cccccccccchhccccccccc
Q 002069 320 STNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIP-LSFASLTSLTTLYLYENSLCD 398 (973)
Q Consensus 320 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~ 398 (973)
++|.++ .+|..+.++++|++|++++|.+++..|..+.++++|++|++++|.+.+..+ ..+..+++|++|++++|.+++
T Consensus 286 ~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 364 (606)
T 3t6q_A 286 TATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364 (606)
T ss_dssp TTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCE
T ss_pred cCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCcccc
Confidence 888887 667778888888888888888887777788888888888888888875444 457888888888888888876
Q ss_pred CC--CcccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccCC-CCCCCcccceeeccCCccCCCCCc
Q 002069 399 SI--PKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPL-GHGKFSSLIQLILNNNELSGQLSP 475 (973)
Q Consensus 399 ~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~-~~~~~~~L~~L~l~~N~l~~~~~~ 475 (973)
.. +..+..+++|++|++++|++++..|..+..+. +|++|++++|++++..+. .+..+++|++|++++|.+++..+.
T Consensus 365 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 443 (606)
T 3t6q_A 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECP-QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ 443 (606)
T ss_dssp EEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCT-TCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTT
T ss_pred ccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCc-cCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHH
Confidence 55 67788888888888888888766666666655 788888888888876554 377888899999999988888888
Q ss_pred ccccccccccccccccccccc---cCccccccccccEEeecCccCCCCCCcccccccccCeecccccccCCCcchhhccc
Q 002069 476 ELGSLNQLEYLDLSANTFHNS---IPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSM 552 (973)
Q Consensus 476 ~l~~l~~L~~L~Ls~N~i~~~---~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~l 552 (973)
.+..+++|++|++++|.+++. .+..+..+++|++|++++|++++..|..|..+++|++|++++|.+++..|..+..+
T Consensus 444 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l 523 (606)
T 3t6q_A 444 LFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHL 523 (606)
T ss_dssp TTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTC
T ss_pred HHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCcc
Confidence 888888999999999988762 33568888899999999999988888888889999999999999988888889889
Q ss_pred ccccccccccccccCccchhhhccccccEEeCcCCCCCCCCCC
Q 002069 553 QSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPN 595 (973)
Q Consensus 553 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 595 (973)
+.| +|++++|++++..+..+..++.|+.|++++|+|++.++.
T Consensus 524 ~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 524 KGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp CSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred ccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 999 999999999988888888899999999999998887763
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-59 Score=560.36 Aligned_cols=520 Identities=22% Similarity=0.210 Sum_probs=392.2
Q ss_pred CcEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccC
Q 002069 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGN 81 (973)
Q Consensus 2 l~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~ 81 (973)
+++|||++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|.+|+++++|++|++++
T Consensus 35 l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 114 (606)
T 3t6q_A 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQ 114 (606)
T ss_dssp CCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTT
T ss_pred CcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccc
Confidence 78999999999977788999999999999999999998899999999999999999999988899999999999999999
Q ss_pred CcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCC--ceecccCCCCCC
Q 002069 82 NLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLS--DLQVSYNTLSGA 159 (973)
Q Consensus 82 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~--~L~l~~N~l~~~ 159 (973)
|++++..|..++.+++|++|++++|++++..+..+..+++|++|++++|++++..|+.|+.+++|+ .|++++|.+++.
T Consensus 115 n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~ 194 (606)
T 3t6q_A 115 TGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGI 194 (606)
T ss_dssp SCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEE
T ss_pred cCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCcc
Confidence 999976688899999999999999999964444555699999999999999987788899999999 889999999977
Q ss_pred CCccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCcccccc
Q 002069 160 IPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNL 239 (973)
Q Consensus 160 ~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l 239 (973)
.|..+.. .+|+.|++++|. .++..+.++..++...+..+.+. .+.. ..+.+..|.++
T Consensus 195 ~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~-----------~~~~--------~~i~~~~~~~l 251 (606)
T 3t6q_A 195 EPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFE-----------DMDD--------EDISPAVFEGL 251 (606)
T ss_dssp CTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCT-----------TSCC--------CCCCGGGGGGG
T ss_pred ChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhc-----------cccc--------cccChhHhchh
Confidence 6666544 678888888876 34455555555444433322222 1111 12223444444
Q ss_pred c--cccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCcccee
Q 002069 240 K--SLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATL 317 (973)
Q Consensus 240 ~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 317 (973)
. +|+.|++++|.+++..+..|+ .+++|++|++++|+++ .+|..+..+++|++|
T Consensus 252 ~~~~L~~L~l~~n~l~~~~~~~~~------------------------~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L 306 (606)
T 3t6q_A 252 CEMSVESINLQKHYFFNISSNTFH------------------------CFSGLQELDLTATHLS-ELPSGLVGLSTLKKL 306 (606)
T ss_dssp GGSEEEEEECTTCCCSSCCTTTTT------------------------TCTTCSEEECTTSCCS-CCCSSCCSCTTCCEE
T ss_pred hcCceeEEEeecCccCccCHHHhc------------------------cccCCCEEeccCCccC-CCChhhcccccCCEE
Confidence 3 677888888877766555554 4455566666666665 455556666666666
Q ss_pred eccccccCCCCCccccCCCCCCcEEcCCCCCCCcch-hccCCCCCCcEEEccCCcccCCC--Ccccccccccchhccccc
Q 002069 318 YFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIP-LALGNLTKLVSLDLSINKLSGSI--PLSFASLTSLTTLYLYEN 394 (973)
Q Consensus 318 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~--~~~~~~l~~L~~L~L~~N 394 (973)
++++|.+++..|..+..+++|++|++++|.+.+..+ ..+..+++|++|++++|++++.. +..+..+++|++|++++|
T Consensus 307 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n 386 (606)
T 3t6q_A 307 VLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYN 386 (606)
T ss_dssp ECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSC
T ss_pred ECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCC
Confidence 666666665556666666666666666666654333 34666666666666666666544 556666667777777777
Q ss_pred ccccCCCcccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccCC---
Q 002069 395 SLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSG--- 471 (973)
Q Consensus 395 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~--- 471 (973)
++++..|..|..+++|++|++++|++++..+.......++|++|++++|.+++..+..++.+++|++|++++|++++
T Consensus 387 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 466 (606)
T 3t6q_A 387 EPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466 (606)
T ss_dssp SCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEE
T ss_pred cCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCcccc
Confidence 66666666677777777777777776655444422223367777777777776667777777777777777777765
Q ss_pred CCCcccccccccccccccccccccccCccccccccccEEeecCccCCCCCCcccccccccCeecccccccCCCcchhhcc
Q 002069 472 QLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCS 551 (973)
Q Consensus 472 ~~~~~l~~l~~L~~L~Ls~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~ 551 (973)
..+..+..+++|++|++++|.+++..|..|..+++|++|+|++|++++.+|..+..++.| .|++++|.+++..|..+..
T Consensus 467 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~ 545 (606)
T 3t6q_A 467 QKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPI 545 (606)
T ss_dssp CSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHH
T ss_pred ccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhccc
Confidence 233567888889999999998888888888888899999999999988888888888888 8999999998888888889
Q ss_pred cccccccccccccccCccc
Q 002069 552 MQSLEKLNLSHNNLSGSIS 570 (973)
Q Consensus 552 l~~L~~L~L~~N~l~~~~~ 570 (973)
+++|++|++++|+++...+
T Consensus 546 l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 546 LSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp HHTSSEEECTTCCEECSGG
T ss_pred CCCCCEEeCCCCCccccCC
Confidence 9999999999999986544
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-57 Score=563.64 Aligned_cols=534 Identities=23% Similarity=0.228 Sum_probs=356.3
Q ss_pred EEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCC-CCcccCCCCCcEEEccCC
Q 002069 4 VLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSI-PPSLGNLTSLIYIDIGNN 82 (973)
Q Consensus 4 ~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~-p~~~~~l~~L~~L~l~~n 82 (973)
..|.++++++ .+|. ..++|++|||++|.+++..|..|..+++|++|+|++|...+.+ |.+|+++++|++|+|++|
T Consensus 8 ~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 5688899998 7887 5688999999999999888899999999999999999665565 788999999999999999
Q ss_pred cCcccCCccccCccccceeeccCCcCCCCCCCc--cccCCccceeecccccccccCc-ccccccCCCCceecccCCCCCC
Q 002069 83 LLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSS--LGNLTNLVTLYLHMNALSGSIP-DEIGNLKFLSDLQVSYNTLSGA 159 (973)
Q Consensus 83 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~ 159 (973)
.+++..|..|+++++|++|+|++|++++..|.. |+++++|++|+|++|.+++..+ ..|+++++|++|++++|.+++.
T Consensus 84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~ 163 (844)
T 3j0a_A 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163 (844)
T ss_dssp CCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred cCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence 999888999999999999999999998766665 8899999999999999886544 5788999999999999998888
Q ss_pred CCccccCc--cccceeeecccccCCCCCccccccCc------cceeeccccccccccccccCCC---CcccEEecCCccc
Q 002069 160 IPFSLGNL--TNLVTLYIGINALSGSIPNEIGNLKS------LSDLRLDYNTLSGSILYSFGNL---TKLEILYLDVNAL 228 (973)
Q Consensus 160 ~p~~l~~l--~~L~~L~l~~n~l~~~~p~~~~~l~~------L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~n~i 228 (973)
.|..+..+ ++|+.|+++.|.+.+..|..+..+++ |++|++++|.+++..+..+... .+++.|.++.+.+
T Consensus 164 ~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~ 243 (844)
T 3j0a_A 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243 (844)
T ss_dssp CSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCC
T ss_pred CHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccc
Confidence 88888877 78888888888888777776666554 6666666666655444444322 3444444443222
Q ss_pred CCCCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccc--cccceEEcccccccCCcCc
Q 002069 229 SGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNL--KSLLHLQLNYNTLSGSIPL 306 (973)
Q Consensus 229 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l--~~L~~L~l~~n~l~~~~~~ 306 (973)
.. ....+.+. ......|.++ ++|+.|++++|.+.+..+.
T Consensus 244 ~~---------------~~~~~~l~------------------------~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~ 284 (844)
T 3j0a_A 244 GA---------------GFGFHNIK------------------------DPDQNTFAGLARSSVRHLDLSHGFVFSLNSR 284 (844)
T ss_dssp BC---------------SSSCSSST------------------------TGGGTTTTTTTTSCCCEEECTTCCCCEECSC
T ss_pred cc---------------cccccccC------------------------CCChhhhhccccCCccEEECCCCcccccChh
Confidence 11 01112222 2222233332 4556666666666555555
Q ss_pred hhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCccccccccc
Q 002069 307 SLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSL 386 (973)
Q Consensus 307 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L 386 (973)
.|..+++|+.|++++|.+++..|..|.++++|++|+|++|.+++..+..|.++++|++|++++|+++...+..|.++++|
T Consensus 285 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L 364 (844)
T 3j0a_A 285 VFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKL 364 (844)
T ss_dssp CSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCC
T ss_pred hhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCC
Confidence 56666666666666666655555556666666666666666655555566666666666666666665555556666666
Q ss_pred chhcccccccccCCCcccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccC-CCCCCCcccceeecc
Q 002069 387 TTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIP-LGHGKFSSLIQLILN 465 (973)
Q Consensus 387 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~-~~~~~~~~L~~L~l~ 465 (973)
++|+|++|.+++. ..+++|+.|++++|+++ .+|.. ..+++.|++++|++++... ..+..+++|+.|+++
T Consensus 365 ~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~-~l~~~----~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls 434 (844)
T 3j0a_A 365 QTLDLRDNALTTI-----HFIPSIPDIFLSGNKLV-TLPKI----NLTANLIHLSENRLENLDILYFLLRVPHLQILILN 434 (844)
T ss_dssp CEEEEETCCSCCC-----SSCCSCSEEEEESCCCC-CCCCC----CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEE
T ss_pred CEEECCCCCCCcc-----cCCCCcchhccCCCCcc-ccccc----ccccceeecccCccccCchhhhhhcCCccceeeCC
Confidence 6666666665432 22555666666666665 33332 1245666666666654321 112355666666666
Q ss_pred CCccCCCCCc-ccccccccccccccccccc-----cccCccccccccccEEeecCccCCCCCCcccccccccCeeccccc
Q 002069 466 NNELSGQLSP-ELGSLNQLEYLDLSANTFH-----NSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYK 539 (973)
Q Consensus 466 ~N~l~~~~~~-~l~~l~~L~~L~Ls~N~i~-----~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n 539 (973)
+|++++..+. .+..+++|+.|+|++|.++ +..+..|.++++|+.|+|++|++++.++..|..+++|++|+|++|
T Consensus 435 ~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 514 (844)
T 3j0a_A 435 QNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSN 514 (844)
T ss_dssp SCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESC
T ss_pred CCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCC
Confidence 6666543322 3344566666666666665 233345666666667777777666666666666666777777777
Q ss_pred ccCCCcchhhcccccccccccccccccCccchhhhccccccEEeCcCCCCCCCCCC
Q 002069 540 IFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPN 595 (973)
Q Consensus 540 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 595 (973)
.|++..+..+. ++|+.|+|++|+|++..+..| ..|+.+++++|++.+.++.
T Consensus 515 ~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 515 RLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECEL 565 (844)
T ss_dssp CCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSSC
T ss_pred CCCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCccccccc
Confidence 66665555554 677777777777777776554 3667778888888777664
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-58 Score=553.14 Aligned_cols=541 Identities=21% Similarity=0.221 Sum_probs=343.4
Q ss_pred EEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCc
Q 002069 4 VLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNL 83 (973)
Q Consensus 4 ~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~ 83 (973)
+++.++++++ .+|+.+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|.+|+++++|++|+|++|+
T Consensus 15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~ 91 (606)
T 3vq2_A 15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91 (606)
T ss_dssp EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence 4555555555 5555443 555666666666555555555555555555555555554445555555555555555555
Q ss_pred CcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccc-cCcccccccCCCCceecccCCCCCCCCc
Q 002069 84 LSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSG-SIPDEIGNLKFLSDLQVSYNTLSGAIPF 162 (973)
Q Consensus 84 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 162 (973)
+++..|..|+++++|++|+|++|++++..|..++++++|++|++++|++++ .+|..|+++++|++|++++|++++..|.
T Consensus 92 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~ 171 (606)
T 3vq2_A 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171 (606)
T ss_dssp CCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred ccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence 554445555555555555555555554444555555555555555555543 3455555555555555555555544444
Q ss_pred cccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccC-CCCCcccccccc
Q 002069 163 SLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALS-GLIPNEIGNLKS 241 (973)
Q Consensus 163 ~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~-~~~~~~~~~l~~ 241 (973)
.|+.+++|+. .+.+|++++|.++++++..|... +|+.|++++|.++ +..|..+.++++
T Consensus 172 ~~~~l~~L~~--------------------~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~ 230 (606)
T 3vq2_A 172 DLQFLRENPQ--------------------VNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAG 230 (606)
T ss_dssp TTHHHHHCTT--------------------CCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTT
T ss_pred hhhhhhcccc--------------------ccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccc
Confidence 4444444431 01134555555544444444333 4555555555443 223444555555
Q ss_pred ccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEc-ccccccCCcCchhhcCCccceeecc
Q 002069 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQL-NYNTLSGSIPLSLGSLTNLATLYFS 320 (973)
Q Consensus 242 L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l-~~n~l~~~~~~~~~~l~~L~~L~L~ 320 (973)
|+.+++..+.+..... +. . +.......+..+ +++.+++ ..|.+.+..|. +..+++|+.|+++
T Consensus 231 L~~l~l~~~~~~~~~~--l~---~----------~~~~~~~~l~~l-~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~ 293 (606)
T 3vq2_A 231 LHVHRLILGEFKDERN--LE---I----------FEPSIMEGLCDV-TIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLA 293 (606)
T ss_dssp CEEEEEEEECCTTSCC--CS---C----------CCGGGGTTGGGS-EEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEE
T ss_pred cccccccccccccCCc--cc---c----------cChHHhhhhhhc-cHhheeccccccccccccc-cccCCCCCEEEec
Confidence 5555554443321100 00 0 000011111122 3455555 55566655555 6677777777777
Q ss_pred ccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccC-
Q 002069 321 TNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDS- 399 (973)
Q Consensus 321 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~- 399 (973)
+|.+. .+| .+..+++|++|++++|.++ .+| .+ .+++|++|++++|+..+. ..+..+++|++|++++|++++.
T Consensus 294 ~~~~~-~l~-~l~~~~~L~~L~l~~n~l~-~lp-~~-~l~~L~~L~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~ 366 (606)
T 3vq2_A 294 GVSIK-YLE-DVPKHFKWQSLSIIRCQLK-QFP-TL-DLPFLKSLTLTMNKGSIS--FKKVALPSLSYLDLSRNALSFSG 366 (606)
T ss_dssp SCCCC-CCC-CCCTTCCCSEEEEESCCCS-SCC-CC-CCSSCCEEEEESCSSCEE--CCCCCCTTCCEEECCSSCEEEEE
T ss_pred Cccch-hhh-hccccccCCEEEcccccCc-ccc-cC-CCCccceeeccCCcCccc--hhhccCCCCCEEECcCCccCCCc
Confidence 77775 344 6667777777777777773 455 34 677777777777754432 2556677777777777777654
Q ss_pred -CCcccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccC-CCCCCCcccceeeccCCccCCCCCccc
Q 002069 400 -IPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIP-LGHGKFSSLIQLILNNNELSGQLSPEL 477 (973)
Q Consensus 400 -~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~-~~~~~~~~L~~L~l~~N~l~~~~~~~l 477 (973)
.+..+..+++|++|++++|.++ .+|..+..+. +|++|++++|++++..+ ..+..+++|++|++++|.+++..+..+
T Consensus 367 ~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 444 (606)
T 3vq2_A 367 CCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLE-ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIF 444 (606)
T ss_dssp ECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCT-TCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTT
T ss_pred chhhhhccCCcccEeECCCCccc-cchhhccCCC-CCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhh
Confidence 2666777777777777777776 4555555544 67778887777777666 567778888888888888887778888
Q ss_pred cccccccccccccccccc-ccCccccccccccEEeecCccCCCCCCcccccccccCeecccccccCCCcchhhccccccc
Q 002069 478 GSLNQLEYLDLSANTFHN-SIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLE 556 (973)
Q Consensus 478 ~~l~~L~~L~Ls~N~i~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~l~~L~ 556 (973)
..+++|++|++++|.+++ ..|..+..+++|++|+|++|++++..|..+..+++|++|++++|.+++..|..+..+++|+
T Consensus 445 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 524 (606)
T 3vq2_A 445 LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLS 524 (606)
T ss_dssp TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCC
T ss_pred cCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCC
Confidence 888888888888888886 4688888888899999999998888888888888999999999998888888899999999
Q ss_pred ccccccccccCccchhhhccc-cccEEeCcCCCCCCCCCC
Q 002069 557 KLNLSHNNLSGSISRCFEEMH-WLSCIDISYNALQGLIPN 595 (973)
Q Consensus 557 ~L~L~~N~l~~~~~~~~~~l~-~L~~l~l~~N~l~~~~~~ 595 (973)
+|+|++|+++. .|..+..++ +|+.|++++|+|.+.++.
T Consensus 525 ~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 525 TLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp EEECTTSCCCC-EESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred EEECCCCcCcc-cCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 99999999984 444488886 599999999999988775
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-57 Score=560.84 Aligned_cols=532 Identities=23% Similarity=0.267 Sum_probs=435.0
Q ss_pred CEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccC-CccccCccccceeeccC
Q 002069 27 KLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSI-PNEVGSLKSLSDLRLSN 105 (973)
Q Consensus 27 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~-p~~~~~l~~L~~L~L~~ 105 (973)
+..|.++++++ .+|. -.++|++|+|++|++++..|.+|+++++|++|+|++|...+.+ |+.|+++++|++|+|++
T Consensus 7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~ 82 (844)
T 3j0a_A 7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82 (844)
T ss_dssp EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence 46788888888 4565 4578999999999998777888999999999999988655455 77888899999999999
Q ss_pred CcCCCCCCCccccCCccceeecccccccccCccc--ccccCCCCceecccCCCCCCCC-ccccCccccceeeecccccCC
Q 002069 106 NSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDE--IGNLKFLSDLQVSYNTLSGAIP-FSLGNLTNLVTLYIGINALSG 182 (973)
Q Consensus 106 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~l~~n~l~~ 182 (973)
|++++..|..|+++++|++|+|++|.+++..|.. |+++++|++|+|++|.+++..+ ..|+++++|++|++++|.+++
T Consensus 83 N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~ 162 (844)
T 3j0a_A 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162 (844)
T ss_dssp CCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC
T ss_pred CcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe
Confidence 9988777888999999999999999888656655 8888888888888888876544 568888888888888888887
Q ss_pred CCCcccccc--CccceeeccccccccccccccCCCCc------ccEEecCCcccCCCCCcccccc---ccccceeccccc
Q 002069 183 SIPNEIGNL--KSLSDLRLDYNTLSGSILYSFGNLTK------LEILYLDVNALSGLIPNEIGNL---KSLLALQLNYNT 251 (973)
Q Consensus 183 ~~p~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~------L~~L~L~~n~i~~~~~~~~~~l---~~L~~L~L~~N~ 251 (973)
..|..+..+ ++|+.|+++.|.+.+..+..++.+++ |+.|++++|.+++..+..+... .+++.|.++.+.
T Consensus 163 ~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~ 242 (844)
T 3j0a_A 163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI 242 (844)
T ss_dssp CCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSC
T ss_pred eCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccc
Confidence 778888777 78888888888887766666655554 6666666666655544444332 223333332221
Q ss_pred ccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcC--CccceeeccccccCCCCC
Q 002069 252 LSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSL--TNLATLYFSTNALSGSIP 329 (973)
Q Consensus 252 l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~ 329 (973)
+ . -....+.+.+.....|.++ ++|+.|++++|.+.+..|
T Consensus 243 ~------------------------~---------------~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~ 283 (844)
T 3j0a_A 243 M------------------------G---------------AGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS 283 (844)
T ss_dssp C------------------------B---------------CSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECS
T ss_pred c------------------------c---------------ccccccccCCCChhhhhccccCCccEEECCCCcccccCh
Confidence 1 0 0123344554555566655 789999999999998889
Q ss_pred ccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCC
Q 002069 330 NEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKS 409 (973)
Q Consensus 330 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 409 (973)
..|..+++|+.|+|++|.+++..+..|.++++|++|+|++|++++..+..|.++++|+.|++++|+++...+..|..+++
T Consensus 284 ~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~ 363 (844)
T 3j0a_A 284 RVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEK 363 (844)
T ss_dssp CCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCC
T ss_pred hhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCC
Confidence 99999999999999999999888999999999999999999999888999999999999999999999988889999999
Q ss_pred CCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCC-cccccccccccccc
Q 002069 410 LSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLS-PELGSLNQLEYLDL 488 (973)
Q Consensus 410 L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~-~~l~~l~~L~~L~L 488 (973)
|++|+|++|.+++ ++. .++|+.|++++|+++.. |. ...+++.|++++|++++... ..+..+++|+.|+|
T Consensus 364 L~~L~Ls~N~l~~-i~~-----~~~L~~L~l~~N~l~~l-~~---~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~L 433 (844)
T 3j0a_A 364 LQTLDLRDNALTT-IHF-----IPSIPDIFLSGNKLVTL-PK---INLTANLIHLSENRLENLDILYFLLRVPHLQILIL 433 (844)
T ss_dssp CCEEEEETCCSCC-CSS-----CCSCSEEEEESCCCCCC-CC---CCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEE
T ss_pred CCEEECCCCCCCc-ccC-----CCCcchhccCCCCcccc-cc---cccccceeecccCccccCchhhhhhcCCccceeeC
Confidence 9999999999984 332 45899999999999844 33 25679999999999986432 34568899999999
Q ss_pred cccccccccCc-cccccccccEEeecCccCC-----CCCCcccccccccCeecccccccCCCcchhhccccccccccccc
Q 002069 489 SANTFHNSIPE-SLGNLVKLHYLNLSNNQFS-----QKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSH 562 (973)
Q Consensus 489 s~N~i~~~~~~-~l~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~ 562 (973)
++|++++..+. .+..+++|+.|+|++|.++ +..+..|..+++|++|+|++|.|++..+..|..+++|++|+|++
T Consensus 434 s~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 513 (844)
T 3j0a_A 434 NQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNS 513 (844)
T ss_dssp ESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEES
T ss_pred CCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCC
Confidence 99999865443 4567899999999999997 34456789999999999999999999999999999999999999
Q ss_pred ccccCccchhhhccccccEEeCcCCCCCCCCCCCccCCCCCcchhcCCCCccC
Q 002069 563 NNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCG 615 (973)
Q Consensus 563 N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~N~~~c~ 615 (973)
|+|++..+..+. +.|+.||+++|++++.+|. .+..+..+.+.+|||.|+
T Consensus 514 N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~--~~~~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 514 NRLTVLSHNDLP--ANLEILDISRNQLLAPNPD--VFVSLSVLDITHNKFICE 562 (844)
T ss_dssp CCCSSCCCCCCC--SCCCEEEEEEECCCCCCSC--CCSSCCEEEEEEECCCCS
T ss_pred CCCCccChhhhh--ccccEEECCCCcCCCCChh--HhCCcCEEEecCCCcccc
Confidence 999998887776 8999999999999999987 466889999999999994
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=539.12 Aligned_cols=531 Identities=23% Similarity=0.233 Sum_probs=440.0
Q ss_pred CCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeeccc
Q 002069 50 LNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHM 129 (973)
Q Consensus 50 L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 129 (973)
.++++.+++.++ .+|..+. ++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++
T Consensus 13 ~~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~ 89 (606)
T 3vq2_A 13 NITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTG 89 (606)
T ss_dssp TTEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CCceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCC
Confidence 467888888888 7887665 7888888888888877777888888888888888888876778888888888888888
Q ss_pred ccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCC-CCCccccccCccceeecccccccccc
Q 002069 130 NALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSG-SIPNEIGNLKSLSDLRLDYNTLSGSI 208 (973)
Q Consensus 130 n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~ 208 (973)
|++++..|+.|+++++|++|++++|.+++..|..++++++|++|++++|.+++ .+|..++++++|++|++++|+++++.
T Consensus 90 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~ 169 (606)
T 3vq2_A 90 NPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT 169 (606)
T ss_dssp CCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEEC
T ss_pred CcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecC
Confidence 88887778888888888888888888887777788888888888888888875 46888888888888888888888777
Q ss_pred ccccCCCCccc----EEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhh
Q 002069 209 LYSFGNLTKLE----ILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEI 284 (973)
Q Consensus 209 ~~~~~~l~~L~----~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~ 284 (973)
+..|+.+++|+ +|++++|.++++.+..+... +|+.|++++|.+++ ...+..+
T Consensus 170 ~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~-----------------------~~~~~~~ 225 (606)
T 3vq2_A 170 VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSS-----------------------NIMKTCL 225 (606)
T ss_dssp TTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCH-----------------------HHHHHHH
T ss_pred hhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccch-----------------------hHHHHHh
Confidence 77777776665 68888888877766666554 77888887777642 1234455
Q ss_pred ccccccceEEcccccccC------CcCchhhcCC--ccceeec-cccccCCCCCccccCCCCCCcEEcCCCCCCCcchhc
Q 002069 285 GNLKSLLHLQLNYNTLSG------SIPLSLGSLT--NLATLYF-STNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLA 355 (973)
Q Consensus 285 ~~l~~L~~L~l~~n~l~~------~~~~~~~~l~--~L~~L~L-~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 355 (973)
.++++|+.+++..+.+.+ ..+..+..+. .++.+++ ..|.+.+..|. +..+++|+.|++++|.++. +| .
T Consensus 226 ~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~ 302 (606)
T 3vq2_A 226 QNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-D 302 (606)
T ss_dssp HTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-C
T ss_pred ccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchh-hh-h
Confidence 666666666665444332 1122222222 4667777 67788877777 9999999999999999985 45 8
Q ss_pred cCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCCCCEEEccCCCCCCC--cchhhhhhcc
Q 002069 356 LGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGS--IPLSLANLTN 433 (973)
Q Consensus 356 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~~~~ 433 (973)
+..+++|++|++++|++. ..| .+ .+++|++|++++|+..+.. .+..+++|++|++++|++++. .|..+..+.
T Consensus 303 l~~~~~L~~L~l~~n~l~-~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~- 376 (606)
T 3vq2_A 303 VPKHFKWQSLSIIRCQLK-QFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTN- 376 (606)
T ss_dssp CCTTCCCSEEEEESCCCS-SCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCS-
T ss_pred ccccccCCEEEcccccCc-ccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCC-
Confidence 999999999999999995 667 45 9999999999999655433 678999999999999999854 266776665
Q ss_pred cceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCC-cccccccccccccccccccccccCccccccccccEEee
Q 002069 434 SLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLS-PELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNL 512 (973)
Q Consensus 434 ~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~-~~l~~l~~L~~L~Ls~N~i~~~~~~~l~~l~~L~~L~L 512 (973)
+|++|++++|.+++ .+..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..|..+.++++|++|++
T Consensus 377 ~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 455 (606)
T 3vq2_A 377 SLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKM 455 (606)
T ss_dssp CCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEEC
T ss_pred cccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEEC
Confidence 89999999999986 45888999999999999999998777 78999999999999999999989999999999999999
Q ss_pred cCccCCC-CCCcccccccccCeecccccccCCCcchhhcccccccccccccccccCccchhhhccccccEEeCcCCCCCC
Q 002069 513 SNNQFSQ-KIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQG 591 (973)
Q Consensus 513 ~~N~l~~-~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 591 (973)
++|++++ .+|..+..+++|++|++++|.+++..|..+..+++|++|+|++|++++..+..+..++.|++||+++|++++
T Consensus 456 ~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 535 (606)
T 3vq2_A 456 AGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET 535 (606)
T ss_dssp TTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC
T ss_pred CCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc
Confidence 9999988 478899999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred CCCCCccCC-CCCcchhcCCCCccCCC
Q 002069 592 LIPNSTAFR-DAPMLALQGNKRLCGDI 617 (973)
Q Consensus 592 ~~~~~~~~~-~~~~~~~~~N~~~c~~~ 617 (973)
+++....+. .+..+.+.+|||.|+-.
T Consensus 536 ~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 536 SKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp EESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred cCHhHhhhcccCcEEEccCCCcccCCc
Confidence 887755554 48889999999999643
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=497.05 Aligned_cols=538 Identities=23% Similarity=0.218 Sum_probs=354.7
Q ss_pred CCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccC
Q 002069 26 LKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSN 105 (973)
Q Consensus 26 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~ 105 (973)
.+.++.++.+++ .+|..+. +++++|+|++|++++..|.+|.++++|++|+|++|++++..|..|+++++|++|+|++
T Consensus 9 ~~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 85 (570)
T 2z63_A 9 NITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG 85 (570)
T ss_dssp TTEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CcEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcC
Confidence 456777777776 5676554 5678888888888766666788888888888888888766667777888888888888
Q ss_pred CcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCC-CCCccccCccccceeeecccccCCCC
Q 002069 106 NSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSG-AIPFSLGNLTNLVTLYIGINALSGSI 184 (973)
Q Consensus 106 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~l~~l~~L~~L~l~~n~l~~~~ 184 (973)
|++++..|..|+++++|++|++++|++++..+..|+++++|++|++++|.+++ .+|..|+++++|++|++++|++++..
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~ 165 (570)
T 2z63_A 86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165 (570)
T ss_dssp CCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEEC
T ss_pred CcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceec
Confidence 88876666778888888888888888775444467777788888888777775 35777777777777777777777666
Q ss_pred CccccccCcc----ceeeccccccccccccccCCCCcccEEecCCcccCC-CCCccccccccccceecccccccCCCCcc
Q 002069 185 PNEIGNLKSL----SDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSG-LIPNEIGNLKSLLALQLNYNTLSGSIPCS 259 (973)
Q Consensus 185 p~~~~~l~~L----~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 259 (973)
|..++.+++| +.|++++|.+.++.+..|..+ +|+.|++++|.... ..+..+.++++++.+.+..+.+..
T Consensus 166 ~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~----- 239 (570)
T 2z63_A 166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN----- 239 (570)
T ss_dssp GGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCC-----
T ss_pred HHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccC-----
Confidence 6667777666 667777777776666666655 67777776664321 123344444444444443332211
Q ss_pred cCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeecccc-ccCCCCCccccCCCCC
Q 002069 260 FGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTN-ALSGSIPNEITNLRSL 338 (973)
Q Consensus 260 ~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L 338 (973)
...+ .......+..++++ .++.+++++| .+.+..|..+..+++|
T Consensus 240 ---~~~l----------~~~~~~~~~~l~~l----------------------~l~~l~l~~~~~~~~~~~~~~~~l~~L 284 (570)
T 2z63_A 240 ---EGNL----------EKFDKSALEGLCNL----------------------TIEEFRLAYLDYYLDDIIDLFNCLTNV 284 (570)
T ss_dssp ---CSSC----------EECCTTTTGGGGGS----------------------EEEEEEEEETTEEESCSTTTTGGGTTC
T ss_pred ---chhh----------hhcchhhhcccccc----------------------chhhhhhhcchhhhhhchhhhcCcCcc
Confidence 0000 01111112222111 2334444444 3444445555555555
Q ss_pred CcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCCCCEEEccCC
Q 002069 339 SDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSN 418 (973)
Q Consensus 339 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 418 (973)
++|++++|.++ .+|..+..+ +|++|++++|.+. ..|. ..+++|+.|++++|.+.+..+. ..+++|++|++++|
T Consensus 285 ~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n 357 (570)
T 2z63_A 285 SSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRN 357 (570)
T ss_dssp SEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSS
T ss_pred cEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCC
Confidence 55555555555 344445555 5566666666555 2222 2445566666666655543333 55666777777777
Q ss_pred CCCCCc--chhhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCC-ccccccccccccccccccccc
Q 002069 419 KLNGSI--PLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLS-PELGSLNQLEYLDLSANTFHN 495 (973)
Q Consensus 419 ~l~~~~--~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~-~~l~~l~~L~~L~Ls~N~i~~ 495 (973)
++++.. |..+..+. +|++|++++|.+++..+. +..+++|++|++++|.+++..+ ..+..+++|++|++++|.+++
T Consensus 358 ~l~~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~ 435 (570)
T 2z63_A 358 GLSFKGCCSQSDFGTT-SLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435 (570)
T ss_dssp CCBEEEEEEHHHHTCS-CCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEE
T ss_pred ccCccccccccccccC-ccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccc
Confidence 666332 44454443 677777777777655444 6677778888888887776544 467778888888888888887
Q ss_pred ccCccccccccccEEeecCccCC-CCCCcccccccccCeecccccccCCCcchhhcccccccccccccccccCccchhhh
Q 002069 496 SIPESLGNLVKLHYLNLSNNQFS-QKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFE 574 (973)
Q Consensus 496 ~~~~~l~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 574 (973)
..|..+.++++|++|++++|+++ +.+|..+..+++|++|++++|.+++..|..+..+++|++|++++|++++..+..+.
T Consensus 436 ~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 515 (570)
T 2z63_A 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFD 515 (570)
T ss_dssp CCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred cchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhh
Confidence 77778888888888888888886 46777888888888888888888888888888889999999999999988888888
Q ss_pred ccccccEEeCcCCCCCCCCCCCccC---CCCCcchhcCCCCccCCC
Q 002069 575 EMHWLSCIDISYNALQGLIPNSTAF---RDAPMLALQGNKRLCGDI 617 (973)
Q Consensus 575 ~l~~L~~l~l~~N~l~~~~~~~~~~---~~~~~~~~~~N~~~c~~~ 617 (973)
.++.|+.|++++|++++.++....+ -.-....+.+.+ .|..+
T Consensus 516 ~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~~~~~~~~-~C~~~ 560 (570)
T 2z63_A 516 RLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSA-KCSGS 560 (570)
T ss_dssp TCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTGGGEESCC-BBTTT
T ss_pred cccCCcEEEecCCcccCCCcchHHHHHHHHhccccCCCch-hhCCC
Confidence 9999999999999999988864322 111222344555 77654
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=495.98 Aligned_cols=514 Identities=21% Similarity=0.196 Sum_probs=348.7
Q ss_pred cEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCC
Q 002069 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNN 82 (973)
Q Consensus 3 ~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n 82 (973)
+..+-++.+++ .+|..+. .++++|+|++|++++..|..|..+++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 10 ~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 86 (570)
T 2z63_A 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86 (570)
T ss_dssp TEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred cEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCC
Confidence 45778888898 8998664 68999999999999888889999999999999999999777788999999999999999
Q ss_pred cCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccc-cCcccccccCCCCceecccCCCCCCCC
Q 002069 83 LLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSG-SIPDEIGNLKFLSDLQVSYNTLSGAIP 161 (973)
Q Consensus 83 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p 161 (973)
++++..|..|+.+++|++|++++|++++..+..++++++|++|++++|.+++ .+|..|+++++|++|++++|.+++..|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~ 166 (570)
T 2z63_A 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166 (570)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECG
T ss_pred cCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecH
Confidence 9997777899999999999999999996555579999999999999999986 469999999999999999999998888
Q ss_pred ccccCcccc----ceeeecccccCCCCCccccccCccceeecccccccc-ccccccCCCCcccEEecCCcccCCCCCccc
Q 002069 162 FSLGNLTNL----VTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSG-SILYSFGNLTKLEILYLDVNALSGLIPNEI 236 (973)
Q Consensus 162 ~~l~~l~~L----~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~ 236 (973)
..++.+++| +.|++++|.+++..|..+..+ +|++|++++|.... ..+..+.++++++.+.+....+...
T Consensus 167 ~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~----- 240 (570)
T 2z63_A 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE----- 240 (570)
T ss_dssp GGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCC-----
T ss_pred HHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCc-----
Confidence 899999999 899999999998778777766 89999999986542 2345567788888777665443321
Q ss_pred cccccccceecccccccCCCCcccCCcchh--hhccCCCc-ccCchhhhhhccccccceEEcccccccCCcCchhhcCCc
Q 002069 237 GNLKSLLALQLNYNTLSGSIPCSFGNLTKL--VISCLGTN-ALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTN 313 (973)
Q Consensus 237 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~l~l~~n-~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 313 (973)
.+++ ......|.++.++ +.+.+..+ .+....++.+..+++|++|++++|.++ .+|..+..+ +
T Consensus 241 ---~~l~----------~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~ 305 (570)
T 2z63_A 241 ---GNLE----------KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-G 305 (570)
T ss_dssp ---SSCE----------ECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-C
T ss_pred ---hhhh----------hcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-C
Confidence 0111 1111122222221 11222222 222233445555666666777776666 355556665 6
Q ss_pred cceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCC--Ccccccccccchhcc
Q 002069 314 LATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSI--PLSFASLTSLTTLYL 391 (973)
Q Consensus 314 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~--~~~~~~l~~L~~L~L 391 (973)
|++|++++|.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|++|++++|++++.. +..+.++++|++|++
T Consensus 306 L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l 380 (570)
T 2z63_A 306 WQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380 (570)
T ss_dssp CSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEEC
T ss_pred ccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEEC
Confidence 666666666666 3333 3556666666666666544332 45566666666666665432 444555555555555
Q ss_pred cccccccCCCcccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccCC
Q 002069 392 YENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSG 471 (973)
Q Consensus 392 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~ 471 (973)
++|.+++..+. +..+++|++|++++|.+++..+. ..+..+++|++|++++|.+++
T Consensus 381 ~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~------------------------~~~~~l~~L~~L~l~~n~l~~ 435 (570)
T 2z63_A 381 SFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEF------------------------SVFLSLRNLIYLDISHTHTRV 435 (570)
T ss_dssp CSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTS------------------------CTTTTCTTCCEEECTTSCCEE
T ss_pred CCCcccccccc-ccccCCCCEEEccCCccccccch------------------------hhhhcCCCCCEEeCcCCcccc
Confidence 55555443222 55555555555555555433331 234445555555555555555
Q ss_pred CCCcccccccccccccccccccc-cccCccccccccccEEeecCccCCCCCCcccccccccCeecccccccCCCcchhhc
Q 002069 472 QLSPELGSLNQLEYLDLSANTFH-NSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVC 550 (973)
Q Consensus 472 ~~~~~l~~l~~L~~L~Ls~N~i~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~ 550 (973)
..+..+..+++|++|++++|.++ +.+|..+..+++|++|+|++|++++..|..+..+++|++|++++|.+++..+..+.
T Consensus 436 ~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 515 (570)
T 2z63_A 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFD 515 (570)
T ss_dssp CCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred cchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhh
Confidence 55555555556666666666555 34555556666666666666666655555666666666666666666665566666
Q ss_pred ccccccccccccccccCccc
Q 002069 551 SMQSLEKLNLSHNNLSGSIS 570 (973)
Q Consensus 551 ~l~~L~~L~L~~N~l~~~~~ 570 (973)
.+++|++|++++|++++..+
T Consensus 516 ~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 516 RLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp TCTTCCEEECCSSCBCCCTT
T ss_pred cccCCcEEEecCCcccCCCc
Confidence 66666666666666665543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-51 Score=484.38 Aligned_cols=482 Identities=21% Similarity=0.210 Sum_probs=367.6
Q ss_pred EEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCc
Q 002069 4 VLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNL 83 (973)
Q Consensus 4 ~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~ 83 (973)
+.|.++++++ .+|+.+. ++|++|+|++|++++..|..|..+++|++|+|++|++++..|++|+++++|++|+|++|+
T Consensus 9 ~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 85 (549)
T 2z81_A 9 VCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNH 85 (549)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred eEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCc
Confidence 4688999998 8999775 899999999999998888999999999999999999997778899999999999999999
Q ss_pred CcccCCccccCccccceeeccCCcCCC-CCCCccccCCccceeecccccccccCc-ccccccCCCCceecccCCCCCCCC
Q 002069 84 LSGSIPNEVGSLKSLSDLRLSNNSLNG-SIPSSLGNLTNLVTLYLHMNALSGSIP-DEIGNLKFLSDLQVSYNTLSGAIP 161 (973)
Q Consensus 84 l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p 161 (973)
+++..|..|+.+++|++|+|++|++++ ..|..++++++|++|++++|++.+.+| ..|+++++|++|++++|.+++..|
T Consensus 86 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 165 (549)
T 2z81_A 86 LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS 165 (549)
T ss_dssp CCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECT
T ss_pred cCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccCh
Confidence 997766779999999999999999985 357889999999999999998433454 689999999999999999998899
Q ss_pred ccccCccccceeeecccccCCCCCccc-cccCccceeecccccccccc---ccccCCCCcccEEecCCcccCCCCC----
Q 002069 162 FSLGNLTNLVTLYIGINALSGSIPNEI-GNLKSLSDLRLDYNTLSGSI---LYSFGNLTKLEILYLDVNALSGLIP---- 233 (973)
Q Consensus 162 ~~l~~l~~L~~L~l~~n~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~L~~n~i~~~~~---- 233 (973)
..++.+++|++|+++.|.+. .+|..+ ..+++|++|++++|++++.. ......+++|+.|++++|.+++..+
T Consensus 166 ~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~ 244 (549)
T 2z81_A 166 QSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL 244 (549)
T ss_dssp TTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHH
T ss_pred hhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHH
Confidence 99999999999999999987 455554 56899999999999998753 2334568899999999998875433
Q ss_pred ccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCC-----cCchh
Q 002069 234 NEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGS-----IPLSL 308 (973)
Q Consensus 234 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~-----~~~~~ 308 (973)
..+..+++|+.+++++|.+.+..... ......+..+++|+.|++.++.+... .+..+
T Consensus 245 ~~~~~~~~L~~l~l~~~~~~~~~~~~------------------~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~ 306 (549)
T 2z81_A 245 KLLRYILELSEVEFDDCTLNGLGDFN------------------PSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVY 306 (549)
T ss_dssp GGGGGCTTCCEEEEESCEEECCSCCC------------------CCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHH
T ss_pred HHhhhhcccccccccccccccccccc------------------ccchhhhhhhcccccccccccccchhhhcccchhhh
Confidence 33466788999999999887532210 01112345667778888888776532 22234
Q ss_pred hcCCccceeeccccccCCCCCccc-cCCCCCCcEEcCCCCCCCcch---hccCCCCCCcEEEccCCcccCCCC--ccccc
Q 002069 309 GSLTNLATLYFSTNALSGSIPNEI-TNLRSLSDLQLSENTLNGSIP---LALGNLTKLVSLDLSINKLSGSIP--LSFAS 382 (973)
Q Consensus 309 ~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~i~~~~~--~~~~~ 382 (973)
...++|+.|++++|.+. .+|..+ ..+++|++|++++|.+++..| ..++.+++|++|+|++|++++..+ ..+..
T Consensus 307 ~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 385 (549)
T 2z81_A 307 SLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385 (549)
T ss_dssp HHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGG
T ss_pred hhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhc
Confidence 45678888889888887 455555 578889999999998887654 347788889999999998886533 45778
Q ss_pred ccccchhcccccccccCCCcccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccCCCCCCCccccee
Q 002069 383 LTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQL 462 (973)
Q Consensus 383 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L 462 (973)
+++|++|++++|+++. +|..+..+++|++|++++|+++ .+|..+ +++|++|++++|++++.+ ..+++|++|
T Consensus 386 l~~L~~L~Ls~N~l~~-lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~---~~~L~~L~Ls~N~l~~~~----~~l~~L~~L 456 (549)
T 2z81_A 386 LKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR-VVKTCI---PQTLEVLDVSNNNLDSFS----LFLPRLQEL 456 (549)
T ss_dssp CTTCCEEECTTCCCCC-CCSCCCCCTTCCEEECTTSCCS-CCCTTS---CTTCSEEECCSSCCSCCC----CCCTTCCEE
T ss_pred CCCCCEEECCCCCCcc-CChhhcccccccEEECCCCCcc-cccchh---cCCceEEECCCCChhhhc----ccCChhcEE
Confidence 8888888888888874 6777888888888888888887 444333 236777777777776532 345566666
Q ss_pred eccCCccCCCCCcccccccccccccccccccccccCccccccccccEEeecCccCCC
Q 002069 463 ILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQ 519 (973)
Q Consensus 463 ~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~ 519 (973)
++++|+|+ .+|. ...+++|++|+|++|++++..|..+..+++|+.|++++|++++
T Consensus 457 ~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 511 (549)
T 2z81_A 457 YISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 511 (549)
T ss_dssp ECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCC
T ss_pred ECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccC
Confidence 66666665 2332 3445555666666665555555555555555555555555543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=436.86 Aligned_cols=255 Identities=21% Similarity=0.332 Sum_probs=208.9
Q ss_pred cCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccce
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH 774 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 774 (973)
.++++.++||+|+||+||+|.+. +++.||||+++..... ...++|.+|+.++++++|||||+++|+|.+++.
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 45677889999999999999762 5678999999765333 336889999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHhccCc-------------cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC
Q 002069 775 SFVVYEYLEMGSLAMILSNDA-------------AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL 841 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~ 841 (973)
.++|||||++|+|.+++.... ....++|.++++|+.|||.|++|||++ +||||||||+|||+++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECC
Confidence 999999999999999996532 134689999999999999999999999 9999999999999999
Q ss_pred CCceEEecccccccccCCC--CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhh
Q 002069 842 EYEAHVSDFGISKFLKLGL--SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSS 918 (973)
Q Consensus 842 ~~~~kl~Dfg~a~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~ 918 (973)
++.+||+|||+|+...... .......||+.|||||++.+..++.++|||||||++|||+| |+.||......
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~------ 254 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------ 254 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH------
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH------
Confidence 9999999999998765432 22345679999999999999999999999999999999998 89999754321
Q ss_pred hhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 919 NLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.....+......+.. ..++..+.+++.+||+.||++||||+||++.|+
T Consensus 255 ---~~~~~i~~~~~~~~p---~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~ 302 (308)
T 4gt4_A 255 ---DVVEMIRNRQVLPCP---DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302 (308)
T ss_dssp ---HHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---HHHHHHHcCCCCCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 111111121111111 123445789999999999999999999999986
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-50 Score=475.62 Aligned_cols=492 Identities=20% Similarity=0.177 Sum_probs=349.2
Q ss_pred CCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccC
Q 002069 26 LKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSN 105 (973)
Q Consensus 26 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~ 105 (973)
.-..|.++|+++ .+|..+. ++|++|+|++|++++..|.+|+++++|++|++++|++++..|..|+.+++|++|+|++
T Consensus 7 ~~~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~ 83 (549)
T 2z81_A 7 SGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSD 83 (549)
T ss_dssp TSEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTT
T ss_pred CceEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCC
Confidence 344688888888 5677665 7899999999999877788899999999999999999877778899999999999999
Q ss_pred CcCCCCCCCccccCCccceeecccccccc-cCcccccccCCCCceecccCC-CCCCCCccccCccccceeeecccccCCC
Q 002069 106 NSLNGSIPSSLGNLTNLVTLYLHMNALSG-SIPDEIGNLKFLSDLQVSYNT-LSGAIPFSLGNLTNLVTLYIGINALSGS 183 (973)
Q Consensus 106 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~l~~l~~L~~L~l~~n~l~~~ 183 (973)
|++++..|..|+++++|++|+|++|++++ ..|..|+++++|++|++++|. ++...+..|.++++|++|++++|++++.
T Consensus 84 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 163 (549)
T 2z81_A 84 NHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNY 163 (549)
T ss_dssp SCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEE
T ss_pred CccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccccc
Confidence 99986666668899999999999999875 356788889999999999988 4434446788888888888888888887
Q ss_pred CCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCC---CccccccccccceecccccccCCCCccc
Q 002069 184 IPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLI---PNEIGNLKSLLALQLNYNTLSGSIPCSF 260 (973)
Q Consensus 184 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~---~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 260 (973)
.|..+..+++|++|+++.|.+..++...+..+++|+.|++++|++++.. ......+++|+.|++++|.+++..+..
T Consensus 164 ~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~- 242 (549)
T 2z81_A 164 QSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE- 242 (549)
T ss_dssp CTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHH-
T ss_pred ChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHH-
Confidence 8888888888888888888887665555567888888888888887652 122344567777777777665322211
Q ss_pred CCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCc
Q 002069 261 GNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSD 340 (973)
Q Consensus 261 ~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 340 (973)
....+..+++|+.+++++|.+.+..... ......+..+++|+.
T Consensus 243 -------------------l~~~~~~~~~L~~l~l~~~~~~~~~~~~------------------~~~~~~~~~l~~L~~ 285 (549)
T 2z81_A 243 -------------------LLKLLRYILELSEVEFDDCTLNGLGDFN------------------PSESDVVSELGKVET 285 (549)
T ss_dssp -------------------HHGGGGGCTTCCEEEEESCEEECCSCCC------------------CCTTTCCCCCTTCCE
T ss_pred -------------------HHHHhhhhcccccccccccccccccccc------------------ccchhhhhhhccccc
Confidence 1223455667777777777766421100 000112333444555
Q ss_pred EEcCCCCCCCc-----chhccCCCCCCcEEEccCCcccCCCCccc-ccccccchhcccccccccCCC---cccCCCCCCC
Q 002069 341 LQLSENTLNGS-----IPLALGNLTKLVSLDLSINKLSGSIPLSF-ASLTSLTTLYLYENSLCDSIP---KEIGDMKSLS 411 (973)
Q Consensus 341 L~L~~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~ 411 (973)
|++.++.+... .+..+...++|++|++++|+++ ..|..+ ..+++|++|++++|++++..| ..++.+++|+
T Consensus 286 L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~ 364 (549)
T 2z81_A 286 VTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQ 364 (549)
T ss_dssp EEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCC
T ss_pred ccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCc
Confidence 55555444321 1111223456677777777766 344333 456777777777777665442 3356677777
Q ss_pred EEEccCCCCCCCcc--hhhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCCccccccccccccccc
Q 002069 412 ILDLSSNKLNGSIP--LSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLS 489 (973)
Q Consensus 412 ~L~Ls~N~l~~~~~--~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls 489 (973)
+|+|++|++++..+ ..+..+ ++|++|++++|+++ .+|..+..+++|++|++++|++++. +..+ .++|++|+++
T Consensus 365 ~L~Ls~N~l~~~~~~~~~~~~l-~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l-~~~~--~~~L~~L~Ls 439 (549)
T 2z81_A 365 TLVLSQNHLRSMQKTGEILLTL-KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVV-KTCI--PQTLEVLDVS 439 (549)
T ss_dssp EEECTTSCCCCHHHHHHHGGGC-TTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCC-CTTS--CTTCSEEECC
T ss_pred EEEccCCcccccccchhhhhcC-CCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccc-cchh--cCCceEEECC
Confidence 77777777763221 223333 36778888888777 4566677777888888888887743 3222 2578888888
Q ss_pred ccccccccCccccccccccEEeecCccCCCCCCcccccccccCeecccccccCCCcchhhcccccccccccccccccCcc
Q 002069 490 ANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSI 569 (973)
Q Consensus 490 ~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 569 (973)
+|++++. ...+++|++|+|++|+|+. +|. ...+++|++|++++|.+++..+..+..+++|++|++++|++++..
T Consensus 440 ~N~l~~~----~~~l~~L~~L~Ls~N~l~~-ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 513 (549)
T 2z81_A 440 NNNLDSF----SLFLPRLQELYISRNKLKT-LPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 513 (549)
T ss_dssp SSCCSCC----CCCCTTCCEEECCSSCCSS-CCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCH
T ss_pred CCChhhh----cccCChhcEEECCCCccCc-CCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCC
Confidence 8888753 2567888999999998874 444 467888999999999998888888889999999999999998776
Q ss_pred c
Q 002069 570 S 570 (973)
Q Consensus 570 ~ 570 (973)
+
T Consensus 514 ~ 514 (549)
T 2z81_A 514 P 514 (549)
T ss_dssp H
T ss_pred c
Confidence 5
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=435.29 Aligned_cols=254 Identities=25% Similarity=0.420 Sum_probs=207.4
Q ss_pred cCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccce
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH 774 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 774 (973)
++|.+.+.||+|+||+||+|++. +++.||||+++.. .....++|.+|++++++++|||||+++|+|.+++.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 56888999999999999999753 4778999999753 33446889999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHhccCc----------cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCc
Q 002069 775 SFVVYEYLEMGSLAMILSNDA----------AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYE 844 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~ 844 (973)
.++|||||++|+|.++++..+ ....++|.+++.|+.|||.|++|||++ +|+||||||+|||++.++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCc
Confidence 999999999999999997643 234699999999999999999999999 9999999999999999999
Q ss_pred eEEecccccccccCCCCc--ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhh
Q 002069 845 AHVSDFGISKFLKLGLSN--RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLN 921 (973)
Q Consensus 845 ~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~ 921 (973)
+||+|||+|+........ .....||+.|||||++.+..++.++|||||||++|||+| |+.||....... ..
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~------~~ 240 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VI 240 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HH
Confidence 999999999876543222 223568999999999999999999999999999999998 999997543210 01
Q ss_pred hhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 922 IALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+.....+..+. ..+..+.+++.+||+.||++||||++|++.|+
T Consensus 241 ~~i~~~~~~~~p~------~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~ 285 (299)
T 4asz_A 241 ECITQGRVLQRPR------TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQ 285 (299)
T ss_dssp HHHHHTCCCCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHcCCCCCCCc------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 1111111112221 22345789999999999999999999998875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=428.60 Aligned_cols=257 Identities=24% Similarity=0.364 Sum_probs=202.9
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.+++++.++||+|+||+||+|++. ..||||+++..... ....+.|.+|+.++++++|||||+++|++.+ +..++||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPT-PEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 467888999999999999999874 36999998754333 3446889999999999999999999999865 4689999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
|||++|+|.++++... ..+++.++..|+.|||.||+|||++ +||||||||+|||+++++.+||+|||+|+.....
T Consensus 111 Ey~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp ECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999999997543 4689999999999999999999999 9999999999999999999999999999876543
Q ss_pred C--CcccccccccCccccccccc---CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCC
Q 002069 860 L--SNRTELAGTFGYIAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934 (973)
Q Consensus 860 ~--~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (973)
. .......||+.|||||++.+ .+|+.++|||||||++|||+||+.||.......... .........+..+.
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~----~~~~~~~~~p~~~~ 261 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII----FMVGRGYASPDLSK 261 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH----HHHHTTCCCCCSTT
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH----HHHhcCCCCCCccc
Confidence 2 23345689999999999864 458999999999999999999999997543211100 11111122222222
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
... .++..+.+++.+||+.||++||||+||++.|+
T Consensus 262 ~~~---~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 262 LYK---NCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp SCT---TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred ccc---cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 222 23456788999999999999999999998875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=439.16 Aligned_cols=252 Identities=20% Similarity=0.299 Sum_probs=205.0
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||+|+. .+|+.||||++....... ...+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 6899999999999999999965 589999999997654333 34678999999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
|||+||+|.+++.... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus 103 Ey~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999996543 24578999999999999999999999 9999999999999999999999999999877544
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
.......+||+.|||||++.+..|+.++||||+||++|||+||+.||...... .....+....++....
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---------~~~~~i~~~~~~~~~~-- 247 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK---------NLVLKIISGSFPPVSL-- 247 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---------HHHHHHHHTCCCCCCT--
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---------HHHHHHHcCCCCCCCc--
Confidence 33344568999999999999999999999999999999999999999754321 1111222222221111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
..+.++.++|.+||+.||++|||++|+++
T Consensus 248 -~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 248 -HYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12345788999999999999999999976
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=435.82 Aligned_cols=254 Identities=24% Similarity=0.420 Sum_probs=202.7
Q ss_pred cCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccce
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH 774 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 774 (973)
++|.+.++||+|+||+||+|++. +++.||||+++.. .....++|.+|++++++++|||||+++|+|.+++.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 46778899999999999999753 4788999999753 33446889999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHhccCcc------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC
Q 002069 775 SFVVYEYLEMGSLAMILSNDAA------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE 842 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~ 842 (973)
.++|||||++|+|.++++.... ..+++|.+++.|+.|||.|++|||+. +|+||||||+|||++.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG 194 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC
Confidence 9999999999999999976532 24689999999999999999999999 99999999999999999
Q ss_pred CceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhh
Q 002069 843 YEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSN 919 (973)
Q Consensus 843 ~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~ 919 (973)
+.+||+|||+|+....... ......||+.|||||++.+..++.++|||||||++|||+| |+.||........
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~----- 269 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA----- 269 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH-----
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH-----
Confidence 9999999999987654322 2334679999999999999999999999999999999999 9999975432110
Q ss_pred hhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 920 LNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+....++..+. ..+..+.+++.+||+.||++||||+||++.|+
T Consensus 270 -~~~i~~g~~~~~p~------~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 315 (329)
T 4aoj_A 270 -IDCITQGRELERPR------ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315 (329)
T ss_dssp -HHHHHHTCCCCCCT------TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred -HHHHHcCCCCCCcc------cccHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 01111111222222 12345789999999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=434.65 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=210.3
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
..|++.++||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5699999999999999999965 48999999998643222 2456889999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
|||++|+|.++++. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+.+...
T Consensus 151 Ey~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 151 EFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp CCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred eCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 99999999999964 3589999999999999999999999 9999999999999999999999999999988766
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||........ ...+.....+.+. ..
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~------~~~i~~~~~~~~~----~~ 293 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA------MKMIRDNLPPRLK----NL 293 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSSCCCCS----CG
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHcCCCCCCC----cc
Confidence 5566678999999999999999999999999999999999999999975432110 0111111122221 12
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...+.++.+++.+||+.||++|||++|+++.
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2234467889999999999999999999863
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=483.88 Aligned_cols=458 Identities=20% Similarity=0.249 Sum_probs=288.0
Q ss_pred CCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCC------C------CCCCcccCCCCCcEEEccCCcCcccCCcc
Q 002069 24 THLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK------G------SIPPSLGNLTSLIYIDIGNNLLSGSIPNE 91 (973)
Q Consensus 24 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~------~------~~p~~~~~l~~L~~L~l~~n~l~~~~p~~ 91 (973)
.+++.|+|++|.++|.+|++|++|++|++|+|++|.+. + .+|... +..|+ +++++|.+.+.+|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 46777788888777777777777778888888777651 1 233333 44555 666667666666665
Q ss_pred ccC-ccccceeeccCCcCCCCCCCccccCCccceeecc--cccccccCcccccccCCCCceecccCCCCCC---------
Q 002069 92 VGS-LKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLH--MNALSGSIPDEIGNLKFLSDLQVSYNTLSGA--------- 159 (973)
Q Consensus 92 ~~~-l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~--~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--------- 159 (973)
+.. +..+..+++....+.. .....++.+++. .|++++ +|+.|+++++|++|+|++|++++.
T Consensus 158 ~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~ 230 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENE 230 (636)
T ss_dssp SCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCT
T ss_pred HHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccccc
Confidence 553 2334444444333321 111222223332 467776 777777777777777777777764
Q ss_pred --------CCcccc--CccccceeeecccccCCCCCccccccCccceeeccccc-ccc-ccccccCCC------CcccEE
Q 002069 160 --------IPFSLG--NLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNT-LSG-SILYSFGNL------TKLEIL 221 (973)
Q Consensus 160 --------~p~~l~--~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~l------~~L~~L 221 (973)
+|..++ ++++|++|++++|++.+.+|..++++++|++|++++|+ +++ ..|..++.+ ++|++|
T Consensus 231 ~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L 310 (636)
T 4eco_A 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310 (636)
T ss_dssp TSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEE
T ss_pred ccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEE
Confidence 677777 77777777777777777777777777777777777776 766 555556554 777777
Q ss_pred ecCCcccCCCCCc--cccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccc-cceEEcccc
Q 002069 222 YLDVNALSGLIPN--EIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKS-LLHLQLNYN 298 (973)
Q Consensus 222 ~L~~n~i~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~-L~~L~l~~n 298 (973)
++++|+++. .|. .++++++|+.|++++|++++.+| .|+.+++|+.|++++|.+. ..+..+..+++ |++|++++|
T Consensus 311 ~L~~n~l~~-ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N 387 (636)
T 4eco_A 311 YIGYNNLKT-FPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHN 387 (636)
T ss_dssp ECCSSCCSS-CCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSS
T ss_pred ECCCCcCCc-cCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCC
Confidence 777777774 455 67777777777777777775555 6666666666666665555 33344666666 777777777
Q ss_pred cccCCcCchhhcCC--ccceeeccccccCCCCCcccc-------CCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccC
Q 002069 299 TLSGSIPLSLGSLT--NLATLYFSTNALSGSIPNEIT-------NLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSI 369 (973)
Q Consensus 299 ~l~~~~~~~~~~l~--~L~~L~L~~n~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 369 (973)
.++ .+|..+..++ +|++|++++|.+++..|..+. .+++|++|+|++|.++...+..+..+++|++|+|++
T Consensus 388 ~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~ 466 (636)
T 4eco_A 388 KLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMG 466 (636)
T ss_dssp CCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCS
T ss_pred cCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCC
Confidence 776 5555555543 677777777777766666666 566677777777777654444555666777777777
Q ss_pred CcccCCCCccccccc-------ccchhcccccccccCCCcccC--CCCCCCEEEccCCCCCCCcchhhhhhcccceEEEe
Q 002069 370 NKLSGSIPLSFASLT-------SLTTLYLYENSLCDSIPKEIG--DMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYL 440 (973)
Q Consensus 370 N~i~~~~~~~~~~l~-------~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L 440 (973)
|+++...+..+.... +|+.|+|++|+++ .+|..+. .+++|++|+|++|++++ +|..+..+. +|++|+|
T Consensus 467 N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~-~L~~L~L 543 (636)
T 4eco_A 467 NMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSS-TLKGFGI 543 (636)
T ss_dssp SCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCS-SCCEEEC
T ss_pred CCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCC-CCCEEEC
Confidence 776633333333222 5666666666665 3444444 55566666666666653 555555433 4555555
Q ss_pred eCcccccccCCCCCCCcccceeeccCCccCCCCCcccccccccccccccccccccccCccccccccccEEeecCccCCC
Q 002069 441 SSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQ 519 (973)
Q Consensus 441 ~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~ 519 (973)
++|+ ++++|++.+..|..+..+++|++|+|++|.+ +.+|..+. ++|+.|+|++|++..
T Consensus 544 s~N~------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 544 RNQR------------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNIS 601 (636)
T ss_dssp CSCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCE
T ss_pred CCCc------------------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcc
Confidence 5543 2355666666677777777777777777777 35555554 567777777776654
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=464.27 Aligned_cols=455 Identities=22% Similarity=0.204 Sum_probs=314.0
Q ss_pred cEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCC
Q 002069 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNN 82 (973)
Q Consensus 3 ~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n 82 (973)
++||+++|+++ .+|+.+. ++|++|+|++|++++..|..|..+++|++|+|++|++++..|.+|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 58999999999 8999887 99999999999999887789999999999999999999777999999999999999999
Q ss_pred cCcccCCccccCccccceeeccCCcCCC-CCCCccccCCccceeecccccccccCcccccccCCC--CceecccCCC--C
Q 002069 83 LLSGSIPNEVGSLKSLSDLRLSNNSLNG-SIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFL--SDLQVSYNTL--S 157 (973)
Q Consensus 83 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L--~~L~l~~N~l--~ 157 (973)
+++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|++++ ..+..+++| ++|++++|.+ +
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 999 67777 89999999999999986 478999999999999999999985 568888888 9999999999 7
Q ss_pred CCCCccccCcc-ccceeeecccccCCCCCc-cccccCccceeeccccc-------cccccccccCCCCcccEEecCCccc
Q 002069 158 GAIPFSLGNLT-NLVTLYIGINALSGSIPN-EIGNLKSLSDLRLDYNT-------LSGSILYSFGNLTKLEILYLDVNAL 228 (973)
Q Consensus 158 ~~~p~~l~~l~-~L~~L~l~~n~l~~~~p~-~~~~l~~L~~L~L~~N~-------l~~~~~~~~~~l~~L~~L~L~~n~i 228 (973)
+..|..+..+. +...+++++|.+.+.++. .+.++++|+.|++++|. +.+..+ .|+.+++|+.|++++|.+
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l 232 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET 232 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence 78888888877 445677888888765554 67889999999999997 665544 789999999999999988
Q ss_pred CCCCCcccc---ccccccceecccccccCCCCccc-----CCcchhhhccCCCcccCchhhhhhccccccceEEcccccc
Q 002069 229 SGLIPNEIG---NLKSLLALQLNYNTLSGSIPCSF-----GNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTL 300 (973)
Q Consensus 229 ~~~~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l 300 (973)
++..+..+. ..++|++|++++|++++..|..+ +.++.|+.+++..|.+ ..+.+.+..+
T Consensus 233 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~------------- 298 (520)
T 2z7x_B 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEI------------- 298 (520)
T ss_dssp EHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHH-------------
T ss_pred CHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecchhhhhcc-------------
Confidence 753222111 23589999999999998777766 5555555555555444 2222233322
Q ss_pred cCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccC--CCCc
Q 002069 301 SGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSG--SIPL 378 (973)
Q Consensus 301 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~--~~~~ 378 (973)
...++|+.|++++|.+.... .+..+++|++|++++|.+++..|..++++++|++|+|++|++++ ..|.
T Consensus 299 --------~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~ 368 (520)
T 2z7x_B 299 --------FSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAE 368 (520)
T ss_dssp --------HHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHH
T ss_pred --------cccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchH
Confidence 00034444444444443211 11344445555555555544444444555555555555555543 2233
Q ss_pred ccccccccchhcccccccccCCC-cccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccCCCCCCCc
Q 002069 379 SFASLTSLTTLYLYENSLCDSIP-KEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFS 457 (973)
Q Consensus 379 ~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 457 (973)
.|..+++|++|++++|++++.+| ..+..+++|++|++++|++++..|..+. ++|++|++++|+++ .+|..+..++
T Consensus 369 ~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~---~~L~~L~Ls~N~l~-~ip~~~~~l~ 444 (520)
T 2z7x_B 369 MTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP---PRIKVLDLHSNKIK-SIPKQVVKLE 444 (520)
T ss_dssp HHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC---TTCCEEECCSSCCC-CCCGGGGGCT
T ss_pred HHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc---ccCCEEECCCCccc-ccchhhhcCC
Confidence 44445555555555555544222 2344555555555555555544443332 34555555555555 3444444555
Q ss_pred ccceeeccCCccCCCCCccccccccccccccccccccc
Q 002069 458 SLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHN 495 (973)
Q Consensus 458 ~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~ 495 (973)
+|++|++++|++++..+..+..+++|++|++++|++++
T Consensus 445 ~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c 482 (520)
T 2z7x_B 445 ALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 482 (520)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcc
Confidence 66666666666654333336666666666666666654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=486.22 Aligned_cols=431 Identities=22% Similarity=0.294 Sum_probs=216.8
Q ss_pred CcEEeCCCCCCCCCCCcccCCCCCCCEEECCCCccc------c------cCCcCccCCCCCCeeeccCCcCCCCCCCccc
Q 002069 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLS------G------LIPHEIGRLSSLNGLSLYSNFLKGSIPPSLG 69 (973)
Q Consensus 2 l~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~------~------~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~ 69 (973)
++.|+|++++++|.+|++++.|++|++|+|++|.+. + .+|.+. +..|+ ++++.|.+.+.+|..+.
T Consensus 83 V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~ 159 (636)
T 4eco_A 83 VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFS 159 (636)
T ss_dssp EEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSC
T ss_pred EEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHH
Confidence 578999999999999999999999999999999762 1 122221 23333 44444444444443333
Q ss_pred CC-C------------------CCcEEEcc--CCcCcccCCccccCccccceeeccCCcCCCC-----------------
Q 002069 70 NL-T------------------SLIYIDIG--NNLLSGSIPNEVGSLKSLSDLRLSNNSLNGS----------------- 111 (973)
Q Consensus 70 ~l-~------------------~L~~L~l~--~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~----------------- 111 (973)
.+ . .++.+.+. +|++++ +|..++++++|++|+|++|++++.
T Consensus 160 ~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ 238 (636)
T 4eco_A 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQY 238 (636)
T ss_dssp HHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHH
T ss_pred HHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhccc
Confidence 10 0 11111111 344443 444444444444444444444432
Q ss_pred CCCccc--cCCccceeecccccccccCcccccccCCCCceecccCC-CCC-CCCccccCc------cccceeeecccccC
Q 002069 112 IPSSLG--NLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNT-LSG-AIPFSLGNL------TNLVTLYIGINALS 181 (973)
Q Consensus 112 ~p~~~~--~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~-l~~-~~p~~l~~l------~~L~~L~l~~n~l~ 181 (973)
+|..++ ++++|++|+|++|++.+.+|+.|+++++|++|++++|+ +++ .+|..++.+ ++|++|++++|+++
T Consensus 239 ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~ 318 (636)
T 4eco_A 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318 (636)
T ss_dssp TTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred CchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence 444444 44444444444444444444444444444444444444 443 344444433 44444444444444
Q ss_pred CCCCc--cccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCcccccccc-ccceecccccccCCCCc
Q 002069 182 GSIPN--EIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS-LLALQLNYNTLSGSIPC 258 (973)
Q Consensus 182 ~~~p~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~ 258 (973)
.+|. .++++++|++|++++|++++..+ .|+.+++|+.|++++|+++. .|..+.++++ |++|++++|+++ .+|.
T Consensus 319 -~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~-lp~~l~~l~~~L~~L~Ls~N~l~-~lp~ 394 (636)
T 4eco_A 319 -TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIPN 394 (636)
T ss_dssp -SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEE-CCTTSEEECTTCCEEECCSSCCS-SCCS
T ss_pred -ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCcccc-ccHhhhhhcccCcEEEccCCcCc-ccch
Confidence 3444 44444444444444444443222 44444444444444444442 2334444444 444444444444 2333
Q ss_pred ccCCcc--hhhhccCCCcccCchhhhhhc-------cccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCC
Q 002069 259 SFGNLT--KLVISCLGTNALSSSILEEIG-------NLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIP 329 (973)
Q Consensus 259 ~~~~l~--~L~~l~l~~n~i~~~~~~~~~-------~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 329 (973)
.+..+. +|+.+++++|.+....+..|. .+++|++|++++|+++...+..+..+++|++|++++|.++...+
T Consensus 395 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~ 474 (636)
T 4eco_A 395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPK 474 (636)
T ss_dssp CCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCS
T ss_pred hhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCH
Confidence 333222 333333333333333333333 44456666666666664333344455666666666666653222
Q ss_pred ccccCC-------CCCCcEEcCCCCCCCcchhccC--CCCCCcEEEccCCcccCCCCcccccccccchhcc------ccc
Q 002069 330 NEITNL-------RSLSDLQLSENTLNGSIPLALG--NLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYL------YEN 394 (973)
Q Consensus 330 ~~~~~l-------~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L------~~N 394 (973)
..+... ++|++|+|++|+++ .+|..+. .+++|++|+|++|++++ .|..+..+++|+.|+| ++|
T Consensus 475 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N 552 (636)
T 4eco_A 475 NSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGN 552 (636)
T ss_dssp SSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCC
T ss_pred HHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccC
Confidence 222222 25666666666665 4444444 56666666666666664 5555556666666666 345
Q ss_pred ccccCCCcccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccc
Q 002069 395 SLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIV 446 (973)
Q Consensus 395 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~ 446 (973)
++.+..|..+..+++|++|+|++|++ +.+|..+. ++|++|++++|.+.
T Consensus 553 ~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~---~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 553 RTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT---PNISVLDIKDNPNI 600 (636)
T ss_dssp BCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC---TTCCEEECCSCTTC
T ss_pred cccccChHHHhcCCCCCEEECCCCcC-CccCHhHh---CcCCEEECcCCCCc
Confidence 55555555555566666666666665 24554433 34555555555554
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=479.82 Aligned_cols=414 Identities=24% Similarity=0.274 Sum_probs=284.1
Q ss_pred CcEEeCCCCCCCCCCCcccCCCCCCCEEEC-CCCcccccCCcCc------------------------------------
Q 002069 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSF-SKNQLSGLIPHEI------------------------------------ 44 (973)
Q Consensus 2 l~~L~l~~~~l~~~~p~~~~~l~~L~~L~l-~~n~l~~~~p~~~------------------------------------ 44 (973)
++.|+|++|+++|.+|++|+.|++|++|+| ++|.+.|..|..-
T Consensus 325 V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~ 404 (876)
T 4ecn_A 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLL 404 (876)
T ss_dssp EEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHH
T ss_pred EEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHH
Confidence 578999999999999999999999999999 8998877633221
Q ss_pred ---------------cCCCCCCeeeccC--CcCCCCCCCcccCCCCCcEEEccCCcCcc-----------------cCCc
Q 002069 45 ---------------GRLSSLNGLSLYS--NFLKGSIPPSLGNLTSLIYIDIGNNLLSG-----------------SIPN 90 (973)
Q Consensus 45 ---------------~~l~~L~~L~l~~--n~~~~~~p~~~~~l~~L~~L~l~~n~l~~-----------------~~p~ 90 (973)
.....++.+.+.. |++++ +|.+|+++++|++|+|++|++++ .+|.
T Consensus 405 ~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~ 483 (876)
T 4ecn_A 405 QDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE 483 (876)
T ss_dssp HHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS
T ss_pred HHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCCh
Confidence 1112333344433 67775 77778888888888888888876 2777
Q ss_pred ccc--CccccceeeccCCcCCCCCCCccccCCccceeeccccc-ccc-cCcccccccC-------CCCceecccCCCCCC
Q 002069 91 EVG--SLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNA-LSG-SIPDEIGNLK-------FLSDLQVSYNTLSGA 159 (973)
Q Consensus 91 ~~~--~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~-l~~-~~p~~~~~l~-------~L~~L~l~~N~l~~~ 159 (973)
.++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..|++++ +|++|++++|.++ .
T Consensus 484 ~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ 562 (876)
T 4ecn_A 484 ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-E 562 (876)
T ss_dssp CCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-B
T ss_pred hhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-c
Confidence 766 77777778887777777777777777777777777777 776 6777666665 7777777777777 6
Q ss_pred CCc--cccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCc-ccEEecCCcccCCCCCccc
Q 002069 160 IPF--SLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTK-LEILYLDVNALSGLIPNEI 236 (973)
Q Consensus 160 ~p~--~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~n~i~~~~~~~~ 236 (973)
+|. .|+++++|+.|++++|+++ .+| .++.+++|+.|+|++|+++ ..+..+.++++ |+.|+|++|.++. .|..+
T Consensus 563 ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~-lp~~~ 638 (876)
T 4ecn_A 563 FPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIF 638 (876)
T ss_dssp CCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCS-CCSCC
T ss_pred cCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCc-Cchhh
Confidence 666 7777777777777777777 666 7777777777777777777 44455777777 7777777777774 35666
Q ss_pred ccccc--ccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCcc
Q 002069 237 GNLKS--LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNL 314 (973)
Q Consensus 237 ~~l~~--L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 314 (973)
..++. |+.|+|++|++++.+|.....+. ...+++|+.|++++|.++...+..+..+++|
T Consensus 639 ~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~-------------------~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L 699 (876)
T 4ecn_A 639 NAKSVYVMGSVDFSYNKIGSEGRNISCSMD-------------------DYKGINASTVTLSYNEIQKFPTELFATGSPI 699 (876)
T ss_dssp CTTCSSCEEEEECCSSCTTTTSSSCSSCTT-------------------TCCCCCEEEEECCSSCCCSCCHHHHHTTCCC
T ss_pred hccccCCCCEEECcCCcCCCccccchhhhc-------------------cccCCCcCEEEccCCcCCccCHHHHccCCCC
Confidence 65543 77777777777665443221110 1123477888888888874433444577888
Q ss_pred ceeeccccccCCCCCccccC-------CCCCCcEEcCCCCCCCcchhccC--CCCCCcEEEccCCcccCCCCcccccccc
Q 002069 315 ATLYFSTNALSGSIPNEITN-------LRSLSDLQLSENTLNGSIPLALG--NLTKLVSLDLSINKLSGSIPLSFASLTS 385 (973)
Q Consensus 315 ~~L~L~~n~l~~~~~~~~~~-------l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~i~~~~~~~~~~l~~ 385 (973)
+.|+|++|.++...+..+.. +++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++
T Consensus 700 ~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~ 777 (876)
T 4ecn_A 700 STIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQ 777 (876)
T ss_dssp SEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTT
T ss_pred CEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCC
Confidence 88888888887433333332 237888888888888 5666665 88888888888888886 6777888888
Q ss_pred cchhcccc------cccccCCCcccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccc
Q 002069 386 LTTLYLYE------NSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIV 446 (973)
Q Consensus 386 L~~L~L~~------N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~ 446 (973)
|+.|+|++ |++.+.+|..|.++++|+.|+|++|++ +.+|..+. ++|+.|+|++|++.
T Consensus 778 L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~---~~L~~LdLs~N~l~ 840 (876)
T 4ecn_A 778 LKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT---PQLYILDIADNPNI 840 (876)
T ss_dssp CCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC---SSSCEEECCSCTTC
T ss_pred CCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc---CCCCEEECCCCCCC
Confidence 88888876 444455555555555555555555555 34444432 24444444444444
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=412.44 Aligned_cols=247 Identities=23% Similarity=0.309 Sum_probs=191.3
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||+|.. .+|+.||||++...........+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999965 479999999997655444445678999999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+ +|+|.+++.+. ..+++.++..++.||+.|++|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 68999998754 3689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccccCcccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCC--CCCCCc
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPL 936 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 936 (973)
.......||+.|||||++.+..+ +.++||||+||++|||+||+.||...... ......... .++..
T Consensus 166 -~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---------~~~~~i~~~~~~~p~~- 234 (275)
T 3hyh_A 166 -NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---------VLFKNISNGVYTLPKF- 234 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHTCCCCCTT-
T ss_pred -CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---------HHHHHHHcCCCCCCCC-
Confidence 33445789999999999998876 57999999999999999999999743311 111111111 12221
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.+..+.+++.+||+.||++|||++|+++.
T Consensus 235 -----~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 235 -----LSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp -----SCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred -----CCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 23356789999999999999999999873
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=460.15 Aligned_cols=454 Identities=20% Similarity=0.222 Sum_probs=290.8
Q ss_pred CEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCC
Q 002069 27 KLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNN 106 (973)
Q Consensus 27 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n 106 (973)
++||+++|+++ .+|..+. ++|++|+|++|++++..|.+|+++++|++|+|++|++++..|..|+.+++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 68999999998 5788777 89999999999999777788999999999999999999777889999999999999999
Q ss_pred cCCCCCCCccccCCccceeecccccccc-cCcccccccCCCCceecccCCCCCCCCccccCcccc--ceeeeccccc--C
Q 002069 107 SLNGSIPSSLGNLTNLVTLYLHMNALSG-SIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNL--VTLYIGINAL--S 181 (973)
Q Consensus 107 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L--~~L~l~~n~l--~ 181 (973)
+++ .+|.. .+++|++|+|++|++++ .+|+.|+++++|++|++++|.+++ ..+..+++| +.|++++|.+ .
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 998 67776 88999999999999986 467899999999999999999875 456777777 8888888888 6
Q ss_pred CCCCccccccC-ccceeecccccccc-ccccccCCCCcccEEecCCcc-------cCCCCCccccccccccceecccccc
Q 002069 182 GSIPNEIGNLK-SLSDLRLDYNTLSG-SILYSFGNLTKLEILYLDVNA-------LSGLIPNEIGNLKSLLALQLNYNTL 252 (973)
Q Consensus 182 ~~~p~~~~~l~-~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~-------i~~~~~~~~~~l~~L~~L~L~~N~l 252 (973)
+..|..+..+. +...+++++|++.+ +....+.++++|+.|++++|. +.+..| .++.+++|+.|++++|.+
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l 232 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET 232 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence 67777777665 33345666666554 333455566666666666665 333322 455555555555555555
Q ss_pred cCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchh-----hcCCccceeeccccccCCC
Q 002069 253 SGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSL-----GSLTNLATLYFSTNALSGS 327 (973)
Q Consensus 253 ~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~L~~n~l~~~ 327 (973)
++..+. ... .. ..+++|++|++++|++++.+|..+ +.+++|+.+++++|.+ .
T Consensus 233 ~~~~~~-------------------~~~-~~-~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~ 289 (520)
T 2z7x_B 233 TWNSFI-------------------RIL-QL-VWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--G 289 (520)
T ss_dssp EHHHHH-------------------HHH-HH-HHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--C
T ss_pred CHHHHH-------------------HHH-HH-hhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--e
Confidence 421110 000 01 113467777777777776666666 6677777777777766 2
Q ss_pred CC-ccccCC---CCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhccccccccc--CCC
Q 002069 328 IP-NEITNL---RSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCD--SIP 401 (973)
Q Consensus 328 ~~-~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~ 401 (973)
+| ..+..+ .+|+.|++++|.+.... .+..+++|++|++++|++++..|..+..+++|++|++++|++++ ..|
T Consensus 290 ~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~ 367 (520)
T 2z7x_B 290 FPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIA 367 (520)
T ss_dssp SCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHH
T ss_pred cchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccch
Confidence 33 344333 45666677666665321 12456666666666666666566666666666666666666654 334
Q ss_pred cccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCCccccccc
Q 002069 402 KEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLN 481 (973)
Q Consensus 402 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~ 481 (973)
..++.+++|++|++++|++++.+|...+...++|++|++++|++++..+..+. ++|+.|++++|+++ .+|..+..++
T Consensus 368 ~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~ 444 (520)
T 2z7x_B 368 EMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLE 444 (520)
T ss_dssp HHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCT
T ss_pred HHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCC
Confidence 55666666666666666666445544222223555555555555544433322 34444444444444 3333333444
Q ss_pred ccccccccccccccccCccccccccccEEeecCccCC
Q 002069 482 QLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFS 518 (973)
Q Consensus 482 ~L~~L~Ls~N~i~~~~~~~l~~l~~L~~L~L~~N~l~ 518 (973)
+|++|++++|+|+...+..+..+++|++|++++|+++
T Consensus 445 ~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~ 481 (520)
T 2z7x_B 445 ALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481 (520)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCc
Confidence 4444444444444221112444444444444444443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=423.71 Aligned_cols=247 Identities=20% Similarity=0.285 Sum_probs=207.0
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||+|+. .+|+.||||++...........+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999965 589999999986432222333578999999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||++||+|.+++++. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999754 3689999999999999999999999 9999999999999999999999999999987543
Q ss_pred C--CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcC--CCCCCC
Q 002069 860 L--SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLD--PRLPTP 935 (973)
Q Consensus 860 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 935 (973)
. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||...... .....+.. ..++..
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---------~~~~~i~~~~~~~p~~ 256 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---------LIFAKIIKLEYDFPEK 256 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHTCCCCCTT
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHcCCCCCCcc
Confidence 2 2345678999999999999999999999999999999999999999743321 11111111 122222
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVS 968 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~ 968 (973)
.+.++.++|.+|++.||++|||++|+.
T Consensus 257 ------~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 257 ------FFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ------CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ------cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 223467899999999999999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=435.56 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=210.8
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.+.|++.+.||+|+||+||+|.. .+|+.||||++....... .+.+.+|+.+|++++|||||++++++.+++..|+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 35799999999999999999965 589999999997543332 46688999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
||||+||+|.++++.. .+++.++..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+.+..
T Consensus 227 mEy~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 227 MEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp EECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred EeCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 9999999999999643 589999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
........+||+.|||||++.+..|+.++||||+||++|||++|+.||........ ...+.....+.+..
T Consensus 300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~------~~~i~~~~~~~~~~---- 369 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA------MKMIRDNLPPRLKN---- 369 (423)
T ss_dssp SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSCCCCCSC----
T ss_pred CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHcCCCCCCcc----
Confidence 65566678999999999999999999999999999999999999999975432111 01111111222211
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
....+..+.+++.+||+.||++|||++|+++.
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11223457889999999999999999999863
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=460.48 Aligned_cols=530 Identities=21% Similarity=0.188 Sum_probs=277.9
Q ss_pred CCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCccc
Q 002069 8 SFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGS 87 (973)
Q Consensus 8 ~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~ 87 (973)
++.+++ .+|+.+. +++++|||++|+|++..|..|.++++|++|+|++|+|++..|++|++|++|++|+|++|++++.
T Consensus 39 ~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l 115 (635)
T 4g8a_A 39 MELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 115 (635)
T ss_dssp TTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEE
T ss_pred CCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCC
Confidence 344555 5665442 3566666666666655555666666666666666666644445566666666666666666644
Q ss_pred CCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccc-cCcccccccCCCCceecccCCCCCCCCccccC
Q 002069 88 IPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSG-SIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGN 166 (973)
Q Consensus 88 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~ 166 (973)
.|..|+++++|++|+|++|++++..+..|+++++|++|+|++|++++ ..|..++++++|++|++++|++++..|..|..
T Consensus 116 ~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~ 195 (635)
T 4g8a_A 116 ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 195 (635)
T ss_dssp CGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHH
T ss_pred CHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccc
Confidence 44456666666666666666664444456666666666666666653 24555666666666666666666555555555
Q ss_pred ccccc----eeeecccccCCCCCccccccCccceeecccccccc-ccccccCCCCcccEEecCCcccC------CCCCcc
Q 002069 167 LTNLV----TLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSG-SILYSFGNLTKLEILYLDVNALS------GLIPNE 235 (973)
Q Consensus 167 l~~L~----~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~i~------~~~~~~ 235 (973)
+.+++ .++++.|.++.. +........++.+++++|.... +....+.++..++...+..+... ......
T Consensus 196 L~~l~~~~~~~~ls~n~l~~i-~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~ 274 (635)
T 4g8a_A 196 LHQMPLLNLSLDLSLNPMNFI-QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 274 (635)
T ss_dssp HHTCTTCCCEEECTTCCCCEE-CTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTT
T ss_pred hhhhhhhhhhhhcccCccccc-CcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccc
Confidence 54433 344555555532 2222233344555555554331 22233444444444443322211 111222
Q ss_pred ccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccc
Q 002069 236 IGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLA 315 (973)
Q Consensus 236 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 315 (973)
+..+..+...++..+..... .......+..+.+++.+++.++.+.... .+.....|+
T Consensus 275 ~~~~~~l~~~~l~~~~~~~~---------------------~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~ 331 (635)
T 4g8a_A 275 LEGLCNLTIEEFRLAYLDYY---------------------LDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQ 331 (635)
T ss_dssp TGGGGGSEEEEEEEECCCSC---------------------EEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCS
T ss_pred cccccchhhhhhhhhhhccc---------------------ccchhhhhhhhccccccccccccccccc--ccccchhhh
Confidence 22222222222222221100 0011223444455566666666554322 244445566
Q ss_pred eeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccC--CCCcccccccccchhcccc
Q 002069 316 TLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSG--SIPLSFASLTSLTTLYLYE 393 (973)
Q Consensus 316 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~--~~~~~~~~l~~L~~L~L~~ 393 (973)
.|++++|.+....+ ..+..|+.+++..|.+... .....+++|+.|++++|.+.. ..+..+..+.+|+.|+++.
T Consensus 332 ~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~ 406 (635)
T 4g8a_A 332 HLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSF 406 (635)
T ss_dssp EEEEESCEESSCCC---CBCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCS
T ss_pred hhhcccccccCcCc---ccchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccc
Confidence 66666666553322 2344555666666655422 223345566666666665542 2233334445555555555
Q ss_pred cccccCCCcccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCC
Q 002069 394 NSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQL 473 (973)
Q Consensus 394 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~ 473 (973)
|.+.. .+..+..+++|+.+++++|......+. ..+..+++++.++++.|.+.+..
T Consensus 407 ~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~------------------------~~~~~l~~l~~l~ls~n~l~~~~ 461 (635)
T 4g8a_A 407 NGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEF------------------------SVFLSLRNLIYLDISHTHTRVAF 461 (635)
T ss_dssp CSEEE-ECSCCTTCTTCCEEECTTSEEESTTSS------------------------CTTTTCTTCCEEECTTSCCEECC
T ss_pred ccccc-ccccccccccccchhhhhccccccccc------------------------ccccccccccccccccccccccc
Confidence 55433 333444555555555555544333222 23344455555555555555455
Q ss_pred Ccccccccccccccccccccc-cccCccccccccccEEeecCccCCCCCCcccccccccCeecccccccCCCcchhhccc
Q 002069 474 SPELGSLNQLEYLDLSANTFH-NSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSM 552 (973)
Q Consensus 474 ~~~l~~l~~L~~L~Ls~N~i~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~l 552 (973)
+..+..++.|+.|++++|.+. ...|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+
T Consensus 462 ~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l 541 (635)
T 4g8a_A 462 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 541 (635)
T ss_dssp TTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTC
T ss_pred ccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCC
Confidence 555555555555555555533 2345555556666666666666665555566666666666666666666556666666
Q ss_pred ccccccccccccccCccchhhhcc-ccccEEeCcCCCCCCCCC
Q 002069 553 QSLEKLNLSHNNLSGSISRCFEEM-HWLSCIDISYNALQGLIP 594 (973)
Q Consensus 553 ~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~l~l~~N~l~~~~~ 594 (973)
++|++|+|++|+|++..+..+..+ +.|++|++++|+|++.+.
T Consensus 542 ~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 542 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 666666666666666666666665 456777777777766654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=413.53 Aligned_cols=248 Identities=22% Similarity=0.325 Sum_probs=198.5
Q ss_pred CcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec----cceeEE
Q 002069 703 FDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH----ALHSFV 777 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l 777 (973)
|++.++||+|+||+||+|.+ .+++.||||++...... ....+.|.+|+.++++++|||||++++++.+ +...|+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 36677899999999999965 47899999998754332 2346789999999999999999999999864 346799
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEeecCCCCCeeecC-CCceEEecccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP--IVHRDISSKNVLLNL-EYEAHVSDFGISK 854 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlk~~Nill~~-~~~~kl~Dfg~a~ 854 (973)
|||||++|+|.+++++. ..+++..+..++.||+.||+|||++ + |+||||||+|||++. ++.+||+|||+|+
T Consensus 107 vmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 99999999999999753 4689999999999999999999998 6 999999999999974 7999999999998
Q ss_pred cccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCC
Q 002069 855 FLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934 (973)
Q Consensus 855 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (973)
.... .......||+.|||||++.+ +|+.++|||||||++|||+||+.||........ ....+.....+.
T Consensus 181 ~~~~--~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--------~~~~i~~~~~~~ 249 (290)
T 3fpq_A 181 LKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--------IYRRVTSGVKPA 249 (290)
T ss_dssp GCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--------HHHHHTTTCCCG
T ss_pred eCCC--CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--------HHHHHHcCCCCC
Confidence 6443 33456789999999998865 699999999999999999999999964332111 111111111111
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
... ...+.++.+++.+||+.||++|||++|+++.
T Consensus 250 ~~~--~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 250 SFD--KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGG--GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCC--ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 1122357889999999999999999999873
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=462.76 Aligned_cols=534 Identities=24% Similarity=0.223 Sum_probs=352.7
Q ss_pred CEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCC
Q 002069 27 KLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNN 106 (973)
Q Consensus 27 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n 106 (973)
++.+-++-+++ .+|..+. +++++|+|++|+|++..|.+|+++++|++|||++|++++..|..|++|++|++|+|++|
T Consensus 34 ~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N 110 (635)
T 4g8a_A 34 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 110 (635)
T ss_dssp TEEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred CEEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCC
Confidence 34555555665 4565443 35667777777766444456666777777777777666545556666666777777666
Q ss_pred cCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCC-CCCccccCccccceeeecccccCCCCC
Q 002069 107 SLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSG-AIPFSLGNLTNLVTLYIGINALSGSIP 185 (973)
Q Consensus 107 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~l~~l~~L~~L~l~~n~l~~~~p 185 (973)
+|++..|..|.++++|++|+|++|++++..+..|+++++|++|++++|.+++ ..|..++.+++|++|++++|++++..|
T Consensus 111 ~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 190 (635)
T 4g8a_A 111 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 190 (635)
T ss_dssp CCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred cCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccc
Confidence 6664444556666666666666666665444556666666666666666653 235555666666666666666665555
Q ss_pred ccccccCccc----eeeccccccccccccccCCCCcccEEecCCcccCC-CCCccccccccccceecccccccCCCCccc
Q 002069 186 NEIGNLKSLS----DLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSG-LIPNEIGNLKSLLALQLNYNTLSGSIPCSF 260 (973)
Q Consensus 186 ~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 260 (973)
..+..+.+++ .++++.|.+..+.+..+.. ..++.+++.+|.... ..+..+.++..++...+..+....
T Consensus 191 ~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~-~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~------ 263 (635)
T 4g8a_A 191 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN------ 263 (635)
T ss_dssp GGGHHHHTCTTCCCEEECTTCCCCEECTTTTTT-CEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTT------
T ss_pred ccccchhhhhhhhhhhhcccCcccccCcccccc-hhhhhhhhhcccccccccchhhcCCccccccccccccccc------
Confidence 5555444333 3444555554443333322 233444444443221 111222333333332222221110
Q ss_pred CCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCC---CCCccccCCCC
Q 002069 261 GNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSG---SIPNEITNLRS 337 (973)
Q Consensus 261 ~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~---~~~~~~~~l~~ 337 (973)
...+.......+..+..+....+..+.... ..+..+..+.+
T Consensus 264 ------------------------------------~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~ 307 (635)
T 4g8a_A 264 ------------------------------------EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTN 307 (635)
T ss_dssp ------------------------------------SCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTT
T ss_pred ------------------------------------ccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcc
Confidence 001111122223333333333333332221 22334555667
Q ss_pred CCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCCCCEEEccC
Q 002069 338 LSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSS 417 (973)
Q Consensus 338 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 417 (973)
++.+.+.+|.+.... .+.....|+.|++++|.+....+. .+..|+.+++..|.+... .....+++|+.|++++
T Consensus 308 l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~ 380 (635)
T 4g8a_A 308 VSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSR 380 (635)
T ss_dssp CSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCS
T ss_pred ccccccccccccccc--ccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhc
Confidence 777777777665332 345566788888888877754443 345677777887776543 2345688899999999
Q ss_pred CCCCC--CcchhhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCC-CCcccccccccccccccccccc
Q 002069 418 NKLNG--SIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQ-LSPELGSLNQLEYLDLSANTFH 494 (973)
Q Consensus 418 N~l~~--~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~-~~~~l~~l~~L~~L~Ls~N~i~ 494 (973)
|.+.. ..+..+.... +|+.++++.|.+.. .+..+..+++|+.+++++|..... ....+..+.+++.++++.|.+.
T Consensus 381 n~l~~~~~~~~~~~~~~-~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~ 458 (635)
T 4g8a_A 381 NGLSFKGCCSQSDFGTI-SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 458 (635)
T ss_dssp SCCBEEEECCHHHHSCS-CCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCE
T ss_pred cccccccccccchhhhh-hhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccc
Confidence 98863 2344444444 79999999998874 455677889999999998887654 3467888999999999999999
Q ss_pred cccCccccccccccEEeecCccC-CCCCCcccccccccCeecccccccCCCcchhhcccccccccccccccccCccchhh
Q 002069 495 NSIPESLGNLVKLHYLNLSNNQF-SQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCF 573 (973)
Q Consensus 495 ~~~~~~l~~l~~L~~L~L~~N~l-~~~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 573 (973)
...+..+..++.|+.|+|++|.+ ....|..|..+++|++|||++|.|++..|..|..+++|++|+|++|+|++..+..|
T Consensus 459 ~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~ 538 (635)
T 4g8a_A 459 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY 538 (635)
T ss_dssp ECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGG
T ss_pred cccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHH
Confidence 88899999999999999999985 44678899999999999999999999999999999999999999999999999999
Q ss_pred hccccccEEeCcCCCCCCCCCCCc-cC-CCCCcchhcCCCCccC
Q 002069 574 EEMHWLSCIDISYNALQGLIPNST-AF-RDAPMLALQGNKRLCG 615 (973)
Q Consensus 574 ~~l~~L~~l~l~~N~l~~~~~~~~-~~-~~~~~~~~~~N~~~c~ 615 (973)
..+++|++||+++|++++.+|... .+ ..+..+.+.+|||.|+
T Consensus 539 ~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 539 KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp TTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred hCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 999999999999999999988743 33 5688899999999996
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=423.20 Aligned_cols=248 Identities=22% Similarity=0.239 Sum_probs=200.0
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.+.|++.++||+|+||+||+|++ .+|+.||||+++.... ..+|+.++++++|||||++++++.+++..|+|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35688889999999999999965 5799999999975322 23699999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC-ceEEeccccccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY-EAHVSDFGISKFLK 857 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~ 857 (973)
|||++||+|.+++++. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.+| ++||+|||+|+...
T Consensus 129 mEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp ECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred EeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 9999999999999754 3689999999999999999999999 999999999999999987 69999999999776
Q ss_pred CCCC-----cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 858 LGLS-----NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 858 ~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
.... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||...... .....+.....
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---------~~~~~i~~~~~ 273 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG---------PLCLKIASEPP 273 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS---------CCHHHHHHSCC
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---------HHHHHHHcCCC
Confidence 4322 123357999999999999999999999999999999999999999743311 00011111110
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
+ ........+..+.+++.+||+.||.+|||++|+++.+
T Consensus 274 ~-~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l 311 (336)
T 4g3f_A 274 P-IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKV 311 (336)
T ss_dssp G-GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred C-chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 0 0000112334577899999999999999999998876
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=417.42 Aligned_cols=262 Identities=22% Similarity=0.303 Sum_probs=200.4
Q ss_pred cCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc----eeE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL----HSF 776 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~ 776 (973)
++|.+.++||+|+||+||+|++ +|+.||||++... ......+..|+..+.+++|||||+++|+|.+++ ..|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~----~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc----chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4688889999999999999988 6899999998632 121233345666677899999999999997653 579
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEeecCCCCCeeecCCCceEEeccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC-----FPPIVHRDISSKNVLLNLEYEAHVSDFG 851 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~Dlk~~Nill~~~~~~kl~Dfg 851 (973)
+|||||++|+|.++++.. .+++.++.+++.|+|.|++|||+++ .++|+||||||+|||++.++++||+|||
T Consensus 78 lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 999999999999999753 4789999999999999999999862 3489999999999999999999999999
Q ss_pred ccccccCCCCc----ccccccccCcccccccccC------CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhh----
Q 002069 852 ISKFLKLGLSN----RTELAGTFGYIAPELAYTM------KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLS---- 917 (973)
Q Consensus 852 ~a~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~---- 917 (973)
+|+........ .....||+.|||||++.+. .++.++|||||||++|||+||+.||...........
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 99877554322 2345799999999998764 367799999999999999999888754321111100
Q ss_pred --hhhhh----hhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 918 --SNLNI----ALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 918 --~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..... ......++.++..... .+....+.+++.+||+.||++||||+||++.|+
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 293 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPNIPNRWQS-CEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGS-SHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred ccchHHHHHHHHhcccCCCCCCccccc-hHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 01111 1223334444433222 245567889999999999999999999999875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=465.93 Aligned_cols=441 Identities=22% Similarity=0.257 Sum_probs=299.6
Q ss_pred CCCCEEECCCCcccccCCcCccCCCCCCeeec-cCCcCCCCCCCcc----------------------------------
Q 002069 24 THLKLLSFSKNQLSGLIPHEIGRLSSLNGLSL-YSNFLKGSIPPSL---------------------------------- 68 (973)
Q Consensus 24 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l-~~n~~~~~~p~~~---------------------------------- 68 (973)
.+++.|+|++|.+.|.+|++|++|++|++|+| ++|.+.|..|-.-
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 56899999999999999999999999999999 8887765533211
Q ss_pred -----------------cCCCCCcEEEcc--CCcCcccCCccccCccccceeeccCCcCCC-----------------CC
Q 002069 69 -----------------GNLTSLIYIDIG--NNLLSGSIPNEVGSLKSLSDLRLSNNSLNG-----------------SI 112 (973)
Q Consensus 69 -----------------~~l~~L~~L~l~--~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-----------------~~ 112 (973)
.....++.+.++ .|++++ +|..|+++++|++|+|++|++++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 111222233333 266664 66666666677777777776665 25
Q ss_pred CCccc--cCCccceeecccccccccCcccccccCCCCceecccCC-CCC-CCCccccCcc-------ccceeeecccccC
Q 002069 113 PSSLG--NLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNT-LSG-AIPFSLGNLT-------NLVTLYIGINALS 181 (973)
Q Consensus 113 p~~~~--~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~-l~~-~~p~~l~~l~-------~L~~L~l~~n~l~ 181 (973)
|..++ ++++|++|+|++|.+.+.+|..|+++++|++|+|++|+ +++ .+|..++.++ +|+.|++++|+++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 66655 66666666666666666666666666666666666665 655 4555555444 6666666666666
Q ss_pred CCCCc--cccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCcccccccc-ccceecccccccCCCCc
Q 002069 182 GSIPN--EIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS-LLALQLNYNTLSGSIPC 258 (973)
Q Consensus 182 ~~~p~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~ 258 (973)
.+|. .++++++|++|+|++|+++.++ .|+.+++|+.|+|++|+++ ..|..+.++++ |+.|+|++|+++ .+|.
T Consensus 562 -~ip~~~~l~~L~~L~~L~Ls~N~l~~lp--~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~ 636 (876)
T 4ecn_A 562 -EFPASASLQKMVKLGLLDCVHNKVRHLE--AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN 636 (876)
T ss_dssp -BCCCHHHHTTCTTCCEEECTTSCCCBCC--CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred -ccCChhhhhcCCCCCEEECCCCCcccch--hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCch
Confidence 5555 5666666666666666666333 5666666666666666666 33555666665 666666666655 3333
Q ss_pred ccCCcchhhhccCCCcccCchhhhhhccc--cccceEEcccccccCCcCch---hh--cCCccceeeccccccCCCCCcc
Q 002069 259 SFGNLTKLVISCLGTNALSSSILEEIGNL--KSLLHLQLNYNTLSGSIPLS---LG--SLTNLATLYFSTNALSGSIPNE 331 (973)
Q Consensus 259 ~~~~l~~L~~l~l~~n~i~~~~~~~~~~l--~~L~~L~l~~n~l~~~~~~~---~~--~l~~L~~L~L~~n~l~~~~~~~ 331 (973)
.+..+ ++|+.|++++|++++.+|.. +. .+++|+.|++++|.++...+..
T Consensus 637 ------------------------~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~ 692 (876)
T 4ecn_A 637 ------------------------IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTEL 692 (876)
T ss_dssp ------------------------CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHH
T ss_pred ------------------------hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHH
Confidence 33333 34899999999998765532 22 3458999999999999544444
Q ss_pred ccCCCCCCcEEcCCCCCCCcchhccCCC-------CCCcEEEccCCcccCCCCcccc--cccccchhcccccccccCCCc
Q 002069 332 ITNLRSLSDLQLSENTLNGSIPLALGNL-------TKLVSLDLSINKLSGSIPLSFA--SLTSLTTLYLYENSLCDSIPK 402 (973)
Q Consensus 332 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l-------~~L~~L~Ls~N~i~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~ 402 (973)
+..+++|+.|+|++|.++.+.+..+... ++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|.
T Consensus 693 ~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~ 770 (876)
T 4ecn_A 693 FATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPT 770 (876)
T ss_dssp HHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCC
T ss_pred HccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cch
Confidence 5689999999999999995444444433 39999999999999 6777776 89999999999999988 788
Q ss_pred ccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCCcccccccc
Q 002069 403 EIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQ 482 (973)
Q Consensus 403 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~ 482 (973)
.+..+++|+.|+|++|+ ++++|++.+.+|..+..+++|+.|+|++|++ +.+|..+. ++
T Consensus 771 ~l~~L~~L~~L~Ls~N~-------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~ 828 (876)
T 4ecn_A 771 QPLNSSQLKAFGIRHQR-------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQ 828 (876)
T ss_dssp GGGGCTTCCEEECCCCB-------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SS
T ss_pred hhhcCCCCCEEECCCCC-------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CC
Confidence 89999999999998865 3455666666666666666666666666666 34555443 46
Q ss_pred cccccccccccccccCccccccccccEEeecCccCC
Q 002069 483 LEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFS 518 (973)
Q Consensus 483 L~~L~Ls~N~i~~~~~~~l~~l~~L~~L~L~~N~l~ 518 (973)
|+.|||++|++....+..+.....+..+.|.+|++.
T Consensus 829 L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 829 LYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp SCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred CCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence 777777777776555555555555666666666653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=417.34 Aligned_cols=249 Identities=22% Similarity=0.282 Sum_probs=197.7
Q ss_pred cCCcccccccCCCceeEEEEEc----CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL----PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (973)
++|++.+.||+|+||+||+|+. .+++.||||+++....... ....+.+|++++++++|||||++++++.+++..|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 5799999999999999999964 2578999999875432221 2346888999999999999999999999999999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
+||||++||+|.+++++. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+..
T Consensus 103 ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EEECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999999754 3689999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 857 KLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 857 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
...........||+.|||||++.+..|+.++||||+||++|||+||+.||...... .....+.......+
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---------~~~~~i~~~~~~~p- 246 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---------ETMTMILKAKLGMP- 246 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHCCCCCC-
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---------HHHHHHHcCCCCCC-
Confidence 65545556678999999999999999999999999999999999999999754321 11111111111111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCH-----HHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTM-----QKVSQ 969 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ev~~ 969 (973)
. ..+.++.+++.+||+.||++|||+ +|+++
T Consensus 247 ~---~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 247 Q---FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp T---TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred C---cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1 123357789999999999999984 67764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=424.53 Aligned_cols=263 Identities=22% Similarity=0.344 Sum_probs=211.7
Q ss_pred HHHHHHhcCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCC-Cceeeec
Q 002069 694 EEIIRATKNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH-RNIVKFY 766 (973)
Q Consensus 694 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~ 766 (973)
.+++...++|++.+.||+|+||+||+|.+. .++.||||+++..... ...++|.+|+.++++++| ||||+++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~--~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh--HHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 444455688999999999999999999653 2368999999865332 346789999999999965 8999999
Q ss_pred eeeecc-ceeEEEEEecCCCChHHHhccCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecC
Q 002069 767 GFCSHA-LHSFVVYEYLEMGSLAMILSNDAA-------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDI 832 (973)
Q Consensus 767 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dl 832 (973)
|+|.++ +..++|||||++|+|.++++.... ...+++.++..++.|||.|++|||++ +||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence 999764 568999999999999999975432 24589999999999999999999999 9999999
Q ss_pred CCCCeeecCCCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcch
Q 002069 833 SSKNVLLNLEYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFI 909 (973)
Q Consensus 833 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~ 909 (973)
||+|||+++++.+||+|||+|+....+.. ......||+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987754432 2334678999999999999999999999999999999998 99999753
Q ss_pred hhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 910 SSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.... .....+.+...+..+.. .+.++.+++.+||+.||++||||+||+++|+
T Consensus 292 ~~~~-----~~~~~i~~g~~~~~p~~------~~~~~~~li~~c~~~dP~~RPt~~eil~~L~ 343 (353)
T 4ase_A 292 KIDE-----EFCRRLKEGTRMRAPDY------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 343 (353)
T ss_dssp CCSH-----HHHHHHHHTCCCCCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHH-----HHHHHHHcCCCCCCCcc------CCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 3111 11111222222222222 2345788999999999999999999999874
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=406.50 Aligned_cols=251 Identities=21% Similarity=0.368 Sum_probs=195.2
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc-----
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL----- 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 773 (973)
..+|++.+.||+|+||+||+|+. .+|+.||||+++... .....+.+.+|+.++++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 35699999999999999999965 489999999987543 2334678999999999999999999999986543
Q ss_pred -------eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceE
Q 002069 774 -------HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAH 846 (973)
Q Consensus 774 -------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~k 846 (973)
..|+||||+++|+|.++++......+..+..++.++.||+.||+|||++ +|+||||||+|||++.++.+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence 3689999999999999998776666677888999999999999999999 999999999999999999999
Q ss_pred EecccccccccCCCCc------------ccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh
Q 002069 847 VSDFGISKFLKLGLSN------------RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS 914 (973)
Q Consensus 847 l~Dfg~a~~~~~~~~~------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 914 (973)
|+|||+|+........ ....+||+.|||||++.+..|+.++||||+||++|||++ ||....+..
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~- 234 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV- 234 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH-
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH-
Confidence 9999999877543221 233579999999999999999999999999999999996 775322111
Q ss_pred hhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 915 SLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
...........+. ..........+++.+||+.||++|||++|+++
T Consensus 235 -------~~~~~~~~~~~p~---~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 -------RTLTDVRNLKFPP---LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -------HHHHHHHTTCCCH---HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------HHHHHHhcCCCCC---CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111222222222 12233445678999999999999999999987
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=439.33 Aligned_cols=457 Identities=24% Similarity=0.218 Sum_probs=324.4
Q ss_pred cEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCC
Q 002069 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNN 82 (973)
Q Consensus 3 ~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n 82 (973)
+++|+++|+++ .+|..+. ++|++|+|++|.+++..|..|..+++|++|+|++|++++..|++|+++++|++|+|++|
T Consensus 34 ~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 57899999998 6888765 88999999999999877788999999999999999999777888999999999999999
Q ss_pred cCcccCCccccCccccceeeccCCcCCC-CCCCccccCCccceeecccccccccCcccccccCCC--CceecccCCC--C
Q 002069 83 LLSGSIPNEVGSLKSLSDLRLSNNSLNG-SIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFL--SDLQVSYNTL--S 157 (973)
Q Consensus 83 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L--~~L~l~~N~l--~ 157 (973)
+++ .+|.. .+++|++|+|++|++++ ..|..|+++++|++|++++|++++ ..+..+++| ++|++++|.+ +
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~L~~n~l~~~ 184 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSYHIK 184 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT---TTTGGGTTSCEEEEEEEESSCCCC
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc---CchhhhhhceeeEEEeeccccccc
Confidence 998 67766 78999999999999985 345789999999999999999874 345666666 9999999998 7
Q ss_pred CCCCccccCcc--ccceeeecccccCCCCCc-cccccCccceeeccccc-----cccccccccCCCCcccEEecCCcccC
Q 002069 158 GAIPFSLGNLT--NLVTLYIGINALSGSIPN-EIGNLKSLSDLRLDYNT-----LSGSILYSFGNLTKLEILYLDVNALS 229 (973)
Q Consensus 158 ~~~p~~l~~l~--~L~~L~l~~n~l~~~~p~-~~~~l~~L~~L~L~~N~-----l~~~~~~~~~~l~~L~~L~L~~n~i~ 229 (973)
+..|..+..+. .| .++++.|.+.+.++. .+..+++|+.|++++|+ +.+ ....|..+++|+.|+++++.+.
T Consensus 185 ~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~ 262 (562)
T 3a79_B 185 GGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETT 262 (562)
T ss_dssp SSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEEC
T ss_pred ccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCc
Confidence 78888887765 33 557788888765554 45678899999999885 221 2345778888888888887765
Q ss_pred CCCCc---cccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCc
Q 002069 230 GLIPN---EIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPL 306 (973)
Q Consensus 230 ~~~~~---~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 306 (973)
+.... .....++|++|++++|.+++.+|..+-.. ....++.|+.++++.|.+. ....
T Consensus 263 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~-------------------~~~~L~~L~~~~~~~~~~~-~p~~ 322 (562)
T 3a79_B 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTY-------------------SETALKSLMIEHVKNQVFL-FSKE 322 (562)
T ss_dssp HHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCC-------------------CSCSCCEEEEEEEEECCCS-SCHH
T ss_pred HHHHHHHHHhhhcccccEEEEeccEeeccccchhhhc-------------------ccccchheehhhcccceee-cChh
Confidence 42111 01123488899999999887666654100 0133444445555555541 1112
Q ss_pred hhhc---CCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCC--Ccccc
Q 002069 307 SLGS---LTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSI--PLSFA 381 (973)
Q Consensus 307 ~~~~---l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~--~~~~~ 381 (973)
.+.. ..+|++|++++|.+.... ....+++|++|++++|.+++..|..++++++|++|+|++|++++.. |..|.
T Consensus 323 ~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 400 (562)
T 3a79_B 323 ALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTK 400 (562)
T ss_dssp HHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTT
T ss_pred hhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhc
Confidence 2222 245666666666664221 1245667777777777777666666777777777777777776532 34566
Q ss_pred cccccchhccccccccc-CCCcccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccCCCCCCCcccc
Q 002069 382 SLTSLTTLYLYENSLCD-SIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLI 460 (973)
Q Consensus 382 ~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~ 460 (973)
++++|++|++++|++++ ..+..+..+++|++|++++|++++.+|..+. ++|++|+|++|+++ .+|..+..+++|+
T Consensus 401 ~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~---~~L~~L~L~~N~l~-~ip~~~~~l~~L~ 476 (562)
T 3a79_B 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP---PKVKVLDLHNNRIM-SIPKDVTHLQALQ 476 (562)
T ss_dssp TCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC---TTCSEEECCSSCCC-CCCTTTTSSCCCS
T ss_pred CCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc---CcCCEEECCCCcCc-ccChhhcCCCCCC
Confidence 77777777777777766 3334566777777777777777755554433 46778888888777 4555555778888
Q ss_pred eeeccCCccCCCCCcccccccccccccccccccccc
Q 002069 461 QLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNS 496 (973)
Q Consensus 461 ~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~ 496 (973)
+|++++|++++..+..+..+++|+.|++++|++.+.
T Consensus 477 ~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~ 512 (562)
T 3a79_B 477 ELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 512 (562)
T ss_dssp EEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred EEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCC
Confidence 888888888854444478888888888888888754
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=436.73 Aligned_cols=456 Identities=20% Similarity=0.224 Sum_probs=276.7
Q ss_pred CCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeec
Q 002069 24 THLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRL 103 (973)
Q Consensus 24 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L 103 (973)
...+++|+++|++++ +|..+. ++|++|+|++|++++..|.+|+++++|++|+|++|++++..|+.|+.+++|++|+|
T Consensus 31 ~~~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 107 (562)
T 3a79_B 31 ELESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDV 107 (562)
T ss_dssp --CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEEC
Confidence 345889999999984 777665 78999999999998766678999999999999999998777888999999999999
Q ss_pred cCCcCCCCCCCccccCCccceeecccccccc-cCcccccccCCCCceecccCCCCCCCCccccCcccc--ceeeeccccc
Q 002069 104 SNNSLNGSIPSSLGNLTNLVTLYLHMNALSG-SIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNL--VTLYIGINAL 180 (973)
Q Consensus 104 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L--~~L~l~~n~l 180 (973)
++|+++ .+|.. .+++|++|+|++|++++ ..|+.|+++++|++|++++|++++. .+..+++| +.|++++|.+
T Consensus 108 s~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l 181 (562)
T 3a79_B 108 SHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSY 181 (562)
T ss_dssp TTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSC
T ss_pred CCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccc
Confidence 999998 67776 78999999999999885 2457888999999999999988753 45555555 8888888888
Q ss_pred --CCCCCccccccC--ccceeeccccccccc-cccccCCCCcccEEecCCccc-----CCCCCccccccccccceecccc
Q 002069 181 --SGSIPNEIGNLK--SLSDLRLDYNTLSGS-ILYSFGNLTKLEILYLDVNAL-----SGLIPNEIGNLKSLLALQLNYN 250 (973)
Q Consensus 181 --~~~~p~~~~~l~--~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~n~i-----~~~~~~~~~~l~~L~~L~L~~N 250 (973)
++..|..+..+. .+ .++++.|.+.+. ....+..+++|+.|++++|+. .+. ...+.++++|+.|+++++
T Consensus 182 ~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~L~~~ 259 (562)
T 3a79_B 182 HIKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVTLQHI 259 (562)
T ss_dssp CCCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEEEEEE
T ss_pred cccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHHH-HHHHhccCcceEEEecCC
Confidence 777777777654 33 446666666542 333455666666666666631 111 123444555555555555
Q ss_pred cccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchh-----hcCCccceeeccccccC
Q 002069 251 TLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSL-----GSLTNLATLYFSTNALS 325 (973)
Q Consensus 251 ~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~L~~n~l~ 325 (973)
.+++ +.+.... .. ...++|++|++++|.+++.+|..+ ..++.|+.++++.|.+
T Consensus 260 ~l~~-------------------~~~~~~~-~~-~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~- 317 (562)
T 3a79_B 260 ETTW-------------------KCSVKLF-QF-FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF- 317 (562)
T ss_dssp EECH-------------------HHHHHHH-HH-HTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC-
T ss_pred cCcH-------------------HHHHHHH-Hh-hhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee-
Confidence 4431 1111111 11 122366666666666665555555 5555555555555555
Q ss_pred CCCC-ccccCC---CCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccC--
Q 002069 326 GSIP-NEITNL---RSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDS-- 399 (973)
Q Consensus 326 ~~~~-~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-- 399 (973)
.+| ..+..+ .+|++|++++|.+.... ....+++|++|++++|++++..|..|.++++|+.|++++|++++.
T Consensus 318 -~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 394 (562)
T 3a79_B 318 -LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFK 394 (562)
T ss_dssp -SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTH
T ss_pred -ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCccc
Confidence 222 222211 44666666666554221 124555666666666666655555555566666666666655542
Q ss_pred CCcccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCCccccc
Q 002069 400 IPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGS 479 (973)
Q Consensus 400 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~ 479 (973)
.|..|..+++|++|++++|++++.+|...+...++|++|++++|++++..+..+.
T Consensus 395 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~------------------------- 449 (562)
T 3a79_B 395 VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP------------------------- 449 (562)
T ss_dssp HHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC-------------------------
T ss_pred chhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc-------------------------
Confidence 2344555555666666666555434443322223455555555555443333222
Q ss_pred ccccccccccccccccccCccccccccccEEeecCccCCCCCCcccccccccCeecccccccC
Q 002069 480 LNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFG 542 (973)
Q Consensus 480 l~~L~~L~Ls~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~i~ 542 (973)
++|++|+|++|+|+ .+|..+..+++|++|+|++|+++...+..+..+++|+.|++++|.+.
T Consensus 450 -~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~ 510 (562)
T 3a79_B 450 -PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWD 510 (562)
T ss_dssp -TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBC
T ss_pred -CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcC
Confidence 34555555555554 34444445555555555555555433333555555555555555554
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=398.26 Aligned_cols=262 Identities=24% Similarity=0.315 Sum_probs=201.8
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec------cc
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH------AL 773 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~ 773 (973)
++|++.+.||+|+||+||+|.. .+|+.||||++...... ....+.+.+|+.++++++|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 5799999999999999999965 58999999999765433 2345778899999999999999999998753 35
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
..|+|||||+ |+|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 6799999754 3689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCC----CCcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhhhhh
Q 002069 854 KFLKLG----LSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSNLNI 922 (973)
Q Consensus 854 ~~~~~~----~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~ 922 (973)
+.+... .......+||+.|||||++.+. .++.++||||+||++|||++|++||........ ..+.....
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 876432 1234457899999999998875 468999999999999999999999975432110 00000000
Q ss_pred -----------hhhhhcCCCCCCCchh-hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 923 -----------ALDEMLDPRLPTPLRN-VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 923 -----------~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+.+..+..+.. .......+.+++.+||+.||.+|||++|++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000111111111110 01123457789999999999999999999863
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=401.90 Aligned_cols=388 Identities=21% Similarity=0.195 Sum_probs=274.9
Q ss_pred EEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCC-CCcccCCCCCcEEEccCC
Q 002069 4 VLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSI-PPSLGNLTSLIYIDIGNN 82 (973)
Q Consensus 4 ~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~-p~~~~~l~~L~~L~l~~n 82 (973)
.++.++++++ .+|. + .++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ |..|+++++|++|+|++|
T Consensus 14 ~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n 89 (455)
T 3v47_A 14 NAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89 (455)
T ss_dssp EEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTC
T ss_pred ccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCC
Confidence 4666777776 6776 2 267777777777777766777777777777777777776444 456777777777777777
Q ss_pred cCcccCCccccCccccceeeccCCcCCCCCCCc--cccCCccceeecccccccccCccc-ccccCCCCceecccCCCCCC
Q 002069 83 LLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSS--LGNLTNLVTLYLHMNALSGSIPDE-IGNLKFLSDLQVSYNTLSGA 159 (973)
Q Consensus 83 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~ 159 (973)
++++..|..|+++++|++|+|++|++++..|.. +.++++|++|+|++|++++..|.. |+++++|++|++++|++++.
T Consensus 90 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 169 (455)
T 3v47_A 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSI 169 (455)
T ss_dssp TTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCC
T ss_pred ccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccccc
Confidence 777666777777777777777777776544433 777777777777777777655655 67777777777777777766
Q ss_pred CCccccCc--cccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCcccc
Q 002069 160 IPFSLGNL--TNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIG 237 (973)
Q Consensus 160 ~p~~l~~l--~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~ 237 (973)
.|..+..+ .+|+.|++++|.+.+..+..++. .....+..+++|++|++++|++++..|..+.
T Consensus 170 ~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~----------------~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~ 233 (455)
T 3v47_A 170 CEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW----------------EKCGNPFKNTSITTLDLSGNGFKESMAKRFF 233 (455)
T ss_dssp CTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH----------------HHHCCTTTTCEEEEEECTTSCCCHHHHHHHH
T ss_pred ChhhhhccccccccccccccCcccccchhhccc----------------cccccccccceeeeEecCCCcccccchhhhh
Confidence 66666655 56666666666666433322210 0001122344555555555555444444443
Q ss_pred cc---ccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhcc--ccccceEEcccccccCCcCchhhcCC
Q 002069 238 NL---KSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGN--LKSLLHLQLNYNTLSGSIPLSLGSLT 312 (973)
Q Consensus 238 ~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~--l~~L~~L~l~~n~l~~~~~~~~~~l~ 312 (973)
.. ++|+.|++++|.+.+... ..+.+.......+.. .++|++|++++|.+++..|..++.++
T Consensus 234 ~~~~~~~L~~L~l~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~ 299 (455)
T 3v47_A 234 DAIAGTKIQSLILSNSYNMGSSF--------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFT 299 (455)
T ss_dssp HHTTTCCEEEEECTTCTTTSCCT--------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCT
T ss_pred ccccccceeeEeecccccccccc--------------chhhhccCcccccccccccCceEEEecCccccccchhhcccCC
Confidence 33 455555555555432111 011111111222222 36899999999999988888999999
Q ss_pred ccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhccc
Q 002069 313 NLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLY 392 (973)
Q Consensus 313 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~ 392 (973)
+|++|++++|.+++..|..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 300 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 379 (455)
T 3v47_A 300 DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALD 379 (455)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECC
Confidence 99999999999998888899999999999999999988888889999999999999999998888899999999999999
Q ss_pred ccccccCCCcccCCCCCCCEEEccCCCCCCCcc
Q 002069 393 ENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIP 425 (973)
Q Consensus 393 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 425 (973)
+|++++..+..|..+++|++|++++|++++..|
T Consensus 380 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 380 TNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999988777788899999999999999987776
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=389.25 Aligned_cols=197 Identities=26% Similarity=0.306 Sum_probs=170.0
Q ss_pred HHHhcCCcccccccCCCceeEEEEEc----CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeec
Q 002069 697 IRATKNFDDEHCIGNGGQGSVYKAEL----PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSH 771 (973)
Q Consensus 697 ~~~~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 771 (973)
....++|++.+.||+|+||+||+|+. .+++.||||++.... ...++.+|+++++.+ +|||||++++++.+
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 34567899999999999999999954 256889999986532 135678999999988 69999999999999
Q ss_pred cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC-CceEEecc
Q 002069 772 ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE-YEAHVSDF 850 (973)
Q Consensus 772 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl~Df 850 (973)
.++.|+||||+++|+|.++++ .+++.++..++.|++.||+|||++ ||+||||||+|||++.+ +.+||+||
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcC
Confidence 999999999999999999984 478999999999999999999999 99999999999999877 89999999
Q ss_pred cccccccCCCC----------------------------cccccccccCcccccccccC-CCCCccchHHHHHHHHHHHh
Q 002069 851 GISKFLKLGLS----------------------------NRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIK 901 (973)
Q Consensus 851 g~a~~~~~~~~----------------------------~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~t 901 (973)
|+|+....... .....+||+.|||||++.+. .++.++||||+||++|||+|
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 99986543211 12335799999999999875 48999999999999999999
Q ss_pred CCCCCc
Q 002069 902 GKHPRD 907 (973)
Q Consensus 902 g~~p~~ 907 (973)
|+.||.
T Consensus 243 G~~Pf~ 248 (361)
T 4f9c_A 243 GRYPFY 248 (361)
T ss_dssp TCSSSS
T ss_pred CCCCCC
Confidence 999995
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=397.05 Aligned_cols=362 Identities=22% Similarity=0.213 Sum_probs=272.1
Q ss_pred CcEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccC-CcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEcc
Q 002069 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLI-PHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIG 80 (973)
Q Consensus 2 l~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~-p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~ 80 (973)
|++|||++|++++..|..++++++|++|+|++|.+.+.+ |..|..+++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 32 l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 111 (455)
T 3v47_A 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLT 111 (455)
T ss_dssp CCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECT
T ss_pred cCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCC
Confidence 789999999999777889999999999999999997544 6679999999999999999997789999999999999999
Q ss_pred CCcCcccCCcc--ccCccccceeeccCCcCCCCCCCc-cccCCccceeecccccccccCccccccc--CCCCceecccCC
Q 002069 81 NNLLSGSIPNE--VGSLKSLSDLRLSNNSLNGSIPSS-LGNLTNLVTLYLHMNALSGSIPDEIGNL--KFLSDLQVSYNT 155 (973)
Q Consensus 81 ~n~l~~~~p~~--~~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~l~~N~ 155 (973)
+|++++..|.. ++.+++|++|+|++|++++..|.. +.++++|++|++++|++++..|..+..+ .+|+.|++++|.
T Consensus 112 ~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~ 191 (455)
T 3v47_A 112 QCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSIT 191 (455)
T ss_dssp TSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCB
T ss_pred CCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCc
Confidence 99998756655 999999999999999999777876 8999999999999999998889999887 799999999999
Q ss_pred CCCCCCccc--------cCccccceeeecccccCCCCCcccccc---CccceeeccccccccccccccCCCCcccEEecC
Q 002069 156 LSGAIPFSL--------GNLTNLVTLYIGINALSGSIPNEIGNL---KSLSDLRLDYNTLSGSILYSFGNLTKLEILYLD 224 (973)
Q Consensus 156 l~~~~p~~l--------~~l~~L~~L~l~~n~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 224 (973)
+.+..+..+ ..+++|++|++++|++++..|..+..+ ++|+.|++++|.+.+.. +.
T Consensus 192 l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------~~ 257 (455)
T 3v47_A 192 LQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------FG 257 (455)
T ss_dssp CTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------TT
T ss_pred ccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------------cc
Confidence 986655443 356788888888888887777766654 77888888877665321 11
Q ss_pred CcccCCCCCcccccc--ccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccC
Q 002069 225 VNALSGLIPNEIGNL--KSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSG 302 (973)
Q Consensus 225 ~n~i~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~ 302 (973)
.+.+....+..+.++ ++|+.|++++|.+++..|..|+.+++|+.|++++|.+....+..|.++++|++|++++|.+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 337 (455)
T 3v47_A 258 HTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGS 337 (455)
T ss_dssp CCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred hhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCC
Confidence 222222223333333 466667777766666656555555555555555555555555556666666666666666666
Q ss_pred CcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCC
Q 002069 303 SIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIP 377 (973)
Q Consensus 303 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~ 377 (973)
..+..|..+++|++|++++|.+++..|..|..+++|++|+|++|++++..+..+..+++|++|++++|++++..|
T Consensus 338 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 338 IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp ECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred cChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 556666666666666666666666556666666666666666666666555566666666666666666664433
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=407.62 Aligned_cols=253 Identities=20% Similarity=0.268 Sum_probs=209.4
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|.. .+|+.||+|++.... ....+.+.+|+.+|+.++|||||++++++.++...|+|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 36899999999999999999955 589999999987542 23357789999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC--CceEEecccccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE--YEAHVSDFGISKFL 856 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~--~~~kl~Dfg~a~~~ 856 (973)
||||+||+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 233 ~E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 233 YEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EeecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 99999999999986433 3588999999999999999999999 99999999999999855 89999999999987
Q ss_pred cCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 857 KLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 857 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
... .......||+.|||||++.+..|+.++||||+||++|||++|+.||...... .....+.........
T Consensus 308 ~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---------~~~~~i~~~~~~~~~ 377 (573)
T 3uto_A 308 DPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---------ETLRNVKSCDWNMDD 377 (573)
T ss_dssp CTT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---------HHHHHHHTTCCCCCS
T ss_pred cCC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---------HHHHHHHhCCCCCCc
Confidence 654 3344568999999999999999999999999999999999999999754321 111222222221111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+..+.++|.+||+.||.+|||++|++++
T Consensus 378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122234457789999999999999999999873
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=402.36 Aligned_cols=250 Identities=20% Similarity=0.205 Sum_probs=199.0
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHH---HHHHHHhhcCCCCceeeeceeeecccee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEF---LNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
.++|++.+.||+|+||+||+|+. .+|+.||||++.............+ ..++.+++.++|||||++++++.+++..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 36799999999999999999965 4899999999864221111112223 3446677888999999999999999999
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
|+||||++||+|.+++.+. ..+++..+..++.||+.||+|||++ +||||||||+|||++.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999999754 3689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhc--CCCC
Q 002069 856 LKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML--DPRL 932 (973)
Q Consensus 856 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 932 (973)
+... .....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||....... ......... ...+
T Consensus 342 ~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~------~~~i~~~i~~~~~~~ 413 (689)
T 3v5w_A 342 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD------KHEIDRMTLTMAVEL 413 (689)
T ss_dssp CSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC------HHHHHHHHHHCCCCC
T ss_pred cCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhhcCCCCCC
Confidence 7543 3345789999999999964 579999999999999999999999997432110 011111111 1122
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHH
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPT-----MQKVSQ 969 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~ 969 (973)
+.. .+..+.++|.+||+.||.+|++ ++||.+
T Consensus 414 p~~------~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 414 PDS------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CTT------SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred Ccc------CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 222 2334678999999999999998 677765
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=388.07 Aligned_cols=410 Identities=26% Similarity=0.288 Sum_probs=194.3
Q ss_pred CCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCC-------------cEEEccCCcCcccC
Q 002069 22 HLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSL-------------IYIDIGNNLLSGSI 88 (973)
Q Consensus 22 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L-------------~~L~l~~n~l~~~~ 88 (973)
+.++|++|++++|.+ +.+|++|+++++|++|++++|++.+.+|.+++++++| ++|++++|.++ .+
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~-~l 86 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SL 86 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-CC
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-cC
Confidence 445566666666666 4556666666666666666666655666666665554 66677776666 34
Q ss_pred CccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCcc
Q 002069 89 PNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLT 168 (973)
Q Consensus 89 p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~ 168 (973)
|.. .++|++|++++|++++ +|..+ ++|++|++++|++++ +|.. .++|++|++++|++++ +| +|++++
T Consensus 87 p~~---~~~L~~L~l~~n~l~~-lp~~~---~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~ 153 (454)
T 1jl5_A 87 PEL---PPHLESLVASCNSLTE-LPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSS 153 (454)
T ss_dssp CSC---CTTCSEEECCSSCCSS-CCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCT
T ss_pred CCC---cCCCCEEEccCCcCCc-ccccc---CCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCC
Confidence 442 2466667777776664 55432 566666666666653 3321 1566666666666664 44 466666
Q ss_pred ccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecc
Q 002069 169 NLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLN 248 (973)
Q Consensus 169 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 248 (973)
+|++|++++|++++ +|..+ ++|++|++++|++++++ .|+++++|+.|++++|+++++ |... ++|++|+++
T Consensus 154 ~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l~--~~~~l~~L~~L~l~~N~l~~l-~~~~---~~L~~L~l~ 223 (454)
T 1jl5_A 154 FLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEELP--ELQNLPFLTAIYADNNSLKKL-PDLP---LSLESIVAG 223 (454)
T ss_dssp TCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSCC--CCTTCTTCCEEECCSSCCSSC-CCCC---TTCCEEECC
T ss_pred CCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcCc--cccCCCCCCEEECCCCcCCcC-CCCc---CcccEEECc
Confidence 66666666666663 44432 36666666666666543 466666666666666666653 2221 356666666
Q ss_pred cccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCC
Q 002069 249 YNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSI 328 (973)
Q Consensus 249 ~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 328 (973)
+|.++. +| . ++.+++|++|++++|++++ +|.. +++|++|++++|.+++ +
T Consensus 224 ~n~l~~-lp-~------------------------~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l 272 (454)
T 1jl5_A 224 NNILEE-LP-E------------------------LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-L 272 (454)
T ss_dssp SSCCSS-CC-C------------------------CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-C
T ss_pred CCcCCc-cc-c------------------------cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-c
Confidence 666652 22 1 3344555556666665553 2221 2556666666666664 3
Q ss_pred CccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccc-cccchhcccccccccCCCcccCCC
Q 002069 329 PNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASL-TSLTTLYLYENSLCDSIPKEIGDM 407 (973)
Q Consensus 329 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l 407 (973)
|.. .++|++|++++|.+++. +.. .++|++|++++|++++. + .+ ++|+.|++++|++++ +|.. +
T Consensus 273 ~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~ 336 (454)
T 1jl5_A 273 PEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---P 336 (454)
T ss_dssp CCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---C
T ss_pred Ccc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---C
Confidence 332 25666666666666642 111 15667777777766642 1 22 367777777777765 3432 4
Q ss_pred CCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCccccc--ccCCCCCCCcccceeeccCCccCCCCCccccccccccc
Q 002069 408 KSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVG--EIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEY 485 (973)
Q Consensus 408 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~--~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~ 485 (973)
++|++|++++|+++ .+|. ..++|++|++++|++++ .+|..+. . ++.|.+.+..|.. +++|++
T Consensus 337 ~~L~~L~L~~N~l~-~lp~----~l~~L~~L~L~~N~l~~l~~ip~~l~------~--L~~n~~~~~i~~~---~~~L~~ 400 (454)
T 1jl5_A 337 PRLERLIASFNHLA-EVPE----LPQNLKQLHVEYNPLREFPDIPESVE------D--LRMNSHLAEVPEL---PQNLKQ 400 (454)
T ss_dssp TTCCEEECCSSCCS-CCCC----CCTTCCEEECCSSCCSSCCCCCTTCC------E--EECCC-----------------
T ss_pred CcCCEEECCCCccc-cccc----hhhhccEEECCCCCCCcCCCChHHHH------h--hhhcccccccccc---cCcCCE
Confidence 67777777777776 4554 23467777777777776 4444333 2 2345555555542 467888
Q ss_pred cccccccccc--ccCccccccccccEEeecCccCCCCCCccc
Q 002069 486 LDLSANTFHN--SIPESLGNLVKLHYLNLSNNQFSQKIPNPI 525 (973)
Q Consensus 486 L~Ls~N~i~~--~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 525 (973)
||+++|.+++ .+| ..|+.|.+++|.+.+..+...
T Consensus 401 L~ls~N~l~~~~~iP------~sl~~L~~~~~~~~~~~~~~~ 436 (454)
T 1jl5_A 401 LHVETNPLREFPDIP------ESVEDLRMNSERVVDPYEFAH 436 (454)
T ss_dssp ------------------------------------------
T ss_pred EECCCCcCCccccch------hhHhheeCcCcccCCccccCH
Confidence 8888888875 344 346667778888776554433
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=386.65 Aligned_cols=406 Identities=26% Similarity=0.272 Sum_probs=260.8
Q ss_pred CCcEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCC-------------CeeeccCCcCCCCCCCc
Q 002069 1 MLKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSL-------------NGLSLYSNFLKGSIPPS 67 (973)
Q Consensus 1 ~l~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L-------------~~L~l~~n~~~~~~p~~ 67 (973)
.|++|++++|++ |.+|++++++++|++|++++|++++.+|..++.+.+| ++|++++|+++ .+|..
T Consensus 12 ~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~-~lp~~ 89 (454)
T 1jl5_A 12 FLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPEL 89 (454)
T ss_dssp -----------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-CCCSC
T ss_pred cchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-cCCCC
Confidence 478999999999 6999999999999999999999999999999999875 99999999999 56762
Q ss_pred ccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCC
Q 002069 68 LGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLS 147 (973)
Q Consensus 68 ~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 147 (973)
.++|++|++++|++++ +|.. +++|++|++++|++++ +|... ++|++|++++|++++ +| .|+++++|+
T Consensus 90 ---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~~---~~L~~L~L~~n~l~~-lp-~~~~l~~L~ 156 (454)
T 1jl5_A 90 ---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDLP---PLLEYLGVSNNQLEK-LP-ELQNSSFLK 156 (454)
T ss_dssp ---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSCC---TTCCEEECCSSCCSS-CC-CCTTCTTCC
T ss_pred ---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCCC---CCCCEEECcCCCCCC-Cc-ccCCCCCCC
Confidence 4789999999999995 7764 4789999999999984 55432 799999999999995 77 699999999
Q ss_pred ceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcc
Q 002069 148 DLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNA 227 (973)
Q Consensus 148 ~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~ 227 (973)
+|++++|++++ +|..+ .+|++|++++|++++ +| .++++++|++|++++|++++++.. .++|++|++++|.
T Consensus 157 ~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~----~~~L~~L~l~~n~ 226 (454)
T 1jl5_A 157 IIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDL----PLSLESIVAGNNI 226 (454)
T ss_dssp EEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCC----CTTCCEEECCSSC
T ss_pred EEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCC----cCcccEEECcCCc
Confidence 99999999995 56543 599999999999995 67 699999999999999999975432 3699999999999
Q ss_pred cCCCCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCch
Q 002069 228 LSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLS 307 (973)
Q Consensus 228 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 307 (973)
++.+ | .+..+++|++|++++|++++. |.. .++|+.|++++|.+..++. .+++|++|++++|++++. +..
T Consensus 227 l~~l-p-~~~~l~~L~~L~l~~N~l~~l-~~~---~~~L~~L~l~~N~l~~l~~----~~~~L~~L~ls~N~l~~l-~~~ 295 (454)
T 1jl5_A 227 LEEL-P-ELQNLPFLTTIYADNNLLKTL-PDL---PPSLEALNVRDNYLTDLPE----LPQSLTFLDVSENIFSGL-SEL 295 (454)
T ss_dssp CSSC-C-CCTTCTTCCEEECCSSCCSSC-CSC---CTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSEE-SCC
T ss_pred CCcc-c-ccCCCCCCCEEECCCCcCCcc-ccc---ccccCEEECCCCcccccCc----ccCcCCEEECcCCccCcc-cCc
Confidence 9965 5 499999999999999999864 332 3667777777777776332 236777778887777752 211
Q ss_pred hhcCCccceeeccccccCCCCCccccCC-CCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCccccccccc
Q 002069 308 LGSLTNLATLYFSTNALSGSIPNEITNL-RSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSL 386 (973)
Q Consensus 308 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L 386 (973)
.++|++|++++|.+++ ++ .+ ++|++|++++|++++ +|.. +++|++|++++|+++. .|. .+++|
T Consensus 296 ---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L 359 (454)
T 1jl5_A 296 ---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNL 359 (454)
T ss_dssp ---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTC
T ss_pred ---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhc
Confidence 2577777777777764 22 22 477777777777775 3332 4677777777777774 444 35677
Q ss_pred chhccccccccc--CCCcccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCccccc--ccCCCCCCCccccee
Q 002069 387 TTLYLYENSLCD--SIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVG--EIPLGHGKFSSLIQL 462 (973)
Q Consensus 387 ~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~--~~~~~~~~~~~L~~L 462 (973)
++|++++|++++ .+|..+.. |+.|.+.+.+|.. .++|++|++++|.+++ .+| ++++.|
T Consensus 360 ~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~----~~~L~~L~ls~N~l~~~~~iP------~sl~~L 421 (454)
T 1jl5_A 360 KQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL----PQNLKQLHVETNPLREFPDIP------ESVEDL 421 (454)
T ss_dssp CEEECCSSCCSSCCCCCTTCCE--------EECCC---------------------------------------------
T ss_pred cEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc----cCcCCEEECCCCcCCccccch------hhHhhe
Confidence 777777777776 44444432 2335555555542 2479999999999986 333 357788
Q ss_pred eccCCccCCCCCcc
Q 002069 463 ILNNNELSGQLSPE 476 (973)
Q Consensus 463 ~l~~N~l~~~~~~~ 476 (973)
.+++|.+.+..+..
T Consensus 422 ~~~~~~~~~~~~~~ 435 (454)
T 1jl5_A 422 RMNSERVVDPYEFA 435 (454)
T ss_dssp --------------
T ss_pred eCcCcccCCccccC
Confidence 88888887654433
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=370.31 Aligned_cols=259 Identities=29% Similarity=0.420 Sum_probs=204.3
Q ss_pred HHhcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
....+|++.+.||+|+||+||+|+. +|+.||||++...... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 3467899999999999999999987 6889999998765433 3345789999999999999999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEeecCCCCCeeecCCCceEEeccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP--IVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
||||+++++|.+++........+++..++.++.|++.|++|||+. + |+||||||+||+++.++.+||+|||+++.
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999998766555689999999999999999999999 8 99999999999999999999999999986
Q ss_pred ccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 856 LKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 856 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
............||+.|+|||++.+..++.++|||||||++|||++|+.||........ .............+..
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~ 263 (309)
T 3p86_A 189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV-----VAAVGFKCKRLEIPRN 263 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH-----HHHHHHSCCCCCCCTT
T ss_pred ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhcCCCCCCCcc
Confidence 65544444567899999999999999999999999999999999999999975432110 0000001111122221
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+..+.+++.+||+.||.+|||++++++.|+
T Consensus 264 ------~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~ 294 (309)
T 3p86_A 264 ------LNPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294 (309)
T ss_dssp ------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ------CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 2235788999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=371.47 Aligned_cols=281 Identities=32% Similarity=0.581 Sum_probs=226.7
Q ss_pred CccccHHHHHHHhcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeece
Q 002069 688 DGKIVHEEIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767 (973)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~ 767 (973)
...++.+++....++|++.+.||+|+||.||+|+..+++.||||++........ ...+.+|+.+++.++||||+++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEE
Confidence 345678889999999999999999999999999888899999999976433222 246889999999999999999999
Q ss_pred eeeccceeEEEEEecCCCChHHHhccCcc-ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceE
Q 002069 768 FCSHALHSFVVYEYLEMGSLAMILSNDAA-AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAH 846 (973)
Q Consensus 768 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~k 846 (973)
++..+...++||||+++++|.++++.... ...+++..++.++.|++.|++|||+.+.++|+||||||+||+++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999976543 34589999999999999999999998666899999999999999999999
Q ss_pred EecccccccccCCCC-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhh-------hhhhh
Q 002069 847 VSDFGISKFLKLGLS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIC-------SSLSS 918 (973)
Q Consensus 847 l~Dfg~a~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-------~~~~~ 918 (973)
|+|||.++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||+...... .+...
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 999999987754333 2334569999999999998889999999999999999999999997432110 01100
Q ss_pred hh-hhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 919 NL-NIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 919 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.. ........+...... ........+.+++.+||+.||.+|||++||+++|+
T Consensus 255 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGN--YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TTSSCCSTTSSCTTCTTS--CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred HhhchhhhhhcChhhccc--cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 00 111222222222222 23456778999999999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=368.37 Aligned_cols=271 Identities=33% Similarity=0.505 Sum_probs=219.5
Q ss_pred HHHHHHhcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc
Q 002069 694 EEIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL 773 (973)
Q Consensus 694 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 773 (973)
.++...+++|++.+.||+|+||+||+|...+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 344456789999999999999999999988899999999875432 23578999999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHhccCcc-ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAA-AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
..++||||+++++|.+++..... ...+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999975542 23689999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhh-----hhhh-hhhhhhh
Q 002069 853 SKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIC-----SSLS-SNLNIAL 924 (973)
Q Consensus 853 a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-----~~~~-~~~~~~~ 924 (973)
++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .+.. .......
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 986543221 2234568999999999998899999999999999999999999987432110 0000 0001112
Q ss_pred hhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 925 DEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+++...... .......+.+++.+||+.||++|||++|+++.|+
T Consensus 266 ~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 266 EQIVDPNLADKI--RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp CSSSSSSCTTCS--CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhcChhhcccc--CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 222333332222 2456778999999999999999999999999885
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=365.15 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=209.3
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|.. .+++.||||++...... ..+.+.+|+.++++++||||+++++++..++..++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 46899999999999999999965 58999999998643222 246788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.++++.. .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999999999753 478999999999999999999999 999999999999999999999999999988776
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||.......... .......+....+
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~~~~~~~~~~~~~--- 239 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGTPELQNP--- 239 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHCSCCCSCG---
T ss_pred cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCCCCCCCc---
Confidence 6555566789999999999999999999999999999999999999997543221110 0111111111111
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...+..+.+++.+||+.||.+|||++|+++.
T Consensus 240 -~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 240 -EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp -GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1233457889999999999999999999873
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=360.50 Aligned_cols=255 Identities=25% Similarity=0.438 Sum_probs=207.1
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 36799999999999999999965 47999999998643 334468899999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.++++... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++....
T Consensus 86 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 99999999999997543 4589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcc--------------cccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhh
Q 002069 859 GLSNR--------------TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIAL 924 (973)
Q Consensus 859 ~~~~~--------------~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 924 (973)
..... ....||+.|+|||++.+..++.++||||||+++|||++|..||..................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc
Confidence 32211 1457999999999999999999999999999999999999998643221111111111111
Q ss_pred hhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 925 DEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.....+.. +..+.+++.+||+.||++|||++++++.|+
T Consensus 241 ~~~~~~~~----------~~~l~~li~~~l~~dP~~Rps~~~l~~~L~ 278 (310)
T 3s95_A 241 DRYCPPNC----------PPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278 (310)
T ss_dssp HHTCCTTC----------CTTHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cccCCCCC----------CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 11111111 124678999999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=362.81 Aligned_cols=262 Identities=26% Similarity=0.376 Sum_probs=214.6
Q ss_pred ccccHHHHHHHhcC----------CcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC
Q 002069 689 GKIVHEEIIRATKN----------FDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI 757 (973)
Q Consensus 689 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l 757 (973)
+.++.+++..+++. |+..+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.+++++
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l 99 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDY 99 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhC
Confidence 45667777777654 777889999999999999765 8999999998754332 257789999999999
Q ss_pred CCCceeeeceeeeccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCe
Q 002069 758 RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNV 837 (973)
Q Consensus 758 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni 837 (973)
+||||+++++++..++..++||||+++++|.++++.. .+++.++..++.|++.|++|||+. +|+||||||+||
T Consensus 100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI 172 (321)
T 2c30_A 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSI 172 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence 9999999999999999999999999999999998643 589999999999999999999999 999999999999
Q ss_pred eecCCCceEEecccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhh
Q 002069 838 LLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLS 917 (973)
Q Consensus 838 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 917 (973)
+++.++.+||+|||+++.............||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~--- 249 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--- 249 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---
T ss_pred EECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence 99999999999999998776554445567899999999999999999999999999999999999999974332110
Q ss_pred hhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 918 SNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.........+.... ....+..+.+++.+||+.||++|||++++++.
T Consensus 250 ---~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 ---MKRLRDSPPPKLKN----SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ---HHHHHHSSCCCCTT----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---HHHHhcCCCCCcCc----cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111111122111 11223457889999999999999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=364.65 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=207.1
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|.. .+|+.||||++...... ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 46899999999999999999965 58999999998754332 23457788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.+++... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999998654 3588999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccCcccccccccCCCC-CccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
. .......||+.|+|||++.+..+. .++||||+||++|||++|+.||+.... ..............+..
T Consensus 167 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------~~~~~~i~~~~~~~p~~ 236 (328)
T 3fe3_A 167 G-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL---------KELRERVLRGKYRIPFY 236 (328)
T ss_dssp S-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHHHHHHCCCCCCTT
T ss_pred C-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH---------HHHHHHHHhCCCCCCCC
Confidence 4 334556899999999999888775 789999999999999999999975431 11111111122111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.+..+.+++.+||+.||.+|||++|+++.
T Consensus 237 ----~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 237 ----MSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----SCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22346789999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=366.13 Aligned_cols=255 Identities=20% Similarity=0.253 Sum_probs=209.2
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcc---hhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGE---MACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
.+.|++.+.||+|+||+||+|... +|+.||+|++....... ....+.+.+|+.++++++||||+++++++.++...
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999654 79999999987543221 11357899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC----ceEEeccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY----EAHVSDFG 851 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~----~~kl~Dfg 851 (973)
++||||+++|+|.+++... ..+++.++..++.||+.|++|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 9999999999999999654 3689999999999999999999999 999999999999998876 79999999
Q ss_pred ccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 852 ISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 852 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
+++..... .......||+.|+|||++.+..++.++||||+||++|+|++|..||...... .....+....
T Consensus 165 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---------~~~~~i~~~~ 234 (361)
T 2yab_A 165 LAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---------ETLANITAVS 234 (361)
T ss_dssp SCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---------HHHHHHHTTC
T ss_pred CceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHhcC
Confidence 99877654 2334567999999999999989999999999999999999999999743321 1112222222
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.......+...+..+.+++.+||+.||.+|||++|+++.
T Consensus 235 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 222211122234567899999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=368.02 Aligned_cols=256 Identities=24% Similarity=0.359 Sum_probs=208.4
Q ss_pred hcCCcccccccCCCceeEEEEEc--------CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL--------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCS 770 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 770 (973)
.++|++.+.||+|+||.||+|.+ .++..||||+++... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 46899999999999999999964 245679999997653 333467899999999999 8999999999999
Q ss_pred ccceeEEEEEecCCCChHHHhccCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCe
Q 002069 771 HALHSFVVYEYLEMGSLAMILSNDAA-------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNV 837 (973)
Q Consensus 771 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni 837 (973)
+.+..|+||||+++|+|.++++.... ...+++.+++.++.||+.||+|||++ +|+||||||+||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI 234 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 234 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhE
Confidence 99999999999999999999976442 23578999999999999999999999 999999999999
Q ss_pred eecCCCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhh
Q 002069 838 LLNLEYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICS 914 (973)
Q Consensus 838 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 914 (973)
+++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.......
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~- 313 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 313 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence 999999999999999987654322 2233457889999999999999999999999999999999 999997433110
Q ss_pred hhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 915 SLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..........+..+. .....+.+++.+||+.||.+||++.|+++.|+
T Consensus 314 -----~~~~~~~~~~~~~~~------~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 360 (370)
T 2psq_A 314 -----LFKLLKEGHRMDKPA------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360 (370)
T ss_dssp -----HHHHHHTTCCCCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -----HHHHHhcCCCCCCCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 011111111111121 12345788999999999999999999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=362.68 Aligned_cols=252 Identities=20% Similarity=0.232 Sum_probs=208.9
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|.. .+++.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 46899999999999999999965 47889999998743 22356788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC--CCceEEecccccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL--EYEAHVSDFGISKFL 856 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~--~~~~kl~Dfg~a~~~ 856 (973)
|||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++. ++.+||+|||.++..
T Consensus 80 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 99999999999996543 3689999999999999999999999 9999999999999987 789999999999877
Q ss_pred cCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 857 KLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 857 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... ...............
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~i~~~~~~~~~ 224 (321)
T 1tki_A 155 KPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---------QIIENIMNAEYTFDE 224 (321)
T ss_dssp CTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---------HHHHHHHHTCCCCCH
T ss_pred CCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---------HHHHHHHcCCCCCCh
Confidence 654 2334567999999999999888999999999999999999999999743321 111222222222222
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+..+.+++.+||+.||.+|||++|+++.
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2222334568899999999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=358.43 Aligned_cols=258 Identities=24% Similarity=0.337 Sum_probs=206.5
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|.. .+++.||+|++...........+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46799999999999999999964 57899999998766555556678899999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.+++... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++....
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999654 3689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC-c
Q 002069 859 GLS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP-L 936 (973)
Q Consensus 859 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 936 (973)
... ......||+.|+|||.+.+..++.++||||+|+++|||+||+.||......... ...+....+.. .
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~---------~~~~~~~~~~~~~ 234 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA---------IKHIQDSVPNVTT 234 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH---------HHHHSSCCCCHHH
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH---------HHHhhccCCCcch
Confidence 322 233457999999999999999999999999999999999999999754321110 11111111111 0
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCC-CHHHHHHHhc
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRP-TMQKVSQLLK 972 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ev~~~L~ 972 (973)
......+..+.+++.+|++.||.+|| +++++.+.|+
T Consensus 235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 01112334578899999999999998 8888887764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=375.80 Aligned_cols=257 Identities=19% Similarity=0.233 Sum_probs=209.0
Q ss_pred HHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeE
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (973)
...++|++.+.||+|+||+||+|.. .+|+.||+|++...... ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 3467899999999999999999954 58999999998765432 233577899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeec---CCCceEEeccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLN---LEYEAHVSDFGIS 853 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~---~~~~~kl~Dfg~a 853 (973)
+||||+++|+|.+++... ..+++.++..++.||+.|++|||+. +|+||||||+||+++ .++.+||+|||++
T Consensus 87 lv~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EEECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 999999999999998754 3589999999999999999999999 999999999999998 4578999999999
Q ss_pred ccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 854 KFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 854 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
+.............||+.|+|||++.+..++.++||||+||++|+|++|..||...... ............
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---------~~~~~i~~~~~~ 231 (444)
T 3soa_A 161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---------RLYQQIKAGAYD 231 (444)
T ss_dssp BCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---------HHHHHHHHTCCC
T ss_pred EEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---------HHHHHHHhCCCC
Confidence 87766555555678999999999999999999999999999999999999999743321 111111111111
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.+...+...+..+.+++.+||+.||.+|||++|+++.
T Consensus 232 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111112233457889999999999999999999874
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=362.50 Aligned_cols=252 Identities=22% Similarity=0.259 Sum_probs=206.8
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|+.. +|+.||+|++.............+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367999999999999999999654 7999999998643211222356788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++|+|.+++... ..+++.+++.++.||+.|++|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999999998643 3688999999999999999999999 999999999999999999999999999986544
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||....... ........ ...++..
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~i~~~--~~~~p~~--- 227 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFELILME--EIRFPRT--- 227 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHC--CCCCCTT---
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-----HHHHHHcC--CCCCCCC---
Confidence 4444556789999999999999999999999999999999999999997433210 00111111 1122221
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 002069 939 VQDKLISIMEVSISCLDESPTSRP-----TMQKVSQL 970 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 970 (973)
.+..+.+++.+||+.||.+|| +++|+++.
T Consensus 228 ---~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 228 ---LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 223577899999999999999 89998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=353.25 Aligned_cols=276 Identities=31% Similarity=0.508 Sum_probs=224.2
Q ss_pred ccccHHHHHHHhcCCccc------ccccCCCceeEEEEEcCCCCEEEEEEcCCCCC-cchhhHHHHHHHHHHhhcCCCCc
Q 002069 689 GKIVHEEIIRATKNFDDE------HCIGNGGQGSVYKAELPTGEIVAVKKFHSPLP-GEMACQQEFLNEGNALTKIRHRN 761 (973)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~n 761 (973)
..+..+++..++.+|... +.||+|+||.||+|.. +++.||||++..... ......+.+.+|+.++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 457788999999888877 8999999999999987 688999999875432 22334678999999999999999
Q ss_pred eeeeceeeeccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC
Q 002069 762 IVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL 841 (973)
Q Consensus 762 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~ 841 (973)
|+++++++.+.+..++||||+++++|.+++........+++..++.++.|++.|++|||+. +++||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 9999999999999999999999999999997655556789999999999999999999999 9999999999999999
Q ss_pred CCceEEecccccccccCCCCc--ccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhh--hhhh
Q 002069 842 EYEAHVSDFGISKFLKLGLSN--RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIC--SSLS 917 (973)
Q Consensus 842 ~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~--~~~~ 917 (973)
++.+||+|||.++........ .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||+...... ..+.
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 999999999999876543221 234578999999998865 48899999999999999999999997533211 0000
Q ss_pred h---hhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 918 S---NLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 918 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
. .........+++.+... .......+.+++.+||+.||.+|||+++|++.|+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~ 302 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKMNDA---DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302 (307)
T ss_dssp HHHHTTSCCHHHHSCSSCSCC---CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHhhhhhhhhhhhcccccccc---chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 0 00111233344443322 2345667889999999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=357.03 Aligned_cols=264 Identities=20% Similarity=0.275 Sum_probs=202.9
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.++|++.+.||+|+||+||+|...+|+.||+|++...... ......+.+|+.++++++||||+++++++.++...++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 4789999999999999999998888999999999754322 223577889999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++ ++.+++.... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.....
T Consensus 99 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99984 7888876543 3589999999999999999999999 9999999999999999999999999999887655
Q ss_pred CCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh--hh----hhhhhhh------hhh
Q 002069 860 LSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS--SL----SSNLNIA------LDE 926 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~----~~~~~~~------~~~ 926 (973)
........||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ .. ....... ...
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 455556688999999999876 5689999999999999999999999975332110 00 0000000 000
Q ss_pred hcCCCC---C-CCch-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 927 MLDPRL---P-TPLR-NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 927 ~~~~~~---~-~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...... . ..+. .......++.+++.+||+.||.+|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000 0 0000 011123457899999999999999999999873
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=363.10 Aligned_cols=254 Identities=25% Similarity=0.414 Sum_probs=204.5
Q ss_pred hcCCcccccccCCCceeEEEEEcC----CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP----TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
..+|++.+.||+|+||+||+|... .+..||||+++... .....+.+.+|+.++++++||||+++++++.+++..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 467899999999999999999763 34569999997543 233467899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+++++|.++++... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 99999999999999996543 4689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCc---ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 856 LKLGLSN---RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 856 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
....... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ............
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~~~~~~~~~ 274 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD------VISSVEEGYRLP 274 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHHHHTTCCCC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHHcCCCCC
Confidence 7543221 223346778999999998899999999999999999999 999996433210 011111111111
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+. ..+..+.+++.+||+.||.+|||++++++.|+
T Consensus 275 ~~~------~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~ 309 (325)
T 3kul_A 275 APM------GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309 (325)
T ss_dssp CCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCC------CcCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 111 22345788999999999999999999999885
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=370.82 Aligned_cols=366 Identities=20% Similarity=0.216 Sum_probs=271.6
Q ss_pred CCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCcc
Q 002069 12 FSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNE 91 (973)
Q Consensus 12 l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~ 91 (973)
..+..+..++.+++|++|++++|.+++. | .++.+++|++|++++|++++ +| ++.+++|++|++++|++++ +|
T Consensus 30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~-- 101 (457)
T 3bz5_A 30 MQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD-- 101 (457)
T ss_dssp CCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--
T ss_pred cCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--
Confidence 3445566788889999999999999864 5 68889999999999999885 44 8889999999999999984 44
Q ss_pred ccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccc
Q 002069 92 VGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLV 171 (973)
Q Consensus 92 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~ 171 (973)
++.+++|++|++++|++++ +| ++.+++|++|++++|++++ ++ ++++++|++|++++|...+.+ .++.+++|+
T Consensus 102 ~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~ 173 (457)
T 3bz5_A 102 VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLT 173 (457)
T ss_dssp CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCC
T ss_pred cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc--ccccCCcCC
Confidence 8889999999999999985 54 8889999999999999985 33 888999999999999654444 477889999
Q ss_pred eeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceeccccc
Q 002069 172 TLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNT 251 (973)
Q Consensus 172 ~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~ 251 (973)
.|++++|++++ +| ++.+++|++|++++|+++++ .++.+++|+.|++++|+++++ | +..+++|+.|++++|+
T Consensus 174 ~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~~N~ 244 (457)
T 3bz5_A 174 TLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCSVNP 244 (457)
T ss_dssp EEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSC
T ss_pred EEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--ccccCCCCEEEeeCCc
Confidence 99999999985 55 78889999999999999876 478889999999999999885 4 7888999999999999
Q ss_pred ccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCc-
Q 002069 252 LSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPN- 330 (973)
Q Consensus 252 l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~- 330 (973)
+++..+.. +++|+.++++.| +|+.|++++|.+.+.+| ++.+++|+.|++++|...+.+|.
T Consensus 245 l~~~~~~~---l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~ 305 (457)
T 3bz5_A 245 LTELDVST---LSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQ 305 (457)
T ss_dssp CSCCCCTT---CTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECT
T ss_pred CCCcCHHH---CCCCCEEeccCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccC
Confidence 98766544 445555555443 34566677776655544 45667777777777765544442
Q ss_pred -------cccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcc
Q 002069 331 -------EITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKE 403 (973)
Q Consensus 331 -------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 403 (973)
.++++++|++|++++|++++. .++++++|+.|++++|++++ ++.|..|++++|.+.+.
T Consensus 306 ~~~L~~L~l~~~~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~---- 370 (457)
T 3bz5_A 306 AAGITELDLSQNPKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE---- 370 (457)
T ss_dssp TCCCSCCCCTTCTTCCEEECTTCCCSCC---CCTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE----
T ss_pred CCcceEechhhcccCCEEECCCCccccc---ccccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec----
Confidence 133445677777777777763 26677777777777777764 24566667777777653
Q ss_pred cCCCCCCCEEEccCCCCCCCcchhhhhhcccceE
Q 002069 404 IGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKV 437 (973)
Q Consensus 404 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~ 437 (973)
..+..|+.+++++|+++|.+|..+.....++..
T Consensus 371 -~~~~~l~~l~l~~N~l~g~ip~~~~~~~~~~~~ 403 (457)
T 3bz5_A 371 -GQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN 403 (457)
T ss_dssp -EEEEECCCBCCBTTBEEEECCTTCBCTTSCCCE
T ss_pred -ceeeecCccccccCcEEEEcChhHhcccCceee
Confidence 234556666777777777777665544433333
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=368.11 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=201.2
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 777 (973)
.++|++.+.||+|+||+||+|+.. +++.||+|+++..........+.+..|..++.++ +||||+++++++.+++..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999654 7889999999754333333345678899998876 89999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|+...
T Consensus 131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999998753 3689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCC--CCCCC
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTP 935 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 935 (973)
..........||+.|+|||++.+..++.++||||+||++|||++|+.||........................ .++..
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 4444556678999999999999999999999999999999999999999643211111000011111111111 22221
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTM 964 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 964 (973)
....+.+++.+||+.||.+||++
T Consensus 285 ------~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 285 ------LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ------SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ------CCHHHHHHHHHHhcCCHhHcCCC
Confidence 22346789999999999999995
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=359.41 Aligned_cols=255 Identities=19% Similarity=0.261 Sum_probs=207.2
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcc---hhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGE---MACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
.+.|++.+.||+|+||.||+|.. .+|+.||+|++....... ....+.+.+|+.++++++||||+++++++.++...
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 45699999999999999999965 479999999987543221 11357899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC----ceEEeccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY----EAHVSDFG 851 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~----~~kl~Dfg 851 (973)
++||||+++++|.+++... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999999654 3589999999999999999999999 999999999999999887 89999999
Q ss_pred ccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 852 ISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 852 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||....... .........
T Consensus 164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------~~~~~~~~~ 233 (326)
T 2y0a_A 164 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---------TLANVSAVN 233 (326)
T ss_dssp TCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---------HHHHHHHTC
T ss_pred CCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---------HHHHHHhcC
Confidence 998775432 3345679999999999998899999999999999999999999997433210 111111111
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...........+..+.+++.+||+.||.+|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111112234457889999999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=367.14 Aligned_cols=258 Identities=20% Similarity=0.240 Sum_probs=207.7
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCC--cchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLP--GEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (973)
.++|++.+.||+|+||+||+|.. .+++.||||++..... ......+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46799999999999999999965 5799999999853210 11112577999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCc---eEEecccc
Q 002069 777 VVYEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYE---AHVSDFGI 852 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~---~kl~Dfg~ 852 (973)
+||||+++++|.+++.... ....+++..++.++.||+.|++|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988875433 233589999999999999999999999 9999999999999987654 99999999
Q ss_pred cccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
++.............||+.|+|||++.+..++.++||||+||++|+|++|+.||..... ...........
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------~~~~~i~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----------RLFEGIIKGKY 249 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----------HHHHHHHHTCC
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----------HHHHHHHcCCC
Confidence 98876554445567899999999999999999999999999999999999999974321 11111111222
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+...+..+.+++.+||+.||++|||+.++++.
T Consensus 250 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 250 KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22211122234567899999999999999999999863
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=364.31 Aligned_cols=255 Identities=20% Similarity=0.275 Sum_probs=207.8
Q ss_pred HhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
..++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 356899999999999999999965 47899999999765433 2335778999999999999999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC---CceEEecccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE---YEAHVSDFGISK 854 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~---~~~kl~Dfg~a~ 854 (973)
||||+++|+|.+++... ..+++.++..++.||+.|++|||+. +|+||||||+||+++.+ +.+||+|||+++
T Consensus 106 v~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999998654 3589999999999999999999999 99999999999999865 459999999998
Q ss_pred cccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCC
Q 002069 855 FLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934 (973)
Q Consensus 855 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (973)
..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... .............
T Consensus 180 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---------~~~~~i~~~~~~~ 249 (362)
T 2bdw_A 180 EVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---------RLYAQIKAGAYDY 249 (362)
T ss_dssp CCTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHTCCCC
T ss_pred EecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---------HHHHHHHhCCCCC
Confidence 77543 2334567999999999999989999999999999999999999999743321 1111111111111
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
+...+...+..+.+++.+||+.||.+|||++++++.
T Consensus 250 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111122234457889999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=363.77 Aligned_cols=250 Identities=22% Similarity=0.273 Sum_probs=202.4
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|.+.+.||+|+||+||+|.. .+++.||||++.............+.+|+.+++.++||||+++++++..++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999965 68999999998643212222246788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+ +|++.+++... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 68898888643 3689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccCcccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
. .......||+.|+|||++.+..+ ++++||||+||++|+|++|+.||+.... ..............+
T Consensus 161 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---------~~~~~~i~~~~~~~p-- 228 (336)
T 3h4j_B 161 G-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI---------PNLFKKVNSCVYVMP-- 228 (336)
T ss_dssp S-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS---------TTCBCCCCSSCCCCC--
T ss_pred C-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH---------HHHHHHHHcCCCCCc--
Confidence 4 23345679999999999988776 6899999999999999999999974321 111111111111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...+..+.+++.+||+.||.+|||++|+++.
T Consensus 229 --~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 229 --DFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp --TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred --ccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1123357789999999999999999999763
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=349.22 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=207.8
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.++|++.+.||+|+||+||+|...+++.||+|++...... .+++.+|+.++++++||||+++++++.+++..++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 3679999999999999999998888899999999854322 467999999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.++++... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.....
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp ECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999996543 3589999999999999999999999 9999999999999999999999999999866433
Q ss_pred C-CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 860 L-SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 860 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
. .......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||....... .............+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~-- 231 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDISTGFRLYKPRL-- 231 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCCCCCCTT--
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHHhcCccCCCCCc--
Confidence 2 12234557788999999998899999999999999999999 999997433210 0111111111111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+..+.+++.+||+.||.+|||++++++.|+
T Consensus 232 ----~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~ 262 (269)
T 4hcu_A 232 ----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 262 (269)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----CCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 1335788999999999999999999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=360.03 Aligned_cols=258 Identities=23% Similarity=0.310 Sum_probs=206.5
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 777 (973)
.++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|..+++++ +||||+++++++.+++..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 367999999999999999999664 7899999999765444444567788999999988 89999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||||+++|+|.+++... ..+++..++.++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999998643 3589999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCC--CCCCC
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTP 935 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 935 (973)
..........||+.|+|||++.+..++.++||||+||++|||++|+.||........................ .++..
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 241 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence 4434455678999999999999999999999999999999999999999643211100000001111111111 22221
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCH------HHHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTM------QKVSQ 969 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~ev~~ 969 (973)
.+..+.+++.+||+.||.+||++ +|+++
T Consensus 242 ------~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 242 ------LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp ------SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ------CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 23357789999999999999996 56654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=354.23 Aligned_cols=264 Identities=19% Similarity=0.251 Sum_probs=209.0
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc--eeEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL--HSFV 777 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~l 777 (973)
++|++.+.||+|+||+||+|... +++.||||++...... ...+.+.+|++++++++||||+++++++.... ..++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 67999999999999999999654 6999999998753222 22577889999999999999999999987654 7799
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeee----cCCCceEEeccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL----NLEYEAHVSDFGIS 853 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill----~~~~~~kl~Dfg~a 853 (973)
||||+++++|.++++.......+++.+++.++.|++.|++|||+. +|+||||||+||++ +.++.+||+|||.+
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999998766555689999999999999999999999 99999999999999 77788999999999
Q ss_pred ccccCCCCcccccccccCcccccccc--------cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhh
Q 002069 854 KFLKLGLSNRTELAGTFGYIAPELAY--------TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALD 925 (973)
Q Consensus 854 ~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 925 (973)
+...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||.......... ........
T Consensus 164 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~ 241 (319)
T 4euu_A 164 RELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYKIIT 241 (319)
T ss_dssp EECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH-HHHHHHHH
T ss_pred eecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH-HHHHHHhc
Confidence 8775542 334567999999999886 5678999999999999999999999996432111000 00000000
Q ss_pred hh-----------------cCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 926 EM-----------------LDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 926 ~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
.. ..+.++............+.+++.+||+.||++|||++|+++..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 00 00122222222345667788999999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=365.50 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=200.4
Q ss_pred HhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 776 (973)
..++|++.+.||+|+||+||+|+. .+++.||||++...........+.+..|..+++.+ +||||+++++++.+++..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 357899999999999999999965 47899999998743222233356788899999988 7999999999999999999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
+||||+++|+|.++++.. ..+++.+++.++.||+.|++|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999999653 3589999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 857 KLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 857 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
...........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......+.
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---------~~~~~i~~~~~~~p~ 245 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---------DLFEAILNDEVVYPT 245 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHCCCCCCT
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---------HHHHHHHcCCCCCCC
Confidence 54444555678999999999999889999999999999999999999999744321 111111111111111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCH------HHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTM------QKVSQ 969 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~------~ev~~ 969 (973)
.....+.+++.+|++.||.+||++ +++++
T Consensus 246 ----~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 246 ----WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ----CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 122346789999999999999998 67765
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=366.48 Aligned_cols=346 Identities=32% Similarity=0.429 Sum_probs=261.9
Q ss_pred CCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCcccccee
Q 002069 22 HLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDL 101 (973)
Q Consensus 22 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L 101 (973)
.+.+|++|++++|.++. +| .+..+++|++|++++|.++ .+|+ ++++++|++|++++|++++ ++. ++.+++|++|
T Consensus 44 ~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~-~~~~-~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L 117 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIAD-ITP-LANLTNLTGL 117 (466)
T ss_dssp HHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCC-CGG-GTTCTTCCEE
T ss_pred HhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccC-Cchh-hhccccCCEEECCCCcccc-Chh-hcCCCCCCEE
Confidence 45677788888887774 45 3777788888888888877 3444 7778888888888888774 443 7778888888
Q ss_pred eccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccC
Q 002069 102 RLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181 (973)
Q Consensus 102 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~ 181 (973)
++++|++++ +|. +.++++|++|++++|++++ ++ .++++++|++|+++ |.+.+.. .+.++++|+.|++++|.++
T Consensus 118 ~L~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~ 190 (466)
T 1o6v_A 118 TLFNNQITD-IDP-LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVS 190 (466)
T ss_dssp ECCSSCCCC-CGG-GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred ECCCCCCCC-ChH-HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCC
Confidence 888888774 443 7778888888888888773 33 47778888888876 4444333 2777888888888888877
Q ss_pred CCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccC
Q 002069 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFG 261 (973)
Q Consensus 182 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 261 (973)
+ + ..+..+++|++|++++|++.+..+ ++.+++|+.|++++|+++++ ..+..+++|+.|++++|.+++..+ +.
T Consensus 191 ~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~ 262 (466)
T 1o6v_A 191 D-I-SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LS 262 (466)
T ss_dssp C-C-GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GT
T ss_pred C-C-hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hh
Confidence 4 3 347777888888888888776554 66778888888888887765 467777888888888888876555 77
Q ss_pred CcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcE
Q 002069 262 NLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDL 341 (973)
Q Consensus 262 ~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 341 (973)
.+++|+.|++++|.+....+ +..+++|+.|++++|++++..+ ++.+++|+.|++++|.+++..| +..+++|++|
T Consensus 263 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 336 (466)
T 1o6v_A 263 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336 (466)
T ss_dssp TCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEE
T ss_pred cCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEe
Confidence 77888888888888776654 7788888888888888886544 7788888888888888886655 7788888888
Q ss_pred EcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhccccccccc
Q 002069 342 QLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCD 398 (973)
Q Consensus 342 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 398 (973)
++++|.+++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|++++
T Consensus 337 ~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 337 FFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp ECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred ECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 8888888865 467888888888888888887666 7888888888888888876
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.68 Aligned_cols=252 Identities=25% Similarity=0.421 Sum_probs=207.7
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.++|++.+.||+|+||+||+|+..+++.||||++...... .+++.+|+.++++++||||+++++++.++...++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 4679999999999999999999888889999999754322 467899999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.....
T Consensus 83 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp ECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999996543 3589999999999999999999999 9999999999999999999999999999876544
Q ss_pred CC-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 860 LS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 860 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
.. ......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||+....... ............+..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~-- 229 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV------VLKVSQGHRLYRPHL-- 229 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HHHHHTTCCCCCCTT--
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH------HHHHHcCCCCCCCCc--
Confidence 22 2233456778999999998889999999999999999999 9999974432110 001111111111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+..+.+++.+||+.||.+|||++++++.|+
T Consensus 230 ----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 260 (268)
T 3sxs_A 230 ----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260 (268)
T ss_dssp ----SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHG
T ss_pred ----ChHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1235788999999999999999999999886
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=368.09 Aligned_cols=344 Identities=32% Similarity=0.413 Sum_probs=160.9
Q ss_pred CCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceee
Q 002069 47 LSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLY 126 (973)
Q Consensus 47 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 126 (973)
+++|+.|++++|.+. .+|. +..+++|++|++++|.+++ +|. ++.+++|++|++++|++++ ++. ++++++|++|+
T Consensus 45 l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~ 118 (466)
T 1o6v_A 45 LDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD-ITP-LANLTNLTGLT 118 (466)
T ss_dssp HHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEE
T ss_pred hccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCC-chh-hhccccCCEEECCCCcccc-Chh-hcCCCCCCEEE
Confidence 344555555555544 3332 4445555555555555542 222 4445555555555555542 222 44555555555
Q ss_pred cccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeecccccccc
Q 002069 127 LHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSG 206 (973)
Q Consensus 127 L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 206 (973)
+++|++++. +. ++++++|++|++++|.+++. + .+..+++|+.|+++ |.+.+. + .+.++++|++|++++|.+++
T Consensus 119 L~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~-~-~~~~l~~L~~L~l~~n~l~~ 191 (466)
T 1o6v_A 119 LFNNQITDI-DP-LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDL-K-PLANLTTLERLDISSNKVSD 191 (466)
T ss_dssp CCSSCCCCC-GG-GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCC-G-GGTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCC-hH-HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCc-h-hhccCCCCCEEECcCCcCCC
Confidence 555555422 21 44555555555555554422 2 24445555555553 233321 1 24445555555555555443
Q ss_pred ccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhcc
Q 002069 207 SILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGN 286 (973)
Q Consensus 207 ~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~ 286 (973)
+. .+..+++|+.|++++|.+++..| ++.+++|+.|++++|.+++. ..+..+++|+.|++++|.+....+ +..
T Consensus 192 ~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~ 263 (466)
T 1o6v_A 192 IS--VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSG 263 (466)
T ss_dssp CG--GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTT
T ss_pred Ch--hhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhc
Confidence 32 24445555555555555544322 44445555555555554432 234444555555555555444332 444
Q ss_pred ccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEE
Q 002069 287 LKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLD 366 (973)
Q Consensus 287 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 366 (973)
+++|++|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++..| +..+++|++|+
T Consensus 264 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 337 (466)
T 1o6v_A 264 LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 337 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEE
T ss_pred CCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeE
Confidence 5555555555555543322 4445555555555555543322 4445555555555555544333 34445555555
Q ss_pred ccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCCCCEEEccCCCCC
Q 002069 367 LSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421 (973)
Q Consensus 367 Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 421 (973)
+++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|+++
T Consensus 338 l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 338 FYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388 (466)
T ss_dssp CCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred CCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCccc
Confidence 555555432 234445555555555555544333 444555555555555544
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=358.76 Aligned_cols=253 Identities=20% Similarity=0.354 Sum_probs=205.5
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc----
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL---- 773 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 773 (973)
..++|++.+.||+|+||.||+|... +|+.||||++..... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST--TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 3567999999999999999999765 899999999975432 234688999999999999999999999985543
Q ss_pred -----------------------------------------------------eeEEEEEecCCCChHHHhccCccccCC
Q 002069 774 -----------------------------------------------------HSFVVYEYLEMGSLAMILSNDAAAEEF 800 (973)
Q Consensus 774 -----------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~ 800 (973)
..++||||+++++|.++++........
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 379999999999999999887766677
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC------------Cccccccc
Q 002069 801 GWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL------------SNRTELAG 868 (973)
Q Consensus 801 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~g 868 (973)
++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++...... .......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 8888999999999999999999 99999999999999999999999999998776542 12234579
Q ss_pred ccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHH
Q 002069 869 TFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIME 948 (973)
Q Consensus 869 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 948 (973)
|+.|+|||++.+..++.++||||+||++|||++|..|+...... .........+ .........+.+
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~-----------~~~~~~~~~~---~~~~~~~~~~~~ 304 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI-----------ITDVRNLKFP---LLFTQKYPQEHM 304 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH-----------HHHHHTTCCC---HHHHHHCHHHHH
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH-----------HHHhhccCCC---cccccCChhHHH
Confidence 99999999999999999999999999999999998885422111 1111112221 122334456788
Q ss_pred HHhcccCCCCCCCCCHHHHHHH
Q 002069 949 VSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 949 li~~cl~~dP~~RPs~~ev~~~ 970 (973)
++.+||+.||.+|||++|+++.
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCCCCcCCCHHHHhhc
Confidence 9999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=359.27 Aligned_cols=263 Identities=25% Similarity=0.345 Sum_probs=204.0
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc----ee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL----HS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~ 775 (973)
..+|++.+.||+|+||+||+|++ .++.||||++... ......+..|+.++++++||||+++++++.++. ..
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 46899999999999999999987 4799999998642 223455667899999999999999999997754 46
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCC-------CCCeEeecCCCCCeeecCCCceEEe
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC-------FPPIVHRDISSKNVLLNLEYEAHVS 848 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------~~~i~H~Dlk~~Nill~~~~~~kl~ 848 (973)
++||||+++|+|.++++.. .+++.+++.++.|++.|++|||+.. .++|+||||||+||+++.++.+||+
T Consensus 98 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 9999999999999999653 4889999999999999999999861 1279999999999999999999999
Q ss_pred cccccccccCCCC--cccccccccCcccccccccC-----CCCCccchHHHHHHHHHHHhCCCCCcchhhh-----hhhh
Q 002069 849 DFGISKFLKLGLS--NRTELAGTFGYIAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPRDFISSI-----CSSL 916 (973)
Q Consensus 849 Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-----~~~~ 916 (973)
|||.++....... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||...... ....
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999987654432 23346799999999998863 4566889999999999999999999743211 0000
Q ss_pred --hhhhhhh----hhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 917 --SSNLNIA----LDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 917 --~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
....... ......+.++..+. ....+..+.+++.+||+.||++|||+++|++.|+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 314 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQ-KHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGG-SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCcccccc-ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 0001111 11112222222211 2234566899999999999999999999999885
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=367.72 Aligned_cols=254 Identities=23% Similarity=0.364 Sum_probs=206.7
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|.+. +++.||||+++... .....+.|.+|+.++++++||||+++++++..++..++|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 467999999999999999999775 78999999987542 223356789999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++|+|.++++... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 191 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999997433 4588999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCcc--cccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 859 GLSNR--TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 859 ~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
..... ....+++.|+|||.+.+..++.++|||||||++|||+| |+.||....... .............+.
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~~- 338 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ------TREFVEKGGRLPCPE- 338 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH------HHHHHHTTCCCCCCT-
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCC-
Confidence 32111 12335778999999998889999999999999999998 999997543211 011111111111111
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+..+.+++.+||+.||++|||++++++.|+
T Consensus 339 -----~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 370 (377)
T 3cbl_A 339 -----LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370 (377)
T ss_dssp -----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 12345788999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=364.04 Aligned_cols=254 Identities=25% Similarity=0.429 Sum_probs=195.4
Q ss_pred hcCCcccccccCCCceeEEEEEcC----CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP----TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
..+|++.+.||+|+||.||+|+.. ++..||||+++... .....++|.+|+.++++++||||+++++++.+.+..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 357999999999999999999764 57789999997643 233467899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+++++|.++++... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999997543 4689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCc---ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 856 LKLGLSN---RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 856 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
....... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ............
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~------~~~~i~~~~~~~ 270 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEGYRLP 270 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH------HHHHHHTTEECC
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCC
Confidence 7543221 122345778999999999999999999999999999998 999986433210 001111111111
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+. ..+..+.+++.+||+.||.+||++++|++.|+
T Consensus 271 ~~~------~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~ 305 (373)
T 2qol_A 271 PPM------DCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305 (373)
T ss_dssp CCT------TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCc------cccHHHHHHHHHHhCcChhhCcCHHHHHHHHH
Confidence 111 22345789999999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=350.91 Aligned_cols=263 Identities=22% Similarity=0.323 Sum_probs=200.5
Q ss_pred cCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
++|++.+.||+|+||+||+|...+++.||+|++...... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 579999999999999999998888999999999754322 2224678899999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++ +|.+++.... ..+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.++......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 9985 8998886543 4588999999999999999999999 99999999999999999999999999998765443
Q ss_pred CcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh------hhhhhh---hhh--hhc
Q 002069 861 SNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL------SSNLNI---ALD--EML 928 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~------~~~~~~---~~~--~~~ 928 (973)
.......||+.|+|||++.+. .++.++||||+||++|||++|+.||.......... ...... ... ...
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 444556789999999998764 58999999999999999999999997543211100 000000 000 000
Q ss_pred CCCCC----CCch-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 929 DPRLP----TPLR-NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 929 ~~~~~----~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
++.+. ..+. ........+.+++.+||+.||.+|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11110 0000 001123457789999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=352.71 Aligned_cols=258 Identities=24% Similarity=0.402 Sum_probs=198.8
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhc--CCCCceeeeceeeec----cc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTK--IRHRNIVKFYGFCSH----AL 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~ 773 (973)
.++|++.+.||+|+||+||+|.. +++.||||++... ....+..|.+++.. ++||||+++++++.. ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 46899999999999999999987 7899999998632 23555566666555 799999999998654 34
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEeecCCCCCeeecCCCce
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMH--------TNCFPPIVHRDISSKNVLLNLEYEA 845 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~Dlk~~Nill~~~~~~ 845 (973)
..++||||+++|+|.++++.. .+++..++.++.|++.|++||| +. +|+||||||+||+++.++.+
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred eeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence 679999999999999999643 5889999999999999999999 77 99999999999999999999
Q ss_pred EEecccccccccCCCCc----ccccccccCcccccccccC------CCCCccchHHHHHHHHHHHhC----------CCC
Q 002069 846 HVSDFGISKFLKLGLSN----RTELAGTFGYIAPELAYTM------KVTEKCDVYSFGVLALEVIKG----------KHP 905 (973)
Q Consensus 846 kl~Dfg~a~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slG~~l~el~tg----------~~p 905 (973)
||+|||+++........ .....||+.|+|||++.+. .++.++|||||||++|||+|| +.|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 99999999876544322 2334799999999999876 455789999999999999999 777
Q ss_pred CcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 906 RDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
|.......................+..+... ........+.+++.+||+.||++|||+++|++.|+
T Consensus 233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 298 (301)
T 3q4u_A 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRW-FSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298 (301)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-GGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred ccccCCCCcchhhhhHHHhccCCCCCCChhh-ccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence 7532211111111001111111222222211 12345677899999999999999999999999885
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=367.36 Aligned_cols=368 Identities=21% Similarity=0.238 Sum_probs=245.9
Q ss_pred CCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCC
Q 002069 33 KNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSI 112 (973)
Q Consensus 33 ~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 112 (973)
.+...+..+..++.+++|++|++++|.+++ +| +++.+++|++|++++|++++ +| ++.+++|++|++++|++++ +
T Consensus 27 ~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~ 100 (457)
T 3bz5_A 27 AFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-L 100 (457)
T ss_dssp HTTCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-C
T ss_pred hcCcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-e
Confidence 334444455678888999999999999884 56 68889999999999999884 54 8888899999999999885 4
Q ss_pred CCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccC
Q 002069 113 PSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLK 192 (973)
Q Consensus 113 p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~ 192 (973)
| ++++++|++|++++|++++ +| ++++++|++|++++|++++. + ++.+++|+.|++++|+..+.+ .+..++
T Consensus 101 ~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~ 170 (457)
T 3bz5_A 101 D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQT 170 (457)
T ss_dssp C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCT
T ss_pred e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCC
Confidence 4 8888999999999998885 44 88888899999999988864 3 778888888888888554444 477888
Q ss_pred ccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcchhhhccCC
Q 002069 193 SLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLG 272 (973)
Q Consensus 193 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~ 272 (973)
+|++|++++|++++++ ++.+++|+.|++++|+++++ .++.+++|+.|++++|+++++ | ++
T Consensus 171 ~L~~L~ls~n~l~~l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~~----------- 230 (457)
T 3bz5_A 171 QLTTLDCSFNKITELD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--VT----------- 230 (457)
T ss_dssp TCCEEECCSSCCCCCC---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--CT-----------
T ss_pred cCCEEECCCCccceec---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--cc-----------
Confidence 8888888888888754 77788888888888888876 377788888888888888753 2 44
Q ss_pred CcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcc
Q 002069 273 TNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSI 352 (973)
Q Consensus 273 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 352 (973)
.+++|+.|++++|++++.. ++.+++|+.|++++| +|+.|++++|.+.+.+
T Consensus 231 -------------~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~ 280 (457)
T 3bz5_A 231 -------------PLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYF 280 (457)
T ss_dssp -------------TCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEE
T ss_pred -------------ccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCcc
Confidence 4455556666666665432 234455555555443 2344555555554444
Q ss_pred hhccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCCCCEEEccCCCCCCCcchhhhhhc
Q 002069 353 PLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLT 432 (973)
Q Consensus 353 ~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 432 (973)
| ++.+++|+.|++++|...+..|. ...+|+.|++++| ++|++|++++|++++ ++ +..+.
T Consensus 281 ~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~-l~--l~~l~ 339 (457)
T 3bz5_A 281 Q--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTE-LD--VSHNT 339 (457)
T ss_dssp E--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSC-CC--CTTCT
T ss_pred c--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCcccc-cc--cccCC
Confidence 4 34555666666666655444442 2233444433333 455666666666654 22 33332
Q ss_pred ccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCCcccccccccccccccccccccccCccc
Q 002069 433 NSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESL 501 (973)
Q Consensus 433 ~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~~~~l 501 (973)
+|+.|++++|++++ ++.|..|++++|.+.|. ..+..|..+++++|+++|.+|..+
T Consensus 340 -~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~ 394 (457)
T 3bz5_A 340 -KLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDL 394 (457)
T ss_dssp -TCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTC
T ss_pred -cCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhH
Confidence 56666666666553 23455556666666543 244556666666666666665543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=348.71 Aligned_cols=263 Identities=19% Similarity=0.283 Sum_probs=202.3
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||+|.. .+++.||||++...... ......+.+|+.++++++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc-CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 5799999999999999999965 47899999999765433 233578889999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++ ++.+++.... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.....
T Consensus 81 e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp ECCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred ecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 99986 5555554322 4689999999999999999999999 9999999999999999999999999999887655
Q ss_pred CCcccccccccCcccccccccCC-CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhh-------hhh---hhhhc
Q 002069 860 LSNRTELAGTFGYIAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNL-------NIA---LDEML 928 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~-------~~~---~~~~~ 928 (973)
........||+.|+|||++.+.. ++.++||||+||++|||++|..||.............. ... .....
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 55556678999999999988766 79999999999999999998888532211111000000 000 00000
Q ss_pred C-------CCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 929 D-------PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 929 ~-------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
+ +...............+.+++.+|++.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 00000000111233457799999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=352.39 Aligned_cols=249 Identities=23% Similarity=0.347 Sum_probs=204.4
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|+.. +|+.||+|++...........+.+.+|..+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999654 7999999998643222222356788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++|+|.+++... ..+++..++.++.||+.|++|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999999754 3588999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ....... ...++..
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~i~~~--~~~~p~~--- 225 (318)
T 1fot_A 159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEKILNA--ELRFPPF--- 225 (318)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHHC--CCCCCTT---
T ss_pred ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhC--CCCCCCC---
Confidence 23356799999999999999999999999999999999999999974332110 0111111 1122221
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 002069 939 VQDKLISIMEVSISCLDESPTSRP-----TMQKVSQL 970 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 970 (973)
....+.+++.+|++.||.+|| +++++++.
T Consensus 226 ---~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 226 ---FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ---SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 123577899999999999999 88888753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=352.00 Aligned_cols=253 Identities=21% Similarity=0.287 Sum_probs=198.0
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcc-----------------------hhhHHHHHHHHHHhh
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGE-----------------------MACQQEFLNEGNALT 755 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~e~~~l~ 755 (973)
.++|++.+.||+|+||.||+|.. .+++.||||++....... ....+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999965 578999999987543211 112356889999999
Q ss_pred cCCCCceeeeceeeec--cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCC
Q 002069 756 KIRHRNIVKFYGFCSH--ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDIS 833 (973)
Q Consensus 756 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk 833 (973)
+++||||+++++++.+ ....++||||+++++|.++... ..+++.+++.++.|++.|++|||+. +|+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 9999999999999976 5678999999999999886542 3689999999999999999999999 99999999
Q ss_pred CCCeeecCCCceEEecccccccccCCCCcccccccccCcccccccccCC---CCCccchHHHHHHHHHHHhCCCCCcchh
Q 002069 834 SKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFIS 910 (973)
Q Consensus 834 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~el~tg~~p~~~~~ 910 (973)
|+||+++.++.+||+|||+++.............||+.|+|||.+.+.. ++.++|||||||++|||++|+.||....
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999999987765544445568999999999987665 3678999999999999999999997433
Q ss_pred hhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 911 SICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
... . ........ ...+.. ...+..+.+++.+||+.||.+|||++|+++.
T Consensus 245 ~~~--~---~~~~~~~~--~~~~~~----~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 IMC--L---HSKIKSQA--LEFPDQ----PDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHH--H---HHHHHHCC--CCCCSS----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHH--H---HHHHhccc--CCCCCc----cccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 211 0 00011111 111111 1123457889999999999999999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=358.23 Aligned_cols=255 Identities=23% Similarity=0.331 Sum_probs=198.9
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccce----
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH---- 774 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 774 (973)
.++|++.+.||+|+||+||+|.. .+++.||||++.............+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999964 5889999999987655555556789999999999999999999999876543
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.++||||+++++|.++++.. ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 39999999999999999643 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCC---cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 855 FLKLGLS---NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 855 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ........
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~---------~~~~~~~~ 235 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV---------AYQHVRED 235 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---------HHHHHHCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH---------HHHHhcCC
Confidence 7654322 22345689999999999999999999999999999999999999975432111 11111111
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
...........+..+.+++.+||+.||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 236 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 11111111123456789999999999999998777664
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=347.20 Aligned_cols=252 Identities=24% Similarity=0.390 Sum_probs=205.2
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.++|++.+.||+|+||+||+|++.+++.||||++...... .+++.+|+.++++++||||+++++++.++...++||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 4689999999999999999999888889999999854322 467899999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.....
T Consensus 99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 99 EYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 9999999999997533 4589999999999999999999999 9999999999999999999999999999866432
Q ss_pred C-CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 860 L-SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 860 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
. .......+|+.|+|||.+.+..++.++||||+|+++|||+| |+.||....... .............+..
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~-- 245 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYRPHL-- 245 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTTCCCCCCTT--
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH------HHHHHhcccCCCCCCc--
Confidence 1 12233456788999999998899999999999999999998 999997443211 1111111111111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
....+.+++.+||+.||.+|||++++++.|+
T Consensus 246 ----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 276 (283)
T 3gen_A 246 ----ASEKVYTIMYSCWHEKADERPTFKILLSNIL 276 (283)
T ss_dssp ----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ----CCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 1235788999999999999999999999874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=359.45 Aligned_cols=257 Identities=22% Similarity=0.399 Sum_probs=208.3
Q ss_pred HhcCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA 772 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 772 (973)
..++|++.+.||+|+||.||+|... +++.||||+++.... ....+.+.+|+.++++++||||+++++++.++
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 4578999999999999999999663 348899999986532 33467899999999999999999999999999
Q ss_pred ceeEEEEEecCCCChHHHhccCcc---------------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeec
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAA---------------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRD 831 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~D 831 (973)
+..++||||+++++|.+++..... ...+++.+++.++.||+.|++|||++ +|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 999999999999999999976431 14689999999999999999999999 999999
Q ss_pred CCCCCeeecCCCceEEecccccccccCCC--CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcc
Q 002069 832 ISSKNVLLNLEYEAHVSDFGISKFLKLGL--SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDF 908 (973)
Q Consensus 832 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~ 908 (973)
|||+||+++.++.+||+|||.++...... .......+|+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999998664332 22234568899999999998899999999999999999999 9999974
Q ss_pred hhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 909 ISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.... ................ ..+..+.+++.+||+.||.+|||++++++.|+
T Consensus 280 ~~~~---------~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~ 331 (343)
T 1luf_A 280 MAHE---------EVIYYVRDGNILACPE---NCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331 (343)
T ss_dssp SCHH---------HHHHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CChH---------HHHHHHhCCCcCCCCC---CCCHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence 3321 1111111111111111 12345788999999999999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=361.15 Aligned_cols=253 Identities=18% Similarity=0.250 Sum_probs=205.7
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.+.|++.+.||+|+||+||+|.. .+|+.||+|++.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 46799999999999999999965 478999999987542 22356789999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC--CCceEEecccccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL--EYEAHVSDFGISKFL 856 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~--~~~~kl~Dfg~a~~~ 856 (973)
|||+++++|.+++.... ..+++.+++.++.||+.|++|||+. +|+||||||+||+++. ++.+||+|||+++..
T Consensus 127 ~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 127 LEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence 99999999999986543 3588999999999999999999999 9999999999999974 478999999999877
Q ss_pred cCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 857 KLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 857 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...+.........
T Consensus 202 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---------~~~i~~~~~~~~~ 271 (387)
T 1kob_A 202 NPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---------LQNVKRCDWEFDE 271 (387)
T ss_dssp CTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---------HHHHHHCCCCCCS
T ss_pred CCC-cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH---------HHHHHhCCCCCCc
Confidence 544 233445799999999999999999999999999999999999999975432110 0111111111111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+..+.+++.+||+.||.+|||++|+++.
T Consensus 272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1111223457899999999999999999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.16 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=204.6
Q ss_pred HHhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeecccee
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 775 (973)
...++|++.+.||+|+||.||+|+.. +|+.||||+++..........+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 44678999999999999999999764 7899999998643211122346678888888876 999999999999999999
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
|+||||+++|+|.+++... ..+++.++..++.||+.|++|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999999653 3589999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 856 LKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 856 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
............||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...... ..+.++..
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----~~~i~~--~~~~~p~~ 240 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-----FHSIRM--DNPFYPRW 240 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHH--CCCCCCTT
T ss_pred cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH-----HHHHHh--CCCCCCcc
Confidence 55444445567899999999999999999999999999999999999999974432100 000100 11222221
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHH-HHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQ-KVSQ 969 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ev~~ 969 (973)
....+.+++.+||+.||.+||++. ++.+
T Consensus 241 ------~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 241 ------LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ------SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------cCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 223577899999999999999997 6654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=350.11 Aligned_cols=253 Identities=24% Similarity=0.387 Sum_probs=184.8
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|.. .+++.||||++...........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999965 58999999998643222222347789999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999997543 4689999999999999999999999 999999999999999999999999999987764
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.........|++.|+|||.+.+..++.++||||+|+++|||++|+.||...... .............+
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~~~--- 232 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK---------NTLNKVVLADYEMP--- 232 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------CCSSCCCCC---
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH---------HHHHHHhhcccCCc---
Confidence 434444567899999999999888999999999999999999999999743211 11111111111111
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...+..+.+++.+||+.||++|||++++++.
T Consensus 233 -~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 233 -SFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -cccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 1123357789999999999999999999863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=354.90 Aligned_cols=255 Identities=22% Similarity=0.293 Sum_probs=187.1
Q ss_pred CCccc---ccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeeccceeE
Q 002069 702 NFDDE---HCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 702 ~~~~~---~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 776 (973)
+|++. +.||+|+||+||+|.. .+++.||||++.. .....+.+|+.+++.+. ||||+++++++.++...+
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG------GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh------hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 45543 7899999999999965 4789999999853 22467789999999996 999999999999999999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC---ceEEeccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY---EAHVSDFGIS 853 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~---~~kl~Dfg~a 853 (973)
+||||+++++|.+++... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++ .+||+|||.+
T Consensus 83 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFA 156 (325)
T ss_dssp EEECCCCSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred EEEEccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccc
Confidence 999999999999999754 3689999999999999999999999 999999999999998765 8999999999
Q ss_pred ccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 854 KFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 854 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
+.............||+.|+|||++.+..++.++||||+||++|||++|+.||........ .................
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~i~~~~~~ 234 (325)
T 3kn6_A 157 RLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT--CTSAVEIMKKIKKGDFS 234 (325)
T ss_dssp EECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCCHHHHHHHHTTTCCC
T ss_pred eecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc--cccHHHHHHHHHcCCCC
Confidence 8776554555567789999999999999999999999999999999999999975432110 01112223333344443
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+...+..+.+++.+||+.||.+|||++|+++.
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 3333333455678899999999999999999998753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=363.62 Aligned_cols=259 Identities=24% Similarity=0.369 Sum_probs=207.9
Q ss_pred HHhcCCcccccccCCCceeEEEEEcC-CC-----CEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeee
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAELP-TG-----EIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCS 770 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 770 (973)
...++|++.+.||+|+||+||+|... ++ +.||+|++..... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH--ADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC--hHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34578999999999999999999653 23 4899999976532 23467899999999999 8999999999999
Q ss_pred ccceeEEEEEecCCCChHHHhccCcc-----------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeee
Q 002069 771 HALHSFVVYEYLEMGSLAMILSNDAA-----------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL 839 (973)
Q Consensus 771 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill 839 (973)
+++..++||||+++|+|.+++..... ...+++..++.++.|++.|++|||+. +|+||||||+||++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence 99999999999999999999965431 23578999999999999999999999 99999999999999
Q ss_pred cCCCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhh
Q 002069 840 NLEYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSL 916 (973)
Q Consensus 840 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~ 916 (973)
+.++.+||+|||+++....... ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-- 275 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-- 275 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--
Confidence 9999999999999987654322 1233557889999999998899999999999999999998 9999874321110
Q ss_pred hhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 917 SSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.............+.. .+..+.+++.+||+.||.+|||++++++.|+
T Consensus 276 ---~~~~~~~~~~~~~~~~------~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 322 (333)
T 2i1m_A 276 ---FYKLVKDGYQMAQPAF------APKNIYSIMQACWALEPTHRPTFQQICSFLQ 322 (333)
T ss_dssp ---HHHHHHHTCCCCCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---HHHHHhcCCCCCCCCC------CCHHHHHHHHHHhccChhhCcCHHHHHHHHH
Confidence 1111111111111111 1335788999999999999999999999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=361.54 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=205.5
Q ss_pred hcCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 773 (973)
.++|++.+.||+|+||+||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 467999999999999999999742 56789999997542 2334567899999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHhccCc----cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC---ceE
Q 002069 774 HSFVVYEYLEMGSLAMILSNDA----AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY---EAH 846 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~---~~k 846 (973)
..++||||+++|+|.++++... ....+++.+++.++.|++.|++|||+. +|+||||||+||+++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999996543 224589999999999999999999999 999999999999999555 599
Q ss_pred EecccccccccCCC--CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhh
Q 002069 847 VSDFGISKFLKLGL--SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIA 923 (973)
Q Consensus 847 l~Dfg~a~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 923 (973)
|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++ |..||...... ..
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---------~~ 295 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---------EV 295 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---------HH
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---------HH
Confidence 99999998653321 22334567899999999999999999999999999999998 99999744321 11
Q ss_pred hhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 924 LDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.............. ..+..+.+++.+||+.||.+|||+++|++.|+
T Consensus 296 ~~~i~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~ 341 (367)
T 3l9p_A 296 LEFVTSGGRMDPPK---NCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341 (367)
T ss_dssp HHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHcCCCCCCCc---cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 11111111111111 12335788999999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=358.76 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=203.8
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|.. .+++.||+|++...........+.+.+|+.+++.++|||||++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 36799999999999999999965 47899999998643222223357788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++|+|.++++.. ..+++..++.++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 94 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999999754 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccCccccccccc---CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhc--CCCCC
Q 002069 859 GLSNRTELAGTFGYIAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML--DPRLP 933 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 933 (973)
. .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ......... ...++
T Consensus 168 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~------~~~~~~~~~~~~~~~p 240 (384)
T 4fr4_A 168 E-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS------SKEIVHTFETTVVTYP 240 (384)
T ss_dssp T-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC------HHHHHHHHHHCCCCCC
T ss_pred C-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc------HHHHHHHHhhcccCCC
Confidence 3 34456789999999999864 458899999999999999999999997432110 001111111 11222
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCC-HHHHHH
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPT-MQKVSQ 969 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ev~~ 969 (973)
.. .+..+.+++.+||+.||.+||+ ++++.+
T Consensus 241 ~~------~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 241 SA------WSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp TT------SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred Cc------CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 21 2235788999999999999998 777764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=354.70 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=202.5
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|... +++.||||++...... ...+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 468999999999999999999654 8999999998654322 2246788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.++++... .+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.+..
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp EECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 99999999999986543 589999999999999999999999 999999999999999999999999999987653
Q ss_pred CC--CcccccccccCcccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCC-CCCC
Q 002069 859 GL--SNRTELAGTFGYIAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDP-RLPT 934 (973)
Q Consensus 859 ~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 934 (973)
.. .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.......... ...... ....
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--------~~~~~~~~~~~ 229 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--------SDWKEKKTYLN 229 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH--------HHHHTTCTTST
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH--------HHHhcccccCC
Confidence 32 22345679999999999987775 678999999999999999999997543221111 111111 1111
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.. ......+.+++.+||+.||.+|||++|+++.
T Consensus 230 ~~---~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 PW---KKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TG---GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cc---ccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11 1223456789999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=361.23 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=208.6
Q ss_pred hcCCcccccccCCCceeEEEEEc--------CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL--------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCS 770 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 770 (973)
.++|++.+.||+|+||+||+|.. ..++.||||++.... .....+.+.+|+++++++ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 46899999999999999999964 234579999997653 233467899999999999 9999999999999
Q ss_pred ccceeEEEEEecCCCChHHHhccCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCe
Q 002069 771 HALHSFVVYEYLEMGSLAMILSNDAA-------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNV 837 (973)
Q Consensus 771 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni 837 (973)
.++..++||||+++|+|.++++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 99999999999999999999976542 24589999999999999999999999 999999999999
Q ss_pred eecCCCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhh
Q 002069 838 LLNLEYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICS 914 (973)
Q Consensus 838 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 914 (973)
+++.++.+||+|||.++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-- 300 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 300 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999987654322 2334567889999999999999999999999999999999 99999743311
Q ss_pred hhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 915 SLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..............+.. ....+.+++.+||+.||.+|||++||++.|+
T Consensus 301 ----~~~~~~~~~~~~~~~~~------~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 348 (382)
T 3tt0_A 301 ----ELFKLLKEGHRMDKPSN------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348 (382)
T ss_dssp ----HHHHHHHTTCCCCCCSS------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----HHHHHHHcCCCCCCCcc------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 01111111111122211 2335788999999999999999999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=357.56 Aligned_cols=252 Identities=20% Similarity=0.268 Sum_probs=204.8
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 776 (973)
..++|++.+.||+|+||.||+|+.. +++.||||+++..........+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3578999999999999999999765 6889999998643221222356788999999988 8999999999999999999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
+||||+++|+|.++++.. ..+++.+++.++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999999643 3589999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 857 KLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 857 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
...........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......+.
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---------~~~~~i~~~~~~~p~ 242 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---------ELFQSIMEHNVAYPK 242 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHCCCCCCT
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---------HHHHHHHhCCCCCCC
Confidence 44444455678999999999999999999999999999999999999999743321 111111111111111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPT-----MQKVSQ 969 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~ 969 (973)
..+..+.+++.+||+.||.+||+ ++++.+
T Consensus 243 ----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 243 ----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ----TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 12335778999999999999995 577764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=356.14 Aligned_cols=247 Identities=21% Similarity=0.266 Sum_probs=204.9
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|+.. +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367999999999999999999654 7999999998643222223356788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++|+|.+++... ..+++.+++.++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999999753 3589999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCC--CCCCCc
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTPL 936 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 936 (973)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... .++..
T Consensus 194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---------~~~~~i~~~~~~~p~~- 260 (350)
T 1rdq_E 194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---------QIYEKIVSGKVRFPSH- 260 (350)
T ss_dssp C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHCCCCCCTT-
T ss_pred C---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH---------HHHHHHHcCCCCCCCC-
Confidence 2 33467999999999999999999999999999999999999999743321 111111111 12221
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPT-----MQKVSQL 970 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~ 970 (973)
.+..+.+++.+||+.||.+||+ ++|+++.
T Consensus 261 -----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 261 -----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 2335788999999999999998 8888753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=366.27 Aligned_cols=264 Identities=22% Similarity=0.349 Sum_probs=210.0
Q ss_pred HHHHHHHhcCCcccccccCCCceeEEEEEc------CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeee
Q 002069 693 HEEIIRATKNFDDEHCIGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKF 765 (973)
Q Consensus 693 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~ 765 (973)
........++|++.+.||+|+||.||+|++ .+++.||||+++.... ....+.+.+|+.+++++ +||||+++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC--HHHHHHHHHHHHHHHhhcCCcceeee
Confidence 444555678999999999999999999962 3568999999976432 23357899999999999 89999999
Q ss_pred ceeeeccc-eeEEEEEecCCCChHHHhccCcc------------------------------------------------
Q 002069 766 YGFCSHAL-HSFVVYEYLEMGSLAMILSNDAA------------------------------------------------ 796 (973)
Q Consensus 766 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------ 796 (973)
++++.+.+ ..++||||+++|+|.++++....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99997754 48999999999999999976532
Q ss_pred ---------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC
Q 002069 797 ---------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS 861 (973)
Q Consensus 797 ---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 861 (973)
...+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 11288999999999999999999999 999999999999999999999999999987644322
Q ss_pred --cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 862 --NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 862 --~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||....... ..............+..
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~--- 320 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKEGTRMRAPDY--- 320 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-----HHHHHHHHTCCCCCCTT---
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-----HHHHHHHcCCCCCCCCC---
Confidence 2334668899999999999999999999999999999998 999997433111 01111111112222211
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
....+.+++.+||+.||.+|||++|++++|+
T Consensus 321 ---~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 351 (359)
T 3vhe_A 321 ---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351 (359)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---CCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 2235788999999999999999999999885
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=372.07 Aligned_cols=259 Identities=19% Similarity=0.236 Sum_probs=204.9
Q ss_pred HHHHhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccce
Q 002069 696 IIRATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH 774 (973)
Q Consensus 696 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 774 (973)
+....++|++.+.||+|+||+||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+++.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3344678999999999999999999664 789999999864211111112457889999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.|+||||+++|+|.++++.. .+++..++.++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+|+
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 99999999999999999643 478999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCC-cccccccccCcccccccccCC----CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcC
Q 002069 855 FLKLGLS-NRTELAGTFGYIAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLD 929 (973)
Q Consensus 855 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 929 (973)
....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ ..........
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----~~~i~~~~~~ 291 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-----YSKIMNHKNS 291 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHTHHHH
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH-----HHHHHhcccc
Confidence 7654422 234568999999999998665 78899999999999999999999974432110 1111111101
Q ss_pred CCCCCCchhhHHHHHHHHHHHhcccCCCCCC--CCCHHHHHHH
Q 002069 930 PRLPTPLRNVQDKLISIMEVSISCLDESPTS--RPTMQKVSQL 970 (973)
Q Consensus 930 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~ 970 (973)
..++.. ...+..+.+++.+|++.+|.+ ||+++||+++
T Consensus 292 ~~~p~~----~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 292 LTFPDD----NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCCTT----CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccCCCc----ccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 111111 012234678999999999999 9999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=350.74 Aligned_cols=265 Identities=20% Similarity=0.312 Sum_probs=191.4
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
..+|++.+.||+|+||+||+|... +|+.||||++...... ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 467999999999999999999664 7899999998754322 2246788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCc---cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 779 YEYLEMGSLAMILSNDA---AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
|||++ ++|.+++.... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99998 69999886432 123588999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh--hh----hhhhhh---hhh
Q 002069 856 LKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS--SL----SSNLNI---ALD 925 (973)
Q Consensus 856 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~----~~~~~~---~~~ 925 (973)
............||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ .. ...... ...
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 7654444456678999999999876 4689999999999999999999999975432110 00 000000 000
Q ss_pred h--hcCCCC----CCCchh------hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 926 E--MLDPRL----PTPLRN------VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 926 ~--~~~~~~----~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
. ...+.+ +..... .......+.+++.+||+.||.+|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 000000 000000 00123467899999999999999999999863
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=348.27 Aligned_cols=262 Identities=23% Similarity=0.357 Sum_probs=202.4
Q ss_pred hcCCcccccccCCCceeEEEEEc-----CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc--
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-----PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA-- 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-- 772 (973)
.++|++.+.||+|+||+||+|++ .+++.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 46899999999999999999973 36889999999753 233457899999999999999999999998553
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
...++||||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred CceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 45899999999999999997653 3589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCC---cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhh-hhhhhh-----h-hh
Q 002069 853 SKFLKLGLS---NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIC-SSLSSN-----L-NI 922 (973)
Q Consensus 853 a~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-~~~~~~-----~-~~ 922 (973)
++....... ......+++.|+|||.+.+..++.++||||||+++|||+||..||....... ...... . ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 987654322 2233457788999999999999999999999999999999999987543211 000000 0 01
Q ss_pred hhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 923 ALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.............. ...+..+.+++.+||+.||.+|||++|+++.|+
T Consensus 241 ~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~ 287 (295)
T 3ugc_A 241 LIELLKNNGRLPRP---DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287 (295)
T ss_dssp HHHHHHTTCCCCCC---TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhccCcCCCC---cCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 11111111111111 122345788999999999999999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=358.04 Aligned_cols=249 Identities=22% Similarity=0.253 Sum_probs=197.5
Q ss_pred cccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEec
Q 002069 704 DDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYL 782 (973)
Q Consensus 704 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 782 (973)
...+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 3367899999999999965 579999999997542 234578999999999999999999999999999999999999
Q ss_pred CCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeee--cCCCceEEecccccccccCCC
Q 002069 783 EMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL--NLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 783 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill--~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
++++|.+++.... ..+++.+++.++.||+.|++|||+. +|+||||||+||++ +.++.+||+|||+++......
T Consensus 169 ~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 169 DGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp TTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 9999999886443 3588999999999999999999999 99999999999999 567899999999998775542
Q ss_pred CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhH
Q 002069 861 SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (973)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.............
T Consensus 244 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---------~~~~~i~~~~~~~~~~~~~ 313 (373)
T 2x4f_A 244 -KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---------ETLNNILACRWDLEDEEFQ 313 (373)
T ss_dssp -BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---------HHHHHHHHTCCCSCSGGGT
T ss_pred -ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHhccCCCChhhhc
Confidence 233457999999999999889999999999999999999999999754321 1111111111111111112
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 941 DKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 941 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+.+++.+||+.||.+|||++|+++.
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 234567899999999999999999999873
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.91 Aligned_cols=255 Identities=20% Similarity=0.239 Sum_probs=207.7
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcc---hhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGE---MACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
.++|++.+.||+|+||.||+|... +|+.||||++....... ....+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999654 78999999987543222 11357899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC----ceEEeccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY----EAHVSDFG 851 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~----~~kl~Dfg 851 (973)
++||||+++++|.+++... ..+++..++.++.|++.|++|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 9999999999999999754 3578999999999999999999999 999999999999999887 79999999
Q ss_pred ccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 852 ISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 852 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
.++..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ..........
T Consensus 165 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------~~~~~i~~~~ 234 (321)
T 2a2a_A 165 LAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---------ETLANITSVS 234 (321)
T ss_dssp TCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---------HHHHHHHTTC
T ss_pred cceecCcc-ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---------HHHHHHHhcc
Confidence 99877554 2334567999999999999999999999999999999999999999743321 1111111111
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...........+..+.+++.+||+.||.+|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111111111233457899999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=345.45 Aligned_cols=255 Identities=25% Similarity=0.411 Sum_probs=194.2
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcc-hhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGE-MACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|.+ .++.||||++....... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46799999999999999999987 48899999987543222 22357789999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC--------CCceEEecc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL--------EYEAHVSDF 850 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~--------~~~~kl~Df 850 (973)
|||+++++|.++++. ..+++.+++.++.|++.|++|||++...+++||||||+||+++. ++.+|++||
T Consensus 85 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999999863 35889999999999999999999992222999999999999986 678999999
Q ss_pred cccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCC
Q 002069 851 GISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDP 930 (973)
Q Consensus 851 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (973)
|.++...... .....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||......... ..........
T Consensus 161 g~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~ 233 (271)
T 3dtc_A 161 GLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA-----YGVAMNKLAL 233 (271)
T ss_dssp CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-----HHHHTSCCCC
T ss_pred Cccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HhhhcCCCCC
Confidence 9998665432 23457899999999999989999999999999999999999999754321110 0011111111
Q ss_pred CCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 931 RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 931 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+. ..+..+.+++.+||+.||.+|||++|+++.|+
T Consensus 234 ~~~~------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~ 269 (271)
T 3dtc_A 234 PIPS------TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269 (271)
T ss_dssp CCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCc------ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHh
Confidence 1111 12345788999999999999999999999885
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=352.02 Aligned_cols=250 Identities=23% Similarity=0.315 Sum_probs=194.5
Q ss_pred hcCCcccccccCCCceeEEEEEc----CCCCEEEEEEcCCCCCc-chhhHHHHHHHHHHhhcCCCCceeeeceeeeccce
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL----PTGEIVAVKKFHSPLPG-EMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH 774 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 774 (973)
.++|++.+.||+|+||.||+|+. .+++.||+|+++..... .......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999965 47899999999764321 12234668889999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.++||||+++++|.+++... ..+++..+..++.||+.|++|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999999643 3578999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCC--CC
Q 002069 855 FLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDP--RL 932 (973)
Q Consensus 855 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 932 (973)
.............||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... .+
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~~~i~~~~~~~ 240 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---------KTIDKILKCKLNL 240 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---------HHHHHHHHTCCCC
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---------HHHHHHHhCCCCC
Confidence 6554434445567999999999999989999999999999999999999999754321 111111111 12
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRP-----TMQKVSQL 970 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 970 (973)
+.. ....+.+++.+||+.||.+|| +++++++.
T Consensus 241 p~~------~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 241 PPY------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp CTT------SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred CCC------CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 211 223577899999999999999 77787753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=355.97 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=189.9
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
..++|++.+.||+|+||+||+|... +++.||||++.... ..+.+.+|+.++++++||||+++++++.+++..++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 3567999999999999999999665 68899999997542 24678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC---CCceEEecccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL---EYEAHVSDFGISK 854 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---~~~~kl~Dfg~a~ 854 (973)
||||+++++|.+++.... .+++.+++.++.|++.|++|||+. +|+||||||+||+++. ++.+||+|||+++
T Consensus 126 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp EECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 999999999999997543 589999999999999999999999 9999999999999975 7899999999998
Q ss_pred cccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCC
Q 002069 855 FLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934 (973)
Q Consensus 855 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (973)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ............
T Consensus 200 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--------~~~~i~~~~~~~ 270 (349)
T 2w4o_A 200 IVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--------MFRRILNCEYYF 270 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--------HHHHHHTTCCCC
T ss_pred ccCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--------HHHHHHhCCCcc
Confidence 76543 223446799999999999999999999999999999999999999964332110 111111111111
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
........+..+.+++.+||+.||++|||+.|+++.
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111112233457899999999999999999999874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=351.10 Aligned_cols=256 Identities=25% Similarity=0.374 Sum_probs=208.3
Q ss_pred hcCCcccccccCCCceeEEEEEc------CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 773 (973)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 56899999999999999999964 345889999997543 2344678999999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHhccCcc---------------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecC
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAA---------------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDI 832 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dl 832 (973)
..++||||+++++|.+++..... ...+++.+++.++.|++.|++|||++ +|+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccccc
Confidence 99999999999999999976432 23478999999999999999999999 9999999
Q ss_pred CCCCeeecCCCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcch
Q 002069 833 SSKNVLLNLEYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFI 909 (973)
Q Consensus 833 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~ 909 (973)
||+||+++.++.+||+|||.++....... ......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654322 2233457889999999998889999999999999999999 99999743
Q ss_pred hhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 910 SSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.... .............+. ..+..+.+++.+||+.||.+||+++++++.|+
T Consensus 257 ~~~~------~~~~~~~~~~~~~~~------~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~ 307 (314)
T 2ivs_A 257 PPER------LFNLLKTGHRMERPD------NCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307 (314)
T ss_dssp CGGG------HHHHHHTTCCCCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHH------HHHHhhcCCcCCCCc------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 3210 011111111111111 12345789999999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=358.61 Aligned_cols=245 Identities=23% Similarity=0.269 Sum_probs=193.6
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHH-hhcCCCCceeeeceeeeccceeEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNA-LTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
.++|++.+.||+|+||.||+|+.. +++.||||++.............+..|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999664 788999999975543333334566777776 577899999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||||+++|+|.+++++. ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999999653 3588999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCC--CCCCC
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTP 935 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 935 (973)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....++.. .++..
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---------~~~~~i~~~~~~~~~~ 261 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---------EMYDNILNKPLQLKPN 261 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---------HHHHHHHHSCCCCCSS
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---------HHHHHHHhcccCCCCC
Confidence 4444555678999999999999999999999999999999999999999743321 111111111 11211
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQ 965 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 965 (973)
....+.+++.+||+.||.+||++.
T Consensus 262 ------~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 262 ------ITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp ------SCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred ------CCHHHHHHHHHHcccCHHhCCCCC
Confidence 223467899999999999999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=366.10 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=206.1
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|.+.+.||+|+||.||+|... +|+.||||++.............+.+|+.+++.++||||+++++++..++..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367999999999999999999664 8999999998643222222356789999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++|+|.+++... ..+++.+++.++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 95 ~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999999754 3589999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCcccccccccCcccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
. .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||+.... ......+.......+.
T Consensus 169 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---------~~~~~~i~~~~~~~p~- 237 (476)
T 2y94_A 169 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---------PTLFKKICDGIFYTPQ- 237 (476)
T ss_dssp T-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---------HHHHHHHHTTCCCCCT-
T ss_pred c-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---------HHHHHHHhcCCcCCCc-
Confidence 4 23345679999999999988765 6799999999999999999999974331 1111112222211111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+.+++.+||+.||.+|||++|+++.
T Consensus 238 ---~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 238 ---YLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ---TCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---cCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 112347789999999999999999999863
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.67 Aligned_cols=254 Identities=20% Similarity=0.281 Sum_probs=205.3
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|+.++++++||||+++++++.++...++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 47899999999999999999965 47899999998754332 23357788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCc---eEEeccccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYE---AHVSDFGISKF 855 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~---~kl~Dfg~a~~ 855 (973)
|||+++++|.+++... ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++. +||+|||.+..
T Consensus 84 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999888643 3589999999999999999999999 9999999999999987655 99999999987
Q ss_pred ccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 856 LKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 856 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
.... .......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||....... ............+
T Consensus 158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~~~~~~~~ 227 (284)
T 3kk8_A 158 VNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---------LYAQIKAGAYDYP 227 (284)
T ss_dssp CCSS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHTCCCCC
T ss_pred cccC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---------HHHHHHhccccCC
Confidence 6543 23345679999999999999999999999999999999999999997433211 0011111111111
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.......+..+.+++.+||+.||.+|||++|+++.
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 228 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11111223457889999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.03 Aligned_cols=248 Identities=22% Similarity=0.254 Sum_probs=195.3
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 777 (973)
.++|++.++||+|+||+||+|... +++.||||++......... ...+..|+..+.++ +||||+++++++.+++..++
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 367999999999999999999665 8999999998765444333 34455555555544 99999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||||+ +++|.+++.... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 135 v~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 678988886543 4689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
.. .......||+.|+|||++.+ .++.++|||||||++|||++|..|+...... ........+..
T Consensus 209 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~------------~~~~~~~~~~~-- 272 (311)
T 3p1a_A 209 TA-GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW------------QQLRQGYLPPE-- 272 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH------------HHHTTTCCCHH--
T ss_pred cC-CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH------------HHHhccCCCcc--
Confidence 43 23344569999999999876 6899999999999999999997765432221 11111111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+..+.+++.+||+.||++|||++|+++.
T Consensus 273 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 273 FTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111234568899999999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=342.69 Aligned_cols=252 Identities=21% Similarity=0.276 Sum_probs=205.7
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
..++|++.+.||+|+||+||+|... +++.||+|++...... ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 3567999999999999999999654 6789999998754322 25789999999999999999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeee---cCCCceEEecccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL---NLEYEAHVSDFGISK 854 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill---~~~~~~kl~Dfg~a~ 854 (973)
||||+++++|.+++... ..+++.+++.++.|++.|++|||+. +++||||||+||++ +.++.+||+|||.+.
T Consensus 84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 84 VMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 99999999999988643 3589999999999999999999999 99999999999999 778999999999998
Q ss_pred cccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCC
Q 002069 855 FLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934 (973)
Q Consensus 855 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (973)
..... .......||+.|+|||.+.+. ++.++||||+|+++|||++|+.||...... .............
T Consensus 158 ~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~~ 226 (277)
T 3f3z_A 158 RFKPG-KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS---------EVMLKIREGTFTF 226 (277)
T ss_dssp ECCTT-SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHCCCCC
T ss_pred eccCc-cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH---------HHHHHHHhCCCCC
Confidence 77544 233456799999999998764 899999999999999999999999754321 1111111222222
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
+.......+..+.+++.+|++.||.+|||+.++++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 227 PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 222112234568899999999999999999999863
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=357.36 Aligned_cols=255 Identities=18% Similarity=0.202 Sum_probs=203.5
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 777 (973)
..+|++.+.||+|+||+||+|.. .+++.||||++..... .+.+.+|+.+++++ +||||+++++++..++..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 36799999999999999999964 5889999999875422 24578899999999 99999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCc-----eEEecccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYE-----AHVSDFGI 852 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~-----~kl~Dfg~ 852 (973)
||||+ +++|.+++... ...+++.+++.++.|++.|++|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 83 v~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred EEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 99999 89999999754 24689999999999999999999999 9999999999999998887 99999999
Q ss_pred cccccCCCCc-------ccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhh
Q 002069 853 SKFLKLGLSN-------RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALD 925 (973)
Q Consensus 853 a~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 925 (973)
++.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~------~~~~~~ 230 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT------LKERYQ 230 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS------HHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc------HHHHHH
Confidence 9876543221 245679999999999999999999999999999999999999997532100 000000
Q ss_pred hhcCCCCCCCchh-hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 926 EMLDPRLPTPLRN-VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 926 ~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.......+..... ....+ .+.+++..||+.||.+||++++|.+.|+
T Consensus 231 ~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~ 277 (330)
T 2izr_A 231 KIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT 277 (330)
T ss_dssp HHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred HHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence 0000000000000 00112 6889999999999999999999998774
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=346.96 Aligned_cols=252 Identities=27% Similarity=0.443 Sum_probs=197.0
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.++|++.+.||+|+||+||+|.+ .++.||||++... ...+.|.+|+.++++++||||+++++++.+ ..++||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 35789999999999999999987 4789999998642 235789999999999999999999999874 478999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCc-eEEecccccccccC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYE-AHVSDFGISKFLKL 858 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~-~kl~Dfg~a~~~~~ 858 (973)
||+++++|.++++.......+++..++.++.|+++|++|||+....+|+||||||+||+++.++. +||+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999999987665556889999999999999999999932128999999999999998886 79999999976543
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||+....... ...........+....
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~- 227 (307)
T 2eva_A 159 H---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-------RIMWAVHNGTRPPLIK- 227 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-------HHHHHHHTTCCCCCBT-
T ss_pred c---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-------HHHHHHhcCCCCCccc-
Confidence 2 2345689999999999999999999999999999999999999974321100 0000111111111111
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+..+.+++.+||+.||.+|||++++++.|+
T Consensus 228 --~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 259 (307)
T 2eva_A 228 --NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259 (307)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 12335778999999999999999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=351.48 Aligned_cols=257 Identities=21% Similarity=0.340 Sum_probs=190.5
Q ss_pred hcCCcccccccCCCceeEEEEEcCC-C---CEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPT-G---EIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
.++|++.+.||+|+||+||+|.... + ..||||++....... ...+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 4689999999999999999997653 3 279999997643322 3367899999999999999999999999776554
Q ss_pred ------EEEEEecCCCChHHHhccCcc---ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceE
Q 002069 776 ------FVVYEYLEMGSLAMILSNDAA---AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAH 846 (973)
Q Consensus 776 ------~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~k 846 (973)
++||||+++++|.+++..... ...+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence 899999999999999964332 12589999999999999999999999 999999999999999999999
Q ss_pred EecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhh
Q 002069 847 VSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIA 923 (973)
Q Consensus 847 l~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 923 (973)
|+|||.++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... ..
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---------~~ 248 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---------EI 248 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---------GH
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---------HH
Confidence 999999987654322 2223456789999999999999999999999999999999 99999744321 11
Q ss_pred hhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 924 LDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
............. ...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 249 ~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 294 (323)
T 3qup_A 249 YNYLIGGNRLKQP---PECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294 (323)
T ss_dssp HHHHHTTCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhcCCCCCCC---CccCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1111111111111 112345789999999999999999999998875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=369.10 Aligned_cols=253 Identities=23% Similarity=0.393 Sum_probs=206.7
Q ss_pred HhcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
..++|++.+.||+|+||+||+|.+.+++.||||+++.... ..+.|.+|+.++++++||||+++++++. .+..++|
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 3568999999999999999999988889999999975432 2578999999999999999999999987 5578999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++|+|.++++... ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 261 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp ECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 99999999999997543 23578999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 859 GLS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 859 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
... ......+++.|+|||++....++.++|||||||++|||+| |+.||....... ....+........+.
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~------~~~~i~~~~~~~~~~-- 408 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE------VIRALERGYRMPRPE-- 408 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHHHTCCCCCCT--
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCC--
Confidence 211 1223456789999999998899999999999999999999 999997543211 011111111111111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+..+.+++.+||+.||++|||+++|++.|+
T Consensus 409 ----~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~ 440 (454)
T 1qcf_A 409 ----NCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440 (454)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 22345789999999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=356.49 Aligned_cols=263 Identities=24% Similarity=0.236 Sum_probs=203.5
Q ss_pred HHHHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCC--cchhhHHHHHHHHHHhhcCCCCceeeeceeeecc
Q 002069 696 IIRATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLP--GEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA 772 (973)
Q Consensus 696 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 772 (973)
+....++|++.+.||+|+||+||+|.. .+++.||+|++..... ......+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345678899999999999999999955 5788999999863211 1123357899999999999999999999999999
Q ss_pred ceeEEEEEecCCCChHHHhccCcc-------------------------------------ccCCCHHHHHHHHHHHHHH
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAA-------------------------------------AEEFGWTKRMNAIKGVADA 815 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------~~~~~~~~~~~i~~~i~~~ 815 (973)
+..++||||+++|+|.+++..... ...+++..++.++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999852110 1123577888999999999
Q ss_pred HHHHhhCCCCCeEeecCCCCCeeecCCC--ceEEecccccccccCCCC----cccccccccCccccccccc--CCCCCcc
Q 002069 816 LLYMHTNCFPPIVHRDISSKNVLLNLEY--EAHVSDFGISKFLKLGLS----NRTELAGTFGYIAPELAYT--MKVTEKC 887 (973)
Q Consensus 816 l~~LH~~~~~~i~H~Dlk~~Nill~~~~--~~kl~Dfg~a~~~~~~~~----~~~~~~g~~~y~aPE~~~~--~~~~~~~ 887 (973)
++|||+. +|+||||||+||+++.++ .+||+|||.++.+..... ......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998776 899999999986643221 2345679999999999875 6788999
Q ss_pred chHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHH
Q 002069 888 DVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967 (973)
Q Consensus 888 Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 967 (973)
|||||||++|||++|+.||...... ........................+.+++.+||+.||.+||++.++
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA---------DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH---------HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 9999999999999999999754321 1111111222211112222234567899999999999999999999
Q ss_pred HHH
Q 002069 968 SQL 970 (973)
Q Consensus 968 ~~~ 970 (973)
++.
T Consensus 329 l~h 331 (345)
T 3hko_A 329 LQH 331 (345)
T ss_dssp HHS
T ss_pred hcC
Confidence 874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=343.59 Aligned_cols=252 Identities=22% Similarity=0.310 Sum_probs=209.6
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|.+.+.||+|+||.||+|... +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999654 6889999998755444445567899999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.+++... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++....
T Consensus 94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999988643 3688999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.........|++.|+|||.+.+..++.++||||+|+++|+|++|+.||....... ............+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~~~~-- 236 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---------TYLRIKKNEYSIPK-- 236 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------HHHHHHTTCCCCCT--
T ss_pred CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHhhccCCCcc--
Confidence 5445556779999999999999889999999999999999999999997433211 11111111111111
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+.+++.+||+.||++|||++|+++.
T Consensus 237 --~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 237 --HINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 112347789999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=355.44 Aligned_cols=253 Identities=24% Similarity=0.280 Sum_probs=193.7
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|... +++.||||++...... .+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 468999999999999999999664 8999999999754322 36688999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCc--eEEecccccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYE--AHVSDFGISKFL 856 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~--~kl~Dfg~a~~~ 856 (973)
|||+++|+|.+++... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++. +||+|||.++..
T Consensus 95 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 95 MEYASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 9999999999998643 3589999999999999999999999 9999999999999987765 999999999754
Q ss_pred cCCCCcccccccccCcccccccccCCCCCc-cchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 857 KLGLSNRTELAGTFGYIAPELAYTMKVTEK-CDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 857 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
... .......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||........ ...............+
T Consensus 169 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~ 242 (361)
T 3uc3_A 169 VLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-----YRKTIQRILSVKYSIP 242 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-----HHHHHHHHHTTCCCCC
T ss_pred ccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-----HHHHHHHHhcCCCCCC
Confidence 332 23345679999999999988887665 8999999999999999999975432111 1111222222221111
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.. ...+..+.+++.+||+.||.+|||++|+++.
T Consensus 243 ~~--~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 243 DD--IRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TT--SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred Cc--CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 10 1122357789999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=357.48 Aligned_cols=258 Identities=22% Similarity=0.351 Sum_probs=206.4
Q ss_pred HhcCCcccccccCCCceeEEEEEc------CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeec
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSH 771 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 771 (973)
..++|++.+.||+|+||.||+|.. .+++.||||++...... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 457899999999999999999974 24568999999754322 2357899999999999 89999999999999
Q ss_pred cceeEEEEEecCCCChHHHhccCccc--------------------cCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeec
Q 002069 772 ALHSFVVYEYLEMGSLAMILSNDAAA--------------------EEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRD 831 (973)
Q Consensus 772 ~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~D 831 (973)
.+..++||||+++|+|.+++...... ..+++.+++.++.|++.|++|||+. +|+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence 99999999999999999999765421 3478999999999999999999999 999999
Q ss_pred CCCCCeeecCCCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcc
Q 002069 832 ISSKNVLLNLEYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDF 908 (973)
Q Consensus 832 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~ 908 (973)
|||+||+++.++.+||+|||.+........ ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999987654432 2234567889999999998899999999999999999998 9999975
Q ss_pred hhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 909 ISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...... .............+. ..+..+.+++.+||+.||.+|||++++++.|+
T Consensus 278 ~~~~~~-----~~~~~~~~~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 278 IPVDAN-----FYKLIQNGFKMDQPF------YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CCCSHH-----HHHHHHTTCCCCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCcHHH-----HHHHHhcCCCCCCCC------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 432110 111111111222111 12345788999999999999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=343.65 Aligned_cols=254 Identities=30% Similarity=0.449 Sum_probs=202.4
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhh----HHHHHHHHHHhhcCCCCceeeeceeeeccce
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMAC----QQEFLNEGNALTKIRHRNIVKFYGFCSHALH 774 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 774 (973)
.++|++.+.||+|+||+||+|.. .+++.||||++.......... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36899999999999999999965 589999999987654332221 167899999999999999999999997654
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEeecCCCCCeeecCCCc-----eEE
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP--IVHRDISSKNVLLNLEYE-----AHV 847 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlk~~Nill~~~~~-----~kl 847 (973)
++||||+++++|.+++.... ..+++..++.++.|++.|++|||+. + |+||||||+||+++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 69999999999999886543 4689999999999999999999999 8 999999999999988776 999
Q ss_pred ecccccccccCCCCcccccccccCcccccccc--cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhh
Q 002069 848 SDFGISKFLKLGLSNRTELAGTFGYIAPELAY--TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALD 925 (973)
Q Consensus 848 ~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 925 (973)
+|||.++.... ......||+.|+|||++. ...++.++||||+||++|||++|+.||.......... ......
T Consensus 171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~ 244 (287)
T 4f0f_A 171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF---INMIRE 244 (287)
T ss_dssp CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH---HHHHHH
T ss_pred CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH---HHHHhc
Confidence 99999975433 334567999999999984 4557889999999999999999999997433111000 011111
Q ss_pred hhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 926 EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
....+..+. ..+..+.+++.+||+.||.+|||++++++.|+
T Consensus 245 ~~~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 285 (287)
T 4f0f_A 245 EGLRPTIPE------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285 (287)
T ss_dssp SCCCCCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCCCCCCCc------ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 112222222 12345789999999999999999999999885
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=354.79 Aligned_cols=253 Identities=20% Similarity=0.226 Sum_probs=201.3
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 776 (973)
..++|++.+.||+|+||.||+|... +++.||||++...... +.+|++++.++ +||||+++++++.+++..|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 4567999999999999999999654 7899999999754322 34577777777 7999999999999999999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC----CceEEecccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE----YEAHVSDFGI 852 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~----~~~kl~Dfg~ 852 (973)
+||||+++|+|.+++.... .+++.++..++.||+.|++|||+. +|+||||||+||++..+ +.+||+|||+
T Consensus 93 lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp EEECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 9999999999999997543 589999999999999999999999 99999999999998443 3599999999
Q ss_pred cccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
++.............||+.|+|||++.+..++.++||||+||++|||++|+.||...... ........+....+
T Consensus 167 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~~~~i~~~~~ 240 (342)
T 2qr7_A 167 AKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD------TPEEILARIGSGKF 240 (342)
T ss_dssp CEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS------CHHHHHHHHHHCCC
T ss_pred cccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC------CHHHHHHHHccCCc
Confidence 987765544555678999999999998888899999999999999999999999743210 01111111111122
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+...+..+.+++.+||+.||++|||++++++.
T Consensus 241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11111112233457889999999999999999999863
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=366.46 Aligned_cols=264 Identities=19% Similarity=0.223 Sum_probs=207.1
Q ss_pred HHHHHHhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc
Q 002069 694 EEIIRATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA 772 (973)
Q Consensus 694 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 772 (973)
.++....++|++.++||+|+||+||+|+.. +++.||+|++.............+.+|..++..++||||+++++++.++
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 344445689999999999999999999765 6889999998642111111223488899999999999999999999999
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
+..++||||+++|+|.+++.... ..+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhh
Confidence 99999999999999999997532 4689999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCC-cccccccccCcccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhh
Q 002069 853 SKFLKLGLS-NRTELAGTFGYIAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDE 926 (973)
Q Consensus 853 a~~~~~~~~-~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 926 (973)
|+....... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ .......
T Consensus 222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-----~~~i~~~ 296 (437)
T 4aw2_A 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----YGKIMNH 296 (437)
T ss_dssp CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHTH
T ss_pred hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-----HHhhhhc
Confidence 987654433 233467999999999987 45689999999999999999999999975432111 1111111
Q ss_pred hcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCC--CCCHHHHHHH
Q 002069 927 MLDPRLPTPLRNVQDKLISIMEVSISCLDESPTS--RPTMQKVSQL 970 (973)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~ 970 (973)
.....++..... .+..+.+++.+|+..+|++ ||+++|+++.
T Consensus 297 ~~~~~~p~~~~~---~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 297 KERFQFPTQVTD---VSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHCCCCSSCCC---SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccccCCccccc---CCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 111122221111 2234678899999998888 9999999863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=354.89 Aligned_cols=264 Identities=22% Similarity=0.344 Sum_probs=210.9
Q ss_pred ccHHHHHHHhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCc-----chhhHHHHHHHHHHhhcC-CCCcee
Q 002069 691 IVHEEIIRATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPG-----EMACQQEFLNEGNALTKI-RHRNIV 763 (973)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l-~h~niv 763 (973)
...+......++|++.+.||+|+||.||+|... +|+.||||++...... .....+.+.+|+.+++++ +||||+
T Consensus 84 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv 163 (365)
T 2y7j_A 84 PDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163 (365)
T ss_dssp CHHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred ccchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEe
Confidence 344455566788999999999999999999764 7999999998754321 122246788999999999 899999
Q ss_pred eeceeeeccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC
Q 002069 764 KFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY 843 (973)
Q Consensus 764 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~ 843 (973)
++++++......++||||+++++|.+++... ..+++..+..++.|++.|++|||+. |++||||||+||+++.++
T Consensus 164 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNM 237 (365)
T ss_dssp CEEEEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred EEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence 9999999999999999999999999999643 3689999999999999999999999 999999999999999999
Q ss_pred ceEEecccccccccCCCCcccccccccCccccccccc------CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhh
Q 002069 844 EAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYT------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLS 917 (973)
Q Consensus 844 ~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 917 (973)
.+|++|||++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 238 ~ikl~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---- 312 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---- 312 (365)
T ss_dssp CEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----
T ss_pred CEEEEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH----
Confidence 9999999999877644 23345679999999998863 357889999999999999999999997433211
Q ss_pred hhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 918 SNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
................+...+..+.+++.+||+.||.+|||++++++.
T Consensus 313 -----~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 313 -----MLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp -----HHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----HHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111111111111112234457899999999999999999999874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=347.61 Aligned_cols=263 Identities=21% Similarity=0.299 Sum_probs=200.0
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||+|... +|+.||||++..... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 67999999999999999999664 699999999876533 3334677889999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||++++++.++++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.....
T Consensus 82 e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999988644 3588999999999999999999999 9999999999999999999999999999877655
Q ss_pred CCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh------hhhhhhhh-----hhhh
Q 002069 860 LSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS------LSSNLNIA-----LDEM 927 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~------~~~~~~~~-----~~~~ 927 (973)
........||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||......... ........ ....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 444556689999999999876 56899999999999999999999999754321110 00000000 0000
Q ss_pred c-CCCCCCC------chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 928 L-DPRLPTP------LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 928 ~-~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
. ....+.. .......+..+.+++.+||+.||.+|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 0011100 00011234457899999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=364.05 Aligned_cols=248 Identities=28% Similarity=0.408 Sum_probs=202.0
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc-eeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL-HSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv 778 (973)
.++|++.+.||+|+||.||+|.+ .++.||||+++... ..+.|.+|+.++++++||||+++++++.+.. ..++|
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 46789999999999999999988 47899999998543 2478999999999999999999999987654 78999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++|+|.++++... ...+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 266 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 99999999999997543 23478999999999999999999999 999999999999999999999999999985432
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
. .....+++.|+|||++.+..++.++|||||||++|||+| |+.||....... ....+........+.
T Consensus 342 ~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~------~~~~i~~~~~~~~p~--- 409 (450)
T 1k9a_A 342 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPD--- 409 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT------HHHHHHTTCCCCCCT---
T ss_pred c---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCC---
Confidence 2 223467889999999999999999999999999999998 999997443210 011111111111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+..+.+++.+||+.||.+|||+.++++.|+
T Consensus 410 ---~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~ 441 (450)
T 1k9a_A 410 ---GCPPAVYDVMKNCWHLDAATRPTFLQLREQLE 441 (450)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 22345788999999999999999999998875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=347.08 Aligned_cols=261 Identities=22% Similarity=0.277 Sum_probs=198.2
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
..+|++.+.||+|+||.||+|.. .+|+.||||++.............+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 46799999999999999999965 58999999999865444455578899999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 779 YEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
|||+++++|.+++.... ....+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999986432 234588999999999999999999999 99999999999999999999999999998766
Q ss_pred CCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
..........|++.|+|||.+.+..++.++||||||+++|+|++|+.||........ ...........+....
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~ 260 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-------SLCKKIEQCDYPPLPS 260 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-------HHHHHHHTTCSCCCCT
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-------HHHHHhhcccCCCCcc
Confidence 544444456789999999999998999999999999999999999999864321100 0111111111111100
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+..+.+++.+||+.||.+|||+++|++.|+
T Consensus 261 --~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~ 293 (310)
T 2wqm_A 261 --DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293 (310)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 112345788999999999999999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=369.63 Aligned_cols=250 Identities=22% Similarity=0.258 Sum_probs=196.1
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|.. .+|+.||||++.............+.+|+.+++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999964 58999999998643222223346778899999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT-NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+|+...
T Consensus 227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999998653 368999999999999999999998 7 99999999999999999999999999998655
Q ss_pred CCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhc--CCCCCCC
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML--DPRLPTP 935 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 935 (973)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... ...++..
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---------~~~~~i~~~~~~~p~~ 371 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---------KLFELILMEEIRFPRT 371 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHCCCCCCTT
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---------HHHHHHHhCCCCCCcc
Confidence 4444555678999999999999999999999999999999999999999743321 1111111 1112221
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRP-----TMQKVSQL 970 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 970 (973)
....+.+++.+||+.||.+|| +++|+++.
T Consensus 372 ------~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 372 ------LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ------SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ------CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 223577899999999999999 99999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=348.33 Aligned_cols=258 Identities=20% Similarity=0.289 Sum_probs=199.1
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
..++|++.+.||+|+||.||+|... +++.||||++...........+.+.+|+.++++++||||+++++++..++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999654 789999999976544444456889999999999999999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||||+++++|.++++.. ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999999753 3589999999999999999999999 99999999999999999999999999998665
Q ss_pred CCC-CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 858 LGL-SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 858 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .. ..... ...+...
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~----~~~~~----~~~~~~~ 255 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VM----GAHIN----QAIPRPS 255 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HH----HHHHH----SCCCCGG
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HH----HHHhc----cCCCCcc
Confidence 432 2233457899999999999999999999999999999999999999754321 00 01111 1111111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCC-CHHHHHHHhc
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRP-TMQKVSQLLK 972 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ev~~~L~ 972 (973)
......+..+.+++.+||+.||++|| +++++++.|+
T Consensus 256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~ 292 (309)
T 2h34_A 256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAH 292 (309)
T ss_dssp GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHH
Confidence 11112233577899999999999999 9999998874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=353.88 Aligned_cols=260 Identities=22% Similarity=0.338 Sum_probs=209.5
Q ss_pred HHHHhcCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceee
Q 002069 696 IIRATKNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFC 769 (973)
Q Consensus 696 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 769 (973)
+....++|++.+.||+|+||.||+|... +++.||||++.... .......+.+|+.++++++||||+++++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 3445678999999999999999999653 46789999997543 233457799999999999999999999999
Q ss_pred eccceeEEEEEecCCCChHHHhccCcc-------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC
Q 002069 770 SHALHSFVVYEYLEMGSLAMILSNDAA-------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE 842 (973)
Q Consensus 770 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~ 842 (973)
.+++..++||||+++++|.++++.... ...+++..++.++.|++.|++|||++ +|+||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence 999999999999999999999965332 14578999999999999999999999 99999999999999999
Q ss_pred CceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhh
Q 002069 843 YEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSN 919 (973)
Q Consensus 843 ~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~ 919 (973)
+.+||+|||.++....... ......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||......
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------- 247 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------- 247 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-------
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-------
Confidence 9999999999986644322 1223456889999999998899999999999999999999 89998743321
Q ss_pred hhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 920 LNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
................ ..+..+.+++.+||+.||.+|||+.|+++.|+
T Consensus 248 --~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~ 295 (322)
T 1p4o_A 248 --QVLRFVMEGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295 (322)
T ss_dssp --HHHHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred --HHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1111111111111111 12345788999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=339.73 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=206.9
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.++|++.+.||+|+||.||+|...+++.||+|++...... .+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 3679999999999999999998888899999999864332 467899999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++.....
T Consensus 83 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999997543 3578999999999999999999999 9999999999999999999999999999866432
Q ss_pred C-CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 860 L-SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 860 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
. .......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||....... .............+..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~i~~~~~~~~~~~-- 229 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDISTGFRLYKPRL-- 229 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCCCCCCTT--
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH------HHHHHhcCCcCCCCcc--
Confidence 1 12233557889999999998889999999999999999999 899987433210 0011111111111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+..+.+++.+||+.||.+|||++++++.|+
T Consensus 230 ----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 260 (267)
T 3t9t_A 230 ----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260 (267)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----CcHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 2335788999999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=342.54 Aligned_cols=253 Identities=21% Similarity=0.352 Sum_probs=193.0
Q ss_pred hcCCcccccccCCCceeEEEEEcC----CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP----TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
.++|++.+.||+|+||.||+|... .+..||+|++.... .....+.+.+|+.++++++||||+++++++. ++..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 468999999999999999999653 24579999987543 2344678999999999999999999999985 4578
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 89999999999999997543 3588999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCC-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 856 LKLGLS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 856 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||....... .............+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~------~~~~i~~~~~~~~~ 239 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPMP 239 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHHHTTCCCCCC
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH------HHHHHHcCCCCCCC
Confidence 654322 2233456789999999998899999999999999999997 999997433210 00011111111111
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
. ..+..+.+++.+||+.||.+|||+.++++.|+
T Consensus 240 ~------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 272 (281)
T 1mp8_A 240 P------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 272 (281)
T ss_dssp T------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred C------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1 12345778999999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.13 Aligned_cols=251 Identities=19% Similarity=0.279 Sum_probs=204.3
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc--ceeEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA--LHSFV 777 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 777 (973)
.++|++.+.||+|+||+||+|.+ +++.||||++...... ....+.+.+|+.++++++||||+++++++.++ ...++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 46799999999999999999988 4889999999865433 33457899999999999999999999999876 77899
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEeecCCCCCeeecCCCceEEeccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP--IVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
||||+++++|.++++... ...+++.+++.++.|++.|++|||+. + ++||||||+||+++.++.++++|||++..
T Consensus 87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred eecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999997643 23589999999999999999999998 7 99999999999999999999999998765
Q ss_pred ccCCCCcccccccccCcccccccccCCCCC---ccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 856 LKLGLSNRTELAGTFGYIAPELAYTMKVTE---KCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 856 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
... ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||........ ..........+..
T Consensus 163 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~ 232 (271)
T 3kmu_A 163 FQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-----GMKVALEGLRPTI 232 (271)
T ss_dssp TSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-----HHHHHHSCCCCCC
T ss_pred ecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-----HHHHHhcCCCCCC
Confidence 332 3356899999999998765544 79999999999999999999974432111 0111111222222
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+.. .+..+.+++.+||+.||++|||++++++.|+
T Consensus 233 ~~~------~~~~~~~li~~~l~~~p~~Rps~~~il~~L~ 266 (271)
T 3kmu_A 233 PPG------ISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266 (271)
T ss_dssp CTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCC------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 222 2335788999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=351.56 Aligned_cols=257 Identities=22% Similarity=0.378 Sum_probs=209.3
Q ss_pred hcCCcccccccCCCceeEEEEEc------CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeecc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHA 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 772 (973)
.++|++.+.||+|+||+||+|.. .+++.||||++..... ....+.+.+|+.+++++ +||||+++++++..+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 46899999999999999999963 3578999999975432 23467899999999999 999999999999999
Q ss_pred ceeEEEEEecCCCChHHHhccCcc---------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCe
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAA---------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNV 837 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni 837 (973)
+..++||||+++|+|.+++..... ...+++.+++.++.|++.|++|||+. +++||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence 999999999999999999975542 12589999999999999999999999 999999999999
Q ss_pred eecCCCceEEecccccccccCCCCc--ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhh
Q 002069 838 LLNLEYEAHVSDFGISKFLKLGLSN--RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICS 914 (973)
Q Consensus 838 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 914 (973)
+++.++.+||+|||.++........ .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||.......
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 255 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS- 255 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-
Confidence 9999999999999999877654321 233557889999999999899999999999999999999 999997433211
Q ss_pred hhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 915 SLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..............+. ..+..+.+++.+||+.||.+|||++++++.|+
T Consensus 256 ----~~~~~~~~~~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 303 (313)
T 1t46_A 256 ----KFYKMIKEGFRMLSPE------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (313)
T ss_dssp ----HHHHHHHHTCCCCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----HHHHHhccCCCCCCcc------cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 0111111222221111 12345788999999999999999999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.60 Aligned_cols=250 Identities=26% Similarity=0.438 Sum_probs=201.4
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|.. .+++.||||++.............+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 57899999999999999999955 47889999998643222223356789999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.+++... ..+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+.....
T Consensus 88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999998643 3588999999999999999999999 999999999999999999999999999865543
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
. ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||........ ...... .....+..
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~-~~~~~~~~--- 229 (279)
T 3fdn_A 162 S--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISR-VEFTFPDF--- 229 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHH-TCCCCCTT---
T ss_pred c--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH------HHHHHh-CCCCCCCc---
Confidence 2 23446789999999999999999999999999999999999999974332110 000111 11112211
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
....+.+++.+||+.||.+|||++|+++.
T Consensus 230 ---~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 230 ---VTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---SCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---CCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 22346789999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=369.40 Aligned_cols=253 Identities=23% Similarity=0.390 Sum_probs=207.7
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
..+|++.+.||+|+||.||+|.+. +++.||||+++.... ..++|.+|+.++++++||||+++++++.+.+..++|
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 467899999999999999999765 588999999975432 257899999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++|+|.++++... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 295 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999997543 24588999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 859 GLS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 859 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
... ......+++.|+|||++.+..++.++|||||||++|||+| |+.||...... .....+........+.
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~~~~~~-- 442 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPE-- 442 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG------GHHHHHHTTCCCCCCT--
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCCCCCC--
Confidence 322 2233456789999999998899999999999999999999 99998744321 0111111111111111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+..+.+++.+||+.||.+|||++++++.|+
T Consensus 443 ----~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~ 474 (495)
T 1opk_A 443 ----GCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474 (495)
T ss_dssp ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 22345788999999999999999999999885
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=352.53 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=202.7
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.+.|+..+.||+|+||+||+|.. .+++.||||++...........+.+.+|+.++++++||||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35589999999999999999964 58999999999765444445567899999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||++ |++.+++... ...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99998 6788877533 24689999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCcccccccccCcccccccc---cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 859 GLSNRTELAGTFGYIAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||......... .. ......+....
T Consensus 207 ----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-----~~-~~~~~~~~~~~- 275 (348)
T 1u5q_A 207 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----YH-IAQNESPALQS- 275 (348)
T ss_dssp ----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HH-HHHSCCCCCCC-
T ss_pred ----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-----HH-HHhcCCCCCCC-
Confidence 23457999999999984 567899999999999999999999998743321110 00 11111111111
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
. ..+..+.+++.+||+.||.+|||++++++.
T Consensus 276 -~---~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 276 -G---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp -T---TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -C---CCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 122347789999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=350.17 Aligned_cols=256 Identities=24% Similarity=0.362 Sum_probs=206.4
Q ss_pred hcCCcccccccCCCceeEEEEEc--------CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL--------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCS 770 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 770 (973)
.++|++.+.||+|+||+||+|.. .+++.||||++.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 47899999999999999999965 356789999997543 233467899999999999 8999999999999
Q ss_pred ccceeEEEEEecCCCChHHHhccCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCe
Q 002069 771 HALHSFVVYEYLEMGSLAMILSNDAA-------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNV 837 (973)
Q Consensus 771 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni 837 (973)
+.+..++||||+++++|.+++..... ...+++.+++.++.|++.|++|||+. +|+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceE
Confidence 99999999999999999999976542 23489999999999999999999999 999999999999
Q ss_pred eecCCCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhh
Q 002069 838 LLNLEYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICS 914 (973)
Q Consensus 838 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 914 (973)
+++.++.+||+|||.++....... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 267 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 267 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH-
Confidence 999999999999999987654322 2233457889999999988889999999999999999999 999997433110
Q ss_pred hhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 915 SLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.............+. .....+.+++.+||+.||.+|||++++++.|+
T Consensus 268 -----~~~~~~~~~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 314 (334)
T 2pvf_A 268 -----LFKLLKEGHRMDKPA------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314 (334)
T ss_dssp -----HHHHHHHTCCCCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -----HHHHHhcCCCCCCCc------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 011111111111111 12345788999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=350.36 Aligned_cols=253 Identities=22% Similarity=0.385 Sum_probs=197.3
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCC----EEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccce
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGE----IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH 774 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 774 (973)
.++|++.+.||+|+||+||+|.+. +++ +||+|.+..... ....+.+.+|+.++++++||||+++++++.++.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 357999999999999999999653 444 368888864332 233578999999999999999999999998764
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.++|+||+++|+|.+++.... ..+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred eEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence 779999999999999997543 4689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCc--ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 855 FLKLGLSN--RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 855 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
........ .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||+..... .............
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~~~~~~~~~ 239 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------EISSILEKGERLP 239 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------GHHHHHHTTCCCC
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH------HHHHHHHcCCCCC
Confidence 77544322 233456889999999999999999999999999999999 99999743321 0111111111111
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+. .....+.+++.+||+.||.+||++.++++.|+
T Consensus 240 ~~~------~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 274 (327)
T 3poz_A 240 QPP------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 274 (327)
T ss_dssp CCT------TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred CCc------cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 111 12335788999999999999999999998874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=349.32 Aligned_cols=252 Identities=22% Similarity=0.308 Sum_probs=209.5
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|.+.+.||+|+||.||+|... +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 468999999999999999999654 6889999998755444445568899999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.+++... ..+++.+++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.++....
T Consensus 120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999998643 3689999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.........|++.|+|||++.+..++.++||||||+++|||++|+.||......... ...... ...++..
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~--~~~~~~~--- 263 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-----LRIKKN--EYSIPKH--- 263 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----HHHHHT--CCCCCTT---
T ss_pred CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH-----HHHhcC--CCCCCcc---
Confidence 544555677999999999999988999999999999999999999999743321100 000000 1111211
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
....+.+++.+||+.||.+|||++|+++.
T Consensus 264 ---~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 264 ---INPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12347789999999999999999999863
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=340.79 Aligned_cols=254 Identities=20% Similarity=0.273 Sum_probs=203.3
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcc---hhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGE---MACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (973)
++|++.+.||+|+||.||+|... +++.||+|+++...... ....+.+.+|+.++++++||||+++++++.++...+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56999999999999999999665 79999999987543221 123578999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC----ceEEecccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY----EAHVSDFGI 852 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~----~~kl~Dfg~ 852 (973)
+||||+++++|.+++... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++ .+||+|||.
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999999643 3689999999999999999999999 999999999999998877 899999999
Q ss_pred cccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
+....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ...........
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------~~~~~~~~~~~ 228 (283)
T 3bhy_A 159 AHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---------ETLTNISAVNY 228 (283)
T ss_dssp CEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---------HHHHHHHTTCC
T ss_pred ceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---------HHHHHhHhccc
Confidence 98765432 234457899999999999889999999999999999999999999754321 11111111111
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..........+..+.+++.+||+.||.+|||++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 229 DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 11111112234457899999999999999999999873
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=349.13 Aligned_cols=247 Identities=20% Similarity=0.284 Sum_probs=204.1
Q ss_pred HHhcCCcccccccCCCceeEEEEE-cCCCCEEEEEEcCCCCCcch-----hhHHHHHHHHHHhhcCCCCceeeeceeeec
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEM-----ACQQEFLNEGNALTKIRHRNIVKFYGFCSH 771 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 771 (973)
...++|++.+.||+|+||+||+|. ..+++.||||++........ .....+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 346789999999999999999996 45889999999876532211 123467789999999999999999999999
Q ss_pred cceeEEEEEecCCC-ChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecc
Q 002069 772 ALHSFVVYEYLEMG-SLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDF 850 (973)
Q Consensus 772 ~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df 850 (973)
.+..++||||+.+| +|.+++.... .+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 99999999999777 9999997543 589999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCcccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcC
Q 002069 851 GISKFLKLGLSNRTELAGTFGYIAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLD 929 (973)
Q Consensus 851 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 929 (973)
|.++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ..
T Consensus 175 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------~~ 238 (335)
T 3dls_A 175 GSAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------VE 238 (335)
T ss_dssp TTCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------TT
T ss_pred ccceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------Hh
Confidence 9998775542 3344679999999999988776 78899999999999999999999742211 11
Q ss_pred CCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 930 PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 930 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+.. .+..+.+++.+||+.||++|||++++++.
T Consensus 239 ~~~~~~~~----~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 AAIHPPYL----VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TCCCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hccCCCcc----cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111 22357889999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=365.32 Aligned_cols=252 Identities=24% Similarity=0.393 Sum_probs=200.8
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.++|++.+.||+|+||.||+|.+.++..||||+++..... .++|.+|+.++++++||||+++++++.+ +..++||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 4678999999999999999999888888999999864322 4689999999999999999999999976 6789999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|+|.++++... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 258 e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 9999999999996432 24589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CC-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 860 LS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 860 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
.. ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... ....+........+.
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~------~~~~i~~~~~~~~~~--- 404 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYRMPCPP--- 404 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCCCCCT---
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCC---
Confidence 22 2233457889999999998899999999999999999999 999997443210 001111111111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+..+.+++.+||+.||++|||++++++.|+
T Consensus 405 ---~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~ 436 (452)
T 1fmk_A 405 ---ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436 (452)
T ss_dssp ---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 22345788999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=358.73 Aligned_cols=267 Identities=19% Similarity=0.260 Sum_probs=208.5
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc--eeE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL--HSF 776 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~ 776 (973)
.++|++.+.||+|+||+||+|... +|+.||||++...... ...+.+.+|++++++++||||+++++++.... ..+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 367999999999999999999654 6999999998753222 22577889999999999999999999987654 679
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeee----cCCCceEEecccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL----NLEYEAHVSDFGI 852 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill----~~~~~~kl~Dfg~ 852 (973)
+||||+++|+|.++++.......+++.+++.++.|++.|++|||+. +|+||||||+||++ +.++.+||+|||.
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 9999999999999998766555589999999999999999999999 99999999999999 7778899999999
Q ss_pred cccccCCCCcccccccccCccccccccc--------CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh---hhhhhh-
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYT--------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS---SLSSNL- 920 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~---~~~~~~- 920 (973)
++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ......
T Consensus 163 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 163 ARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp CEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred ceEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 9876543 23345679999999999865 5677899999999999999999999964321110 000000
Q ss_pred ---hhh---hhhh------cCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 921 ---NIA---LDEM------LDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 921 ---~~~---~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
... .... ....++............+.+++.+||+.||++||+++++++.++
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~ 305 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHH
Confidence 000 0000 001112222223456677889999999999999999999988763
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.80 Aligned_cols=257 Identities=24% Similarity=0.328 Sum_probs=205.6
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeee--ccceeE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCS--HALHSF 776 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~ 776 (973)
.++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+.++++++||||+++++++. .....+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 468999999999999999999654 7899999999765433 334678999999999999999999999874 456789
Q ss_pred EEEEecCCCChHHHhccCcc-ccCCCHHHHHHHHHHHHHHHHHHhhCCCCC-----eEeecCCCCCeeecCCCceEEecc
Q 002069 777 VVYEYLEMGSLAMILSNDAA-AEEFGWTKRMNAIKGVADALLYMHTNCFPP-----IVHRDISSKNVLLNLEYEAHVSDF 850 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----i~H~Dlk~~Nill~~~~~~kl~Df 850 (973)
+||||+++++|.+++..... ...+++.+++.++.|++.|++|||+. + ++||||||+||+++.++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 99999999999999975432 23589999999999999999999998 7 999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCC
Q 002069 851 GISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDP 930 (973)
Q Consensus 851 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (973)
|.++.............|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ..........+
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~i~~~~~~ 234 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAGKIREGKFR 234 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCCC
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH------HHHHHhhcccc
Confidence 999876554333344678999999999999899999999999999999999999997543210 01111111111
Q ss_pred CCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 931 RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 931 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.++.. .+..+.+++.+||+.||.+|||++|+++.+.
T Consensus 235 ~~~~~------~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 235 RIPYR------YSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp CCCTT------SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred cCCcc------cCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 22211 2345788999999999999999999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=343.94 Aligned_cols=263 Identities=21% Similarity=0.331 Sum_probs=204.4
Q ss_pred hcCCcccccccCCCceeEEEEEc-----CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc--
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-----PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA-- 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-- 772 (973)
.+.|++.+.||+|+||.||+|.+ .+++.||||++...... ...+.+.+|+.++++++||||+++++++...
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 35689999999999999999973 47889999999754322 2357899999999999999999999999876
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
...++||||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccc
Confidence 56899999999999999995433 4589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCC---cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh-----hhh-hhhh
Q 002069 853 SKFLKLGLS---NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL-----SSN-LNIA 923 (973)
Q Consensus 853 a~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~-----~~~-~~~~ 923 (973)
++....... ......||..|+|||.+.+..++.++||||+|+++|||+||..|+.......... ... ....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 987765432 2334568888999999999889999999999999999999999975332110000 000 0111
Q ss_pred hhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 924 LDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
............. ...+..+.+++.+||+.||.+|||++++++.|+
T Consensus 253 ~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 298 (302)
T 4e5w_A 253 VNTLKEGKRLPCP---PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298 (302)
T ss_dssp HHHHHTTCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhccCCCCCC---CCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 1111111111111 122345789999999999999999999999885
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=356.15 Aligned_cols=265 Identities=19% Similarity=0.234 Sum_probs=204.6
Q ss_pred hcCCcccccccCC--CceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeE
Q 002069 700 TKNFDDEHCIGNG--GQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 700 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (973)
.++|++.+.||+| +||+||+|... +++.||||++...... ....+.+.+|+.++++++|||||++++++.+++..+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 4689999999999 99999999664 7999999999754332 344678889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
+||||+++++|.+++.... ...+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||.+...
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999997543 23589999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCC-------CcccccccccCccccccccc--CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhh
Q 002069 857 KLGL-------SNRTELAGTFGYIAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEM 927 (973)
Q Consensus 857 ~~~~-------~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 927 (973)
.... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||........... .........
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~ 257 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE-KLNGTVPCL 257 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH-C--------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HhcCCCCcc
Confidence 3221 11223478999999999987 5789999999999999999999999975332111000 000000000
Q ss_pred cCC---------------------------CC-------CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 928 LDP---------------------------RL-------PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 928 ~~~---------------------------~~-------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.+. .. .............+.+++.+||+.||.+|||++|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000 00 00000111233568899999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=364.39 Aligned_cols=262 Identities=22% Similarity=0.207 Sum_probs=204.6
Q ss_pred HHHHHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc
Q 002069 695 EIIRATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL 773 (973)
Q Consensus 695 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 773 (973)
+.....++|++.+.||+|+||+||+|+. .+|+.||||++...........+.+.+|..++..++||||+++++++.+++
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 3444568899999999999999999966 479999999986422111222345788999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
..|+||||+++|+|.+++.+.. ..+++..++.++.||+.|++|||+. +|+||||||+||+++.++++||+|||++
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhh
Confidence 9999999999999999997532 3689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCC-cccccccccCcccccccc-------cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhh
Q 002069 854 KFLKLGLS-NRTELAGTFGYIAPELAY-------TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALD 925 (973)
Q Consensus 854 ~~~~~~~~-~~~~~~g~~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 925 (973)
+....... ......||+.|+|||++. +..++.++|||||||++|||++|+.||........ ......
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~~~i~~ 284 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET-----YGKIVH 284 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHT
T ss_pred eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-----HHHHHh
Confidence 87755433 223467999999999987 35689999999999999999999999975432110 011111
Q ss_pred hhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCC---CCHHHHHHH
Q 002069 926 EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSR---PTMQKVSQL 970 (973)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ev~~~ 970 (973)
......++... ...+..+.++|.+||. +|.+| |+++|++++
T Consensus 285 ~~~~~~~p~~~---~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 285 YKEHLSLPLVD---EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHCCCC-------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred cccCcCCCccc---cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 00001111100 1123457789999999 99998 689998763
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=364.09 Aligned_cols=321 Identities=21% Similarity=0.205 Sum_probs=215.4
Q ss_pred cEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCC
Q 002069 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNN 82 (973)
Q Consensus 3 ~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n 82 (973)
+.++.++++++ .+|..+. +++++|+|++|++++..|..|..+++|++|+|++|.+++..|.+|+++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 35666777776 6776553 56777777777777666667777777777777777777656677777777777777777
Q ss_pred cCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCc
Q 002069 83 LLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPF 162 (973)
Q Consensus 83 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 162 (973)
++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|++++|.+++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 77643334566777777777777777766666677777777777777777666666677777777777777777655555
Q ss_pred cccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccc
Q 002069 163 SLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSL 242 (973)
Q Consensus 163 ~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 242 (973)
.|..+++|+.|++++|.+.+..+..|..+++|++|++++|...+..+.......+|+.|++++|+++.+.+..|..+++|
T Consensus 171 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L 250 (477)
T 2id5_A 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL 250 (477)
T ss_dssp HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTC
T ss_pred HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCcccc
Confidence 66666677777777666665555566666666666666665554444444444466666666666665544556666666
Q ss_pred cceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeecccc
Q 002069 243 LALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTN 322 (973)
Q Consensus 243 ~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 322 (973)
+.|+|++|.+++..+ ..|.++++|+.|++++|++++..|..|..+++|+.|++++|
T Consensus 251 ~~L~Ls~n~l~~~~~------------------------~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 306 (477)
T 2id5_A 251 RFLNLSYNPISTIEG------------------------SMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN 306 (477)
T ss_dssp CEEECCSSCCCEECT------------------------TSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSS
T ss_pred CeeECCCCcCCccCh------------------------hhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCC
Confidence 666666666654444 44555666677777777777666777777777777777777
Q ss_pred ccCCCCCccccCCCCCCcEEcCCCCCCC
Q 002069 323 ALSGSIPNEITNLRSLSDLQLSENTLNG 350 (973)
Q Consensus 323 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 350 (973)
.+++..+..|..+++|++|+|++|.+..
T Consensus 307 ~l~~~~~~~~~~l~~L~~L~l~~N~l~c 334 (477)
T 2id5_A 307 QLTTLEESVFHSVGNLETLILDSNPLAC 334 (477)
T ss_dssp CCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred cCceeCHhHcCCCcccCEEEccCCCccC
Confidence 7776666667777777777777777653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=369.78 Aligned_cols=254 Identities=25% Similarity=0.351 Sum_probs=209.3
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|... +++.||||++...........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999654 8999999998765443344468899999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeee---cCCCceEEeccccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL---NLEYEAHVSDFGISKF 855 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill---~~~~~~kl~Dfg~a~~ 855 (973)
|||+++++|.+++.... .+++.++..++.|++.|++|||++ +|+||||||+||++ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999986543 588999999999999999999999 99999999999999 5678999999999987
Q ss_pred ccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 856 LKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 856 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
+... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .....+........
T Consensus 179 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~i~~~~~~~~ 247 (484)
T 3nyv_A 179 FEAS-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---------DILKKVEKGKYTFE 247 (484)
T ss_dssp BCCC-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHCCCCCC
T ss_pred cccc-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---------HHHHHHHcCCCCCC
Confidence 7544 23345679999999999876 6899999999999999999999999754321 11112222222222
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...+...+..+.+++.+||+.||.+|||++|+++.
T Consensus 248 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 248 LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 22223344567899999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=349.68 Aligned_cols=252 Identities=22% Similarity=0.328 Sum_probs=197.4
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCC--CceeeeceeeeccceeEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH--RNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~l 777 (973)
.++|++.+.||+|+||.||+|...+++.||||++...... ....+.+.+|+.++++++| +||+++++++..+...++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccc-hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 4679999999999999999998888999999998755332 3345789999999999976 999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||| +.+++|.+++... ..+++.++..++.|++.|++|||+. +|+||||||+||+++ ++.+||+|||+++...
T Consensus 87 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 5678999999754 3688999999999999999999999 999999999999997 6889999999998775
Q ss_pred CCCC--cccccccccCccccccccc-----------CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhh
Q 002069 858 LGLS--NRTELAGTFGYIAPELAYT-----------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIAL 924 (973)
Q Consensus 858 ~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 924 (973)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--------~~ 230 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------KL 230 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--------HH
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH--------HH
Confidence 4432 2335679999999999864 6688899999999999999999999974322111 11
Q ss_pred hhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 925 DEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...+++........ .....+.+++.+||+.||.+|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~--~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 231 HAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhcCCcccCCcc--cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11222211111111 012347789999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=345.76 Aligned_cols=257 Identities=18% Similarity=0.222 Sum_probs=204.3
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 777 (973)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+.+++.+ +|++++++++++.+....++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 46799999999999999999964 5899999999865432 24577899999999 89999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCc-----eEEecccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYE-----AHVSDFGI 852 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~-----~kl~Dfg~ 852 (973)
||||+ +++|.++++... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++. +||+|||.
T Consensus 84 v~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 99999 999999997543 3589999999999999999999999 9999999999999987776 99999999
Q ss_pred cccccCCCC-------cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhh
Q 002069 853 SKFLKLGLS-------NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALD 925 (973)
Q Consensus 853 a~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 925 (973)
++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~ 235 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK--QKYERIGE 235 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH--HHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH--HHHHHHHh
Confidence 987765422 234567999999999999999999999999999999999999999753211000 00000000
Q ss_pred hhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 926 EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
....... .......+..+.+++.+||+.||.+||++++|++.|+
T Consensus 236 ~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~ 279 (298)
T 1csn_A 236 KKQSTPL---RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 279 (298)
T ss_dssp HHHHSCH---HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred hccCccH---HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 0000000 0000112346789999999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=356.21 Aligned_cols=253 Identities=21% Similarity=0.244 Sum_probs=190.5
Q ss_pred hcCCccc-ccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhh-cCCCCceeeeceeeec----c
Q 002069 700 TKNFDDE-HCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALT-KIRHRNIVKFYGFCSH----A 772 (973)
Q Consensus 700 ~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~----~ 772 (973)
.++|.+. +.||+|+||+||+|.. .+++.||||++... ..+.+|+.++. ..+||||+++++++.. .
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 3567776 6899999999999965 47899999998631 45667887764 4589999999998865 5
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC---CCceEEec
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL---EYEAHVSD 849 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---~~~~kl~D 849 (973)
...|+||||+++|+|.+++.... ...+++.++..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence 67899999999999999997643 24589999999999999999999999 9999999999999998 78999999
Q ss_pred ccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcC
Q 002069 850 FGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLD 929 (973)
Q Consensus 850 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 929 (973)
||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... . ........
T Consensus 208 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~---~~~~~i~~ 281 (400)
T 1nxk_A 208 FGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--P---GMKTRIRM 281 (400)
T ss_dssp CTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC--C---SHHHHHHH
T ss_pred cccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc--H---HHHHHHHc
Confidence 9999866533 2234567899999999999999999999999999999999999999743321100 0 00001111
Q ss_pred CCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 930 PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 930 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..+......+...+..+.+++.+||+.||.+|||++|+++.
T Consensus 282 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 282 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11111111112233457899999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=339.45 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=194.2
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.++|++.+.||+|+||+||+|... ..||||+++..... ....+.+.+|+.++++++||||+++++++. ....++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEE
Confidence 468999999999999999999864 36999999765433 344678999999999999999999999764 45689999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.....
T Consensus 99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence 9999999999996543 4689999999999999999999999 9999999999999999999999999999865432
Q ss_pred --CCcccccccccCcccccccc---cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCC
Q 002069 860 --LSNRTELAGTFGYIAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934 (973)
Q Consensus 860 --~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (973)
........||+.|+|||.+. +..++.++||||+|+++|||++|+.||.......... .........+....
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII----EMVGRGSLSPDLSK 249 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH----HHHHHTSCCCCTTS
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH----HHhcccccCcchhh
Confidence 12234467899999999986 5678889999999999999999999997543211110 01111111121111
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.. ...+..+.+++.+||+.||.+|||++++++.|+
T Consensus 250 ~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 284 (289)
T 3og7_A 250 VR---SNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284 (289)
T ss_dssp SC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cc---ccCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 11 122345789999999999999999999999885
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=341.97 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=198.0
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|.. .+++.||+|++...... ...+.+.+|++++++++||||+++++++.+....++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 46799999999999999999965 47899999998754322 2257899999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeee---cCCCceEEecccccc
Q 002069 779 YEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL---NLEYEAHVSDFGISK 854 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill---~~~~~~kl~Dfg~a~ 854 (973)
|||+++++|.+++.... ....+++..++.++.|++.|++|||+. +|+||||||+||++ +.++.+||+|||.++
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 99999999999985432 234689999999999999999999999 99999999999999 455889999999998
Q ss_pred cccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCC
Q 002069 855 FLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934 (973)
Q Consensus 855 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (973)
..... .......|++.|+|||++. ..++.++||||+|+++|||++|+.||......... .. .....+....
T Consensus 176 ~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~-----~~--~~~~~~~~~~ 246 (285)
T 3is5_A 176 LFKSD-EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ-----QK--ATYKEPNYAV 246 (285)
T ss_dssp C-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----HH--HHHCCCCCCC
T ss_pred ecCCc-ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH-----hh--hccCCccccc
Confidence 76543 2334567999999999876 46889999999999999999999999754321100 00 0111111111
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.... ....+.+++.+||+.||.+|||++|+++.
T Consensus 247 ~~~~---~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 247 ECRP---LTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp --CC---CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccCc---CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 12356789999999999999999999863
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=358.98 Aligned_cols=260 Identities=20% Similarity=0.281 Sum_probs=196.6
Q ss_pred hcCCcccccccCCCceeEEEEE-cCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc------
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA------ 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 772 (973)
.++|++.+.||+|+||+||+|. ..+++.||||++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 4689999999999999999995 45789999999975422 334467889999999999999999999999654
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
...|+||||++++ +.+.+.. .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 3569999999864 6666542 378999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh------hh-------hh
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS------LS-------SN 919 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~------~~-------~~ 919 (973)
|+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......... .+ ..
T Consensus 211 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 211 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp C-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred eeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 9876543 2344568999999999999999999999999999999999999999754321110 00 00
Q ss_pred hhhhhhhhcCCC----------------CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 920 LNIALDEMLDPR----------------LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 920 ~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
............ .+............+.+++.+||+.||++|||++|+++.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000011111100 001111112235668899999999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=370.46 Aligned_cols=258 Identities=22% Similarity=0.294 Sum_probs=207.1
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.............+.+|+.++++++||||+++++++.+....|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999764 7999999998643222222346788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCcc-ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 779 YEYLEMGSLAMILSNDAA-AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
|||+++|+|.+++..... ...+++..++.++.||+.|++|||+. +|+||||||+||+++.+|.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999975442 34689999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
..........||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...............+
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-----~~~~~~~i~~~~~~~p-- 413 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-----NKELKQRVLEQAVTYP-- 413 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-----HHHHHHHHHHCCCCCC--
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-----HHHHHHHHhhcccCCC--
Confidence 554444556899999999999999999999999999999999999999975321000 0111111111111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCH-----HHHHH
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTM-----QKVSQ 969 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ev~~ 969 (973)
...+..+.+++.+||+.||.+||++ +++.+
T Consensus 414 --~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 414 --DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1123357789999999999999975 56654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=353.90 Aligned_cols=261 Identities=21% Similarity=0.233 Sum_probs=202.9
Q ss_pred HHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-----CCceeeeceeeec
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-----HRNIVKFYGFCSH 771 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~~~~~~ 771 (973)
...++|++.+.||+|+||+||+|.. .+++.||||++... ......+..|+.+++.++ ||||+++++++..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 3457899999999999999999965 57899999998632 233567788999999886 9999999999999
Q ss_pred cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC----------
Q 002069 772 ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL---------- 841 (973)
Q Consensus 772 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---------- 841 (973)
.+..++||||+ +++|.+++..... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccch
Confidence 99999999999 8999999975542 3589999999999999999999999 9999999999999975
Q ss_pred ---------------CCceEEecccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 002069 842 ---------------EYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPR 906 (973)
Q Consensus 842 ---------------~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~ 906 (973)
++.+||+|||.++.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred hcccccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 78999999999986543 234567899999999999999999999999999999999999999
Q ss_pred cchhhhhh------hhhhhhhhhhh--------hhc-----CCCCCCCchhhH--------------HHHHHHHHHHhcc
Q 002069 907 DFISSICS------SLSSNLNIALD--------EML-----DPRLPTPLRNVQ--------------DKLISIMEVSISC 953 (973)
Q Consensus 907 ~~~~~~~~------~~~~~~~~~~~--------~~~-----~~~~~~~~~~~~--------------~~~~~l~~li~~c 953 (973)
........ ........... ... ....+....... .....+.+++.+|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 339 (360)
T 3llt_A 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI 339 (360)
T ss_dssp CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence 75332110 00000000000 000 000011100000 0114577999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 002069 954 LDESPTSRPTMQKVSQL 970 (973)
Q Consensus 954 l~~dP~~RPs~~ev~~~ 970 (973)
|+.||++|||++|+++.
T Consensus 340 L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 340 LQIDPTLRPSPAELLKH 356 (360)
T ss_dssp CCSSGGGSCCHHHHTTS
T ss_pred hcCChhhCCCHHHHhcC
Confidence 99999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.16 Aligned_cols=254 Identities=24% Similarity=0.394 Sum_probs=208.9
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
...+|++.+.||+|+||+||+|.+. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 4578999999999999999999664 58899999997532 235789999999999999999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||||+++++|.++++... ...+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 87 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999997543 34589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 858 LGLS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 858 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
.... ......+++.|+|||.+.+..++.++||||+|+++|+|++ |..||...... ..............+.
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~- 235 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMERPE- 235 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG------GHHHHHHTTCCCCCCT-
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHhccCCCCCCC-
Confidence 4432 2233557889999999998899999999999999999999 99998743311 0111111111112121
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+..+.+++.+|++.||.+|||++++++.|+
T Consensus 236 -----~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~ 267 (288)
T 3kfa_A 236 -----GCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267 (288)
T ss_dssp -----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -----CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHH
Confidence 12345789999999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=356.69 Aligned_cols=262 Identities=18% Similarity=0.219 Sum_probs=199.2
Q ss_pred hcCCcccccccCCCceeEEEEEcCC------CCEEEEEEcCCCCCcchh--------hHHHHHHHHHHhhcCCCCceeee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPT------GEIVAVKKFHSPLPGEMA--------CQQEFLNEGNALTKIRHRNIVKF 765 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~ 765 (973)
.++|++.+.||+|+||+||+|.+.. ++.||||++......... ....+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4689999999999999999997654 478999998754321111 01234456667788899999999
Q ss_pred ceeeecc----ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeec-
Q 002069 766 YGFCSHA----LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLN- 840 (973)
Q Consensus 766 ~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~- 840 (973)
++++... ...++||||+ +++|.++++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence 9998764 4579999999 999999997542 4689999999999999999999999 999999999999999
Q ss_pred -CCCceEEecccccccccCCCC-------cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhh
Q 002069 841 -LEYEAHVSDFGISKFLKLGLS-------NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSI 912 (973)
Q Consensus 841 -~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 912 (973)
.++.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 889999999999987654321 113355999999999999999999999999999999999999999853211
Q ss_pred hhh---hhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 913 CSS---LSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 913 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
... .............++.++. ...+..+.+++..||+.||.+||+++++++.|+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~ 325 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPA-----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILL 325 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCT-----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred HHHHHHHHHHhhhhHHHHHHHhccc-----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence 111 1111111111221111110 011345788999999999999999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=337.57 Aligned_cols=252 Identities=22% Similarity=0.388 Sum_probs=205.2
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.++|++.+.||+|+||.||+|...+++.||||++..... ..+.+.+|++++++++||||+++++++.+ +..++||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 86 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence 468999999999999999999888888999999975432 24788999999999999999999999874 4688999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.+++.... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 87 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp ECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred ecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 9999999999996532 23689999999999999999999999 9999999999999999999999999999877543
Q ss_pred CC-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 860 LS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 860 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
.. ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .............+.
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~--- 233 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGYRMVRPD--- 233 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCCCCCT---
T ss_pred ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------HHHHHhcccCCCCcc---
Confidence 22 2233457889999999988889999999999999999999 999987433210 001111111111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+..+.+++.+|++.||++|||++++++.|+
T Consensus 234 ---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 265 (279)
T 1qpc_A 234 ---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (279)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---cccHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 12345788999999999999999999999875
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=362.43 Aligned_cols=320 Identities=21% Similarity=0.205 Sum_probs=193.8
Q ss_pred CEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCC
Q 002069 27 KLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNN 106 (973)
Q Consensus 27 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n 106 (973)
+.++.++++++ .+|..+. +++++|+|++|++++..|..|.++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 56777777776 4566553 57777777777777655667777777777777777777666777777777777777777
Q ss_pred cCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCc
Q 002069 107 SLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPN 186 (973)
Q Consensus 107 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~ 186 (973)
++++..+..|.++++|++|+|++|++++..|..|.++++|++|++++|.+++..|..|.++++|+.|++++|++++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 77744445567777777777777777766666677777777777777777666666666666666666666666654444
Q ss_pred cccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcchh
Q 002069 187 EIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKL 266 (973)
Q Consensus 187 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 266 (973)
.+.++++|+.|++++|.+.++.+..|..+++|+.|++++|...+..|..+....+|+.|++++|+++
T Consensus 171 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~------------- 237 (477)
T 2id5_A 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT------------- 237 (477)
T ss_dssp HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCC-------------
T ss_pred HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCccc-------------
Confidence 5666666666666666666555555555555555555555443333333222334444444444333
Q ss_pred hhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCC
Q 002069 267 VISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSEN 346 (973)
Q Consensus 267 ~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 346 (973)
.++...|..+++|+.|++++|.+++..+..|..+++|+.|++++|++++..|..|.++++|++|+|++|
T Consensus 238 -----------~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 306 (477)
T 2id5_A 238 -----------AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN 306 (477)
T ss_dssp -----------SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSS
T ss_pred -----------ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCC
Confidence 222233444555555555555555544455555555555555555555555555555555555555555
Q ss_pred CCCCcchhccCCCCCCcEEEccCCccc
Q 002069 347 TLNGSIPLALGNLTKLVSLDLSINKLS 373 (973)
Q Consensus 347 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~ 373 (973)
++++..+..|..+++|++|+|++|.+.
T Consensus 307 ~l~~~~~~~~~~l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 307 QLTTLEESVFHSVGNLETLILDSNPLA 333 (477)
T ss_dssp CCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred cCceeCHhHcCCCcccCEEEccCCCcc
Confidence 555444445555555555555555554
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=366.04 Aligned_cols=255 Identities=24% Similarity=0.321 Sum_probs=204.7
Q ss_pred HhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcc----------hhhHHHHHHHHHHhhcCCCCceeeece
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGE----------MACQQEFLNEGNALTKIRHRNIVKFYG 767 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~niv~~~~ 767 (973)
..++|++.+.||+|+||+||+|.. .+++.||||++....... ....+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 357899999999999999999965 478999999987543221 123578999999999999999999999
Q ss_pred eeeccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC---c
Q 002069 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY---E 844 (973)
Q Consensus 768 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~---~ 844 (973)
++.++...++||||+++|+|.+++... ..+++..++.++.|++.|++|||+. +|+||||||+||+++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999988643 3589999999999999999999999 999999999999998776 6
Q ss_pred eEEecccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhh
Q 002069 845 AHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIAL 924 (973)
Q Consensus 845 ~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 924 (973)
+||+|||+++..... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ....
T Consensus 188 ~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~ 256 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND---------QDII 256 (504)
T ss_dssp EEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHH
T ss_pred EEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH---------HHHH
Confidence 999999999877654 33445679999999999874 689999999999999999999999975332 1112
Q ss_pred hhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 925 DEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..+...........+...+..+.+++.+||+.||.+|||++|+++.
T Consensus 257 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 257 KKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 2222222222222222334568899999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=348.87 Aligned_cols=265 Identities=20% Similarity=0.278 Sum_probs=206.5
Q ss_pred ccHHHHHHHhcCCccc-ccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeece
Q 002069 691 IVHEEIIRATKNFDDE-HCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYG 767 (973)
Q Consensus 691 ~~~~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~ 767 (973)
+.+.......++|.+. +.||+|+||.||+|... +++.||||++....... .....+.+|+.+++.+ +||||+++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 3344455566778887 88999999999999654 79999999987543322 2357889999999999 5699999999
Q ss_pred eeeccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC---CCc
Q 002069 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL---EYE 844 (973)
Q Consensus 768 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---~~~ 844 (973)
++.+.+..++||||+++++|.+++.... ...+++.+++.++.|++.|++|||+. +|+||||||+||+++. ++.
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCC
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCc
Confidence 9999999999999999999999986433 34689999999999999999999999 9999999999999988 789
Q ss_pred eEEecccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhh
Q 002069 845 AHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIAL 924 (973)
Q Consensus 845 ~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 924 (973)
+||+|||.++..... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||......... ...
T Consensus 173 ~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~i 245 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHA-CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY------LNI 245 (327)
T ss_dssp EEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHH
T ss_pred EEEeeCccccccCCc-cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH------HHH
Confidence 999999999877543 2234467999999999999999999999999999999999999999754321110 001
Q ss_pred hhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 925 DEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.... ...+. .........+.+++.+||+.||.+|||++++++.
T Consensus 246 ~~~~-~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 246 SQVN-VDYSE--ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHTC-CCCCT--TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred Hhcc-cccCc--hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1111 11111 1111223457789999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=348.60 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=198.1
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCE----EEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEI----VAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
++|++.+.||+|+||+||+|.+. +++. ||+|.+....... ....+.+|+.++++++||||+++++++.+ ...
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 89 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSL 89 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS--CBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Ccc
Confidence 57999999999999999999653 4543 8888876443221 23567789999999999999999999864 568
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+++|+|.+++.... ..+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 90 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 89999999999999997653 4688899999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 856 LKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 856 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
...... ......+++.|+|||++.+..++.++|||||||++|||+| |+.||...... ..............
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~~~ 238 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA------EVPDLLEKGERLAQ 238 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT------HHHHHHHTTCBCCC
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH------HHHHHHHcCCCCCC
Confidence 754432 2344567889999999998999999999999999999999 99999743311 00111111111111
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+.. ....+.+++.+||+.||.+|||++++++.|+
T Consensus 239 ~~~------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~ 272 (325)
T 3kex_A 239 PQI------CTIDVYMVMVKCWMIDENIRPTFKELANEFT 272 (325)
T ss_dssp CTT------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHH
T ss_pred CCc------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111 1224678899999999999999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=343.60 Aligned_cols=266 Identities=23% Similarity=0.301 Sum_probs=198.8
Q ss_pred HhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCc--chhhHHHHHHHHHHhhcC---CCCceeeeceeeecc
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPG--EMACQQEFLNEGNALTKI---RHRNIVKFYGFCSHA 772 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~ 772 (973)
..++|++.+.||+|+||+||+|.. .+++.||||++...... .......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999975 57899999998633211 111124566777776666 599999999999765
Q ss_pred c-----eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEE
Q 002069 773 L-----HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV 847 (973)
Q Consensus 773 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl 847 (973)
. ..++||||++ ++|.+++..... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 4 5799999997 699999976542 3489999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh--hhhh----hh
Q 002069 848 SDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS--LSSN----LN 921 (973)
Q Consensus 848 ~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~--~~~~----~~ 921 (973)
+|||.++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......... .... ..
T Consensus 162 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 162 ADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp CSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 999999876543 2334567899999999999999999999999999999999999999754321110 0000 00
Q ss_pred hhh-------hhhcCCCCCCC-chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 922 IAL-------DEMLDPRLPTP-LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 922 ~~~-------~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
... .....+..+.. ..........+.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000 00000000000 00011223567899999999999999999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=339.72 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=208.3
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.+.|++.+.||+|+||.||+|.. .+++.||||++...... ...+.+.+|+.++++++||||+++++++.+....++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 46799999999999999999954 57999999999765333 2357899999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.+++.. ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 99 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp EECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 999999999999864 3588999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.........|++.|+|||++.+..++.++||||||+++|+|++|+.||........ .........+.....
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~--- 242 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV------LFLIPKNNPPTLEGN--- 242 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSCCCCCCSS---
T ss_pred cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH------HHHhhcCCCCCCccc---
Confidence 54445567799999999999999999999999999999999999999974332110 001111111222211
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.+..+.+++.+||+.||.+|||++++++.
T Consensus 243 ---~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 243 ---YSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ---CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ---cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 22347889999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=352.18 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=191.2
Q ss_pred cCCcccccccCCCceeEEEEEcC--CC--CEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec-ccee
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP--TG--EIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH-ALHS 775 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~ 775 (973)
..|++.+.||+|+||+||+|.+. ++ ..||||.+.... .....+.|.+|+.++++++||||+++++++.+ ++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 35778899999999999999653 22 368999987543 23346889999999999999999999998754 5578
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+++|+|.++++... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccc
Confidence 99999999999999997543 3578999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCC----cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCC
Q 002069 856 LKLGLS----NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDP 930 (973)
Q Consensus 856 ~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (973)
...... ......+++.|+|||.+.+..++.++|||||||++|||+| |.+||....... ...........
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~------~~~~~~~~~~~ 315 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQGRRL 315 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC------HHHHHHTTCCC
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH------HHHHHHcCCCC
Confidence 643321 1233557889999999999999999999999999999999 677776432110 00011111111
Q ss_pred CCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 931 RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 931 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+. ..+..+.+++.+||+.||++|||++++++.|+
T Consensus 316 ~~p~------~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 351 (373)
T 3c1x_A 316 LQPE------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351 (373)
T ss_dssp CCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111 12345788999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=342.46 Aligned_cols=259 Identities=25% Similarity=0.383 Sum_probs=203.2
Q ss_pred CcccccccCCCceeEEEEEc-----CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec--ccee
Q 002069 703 FDDEHCIGNGGQGSVYKAEL-----PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH--ALHS 775 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 775 (973)
|++.+.||+|+||+||++.+ .+++.||||++.... .....+.+.+|+.++++++||||+++++++.+ ....
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 49999999999999998854 267899999998653 23346789999999999999999999999987 4578
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+++++|.+++... .+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.
T Consensus 111 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence 9999999999999999754 388999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCC---cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh-----hhhhhhhhhhh
Q 002069 856 LKLGLS---NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL-----SSNLNIALDEM 927 (973)
Q Consensus 856 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~-----~~~~~~~~~~~ 927 (973)
...... ......+++.|+|||++.+..++.++||||+|+++|||+||+.||.......... .........+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 765432 2234567888999999998889999999999999999999999987543211000 00000011111
Q ss_pred cCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 928 LDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+........ ....+..+.+++.+||+.||.+|||++++++.|+
T Consensus 264 ~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 306 (318)
T 3lxp_A 264 LERGERLPR--PDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306 (318)
T ss_dssp HHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HhcccCCCC--CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 111111000 0122345789999999999999999999999875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=349.72 Aligned_cols=262 Identities=17% Similarity=0.226 Sum_probs=194.0
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||+|... +++.||||++....... ....+.+|+.++++++||||+++++++..++..++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 57999999999999999999664 88999999987543221 1234557999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||++ ++|.+++.... ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.....
T Consensus 80 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp ECCS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred cccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 9998 58988886543 3588999999999999999999999 9999999999999999999999999999876654
Q ss_pred CCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh--hhhhh----hh---------hh
Q 002069 860 LSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS--SLSSN----LN---------IA 923 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~~~~----~~---------~~ 923 (973)
........||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ..... .. ..
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 444555678999999999876 5689999999999999999999999975432110 00000 00 00
Q ss_pred hhhhcCCCCCCC--chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 924 LDEMLDPRLPTP--LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 924 ~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+..... ..........+.+++.+||+.||.+|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000110000 00111223457899999999999999999999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=353.40 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=198.3
Q ss_pred cCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC--CCceeeeceeeeccceeEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR--HRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv 778 (973)
..|++.+.||+|+||.||+|...+++.||||++..... .....+.+.+|+.++++++ ||||+++++++..++..++|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 56999999999999999999888899999999875433 2334678999999999996 59999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|| +.+++|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 56889999997543 678899999999999999999999 999999999999995 68999999999987754
Q ss_pred CCC--cccccccccCccccccccc-----------CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhh
Q 002069 859 GLS--NRTELAGTFGYIAPELAYT-----------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALD 925 (973)
Q Consensus 859 ~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 925 (973)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--------~~~~ 278 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--------SKLH 278 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--------HHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH--------HHHH
Confidence 322 2345679999999999865 368889999999999999999999997432111 1112
Q ss_pred hhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 926 EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..+++......... ....+.+++.+||+.||.+|||++|+++.
T Consensus 279 ~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 279 AIIDPNHEIEFPDI--PEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHCTTSCCCCCCC--SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhCccccCCCCcc--chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 22222211111111 12357789999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=371.39 Aligned_cols=257 Identities=21% Similarity=0.283 Sum_probs=206.7
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|.. .+|+.||||++.............+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999965 48999999998643222222346788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++|+|.+++.... ...+++..++.++.||+.|++|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999997544 23589999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ .......... ....++..
T Consensus 339 ~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~~i~~~i~~-~~~~~p~~--- 411 (576)
T 2acx_A 339 GQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKE-VPEEYSER--- 411 (576)
T ss_dssp TC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HHHHHHHHHH-CCCCCCTT---
T ss_pred Cc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HHHHHHHhhc-ccccCCcc---
Confidence 42 33446899999999999998999999999999999999999999975321100 0000011111 11122211
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 002069 939 VQDKLISIMEVSISCLDESPTSRP-----TMQKVSQL 970 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 970 (973)
.+..+.+++.+||+.||.+|| +++|++++
T Consensus 412 ---~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 412 ---FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ---CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 223577899999999999999 78888753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=353.41 Aligned_cols=261 Identities=20% Similarity=0.221 Sum_probs=196.8
Q ss_pred hcCCcccccccCCCceeEEEEEcC----CCCEEEEEEcCCCCCcchh--------hHHHHHHHHHHhhcCCCCceeeece
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP----TGEIVAVKKFHSPLPGEMA--------CQQEFLNEGNALTKIRHRNIVKFYG 767 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~ 767 (973)
.++|++.+.||+|+||+||+|... +++.||||++......... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999764 6788999998765322111 1234677888999999999999999
Q ss_pred eeec----cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC
Q 002069 768 FCSH----ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY 843 (973)
Q Consensus 768 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~ 843 (973)
++.. ....++||||+ +++|.+++.... .+++.+++.++.||+.|++|||+. +|+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 9977 67889999999 999999997544 689999999999999999999999 999999999999999887
Q ss_pred --ceEEecccccccccCCCC-------cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh
Q 002069 844 --EAHVSDFGISKFLKLGLS-------NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS 914 (973)
Q Consensus 844 --~~kl~Dfg~a~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 914 (973)
.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 999999999987643211 12446799999999999999999999999999999999999999964221111
Q ss_pred hhhhhhhhhhhhhcCCCCCCCchh---hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 915 SLSSNLNIALDEMLDPRLPTPLRN---VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.... ......+.++..... ....+..+.+++.+||+.||++||++++|++.|+
T Consensus 269 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 324 (345)
T 2v62_A 269 AVQT-----AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILN 324 (345)
T ss_dssp HHHH-----HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHC
T ss_pred HHHH-----HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 0000 000000011100000 0022346889999999999999999999999885
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=345.25 Aligned_cols=265 Identities=25% Similarity=0.358 Sum_probs=199.7
Q ss_pred HHHHhcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC--CCCceeeeceeeecc-
Q 002069 696 IIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI--RHRNIVKFYGFCSHA- 772 (973)
Q Consensus 696 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~- 772 (973)
.....++|++.+.||+|+||.||+|+. .++.||||++... ....+..|.+++... +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred ccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 334567899999999999999999987 4899999998532 134455555555554 999999999999776
Q ss_pred ---ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEeecCCCCCeeecCCCc
Q 002069 773 ---LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC-----FPPIVHRDISSKNVLLNLEYE 844 (973)
Q Consensus 773 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~Dlk~~Nill~~~~~ 844 (973)
...++||||+++|+|.++++.. .+++.+++.++.|++.|++|||+.. .++|+||||||+||+++.++.
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 6789999999999999999643 5889999999999999999999862 238999999999999999999
Q ss_pred eEEecccccccccCCCCc----ccccccccCcccccccccCCCCCc------cchHHHHHHHHHHHhC----------CC
Q 002069 845 AHVSDFGISKFLKLGLSN----RTELAGTFGYIAPELAYTMKVTEK------CDVYSFGVLALEVIKG----------KH 904 (973)
Q Consensus 845 ~kl~Dfg~a~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~------~Dv~slG~~l~el~tg----------~~ 904 (973)
+||+|||.++.+...... .....||+.|+|||++.+.....+ +|||||||++|||+|| +.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 999999999766543222 224579999999999987766665 9999999999999999 55
Q ss_pred CCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 905 PRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 905 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
||.......................+..+.... .......+.+++.+||+.||.+|||+++|++.|+
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 327 (337)
T 3mdy_A 261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWS-SDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327 (337)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGG-GSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred cHhhhcCCCCchhhhHHHHhhhccCccccccch-hhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence 554221110000000011111122222222211 2356677899999999999999999999999885
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.20 Aligned_cols=252 Identities=25% Similarity=0.330 Sum_probs=203.4
Q ss_pred cCCcccc-cccCCCceeEEEEEcC---CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeE
Q 002069 701 KNFDDEH-CIGNGGQGSVYKAELP---TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 701 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (973)
++|.+.+ .||+|+||.||+|... +++.||||+++... .....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 5666666 9999999999999643 67789999998643 234467899999999999999999999999 455689
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
+||||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++..
T Consensus 86 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999999996443 4589999999999999999999999 9999999999999999999999999999877
Q ss_pred cCCCCc---ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 857 KLGLSN---RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 857 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
...... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ..........+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~i~~~~~~~~ 234 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRMEC 234 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------HHHHHHTTCCCCC
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHhcCCcCCC
Confidence 543221 223456889999999988889999999999999999998 999997433210 0111111111122
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+. ..+..+.+++.+||+.||.+||++.++++.|+
T Consensus 235 ~~------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 235 PP------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp CT------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CC------CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 21 12345788999999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=347.39 Aligned_cols=265 Identities=18% Similarity=0.265 Sum_probs=193.9
Q ss_pred HHhcCCcccccccCCCceeEEEEE-cCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeE
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (973)
...++|++.+.||+|+||+||+|. ..+++.||||++...... ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 345789999999999999999995 458899999999755332 223567889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeec-----CCCceEEeccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLN-----LEYEAHVSDFG 851 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~-----~~~~~kl~Dfg 851 (973)
+||||++ ++|.+++.... .+++.+++.++.|++.|++|||+. +|+||||||+||+++ .++.+||+|||
T Consensus 110 lv~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999998 59999987543 588999999999999999999999 999999999999994 44569999999
Q ss_pred ccccccCCCCcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhh--h----hhhh-
Q 002069 852 ISKFLKLGLSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSS--N----LNIA- 923 (973)
Q Consensus 852 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~--~----~~~~- 923 (973)
.++.............||+.|+|||++.+. .++.++||||+||++|||++|+.||............ . ....
T Consensus 183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 998776554455566789999999998874 4899999999999999999999999754322110000 0 0000
Q ss_pred -----hhhhcC--CCCCC-Cchh--hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 924 -----LDEMLD--PRLPT-PLRN--VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 924 -----~~~~~~--~~~~~-~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...... +.... .... .......+.+++.+||+.||.+|||++|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 000000 00000 0000 00123567899999999999999999999873
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=344.89 Aligned_cols=252 Identities=29% Similarity=0.474 Sum_probs=197.8
Q ss_pred cCCcccccccCCCceeEEEEEcCC-----CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPT-----GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
.+|++.+.||+|+||+||+|.... +..||||++.... .......+.+|+.++++++||||+++++++.+.+..
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 568888999999999999996532 2369999997543 233457899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999997542 4689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCC---cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCC-
Q 002069 856 LKLGLS---NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDP- 930 (973)
Q Consensus 856 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 930 (973)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .........
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---------~~~~~~~~~~ 267 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---------EVMKAINDGF 267 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---------HHHHHHHTTC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---------HHHHHHHCCC
Confidence 654322 1223346788999999998899999999999999999999 99999643321 111111111
Q ss_pred CCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 931 RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 931 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+.. ...+..+.+++.+||+.||.+||++.++++.|+
T Consensus 268 ~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 305 (333)
T 1mqb_A 268 RLPTP----MDCPSAIYQLMMQCWQQERARRPKFADIVSILD 305 (333)
T ss_dssp CCCCC----TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred cCCCc----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111 112345788999999999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=344.41 Aligned_cols=262 Identities=19% Similarity=0.290 Sum_probs=198.6
Q ss_pred hcCCccc-ccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeE
Q 002069 700 TKNFDDE-HCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 700 ~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 776 (973)
.+.|++. +.||+|+||+||+|.. .+++.||||++..... .....+.+|+.++.++ +||||+++++++.+++..+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 3578885 7899999999999965 4799999999975432 2257889999999885 7999999999999999999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCc---eEEeccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYE---AHVSDFGIS 853 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~---~kl~Dfg~a 853 (973)
+||||+++++|.+++... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 88 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp EEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred EEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 999999999999999653 3588999999999999999999999 9999999999999988766 999999998
Q ss_pred ccccCCCC-------cccccccccCccccccccc-----CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh-----
Q 002069 854 KFLKLGLS-------NRTELAGTFGYIAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL----- 916 (973)
Q Consensus 854 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~----- 916 (973)
........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.........+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 76643211 1223469999999999875 558899999999999999999999997532110000
Q ss_pred -hhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 917 -SSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 917 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..................+.......+..+.+++.+||+.||.+|||++|+++.
T Consensus 242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000011111222222222211112234568899999999999999999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=366.15 Aligned_cols=254 Identities=25% Similarity=0.323 Sum_probs=204.5
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
..++|++.+.||+|+||+||+|... +++.||||++...... ......+.+|+.++++++||||+++++++.+....++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 3567999999999999999999654 8999999998532211 1225778999999999999999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeec---CCCceEEecccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLN---LEYEAHVSDFGISK 854 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~---~~~~~kl~Dfg~a~ 854 (973)
||||+++++|.+++... ..+++.++..++.|++.|++|||+. +|+||||||+||+++ .++.+||+|||+++
T Consensus 99 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999999988643 3689999999999999999999999 999999999999995 45689999999998
Q ss_pred cccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCC
Q 002069 855 FLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934 (973)
Q Consensus 855 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (973)
..... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .....+.......
T Consensus 173 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~i~~~~~~~ 241 (486)
T 3mwu_A 173 CFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---------DILKRVETGKYAF 241 (486)
T ss_dssp TBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHTCCCS
T ss_pred ECCCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHhCCCCC
Confidence 76544 23345679999999999876 5899999999999999999999999744321 1111222222222
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
....+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 242 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 222223344567899999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=347.24 Aligned_cols=264 Identities=22% Similarity=0.322 Sum_probs=201.4
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|... +|+.||||++..... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 468999999999999999999654 689999999875533 333467788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||++++++.++..... .+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++....
T Consensus 103 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999998865433 588999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhh------h---hhh------h
Q 002069 859 GLSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLS------S---NLN------I 922 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~------~---~~~------~ 922 (973)
.........|++.|+|||++.+. .++.++||||+||++|+|++|+.||........... . ... .
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 54445566799999999998875 688999999999999999999999975442111000 0 000 0
Q ss_pred hhhhhcCCCCCCCc---hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 923 ALDEMLDPRLPTPL---RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 923 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.......+...... ......+..+.+++.+||+.||.+|||++|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00011111111110 0111234568899999999999999999999863
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.90 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=195.2
Q ss_pred HhcCCcccccccCCCceeEEEEEcC----CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc-
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP----TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL- 773 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~- 773 (973)
..++|.+.+.||+|+||.||+|... +++.||||++...... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 3578999999999999999999543 3458999999765333 333578999999999999999999999997654
Q ss_pred ----eeEEEEEecCCCChHHHhccCc---cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceE
Q 002069 774 ----HSFVVYEYLEMGSLAMILSNDA---AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAH 846 (973)
Q Consensus 774 ----~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~k 846 (973)
..++||||+++++|.+++.... ....+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence 3499999999999999984322 234689999999999999999999999 999999999999999999999
Q ss_pred EecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhh
Q 002069 847 VSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIA 923 (973)
Q Consensus 847 l~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 923 (973)
|+|||.++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ..
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---------~~ 258 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---------EM 258 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---------GH
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---------HH
Confidence 999999987654321 2233557889999999999999999999999999999999 89998743321 11
Q ss_pred hhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 924 LDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
............. ...+..+.+++.+||+.||.+|||++++++.|+
T Consensus 259 ~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 304 (313)
T 3brb_A 259 YDYLLHGHRLKQP---EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304 (313)
T ss_dssp HHHHHTTCCCCCB---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHcCCCCCCC---ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111111111111 122345789999999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=364.22 Aligned_cols=253 Identities=24% Similarity=0.320 Sum_probs=200.2
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|... +++.||||++....... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 457999999999999999999654 78999999987543222 1247789999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC---CceEEeccccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE---YEAHVSDFGISKF 855 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~---~~~kl~Dfg~a~~ 855 (973)
|||+++|+|.+++... ..+++.++..++.||+.|++|||+. +|+||||||+||+++.. +.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999988643 3588999999999999999999999 99999999999999764 5599999999987
Q ss_pred ccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 856 LKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 856 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
.... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||...... .....+........
T Consensus 189 ~~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~i~~~~~~~~ 257 (494)
T 3lij_A 189 FENQ-KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---------EILRKVEKGKYTFD 257 (494)
T ss_dssp CBTT-BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHTCCCCC
T ss_pred CCCC-ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHhCCCCCC
Confidence 7644 3344567999999999886 46999999999999999999999999754321 11111111222211
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...+...+..+.+++.+||+.||.+|||++++++.
T Consensus 258 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 12222334457899999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=337.67 Aligned_cols=253 Identities=24% Similarity=0.304 Sum_probs=200.3
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
+|.....||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 455556899999999999964 5789999999875432 235779999999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC-CCceEEecccccccccCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL-EYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~ 859 (973)
|+++++|.+++........+++..+..++.|++.|++|||+. +++||||||+||+++. ++.+||+|||.++.....
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999997655445677899999999999999999999 9999999999999987 899999999999877554
Q ss_pred CCcccccccccCcccccccccCC--CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 860 LSNRTELAGTFGYIAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
........|++.|+|||++.+.. ++.++||||||+++|+|++|+.||.......... .........+.++..
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~-- 250 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM----FKVGMFKVHPEIPES-- 250 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH----HHHHHHCCCCCCCTT--
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH----Hhhcccccccccccc--
Confidence 33445567999999999987653 7889999999999999999999997433211110 000111112222221
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.+..+.+++.+||+.||++||+++++++.
T Consensus 251 ----~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 251 ----MSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ----SCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ----CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 22357789999999999999999999863
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=337.74 Aligned_cols=248 Identities=25% Similarity=0.379 Sum_probs=204.3
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|... +++.||||++.............+.+|+.++++++||||+++++++.+++..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999654 6889999998643212222346789999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.+++... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999999654 3588999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcC--CCCCCCc
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLD--PRLPTPL 936 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 936 (973)
. ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ....... ..++..
T Consensus 167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------~~~~~~~~~~~~~~~- 234 (284)
T 2vgo_A 167 L--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---------THRRIVNVDLKFPPF- 234 (284)
T ss_dssp S--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---------HHHHHHTTCCCCCTT-
T ss_pred c--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---------HHHHHhccccCCCCc-
Confidence 2 2344678999999999999999999999999999999999999997433211 1111111 112211
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.+..+.+++.+|++.||.+|||++++++.
T Consensus 235 -----~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 235 -----LSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp -----SCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred -----CCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 22357789999999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=356.36 Aligned_cols=257 Identities=23% Similarity=0.255 Sum_probs=193.5
Q ss_pred HHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCc-----chhhHHHHHHHHHHhhcCCCCceeeeceeeec
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPG-----EMACQQEFLNEGNALTKIRHRNIVKFYGFCSH 771 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 771 (973)
...++|.+.+.||+|+||+||+|.. .+++.||||++...... .......+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3467899999999999999999954 57899999998643211 11123458899999999999999999999865
Q ss_pred cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC---CceEEe
Q 002069 772 ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE---YEAHVS 848 (973)
Q Consensus 772 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~---~~~kl~ 848 (973)
+ ..++||||+++++|.+++... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.+ +.+||+
T Consensus 212 ~-~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 E-DYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp S-EEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred C-ceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 4 578999999999999988654 3689999999999999999999999 99999999999999754 459999
Q ss_pred cccccccccCCCCcccccccccCccccccccc---CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhh
Q 002069 849 DFGISKFLKLGLSNRTELAGTFGYIAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALD 925 (973)
Q Consensus 849 Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 925 (973)
|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....... ....
T Consensus 285 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--------~~~~ 355 (419)
T 3i6u_A 285 DFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--------SLKD 355 (419)
T ss_dssp CSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--------CHHH
T ss_pred ecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--------HHHH
Confidence 99999876543 23345679999999999863 567889999999999999999999997432110 0111
Q ss_pred hhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 926 EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.................+..+.+++.+||+.||.+|||++|+++.
T Consensus 356 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 356 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 111122221111122234567899999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=341.18 Aligned_cols=252 Identities=27% Similarity=0.399 Sum_probs=202.4
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
..++|++.+.||+|+||.||+|... +|+.||||++..... .+.+.+|+.++++++||||+++++++...+..++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 4578999999999999999999654 699999999875421 3678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||||+++++|.+++... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+....
T Consensus 102 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred EeecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 99999999999998632 24689999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
..........|++.|+|||.+.+..++.++||||||+++|+|++|+.||.......... .......+....
T Consensus 177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~~~~~~--- 247 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF------MIPTNPPPTFRK--- 247 (314)
T ss_dssp TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHSCCCCCSS---
T ss_pred hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHhcCCCcccCC---
Confidence 55444556679999999999999899999999999999999999999997543221110 011111111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
....+..+.+++.+||+.||.+|||+.++++.
T Consensus 248 -~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 248 -PELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp -GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11223457899999999999999999999863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=341.22 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=201.4
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|.+.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 467999999999999999999654 7999999999754322 246788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeee---cCCCceEEeccccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL---NLEYEAHVSDFGISKF 855 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill---~~~~~~kl~Dfg~a~~ 855 (973)
|||+++++|.+++... ..+++.+++.++.|++.|++|||+. +++||||||+||++ +.++.+|++|||.++.
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 85 MQLVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp ECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EEcCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 9999999999998643 3588999999999999999999999 99999999999999 7789999999999976
Q ss_pred ccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 856 LKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 856 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
.... ......|++.|+|||.+.+..++.++||||+|+++|||++|+.||...... ..............
T Consensus 159 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------~~~~~i~~~~~~~~ 227 (304)
T 2jam_A 159 EQNG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---------KLFEKIKEGYYEFE 227 (304)
T ss_dssp CCCB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---------HHHHHHHHCCCCCC
T ss_pred cCCC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---------HHHHHHHcCCCCCC
Confidence 5432 233456899999999999999999999999999999999999999743321 01111111111111
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.......+..+.+++.+||+.||.+|||++++++.
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 228 SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111223457899999999999999999999863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=343.80 Aligned_cols=253 Identities=22% Similarity=0.376 Sum_probs=196.1
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCC----EEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccce
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGE----IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH 774 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 774 (973)
..+|++.+.||+|+||+||+|.+. +++ +||+|.+...... ...+.+.+|+.++++++||||+++++++..+.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC--CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 367999999999999999999653 554 3688887654322 23578999999999999999999999998764
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.++|+||+++|+|.+++.... ..+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred ceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 789999999999999997543 4588999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 855 FLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 855 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
....... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||+...... ............
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~~~~~~~~~ 239 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKGERLP 239 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHHHTTCCCC
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH------HHHHHHcCCCCC
Confidence 7654322 2233456789999999999999999999999999999999 999997543210 111111111111
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+.. .+..+.+++.+||+.||.+||+++|+++.|+
T Consensus 240 ~~~~------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 274 (327)
T 3lzb_A 240 QPPI------CTIDVYMIMRKCWMIDADSRPKFRELIIEFS 274 (327)
T ss_dssp CCTT------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCcc------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 1111 2335788999999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=348.02 Aligned_cols=267 Identities=20% Similarity=0.246 Sum_probs=199.0
Q ss_pred HHhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcc--hhhHHHHHHHHHHhhcCCCCceeeeceeeeccce
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGE--MACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH 774 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 774 (973)
...++|++.+.||+|+||.||+|... +|+.||||++....... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999765 68999999987543221 1113468899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.++||||+++ ++.+++.... ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999985 8888886543 4578899999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh---hh---hhhhhhhh--
Q 002069 855 FLKLGLSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS---LS---SNLNIALD-- 925 (973)
Q Consensus 855 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~---~~---~~~~~~~~-- 925 (973)
.............||+.|+|||++.+. .++.++|||||||++|||++|..||......... .. ........
T Consensus 161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 776554455567899999999998764 4789999999999999999999998754321110 00 00000000
Q ss_pred ----hhc-CCCCCCCc--hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 926 ----EML-DPRLPTPL--RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 926 ----~~~-~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
+.. ....+... .........+.+++.+||+.||.+|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 00000000 0001223568899999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=345.58 Aligned_cols=263 Identities=22% Similarity=0.337 Sum_probs=205.9
Q ss_pred HHHHHhcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhc--CCCCceeeeceeeecc
Q 002069 695 EIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTK--IRHRNIVKFYGFCSHA 772 (973)
Q Consensus 695 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~ 772 (973)
.-....++|++.+.||+|+||.||+|.. +++.||||++... ....+.+|.+++.. ++||||+++++++...
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 3344567899999999999999999987 6899999998632 24667788888876 7999999999999876
Q ss_pred c----eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEeecCCCCCeeec
Q 002069 773 L----HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMH--------TNCFPPIVHRDISSKNVLLN 840 (973)
Q Consensus 773 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~Dlk~~Nill~ 840 (973)
. ..++||||+++|+|.+++++. .+++.+++.++.|++.|++||| +. +|+||||||+||+++
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVK 181 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEEC
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEEC
Confidence 5 789999999999999999643 4789999999999999999999 77 999999999999999
Q ss_pred CCCceEEecccccccccCCCC----cccccccccCcccccccccCC------CCCccchHHHHHHHHHHHhC--------
Q 002069 841 LEYEAHVSDFGISKFLKLGLS----NRTELAGTFGYIAPELAYTMK------VTEKCDVYSFGVLALEVIKG-------- 902 (973)
Q Consensus 841 ~~~~~kl~Dfg~a~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~slG~~l~el~tg-------- 902 (973)
.++.+||+|||.++....... ......||+.|+|||++.+.. ++.++|||||||++|||+||
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 999999999999987755432 224457999999999987652 33689999999999999999
Q ss_pred --CCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 903 --KHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 903 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+.||.......................+.++..+. .......+.+++.+||+.||.+|||+++|++.|+
T Consensus 262 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~ 332 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQ-SCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332 (342)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGG-TSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred ccccCccccCcCcccHHHHHHHHHHHHhCCCCccccc-chhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 67775332111001111111112223333332221 2345667899999999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=337.93 Aligned_cols=254 Identities=24% Similarity=0.375 Sum_probs=199.0
Q ss_pred hcCCcccccccCCCceeEEEEEcCC----CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeee-ccce
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPT----GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCS-HALH 774 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~ 774 (973)
..+|++.+.||+|+||+||+|...+ +..||+|.+.... .....+.+.+|+.++++++||||+++++++. .++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 3578899999999999999996532 2368999987643 3334678999999999999999999999864 4567
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.++||||+++++|.++++... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred eEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccc
Confidence 899999999999999997543 4578999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCC----CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcC
Q 002069 855 FLKLGL----SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLD 929 (973)
Q Consensus 855 ~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 929 (973)
...... .......+|+.|+|||.+.+..++.++||||+|+++|||++ |.+||....... ..........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~------~~~~~~~~~~ 250 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQGRR 250 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT------HHHHHHTTCC
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH------HHHHHhcCCC
Confidence 664432 12234567889999999999999999999999999999999 556665322110 0011111111
Q ss_pred CCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 930 PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 930 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+.. .+..+.+++.+||+.||.+|||++++++.|+
T Consensus 251 ~~~~~~------~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 287 (298)
T 3f66_A 251 LLQPEY------CPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287 (298)
T ss_dssp CCCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCcc------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111111 1235788999999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=354.01 Aligned_cols=264 Identities=23% Similarity=0.322 Sum_probs=191.9
Q ss_pred HHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeeccc--
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHAL-- 773 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-- 773 (973)
...++|++.+.||+|+||.||+|.. .+|+.||||++...... ....+.+.+|+.+++++. ||||+++++++..++
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-STDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 3467899999999999999999954 58999999998754333 334677889999999997 999999999997543
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
..|+||||++ ++|.++++. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+|
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 6899999998 689988864 3588999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCC---------------------CCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhh
Q 002069 854 KFLKLG---------------------LSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISS 911 (973)
Q Consensus 854 ~~~~~~---------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 911 (973)
+.+... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 865431 112234679999999999876 6789999999999999999999999975432
Q ss_pred hhhh------hhhhhhhhhh---------------hhc---CCCCCCCchhhH----------HHHHHHHHHHhcccCCC
Q 002069 912 ICSS------LSSNLNIALD---------------EML---DPRLPTPLRNVQ----------DKLISIMEVSISCLDES 957 (973)
Q Consensus 912 ~~~~------~~~~~~~~~~---------------~~~---~~~~~~~~~~~~----------~~~~~l~~li~~cl~~d 957 (973)
.... .......... ... .......+..+. .....+.+++.+||+.|
T Consensus 237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 1110 0000000000 000 000000010000 12345789999999999
Q ss_pred CCCCCCHHHHHHH
Q 002069 958 PTSRPTMQKVSQL 970 (973)
Q Consensus 958 P~~RPs~~ev~~~ 970 (973)
|.+|||++|+++.
T Consensus 317 P~~R~t~~e~l~H 329 (388)
T 3oz6_A 317 PNKRISANDALKH 329 (388)
T ss_dssp GGGSCCHHHHTTS
T ss_pred cccCCCHHHHhCC
Confidence 9999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.45 Aligned_cols=262 Identities=23% Similarity=0.320 Sum_probs=206.8
Q ss_pred hcCCcccccccCCCceeEEEEEc-----CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeee--cc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-----PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCS--HA 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~ 772 (973)
.++|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++. +.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 36899999999999999999973 47889999999754 2334577999999999999999999999886 45
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
...++||||+++++|.++++... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred ceEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence 56899999999999999997533 3589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCC---cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh------hhhhhhh
Q 002069 853 SKFLKLGLS---NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL------SSNLNIA 923 (973)
Q Consensus 853 a~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~------~~~~~~~ 923 (973)
++....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.......... .......
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 987754432 2233567888999999998889999999999999999999999987443211000 0000111
Q ss_pred hhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 924 LDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
............. ...+..+.+++.+||+.||.+|||++++++.|+
T Consensus 254 ~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 299 (327)
T 3lxl_A 254 LELLEEGQRLPAP---PACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299 (327)
T ss_dssp HHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhhcccCCCCC---CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111111111111 122345789999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=343.81 Aligned_cols=256 Identities=24% Similarity=0.369 Sum_probs=201.8
Q ss_pred hcCCcccccccCCCceeEEEEEc------CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 773 (973)
.++|++.+.||+|+||.||+|.+ .+++.||||++.... ......++.+|+.++++++||||+++++++.+.+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 47899999999999999999974 357789999997442 2334578999999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHhccCcc----ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC---CceE
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAA----AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE---YEAH 846 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~---~~~k 846 (973)
..++||||+++++|.+++..... ...+++.+++.++.|++.|++|||+. +|+||||||+||+++.+ ..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999976542 23588999999999999999999999 99999999999999844 5699
Q ss_pred EecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhh
Q 002069 847 VSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIA 923 (973)
Q Consensus 847 l~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 923 (973)
|+|||.++....... ......|++.|+|||.+.+..++.++||||||+++|||+| |+.||...... ..
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---------~~ 254 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---------EV 254 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---------HH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---------HH
Confidence 999999986543322 2234567899999999998899999999999999999998 99998743311 11
Q ss_pred hhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 924 LDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.............. ..+..+.+++.+||+.||.+||+++++++.|+
T Consensus 255 ~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 300 (327)
T 2yfx_A 255 LEFVTSGGRMDPPK---NCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300 (327)
T ss_dssp HHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhcCCCCCCCC---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 11111111111111 12345788999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=339.13 Aligned_cols=253 Identities=27% Similarity=0.375 Sum_probs=201.2
Q ss_pred hcCCcccc-cccCCCceeEEEEEc---CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 700 TKNFDDEH-CIGNGGQGSVYKAEL---PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 700 ~~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
..+|++.+ .||+|+||+||+|.+ .+++.||||++..... .....+.+.+|+.++++++||||+++++++ ..+..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 46788888 999999999999943 3568899999976532 233467899999999999999999999999 55678
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+++++|.+++... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 9999999999999999754 3588999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCc---ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 856 LKLGLSN---RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 856 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ..........+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~ 240 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGERMG 240 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCCC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCCCC
Confidence 7544322 122346788999999988889999999999999999999 999997543210 111111111112
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+. ..+..+.+++.+||+.||.+||+++++++.|+
T Consensus 241 ~~~------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 275 (291)
T 1xbb_A 241 CPA------GCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275 (291)
T ss_dssp CCT------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 211 12345788999999999999999999999875
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=333.14 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=204.9
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
..++|++.+.||+|+||.||+|... +++.||||++...... ...+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 3467999999999999999999654 7899999998643222 235788999999999999999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||||+++++|.+++... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+....
T Consensus 83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp EEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 99999999999998653 3588999999999999999999999 99999999999999999999999999998765
Q ss_pred CCC--CcccccccccCcccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCC-CCC
Q 002069 858 LGL--SNRTELAGTFGYIAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDP-RLP 933 (973)
Q Consensus 858 ~~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 933 (973)
... .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||.......... ...... ...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--------~~~~~~~~~~ 228 (276)
T 2yex_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--------SDWKEKKTYL 228 (276)
T ss_dssp ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH--------HHHHTTCTTS
T ss_pred CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH--------HHhhhccccc
Confidence 332 12345678999999999987765 678999999999999999999997543211111 011111 111
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
... ...+..+.+++.+||+.||.+|||++|+++.
T Consensus 229 ~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 229 NPW---KKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TTG---GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred Cch---hhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 111 1223457789999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=335.70 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=195.7
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|... +++.||||++...........+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 368999999999999999999765 7999999998643222223356889999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.+++... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+.....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999999653 3588999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccCcccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
. .......|++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||+...... ........ ....+..
T Consensus 164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~-~~~~~~~-- 233 (276)
T 2h6d_A 164 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT------LFKKIRGG-VFYIPEY-- 233 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHC-CCCCCTT--
T ss_pred C-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------HHHHhhcC-cccCchh--
Confidence 3 22334578999999999987765 589999999999999999999997433110 00001110 0111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
....+.+++.+||+.||.+|||++++++.
T Consensus 234 ----~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 234 ----LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 12347789999999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.66 Aligned_cols=248 Identities=28% Similarity=0.408 Sum_probs=195.3
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc-ceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA-LHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv 778 (973)
.++|++.+.||+|+||+||+|+. +|+.||||++.... ..+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 46899999999999999999987 58899999997542 247789999999999999999999997554 478999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.+++.... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++....
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp ECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999999999996543 23478999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
. .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... ..............+.
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------~~~~~~~~~~~~~~~~--- 237 (278)
T 1byg_A 170 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVEKGYKMDAPD--- 237 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG------GHHHHHTTTCCCCCCT---
T ss_pred c---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHhcCCCCCCcc---
Confidence 2 223467889999999998899999999999999999998 99998743211 0001111111111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+..+.+++.+||+.||.+|||+.++++.|+
T Consensus 238 ---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 269 (278)
T 1byg_A 238 ---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269 (278)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHH
Confidence 12345788999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=347.01 Aligned_cols=264 Identities=22% Similarity=0.349 Sum_probs=209.4
Q ss_pred HHHHHHHhcCCcccccccCCCceeEEEEEc------CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeee
Q 002069 693 HEEIIRATKNFDDEHCIGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKF 765 (973)
Q Consensus 693 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~ 765 (973)
........++|++.+.||+|+||+||+|.+ .+++.||||++..... ....+.+.+|+.+++++ +||||+++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--cHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 334444568899999999999999999963 3568999999976532 23457899999999999 79999999
Q ss_pred ceeeeccc-eeEEEEEecCCCChHHHhccCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeec
Q 002069 766 YGFCSHAL-HSFVVYEYLEMGSLAMILSNDAA-------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRD 831 (973)
Q Consensus 766 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~D 831 (973)
++++...+ ..++||||+++++|.+++..... ...+++.+++.++.|++.|++|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99987654 58999999999999999976543 12378999999999999999999999 999999
Q ss_pred CCCCCeeecCCCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcc
Q 002069 832 ISSKNVLLNLEYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDF 908 (973)
Q Consensus 832 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~ 908 (973)
|||+||+++.++.+||+|||.++....... ......||+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987654322 2234567889999999999999999999999999999998 9999974
Q ss_pred hhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 909 ISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...... .............+.. ....+.+++.+||+.||.+|||++++++.|+
T Consensus 254 ~~~~~~-----~~~~~~~~~~~~~~~~------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 306 (316)
T 2xir_A 254 VKIDEE-----FCRRLKEGTRMRAPDY------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 306 (316)
T ss_dssp CCCSHH-----HHHHHHHTCCCCCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cchhHH-----HHHHhccCccCCCCCC------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 331110 0111111111111111 2235788999999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.46 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=201.2
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCE--EEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeecccee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEI--VAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 775 (973)
.++|++.+.||+|+||.||+|... +++. ||||++..... ....+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc--hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 368999999999999999999654 5664 49999875322 22356789999999999 999999999999999999
Q ss_pred EEEEEecCCCChHHHhccCc-------------cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC
Q 002069 776 FVVYEYLEMGSLAMILSNDA-------------AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE 842 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~ 842 (973)
++||||+++++|.+++.... ....+++.+++.++.|++.|++|||+. +|+||||||+||+++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC
Confidence 99999999999999997653 234689999999999999999999999 99999999999999999
Q ss_pred CceEEecccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhh
Q 002069 843 YEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLN 921 (973)
Q Consensus 843 ~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~ 921 (973)
+.+||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 179 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~ 251 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LY 251 (327)
T ss_dssp GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HH
T ss_pred CeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------HH
Confidence 99999999998744322 12233457889999999988889999999999999999998 999997433210 00
Q ss_pred hhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 922 IALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...........+. ..+..+.+++.+||+.||.+|||++++++.|+
T Consensus 252 ~~~~~~~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 296 (327)
T 1fvr_A 252 EKLPQGYRLEKPL------NCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296 (327)
T ss_dssp HHGGGTCCCCCCT------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhhcCCCCCCCC------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1111111111111 12345788999999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=359.38 Aligned_cols=246 Identities=13% Similarity=0.096 Sum_probs=191.2
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHH---HHhhcCCCCceeeec-------ee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEG---NALTKIRHRNIVKFY-------GF 768 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~ 768 (973)
.++|++.+.||+|+||+||+|.. .+|+.||||++...........+.+.+|+ ..+++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999976 47999999999754433444568899999 556666899999998 55
Q ss_pred eeccc-----------------eeEEEEEecCCCChHHHhccCcc----ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 002069 769 CSHAL-----------------HSFVVYEYLEMGSLAMILSNDAA----AEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827 (973)
Q Consensus 769 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i 827 (973)
+..++ ..++||||+ +|+|.++++.... ...+++..++.++.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 54442 278999999 5899999975431 11234588889999999999999999 99
Q ss_pred EeecCCCCCeeecCCCceEEecccccccccCCCCcccccccccCcccccccccC-----------CCCCccchHHHHHHH
Q 002069 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTM-----------KVTEKCDVYSFGVLA 896 (973)
Q Consensus 828 ~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Dv~slG~~l 896 (973)
+||||||+||+++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 9999999999999999999999999986432 3345567 999999999887 899999999999999
Q ss_pred HHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 897 LEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 897 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
|||++|+.||....... ........ . . ..+..+.+++.+||+.||.+|||+.++++.
T Consensus 304 ~elltg~~Pf~~~~~~~---------~~~~~~~~-~-~------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 304 YWIWCADLPITKDAALG---------GSEWIFRS-C-K------NIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHSSCCC------C---------CSGGGGSS-C-C------CCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHCCCCCccccccc---------chhhhhhh-c-c------CCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999997433210 11111111 0 0 112357789999999999999999999863
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.41 Aligned_cols=253 Identities=21% Similarity=0.319 Sum_probs=200.2
Q ss_pred hcCCcccccccCCCceeEEEEEcC----CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP----TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
.++|++.+.||+|+||+||+|.+. ++..||||++.... .....+.+.+|+.++++++||||+++++++.++ ..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~ 87 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence 468999999999999999999643 23469999987643 233468899999999999999999999998754 56
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+++++|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 89999999999999996532 4588999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCC-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 856 LKLGLS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 856 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .............+
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~------~~~~~~~~~~~~~~ 236 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD------VIGVLEKGDRLPKP 236 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG------HHHHHHHTCCCCCC
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH------HHHHHhcCCCCCCC
Confidence 654322 2234557889999999998899999999999999999998 999996432210 01111111111111
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.. .+..+.+++.+||+.||.+|||++++++.|+
T Consensus 237 ~~------~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 269 (281)
T 3cc6_A 237 DL------CPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269 (281)
T ss_dssp TT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CC------CCHHHHHHHHHHccCCchhCcCHHHHHHHHH
Confidence 11 2345788999999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=346.47 Aligned_cols=262 Identities=28% Similarity=0.390 Sum_probs=197.1
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHH--hhcCCCCceeeeceeee-----cc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNA--LTKIRHRNIVKFYGFCS-----HA 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~-----~~ 772 (973)
.++|++.+.||+|+||+||+|+. +++.||||++... ....+..|.++ +..++||||+++++++. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA------NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc------chhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 46899999999999999999977 7899999998632 13444444444 45589999999997543 23
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeEeecCCCCCeeecCCCceE
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC------FPPIVHRDISSKNVLLNLEYEAH 846 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------~~~i~H~Dlk~~Nill~~~~~~k 846 (973)
...++||||+++|+|.++++... .++..++.++.|++.|++|||+.. .++|+||||||+||+++.++.+|
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred ceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 46789999999999999996543 478999999999999999999872 22899999999999999999999
Q ss_pred EecccccccccCCC--------CcccccccccCccccccccc-------CCCCCccchHHHHHHHHHHHhCCCCCcchhh
Q 002069 847 VSDFGISKFLKLGL--------SNRTELAGTFGYIAPELAYT-------MKVTEKCDVYSFGVLALEVIKGKHPRDFISS 911 (973)
Q Consensus 847 l~Dfg~a~~~~~~~--------~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 911 (973)
|+|||+++.+.... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998765321 12234579999999999876 4566789999999999999999877642211
Q ss_pred hhh---h----hh--hhh----hhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 912 ICS---S----LS--SNL----NIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 912 ~~~---~----~~--~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
... . .. ... .........+.++..+......+..+.+++.+||+.||++|||++|+++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 000 0 00 000 0011122234444444444456667999999999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=367.37 Aligned_cols=252 Identities=24% Similarity=0.393 Sum_probs=205.6
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.++|++.+.||+|+||.||+|.+.+++.||||+++..... .++|.+|+.++++++||||+++++++.+ +..++||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 4678999999999999999999888888999999864322 4689999999999999999999999976 5789999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|+|.++++... ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 341 e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred ehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 9999999999996432 23588999999999999999999999 9999999999999999999999999999876532
Q ss_pred CC-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 860 LS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 860 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
.. ......++..|+|||++.+..++.++|||||||++|||++ |+.||....... ....+........+.
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~------~~~~i~~~~~~~~~~--- 487 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYRMPCPP--- 487 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH------HHHHHHTTCCCCCCT---
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCC---
Confidence 11 1223456789999999998899999999999999999999 999997443210 011111111111111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+..+.+++.+||+.||++|||+++|++.|+
T Consensus 488 ---~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~ 519 (535)
T 2h8h_A 488 ---ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519 (535)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 22345788999999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=335.33 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=201.0
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 776 (973)
..++|++.+.||+|+||+||+|... +++.||||++....... ....++.+|+..+.++ +||||+++++++.+++..+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 4577999999999999999999664 89999999998654333 2357788999999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHhccCcc-ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC-------------
Q 002069 777 VVYEYLEMGSLAMILSNDAA-AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE------------- 842 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~------------- 842 (973)
+||||+++++|.+++..... ...+++.+++.++.|++.|++|||++ +|+||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999999999975432 24689999999999999999999999 99999999999999844
Q ss_pred ------CceEEecccccccccCCCCcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh
Q 002069 843 ------YEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS 915 (973)
Q Consensus 843 ------~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 915 (973)
..+|++|||.+...... ....||+.|+|||.+.+. .++.++|||||||++|||++|..|+.......
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-- 238 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH-- 238 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH--
T ss_pred cccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH--
Confidence 47999999999876543 234589999999998766 56689999999999999999998765322111
Q ss_pred hhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 916 LSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.......+.++.. .+..+.+++.+||+.||.+|||++++++.
T Consensus 239 -------~~~~~~~~~~~~~------~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 239 -------EIRQGRLPRIPQV------LSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -------HHHTTCCCCCSSC------CCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -------HHHcCCCCCCCcc------cCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1111111222221 22357889999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=371.80 Aligned_cols=252 Identities=20% Similarity=0.277 Sum_probs=206.8
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 776 (973)
...+|++.+.||+|+||.||+|+.. +++.||||+++..........+.+..|..++..+ +||+|+.+++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999654 7889999998743211222346788899999887 7999999999999999999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
+||||+++|+|.++++.. ..+++.+++.++.||+.||+|||+. +|+||||||+|||++.++++||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999754 3689999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 857 KLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 857 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......++......+.
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---------~~~~~~i~~~~~~~p~ 563 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---------DELFQSIMEHNVAYPK 563 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHHHHHSSCCCCCT
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---------HHHHHHHHhCCCCCCc
Confidence 5444455667899999999999999999999999999999999999999975432 1122222222222111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCH-----HHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTM-----QKVSQ 969 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ev~~ 969 (973)
.....+.+++.+||+.||.+||++ +||.+
T Consensus 564 ----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 564 ----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ----TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ----cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 123457889999999999999997 67664
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=344.42 Aligned_cols=259 Identities=21% Similarity=0.266 Sum_probs=196.2
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc-----
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL----- 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 773 (973)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 46799999999999999999965 5899999999976543 3344678899999999999999999999997653
Q ss_pred -eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 774 -HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 774 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
..|+||||+ +++|.++++. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 7899999874 3588999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh------hhhhhhhhh-
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS------LSSNLNIAL- 924 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~------~~~~~~~~~- 924 (973)
++.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......... .+.......
T Consensus 175 a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 175 ARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp CEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 987643 2345678999999999877 67999999999999999999999999754321100 000000000
Q ss_pred ----------hhhcCCCCCCCch-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 925 ----------DEMLDPRLPTPLR-NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 925 ----------~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...+.......+. ........+.+++.+|++.||.+|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000000001110 011223457889999999999999999999873
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=356.17 Aligned_cols=195 Identities=24% Similarity=0.335 Sum_probs=155.3
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec-----cc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH-----AL 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~ 773 (973)
.++|++.+.||+|+||+||+|.. .+++.||||++..... .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 36899999999999999999955 4899999999875433 33446789999999999999999999999843 35
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
..|+||||++ ++|.++++.. ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccc-cchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 6899999985 7899988654 3589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCC---------------------------CcccccccccCccccccc-ccCCCCCccchHHHHHHHHHHHhC
Q 002069 854 KFLKLGL---------------------------SNRTELAGTFGYIAPELA-YTMKVTEKCDVYSFGVLALEVIKG 902 (973)
Q Consensus 854 ~~~~~~~---------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~tg 902 (973)
+...... ......+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 8765321 122345789999999976 566799999999999999999993
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=337.51 Aligned_cols=247 Identities=22% Similarity=0.388 Sum_probs=198.6
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CC-------CEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TG-------EIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH 771 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 771 (973)
.++|++.+.||+|+||+||+|... ++ +.||+|++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 367999999999999999999654 33 47999998643 23346789999999999999999999999999
Q ss_pred cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCc-------
Q 002069 772 ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYE------- 844 (973)
Q Consensus 772 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~------- 844 (973)
++..++||||+++++|.++++... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence 999999999999999999997643 3488999999999999999999999 9999999999999998887
Q ss_pred -eEEecccccccccCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCC-CCcchhhhhhhhhhhhh
Q 002069 845 -AHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKH-PRDFISSICSSLSSNLN 921 (973)
Q Consensus 845 -~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~-p~~~~~~~~~~~~~~~~ 921 (973)
+|++|||.+..... .....|++.|+|||++.+ ..++.++||||||+++|||++|.. ||........ .
T Consensus 159 ~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~------~ 228 (289)
T 4fvq_A 159 FIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK------L 228 (289)
T ss_dssp EEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------H
T ss_pred eeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH------H
Confidence 99999999875532 233568899999999987 678999999999999999999554 4442221100 0
Q ss_pred hhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 922 IALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.... .....+... ...+.+++.+||+.||.+|||++++++.|+
T Consensus 229 ~~~~--~~~~~~~~~------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 271 (289)
T 4fvq_A 229 QFYE--DRHQLPAPK------AAELANLINNCMDYEPDHRPSFRAIIRDLN 271 (289)
T ss_dssp HHHH--TTCCCCCCS------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHhh--ccCCCCCCC------CHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 0000 111222211 123678899999999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=337.34 Aligned_cols=256 Identities=21% Similarity=0.305 Sum_probs=205.5
Q ss_pred HHhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCc------chhhHHHHHHHHHHhhcCC-CCceeeeceee
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPG------EMACQQEFLNEGNALTKIR-HRNIVKFYGFC 769 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~ 769 (973)
...++|++.+.||+|+||.||+|... +++.||||++...... .....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999664 7899999998754321 1223567889999999995 99999999999
Q ss_pred eccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEec
Q 002069 770 SHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSD 849 (973)
Q Consensus 770 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~D 849 (973)
......++||||+++++|.++++.. ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999999653 3689999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCcccccccccCcccccccc------cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhh
Q 002069 850 FGISKFLKLGLSNRTELAGTFGYIAPELAY------TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIA 923 (973)
Q Consensus 850 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 923 (973)
||.+...... .......|++.|+|||++. ...++.++||||||+++|||++|+.||....... .
T Consensus 168 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------~ 237 (298)
T 1phk_A 168 FGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---------M 237 (298)
T ss_dssp CTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------H
T ss_pred ccchhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---------H
Confidence 9999876543 2334567899999999875 4567889999999999999999999997433211 1
Q ss_pred hhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 924 LDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
...................+..+.+++.+||+.||.+|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 238 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111111111111111233456889999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=332.91 Aligned_cols=250 Identities=21% Similarity=0.321 Sum_probs=199.3
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec----ccee
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH----ALHS 775 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~ 775 (973)
..|.+.+.||+|+||+||+|.. .++..||+|++...... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 4588889999999999999955 57889999998754332 3346789999999999999999999998864 3568
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEeecCCCCCeeec-CCCceEEecccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP--IVHRDISSKNVLLN-LEYEAHVSDFGI 852 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlk~~Nill~-~~~~~kl~Dfg~ 852 (973)
++||||+++++|.++++.. ..+++..++.++.|++.|++|||+. + ++||||||+||+++ .++.+||+|||.
T Consensus 105 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 9999999999999999653 3588999999999999999999998 7 99999999999997 789999999999
Q ss_pred cccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
+...... ......|++.|+|||++.+ .++.++||||+|+++|+|++|+.||......... .........
T Consensus 179 ~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--------~~~~~~~~~ 247 (290)
T 1t4h_A 179 ATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--------YRRVTSGVK 247 (290)
T ss_dssp GGGCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--------HHHHTTTCC
T ss_pred ccccccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--------HHHHhccCC
Confidence 9755433 3344679999999998764 5899999999999999999999999743322111 111111111
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
+.... ......+.+++.+||+.||.+|||++|+++.
T Consensus 248 ~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 248 PASFD--KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CGGGG--GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccC--CCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11111 1122357899999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=367.77 Aligned_cols=251 Identities=24% Similarity=0.317 Sum_probs=197.6
Q ss_pred CCcccc-cccCCCceeEEEEEcC---CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 702 NFDDEH-CIGNGGQGSVYKAELP---TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 702 ~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
++.+.+ .||+|+||.||+|.+. ++..||||+++..... ...++|.+|+.++++++|||||++++++.. +..++
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 344444 7999999999999653 5567999999865322 336889999999999999999999999976 46899
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||||+++|+|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 413 v~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 99999999999999654 34689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc---ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 858 LGLSN---RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 858 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
..... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ....+........+
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~~~~i~~~~~~~~p 561 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRMECP 561 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH------HHHHHHTTCCCCCC
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH------HHHHHHcCCCCCCC
Confidence 43221 122345689999999998999999999999999999998 999997543210 01111111111111
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
. ..+..+.+++.+||+.||++||++++|++.|+
T Consensus 562 ~------~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~ 594 (613)
T 2ozo_A 562 P------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594 (613)
T ss_dssp T------TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHH
T ss_pred C------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 1 23345789999999999999999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=343.60 Aligned_cols=263 Identities=24% Similarity=0.312 Sum_probs=199.4
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec-------
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH------- 771 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------- 771 (973)
..+|++.+.||+|+||+||+|.. .+|+.||||++....... .....+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 46899999999999999999965 589999999987553322 224678899999999999999999999876
Q ss_pred -cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecc
Q 002069 772 -ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDF 850 (973)
Q Consensus 772 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df 850 (973)
.+..++||||+++ ++.+.+.... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 3468999999985 7777775443 3589999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCC----CcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh--hhhh----h
Q 002069 851 GISKFLKLGL----SNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS--SLSS----N 919 (973)
Q Consensus 851 g~a~~~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~~~----~ 919 (973)
|.++.+.... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ .... .
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9998765321 22344678999999999876 4579999999999999999999999975432110 0000 0
Q ss_pred hhhh--------hhhhcCCCCCCCchhhHH------HHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 920 LNIA--------LDEMLDPRLPTPLRNVQD------KLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 920 ~~~~--------~~~~~~~~~~~~~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.... ..+.... .......... ....+.+++.+||+.||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLEL-VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCC-CSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred Chhhccccccchhhccccc-ccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000 0000000 0000000111 12457899999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=333.00 Aligned_cols=245 Identities=22% Similarity=0.370 Sum_probs=202.7
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec------
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH------ 771 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------ 771 (973)
...+|++.+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 4567999999999999999999765 89999999987532 346689999999999999999998854
Q ss_pred ----------cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC
Q 002069 772 ----------ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL 841 (973)
Q Consensus 772 ----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~ 841 (973)
....++||||+++++|.++++... ...+++..++.++.|++.|++|||+. +|+||||||+||+++.
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD 157 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence 445799999999999999997543 34689999999999999999999999 9999999999999999
Q ss_pred CCceEEecccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhh
Q 002069 842 EYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLN 921 (973)
Q Consensus 842 ~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 921 (973)
++.+||+|||.++...... ......|++.|+|||.+.+..++.++||||||+++|||++|..|+.......
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-------- 228 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF-------- 228 (284)
T ss_dssp TTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHH--------
T ss_pred CCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHH--------
Confidence 9999999999998775542 3344579999999999999999999999999999999999999975322111
Q ss_pred hhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 922 IALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.......++... +..+.+++.+||+.||.+|||+.|+++.|+
T Consensus 229 ---~~~~~~~~~~~~------~~~~~~li~~~l~~dp~~Rps~~e~l~~l~ 270 (284)
T 2a19_B 229 ---TDLRDGIISDIF------DKKEKTLLQKLLSKKPEDRPNTSEILRTLT 270 (284)
T ss_dssp ---HHHHTTCCCTTS------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---HHhhcccccccC------CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 111112222211 234678999999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=339.08 Aligned_cols=256 Identities=25% Similarity=0.374 Sum_probs=194.6
Q ss_pred hcCCcccccccCCCceeEEEEEcC--CCC--EEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP--TGE--IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
.++|++.+.||+|+||+||+|.+. +++ .||||+++..........+.+.+|+.++++++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 367999999999999999999642 333 69999987654444455688999999999999999999999998765 7
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 89999999999999997542 4588999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCC---cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 856 LKLGLS---NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 856 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
...... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ..........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---------~~~~~~~~~~ 241 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---------QILHKIDKEG 241 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---------HHHHHHHTSC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---------HHHHHHHccC
Confidence 754432 1223457888999999988889999999999999999999 99999743321 1111111111
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..... ....+..+.+++.+||+.||.+|||++++++.|+
T Consensus 242 ~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 280 (291)
T 1u46_A 242 ERLPR--PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280 (291)
T ss_dssp CCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCC--CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 10000 0122345789999999999999999999999874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=352.71 Aligned_cols=200 Identities=24% Similarity=0.322 Sum_probs=168.8
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc-----c
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA-----L 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~ 773 (973)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+.+|+.++++++||||+++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 46899999999999999999955 5788999999976433 334467899999999999999999999999765 5
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
..|+||||++ ++|.++++.. ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 6899999987 6999999754 3589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCC----------------------cccccccccCccccccc-ccCCCCCccchHHHHHHHHHHHhCCCCCc
Q 002069 854 KFLKLGLS----------------------NRTELAGTFGYIAPELA-YTMKVTEKCDVYSFGVLALEVIKGKHPRD 907 (973)
Q Consensus 854 ~~~~~~~~----------------------~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 907 (973)
+....... ......||+.|+|||++ .+..++.++||||+||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 87654321 13557899999999986 56679999999999999999998666554
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=333.47 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=199.5
Q ss_pred cCCcccccccCCCceeEEEEEcC-CC---CEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee-
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TG---EIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS- 775 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~- 775 (973)
..|...+.||+|+||+||+|.+. ++ ..||+|++.... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 35667799999999999999642 22 379999987543 334467899999999999999999999999766554
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+.+++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 99999999999999997643 4678999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCC----CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCC-cchhhhhhhhhhhhhhhhhhhcCC
Q 002069 856 LKLGL----SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPR-DFISSICSSLSSNLNIALDEMLDP 930 (973)
Q Consensus 856 ~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~ 930 (973)
..... .......+++.|+|||.+.+..++.++||||||+++|+|++|..|+ ...... . ...........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-~-----~~~~~~~~~~~ 247 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-D-----LTHFLAQGRRL 247 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-G-----HHHHHHTTCCC
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-H-----HHHHhhcCCCC
Confidence 64321 2233456789999999999999999999999999999999965554 322110 0 01111111111
Q ss_pred CCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 931 RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 931 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+.. .+..+.+++.+||+.||.+|||++++++.|+
T Consensus 248 ~~~~~------~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~ 283 (298)
T 3pls_A 248 PQPEY------CPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283 (298)
T ss_dssp CCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCcc------chHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 11111 2235788999999999999999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=340.80 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=198.4
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 478999999999999999999665 689999999875432 2357889999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 95 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp EECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999986432 4589999999999999999999999 999999999999999999999999999764432
Q ss_pred CCCcccccccccCccccccc-----ccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 859 GLSNRTELAGTFGYIAPELA-----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
.........|++.|+|||++ .+..++.++||||||+++|+|++|+.||......... .. ......+...
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~-~~~~~~~~~~ 243 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL-----LK-IAKSDPPTLL 243 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HH-HHHSCCCCCS
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH-----HH-HhccCCcccC
Confidence 22223445789999999988 3667889999999999999999999999744321100 00 0011111111
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
. ....+..+.+++.+||+.||.+|||++++++.
T Consensus 244 ~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 244 T----PSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp S----GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred C----ccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1 11223457889999999999999999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=345.24 Aligned_cols=247 Identities=17% Similarity=0.129 Sum_probs=198.7
Q ss_pred hcCCcccccccCCCceeEEEEE------cCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC---CCceeeeceeee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAE------LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR---HRNIVKFYGFCS 770 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~ 770 (973)
.++|.+.+.||+|+||+||+|. ..+++.||||++.... ..++..|+.++++++ |+||+++++++.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 4679999999999999999993 4578899999997531 356778888888876 999999999999
Q ss_pred ccceeEEEEEecCCCChHHHhccCc--cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC-------
Q 002069 771 HALHSFVVYEYLEMGSLAMILSNDA--AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL------- 841 (973)
Q Consensus 771 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~------- 841 (973)
.++..++||||+++|+|.++++... ....+++.+++.++.||+.||+|||+. +|+||||||+||+++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccc
Confidence 9999999999999999999996432 235689999999999999999999999 9999999999999998
Q ss_pred ----CCceEEecccccccccC--CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh
Q 002069 842 ----EYEAHVSDFGISKFLKL--GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS 915 (973)
Q Consensus 842 ----~~~~kl~Dfg~a~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 915 (973)
++.+||+|||+|+.+.. .........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-- 292 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-- 292 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence 89999999999976542 2233455679999999999999999999999999999999999999986332100
Q ss_pred hhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCC-CCHHHHHHHhc
Q 002069 916 LSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSR-PTMQKVSQLLK 972 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~ev~~~L~ 972 (973)
.. ....+.... ....+.+++..|++.+|.+| |+++++.+.|+
T Consensus 293 ------~~----~~~~~~~~~-----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~ 335 (365)
T 3e7e_A 293 ------CK----PEGLFRRLP-----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK 335 (365)
T ss_dssp ------EE----ECSCCTTCS-----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred ------ee----echhccccC-----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence 00 111111111 12346678889999999998 56777776553
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=339.90 Aligned_cols=257 Identities=20% Similarity=0.308 Sum_probs=200.7
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeee----ccce
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCS----HALH 774 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~ 774 (973)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 46899999999999999999965 58999999998643 2344678999999999999999999999986 3457
Q ss_pred eEEEEEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
.++||||+++++|.+++.... ....+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+|++|||.+
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 899999999999999996532 234689999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCCc---------ccccccccCcccccccccCC---CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhh
Q 002069 854 KFLKLGLSN---------RTELAGTFGYIAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLN 921 (973)
Q Consensus 854 ~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 921 (973)
......... .....||+.|+|||++.+.. ++.++||||||+++|||++|+.||+......... .
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~ 257 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV----A 257 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH----H
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh----h
Confidence 765422111 12345799999999987554 6889999999999999999999996432111111 1
Q ss_pred hhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 922 IALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...... ...+.. ...+..+.+++.+||+.||.+|||++++++.|+
T Consensus 258 ~~~~~~--~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 302 (317)
T 2buj_A 258 LAVQNQ--LSIPQS----PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302 (317)
T ss_dssp HHHHCC----CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhhcc--CCCCcc----ccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence 111111 111111 112345789999999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=339.33 Aligned_cols=258 Identities=16% Similarity=0.223 Sum_probs=197.5
Q ss_pred HhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceee-eccceeE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFC-SHALHSF 776 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~ 776 (973)
..++|++.+.||+|+||+||+|.. .+++.||||++..... ...+.+|+.+++.++|++++..++++ ...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 457899999999999999999964 5889999998764322 24577899999999888877776665 5667889
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeee---cCCCceEEeccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL---NLEYEAHVSDFGIS 853 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill---~~~~~~kl~Dfg~a 853 (973)
+||||+ +++|.+++.... ..+++.+++.++.|++.|++|||+. +|+||||||+||++ +.++.+||+|||.+
T Consensus 82 lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 999999 899999997433 3589999999999999999999999 99999999999999 78899999999999
Q ss_pred ccccCCCC-------cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhh
Q 002069 854 KFLKLGLS-------NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDE 926 (973)
Q Consensus 854 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 926 (973)
+....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~ 233 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QKYERISEK 233 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS--SHHHHHHHH
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh--hhhhhhhcc
Confidence 87755422 223567999999999999999999999999999999999999999753311000 000000000
Q ss_pred hcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 927 MLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...... .......+..+.+++.+||+.||++|||++++++.|+
T Consensus 234 ~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (296)
T 4hgt_A 234 KMSTPI---EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 276 (296)
T ss_dssp HHHSCH---HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred cccchh---hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHH
Confidence 000000 0000112345789999999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=343.32 Aligned_cols=260 Identities=20% Similarity=0.275 Sum_probs=193.8
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc-----
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL----- 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 773 (973)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 36899999999999999999954 5789999999976433 2344678899999999999999999999987654
Q ss_pred -eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 774 -HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 774 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
..++||||++ +++.+++. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 6799999998 47888775 2478999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhh--h-----------h
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLS--S-----------N 919 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~--~-----------~ 919 (973)
++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........... . .
T Consensus 174 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 174 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred ccccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 9876543 223446799999999999999999999999999999999999999975432111000 0 0
Q ss_pred hhhhhhhhc--CCC--------------CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 920 LNIALDEML--DPR--------------LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 920 ~~~~~~~~~--~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......... .+. .+............+.+++.+||+.||.+|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000 000 011111122335678899999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=347.65 Aligned_cols=260 Identities=22% Similarity=0.313 Sum_probs=203.6
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|... +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 367999999999999999999654 78999999997653 234467899999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.++++.. ..+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||.++....
T Consensus 110 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp ECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EECCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999999653 35889999999999999999999842 799999999999999999999999999976543
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh--hhhh------------------
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS--SLSS------------------ 918 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~~~------------------ 918 (973)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....
T Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 185 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp H--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred c--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 2 23345799999999999999999999999999999999999999974331100 0000
Q ss_pred -------------hhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 919 -------------NLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 919 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..............+.... ...+..+.+++.+||+.||.+|||++|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCT--TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCc--ccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000000011111000000 1123457899999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=348.72 Aligned_cols=256 Identities=9% Similarity=0.003 Sum_probs=184.3
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHH---HhhcCCCCceeeec-------ee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGN---ALTKIRHRNIVKFY-------GF 768 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~---~l~~l~h~niv~~~-------~~ 768 (973)
..+|++.+.||+|+||+||+|.+ .+++.||||++...........+.+.+|+. .++. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 35699999999999999999975 488999999998765545555677888854 5555 799988754 34
Q ss_pred eecc-----------------ceeEEEEEecCCCChHHHhccCccccCCCHHHH------HHHHHHHHHHHHHHhhCCCC
Q 002069 769 CSHA-----------------LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKR------MNAIKGVADALLYMHTNCFP 825 (973)
Q Consensus 769 ~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~~~ 825 (973)
+..+ ...++||||++ ++|.++++... ..+.+..+ +.++.||+.|++|||++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 3322 34799999999 89999997543 23345555 78889999999999999
Q ss_pred CeEeecCCCCCeeecCCCceEEecccccccccCCCCcccccccccCccccccccc--CCCCCccchHHHHHHHHHHHhCC
Q 002069 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYT--MKVTEKCDVYSFGVLALEVIKGK 903 (973)
Q Consensus 826 ~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~ 903 (973)
+|+||||||+||+++.++.+||+|||+++..... .....+++.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999999866422 224567799999999987 67999999999999999999999
Q ss_pred CCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 904 HPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 904 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
.||............ ............. .......+..+.+++.+||+.||++|||++++++
T Consensus 291 ~Pf~~~~~~~~~~~~--~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGSWK--RPSLRVPGTDSLA--FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTCCC--BCCTTSCCCCSCC--CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccchh--hhhhhhccccccc--hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999754321100000 0000000011111 1111123446788999999999999999999976
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=348.96 Aligned_cols=257 Identities=16% Similarity=0.186 Sum_probs=199.0
Q ss_pred cCCcccccccCCCceeEEEEEcC---------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceee-------
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP---------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK------- 764 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~------- 764 (973)
++|++.+.||+|+||.||+|... +++.||||++... +.+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 68999999999999999999765 3789999998643 45778999999999999988
Q ss_pred --------eceeeec-cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCC
Q 002069 765 --------FYGFCSH-ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSK 835 (973)
Q Consensus 765 --------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~ 835 (973)
+++++.. ....++||||+ +++|.+++.... ...+++.+++.++.|++.|++|||++ +|+||||||+
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~ 188 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE 188 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence 5666655 67889999999 999999997542 35689999999999999999999999 9999999999
Q ss_pred CeeecCCC--ceEEecccccccccCCCC-------cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 002069 836 NVLLNLEY--EAHVSDFGISKFLKLGLS-------NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPR 906 (973)
Q Consensus 836 Nill~~~~--~~kl~Dfg~a~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~ 906 (973)
||+++.++ .+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 999999999987654321 123457999999999999989999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 907 DFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
................. ... ...+..........+..+.+++.+||+.||.+|||++++++.|+
T Consensus 269 ~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 332 (352)
T 2jii_A 269 TNCLPNTEDIMKQKQKF-VDK-PGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLE 332 (352)
T ss_dssp GGGTTCHHHHHHHHHHH-HHS-CCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred ccCCcCHHHHHHHHHhc-cCC-hhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHH
Confidence 85431111111110000 000 01111100000112345788999999999999999999999875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=340.47 Aligned_cols=256 Identities=24% Similarity=0.262 Sum_probs=197.1
Q ss_pred HhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCc-----chhhHHHHHHHHHHhhcCCCCceeeeceeeecc
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPG-----EMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA 772 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 772 (973)
..++|++.+.||+|+||.||+|.. .+++.||||++...... .......+.+|+.++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 346799999999999999999965 47899999998754321 112235688999999999999999999998766
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCc---eEEec
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYE---AHVSD 849 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~---~kl~D 849 (973)
. .++||||+++++|.+++... ..+++.+++.++.|++.|++|||++ +|+||||||+||+++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 89999999999999998654 3688999999999999999999999 9999999999999987654 99999
Q ss_pred ccccccccCCCCcccccccccCcccccccc---cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhh
Q 002069 850 FGISKFLKLGLSNRTELAGTFGYIAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDE 926 (973)
Q Consensus 850 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 926 (973)
||.++..... .......||+.|+|||++. ...++.++|||||||++|+|++|+.||........ .....
T Consensus 161 fg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~-- 232 (322)
T 2ycf_A 161 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-----LKDQI-- 232 (322)
T ss_dssp CTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-----HHHHH--
T ss_pred Cccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-----HHHHH--
Confidence 9999876543 2223456899999999874 56688999999999999999999999974321100 00001
Q ss_pred hcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 927 MLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...............+..+.+++.+||+.||.+|||++++++.
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 233 -TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp -HHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -HhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 1111111111112234567899999999999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=340.73 Aligned_cols=261 Identities=26% Similarity=0.405 Sum_probs=204.8
Q ss_pred hcCCcccccccCCCceeEEEEEc-----CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc-
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-----PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL- 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~- 773 (973)
.++|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 46799999999999999999973 47889999999754 2334578999999999999999999999986543
Q ss_pred -eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 774 -HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 774 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
..++||||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred CceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence 6899999999999999997543 3588999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCc---ccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhh-hhhhhh-----hhhhh
Q 002069 853 SKFLKLGLSN---RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSI-CSSLSS-----NLNIA 923 (973)
Q Consensus 853 a~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-~~~~~~-----~~~~~ 923 (973)
++........ .....++..|+|||.+.+..++.++||||||+++|||+||..||...... ...... .....
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 9877554321 22345677899999999888999999999999999999999998643211 110000 00001
Q ss_pred hhhhcC-C-CCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 924 LDEMLD-P-RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 924 ~~~~~~-~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+.+. . ..+.. ...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus 272 ~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~ 318 (326)
T 2w1i_A 272 LIELLKNNGRLPRP----DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318 (326)
T ss_dssp HHHHHHTTCCCCCC----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhhcCCCCCCC----CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111111 1 11111 122345788999999999999999999999875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=338.55 Aligned_cols=261 Identities=26% Similarity=0.381 Sum_probs=186.0
Q ss_pred HhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
..++|++.+.||+|+||.||+|... +++.||||++...... ...+++.+|+.++++++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 3578999999999999999999754 7899999998754322 235678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHhccC-----ccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 778 VYEYLEMGSLAMILSND-----AAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
||||+++++|.+++... .....+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999998641 1234589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCC-----cccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhh
Q 002069 853 SKFLKLGLS-----NRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDE 926 (973)
Q Consensus 853 a~~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 926 (973)
+........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........... ....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----~~~~ 242 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-----TLQN 242 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-----HHTS
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-----Hhcc
Confidence 976654321 1234578999999999875 5689999999999999999999999975432111000 0000
Q ss_pred hcCCCCCCC---chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 927 MLDPRLPTP---LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 927 ~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
. .+..... ..........+.+++.+||+.||.+|||++++++.
T Consensus 243 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 D-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp S-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred C-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 0000000 00001123457889999999999999999999873
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=336.32 Aligned_cols=257 Identities=16% Similarity=0.227 Sum_probs=200.6
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceee-eccceeEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFC-SHALHSFV 777 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~l 777 (973)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+.+++.++|++++..+.++ ...+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 46899999999999999999965 5899999999865432 24688999999999988877666655 56677899
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeee---cCCCceEEecccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL---NLEYEAHVSDFGISK 854 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill---~~~~~~kl~Dfg~a~ 854 (973)
||||+ +++|.+++.... ..+++.+++.++.|++.|++|||++ +|+||||||+||++ +.++.+||+|||.++
T Consensus 83 v~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 99999 899999996433 4689999999999999999999999 99999999999999 478999999999998
Q ss_pred cccCCCC-------cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhh
Q 002069 855 FLKLGLS-------NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEM 927 (973)
Q Consensus 855 ~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 927 (973)
....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~ 234 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--RQKYERISEKK 234 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS--SSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh--hhhhhhhcccc
Confidence 7765432 12456799999999999999999999999999999999999999975321100 00000000000
Q ss_pred cCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 928 LDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...... ......+..+.+++.+||+.||.+|||++++++.|+
T Consensus 235 ~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 276 (296)
T 3uzp_A 235 MSTPIE---VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 276 (296)
T ss_dssp HHSCHH---HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred cCCchH---HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHH
Confidence 000000 000112345789999999999999999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=332.91 Aligned_cols=255 Identities=25% Similarity=0.315 Sum_probs=204.4
Q ss_pred HHhcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeE
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (973)
...++|++.+.||+|+||.||+|... +++.||||++...... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 44678999999999999999999664 7899999998654322 223578999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC---CceEEeccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE---YEAHVSDFGIS 853 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~---~~~kl~Dfg~a 853 (973)
+||||+++++|.+++... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.+ +.+||+|||.+
T Consensus 98 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999999988643 3589999999999999999999999 99999999999999754 47999999999
Q ss_pred ccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 854 KFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 854 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
....... ......|++.|+|||.+.+. ++.++||||||+++|+|++|+.||...... ............
T Consensus 172 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~ 240 (287)
T 2wei_A 172 TCFQQNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY---------DILKRVETGKYA 240 (287)
T ss_dssp GTBCCCS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHCCCC
T ss_pred eeecCCC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHcCCCC
Confidence 8765432 23345689999999988764 889999999999999999999999743321 111111111221
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.........+..+.+++.+||+.||.+|||++++++.
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 1111122234467899999999999999999999873
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=336.20 Aligned_cols=255 Identities=18% Similarity=0.224 Sum_probs=198.6
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeec--ccee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSH--ALHS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~ 775 (973)
.++|++.+.||+|+||+||+|.. .+++.||||++... ..+.+.+|+.++++++ ||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 36799999999999999999954 58999999998742 1467889999999997 9999999999987 5678
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC-ceEEecccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY-EAHVSDFGISK 854 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-~~kl~Dfg~a~ 854 (973)
++||||+++++|.++++ .+++.++..++.|++.|++|||+. +|+||||||+||+++.++ .+||+|||.++
T Consensus 109 ~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 99999999999999874 378899999999999999999999 999999999999999776 89999999998
Q ss_pred cccCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh-------hh-hhhh---
Q 002069 855 FLKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL-------SS-NLNI--- 922 (973)
Q Consensus 855 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~-------~~-~~~~--- 922 (973)
...... ......|++.|+|||++.+ ..++.++||||+||++|||++|+.||.......... .. ....
T Consensus 180 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 180 FYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp ECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred EcCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 765542 3345678999999999877 668999999999999999999999994321110000 00 0000
Q ss_pred --------hhhhhcCCCCCCCch------hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 923 --------ALDEMLDPRLPTPLR------NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 923 --------~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.............+. ........+.+++.+||+.||++|||++|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000000000000 011124567899999999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=345.33 Aligned_cols=256 Identities=19% Similarity=0.294 Sum_probs=203.7
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcch--------------hhHHHHHHHHHHhhcCCCCceeee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEM--------------ACQQEFLNEGNALTKIRHRNIVKF 765 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~~ 765 (973)
.++|++.+.||+|+||.||+|.. +++.||||++........ ...+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999988 999999999864321111 112789999999999999999999
Q ss_pred ceeeeccceeEEEEEecCCCChHHH------hccCccccCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCee
Q 002069 766 YGFCSHALHSFVVYEYLEMGSLAMI------LSNDAAAEEFGWTKRMNAIKGVADALLYMHT-NCFPPIVHRDISSKNVL 838 (973)
Q Consensus 766 ~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nil 838 (973)
++++.+++..++||||+++++|.++ +.... ...+++..++.++.|++.|++|||+ . +++||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 9999999999999999999999998 54321 3568999999999999999999999 7 9999999999999
Q ss_pred ecCCCceEEecccccccccCCCCcccccccccCcccccccccC-CCCC-ccchHHHHHHHHHHHhCCCCCcchhhhhhhh
Q 002069 839 LNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTM-KVTE-KCDVYSFGVLALEVIKGKHPRDFISSICSSL 916 (973)
Q Consensus 839 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 916 (973)
++.++.+||+|||.+...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||.........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~- 261 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL- 261 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH-
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH-
Confidence 999999999999999876543 33456799999999999877 5666 999999999999999999999754321110
Q ss_pred hhhhhhhhhhhcCCCCCCC---------------chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 917 SSNLNIALDEMLDPRLPTP---------------LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...........+ .......+..+.+++.+||+.||.+|||++|+++.
T Consensus 262 -------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 262 -------FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp -------HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -------HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111111000 00002234567899999999999999999999873
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=343.09 Aligned_cols=259 Identities=20% Similarity=0.256 Sum_probs=183.9
Q ss_pred hcCCcccccccCCCceeEEEEE-cCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc------
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA------ 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 772 (973)
.++|++.+.||+|+||.||+|. ..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 4689999999999999999995 45899999999976533 233467888999999999999999999998653
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
...++||||+ +++|.++++. ..+++.++..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999999 6899988864 3589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhhhhhh--
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSNLNIA-- 923 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~~-- 923 (973)
++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ..+......
T Consensus 179 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 179 ARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred ccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9865432 344678999999999877 6789999999999999999999999975442110 000000000
Q ss_pred ------hhh---hcCCCCCCCch-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 924 ------LDE---MLDPRLPTPLR-NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 924 ------~~~---~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
... .+.......+. ........+.+++.+||+.||.+|||++|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 00000001110 001123457899999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=334.46 Aligned_cols=255 Identities=23% Similarity=0.363 Sum_probs=187.0
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|.. .+++.||||++...... ....+.+.++...++.++||||+++++++.+++..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 46899999999999999999965 58899999999765332 22234455555668888999999999999999999999
Q ss_pred EEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 779 YEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
|||++ +++.++++... ....+++..++.++.|++.|++|||++. +++||||||+||+++.++.+||+|||.++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99998 58888775422 2346899999999999999999999953 89999999999999999999999999998765
Q ss_pred CCCCcccccccccCccccccc----ccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 858 LGLSNRTELAGTFGYIAPELA----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
.. .......||+.|+|||++ .+..++.++||||+|+++|||++|+.||+.......... ...... .+..+
T Consensus 162 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~-~~~~~ 235 (290)
T 3fme_A 162 DD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK----QVVEEP-SPQLP 235 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHH----HHHHSC-CCCCC
T ss_pred cc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHH----HHhccC-CCCcc
Confidence 43 223345799999999996 556788999999999999999999999974322111111 111111 11111
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
. ...+..+.+++.+||+.||++|||++|+++
T Consensus 236 ~-----~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 236 A-----DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp T-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred c-----ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1 112345788999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=343.64 Aligned_cols=272 Identities=19% Similarity=0.232 Sum_probs=200.2
Q ss_pred cHHHHHHHhcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCc--------chhhHHHHHHHHHHhhcCCCCcee
Q 002069 692 VHEEIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPG--------EMACQQEFLNEGNALTKIRHRNIV 763 (973)
Q Consensus 692 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~~e~~~l~~l~h~niv 763 (973)
...++....++|++.+.||+|+||.||+|...+|+.||||++...... .....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 456677788999999999999999999998888999999998643222 122347899999999999999999
Q ss_pred eeceeeec-----cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCee
Q 002069 764 KFYGFCSH-----ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVL 838 (973)
Q Consensus 764 ~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nil 838 (973)
++++++.. ....++||||++ |++.+++.... ..+++..++.++.|++.|++|||+. +|+||||||+||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 99999843 346799999998 68888886443 4689999999999999999999999 9999999999999
Q ss_pred ecCCCceEEecccccccccCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh--h
Q 002069 839 LNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS--S 915 (973)
Q Consensus 839 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~ 915 (973)
++.++.+||+|||.++..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||........ .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp ECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EcCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999999755433 23344678999999999876 6789999999999999999999999975331100 0
Q ss_pred h----hhh--------hhhhhhhhcCCCC---C-CCc-hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 916 L----SSN--------LNIALDEMLDPRL---P-TPL-RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 916 ~----~~~--------~~~~~~~~~~~~~---~-~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
. ... ............. + ..+ .........+.+++.+||+.||.+|||++|+++.
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0 000 0000011111111 1 000 0011223457899999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=339.18 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=196.1
Q ss_pred HHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeec----
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSH---- 771 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~---- 771 (973)
...++|++.+.||+|+||.||+|.. .+++.||||++...... .+.+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 3467899999999999999999965 58899999998754222 46788999999998 89999999999976
Q ss_pred --cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEec
Q 002069 772 --ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSD 849 (973)
Q Consensus 772 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~D 849 (973)
....++||||+++++|.+++.... ...+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEee
Confidence 457899999999999999997543 34689999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCcccccccccCcccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhh
Q 002069 850 FGISKFLKLGLSNRTELAGTFGYIAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIAL 924 (973)
Q Consensus 850 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 924 (973)
||.+..............|++.|+|||++. +..++.++|||||||++|+|++|+.||.......... ..
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~ 246 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LI 246 (326)
T ss_dssp CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HH
T ss_pred CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH------Hh
Confidence 999987654433445567999999999987 5668899999999999999999999997443211100 01
Q ss_pred hhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 925 DEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+.... . ..+..+.+++.+||+.||.+||+++++++.
T Consensus 247 ~~~~~~~~~~--~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 247 PRNPAPRLKS--K---KWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHSCCCCCSC--S---CSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hcCccccCCc--c---ccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111111111 1 112357889999999999999999999873
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=339.67 Aligned_cols=251 Identities=20% Similarity=0.270 Sum_probs=185.0
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeee-------
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCS------- 770 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~------- 770 (973)
..+|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 35799999999999999999965 48899999998543 2334578899999999996 999999999983
Q ss_pred -ccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEeecCCCCCeeecCCCceEE
Q 002069 771 -HALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP--IVHRDISSKNVLLNLEYEAHV 847 (973)
Q Consensus 771 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlk~~Nill~~~~~~kl 847 (973)
.....++||||++ |+|.+++........+++.+++.++.|++.|++|||+. + |+||||||+||+++.++.+||
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence 3445799999996 79999987644445799999999999999999999998 7 999999999999999999999
Q ss_pred ecccccccccCCCCc------------ccccccccCccccccc---ccCCCCCccchHHHHHHHHHHHhCCCCCcchhhh
Q 002069 848 SDFGISKFLKLGLSN------------RTELAGTFGYIAPELA---YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSI 912 (973)
Q Consensus 848 ~Dfg~a~~~~~~~~~------------~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 912 (973)
+|||.++........ .....||+.|+|||++ .+..++.++|||||||++|||++|+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 999999876543211 1134589999999998 5667889999999999999999999999743221
Q ss_pred hhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 913 CSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.............. ....+.+++.+||+.||.+|||++|+++.|+
T Consensus 260 ---------~~~~~~~~~~~~~~------~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 260 ---------RIVNGKYSIPPHDT------QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ---------------CCCCTTCC------SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ---------HhhcCcccCCcccc------cchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 01111111111111 1123678899999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=366.14 Aligned_cols=246 Identities=26% Similarity=0.384 Sum_probs=195.4
Q ss_pred ccccCCCceeEEEEEc---CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecC
Q 002069 707 HCIGNGGQGSVYKAEL---PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLE 783 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 783 (973)
+.||+|+||+||+|.+ .+++.||||+++.... .....+++.+|+.++++++|||||++++++..+ ..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccC
Confidence 4799999999999944 2567899999975422 223468899999999999999999999999654 5789999999
Q ss_pred CCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC--
Q 002069 784 MGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS-- 861 (973)
Q Consensus 784 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-- 861 (973)
+|+|.++++.. ..+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 453 ~g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 453 LGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp TEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999999643 3589999999999999999999999 999999999999999999999999999987754422
Q ss_pred -cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 862 -NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 862 -~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ....+........+.
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~~~~i~~~~~~~~p~----- 595 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGERMGCPA----- 595 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCCCCCT-----
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCC-----
Confidence 1223456789999999999999999999999999999998 999997543210 111111111122221
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+..+.+++.+||+.||++||++++|++.|+
T Consensus 596 -~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~ 627 (635)
T 4fl3_A 596 -GCPREMYDLMNLCWTYDVENRPGFAAVELRLR 627 (635)
T ss_dssp -TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred -CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 12345789999999999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=340.09 Aligned_cols=258 Identities=21% Similarity=0.288 Sum_probs=197.3
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee---
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS--- 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~--- 775 (973)
.++|.+.+.||+|+||+||+|.. .+|+.||||++...... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc-hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 46899999999999999999954 57899999999765433 34467889999999999999999999999876654
Q ss_pred ---EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 776 ---FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 776 ---~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
++||||++ ++|.+++. ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 68888774 2488999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh--hhh-----------
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS--LSS----------- 918 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~--~~~----------- 918 (973)
++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......... ...
T Consensus 191 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 191 ARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp C-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 9865432 344678999999999887 67899999999999999999999999754321100 000
Q ss_pred ----hhhhhhhhhcCCCCCCCc-hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 919 ----NLNIALDEMLDPRLPTPL-RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 919 ----~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.................. .........+.+++.+||+.||.+|||++|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000000111111110 0011224568899999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=340.20 Aligned_cols=261 Identities=21% Similarity=0.261 Sum_probs=200.0
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc-----c
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA-----L 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~ 773 (973)
..+|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.++++++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 46899999999999999999965 478899999997532 233457899999999999999999999998654 3
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
..++||||++ ++|.++++. ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcce
Confidence 6799999998 589998864 3588999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCC---cccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh------hhhhhhhh
Q 002069 854 KFLKLGLS---NRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS------LSSNLNIA 923 (973)
Q Consensus 854 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~------~~~~~~~~ 923 (973)
+....... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......... ........
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 87654322 1244579999999998654 45899999999999999999999999754321100 00000000
Q ss_pred hh-----------hhcCCCCCCCch-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 924 LD-----------EMLDPRLPTPLR-NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 924 ~~-----------~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.. ..........+. ........+.+++.+||+.||.+|||++|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000000000000 001123457899999999999999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=350.95 Aligned_cols=199 Identities=21% Similarity=0.329 Sum_probs=154.5
Q ss_pred cCCcc-cccccCCCceeEEEEEcC---CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeee--ccce
Q 002069 701 KNFDD-EHCIGNGGQGSVYKAELP---TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCS--HALH 774 (973)
Q Consensus 701 ~~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~ 774 (973)
+.|++ .++||+|+||+||+|.+. +++.||||++..... ...+.+|+.++++++||||+++++++. ....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 45666 458999999999999754 578999999975422 256789999999999999999999994 4678
Q ss_pred eEEEEEecCCCChHHHhccCc------cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeee----cCCCc
Q 002069 775 SFVVYEYLEMGSLAMILSNDA------AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL----NLEYE 844 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill----~~~~~ 844 (973)
.++||||++ ++|.+++.... ....+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence 899999997 57887775322 122489999999999999999999999 99999999999999 67789
Q ss_pred eEEecccccccccCCC---CcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcc
Q 002069 845 AHVSDFGISKFLKLGL---SNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDF 908 (973)
Q Consensus 845 ~kl~Dfg~a~~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~ 908 (973)
+||+|||+|+...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 9999999998765432 223446789999999998874 589999999999999999999999964
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=349.86 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=200.4
Q ss_pred hcCCcccccccCCCceeEEEEEc----CCCCEEEEEEcCCCCC-cchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL----PTGEIVAVKKFHSPLP-GEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHAL 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 773 (973)
.++|++.+.||+|+||.||+|+. .+++.||||+++.... ......+.+.+|+.+++.+ +||||+++++++..+.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999976 4789999999874321 1112235577889999999 6999999999999999
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
..++||||+++++|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999999653 3588999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCC-CcccccccccCccccccccc--CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhc--
Q 002069 854 KFLKLGL-SNRTELAGTFGYIAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML-- 928 (973)
Q Consensus 854 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 928 (973)
+.+.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .........
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-----~~~~~~~~~~~ 281 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-----QAEISRRILKS 281 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-----HHHHHHHHHHC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-----HHHHHHHHhcc
Confidence 8664332 22334679999999999985 3478899999999999999999999974321100 011111111
Q ss_pred CCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHh
Q 002069 929 DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRP-----TMQKVSQLL 971 (973)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~L 971 (973)
.+..+.. ....+.+++.+||+.||.+|| +++++++..
T Consensus 282 ~~~~~~~------~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 EPPYPQE------MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CCCCCTT------SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CCCCCcc------cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1122221 223467899999999999999 999998753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=347.36 Aligned_cols=260 Identities=22% Similarity=0.246 Sum_probs=194.5
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc------
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL------ 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 773 (973)
..+|++.+.||+|+||+||+|+...+..||+|++...... ..+|+.+++.++||||+++++++...+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 3579999999999999999998877777999988654222 236899999999999999999985433
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeec-CCCceEEecccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLN-LEYEAHVSDFGI 852 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~-~~~~~kl~Dfg~ 852 (973)
..++||||++++.+............+++..++.++.||+.|++|||+. +|+||||||+||+++ .++.+||+|||+
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 3789999998765444333222345689999999999999999999999 999999999999999 789999999999
Q ss_pred cccccCCCCcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh------hhhhhhh---
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS------LSSNLNI--- 922 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~------~~~~~~~--- 922 (973)
|+..... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||......... .+.....
T Consensus 189 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 189 AKILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CEECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9876544 233456789999999998765 5899999999999999999999999754422110 0000000
Q ss_pred -hhhhhcCCCCCCC----chh--hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 923 -ALDEMLDPRLPTP----LRN--VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 923 -~~~~~~~~~~~~~----~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.........++.. +.. ....+..+.+++.+||+.||.+|||+.|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0001111111110 000 01123467899999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=331.26 Aligned_cols=253 Identities=20% Similarity=0.258 Sum_probs=197.2
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcc-hhhHHHHHHHHHHhhcCCCCceeeeceee--ecccee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGE-MACQQEFLNEGNALTKIRHRNIVKFYGFC--SHALHS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~--~~~~~~ 775 (973)
.++|++.+.||+|+||.||+|.. .+++.||+|++....... ....+.+.+|+.++++++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47899999999999999999976 478999999986432111 12357899999999999999999999998 445678
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||++++ +.+++.... ...+++.+++.++.|++.|++|||++ +++||||||+||+++.++.+|++|||.+..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999977 777775433 34689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCC--CcccccccccCcccccccccCC--CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 856 LKLGL--SNRTELAGTFGYIAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 856 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
..... .......|++.|+|||++.+.. ++.++||||||+++|||++|+.||...... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------~~~~~i~~~~ 229 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---------KLFENIGKGS 229 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---------HHHHHHHHCC
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---------HHHHHHhcCC
Confidence 65322 2233466899999999987644 377999999999999999999999743311 0111111111
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..... .....+.+++.+||+.||.+|||++|+++.
T Consensus 230 ~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 YAIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CCCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111 122357789999999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=344.55 Aligned_cols=261 Identities=21% Similarity=0.209 Sum_probs=194.9
Q ss_pred HHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec-----
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH----- 771 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----- 771 (973)
...++|++.+.||+|+||+||+|.. .+|+.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 4467899999999999999999954 68999999998754222 2369999999999999999999843
Q ss_pred ---------------------------------cceeEEEEEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHH
Q 002069 772 ---------------------------------ALHSFVVYEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALL 817 (973)
Q Consensus 772 ---------------------------------~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~ 817 (973)
....++||||++ ++|.+.+.... ....+++..+..++.|++.|++
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 234789999998 58777775321 2346899999999999999999
Q ss_pred HHhhCCCCCeEeecCCCCCeeec-CCCceEEecccccccccCCCCcccccccccCcccccccccC-CCCCccchHHHHHH
Q 002069 818 YMHTNCFPPIVHRDISSKNVLLN-LEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVL 895 (973)
Q Consensus 818 ~LH~~~~~~i~H~Dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~ 895 (973)
|||+. +|+||||||+||+++ .++.+||+|||.|+..... .......||+.|+|||.+.+. .++.++||||+||+
T Consensus 156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999 999999999999998 6899999999999876544 233456789999999998765 48999999999999
Q ss_pred HHHHHhCCCCCcchhhhhhhh------hhhhhhhhhh-------hcCCCCC-CCchh--hHHHHHHHHHHHhcccCCCCC
Q 002069 896 ALEVIKGKHPRDFISSICSSL------SSNLNIALDE-------MLDPRLP-TPLRN--VQDKLISIMEVSISCLDESPT 959 (973)
Q Consensus 896 l~el~tg~~p~~~~~~~~~~~------~~~~~~~~~~-------~~~~~~~-~~~~~--~~~~~~~l~~li~~cl~~dP~ 959 (973)
+|||++|+.||.......... +......... ...+... ..+.. ....+..+.+++.+||+.||.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999999998544221100 0000000000 0001100 00000 011234578999999999999
Q ss_pred CCCCHHHHHHH
Q 002069 960 SRPTMQKVSQL 970 (973)
Q Consensus 960 ~RPs~~ev~~~ 970 (973)
+|||+.|+++.
T Consensus 312 ~R~t~~e~l~h 322 (383)
T 3eb0_A 312 LRINPYEAMAH 322 (383)
T ss_dssp GSCCHHHHHTS
T ss_pred hCCCHHHHhcC
Confidence 99999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=347.91 Aligned_cols=199 Identities=21% Similarity=0.254 Sum_probs=172.0
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC------CCCceeeeceeeecc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI------RHRNIVKFYGFCSHA 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~ 772 (973)
..+|++.+.||+|+||+||+|.. .+++.||||++... ......+.+|+.+++.+ .|+||+++++++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 45799999999999999999954 57899999999743 23346677788777766 577999999999999
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCc--eEEecc
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYE--AHVSDF 850 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~--~kl~Df 850 (973)
...++||||+. ++|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred CeEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence 99999999996 689998875442 3589999999999999999999999 9999999999999999987 999999
Q ss_pred cccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchh
Q 002069 851 GISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS 910 (973)
Q Consensus 851 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 910 (973)
|+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 247 G~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 247 GSSCYEHQ---RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TTCEETTC---CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccceecCC---cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99976543 2334678999999999999999999999999999999999999997543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=350.86 Aligned_cols=257 Identities=16% Similarity=0.234 Sum_probs=200.6
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCC-CceeeeceeeeccceeEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH-RNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~l 777 (973)
.++|++.+.||+|+||.||+|.. .+++.||||++...... .++..|+++++.++| ++++.+..++...+..++
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 46899999999999999999964 58999999987654322 457789999999976 556666666677888899
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeee---cCCCceEEecccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL---NLEYEAHVSDFGISK 854 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill---~~~~~~kl~Dfg~a~ 854 (973)
||||+ +++|.++++... ..+++.+++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 81 vme~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 99999 899999997433 4689999999999999999999999 99999999999999 688999999999998
Q ss_pred cccCCCCc-------ccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhh
Q 002069 855 FLKLGLSN-------RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEM 927 (973)
Q Consensus 855 ~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 927 (973)
.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~i~~~~ 232 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--KQKYEKISEKK 232 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH--HHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH--HHHHHHHhhcc
Confidence 77654321 2256799999999999999999999999999999999999999975332100 00000111110
Q ss_pred cCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 928 LDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+..... ......+..+.+++..||+.||++||++++|++.|+
T Consensus 233 ~~~~~~---~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~ 274 (483)
T 3sv0_A 233 VATSIE---ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR 274 (483)
T ss_dssp HHSCHH---HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred ccccHH---HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 000000 000112346789999999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=329.80 Aligned_cols=252 Identities=24% Similarity=0.381 Sum_probs=192.4
Q ss_pred HhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec------
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH------ 771 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------ 771 (973)
..++|++.+.||+|+||.||+|.. .+++.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 356799999999999999999965 4899999999853 23446789999999999999999999998754
Q ss_pred -------cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCc
Q 002069 772 -------ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYE 844 (973)
Q Consensus 772 -------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~ 844 (973)
....++||||+++++|.+++.... ..+++.+++.++.|++.|++|||++ +++||||||+||+++.++.
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence 456799999999999999997543 3567899999999999999999999 9999999999999999999
Q ss_pred eEEecccccccccCCC--------------CcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcch
Q 002069 845 AHVSDFGISKFLKLGL--------------SNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFI 909 (973)
Q Consensus 845 ~kl~Dfg~a~~~~~~~--------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~ 909 (973)
+|++|||.++...... .......|++.|+|||++.+. .++.++||||+||++|||++ ||...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 9999999998664321 122345689999999998764 68999999999999999998 54321
Q ss_pred hhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 910 SSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
....... ..... ....++.... ...+..+.+++.+||+.||.+|||++++++.
T Consensus 232 ~~~~~~~-----~~~~~-~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 MERVNIL-----KKLRS-VSIEFPPDFD--DNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHH-----HHHHS-TTCCCCTTCC--TTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhHHHHH-----Hhccc-cccccCcccc--ccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1111000 01111 1111121111 1223457789999999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=340.20 Aligned_cols=267 Identities=22% Similarity=0.199 Sum_probs=188.2
Q ss_pred HHHHHHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc
Q 002069 694 EEIIRATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA 772 (973)
Q Consensus 694 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 772 (973)
++.....++|++.+.||+|+||+||+|.. .+++.||||++...... ...+.+++..++.++||||+++++++...
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 45556778999999999999999999966 47899999998654322 24556777788888999999999998653
Q ss_pred ce-------eEEEEEecCCCChHHHhcc-CccccCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeEeecCCCCCeeecC-
Q 002069 773 LH-------SFVVYEYLEMGSLAMILSN-DAAAEEFGWTKRMNAIKGVADALLYMH--TNCFPPIVHRDISSKNVLLNL- 841 (973)
Q Consensus 773 ~~-------~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH--~~~~~~i~H~Dlk~~Nill~~- 841 (973)
+. .++||||+++ ++.+.+.. ......+++..+..++.|++.|++||| +. +|+||||||+||+++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEA 167 (360)
T ss_dssp CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETT
T ss_pred ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCC
Confidence 33 7899999986 44443322 222346789999999999999999999 87 9999999999999997
Q ss_pred CCceEEecccccccccCCCCcccccccccCcccccccccCC-CCCccchHHHHHHHHHHHhCCCCCcchhhhhhh-----
Q 002069 842 EYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSICSS----- 915 (973)
Q Consensus 842 ~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~----- 915 (973)
++.+||+|||.++..... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.........
T Consensus 168 ~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246 (360)
T ss_dssp TTEEEECCCTTCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCcEEEeeCCCceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence 899999999999877544 2334567899999999986654 899999999999999999999999754321100
Q ss_pred -hhhhhhhhhhhhcCCCC---------CCCchh-----hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 916 -LSSNLNIALDEMLDPRL---------PTPLRN-----VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 916 -~~~~~~~~~~~~~~~~~---------~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
............ .+.. ...+.. .......+.+++.+||+.||.+|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 247 VLGCPSREVLRKL-NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHCCCCHHHHHHH-CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HcCCCCHHHHHhc-ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000001000 0000 000000 00134568899999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=337.24 Aligned_cols=254 Identities=20% Similarity=0.311 Sum_probs=197.6
Q ss_pred HhcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
..++|++.+.||+|+||.||+|.... .||+|+++...... ...+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 35789999999999999999998743 49999987543222 2235677899999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++ ++.+||+|||+++....
T Consensus 108 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred eecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 99999999999997543 4588999999999999999999999 999999999999998 68999999999876532
Q ss_pred C-----CCcccccccccCccccccccc---------CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhh
Q 002069 859 G-----LSNRTELAGTFGYIAPELAYT---------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIAL 924 (973)
Q Consensus 859 ~-----~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 924 (973)
. ........|++.|+|||++.+ ..++.++||||||+++|||++|+.||........ ....
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~ 255 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI------IWQM 255 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH------HHHH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHh
Confidence 1 122334568999999999864 3478899999999999999999999974432110 0111
Q ss_pred hhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 925 DEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.....+..... ..+..+.+++.+||+.||.+|||++++++.|+
T Consensus 256 ~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~ 298 (319)
T 2y4i_B 256 GTGMKPNLSQI-----GMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298 (319)
T ss_dssp HTTCCCCCCCS-----SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHT
T ss_pred ccCCCCCCCcC-----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 11111211111 11234778999999999999999999999885
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=334.74 Aligned_cols=265 Identities=20% Similarity=0.285 Sum_probs=198.5
Q ss_pred HhcCCcccccccCCCceeEEEEEc--CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC---CCCceeeeceeee---
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAEL--PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI---RHRNIVKFYGFCS--- 770 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~--- 770 (973)
+.++|++.+.||+|+||.||+|.. .+++.||||++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 457899999999999999999976 468899999986432211 1123455666666555 8999999999986
Q ss_pred --ccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEe
Q 002069 771 --HALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVS 848 (973)
Q Consensus 771 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~ 848 (973)
.....++||||++ ++|.+++.... ...+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999998 69999987544 23489999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh--hhhh----hhh
Q 002069 849 DFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS--LSSN----LNI 922 (973)
Q Consensus 849 Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~--~~~~----~~~ 922 (973)
|||.++..... .......|++.|+|||++.+..++.++||||||+++|||++|+.||......... .... ...
T Consensus 163 Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 163 DFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp SCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred cCcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 99999866533 2334567899999999999989999999999999999999999999754321110 0000 000
Q ss_pred hh-------hhhcCC-CCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 923 AL-------DEMLDP-RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 923 ~~-------~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.. ...... ...............+.+++.+||+.||.+|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 000000 0000000011223457789999999999999999999863
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=342.10 Aligned_cols=258 Identities=26% Similarity=0.311 Sum_probs=192.4
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc------c
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA------L 773 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 773 (973)
.+|++.+.||+|+||+||+|... +|+.||||++..... .+.+|++++++++||||+++++++... .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 46999999999999999999664 799999999865322 223699999999999999999988432 2
Q ss_pred eeEEEEEecCCCChHHHhccC-ccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC-CceEEeccc
Q 002069 774 HSFVVYEYLEMGSLAMILSND-AAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE-YEAHVSDFG 851 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl~Dfg 851 (973)
..++||||+++ ++.+++... .....+++..++.++.||+.||+|||+. +|+||||||+||+++.+ +.+||+|||
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence 36799999985 566655422 2234689999999999999999999999 99999999999999965 578999999
Q ss_pred ccccccCCCCcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh------hhhhhhhhh
Q 002069 852 ISKFLKLGLSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS------LSSNLNIAL 924 (973)
Q Consensus 852 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~------~~~~~~~~~ 924 (973)
+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... .+......+
T Consensus 203 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 203 SAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp TCEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 998765432 33456789999999998764 7899999999999999999999999754422110 000000111
Q ss_pred hhh----cCCCCCC----Cchh--hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 925 DEM----LDPRLPT----PLRN--VQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 925 ~~~----~~~~~~~----~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
... ....++. .+.. .......+.+++.+||+.||.+|||+.|+++.
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 111 0001111 0100 01123467899999999999999999999863
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=343.47 Aligned_cols=260 Identities=20% Similarity=0.237 Sum_probs=198.5
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC--------CCceeeeceeee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR--------HRNIVKFYGFCS 770 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~ 770 (973)
.++|++.+.||+|+||+||+|.. .+++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 36899999999999999999954 57899999999742 234577889999999885 788999999987
Q ss_pred ----ccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC---
Q 002069 771 ----HALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY--- 843 (973)
Q Consensus 771 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~--- 843 (973)
.....++||||+. +++.+++.... ...+++.+++.++.||+.||+|||+++ +|+||||||+||+++.++
T Consensus 112 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLG-HHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEETTEEEEEEEECCCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred ecCCCCceEEEEEeccC-ccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence 5568899999994 56666554332 245899999999999999999999964 799999999999999775
Q ss_pred ----------------------------------------------ceEEecccccccccCCCCcccccccccCcccccc
Q 002069 844 ----------------------------------------------EAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL 877 (973)
Q Consensus 844 ----------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~ 877 (973)
.+||+|||.++..... .....||+.|+|||+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChh
Confidence 7999999999876543 344578999999999
Q ss_pred cccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhh------------hhhhhhhhhh------hhhhcCC-----CC--
Q 002069 878 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIC------------SSLSSNLNIA------LDEMLDP-----RL-- 932 (973)
Q Consensus 878 ~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~------------~~~~~~~~~~------~~~~~~~-----~~-- 932 (973)
+.+..++.++|||||||++|||+||+.||....... ...+...... ....... .+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999999999997432100 0000000000 0000000 00
Q ss_pred --CC--------CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 933 --PT--------PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 933 --~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
+. ...........+.+++.+||+.||++|||++|+++.
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00 001124456678999999999999999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=337.29 Aligned_cols=261 Identities=22% Similarity=0.299 Sum_probs=198.6
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc-----c
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA-----L 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~ 773 (973)
.++|++.+.||+|+||.||+|... +|+.||||++.... .......+.+|+.++++++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 468999999999999999999654 78999999996432 233457788999999999999999999988654 6
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
..++||||++ ++|.+++.. ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 7899999997 689998864 3589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCc----------ccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh------
Q 002069 854 KFLKLGLSN----------RTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL------ 916 (973)
Q Consensus 854 ~~~~~~~~~----------~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~------ 916 (973)
+........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 876533211 223578999999998754 678999999999999999999999997543211000
Q ss_pred hhh---------hhhhhhhhcC--CCCCC-C-chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 917 SSN---------LNIALDEMLD--PRLPT-P-LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 917 ~~~---------~~~~~~~~~~--~~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
... ......+... +..+. . .......+..+.+++.+||+.||.+|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 0000000000 00000 0 00011234567899999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=333.31 Aligned_cols=259 Identities=19% Similarity=0.245 Sum_probs=200.6
Q ss_pred hcCCcccccccCCCceeEEEEEc--CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCC------ceeeeceeeec
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL--PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR------NIVKFYGFCSH 771 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~ 771 (973)
.++|++.+.||+|+||+||+|.. .+++.||||++... ....+.+.+|+.+++.++|+ +++++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 46899999999999999999964 37889999998642 23357788899988887654 59999999999
Q ss_pred cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC----------
Q 002069 772 ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL---------- 841 (973)
Q Consensus 772 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---------- 841 (973)
.+..++||||+ +++|.+++..... ..+++.+++.++.|++.|++|||++ +|+||||||+||+++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence 99999999999 8999999975542 3588999999999999999999999 9999999999999987
Q ss_pred ---------CCceEEecccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhh
Q 002069 842 ---------EYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSI 912 (973)
Q Consensus 842 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 912 (973)
++.+||+|||.++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 66899999999986543 234467899999999999999999999999999999999999999754321
Q ss_pred hh--hh----hhhhhhhhhhhc-------------------------CCCCCCCchhhHHHHHHHHHHHhcccCCCCCCC
Q 002069 913 CS--SL----SSNLNIALDEML-------------------------DPRLPTPLRNVQDKLISIMEVSISCLDESPTSR 961 (973)
Q Consensus 913 ~~--~~----~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 961 (973)
.. .. ............ .................+.+++.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 10 00 000000000000 000000000112345678899999999999999
Q ss_pred CCHHHHHHH
Q 002069 962 PTMQKVSQL 970 (973)
Q Consensus 962 Ps~~ev~~~ 970 (973)
||++|+++.
T Consensus 321 pt~~ell~h 329 (339)
T 1z57_A 321 ITLREALKH 329 (339)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=333.68 Aligned_cols=255 Identities=21% Similarity=0.287 Sum_probs=195.8
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccce----
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH---- 774 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 774 (973)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 36799999999999999999965 4799999999976533 23346788999999999999999999999976643
Q ss_pred --eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 775 --SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 775 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
.++||||++ ++|.+++.. .+++.++..++.||+.|++|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999998 688877642 488999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh--h----hhhhh----
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS--L----SSNLN---- 921 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~--~----~~~~~---- 921 (973)
++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......... . +....
T Consensus 173 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 173 ARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp TTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred ccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9865432 334578999999999877 67899999999999999999999999754321100 0 00000
Q ss_pred --------hhhhhh---cCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 922 --------IALDEM---LDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 922 --------~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...... ..+.+... .......+.+++.+|++.||.+|||++++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQL---FPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTT---CTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHh---cCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 00111111 11234567899999999999999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=329.29 Aligned_cols=252 Identities=22% Similarity=0.324 Sum_probs=196.2
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC--CCceeeeceeeeccceeEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR--HRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~l 777 (973)
.++|++.+.||+|+||.||+|...+++.||||++...... ....+.+.+|+.++++++ |+||+++++++..++..++
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 4679999999999999999998888999999998754332 334678999999999996 5999999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
||| +.+++|.+++.... .+++.+++.++.|++.|++|||+. +|+||||||+||+++ ++.+||+|||.++...
T Consensus 106 v~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeecccccccc
Confidence 999 56789999997543 678999999999999999999999 999999999999996 5899999999998765
Q ss_pred CCCC--cccccccccCccccccccc-----------CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhh
Q 002069 858 LGLS--NRTELAGTFGYIAPELAYT-----------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIAL 924 (973)
Q Consensus 858 ~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 924 (973)
.... ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||........ ..
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--------~~ 249 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------KL 249 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--------HH
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH--------HH
Confidence 4322 2234578999999999875 4678899999999999999999999974321111 11
Q ss_pred hhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 925 DEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
....++........ .....+.+++.+||+.||.+||+++|+++.
T Consensus 250 ~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 250 HAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhcccccCCcc--cchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11122211111110 012357889999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=329.79 Aligned_cols=260 Identities=20% Similarity=0.258 Sum_probs=192.0
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeee--------
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCS-------- 770 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-------- 770 (973)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 468999999999999999999665 6899999998753 2344678999999999999999999998873
Q ss_pred ------ccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeec-CCC
Q 002069 771 ------HALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLN-LEY 843 (973)
Q Consensus 771 ------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~-~~~ 843 (973)
+....++||||++ |+|.++++. ..+++..++.++.|++.|++|||+. +|+||||||+||+++ .++
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence 3467899999998 699999864 3588999999999999999999999 999999999999997 567
Q ss_pred ceEEecccccccccCCC---CcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh---h
Q 002069 844 EAHVSDFGISKFLKLGL---SNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS---L 916 (973)
Q Consensus 844 ~~kl~Dfg~a~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~---~ 916 (973)
.+||+|||.++...... .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......... .
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999998765332 12234567899999998765 67899999999999999999999999754321100 0
Q ss_pred h---hhhhhhhh-----------hhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 917 S---SNLNIALD-----------EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 917 ~---~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
. ........ .................+..+.+++.+||+.||.+|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0 00000000 000000000000011234568899999999999999999999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=354.26 Aligned_cols=263 Identities=26% Similarity=0.271 Sum_probs=201.4
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec------c
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH------A 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~ 772 (973)
.++|++.+.||+|+||+||+|.. .+|+.||||++.... .....+.+.+|+.++++++||||+++++++.. .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 47899999999999999999965 478999999987643 23446789999999999999999999998765 6
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCc---eEEec
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYE---AHVSD 849 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~---~kl~D 849 (973)
+..++||||+++|+|.+++........+++..++.++.|++.|++|||+. +|+||||||+||+++.++. +||+|
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcc
Confidence 67899999999999999998766555789999999999999999999999 9999999999999997765 99999
Q ss_pred ccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhh-----hh
Q 002069 850 FGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNI-----AL 924 (973)
Q Consensus 850 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~-----~~ 924 (973)
||.++...... ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||........+....... ..
T Consensus 168 FG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 168 LGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 99998775542 3345679999999999999999999999999999999999999996432211111100000 00
Q ss_pred hhhc------CCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHH
Q 002069 925 DEML------DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVS 968 (973)
Q Consensus 925 ~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~ 968 (973)
.... ....+.+.......+..+.+++.+||+.||++|||+++++
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 0000 1111111111223456788999999999999999998754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=359.05 Aligned_cols=253 Identities=21% Similarity=0.352 Sum_probs=200.8
Q ss_pred hcCCcccccccCCCceeEEEEEcC----CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP----TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
.++|++.+.||+|+||.||+|.+. .+..||||++.... .....+.+.+|+.++++++||||+++++++.+ +..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 465 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 465 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence 467999999999999999999653 34579999987543 23346789999999999999999999999854 568
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+++|+|.++++... ..+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCee
Confidence 99999999999999997543 3588999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCC-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 856 LKLGLS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 856 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
...... ......+++.|+|||++.+..++.++|||||||++|||++ |..||....... .............+
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------~~~~i~~~~~~~~~ 614 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPMP 614 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHHTCCCCCC
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHcCCCCCCC
Confidence 654322 2233456789999999998899999999999999999997 999997443211 00111111111122
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
. ..+..+.+++.+||+.||.+|||+.++++.|+
T Consensus 615 ~------~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~ 647 (656)
T 2j0j_A 615 P------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647 (656)
T ss_dssp T------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred c------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 1 12345788999999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=333.55 Aligned_cols=253 Identities=19% Similarity=0.234 Sum_probs=172.1
Q ss_pred hcCCcccc-cccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec----cc
Q 002069 700 TKNFDDEH-CIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH----AL 773 (973)
Q Consensus 700 ~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~ 773 (973)
.++|++.+ .||+|+||+||+|... +++.||||++... . ....+....++.++||||+++++++.. ..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 57888855 6999999999999664 7999999998642 1 111222233566799999999999865 44
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC---CCceEEecc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL---EYEAHVSDF 850 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---~~~~kl~Df 850 (973)
..++||||+++|+|.+++.... ...+++.+++.++.|++.|++|||+. +|+||||||+||+++. ++.+||+||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred eEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence 5899999999999999997654 24689999999999999999999999 9999999999999976 455999999
Q ss_pred cccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCC
Q 002069 851 GISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDP 930 (973)
Q Consensus 851 g~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (973)
|.++..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ..........
T Consensus 176 g~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~~~~~ 248 (336)
T 3fhr_A 176 GFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS-----PGMKRRIRLG 248 (336)
T ss_dssp TTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh-----hhHHHhhhcc
Confidence 999866532 233457899999999998888999999999999999999999999643321100 0000011111
Q ss_pred CCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 931 RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 931 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
............+..+.+++.+||+.||.+|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111111112234457889999999999999999999873
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=336.56 Aligned_cols=336 Identities=22% Similarity=0.195 Sum_probs=265.0
Q ss_pred chhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEc
Q 002069 264 TKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQL 343 (973)
Q Consensus 264 ~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 343 (973)
.+++.+++.+|.+..++...|..+++|++|++++|.+++..+..|..+++|++|++++|.+++..|..|.++++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 33444444444444555566777888888888888888777778888888888888888888777888888888888888
Q ss_pred CCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCCCCEEEccCCCCCCC
Q 002069 344 SENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGS 423 (973)
Q Consensus 344 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 423 (973)
++|.++...+..|.++++|++|++++|++++..+..|..+++|++|++++|++++. .+..+++|+.|++++|.+++
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~- 200 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST- 200 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE-
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc-
Confidence 88888866666678888888888888888877788888888888888888888764 35667888999999998873
Q ss_pred cchhhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCCcccccccccccccccccccccccCccccc
Q 002069 424 IPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGN 503 (973)
Q Consensus 424 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~~~~l~~ 503 (973)
++ .+++|++|++++|.++.... ..+++|+.|++++|.+++. ..+..+++|++|++++|.+++..|..|..
T Consensus 201 ~~-----~~~~L~~L~l~~n~l~~~~~---~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~ 270 (390)
T 3o6n_A 201 LA-----IPIAVEELDASHNSINVVRG---PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVK 270 (390)
T ss_dssp EE-----CCSSCSEEECCSSCCCEEEC---CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTT
T ss_pred cC-----CCCcceEEECCCCeeeeccc---cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccc
Confidence 21 23478999999998886533 2347899999999999864 67888999999999999999888889999
Q ss_pred cccccEEeecCccCCCCCCcccccccccCeecccccccCCCcchhhcccccccccccccccccCccchhhhccccccEEe
Q 002069 504 LVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCID 583 (973)
Q Consensus 504 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ 583 (973)
+++|++|+|++|++++. +..+..+++|++|++++|.++. .|..+..+++|++|+|++|++++.. +..++.|+.|+
T Consensus 271 l~~L~~L~L~~n~l~~~-~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L~ 345 (390)
T 3o6n_A 271 MQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLT 345 (390)
T ss_dssp CSSCCEEECCSSCCCEE-ECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEE
T ss_pred cccCCEEECCCCcCccc-CcccCCCCCCCEEECCCCccee-cCccccccCcCCEEECCCCccceeC---chhhccCCEEE
Confidence 99999999999999763 4556778899999999999874 4556788899999999999998664 56788999999
Q ss_pred CcCCCCCCCCCCCccCCCCCcchhcCCCCccCCCcc
Q 002069 584 ISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKR 619 (973)
Q Consensus 584 l~~N~l~~~~~~~~~~~~~~~~~~~~N~~~c~~~~~ 619 (973)
+++|+|++.+.. ..+.......+.+++..|+.+..
T Consensus 346 l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~~~ 380 (390)
T 3o6n_A 346 LSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDYQ 380 (390)
T ss_dssp CCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTTCE
T ss_pred cCCCCccchhHH-HHHHHHHhhcccccCceeccccc
Confidence 999999875432 33555666677888988975433
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=330.59 Aligned_cols=257 Identities=25% Similarity=0.339 Sum_probs=178.6
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHH-HhhcCCCCceeeeceeeeccceeEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGN-ALTKIRHRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~l 777 (973)
.++|++.+.||+|+||.||+|.. .+|+.||||++...... ....++..|+. +++.++||||+++++++.+++..++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH--HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc--hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 36799999999999999999966 47899999999765322 23455666665 6777899999999999999999999
Q ss_pred EEEecCCCChHHHhccCc--cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 778 VYEYLEMGSLAMILSNDA--AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
||||+++ +|.+++.... ....+++..+..++.|++.|++|||+.. +++||||||+||+++.++.+||+|||.++.
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 9999985 7877775311 1346899999999999999999999963 799999999999999999999999999987
Q ss_pred ccCCCCcccccccccCccccccc----ccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 856 LKLGLSNRTELAGTFGYIAPELA----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 856 ~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
..... ......|++.|+|||++ .+..++.++||||||+++|||++|+.||......... ........
T Consensus 176 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--------~~~~~~~~ 246 (327)
T 3aln_A 176 LVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ--------LTQVVKGD 246 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------CCCCCSC
T ss_pred ccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH--------HHHHhcCC
Confidence 65432 22334799999999998 4567899999999999999999999999743221111 11111111
Q ss_pred CCC-CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 932 LPT-PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 932 ~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.+. ...........+.+++.+||+.||.+|||++++++.
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 110 000001123457899999999999999999999763
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=332.52 Aligned_cols=201 Identities=24% Similarity=0.246 Sum_probs=170.1
Q ss_pred HhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CC-----ceeeeceeeec
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HR-----NIVKFYGFCSH 771 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~ 771 (973)
..++|++.+.||+|+||+||+|.. .+++.||||++... .....++..|+.+++.++ |+ +++++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 357899999999999999999965 47889999999742 233567778888887774 44 49999999999
Q ss_pred cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeec--CCCceEEec
Q 002069 772 ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLN--LEYEAHVSD 849 (973)
Q Consensus 772 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~--~~~~~kl~D 849 (973)
.+..++||||++ ++|.+++..... ..+++..+..++.|++.|++|||++. .+|+||||||+||+++ .++.+||+|
T Consensus 128 ~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 128 RNHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CCceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 999999999996 599999975432 35899999999999999999999521 2899999999999995 468899999
Q ss_pred ccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcch
Q 002069 850 FGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFI 909 (973)
Q Consensus 850 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 909 (973)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 205 FG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 205 FGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999876432 34567899999999999999999999999999999999999999754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=340.47 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=187.3
Q ss_pred cCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 779 (973)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+++..++||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 345567889999999998776668999999998632 235678899999876 8999999999999999999999
Q ss_pred EecCCCChHHHhccCccccC----CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC-------------
Q 002069 780 EYLEMGSLAMILSNDAAAEE----FGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE------------- 842 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~------------- 842 (973)
||++ |+|.++++....... .++..++.++.||+.|++|||+. +|+||||||+||+++.+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCc
Confidence 9996 699999976543211 13335678999999999999999 99999999999999754
Q ss_pred CceEEecccccccccCCCCc----ccccccccCccccccccc-------CCCCCccchHHHHHHHHHHHh-CCCCCcchh
Q 002069 843 YEAHVSDFGISKFLKLGLSN----RTELAGTFGYIAPELAYT-------MKVTEKCDVYSFGVLALEVIK-GKHPRDFIS 910 (973)
Q Consensus 843 ~~~kl~Dfg~a~~~~~~~~~----~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~ 910 (973)
+.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||+| |+.||....
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 48999999999877654221 234579999999999875 568899999999999999999 999997432
Q ss_pred hhhhhhhhhhhhhhhhhcC-CCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 911 SICSSLSSNLNIALDEMLD-PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.... ........ +... .......+..+.+++.+||+.||.+|||+.++++.
T Consensus 245 ~~~~-------~i~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 245 SRES-------NIIRGIFSLDEMK--CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp THHH-------HHHHTCCCCCCCT--TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhHH-------HHhcCCCCccccc--ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 1110 11111111 1111 11123455678899999999999999999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=338.52 Aligned_cols=249 Identities=22% Similarity=0.319 Sum_probs=186.6
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 778 (973)
..+|+..+.||+|+||+||.....+++.||||++..... ..+.+|+.+++++ +|||||++++++.+....++|
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 356899999999999997655555899999999875322 2345789999998 899999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC---C--CceEEeccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL---E--YEAHVSDFGIS 853 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---~--~~~kl~Dfg~a 853 (973)
|||++ |+|.+++..... ...+.+++.++.||+.|++|||+. +|+||||||+||+++. + ..+||+|||+|
T Consensus 97 ~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 99997 699999975542 334456788999999999999999 9999999999999953 2 35789999999
Q ss_pred ccccCCC---CcccccccccCcccccccc---cCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhh
Q 002069 854 KFLKLGL---SNRTELAGTFGYIAPELAY---TMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDE 926 (973)
Q Consensus 854 ~~~~~~~---~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 926 (973)
+...... .......||+.|+|||++. ...++.++||||+||++|||++ |..||....... ...
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----------~~~ 240 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----------ANI 240 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----------HHH
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----------HHH
Confidence 8775432 2234467999999999987 4567889999999999999999 999986332110 000
Q ss_pred hcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 927 MLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...................+.+++.+||+.||.+|||+++|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 241 LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp HTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 11110001111112234457789999999999999999999863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=335.20 Aligned_cols=260 Identities=18% Similarity=0.224 Sum_probs=197.4
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-----------CCceeeece
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-----------HRNIVKFYG 767 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~ 767 (973)
.++|++.+.||+|+||+||+|.. .+++.||||++... ....+.+.+|+.++++++ |+||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 36899999999999999999965 58899999998742 233577888999988875 899999999
Q ss_pred eeeccc----eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeec---
Q 002069 768 FCSHAL----HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLN--- 840 (973)
Q Consensus 768 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~--- 840 (973)
++...+ ..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+++ +|+||||||+||+++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEE
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccC
Confidence 987654 789999999 899999997543 235899999999999999999999963 899999999999995
Q ss_pred ---CCCceEEecccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhh
Q 002069 841 ---LEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLS 917 (973)
Q Consensus 841 ---~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 917 (973)
..+.+||+|||.++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 3348999999999876532 3345789999999999999999999999999999999999999974321000000
Q ss_pred -hhhhhhh-----------------hhhcCC-----CCC------------CCchhhHHHHHHHHHHHhcccCCCCCCCC
Q 002069 918 -SNLNIAL-----------------DEMLDP-----RLP------------TPLRNVQDKLISIMEVSISCLDESPTSRP 962 (973)
Q Consensus 918 -~~~~~~~-----------------~~~~~~-----~~~------------~~~~~~~~~~~~l~~li~~cl~~dP~~RP 962 (973)
....... ...... .+. ............+.+++.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 0000000 000000 000 00011134567789999999999999999
Q ss_pred CHHHHHHH
Q 002069 963 TMQKVSQL 970 (973)
Q Consensus 963 s~~ev~~~ 970 (973)
|++|+++.
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=328.15 Aligned_cols=254 Identities=21% Similarity=0.310 Sum_probs=180.5
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|... +|+.||||++...... ....+.+.++..+++.++||||+++++++.+++..++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 467999999999999999999664 7999999999765332 22234455555678888999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT-NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
|||+ ++.+..+.... ...+++..++.++.|++.|++|||+ . +++||||||+||+++.++.+||+|||.+....
T Consensus 103 ~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 45565555322 2468999999999999999999998 5 89999999999999999999999999997665
Q ss_pred CCCCcccccccccCcccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 858 LGLSNRTELAGTFGYIAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
.. .......|++.|+|||++. ...++.++||||||+++|||++|+.||........... ... ....+..
T Consensus 177 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~-~~~~~~~ 250 (318)
T 2dyl_A 177 DD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT----KVL-QEEPPLL 250 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH----HHH-HSCCCCC
T ss_pred CC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH----HHh-ccCCCCC
Confidence 43 2233457899999999984 45688899999999999999999999974321111110 011 1111111
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
+... ..+..+.+++.+||+.||.+||+++++++.
T Consensus 251 ~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 251 PGHM----GFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CSSS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccC----CCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111 123357789999999999999999999863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=329.52 Aligned_cols=259 Identities=19% Similarity=0.252 Sum_probs=197.4
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CC-CEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCc------eeeeceeeec
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TG-EIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN------IVKFYGFCSH 771 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~ 771 (973)
.++|++.+.||+|+||+||+|... ++ +.||||++... ....+.+.+|+.++++++|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 468999999999999999999653 44 68999999642 233577888999998887655 8999999999
Q ss_pred cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeee------------
Q 002069 772 ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL------------ 839 (973)
Q Consensus 772 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill------------ 839 (973)
.+..++||||+ ++++.+++.... ...+++.+++.++.||+.||+|||+. +|+||||||+||++
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred CCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence 99999999999 566777765433 23589999999999999999999999 99999999999999
Q ss_pred -------cCCCceEEecccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhh
Q 002069 840 -------NLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSI 912 (973)
Q Consensus 840 -------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 912 (973)
+.++.+||+|||.++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999865432 34467999999999999999999999999999999999999999754321
Q ss_pred hh------hhhhhhhhhhhhhc------C-------------------CCCCCCchhhHHHHHHHHHHHhcccCCCCCCC
Q 002069 913 CS------SLSSNLNIALDEML------D-------------------PRLPTPLRNVQDKLISIMEVSISCLDESPTSR 961 (973)
Q Consensus 913 ~~------~~~~~~~~~~~~~~------~-------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 961 (973)
.. .............. . +...............+.+++.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 10 00000000000000 0 00000000111234568899999999999999
Q ss_pred CCHHHHHHH
Q 002069 962 PTMQKVSQL 970 (973)
Q Consensus 962 Ps~~ev~~~ 970 (973)
||++|+++.
T Consensus 326 pt~~e~l~h 334 (355)
T 2eu9_A 326 ITLAEALLH 334 (355)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999863
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=321.76 Aligned_cols=306 Identities=28% Similarity=0.422 Sum_probs=160.8
Q ss_pred cCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccce
Q 002069 45 GRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVT 124 (973)
Q Consensus 45 ~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 124 (973)
..+++|++|++++|.+. .+|. ++.+++|++|++++|+++ .+|. +..+++|++|++++|+++. +| .+.++++|++
T Consensus 41 ~~l~~L~~L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~-~~~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~ 114 (347)
T 4fmz_A 41 EELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQIT-DISP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRE 114 (347)
T ss_dssp HHHTTCSEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSE
T ss_pred hhcccccEEEEeCCccc-cchh-hhhcCCccEEEccCCccc-cchh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCE
Confidence 34445555555555544 3332 444555555555555554 2332 4455555555555555542 22 3455555555
Q ss_pred eecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeecccccc
Q 002069 125 LYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTL 204 (973)
Q Consensus 125 L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 204 (973)
|++++|++++ ++. +.++++|++|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|++|++++|.+
T Consensus 115 L~l~~n~i~~-~~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l 189 (347)
T 4fmz_A 115 LYLNEDNISD-ISP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI 189 (347)
T ss_dssp EECTTSCCCC-CGG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCC
T ss_pred EECcCCcccC-chh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcc
Confidence 5555555542 222 4555555555555553332222 24555555555555555542221 55555555555555555
Q ss_pred ccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhh
Q 002069 205 SGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEI 284 (973)
Q Consensus 205 ~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~ 284 (973)
.++.+ +..+++|+.|++++|.+++..+ +..+++|++|++++|.+++..+ +
T Consensus 190 ~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--------------------------~ 239 (347)
T 4fmz_A 190 EDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--------------------------L 239 (347)
T ss_dssp CCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--------------------------G
T ss_pred ccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--------------------------h
Confidence 54333 5555556666666665554422 5555556666666555543211 3
Q ss_pred ccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcE
Q 002069 285 GNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVS 364 (973)
Q Consensus 285 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 364 (973)
..+++|++|++++|.+++. ..+..+++|++|++++|.+++. ..+..+++|++|++++|.+++..+..++++++|++
T Consensus 240 ~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 315 (347)
T 4fmz_A 240 ANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT 315 (347)
T ss_dssp TTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSE
T ss_pred hcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCE
Confidence 3445555555555555532 3455566666666666666543 34566666666666666666666666666666666
Q ss_pred EEccCCcccCCCCcccccccccchhcccccccc
Q 002069 365 LDLSINKLSGSIPLSFASLTSLTTLYLYENSLC 397 (973)
Q Consensus 365 L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 397 (973)
|++++|++++..| +..+++|++|++++|.|+
T Consensus 316 L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 316 LFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp EECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred EEccCCccccccC--hhhhhccceeehhhhccc
Confidence 6666666665444 566666666666666653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=330.67 Aligned_cols=246 Identities=20% Similarity=0.268 Sum_probs=199.5
Q ss_pred HHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcc---hhhHHHHHHHHHHhhcCC--CCceeeeceeeec
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGE---MACQQEFLNEGNALTKIR--HRNIVKFYGFCSH 771 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~ 771 (973)
....+|++.+.||+|+||.||+|.. .+++.||||++....... ....+.+.+|+.++++++ |+||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457899999999999999999954 588999999986543221 011245677899999885 5999999999999
Q ss_pred cceeEEEEEecCC-CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeec-CCCceEEec
Q 002069 772 ALHSFVVYEYLEM-GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLN-LEYEAHVSD 849 (973)
Q Consensus 772 ~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~-~~~~~kl~D 849 (973)
++..++||||+.+ ++|.+++... ..+++..++.++.|++.|++|||+. +|+||||||+||+++ .++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999986 8999998653 3688999999999999999999999 999999999999999 779999999
Q ss_pred ccccccccCCCCcccccccccCcccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhc
Q 002069 850 FGISKFLKLGLSNRTELAGTFGYIAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML 928 (973)
Q Consensus 850 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 928 (973)
||.++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ..
T Consensus 194 fg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-----------~~- 259 (320)
T 3a99_A 194 FGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-----------GQ- 259 (320)
T ss_dssp CTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH-----------CC-
T ss_pred Cccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhc-----------cc-
Confidence 9999876543 2344679999999999887665 6789999999999999999999974432110 00
Q ss_pred CCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 929 DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...+.. .+..+.+++.+||+.||++|||++++++.
T Consensus 260 -~~~~~~------~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 260 -VFFRQR------VSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -CCCSSC------CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -cccccc------CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111 12357789999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.93 Aligned_cols=248 Identities=21% Similarity=0.263 Sum_probs=191.9
Q ss_pred HHHHhcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcch---hhHHHHHHHHHHhhcC----CCCceeeece
Q 002069 696 IIRATKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEM---ACQQEFLNEGNALTKI----RHRNIVKFYG 767 (973)
Q Consensus 696 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l----~h~niv~~~~ 767 (973)
.....++|++.+.||+|+||.||+|.. .+++.||||++........ .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999965 4789999999975433221 1234456788888887 8999999999
Q ss_pred eeeccceeEEEEEe-cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeec-CCCce
Q 002069 768 FCSHALHSFVVYEY-LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLN-LEYEA 845 (973)
Q Consensus 768 ~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~-~~~~~ 845 (973)
++...+..++|||| +++++|.+++... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 99998899999999 7899999999753 3589999999999999999999999 999999999999999 78999
Q ss_pred EEecccccccccCCCCcccccccccCcccccccccCCCC-CccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhh
Q 002069 846 HVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIAL 924 (973)
Q Consensus 846 kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 924 (973)
||+|||.++..... ......|++.|+|||++.+..+. .++||||+|+++|||++|+.||........
T Consensus 180 kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------- 247 (312)
T 2iwi_A 180 KLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE---------- 247 (312)
T ss_dssp EECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH----------
T ss_pred EEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhh----------
Confidence 99999999876543 33456799999999998876664 589999999999999999999974332110
Q ss_pred hhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 925 DEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
. ...++.. ....+.+++.+||+.||++|||++|+++.
T Consensus 248 -~--~~~~~~~------~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 248 -A--ELHFPAH------VSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -T--CCCCCTT------SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -h--ccCCccc------CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 1111111 22347789999999999999999999874
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=351.10 Aligned_cols=333 Identities=22% Similarity=0.201 Sum_probs=268.4
Q ss_pred hhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCC
Q 002069 267 VISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSEN 346 (973)
Q Consensus 267 ~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 346 (973)
+.+.+.+|.+..+++..|.++++|+.|++++|.+++..+..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 54 ~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 133 (597)
T 3oja_B 54 KIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 133 (597)
T ss_dssp SEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCC
Confidence 33444444444555566777888888888888888777778888888888888888888888888888888888888888
Q ss_pred CCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCCCCEEEccCCCCCCCcch
Q 002069 347 TLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPL 426 (973)
Q Consensus 347 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 426 (973)
.+++..+..|+++++|++|+|++|.+++..|..|.++++|++|+|++|.+++. .+..+++|+.|++++|.+++ ++
T Consensus 134 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~-l~- 208 (597)
T 3oja_B 134 DLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST-LA- 208 (597)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSE-EE-
T ss_pred CCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCcccc-cc-
Confidence 88877777778888888888888888888888888888888888888888764 25567888999999998873 21
Q ss_pred hhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCCcccccccccccccccccccccccCcccccccc
Q 002069 427 SLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVK 506 (973)
Q Consensus 427 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~~~~l~~l~~ 506 (973)
.+.+|+.|++++|.++...+.. .++|+.|++++|.+++ +..+..+++|+.|+|++|.+++..|..|..+++
T Consensus 209 ----~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 279 (597)
T 3oja_B 209 ----IPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQR 279 (597)
T ss_dssp ----CCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSS
T ss_pred ----CCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccC
Confidence 2347899999999888554432 3689999999999986 377889999999999999999888999999999
Q ss_pred ccEEeecCccCCCCCCcccccccccCeecccccccCCCcchhhcccccccccccccccccCccchhhhccccccEEeCcC
Q 002069 507 LHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISY 586 (973)
Q Consensus 507 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~ 586 (973)
|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|++|+|++|++++.. +..++.|+.|++++
T Consensus 280 L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~ 354 (597)
T 3oja_B 280 LERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSH 354 (597)
T ss_dssp CCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCS
T ss_pred CCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeC
Confidence 9999999999986 4556677899999999999998 46667788999999999999998764 56678999999999
Q ss_pred CCCCCCCCCCccCCCCCcchhcCCCCccCCCcc
Q 002069 587 NALQGLIPNSTAFRDAPMLALQGNKRLCGDIKR 619 (973)
Q Consensus 587 N~l~~~~~~~~~~~~~~~~~~~~N~~~c~~~~~ 619 (973)
|+|++.+.. ..+..+....+.+++..|+....
T Consensus 355 N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~~~ 386 (597)
T 3oja_B 355 NDWDCNSLR-ALFRNVARPAVDDADQHCKIDYQ 386 (597)
T ss_dssp SCEEHHHHH-HHTTTCCTTTBCCCCCCCCTTCE
T ss_pred CCCCChhHH-HHHHHHhhhccccccccCCcchh
Confidence 999876532 33556666678899999987544
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=316.94 Aligned_cols=308 Identities=28% Similarity=0.411 Sum_probs=248.1
Q ss_pred ccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCcccc
Q 002069 19 EIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSL 98 (973)
Q Consensus 19 ~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 98 (973)
.+..+++|++|++++|.++. +| .+..+++|++|++++|+++ .+|. +..+++|++|++++|.++ .+| .+..+++|
T Consensus 39 ~~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~-~~~~-~~~l~~L~~L~L~~n~i~-~~~-~~~~l~~L 112 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQIT-DISP-LSNLVKLTNLYIGTNKIT-DIS-ALQNLTNL 112 (347)
T ss_dssp CHHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTC
T ss_pred cchhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccc-cchh-hhcCCcCCEEEccCCccc-Cch-HHcCCCcC
Confidence 34577888888888888874 44 4888888888888888888 4555 888888888888888887 444 58888888
Q ss_pred ceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeeccc
Q 002069 99 SDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGIN 178 (973)
Q Consensus 99 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n 178 (973)
++|++++|++++ +|. +..+++|++|++++|.... .+..+..+++|++|++++|.+++..+ +..+++|+.|++++|
T Consensus 113 ~~L~l~~n~i~~-~~~-~~~l~~L~~L~l~~n~~~~-~~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 113 RELYLNEDNISD-ISP-LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187 (347)
T ss_dssp SEEECTTSCCCC-CGG-GTTCTTCCEEECTTCTTCC-CCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred CEEECcCCcccC-chh-hccCCceeEEECCCCCCcc-cccchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence 888888888874 444 8888888888888886553 34448888888888888888875443 778888888888888
Q ss_pred ccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCc
Q 002069 179 ALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPC 258 (973)
Q Consensus 179 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 258 (973)
.+.+ ++. +..+++|+.|++++|.+.+..+ +..+++|++|++++|.+++..+ +..+++|++|++++|.+++. .
T Consensus 188 ~l~~-~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~ 259 (347)
T 4fmz_A 188 QIED-ISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--N 259 (347)
T ss_dssp CCCC-CGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--G
T ss_pred cccc-ccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--h
Confidence 8884 333 7888888888888888886654 7888888888888888887643 88888888888888888764 4
Q ss_pred ccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCC
Q 002069 259 SFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSL 338 (973)
Q Consensus 259 ~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 338 (973)
.+..+++|+.+++++|.++.. ..+..+++|+.|++++|.+++..+..++.+++|++|++++|.+++..| +..+++|
T Consensus 260 ~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L 335 (347)
T 4fmz_A 260 AVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKM 335 (347)
T ss_dssp GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTC
T ss_pred hHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhcc
Confidence 678888888888888888876 468889999999999999998888899999999999999999997666 8889999
Q ss_pred CcEEcCCCCCC
Q 002069 339 SDLQLSENTLN 349 (973)
Q Consensus 339 ~~L~L~~N~l~ 349 (973)
++|++++|.|+
T Consensus 336 ~~L~l~~N~i~ 346 (347)
T 4fmz_A 336 DSADFANQVIK 346 (347)
T ss_dssp SEESSSCC---
T ss_pred ceeehhhhccc
Confidence 99999999886
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=324.40 Aligned_cols=308 Identities=22% Similarity=0.226 Sum_probs=180.3
Q ss_pred CCCcEEEccCCcCcccCCc-cccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCcee
Q 002069 72 TSLIYIDIGNNLLSGSIPN-EVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQ 150 (973)
Q Consensus 72 ~~L~~L~l~~n~l~~~~p~-~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 150 (973)
.++++|++++|.++ .+|. .+..+++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+
T Consensus 45 ~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp CCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 44444444444444 2222 234444444444444444433333444444444444444444444444444444455555
Q ss_pred cccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCC
Q 002069 151 VSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSG 230 (973)
Q Consensus 151 l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~ 230 (973)
+++|+++...+..|.++++|++|++++|++++..|..+.++++|++|++++|+++++. +..+++|+.|++++|.+++
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~~ 200 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST 200 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCSE
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeecccccccc
Confidence 5555444333333444555555555555554444444555555555555555555432 3344555555555555543
Q ss_pred CCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhc
Q 002069 231 LIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGS 310 (973)
Q Consensus 231 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 310 (973)
+ ...++|++|++++|.++.... ...++|+.|++++|.+++. ..+..
T Consensus 201 ~-----~~~~~L~~L~l~~n~l~~~~~---------------------------~~~~~L~~L~l~~n~l~~~--~~l~~ 246 (390)
T 3o6n_A 201 L-----AIPIAVEELDASHNSINVVRG---------------------------PVNVELTILKLQHNNLTDT--AWLLN 246 (390)
T ss_dssp E-----ECCSSCSEEECCSSCCCEEEC---------------------------CCCSSCCEEECCSSCCCCC--GGGGG
T ss_pred c-----CCCCcceEEECCCCeeeeccc---------------------------cccccccEEECCCCCCccc--HHHcC
Confidence 2 223456666666666543211 0124567777777777643 46777
Q ss_pred CCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhc
Q 002069 311 LTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLY 390 (973)
Q Consensus 311 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~ 390 (973)
+++|++|++++|.+++..|..|..+++|++|+|++|++++ ++..+..+++|++|+|++|+++ ..|..+..+++|+.|+
T Consensus 247 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~ 324 (390)
T 3o6n_A 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 324 (390)
T ss_dssp CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred CCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEE
Confidence 7778888888887777777777788888888888888874 4556677888888888888887 4566677788888888
Q ss_pred ccccccccCCCcccCCCCCCCEEEccCCCCCC
Q 002069 391 LYENSLCDSIPKEIGDMKSLSILDLSSNKLNG 422 (973)
Q Consensus 391 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 422 (973)
+++|+++.. + +..+++|++|++++|++++
T Consensus 325 L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 325 LDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp CCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred CCCCcccee-C--chhhccCCEEEcCCCCccc
Confidence 888888664 2 6677888888888888874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=314.04 Aligned_cols=230 Identities=13% Similarity=0.074 Sum_probs=183.8
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||.||+|... +++.||||++...........+.+.+|+..+++++||||+++++++.+++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 67999999999999999999664 68999999998765555555688999999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++++|.++++.. ....++.+++.|++.|++|||++ +|+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999999542 35567899999999999999999 99999999999999999999998553
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
|++ +++.++|||||||++|||+||+.||......... . .................
T Consensus 175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~ 229 (286)
T 3uqc_A 175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-----A-PAERDTAGQPIEPADID 229 (286)
T ss_dssp ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-----E-ECCBCTTSCBCCHHHHC
T ss_pred ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-----H-HHHHHhccCCCChhhcc
Confidence 333 3678999999999999999999999754321100 0 00000111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...+..+.+++.+||+.||.+| |++|+++.|+
T Consensus 230 ~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~ 261 (286)
T 3uqc_A 230 RDIPFQISAVAARSVQGDGGIR-SASTLLNLMQ 261 (286)
T ss_dssp TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHcccCCccC-CHHHHHHHHH
Confidence 1234457899999999999999 9999999875
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=311.19 Aligned_cols=304 Identities=24% Similarity=0.310 Sum_probs=228.8
Q ss_pred CCCCCCCCCCcccCCC------CCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccC
Q 002069 8 SFNQFSGSIPPEIGHL------THLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGN 81 (973)
Q Consensus 8 ~~~~l~~~~p~~~~~l------~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~ 81 (973)
+.+.++ .+|+.+... .+++.+++++|.++ .+|..+. ++|++|++++|++++..|.+|+++++|++|++++
T Consensus 12 ~~~~l~-~lp~~~~~~cp~~c~c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~ 87 (332)
T 2ft3_A 12 GIPDLD-SLPPTYSAMCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVN 87 (332)
T ss_dssp --------------CCCCSSCEEETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCCccc-cCCCcccCCCCCCCcccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCC
Confidence 344555 677766544 37899999999998 6777664 6899999999999866677899999999999999
Q ss_pred CcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCC--CC
Q 002069 82 NLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLS--GA 159 (973)
Q Consensus 82 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~ 159 (973)
|++++..|..|+.+++|++|+|++|+++ .+|..+. ++|++|++++|++++..+..|+++++|++|++++|.++ +.
T Consensus 88 n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 164 (332)
T 2ft3_A 88 NKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGF 164 (332)
T ss_dssp SCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGS
T ss_pred CccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCC
Confidence 9998777888999999999999999998 6777665 78999999999998666667899999999999999985 36
Q ss_pred CCccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCcccccc
Q 002069 160 IPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNL 239 (973)
Q Consensus 160 ~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l 239 (973)
.|..+..+ +|+.|++++|++++ +|..+. ++|++|++++|+++++.+..|..+++|+.|++++|+++++.+..|..+
T Consensus 165 ~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 240 (332)
T 2ft3_A 165 EPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL 240 (332)
T ss_dssp CTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGC
T ss_pred CcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCC
Confidence 67778888 88899999998884 666554 688888888888888887888888888888888888888877788888
Q ss_pred ccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhc------CCc
Q 002069 240 KSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGS------LTN 313 (973)
Q Consensus 240 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~------l~~ 313 (973)
++|++|++++|+++ .+|.. +..+++|++|++++|++++..+..|.. .+.
T Consensus 241 ~~L~~L~L~~N~l~-~lp~~------------------------l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~ 295 (332)
T 2ft3_A 241 PTLRELHLDNNKLS-RVPAG------------------------LPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAY 295 (332)
T ss_dssp TTCCEEECCSSCCC-BCCTT------------------------GGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCC
T ss_pred CCCCEEECCCCcCe-ecChh------------------------hhcCccCCEEECCCCCCCccChhHcccccccccccc
Confidence 88888888888876 33333 445566666777777766655555543 356
Q ss_pred cceeeccccccC--CCCCccccCCCCCCcEEcCCCC
Q 002069 314 LATLYFSTNALS--GSIPNEITNLRSLSDLQLSENT 347 (973)
Q Consensus 314 L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~~N~ 347 (973)
|+.|++++|.+. +..|..|..+++|+.+++++|+
T Consensus 296 l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 296 YNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp BSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 777888888776 4667777788888888887764
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=309.40 Aligned_cols=293 Identities=24% Similarity=0.265 Sum_probs=256.4
Q ss_pred CcEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccC
Q 002069 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGN 81 (973)
Q Consensus 2 l~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~ 81 (973)
++.+++++++++ .+|..+. ++|++|+|++|.+++..|..|..+++|++|++++|++++..|..|+++++|++|++++
T Consensus 35 l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred CCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 688999999998 8998875 7999999999999988888999999999999999999977799999999999999999
Q ss_pred CcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeeccccccc--ccCcccccccCCCCceecccCCCCCC
Q 002069 82 NLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALS--GSIPDEIGNLKFLSDLQVSYNTLSGA 159 (973)
Q Consensus 82 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~--~~~p~~~~~l~~L~~L~l~~N~l~~~ 159 (973)
|+++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|.++ +..|..+..+ +|++|++++|++++
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~- 186 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG- 186 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-
Confidence 9999 7887776 79999999999999655667999999999999999996 3678889998 99999999999994
Q ss_pred CCccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCcccccc
Q 002069 160 IPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNL 239 (973)
Q Consensus 160 ~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l 239 (973)
+|..+. ++|++|++++|++++..|..+.++++|++|++++|+++++.+..|..+++|+.|++++|+++.+ |..+..+
T Consensus 187 l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l-p~~l~~l 263 (332)
T 2ft3_A 187 IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRV-PAGLPDL 263 (332)
T ss_dssp CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBC-CTTGGGC
T ss_pred cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeec-ChhhhcC
Confidence 565554 7999999999999988889999999999999999999999988999999999999999999965 7779999
Q ss_pred ccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEccccccc--CCcCchhhcCCcccee
Q 002069 240 KSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLS--GSIPLSLGSLTNLATL 317 (973)
Q Consensus 240 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L 317 (973)
++|+.|++++|++++..+..|....- -....+|+.|++++|.+. +..|..|..+++|+.+
T Consensus 264 ~~L~~L~l~~N~l~~~~~~~~~~~~~------------------~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l 325 (332)
T 2ft3_A 264 KLLQVVYLHTNNITKVGVNDFCPVGF------------------GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAI 325 (332)
T ss_dssp TTCCEEECCSSCCCBCCTTSSSCSSC------------------CSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTE
T ss_pred ccCCEEECCCCCCCccChhHcccccc------------------ccccccccceEeecCcccccccCcccccccchhhhh
Confidence 99999999999999888777764320 012456788888888887 5677888888999999
Q ss_pred eccccc
Q 002069 318 YFSTNA 323 (973)
Q Consensus 318 ~L~~n~ 323 (973)
++++|+
T Consensus 326 ~l~~n~ 331 (332)
T 2ft3_A 326 QFGNYK 331 (332)
T ss_dssp EC----
T ss_pred hccccc
Confidence 988874
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=339.09 Aligned_cols=310 Identities=22% Similarity=0.212 Sum_probs=196.1
Q ss_pred CCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCcee
Q 002069 71 LTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQ 150 (973)
Q Consensus 71 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 150 (973)
+.+++.|++++|.++...+..++.+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 34555555555555533333344555555555555555544444555555555555555555554445555555555555
Q ss_pred cccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCC
Q 002069 151 VSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSG 230 (973)
Q Consensus 151 l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~ 230 (973)
|++|.+++..+..|+++++|++|++++|.+++..|..|.++++|++|++++|.+++++ ++.+++|+.|++++|.+++
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~ 206 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST 206 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc
Confidence 5555555444444555555555555555555555555566666666666666655442 3445566666666665543
Q ss_pred CCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhc
Q 002069 231 LIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGS 310 (973)
Q Consensus 231 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 310 (973)
+ ...++|+.|++++|.++...+.. .++|+.|++++|.+++ +..++.
T Consensus 207 l-----~~~~~L~~L~ls~n~l~~~~~~~---------------------------~~~L~~L~L~~n~l~~--~~~l~~ 252 (597)
T 3oja_B 207 L-----AIPIAVEELDASHNSINVVRGPV---------------------------NVELTILKLQHNNLTD--TAWLLN 252 (597)
T ss_dssp E-----ECCTTCSEEECCSSCCCEEECSC---------------------------CSCCCEEECCSSCCCC--CGGGGG
T ss_pred c-----cCCchhheeeccCCccccccccc---------------------------CCCCCEEECCCCCCCC--Chhhcc
Confidence 2 23345666666666665322110 1367777777777774 356777
Q ss_pred CCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhc
Q 002069 311 LTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLY 390 (973)
Q Consensus 311 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~ 390 (973)
+++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+
T Consensus 253 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~ 330 (597)
T 3oja_B 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 330 (597)
T ss_dssp CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred CCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEE
Confidence 8888888888888877777788888888888888888874 4666677888888888888888 4666777788888888
Q ss_pred ccccccccCCCcccCCCCCCCEEEccCCCCCC
Q 002069 391 LYENSLCDSIPKEIGDMKSLSILDLSSNKLNG 422 (973)
Q Consensus 391 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 422 (973)
|++|.+++. .+..+++|+.|+|++|.+.+
T Consensus 331 L~~N~l~~~---~~~~~~~L~~L~l~~N~~~~ 359 (597)
T 3oja_B 331 LDHNSIVTL---KLSTHHTLKNLTLSHNDWDC 359 (597)
T ss_dssp CCSSCCCCC---CCCTTCCCSEEECCSSCEEH
T ss_pred CCCCCCCCc---ChhhcCCCCEEEeeCCCCCC
Confidence 888888664 26667788888888888764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=309.98 Aligned_cols=232 Identities=20% Similarity=0.256 Sum_probs=179.8
Q ss_pred hcCCccc-ccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHh-hcCCCCceeeeceeeec----c
Q 002069 700 TKNFDDE-HCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNAL-TKIRHRNIVKFYGFCSH----A 772 (973)
Q Consensus 700 ~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~ 772 (973)
.++|.+. +.||+|+||.||+|.. .+++.||+|++.. ...+.+|+.++ +..+||||+++++++.. .
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 3567777 7799999999999965 5889999999863 24566788877 55699999999999876 6
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC---CCceEEec
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL---EYEAHVSD 849 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---~~~~kl~D 849 (973)
...++||||+++++|.+++.... ...+++.+++.++.|++.|++|||+. +|+||||||+||+++. ++.+||+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred ceEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEec
Confidence 77899999999999999997643 23689999999999999999999999 9999999999999998 78999999
Q ss_pred ccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcC
Q 002069 850 FGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLD 929 (973)
Q Consensus 850 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 929 (973)
||++.... +..++.++||||+||++|||++|+.||......... .........
T Consensus 164 fg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----~~~~~~~~~ 216 (299)
T 3m2w_A 164 FGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----PGMKTRIRM 216 (299)
T ss_dssp CTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------CCSCCSSCT
T ss_pred cccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----HHHHHHHhh
Confidence 99986543 134677899999999999999999999743321100 000111111
Q ss_pred CCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 930 PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 930 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+.......+..+.+++.+||+.||.+|||++|+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11111111112234568899999999999999999999874
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=307.59 Aligned_cols=289 Identities=22% Similarity=0.259 Sum_probs=162.1
Q ss_pred CCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeecc
Q 002069 25 HLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLS 104 (973)
Q Consensus 25 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~ 104 (973)
++++++++++.++ .+|..+. ++|++|++++|++++..+..|+++++|++|+|++|++++..|..|+.+++|++|+|+
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 4555555555554 3444332 455555555555554333455555555555555555554445555555555555555
Q ss_pred CCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCC--CCCccccCccccceeeecccccCC
Q 002069 105 NNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSG--AIPFSLGNLTNLVTLYIGINALSG 182 (973)
Q Consensus 105 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~l~~l~~L~~L~l~~n~l~~ 182 (973)
+|+++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|.++. ..+..+.++++|+.|++++|.++
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~- 184 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT- 184 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-
Confidence 55555 3444443 455555555555554444445555555555555555532 34445555555555555555555
Q ss_pred CCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCC
Q 002069 183 SIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGN 262 (973)
Q Consensus 183 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 262 (973)
.+|..+. ++|++|++++|+++++.+..|.++++|+.|++++|.++++.+..|..+++|++|++++|+++ .+|..+..
T Consensus 185 ~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 261 (330)
T 1xku_A 185 TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261 (330)
T ss_dssp SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhcc
Confidence 3443333 45555555555555555555555555555555555555554455555555555555555555 34444555
Q ss_pred cchhhhccCCCcccCchhhhhhcc------ccccceEEcccccccC--CcCchhhcCCccceeeccccc
Q 002069 263 LTKLVISCLGTNALSSSILEEIGN------LKSLLHLQLNYNTLSG--SIPLSLGSLTNLATLYFSTNA 323 (973)
Q Consensus 263 l~~L~~l~l~~n~i~~~~~~~~~~------l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~L~~n~ 323 (973)
+++|+.+++++|.++.+....|.. .++++.|++++|.+.. ..|..|..++.++.+++++|+
T Consensus 262 l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 555555555555555555555433 3678899999998864 567889999999999999885
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=346.86 Aligned_cols=235 Identities=24% Similarity=0.322 Sum_probs=190.3
Q ss_pred hcCCcccccccCCCceeEEEEEcC--CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccce---
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP--TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALH--- 774 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--- 774 (973)
.++|++.+.||+|+||+||+|... +++.||||++.... .......+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 368999999999999999999664 68999999987532 23446788999999999999999999999987655
Q ss_pred --eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 775 --SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 775 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
.|+||||+++++|.+++.. .+++.+++.++.||+.||+|||++ +|+||||||+||+++.+ .+||+|||+
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 6999999999999987753 589999999999999999999999 99999999999999975 999999999
Q ss_pred cccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
++..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||..... ..+
T Consensus 228 a~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~------------------~~~ 284 (681)
T 2pzi_A 228 VSRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV------------------DGL 284 (681)
T ss_dssp CEETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC------------------SSC
T ss_pred chhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc------------------ccc
Confidence 9876543 4467999999999987654 8899999999999999999988762110 001
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCH-HHHHH
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTM-QKVSQ 969 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-~ev~~ 969 (973)
+. ..........+.+++.+||+.||.+||+. +++.+
T Consensus 285 ~~-~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 321 (681)
T 2pzi_A 285 PE-DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSA 321 (681)
T ss_dssp CT-TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred cc-cccccccCHHHHHHHhhhccCChhhCCCHHHHHHH
Confidence 11 11122334568899999999999999964 44444
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=325.43 Aligned_cols=245 Identities=13% Similarity=0.089 Sum_probs=181.7
Q ss_pred hcCCcccccccCCCceeEEEEE-cCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCC-Cceeeec-----------
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH-RNIVKFY----------- 766 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~----------- 766 (973)
...|...+.||+|+||+||+|. ..+|+.||||++...........+.+.+|+.+++.++| ++.....
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3567888999999999999996 55899999999885444433445789999999999977 3221111
Q ss_pred ----------eeeec-----cceeEEEEEecCCCChHHHhccC----ccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 002069 767 ----------GFCSH-----ALHSFVVYEYLEMGSLAMILSND----AAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827 (973)
Q Consensus 767 ----------~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i 827 (973)
.++.. ....+++|+++ +++|.++++.. .....+++..++.++.|++.||+|||++ +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 11111 12346677755 68999988421 1234577889999999999999999999 99
Q ss_pred EeecCCCCCeeecCCCceEEecccccccccCCCCcccccccccCccccccc----------ccCCCCCccchHHHHHHHH
Q 002069 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELA----------YTMKVTEKCDVYSFGVLAL 897 (973)
Q Consensus 828 ~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~Dv~slG~~l~ 897 (973)
+||||||+||+++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 99999999999999999999999998865432 344567 999999998 5556888999999999999
Q ss_pred HHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 898 EVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 898 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
||++|+.||...... ......+.... ..+..+.+++.+||+.||++||++.++++
T Consensus 309 elltg~~Pf~~~~~~---------~~~~~~~~~~~--------~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAAL---------GGSEWIFRSCK--------NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGG---------SCSGGGGSSCC--------CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchh---------hhHHHHHhhcc--------cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999743321 11111111110 11245788999999999999999988865
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=313.32 Aligned_cols=249 Identities=33% Similarity=0.512 Sum_probs=201.0
Q ss_pred CCCCEEECCCCcccc--cCCcCccCCCCCCeeeccC-CcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccce
Q 002069 24 THLKLLSFSKNQLSG--LIPHEIGRLSSLNGLSLYS-NFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSD 100 (973)
Q Consensus 24 ~~L~~L~l~~n~l~~--~~p~~~~~l~~L~~L~l~~-n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 100 (973)
.++++|+|++|.+++ .+|..|+++++|++|++++ |.+.+.+|..|+++++|++|+|++|++++.+|..++.+++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 567888888888877 7788888888888888884 7777778888888888888888888887778888888888888
Q ss_pred eeccCCcCCCCCCCccccCCccceeecccccccccCcccccccC-CCCceecccCCCCCCCCccccCccccceeeecccc
Q 002069 101 LRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLK-FLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINA 179 (973)
Q Consensus 101 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~ 179 (973)
|+|++|++++.+|..++++++|++|+|++|++++.+|..+++++ +|++|++++|++++..|..+..++ |+.|++++|+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 88888888877888888888888888888888777888888887 888888888888777787887776 8888888888
Q ss_pred cCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcc
Q 002069 180 LSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCS 259 (973)
Q Consensus 180 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 259 (973)
+++..|..+..+++|++|++++|++++..+. +..+++|++|++++|++++..|..|..+++|+.|+|++|++++.+|..
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 8877788888888888888888888765554 777888888888888888777888888888888888888888777765
Q ss_pred cCCcchhhhccCCCcc
Q 002069 260 FGNLTKLVISCLGTNA 275 (973)
Q Consensus 260 ~~~l~~L~~l~l~~n~ 275 (973)
+.+++|+.+++.+|.
T Consensus 288 -~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 288 -GNLQRFDVSAYANNK 302 (313)
T ss_dssp -TTGGGSCGGGTCSSS
T ss_pred -ccccccChHHhcCCC
Confidence 778888888888776
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=303.23 Aligned_cols=289 Identities=21% Similarity=0.254 Sum_probs=186.9
Q ss_pred CCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecc
Q 002069 49 SLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLH 128 (973)
Q Consensus 49 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 128 (973)
+|+.++++++.++ .+|..+. ++|++|++++|++++..+..|+.+++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 5667777777766 5665543 466777777777765444566667777777777777765556667777777777777
Q ss_pred cccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCC--CCCccccccCccceeecccccccc
Q 002069 129 MNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSG--SIPNEIGNLKSLSDLRLDYNTLSG 206 (973)
Q Consensus 129 ~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~--~~p~~~~~l~~L~~L~L~~N~l~~ 206 (973)
+|+++ .+|..+. ++|++|++++|.+++..+..|.++++|+.|++++|.++. ..+..+.++++|++|++++|+++.
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 77766 4555443 567777777777765555666677777777777776642 455666667777777777777665
Q ss_pred ccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhcc
Q 002069 207 SILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGN 286 (973)
Q Consensus 207 ~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~ 286 (973)
++...+ ++|++|++++|+++++.+..|.++++|+.|++++|.+++..+..|..+++|+.|++++|.++.+ +..+..
T Consensus 186 l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l-p~~l~~ 261 (330)
T 1xku_A 186 IPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLAD 261 (330)
T ss_dssp CCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSC-CTTTTT
T ss_pred CCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccC-Chhhcc
Confidence 443322 5677777777777666666677777777777777777666666666777777777777776633 345666
Q ss_pred ccccceEEcccccccCCcCchhhc------CCccceeeccccccCC--CCCccccCCCCCCcEEcCCCC
Q 002069 287 LKSLLHLQLNYNTLSGSIPLSLGS------LTNLATLYFSTNALSG--SIPNEITNLRSLSDLQLSENT 347 (973)
Q Consensus 287 l~~L~~L~l~~n~l~~~~~~~~~~------l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~N~ 347 (973)
+++|++|++++|++++..+..|.. .+.++.|++++|.+.. ..|..|..+.+++.++|++|+
T Consensus 262 l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 677777777777776655555543 2566667777776643 455666666777777776663
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=317.58 Aligned_cols=245 Identities=16% Similarity=0.124 Sum_probs=186.2
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCc-----chhhHHHHHHHHHHhhcCC----------------
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPG-----EMACQQEFLNEGNALTKIR---------------- 758 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~---------------- 758 (973)
.++|++.+.||+|+||+||+|+. +|+.||||++...... .....+.+.+|+.+++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999987 7899999999754321 2223477888888888775
Q ss_pred ----------CCceeeeceeeec-------------cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHH
Q 002069 759 ----------HRNIVKFYGFCSH-------------ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADA 815 (973)
Q Consensus 759 ----------h~niv~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~ 815 (973)
||||+++++++.+ .+..++||||+++|++.+.+.+ ..+++.+++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 5555555555544 6789999999999977666643 357899999999999999
Q ss_pred HHHHh-hCCCCCeEeecCCCCCeeecCCC--------------------ceEEecccccccccCCCCcccccccccCccc
Q 002069 816 LLYMH-TNCFPPIVHRDISSKNVLLNLEY--------------------EAHVSDFGISKFLKLGLSNRTELAGTFGYIA 874 (973)
Q Consensus 816 l~~LH-~~~~~~i~H~Dlk~~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~a 874 (973)
|+||| +. +|+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a 245 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence 99999 88 999999999999999887 8999999999876532 3479999999
Q ss_pred ccccccCCCCCccchHHHHHH-HHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcc
Q 002069 875 PELAYTMKVTEKCDVYSFGVL-ALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISC 953 (973)
Q Consensus 875 PE~~~~~~~~~~~Dv~slG~~-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 953 (973)
||++.+.. +.++||||+|++ .+++++|..||...... ........... ..............+..+.+++.+|
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~----~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~dli~~~ 319 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL----HYLTDKMLKQM-TFKTKCNTPAMKQIKRKIQEFHRTM 319 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH----HHHHHHHHHTC-CCSSCCCSHHHHHHHHHHHHHHHHG
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh----hHHHHhhhhhh-ccCcccchhhhhhcCHHHHHHHHHH
Confidence 99998776 889999998777 78888999998632110 00011111111 1111122223345677899999999
Q ss_pred cCCCCCCCCCHHHHH
Q 002069 954 LDESPTSRPTMQKVS 968 (973)
Q Consensus 954 l~~dP~~RPs~~ev~ 968 (973)
|+.| |++|++
T Consensus 320 L~~d-----sa~e~l 329 (336)
T 2vuw_A 320 LNFS-----SATDLL 329 (336)
T ss_dssp GGSS-----SHHHHH
T ss_pred hccC-----CHHHHH
Confidence 9976 999998
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=307.07 Aligned_cols=246 Identities=29% Similarity=0.465 Sum_probs=122.5
Q ss_pred cEEeCCCCCCCC--CCCcccCCCCCCCEEECCC-CcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEc
Q 002069 3 KVLGLSFNQFSG--SIPPEIGHLTHLKLLSFSK-NQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDI 79 (973)
Q Consensus 3 ~~L~l~~~~l~~--~~p~~~~~l~~L~~L~l~~-n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l 79 (973)
+.|+|++|+++| .+|+.++.+++|++|+|++ |.+.+.+|..|+.+++|++|+|++|++++.+|..|+++++|++|++
T Consensus 53 ~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 132 (313)
T 1ogq_A 53 NNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132 (313)
T ss_dssp EEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEEC
T ss_pred EEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeC
Confidence 445555555544 4555555555555555552 4444444555555555555555555554444555555555555555
Q ss_pred cCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCC-ccceeecccccccccCcccccccCCCCceecccCCCCC
Q 002069 80 GNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLT-NLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSG 158 (973)
Q Consensus 80 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 158 (973)
++|++++.+|..++.+++|++|+|++|++++.+|..++.++ +|++|++++|++++..|..|+.++ |++|++++|.+++
T Consensus 133 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~ 211 (313)
T 1ogq_A 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEG 211 (313)
T ss_dssp CSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEE
T ss_pred CCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccC
Confidence 55555444455555555555555555555444455555544 455555555555444455555444 5555555555544
Q ss_pred CCCccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccc
Q 002069 159 AIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGN 238 (973)
Q Consensus 159 ~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 238 (973)
..|..|..+++|+.|++++|++++.+|. +..+++|++|++++|++++..+..|..+++|+.|++++|++++..|.. ..
T Consensus 212 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~ 289 (313)
T 1ogq_A 212 DASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GN 289 (313)
T ss_dssp CCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TT
T ss_pred cCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-cc
Confidence 4444455555555555555555433332 444455555555555554444444555555555555555554443433 44
Q ss_pred cccccceeccccc
Q 002069 239 LKSLLALQLNYNT 251 (973)
Q Consensus 239 l~~L~~L~L~~N~ 251 (973)
+++|+.|++++|+
T Consensus 290 l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 290 LQRFDVSAYANNK 302 (313)
T ss_dssp GGGSCGGGTCSSS
T ss_pred ccccChHHhcCCC
Confidence 4555555555554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=5.7e-36 Score=347.56 Aligned_cols=381 Identities=23% Similarity=0.159 Sum_probs=208.4
Q ss_pred ccccceeeecccccCCCCCcc-ccccCccceeeccccccccc----cccccCCCCcccEEecCCcccCCCCCccc-cccc
Q 002069 167 LTNLVTLYIGINALSGSIPNE-IGNLKSLSDLRLDYNTLSGS----ILYSFGNLTKLEILYLDVNALSGLIPNEI-GNLK 240 (973)
Q Consensus 167 l~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~~~-~~l~ 240 (973)
+++|++|++++|+++...... +..+++|++|++++|+++.. .+..+..+++|++|++++|.+++..+..+ ..++
T Consensus 2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~ 81 (461)
T 1z7x_W 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ 81 (461)
T ss_dssp CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence 356788888888877433222 66778888888888887743 23456667788888888887765333333 2344
Q ss_pred ----cccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhc-----C
Q 002069 241 ----SLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGS-----L 311 (973)
Q Consensus 241 ----~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-----l 311 (973)
+|++|+|++|+++.... ...+..+..+++|++|++++|.+++..+..+.. .
T Consensus 82 ~~~~~L~~L~L~~n~i~~~~~--------------------~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~ 141 (461)
T 1z7x_W 82 TPSCKIQKLSLQNCCLTGAGC--------------------GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ 141 (461)
T ss_dssp STTCCCCEEECTTSCCBGGGH--------------------HHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTT
T ss_pred hCCCceeEEEccCCCCCHHHH--------------------HHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCC
Confidence 57777777777653110 012344445555555555555554332222221 3
Q ss_pred CccceeeccccccCCCC----CccccCCCCCCcEEcCCCCCCCcchhccC-----CCCCCcEEEccCCcccCC----CCc
Q 002069 312 TNLATLYFSTNALSGSI----PNEITNLRSLSDLQLSENTLNGSIPLALG-----NLTKLVSLDLSINKLSGS----IPL 378 (973)
Q Consensus 312 ~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~i~~~----~~~ 378 (973)
++|++|++++|.+++.. +..+..+++|++|++++|.+++..+..+. ..++|++|++++|.+++. .+.
T Consensus 142 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 221 (461)
T 1z7x_W 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 221 (461)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHH
T ss_pred CcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHH
Confidence 34555555555555322 33344455555555555555433333322 234566666666655542 244
Q ss_pred ccccccccchhcccccccccCC-----CcccCCCCCCCEEEccCCCCCCC----cchhhhhhcccceEEEeeCccccccc
Q 002069 379 SFASLTSLTTLYLYENSLCDSI-----PKEIGDMKSLSILDLSSNKLNGS----IPLSLANLTNSLKVLYLSSNHIVGEI 449 (973)
Q Consensus 379 ~~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~~~~~L~~L~L~~n~l~~~~ 449 (973)
.+..+++|++|++++|++++.. +..+..+++|++|++++|++++. ++..+... ++|++|++++|.+++..
T Consensus 222 ~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~-~~L~~L~Ls~n~i~~~~ 300 (461)
T 1z7x_W 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK-ESLKELSLAGNELGDEG 300 (461)
T ss_dssp HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHC-TTCCEEECTTCCCHHHH
T ss_pred HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhC-CCcceEECCCCCCchHH
Confidence 4445555666666666554322 22223456666666666666532 23333332 25666666666665433
Q ss_pred CCCCC-----CCcccceeeccCCccCCC----CCcccccccccccccccccccccccCccccc-----cccccEEeecCc
Q 002069 450 PLGHG-----KFSSLIQLILNNNELSGQ----LSPELGSLNQLEYLDLSANTFHNSIPESLGN-----LVKLHYLNLSNN 515 (973)
Q Consensus 450 ~~~~~-----~~~~L~~L~l~~N~l~~~----~~~~l~~l~~L~~L~Ls~N~i~~~~~~~l~~-----l~~L~~L~L~~N 515 (973)
+..+. ..++|++|++++|.+++. ++..+..+++|++|++++|.+++..+..+.. .++|++|+|++|
T Consensus 301 ~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n 380 (461)
T 1z7x_W 301 ARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 380 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred HHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCC
Confidence 32221 124666666666666543 3444555677777777777776554444432 456777777777
Q ss_pred cCCC----CCCcccccccccCeecccccccCCCcchhhcc-----cccccccccccccccCc
Q 002069 516 QFSQ----KIPNPIEKLIHLSELDLSYKIFGEEIPSQVCS-----MQSLEKLNLSHNNLSGS 568 (973)
Q Consensus 516 ~l~~----~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~-----l~~L~~L~L~~N~l~~~ 568 (973)
++++ .++..+..+++|++|++++|.|++.+...+.. ...|+.|++.++.+...
T Consensus 381 ~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~ 442 (461)
T 1z7x_W 381 DVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 442 (461)
T ss_dssp CCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred CCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHH
Confidence 7765 45555666667777777777666554444331 12355555555554433
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-35 Score=343.98 Aligned_cols=355 Identities=19% Similarity=0.172 Sum_probs=191.4
Q ss_pred CCCCeeeccCCcCCCCCCC-cccCCCCCcEEEccCCcCcc----cCCccccCccccceeeccCCcCCCCCCCcc-ccCC-
Q 002069 48 SSLNGLSLYSNFLKGSIPP-SLGNLTSLIYIDIGNNLLSG----SIPNEVGSLKSLSDLRLSNNSLNGSIPSSL-GNLT- 120 (973)
Q Consensus 48 ~~L~~L~l~~n~~~~~~p~-~~~~l~~L~~L~l~~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~-~~l~- 120 (973)
++|++|++++|+++..... .+..+++|++|++++|.++. .+|..+..+++|++|+|++|++....+..+ ..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 4577788887777632222 26667778888888877763 345566667777777777777764323222 2244
Q ss_pred ---ccceeecccccccc----cCcccccccCCCCceecccCCCCCCCCcccc-----CccccceeeecccccCCCC----
Q 002069 121 ---NLVTLYLHMNALSG----SIPDEIGNLKFLSDLQVSYNTLSGAIPFSLG-----NLTNLVTLYIGINALSGSI---- 184 (973)
Q Consensus 121 ---~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~-----~l~~L~~L~l~~n~l~~~~---- 184 (973)
+|++|+|++|+++. .+|..+.++++|++|++++|.+++..+..+. ..++|++|++++|++++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 57777777777763 3466677777777777777776543332222 2345666777666666422
Q ss_pred CccccccCccceeeccccccccccccccC-----CCCcccEEecCCcccCCC----CCccccccccccceecccccccCC
Q 002069 185 PNEIGNLKSLSDLRLDYNTLSGSILYSFG-----NLTKLEILYLDVNALSGL----IPNEIGNLKSLLALQLNYNTLSGS 255 (973)
Q Consensus 185 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~ 255 (973)
+..+..+++|++|++++|.+....+..+. .+++|++|++++|.+++. .+..+..+++|++|++++|.++..
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~ 242 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence 44455556666666666666544433332 244666666666666543 234444555555555555555321
Q ss_pred CCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCC----cCchhhcCCccceeeccccccCCCCCcc
Q 002069 256 IPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGS----IPLSLGSLTNLATLYFSTNALSGSIPNE 331 (973)
Q Consensus 256 ~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 331 (973)
... .+....+..+++|++|++++|.+++. ++..+..+++|++|++++|.+++..+..
T Consensus 243 ~~~-------------------~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~ 303 (461)
T 1z7x_W 243 GMA-------------------ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 303 (461)
T ss_dssp HHH-------------------HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHH
T ss_pred HHH-------------------HHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHH
Confidence 100 00112222455666666666665532 3444455556666666666554332222
Q ss_pred ccC-----CCCCCcEEcCCCCCCCc----chhccCCCCCCcEEEccCCcccCCCCccccc-----ccccchhcccccccc
Q 002069 332 ITN-----LRSLSDLQLSENTLNGS----IPLALGNLTKLVSLDLSINKLSGSIPLSFAS-----LTSLTTLYLYENSLC 397 (973)
Q Consensus 332 ~~~-----l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~-----l~~L~~L~L~~N~l~ 397 (973)
+.. .++|++|++++|.+++. ++..+..+++|++|+|++|++++..+..+.. .++|++|++++|+++
T Consensus 304 l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~ 383 (461)
T 1z7x_W 304 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383 (461)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred HHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence 222 14555566665555543 2344445555555565555555433333322 334555555555444
Q ss_pred c----CCCcccCCCCCCCEEEccCCCCC
Q 002069 398 D----SIPKEIGDMKSLSILDLSSNKLN 421 (973)
Q Consensus 398 ~----~~~~~~~~l~~L~~L~Ls~N~l~ 421 (973)
+ .++..+..+++|++|++++|+++
T Consensus 384 ~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 384 DSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp HHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred hhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 3 33444444455555555555544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-30 Score=280.81 Aligned_cols=248 Identities=23% Similarity=0.249 Sum_probs=208.1
Q ss_pred cEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCC--CCCCcccCCCCCcEEEcc
Q 002069 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKG--SIPPSLGNLTSLIYIDIG 80 (973)
Q Consensus 3 ~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~--~~p~~~~~l~~L~~L~l~ 80 (973)
+.++.++++++ .+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|+++. ..|..+..+++|++|+++
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 46788888887 7888654 689999999999985444457889999999999999872 236777788999999999
Q ss_pred CCcCcccCCccccCccccceeeccCCcCCCCCC-CccccCCccceeecccccccccCcccccccCCCCceecccCCCCC-
Q 002069 81 NNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIP-SSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSG- 158 (973)
Q Consensus 81 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~- 158 (973)
+|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..|..|.++++|++|++++|.+++
T Consensus 87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 165 (306)
T 2z66_A 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165 (306)
T ss_dssp SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence 99988 678888889999999999999885443 578889999999999999887788888889999999999998875
Q ss_pred CCCccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccc
Q 002069 159 AIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGN 238 (973)
Q Consensus 159 ~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 238 (973)
..|..+..+++|++|++++|++++..|..+..+++|++|++++|+++++++..|..+++|+.|++++|++++..|..+..
T Consensus 166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 245 (306)
T 2z66_A 166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 245 (306)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCC
T ss_pred cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHh
Confidence 57888888899999999999888777888888888999999999888888778888888999999999888888888888
Q ss_pred cc-cccceecccccccC
Q 002069 239 LK-SLLALQLNYNTLSG 254 (973)
Q Consensus 239 l~-~L~~L~L~~N~l~~ 254 (973)
++ +|++|+|++|.++.
T Consensus 246 ~~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 246 FPSSLAFLNLTQNDFAC 262 (306)
T ss_dssp CCTTCCEEECTTCCEEC
T ss_pred hhccCCEEEccCCCeec
Confidence 84 88888888888864
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=279.05 Aligned_cols=227 Identities=22% Similarity=0.271 Sum_probs=188.7
Q ss_pred CCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceee
Q 002069 23 LTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLR 102 (973)
Q Consensus 23 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ 102 (973)
..++++|+|++|+++ .+|..++++++|++|+|++|+++ .+|..++++++|++|+|++|+++ .+|..++.+++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 467888888888887 66777888888888888888887 78888888888888888888887 7788888888888888
Q ss_pred ccCCcCCCCCCCcccc---------CCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCcccccee
Q 002069 103 LSNNSLNGSIPSSLGN---------LTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTL 173 (973)
Q Consensus 103 L~~n~l~~~~p~~~~~---------l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L 173 (973)
|++|++.+.+|..++. +++|++|+|++|+++ .+|..|+++++|++|++++|+++ .+|..+..+++|+.|
T Consensus 157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L 234 (328)
T 4fcg_A 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEEL 234 (328)
T ss_dssp EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEE
T ss_pred CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEE
Confidence 8887777778877654 888888888888888 78888888888888888888888 456678888888888
Q ss_pred eecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceeccccccc
Q 002069 174 YIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLS 253 (973)
Q Consensus 174 ~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (973)
++++|.+.+.+|..++++++|++|++++|.+.+..+..|.++++|+.|+|++|.+.+..|..+.++++|+.+++..+.+.
T Consensus 235 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp ECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred ECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 88888888888888888888888888888888888888888888888999888888888888888888888888877665
Q ss_pred C
Q 002069 254 G 254 (973)
Q Consensus 254 ~ 254 (973)
.
T Consensus 315 ~ 315 (328)
T 4fcg_A 315 Q 315 (328)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-32 Score=325.29 Aligned_cols=399 Identities=16% Similarity=0.102 Sum_probs=255.4
Q ss_pred CccccceeeecccccCCCCCcccccc-C-ccceeeccccc-ccccc-ccccCCCCcccEEecCCcccCCCCC----cccc
Q 002069 166 NLTNLVTLYIGINALSGSIPNEIGNL-K-SLSDLRLDYNT-LSGSI-LYSFGNLTKLEILYLDVNALSGLIP----NEIG 237 (973)
Q Consensus 166 ~l~~L~~L~l~~n~l~~~~p~~~~~l-~-~L~~L~L~~N~-l~~~~-~~~~~~l~~L~~L~L~~n~i~~~~~----~~~~ 237 (973)
.+++|++|+|++|.+++..+..+... + +|++|+|++|. ++... .....++++|++|+|++|.+++... ..+.
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~ 189 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence 45666666666666554444445442 3 37777776665 22111 1112356777777777777665422 2344
Q ss_pred ccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCcccee
Q 002069 238 NLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATL 317 (973)
Q Consensus 238 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 317 (973)
++++|+.|++++|.+++.... .....+.++++|++|++++|.+.+ ++..+..+++|++|
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~--------------------~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L 248 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPK--------------------DLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEF 248 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHH--------------------HHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEE
T ss_pred cCCCccEEEeeccCCCccCHH--------------------HHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhh
Confidence 566777777777766522111 123345566777888888777774 55677777888888
Q ss_pred eccccccC---CCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCC-cccccccccchhcccc
Q 002069 318 YFSTNALS---GSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIP-LSFASLTSLTTLYLYE 393 (973)
Q Consensus 318 ~L~~n~l~---~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~L~~ 393 (973)
+++.+... ...+..+..+++|+.|+++++... ..|..+..+++|++|+|++|.+++... ..+..+++|++|+++
T Consensus 249 ~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~- 326 (592)
T 3ogk_B 249 CGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR- 326 (592)
T ss_dssp EECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-
T ss_pred cccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-
Confidence 87753322 233455667778888888775443 566677777888888888887664333 235677788888887
Q ss_pred ccccc-CCCcccCCCCCCCEEEcc-----------CCCCCCCcchhhhhhcccceEEEeeCcccccccCCCCCC-Ccccc
Q 002069 394 NSLCD-SIPKEIGDMKSLSILDLS-----------SNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGK-FSSLI 460 (973)
Q Consensus 394 N~l~~-~~~~~~~~l~~L~~L~Ls-----------~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~-~~~L~ 460 (973)
|.+++ ..+..+..+++|++|+++ .|.+++.....+....++|++|+++.|.+++.....++. +++|+
T Consensus 327 ~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~ 406 (592)
T 3ogk_B 327 NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLC 406 (592)
T ss_dssp GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCC
T ss_pred CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCc
Confidence 44433 233333567788888888 356664434444443457888888888887766555544 67888
Q ss_pred eeecc----CCccCCC-----CCcccccccccccccccccc--cccccCcccc-ccccccEEeecCccCCCC-CCccccc
Q 002069 461 QLILN----NNELSGQ-----LSPELGSLNQLEYLDLSANT--FHNSIPESLG-NLVKLHYLNLSNNQFSQK-IPNPIEK 527 (973)
Q Consensus 461 ~L~l~----~N~l~~~-----~~~~l~~l~~L~~L~Ls~N~--i~~~~~~~l~-~l~~L~~L~L~~N~l~~~-~~~~~~~ 527 (973)
+|+++ .|.+++. .+..+..+++|++|+++.|. +++..+..+. .+++|++|+|++|++++. .+..+..
T Consensus 407 ~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 486 (592)
T 3ogk_B 407 DFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRG 486 (592)
T ss_dssp EEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTC
T ss_pred EEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhc
Confidence 88885 6677753 22335668889999987543 6655555554 378899999999988763 3445577
Q ss_pred ccccCeecccccccCCCcchh-hcccccccccccccccccCccchhhh-ccccccEEeCcCC
Q 002069 528 LIHLSELDLSYKIFGEEIPSQ-VCSMQSLEKLNLSHNNLSGSISRCFE-EMHWLSCIDISYN 587 (973)
Q Consensus 528 l~~L~~L~ls~n~i~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~l~l~~N 587 (973)
+++|+.|++++|.+++.+... +..+++|++|+|++|++++.+...+. .++++....+..+
T Consensus 487 ~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 487 CPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp CTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred CcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 888999999998887654444 34688899999999998877655543 4677766666554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.4e-30 Score=284.02 Aligned_cols=280 Identities=20% Similarity=0.166 Sum_probs=134.2
Q ss_pred CeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccc
Q 002069 51 NGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMN 130 (973)
Q Consensus 51 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 130 (973)
...++++|+++ .+|..+. ++|++|++++|++++..+..+..+++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 34 ~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (353)
T 2z80_A 34 GICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN 110 (353)
T ss_dssp SEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred eEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCC
Confidence 33444444444 3444332 24444444444444333334444444444444444444333444444444445555444
Q ss_pred cccccCcccccccCCCCceecccCCCCCCCC-ccccCccccceeeeccc-ccCCCCCccccccCccceeecccccccccc
Q 002069 131 ALSGSIPDEIGNLKFLSDLQVSYNTLSGAIP-FSLGNLTNLVTLYIGIN-ALSGSIPNEIGNLKSLSDLRLDYNTLSGSI 208 (973)
Q Consensus 131 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~l~~n-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 208 (973)
++++..+..|+++++|++|++++|++++..+ ..+..+++|++|++++| .++...|..+.++++|++|++++|+++++.
T Consensus 111 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 190 (353)
T 2z80_A 111 YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYE 190 (353)
T ss_dssp CCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEEC
T ss_pred cCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccC
Confidence 4443222234444555555555554442222 24445555555555554 244333444555555555555555555555
Q ss_pred ccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhcccc
Q 002069 209 LYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLK 288 (973)
Q Consensus 209 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~ 288 (973)
+..|..+++|++|++++|.++.+.+..+..+++|+.|++++|++++..+..+.. .....
T Consensus 191 ~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~---------------------~~~~~ 249 (353)
T 2z80_A 191 PKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST---------------------GETNS 249 (353)
T ss_dssp TTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC---------------------------CCC
T ss_pred HHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc---------------------ccccc
Confidence 555555555555555555554443333344555566666666555433322111 11223
Q ss_pred ccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEcc
Q 002069 289 SLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLS 368 (973)
Q Consensus 289 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 368 (973)
.++.++++++.+++ |.+. .+|..+..+++|++|+|++|+++...+..|.++++|++|+|+
T Consensus 250 ~l~~l~L~~~~l~~-------------------~~l~-~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~ 309 (353)
T 2z80_A 250 LIKKFTFRNVKITD-------------------ESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLH 309 (353)
T ss_dssp CCCEEEEESCBCCH-------------------HHHH-HHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred hhhccccccccccC-------------------cchh-hhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEee
Confidence 34444444444332 1111 234455666666666666666664444445667777777777
Q ss_pred CCcccC
Q 002069 369 INKLSG 374 (973)
Q Consensus 369 ~N~i~~ 374 (973)
+|++.+
T Consensus 310 ~N~~~~ 315 (353)
T 2z80_A 310 TNPWDC 315 (353)
T ss_dssp SSCBCC
T ss_pred CCCccC
Confidence 777664
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-30 Score=284.88 Aligned_cols=274 Identities=21% Similarity=0.206 Sum_probs=155.9
Q ss_pred EeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcC
Q 002069 5 LGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLL 84 (973)
Q Consensus 5 L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l 84 (973)
.|+++++++ .+|..+. ++|++|++++|++++..+..|..+++|++|++++|++++..|..|+++++|++|++++|++
T Consensus 36 c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 112 (353)
T 2z80_A 36 CKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112 (353)
T ss_dssp EECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred eeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcC
Confidence 456666665 5666544 3666666666666655444666666666666666666655555666666666666666666
Q ss_pred cccCCccccCccccceeeccCCcCCCCCCC--ccccCCccceeecccc-cccccCcccccccCCCCceecccCCCCCCCC
Q 002069 85 SGSIPNEVGSLKSLSDLRLSNNSLNGSIPS--SLGNLTNLVTLYLHMN-ALSGSIPDEIGNLKFLSDLQVSYNTLSGAIP 161 (973)
Q Consensus 85 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 161 (973)
++..+..++.+++|++|++++|+++ .+|. .+.++++|++|++++| .++...|..|+++++|++|++++|++++..|
T Consensus 113 ~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 191 (353)
T 2z80_A 113 SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP 191 (353)
T ss_dssp SSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECT
T ss_pred CcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCH
Confidence 6322233666666666666666666 3443 5666666666666666 3554445556666666666666666665556
Q ss_pred ccccCccccceeeecccccCCCCCcc-ccccCccceeeccccccccccccccC---CCCcccEEecCCcccCCCCCcccc
Q 002069 162 FSLGNLTNLVTLYIGINALSGSIPNE-IGNLKSLSDLRLDYNTLSGSILYSFG---NLTKLEILYLDVNALSGLIPNEIG 237 (973)
Q Consensus 162 ~~l~~l~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~L~~n~i~~~~~~~~~ 237 (973)
..+..+++|++|++++|+++. +|.. +..+++|++|++++|++++..+..+. ....++.++++++.+++.
T Consensus 192 ~~l~~l~~L~~L~l~~n~l~~-~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~------ 264 (353)
T 2z80_A 192 KSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE------ 264 (353)
T ss_dssp TTTTTCSEEEEEEEECSCSTT-HHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHH------
T ss_pred HHHhccccCCeecCCCCcccc-chhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCc------
Confidence 666666666666666666652 3332 33456666666666666554433322 233444444444444321
Q ss_pred ccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCC
Q 002069 238 NLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGS 303 (973)
Q Consensus 238 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~ 303 (973)
.+. .+|..+..+++|+.|++++|.++.++...|..+++|++|++++|.+.+.
T Consensus 265 -------------~l~-~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~ 316 (353)
T 2z80_A 265 -------------SLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 316 (353)
T ss_dssp -------------HHH-HHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred -------------chh-hhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCc
Confidence 111 1233444445555555555555544444456677777888888877753
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-29 Score=269.85 Aligned_cols=255 Identities=22% Similarity=0.190 Sum_probs=189.4
Q ss_pred cEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCC
Q 002069 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNN 82 (973)
Q Consensus 3 ~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n 82 (973)
++++.++++++ .+|..+ .++|++|+|++|++++..|..|..+++|++|++++|++++..|..|+.+++|++|++++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 45778888887 677654 467888888888888766677888888888888888888666778888888888888888
Q ss_pred c-CcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCC
Q 002069 83 L-LSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIP 161 (973)
Q Consensus 83 ~-l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 161 (973)
. ++...|..+..+++|++|++++|++++..|..+.++++|++|++++|++++..+..|+++++|++|++++|++++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 6 665557778888888888888888886667778888888888888888876555667888888888888888876666
Q ss_pred ccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCcccccccc
Q 002069 162 FSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241 (973)
Q Consensus 162 ~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~ 241 (973)
..|..+++|+.|++++|++++..|..+.++++|++|++++|+++++++..|..+++|+.|++++|.+....+. ..-...
T Consensus 171 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~ 249 (285)
T 1ozn_A 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAW 249 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHH
T ss_pred HHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHHHHH
Confidence 6677788888888888888776677777788888888888888777777777788888888888877654221 122234
Q ss_pred ccceecccccccCCCCcccC
Q 002069 242 LLALQLNYNTLSGSIPCSFG 261 (973)
Q Consensus 242 L~~L~L~~N~l~~~~~~~~~ 261 (973)
++.+..+.+.+....|..+.
T Consensus 250 l~~~~~~~~~~~c~~p~~l~ 269 (285)
T 1ozn_A 250 LQKFRGSSSEVPCSLPQRLA 269 (285)
T ss_dssp HHHCCSEECCCBEEESGGGT
T ss_pred HHhcccccCccccCCchHhC
Confidence 55556666666655555443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-32 Score=324.03 Aligned_cols=395 Identities=14% Similarity=0.075 Sum_probs=206.0
Q ss_pred CCCCCcEEEccCCcCcccCCccccCc--cccceeeccCCcC-CC-CCCCccccCCccceeeccccccccc----Cccccc
Q 002069 70 NLTSLIYIDIGNNLLSGSIPNEVGSL--KSLSDLRLSNNSL-NG-SIPSSLGNLTNLVTLYLHMNALSGS----IPDEIG 141 (973)
Q Consensus 70 ~l~~L~~L~l~~n~l~~~~p~~~~~l--~~L~~L~L~~n~l-~~-~~p~~~~~l~~L~~L~L~~n~l~~~----~p~~~~ 141 (973)
.+++|++|+|++|.+++..+..+..+ .+|++|+|++|.- .. .++....++++|++|+|++|.+++. ++..+.
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~ 189 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence 56777777777777765555555553 3477777777652 10 1222234667777777777776544 333455
Q ss_pred ccCCCCceecccCCCCC----CCCccccCccccceeeecccccCCCCCccccccCccceeeccccccc---cccccccCC
Q 002069 142 NLKFLSDLQVSYNTLSG----AIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLS---GSILYSFGN 214 (973)
Q Consensus 142 ~l~~L~~L~l~~N~l~~----~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~~~~~~~ 214 (973)
++++|++|++++|.+++ .++..+.++++|+.|++++|.+.+ +|..+.++++|++|+++..... ......+..
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~ 268 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVF 268 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCC
T ss_pred cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhc
Confidence 67777777777777762 233344566777777777777773 5667777777777777643222 122345566
Q ss_pred CCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEE
Q 002069 215 LTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQ 294 (973)
Q Consensus 215 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~ 294 (973)
+++|+.|+++++... ..|..+..+++|++|+|++|.++.... ...+..+++|++|+
T Consensus 269 ~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~-----------------------~~~~~~~~~L~~L~ 324 (592)
T 3ogk_B 269 PRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDH-----------------------CTLIQKCPNLEVLE 324 (592)
T ss_dssp CTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHH-----------------------HHHHTTCTTCCEEE
T ss_pred cccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHH-----------------------HHHHHhCcCCCEEe
Confidence 777777777765433 235666677777777777776542211 12234445555555
Q ss_pred cccccccC-CcCchhhcCCccceeeccc-----------cccCCC-CCccccCCCCCCcEEcCCCCCCCcchhccCC-CC
Q 002069 295 LNYNTLSG-SIPLSLGSLTNLATLYFST-----------NALSGS-IPNEITNLRSLSDLQLSENTLNGSIPLALGN-LT 360 (973)
Q Consensus 295 l~~n~l~~-~~~~~~~~l~~L~~L~L~~-----------n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~ 360 (973)
++ +.+.+ ..+..+..+++|++|++++ |.+++. .+..+..+++|++|+++.|.+++..+..+.. ++
T Consensus 325 L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~ 403 (592)
T 3ogk_B 325 TR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLK 403 (592)
T ss_dssp EE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCC
T ss_pred cc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCC
Confidence 54 22221 1222223445555555552 333321 1111233455555555555555444444433 55
Q ss_pred CCcEEEcc----CCcccCC-----CCcccccccccchhccccc--ccccCCCcccC-CCCCCCEEEccCCCCCCCcchhh
Q 002069 361 KLVSLDLS----INKLSGS-----IPLSFASLTSLTTLYLYEN--SLCDSIPKEIG-DMKSLSILDLSSNKLNGSIPLSL 428 (973)
Q Consensus 361 ~L~~L~Ls----~N~i~~~-----~~~~~~~l~~L~~L~L~~N--~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~ 428 (973)
+|+.|+++ .|.+++. .+..+.++++|+.|+++.| .+++..+..+. .+++|++|+|++|++++.....+
T Consensus 404 ~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~ 483 (592)
T 3ogk_B 404 NLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEF 483 (592)
T ss_dssp SCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHH
T ss_pred CCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHH
Confidence 55555554 4444432 1122344555555555432 23332222222 24556666666666553222222
Q ss_pred hhhcccceEEEeeCccccccc-CCCCCCCcccceeeccCCccCCCCCcccc-cccccccccccc
Q 002069 429 ANLTNSLKVLYLSSNHIVGEI-PLGHGKFSSLIQLILNNNELSGQLSPELG-SLNQLEYLDLSA 490 (973)
Q Consensus 429 ~~~~~~L~~L~L~~n~l~~~~-~~~~~~~~~L~~L~l~~N~l~~~~~~~l~-~l~~L~~L~Ls~ 490 (973)
....++|++|++++|.+++.. +.....+++|++|++++|++++.....+. .++.+....+..
T Consensus 484 ~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~ 547 (592)
T 3ogk_B 484 SRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPS 547 (592)
T ss_dssp HTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECC
T ss_pred HhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecC
Confidence 222235666666666654332 22223455666666666666544333332 344444443333
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=275.27 Aligned_cols=246 Identities=24% Similarity=0.223 Sum_probs=210.7
Q ss_pred CCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCC-cccCCCCCcEEEccCCcCcc--cCCccccCccccceee
Q 002069 26 LKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPP-SLGNLTSLIYIDIGNNLLSG--SIPNEVGSLKSLSDLR 102 (973)
Q Consensus 26 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~-~~~~l~~L~~L~l~~n~l~~--~~p~~~~~l~~L~~L~ 102 (973)
-+.++.+++.++ .+|..+. ++|++|++++|+++ .+|. .|+++++|++|+|++|+++. ..|..+..+++|++|+
T Consensus 9 ~~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~ 84 (306)
T 2z66_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84 (306)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEE
T ss_pred CCEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEE
Confidence 368999999998 5777654 79999999999999 5554 57999999999999999973 2367778899999999
Q ss_pred ccCCcCCCCCCCccccCCccceeecccccccccCc-ccccccCCCCceecccCCCCCCCCccccCccccceeeecccccC
Q 002069 103 LSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIP-DEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181 (973)
Q Consensus 103 L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~ 181 (973)
|++|+++ .+|..+.++++|++|++++|++++..+ ..+.++++|++|++++|.+++..|..+.++++|++|++++|.++
T Consensus 85 Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 163 (306)
T 2z66_A 85 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 163 (306)
T ss_dssp CCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEG
T ss_pred CCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccc
Confidence 9999998 688889999999999999999985544 57999999999999999999888888999999999999999998
Q ss_pred C-CCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCccc
Q 002069 182 G-SIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSF 260 (973)
Q Consensus 182 ~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 260 (973)
+ ..|..+..+++|++|++++|+++++.+..|..+++|+.|++++|+++++.+..+..+++|+.|++++|++++..+..+
T Consensus 164 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 243 (306)
T 2z66_A 164 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 243 (306)
T ss_dssp GGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSC
T ss_pred cccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHH
Confidence 6 578889999999999999999998888899999999999999999998888789999999999999999988777766
Q ss_pred CCcc-hhhhccCCCccc
Q 002069 261 GNLT-KLVISCLGTNAL 276 (973)
Q Consensus 261 ~~l~-~L~~l~l~~n~i 276 (973)
..++ +|+.+++++|.+
T Consensus 244 ~~~~~~L~~L~L~~N~~ 260 (306)
T 2z66_A 244 QHFPSSLAFLNLTQNDF 260 (306)
T ss_dssp CCCCTTCCEEECTTCCE
T ss_pred HhhhccCCEEEccCCCe
Confidence 6552 444444444444
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-29 Score=272.96 Aligned_cols=226 Identities=24% Similarity=0.285 Sum_probs=152.7
Q ss_pred CCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceee
Q 002069 47 LSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLY 126 (973)
Q Consensus 47 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 126 (973)
..+++.|+|++|+++ .+|..++++++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..++++++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 356666777777766 66666666777777777777766 66666666777777777777766 5666666777777777
Q ss_pred cccccccccCcccccc---------cCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCcccee
Q 002069 127 LHMNALSGSIPDEIGN---------LKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDL 197 (973)
Q Consensus 127 L~~n~l~~~~p~~~~~---------l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L 197 (973)
|++|.+.+.+|..++. +++|++|++++|+++ .+|..++.+++|++|++++|+++ .+|..+..+++|++|
T Consensus 157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L 234 (328)
T 4fcg_A 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEEL 234 (328)
T ss_dssp EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEE
T ss_pred CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEE
Confidence 7766666566665543 667777777777666 55666666777777777777766 355566666777777
Q ss_pred eccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccC
Q 002069 198 RLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALS 277 (973)
Q Consensus 198 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~ 277 (973)
++++|.+.+..+..|+++++|+.|++++|.+.+..|..+.++++|+.|+|++|++.+.+|..++++++|+.+.+..+.+.
T Consensus 235 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp ECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred ECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 77776666666666666777777777776666666666666777777777776666666666777776666666655544
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=284.88 Aligned_cols=245 Identities=22% Similarity=0.227 Sum_probs=154.9
Q ss_pred EEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCc
Q 002069 4 VLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNL 83 (973)
Q Consensus 4 ~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~ 83 (973)
.++.++++++ .+|..+. +++++|+|++|++++..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus 58 ~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 58 KVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 4556666665 5665544 466666666666666666666666666666666666665555666666666666666666
Q ss_pred CcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeeccc-ccccccCcccccccCCCCceecccCCCCCCCCc
Q 002069 84 LSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHM-NALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPF 162 (973)
Q Consensus 84 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 162 (973)
+++..+..|+.+++|++|+|++|+++...+..|.++++|++|++++ |.+....+..|.++++|++|++++|++++. |
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~- 212 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P- 212 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-
T ss_pred CCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-
Confidence 6644444566666666666666666644444666666666666666 344433334566666666666666666632 3
Q ss_pred cccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccc
Q 002069 163 SLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSL 242 (973)
Q Consensus 163 ~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 242 (973)
.+..+++|+.|++++|++++..|..|.++++|++|++++|+++++.+..|.++++|+.|+|++|+++++.+..|..+++|
T Consensus 213 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 292 (452)
T 3zyi_A 213 NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYL 292 (452)
T ss_dssp CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTC
T ss_pred cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCC
Confidence 35666666666666666666556666666666666666666666666666666666666666666666666666666666
Q ss_pred cceeccccccc
Q 002069 243 LALQLNYNTLS 253 (973)
Q Consensus 243 ~~L~L~~N~l~ 253 (973)
+.|+|++|.+.
T Consensus 293 ~~L~L~~Np~~ 303 (452)
T 3zyi_A 293 VELHLHHNPWN 303 (452)
T ss_dssp CEEECCSSCEE
T ss_pred CEEEccCCCcC
Confidence 66666666654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=283.72 Aligned_cols=244 Identities=23% Similarity=0.222 Sum_probs=119.0
Q ss_pred EEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCc
Q 002069 4 VLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNL 83 (973)
Q Consensus 4 ~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~ 83 (973)
.++.++++++ .+|+.+. +++++|+|++|++++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus 47 ~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 47 KVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp EEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred EEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 3444444554 4554433 345555555555554444455555555555555555553344445555555555555555
Q ss_pred CcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccc-cccccCcccccccCCCCceecccCCCCCCCCc
Q 002069 84 LSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMN-ALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPF 162 (973)
Q Consensus 84 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 162 (973)
++...+..|..+++|++|+|++|+++...+..|.++++|++|+|++| .+....+..|.++++|++|++++|.++ .+|
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~- 201 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP- 201 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-
T ss_pred CCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-
Confidence 55333334455555555555555554333334555555555555542 233222234555555555555555554 222
Q ss_pred cccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccc
Q 002069 163 SLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSL 242 (973)
Q Consensus 163 ~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 242 (973)
.+..+++|+.|+|++|++++..|..|.++++|++|+|++|+++++.+..|.++++|+.|+|++|+++++.+..|..+++|
T Consensus 202 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 281 (440)
T 3zyj_A 202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHL 281 (440)
T ss_dssp CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTC
T ss_pred ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCC
Confidence 24445555555555555554444455555555555555555554444455555555555555555554444444455555
Q ss_pred cceecccccc
Q 002069 243 LALQLNYNTL 252 (973)
Q Consensus 243 ~~L~L~~N~l 252 (973)
+.|+|++|.+
T Consensus 282 ~~L~L~~Np~ 291 (440)
T 3zyj_A 282 ERIHLHHNPW 291 (440)
T ss_dssp CEEECCSSCE
T ss_pred CEEEcCCCCc
Confidence 5555555544
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=264.97 Aligned_cols=226 Identities=26% Similarity=0.254 Sum_probs=204.8
Q ss_pred CCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccC
Q 002069 26 LKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSN 105 (973)
Q Consensus 26 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~ 105 (973)
-++++.+++.++ .+|..+ .++|++|++++|++++..|..|+.+++|++|++++|.+++..|..++.+++|++|++++
T Consensus 13 ~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 13 KVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp SCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 478999999998 567654 57999999999999966667899999999999999999977789999999999999999
Q ss_pred Cc-CCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCC
Q 002069 106 NS-LNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSI 184 (973)
Q Consensus 106 n~-l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~ 184 (973)
|+ +....|..+..+++|++|++++|++++..|..|.++++|++|++++|++++..+..|..+++|+.|++++|++++..
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 169 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence 97 88666889999999999999999999877889999999999999999999777778999999999999999999766
Q ss_pred CccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccC
Q 002069 185 PNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSG 254 (973)
Q Consensus 185 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 254 (973)
+..+..+++|++|++++|+++++.+..|..+++|+.|++++|.++++.+..+..+++|+.|++++|.+..
T Consensus 170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 239 (285)
T 1ozn_A 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccC
Confidence 6679999999999999999999889999999999999999999999877889999999999999999874
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=277.98 Aligned_cols=237 Identities=23% Similarity=0.250 Sum_probs=176.9
Q ss_pred CCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeecc
Q 002069 25 HLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLS 104 (973)
Q Consensus 25 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~ 104 (973)
..+.++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|++++..|..|..+++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 3567888888887 5676665 678888888888886666778888888888888888886666778888888888888
Q ss_pred CCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceeccc-CCCCCCCCccccCccccceeeecccccCCC
Q 002069 105 NNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSY-NTLSGAIPFSLGNLTNLVTLYIGINALSGS 183 (973)
Q Consensus 105 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~ 183 (973)
+|++++..+..|..+++|++|+|++|+++...+..|.++++|++|++++ |.++...+..|.++++|+.|++++|+++ .
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~ 199 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-E 199 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-S
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-c
Confidence 8888855555788888888888888888766666788888888888887 4455444556777888888888888877 4
Q ss_pred CCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCc
Q 002069 184 IPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNL 263 (973)
Q Consensus 184 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 263 (973)
+| .+..+++|++|+|++|+++++.+..|.++++|+.|+|++|+++++.+..|.++++|+.|+|++|++++..+..|..+
T Consensus 200 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 278 (440)
T 3zyj_A 200 IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278 (440)
T ss_dssp CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence 55 46777777777777777777777777777777777777777777777777777777777777777765555444443
Q ss_pred chh
Q 002069 264 TKL 266 (973)
Q Consensus 264 ~~L 266 (973)
++|
T Consensus 279 ~~L 281 (440)
T 3zyj_A 279 HHL 281 (440)
T ss_dssp TTC
T ss_pred cCC
Confidence 333
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=278.53 Aligned_cols=236 Identities=23% Similarity=0.254 Sum_probs=166.1
Q ss_pred CCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccC
Q 002069 26 LKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSN 105 (973)
Q Consensus 26 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~ 105 (973)
.+.++.+++.++ .+|..+. ++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|..+++|++|+|++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 466777777776 4666554 5777778887777766677777777778888877777766667777777777777777
Q ss_pred CcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceeccc-CCCCCCCCccccCccccceeeecccccCCCC
Q 002069 106 NSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSY-NTLSGAIPFSLGNLTNLVTLYIGINALSGSI 184 (973)
Q Consensus 106 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~ 184 (973)
|++++..+..|.++++|++|+|++|+++...+..|.++++|++|++++ |.++...+..|.++++|+.|++++|++++ +
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~ 211 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-M 211 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-C
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-c
Confidence 777755555677777777777777777755556677777777777777 44544444567777777777777777773 3
Q ss_pred CccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcc
Q 002069 185 PNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLT 264 (973)
Q Consensus 185 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 264 (973)
| .+..+++|++|+|++|+++++.+..|.++++|+.|++++|+++++.+..|.++++|+.|+|++|++++..+..|..++
T Consensus 212 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 290 (452)
T 3zyi_A 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290 (452)
T ss_dssp C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT
T ss_pred c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc
Confidence 4 466677777777777777777677777777777777777777776666777777777777777777655554444433
Q ss_pred hh
Q 002069 265 KL 266 (973)
Q Consensus 265 ~L 266 (973)
+|
T Consensus 291 ~L 292 (452)
T 3zyi_A 291 YL 292 (452)
T ss_dssp TC
T ss_pred CC
Confidence 33
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-29 Score=275.84 Aligned_cols=249 Identities=20% Similarity=0.198 Sum_probs=181.0
Q ss_pred cCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCC-CCCCCccc-------CCCCCcEEEccCCcCcccCCcc
Q 002069 20 IGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK-GSIPPSLG-------NLTSLIYIDIGNNLLSGSIPNE 91 (973)
Q Consensus 20 ~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~-~~~p~~~~-------~l~~L~~L~l~~n~l~~~~p~~ 91 (973)
++..++|++|++++|.+ .+|..+... |+.|+|++|++. +.+|..+. ++++|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 34566778888888887 567666654 777888888873 44666655 6778888888888887777776
Q ss_pred c--cCccccceeeccCCcCCCCCCCccccC-----CccceeecccccccccCcccccccCCCCceecccCCCCCC--CCc
Q 002069 92 V--GSLKSLSDLRLSNNSLNGSIPSSLGNL-----TNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGA--IPF 162 (973)
Q Consensus 92 ~--~~l~~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~ 162 (973)
+ +.+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|+.|+++++|++|++++|++.+. .|.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 5 7778888888888888754 7777776 7888888888888766667788888888888888877643 233
Q ss_pred cc--cCccccceeeecccccCCC--CC-ccccccCccceeeccccccccccc-cccCCCCcccEEecCCcccCCCCCccc
Q 002069 163 SL--GNLTNLVTLYIGINALSGS--IP-NEIGNLKSLSDLRLDYNTLSGSIL-YSFGNLTKLEILYLDVNALSGLIPNEI 236 (973)
Q Consensus 163 ~l--~~l~~L~~L~l~~n~l~~~--~p-~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~ 236 (973)
.+ ..+++|++|++++|++++. ++ ..+.++++|++|++++|++++..+ ..+..+++|++|+|++|+++.+ |..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~i-p~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQV-PKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSC-CSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChh-hhhc
Confidence 33 7778888888888887721 11 234566788888888888877553 4566678888888888888754 5445
Q ss_pred cccccccceecccccccCCCCcccCCcchhhhccCCCcccCc
Q 002069 237 GNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSS 278 (973)
Q Consensus 237 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~ 278 (973)
. ++|++|+|++|++++. |. +..+++|+.+++++|.++.
T Consensus 273 ~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp C--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred c--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 4 7788888888888766 44 7788888888888887764
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-27 Score=279.36 Aligned_cols=267 Identities=25% Similarity=0.279 Sum_probs=190.8
Q ss_pred CcEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccC
Q 002069 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGN 81 (973)
Q Consensus 2 l~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~ 81 (973)
+++|++++|+++ .+|..+. ++|++|+|++|.++ .+|. .+++|++|+|++|+++ .+|. .+++|++|+|++
T Consensus 42 l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~ 110 (622)
T 3g06_A 42 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFS 110 (622)
T ss_dssp CCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECS
T ss_pred CcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcC
Confidence 567888888887 7787766 78888888888887 4555 5678888888888877 5666 667788888888
Q ss_pred CcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCC
Q 002069 82 NLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIP 161 (973)
Q Consensus 82 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 161 (973)
|+++ .+|. .+++|++|++++|+++ .+|.. +++|++|+|++|+++ .+|. .+++|+.|++++|.+++ +|
T Consensus 111 N~l~-~l~~---~l~~L~~L~L~~N~l~-~lp~~---l~~L~~L~Ls~N~l~-~l~~---~~~~L~~L~L~~N~l~~-l~ 177 (622)
T 3g06_A 111 NPLT-HLPA---LPSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLA-SLPA---LPSELCKLWAYNNQLTS-LP 177 (622)
T ss_dssp CCCC-CCCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSC-CC
T ss_pred CcCC-CCCC---CCCCcCEEECCCCCCC-cCCCC---CCCCCEEECcCCcCC-CcCC---ccCCCCEEECCCCCCCC-Cc
Confidence 8887 4555 4567888888888887 46654 377788888888877 3454 24567777788887774 44
Q ss_pred ccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCcccccccc
Q 002069 162 FSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241 (973)
Q Consensus 162 ~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~ 241 (973)
..+++|+.|++++|.+++ +|.. +++|+.|++++|.++.++. .+++|+.|++++|+++++ | ..+++
T Consensus 178 ---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l~~----~~~~L~~L~Ls~N~L~~l-p---~~l~~ 242 (622)
T 3g06_A 178 ---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPA----LPSGLKELIVSGNRLTSL-P---VLPSE 242 (622)
T ss_dssp ---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSCCC----CCTTCCEEECCSSCCSCC-C---CCCTT
T ss_pred ---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccccCC----CCCCCCEEEccCCccCcC-C---CCCCc
Confidence 346777777777777773 4432 3667777777777775442 246677777777777764 3 34466
Q ss_pred ccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccc
Q 002069 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFST 321 (973)
Q Consensus 242 L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 321 (973)
|+.|+|++|+|+++++ .+++|+.|++++|+|+ .+|..+..+++|+.|++++
T Consensus 243 L~~L~Ls~N~L~~lp~----------------------------~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~ 293 (622)
T 3g06_A 243 LKELMVSGNRLTSLPM----------------------------LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293 (622)
T ss_dssp CCEEECCSSCCSCCCC----------------------------CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCS
T ss_pred CcEEECCCCCCCcCCc----------------------------ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecC
Confidence 7777777776653221 3467888899999888 6677888899999999999
Q ss_pred cccCCCCCccccCCC
Q 002069 322 NALSGSIPNEITNLR 336 (973)
Q Consensus 322 n~l~~~~~~~~~~l~ 336 (973)
|.+++..|..+..++
T Consensus 294 N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 294 NPLSERTLQALREIT 308 (622)
T ss_dssp CCCCHHHHHHHHHHH
T ss_pred CCCCCcCHHHHHhcc
Confidence 998887777776655
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-27 Score=276.92 Aligned_cols=267 Identities=24% Similarity=0.266 Sum_probs=138.5
Q ss_pred CCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeecc
Q 002069 25 HLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLS 104 (973)
Q Consensus 25 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~ 104 (973)
++++|++++|.++ .+|..+. ++|++|+|++|+++ .+|. .+++|++|+|++|+++ .+|. .+++|++|+|+
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECc
Confidence 3555666666655 4454444 55555555555555 4444 3455555555555555 3443 34555555555
Q ss_pred CCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCC
Q 002069 105 NNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSI 184 (973)
Q Consensus 105 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~ 184 (973)
+|+++ .+|. .+++|++|++++|+++ .+|.. +++ |++|++++|++++ +
T Consensus 110 ~N~l~-~l~~---~l~~L~~L~L~~N~l~-~lp~~---l~~------------------------L~~L~Ls~N~l~~-l 156 (622)
T 3g06_A 110 SNPLT-HLPA---LPSGLCKLWIFGNQLT-SLPVL---PPG------------------------LQELSVSDNQLAS-L 156 (622)
T ss_dssp SCCCC-CCCC---CCTTCCEEECCSSCCS-CCCCC---CTT------------------------CCEEECCSSCCSC-C
T ss_pred CCcCC-CCCC---CCCCcCEEECCCCCCC-cCCCC---CCC------------------------CCEEECcCCcCCC-c
Confidence 55555 2333 3344555555555554 23322 234 4444444444442 2
Q ss_pred CccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcc
Q 002069 185 PNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLT 264 (973)
Q Consensus 185 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 264 (973)
|. .+++|+.|++++|++++++ ..+++|+.|++++|.++++. . .+++|+.|++++|.++.+..
T Consensus 157 ~~---~~~~L~~L~L~~N~l~~l~----~~~~~L~~L~Ls~N~l~~l~-~---~~~~L~~L~L~~N~l~~l~~------- 218 (622)
T 3g06_A 157 PA---LPSELCKLWAYNNQLTSLP----MLPSGLQELSVSDNQLASLP-T---LPSELYKLWAYNNRLTSLPA------- 218 (622)
T ss_dssp CC---CCTTCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCSCCC-C---CCTTCCEEECCSSCCSSCCC-------
T ss_pred CC---ccCCCCEEECCCCCCCCCc----ccCCCCcEEECCCCCCCCCC-C---ccchhhEEECcCCcccccCC-------
Confidence 22 1234455555555555433 23455555555555555432 1 12455555555555542110
Q ss_pred hhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcC
Q 002069 265 KLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLS 344 (973)
Q Consensus 265 ~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 344 (973)
.+++|+.|++++|++++ +| ..+++|+.|++++|.|+. +|. .+++|+.|+|+
T Consensus 219 ---------------------~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls 269 (622)
T 3g06_A 219 ---------------------LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVY 269 (622)
T ss_dssp ---------------------CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred ---------------------CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCC
Confidence 11355666666666664 33 334566666666666663 333 45667777777
Q ss_pred CCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccc
Q 002069 345 ENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASL 383 (973)
Q Consensus 345 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l 383 (973)
+|.|+ .+|..+.++++|+.|+|++|.+++..|..+..+
T Consensus 270 ~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L 307 (622)
T 3g06_A 270 RNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 307 (622)
T ss_dssp SSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred CCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence 77776 445666667777777777777766555544433
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-28 Score=269.18 Aligned_cols=256 Identities=18% Similarity=0.147 Sum_probs=134.8
Q ss_pred CEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCC
Q 002069 27 KLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNN 106 (973)
Q Consensus 27 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n 106 (973)
+.++++.+.+...++..+..+++|++|+|++|++++..|..|+.+++|++|+|++|++++..| +..+++|++|++++|
T Consensus 13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90 (317)
T ss_dssp EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence 334444444443333333344455555555555554444455555555555555555553322 555555555555555
Q ss_pred cCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCc
Q 002069 107 SLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPN 186 (973)
Q Consensus 107 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~ 186 (973)
++++ +| ..++|++|++++|++++..+. .+++|++|++++|++++..|..+..+++|++|++++|++++..|.
T Consensus 91 ~l~~-l~----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 162 (317)
T 3o53_A 91 YVQE-LL----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162 (317)
T ss_dssp EEEE-EE----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGG
T ss_pred cccc-cc----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHH
Confidence 5552 22 225555555555555533322 234556666666666555555566666666666666666654444
Q ss_pred ccc-ccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcch
Q 002069 187 EIG-NLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTK 265 (973)
Q Consensus 187 ~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 265 (973)
.+. .+++|++|++++|++++++. ...+++|++|++++|++++++ ..+..+++|+.|+|++|++++ +|..+..+++
T Consensus 163 ~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~l~-~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~ 238 (317)
T 3o53_A 163 ELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMG-PEFQSAAGVTWISLRNNKLVL-IEKALRFSQN 238 (317)
T ss_dssp GGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEEC-GGGGGGTTCSEEECTTSCCCE-ECTTCCCCTT
T ss_pred HHhhccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCCcch-hhhcccCcccEEECcCCcccc-hhhHhhcCCC
Confidence 442 56666666666666665422 233666666666666666553 336666666666666666653 3333444444
Q ss_pred hhhccCCCcccC-chhhhhhccccccceEEcc
Q 002069 266 LVISCLGTNALS-SSILEEIGNLKSLLHLQLN 296 (973)
Q Consensus 266 L~~l~l~~n~i~-~~~~~~~~~l~~L~~L~l~ 296 (973)
|+.+++++|.+. ...+..+..+++|+.|+++
T Consensus 239 L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp CCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred CCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence 444444444333 2333444444555555554
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-28 Score=288.64 Aligned_cols=188 Identities=19% Similarity=0.094 Sum_probs=133.7
Q ss_pred cccCCCceeEEEE-EcCCCCEEEEEEcCCCCCc-------chhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeEEE
Q 002069 708 CIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPG-------EMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 708 ~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 778 (973)
..+.|++|.+..+ +.-.|+.||||++...... .....++|.+|+++++++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4566777766665 2336889999998654211 123356799999999999 799999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||++|++|.+++.+.+ +++.. +|+.||+.||+|+|++ |||||||||+|||++.+|.+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999997654 34443 5899999999999999 999999999999999999999999999998766
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCC
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p 905 (973)
........+||+.|||||++.+. +..++|+||+|++.+++.++..|
T Consensus 392 ~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 65556667899999999998764 67789999999998887665444
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-28 Score=266.52 Aligned_cols=267 Identities=22% Similarity=0.200 Sum_probs=180.6
Q ss_pred cceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecc
Q 002069 98 LSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGI 177 (973)
Q Consensus 98 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~ 177 (973)
++.++++.+.+...++..+..+++|++|+|++|++++..|+.|+++++|++|++++|++++..| +..+++|++|++++
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~ 89 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN 89 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence 4445555555553333344455566666666666665555666666666666666666654333 56666666666666
Q ss_pred cccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCC
Q 002069 178 NALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIP 257 (973)
Q Consensus 178 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 257 (973)
|++++ + ...++|++|++++|+++++.+.. +++|++|++++|+++++.+..+..+++|++|++++|.++
T Consensus 90 n~l~~-l----~~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~---- 157 (317)
T 3o53_A 90 NYVQE-L----LVGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID---- 157 (317)
T ss_dssp SEEEE-E----EECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCC----
T ss_pred Ccccc-c----cCCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCC----
Confidence 66652 1 12356666666666665544332 345566666666665555555555555555555555554
Q ss_pred cccCCcchhhhccCCCcccCchhhhhh-ccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCC
Q 002069 258 CSFGNLTKLVISCLGTNALSSSILEEI-GNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLR 336 (973)
Q Consensus 258 ~~~~~l~~L~~l~l~~n~i~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 336 (973)
...+..+ ..+++|++|++++|.+++.. ....+++|++|++++|.+++ +|..+..++
T Consensus 158 --------------------~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~ 214 (317)
T 3o53_A 158 --------------------TVNFAELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAF-MGPEFQSAA 214 (317)
T ss_dssp --------------------EEEGGGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCE-ECGGGGGGT
T ss_pred --------------------cccHHHHhhccCcCCEEECCCCcCcccc--cccccccCCEEECCCCcCCc-chhhhcccC
Confidence 4434444 36788999999999998652 23358999999999999985 455688999
Q ss_pred CCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCccc-CCCCcccccccccchhccccc-ccccCCCc
Q 002069 337 SLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLS-GSIPLSFASLTSLTTLYLYEN-SLCDSIPK 402 (973)
Q Consensus 337 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~-~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~ 402 (973)
+|++|+|++|+++ .+|..+..+++|+.|++++|++. +..+..+..+++|+.|++++| .+.+..+.
T Consensus 215 ~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp TCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred cccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 9999999999999 56778999999999999999998 677888899999999999955 55554443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.7e-28 Score=262.40 Aligned_cols=248 Identities=19% Similarity=0.175 Sum_probs=121.2
Q ss_pred cccCCCCceecccCCCCCCCCccccCccccceeeecccccC-CCCCcccc-------ccCccceeecccccccccccccc
Q 002069 141 GNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS-GSIPNEIG-------NLKSLSDLRLDYNTLSGSILYSF 212 (973)
Q Consensus 141 ~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~-~~~p~~~~-------~l~~L~~L~L~~N~l~~~~~~~~ 212 (973)
++.++|++|++++|.+ .+|..+... |+.|++++|.++ ..+|..+. ++++|++|++++|++++..+..+
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 3444455555555554 333333322 555555555552 23343333 45555555565555555444443
Q ss_pred --CCCCcccEEecCCcccCCCCCcccccc-----ccccceecccccccCCCCcccCCcchhhhccCCCcccCch--hhhh
Q 002069 213 --GNLTKLEILYLDVNALSGLIPNEIGNL-----KSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSS--ILEE 283 (973)
Q Consensus 213 --~~l~~L~~L~L~~n~i~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~--~~~~ 283 (973)
..+++|++|++++|++++. |..++.+ ++|++|+|++|++++..+..|+++++|+.|++++|.+... .+..
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 194 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence 5556666666666666555 5555555 5666666666666554444444444443333333333221 1112
Q ss_pred h--ccccccceEEcccccccCC---cCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCC
Q 002069 284 I--GNLKSLLHLQLNYNTLSGS---IPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGN 358 (973)
Q Consensus 284 ~--~~l~~L~~L~l~~n~l~~~---~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 358 (973)
+ ..+++|++|++++|++++. ....+..+++|++|++++|.+++..|. ..+..
T Consensus 195 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-----------------------~~~~~ 251 (312)
T 1wwl_A 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA-----------------------PSCDW 251 (312)
T ss_dssp SCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCC-----------------------SCCCC
T ss_pred HHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccch-----------------------hhhhh
Confidence 2 4555555555555555521 112223444444444444444433321 23334
Q ss_pred CCCCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCCCCEEEccCCCCC
Q 002069 359 LTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421 (973)
Q Consensus 359 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 421 (973)
+++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++. |. +..+++|++|+|++|+++
T Consensus 252 l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp CTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred cCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 455555555555555 3344333 5555666666665553 33 555666666666666655
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.9e-30 Score=306.01 Aligned_cols=438 Identities=15% Similarity=0.127 Sum_probs=259.6
Q ss_pred eeecccccccccCcccccccCCCCceecccCCCCC---CCCcc------------ccCccccceeeecccccCCCCCccc
Q 002069 124 TLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSG---AIPFS------------LGNLTNLVTLYIGINALSGSIPNEI 188 (973)
Q Consensus 124 ~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~---~~p~~------------l~~l~~L~~L~l~~n~l~~~~p~~~ 188 (973)
.++++++... ..+..+..+++|++|+++++.... ..|.. ...+++|++|++++|.+++..+..+
T Consensus 47 ~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l 125 (594)
T 2p1m_B 47 KVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELI 125 (594)
T ss_dssp EEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHH
T ss_pred EEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHH
Confidence 4555544322 223446677888899888875211 11211 2345677777777777665555555
Q ss_pred c-ccCccceeecccc-ccccccc-cccCCCCcccEEecCCcccCCCCCcccc----ccccccceecccccccCCCCcccC
Q 002069 189 G-NLKSLSDLRLDYN-TLSGSIL-YSFGNLTKLEILYLDVNALSGLIPNEIG----NLKSLLALQLNYNTLSGSIPCSFG 261 (973)
Q Consensus 189 ~-~l~~L~~L~L~~N-~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~----~l~~L~~L~L~~N~l~~~~~~~~~ 261 (973)
. .+++|++|+|++| .++.... ..+.++++|++|++++|.+++..+..+. .+++|+.|++++|. ..+....
T Consensus 126 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~-- 202 (594)
T 2p1m_B 126 AKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSA-- 202 (594)
T ss_dssp HHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHH--
T ss_pred HHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHH--
Confidence 4 5677777777776 4443222 2233567777777777776655444333 34466666666664 1111111
Q ss_pred CcchhhhccCCCcccCchhhhhhccccccceEEcccc-cccCCcCchhhcCCccceeecccc-------ccCCCCCcccc
Q 002069 262 NLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYN-TLSGSIPLSLGSLTNLATLYFSTN-------ALSGSIPNEIT 333 (973)
Q Consensus 262 ~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~L~~n-------~l~~~~~~~~~ 333 (973)
....+..+++|++|++++| .+. .++..+..+++|+.|+++.+ .+.+ ++..+.
T Consensus 203 ------------------l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~ 262 (594)
T 2p1m_B 203 ------------------LERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALS 262 (594)
T ss_dssp ------------------HHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHH
T ss_pred ------------------HHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHh
Confidence 1112234566777777766 333 25556666677777764433 2332 233556
Q ss_pred CCCCCCcE-EcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCc-ccccccccchhcccccccccCC-CcccCCCCCC
Q 002069 334 NLRSLSDL-QLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPL-SFASLTSLTTLYLYENSLCDSI-PKEIGDMKSL 410 (973)
Q Consensus 334 ~l~~L~~L-~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~-~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L 410 (973)
++++|+.| .+.+... +.++..+..+++|++|+|++|.+++.... .+..+++|++|++++| +++.. +.....+++|
T Consensus 263 ~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L 340 (594)
T 2p1m_B 263 GCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDL 340 (594)
T ss_dssp TCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTC
T ss_pred cCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCC
Confidence 66677766 3333222 13334444567777777777775532222 2345677777777766 43221 1222246777
Q ss_pred CEEEc---------cCCCCCCCcchhhhhhcccceEEEeeCcccccccCCCCC-CCcccceeecc--C----CccCCCCC
Q 002069 411 SILDL---------SSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHG-KFSSLIQLILN--N----NELSGQLS 474 (973)
Q Consensus 411 ~~L~L---------s~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~-~~~~L~~L~l~--~----N~l~~~~~ 474 (973)
++|++ +.+.+++.....+....++|++|.++.|.+++.....+. .+++|+.|+++ + |.+++...
T Consensus 341 ~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~ 420 (594)
T 2p1m_B 341 RELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPL 420 (594)
T ss_dssp CEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCT
T ss_pred CEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCch
Confidence 77777 334555443444444335788887777777765544443 46778888887 4 45553211
Q ss_pred -----cccccccccccccccccccccccCccccc-cccccEEeecCccCCCCCCccc-ccccccCeecccccccCCCcch
Q 002069 475 -----PELGSLNQLEYLDLSANTFHNSIPESLGN-LVKLHYLNLSNNQFSQKIPNPI-EKLIHLSELDLSYKIFGEEIPS 547 (973)
Q Consensus 475 -----~~l~~l~~L~~L~Ls~N~i~~~~~~~l~~-l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~ls~n~i~~~~~~ 547 (973)
..+..+++|++|++++ .+++..+..+.. +++|++|+|++|.+++..+..+ ..+++|++|++++|.+++.+..
T Consensus 421 ~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~ 499 (594)
T 2p1m_B 421 DIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALL 499 (594)
T ss_dssp HHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHH
T ss_pred hhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHH
Confidence 2256678899999977 676655555655 7889999999999877655555 6688899999999988666555
Q ss_pred hh-cccccccccccccccccCccchhh-hccccccEEeCcCCC
Q 002069 548 QV-CSMQSLEKLNLSHNNLSGSISRCF-EEMHWLSCIDISYNA 588 (973)
Q Consensus 548 ~~-~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~l~l~~N~ 588 (973)
.+ ..+++|++|++++|+++..+...+ ..++.++...+..+.
T Consensus 500 ~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~ 542 (594)
T 2p1m_B 500 ANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERG 542 (594)
T ss_dssp HTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSS
T ss_pred HHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCC
Confidence 33 358899999999998876655555 557777776666553
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.6e-30 Score=305.69 Aligned_cols=435 Identities=15% Similarity=0.116 Sum_probs=294.3
Q ss_pred ceeeccCCcCCCCCCCccccCCccceeecccccccc---cCcc------------cccccCCCCceecccCCCCCCCCcc
Q 002069 99 SDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSG---SIPD------------EIGNLKFLSDLQVSYNTLSGAIPFS 163 (973)
Q Consensus 99 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~---~~p~------------~~~~l~~L~~L~l~~N~l~~~~p~~ 163 (973)
+.++++..... ..+..+..+++|++|++++|.... ..|. .+..+++|++|++++|.+++..+..
T Consensus 46 ~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~ 124 (594)
T 2p1m_B 46 RKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLEL 124 (594)
T ss_dssp CEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHH
T ss_pred eEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHH
Confidence 45666554433 233456788999999999986321 1221 2346889999999999998766666
Q ss_pred cc-Cccccceeeeccc-ccCCC-CCccccccCccceeeccccccccccccccC----CCCcccEEecCCcccCCCCCccc
Q 002069 164 LG-NLTNLVTLYIGIN-ALSGS-IPNEIGNLKSLSDLRLDYNTLSGSILYSFG----NLTKLEILYLDVNALSGLIPNEI 236 (973)
Q Consensus 164 l~-~l~~L~~L~l~~n-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~----~l~~L~~L~L~~n~i~~~~~~~~ 236 (973)
+. .+++|++|++++| .++.. ++..+.++++|++|++++|.+++..+..+. .+++|+.|++++|. ..+....+
T Consensus 125 l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l 203 (594)
T 2p1m_B 125 IAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSAL 203 (594)
T ss_dssp HHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHH
T ss_pred HHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHH
Confidence 65 6899999999998 55522 444556899999999999998876554443 67799999999997 32323333
Q ss_pred ----cccccccceecccc-cccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEccc-------ccccCCc
Q 002069 237 ----GNLKSLLALQLNYN-TLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNY-------NTLSGSI 304 (973)
Q Consensus 237 ----~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~-------n~l~~~~ 304 (973)
.++++|+.|++++| .+++ . +..+..+++|++|++.. +.+.+ .
T Consensus 204 ~~l~~~~~~L~~L~L~~~~~~~~-l------------------------~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l 257 (594)
T 2p1m_B 204 ERLVTRCPNLKSLKLNRAVPLEK-L------------------------ATLLQRAPQLEELGTGGYTAEVRPDVYSG-L 257 (594)
T ss_dssp HHHHHHCTTCCEEECCTTSCHHH-H------------------------HHHHHHCTTCSEEECSBCCCCCCHHHHHH-H
T ss_pred HHHHHhCCCCcEEecCCCCcHHH-H------------------------HHHHhcCCcceEcccccccCccchhhHHH-H
Confidence 34588999999888 3322 2 23444556666666333 33332 3
Q ss_pred CchhhcCCcccee-eccccccCCCCCccccCCCCCCcEEcCCCCCCCcch-hccCCCCCCcEEEccCCcccCCCCcc-cc
Q 002069 305 PLSLGSLTNLATL-YFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIP-LALGNLTKLVSLDLSINKLSGSIPLS-FA 381 (973)
Q Consensus 305 ~~~~~~l~~L~~L-~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~~~~-~~ 381 (973)
+..+.++++|+.| .+.+... ..++..+..+++|++|+|++|.+++... ..+..+++|++|++++| +++..... ..
T Consensus 258 ~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~ 335 (594)
T 2p1m_B 258 SVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLAS 335 (594)
T ss_dssp HHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHH
T ss_pred HHHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHH
Confidence 3466777777777 3433322 2344445567788888888888664322 33567788888888877 44222222 23
Q ss_pred cccccchhccc---------ccccccCCCcccC-CCCCCCEEEccCCCCCCCcchhhhhhcccceEEEee--C----ccc
Q 002069 382 SLTSLTTLYLY---------ENSLCDSIPKEIG-DMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLS--S----NHI 445 (973)
Q Consensus 382 ~l~~L~~L~L~---------~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~--~----n~l 445 (973)
.+++|++|+++ .+.+++.....+. .+++|++|+++.|.+++..+..+....++|+.|+++ + |.+
T Consensus 336 ~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l 415 (594)
T 2p1m_B 336 TCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYL 415 (594)
T ss_dssp HCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTT
T ss_pred hCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccc
Confidence 46778888773 3455543333333 378899998888888866666666545689999998 4 555
Q ss_pred cccc-----CCCCCCCcccceeeccCCccCCCCCccccc-ccccccccccccccccccCccc-cccccccEEeecCccCC
Q 002069 446 VGEI-----PLGHGKFSSLIQLILNNNELSGQLSPELGS-LNQLEYLDLSANTFHNSIPESL-GNLVKLHYLNLSNNQFS 518 (973)
Q Consensus 446 ~~~~-----~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~-l~~L~~L~Ls~N~i~~~~~~~l-~~l~~L~~L~L~~N~l~ 518 (973)
++.. +..+..+++|+.|++++ .+++.....+.. +++|++|+|++|.+++..+..+ ..+++|++|+|++|+++
T Consensus 416 ~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~ 494 (594)
T 2p1m_B 416 TLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG 494 (594)
T ss_dssp TCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred cCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence 5221 11145667899999987 666555555555 7889999999999987655555 66899999999999996
Q ss_pred CCCCc-ccccccccCeecccccccCCCcchhh-ccccccccccccccc
Q 002069 519 QKIPN-PIEKLIHLSELDLSYKIFGEEIPSQV-CSMQSLEKLNLSHNN 564 (973)
Q Consensus 519 ~~~~~-~~~~l~~L~~L~ls~n~i~~~~~~~~-~~l~~L~~L~L~~N~ 564 (973)
+.... .+..+++|+.|++++|.++..+...+ ..++.|+...+..+.
T Consensus 495 ~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~ 542 (594)
T 2p1m_B 495 DKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERG 542 (594)
T ss_dssp HHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSS
T ss_pred HHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCC
Confidence 65444 44568999999999999876666666 457777766666554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-27 Score=274.47 Aligned_cols=245 Identities=19% Similarity=0.178 Sum_probs=149.4
Q ss_pred CCCcccCCCC----CCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCc
Q 002069 15 SIPPEIGHLT----HLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPN 90 (973)
Q Consensus 15 ~~p~~~~~l~----~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~ 90 (973)
.+|..+..+. +|++|+|++|.+++..|..|+.+++|++|+|++|.+++..| ++.+++|++|+|++|.+++ +|
T Consensus 21 ~l~~~l~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~- 96 (487)
T 3oja_A 21 SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LL- 96 (487)
T ss_dssp THHHHHHTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEE-EE-
T ss_pred hhHHHHHHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCC-CC-
Confidence 3455554443 67777777777776666677777777777777777764433 6777777777777777763 32
Q ss_pred cccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCcccc-Cccc
Q 002069 91 EVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLG-NLTN 169 (973)
Q Consensus 91 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~-~l~~ 169 (973)
..++|++|++++|++++..+. .+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..+. .+++
T Consensus 97 ---~~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~ 170 (487)
T 3oja_A 97 ---VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170 (487)
T ss_dssp ---ECTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTT
T ss_pred ---CCCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCc
Confidence 226677777777777644332 345666777777776666666666666666666666666655555554 5666
Q ss_pred cceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceeccc
Q 002069 170 LVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNY 249 (973)
Q Consensus 170 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 249 (973)
|+.|+|++|.+++. | .+..+++|++|+|++|.++++++. |..+++|+.|+|++|.++++ |..+..+++|+.|++++
T Consensus 171 L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~l-p~~l~~l~~L~~L~l~~ 246 (487)
T 3oja_A 171 LEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVLI-EKALRFSQNLEHFDLRG 246 (487)
T ss_dssp CCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCEE-CTTCCCCTTCCEEECTT
T ss_pred ccEEecCCCccccc-c-ccccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCccc-chhhccCCCCCEEEcCC
Confidence 66666666666633 2 222456666666666666654443 55566666666666666543 44455555566666655
Q ss_pred ccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcc
Q 002069 250 NTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLN 296 (973)
Q Consensus 250 N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~ 296 (973)
|.+.. ...+..+..++.|+.+++.
T Consensus 247 N~l~c-----------------------~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 247 NGFHC-----------------------GTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CCBCH-----------------------HHHHHHHTTCHHHHHHHHH
T ss_pred CCCcC-----------------------cchHHHHHhCCCCcEEecc
Confidence 55541 2334556666666666654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.9e-26 Score=242.13 Aligned_cols=222 Identities=22% Similarity=0.207 Sum_probs=142.7
Q ss_pred EEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCc
Q 002069 4 VLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNL 83 (973)
Q Consensus 4 ~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~ 83 (973)
..+-++.+++ .+|+.+. ++|++|+|++|++++..+..|..+++|++|++++|++.+..+..|+++++|++|++++|+
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 3455666666 6777654 567888888888876666677778888888888888775555677778888888888888
Q ss_pred CcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeeccccccccc-CcccccccCCCCceecccCCCCCCCCc
Q 002069 84 LSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGS-IPDEIGNLKFLSDLQVSYNTLSGAIPF 162 (973)
Q Consensus 84 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~ 162 (973)
+++..|..+..+++|++|++++|++.+..+..++++++|++|++++|++++. +|..|+++++|++|++++|++++..+.
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~ 167 (276)
T 2z62_A 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (276)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence 7766667777777788888887777755555677777777777777777642 466777777777777777777655555
Q ss_pred cccCccccc----eeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccC
Q 002069 163 SLGNLTNLV----TLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALS 229 (973)
Q Consensus 163 ~l~~l~~L~----~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~ 229 (973)
.+..+++|+ .|++++|++++..+. .....+|++|++++|+++++++..|..+++|+.|++++|.++
T Consensus 168 ~~~~l~~L~~l~l~L~ls~n~l~~~~~~-~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 237 (276)
T 2z62_A 168 DLRVLHQMPLLNLSLDLSLNPMNFIQPG-AFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237 (276)
T ss_dssp GGHHHHTCTTCCEEEECCSSCCCEECTT-SSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred HhhhhhhccccceeeecCCCcccccCcc-ccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCccc
Confidence 555555555 445555555432222 222224444444444444444444444444444444444444
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=239.25 Aligned_cols=224 Identities=24% Similarity=0.234 Sum_probs=195.0
Q ss_pred CEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCC
Q 002069 27 KLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNN 106 (973)
Q Consensus 27 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n 106 (973)
...+.++..++ .+|..+. ++|++|++++|++++..+..|+++++|++|++++|++++..+..+..+++|++|+|++|
T Consensus 10 ~~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 86 (276)
T 2z62_A 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86 (276)
T ss_dssp TEEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred ceEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCC
Confidence 35677777776 5677665 58999999999999666668999999999999999999777778999999999999999
Q ss_pred cCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCC-CCccccCccccceeeecccccCCCCC
Q 002069 107 SLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGA-IPFSLGNLTNLVTLYIGINALSGSIP 185 (973)
Q Consensus 107 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~l~~l~~L~~L~l~~n~l~~~~p 185 (973)
++++..|..|.++++|++|++++|.+++..+..++++++|++|++++|.+++. +|..+.++++|++|++++|++++..+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~ 166 (276)
T 2z62_A 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166 (276)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred ccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCH
Confidence 99977778899999999999999999976676899999999999999999864 58899999999999999999997777
Q ss_pred ccccccCccc----eeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccC
Q 002069 186 NEIGNLKSLS----DLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSG 254 (973)
Q Consensus 186 ~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 254 (973)
..+..+++|+ .|++++|+++++++..+... +|+.|++++|+++++.+..|.++++|+.|++++|+++.
T Consensus 167 ~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp GGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSC-CEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred HHhhhhhhccccceeeecCCCcccccCccccCCC-cccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence 7888888887 89999999998877766654 89999999999998887788999999999999999874
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=267.12 Aligned_cols=233 Identities=21% Similarity=0.198 Sum_probs=206.6
Q ss_pred CcEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccC
Q 002069 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGN 81 (973)
Q Consensus 2 l~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~ 81 (973)
|++|+|++|++++..|..|+.+++|++|+|++|.+++..| ++.+++|++|+|++|.++ .+|. .++|++|++++
T Consensus 36 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~-~l~~----~~~L~~L~L~~ 108 (487)
T 3oja_A 36 VKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLV----GPSIETLHAAN 108 (487)
T ss_dssp CCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEE-EEEE----CTTCCEEECCS
T ss_pred ccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCC-CCCC----CCCcCEEECcC
Confidence 7899999999997667899999999999999999997655 999999999999999998 4443 38999999999
Q ss_pred CcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCccccc-ccCCCCceecccCCCCCCC
Q 002069 82 NLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIG-NLKFLSDLQVSYNTLSGAI 160 (973)
Q Consensus 82 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~ 160 (973)
|.+++..+. .+++|++|+|++|++++..|..++++++|++|+|++|.+++..|..+. .+++|++|+|++|.+++..
T Consensus 109 N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~ 185 (487)
T 3oja_A 109 NNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK 185 (487)
T ss_dssp SCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE
T ss_pred CcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccccc
Confidence 999965443 468999999999999988888999999999999999999988888886 8999999999999999653
Q ss_pred CccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccC-CCCCcccccc
Q 002069 161 PFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALS-GLIPNEIGNL 239 (973)
Q Consensus 161 p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~-~~~~~~~~~l 239 (973)
+ +..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++++ +..+..+++|+.|++++|.+. +..|..+..+
T Consensus 186 ~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~l-p~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l 261 (487)
T 3oja_A 186 G--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLI-EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261 (487)
T ss_dssp C--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEE-CTTCCCCTTCCEEECTTCCBCHHHHHHHHTTC
T ss_pred c--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCccc-chhhccCCCCCEEEcCCCCCcCcchHHHHHhC
Confidence 3 4469999999999999995 556699999999999999999975 456899999999999999998 4457788889
Q ss_pred ccccceecc
Q 002069 240 KSLLALQLN 248 (973)
Q Consensus 240 ~~L~~L~L~ 248 (973)
++|+.++++
T Consensus 262 ~~L~~l~~~ 270 (487)
T 3oja_A 262 QRVQTVAKQ 270 (487)
T ss_dssp HHHHHHHHH
T ss_pred CCCcEEecc
Confidence 999999886
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-24 Score=230.30 Aligned_cols=204 Identities=27% Similarity=0.290 Sum_probs=163.6
Q ss_pred CCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeecc
Q 002069 25 HLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLS 104 (973)
Q Consensus 25 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~ 104 (973)
..+++++++++++ .+|..+. ++|++|++++|++++..+..|+++++|++|++++|+++...+..|..+++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 4677888888887 4666554 578888888888875555678888888888888888874444445778888888888
Q ss_pred CCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCC
Q 002069 105 NNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSI 184 (973)
Q Consensus 105 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~ 184 (973)
+|++++..+..|.++++|++|+|++|++++..+..|+++++|++|++++|++++..+..|..+++|+.|++++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 88888655566788888888888888888767777888888888888888888766677888888888888888888766
Q ss_pred CccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCC
Q 002069 185 PNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGL 231 (973)
Q Consensus 185 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~ 231 (973)
+..|.++++|++|++++|+++++++..|..+++|+.|++++|.+...
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 67788899999999999999988888888999999999999988765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=237.48 Aligned_cols=230 Identities=25% Similarity=0.262 Sum_probs=181.5
Q ss_pred CCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeec
Q 002069 24 THLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRL 103 (973)
Q Consensus 24 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L 103 (973)
..+..+++.++.+.+. ..+..+++|+.|++++|.++ .++ .++.+++|++|++++|.+++ + ..++.+++|++|+|
T Consensus 19 ~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L 92 (272)
T 3rfs_A 19 AETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLIL 92 (272)
T ss_dssp HHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEEC
T ss_pred HHHHHHHhcCcccccc--cccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEEC
Confidence 4455566777766643 34667788888888888877 444 47788888888888888873 3 36778888888888
Q ss_pred cCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCC
Q 002069 104 SNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGS 183 (973)
Q Consensus 104 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~ 183 (973)
++|++++..|..|+++++|++|+|++|++++..+..|+++++|++|++++|++++..+..+..+++|+.|++++|++++.
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 172 (272)
T 3rfs_A 93 TGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSL 172 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCcc
Confidence 88888866666678888888888888888866666688888888888888888877777788888888888888888877
Q ss_pred CCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCc
Q 002069 184 IPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNL 263 (973)
Q Consensus 184 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 263 (973)
.+..+..+++|++|++++|+++++++..|..+++|+.|++++|.+.+. +++|+.|+++.|.+++.+|.+++.+
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 173 PEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred CHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccccc
Confidence 677778888999999999998888888888899999999999987754 4578889999999998888888776
Q ss_pred chh
Q 002069 264 TKL 266 (973)
Q Consensus 264 ~~L 266 (973)
...
T Consensus 246 ~~~ 248 (272)
T 3rfs_A 246 APD 248 (272)
T ss_dssp CGG
T ss_pred CCC
Confidence 554
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-24 Score=229.22 Aligned_cols=204 Identities=28% Similarity=0.308 Sum_probs=170.8
Q ss_pred CCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeec
Q 002069 48 SSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYL 127 (973)
Q Consensus 48 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 127 (973)
.+.+++++++++++ .+|..+. ++|++|++++|++++..+..|+.+++|++|+|++|+++...+..|.++++|++|+|
T Consensus 16 ~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l 92 (270)
T 2o6q_A 16 NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV 92 (270)
T ss_dssp TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEEC
T ss_pred CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEEC
Confidence 45788899988888 6787665 67889999999988655567888889999999999888555556688889999999
Q ss_pred ccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeeccccccccc
Q 002069 128 HMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGS 207 (973)
Q Consensus 128 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 207 (973)
++|++++..+..|.++++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|+++++
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 172 (270)
T 2o6q_A 93 TDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV 172 (270)
T ss_dssp CSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence 99988866667788889999999999998877778888889999999999988866666688888999999999998888
Q ss_pred cccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccC
Q 002069 208 ILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSG 254 (973)
Q Consensus 208 ~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 254 (973)
++..|.++++|+.|++++|+++++.+..|..+++|+.|+|++|.+..
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred ChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 88888888999999999999888877788888889999999988864
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-24 Score=230.67 Aligned_cols=206 Identities=23% Similarity=0.228 Sum_probs=176.9
Q ss_pred ccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCcccc
Q 002069 19 EIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSL 98 (973)
Q Consensus 19 ~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 98 (973)
++..+++++++++++|+++ .+|..+. +++++|+|++|++++..|..|..+++|++|+|++|.+++ +|.. +.+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTC
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcC
Confidence 3678888999999999998 5676665 689999999999987777889999999999999999984 4443 788999
Q ss_pred ceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeeccc
Q 002069 99 SDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGIN 178 (973)
Q Consensus 99 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n 178 (973)
++|+|++|+++ .+|..+.++++|++|+|++|++++..|..|.++++|++|++++|++++..+..|..+++|+.|++++|
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 99999999998 78888999999999999999999766788999999999999999999887888899999999999999
Q ss_pred ccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCC
Q 002069 179 ALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGL 231 (973)
Q Consensus 179 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~ 231 (973)
+++...+..|.++++|++|+|++|+++.++ ..+..+++|+.|+|++|.+...
T Consensus 159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip-~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 159 NLTELPAGLLNGLENLDTLLLQENSLYTIP-KGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCCCCC-TTTTTTCCCSEEECCSCCBCCS
T ss_pred cCCccCHHHhcCcCCCCEEECCCCcCCccC-hhhcccccCCeEEeCCCCccCc
Confidence 999666667788999999999999999655 4556678999999999988753
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=231.27 Aligned_cols=204 Identities=26% Similarity=0.264 Sum_probs=184.0
Q ss_pred CccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCcc
Q 002069 43 EIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNL 122 (973)
Q Consensus 43 ~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 122 (973)
+++++++|+++++++|+++ .+|..+. +++++|+|++|++++..|..|..+++|++|+|++|++++ +|.. +.+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTC
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcC
Confidence 4778899999999999999 7887775 789999999999997778899999999999999999984 4443 889999
Q ss_pred ceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeecccc
Q 002069 123 VTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYN 202 (973)
Q Consensus 123 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N 202 (973)
++|+|++|+++ .+|..+.++++|++|++++|++++..|..|.++++|++|++++|++++..+..|..+++|+.|+|++|
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 99999999998 78889999999999999999999888889999999999999999999777777899999999999999
Q ss_pred ccccccccccCCCCcccEEecCCcccCCCCCccccccccccceeccccccc
Q 002069 203 TLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLS 253 (973)
Q Consensus 203 ~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (973)
+++.+++..|..+++|+.|+|++|+++.+ |..+....+|+.|+|++|.+.
T Consensus 159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~~i-p~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 159 NLTELPAGLLNGLENLDTLLLQENSLYTI-PKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCCCC-CTTTTTTCCCSEEECCSCCBC
T ss_pred cCCccCHHHhcCcCCCCEEECCCCcCCcc-ChhhcccccCCeEEeCCCCcc
Confidence 99998888899999999999999999976 666777789999999999885
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=6.9e-25 Score=234.27 Aligned_cols=225 Identities=24% Similarity=0.262 Sum_probs=196.6
Q ss_pred EeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcC
Q 002069 5 LGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLL 84 (973)
Q Consensus 5 L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l 84 (973)
+++..+.+... ..+..+++|++|++++|.++. + ..+..+++|++|++++|++++ + +.++.+++|++|++++|.+
T Consensus 24 l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l 97 (272)
T 3rfs_A 24 ANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQL 97 (272)
T ss_dssp HHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCC
T ss_pred HHhcCcccccc--cccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCcc
Confidence 45566666522 446688999999999999984 3 468999999999999999984 4 4799999999999999999
Q ss_pred cccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccc
Q 002069 85 SGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSL 164 (973)
Q Consensus 85 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l 164 (973)
++..|..++.+++|++|++++|++++..|..|+++++|++|++++|++++..+..|+++++|++|++++|++++..+..+
T Consensus 98 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 177 (272)
T 3rfs_A 98 QSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVF 177 (272)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred CccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHh
Confidence 97666778999999999999999997777778999999999999999997777778999999999999999998888888
Q ss_pred cCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccc
Q 002069 165 GNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSL 242 (973)
Q Consensus 165 ~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 242 (973)
+.+++|+.|++++|++++..|..+..+++|++|++++|.+. +.+++|+.|+++.|.+++..|..++.+...
T Consensus 178 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~-------~~~~~l~~l~~~~n~~~g~ip~~~~~~~~~ 248 (272)
T 3rfs_A 178 DKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD-------CTCPGIRYLSEWINKHSGVVRNSAGSVAPD 248 (272)
T ss_dssp TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC-------CCTTTTHHHHHHHHHTGGGBBCTTSCBCGG
T ss_pred cCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcc-------ccCcHHHHHHHHHHhCCCcccCcccccCCC
Confidence 99999999999999999888888999999999999999887 346789999999999999889888877653
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.91 E-value=7.8e-26 Score=252.49 Aligned_cols=106 Identities=24% Similarity=0.163 Sum_probs=52.1
Q ss_pred EEcccccccCCcCchhhcCCccceeeccccccCCCCC----ccccCCC-CCCcEEcCCCCCCCcchhccCCC-----CCC
Q 002069 293 LQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIP----NEITNLR-SLSDLQLSENTLNGSIPLALGNL-----TKL 362 (973)
Q Consensus 293 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~~L 362 (973)
+++++|.+++.+|..+...++|++|++++|.+++..+ ..+..++ +|++|+|++|.+++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4555555555555544444445555555555554443 4444454 55555555555554444444332 555
Q ss_pred cEEEccCCcccCCCCcccccc-----cccchhccccccccc
Q 002069 363 VSLDLSINKLSGSIPLSFASL-----TSLTTLYLYENSLCD 398 (973)
Q Consensus 363 ~~L~Ls~N~i~~~~~~~~~~l-----~~L~~L~L~~N~l~~ 398 (973)
++|+|++|++++..+..+... ++|++|+|++|++++
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 123 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSS 123 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGG
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCc
Confidence 555555555554444333222 344444444444443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7e-25 Score=255.87 Aligned_cols=187 Identities=14% Similarity=0.173 Sum_probs=148.0
Q ss_pred cccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcc-----hhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 704 DDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGE-----MACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 704 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
...+.||+|+||+||+|.. .++.+|+|+........ ....+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999965 67889999865432221 11245689999999999999999777777777788999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++++|.++++. +..++.|++.|++|||++ +|+||||||+||+++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999864 568999999999999999 9999999999999998 999999999998754
Q ss_pred CCCc-------ccccccccCccccccccc--CCCCCccchHHHHHHHHHHHhCCCCCc
Q 002069 859 GLSN-------RTELAGTFGYIAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRD 907 (973)
Q Consensus 859 ~~~~-------~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~ 907 (973)
.... .....||+.|||||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 3221 135679999999999986 567888999999999888888777653
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-25 Score=250.48 Aligned_cols=255 Identities=18% Similarity=0.184 Sum_probs=128.1
Q ss_pred eeccccccCCCCCccccCCCCCCcEEcCCCCCCCcch----hccCCCC-CCcEEEccCCcccCCCCcccccc-----ccc
Q 002069 317 LYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIP----LALGNLT-KLVSLDLSINKLSGSIPLSFASL-----TSL 386 (973)
Q Consensus 317 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~-~L~~L~Ls~N~i~~~~~~~~~~l-----~~L 386 (973)
+.++.|.+++.+|..+...++|++|+|++|.+++..+ ..+.+++ +|++|+|++|+|++..+..|..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4556666665555555555556666666666665544 5555565 56666666666665555555554 556
Q ss_pred chhcccccccccCCCcccC----CC-CCCCEEEccCCCCCCCcchhhhhh----cccceEEEeeCcccccccCCCCCCCc
Q 002069 387 TTLYLYENSLCDSIPKEIG----DM-KSLSILDLSSNKLNGSIPLSLANL----TNSLKVLYLSSNHIVGEIPLGHGKFS 457 (973)
Q Consensus 387 ~~L~L~~N~l~~~~~~~~~----~l-~~L~~L~Ls~N~l~~~~~~~~~~~----~~~L~~L~L~~n~l~~~~~~~~~~~~ 457 (973)
++|+|++|++++..+..+. .+ ++|++|+|++|++++..+..+... ..+|++|+|++|.+++.....+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l---- 158 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL---- 158 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH----
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH----
Confidence 6666666665554444322 22 556666666666554444443332 2245555555555553222111
Q ss_pred ccceeeccCCccCCCCCccccccc-ccccccccccccccccCccccc----c-ccccEEeecCccCCCCCCc----cccc
Q 002069 458 SLIQLILNNNELSGQLSPELGSLN-QLEYLDLSANTFHNSIPESLGN----L-VKLHYLNLSNNQFSQKIPN----PIEK 527 (973)
Q Consensus 458 ~L~~L~l~~N~l~~~~~~~l~~l~-~L~~L~Ls~N~i~~~~~~~l~~----l-~~L~~L~L~~N~l~~~~~~----~~~~ 527 (973)
+..+..++ +|++|+|++|.|++..+..+.. + ++|++|+|++|+|++.... .+..
T Consensus 159 ----------------~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~ 222 (362)
T 3goz_A 159 ----------------IQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS 222 (362)
T ss_dssp ----------------HHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHH
T ss_pred ----------------HHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhc
Confidence 11222222 4555555555554443332222 2 3555555555555443222 2222
Q ss_pred -ccccCeecccccccCCCcchh----hcccccccccccccccccCccc-------hhhhccccccEEeCcCCCCCC
Q 002069 528 -LIHLSELDLSYKIFGEEIPSQ----VCSMQSLEKLNLSHNNLSGSIS-------RCFEEMHWLSCIDISYNALQG 591 (973)
Q Consensus 528 -l~~L~~L~ls~n~i~~~~~~~----~~~l~~L~~L~L~~N~l~~~~~-------~~~~~l~~L~~l~l~~N~l~~ 591 (973)
.++|++||+++|.|++.++.. +..+++|++|+|++|.+.+..+ ..+..++.|+.||+++|++..
T Consensus 223 ~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp SCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred CCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 235555555555555544422 2234556666666665443322 234455566666666666543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.7e-24 Score=222.65 Aligned_cols=196 Identities=20% Similarity=0.203 Sum_probs=121.5
Q ss_pred CCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCc-CcccCCccccCccccceeeccC-CcCCCCCCCccccCCccceee
Q 002069 49 SLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNL-LSGSIPNEVGSLKSLSDLRLSN-NSLNGSIPSSLGNLTNLVTLY 126 (973)
Q Consensus 49 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~-l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~ 126 (973)
+|++|++++|++++..+..|+++++|++|++++|+ ++...+..|..+++|++|++++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 56666666666654333456666666666666664 5533334556666666666665 666644445566666666666
Q ss_pred cccccccccCcccccccCCCC---ceecccC-CCCCCCCccccCccccc-eeeecccccCCCCCccccccCccceeeccc
Q 002069 127 LHMNALSGSIPDEIGNLKFLS---DLQVSYN-TLSGAIPFSLGNLTNLV-TLYIGINALSGSIPNEIGNLKSLSDLRLDY 201 (973)
Q Consensus 127 L~~n~l~~~~p~~~~~l~~L~---~L~l~~N-~l~~~~p~~l~~l~~L~-~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~ 201 (973)
+++|++++ +|+ |+++++|+ +|++++| .+++..+..|.++++|+ .|++++|+++ .+|......++|++|++++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCC
Confidence 66666653 444 55666665 6666666 66655555666677777 7777777766 3443333336777777777
Q ss_pred cc-cccccccccCCC-CcccEEecCCcccCCCCCccccccccccceecccc
Q 002069 202 NT-LSGSILYSFGNL-TKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYN 250 (973)
Q Consensus 202 N~-l~~~~~~~~~~l-~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N 250 (973)
|+ ++.+++..|.++ ++|+.|++++|+++++++. .+++|+.|+++++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 74 777767777777 7777777777777766443 4556666766654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3.2e-25 Score=245.44 Aligned_cols=253 Identities=19% Similarity=0.216 Sum_probs=192.1
Q ss_pred CcEEeCCCCCCCCCCCcccCCC--CCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCC-CCCcccCCCCCcEEE
Q 002069 2 LKVLGLSFNQFSGSIPPEIGHL--THLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGS-IPPSLGNLTSLIYID 78 (973)
Q Consensus 2 l~~L~l~~~~l~~~~p~~~~~l--~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~-~p~~~~~l~~L~~L~ 78 (973)
++.+|++++++. |..+..+ +++++|++++|.+.+..| .+..+++|++|++++|.+.+. +|..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~-~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccch-hhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 567888888775 4666777 888888888888886644 466788888888888888754 777788888888888
Q ss_pred ccCCcCcccCCccccCccccceeeccCC-cCCC-CCCCccccCCccceeecccc-ccccc-CcccccccC-CCCceeccc
Q 002069 79 IGNNLLSGSIPNEVGSLKSLSDLRLSNN-SLNG-SIPSSLGNLTNLVTLYLHMN-ALSGS-IPDEIGNLK-FLSDLQVSY 153 (973)
Q Consensus 79 l~~n~l~~~~p~~~~~l~~L~~L~L~~n-~l~~-~~p~~~~~l~~L~~L~L~~n-~l~~~-~p~~~~~l~-~L~~L~l~~ 153 (973)
+++|.+++..|..++.+++|++|+|++| .+++ .+|..+.++++|++|++++| .+++. ++..+..++ +|++|++++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 8888888777788888888888888888 5664 25666778888888888888 77743 567788888 888888888
Q ss_pred C--CCC-CCCCccccCccccceeeecccc-cCCCCCccccccCccceeeccccc-cccccccccCCCCcccEEecCCccc
Q 002069 154 N--TLS-GAIPFSLGNLTNLVTLYIGINA-LSGSIPNEIGNLKSLSDLRLDYNT-LSGSILYSFGNLTKLEILYLDVNAL 228 (973)
Q Consensus 154 N--~l~-~~~p~~l~~l~~L~~L~l~~n~-l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~n~i 228 (973)
| .++ +.+|..+..+++|+.|++++|. +++..+..+.++++|++|++++|. +.......+.++++|+.|++++| +
T Consensus 205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i 283 (336)
T 2ast_B 205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-V 283 (336)
T ss_dssp CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-S
T ss_pred CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-c
Confidence 8 454 3456677788888888888888 666667788888888888888884 43333346778888888888888 3
Q ss_pred CCCCCccccccc-cccceecccccccCCCCcccCC
Q 002069 229 SGLIPNEIGNLK-SLLALQLNYNTLSGSIPCSFGN 262 (973)
Q Consensus 229 ~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~ 262 (973)
+ ...+..+. ++..|++++|++++..|..++.
T Consensus 284 ~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 284 P---DGTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp C---TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred C---HHHHHHHHhhCcceEEecccCccccCCcccc
Confidence 3 34555553 4778888888888877776654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.1e-24 Score=221.90 Aligned_cols=196 Identities=18% Similarity=0.204 Sum_probs=96.4
Q ss_pred CCCEEECCCCcccccCCcCccCCCCCCeeeccCCc-CCCCCCCcccCCCCCcEEEccC-CcCcccCCccccCccccceee
Q 002069 25 HLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNF-LKGSIPPSLGNLTSLIYIDIGN-NLLSGSIPNEVGSLKSLSDLR 102 (973)
Q Consensus 25 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~-~~~~~p~~~~~l~~L~~L~l~~-n~l~~~~p~~~~~l~~L~~L~ 102 (973)
+|++|++++|++++..+..|..+++|++|++++|+ +++..+..|.++++|++|++++ |++++..+..|..+++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 45555555555554444445555555555555554 4433333455555555555555 555533334455555555555
Q ss_pred ccCCcCCCCCCCccccCCccc---eeecccc-cccccCcccccccCCCC-ceecccCCCCCCCCccccCccccceeeecc
Q 002069 103 LSNNSLNGSIPSSLGNLTNLV---TLYLHMN-ALSGSIPDEIGNLKFLS-DLQVSYNTLSGAIPFSLGNLTNLVTLYIGI 177 (973)
Q Consensus 103 L~~n~l~~~~p~~~~~l~~L~---~L~L~~n-~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~ 177 (973)
+++|++++ +|. +..+++|+ +|++++| ++++..+..|.++++|+ +|++++|+++...+..+.. ++|+.|++++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence 55555552 443 44555554 5555555 55543334455555555 5555555555222222332 4555555555
Q ss_pred cc-cCCCCCcccccc-CccceeeccccccccccccccCCCCcccEEecCCc
Q 002069 178 NA-LSGSIPNEIGNL-KSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVN 226 (973)
Q Consensus 178 n~-l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n 226 (973)
|+ ++...+..|.++ ++|++|++++|++++++.. .+++|+.|+++++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 53 553334445555 5555555555555544332 3344445554443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.4e-23 Score=225.85 Aligned_cols=225 Identities=16% Similarity=0.137 Sum_probs=184.1
Q ss_pred CCCCEEECCCCcccccCCc---CccCCCCCCeeeccCCcCCCCCCCcc--cCCCCCcEEEccCCcCcccCC----ccccC
Q 002069 24 THLKLLSFSKNQLSGLIPH---EIGRLSSLNGLSLYSNFLKGSIPPSL--GNLTSLIYIDIGNNLLSGSIP----NEVGS 94 (973)
Q Consensus 24 ~~L~~L~l~~n~l~~~~p~---~~~~l~~L~~L~l~~n~~~~~~p~~~--~~l~~L~~L~l~~n~l~~~~p----~~~~~ 94 (973)
..++.|.+.++.++...-. .+..+++|++|++++|++.+..|..+ +.+++|++|+|++|.+++..| ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 3478889988887532000 12335779999999999998899888 899999999999999986555 34567
Q ss_pred ccccceeeccCCcCCCCCCCccccCCccceeeccccccccc--C--cccccccCCCCceecccCCCCCCCCc----cccC
Q 002069 95 LKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGS--I--PDEIGNLKFLSDLQVSYNTLSGAIPF----SLGN 166 (973)
Q Consensus 95 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~--~--p~~~~~l~~L~~L~l~~N~l~~~~p~----~l~~ 166 (973)
+++|++|+|++|++.+..|..|+++++|++|+|++|++.+. + +..++.+++|++|++++|+++ .++. .+..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence 89999999999999987888999999999999999997642 2 233578999999999999997 3333 3578
Q ss_pred ccccceeeecccccCCCCCcccccc---CccceeeccccccccccccccCCCCcccEEecCCcccCCCCCcccccccccc
Q 002069 167 LTNLVTLYIGINALSGSIPNEIGNL---KSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLL 243 (973)
Q Consensus 167 l~~L~~L~l~~n~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 243 (973)
+++|++|++++|++++..|..+..+ ++|++|+|++|+++.++. .+. ++|+.|+|++|+++++ |. +..+++|+
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~-~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~ 297 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPK-GLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVD 297 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCS-CCC--SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhh-hhc--CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence 8999999999999998778888877 699999999999996644 443 8999999999999986 33 78889999
Q ss_pred ceecccccccC
Q 002069 244 ALQLNYNTLSG 254 (973)
Q Consensus 244 ~L~L~~N~l~~ 254 (973)
.|+|++|+++.
T Consensus 298 ~L~L~~N~l~~ 308 (310)
T 4glp_A 298 NLTLDGNPFLV 308 (310)
T ss_dssp CEECSSTTTSC
T ss_pred EEECcCCCCCC
Confidence 99999999863
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-22 Score=211.70 Aligned_cols=176 Identities=24% Similarity=0.229 Sum_probs=99.8
Q ss_pred cEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCC
Q 002069 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNN 82 (973)
Q Consensus 3 ~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n 82 (973)
+++++++++++ .+|..+. +++++|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|
T Consensus 17 ~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 93 (251)
T 3m19_A 17 KEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANN 93 (251)
T ss_dssp TEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred eEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCC
Confidence 45566666665 5665544 45666666666666555555666666666666666666555555566666666666666
Q ss_pred cCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCc
Q 002069 83 LLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPF 162 (973)
Q Consensus 83 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 162 (973)
++++..|..|+.+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|+++++|++|+|++|++++..+.
T Consensus 94 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 173 (251)
T 3m19_A 94 QLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHG 173 (251)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred cccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHH
Confidence 66544444555556666666666666543334455555666666665555544444555555555555555555544444
Q ss_pred cccCccccceeeecccccC
Q 002069 163 SLGNLTNLVTLYIGINALS 181 (973)
Q Consensus 163 ~l~~l~~L~~L~l~~n~l~ 181 (973)
.|..+++|+.|++++|.+.
T Consensus 174 ~~~~l~~L~~L~l~~N~~~ 192 (251)
T 3m19_A 174 AFDRLGKLQTITLFGNQFD 192 (251)
T ss_dssp TTTTCTTCCEEECCSCCBC
T ss_pred HHhCCCCCCEEEeeCCcee
Confidence 5555555555555555554
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=5.7e-23 Score=223.39 Aligned_cols=192 Identities=29% Similarity=0.449 Sum_probs=92.8
Q ss_pred CCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCcccccee
Q 002069 22 HLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDL 101 (973)
Q Consensus 22 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L 101 (973)
.+.+|++|++++|.++. +| .+..+++|++|++++|+++ .+|. ++.+++|++|++++|+++ .+| .+..+++|++|
T Consensus 39 ~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~-~~~~-~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L 112 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTL 112 (308)
T ss_dssp HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEE
T ss_pred HcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCC-CChh-HccCCCCCEEEccCCcCC-Cch-hhcCCCCCCEE
Confidence 34455555555555542 23 3445555555555555554 2333 455555555555555554 222 34445555555
Q ss_pred eccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccC
Q 002069 102 RLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181 (973)
Q Consensus 102 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~ 181 (973)
++++|++++ +|. +..+++|++|++++|+++ +..+ +..+++|+.|++++|+++
T Consensus 113 ~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~------------------------~~~~--l~~l~~L~~L~l~~n~l~ 164 (308)
T 1h6u_A 113 DLTSTQITD-VTP-LAGLSNLQVLYLDLNQIT------------------------NISP--LAGLTNLQYLSIGNAQVS 164 (308)
T ss_dssp ECTTSCCCC-CGG-GTTCTTCCEEECCSSCCC------------------------CCGG--GGGCTTCCEEECCSSCCC
T ss_pred ECCCCCCCC-chh-hcCCCCCCEEECCCCccC------------------------cCcc--ccCCCCccEEEccCCcCC
Confidence 555555542 222 444445555555555444 3222 444445555555555444
Q ss_pred CCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceeccccccc
Q 002069 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLS 253 (973)
Q Consensus 182 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (973)
+ ++. +..+++|++|++++|+++++.+ +..+++|+.|++++|+++++. .+..+++|+.|++++|+++
T Consensus 165 ~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 165 D-LTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp C-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred C-Chh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence 2 222 4455555555555555554332 455555555555555555442 2555555555555555554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.5e-23 Score=225.70 Aligned_cols=223 Identities=18% Similarity=0.163 Sum_probs=186.8
Q ss_pred CcEEeCCCCCCCCC-CCc--ccCCCCCCCEEECCCCcccccCCcCc--cCCCCCCeeeccCCcCCCCCC----CcccCCC
Q 002069 2 LKVLGLSFNQFSGS-IPP--EIGHLTHLKLLSFSKNQLSGLIPHEI--GRLSSLNGLSLYSNFLKGSIP----PSLGNLT 72 (973)
Q Consensus 2 l~~L~l~~~~l~~~-~p~--~~~~l~~L~~L~l~~n~l~~~~p~~~--~~l~~L~~L~l~~n~~~~~~p----~~~~~l~ 72 (973)
++.|+++++.++.. +.. ....+++|++|+|++|.+++..|..+ ..+++|++|+|++|++.+..| ..+..++
T Consensus 66 l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~ 145 (310)
T 4glp_A 66 VRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKP 145 (310)
T ss_dssp CCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCS
T ss_pred eeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhcc
Confidence 46677777776521 111 12245679999999999999999988 899999999999999997655 4456799
Q ss_pred CCcEEEccCCcCcccCCccccCccccceeeccCCcCCCC--C--CCccccCCccceeecccccccccCcc----cccccC
Q 002069 73 SLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGS--I--PSSLGNLTNLVTLYLHMNALSGSIPD----EIGNLK 144 (973)
Q Consensus 73 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~--~--p~~~~~l~~L~~L~L~~n~l~~~~p~----~~~~l~ 144 (973)
+|++|+|++|++++..|..++.+++|++|+|++|++.+. + +..++.+++|++|+|++|+++ .++. .+++++
T Consensus 146 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~ 224 (310)
T 4glp_A 146 GLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGV 224 (310)
T ss_dssp CCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTC
T ss_pred CCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCC
Confidence 999999999999977788999999999999999998642 2 334578999999999999997 4444 367889
Q ss_pred CCCceecccCCCCCCCCccccCc---cccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEE
Q 002069 145 FLSDLQVSYNTLSGAIPFSLGNL---TNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEIL 221 (973)
Q Consensus 145 ~L~~L~l~~N~l~~~~p~~l~~l---~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 221 (973)
+|++|+|++|++++..|..+..+ ++|++|++++|+++ .+|..+. ++|++|+|++|++++++. +..+++|+.|
T Consensus 225 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L 299 (310)
T 4glp_A 225 QPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAPQ--PDELPEVDNL 299 (310)
T ss_dssp CCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCCC--TTSCCCCSCE
T ss_pred CCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCch--hhhCCCccEE
Confidence 99999999999998878888777 69999999999999 6788775 899999999999997643 7889999999
Q ss_pred ecCCcccCC
Q 002069 222 YLDVNALSG 230 (973)
Q Consensus 222 ~L~~n~i~~ 230 (973)
++++|.++.
T Consensus 300 ~L~~N~l~~ 308 (310)
T 4glp_A 300 TLDGNPFLV 308 (310)
T ss_dssp ECSSTTTSC
T ss_pred ECcCCCCCC
Confidence 999999975
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-25 Score=252.11 Aligned_cols=93 Identities=24% Similarity=0.238 Sum_probs=43.7
Q ss_pred cCchhhcCCccceeeccccccCCCCC----ccccCCCCCCcEEcCCCCCC---Ccchhcc-------CCCCCCcEEEccC
Q 002069 304 IPLSLGSLTNLATLYFSTNALSGSIP----NEITNLRSLSDLQLSENTLN---GSIPLAL-------GNLTKLVSLDLSI 369 (973)
Q Consensus 304 ~~~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~N~l~---~~~~~~~-------~~l~~L~~L~Ls~ 369 (973)
++..+..+++|++|+|++|.++...+ ..+..+++|++|+|++|.+. +.+|..+ ..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 44455555666666666666554322 22445555555555554332 2223222 4455555555555
Q ss_pred CcccC----CCCcccccccccchhccccccc
Q 002069 370 NKLSG----SIPLSFASLTSLTTLYLYENSL 396 (973)
Q Consensus 370 N~i~~----~~~~~~~~l~~L~~L~L~~N~l 396 (973)
|++++ ..+..+..+++|++|+|++|.+
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l 134 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL 134 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCC
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCC
Confidence 55543 1233333444444444444444
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-22 Score=225.95 Aligned_cols=216 Identities=20% Similarity=0.139 Sum_probs=101.7
Q ss_pred EEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCC-CcccCCCCCcE-EEccC
Q 002069 4 VLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIP-PSLGNLTSLIY-IDIGN 81 (973)
Q Consensus 4 ~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p-~~~~~l~~L~~-L~l~~ 81 (973)
+++-++++++ .+|..+ .+++++|+|++|+|+...+..|.++++|++|+|++|++.+.+| .+|.++++|++ ++++.
T Consensus 13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 3444555555 555544 2455555555555554333345555555555555555543333 23455555443 34444
Q ss_pred CcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeeccc-ccccccCcccccccCCCCceecccCCCCCCC
Q 002069 82 NLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHM-NALSGSIPDEIGNLKFLSDLQVSYNTLSGAI 160 (973)
Q Consensus 82 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 160 (973)
|+++...|+.|..+++|++|++++|++++..+..+....++..|++.+ |++....+..|..+.
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~---------------- 153 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS---------------- 153 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB----------------
T ss_pred CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcc----------------
Confidence 555544444555555555555555555533333444444455555533 344433333344432
Q ss_pred CccccCccccceeeecccccCCCCCccccccCccceeecc-ccccccccccccCCCCcccEEecCCcccCCCCCcccccc
Q 002069 161 PFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLD-YNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNL 239 (973)
Q Consensus 161 p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l 239 (973)
..++.|++++|+|+ .+|.......+|++|+++ +|.++.++.+.|.++++|++|+|++|+|+.+++..|.++
T Consensus 154 -------~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L 225 (350)
T 4ay9_X 154 -------FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 225 (350)
T ss_dssp -------SSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTC
T ss_pred -------hhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccc
Confidence 13444444444444 233333333444455544 244444444445555555555555555554444444444
Q ss_pred cccccee
Q 002069 240 KSLLALQ 246 (973)
Q Consensus 240 ~~L~~L~ 246 (973)
++|+.++
T Consensus 226 ~~L~~l~ 232 (350)
T 4ay9_X 226 KKLRARS 232 (350)
T ss_dssp CEEECTT
T ss_pred hHhhhcc
Confidence 4444433
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=225.16 Aligned_cols=239 Identities=19% Similarity=0.129 Sum_probs=161.0
Q ss_pred CeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCC-CccccCCccce-eecc
Q 002069 51 NGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIP-SSLGNLTNLVT-LYLH 128 (973)
Q Consensus 51 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~-L~L~ 128 (973)
++++.++++++ .+|..+ .+++++|+|++|+++...+..|.++++|++|+|++|++.+.+| ..|.++++|++ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 45566666666 566555 2466777777777763333456677777777777777654444 35666766554 4555
Q ss_pred cccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecc-cccCCCCCccccccC-ccceeecccccccc
Q 002069 129 MNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGI-NALSGSIPNEIGNLK-SLSDLRLDYNTLSG 206 (973)
Q Consensus 129 ~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~-n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~ 206 (973)
.|+++...|+.|.++++|++|++++|+++...+..+....++..|++.. +++....+..|..+. .++.|+|++|+|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 6777766667777777777777777777766666666677777777754 566655555666664 68889999999998
Q ss_pred ccccccCCCCcccEEecC-CcccCCCCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhc
Q 002069 207 SILYSFGNLTKLEILYLD-VNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIG 285 (973)
Q Consensus 207 ~~~~~~~~l~~L~~L~L~-~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~ 285 (973)
++...|. ..+|+.|+++ +|.++.+.++.|.++++|++|+|++|+|+.+++..|.++++|+.+++. .+...+ .+.
T Consensus 169 i~~~~f~-~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~~--~l~~lP--~l~ 243 (350)
T 4ay9_X 169 IHNSAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY--NLKKLP--TLE 243 (350)
T ss_dssp ECTTSST-TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTCT--TCCCCC--CTT
T ss_pred CChhhcc-ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccCC--CcCcCC--Cch
Confidence 7776664 4678888886 578888877888999999999999999988777777777766655442 222222 244
Q ss_pred cccccceEEccc
Q 002069 286 NLKSLLHLQLNY 297 (973)
Q Consensus 286 ~l~~L~~L~l~~ 297 (973)
++++|+.+++.+
T Consensus 244 ~l~~L~~l~l~~ 255 (350)
T 4ay9_X 244 KLVALMEASLTY 255 (350)
T ss_dssp TCCSCCEEECSC
T ss_pred hCcChhhCcCCC
Confidence 455555555543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-22 Score=218.84 Aligned_cols=191 Identities=25% Similarity=0.347 Sum_probs=157.7
Q ss_pred CcEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccC
Q 002069 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGN 81 (973)
Q Consensus 2 l~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~ 81 (973)
|+.|++++|+++ .+| .+..+++|++|+|++|++++. |. +..+++|++|++++|+++ .+| .++.+++|++|++++
T Consensus 43 L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~l~~ 116 (308)
T 1h6u_A 43 ITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTS 116 (308)
T ss_dssp CCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTT
T ss_pred cCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCC-Cch-hhcCCCCCCEEECCC
Confidence 789999999998 676 699999999999999999964 44 999999999999999998 455 699999999999999
Q ss_pred CcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCC
Q 002069 82 NLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIP 161 (973)
Q Consensus 82 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 161 (973)
|++++ +|. +..+++|++|++++|++++ +|. ++.+++|++|++++|++++ ++. +.++++|++|++++|++++..+
T Consensus 117 n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~ 190 (308)
T 1h6u_A 117 TQITD-VTP-LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISP 190 (308)
T ss_dssp SCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG
T ss_pred CCCCC-chh-hcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChh
Confidence 99984 554 8999999999999999985 444 8899999999999999984 444 8888888888888888875443
Q ss_pred ccccCccccceeeecccccCCCCCccccccCccceeecccccccccc
Q 002069 162 FSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSI 208 (973)
Q Consensus 162 ~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 208 (973)
+..+++|+.|++++|++++.. .+..+++|++|++++|++++.+
T Consensus 191 --l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 191 --LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp --GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEECCC
T ss_pred --hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeecCC
Confidence 667777777777777777433 2666777777777777766533
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=5.5e-22 Score=209.07 Aligned_cols=180 Identities=26% Similarity=0.258 Sum_probs=100.4
Q ss_pred CCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeecc
Q 002069 25 HLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLS 104 (973)
Q Consensus 25 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~ 104 (973)
..++++++++.++ .+|..+. ++|+.|+|++|++.+..|..|+++++|++|+|++|++++..|..+..+++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 3455666666665 3454443 455566666666554444555555555555555555554444445555555555555
Q ss_pred CCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCC
Q 002069 105 NNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSI 184 (973)
Q Consensus 105 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~ 184 (973)
+|++++..|..|..+++|++|+|++|+++ +..+..|..+++|+.|++++|++++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~------------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 147 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLK------------------------SLPSGVFDRLTKLKELRLNTNQLQSIP 147 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCC------------------------CCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCC------------------------CcChhHhccCCcccEEECcCCcCCccC
Confidence 55555433444455555555555555554 343444455555555555555555444
Q ss_pred CccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCC
Q 002069 185 PNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGL 231 (973)
Q Consensus 185 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~ 231 (973)
+..|..+++|++|+|++|+++++++..|..+++|+.|++++|.++..
T Consensus 148 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 148 AGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred HHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 44555666666666666666666666666666666666666666544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-24 Score=244.64 Aligned_cols=261 Identities=19% Similarity=0.170 Sum_probs=134.2
Q ss_pred CCccccCccccceeeecccccCCCCC----ccccccCccceeeccccccc---cccccc-------cCCCCcccEEecCC
Q 002069 160 IPFSLGNLTNLVTLYIGINALSGSIP----NEIGNLKSLSDLRLDYNTLS---GSILYS-------FGNLTKLEILYLDV 225 (973)
Q Consensus 160 ~p~~l~~l~~L~~L~l~~n~l~~~~p----~~~~~l~~L~~L~L~~N~l~---~~~~~~-------~~~l~~L~~L~L~~ 225 (973)
++..+..+++|+.|++++|.++...+ ..+..+++|++|+|++|.+. +..+.. |..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 34445555555555555555553322 22445555555555554332 111222 24445555555555
Q ss_pred cccCC----CCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccc---------cccce
Q 002069 226 NALSG----LIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNL---------KSLLH 292 (973)
Q Consensus 226 n~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l---------~~L~~ 292 (973)
|.++. ..+..+..+++|+.|+|++|.++...+..+ ...+..+ ++|++
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l--------------------~~~l~~l~~~~~~~~~~~L~~ 163 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI--------------------ARALQELAVNKKAKNAPPLRS 163 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHH--------------------HHHHHHHHHHHHHHTCCCCCE
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHH--------------------HHHHHHHhhhhhcccCCCCcE
Confidence 55544 123344444555555555554432111111 1112222 66777
Q ss_pred EEcccccccC-CcC---chhhcCCccceeeccccccCC-----CCCccccCCCCCCcEEcCCCCCC----CcchhccCCC
Q 002069 293 LQLNYNTLSG-SIP---LSLGSLTNLATLYFSTNALSG-----SIPNEITNLRSLSDLQLSENTLN----GSIPLALGNL 359 (973)
Q Consensus 293 L~l~~n~l~~-~~~---~~~~~l~~L~~L~L~~n~l~~-----~~~~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l 359 (973)
|++++|+++. ..+ ..+..+++|++|++++|.++. ..+..+..+++|+.|+|++|.++ ..+|..+..+
T Consensus 164 L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~ 243 (386)
T 2ca6_A 164 IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243 (386)
T ss_dssp EECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGC
T ss_pred EECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccC
Confidence 7777777652 223 345566667777777776652 23335666666777777777664 3455566666
Q ss_pred CCCcEEEccCCcccCC----CCcccc--cccccchhccccccccc----CCCccc-CCCCCCCEEEccCCCCCCCcc--h
Q 002069 360 TKLVSLDLSINKLSGS----IPLSFA--SLTSLTTLYLYENSLCD----SIPKEI-GDMKSLSILDLSSNKLNGSIP--L 426 (973)
Q Consensus 360 ~~L~~L~Ls~N~i~~~----~~~~~~--~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~Ls~N~l~~~~~--~ 426 (973)
++|++|+|++|+|++. .+..+. .+++|+.|+|++|.+++ .+|..+ .++++|++|++++|++++..+ .
T Consensus 244 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~~~~ 323 (386)
T 2ca6_A 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVD 323 (386)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSHHHH
T ss_pred CCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchhHHH
Confidence 6677777777766643 233332 25666666666666655 244444 445666666666666665443 4
Q ss_pred hhhhhcccceEEEe
Q 002069 427 SLANLTNSLKVLYL 440 (973)
Q Consensus 427 ~~~~~~~~L~~L~L 440 (973)
.+....++++.+++
T Consensus 324 ~l~~~l~~~~~~~l 337 (386)
T 2ca6_A 324 EIREVFSTRGRGEL 337 (386)
T ss_dssp HHHHHHHHHTCCEE
T ss_pred HHHHHhhhcCcchh
Confidence 44444444443333
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=5.5e-24 Score=235.44 Aligned_cols=252 Identities=20% Similarity=0.294 Sum_probs=190.0
Q ss_pred CCCEEECCCCcccccCCcCccCC--CCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCccc-CCccccCcccccee
Q 002069 25 HLKLLSFSKNQLSGLIPHEIGRL--SSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGS-IPNEVGSLKSLSDL 101 (973)
Q Consensus 25 ~L~~L~l~~n~l~~~~p~~~~~l--~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~-~p~~~~~l~~L~~L 101 (973)
.++.||+++|.+. |..+..+ ++++.|++++|.+.+..|. +..+++|++|++++|.+++. +|..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4788899988876 4567777 8899999999998855444 66788999999999988754 77788888899999
Q ss_pred eccCCcCCCCCCCccccCCccceeecccc-cccc-cCcccccccCCCCceecccC-CCCCC-CCccccCcc-ccceeeec
Q 002069 102 RLSNNSLNGSIPSSLGNLTNLVTLYLHMN-ALSG-SIPDEIGNLKFLSDLQVSYN-TLSGA-IPFSLGNLT-NLVTLYIG 176 (973)
Q Consensus 102 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~n-~l~~-~~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~l~~l~-~L~~L~l~ 176 (973)
+|++|++++..|..++.+++|++|+|++| .+++ .++..+.++++|++|++++| .+++. ++..+..++ +|++|+++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 99999887777778888889999999988 6764 26677888888888888888 88743 566677888 88888888
Q ss_pred ccc--cC-CCCCccccccCccceeeccccc-cccccccccCCCCcccEEecCCcccCCCCCc---cccccccccceeccc
Q 002069 177 INA--LS-GSIPNEIGNLKSLSDLRLDYNT-LSGSILYSFGNLTKLEILYLDVNALSGLIPN---EIGNLKSLLALQLNY 249 (973)
Q Consensus 177 ~n~--l~-~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~---~~~~l~~L~~L~L~~ 249 (973)
+|. ++ +.+|..+.++++|++|++++|. +++..+..+..+++|+.|++++|. .+.+. .+.++++|+.|++++
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~--~~~~~~~~~l~~~~~L~~L~l~~ 281 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY--DIIPETLLELGEIPTLKTLQVFG 281 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT--TCCGGGGGGGGGCTTCCEEECTT
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC--CCCHHHHHHHhcCCCCCEEeccC
Confidence 884 43 3456677778888888888888 666666677888888888888885 22233 567777778887777
Q ss_pred ccccCCCCcccCCcchhhhccCCCcccCchhhhhhccc-cccceEEcccccccCCcCchhhc
Q 002069 250 NTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNL-KSLLHLQLNYNTLSGSIPLSLGS 310 (973)
Q Consensus 250 N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~ 310 (973)
| ++ .. .+..+ .+++.|++++|++++..|..++.
T Consensus 282 ~-i~---~~------------------------~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 282 I-VP---DG------------------------TLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp S-SC---TT------------------------CHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred c-cC---HH------------------------HHHHHHhhCcceEEecccCccccCCcccc
Confidence 7 32 11 12222 24667778899998888877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.2e-22 Score=212.70 Aligned_cols=154 Identities=18% Similarity=0.106 Sum_probs=122.7
Q ss_pred HHHHHhcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcch---------------hhHHHHHHHHHHhhcCCC
Q 002069 695 EIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEM---------------ACQQEFLNEGNALTKIRH 759 (973)
Q Consensus 695 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~e~~~l~~l~h 759 (973)
........|++.+.||+|+||.||+|...+|+.||||+++....... .....+.+|+.++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 34444567778899999999999999778899999999864322110 23567899999999998
Q ss_pred CceeeeceeeeccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeee
Q 002069 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLL 839 (973)
Q Consensus 760 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill 839 (973)
| +++.+++.. +..++||||+++++|.+ +.. .+...++.|++.|++|||+. +|+||||||+||++
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl 226 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV 226 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEE
Confidence 5 677776544 46699999999999988 421 23457999999999999999 99999999999999
Q ss_pred cCCCceEEecccccccccCCCCcccccccccCcccccccc
Q 002069 840 NLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAY 879 (973)
Q Consensus 840 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~ 879 (973)
+ ++.+||+|||+|+. +..|+|||++.
T Consensus 227 ~-~~~vkl~DFG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp E-TTEEEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred E-CCcEEEEECCCCeE-------------CCCCCHHHHHH
Confidence 9 99999999999863 33478899874
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=5.2e-21 Score=195.37 Aligned_cols=181 Identities=24% Similarity=0.245 Sum_probs=137.4
Q ss_pred cEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCC
Q 002069 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNN 82 (973)
Q Consensus 3 ~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n 82 (973)
+.++.++++++ .+|..+ .++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 45777888887 677665 357888888888888666666788888888888888888555556778888888888888
Q ss_pred cCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCc
Q 002069 83 LLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPF 162 (973)
Q Consensus 83 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 162 (973)
++++..+..++.+++|++|++++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|++++|.+.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~---- 162 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC---- 162 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence 8885555557788888888888888886555567888888888888888886555567888888888888887653
Q ss_pred cccCccccceeeecccccCCCCCccccccCc
Q 002069 163 SLGNLTNLVTLYIGINALSGSIPNEIGNLKS 193 (973)
Q Consensus 163 ~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~ 193 (973)
.+++|+.|+++.|++++.+|..++.++.
T Consensus 163 ---~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 163 ---TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ---CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ---CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 3557777888888888777877776554
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.1e-20 Score=219.95 Aligned_cols=189 Identities=26% Similarity=0.305 Sum_probs=142.2
Q ss_pred CCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeecc
Q 002069 25 HLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLS 104 (973)
Q Consensus 25 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~ 104 (973)
+|++|+|++|++++ +|..+. ++|++|+|++|+++ .+| ..+++|++|+|++|++++ +|. +.. +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 78888888888875 666653 77888888888887 677 456788888888888874 776 655 78888888
Q ss_pred CCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCC
Q 002069 105 NNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSI 184 (973)
Q Consensus 105 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~ 184 (973)
+|++++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|++++ +|. |. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 888874 666 57788888888888874 565 56788888888888875 555 55 78888888888888 56
Q ss_pred CccccccCcc-------ceeeccccccccccccccCCCCcccEEecCCcccCCCCCcccccccc
Q 002069 185 PNEIGNLKSL-------SDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241 (973)
Q Consensus 185 p~~~~~l~~L-------~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~ 241 (973)
|. +.. +| +.|+|++|+|+.++. .+..+++|+.|+|++|.+++..|..+..+..
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp~-~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRITHIPE-NILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCCCCCG-GGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcceecCH-HHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 66 554 66 889999999986544 4555899999999999998877777776654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.1e-20 Score=189.63 Aligned_cols=180 Identities=25% Similarity=0.225 Sum_probs=115.0
Q ss_pred CEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCC
Q 002069 27 KLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNN 106 (973)
Q Consensus 27 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n 106 (973)
+.++.+++.++ .+|..+ .++|++|++++|++++..+..|+.+++|++|++++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 56777777776 455444 357777777777777555555677777777777777777444445667777777777777
Q ss_pred cCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCc
Q 002069 107 SLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPN 186 (973)
Q Consensus 107 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~ 186 (973)
++++..+..|.++++|++|++++|++++..+..|.++++|++|++++|++++..+..+..+++|+.|++++|.+.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~---- 162 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC---- 162 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence 7775444556677777777777777765555556666777777777776665555556666666666666665542
Q ss_pred cccccCccceeeccccccccccccccCCCC
Q 002069 187 EIGNLKSLSDLRLDYNTLSGSILYSFGNLT 216 (973)
Q Consensus 187 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 216 (973)
.+++|+.|+++.|++++..+..++.++
T Consensus 163 ---~~~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 163 ---TCPGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp ---CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred ---CCCCHHHHHHHHHhCCceeeccCcccc
Confidence 234555555666666555555444443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.1e-20 Score=216.25 Aligned_cols=189 Identities=25% Similarity=0.299 Sum_probs=163.2
Q ss_pred CCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecc
Q 002069 49 SLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLH 128 (973)
Q Consensus 49 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 128 (973)
+|+.|+|++|++++ +|..+. ++|++|+|++|+++ .+| ..+++|++|+|++|++++ +|. +.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 99999999999995 888774 89999999999999 788 457899999999999995 887 765 99999999
Q ss_pred cccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeecccccccccc
Q 002069 129 MNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSI 208 (973)
Q Consensus 129 ~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 208 (973)
+|+|++ +|. .+++|+.|++++|.+++ +|. .+++|+.|++++|++++ +|. |. ++|+.|+|++|+|+.++
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp 196 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESLP 196 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCchh
Confidence 999995 676 68999999999999996 555 67899999999999995 777 66 99999999999999766
Q ss_pred ccccCCCCcc-------cEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcch
Q 002069 209 LYSFGNLTKL-------EILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTK 265 (973)
Q Consensus 209 ~~~~~~l~~L-------~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 265 (973)
. |.. +| +.|+|++|+|+.+ |..+..+++|+.|+|++|++++..|..|..++.
T Consensus 197 ~--~~~--~L~~~~~~L~~L~Ls~N~l~~l-p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 197 A--VPV--RNHHSEETEIFFRCRENRITHI-PENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp C--CC----------CCEEEECCSSCCCCC-CGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred h--HHH--hhhcccccceEEecCCCcceec-CHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 5 554 77 9999999999976 677777999999999999999888887776554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.1e-20 Score=199.88 Aligned_cols=172 Identities=27% Similarity=0.354 Sum_probs=75.8
Q ss_pred cCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccce
Q 002069 45 GRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVT 124 (973)
Q Consensus 45 ~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 124 (973)
..+++|++|++++|.+. .+|. ++.+++|++|++++|++++ ++. +..+++|++|++++|++++ +| .+..+++|++
T Consensus 43 ~~l~~L~~L~l~~~~i~-~~~~-~~~l~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCC-CCTT-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCE
T ss_pred hhcCcccEEEccCCCcc-cChh-HhcCCCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCE
Confidence 34444444444444444 2222 4444444444444444442 222 4444444444444444442 22 2444444444
Q ss_pred eecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeecccccc
Q 002069 125 LYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTL 204 (973)
Q Consensus 125 L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 204 (973)
|++++|++++ + +.+..+++|++|++++|++++. ..+..+++|+.|++++|++++..| +..+++|++|++++|++
T Consensus 117 L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 117 LSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp EECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence 4444444442 1 2344444444444444444422 234444444444444444443222 44444444455544444
Q ss_pred ccccccccCCCCcccEEecCCcccCC
Q 002069 205 SGSILYSFGNLTKLEILYLDVNALSG 230 (973)
Q Consensus 205 ~~~~~~~~~~l~~L~~L~L~~n~i~~ 230 (973)
++++ .+..+++|+.|++++|.++.
T Consensus 191 ~~l~--~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 191 SDLR--ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CBCG--GGTTCTTCSEEEEEEEEEEC
T ss_pred CCCh--hhccCCCCCEEECcCCcccC
Confidence 4332 24444555555555554443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.9e-20 Score=201.63 Aligned_cols=192 Identities=25% Similarity=0.357 Sum_probs=163.5
Q ss_pred EeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcC
Q 002069 5 LGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLL 84 (973)
Q Consensus 5 L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l 84 (973)
+.+..+.+++. ..+..+++|++|++++|.+++. | .+..+++|++|++++|++++ +|. ++.+++|++|++++|++
T Consensus 29 ~~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l 102 (291)
T 1h6t_A 29 DNLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKV 102 (291)
T ss_dssp HHTTCSCTTSE--ECHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCC
T ss_pred HHhcCCCcccc--cchhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcC
Confidence 35566666532 2346789999999999999854 4 59999999999999999994 555 99999999999999999
Q ss_pred cccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccc
Q 002069 85 SGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSL 164 (973)
Q Consensus 85 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l 164 (973)
+ .+| .++.+++|++|++++|++++ + ..+..+++|++|++++|++++. ..++.+++|++|++++|++++..| +
T Consensus 103 ~-~~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l 174 (291)
T 1h6t_A 103 K-DLS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--L 174 (291)
T ss_dssp C-CGG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--G
T ss_pred C-CCh-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--h
Confidence 8 454 48999999999999999985 4 5799999999999999999854 689999999999999999996655 8
Q ss_pred cCccccceeeecccccCCCCCccccccCccceeecccccccccccccc
Q 002069 165 GNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSF 212 (973)
Q Consensus 165 ~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~ 212 (973)
..+++|+.|++++|.+++ +| .+..+++|+.|++++|++...+...+
T Consensus 175 ~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~~~~~~ 220 (291)
T 1h6t_A 175 AGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNKPINHQ 220 (291)
T ss_dssp TTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECCCEECC
T ss_pred cCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCCccccc
Confidence 999999999999999995 55 48999999999999999987554443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=2.5e-20 Score=219.71 Aligned_cols=193 Identities=24% Similarity=0.315 Sum_probs=123.5
Q ss_pred CCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeec
Q 002069 24 THLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRL 103 (973)
Q Consensus 24 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L 103 (973)
..+..+.++.+.+.+..+ +..|++|+.|++++|.+. .+| .++.+++|++|+|++|++++ +|. +..+++|++|+|
T Consensus 21 ~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~-~~~-l~~l~~L~~L~L 94 (605)
T 1m9s_A 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IKP-LTNLKNLGWLFL 94 (605)
T ss_dssp HHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCC-CGG-GGGCTTCCEEEC
T ss_pred HHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCC-Chh-hccCCCCCEEEC
Confidence 334555666666664432 566777777777777776 444 47777777777777777764 333 667777777777
Q ss_pred cCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCC
Q 002069 104 SNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGS 183 (973)
Q Consensus 104 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~ 183 (973)
++|++++ +| .+..+++|++|+|++|++++ + ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++.+.
T Consensus 95 s~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~ 168 (605)
T 1m9s_A 95 DENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI 168 (605)
T ss_dssp CSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCC
T ss_pred cCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCc
Confidence 7777763 33 56777777777777777763 2 3466677777777777776643 4566666666666666666644
Q ss_pred CCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCC
Q 002069 184 IPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLI 232 (973)
Q Consensus 184 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~ 232 (973)
.| +..+++|+.|+|++|+|+++ ..+..+++|+.|+|++|.+.+.+
T Consensus 169 ~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p 213 (605)
T 1m9s_A 169 VP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKP 213 (605)
T ss_dssp GG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCC
T ss_pred hh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCc
Confidence 33 66666666666666666654 24666666666666666665543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=6.4e-20 Score=216.26 Aligned_cols=202 Identities=25% Similarity=0.347 Sum_probs=172.0
Q ss_pred EEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCc
Q 002069 4 VLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNL 83 (973)
Q Consensus 4 ~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~ 83 (973)
.++++.+.++. ++ .+..|.+|++|++++|.+.. +| .+..+++|+.|+|++|++.+ +|. +..+++|++|+|++|+
T Consensus 25 ~l~l~~~~i~~-~~-~~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~-~~~-l~~l~~L~~L~Ls~N~ 98 (605)
T 1m9s_A 25 KDNLKKKSVTD-AV-TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IKP-LTNLKNLGWLFLDENK 98 (605)
T ss_dssp HHHTTCSCTTS-EE-CHHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCC-CGG-GGGCTTCCEEECCSSC
T ss_pred HHhccCCCccc-cc-chhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCC-Chh-hccCCCCCEEECcCCC
Confidence 35677777763 32 35788999999999999985 45 69999999999999999995 444 9999999999999999
Q ss_pred CcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCcc
Q 002069 84 LSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFS 163 (973)
Q Consensus 84 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 163 (973)
++ .+| .+..+++|++|+|++|++++ + ..+..+++|+.|+|++|++++. ..|+.+++|+.|+|++|++++..|
T Consensus 99 l~-~l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-- 170 (605)
T 1m9s_A 99 IK-DLS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-- 170 (605)
T ss_dssp CC-CCT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--
T ss_pred CC-CCh-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--
Confidence 98 455 79999999999999999984 4 4699999999999999999854 689999999999999999997766
Q ss_pred ccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEE
Q 002069 164 LGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEIL 221 (973)
Q Consensus 164 l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 221 (973)
+..+++|+.|+|++|.|++ + ..+..+++|+.|+|++|.+.+.+...+..+..+..+
T Consensus 171 l~~l~~L~~L~Ls~N~i~~-l-~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~~~~~l 226 (605)
T 1m9s_A 171 LAGLTKLQNLYLSKNHISD-L-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 226 (605)
T ss_dssp GTTCTTCCEEECCSSCCCB-C-GGGTTCTTCSEEECCSEEEECCCCCCCSSCEEECCC
T ss_pred hccCCCCCEEECcCCCCCC-C-hHHccCCCCCEEEccCCcCcCCcccccccEEecccc
Confidence 9999999999999999995 4 469999999999999999998766655555444433
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.6e-19 Score=185.52 Aligned_cols=151 Identities=21% Similarity=0.221 Sum_probs=79.1
Q ss_pred EEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCC-CcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCC
Q 002069 28 LLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIP-PSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNN 106 (973)
Q Consensus 28 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n 106 (973)
++++++|.++ .+|..+. ..+++|+|++|++++..| ..|+.+++|++|+|++|++++..|..|+.+++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 4555555554 2344332 233455555555553322 23455555555555555555444445555555555555555
Q ss_pred cCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccC
Q 002069 107 SLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181 (973)
Q Consensus 107 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~ 181 (973)
++++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|..+++|+.|++++|.+.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 555444444555555555555555555444555555555555555555555555555555666666666666555
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=2.1e-19 Score=184.72 Aligned_cols=152 Identities=23% Similarity=0.275 Sum_probs=92.3
Q ss_pred CEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCC
Q 002069 27 KLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNN 106 (973)
Q Consensus 27 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n 106 (973)
+.+++++|+++ .+|..+. ++|++|++++|++++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 45555555555 3454443 45666666666665444445666666666666666666555666666666666666666
Q ss_pred cCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccC
Q 002069 107 SLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181 (973)
Q Consensus 107 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~ 181 (973)
+++...+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..+..|..+++|+.|++++|.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 666433344566666666666666666555666666666666666666666555556666666777777766665
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=9.4e-20 Score=202.89 Aligned_cols=176 Identities=24% Similarity=0.191 Sum_probs=101.7
Q ss_pred CEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCccc-CCCCCcEEEccCCcCcccCCccccCccccceeeccC
Q 002069 27 KLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLG-NLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSN 105 (973)
Q Consensus 27 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~-~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~ 105 (973)
+.+++++|+++ .+|..+. ..++.|+|++|++++..+..+. ++++|++|+|++|++++..|..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 45566666555 3454443 2355666666666544444444 566666666666666544445566666666666666
Q ss_pred CcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccc---cCccccceeeecccccCC
Q 002069 106 NSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSL---GNLTNLVTLYIGINALSG 182 (973)
Q Consensus 106 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l---~~l~~L~~L~l~~n~l~~ 182 (973)
|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..+..| ..+++|+.|+|++|+|+.
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 66654444455666666666666666665555566666666666666666664333333 456666666666666664
Q ss_pred CCCccccccCc--cceeeccccccc
Q 002069 183 SIPNEIGNLKS--LSDLRLDYNTLS 205 (973)
Q Consensus 183 ~~p~~~~~l~~--L~~L~L~~N~l~ 205 (973)
..+..+..++. |+.|+|++|.+.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCHHHhhhccHhhcceEEecCCCcc
Confidence 44455666665 366777777765
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=9.8e-20 Score=202.76 Aligned_cols=175 Identities=26% Similarity=0.238 Sum_probs=96.2
Q ss_pred EEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccc-cCCccceeecccccccccCcccccccCCCCceecccC
Q 002069 76 YIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLG-NLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYN 154 (973)
Q Consensus 76 ~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N 154 (973)
.+++++|.++ .+|..+.. .+++|+|++|+|++..+..+. ++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 22 ~l~c~~~~l~-~iP~~~~~--~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCS-SCCSSCCT--TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCccCCC--CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 4444444444 34443322 344455555554433333343 4455555555555554444444555555555555555
Q ss_pred CCCCCCCccccCccccceeeecccccCCCCCccccccCccceeecccccccccccccc---CCCCcccEEecCCcccCCC
Q 002069 155 TLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSF---GNLTKLEILYLDVNALSGL 231 (973)
Q Consensus 155 ~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~L~~n~i~~~ 231 (973)
+++...+..|.++++|+.|+|++|+|+...|..|.++++|++|+|++|+++.++...| ..+++|+.|+|++|+|+.+
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 178 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence 5554444445555555555555555554455556666666666666666666555555 4567777777777777766
Q ss_pred CCcccccccc--ccceeccccccc
Q 002069 232 IPNEIGNLKS--LLALQLNYNTLS 253 (973)
Q Consensus 232 ~~~~~~~l~~--L~~L~L~~N~l~ 253 (973)
.+..|..++. ++.|+|++|.+.
T Consensus 179 ~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 179 PLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CHHHHHHSCHHHHTTEECCSSCEE
T ss_pred CHHHhhhccHhhcceEEecCCCcc
Confidence 6666666665 367777777775
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=8.1e-19 Score=181.63 Aligned_cols=152 Identities=22% Similarity=0.266 Sum_probs=87.4
Q ss_pred CEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCC
Q 002069 27 KLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNN 106 (973)
Q Consensus 27 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n 106 (973)
+.++.++++++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|+++...+..|..+++|++|+|++|
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 44555555554 3444433 55556666666655555555556666666666666665333334455666666666666
Q ss_pred cCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCC
Q 002069 107 SLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSG 182 (973)
Q Consensus 107 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~ 182 (973)
++++..+..|..+++|++|+|++|+|+ .+|..+.++++|++|+|++|++++..+..|..+++|+.|++++|.+..
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 665444444555666666666666665 455556666666666666666665555556666666666666666653
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=5.3e-19 Score=181.69 Aligned_cols=151 Identities=19% Similarity=0.221 Sum_probs=83.4
Q ss_pred EEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCc
Q 002069 4 VLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNL 83 (973)
Q Consensus 4 ~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~ 83 (973)
.+++++++++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 4555555555 5555443 455555555555555444455555555555555555554445555555555555555555
Q ss_pred CcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCC
Q 002069 84 LSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLS 157 (973)
Q Consensus 84 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~ 157 (973)
++...+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..++.|..+++|++|++++|.+.
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 55322233455555555555555555544555555555555555555555444445555555555555555553
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.3e-19 Score=191.80 Aligned_cols=172 Identities=21% Similarity=0.269 Sum_probs=104.3
Q ss_pred CCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCcccccee
Q 002069 22 HLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDL 101 (973)
Q Consensus 22 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L 101 (973)
.+.+++.+++++|.+++. + .+..+++|++|++++|+++ .+| .++.+++|++|+|++|++++ +|. ++.+++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEE
Confidence 345556666666666643 3 4666666666666666666 455 46666666777776666663 333 6666666677
Q ss_pred eccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccC
Q 002069 102 RLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181 (973)
Q Consensus 102 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~ 181 (973)
+|++|++++ +|... . ++|++|+|++|++++ + +.++++++|++|++++|++++. + .+..+++|+.|++++|+++
T Consensus 91 ~L~~N~l~~-l~~~~-~-~~L~~L~L~~N~l~~-~-~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKN-LNGIP-S-ACLSRLFLDNNELRD-T-DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSC-CTTCC-C-SSCCEEECCSSCCSB-S-GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCC-cCccc-c-CcccEEEccCCccCC-C-hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 777666663 44322 2 666666666666663 2 2466666666666666666633 2 4566666666666666666
Q ss_pred CCCCccccccCccceeecccccccccc
Q 002069 182 GSIPNEIGNLKSLSDLRLDYNTLSGSI 208 (973)
Q Consensus 182 ~~~p~~~~~l~~L~~L~L~~N~l~~~~ 208 (973)
+. ..+..+++|+.|++++|.+...+
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred ch--HHhccCCCCCEEeCCCCcccCCc
Confidence 43 45566666666666666665543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.78 E-value=9.5e-20 Score=200.23 Aligned_cols=221 Identities=13% Similarity=0.102 Sum_probs=137.2
Q ss_pred cCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceeccccc----ccCCCCcccCCcchh
Q 002069 191 LKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNT----LSGSIPCSFGNLTKL 266 (973)
Q Consensus 191 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~----l~~~~~~~~~~l~~L 266 (973)
+++|+.|+|.+ .++.+...+|.+|++|+.+++++|.+..+.+.+|.++.++..+.+..+. ...+...+|.++..|
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 55555555555 4555555555555555555555555555555555555444444443321 122223334333333
Q ss_pred h-hccCCCcc-cCchhhhhhccccccceEEcccccccCCcCchh-hcCCccceeeccccccCCCCCccccCCCCCCcEEc
Q 002069 267 V-ISCLGTNA-LSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSL-GSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQL 343 (973)
Q Consensus 267 ~-~l~l~~n~-i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 343 (973)
+ .+.+.... +.......--...++..+.+.++-.. .....+ ..+++|+.+++++|+++.+.+.+|.++++|+.|+|
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l 257 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKL 257 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEEC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEEC
Confidence 3 12211110 11111111123566677777655322 222222 23788999999988888777888888999999999
Q ss_pred CCCCCCCcchhccCCCCCCc-EEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCCCCEEEc
Q 002069 344 SENTLNGSIPLALGNLTKLV-SLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDL 415 (973)
Q Consensus 344 ~~N~l~~~~~~~~~~l~~L~-~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 415 (973)
.+| ++.+.+.+|.++++|+ .+++.+ .++.+.+.+|.+|++|+.++++.|+++...+.+|.++++|+.++.
T Consensus 258 ~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 258 PHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred Ccc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 887 7767778888999998 999988 777778888999999999998888888888888888888888763
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=6.3e-19 Score=181.15 Aligned_cols=131 Identities=20% Similarity=0.200 Sum_probs=56.0
Q ss_pred ceeeccCCcCCCCCC-CccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecc
Q 002069 99 SDLRLSNNSLNGSIP-SSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGI 177 (973)
Q Consensus 99 ~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~ 177 (973)
++|+|++|++++..| ..|.++++|++|+|++|+|++..+..|+++++|++|+|++|++++..|..|.++++|++|++++
T Consensus 35 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 114 (220)
T 2v70_A 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS 114 (220)
T ss_dssp SEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTT
T ss_pred CEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCC
Confidence 444444444442212 2234444444444444444433333444444444444444444433333344444444444444
Q ss_pred cccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccC
Q 002069 178 NALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALS 229 (973)
Q Consensus 178 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~ 229 (973)
|++++..|..|..+++|++|+|++|+++++.+..|..+++|+.|+|++|.+.
T Consensus 115 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 115 NRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp SCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred CcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 4444333444444444444444444444444444444444444444444443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.3e-21 Score=227.29 Aligned_cols=190 Identities=18% Similarity=0.156 Sum_probs=137.7
Q ss_pred cCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCc-------------CcccCCccccCccccceee-ccCCcCCC
Q 002069 45 GRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNL-------------LSGSIPNEVGSLKSLSDLR-LSNNSLNG 110 (973)
Q Consensus 45 ~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~-------------l~~~~p~~~~~l~~L~~L~-L~~n~l~~ 110 (973)
..++.|+.|+|++|+++ .+|+++++|++|+.|++++|. ..+..|+.++.+++|+.|+ ++.|.+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-- 422 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-- 422 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence 34555555555555555 555555555555555555443 3344555555556666665 444432
Q ss_pred CCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccc
Q 002069 111 SIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGN 190 (973)
Q Consensus 111 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~ 190 (973)
++|+.+.+++|.++. +|. ..|+.|+|++|.+++ +|. |+.+++|+.|+|++|+|+ .+|..+++
T Consensus 423 ---------~~L~~l~l~~n~i~~-l~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 423 ---------DDLRSKFLLENSVLK-MEY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ---------HHHHHHHHHHHHHHH-HHH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ---------chhhhhhhhcccccc-cCc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence 234455566666653 222 248889999999985 565 899999999999999999 78889999
Q ss_pred cCccceeeccccccccccccccCCCCcccEEecCCcccCCCC-CccccccccccceecccccccCCCC
Q 002069 191 LKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLI-PNEIGNLKSLLALQLNYNTLSGSIP 257 (973)
Q Consensus 191 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~ 257 (973)
+++|+.|+|++|++++++ .|+++++|+.|+|++|+|+++. |..|+++++|+.|+|++|.+++.+|
T Consensus 485 l~~L~~L~Ls~N~l~~lp--~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 485 LRCLEVLQASDNALENVD--GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCEEECCCCCCCCCc--ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 999999999999999754 7899999999999999999887 8899999999999999999986655
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.4e-18 Score=178.09 Aligned_cols=152 Identities=26% Similarity=0.289 Sum_probs=102.4
Q ss_pred cEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCC
Q 002069 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNN 82 (973)
Q Consensus 3 ~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n 82 (973)
+.++.++++++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|++....+..|..+++|++|+|++|
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 35666777765 6666554 66777777777777666666777777777777777776433445667777777777777
Q ss_pred cCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCC
Q 002069 83 LLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSG 158 (973)
Q Consensus 83 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 158 (973)
++++..+..|..+++|++|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|++++|.+..
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 776444445666777777777777776 566667777777777777777765555566777777777777777653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.8e-19 Score=190.66 Aligned_cols=171 Identities=25% Similarity=0.261 Sum_probs=133.4
Q ss_pred CCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCcccee
Q 002069 46 RLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTL 125 (973)
Q Consensus 46 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 125 (973)
.+.++..+++++|.++ .++ .+..+++|++|++++|.++ .+| .+..+++|++|+|++|++++ +|. +.++++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~-~~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTT-SEE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCcc-ccc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEE
Confidence 5677888889999888 555 5888899999999999888 566 78888899999999999884 444 8888899999
Q ss_pred ecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeeccccccc
Q 002069 126 YLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLS 205 (973)
Q Consensus 126 ~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 205 (973)
+|++|++++ +|... . ++|++|++++|++++. + .+..+++|+.|++++|++++ +| .+..+++|++|++++|+++
T Consensus 91 ~L~~N~l~~-l~~~~-~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKN-LNGIP-S-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSC-CTTCC-C-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCC-cCccc-c-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCc
Confidence 999998874 44433 3 8888888888888743 3 57788888888888888874 33 6777888888888888887
Q ss_pred cccccccCCCCcccEEecCCcccCCC
Q 002069 206 GSILYSFGNLTKLEILYLDVNALSGL 231 (973)
Q Consensus 206 ~~~~~~~~~l~~L~~L~L~~n~i~~~ 231 (973)
++ ..+..+++|+.|++++|.++..
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ch--HHhccCCCCCEEeCCCCcccCC
Confidence 65 5677777788888888877765
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=3.4e-21 Score=225.81 Aligned_cols=203 Identities=22% Similarity=0.212 Sum_probs=122.9
Q ss_pred CCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCc-------------CCCCCCCcccCCCCCcEEE-ccCCcCcc
Q 002069 21 GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNF-------------LKGSIPPSLGNLTSLIYID-IGNNLLSG 86 (973)
Q Consensus 21 ~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~-------------~~~~~p~~~~~l~~L~~L~-l~~n~l~~ 86 (973)
..+++|+.|+|++|+++ .+|.+|+.+++|+.|++++|. ..+.+|..++.+++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 67899999999999998 679999999999999998875 5567888899999999999 6776543
Q ss_pred cCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccC
Q 002069 87 SIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGN 166 (973)
Q Consensus 87 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~ 166 (973)
+|+.+.+++|.++. +|. ..|++|+|++|+|++ +|. |+++++|+.|+|++|.++ .+|..|++
T Consensus 424 ----------~L~~l~l~~n~i~~-l~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLK-MEY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ----------HHHHHHHHHHHHHH-HHH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ----------hhhhhhhhcccccc-cCc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence 33444444444441 111 124445555555542 343 555555555555555554 44445555
Q ss_pred ccccceeeecccccCCCCCccccccCccceeecccccccccc-ccccCCCCcccEEecCCcccCCCCCc---cccccccc
Q 002069 167 LTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSI-LYSFGNLTKLEILYLDVNALSGLIPN---EIGNLKSL 242 (973)
Q Consensus 167 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~n~i~~~~~~---~~~~l~~L 242 (973)
+++|+.|+|++|+|++ +| .++++++|++|+|++|+++++. |..|+.+++|+.|+|++|.+++.+|. .+..+++|
T Consensus 485 l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L 562 (567)
T 1dce_A 485 LRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 562 (567)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTC
T ss_pred CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCccc
Confidence 5555555555555553 34 4555555555555555555544 45555555555555555555544331 12335555
Q ss_pred ccee
Q 002069 243 LALQ 246 (973)
Q Consensus 243 ~~L~ 246 (973)
+.|+
T Consensus 563 ~~L~ 566 (567)
T 1dce_A 563 SSIL 566 (567)
T ss_dssp SEEE
T ss_pred CccC
Confidence 5554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.8e-19 Score=198.08 Aligned_cols=221 Identities=10% Similarity=0.024 Sum_probs=139.6
Q ss_pred ccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcc----cCCCCCccccccccc
Q 002069 167 LTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNA----LSGLIPNEIGNLKSL 242 (973)
Q Consensus 167 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~----i~~~~~~~~~~l~~L 242 (973)
+++|+.|+|.. .++...+.+|.++++|+.+++++|.+..+...+|.++.++..+.+..+. ...+...+|.++.+|
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 45555555544 4443334445555555555555555555555555555555555444421 122333445444444
Q ss_pred c-ceecccccc-cCCCCcccCCcchhhhccCCCcccCchhhhhh-ccccccceEEcccccccCCcCchhhcCCccceeec
Q 002069 243 L-ALQLNYNTL-SGSIPCSFGNLTKLVISCLGTNALSSSILEEI-GNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYF 319 (973)
Q Consensus 243 ~-~L~L~~N~l-~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 319 (973)
+ .+++....- .......--...++..+.+.++ +.......+ ..+++|+.|++++|+++.+.+.+|.++++|+.+++
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~-l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l 257 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGK-LDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKL 257 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEEC-CCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEEC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeee-ecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEEC
Confidence 4 222221110 0000000001222222333222 222222223 24789999999999999888889999999999999
Q ss_pred cccccCCCCCccccCCCCCC-cEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhcc
Q 002069 320 STNALSGSIPNEITNLRSLS-DLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYL 391 (973)
Q Consensus 320 ~~n~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L 391 (973)
.+| ++.+.+.+|.++++|+ .+++.+ .++.+.+.+|.++++|+.+++++|+++.+.+.+|.++++|+.++.
T Consensus 258 ~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 258 PHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred Ccc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 998 7778889999999999 999988 788788899999999999999999999889999999999998864
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-18 Score=175.35 Aligned_cols=154 Identities=15% Similarity=0.259 Sum_probs=134.0
Q ss_pred cCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccc
Q 002069 20 IGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLS 99 (973)
Q Consensus 20 ~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 99 (973)
.+.+++|++|++++|.++ .+| .+..+++|++|++++|.+. . ++.+..+++|++|++++|++++..|..++.+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 367889999999999998 566 6999999999999999776 3 34799999999999999999977888999999999
Q ss_pred eeeccCCcCCCCCCCccccCCccceeeccccc-ccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeeccc
Q 002069 100 DLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNA-LSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGIN 178 (973)
Q Consensus 100 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n 178 (973)
+|++++|++++..|..++.+++|++|++++|+ ++ .+| .+..+++|++|++++|++++ ++ .+..+++|+.|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCc
Confidence 99999999997778889999999999999998 66 555 69999999999999999985 44 7889999999999999
Q ss_pred ccC
Q 002069 179 ALS 181 (973)
Q Consensus 179 ~l~ 181 (973)
++.
T Consensus 192 ~i~ 194 (197)
T 4ezg_A 192 TIG 194 (197)
T ss_dssp ---
T ss_pred ccC
Confidence 986
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=1e-18 Score=176.52 Aligned_cols=152 Identities=22% Similarity=0.305 Sum_probs=75.5
Q ss_pred cCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccce
Q 002069 45 GRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVT 124 (973)
Q Consensus 45 ~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 124 (973)
+.+++|++|++++|+++ .+| .+..+++|++|++++|.++ .+ ..+..+++|++|++++|++++..|..++.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 44555555666555555 444 4555555555555555443 22 24555555555555555555444555555555555
Q ss_pred eecccccccccCcccccccCCCCceecccCC-CCCCCCccccCccccceeeecccccCCCCCccccccCccceeeccccc
Q 002069 125 LYLHMNALSGSIPDEIGNLKFLSDLQVSYNT-LSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNT 203 (973)
Q Consensus 125 L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 203 (973)
|++++|++++..|..++++++|++|++++|. ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|++|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence 5555555554445555555555555555554 33 222 34444444444444444442 22 33444444444444444
Q ss_pred c
Q 002069 204 L 204 (973)
Q Consensus 204 l 204 (973)
+
T Consensus 193 i 193 (197)
T 4ezg_A 193 I 193 (197)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.9e-19 Score=217.86 Aligned_cols=186 Identities=24% Similarity=0.234 Sum_probs=89.3
Q ss_pred CCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccC
Q 002069 57 SNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSI 136 (973)
Q Consensus 57 ~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 136 (973)
.|++. ..|+.+..+++|++|+|++|.+. .+|..+..+++|++|+|++|+|+ .+|..|++|++|++|+|++|+|+ .+
T Consensus 210 ~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~l 285 (727)
T 4b8c_D 210 ENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SL 285 (727)
T ss_dssp -------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SC
T ss_pred cccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-cc
Confidence 34444 45566666666666666666666 56666666666666666666666 56666666666666666666666 55
Q ss_pred cccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCc-cceeeccccccccccccccCCC
Q 002069 137 PDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKS-LSDLRLDYNTLSGSILYSFGNL 215 (973)
Q Consensus 137 p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l 215 (973)
|..|++|++|++|+|++|.|+ .+|..|+.+++|+.|+|++|.+++.+|..+..+.. +..++|++|.+++..+.
T Consensus 286 p~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~----- 359 (727)
T 4b8c_D 286 PAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH----- 359 (727)
T ss_dssp CSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC-----
T ss_pred ChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc-----
Confidence 666666666666666666665 55555666666666666666666666665554322 22356666666654443
Q ss_pred CcccEEecCCc--------ccCCCCCccccccccccceeccccccc
Q 002069 216 TKLEILYLDVN--------ALSGLIPNEIGNLKSLLALQLNYNTLS 253 (973)
Q Consensus 216 ~~L~~L~L~~n--------~i~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (973)
.|+.|+++.| .+.+..+..+..+..+....+++|-+.
T Consensus 360 -~l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 360 -ERRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp -C-----------------------------------------CCC
T ss_pred -ccceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 3444555554 333444445556666666777777664
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.74 E-value=7.7e-19 Score=212.60 Aligned_cols=151 Identities=28% Similarity=0.307 Sum_probs=81.0
Q ss_pred ccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCC
Q 002069 79 IGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSG 158 (973)
Q Consensus 79 l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 158 (973)
++.|.+. ..|+.+..+.+|++|+|++|++. .+|..++++++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+
T Consensus 208 ~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 208 DIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp ---------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred cccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 3344444 44555666666666666666665 55555556666666666666665 55666666666666666666666
Q ss_pred CCCccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCc-ccEEecCCcccCCCCCc
Q 002069 159 AIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTK-LEILYLDVNALSGLIPN 234 (973)
Q Consensus 159 ~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~n~i~~~~~~ 234 (973)
.+|..|++|++|++|+|++|.|+ .+|..|+++++|++|+|++|.+++..+..+..+.. +..++|++|.+++..|.
T Consensus 284 ~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 284 SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 45666666666666666666665 45555666666666666666666555555543322 12355666666555443
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=5.6e-18 Score=178.64 Aligned_cols=140 Identities=16% Similarity=0.175 Sum_probs=107.8
Q ss_pred CCcccccccCCCceeEEEEEc-CCCCE--EEEEEcCCCCCc---------------------chhhHHHHHHHHHHhhcC
Q 002069 702 NFDDEHCIGNGGQGSVYKAEL-PTGEI--VAVKKFHSPLPG---------------------EMACQQEFLNEGNALTKI 757 (973)
Q Consensus 702 ~~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~---------------------~~~~~~~~~~e~~~l~~l 757 (973)
-|++.+.||+|+||.||+|.. .+|+. ||||+++..... .......+.+|+..+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999977 68888 999997643211 011234688999999999
Q ss_pred CCCce--eeeceeeeccceeEEEEEecCC-C----ChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEe
Q 002069 758 RHRNI--VKFYGFCSHALHSFVVYEYLEM-G----SLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMH-TNCFPPIVH 829 (973)
Q Consensus 758 ~h~ni--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H 829 (973)
.|+++ +.++++ ...++||||+.+ | +|.++... .++.++..++.|++.|++||| +. +|+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 88764 333432 356899999952 3 66665432 124567889999999999999 87 9999
Q ss_pred ecCCCCCeeecCCCceEEecccccccc
Q 002069 830 RDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 830 ~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
|||||+||+++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=1.8e-17 Score=166.37 Aligned_cols=130 Identities=24% Similarity=0.341 Sum_probs=88.4
Q ss_pred cEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCc-CccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccC
Q 002069 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPH-EIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGN 81 (973)
Q Consensus 3 ~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~-~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~ 81 (973)
+++++++|+++ .+|+.+.. +|++|+|++|++++..|. .|+.+++|++|+|++|++++..|..|+++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 46777777775 67766544 677777777777655443 366777777777777777766666777777777777777
Q ss_pred CcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeeccccccccc
Q 002069 82 NLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGS 135 (973)
Q Consensus 82 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 135 (973)
|++++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|.+++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 777765566666677777777777777666666666677777777777666643
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.69 E-value=8.6e-17 Score=180.16 Aligned_cols=265 Identities=11% Similarity=0.075 Sum_probs=124.7
Q ss_pred CCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEec
Q 002069 144 KFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYL 223 (973)
Q Consensus 144 ~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 223 (973)
..++.+.+.+ .++.+...+|.+. +|+.+.+..+ ++.....+|.++ +|+.+.+.. .++.+...+|.+|++|+.+++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 4444444443 2332334444442 4555554433 332333334432 344444443 344444444444444444444
Q ss_pred CCcccCCCCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCC
Q 002069 224 DVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGS 303 (973)
Q Consensus 224 ~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~ 303 (973)
.+|.++.+...+|. ..+|+.+.+..+ +..+...+|.++++|+.+++..| ++.+
T Consensus 188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-------------------------l~~I~~~aF~~~~~L~~l~l~~~-l~~I 240 (401)
T 4fdw_A 188 SKTKITKLPASTFV-YAGIEEVLLPVT-------------------------LKEIGSQAFLKTSQLKTIEIPEN-VSTI 240 (401)
T ss_dssp TTSCCSEECTTTTT-TCCCSEEECCTT-------------------------CCEECTTTTTTCTTCCCEECCTT-CCEE
T ss_pred CCCcceEechhhEe-ecccCEEEeCCc-------------------------hheehhhHhhCCCCCCEEecCCC-ccCc
Confidence 44444444444443 234444444322 33334444445555555555443 3334
Q ss_pred cCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCC-----CcchhccCCCCCCcEEEccCCcccCCCCc
Q 002069 304 IPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLN-----GSIPLALGNLTKLVSLDLSINKLSGSIPL 378 (973)
Q Consensus 304 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~ 378 (973)
...+|.+ .+|+.+.+ .+.++.+...+|.++++|+.+++.+|.+. .+.+.+|.++++|+.++|. +.++.+...
T Consensus 241 ~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~ 317 (401)
T 4fdw_A 241 GQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQG 317 (401)
T ss_dssp CTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTT
T ss_pred ccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhh
Confidence 4444444 45555555 23344344555555555555555554443 2344555566666666665 335545555
Q ss_pred ccccccccchhcccccccccCCCcccCCCCCCCEEEccCCCCCCCcchhhhhhcccceEEEeeCccc
Q 002069 379 SFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 445 (973)
Q Consensus 379 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l 445 (973)
+|.+|++|+.+.|..| ++.....+|.++ +|+.+++++|.+....+..|.+...+++.|++..+.+
T Consensus 318 aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 318 LLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp TTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred hhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 5666666666666433 444455556665 5666666666554333333333333455555554443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=6.4e-17 Score=162.28 Aligned_cols=131 Identities=24% Similarity=0.309 Sum_probs=99.3
Q ss_pred CEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCC-cccCCCCCcEEEccCCcCcccCCccccCccccceeeccC
Q 002069 27 KLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPP-SLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSN 105 (973)
Q Consensus 27 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~ 105 (973)
+++++++|+++ .+|..+.. +|++|++++|++++..|. .|+.+++|++|+|++|++++..|..|+.+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 67888888886 56766654 788888888888744433 377888888888888888866677788888888888888
Q ss_pred CcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCC
Q 002069 106 NSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAI 160 (973)
Q Consensus 106 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 160 (973)
|++++..|..|.++++|++|+|++|++++..|..|..+++|++|++++|.+++..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 8887666666777888888888888887777777777777777777777776543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.6e-16 Score=178.07 Aligned_cols=268 Identities=12% Similarity=0.090 Sum_probs=201.7
Q ss_pred ccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccce
Q 002069 117 GNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSD 196 (973)
Q Consensus 117 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 196 (973)
..+..++.+.+.+ .++.+...+|.++ +|+.+.+..| ++.+...+|.+. +|+.+.+.. .++...+.+|.++++|+.
T Consensus 110 ~~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~ 184 (401)
T 4fdw_A 110 EILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKK 184 (401)
T ss_dssp EECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCE
T ss_pred EecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCe
Confidence 3447788888874 5665667788886 7999999877 776777888884 799999986 677567789999999999
Q ss_pred eeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcchhhhccCCCccc
Q 002069 197 LRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNAL 276 (973)
Q Consensus 197 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i 276 (973)
++++.|+++.++..+|. +.+|+.+.+..+ ++.+...+|.++++|+.+++..| ++.+...+|.+
T Consensus 185 l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-------------- 247 (401)
T 4fdw_A 185 ADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-------------- 247 (401)
T ss_dssp EECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT--------------
T ss_pred eecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc--------------
Confidence 99999999999999998 589999999855 88888899999999999999865 55455555544
Q ss_pred CchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccC-----CCCCccccCCCCCCcEEcCCCCCCCc
Q 002069 277 SSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALS-----GSIPNEITNLRSLSDLQLSENTLNGS 351 (973)
Q Consensus 277 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~~ 351 (973)
.+|+.+.+ .+.++.+...+|.++++|+.+++.+|.+. .+.+.+|.++++|+.++|. +.++.+
T Consensus 248 -----------~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I 314 (401)
T 4fdw_A 248 -----------SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRIL 314 (401)
T ss_dssp -----------CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEE
T ss_pred -----------CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEE
Confidence 34555555 33444455566666666666666665543 3556677788888888887 446666
Q ss_pred chhccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCC-CCCEEEccCCCCC
Q 002069 352 IPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMK-SLSILDLSSNKLN 421 (973)
Q Consensus 352 ~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~ 421 (973)
...+|.++++|+.++|..| ++.+...+|.++ +|+.+++++|.+.......|.+++ +++.|.+..+.+.
T Consensus 315 ~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 315 GQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred hhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 6777888888888888554 666777788888 888888888877777777777774 6778887776543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.4e-16 Score=156.27 Aligned_cols=133 Identities=22% Similarity=0.185 Sum_probs=94.4
Q ss_pred CCCCCCEEECCCCccc-ccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccce
Q 002069 22 HLTHLKLLSFSKNQLS-GLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSD 100 (973)
Q Consensus 22 ~l~~L~~L~l~~n~l~-~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 100 (973)
..++|++|++++|+++ +.+|..+..+++|++|++++|.+++. ..++.+++|++|++++|++++.+|..++.+++|++
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 3466778888888776 56677777777777777777777743 66777777777777777777556666666777777
Q ss_pred eeccCCcCCCCCC--CccccCCccceeecccccccccCc---ccccccCCCCceecccCCCC
Q 002069 101 LRLSNNSLNGSIP--SSLGNLTNLVTLYLHMNALSGSIP---DEIGNLKFLSDLQVSYNTLS 157 (973)
Q Consensus 101 L~L~~n~l~~~~p--~~~~~l~~L~~L~L~~n~l~~~~p---~~~~~l~~L~~L~l~~N~l~ 157 (973)
|+|++|++++ +| ..+..+++|++|++++|++++..+ ..|..+++|++|++++|.+.
T Consensus 100 L~Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 100 LNLSGNKLKD-ISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp EECBSSSCCS-SGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred EeccCCccCc-chhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 7777777773 33 567777777777777777764333 36667777777777777665
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=156.97 Aligned_cols=133 Identities=22% Similarity=0.259 Sum_probs=120.9
Q ss_pred CcEEeCCCCCCC-CCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEcc
Q 002069 2 LKVLGLSFNQFS-GSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIG 80 (973)
Q Consensus 2 l~~L~l~~~~l~-~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~ 80 (973)
|++|+|++|+++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|++++|++.+.+|..++.+++|++|+++
T Consensus 26 L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 103 (168)
T 2ell_A 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLS 103 (168)
T ss_dssp CSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECB
T ss_pred CCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEecc
Confidence 789999999998 78999999999999999999999965 789999999999999999997688888889999999999
Q ss_pred CCcCcccCC--ccccCccccceeeccCCcCCCCCCC----ccccCCccceeecccccccccCccc
Q 002069 81 NNLLSGSIP--NEVGSLKSLSDLRLSNNSLNGSIPS----SLGNLTNLVTLYLHMNALSGSIPDE 139 (973)
Q Consensus 81 ~n~l~~~~p--~~~~~l~~L~~L~L~~n~l~~~~p~----~~~~l~~L~~L~L~~n~l~~~~p~~ 139 (973)
+|+++ .+| ..+..+++|++|++++|.+++ .|. .+..+++|++|++++|.+. ..|++
T Consensus 104 ~N~l~-~~~~~~~l~~l~~L~~L~l~~N~l~~-~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 104 GNKLK-DISTLEPLKKLECLKSLDLFNCEVTN-LNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp SSSCC-SSGGGGGGSSCSCCCEEECCSSGGGT-STTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred CCccC-cchhHHHHhcCCCCCEEEeeCCcCcc-hHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 99998 454 789999999999999999995 555 8999999999999999987 55654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=6e-16 Score=155.10 Aligned_cols=127 Identities=28% Similarity=0.353 Sum_probs=63.4
Q ss_pred CEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCC
Q 002069 27 KLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNN 106 (973)
Q Consensus 27 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n 106 (973)
+++++++|+++ .+|..+. ++|++|++++|+++ .+|..|.++++|++|+|++|++++..|..|..+++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 34455555544 3343332 34555555555554 44455555555555555555555433444555555555555555
Q ss_pred cCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCC
Q 002069 107 SLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLS 157 (973)
Q Consensus 107 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~ 157 (973)
++++..|..|.++++|++|+|++|+|+...+..|..+++|+.|++++|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 555444444555555555555555555333334555555555555555543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.64 E-value=2.7e-15 Score=168.99 Aligned_cols=315 Identities=11% Similarity=-0.020 Sum_probs=180.0
Q ss_pred ccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCc
Q 002069 36 LSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSS 115 (973)
Q Consensus 36 l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 115 (973)
++.+-...|.++.+|+.+.+.++ ++.+-..+|.++++|+.+++.++ ++..-...|..+.+|+.+.+..+ +...-...
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~a 135 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEA 135 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeeccee
Confidence 44444556777888888888744 65344567888888888888765 44344456777788888777654 33244556
Q ss_pred cccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccc
Q 002069 116 LGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLS 195 (973)
Q Consensus 116 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 195 (973)
|.++..++....... ......+|.++++|+.+.+..+..+ +....|.++.+|+.+.+..| ++......|.++..|+
T Consensus 136 F~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~ 211 (394)
T 4fs7_A 136 FKGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLE 211 (394)
T ss_dssp TTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCC
T ss_pred eecccccccccCccc--cccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccc
Confidence 666654443333222 2234567888888888888765433 55677888888888888766 4435566778888888
Q ss_pred eeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcc
Q 002069 196 DLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNA 275 (973)
Q Consensus 196 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~ 275 (973)
.+.+..+... +. +.+....+|+.+.+..+ ++.+...+|.+..+|+.+.+..+... +....|.+...++......+.
T Consensus 212 ~i~~~~~~~~-i~-~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~ 287 (394)
T 4fs7_A 212 NMEFPNSLYY-LG-DFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVI 287 (394)
T ss_dssp BCCCCTTCCE-EC-TTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSE
T ss_pred eeecCCCceE-ee-hhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCcee
Confidence 8887766543 22 23344567888877643 34455677888888888888766443 445555555544444333322
Q ss_pred cCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhc
Q 002069 276 LSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLA 355 (973)
Q Consensus 276 i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 355 (973)
+ ....|..+.+|+.+.+..+ ++.+...+|.++++|+.+++.++ ++.+...+|.++.+|+.+.+..| ++.+...+
T Consensus 288 i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~a 361 (394)
T 4fs7_A 288 V---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANA 361 (394)
T ss_dssp E---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTT
T ss_pred e---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHH
Confidence 2 1233444444555444432 33233344444444444444322 33233344444444444444333 33333344
Q ss_pred cCCCCCCcEEEc
Q 002069 356 LGNLTKLVSLDL 367 (973)
Q Consensus 356 ~~~l~~L~~L~L 367 (973)
|.++++|+.+++
T Consensus 362 F~~C~~L~~i~l 373 (394)
T 4fs7_A 362 FQGCINLKKVEL 373 (394)
T ss_dssp BTTCTTCCEEEE
T ss_pred hhCCCCCCEEEE
Confidence 444444444444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.3e-15 Score=171.71 Aligned_cols=62 Identities=15% Similarity=0.202 Sum_probs=33.1
Q ss_pred CccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecc
Q 002069 185 PNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLN 248 (973)
Q Consensus 185 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 248 (973)
..+|.++.+|+.+.+.. .++.+...+|.++++|+.+++.++ ++.+...+|.++.+|+.+.+.
T Consensus 64 ~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p 125 (394)
T 4fs7_A 64 YAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLP 125 (394)
T ss_dssp TTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred HHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhccc
Confidence 34555555666665543 255555555666666666655433 444444555555555555444
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3e-16 Score=150.45 Aligned_cols=128 Identities=21% Similarity=0.201 Sum_probs=96.1
Q ss_pred CCCCCEEECCCCccc-ccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCcccccee
Q 002069 23 LTHLKLLSFSKNQLS-GLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDL 101 (973)
Q Consensus 23 l~~L~~L~l~~n~l~-~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L 101 (973)
.++|++|++++|.++ +.+|..+..+++|++|++++|++++. ..++.+++|++|++++|++++.+|..++.+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 467888888888887 56777778888888888888888744 667888888888888888875577777778888888
Q ss_pred eccCCcCCCC-CCCccccCCccceeecccccccccCc---ccccccCCCCceecc
Q 002069 102 RLSNNSLNGS-IPSSLGNLTNLVTLYLHMNALSGSIP---DEIGNLKFLSDLQVS 152 (973)
Q Consensus 102 ~L~~n~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~p---~~~~~l~~L~~L~l~ 152 (973)
++++|++++. .|..++.+++|++|++++|++++..+ ..++.+++|++|+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 8888888742 23677778888888888888775443 367777777777765
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=1e-15 Score=153.44 Aligned_cols=126 Identities=28% Similarity=0.332 Sum_probs=63.2
Q ss_pred eeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeeccccc
Q 002069 52 GLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNA 131 (973)
Q Consensus 52 ~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~ 131 (973)
++++++|+++ .+|..+. ++|++|+|++|+++ .+|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 4555555554 4444332 34555555555554 444555555555555555555554444445555555555555555
Q ss_pred ccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccC
Q 002069 132 LSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181 (973)
Q Consensus 132 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~ 181 (973)
|++..|..|.++++|++|+|++|+++...+..|..+++|+.|++++|.+.
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 55444444555555555555555555443444555555555555555444
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=2e-15 Score=149.33 Aligned_cols=127 Identities=24% Similarity=0.303 Sum_probs=61.1
Q ss_pred EEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCc
Q 002069 4 VLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNL 83 (973)
Q Consensus 4 ~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~ 83 (973)
.+++++++++ .+|..+. ++|++|++++|++++..+..+..+++|++|++++|++++..+..|+.+++|++|++++|+
T Consensus 11 ~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 87 (177)
T 2o6r_A 11 EIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87 (177)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence 4555555554 4454332 455555555555554433344555555555555555553333334555555555555555
Q ss_pred CcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeeccccccc
Q 002069 84 LSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALS 133 (973)
Q Consensus 84 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 133 (973)
+++..+..+..+++|++|++++|++++..+..+..+++|++|+|++|.+.
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 88 LQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 55333333444555555555555554322233344455555555555444
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=2.7e-16 Score=150.82 Aligned_cols=126 Identities=19% Similarity=0.202 Sum_probs=114.0
Q ss_pred CcEEeCCCCCCC-CCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEcc
Q 002069 2 LKVLGLSFNQFS-GSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIG 80 (973)
Q Consensus 2 l~~L~l~~~~l~-~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~ 80 (973)
|+.|++++|+++ +.+|+.+..+++|++|++++|.+++. ..++.+++|++|++++|++++.+|..++.+++|++|+++
T Consensus 19 l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls 96 (149)
T 2je0_A 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLS 96 (149)
T ss_dssp CSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECT
T ss_pred CeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECC
Confidence 789999999998 78999999999999999999999965 789999999999999999997689888899999999999
Q ss_pred CCcCccc-CCccccCccccceeeccCCcCCCCCC---CccccCCccceeeccc
Q 002069 81 NNLLSGS-IPNEVGSLKSLSDLRLSNNSLNGSIP---SSLGNLTNLVTLYLHM 129 (973)
Q Consensus 81 ~n~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~p---~~~~~l~~L~~L~L~~ 129 (973)
+|++++. .|..++.+++|++|++++|++++..+ ..+..+++|++|++++
T Consensus 97 ~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 97 GNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp TSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999852 34889999999999999999995444 4799999999999863
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=3.6e-16 Score=170.13 Aligned_cols=143 Identities=10% Similarity=0.095 Sum_probs=101.2
Q ss_pred cCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCc---------------chh----hHHHHHHHHHHhhcCCCCc
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPG---------------EMA----CQQEFLNEGNALTKIRHRN 761 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------~~~----~~~~~~~e~~~l~~l~h~n 761 (973)
.-|++.++||+|+||.||+|...+|+.||||+++..... ... .+.....|...+.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 348999999999999999999889999999987532110 000 0111234555555554433
Q ss_pred eeeeceeeeccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC
Q 002069 762 IVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL 841 (973)
Q Consensus 762 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~ 841 (973)
+....-+.. ...++||||++|+++.++... .....++.|++.++.|||+. |||||||||.|||+++
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 322111111 234799999999888765321 23456889999999999998 9999999999999988
Q ss_pred CCc----------eEEeccccccccc
Q 002069 842 EYE----------AHVSDFGISKFLK 857 (973)
Q Consensus 842 ~~~----------~kl~Dfg~a~~~~ 857 (973)
++. +.|+||+.+....
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCcccccccccceEEEEeCCcccCC
Confidence 763 8999999887544
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.60 E-value=5.2e-15 Score=146.39 Aligned_cols=130 Identities=23% Similarity=0.207 Sum_probs=78.6
Q ss_pred CCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccC
Q 002069 26 LKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSN 105 (973)
Q Consensus 26 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~ 105 (973)
.+.+++++|+++ .+|..+. ++|++|++++|++++..+..|+.+++|++|++++|++++..+..++.+++|++|++++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 466777777776 3454332 5667777777776644444566666677777776666644444456666666666666
Q ss_pred CcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCC
Q 002069 106 NSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSG 158 (973)
Q Consensus 106 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 158 (973)
|++++..+..+.++++|++|++++|++++..+..|.++++|++|++++|.+++
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 66664444455666666666666666664433445556666666666665553
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.3e-17 Score=166.63 Aligned_cols=153 Identities=25% Similarity=0.349 Sum_probs=98.3
Q ss_pred CCCCCCEEECCCCcccccCCc------CccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCc
Q 002069 22 HLTHLKLLSFSKNQLSGLIPH------EIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSL 95 (973)
Q Consensus 22 ~l~~L~~L~l~~n~l~~~~p~------~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 95 (973)
....++.++++.+.+.+..|. .+..+++|++|++++|+++ .+| .++.+++|++|++++|+++ .+|..+..+
T Consensus 16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~-~l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~ 92 (198)
T 1ds9_A 16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVA 92 (198)
T ss_dssp HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEES-CCC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHH
T ss_pred hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCc-ccc-ccccCCCCCEEECCCCCcc-cccchhhcC
Confidence 344555566666666655555 6666777777777777776 355 6667777777777777776 566666666
Q ss_pred cccceeeccCCcCCCCCCCccccCCccceeecccccccccCc-ccccccCCCCceecccCCCCCCCCcc----------c
Q 002069 96 KSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIP-DEIGNLKFLSDLQVSYNTLSGAIPFS----------L 164 (973)
Q Consensus 96 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~----------l 164 (973)
++|++|++++|++++ +| .+..+++|++|++++|++++..+ +.+..+++|++|++++|.+++..|.. +
T Consensus 93 ~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~ 170 (198)
T 1ds9_A 93 DTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVV 170 (198)
T ss_dssp HHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHH
T ss_pred CcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHH
Confidence 677777777777763 44 56667777777777777763222 35667777777777777766544432 6
Q ss_pred cCccccceeeecccccC
Q 002069 165 GNLTNLVTLYIGINALS 181 (973)
Q Consensus 165 ~~l~~L~~L~l~~n~l~ 181 (973)
..+++|+.|+ +|.++
T Consensus 171 ~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 171 KRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHCSSCSEEC--CGGGT
T ss_pred HhCCCcEEEC--CcccC
Confidence 6677777765 55554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=4e-17 Score=164.87 Aligned_cols=133 Identities=23% Similarity=0.262 Sum_probs=80.5
Q ss_pred ccCCCCCCeeeccCCcCCCCCCC------cccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccc
Q 002069 44 IGRLSSLNGLSLYSNFLKGSIPP------SLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLG 117 (973)
Q Consensus 44 ~~~l~~L~~L~l~~n~~~~~~p~------~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 117 (973)
+.....++.++++.+.+.+.+|. .++.+++|++|++++|+++ .+| .+..+++|++|++++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~-~l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEES-CCC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCc-ccc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 44556777777777777766665 6666666666666666666 355 6666666666666666666 5666666
Q ss_pred cCCccceeecccccccccCcccccccCCCCceecccCCCCCCCC-ccccCccccceeeecccccC
Q 002069 118 NLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIP-FSLGNLTNLVTLYIGINALS 181 (973)
Q Consensus 118 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~l~~n~l~ 181 (973)
.+++|++|+|++|++++ +| .++++++|++|++++|++++..+ ..+..+++|+.|++++|.+.
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~ 153 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHH
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccc
Confidence 66666666666666653 33 45555666666666665553211 24444555555555555544
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.55 E-value=5.6e-15 Score=145.90 Aligned_cols=134 Identities=18% Similarity=0.203 Sum_probs=89.9
Q ss_pred cccCCCCCCCEEECCCCcccccCCcCccCCC-CCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCcc
Q 002069 18 PEIGHLTHLKLLSFSKNQLSGLIPHEIGRLS-SLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLK 96 (973)
Q Consensus 18 ~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~-~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~ 96 (973)
+.+..+.+|++|++++|++++ +|. +..+. +|++|++++|++++ + +.|+.+++|++|++++|++++..|..++.++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~-~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCc-c-cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 345667777777777777774 443 44444 77777777777773 3 5677777777777777777743333346777
Q ss_pred ccceeeccCCcCCCCCCC--ccccCCccceeecccccccccCccc----ccccCCCCceecccCCCC
Q 002069 97 SLSDLRLSNNSLNGSIPS--SLGNLTNLVTLYLHMNALSGSIPDE----IGNLKFLSDLQVSYNTLS 157 (973)
Q Consensus 97 ~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~L~~n~l~~~~p~~----~~~l~~L~~L~l~~N~l~ 157 (973)
+|++|+|++|++. .+|. .+..+++|++|++++|.++ ..|.. ++.+++|+.|++++|.+.
T Consensus 89 ~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 89 DLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp TCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 7777777777775 5565 6777777777777777776 44543 666666777766666543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.54 E-value=5.7e-15 Score=145.87 Aligned_cols=132 Identities=20% Similarity=0.198 Sum_probs=63.9
Q ss_pred ccCCCCCcEEEccCCcCcccCCccccCcc-ccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCC
Q 002069 68 LGNLTSLIYIDIGNNLLSGSIPNEVGSLK-SLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFL 146 (973)
Q Consensus 68 ~~~l~~L~~L~l~~n~l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 146 (973)
+.++.+|++|++++|+++ .+|. +..+. +|++|++++|++++ + ..++.+++|++|+|++|++++..+..|+++++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~-~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCc-c-cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 334444444444444444 2332 22222 45555555555442 2 344455555555555555543222333555555
Q ss_pred CceecccCCCCCCCCc--cccCccccceeeecccccCCCCCcc----ccccCccceeeccccccc
Q 002069 147 SDLQVSYNTLSGAIPF--SLGNLTNLVTLYIGINALSGSIPNE----IGNLKSLSDLRLDYNTLS 205 (973)
Q Consensus 147 ~~L~l~~N~l~~~~p~--~l~~l~~L~~L~l~~n~l~~~~p~~----~~~l~~L~~L~L~~N~l~ 205 (973)
++|++++|+++ .+|. .+..+++|+.|++++|.++ .+|.. +..+++|+.|+++.|.+.
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 55555555554 2332 4555555555555555555 33442 556666666666666554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=1.8e-13 Score=134.02 Aligned_cols=106 Identities=25% Similarity=0.328 Sum_probs=70.0
Q ss_pred CCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccC
Q 002069 26 LKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSN 105 (973)
Q Consensus 26 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~ 105 (973)
.++|++++|+++ .+|..+. ++|++|+|++|+|++..|..|+++++|++|+|++|++++..|..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 456666666666 3555553 6667777777777655566677777777777777777644444556777777777777
Q ss_pred CcCCCCCCCccccCCccceeecccccccc
Q 002069 106 NSLNGSIPSSLGNLTNLVTLYLHMNALSG 134 (973)
Q Consensus 106 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~ 134 (973)
|++++..|..|.++++|++|+|++|+++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 77775444557777777777777777663
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.2e-13 Score=135.64 Aligned_cols=104 Identities=23% Similarity=0.308 Sum_probs=68.0
Q ss_pred CEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCC
Q 002069 27 KLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNN 106 (973)
Q Consensus 27 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n 106 (973)
+.+++++|+++ .+|..+. ++|++|+|++|++++..|..|+++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 56666666665 4565554 66677777777776555666777777777777777776433334566777777777777
Q ss_pred cCCCCCCCccccCCccceeeccccccc
Q 002069 107 SLNGSIPSSLGNLTNLVTLYLHMNALS 133 (973)
Q Consensus 107 ~l~~~~p~~~~~l~~L~~L~L~~n~l~ 133 (973)
+|++..+..|..+++|++|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 776443444667777777777777766
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.46 E-value=2.8e-13 Score=132.56 Aligned_cols=104 Identities=28% Similarity=0.340 Sum_probs=50.1
Q ss_pred cEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCC
Q 002069 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNN 82 (973)
Q Consensus 3 ~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n 82 (973)
+++|+++|+++ .+|+.+. ++|++|+|++|+|++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 34455555554 4444432 44555555555555444444555555555555555555333333445555555555555
Q ss_pred cCcccCCccccCccccceeeccCCcCC
Q 002069 83 LLSGSIPNEVGSLKSLSDLRLSNNSLN 109 (973)
Q Consensus 83 ~l~~~~p~~~~~l~~L~~L~L~~n~l~ 109 (973)
++++..|..|..+++|++|+|++|.+.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 554333333445555555555555444
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=3.1e-13 Score=132.63 Aligned_cols=104 Identities=23% Similarity=0.239 Sum_probs=53.5
Q ss_pred CeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccc
Q 002069 51 NGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMN 130 (973)
Q Consensus 51 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 130 (973)
+.+++++|+++ .+|..+. ++|++|+|++|++++..|..|+.+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 44555555554 4554443 45555555555555444455555555555555555555333333455555555555555
Q ss_pred cccccCcccccccCCCCceecccCCCC
Q 002069 131 ALSGSIPDEIGNLKFLSDLQVSYNTLS 157 (973)
Q Consensus 131 ~l~~~~p~~~~~l~~L~~L~l~~N~l~ 157 (973)
+|++..+..|.++++|++|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 555333333555555555555555554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.8e-12 Score=145.80 Aligned_cols=131 Identities=12% Similarity=0.115 Sum_probs=53.9
Q ss_pred hhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCC
Q 002069 281 LEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLT 360 (973)
Q Consensus 281 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 360 (973)
..+|.++.+|+.+.+..+..+ .....|.++++|+.+.+. +.++.+...+|.++.+|+.++|.++ ++.+...+|.++.
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~ 334 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE 334 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred cceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC
Confidence 344445555555555433322 334444445555555543 2233333444445555555555432 3333344444555
Q ss_pred CCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCCCCEEEccCC
Q 002069 361 KLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSN 418 (973)
Q Consensus 361 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 418 (973)
+|+.+.+..+ ++.+...+|.+|++|+.+++.++.... .++....+|+.+.+..|
T Consensus 335 ~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~ 388 (394)
T 4gt6_A 335 QLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPG 388 (394)
T ss_dssp TCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC--------
T ss_pred CCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCC
Confidence 5555554322 333444444444444444444443211 23333444444444433
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.2e-12 Score=147.40 Aligned_cols=316 Identities=9% Similarity=0.081 Sum_probs=138.4
Q ss_pred ccccccC-ccceeeccccccccccccccCCCCcccEEecCCcc---cCCCCCccccccccccceecccccccCCCCcccC
Q 002069 186 NEIGNLK-SLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNA---LSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFG 261 (973)
Q Consensus 186 ~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~---i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 261 (973)
.+|.+++ .|+.+.+..+ ++.+...+|.++++|+.+.+..|. ++.+...+|.++.+|+.+.+..+
T Consensus 57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~----------- 124 (394)
T 4gt6_A 57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS----------- 124 (394)
T ss_dssp TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-----------
T ss_pred hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-----------
Confidence 3444442 3555555432 444555555555555555555442 33333444444444444443322
Q ss_pred CcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcE
Q 002069 262 NLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDL 341 (973)
Q Consensus 262 ~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 341 (973)
++.+....|.++.+|+.+.+..+ +.......|..+..|+.+.+..+ ++.+...+|.+ ..|+.+
T Consensus 125 --------------~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i 187 (394)
T 4gt6_A 125 --------------VTEIDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQI 187 (394)
T ss_dssp --------------CSEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEE
T ss_pred --------------cceehhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEE
Confidence 33344455556666666666533 23244555666666666666543 33234444443 456666
Q ss_pred EcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCccccc-------------ccccchhcccccccccCCCcccCCCC
Q 002069 342 QLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFAS-------------LTSLTTLYLYENSLCDSIPKEIGDMK 408 (973)
Q Consensus 342 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~-------------l~~L~~L~L~~N~l~~~~~~~~~~l~ 408 (973)
.+..+-.. ....+|.++.++.......+.........+.. ...+..+.+. +.++.....+|.++.
T Consensus 188 ~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~ 265 (394)
T 4gt6_A 188 HIPAKVTR-IGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCA 265 (394)
T ss_dssp EECTTCCE-ECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCS
T ss_pred EECCcccc-cccchhhhccccceecccccccccccceeecccccccccccccccccccceEEcC-CcceEcccceeeecc
Confidence 66544322 44455666666666665554433211111111 1111111111 122233344555555
Q ss_pred CCCEEEccCCCCCCCcchhhhhhcccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCCcccccccccccccc
Q 002069 409 SLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDL 488 (973)
Q Consensus 409 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L 488 (973)
+|+.+.+.++..+ ....+|..+++|+.+.+. +.++.+...+|..+.+|+.+++
T Consensus 266 ~L~~i~lp~~~~~--------------------------I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~l 318 (394)
T 4gt6_A 266 YLASVKMPDSVVS--------------------------IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDI 318 (394)
T ss_dssp SCCEEECCTTCCE--------------------------ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEEC
T ss_pred cccEEecccccce--------------------------ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEe
Confidence 5555555443321 222333333444444442 2232233344444445555554
Q ss_pred cccccccccCccccccccccEEeecCccCCCCCCcccccccccCeecccccccCCCcchhhccccccccccccccc
Q 002069 489 SANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNN 564 (973)
Q Consensus 489 s~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~N~ 564 (973)
..+ ++.....+|.++.+|+.+.+..+ ++.....+|.++.+|+.++++++... ...+..+.+|+.+.+..|.
T Consensus 319 p~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~---~~~~~~~~~L~~i~i~~~~ 389 (394)
T 4gt6_A 319 PEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ---WNAISTDSGLQNLPVAPGS 389 (394)
T ss_dssp CTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH---HHTCBCCCCC---------
T ss_pred CCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee---hhhhhccCCCCEEEeCCCC
Confidence 433 33333344555555555555432 44444445555555555555544321 1234445556666655543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=8.5e-16 Score=170.42 Aligned_cols=97 Identities=23% Similarity=0.312 Sum_probs=56.3
Q ss_pred ccccccccccccccccc----cCccccccccccEEeecCccCCCCC----CcccccccccCeecccccccCCCcchhhc-
Q 002069 480 LNQLEYLDLSANTFHNS----IPESLGNLVKLHYLNLSNNQFSQKI----PNPIEKLIHLSELDLSYKIFGEEIPSQVC- 550 (973)
Q Consensus 480 l~~L~~L~Ls~N~i~~~----~~~~l~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~ls~n~i~~~~~~~~~- 550 (973)
.++|++|+|++|.|++. ++..+..+++|++|+|++|+|++.. +..+....+|++|+|++|.|++.+...+.
T Consensus 154 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~ 233 (372)
T 3un9_A 154 QCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALAR 233 (372)
T ss_dssp TCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHH
T ss_pred CCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHH
Confidence 34566666666666532 2233344556666666666665432 33445556666666666666654443333
Q ss_pred ---ccccccccccccccccCccchhhhcc
Q 002069 551 ---SMQSLEKLNLSHNNLSGSISRCFEEM 576 (973)
Q Consensus 551 ---~l~~L~~L~L~~N~l~~~~~~~~~~l 576 (973)
.++.|++|+|++|+|+..+...+..+
T Consensus 234 ~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 262 (372)
T 3un9_A 234 AAREHPSLELLHLYFNELSSEGRQVLRDL 262 (372)
T ss_dssp HHHHCSSCCEEECTTSSCCHHHHHHHHHC
T ss_pred HHHhCCCCCEEeccCCCCCHHHHHHHHHH
Confidence 45677777777777776666666554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=4.1e-15 Score=164.86 Aligned_cols=112 Identities=21% Similarity=0.249 Sum_probs=65.5
Q ss_pred ccccccccccccccccccCcccc-----ccccccEEeecCccCCCCCC----cccccccccCeecccccccCCCc----c
Q 002069 480 LNQLEYLDLSANTFHNSIPESLG-----NLVKLHYLNLSNNQFSQKIP----NPIEKLIHLSELDLSYKIFGEEI----P 546 (973)
Q Consensus 480 l~~L~~L~Ls~N~i~~~~~~~l~-----~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~ls~n~i~~~~----~ 546 (973)
+++|++|+|++|.|++.....+. ..++|++|+|++|.|+.... ..+..+++|++|||++|.|++.+ +
T Consensus 125 L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~ 204 (372)
T 3un9_A 125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLA 204 (372)
T ss_dssp HHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHH
T ss_pred HHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHH
Confidence 34566666666666544333332 24567777777777654322 33355666777777777776554 2
Q ss_pred hhhcccccccccccccccccCccc----hhhhccccccEEeCcCCCCCC
Q 002069 547 SQVCSMQSLEKLNLSHNNLSGSIS----RCFEEMHWLSCIDISYNALQG 591 (973)
Q Consensus 547 ~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~l~l~~N~l~~ 591 (973)
..+..++.|++|+|++|.|+..+. .++...+.|++||+++|+++.
T Consensus 205 ~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 205 AQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred HHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 334455667777777777765433 333345667777777776653
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.25 E-value=1.2e-11 Score=136.57 Aligned_cols=103 Identities=24% Similarity=0.207 Sum_probs=60.9
Q ss_pred EEECCCC-cccccCCcCccCCCCCCeeeccC-CcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccC
Q 002069 28 LLSFSKN-QLSGLIPHEIGRLSSLNGLSLYS-NFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSN 105 (973)
Q Consensus 28 ~L~l~~n-~l~~~~p~~~~~l~~L~~L~l~~-n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~ 105 (973)
.++++++ +++ .+|. |+.+++|++|+|++ |++.+..|..|++|++|++|+|++|+|++..|..|+.|++|++|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4466665 565 3455 66666666666664 666644445566666666666666666655555666666666666666
Q ss_pred CcCCCCCCCccccCCccceeeccccccc
Q 002069 106 NSLNGSIPSSLGNLTNLVTLYLHMNALS 133 (973)
Q Consensus 106 n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 133 (973)
|+|++..|..|..++ |++|+|.+|.+.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 666643333343333 666666666665
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.4e-11 Score=136.08 Aligned_cols=104 Identities=21% Similarity=0.217 Sum_probs=92.9
Q ss_pred EEeCCCC-CCCCCCCcccCCCCCCCEEECCC-CcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccC
Q 002069 4 VLGLSFN-QFSGSIPPEIGHLTHLKLLSFSK-NQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGN 81 (973)
Q Consensus 4 ~L~l~~~-~l~~~~p~~~~~l~~L~~L~l~~-n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~ 81 (973)
.++++++ +|+ .+|+ |..+++|++|+|++ |+|++..|..|+.|++|++|+|++|+|++..|..|++|++|++|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 5789998 898 7999 99999999999996 999988778999999999999999999988888999999999999999
Q ss_pred CcCcccCCccccCccccceeeccCCcCCC
Q 002069 82 NLLSGSIPNEVGSLKSLSDLRLSNNSLNG 110 (973)
Q Consensus 82 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~ 110 (973)
|+|++..|..+..+. |++|+|++|.+..
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 999954444555555 9999999999973
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.8e-10 Score=128.83 Aligned_cols=150 Identities=16% Similarity=0.137 Sum_probs=88.5
Q ss_pred ccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhcc
Q 002069 207 SILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGN 286 (973)
Q Consensus 207 ~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~ 286 (973)
+....|..+.+|+.+.+..+ +..+...+|.+..+|+.+.+..+ ++.+....|.+
T Consensus 208 i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-------------------------v~~I~~~aF~~ 261 (379)
T 4h09_A 208 VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-------------------------VTSIGSFLLQN 261 (379)
T ss_dssp ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-------------------------CCEECTTTTTT
T ss_pred Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-------------------------ccEeCccccce
Confidence 33444555555555555433 23333445555555555554433 33344455566
Q ss_pred ccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEE
Q 002069 287 LKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLD 366 (973)
Q Consensus 287 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 366 (973)
+.+|+.+.+..+ ++......|.++++|+.+.+.++.++.+...+|.++.+|+.+.|.++ ++.+...+|.++++|+.+.
T Consensus 262 ~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ 339 (379)
T 4h09_A 262 CTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTIS 339 (379)
T ss_dssp CTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCC
T ss_pred eehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEE
Confidence 666666666543 44455556777777777777766666566667777777777777544 5545566777777777777
Q ss_pred ccCCcccCCCCcccccccc
Q 002069 367 LSINKLSGSIPLSFASLTS 385 (973)
Q Consensus 367 Ls~N~i~~~~~~~~~~l~~ 385 (973)
+..+ ++.+...+|.++..
T Consensus 340 ip~~-v~~I~~~aF~~c~~ 357 (379)
T 4h09_A 340 YPKS-ITLIESGAFEGSSI 357 (379)
T ss_dssp CCTT-CCEECTTTTTTSSC
T ss_pred ECCc-cCEEchhHhhCCCC
Confidence 7554 55566667766643
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.20 E-value=2.9e-10 Score=127.14 Aligned_cols=131 Identities=13% Similarity=0.104 Sum_probs=62.3
Q ss_pred hhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCC
Q 002069 283 EIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKL 362 (973)
Q Consensus 283 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 362 (973)
.+..+.+|+.+.+..+ ++......|..+..|+.+.+..+ ++.+...+|.++.+|+.+.+..+ ++.+...+|.++++|
T Consensus 212 ~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L 288 (379)
T 4h09_A 212 GFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL 288 (379)
T ss_dssp TTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC
T ss_pred ccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccc
Confidence 3444444444444332 22233444445555555555433 33334444555555555555332 333334445555555
Q ss_pred cEEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCCCCEEEccC
Q 002069 363 VSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSS 417 (973)
Q Consensus 363 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 417 (973)
+.+++.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.++++|+.+.+..
T Consensus 289 ~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 289 TKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp CEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred ccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 55555555555444555555555555555432 4444445555555555555543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=7.3e-11 Score=124.71 Aligned_cols=146 Identities=14% Similarity=0.070 Sum_probs=113.0
Q ss_pred HHHhcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeecccee
Q 002069 697 IRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHALHS 775 (973)
Q Consensus 697 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 775 (973)
......|++....+.|+++.||++.. .++.+++|+........ ...+.+|+.+++.+. +..++++++++...+..
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 34456798889999999999999986 46899999986421111 235778888888874 67788999999888889
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC-------------------------------- 823 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------------------------------- 823 (973)
|+||||++|.++.+.+.. ..+...++.+++++++.||+..
T Consensus 86 ~lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred EEEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 999999999999876321 1223478889999999999821
Q ss_pred ------------------------CCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 824 ------------------------FPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 824 ------------------------~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.+.++|||++|.||+++.++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0358999999999999876566799999775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=3e-10 Score=119.94 Aligned_cols=137 Identities=15% Similarity=0.110 Sum_probs=99.9
Q ss_pred cCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCc--eeeeceeeeccceeEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN--IVKFYGFCSHALHSFVV 778 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv 778 (973)
..|.+....+.|..+.||++...+|+.|++|+..... ...+..|+.+++.+.+.+ ++++++++..++..++|
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 4455544444566699999988778889999976431 245667888888775434 56688888877788999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC----------------------------------- 823 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 823 (973)
|||++|.++. ... .. ...++.+++..++.||+..
T Consensus 94 ~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 94 LGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999998884 211 11 2356778888888888752
Q ss_pred --------------------CCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 824 --------------------FPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 824 --------------------~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
...++|||++|.||+++.++.+.++|||.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0129999999999999877667799999875
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.7e-10 Score=126.54 Aligned_cols=151 Identities=17% Similarity=0.214 Sum_probs=94.7
Q ss_pred ccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCCcccc--cccccccccccc--cccccc-----cCccc--
Q 002069 433 NSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELG--SLNQLEYLDLSA--NTFHNS-----IPESL-- 501 (973)
Q Consensus 433 ~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~--~l~~L~~L~Ls~--N~i~~~-----~~~~l-- 501 (973)
++|+.|+|++|.-. ..+. + ..++|++|++..|.++......+. .+++|++|+|+. |...+. +...+
T Consensus 172 P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~ 248 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSK 248 (362)
T ss_dssp TTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCT
T ss_pred CCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhc
Confidence 35666666665211 1111 2 256677777766666533223333 567777777653 221111 11122
Q ss_pred cccccccEEeecCccCCCCCCcccc---cccccCeecccccccCCCcchhh----cccccccccccccccccCccchhhh
Q 002069 502 GNLVKLHYLNLSNNQFSQKIPNPIE---KLIHLSELDLSYKIFGEEIPSQV----CSMQSLEKLNLSHNNLSGSISRCFE 574 (973)
Q Consensus 502 ~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~ls~n~i~~~~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~ 574 (973)
..+++|++|+|++|.+++..+..+. .+++|++|+|++|.|++.++..+ ..+++|+.|+|++|.|+.....++.
T Consensus 249 ~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~ 328 (362)
T 2ra8_A 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQ 328 (362)
T ss_dssp TTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHH
T ss_pred CCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHH
Confidence 2467899999999888765444443 47789999999999887765544 3468899999999999877777766
Q ss_pred c-cccccEEeCcCCC
Q 002069 575 E-MHWLSCIDISYNA 588 (973)
Q Consensus 575 ~-l~~L~~l~l~~N~ 588 (973)
. + ...++++.|+
T Consensus 329 ~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 329 KSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHC--CSEEECCSBC
T ss_pred HHc--CCEEEecCCc
Confidence 5 3 4568888887
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.93 E-value=2.1e-10 Score=125.79 Aligned_cols=84 Identities=17% Similarity=0.329 Sum_probs=48.1
Q ss_pred ccccccccccccccccccCcccc---ccccccEEeecCccCCCCCC----cccccccccCeecccccccCCCcchhhccc
Q 002069 480 LNQLEYLDLSANTFHNSIPESLG---NLVKLHYLNLSNNQFSQKIP----NPIEKLIHLSELDLSYKIFGEEIPSQVCSM 552 (973)
Q Consensus 480 l~~L~~L~Ls~N~i~~~~~~~l~---~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~ls~n~i~~~~~~~~~~l 552 (973)
+++|++|+|++|.+++..+..+. .+++|++|+|+.|.+++..+ ..+..+++|+.|++++|.|++.+...+...
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a 330 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence 45666666666666543333332 35667777777777665432 233456677777777777766555555431
Q ss_pred cccccccccccc
Q 002069 553 QSLEKLNLSHNN 564 (973)
Q Consensus 553 ~~L~~L~L~~N~ 564 (973)
- ...+++++|+
T Consensus 331 l-g~~~~~~~~~ 341 (362)
T 2ra8_A 331 L-PMKIDVSDSQ 341 (362)
T ss_dssp C-CSEEECCSBC
T ss_pred c-CCEEEecCCc
Confidence 1 3446777766
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.92 E-value=2.6e-09 Score=118.31 Aligned_cols=144 Identities=16% Similarity=0.225 Sum_probs=106.8
Q ss_pred cccccccCCCceeEEEEEcCCCCEEEEEEcC--CCCCcchhhHHHHHHHHHHhhcCC--CCceeeeceeeecc---ceeE
Q 002069 704 DDEHCIGNGGQGSVYKAELPTGEIVAVKKFH--SPLPGEMACQQEFLNEGNALTKIR--HRNIVKFYGFCSHA---LHSF 776 (973)
Q Consensus 704 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~ 776 (973)
...+.++.|.++.||++... +..+++|+.. .... ......+.+|..+++.+. +..+++++.++.+. +..|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 34677999999999999875 4688889876 3211 112356778999888886 45678888888766 4589
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC--------------------------------- 823 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------------------------------- 823 (973)
+||||++|..+.+.. ...++..++..++.+++++++.||+..
T Consensus 118 ~vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 999999988774311 124677888999999999999999831
Q ss_pred ----------------------CCCeEeecCCCCCeeecCCCc--eEEeccccccc
Q 002069 824 ----------------------FPPIVHRDISSKNVLLNLEYE--AHVSDFGISKF 855 (973)
Q Consensus 824 ----------------------~~~i~H~Dlk~~Nill~~~~~--~kl~Dfg~a~~ 855 (973)
.+.++|||+++.||+++.++. +.++||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 136899999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.79 E-value=1.9e-09 Score=116.30 Aligned_cols=186 Identities=18% Similarity=0.156 Sum_probs=122.8
Q ss_pred cccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCc--eeeeceeeeccc---eeEEEE
Q 002069 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRN--IVKFYGFCSHAL---HSFVVY 779 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~n--iv~~~~~~~~~~---~~~lv~ 779 (973)
.+.++.|.+..||++. +.+++|+.... .....+.+|..+++.+ .+.. +++++.+..... ..|+||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 4568999999999874 46888986421 2356788999998877 3332 445555544333 358999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCC------------------------------------
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC------------------------------------ 823 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 823 (973)
||++|.++.+... ..++..++..++.+++..++.||+..
T Consensus 96 ~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 96 TKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp ECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred cccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 9999988864321 24567788888889999888888621
Q ss_pred -------------------CCCeEeecCCCCCeeecC--CCceEEecccccccccCCCCcccc--c---cc---------
Q 002069 824 -------------------FPPIVHRDISSKNVLLNL--EYEAHVSDFGISKFLKLGLSNRTE--L---AG--------- 868 (973)
Q Consensus 824 -------------------~~~i~H~Dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~--~---~g--------- 868 (973)
.+.++|+|++|.||+++. +..+.++||+.+..-.+...-... . .+
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence 135799999999999998 456789999998754321100000 0 00
Q ss_pred ccCccc-ccccccCCCCCccchHHHHHHHHHHHhCCCCCc
Q 002069 869 TFGYIA-PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD 907 (973)
Q Consensus 869 ~~~y~a-PE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 907 (973)
..+... |+.... .....+.|++|.++|++.+|+.+|-
T Consensus 251 ~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 251 HYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 001111 221111 1123689999999999999998864
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.67 E-value=2.2e-09 Score=106.24 Aligned_cols=91 Identities=18% Similarity=0.181 Sum_probs=40.2
Q ss_pred CCCcccceeeccCC-ccCCC----CCccccccccccccccccccccccc----CccccccccccEEeecCccCCCCC---
Q 002069 454 GKFSSLIQLILNNN-ELSGQ----LSPELGSLNQLEYLDLSANTFHNSI----PESLGNLVKLHYLNLSNNQFSQKI--- 521 (973)
Q Consensus 454 ~~~~~L~~L~l~~N-~l~~~----~~~~l~~l~~L~~L~Ls~N~i~~~~----~~~l~~l~~L~~L~L~~N~l~~~~--- 521 (973)
...++|++|+|++| .|++. +...+...++|++|+|++|.|++.. .+.+...+.|++|+|++|.|++..
T Consensus 33 ~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~ 112 (185)
T 1io0_A 33 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 112 (185)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHH
Confidence 33445555555555 55431 2233333445555555555554322 222223344555555555554322
Q ss_pred -CcccccccccCeecc--cccccCCC
Q 002069 522 -PNPIEKLIHLSELDL--SYKIFGEE 544 (973)
Q Consensus 522 -~~~~~~l~~L~~L~l--s~n~i~~~ 544 (973)
...+.....|++|+| ++|.|++.
T Consensus 113 l~~~L~~n~~L~~L~L~~~~N~i~~~ 138 (185)
T 1io0_A 113 LVEALQSNTSLIELRIDNQSQPLGNN 138 (185)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHH
T ss_pred HHHHHHhCCCceEEEecCCCCCCCHH
Confidence 223333344444444 44444443
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.63 E-value=1.8e-09 Score=106.73 Aligned_cols=115 Identities=12% Similarity=0.102 Sum_probs=62.1
Q ss_pred ccccccccccccccccc-ccccc----cCccccccccccEEeecCccCCCCCC----cccccccccCeecccccccCCCc
Q 002069 475 PELGSLNQLEYLDLSAN-TFHNS----IPESLGNLVKLHYLNLSNNQFSQKIP----NPIEKLIHLSELDLSYKIFGEEI 545 (973)
Q Consensus 475 ~~l~~l~~L~~L~Ls~N-~i~~~----~~~~l~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~ls~n~i~~~~ 545 (973)
..+...++|++|+|++| .|++. +.+.+...++|++|+|++|+|+.... ..+.....|++|+|++|.|++.+
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence 34445566666666666 66532 22333444566666666666654332 23344456666666666666554
Q ss_pred chh----hccccccccccc--ccccccCccc----hhhhccccccEEeCcCCCC
Q 002069 546 PSQ----VCSMQSLEKLNL--SHNNLSGSIS----RCFEEMHWLSCIDISYNAL 589 (973)
Q Consensus 546 ~~~----~~~l~~L~~L~L--~~N~l~~~~~----~~~~~l~~L~~l~l~~N~l 589 (973)
... +...+.|++|+| ++|.|...+. .++...+.|++|++++|.+
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 332 333455666666 5566654432 2333345666666666655
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.37 E-value=3.6e-08 Score=102.13 Aligned_cols=80 Identities=26% Similarity=0.349 Sum_probs=50.0
Q ss_pred cCCCCCcEEEccCCcCcc--cCCccccCccccceeeccCCcCCCCCCCccccCC--ccceeecccccccccCcc------
Q 002069 69 GNLTSLIYIDIGNNLLSG--SIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLT--NLVTLYLHMNALSGSIPD------ 138 (973)
Q Consensus 69 ~~l~~L~~L~l~~n~l~~--~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~--~L~~L~L~~n~l~~~~p~------ 138 (973)
.++++|++|+|++|++++ .+|..+..+++|++|+|++|+|++. ..+..++ +|++|+|++|.+.+..|+
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 346667777777777664 3345555667777777777777632 3344444 677777777777654442
Q ss_pred -cccccCCCCcee
Q 002069 139 -EIGNLKFLSDLQ 150 (973)
Q Consensus 139 -~~~~l~~L~~L~ 150 (973)
.+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 356677777776
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.36 E-value=1.1e-07 Score=98.49 Aligned_cols=106 Identities=26% Similarity=0.250 Sum_probs=68.0
Q ss_pred ccccccccc--cccccccccc---ccCccccccccccEEeecCccCCC--CCCcccccccccCeecccccccCCCcchhh
Q 002069 477 LGSLNQLEY--LDLSANTFHN---SIPESLGNLVKLHYLNLSNNQFSQ--KIPNPIEKLIHLSELDLSYKIFGEEIPSQV 549 (973)
Q Consensus 477 l~~l~~L~~--L~Ls~N~i~~---~~~~~l~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~ls~n~i~~~~~~~~ 549 (973)
|...+.|+. ++++.|.... .......++++|+.|+|++|+|++ .++..+..+++|+.|+|++|.|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 444555665 6677775431 111112356778888888888876 3445666777888888888877765 223
Q ss_pred cccc--cccccccccccccCccc-------hhhhccccccEEeC
Q 002069 550 CSMQ--SLEKLNLSHNNLSGSIS-------RCFEEMHWLSCIDI 584 (973)
Q Consensus 550 ~~l~--~L~~L~L~~N~l~~~~~-------~~~~~l~~L~~l~l 584 (973)
..+. +|++|+|++|++++..+ ..+..+++|+.||-
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LDg 258 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLDG 258 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEESS
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeECC
Confidence 3333 78888888888876433 34667888888763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=2.3e-06 Score=90.40 Aligned_cols=135 Identities=13% Similarity=0.102 Sum_probs=98.3
Q ss_pred ccccCCCce-eEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeeccceeEEEEEecC
Q 002069 707 HCIGNGGQG-SVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHALHSFVVYEYLE 783 (973)
Q Consensus 707 ~~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 783 (973)
+.+..|..| .||+.... +++.+++|+-.. ....++..|...++.+. +--++++++++.+++..++|||+++
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~ 103 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP 103 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence 345667666 58998664 567899998642 22467788888887773 3347788999988889999999999
Q ss_pred CCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------------
Q 002069 784 MGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC---------------------------------------- 823 (973)
Q Consensus 784 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------- 823 (973)
|.++.+...... .....++.+++..++.||+..
T Consensus 104 G~~~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 104 GKTAFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp SEEHHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred CccccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 988876653211 223456667777777777531
Q ss_pred ---------------CCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 824 ---------------FPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 824 ---------------~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.+.++|||+.+.||+++.++.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0237899999999999987777799999875
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.28 E-value=1.2e-07 Score=90.84 Aligned_cols=87 Identities=10% Similarity=0.104 Sum_probs=59.4
Q ss_pred cccccccccccccccccCccccccccccEEeecCcc-CCCCCCcccccc----cccCeeccccc-ccCCCcchhhccccc
Q 002069 481 NQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQ-FSQKIPNPIEKL----IHLSELDLSYK-IFGEEIPSQVCSMQS 554 (973)
Q Consensus 481 ~~L~~L~Ls~N~i~~~~~~~l~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~ls~n-~i~~~~~~~~~~l~~ 554 (973)
.+|++||+|++.|++..-..+.++++|++|+|++|. |++.....+..+ ++|++|+|++| +|++.+-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 357777777777776666666777777777777774 666555555553 35777777776 477777777777777
Q ss_pred cccccccccc-ccC
Q 002069 555 LEKLNLSHNN-LSG 567 (973)
Q Consensus 555 L~~L~L~~N~-l~~ 567 (973)
|++|+|++++ ++.
T Consensus 141 L~~L~L~~c~~Itd 154 (176)
T 3e4g_A 141 LKYLFLSDLPGVKE 154 (176)
T ss_dssp CCEEEEESCTTCCC
T ss_pred CCEEECCCCCCCCc
Confidence 7777777774 543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.23 E-value=3.8e-07 Score=87.34 Aligned_cols=84 Identities=10% Similarity=0.099 Sum_probs=76.6
Q ss_pred ccccEEeecCccCCCCCCcccccccccCeeccccc-ccCCCcchhhccc----ccccccccccc-cccCccchhhhcccc
Q 002069 505 VKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYK-IFGEEIPSQVCSM----QSLEKLNLSHN-NLSGSISRCFEEMHW 578 (973)
Q Consensus 505 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n-~i~~~~~~~~~~l----~~L~~L~L~~N-~l~~~~~~~~~~l~~ 578 (973)
..|++||+++|.+++.....+.++++|+.|+|++| .|++.+-..++.+ ++|++|+|++| +|+..+...+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 57999999999999988888999999999999999 5999888888875 58999999999 499888889999999
Q ss_pred ccEEeCcCCC
Q 002069 579 LSCIDISYNA 588 (973)
Q Consensus 579 L~~l~l~~N~ 588 (973)
|+.|++++++
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 9999999984
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=7.6e-06 Score=87.85 Aligned_cols=137 Identities=17% Similarity=0.113 Sum_probs=94.6
Q ss_pred cccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCC---ceeeeceeee-ccceeEEEEEe
Q 002069 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR---NIVKFYGFCS-HALHSFVVYEY 781 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~ 781 (973)
.+.++.|....||+. ++.+++|+... ......+..|..+++.+.+. .+++++.++. ..+..++||||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 456888999999998 56788888532 22356788999999988642 3566677664 44567899999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhC---------------------------------------
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTN--------------------------------------- 822 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------------------------------------- 822 (973)
++|.++.+..- ..++..+...++.++++.++.||+.
T Consensus 95 i~G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 95 VQGQILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCSEECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred cCCeECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 99988865321 1233444555555555555555542
Q ss_pred ------------------CCCCeEeecCCCCCeeecC---CCc-eEEecccccccc
Q 002069 823 ------------------CFPPIVHRDISSKNVLLNL---EYE-AHVSDFGISKFL 856 (973)
Q Consensus 823 ------------------~~~~i~H~Dlk~~Nill~~---~~~-~kl~Dfg~a~~~ 856 (973)
..+.++|+|+++.||+++. ++. +.|+||+.+..-
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1235699999999999987 455 489999987643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=8.1e-06 Score=89.99 Aligned_cols=84 Identities=6% Similarity=-0.038 Sum_probs=54.6
Q ss_pred cccc-cCCCceeEEEEEcC-------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-C--Cceeeeceeeecc--
Q 002069 706 EHCI-GNGGQGSVYKAELP-------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-H--RNIVKFYGFCSHA-- 772 (973)
Q Consensus 706 ~~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~-- 772 (973)
.+.| +.|....+|+.... +++.+++|+..............+..|..+++.+. + -.+++++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88889999998653 26789999865422000000134566777777663 2 3567788877655
Q ss_pred -ceeEEEEEecCCCChHH
Q 002069 773 -LHSFVVYEYLEMGSLAM 789 (973)
Q Consensus 773 -~~~~lv~e~~~~~~L~~ 789 (973)
+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.95 E-value=1.4e-06 Score=85.02 Aligned_cols=109 Identities=17% Similarity=0.222 Sum_probs=59.4
Q ss_pred cccccccccccc-ccccc----cCccccccccccEEeecCccCCCCCC----cccccccccCeecccccccCCCcchhhc
Q 002069 480 LNQLEYLDLSAN-TFHNS----IPESLGNLVKLHYLNLSNNQFSQKIP----NPIEKLIHLSELDLSYKIFGEEIPSQVC 550 (973)
Q Consensus 480 l~~L~~L~Ls~N-~i~~~----~~~~l~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~ls~n~i~~~~~~~~~ 550 (973)
.++|++|+|++| .|.+. +.+++..-+.|+.|+|++|+|++... +.+...+.|+.|+|++|.|++.+...++
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 345666666653 55432 23334444556666666666654333 2334456666666666666655554443
Q ss_pred ----ccccccccccccc---cccCc----cchhhhccccccEEeCcCCC
Q 002069 551 ----SMQSLEKLNLSHN---NLSGS----ISRCFEEMHWLSCIDISYNA 588 (973)
Q Consensus 551 ----~l~~L~~L~L~~N---~l~~~----~~~~~~~l~~L~~l~l~~N~ 588 (973)
..+.|++|+|++| .+... +..++..-+.|+.|+++.|.
T Consensus 120 ~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 3445777777654 33322 23445556677777776653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.90 E-value=1.4e-06 Score=85.04 Aligned_cols=84 Identities=15% Similarity=0.175 Sum_probs=42.8
Q ss_pred ccceeeccCCccCC----CCCcccccccccccccccccccccccC----ccccccccccEEeecCc---cCCCC----CC
Q 002069 458 SLIQLILNNNELSG----QLSPELGSLNQLEYLDLSANTFHNSIP----ESLGNLVKLHYLNLSNN---QFSQK----IP 522 (973)
Q Consensus 458 ~L~~L~l~~N~l~~----~~~~~l~~l~~L~~L~Ls~N~i~~~~~----~~l~~l~~L~~L~L~~N---~l~~~----~~ 522 (973)
.|+.|+|++|.|.+ .+.+++...++|++|+|++|.|++... +++..-+.|++|+|++| ++... +.
T Consensus 71 ~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia 150 (197)
T 1pgv_A 71 HIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMM 150 (197)
T ss_dssp CCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHH
T ss_pred CcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHH
Confidence 34444444444432 233455556667777777777765332 33444455777777654 33322 22
Q ss_pred cccccccccCeeccccccc
Q 002069 523 NPIEKLIHLSELDLSYKIF 541 (973)
Q Consensus 523 ~~~~~l~~L~~L~ls~n~i 541 (973)
+.+...+.|+.|++++|.+
T Consensus 151 ~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 151 MAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHCSSCCEEECCCCCH
T ss_pred HHHHhCCCcCeEeccCCCc
Confidence 3444445555555555543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=5.7e-05 Score=84.48 Aligned_cols=78 Identities=17% Similarity=0.076 Sum_probs=48.5
Q ss_pred cccccCCCceeEEEEEcC-CCCEEEEEEcCCCCC--cc--hhhHHHHHHHHHHhhcCCC--C-ceeeeceeeeccceeEE
Q 002069 706 EHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLP--GE--MACQQEFLNEGNALTKIRH--R-NIVKFYGFCSHALHSFV 777 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~--~~~~~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~l 777 (973)
.+.+|.|.++.||++... +++.|+||....... .. ......+..|.++++.+.. + .+++++.+. ++..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 467999999999999654 568899998653211 00 0112445677777776632 3 445566543 445689
Q ss_pred EEEecCCC
Q 002069 778 VYEYLEMG 785 (973)
Q Consensus 778 v~e~~~~~ 785 (973)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.70 E-value=7.3e-05 Score=81.76 Aligned_cols=140 Identities=19% Similarity=0.252 Sum_probs=77.3
Q ss_pred ccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC--CCceeeece------eeeccceeEEE
Q 002069 707 HCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR--HRNIVKFYG------FCSHALHSFVV 778 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~------~~~~~~~~~lv 778 (973)
+.++.|..+.||++...+| .+++|+.... ...+..|..+++.+. .-.+++++. +....+..++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 4466677899999987554 5899998742 122333444444332 113344443 11345677899
Q ss_pred EEecCCCChH-----------HH---hccCcc----c-------cCCCHHHH----------------------------
Q 002069 779 YEYLEMGSLA-----------MI---LSNDAA----A-------EEFGWTKR---------------------------- 805 (973)
Q Consensus 779 ~e~~~~~~L~-----------~~---l~~~~~----~-------~~~~~~~~---------------------------- 805 (973)
|||++|..+. .. ++.... . ....|...
T Consensus 110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 189 (346)
T 2q83_A 110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL 189 (346)
T ss_dssp EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence 9999986542 00 111000 0 01122211
Q ss_pred ---HHHHHHHHHHHHHHhh----------CCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 806 ---MNAIKGVADALLYMHT----------NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 806 ---~~i~~~i~~~l~~LH~----------~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
..+..++..++++|++ .....++|||+++.||+++.++.+.++||+.+.
T Consensus 190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223445666653 012489999999999999888899999999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00019 Score=76.54 Aligned_cols=139 Identities=17% Similarity=0.171 Sum_probs=91.6
Q ss_pred ccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC---CCceeeeceeeeccceeEEEEEe
Q 002069 705 DEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR---HRNIVKFYGFCSHALHSFVVYEY 781 (973)
Q Consensus 705 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~ 781 (973)
..+.++.|.+..+|+... +++.+++|+.... ....+..|...++.+. ...++++++++...+..++||||
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 346789999999999987 5778899986521 2467888888888773 36788889888877889999999
Q ss_pred cCCCChH--------HH---hccCcc----cc---------------CCCHHHHH---HHH----------------HHH
Q 002069 782 LEMGSLA--------MI---LSNDAA----AE---------------EFGWTKRM---NAI----------------KGV 812 (973)
Q Consensus 782 ~~~~~L~--------~~---l~~~~~----~~---------------~~~~~~~~---~i~----------------~~i 812 (973)
+++..+. .. ++.... .. .-+|.... ++. ..+
T Consensus 113 l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l 192 (312)
T 3jr1_A 113 LNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLI 192 (312)
T ss_dssp CCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHH
T ss_pred ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHH
Confidence 9988642 11 111111 00 11344321 111 111
Q ss_pred HHH-HHHHhh-CCCCCeEeecCCCCCeeecCCCceEEeccc
Q 002069 813 ADA-LLYMHT-NCFPPIVHRDISSKNVLLNLEYEAHVSDFG 851 (973)
Q Consensus 813 ~~~-l~~LH~-~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg 851 (973)
+.. .+.|.. ...+.++|+|+.+.|++++.++ +.++||+
T Consensus 193 ~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 193 VQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 111 223432 1235799999999999999887 8899984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00031 Score=78.99 Aligned_cols=76 Identities=13% Similarity=0.127 Sum_probs=47.1
Q ss_pred CCeEeecCCCCCeeecCCCceEEecccccccccCCCCcccccc--cccCcccccccccCC---CCCccchHHHHHHHHHH
Q 002069 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA--GTFGYIAPELAYTMK---VTEKCDVYSFGVLALEV 899 (973)
Q Consensus 825 ~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~--g~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~el 899 (973)
+.++|||+++.||+++.++ ++++||+.+..-.+...- .... -...|.+|+...... .....++......+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 3899999999999999876 999999988754322110 0011 123466666543211 12234556778888877
Q ss_pred HhC
Q 002069 900 IKG 902 (973)
Q Consensus 900 ~tg 902 (973)
.++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00055 Score=72.58 Aligned_cols=80 Identities=16% Similarity=0.221 Sum_probs=57.1
Q ss_pred cCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-C--CceeeeceeeeccceeEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-H--RNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~l 777 (973)
....-++.+|.|..+.||+.+..+|+.|+||+........ ...|..|...++.+. . --+++++++. ..++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 4556678899999999999999999999999875433221 245778888887763 2 2345555543 3479
Q ss_pred EEEecCCCCh
Q 002069 778 VYEYLEMGSL 787 (973)
Q Consensus 778 v~e~~~~~~L 787 (973)
||||++++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0011 Score=72.01 Aligned_cols=143 Identities=15% Similarity=0.112 Sum_probs=73.1
Q ss_pred cccccCCCcee-EEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC--CCceeeeceeeeccceeEEEEEec
Q 002069 706 EHCIGNGGQGS-VYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR--HRNIVKFYGFCSHALHSFVVYEYL 782 (973)
Q Consensus 706 ~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~ 782 (973)
.+.++.|+... +|+....+++.+++|....... ..+..|+.+++.+. .-.+++++.+..+.+ ++|||++
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l 94 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL 94 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence 34566665554 6788765477888887543311 12223444444442 223566676644333 7899999
Q ss_pred CCCChHHHhccCcc-----------------------ccCCCHHHHHH--------------------HHHHHHHHHHHH
Q 002069 783 EMGSLAMILSNDAA-----------------------AEEFGWTKRMN--------------------AIKGVADALLYM 819 (973)
Q Consensus 783 ~~~~L~~~l~~~~~-----------------------~~~~~~~~~~~--------------------i~~~i~~~l~~L 819 (973)
++..+.+++..... ...++...... ....+...++.+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 87776654432110 00111111000 001111222222
Q ss_pred hh---CCCCCeEeecCCCCCeeecCC----CceEEecccccccc
Q 002069 820 HT---NCFPPIVHRDISSKNVLLNLE----YEAHVSDFGISKFL 856 (973)
Q Consensus 820 H~---~~~~~i~H~Dlk~~Nill~~~----~~~kl~Dfg~a~~~ 856 (973)
.+ .....++|||+.+.||+++.+ +.+.++||+.+..-
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 11 112478999999999999875 67899999988644
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0041 Score=67.12 Aligned_cols=159 Identities=13% Similarity=0.121 Sum_probs=88.1
Q ss_pred cccHHHHHHHhcCCcc-----cccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCC--Cce
Q 002069 690 KIVHEEIIRATKNFDD-----EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH--RNI 762 (973)
Q Consensus 690 ~~~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~ni 762 (973)
..+.+.+....+.|.+ ...++ |....||++...+|+.+++|+....... ...+..|..++..+.. -.+
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~v 84 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPV 84 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSB
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCee
Confidence 3455666655555543 23466 8888999998777878999998643211 2455567766666532 124
Q ss_pred eeecee-----eeccceeEEEEEecCCCChH-----HH---------hc----cCcc--ccCCCHHHH------------
Q 002069 763 VKFYGF-----CSHALHSFVVYEYLEMGSLA-----MI---------LS----NDAA--AEEFGWTKR------------ 805 (973)
Q Consensus 763 v~~~~~-----~~~~~~~~lv~e~~~~~~L~-----~~---------l~----~~~~--~~~~~~~~~------------ 805 (973)
++++.. ....+..++||+|++|..+. .+ ++ .... ....++...
T Consensus 85 p~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 164 (328)
T 1zyl_A 85 AAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT 164 (328)
T ss_dssp CCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred cceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcC
Confidence 444443 12245668899999875432 00 01 0000 011222111
Q ss_pred ----------HHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 806 ----------MNAIKGVADALLYMHT-NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 806 ----------~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
...+.+++..++.... .....++|||+++.||+++ + .+.++||+.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 165 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1111122222222111 1223689999999999999 4 899999998754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0058 Score=65.69 Aligned_cols=158 Identities=11% Similarity=0.123 Sum_probs=85.7
Q ss_pred ccHHHHHHHhcCCcc-----cccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCC--cee
Q 002069 691 IVHEEIIRATKNFDD-----EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR--NIV 763 (973)
Q Consensus 691 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv 763 (973)
++.+++.....+|.. .+.++.|....+|+....+| .+++|+...... ...+..|..++..+... .++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~-----~~~l~~e~~~l~~L~~~g~~vP 80 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCP 80 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC-----HHHHHHHHHHHHHHHHCCCCCC
Confidence 455666666666765 34567788899999987555 688898865211 12344555555554211 133
Q ss_pred eecee------eeccceeEEEEEecCCCChHH-----H---------hccC----ccc--cCC---CHHHHHH-------
Q 002069 764 KFYGF------CSHALHSFVVYEYLEMGSLAM-----I---------LSND----AAA--EEF---GWTKRMN------- 807 (973)
Q Consensus 764 ~~~~~------~~~~~~~~lv~e~~~~~~L~~-----~---------l~~~----~~~--~~~---~~~~~~~------- 807 (973)
+++.. ....+..++||+|++|..+.. + ++.. ... ... .|.....
T Consensus 81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~ 160 (322)
T 2ppq_A 81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 160 (322)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence 34322 122356789999999865321 0 1110 000 001 1221110
Q ss_pred -----HHHHHHHHHHHHhhC----CCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 808 -----AIKGVADALLYMHTN----CFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 808 -----i~~~i~~~l~~LH~~----~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
+...+...++++++. ...+++|+|+.+.||+++.++.+.++||+.+.
T Consensus 161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001234445555532 12378999999999999977666899999875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0019 Score=68.90 Aligned_cols=71 Identities=11% Similarity=0.027 Sum_probs=42.8
Q ss_pred cccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCce-eeeceeeeccceeEEEEEec-C
Q 002069 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI-VKFYGFCSHALHSFVVYEYL-E 783 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~ 783 (973)
.+.++.|....+|++ +.+++|+........ .....|..+++.+....+ +++++++ ++..++|+||+ +
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~----~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY----INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C----CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce----eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence 678999999999999 568889876432111 112346655555522122 5566554 33457899999 6
Q ss_pred CCCh
Q 002069 784 MGSL 787 (973)
Q Consensus 784 ~~~L 787 (973)
+.++
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 5444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0033 Score=68.84 Aligned_cols=142 Identities=17% Similarity=0.203 Sum_probs=82.7
Q ss_pred cccccCCCceeEEEEEcC--------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeeccceeE
Q 002069 706 EHCIGNGGQGSVYKAELP--------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 776 (973)
.+.+..|-...+|++... +++.|++|+...... ....+.+|..+++.+. +.-.+++++++.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~----~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ----GVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C----CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc----hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 356777888999999875 357899999643211 1345568888887773 3334667776654 2
Q ss_pred EEEEecCCCChHHH-h----------------ccCc--cccCCC--HHHHHHHHHHHHH-------------------HH
Q 002069 777 VVYEYLEMGSLAMI-L----------------SNDA--AAEEFG--WTKRMNAIKGVAD-------------------AL 816 (973)
Q Consensus 777 lv~e~~~~~~L~~~-l----------------~~~~--~~~~~~--~~~~~~i~~~i~~-------------------~l 816 (973)
+||||++|.++..- + +... ...+.. +.++.++..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 99999998655311 0 1110 011222 3455545443321 22
Q ss_pred HH----HhhC-CCCCeEeecCCCCCeeecCC----CceEEeccccccc
Q 002069 817 LY----MHTN-CFPPIVHRDISSKNVLLNLE----YEAHVSDFGISKF 855 (973)
Q Consensus 817 ~~----LH~~-~~~~i~H~Dlk~~Nill~~~----~~~kl~Dfg~a~~ 855 (973)
++ |... ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 23 3221 12368999999999999876 7899999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0019 Score=72.37 Aligned_cols=73 Identities=19% Similarity=0.263 Sum_probs=49.2
Q ss_pred cccccCCCceeEEEEEcCC--------CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeeccceeE
Q 002069 706 EHCIGNGGQGSVYKAELPT--------GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 776 (973)
.+.|+.|....||++...+ ++.|++|+.... .. ...+..|..+++.+. +.-.+++++.+.+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 4568889899999997653 578999998532 11 134456888877773 3334667776543 3
Q ss_pred EEEEecCCCCh
Q 002069 777 VVYEYLEMGSL 787 (973)
Q Consensus 777 lv~e~~~~~~L 787 (973)
+|+||++|.++
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999986443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0038 Score=56.82 Aligned_cols=56 Identities=29% Similarity=0.367 Sum_probs=33.4
Q ss_pred EEEccCCcCc-ccCCccccCccccceeeccCCcCCCCCCCccccCCccceeeccccccc
Q 002069 76 YIDIGNNLLS-GSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALS 133 (973)
Q Consensus 76 ~L~l~~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 133 (973)
+++.+++.++ ..+|..+. .+|++|+|++|+|+...+..|..+++|++|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5666666664 24554443 25666777777776444445566666666666666654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0065 Score=68.38 Aligned_cols=74 Identities=14% Similarity=0.086 Sum_probs=46.5
Q ss_pred cccccCCCceeEEEEEcCC-CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCc-eeeeceeeeccceeEEEEEecC
Q 002069 706 EHCIGNGGQGSVYKAELPT-GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN-IVKFYGFCSHALHSFVVYEYLE 783 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~ 783 (973)
.+.|+.|-...+|++...+ ++.|++|+........ -+-..|..+++.+...+ .+++++++.. ..||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~----idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI----INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC----SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh----cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeC
Confidence 4568888899999998754 4789999875432111 11146777777774333 3567777632 35999998
Q ss_pred CCCh
Q 002069 784 MGSL 787 (973)
Q Consensus 784 ~~~L 787 (973)
|.++
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7544
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0083 Score=58.64 Aligned_cols=103 Identities=16% Similarity=0.079 Sum_probs=65.9
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCccc
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT 864 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 864 (973)
-+|.++|+... .+++++++|.++.|.+.++.-.-... .-..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc----------
Confidence 47888886543 58999999999999999987762211 111233456888999999988764 1110
Q ss_pred ccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCC
Q 002069 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905 (973)
Q Consensus 865 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p 905 (973)
.....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123466888653 3456788999999999999854444
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.20 E-value=0.029 Score=60.57 Aligned_cols=32 Identities=25% Similarity=0.288 Sum_probs=28.0
Q ss_pred CCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 825 PPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 825 ~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
..++|+|+.+.||+++.++.+.++||+.+..-
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 37899999999999998888999999887643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.15 E-value=0.0055 Score=55.71 Aligned_cols=37 Identities=22% Similarity=0.145 Sum_probs=20.4
Q ss_pred ccceeeccccccccccccccCCCCcccEEecCCcccC
Q 002069 193 SLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALS 229 (973)
Q Consensus 193 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~ 229 (973)
+|++|+|++|+|+.++...|..+++|+.|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555555555555555555555555555555555443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.98 E-value=0.0084 Score=65.90 Aligned_cols=74 Identities=11% Similarity=0.066 Sum_probs=42.9
Q ss_pred cccccCCCceeEEEEEcCC---------CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeecccee
Q 002069 706 EHCIGNGGQGSVYKAELPT---------GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHALHS 775 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 775 (973)
.+.++.|....+|++...+ ++.|++|+....... ..+...|..+++.+. +.-.+++++... .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTFN----G 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEecC----C
Confidence 4567888889999997654 278999987643111 112245666666653 222446665442 3
Q ss_pred EEEEEecCCCCh
Q 002069 776 FVVYEYLEMGSL 787 (973)
Q Consensus 776 ~lv~e~~~~~~L 787 (973)
++||||++|..+
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999997543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.16 E-value=0.08 Score=58.66 Aligned_cols=74 Identities=7% Similarity=-0.012 Sum_probs=46.8
Q ss_pred cccccCCCceeEEEEEcCC--------CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeeccceeE
Q 002069 706 EHCIGNGGQGSVYKAELPT--------GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 776 (973)
++.+..|-...+|+....+ ++.|++|+........ -+..+|..+++.+. +.-.+++++.+. .+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~----idR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF----YDSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC----CCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh----cCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 4567778889999997653 6889999975432111 12235666666553 333455665442 37
Q ss_pred EEEEecCCCCh
Q 002069 777 VVYEYLEMGSL 787 (973)
Q Consensus 777 lv~e~~~~~~L 787 (973)
.||||++|..+
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.82 E-value=0.23 Score=54.89 Aligned_cols=29 Identities=28% Similarity=0.449 Sum_probs=24.7
Q ss_pred eEeecCCCCCeee------cCCCceEEeccccccc
Q 002069 827 IVHRDISSKNVLL------NLEYEAHVSDFGISKF 855 (973)
Q Consensus 827 i~H~Dlk~~Nill------~~~~~~kl~Dfg~a~~ 855 (973)
++|+|+.+.||++ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4457799999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.43 E-value=1.7 Score=42.49 Aligned_cols=116 Identities=9% Similarity=0.077 Sum_probs=78.7
Q ss_pred CCCceeeeceeeeccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCe
Q 002069 758 RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNV 837 (973)
Q Consensus 758 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni 837 (973)
.||++++. .+-.+++...+.++.- .....|-. -...+...+++++.+|+...++++.. +|--+.|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFDN----IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCC--TTSEEGGG----GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcC--cccCCHHH----HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceE
Confidence 68888766 4555555555555543 33332221 23467899999999999998777766 8889999999
Q ss_pred eecCCCceEEecccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCc
Q 002069 838 LLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD 907 (973)
Q Consensus 838 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 907 (973)
+++.++.+++.=.|+...+. |. ..+...=.-.+=+++..+++++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~l~-----------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVVD-----------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTBS-----------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCCC-----------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999998776643322 21 12222234456678888999999886
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 973 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-50 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-50 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-43 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-41 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-40 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-06 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-12 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-14 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 7e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 7e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-56
Identities = 70/283 (24%), Positives = 119/283 (42%), Gaps = 23/283 (8%)
Query: 695 EIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNAL 754
EI IG+G G+VYK + VAVK + P Q F NE L
Sbjct: 4 EIPD--GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQ-AFKNEVGVL 58
Query: 755 TKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVAD 814
K RH NI+ F G+ + +V ++ E SL L +F K ++ + A
Sbjct: 59 RKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQ 115
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL--GLSNRTELAGTFGY 872
+ Y+H I+HRD+ S N+ L+ + + DFG++ G +L+G+ +
Sbjct: 116 GMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 873 IAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLD 929
+APE+ + + DVY+FG++ E++ G+ P I++ + + L
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR----DQIIFMVGRGYLS 228
Query: 930 PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
P L N + +M CL + RP ++ ++
Sbjct: 229 PDLSKVRSNCPKAMKRLMA---ECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-54
Identities = 58/273 (21%), Positives = 111/273 (40%), Gaps = 21/273 (7%)
Query: 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
+ +G G G V+ VAVK FL E N + +++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ----GSMSPDAFLAEANLMKQLQHQ 68
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMH 820
+V+ Y + +++ EY+E GSL L + + K ++ +A+ + ++
Sbjct: 69 RLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIE 126
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG-LSNRTELAGTFGYIAPELAY 879
+HRD+ + N+L++ ++DFG+++ ++ + R + APE
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 880 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939
T K DV+SFG+L E++ +N + + R+ P N
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPY-------PGMTNPEVIQNLERGYRMVRP-DNC 235
Query: 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
++L +M C E P RPT + +L+
Sbjct: 236 PEELYQLMR---LCWKERPEDRPTFDYLRSVLE 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 6e-53
Identities = 60/272 (22%), Positives = 116/272 (42%), Gaps = 19/272 (6%)
Query: 702 NFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
+++ + IG G G K G+I+ K+ E A +Q ++E N L +++H
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHP 63
Query: 761 NIVKFYGFCSHALHS--FVVYEYLEMGSLAMILSNDAAAEE-FGWTKRMNAIKGVADALL 817
NIV++Y ++ ++V EY E G LA +++ + + + + AL
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 818 YMH--TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAP 875
H ++ ++HRD+ NV L+ + + DFG+++ L S GT Y++P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 876 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935
E M EK D++S G L E+ P + + ++ + +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFT---------AFSQKELAGKIREGKFRRI 234
Query: 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
D+L I+ L+ RP+++++
Sbjct: 235 PYRYSDELNEIIT---RMLNLKDYHRPSVEEI 263
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 6e-51
Identities = 63/273 (23%), Positives = 107/273 (39%), Gaps = 21/273 (7%)
Query: 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
IG+G G V+ + VA+K +++F+ E + K+ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE----GAMSEEDFIEEAEVMMKLSHP 60
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMH 820
+V+ YG C +V+E++E G L+ L + V + + Y+
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLE 118
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTE-LAGTFGYIAPELAY 879
C ++HRD++++N L+ VSDFG+++F+ + + +PE+
Sbjct: 119 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 880 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939
+ + K DV+SFGVL EV SN + D RL P R
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-------RSNSEVVEDISTGFRLYKP-RLA 227
Query: 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ IM C E P RP ++ + L
Sbjct: 228 STHVYQIMN---HCWKERPEDRPAFSRLLRQLA 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 7e-51
Identities = 63/276 (22%), Positives = 113/276 (40%), Gaps = 24/276 (8%)
Query: 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
K+ +G G G V + VA+K + EF+ E + + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE----GSMSEDEFIEEAKVMMNLSHE 59
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMH 820
+V+ YG C+ F++ EY+ G L L F + + K V +A+ Y+
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL-KLGLSNRTELAGTFGYIAPELAY 879
+HRD++++N L+N + VSDFG+S+++ ++ + PE+
Sbjct: 118 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174
Query: 880 TMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938
K + K D+++FGVL E+ GK P + + + +
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYE---------RFTNSETAEHIAQGLRLYRPHL 225
Query: 939 VQDKLISIMEVSISCLDESPTSRPTMQKV-SQLLKI 973
+K+ +IM SC E RPT + + S +L +
Sbjct: 226 ASEKVYTIMY---SCWHEKADERPTFKILLSNILDV 258
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-50
Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 22/268 (8%)
Query: 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
++F+ +G G G+VY A + I+A+K + + + E + +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYM 819
NI++ YG+ A +++ EY +G++ L +F + I +A+AL Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYC 122
Query: 820 HTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAY 879
H+ ++HRDI +N+LL E ++DFG S S RT L GT Y+ PE+
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTTLCGTLDYLPPEMIE 177
Query: 880 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939
EK D++S GVL E + GK P + ++ + P V
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFE---------ANTYQETYKRISRVEFTFP-DFV 227
Query: 940 QDKLISIMEVSISCLDESPTSRPTMQKV 967
+ ++ L +P+ RP +++V
Sbjct: 228 TEGARDLIS---RLLKHNPSQRPMLREV 252
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-50
Identities = 63/298 (21%), Positives = 115/298 (38%), Gaps = 41/298 (13%)
Query: 702 NFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
+F+ +G G G V+K P+G ++A K H + + + + + E L +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI--RNQIIRELQVLHECNSP 64
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMH 820
IV FYG + E+++ GSL +L A V L Y+
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLR 121
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYT 880
I+HRD+ N+L+N E + DFG+S L ++N GT Y++PE
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF--VGTRSYMSPERLQG 177
Query: 881 MKVTEKCDVYSFGVLALEVIKGKHP-----------------------------RDFISS 911
+ + D++S G+ +E+ G++P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 912 ICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSI--SCLDESPTSRPTMQKV 967
+ S +A+ E+LD + P + + S+ CL ++P R ++++
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 6e-50
Identities = 65/279 (23%), Positives = 110/279 (39%), Gaps = 23/279 (8%)
Query: 695 EIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNAL 754
EI R ++ E +G G G V+ VA+K + FL E +
Sbjct: 13 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----GTMSPEAFLQEAQVM 66
Query: 755 TKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVAD 814
K+RH +V+ Y S ++V EY+ GSL L + + + ++ +A
Sbjct: 67 KKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIAS 124
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG-LSNRTELAGTFGYI 873
+ Y+ VHRD+ + N+L+ V+DFG+++ ++ + R +
Sbjct: 125 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 181
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933
APE A + T K DV+SFG+L E+ N + R+P
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRV-------PYPGMVNREVLDQVERGYRMP 234
Query: 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
P + L +M C + P RPT + + L+
Sbjct: 235 CP-PECPESLHDLMC---QCWRKEPEERPTFEYLQAFLE 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 175 bits (445), Expect = 1e-49
Identities = 72/298 (24%), Positives = 132/298 (44%), Gaps = 38/298 (12%)
Query: 694 EEIIRATKNFDDE---------HCIGNGGQGSVYKAELP----TGEIVAVKKFHSPLPGE 740
E+ A + F E IG G G V L VA+K S +
Sbjct: 10 EDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK 69
Query: 741 MACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEF 800
+++FL+E + + + H N++ G + + ++ E++E GSL L + +F
Sbjct: 70 Q--RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND--GQF 125
Query: 801 GWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860
+ + ++G+A + Y+ VHRD++++N+L+N VSDFG+S+FL+
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 861 SNRTELA-----GTFGYIAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICS 914
S+ T + + APE K T DV+S+G++ EV+ G+ P ++
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT---- 238
Query: 915 SLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ ++ A+++ D RLP P+ + L +M C + RP ++ L
Sbjct: 239 --NQDVINAIEQ--DYRLPPPM-DCPSALHQLML---DCWQKDRNHRPKFGQIVNTLD 288
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-49
Identities = 69/274 (25%), Positives = 111/274 (40%), Gaps = 27/274 (9%)
Query: 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
K IG G G V + G VAVK + A Q FL E + +T++RH
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHS 60
Query: 761 NIVKFYGFCSHALHS-FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYM 819
N+V+ G ++V EY+ GSL L G + V +A+ Y+
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 820 HTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAY 879
N VHRD++++NVL++ + A VSDFG++K S + + APE
Sbjct: 120 EGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS---STQDTGKLPVKWTAPEALR 173
Query: 880 TMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938
K + K DV+SFG+L E+ G+ P L + +
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYP---------RIPLKDVVPRVEKGYKMDAPDG 224
Query: 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ +M+ +C RP+ ++ + L+
Sbjct: 225 CPPAVYEVMK---NCWHLDAAMRPSFLQLREQLE 255
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (439), Expect = 1e-48
Identities = 64/274 (23%), Positives = 117/274 (42%), Gaps = 25/274 (9%)
Query: 700 TKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
K F D IG+G G+VY A + E+VA+KK Q+ + E L K+R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLY 818
H N +++ G +++V EY + ++ + + + G L Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAY 130
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELA 878
+H++ ++HRD+ + N+LL+ + DFG + ++ GT ++APE+
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANSFVGTPYWMAPEVI 183
Query: 879 YTM---KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935
M + K DV+S G+ +E+ + K P ++++ S+L +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESPALQSGHWSEY 242
Query: 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969
RN + SCL + P RPT + + +
Sbjct: 243 FRN----FVD------SCLQKIPQDRPTSEVLLK 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-48
Identities = 64/275 (23%), Positives = 109/275 (39%), Gaps = 27/275 (9%)
Query: 705 DEHCIGNGGQGSVYKAELP---TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN 761
++ +G+G G+V K + VAVK + + A + E L E N + ++ +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPY 69
Query: 762 IVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT 821
IV+ G C +V E E+G L L + + + V+ + Y+
Sbjct: 70 IVRMIGICEAE-SWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEE 125
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN---RTELAGTFGYIAPELA 878
+ VHRD++++NVLL ++ A +SDFG+SK L+ + +T + APE
Sbjct: 126 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 879 YTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937
K + K DV+SFGVL E G+ P + +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYR---------GMKGSEVTAMLEKGERMGCPA 233
Query: 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
++ +M C +RP V L+
Sbjct: 234 GCPREMYDLMN---LCWTYDVENRPGFAAVELRLR 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-48
Identities = 66/269 (24%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
K + IG G G+VY A ++ TG+ VA+++ + + ++ +NE + + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENK 75
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLY 818
+ NIV + +VV EYL GSL +++ E + + AL +
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALEF 131
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELA 878
+H+N ++HRDI S N+LL ++ ++DFG + S R+ + GT ++APE+
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 879 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938
K D++S G++A+E+I+G+ P +++ + L + IA + + + P L
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP--YLNE--NPLRALYLIATNGTPELQNPEKLSA 244
Query: 939 VQDKLISIMEVSISCLDESPTSRPTMQKV 967
+ ++ CLD R + +++
Sbjct: 245 IFRDFLN------RCLDMDVEKRGSAKEL 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-48
Identities = 61/298 (20%), Positives = 108/298 (36%), Gaps = 43/298 (14%)
Query: 706 EHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF 765
+ IG G G V++ + GE VAVK F S E +RH NI+ F
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGF 62
Query: 766 YGFCSH----ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT 821
+ ++V +Y E GSL L+ + A L ++H
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHM 118
Query: 822 NCF-----PPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN----RTELAGTFGY 872
P I HRD+ SKN+L+ ++D G++ GT Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 873 IAPELAYTM------KVTEKCDVYSFGVLALEVIKGK----------HPRDFISSICSSL 916
+APE+ + ++ D+Y+ G++ E+ + P + S+
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238
Query: 917 SSNLNIALDEMLDPRLPTPLRNVQ--DKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ ++ L P +P ++ + + IM C + +R T ++ + L
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLS 293
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (431), Expect = 6e-48
Identities = 60/281 (21%), Positives = 116/281 (41%), Gaps = 25/281 (8%)
Query: 695 EIIRATKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNA 753
E+ R + +H +G G G VY+ VAVK + +EFL E
Sbjct: 13 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAV 66
Query: 754 LTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVA 813
+ +I+H N+V+ G C+ +++ E++ G+L L + +E + ++
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQIS 125
Query: 814 DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG-LSNRTELAGTFGY 872
A+ Y+ +HRD++++N L+ + V+DFG+S+ + + +
Sbjct: 126 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182
Query: 873 IAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932
APE K + K DV++FGVL E+ + E+L+
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY---------PGIDLSQVYELLEKDY 233
Query: 933 PTPL-RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+K+ +M +C +P+ RP+ ++ Q +
Sbjct: 234 RMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFE 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 6e-48
Identities = 63/287 (21%), Positives = 107/287 (37%), Gaps = 28/287 (9%)
Query: 694 EEIIRATKNFD-DEHCIGNGGQGSVYKAEL---PTGEIVAVKKFHSPLPGEMACQQEFLN 749
+++ N + +G G GSV + VA+K E A +E +
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMR 58
Query: 750 EGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI 809
E + ++ + IV+ G C A +V E G L L EE + +
Sbjct: 59 EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELL 115
Query: 810 KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG---LSNRTEL 866
V+ + Y+ VHRD++++NVLL + A +SDFG+SK L + R+
Sbjct: 116 HQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172
Query: 867 AGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALD 925
+ APE K + + DV+S+GV E + G+ P +
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK---------KMKGPEVMA 223
Query: 926 EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ + +L ++M C RP V Q ++
Sbjct: 224 FIEQGKRMECPPECPPELYALMS---DCWIYKWEDRPDFLTVEQRMR 267
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-47
Identities = 65/271 (23%), Positives = 109/271 (40%), Gaps = 22/271 (8%)
Query: 701 KNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
+++D +G G G V A T E VAVK + + C + E + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNH 62
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYM 819
N+VKFYG ++ EY G L + D + ++Y+
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYL 119
Query: 820 HTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR--TELAGTFGYIAPEL 877
H I HRDI +N+LL+ +SDFG++ + R ++ GT Y+APEL
Sbjct: 120 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 878 AYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936
+ E DV+S G++ ++ G+ P D S C S P
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-------KKTYLNPW 229
Query: 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
+ + ++++ L E+P++R T+ +
Sbjct: 230 KKIDSAPLALLH---KILVENPSARITIPDI 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (429), Expect = 2e-47
Identities = 58/300 (19%), Positives = 112/300 (37%), Gaps = 45/300 (15%)
Query: 702 NFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALT 755
N + IG G G V++A P +VAVK +M Q +F E +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALMA 71
Query: 756 KIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSN---------------------D 794
+ + NIVK G C+ +++EY+ G L L +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 795 AAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854
+++ + VA + Y+ VHRD++++N L+ ++DFG+S+
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSR 188
Query: 855 FLKLG--LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSI 912
+ A ++ PE + + T + DV+++GV+ E+ +
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY---- 244
Query: 913 CSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ + D + N +L ++M C + P RP+ + ++L+
Sbjct: 245 ----GMAHEEVIYYVRDGNILACPENCPLELYNLMR---LCWSKLPADRPSFCSIHRILQ 297
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-47
Identities = 58/265 (21%), Positives = 116/265 (43%), Gaps = 24/265 (9%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G+G G VYKA+ T + A K + E+ ++++ E + L H NIVK
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYMVEIDILASCDHPNIVKLLD 76
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
+ + +++ E+ G++ ++ ++ K DAL Y+H N I
Sbjct: 77 AFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDN---KI 131
Query: 828 VHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTM-----K 882
+HRD+ + N+L L+ + ++DFG+S + R GT ++APE+
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 191
Query: 883 VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDK 942
K DV+S G+ +E+ + + P ++ + + + + + P L P
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPM------RVLLKIAKSEPPTLAQP-SRWSSN 244
Query: 943 LISIMEVSISCLDESPTSRPTMQKV 967
++ CL+++ +R T ++
Sbjct: 245 FKDFLK---KCLEKNVDARWTTSQL 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-47
Identities = 62/272 (22%), Positives = 109/272 (40%), Gaps = 28/272 (10%)
Query: 703 FDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN 761
FD E IG G +VYK T VA + + + +Q F E L ++H N
Sbjct: 13 FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPN 69
Query: 762 IVKFYGFCSHALHS----FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL 817
IV+FY + +V E + G+L L + + + + L
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQ 126
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLE-YEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPE 876
++HT PPI+HRD+ N+ + + D G++ + S + GT ++APE
Sbjct: 127 FLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAPE 183
Query: 877 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936
+ Y K E DVY+FG+ LE+ ++P N + P
Sbjct: 184 M-YEEKYDESVDVYAFGMCMLEMATSEYPYSE--------CQNAAQIYRRVTSGVKPASF 234
Query: 937 -RNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
+ ++ I+E C+ ++ R +++ +
Sbjct: 235 DKVAIPEVKEIIE---GCIRQNKDERYSIKDL 263
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-46
Identities = 64/280 (22%), Positives = 108/280 (38%), Gaps = 29/280 (10%)
Query: 702 NFDDEHCIGNGGQGSVYKAELP----TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI 757
+F++ IG G G VY L AVK + ++ +FL EG +
Sbjct: 30 HFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDF 85
Query: 758 RHRNIVKFYGFCSHALHS-FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADAL 816
H N++ G C + S VV Y++ G L + N+
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG--- 142
Query: 817 LYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG----LSNRTELAGTFGY 872
M VHRD++++N +L+ ++ V+DFG+++ + + N+T +
Sbjct: 143 --MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 873 IAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932
+A E T K T K DV+SFGVL E++ P + +I + + RL
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------PYPDVNTFDITVYLLQGRRL 253
Query: 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
P D L +M C RP+ ++ +
Sbjct: 254 LQP-EYCPDPLYEVML---KCWHPKAEMRPSFSELVSRIS 289
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 1e-45
Identities = 59/279 (21%), Positives = 104/279 (37%), Gaps = 26/279 (9%)
Query: 702 NFDDEHCIGNGGQGSVYKAELPTGE-----IVAVKKFHSPLPGEMACQQEFLNEGNALTK 756
+ IG G G VYK L T VA+K + + + +FL E + +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAGIMGQ 65
Query: 757 IRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADAL 816
H NI++ G S ++ EY+E G+ + E+ G + + +
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGA-----LDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 817 LYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN---RTELAGTFGYI 873
M VHRD++++N+L+N VSDFG+S+ L+ + +
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933
APE K T DV+SFG++ EV+ + + + + + D
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--------ELSNHEVMKAINDGFRL 232
Query: 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ + +M C + RP + +L
Sbjct: 233 PTPMDCPSAIYQLMM---QCWQQERARRPKFADIVSILD 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 3e-45
Identities = 54/279 (19%), Positives = 101/279 (36%), Gaps = 22/279 (7%)
Query: 698 RATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTK 756
+ ++F +G G +V A EL T A+K + E + +++
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 757 IRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADAL 816
+ H VK Y + Y + G L + F T + AL
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSAL 121
Query: 817 LYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG--LSNRTELAGTFGYIA 874
Y+H I+HRD+ +N+LLN + ++DFG +K L + GT Y++
Sbjct: 122 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 875 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934
PEL + D+++ G + +++ G P + N + +++
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFR---------AGNEYLIFQKIIKLEYDF 229
Query: 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLKI 973
P K ++E L T R +++ +
Sbjct: 230 P-EKFFPKARDLVE---KLLVLDATKRLGCEEMEGYGPL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 4e-45
Identities = 64/280 (22%), Positives = 108/280 (38%), Gaps = 25/280 (8%)
Query: 701 KNFDDEHCIGNGGQGSVYKAELP----TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTK 756
K+ +G+G G V + E VAVK + + +F+ E NA+
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 757 IRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADAL 816
+ HRN+++ YG +V E +GSL L G R VA+ +
Sbjct: 68 LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGM 124
Query: 817 LYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN---RTELAGTFGYI 873
Y+ + +HRD++++N+LL + DFG+ + L + + F +
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932
APE T + D + FGV E+ G+ P L+ + + + RL
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-------WIGLNGSQILHKIDKEGERL 234
Query: 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
P P + + ++M C P RPT + L
Sbjct: 235 PRP-EDCPQDIYNVMV---QCWAHKPEDRPTFVALRDFLL 270
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 162 bits (412), Expect = 1e-44
Identities = 57/281 (20%), Positives = 111/281 (39%), Gaps = 24/281 (8%)
Query: 690 KIVHEEIIRATKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFL 748
+I H+ ++ ++D +G G G V++ E TG A K +P + ++
Sbjct: 18 EIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVR 71
Query: 749 NEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNA 808
E ++ +RH +V + ++YE++ G L +++ + + +
Sbjct: 72 KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEY 129
Query: 809 IKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSNRTEL 866
++ V L +MH N VH D+ +N++ + + DFG++ L S +
Sbjct: 130 MRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT- 185
Query: 867 AGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDE 926
GT + APE+A V D++S GVL+ ++ G P F N+
Sbjct: 186 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP--FGGENDDETLRNVKSCDWN 243
Query: 927 MLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
M D + + + L P +R T+ +
Sbjct: 244 MDDSAFS----GISEDGKDFIR---KLLLADPNTRMTIHQA 277
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 5e-44
Identities = 57/295 (19%), Positives = 110/295 (37%), Gaps = 39/295 (13%)
Query: 702 NFDDEHCIGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALT 755
+G G G V +A VAVK + ++ ++E L+
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSAHLTEREALMSELKVLS 81
Query: 756 KI-RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSN---------------DAAAEE 799
+ H NIV G C+ + V+ EY G L L +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 800 FGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859
++ VA + ++ + +HRD++++N+LL + DFG+++ +K
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 860 --LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLS 917
+ ++APE + T + DV+S+G+ E+ + S
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 918 SNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ R+ +P + ++ IM+ +C D P RPT +++ QL++
Sbjct: 259 KMIKE------GFRMLSP-EHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIE 303
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-43
Identities = 61/284 (21%), Positives = 112/284 (39%), Gaps = 28/284 (9%)
Query: 695 EIIRATKNFDDEHCIGNGGQGSVYKAELP----TGEIVAVKKFHSPLPGEMACQQEFLNE 750
EI R + + CIG G G V++ VA+K + + +++FL E
Sbjct: 3 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV--REKFLQE 58
Query: 751 GNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIK 810
+ + H +IVK G + +++ E +G L L + +
Sbjct: 59 ALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAY 115
Query: 811 GVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNR-TELAGT 869
++ AL Y+ + VHRDI+++NVL++ + DFG+S++++ + ++
Sbjct: 116 QLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172
Query: 870 FGYIAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDEML 928
++APE + T DV+ FGV E++ G P N + +
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ---------GVKNNDVIGRIE 223
Query: 929 DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ N L S+M C P+ RP ++ L
Sbjct: 224 NGERLPMPPNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLS 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 7e-43
Identities = 58/301 (19%), Positives = 110/301 (36%), Gaps = 46/301 (15%)
Query: 702 NFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALT 755
N + +G+G G V A VAVK ++ ++E +T
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE--REALMSELKMMT 95
Query: 756 KI-RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSN--------------------D 794
++ H NIV G C+ + ++++EY G L L + +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 795 AAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854
+ + VA + ++ VHRD++++NVL+ + DFG+++
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 855 FLKLG--LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISS 911
+ R ++APE + T K DV+S+G+L E+ G +P
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP---- 268
Query: 912 ICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971
+ + N ++ P +++ IM+ SC RP+ ++ L
Sbjct: 269 ---GIPVDANFYKLIQNGFKMDQP-FYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFL 321
Query: 972 K 972
Sbjct: 322 G 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-42
Identities = 58/287 (20%), Positives = 104/287 (36%), Gaps = 30/287 (10%)
Query: 701 KNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-R 758
+ + IG G G V KA + G + ++F E L K+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEE-------------FGWTKR 805
H NI+ G C H + ++ EY G+L L E +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 806 MNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTE 865
++ VA + Y+ +HRD++++N+L+ Y A ++DFG+S+ ++ +T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTM 185
Query: 866 LAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALD 925
++A E T DV+S+GVL E++ +
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC--------GMTCAELYE 237
Query: 926 EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
++ N D++ +M C E P RP+ ++ L
Sbjct: 238 KLPQGYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSLN 281
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (389), Expect = 6e-42
Identities = 54/275 (19%), Positives = 104/275 (37%), Gaps = 25/275 (9%)
Query: 701 KNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
++F +G G G V+ G A+K + + + +E L+ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYM 819
I++ +G A F++ +Y+E G L +L + L +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 820 HTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAY 879
I++RD+ +N+LL+ ++DFG +K++ L GT YIAPE+
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVVS 174
Query: 880 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939
T + D +SFG+L E++ G P SN +++L+ L P
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFY---------DSNTMKTYEKILNAELRFP-PFF 224
Query: 940 QDKLISIMEVSISCLDESPTSRPTMQKVS--QLLK 972
+ + ++ + + R + +
Sbjct: 225 NEDVKDLLS---RLITRDLSQRLGNLQNGTEDVKN 256
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 154 bits (391), Expect = 9e-42
Identities = 50/263 (19%), Positives = 103/263 (39%), Gaps = 23/263 (8%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G+G G V++ E TG + K ++P P + + NE + + ++ H ++ +
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHD 93
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
++ E+L G L ++ + + + +N ++ + L +MH + I
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH---SI 148
Query: 828 VHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTE 885
VH DI +N++ + + V DFG++ L T + APE+ V
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPVGF 207
Query: 886 KCDVYSFGVLALEVIKGKHPRDFISSICS-SLSSNLNIALDEMLDPRLPTPLRNVQDKLI 944
D+++ GVL ++ G P + + + DE + ++ I
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD----FI 263
Query: 945 SIMEVSISCLDESPTSRPTMQKV 967
+ L + P R T+
Sbjct: 264 K------NLLQKEPRKRLTVHDA 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 2e-41
Identities = 57/273 (20%), Positives = 103/273 (37%), Gaps = 23/273 (8%)
Query: 702 NFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTK-IRH 759
+F +G G G V+ AE T + A+K + + + E L+ H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYM 819
+ + + F V EYL G L + + +F ++ + L ++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFL 119
Query: 820 HTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAY 879
H+ IV+RD+ N+LL+ + ++DFG+ K LG + GT YIAPE+
Sbjct: 120 HSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 176
Query: 880 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939
K D +SFGVL E++ G+ P + + P R +
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFH---------GQDEEELFHSIRMDNPFYP-RWL 226
Query: 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ + ++ P R ++ + +
Sbjct: 227 EKEAKDLLV---KLFVREPEKRLGVR--GDIRQ 254
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-41
Identities = 60/293 (20%), Positives = 114/293 (38%), Gaps = 33/293 (11%)
Query: 695 EIIRATKNFDDEHCIGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFL 748
E+ R + +G G G VY+ VA+K + M + EFL
Sbjct: 16 EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFL 71
Query: 749 NEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMIL-------SNDAAAEEFG 801
NE + + + ++V+ G S + V+ E + G L L +N+
Sbjct: 72 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 802 WTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS 861
+K + +AD + Y++ N VHRD++++N ++ ++ + DFG+++ +
Sbjct: 132 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 188
Query: 862 NR--TELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSN 919
R + +++PE T DV+SFGV+ E+ +
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ--------GLS 240
Query: 920 LNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
L +++ L N D L +M C +P RP+ ++ +K
Sbjct: 241 NEQVLRFVMEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIK 290
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (383), Expect = 2e-41
Identities = 42/288 (14%), Positives = 96/288 (33%), Gaps = 28/288 (9%)
Query: 697 IRATKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALT 755
+R + IG+G G +Y + GE VA+K + E
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYK 57
Query: 756 KIRHRNIVKFYGFC-SHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVAD 814
++ + +C + ++ +V E L + +F + +
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMIS 114
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLE---YEAHVSDFGISKFLKLGLSN-------RT 864
+ Y+H+ +HRD+ N L+ L ++ DFG++K + ++
Sbjct: 115 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 865 ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIAL 924
L GT Y + ++ + + D+ S G + + G P + ++
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL--KAATKRQKYERIS 229
Query: 925 DEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
++ + + + + + + C +P + QL +
Sbjct: 230 EKKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 4e-41
Identities = 61/288 (21%), Positives = 112/288 (38%), Gaps = 33/288 (11%)
Query: 695 EIIRATKNFDDEHCIGNGGQGSVYKAE-LPTGE----IVAVKKFHSPLPGEMACQQEFLN 749
I++ T F +G+G G+VYK +P GE VA+K+ + +E L+
Sbjct: 4 RILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILD 60
Query: 750 EGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAI 809
E + + + ++ + G C + + L + + + G +N
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWC 117
Query: 810 KGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG--LSNRTELA 867
+A + Y+ +VHRD++++NVL+ ++DFG++K L +
Sbjct: 118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 868 GTFGYIAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSLSSNLNIALDE 926
++A E T + DV+S+GV E++ G P D I +
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----------ASEISS 224
Query: 927 MLD--PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+L+ RLP P + IM C SRP +++
Sbjct: 225 ILEKGERLPQP-PICTIDVYMIMV---KCWMIDADSRPKFRELIIEFS 268
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 147 bits (373), Expect = 3e-40
Identities = 64/286 (22%), Positives = 121/286 (42%), Gaps = 29/286 (10%)
Query: 700 TKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
+ ++ +G GG V+ A L VAVK + L + + F E +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 759 HRNIVKFYGFCSHALHS----FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVAD 814
H IV Y + ++V EY++ +L I+ + + + I
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQ 122
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTE---LAGTFG 871
AL + H N I+HRD+ N++++ V DFGI++ + ++ T+ + GT
Sbjct: 123 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 872 YIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPR 931
Y++PE A V + DVYS G + EV+ G+ P S +++A + +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT--------GDSPVSVAYQHVREDP 231
Query: 932 LPTPLR--NVQDKLISIMEVSISCLDESPTSRP-TMQKVSQ-LLKI 973
+P R + L +++ L ++P +R T ++ L+++
Sbjct: 232 IPPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADLVRV 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 8e-40
Identities = 53/268 (19%), Positives = 102/268 (38%), Gaps = 34/268 (12%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYG 767
+G G G V++ E + + K + Q E + L RHRNI+ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPI 827
+++E++ + ++ A E + ++ + V +AL ++H++ I
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NI 123
Query: 828 VHRDISSKNVLLNLEYEAHV--SDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTE 885
H DI +N++ + + +FG ++ LK G + R L Y APE+ V+
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAPEVHQHDVVST 182
Query: 886 KCDVYSFGVLALEVIKGKHP------RDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939
D++S G L ++ G +P + I +I N DE + +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM-----NAEYTFDEEAFKEISIEAMD- 236
Query: 940 QDKLISIMEVSISCLDESPTSRPTMQKV 967
+ L + SR T +
Sbjct: 237 ---FVD------RLLVKERKSRMTASEA 255
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 9e-40
Identities = 54/279 (19%), Positives = 102/279 (36%), Gaps = 28/279 (10%)
Query: 701 KNFDD----EHCIGNGGQGSVYKA-ELPTGEIVAVK---KFHSPLPGEMACQQEFLNEGN 752
+N DD +G+G V K E TG A K K + +++ E +
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 753 ALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGV 812
L +I+H N++ + + ++ E + G L E A + +
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF------LAEKESLTEEEATEFL 119
Query: 813 ADALLYMHTNCFPPIVHRDISSKNVLLNLE----YEAHVSDFGISKFLKLGLSNRTELAG 868
L ++ I H D+ +N++L + DFG++ + G + + G
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFG 178
Query: 869 TFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML 928
T ++APE+ + + D++S GV+ ++ G P F+ +N++ E
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--FLGDTKQETLANVSAVNYEFE 236
Query: 929 DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
D N + L + P R T+Q
Sbjct: 237 DEYFS----NTSALAKDFIR---RLLVKDPKKRMTIQDS 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (371), Expect = 1e-39
Identities = 65/281 (23%), Positives = 110/281 (39%), Gaps = 32/281 (11%)
Query: 698 RATKNFDD----EHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGN 752
+ ++ D +G G V AE T ++VA+K + NE
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIA 59
Query: 753 ALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGV 812
L KI+H NIV H +++ + + G L + + I V
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQV 116
Query: 813 ADALLYMHTNCFPPIVHRDISSKNVLLNLEYE---AHVSDFGISKFLKLGLSNRTELAGT 869
DA+ Y+H IVHRD+ +N+L E +SDFG+SK G S + GT
Sbjct: 117 LDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGT 172
Query: 870 FGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML- 928
GY+APE+ ++ D +S GV+A ++ G P N +++L
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY---------DENDAKLFEQILK 223
Query: 929 -DPRLPTPLR-NVQDKLISIMEVSISCLDESPTSRPTMQKV 967
+ +P ++ D + +++ P R T ++
Sbjct: 224 AEYEFDSPYWDDISDSAKDFIR---HLMEKDPEKRFTCEQA 261
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (369), Expect = 1e-39
Identities = 59/286 (20%), Positives = 111/286 (38%), Gaps = 30/286 (10%)
Query: 702 NFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRN 761
+ IG G G VYKA+ GE A+KK E + E + L +++H N
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSN 61
Query: 762 IVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT 821
IVK Y +V+E+L+ ++ + + + + + + Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD 118
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPE-LAYT 880
++HRD+ +N+L+N E E ++DFG+++ + + T T Y AP+ L +
Sbjct: 119 RR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 881 MKVTEKCDVYSFGVLALEVIKGKHP------RDFISSICSSLSS-------------NLN 921
K + D++S G + E++ G D + I L + +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 922 IALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
+ L+ + + I ++ L P R T ++
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQA 278
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 4e-39
Identities = 60/296 (20%), Positives = 111/296 (37%), Gaps = 42/296 (14%)
Query: 702 NFDDEHCIGNGGQGSVYKAELP--------TGEIVAVKKFHSPLPGEMACQQEFLNEGNA 753
+G G G V AE VAVK S + + ++E
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEM 71
Query: 754 LTKI-RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMIL-------------SNDAAAEE 799
+ I +H+NI+ G C+ +V+ EY G+L L + E+
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 800 FGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859
++ VA + Y+ + +HRD++++NVL+ + ++DFG+++ +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 860 LSNRT--ELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSICSSL 916
+ ++APE + T + DV+SFGVL E+ G P
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP--------- 239
Query: 917 SSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ + + N ++L +M C P+ RPT +++ + L
Sbjct: 240 GVPVEELFKLLKEGHRMDKPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLD 292
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 144 bits (364), Expect = 5e-39
Identities = 57/280 (20%), Positives = 108/280 (38%), Gaps = 30/280 (10%)
Query: 702 NFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQ------QEFLNEGNAL 754
N++ + +G G V + PT + AVK G + + + L E + L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 755 TKIR-HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVA 813
K+ H NI++ F+V++ ++ G L L+ + ++ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALL 120
Query: 814 DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI 873
+ + +H IVHRD+ +N+LL+ + ++DFG S L G E+ GT Y+
Sbjct: 121 EVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYL 176
Query: 874 APELAYTM------KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEM 927
APE+ ++ D++S GV+ ++ G P L + +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-----HRKQMLMLRMIMSGN 231
Query: 928 LDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
P + D + ++ L P R T ++
Sbjct: 232 YQFGSP-EWDDYSDTVKDLVS---RFLVVQPQKRYTAEEA 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 145 bits (366), Expect = 2e-38
Identities = 55/278 (19%), Positives = 96/278 (34%), Gaps = 25/278 (8%)
Query: 702 NFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-- 758
+F IG GG G VY TG++ A+K + LNE L+ +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 759 -HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL 817
IV + + + G L LS F + L
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLE 121
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPE- 876
+MH +V+RD+ N+LL+ +SD G++ + + GT GY+APE
Sbjct: 122 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPEV 176
Query: 877 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936
L + D +S G + ++++G P + + + L + P
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK------TKDKHEIDRMTLTMAVELP- 229
Query: 937 RNVQDKLISIMEVSISCLDESPTSRPTMQK--VSQLLK 972
+ +L S++E L R ++ +
Sbjct: 230 DSFSPELRSLLE---GLLQRDVNRRLGCLGRGAQEVKE 264
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 142 bits (358), Expect = 4e-38
Identities = 47/290 (16%), Positives = 101/290 (34%), Gaps = 38/290 (13%)
Query: 701 KNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
++ IG G G +++ L + VA+K + + +E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAG 59
Query: 760 RN-IVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLY 818
I Y F LH+ +V + L ++ +F A K + +
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQS 116
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAH-----VSDFGISKFLKLGLSN-------RTEL 866
+H +V+RDI N L+ + V DFG+ KF + ++ + L
Sbjct: 117 IHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173
Query: 867 AGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDE 926
+GT Y++ + + + D+ + G + + ++G P + ++ +
Sbjct: 174 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK------AATNKQKYER 227
Query: 927 MLDPRLPTPLR----NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ + + TPLR ++ M + + + P + L
Sbjct: 228 IGEKKQSTPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 6e-37
Identities = 58/283 (20%), Positives = 106/283 (37%), Gaps = 28/283 (9%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEM--ACQQEFLNEGNALTKIRHRNIVKF 765
+G G +VYKA T +IVA+KK E + L E L ++ H NI+
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 766 YGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFP 825
H + +V++++E +I N + + L Y+H +
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 826 PIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKV-T 884
I+HRD+ N+LL+ ++DFG++K T T Y APEL + ++
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 885 EKCDVYSFGVLALEVIKGKHP------RDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938
D+++ G + E++ D ++ I +L + +M ++
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 939 VQDKLISIMEVSIS---------CLDESPTSRPTMQKVSQLLK 972
+ + + +P +R T Q LK
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT---QALK 279
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 7e-37
Identities = 61/284 (21%), Positives = 111/284 (39%), Gaps = 24/284 (8%)
Query: 702 NFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
NF IG G G VYKA TGE+VA+KK E + E + L ++ H
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 61
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMH 820
NIVK ++V+E+L + ++ + + + L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCH 119
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPE-LAY 879
++ ++HRD+ +N+L+N E ++DFG+++ + + T T Y APE L
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 880 TMKVTEKCDVYSFGVLALEVIKGKHP------RDFISSICSSLSSNLNIALDEM-----L 928
+ D++S G + E++ + D + I +L + + +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 929 DPRLPTPLRNVQDKLISIMEVSI-----SCLDESPTSRPTMQKV 967
P P R K++ ++ L P R + +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-36
Identities = 53/275 (19%), Positives = 95/275 (34%), Gaps = 22/275 (8%)
Query: 701 KNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
+FD +G G G V TG A+K + + E L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYM 819
+ V EY G L LS + E A A+ + +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE------ERARFYGAEIVSAL 118
Query: 820 HTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAY 879
+V+RDI +N++L+ + ++DFG+ K + GT Y+APE+
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 880 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939
D + GV+ E++ G+ P + + + +L + P R +
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFY---------NQDHERLFELILMEEIRFP-RTL 228
Query: 940 QDKLISIMEVSISCLDESPTSRPTMQK--VSQLLK 972
+ S++ L + P R ++++
Sbjct: 229 SPEAKSLLA---GLLKKDPKQRLGGGPSDAKEVME 260
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 4e-36
Identities = 58/267 (21%), Positives = 99/267 (37%), Gaps = 34/267 (12%)
Query: 709 IGNGGQGSVYKA-ELPTGEIVAVKKFHSPL---PGEMACQQEFLNEGNALTKIR--HRNI 762
+G+GG GSVY + VA+K GE+ E L K+ +
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 763 VKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTN 822
++ + ++ E E + A + V +A+ + H
Sbjct: 72 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNC 129
Query: 823 CFPPIVHRDISSKNVLLNLE-YEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPE-LAYT 880
++HRDI +N+L++L E + DFG LK + T+ GT Y PE + Y
Sbjct: 130 ---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYH 184
Query: 881 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940
V+S G+L +++ G P + I I R+ + ++
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------IRGQVFFRQRVSSECQH-- 233
Query: 941 DKLISIMEVSISCLDESPTSRPTMQKV 967
LI CL P+ RPT +++
Sbjct: 234 --LIR------WCLALRPSDRPTFEEI 252
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 6e-36
Identities = 58/294 (19%), Positives = 106/294 (36%), Gaps = 38/294 (12%)
Query: 702 NFDDEHCIGNGGQGSVYKA------ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALT 755
+G G G V +A + T VAVK + ++E L
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILI 71
Query: 756 KIRHR-NIVKFYGFCSHALHS-FVVYEYLEMGSLAMILSN-------------DAAAEEF 800
I H N+V G C+ V+ E+ + G+L+ L + D +
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 801 GWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG- 859
+ VA + ++ + +HRD++++N+LL+ + + DFG+++ +
Sbjct: 132 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 860 -LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSS 918
+ + ++APE + T + DV+SFGVL E+ +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVKIDE 244
Query: 919 NLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
L E R P ++ M C P+ RPT ++ + L
Sbjct: 245 EFCRRLKEGTRMRAP---DYTTPEMYQTML---DCWHGEPSQRPTFSELVEHLG 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 3e-35
Identities = 49/286 (17%), Positives = 112/286 (39%), Gaps = 26/286 (9%)
Query: 701 KNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
+ ++ IG G G+V+KA+ T EIVA+K+ E L E L +++H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKH 60
Query: 760 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYM 819
+NIV+ + +V+E+ + S + G + L +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGL 114
Query: 820 HTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAY 879
++HRD+ +N+L+N E +++FG+++ + + + T Y P++ +
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 880 TMKV-TEKCDVYSFGVLALEVIKGKHP----------RDFISSICSSLSSNLNIALDEML 928
K+ + D++S G + E+ P I + + + ++ ++
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 929 DPRLPTPLRNVQDKLISIMEVSIS-------CLDESPTSRPTMQKV 967
D + + + +++ + L +P R + ++
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-35
Identities = 63/290 (21%), Positives = 113/290 (38%), Gaps = 34/290 (11%)
Query: 702 NFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
++ D IGNG G VY+A+L +GE+VA+KK ++ E + K+ H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHC 73
Query: 761 NIVKFYGFCSHA------LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVAD 814
NIV+ F + ++ +V +Y+ + A + + +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAH-VSDFGISKFLKLGLSNRTELAGTFGYI 873
+L Y+H+ I HRDI +N+LL+ + + DFG +K L G N + + +
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVIKGKHP------RDFISSICSSLSSNLNIALDEM 927
+ T DV+S G + E++ G+ D + I L + + EM
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 928 --------LDPRLPTPLRNVQDKLISIMEVSI--SCLDESPTSRPTMQKV 967
P V +++ L+ +PT+R T +
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-34
Identities = 54/294 (18%), Positives = 101/294 (34%), Gaps = 34/294 (11%)
Query: 700 TKNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
+ + IG G G V A + VA+KK Q L E L + R
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFR 64
Query: 759 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLY 818
H NI+ + YL + L + + + L Y
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 819 MHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN---RTELAGTFGYIAP 875
+H+ ++HRD+ N+LLN + + DFG+++ + TE T Y AP
Sbjct: 125 IHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 876 ELAYT-MKVTEKCDVYSFGVLALEVIKGKHP---------------------RDFISSIC 913
E+ T+ D++S G + E++ + ++ ++ I
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 914 SSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
+ + N ++L N K + +++ L +P R +++
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQA 292
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 47/294 (15%), Positives = 96/294 (32%), Gaps = 31/294 (10%)
Query: 698 RATKNFDDEHCIGNGGQGSVYKAE--LPTGEIVAVKKFHSPLPGEMACQQEF--LNEGNA 753
RA + ++ IG G G V+KA G VA+K+ E +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 754 LTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLA---MILSNDAAAEEFGWTKRMNAIK 810
L H N+V+ + C+ + L + + + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 811 GVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTF 870
+ L ++H++ +VHRD+ +N+L+ + ++DFG+++ T + T
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS-FQMALTSVVVTL 179
Query: 871 GYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-----------------RDFISSIC 913
Y APE+ D++S G + E+ + K
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 914 SSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
+ A + + ++ + ++ CL +P R +
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYSA 290
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 3e-34
Identities = 56/271 (20%), Positives = 102/271 (37%), Gaps = 27/271 (9%)
Query: 706 EHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIV 763
+G G G V + T E A+K + E + + +IV
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 68
Query: 764 KFYGFCSHAL----HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYM 819
+ + +V E L+ G L + D + F + +K + +A+ Y+
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYL 127
Query: 820 HTNCFPPIVHRDISSKNVLLNLEYE---AHVSDFGISKFLKLGLSNRTELAGTFGYIAPE 876
H+ I HRD+ +N+L + ++DFG +K S T T Y+APE
Sbjct: 128 HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAPE 183
Query: 877 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936
+ K + CD++S GV+ ++ G P + S I + + P
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS- 242
Query: 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKV 967
V +++ ++ + L PT R T+ +
Sbjct: 243 -EVSEEVKMLIR---NLLKTEPTQRMTITEF 269
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 8e-34
Identities = 64/302 (21%), Positives = 113/302 (37%), Gaps = 38/302 (12%)
Query: 694 EEIIRATKNFDD----EHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFL 748
+E+ + +G+G G+V A + TG VA+KK + P E+ ++
Sbjct: 7 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR-AY 65
Query: 749 NEGNALTKIRHRNIVKFYGFCSHALHSFVVYE-YLEMGSLAMILSNDAAAEEFGWTKRMN 807
E L +RH N++ + + YL M + L E+ G +
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF 125
Query: 808 AIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELA 867
+ + L Y+H HRD+ N+ +N + E + DFG+++ S T
Sbjct: 126 LVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYV 179
Query: 868 GTFGYIAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHP--------------------- 905
T Y APE+ M+ T+ D++S G + E+I GK
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239
Query: 906 RDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQ 965
+F+ + S + N L E+ + L N ++++E L R T
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAG 296
Query: 966 KV 967
+
Sbjct: 297 EA 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (326), Expect = 2e-33
Identities = 54/274 (19%), Positives = 100/274 (36%), Gaps = 25/274 (9%)
Query: 702 NFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHR 760
FD +G G G V + +G A+K ++ + LNE L +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 761 NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMH 820
+VK + ++V EY+ G + L F + Y+H
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLH 158
Query: 821 TNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYT 880
+ +++RD+ +N+L++ + V+DFG +K +K L GT +APE+ +
Sbjct: 159 SLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWTLCGTPEALAPEIILS 212
Query: 881 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQ 940
+ D ++ GVL E+ G P ++ I + E + +
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPP----------FFADQPIQIYEKIVSGKVRFPSHFS 262
Query: 941 DKLISIMEVSISCLDESPTSRPTMQK--VSQLLK 972
L ++ + L T R K V+ +
Sbjct: 263 SDLKDLLR---NLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 53/304 (17%), Positives = 101/304 (33%), Gaps = 40/304 (13%)
Query: 697 IRATKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALT 755
++ IG G G V+KA TG+ VA+KK E L E L
Sbjct: 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF-PITALREIKILQ 64
Query: 756 KIRHRNIVKFYGFCSHAL--------HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMN 807
++H N+V C ++V+++ E ++ +
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV------LVKFTLSE 118
Query: 808 AIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG----LSNR 863
+ + L ++ I+HRD+ + NVL+ + ++DFG+++ L +
Sbjct: 119 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 864 TELAGTFGYIAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHP---------RDFISSIC 913
T T Y PEL + D++ G + E+ IS +C
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 914 SSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSI----------SCLDESPTSRPT 963
S++ + +D ++ + K+ ++ + L P R
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 964 MQKV 967
Sbjct: 299 SDDA 302
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-31
Identities = 54/283 (19%), Positives = 104/283 (36%), Gaps = 26/283 (9%)
Query: 701 KNFDDEHCIGNGGQGSVYKAEL----PTGEIVAVKKFH-SPLPGEMACQQEFLNEGNALT 755
+NF+ +G G G V+ TG++ A+K + + + + E L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 756 KIRHR-NIVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVAD 814
IR +V + ++ +Y+ G L LS E + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137
Query: 815 ALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRT-ELAGTFGYI 873
+L + I++RDI +N+LL+ ++DFG+SK + R + GT Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 874 APELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPR 931
AP++ + D +S GVL E++ G P ++ +L
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT-----VDGEKNSQAEISRRILKSE 252
Query: 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQK--VSQLLK 972
P P + + +++ L + P R ++ +
Sbjct: 253 PPYP-QEMSALAKDLIQ---RLLMKDPKKRLGCGPRDADEIKE 291
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-29
Identities = 54/296 (18%), Positives = 100/296 (33%), Gaps = 35/296 (11%)
Query: 700 TKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR 758
+ + + +G+G GSV A TG VAVKK P + ++ E L ++
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMK 75
Query: 759 HRNIVKFYGFCSHALHSF-VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL 817
H N++ + A YL + L+N ++ I + L
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPEL 877
Y+H+ HRD+ N+ +N + E + DFG+++ +A + +
Sbjct: 136 YIHSADII---HRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIM 190
Query: 878 AYTMKVTEKCDVYSFGVLALEVIKGKHP---------------------RDFISSICSSL 916
M + D++S G + E++ G+ + + I S
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 917 SSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972
+ N +L +M + ++E L R T Q L
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLE---KMLVLDSDKRITAA---QALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 116 bits (290), Expect = 7e-29
Identities = 51/297 (17%), Positives = 97/297 (32%), Gaps = 47/297 (15%)
Query: 702 NFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-H 759
++ +G G V++A + E V VK +++ E L +R
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILENLRGG 89
Query: 760 RNIVKFYGFCSHALHS--FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALL 817
NI+ + +V+E++ + + + + AL
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALD 143
Query: 818 YMHTNCFPPIVHRDISSKNVLLNLE-YEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPE 876
Y H+ I+HRD+ NV+++ E + + D+G+++F G + + PE
Sbjct: 144 YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPE 199
Query: 877 LAYTMK-VTEKCDVYSFGVLALEVIKGKHP-----------------------RDFISSI 912
L + D++S G + +I K P D+I
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 913 CSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSI--SCLDESPTSRPTMQKV 967
L N L R + + L+S + L SR T ++
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 2e-27
Identities = 48/306 (15%), Positives = 101/306 (33%), Gaps = 53/306 (17%)
Query: 701 KNFDDEHCIGNGGQGSVYKA-ELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH 759
K + + IG+G QG V A + VA+KK P + ++ E + + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR-AYRELVLMKCVNH 75
Query: 760 RNIVKFYGFCSHALHS------FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVA 813
+NI+ + ++V E ++ +I E + + +
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQML 129
Query: 814 DALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSNRTELAGTFGYI 873
+ ++H+ +HRD+ N+++ + + DFG+++ T T Y
Sbjct: 130 CGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYR 185
Query: 874 APELAYTMKVTEKCDVYSFGVLALEVIKGKHP---------------------------- 905
APE+ M E D++S G + E+++ K
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 906 ----RDFISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSR 961
R+++ + + L P + + ++ L P R
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS---KMLVIDPAKR 302
Query: 962 PTMQKV 967
++
Sbjct: 303 ISVDDA 308
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 103 bits (257), Expect = 3e-24
Identities = 89/392 (22%), Positives = 154/392 (39%), Gaps = 40/392 (10%)
Query: 162 FSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEIL 221
F+ L + +G ++ ++ +L ++ L+ D + + L L +
Sbjct: 16 FTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQI 71
Query: 222 YLDVNALSGLIPNEIGNLKSLLALQL---------------NYNTLSGSIPCSFGNLTKL 266
N L+ + P + NL L+ + + N L+
Sbjct: 72 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 129
Query: 267 VISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSG 326
++ L LSS+ + +I L L LQ + L +LT L L S+N
Sbjct: 130 NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN--KV 187
Query: 327 SIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSL 386
S + + L +L L + N ++ P LG LT L L L+ N+L + ASLT+L
Sbjct: 188 SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNL 243
Query: 387 TTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIV 446
T L L N + + P + + L+ L L +N+++ P L + L N
Sbjct: 244 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-----LAGLTALTNLELNENQ 296
Query: 447 GEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVK 506
E +L L L N +S + SL +L+ L + N S SL NL
Sbjct: 297 LEDISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKV--SDVSSLANLTN 352
Query: 507 LHYLNLSNNQFSQKIPNPIEKLIHLSELDLSY 538
+++L+ +NQ S P+ L +++L L+
Sbjct: 353 INWLSAGHNQISDLT--PLANLTRITQLGLND 382
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 101 bits (251), Expect = 2e-23
Identities = 90/394 (22%), Positives = 153/394 (38%), Gaps = 40/394 (10%)
Query: 136 IPDEIGNLKFLSDLQVSYNTLSGAIPFS-LGNLTNLVTLYIGINALSGSIPNEIGNLKSL 194
D L + ++ + + L +T L +GI ++ G + L +L
Sbjct: 16 FTDT--ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNL 68
Query: 195 SDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSG 254
+ + N L+ NLTKL + ++ N ++ + P + L L N T
Sbjct: 69 TQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 126
Query: 255 SIPCSFG---------NLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNY----NTLS 301
+ ++ + T+ S ++ +LK L +L ++
Sbjct: 127 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK 186
Query: 302 GSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTK 361
S L LTNL +L + N +S P I +L +L L+ N L L +LT
Sbjct: 187 VSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTN 242
Query: 362 LVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
L LDL+ N++S PLS LT LT L L N + + P + L+ L N
Sbjct: 243 LTDLDLANNQISNLAPLS--GLTKLTELKLGANQISNISP-----LAGLTALTNLELNEN 295
Query: 422 GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLN 481
+S + +L L L N+I P+ + L +L NN++S L +L
Sbjct: 296 QLEDISPISNLKNLTYLTLYFNNISDISPVSS--LTKLQRLFFANNKVSD--VSSLANLT 351
Query: 482 QLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNN 515
+ +L N + P L NL ++ L L++
Sbjct: 352 NINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 101 bits (251), Expect = 2e-23
Identities = 83/387 (21%), Positives = 144/387 (37%), Gaps = 36/387 (9%)
Query: 70 NLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHM 129
L + +G ++ ++ L ++ L+ + SI + L NL +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSN 75
Query: 130 NALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIP---- 185
N L+ P + NL L D+ ++ N ++ P + +TL+ +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 186 --------NEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALS-GLIPNEI 236
N I ++ +LS L G+ + L L L + + + +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 237 GNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLN 296
L +L +L N +S P T L L N L + + +L +L L L
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 297 YNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLAL 356
N +S PLS LT L L N +S P + +L ++ I
Sbjct: 250 NNQISNLAPLS--GLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPIS--- 304
Query: 357 GNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLS 416
NL L L L N +S P+S SLT L L+ N + S + ++ +++ L
Sbjct: 305 -NLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKV--SDVSSLANLTNINWLSAG 359
Query: 417 SNKLNGSIPLSLANLTNSLKVLYLSSN 443
N+++ PL+ NLT + L L+
Sbjct: 360 HNQISDLTPLA--NLTR-ITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 96.6 bits (239), Expect = 8e-22
Identities = 83/387 (21%), Positives = 154/387 (39%), Gaps = 36/387 (9%)
Query: 190 NLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNY 249
L L ++ ++ S +L ++ L D + + + + L +L + +
Sbjct: 20 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75
Query: 250 NTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPL--- 306
N L+ P NLTKLV + N ++ + L L N T +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 307 ---------SLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLN-GSIPLAL 356
++ ++ L+ L G+ ++ L +L+ L+ + + N S L
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 357 GNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLS 416
LT L SL + N++S PL T+L L L N L D + + +L+ LDL+
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 417 SNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPE 476
+N+++ PLS L L L +N I PL + ++L N +
Sbjct: 250 NNQISNLAPLSGL---TKLTELKLGANQISNISPLAGLTALTNLELNENQL----EDISP 302
Query: 477 LGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDL 536
+ +L L YL L N + P + +L KL L +NN+ S + + L +++ L
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS--DVSSLANLTNINWLSA 358
Query: 537 SYKIFGEEIPSQVCSMQSLEKLNLSHN 563
+ + P + ++ + +L L+
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 93.9 bits (232), Expect = 5e-21
Identities = 98/398 (24%), Positives = 163/398 (40%), Gaps = 34/398 (8%)
Query: 94 SLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSY 153
+L L ++ ++ + +L + TL + SI D + L L+ + S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSN 75
Query: 154 NTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFG 213
N L+ P NLT LV + + N ++ P + L + T +
Sbjct: 76 NQLTDITPL--KNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT----DIDPLK 129
Query: 214 NLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGT 273
NLT L L L N +S + Q + NLT L + +
Sbjct: 130 NLTNLNRLELSSNTISDISALSGLTSL-----QQLSFGNQVTDLKPLANLTTLERLDISS 184
Query: 274 NALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEIT 333
N S + + L +L L N +S PL + TNL L + N L +
Sbjct: 185 N--KVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLA 238
Query: 334 NLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYE 393
+L +L+DL L+ N ++ P L LTKL L L N++S P A LT+LT L L E
Sbjct: 239 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNE 294
Query: 394 NSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGH 453
N I ++K+L+ L L N ++ P+S +LT L+ L+ ++N + L +
Sbjct: 295 N--QLEDISPISNLKNLTYLTLYFNNISDISPVS--SLTK-LQRLFFANNKVSDVSSLAN 349
Query: 454 GKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSAN 491
+++ L +N++S L +L ++ L L+
Sbjct: 350 --LTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 93.5 bits (231), Expect = 7e-21
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 21 GHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIG 80
LT+L+ L + NQ+S + P I ++L+ LSL N LK +L +LT+L +D+
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 81 NNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEI 140
NN +S P + L L++L+L N ++ P L LT L L L+ N I
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN--QLEDISPI 303
Query: 141 GNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLD 200
NLK L+ L + +N +S P +LT L L+ N +S + + NL +++ L
Sbjct: 304 SNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 201 YNTLSGSILYSFGNLTKLEILYLDVNA 227
+N +S NLT++ L L+ A
Sbjct: 360 HNQISDLT--PLANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 91.2 bits (225), Expect = 4e-20
Identities = 93/369 (25%), Positives = 159/369 (43%), Gaps = 31/369 (8%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
+ L SI + +L +L ++FS NQL+ + P + L+ L + + +N +
Sbjct: 46 VTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 101
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
P + + + + + + + +L +L+ L LS+N+++ S
Sbjct: 102 DITPLANLTNLTGLTLFNNQI----TDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQ 157
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
++ + + NL L L +S N +S + LTNL +L N +S
Sbjct: 158 QLSFGNQVT-----DLKPLANLTTLERLDISSNKVSDISVLA--KLTNLESLIATNNQIS 210
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKS 241
P I +L +L L+ N L + + +LT L L L N +S L P + L
Sbjct: 211 DITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTK 264
Query: 242 LLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLS 301
L L+L N +S P LT L L N + I NLK+L +L L +N +S
Sbjct: 265 LTELKLGANQISNISP--LAGLTALTNLELNEN--QLEDISPISNLKNLTYLTLYFNNIS 320
Query: 302 GSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTK 361
P + SLT L L+F+ N +S + + NL +++ L N ++ P L NLT+
Sbjct: 321 DISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTR 374
Query: 362 LVSLDLSIN 370
+ L L+
Sbjct: 375 ITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 87.7 bits (216), Expect = 6e-19
Identities = 71/385 (18%), Positives = 135/385 (35%), Gaps = 54/385 (14%)
Query: 238 NLKSLLALQLNYNTLSGSIPCS-FGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLN 296
L + L ++ ++ + +T L LG ++ + + L +L + +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSI-----DGVEYLNNLTQINFS 74
Query: 297 YNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLA- 355
N L+ P L +LT L + + N ++ P + L ++ T +
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 356 -----------LGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYL-YENSLCDSIPKE 403
+ +++ L L G+ L +LTTL +S S
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 404 IGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLI 463
+ + +L L ++N+++ P + +L L L+ N + L ++L L
Sbjct: 193 LAKLTNLESLIATNNQISDITP---LGILTNLDELSLNGNQLKDIGTLAS--LTNLTDLD 247
Query: 464 LNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIP--------------------ESLGN 503
L NN++S L L +L L L AN N P + N
Sbjct: 248 LANNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305
Query: 504 LVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHN 563
L L YL L N S P+ L L L + S + ++ ++ L+ HN
Sbjct: 306 LKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHN 361
Query: 564 NLSGSISRCFEEMHWLSCIDISYNA 588
+S + ++ + ++ A
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 84.7 bits (208), Expect = 6e-18
Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
L L L+ NQ + LT+L L + NQ+S L P + L+ L L L +N +
Sbjct: 221 LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 276
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
P L LT+L +++ N + + +LK+L+ L L N+++ P + +LT
Sbjct: 277 NISP--LAGLTALTNLELNEN--QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTK 330
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINA 179
L L+ N +S + NL ++ L +N +S P L NLT + L + A
Sbjct: 331 LQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 78.5 bits (192), Expect = 6e-16
Identities = 80/365 (21%), Positives = 146/365 (40%), Gaps = 48/365 (13%)
Query: 262 NLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFST 321
L + + + LG ++ ++ + +L + LQ + + SI + L NL + FS
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 75
Query: 322 NALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPL--- 378
N L+ P + NL L D+ ++ N + PLA ++L + +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 379 ---------SFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLA 429
+ + +++L+ L + + ++ + +L+ L+ N +S+
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 430 NLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLS 489
+L+ L ++N I P G ++L +L LN N+L L SL L LDL+
Sbjct: 194 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 490 ANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIP--------------------NPIEKLI 529
N N P L L KL L L NQ S P +PI L
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 530 HLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNAL 589
+L+ L L + + P V S+ L++L ++N +S S + ++ + +N +
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSS--LANLTNINWLSAGHNQI 363
Query: 590 QGLIP 594
L P
Sbjct: 364 SDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 59.6 bits (143), Expect = 9e-10
Identities = 24/82 (29%), Positives = 38/82 (46%), Gaps = 6/82 (7%)
Query: 1 MLKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
L L L FN S P + LT L+ L F+ N++S + L+++N LS N +
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQI 363
Query: 61 KGSIPPSLGNLTSLIYIDIGNN 82
P L NLT + + + +
Sbjct: 364 SDLTP--LANLTRITQLGLNDQ 383
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 94.3 bits (233), Expect = 1e-21
Identities = 64/289 (22%), Positives = 101/289 (34%), Gaps = 15/289 (5%)
Query: 87 SIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFL 146
+P ++ + L L NN + NL NL TL L N +S P L L
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 147 SDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSG 206
L +S N L L L I + S+ N + + + +L + SG
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSG 140
Query: 207 SILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKL 266
+F + KL + + ++ + G SL L L+ N ++ S L L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 267 VISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSG 326
L N++S+ + N L L LN N L +P L + +Y N +S
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256
Query: 327 ------SIPNEITNLRSLSDLQLSENTLNGS--IPLALGNLTKLVSLDL 367
P T S S + L N + P + ++ L
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.1 bits (222), Expect = 3e-20
Identities = 59/270 (21%), Positives = 101/270 (37%), Gaps = 14/270 (5%)
Query: 303 SIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKL 362
+P L + A L N ++ + NL++L L L N ++ P A L KL
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 363 VSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNG 422
L LS N+L +L L + S+ + M + L + K +G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSG 140
Query: 423 SIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQ 482
+ + L + ++ +I + G SL +L L+ N+++ + L LN
Sbjct: 141 IENGAFQGMKK-LSYIRIADTNI---TTIPQGLPPSLTELHLDGNKITKVDAASLKGLNN 196
Query: 483 LEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFG 542
L L LS N+ SL N L L+L+NN+ K+P + ++ + L
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNIS 255
Query: 543 E------EIPSQVCSMQSLEKLNLSHNNLS 566
P S ++L N +
Sbjct: 256 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.6 bits (213), Expect = 5e-19
Identities = 57/257 (22%), Positives = 88/257 (34%), Gaps = 12/257 (4%)
Query: 288 KSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENT 347
L L N ++ +L NL TL N +S P L L L LS+N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 348 LNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDM 407
L L +L + I K+ S+ + + + L M
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSV-FNGLNQMIVVELGTNPLKSSGIENGAFQGM 149
Query: 408 KSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNN 467
K LS + ++ + +IP L SL L+L N I ++L +L L+ N
Sbjct: 150 KKLSYIRIADTNIT-TIP---QGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205
Query: 468 ELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQ------KI 521
+S + L + L L L+ N +P L + + + L NN S
Sbjct: 206 SISAVDNGSLANTPHLRELHLN-NNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264
Query: 522 PNPIEKLIHLSELDLSY 538
P K S + L
Sbjct: 265 PGYNTKKASYSGVSLFS 281
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.2 bits (212), Expect = 8e-19
Identities = 53/273 (19%), Positives = 100/273 (36%), Gaps = 13/273 (4%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
+L L N+ + + +L +L L N++S + P L L L L N LK
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 62 GSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTN 121
L L + + S+ N + + + +L + +G + +
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQGMKK 151
Query: 122 LVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181
L + + ++ +IP G L++L + N ++ SL L NL L + N++S
Sbjct: 152 LSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208
Query: 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPN------E 235
+ N L +L L+ N L + ++++YL N +S + N
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLVKVP-GGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 267
Query: 236 IGNLKSLLALQLNYNTLSGS--IPCSFGNLTKL 266
S + L N + P +F +
Sbjct: 268 NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR 300
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.2 bits (212), Expect = 8e-19
Identities = 54/305 (17%), Positives = 108/305 (35%), Gaps = 27/305 (8%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSL 74
+P ++ LL N+++ + + L +L+ L L +N + P + L L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 75 IYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSG 134
+ + N L +L+ L + S+ + L N +V L + SG
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSG 140
Query: 135 SIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSL 194
+K LS ++++ ++ G +L L++ N ++ + L +L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 195 SDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSG 254
+ L L +N++S S N L L+L+ N L +P + + K + + L+ N +S
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISA 256
Query: 255 SIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGS--IPLSLGSLT 312
F S + L N + P + +
Sbjct: 257 IGSNDF------------------CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 298
Query: 313 NLATL 317
A +
Sbjct: 299 VRAAV 303
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 73.5 bits (179), Expect = 1e-14
Identities = 46/230 (20%), Positives = 90/230 (39%), Gaps = 8/230 (3%)
Query: 385 SLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 444
L + + L + +PK++ ++LDL +NK+ NL N L L L +N
Sbjct: 11 HLRVVQCSDLGL-EKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKN-LHTLILINNK 66
Query: 445 IVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNL 504
I P L +L L+ N+L +L +L + S+ L N
Sbjct: 67 ISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQ 125
Query: 505 VKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNN 564
+ + L + + S + + LS + ++ IP + SL +L+L N
Sbjct: 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGLPP--SLTELHLDGNK 182
Query: 565 LSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLC 614
++ + + ++ L+ + +S+N++ + S A N +L
Sbjct: 183 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.9 bits (115), Expect = 1e-06
Identities = 24/144 (16%), Positives = 46/144 (31%), Gaps = 2/144 (1%)
Query: 496 SIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSL 555
+P+ L L+L NN+ ++ + L +L L L + P + L
Sbjct: 24 KVPKDLPPDTA--LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 556 EKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCG 615
E+L LS N L + + + L + ++ + N L K
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141
Query: 616 DIKRLPPCKAFKSHKQSLKKIWIV 639
+ K + + I +
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTI 165
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 95.5 bits (236), Expect = 1e-21
Identities = 45/216 (20%), Positives = 81/216 (37%), Gaps = 27/216 (12%)
Query: 709 IGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVK--- 764
+G G +V+ A+ + VA+K + G+ + +E L ++ + K
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKI----VRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 765 ------------FYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGV 812
F + +H +V+E L LA+I + + K++ K +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI--SKQL 134
Query: 813 ADALLYMHTNCFPPIVHRDISSKNVLLNLE-YEAHVSDFGISKFL--KLGLSNRTELAGT 869
L YMH C I+H DI +NVL+ + ++ I+ + T T
Sbjct: 135 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 870 FGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 905
Y +PE+ D++S L E+I G
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.0 bits (224), Expect = 1e-20
Identities = 66/265 (24%), Positives = 108/265 (40%), Gaps = 7/265 (2%)
Query: 87 SIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFL 146
++P + + + + L N ++ +S NL L+LH N L+ L L
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 147 SDLQVSYNTLSGAI-PFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLS 205
L +S N ++ P + L L TL++ L P L +L L L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 206 GSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTK 265
+F +L L L+L N +S + L SL L L+ N ++ P +F +L +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 266 LVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALS 325
L+ L N LS+ E + L++L +L+LN N L S++ +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVP 261
Query: 326 GSIPNEITNLRSLSDLQLSENTLNG 350
S+P L +L+ N L G
Sbjct: 262 CSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.9 bits (216), Expect = 1e-19
Identities = 54/260 (20%), Positives = 92/260 (35%), Gaps = 5/260 (1%)
Query: 351 SIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSL 410
++P+ + ++ + L N++S SF + +LT L+L+ N L + L
Sbjct: 25 AVPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 411 SILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELS 470
LDLS N S+ + + L L+L + P ++L L L +N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 471 GQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIH 530
L L +L L N + + L L L L N+ + P+ L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 531 LSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQ 590
L L L + +++L+ L L+ N R WL S + +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVP 261
Query: 591 GLIPNSTAFRDAPMLALQGN 610
+P + L N
Sbjct: 262 CSLPQR--LAGRDLKRLAAN 279
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (207), Expect = 2e-18
Identities = 62/257 (24%), Positives = 99/257 (38%), Gaps = 6/257 (2%)
Query: 216 TKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNA 275
+ ++L N +S + ++L L L+ N L+ +F L L L NA
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 276 LSSSILE-EIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITN 334
S+ L L L L+ L P L L LY NAL + +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 335 LRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYEN 394
L +L+ L L N ++ A L L L L N+++ P +F L L TLYL+ N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 395 SLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHG 454
+L + + +++L L L+ N L L+ SS+ + +P
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCR--ARPLWAWLQKFRGSSSEVPCSLP---Q 266
Query: 455 KFSSLIQLILNNNELSG 471
+ + L N+L G
Sbjct: 267 RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (195), Expect = 7e-17
Identities = 58/254 (22%), Positives = 94/254 (37%), Gaps = 5/254 (1%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLK 61
+ + L N+ S +L +L N L+ + L+ L L L N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 62 GSIPP-SLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLT 120
S+ P + L L + + L P L +L L L +N+L + +L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 121 NLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINAL 180
NL L+LH N +S L L L + N ++ P + +L L+TLY+ N L
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 181 SGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLK 240
S + L++L LRL+ N + L+ + + +P L
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQ---RLA 269
Query: 241 SLLALQLNYNTLSG 254
+L N L G
Sbjct: 270 GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.2 bits (157), Expect = 6e-12
Identities = 39/182 (21%), Positives = 60/182 (32%), Gaps = 4/182 (2%)
Query: 1 MLKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFL 60
L L L P L L+ L N L L L +L L L+ N +
Sbjct: 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI 165
Query: 61 KGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLT 120
+ L SL + + N ++ P+ L L L L N+L+ +L L
Sbjct: 166 SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225
Query: 121 NLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINAL 180
L L L+ N +L + S + + ++P L + N L
Sbjct: 226 ALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLP---QRLAGRDLKRLAANDL 281
Query: 181 SG 182
G
Sbjct: 282 QG 283
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 83.7 bits (206), Expect = 7e-19
Identities = 26/155 (16%), Positives = 46/155 (29%), Gaps = 17/155 (10%)
Query: 709 IGNGGQGSVYKAELPTGEIVAVKK-------FHSPLPGEMACQQEFLNEGNALTKIRHRN 761
+G G + +V+ VK F F + R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 762 IVKFYGFCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT 821
+ K G VY + ++ M L + + + + + +
Sbjct: 68 LQKLQGLAVPK-----VYAWEG-NAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 822 NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856
IVH D+S NVL++ E + DF S +
Sbjct: 122 RG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEV 152
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 84.8 bits (208), Expect = 3e-18
Identities = 82/269 (30%), Positives = 115/269 (42%), Gaps = 7/269 (2%)
Query: 90 NEVGSLKSLSDLRLSNNSLNG--SIPSSLGNLTNLVTLYLHMNA-LSGSIPDEIGNLKFL 146
+ +++L LS +L IPSSL NL L LY+ L G IP I L L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 147 SDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSG 206
L +++ +SGAIP L + LVTL NALSG++P I +L +L + D N +SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 207 SILYSFGNLTKLEILYLDV-NALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTK 265
+I S+G+ +KL N L+G IP NL K
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNML--EGDASVLFGSDK 221
Query: 266 LVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALS 325
+ L ++G K+L L L N + G++P L L L +L S N L
Sbjct: 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 326 GSIPNEITNLRSLSDLQLSENTLNGSIPL 354
G IP + NL+ + N PL
Sbjct: 282 GEIP-QGGNLQRFDVSAYANNKCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 84.0 bits (206), Expect = 5e-18
Identities = 59/270 (21%), Positives = 106/270 (39%), Gaps = 7/270 (2%)
Query: 357 GNLTKLVSLDLSINKLSG--SIPLSFASLTSLTTLYLYEN-SLCDSIPKEIGDMKSLSIL 413
++ +LDLS L IP S A+L L LY+ +L IP I + L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 414 DLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQL 473
++ + +L L S N + G +P +L+ + + N +SG +
Sbjct: 107 YITHTN-VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 474 SPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSE 533
GS ++L + + L +++LS N + ++
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN-TQ 224
Query: 534 LDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCIDISYNALQGLI 593
K +V ++L L+L +N + G++ + ++ +L +++S+N L G I
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 594 PNSTAFRDAPMLALQGNKRLCGDIKRLPPC 623
P + + A NK LCG LP C
Sbjct: 285 PQGGNLQRFDVSAYANNKCLCG--SPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 77.1 bits (188), Expect = 1e-15
Identities = 75/265 (28%), Positives = 108/265 (40%), Gaps = 8/265 (3%)
Query: 138 DEIGNLKFLSDLQVSYNTLSGA--IPFSLGNLTNLVTLYI-GINALSGSIPNEIGNLKSL 194
D +++L +S L IP SL NL L LYI GIN L G IP I L L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 195 SDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSG 254
L + + +SG+I + L L NALSG +P I +L +L+ + + N +SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 255 SIPCSFGNLTKLVISCLGT-NALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTN 313
+IP S+G+ +KL S + N L+ I NL + L
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 314 LATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLS 373
+ ++ + DL N + G++P L L L SL++S N L
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDL--RNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 374 GSIPLSFASLTSLTTLYLYENS-LC 397
G IP +L N LC
Sbjct: 282 GEIP-QGGNLQRFDVSAYANNKCLC 305
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 76.7 bits (187), Expect = 1e-15
Identities = 67/265 (25%), Positives = 109/265 (41%), Gaps = 7/265 (2%)
Query: 69 GNLTSLIYIDIGNNLLSG--SIPNEVGSLKSLSDLRLSNN-SLNGSIPSSLGNLTNLVTL 125
+ +D+ L IP+ + +L L+ L + +L G IP ++ LT L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 126 YLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIP 185
Y+ +SG+IPD + +K L L SYN LSG +P S+ +L NLV + N +SG+IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 186 NEIGNLKSLS-DLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLA 244
+ G+ L + + N L+G I +F NL + + +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT--Q 224
Query: 245 LQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSI 304
G L L N + ++ + + LK L L +++N L G I
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 305 PLSLGSLTNLATLYFSTNALSGSIP 329
P G+L ++ N P
Sbjct: 285 P-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 75.6 bits (184), Expect = 3e-15
Identities = 74/258 (28%), Positives = 113/258 (43%), Gaps = 7/258 (2%)
Query: 21 GHLTHLKLLSFSKNQLSGL--IPHEIGRLSSLNGLSLYSN-FLKGSIPPSLGNLTSLIYI 77
+ L S L IP + L LN L + L G IPP++ LT L Y+
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 78 DIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIP 137
I + +SG+IP+ + +K+L L S N+L+G++P S+ +L NLV + N +SG+IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 138 DEIGNLKFLS-DLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSD 196
D G+ L + +S N L+G IP + NL + + +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM--LEGDASVLFGSDKNTQ 224
Query: 197 LRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSI 256
L G L L L N + G +P + LK L +L +++N L G I
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 257 PCSFGNLTKLVISCLGTN 274
P GNL + +S N
Sbjct: 285 P-QGGNLQRFDVSAYANN 301
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 72.9 bits (177), Expect = 2e-14
Identities = 65/265 (24%), Positives = 101/265 (38%), Gaps = 10/265 (3%)
Query: 2 LKVLGLSFNQFSG--SIPPEIGHLTHLKLLSFSKN-QLSGLIPHEIGRLSSLNGLSLYSN 58
+ L LS IP + +L +L L L G IP I +L+ L+ L +
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 59 FLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGN 118
+ G+IP L + +L+ +D N LSG++P + SL +L + N ++G+IP S G+
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 119 LTNLVTLYLHM-NALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGI 177
+ L T N L+G IP NL A +
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
Query: 178 NALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIG 237
+ + + DLR N + G++ L L L + N L G IP + G
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLR--NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGG 288
Query: 238 NLKSLLALQLNYNTLSGSIP---CS 259
NL+ N P C+
Sbjct: 289 NLQRFDVSAYANNKCLCGSPLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 71.7 bits (174), Expect = 6e-14
Identities = 76/269 (28%), Positives = 118/269 (43%), Gaps = 29/269 (10%)
Query: 230 GLIPNEIGNLKSLLALQLNYNTLSG--SIPCSFGNLTKLVISCLGTNA-LSSSILEEIGN 286
G++ + + L L+ L IP S NL L +G L I I
Sbjct: 40 GVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK 99
Query: 287 LKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSEN 346
L L +L + + +SG+IP L + L TL FS NALSG++P I++L +L + N
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159
Query: 347 TLNGSIPLALGNLTKLVSLDLSI-NKLSGSIPLSFASLTSLTTLYLYE------------ 393
++G+IP + G+ +KL + N+L+G IP +FA+L
Sbjct: 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGS 219
Query: 394 ----------NSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 443
+ ++G K+L+ LDL +N++ G++P L L L L +S N
Sbjct: 220 DKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF-LHSLNVSFN 278
Query: 444 HIVGEIPLGHGKFSSLIQLIL-NNNELSG 471
++ GEIP G G NN L G
Sbjct: 279 NLCGEIPQG-GNLQRFDVSAYANNKCLCG 306
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.7 bits (143), Expect = 4e-10
Identities = 46/251 (18%), Positives = 68/251 (27%), Gaps = 39/251 (15%)
Query: 331 EITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLY 390
E++ + S ++ + L ++P L T L LS N L + T LT L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 391 LYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIP 450
L L +L +L N L L T + S + + +P
Sbjct: 62 LDRAELTKLQV-----DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP 116
Query: 451 LGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYL-DLSANTFHNSIPESLGNLVKLHY 509
LG + +Q + L P L + L+ N L L L
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 510 LNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSI 569
L L N IP L L N
Sbjct: 177 LLLQENSLY-------------------------TIPKGFFGSHLLPFAFLHGNPW---- 207
Query: 570 SRCFEEMHWLS 580
C E+ +
Sbjct: 208 -LCNCEILYFR 217
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (131), Expect = 1e-08
Identities = 46/188 (24%), Positives = 71/188 (37%), Gaps = 6/188 (3%)
Query: 15 SIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSL 74
++PP++ +L S+N L + + L L+L + + G L L
Sbjct: 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA--ELTKLQVDGTLPVL 79
Query: 75 IYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSG 134
+D+ +N L +L+ L +S N L +L L L LYL N L
Sbjct: 80 GTLDLSHNQLQSLPLLGQTL-PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138
Query: 135 SIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSL 194
P + L L ++ N L+ L L NL TL + N+L +IP L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197
Query: 195 SDLRLDYN 202
L N
Sbjct: 198 PFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 52/210 (24%), Positives = 79/210 (37%), Gaps = 7/210 (3%)
Query: 67 SLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLY 126
+ + S + ++ L+ ++P ++ K + L LS N L ++L T L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 127 LHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPN 186
L + G L L L +S+N L L L L + N L+
Sbjct: 62 LDRA--ELTKLQVDGTLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLG 118
Query: 187 EIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQ 246
+ L L +L L N L KLE L L N L+ L + L++L L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 247 LNYNTLSGSIPCSFGNLTKLVISCLGTNAL 276
L N+L +IP F L + L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.0 bits (123), Expect = 1e-07
Identities = 40/212 (18%), Positives = 70/212 (33%), Gaps = 8/212 (3%)
Query: 283 EIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQ 342
E+ + S L + + L+ ++P L + L+ S N L + L+ L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 343 LSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPK 402
L + G L L +LDLS N+L T+ + S+P
Sbjct: 62 LDRA--ELTKLQVDGTLPVLGTLDLSHNQLQSLPL--LGQTLPALTVLDVSFNRLTSLPL 117
Query: 403 EIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQL 462
++P L T L+ L L++N++ +L L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 463 ILNNNELSGQLSPELGSLNQLEYLDLSANTFH 494
+L N L + + L + L N +
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (119), Expect = 3e-07
Identities = 45/212 (21%), Positives = 79/212 (37%), Gaps = 7/212 (3%)
Query: 403 EIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQL 462
E+ + S ++ L ++P +L +L+LS N + ++ L QL
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALP---PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 463 ILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIP 522
L+ EL+ + ++ S+P L L L++S N+ +
Sbjct: 61 NLDRAELTKLQVDGT---LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 523 NPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSCI 582
+ L L EL L P + LEKL+L++NNL+ + + L +
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 583 DISYNALQGLIPNSTAFRDAPMLALQGNKRLC 614
+ N+L + P L GN LC
Sbjct: 178 LLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 1e-05
Identities = 40/176 (22%), Positives = 55/176 (31%), Gaps = 26/176 (14%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSN--- 58
+L LS N + T L L+ + +L+ G L L L L N
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--KLQVDGTLPVLGTLDLSHNQLQ 90
Query: 59 --------------------FLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSL 98
L +L L L + + N L P + L
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL 150
Query: 99 SDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYN 154
L L+NN+L L L NL TL L N+L +IP L + N
Sbjct: 151 EKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 0.001
Identities = 25/101 (24%), Positives = 36/101 (35%), Gaps = 1/101 (0%)
Query: 9 FNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSL 68
FN+ + + L L+ L N+L L P + L LSL +N L L
Sbjct: 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLL 168
Query: 69 GNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLN 109
L +L + + N L +IP L L N
Sbjct: 169 NGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.9 bits (133), Expect = 7e-09
Identities = 47/274 (17%), Positives = 88/274 (32%), Gaps = 18/274 (6%)
Query: 29 LSFSKNQLSGLIPHEIGRLSSLNGLSLY-SNFLKGSIPPSLGNLTSLIYIDIGNNLLSG- 86
L + L P GRL S ++ + + ++D+ N+++
Sbjct: 5 LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 87 SIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFL 146
++ + L +L L L+ I ++L +NLV L L + +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 147 SDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTL-- 204
+++ + + V+ I LSG N + S R
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 205 -------SGSILYSFGNLTKLEILYL-DVNALSGLIPNEIGNLKSLLALQLNYNTLSGSI 256
F L L+ L L + E+G + +L LQ+ G++
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 257 PCSFGNLTKLVISCLGTNALSSSILEEIGNLKSL 290
L L I+C + ++ IGN K+
Sbjct: 242 QLLKEALPHLQINC---SHFTTIARPTIGNKKNQ 272
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 9e-07
Identities = 36/232 (15%), Positives = 81/232 (34%), Gaps = 12/232 (5%)
Query: 364 SLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGS 423
+LDL+ L + S + + + + E + +DLS++ + S
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVS 61
Query: 424 IPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPE------- 476
+ + + L+ L L + I K S+L++L L+ + + +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 477 -LGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELD 535
L LN D + ++ + +L+ N + + + +L LD
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 536 LSY-KIFGEEIPSQVCSMQSLEKLNLSH-NNLSGSISRCFEEMHWLSCIDIS 585
LS + + + + L+ L+LS ++ E+ L + +
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 233
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 3e-06
Identities = 42/275 (15%), Positives = 85/275 (30%), Gaps = 16/275 (5%)
Query: 149 LQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSI 208
L ++ L + L + ++ + + + E + + + L + + S
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVST 62
Query: 209 LYSF-GNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLV 267
L+ +KL+ L L+ LS I N + +L+ L L+ + +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 268 ISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNAL--- 324
+ L + + + + + + LSG S +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 325 ------SGSIPNEITNLRSLSDLQLSE-NTLNGSIPLALGNLTKLVSLDLSINKLSGSIP 377
E L L L LS + L LG + L +L + G++
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 378 LSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSI 412
L +L L + + IG+ K+ I
Sbjct: 243 LLKEALPHLQ---INCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 2e-05
Identities = 35/252 (13%), Positives = 82/252 (32%), Gaps = 15/252 (5%)
Query: 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSG-LIPHEIGRLSSLNGLSLYSNFL 60
+ + + E ++ + S + + + + + S L LSL L
Sbjct: 25 VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 83
Query: 61 KGSIPPSLGNLTSLIYIDIGN--NLLSGSIPNEVGSLKSLSDL------RLSNNSLNGSI 112
I +L ++L+ +++ ++ + S L +L + + ++
Sbjct: 84 SDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV 143
Query: 113 PSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTL-SGAIPFSLGNLTNLV 171
+T L N + + L L +S + + L L
Sbjct: 144 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203
Query: 172 TLYI-GINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSG 230
L + + E+G + +L L++ G++ L L+I + + +
Sbjct: 204 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI---NCSHFTT 260
Query: 231 LIPNEIGNLKSL 242
+ IGN K+
Sbjct: 261 IARPTIGNKKNQ 272
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (127), Expect = 6e-08
Identities = 17/108 (15%), Positives = 33/108 (30%), Gaps = 6/108 (5%)
Query: 479 SLNQLEYLDLSANTF-HNSIPESLGNLVKLHYLNLSNNQFS----QKIPNPIEKLIHLSE 533
SL+ ++ LD+ E L L + + L + + + I + + L+E
Sbjct: 1 SLD-IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 534 LDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSC 581
L+L G+ V + +L S
Sbjct: 60 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 3e-07
Identities = 19/92 (20%), Positives = 37/92 (40%), Gaps = 9/92 (9%)
Query: 362 LVSLDLSINKLSGS-IPLSFASLTSLTTLYLYENSLCDSIPKEIGDM----KSLSILDLS 416
+ SLD+ +LS + L + L + L ++ K+I +L+ L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 417 SNKLNG----SIPLSLANLTNSLKVLYLSSNH 444
SN+L + L + ++ L L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 2e-06
Identities = 17/90 (18%), Positives = 29/90 (32%), Gaps = 10/90 (11%)
Query: 313 NLATLYFSTNALSGSIPNEI-TNLRSLSDLQLSENTLNG----SIPLALGNLTKLVSLDL 367
++ +L LS + E+ L+ ++L + L I AL L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 368 SINKLSGSIPLSFASL-----TSLTTLYLY 392
N+L + L L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 20/82 (24%), Positives = 37/82 (45%), Gaps = 9/82 (10%)
Query: 456 FSSLIQLILNNNELSGQ----LSPELGSLNQLEYLDLSANTFHNSIPESLGNLVK----- 506
S L L L + ++S L+ L + + L LDLS N ++ L V+
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 507 LHYLNLSNNQFSQKIPNPIEKL 528
L L L + +S+++ + ++ L
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 5e-06
Identities = 17/114 (14%), Positives = 32/114 (28%), Gaps = 25/114 (21%)
Query: 409 SLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNE 468
+ LD+ +L+ + L L +V+ L +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGL--------------------TEA 42
Query: 469 LSGQLSPELGSLNQLEYLDLSANTFHNSIPESLG-----NLVKLHYLNLSNNQF 517
+S L L L+L +N + + K+ L+L N
Sbjct: 43 RCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 9e-06
Identities = 20/94 (21%), Positives = 32/94 (34%), Gaps = 8/94 (8%)
Query: 70 NLTSLIYIDIGNNLLSGSIPNEV-GSLKSLSDLRLSNNSLNG----SIPSSLGNLTNLVT 124
++ SL DI LS + E+ L+ +RL + L I S+L L
Sbjct: 3 DIQSL---DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 125 LYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSG 158
L L N L + ++ +L
Sbjct: 60 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 22/99 (22%), Positives = 34/99 (34%), Gaps = 14/99 (14%)
Query: 380 FASLTSLTTLYLYENSL----CDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLA----NL 431
+ L L+L + + C S+ + SL LDLS+N L + L L
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 432 TNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELS 470
L+ L L + E+ L L + L
Sbjct: 425 GCLLEQLVLYDIYWSEEME------DRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 2e-05
Identities = 17/80 (21%), Positives = 27/80 (33%), Gaps = 9/80 (11%)
Query: 506 KLHYLNLSNNQFS----QKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCS-----MQSLE 556
L L L++ S + + L ELDLS G+ Q+ LE
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 557 KLNLSHNNLSGSISRCFEEM 576
+L L S + + +
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 19/95 (20%), Positives = 33/95 (34%), Gaps = 15/95 (15%)
Query: 481 NQLEYLDLSANTFHN----SIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLI-----HL 531
+ L L L+ + S+ +L L L+LSNN + + + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 532 SELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLS 566
+L L + EE+ L+ L +L
Sbjct: 429 EQLVLYDIYWSEEME------DRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 15/92 (16%), Positives = 27/92 (29%), Gaps = 10/92 (10%)
Query: 337 SLSDLQLSENTLNGS-IPLALGNLTKLVSLDLSINKLSG----SIPLSFASLTSLTTLYL 391
+ L + L+ + L L + + L L+ I + +L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 392 YENSLCDSIPKEIGDM-----KSLSILDLSSN 418
N L D + + L L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 20/140 (14%), Positives = 39/140 (27%), Gaps = 10/140 (7%)
Query: 458 SLIQLILNNNELSGQLSPEL-GSLNQLEYLDLSANTFHN----SIPESLGNLVKLHYLNL 512
+ L + ELS EL L Q + + L I +L L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 513 SNNQFSQKIPNPIEKLI-----HLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSG 567
+N+ + + + + + +L L + S +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122
Query: 568 SISRCFEEMHWLSCIDISYN 587
+ ++ +D
Sbjct: 123 LLGDAGLQLLCEGLLDPQCR 142
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 19/93 (20%), Positives = 33/93 (35%), Gaps = 13/93 (13%)
Query: 334 NLRSLSDLQLSENTLNG----SIPLALGNLTKLVSLDLSINKLSGSIPLSFAS-----LT 384
L L L++ ++ S+ L L LDLS N L + L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 385 SLTTLYLYENSLCDSIPKEIGDMK----SLSIL 413
L L LY+ + + + ++ SL ++
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 15/90 (16%), Positives = 27/90 (30%), Gaps = 10/90 (11%)
Query: 289 SLLHLQLNYNTLSGS-IPLSLGSLTNLATLYFSTNALSG----SIPNEITNLRSLSDLQL 343
+ L + LS + L L + L+ I + + +L++L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 344 SENTLNGSIPLALG-----NLTKLVSLDLS 368
N L + K+ L L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 2e-04
Identities = 17/94 (18%), Positives = 34/94 (36%), Gaps = 8/94 (8%)
Query: 262 NLTKLVISCLGTNALSSSILEEI-GNLKSLLHLQLNYNTLSG----SIPLSLGSLTNLAT 316
++ L I C LS + E+ L+ ++L+ L+ I +L LA
Sbjct: 3 DIQSLDIQC---EELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 317 LYFSTNALSGSIPNEITNLRSLSDLQLSENTLNG 350
L +N L + + ++ + +L
Sbjct: 60 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 18/84 (21%), Positives = 32/84 (38%), Gaps = 9/84 (10%)
Query: 70 NLTSLIYIDIGNNLLSG----SIPNEVGSLKSLSDLRLSNNSLNGSIPSSLG-----NLT 120
+ L + + + +S S+ + + SL +L LSNN L + L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 121 NLVTLYLHMNALSGSIPDEIGNLK 144
L L L+ S + D + L+
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 10/68 (14%), Positives = 26/68 (38%), Gaps = 5/68 (7%)
Query: 529 IHLSELDLSYKIFGEEIPSQVCS-MQSLEKLNLSHNNLSG----SISRCFEEMHWLSCID 583
+ + LD+ + + +++ +Q + + L L+ IS L+ ++
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 584 ISYNALQG 591
+ N L
Sbjct: 62 LRSNELGD 69
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 12/91 (13%), Positives = 31/91 (34%), Gaps = 5/91 (5%)
Query: 121 NLVTLYLHMNALSGS-IPDEIGNLKFLSDLQVSYNTLSG----AIPFSLGNLTNLVTLYI 175
++ +L + LS + + + L+ +++ L+ I +L L L +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 176 GINALSGSIPNEIGNLKSLSDLRLDYNTLSG 206
N L + + ++ +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 7e-04
Identities = 17/95 (17%), Positives = 33/95 (34%), Gaps = 5/95 (5%)
Query: 169 NLVTLYIGINALSGSIPNEI-GNLKSLSDLRLDYNTLSG----SILYSFGNLTKLEILYL 223
++ +L I LS + E+ L+ +RLD L+ I + L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 224 DVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPC 258
N L + + + + ++ +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 14/90 (15%), Positives = 28/90 (31%), Gaps = 5/90 (5%)
Query: 26 LKLLSFSKNQLSGL-IPHEIGRLSSLNGLSLYSNFLKG----SIPPSLGNLTSLIYIDIG 80
++ L +LS + L + L L I +L +L +++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 81 NNLLSGSIPNEVGSLKSLSDLRLSNNSLNG 110
+N L + V ++ SL
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 17/81 (20%), Positives = 28/81 (34%), Gaps = 9/81 (11%)
Query: 48 SSLNGLSLYSNFLKG----SIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGS-----LKSL 98
S L L L + S+ +L SL +D+ NN L + ++ L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 99 SDLRLSNNSLNGSIPSSLGNL 119
L L + + + L L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 19/97 (19%), Positives = 32/97 (32%), Gaps = 15/97 (15%)
Query: 166 NLTNLVTLYIGINALSG----SIPNEIGNLKSLSDLRLDYNTLSGSILYSFG-----NLT 216
+ L L++ +S S+ + SL +L L N L + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 217 KLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLS 253
LE L L S + L AL+ + +L
Sbjct: 427 LLEQLVLYDIYWSEEME------DRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 15/81 (18%), Positives = 28/81 (34%), Gaps = 9/81 (11%)
Query: 96 KSLSDLRLSNNSLNG----SIPSSLGNLTNLVTLYLHMNALSGSIPDEIG-----NLKFL 146
L L L++ ++ S+ ++L +L L L N L + ++ L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 147 SDLQVSYNTLSGAIPFSLGNL 167
L + S + L L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.004
Identities = 17/85 (20%), Positives = 28/85 (32%), Gaps = 9/85 (10%)
Query: 286 NLKSLLHLQLNYNTLSG----SIPLSLGSLTNLATLYFSTNALSGSIPNEI-----TNLR 336
L L L +S S+ +L + +L L S N L + ++
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 337 SLSDLQLSENTLNGSIPLALGNLTK 361
L L L + + + L L K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 7e-08
Identities = 25/99 (25%), Positives = 37/99 (37%), Gaps = 12/99 (12%)
Query: 7 LSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPP 66
N S I L+ L+ S N+L +P RL L N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHLA-EVPE 321
Query: 67 SLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSN 105
NL L + N L P+ +S+ DLR+++
Sbjct: 322 LPQNLKQL---HVEYNPLR-EFPD---IPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.9 bits (125), Expect = 8e-08
Identities = 26/90 (28%), Positives = 37/90 (41%), Gaps = 9/90 (10%)
Query: 81 NNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEI 140
N S I + SL +L +SNN L +P+ L L N L+ +P+
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPELP 323
Query: 141 GNLKFLSDLQVSYNTLSGAIPFSLGNLTNL 170
NLK L V YN L P ++ +L
Sbjct: 324 QNLKQLH---VEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 22/101 (21%), Positives = 35/101 (34%), Gaps = 13/101 (12%)
Query: 342 QLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIP 401
N + I L L++S NKL +P A L L N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHL-AEVP 320
Query: 402 KEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSS 442
+ +L L + N L P ++ + L ++S
Sbjct: 321 ELPQ---NLKQLHVEYNPLR-EFPDIPESVED----LRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 1e-06
Identities = 23/95 (24%), Positives = 28/95 (29%), Gaps = 9/95 (9%)
Query: 292 HLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGS 351
N S I +L L S N L +P L L S N L
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-E 318
Query: 352 IPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSL 386
+P NL L + N L P S+ L
Sbjct: 319 VPELPQNLK---QLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 3e-06
Identities = 26/93 (27%), Positives = 38/93 (40%), Gaps = 9/93 (9%)
Query: 222 YLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSIL 281
+NA S I + SL L ++ N L +P L +L+ S N L + +
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLIASF---NHL-AEVP 320
Query: 282 EEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNL 314
E NLK L + YN L P S+ +L
Sbjct: 321 ELPQNLK---QLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 3e-06
Identities = 24/93 (25%), Positives = 35/93 (37%), Gaps = 9/93 (9%)
Query: 439 YLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIP 498
N EI SL +L ++NN+L +L L E L S N +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHL-AEVP 320
Query: 499 ESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHL 531
E N L L++ N + P+ E + L
Sbjct: 321 ELPQN---LKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 4e-06
Identities = 21/92 (22%), Positives = 36/92 (39%), Gaps = 9/92 (9%)
Query: 103 LSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPF 162
N+ + I S +L L + N L +P L+ L S+N L+ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPE 321
Query: 163 SLGNLTNLVTLYIGINALSGSIPNEIGNLKSL 194
NL L++ N L P+ +++ L
Sbjct: 322 LPQNLK---QLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 1e-05
Identities = 23/93 (24%), Positives = 33/93 (35%), Gaps = 9/93 (9%)
Query: 270 CLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIP 329
NA S+ I SL L ++ N L +P L L S N L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVP 320
Query: 330 NEITNLRSLSDLQLSENTLNGSIPLALGNLTKL 362
NL+ L + N L P ++ L
Sbjct: 321 ELPQNLKQLH---VEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 1e-05
Identities = 25/94 (26%), Positives = 38/94 (40%), Gaps = 10/94 (10%)
Query: 390 YLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEI 449
Y N+ + I SL L++S+NKL +P L+ L S NH+ E+
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR----LERLIASFNHL-AEV 319
Query: 450 PLGHGKFSSLIQLILNNNELSGQLSPELGSLNQL 483
P +L QL + N L + S+ L
Sbjct: 320 P---ELPQNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.6 bits (106), Expect = 2e-05
Identities = 20/80 (25%), Positives = 33/80 (41%), Gaps = 8/80 (10%)
Query: 488 LSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPS 547
N N I L LN+SNN+ ++P +L L S+ E+P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHL-AEVPE 321
Query: 548 QVCSMQSLEKLNLSHNNLSG 567
Q+L++L++ +N L
Sbjct: 322 ---LPQNLKQLHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 4e-05
Identities = 22/92 (23%), Positives = 34/92 (36%), Gaps = 10/92 (10%)
Query: 199 LDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPC 258
N S I LE L + N L +P L+ L ++N L+ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLER---LIASFNHLA-EVPE 321
Query: 259 SFGNLTKLVISCLGTNALSS--SILEEIGNLK 288
NL +L + N L I E + +L+
Sbjct: 322 LPQNLKQLHVEY---NPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 5e-05
Identities = 24/95 (25%), Positives = 35/95 (36%), Gaps = 9/95 (9%)
Query: 126 YLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIP 185
++NA S I L +L VS N L +P L L N L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVP 320
Query: 186 NEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEI 220
NLK L ++YN L ++ L +
Sbjct: 321 ELPQNLKQLH---VEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 0.001
Identities = 20/85 (23%), Positives = 34/85 (40%), Gaps = 8/85 (9%)
Query: 508 HYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNNLSG 567
N S +I + + L EL++S E+P+ LE+L S N+L+
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPA---LPPRLERLIASFNHLA- 317
Query: 568 SISRCFEEMHWLSCIDISYNALQGL 592
+ E L + + YN L+
Sbjct: 318 EVP---ELPQNLKQLHVEYNPLREF 339
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.002
Identities = 15/61 (24%), Positives = 28/61 (45%), Gaps = 5/61 (8%)
Query: 96 KSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNT 155
+ +L L+N L+ S+P +L +L N+L+ +P+ +LK L +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 156 L 156
L
Sbjct: 93 L 93
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.003
Identities = 18/98 (18%), Positives = 35/98 (35%), Gaps = 5/98 (5%)
Query: 481 NQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKI 540
Q L+L+ +S+PE +L L S N + ++P + L L + + K
Sbjct: 38 RQAHELELNNLGL-SSLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 541 FGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHW 578
+ P S +L + S + + +
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNN 130
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.9 bits (116), Expect = 1e-07
Identities = 26/128 (20%), Positives = 47/128 (36%), Gaps = 10/128 (7%)
Query: 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKG 62
+VL L+ + + + L + L S N+L L P + L L L N L+
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 63 SIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNG------SIPSSL 116
+ + + N L + + S L L L NSL + L
Sbjct: 58 VDGVANLPRLQELLLC-NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 117 GNLTNLVT 124
++++++T
Sbjct: 117 PSVSSILT 124
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.9 bits (108), Expect = 2e-06
Identities = 29/122 (23%), Positives = 47/122 (38%), Gaps = 5/122 (4%)
Query: 341 LQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSI 400
L L+ L ++ L L + LDLS N+L P + A+L L L +N
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--ALEN 57
Query: 401 PKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLI 460
+ ++ L L L +N+L S + L +L L N + E + L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 461 QL 462
+
Sbjct: 118 SV 119
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.6 bits (102), Expect = 1e-05
Identities = 30/121 (24%), Positives = 50/121 (41%), Gaps = 7/121 (5%)
Query: 27 KLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSG 86
++L + L+ L + +L + L L N L+ +PP+L L L + +N +
Sbjct: 1 RVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDN--AL 55
Query: 87 SIPNEVGSLKSLSDLRLSNNSLNG-SIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKF 145
+ V +L L +L L NN L + L + LV L L N+L L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAE 114
Query: 146 L 146
+
Sbjct: 115 M 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 2e-05
Identities = 22/109 (20%), Positives = 43/109 (39%), Gaps = 6/109 (5%)
Query: 485 YLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEE 544
L L+ ++ L L+ + +L+LS+N+ P + L L L E
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQ--ASDNALE 56
Query: 545 IPSQVCSMQSLEKLNLSHNNL-SGSISRCFEEMHWLSCIDISYNALQGL 592
V ++ L++L L +N L + + L +++ N+L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 5e-05
Identities = 28/121 (23%), Positives = 48/121 (39%), Gaps = 7/121 (5%)
Query: 124 TLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGS 183
L+L L+ + + L ++ L +S+N L P +L L L L N +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--ALE 56
Query: 184 IPNEIGNLKSLSDLRLDYNTL-SGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSL 242
+ + NL L +L L N L + + + +L +L L N+L L +
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
Query: 243 L 243
L
Sbjct: 116 L 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 5e-05
Identities = 31/117 (26%), Positives = 51/117 (43%), Gaps = 10/117 (8%)
Query: 279 SILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSL 338
++L + L + HL L++N L P +L +L L L S N + + + NL L
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--ALENVDGVANLPRL 67
Query: 339 SDLQLSENTLNG-SIPLALGNLTKLVSLDLSINKLSG------SIPLSFASLTSLTT 388
+L L N L + L + +LV L+L N L + S++S+ T
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 124
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.9 bits (95), Expect = 9e-05
Identities = 27/121 (22%), Positives = 47/121 (38%), Gaps = 8/121 (6%)
Query: 388 TLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVG 447
L+L L ++ + + ++ LDLS N+L P L + L ++
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNAL 55
Query: 448 EIPLGHGKFSSLIQLILNNNELSGQLSPE-LGSLNQLEYLDLSANTFHNSIPESLGNLVK 506
E G L +L+L NN L + + L S +L L+L N+ L +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAE 114
Query: 507 L 507
+
Sbjct: 115 M 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.9 bits (90), Expect = 5e-04
Identities = 28/133 (21%), Positives = 47/133 (35%), Gaps = 30/133 (22%)
Query: 436 KVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHN 495
+VL+L+ + + L L L + +LDLS N
Sbjct: 1 RVLHLAHKDL-----------TVL---------------CHLEQLLLVTHLDLSHNRLR- 33
Query: 496 SIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSY-KIFGEEIPSQVCSMQS 554
++P +L L L L + + + + + L L EL L ++ + S
Sbjct: 34 ALPPALAALRCLEVLQ--ASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 91
Query: 555 LEKLNLSHNNLSG 567
L LNL N+L
Sbjct: 92 LVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.002
Identities = 23/107 (21%), Positives = 41/107 (38%), Gaps = 6/107 (5%)
Query: 149 LQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSI 208
L +++ L+ + L L + L + N L P + L+ L L + +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNALEN 57
Query: 209 LYSFGNLTKLEILYLDVNALSGL-IPNEIGNLKSLLALQLNYNTLSG 254
+ NL +L+ L L N L + + L+ L L N+L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 2e-07
Identities = 45/230 (19%), Positives = 86/230 (37%), Gaps = 18/230 (7%)
Query: 162 FSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEIL 221
F L N + + G + ++ ++ +L ++ L ++ + L L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGL 68
Query: 222 YLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSIL 281
L N ++ L P + + L L N +I T + S T+ + L
Sbjct: 69 ELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128
Query: 282 EEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDL 341
+ L L+ N + L+G Y S S + NL L+ L
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTN----------LQYLSIGNAQVSDLTPLANLSKLTTL 178
Query: 342 QLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYL 391
+ +N ++ PL +L L+ + L N++S PL+ + ++L + L
Sbjct: 179 KADDNKISDISPL--ASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 49.6 bits (117), Expect = 4e-07
Identities = 38/218 (17%), Positives = 74/218 (33%), Gaps = 21/218 (9%)
Query: 358 NLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSS 417
L + + + ++ ++ A L +TTL + + + + + +L L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 418 NKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSS------LIQLILNNNELSG 471
N++ PL L++ ++ L K L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 472 QLSPELGSLNQLEYLD-------LSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNP 524
L +L + + L LS S L NL KL L +N+ S P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDIS--P 190
Query: 525 IEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSH 562
+ L +L E+ L + P + + +L + L++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 35/217 (16%), Positives = 73/217 (33%), Gaps = 21/217 (9%)
Query: 334 NLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYE 393
L + + ++ + ++ A +L + +L ++ + + L +L L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQY--LNNLIGLELKD 72
Query: 394 NSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSS----------- 442
N + D P + + L + K +I + T L ++
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 443 --NHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPES 500
+ +I L+ L +L++L L N + P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 501 LGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLS 537
L +L L ++L NNQ S P+ +L + L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 3e-06
Identities = 43/229 (18%), Positives = 82/229 (35%), Gaps = 19/229 (8%)
Query: 286 NLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSE 345
L + + + + ++ ++ + L + TL ++ +I + L +L L+L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 346 NTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIG 405
N + PL + L + K +I + L S + +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQ------SIKTLDLTSTQITDVTPLA 126
Query: 406 DMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILN 465
+ +L +L L N++ PL+ YLS + S L L +
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQ-----YLSIGNAQVSDLTPLANLSKLTTLKAD 181
Query: 466 NNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSN 514
+N++S L SL L + L N + P L N L + L+N
Sbjct: 182 DNKISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 3e-06
Identities = 44/227 (19%), Positives = 80/227 (35%), Gaps = 18/227 (7%)
Query: 190 NLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNY 249
L + + + ++ ++ + +L + L ++ + + L +L+ L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 250 NTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLG 309
N ++ NLTK+ L N L + L L T +
Sbjct: 73 NQIT--DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL-- 128
Query: 310 SLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSI 369
+ I N + LS S L NL+KL +L
Sbjct: 129 ------SNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 370 NKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLS 416
NK+S P ASL +L ++L N + D P + + +L I+ L+
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 3e-06
Identities = 40/213 (18%), Positives = 74/213 (34%), Gaps = 22/213 (10%)
Query: 70 NLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHM 129
L + I I G + ++ ++ L ++ L + + L NL+ L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 130 NALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIG 189
N ++ P + +L + AI T +T + + + +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 190 NLKSLSDLRLDYNTL--------------SGSILYSFGNLTKLEILYLDVNALSGLIPNE 235
L + + + L S L NL+KL L D N +S + P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 236 IGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVI 268
+ +L +L+ + L N +S P N + L I
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.6 bits (109), Expect = 5e-06
Identities = 32/227 (14%), Positives = 76/227 (33%), Gaps = 18/227 (7%)
Query: 94 SLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSY 153
+L + + +++ ++ + +L + TL ++ + + L L L++
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 154 NTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFG 213
N ++ P + L +I + + L +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 214 NLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGT 273
L +++ L+GL + + S NL+KL
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLS----------IGNAQVSDLTPLANLSKLTTLKADD 182
Query: 274 NALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFS 320
N +S + + +L +L+ + L N +S PL+ + +NL + +
Sbjct: 183 NKISD--ISPLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 36/218 (16%), Positives = 80/218 (36%), Gaps = 23/218 (10%)
Query: 238 NLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNY 297
L + + + + ++ ++ + +L + +++ +E + L +L+ L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 298 NTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALG 357
N ++ PL + L + +I + + + L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 358 NL--------------TKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKE 403
L LSI S A+L+ LTTL +N + D P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 404 IGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLS 441
+ + +L + L +N+++ PL+ N +N L ++ L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSPLA--NTSN-LFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 9e-05
Identities = 36/226 (15%), Positives = 75/226 (33%), Gaps = 18/226 (7%)
Query: 23 LTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNN 82
L + ++ K+ ++ + L + LS + + +I + L +LI +++ +N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 83 LLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGN 142
++ P + L+ + + L N++ + L S
Sbjct: 74 QITDLAPLK----------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVT 123
Query: 143 LKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYN 202
I Y+ I S + NL L+ L+ D N
Sbjct: 124 PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 203 TLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLN 248
+S +L L ++L N +S + P + N +L + L
Sbjct: 184 KISDIS--PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 38/224 (16%), Positives = 68/224 (30%), Gaps = 26/224 (11%)
Query: 136 IPDEIGNLKFLSDLQVSYNTLSGAIPFS-LGNLTNLVTLYIGINALSGSIPNEIGNLKSL 194
PD L + + ++ + + L +T L G+ + G + L +L
Sbjct: 13 FPDP--ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNL 65
Query: 195 SDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSG 254
L L N ++ L + I L +
Sbjct: 66 IGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPL 125
Query: 255 SIPCSFGNLTKLVISCLGTNAL--------------SSSILEEIGNLKSLLHLQLNYNTL 300
+ + L + + L S L + NL L L+ + N +
Sbjct: 126 AGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKI 185
Query: 301 SGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLS 344
S PL SL NL ++ N +S P + N +L + L+
Sbjct: 186 SDISPL--ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 3e-04
Identities = 17/74 (22%), Positives = 32/74 (43%), Gaps = 4/74 (5%)
Query: 8 SFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPS 67
S S + +L+ L L N++S + P + L +L + L +N + P
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-- 212
Query: 68 LGNLTSLIYIDIGN 81
L N ++L + + N
Sbjct: 213 LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.004
Identities = 17/67 (25%), Positives = 29/67 (43%), Gaps = 4/67 (5%)
Query: 39 LIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSL 98
+ LS L L N + P L +L +LI + + NN +S P + + +L
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219
Query: 99 SDLRLSN 105
+ L+N
Sbjct: 220 FIVTLTN 226
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 3e-07
Identities = 32/193 (16%), Positives = 63/193 (32%), Gaps = 19/193 (9%)
Query: 358 NLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSS 417
+ + +L ++ ++ + L S+ + + + I + +++ L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 418 NKLNGSIPLS-------LANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELS 470
NKL PL+ L N +K L + + S I +++ +L
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137
Query: 471 GQLSPELGSLNQLEYLDLSANTFHNSI------PESLGNLVKLHYLNLSNNQFSQKIPNP 524
+ L+ + L L KL L LS N S
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LRA 195
Query: 525 IEKLIHLSELDLS 537
+ L +L L+L
Sbjct: 196 LAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 38/209 (18%), Positives = 75/209 (35%), Gaps = 29/209 (13%)
Query: 327 SIPNEI------TNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSF 380
++P I L + ++ ++ L + + + + + + +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQY 66
Query: 381 ASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYL 440
L ++T L+L N L D K + ++K+L L L NK+ L SL + +
Sbjct: 67 --LPNVTKLFLNGNKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN 122
Query: 441 SSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLS---------------PELGSLNQLEY 485
+ I G + L + L + + + +L+ L L +L+
Sbjct: 123 GISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQN 182
Query: 486 LDLSANTFHNSIPESLGNLVKLHYLNLSN 514
L LS N + +L L L L L +
Sbjct: 183 LYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 38/216 (17%), Positives = 74/216 (34%), Gaps = 22/216 (10%)
Query: 183 SIPNEIG------NLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEI 236
++P I L +++ ++ + L ++ + + + + + I
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--I 64
Query: 237 GNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLN 296
L ++ L LN N L+ NL L + + L +
Sbjct: 65 QYLPNVTKLFLNGNKLTD--IKPLANLKNLGWLF------LDENKVKDLSSLKDLKKLKS 116
Query: 297 YNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLAL 356
+ I G + + ++ L L L L +N ++ +PL
Sbjct: 117 LSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPL-- 174
Query: 357 GNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLY 392
LTKL +L LS N +S + + A L +L L L+
Sbjct: 175 AGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.2 bits (103), Expect = 2e-05
Identities = 35/207 (16%), Positives = 73/207 (35%), Gaps = 16/207 (7%)
Query: 162 FSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEIL 221
FS + + +++ ++ L S+ + + + + + L + L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKL 73
Query: 222 YLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSIL 281
+L+ N L+ + NLK N L + + L + +L + +
Sbjct: 74 FLNGNKLTD--IKPLANLK-------NLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124
Query: 282 EEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDL 341
+I L L L+ Y + +++ S + I + L L +L
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNL 183
Query: 342 QLSENTLNGSIPLALGNLTKLVSLDLS 368
LS+N ++ + AL L L L+L
Sbjct: 184 YLSKNHIS-DLR-ALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 26/204 (12%), Positives = 67/204 (32%), Gaps = 17/204 (8%)
Query: 382 SLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLS 441
+ L + S+ D++ + ++ S+ + +++ + + L N + L+L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ--YLPN-VTKLFLN 76
Query: 442 SNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESL 501
N + ++L L + + + + + I +
Sbjct: 77 GNKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLV 131
Query: 502 GNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLS 561
+N + + L L L L + +P + + L+ L LS
Sbjct: 132 HLPQLESLYLGNNKITDITVLSR---LTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLS 186
Query: 562 HNNLSGSISRCFEEMHWLSCIDIS 585
N++S R + L +++
Sbjct: 187 KNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 34/194 (17%), Positives = 64/194 (32%), Gaps = 24/194 (12%)
Query: 70 NLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHM 129
I ++ ++ ++ L S+ + +N+ + + L N+ L+L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 130 NALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIG 189
N L+ + NLK L L + N + ++L + + +
Sbjct: 78 NKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ 135
Query: 190 NLKSLSDLRLDYNTLSGSILY----------------SFGNLTKLEILYLDVNALSGLIP 233
+ S L LTKL+ LYL N +S L
Sbjct: 136 LESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL-- 193
Query: 234 NEIGNLKSLLALQL 247
+ LK+L L+L
Sbjct: 194 RALAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 33/195 (16%), Positives = 67/195 (34%), Gaps = 22/195 (11%)
Query: 238 NLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNY 297
+ L +++ ++ + L + + + S ++ I L ++ L LN
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNG 77
Query: 298 NTLSGSIPLSLGSLTNLATLYFSTNALS---------------GSIPNEITNLRSLSDLQ 342
N L+ PL+ L + + ++I L L L+
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137
Query: 343 LSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPK 402
N + + + + + I A LT L LYL +N + D +
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHISD--LR 194
Query: 403 EIGDMKSLSILDLSS 417
+ +K+L +L+L S
Sbjct: 195 ALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 4e-04
Identities = 32/215 (14%), Positives = 67/215 (31%), Gaps = 22/215 (10%)
Query: 15 SIPPEIG------HLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSL 68
++P I + K ++ + L+S++ + ++ +K +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--I 64
Query: 69 GNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLH 128
L ++ + + N L+ P L +L +L N S +
Sbjct: 65 QYLPNVTKLFLNGNKLTDIKP-----LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSL 119
Query: 129 MNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEI 188
+ I + + S + + L L L I+ + +
Sbjct: 120 EHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-----PL 174
Query: 189 GNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYL 223
L L +L L N +S L + L L++L L
Sbjct: 175 AGLTKLQNLYLSKNHISD--LRALAGLKNLDVLEL 207
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (105), Expect = 7e-06
Identities = 28/154 (18%), Positives = 50/154 (32%), Gaps = 6/154 (3%)
Query: 464 LNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPN 523
L ++ QL + L + L LN ++ + +
Sbjct: 4 LKPEQVE-QLKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSSMAA-TLRI 59
Query: 524 PIEKLIHLSELDLSYKIF--GEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSC 581
E + L L+LS +++ S V +L+ LNLS N L + L
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119
Query: 582 IDISYNALQGLIPNSTAFRDAPMLALQGNKRLCG 615
+ + N+L + + + A RL G
Sbjct: 120 LWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDG 153
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 7e-05
Identities = 22/147 (14%), Positives = 48/147 (32%), Gaps = 6/147 (4%)
Query: 294 QLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIP 353
+L + + L + + + L ++ L + + ++
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSS-MAATLR 58
Query: 354 LALGNLTKLVSLDLSINKLSG--SIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLS 411
+ N+ +L+SL+LS N+L + +L L L N L + L
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 412 ILDLSSNKLNGSIPLSLANLTNSLKVL 438
L L N L+ + ++ +
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAIRERF 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 1e-04
Identities = 28/134 (20%), Positives = 47/134 (35%), Gaps = 5/134 (3%)
Query: 274 NALSSSILEEI-GNLKSLLHLQLNYNTLSG-SIPLSLGSLTNLATLYFSTNALSGSIPNE 331
N L +E++ + L G L + L ++ ++ ++
Sbjct: 2 NELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSS-MAATLRII 60
Query: 332 ITNLRSLSDLQLSENTLNG--SIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTL 389
N+ L L LS N L + + L L+LS N+L L L L
Sbjct: 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL 120
Query: 390 YLYENSLCDSIPKE 403
+L NSL D+ +
Sbjct: 121 WLDGNSLSDTFRDQ 134
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (91), Expect = 6e-04
Identities = 30/146 (20%), Positives = 51/146 (34%), Gaps = 13/146 (8%)
Query: 351 SIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSL 410
+ L + L + L + L +S+ ++ ++ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPEL 67
Query: 411 SILDLSSNKLNG--SIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNE 468
L+LS+N+L + + N LK+L LS N + E L K L +L L+ N
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPN-LKILNLSGNELKSERELDKIKGLKLEELWLDGNS 126
Query: 469 LSGQLSPE-------LGSLNQLEYLD 487
LS + +L LD
Sbjct: 127 LSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.003
Identities = 23/124 (18%), Positives = 46/124 (37%), Gaps = 5/124 (4%)
Query: 40 IPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLS 99
+ + + + +L L+ P L + ++ +++ + ++ ++ L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELL 68
Query: 100 DLRLSNNSLNG--SIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLS 157
L LSNN L + S + NL L L N L + L +L + N+LS
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 158 GAIP 161
Sbjct: 129 DTFR 132
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 4e-05
Identities = 29/190 (15%), Positives = 64/190 (33%), Gaps = 19/190 (10%)
Query: 358 NLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSS 417
L + + L ++ ++ + L +TTL + + + +L+ ++ S+
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 71
Query: 418 NKLNGSIPLS-------------LANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLIL 464
N+L PL L L + + + + +
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 465 NNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNP 524
S +S L+ ++ + + L NL L L++S+N+ S +
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISV 189
Query: 525 IEKLIHLSEL 534
+ KL +L L
Sbjct: 190 LAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 32/200 (16%), Positives = 61/200 (30%), Gaps = 17/200 (8%)
Query: 311 LTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSIN 370
L ++ ++ T+L ++ LQ + SI + L L ++ S N
Sbjct: 17 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNN 72
Query: 371 KLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLAN 430
+L+ PL + + + + + + ++ +L
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 431 LTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSA 490
L S + S S+ + + L +L LE LD+S+
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDL-----------KPLANLTTLERLDISS 181
Query: 491 NTFHNSIPESLGNLVKLHYL 510
N S L L L L
Sbjct: 182 NKV--SDISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 28/187 (14%), Positives = 59/187 (31%), Gaps = 15/187 (8%)
Query: 381 ASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYL 440
+L L + ++ D++ + D+ ++ L + SI + L N L +
Sbjct: 15 TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNN-LTQINF 69
Query: 441 SSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPES 500
S+N + PL + I + N L+ + + + +
Sbjct: 70 SNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 129
Query: 501 LGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNL 560
L L + S DL + ++ +LE+L++
Sbjct: 130 LNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLK----------PLANLTTLERLDI 179
Query: 561 SHNNLSG 567
S N +S
Sbjct: 180 SSNKVSD 186
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.3 bits (90), Expect = 0.001
Identities = 37/198 (18%), Positives = 73/198 (36%), Gaps = 15/198 (7%)
Query: 70 NLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHM 129
L + +G ++ ++ L ++ L+ + SI + L NL +
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSN 71
Query: 130 NALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIG 189
N L+ L +L + L + +T G+ + I +
Sbjct: 72 NQLTDIT--------PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 123
Query: 190 NLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNY 249
+ RL+ ++ + S + + LT L+ L N ++ L P + NL +L L ++
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181
Query: 250 NTLSG-SIPCSFGNLTKL 266
N +S S+ NL L
Sbjct: 182 NKVSDISVLAKLTNLESL 199
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.9 bits (99), Expect = 5e-05
Identities = 39/181 (21%), Positives = 66/181 (36%), Gaps = 7/181 (3%)
Query: 385 SLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 444
TT+ L IP++I + L L+ N+L L L L L N
Sbjct: 9 EGTTVDCTGRGL-KEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65
Query: 445 IVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNL 504
+ G P S + +L L N++ + L+QL+ L+L N +P S +L
Sbjct: 66 LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL 125
Query: 505 VKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLSHNN 564
L LN + + L + L+ PS ++ ++ +L H+
Sbjct: 126 NSLTSLN-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSE 181
Query: 565 L 565
Sbjct: 182 F 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 44/180 (24%), Positives = 69/180 (38%), Gaps = 9/180 (5%)
Query: 269 SCLGTNA-LSSSILEEI--GNLKSLLHLQLNYNTLSGSIPLSL-GSLTNLATLYFSTNAL 324
C GT + L+EI L LN N L L G L +L L N L
Sbjct: 7 HCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL 66
Query: 325 SGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLT 384
+G PN + +LQL EN + L +L +L+L N++S +P SF L
Sbjct: 67 TGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN 126
Query: 385 SLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 444
SLT+L ++ + + L L+ P + + +++ L +
Sbjct: 127 SLTSLN-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRD----VQIKDLPHSE 181
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.2 bits (92), Expect = 4e-04
Identities = 32/165 (19%), Positives = 53/165 (32%), Gaps = 5/165 (3%)
Query: 168 TNLVTLYIGINALSGSIPNEI-GNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVN 226
+ L + N L + + G L L L L N L+G +F + ++ L L N
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88
Query: 227 ALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGN 286
+ + L L L L N +S +P SF +L L + +
Sbjct: 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN-LASNPFNCNCHLAWF 147
Query: 287 LKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNE 331
+ L LN P + ++ + S N
Sbjct: 148 AEWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEFKCSSENS 189
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 37.9 bits (86), Expect = 0.002
Identities = 19/97 (19%), Positives = 38/97 (39%), Gaps = 4/97 (4%)
Query: 325 SGSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLT 384
L L L L +N ++ +P + +L L SL+L+ N + + L++
Sbjct: 91 KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAE 149
Query: 385 SLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
L L + P + ++ + I DL ++
Sbjct: 150 WLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFK 183
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 8e-05
Identities = 33/241 (13%), Positives = 66/241 (27%), Gaps = 12/241 (4%)
Query: 385 SLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVL---YLS 441
S E+ + IP ++ ++ L KL + + + K+
Sbjct: 9 SNRVFLCQESKV-TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 442 SNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESL 501
I ++ K + NN + + Q + + + +
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 502 GNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCSMQSLEKLNLS 561
L + + N + + + + L L+ E Q E
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 562 HNNLSGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLP 621
+NNL + F +DIS + L + L + L K+LP
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSY--GLENLKKLRARSTYNL----KKLP 239
Query: 622 P 622
Sbjct: 240 T 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (96), Expect = 2e-04
Identities = 30/228 (13%), Positives = 53/228 (23%), Gaps = 30/228 (13%)
Query: 337 SLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSL 396
S E+ + IP L + L + KL +F+ L + + +N +
Sbjct: 9 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 397 CDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPL----- 451
+ I ++ N A L SN + +P
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 452 ----------------------GHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLS 489
G + L LN N + + E
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 490 ANTFHNSIPESLGNLVKLHYLNLSNNQFSQKIPNPIEKLIHLSELDLS 537
N + L++S + +E L L
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 9/44 (20%), Positives = 13/44 (29%)
Query: 208 ILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNT 251
F + IL + + L + NLK L A
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (95), Expect = 1e-04
Identities = 20/109 (18%), Positives = 40/109 (36%), Gaps = 2/109 (1%)
Query: 507 LHYLNLSNNQFSQKIPNPIEKLIHLSELDLSYKIFGEEIPSQVCS-MQSLEKLNLSHNNL 565
L + + + + +L+EL + + + + + + L L + + L
Sbjct: 10 SSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 566 SGSISRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLC 614
F LS +++S+NAL+ L + L L GN C
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (92), Expect = 3e-04
Identities = 25/148 (16%), Positives = 45/148 (30%), Gaps = 2/148 (1%)
Query: 289 SLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEI-TNLRSLSDLQLSENT 347
L+ + L NL LY + L L +L + ++
Sbjct: 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 348 LNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDM 407
L P A +L L+LS N L + L+ + C + +
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRW 127
Query: 408 KSLSILDLSSNKLNGSIPLSLANLTNSL 435
+ + + KL LA++ N+
Sbjct: 128 EEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 4e-04
Identities = 22/148 (14%), Positives = 46/148 (31%), Gaps = 3/148 (2%)
Query: 382 SLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLS 441
+ L + + ++L+ L + + + + L L+ L +
Sbjct: 6 CPHGSSGLRCTRDGA-LDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 442 SNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFH-NSIPES 500
+ + P L +L L+ N L LS + L+ L LS N H +
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRW 123
Query: 501 LGNLVKLHYLNLSNNQFSQKIPNPIEKL 528
L + + + P+ +
Sbjct: 124 LQRWEEEGLGGVPEQKLQCHGQGPLAHM 151
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 6e-04
Identities = 41/327 (12%), Positives = 87/327 (26%), Gaps = 19/327 (5%)
Query: 96 KSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSG----SIPDEIGNLKFLSDLQV 151
KSL ++ S+ + L ++ + L N + + + I + K L +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 152 SYNT---LSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSI 208
S + IP +L L + ++ + S + L +T +
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 209 LYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVI 268
L + + + N L ++ N L + T
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL-ENGSMKEWAKTFQSH 185
Query: 269 SCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSI 328
L T + + + G LL L ++ ++
Sbjct: 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 245
Query: 329 PNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFAS-----L 383
N LS + L +L L N++ + + +
Sbjct: 246 RELGLNDCLLSA----RGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301
Query: 384 TSLTTLYLYENSLCDSIPKEIGDMKSL 410
L L L N + +++ +
Sbjct: 302 PDLLFLELNGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 0.002
Identities = 46/335 (13%), Positives = 96/335 (28%), Gaps = 38/335 (11%)
Query: 49 SLNGLSLYSNFLKG----SIPPSLGNLTSLIYIDIGNNLLSG----SIPNEVGSLKSLSD 100
S+ G SL + + S+ L S+ I + N + + + S K L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 101 LRLSNNSL----------NGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQ 150
S+ + +L L T+ L NA + + + +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 151 VSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILY 210
+ + G + +N + + P + + L
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183
Query: 211 SFGNLTKLEILYLDVNALSG------LIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLT 264
S L ++++ + + L + S ++ + +
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243
Query: 265 KLVISCLGTNALSSSILEEIGN------LKSLLHLQLNYNTLSGSIPLSLGS-----LTN 313
L L LS+ + + L L+L YN + +L + + +
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303
Query: 314 LATLYFSTNALS--GSIPNEITNLRSLSDL-QLSE 345
L L + N S + +EI + S +L E
Sbjct: 304 LLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDE 338
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 49/324 (15%), Positives = 91/324 (28%), Gaps = 32/324 (9%)
Query: 273 TNALSSSILEEIGNLKSLLHLQLNYNTLSG----SIPLSLGSLTNLATLYFSTN---ALS 325
T S+ + S+ + L+ NT+ + ++ S +L FS +
Sbjct: 16 TTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVK 75
Query: 326 GSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTS 385
IP + L +T+ S + + LS + + L L
Sbjct: 76 DEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGP 135
Query: 386 LTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN-- 443
+ ++ K+ + L + N+L A S ++L+
Sbjct: 136 QAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQ 195
Query: 444 ------HIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSI 497
I + G L L L +N + S L + +
Sbjct: 196 NGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 255
Query: 498 ----------PESLGNLVKLHYLNLSNNQFSQKIPNPI-----EKLIHLSELDLSYKIFG 542
S + L L L N+ + EK+ L L+L+ F
Sbjct: 256 SARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315
Query: 543 EEIPSQVCSMQSLEKLNLSHNNLS 566
EE V ++ + L
Sbjct: 316 EE-DDVVDEIREVFSTR-GRGELD 337
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.003
Identities = 51/325 (15%), Positives = 99/325 (30%), Gaps = 28/325 (8%)
Query: 232 IPNEIGNLKSLLALQLNYNTLS-------GSIPCSFGNLTKLVISCLGTNALSSSILEEI 284
+ + S+ + L+ NT+ S +L S + T + I E +
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 285 GNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLS 344
L L +T+ S + + S + + L + +++
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142
Query: 345 ENTLNGSIPLALGNLTKLVSLDLSINKLS-GSIPLSFASLTSLTTLYLYENSLCDSIPKE 403
++ N L S+ N+L GS+ + S L+ + P+
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202
Query: 404 IGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLI 463
I + + K+ + +L +S + L S + E+ L S+
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262
Query: 464 LNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESL-----GNLVKLHYLNLSNNQFS 518
+ + L+ L L N +L + L +L L+ N+FS
Sbjct: 263 VVDA-------FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315
Query: 519 ------QKIPNPIEKLIH--LSELD 535
+I L ELD
Sbjct: 316 EEDDVVDEIREVFSTRGRGELDELD 340
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.004
Identities = 14/90 (15%), Positives = 28/90 (31%), Gaps = 5/90 (5%)
Query: 336 RSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSG----SIPLSFASLTSLTTLYL 391
+SL ++ S+ L + + LS N + + + AS L
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 392 YENSLCDSIPKEIGDMKSLSILDLSSNKLN 421
+ + ++ L L KL+
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLH 96
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.004
Identities = 13/106 (12%), Positives = 28/106 (26%), Gaps = 8/106 (7%)
Query: 483 LEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFS----QKIPNPIEKLIHLSELDLS- 537
L+ ++ S+ L + + LS N + + I L + S
Sbjct: 10 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 538 --YKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSISRCFEEMHWLSC 581
+EIP + + + + S +
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 114
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 26/140 (18%), Positives = 43/140 (30%), Gaps = 8/140 (5%)
Query: 378 LSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKV 437
+ + L L + I + +D S N++ L L LK
Sbjct: 12 AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKT 67
Query: 438 LYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSG----QLSPELGSLNQLEYLDLSANTF 493
L +++N I L +LIL NN L L SL L L
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127
Query: 494 HNSIPESLGNLVKLHYLNLS 513
+ + + ++ L+
Sbjct: 128 KHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.002
Identities = 27/143 (18%), Positives = 51/143 (35%), Gaps = 4/143 (2%)
Query: 331 EITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLY 390
+ TN +L L + I L + ++D S N++ L L TL
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLL 69
Query: 391 LYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIP 450
+ N +C + L+ L L++N L L SL L + N + +
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 451 LGHGKFSSLIQL-ILNNNELSGQ 472
+ Q+ +L+ ++ +
Sbjct: 130 YRLYVIYKVPQVRVLDFQKVKLK 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 973 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.85 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.8 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.79 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.79 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.79 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.6 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.59 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.57 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.56 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.55 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.55 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.55 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.53 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.42 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.4 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.36 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.29 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.61 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.48 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.36 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.04 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.9 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.85 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.51 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.48 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.27 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.8 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.12 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.94 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=407.60 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=207.0
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||+|.. .+++.||+|++...........+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999966 478999999986432223334678899999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|+|.+++... ..+++.++..++.||+.|++|||++ +|+||||||+||+++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999999743 3689999999999999999999999 9999999999999999999999999999866543
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
......||+.|||||++.+..++.++||||+||++|||++|+.||...... .............+.
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---------~~~~~i~~~~~~~p~--- 225 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---------ETYKRISRVEFTFPD--- 225 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---------HHHHHHHTTCCCCCT---
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---------HHHHHHHcCCCCCCc---
Confidence 334567999999999999999999999999999999999999999743321 111112222221111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
..+..+.+++.+||+.||++|||++|+++
T Consensus 226 -~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 226 -FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 12345778999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=412.41 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=208.5
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 4799999999999999999965 57999999998743222 2578999999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|+|.+++.+. .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 97 Ey~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp ECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 999999999988643 589999999999999999999999 9999999999999999999999999999988766
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
........||+.|+|||++.+..++.++||||+||++|||+||+.||......... ..... ...+.+.. .
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-----~~~~~-~~~~~~~~----~ 239 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-----YLIAT-NGTPELQN----P 239 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHHHH-HCSCCCSS----G
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH-----HHHHh-CCCCCCCC----c
Confidence 55566778999999999999999999999999999999999999999743321110 00111 11111111 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
...+..+.+++.+||+.||.+|||++|+++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 123345788999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=410.78 Aligned_cols=257 Identities=24% Similarity=0.328 Sum_probs=196.3
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec--cceeEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH--ALHSFV 777 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 777 (973)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ....+.+.+|++++++++|||||++++++.+ ....|+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 6799999999999999999965 58999999999765443 3346789999999999999999999999864 456799
Q ss_pred EEEecCCCChHHHhccCc-cccCCCHHHHHHHHHHHHHHHHHHhhCCC--CCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 778 VYEYLEMGSLAMILSNDA-AAEEFGWTKRMNAIKGVADALLYMHTNCF--PPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
||||+++|+|.+++.+.. ....+++.+++.++.|++.|++|||+... .+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999986543 23568999999999999999999998620 149999999999999999999999999999
Q ss_pred cccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCC
Q 002069 855 FLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934 (973)
Q Consensus 855 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (973)
.............||+.|||||++.+..++.++|||||||++|||+||+.||....... ....+.....+.++.
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~------~~~~i~~~~~~~~~~ 236 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAGKIREGKFRRIPY 236 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHTCCCCCCT
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCCCCCc
Confidence 87765555566789999999999999999999999999999999999999997543210 001111111112222
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
. .+..+.+++.+||+.||.+|||++|+++.
T Consensus 237 ~------~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 237 R------YSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp T------SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c------cCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1 23357889999999999999999999863
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-48 Score=408.32 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=201.5
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.++|++.+.||+|+||+||+|+++ ..||||+++...... ...+.|.+|+.++++++|||||++++++.+ +..++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 467999999999999999999874 369999997554333 346889999999999999999999999865 4679999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|+|.+++.... ..+++.++..++.|||+||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 83 Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp ECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred ecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 9999999999996543 3589999999999999999999999 9999999999999999999999999999876543
Q ss_pred C--CcccccccccCccccccccc---CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCC
Q 002069 860 L--SNRTELAGTFGYIAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934 (973)
Q Consensus 860 ~--~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (973)
. .......||+.|||||++.+ ..++.++|||||||++|||+||+.||.......... .........+....
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~----~~~~~~~~~p~~~~ 233 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII----FMVGRGYLSPDLSK 233 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH----HHHHHTSCCCCGGG
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH----HHHhcCCCCCcchh
Confidence 2 23345679999999999864 357899999999999999999999997543211100 01111111222111
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.. ...+..+.+++.+||+.||.+||||+||++.|+
T Consensus 234 ~~---~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le 268 (276)
T d1uwha_ 234 VR---SNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268 (276)
T ss_dssp SC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cc---ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 11 123346789999999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=406.57 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=197.1
Q ss_pred cCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
++|++.+.||+|+||+||+|.+.+++.||||++..... ..++|.+|++++++++|||||+++|+|.+++..++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 57889999999999999999988889999999875332 24789999999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++|+|.+++.... ..+++..++.++.|+|.|++|+|+. +|+||||||+||+++.++.+||+|||+|+......
T Consensus 81 ~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred ecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 999999999987543 4688999999999999999999999 99999999999999999999999999998775443
Q ss_pred C-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhC-CCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 861 S-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKG-KHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 861 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
. ......||+.|+|||++.+..++.++|||||||++|||+|+ ++||...... .. ............+..
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-~~-----~~~i~~~~~~~~p~~--- 226 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EV-----VEDISTGFRLYKPRL--- 226 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-HH-----HHHHHHTCCCCCCTT---
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-HH-----HHHHHhcCCCCCccc---
Confidence 2 23346789999999999999999999999999999999995 5555432210 00 111111112222211
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+..+.+++.+||+.||++||||+||++.|+
T Consensus 227 ---~~~~l~~li~~cl~~~p~~Rps~~~il~~L~ 257 (263)
T d1sm2a_ 227 ---ASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257 (263)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---cCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 2345789999999999999999999999885
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=409.07 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=203.7
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|.. .+|+.||||++...... ...+.+.+|+.++++++|||||++++++.+++..|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 35799999999999999999965 57999999998754322 2346789999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++|+|.++++.. ..+++.+++.++.||+.|++|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 82 mEy~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp EECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EeccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 9999999999999654 3689999999999999999999999 999999999999999999999999999987754
Q ss_pred CC--CcccccccccCcccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcC-CCCCC
Q 002069 859 GL--SNRTELAGTFGYIAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLD-PRLPT 934 (973)
Q Consensus 859 ~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 934 (973)
.. ......+||+.|||||++.+..+ +.++||||+||++|||+||+.||.......... ..... +....
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~--------~~~~~~~~~~~ 227 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--------SDWKEKKTYLN 227 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH--------HHHHTTCTTST
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH--------HHHhcCCCCCC
Confidence 42 22345689999999999988876 578999999999999999999997443211111 01111 11111
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
... ..+..+.+++.+||+.||++|||++|+++.
T Consensus 228 ~~~---~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 228 PWK---KIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TGG---GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccc---cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 112 223456788999999999999999999763
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-48 Score=411.87 Aligned_cols=254 Identities=22% Similarity=0.361 Sum_probs=207.9
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|.+. +++.||||+++.... ..++|.+|+.++++++|||||+++|++.+++..++|
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 467999999999999999999664 688999999875432 257899999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++|++.+++.... ...+++..++.++.|||.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 92 ~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999996543 34689999999999999999999999 999999999999999999999999999987755
Q ss_pred CCC-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 859 GLS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 859 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
... ......|++.|+|||++.+..++.++|||||||++|||++|..||........ ....+.....+..+..
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-----~~~~i~~~~~~~~~~~-- 240 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEKDYRMERPEG-- 240 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HHHHHHTTCCCCCCTT--
T ss_pred CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-----HHHHHhcCCCCCCCcc--
Confidence 432 23345689999999999999999999999999999999997777542221111 0111111122222221
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+..+.+++.+||+.||++|||++||++.|+
T Consensus 241 ----~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~ 271 (287)
T d1opja_ 241 ----CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271 (287)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 2345789999999999999999999998774
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=396.33 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=209.3
Q ss_pred cCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
++|++.++||+|+||+||+|++++++.||||+++..... .++|.+|+.++++++||||++++|+|.+++..++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 579999999999999999999988889999999864332 4789999999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++|++.+++.... ..+++..+++++.|+|+|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 80 y~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 80 YMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred ccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 999999999976543 4688999999999999999999999 99999999999999999999999999998765443
Q ss_pred C-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 861 S-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 861 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
. ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||+...... . ...+........+.
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~----~~~i~~~~~~~~p~---- 224 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--T----AEHIAQGLRLYRPH---- 224 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--H----HHHHHTTCCCCCCT----
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--H----HHHHHhCCCCCCcc----
Confidence 2 2334678999999999999999999999999999999998 899997543210 1 11111111222221
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHh
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLL 971 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 971 (973)
..+..+.+++.+||+.||.+|||++++++.|
T Consensus 225 --~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 255 (258)
T d1k2pa_ 225 --LASEKVYTIMYSCWHEKADERPTFKILLSNI 255 (258)
T ss_dssp --TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred --cccHHHHHHHHHHccCCHhHCcCHHHHHHHh
Confidence 1234578999999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-47 Score=408.03 Aligned_cols=253 Identities=26% Similarity=0.465 Sum_probs=195.3
Q ss_pred cCCcccccccCCCceeEEEEEcC-CC---CEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TG---EIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (973)
++|++.+.||+|+||+||+|.+. ++ ..||||++..... ....++|.+|+.++++++|||||+++|++.+++..+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 56788899999999999999764 33 2689999875433 334678999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
+||||+++|+|.+++.... ..+++.++..++.|||+||+|||++ +|+||||||+|||++.++++||+|||+|+..
T Consensus 104 iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999999987543 4689999999999999999999999 9999999999999999999999999999877
Q ss_pred cCCCCc-----ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCC
Q 002069 857 KLGLSN-----RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDP 930 (973)
Q Consensus 857 ~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (973)
...... .....||+.|||||.+.+..++.++|||||||++|||+| |+.||....... ....+....
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~------~~~~i~~~~-- 250 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD------VINAIEQDY-- 250 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTC--
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCC--
Confidence 543221 122457899999999999999999999999999999998 899987443210 001111111
Q ss_pred CCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 931 RLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 931 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+.+.+ ...+..+.+++.+||+.||.+||||+||++.|+
T Consensus 251 ~~~~~----~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~ 288 (299)
T d1jpaa_ 251 RLPPP----MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288 (299)
T ss_dssp CCCCC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCCCC----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 11111 123345788999999999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=409.12 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=204.9
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
+.|++.+.||+|+||+||+|.. .+++.||||++...... ..+.+.+|++++++++|||||++++++.+++..++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 4689999999999999999965 57999999998754322 2467899999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|+|.+++.+.. ..+++.++..++.||+.|++|||++ +|+||||||+||+++.++.+||+|||+|+.....
T Consensus 89 Ey~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 89 EFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp ECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred ecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 9999999999975432 4689999999999999999999999 9999999999999999999999999999866543
Q ss_pred CCcccccccccCcccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCC
Q 002069 860 LSNRTELAGTFGYIAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (973)
........||+.|+|||++. +..++.++||||+||++|||+||+.||....... ..........+
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---------~~~~i~~~~~~- 233 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---------VLLKIAKSEPP- 233 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---------HHHHHHHSCCC-
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---------HHHHHHcCCCC-
Confidence 33445678999999999984 4568899999999999999999999997443211 11111111111
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
........+..+.+++.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111223446788999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=402.69 Aligned_cols=253 Identities=21% Similarity=0.341 Sum_probs=205.3
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.++|++.+.||+|+||+||+|.+++++.||||+++.... ..+.|.+|++++++++|||||+++|++.+ +..++||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 467999999999999999999988889999999975432 24679999999999999999999998865 4678999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|+|.+++.... ...+++.++++|+.|||+|++|||++ +|+||||||+||+++.++.+||+|||+|+.....
T Consensus 87 Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp ECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCC
Confidence 9999999999886443 34689999999999999999999999 9999999999999999999999999999987654
Q ss_pred CC-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 860 LS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 860 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.. ......||+.|+|||++.+..++.++|||||||++|||+||..|+......... ...+.....+..+..
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~-----~~~i~~~~~~~~p~~--- 234 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-----IQNLERGYRMVRPDN--- 234 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----HHHHHTTCCCCCCTT---
T ss_pred ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH-----HHHHHhcCCCCCccc---
Confidence 32 334467899999999999999999999999999999999966554322211110 111111122222221
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+..+.+++.+||+.||++||||++|++.|+
T Consensus 235 ---~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~ 265 (272)
T d1qpca_ 235 ---CPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (272)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 2335788999999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-47 Score=408.90 Aligned_cols=253 Identities=25% Similarity=0.301 Sum_probs=191.3
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.+.|++.+.||+|+||+||+|+. .+|+.||||++....... ..+.+.+|+.++++++|||||++++++.+++..|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46799999999999999999965 479999999987543322 246788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeec---CCCceEEeccccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLN---LEYEAHVSDFGISKF 855 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~---~~~~~kl~Dfg~a~~ 855 (973)
|||+++|+|.+++... ..+++.++..++.||+.|++|||++ +|+||||||+||++. +++.+||+|||+|+.
T Consensus 86 mE~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp ECCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred EeccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 9999999999999754 3689999999999999999999999 999999999999994 578999999999987
Q ss_pred ccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 856 LKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 856 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
.... .......||+.|||||++.+..++.++||||+||++|||++|+.||...... ..............
T Consensus 160 ~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---------~~~~~i~~~~~~~~ 229 (307)
T d1a06a_ 160 EDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---------KLFEQILKAEYEFD 229 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---------HHHHHHHTTCCCCC
T ss_pred ccCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---------HHHHHHhccCCCCC
Confidence 6544 2334567999999999999999999999999999999999999999743321 11111222222111
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.......+..+.+++.+||+.||++|||++|+++.
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11112233457899999999999999999999873
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=399.81 Aligned_cols=252 Identities=25% Similarity=0.328 Sum_probs=203.8
Q ss_pred cCCccccc-ccCCCceeEEEEEcC---CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeE
Q 002069 701 KNFDDEHC-IGNGGQGSVYKAELP---TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 701 ~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (973)
++|.+.+. ||+|+||+||+|.++ ++..||||+++... .....++|.+|++++++++|||||+++|++..+ ..+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEE
Confidence 45666674 999999999999653 45579999997643 234468899999999999999999999998654 678
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
+||||+++|+|.+++.... ..+++.++..++.|+|.||+|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 85 lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence 9999999999999985443 4689999999999999999999999 9999999999999999999999999999877
Q ss_pred cCCCC---cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 857 KLGLS---NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 857 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
..... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||....... ....+.....+..
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~------~~~~i~~~~~~~~ 233 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRMEC 233 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------HHHHHHTTCCCCC
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCC
Confidence 55432 2234568999999999999999999999999999999998 999997543210 1111111122222
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+.. .+.++.+++.+||+.||++||||.+|++.|+
T Consensus 234 p~~------~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~ 267 (285)
T d1u59a_ 234 PPE------CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267 (285)
T ss_dssp CTT------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CCc------CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 221 2345789999999999999999999998875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=405.45 Aligned_cols=248 Identities=20% Similarity=0.290 Sum_probs=203.3
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||+|.. .+|+.||||++...........+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5699999999999999999965 589999999986432222233577999999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|+|.+++... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999998644 3689999999999999999999999 9999999999999999999999999999877543
Q ss_pred C--CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCC--CCCCC
Q 002069 860 L--SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDP--RLPTP 935 (973)
Q Consensus 860 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 935 (973)
. .......||+.|+|||++.+..++.++||||+||++|||+||+.||...... .....+... .++..
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---------~~~~~i~~~~~~~p~~ 232 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---------LIFQKIIKLEYDFPEK 232 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHTTCCCCCTT
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---------HHHHHHHcCCCCCCcc
Confidence 2 2334567999999999999999999999999999999999999999743321 111111222 22222
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
.+..+.++|.+||+.||.+|||++|+.+
T Consensus 233 ------~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 233 ------FFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ------CCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ------CCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 2335778999999999999999998643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-47 Score=406.92 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=203.8
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
+.|+..+.||+|+||+||+|.. .+|+.||||++...........+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4599999999999999999964 588999999998765555555678999999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|++..++... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 999999998776543 3689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcccccccccCccccccccc---CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 860 LSNRTELAGTFGYIAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||........ ..... ....+....
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-----~~~i~-~~~~~~~~~-- 236 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIA-QNESPALQS-- 236 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHH-HSCCCCCSC--
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-----HHHHH-hCCCCCCCC--
Confidence 234679999999999864 4589999999999999999999999974332110 00111 111111111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
. ..+..+.+++.+||+.||.+|||++|+++
T Consensus 237 ~---~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 G---HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp T---TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C---CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 12345788999999999999999999976
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=394.48 Aligned_cols=247 Identities=22% Similarity=0.331 Sum_probs=197.3
Q ss_pred CcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec----cceeEE
Q 002069 703 FDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH----ALHSFV 777 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l 777 (973)
|++.++||+|+||+||+|.. .+++.||+|++...... ....+.|.+|++++++++|||||++++++.+ ....|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 36677899999999999965 47899999998754332 2346789999999999999999999999864 346799
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEeecCCCCCeeec-CCCceEEecccccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPP--IVHRDISSKNVLLN-LEYEAHVSDFGISK 854 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlk~~Nill~-~~~~~kl~Dfg~a~ 854 (973)
||||+++|+|.+++++. ..+++.+++.++.||+.|++|||++ + |+||||||+|||++ +++.+||+|||+|+
T Consensus 90 vmE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 99999999999999653 3689999999999999999999998 6 99999999999996 57899999999998
Q ss_pred cccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCC
Q 002069 855 FLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPT 934 (973)
Q Consensus 855 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (973)
.... .......||+.|||||++.+ .++.++||||+||++|||++|+.||........ ....+.....+.
T Consensus 164 ~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--------~~~~i~~~~~~~ 232 (270)
T d1t4ha_ 164 LKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--------IYRRVTSGVKPA 232 (270)
T ss_dssp GCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--------HHHHHTTTCCCG
T ss_pred eccC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--------HHHHHHcCCCCc
Confidence 6543 23345689999999998865 599999999999999999999999974332111 111111111111
Q ss_pred CchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 935 PLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 935 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
... .....++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~--~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 SFD--KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGG--GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccC--ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111 112334778999999999999999999987
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=409.52 Aligned_cols=259 Identities=23% Similarity=0.329 Sum_probs=204.5
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|.. .+|+.||+|+++.... ......+.+|+.++++++|||||++++++.++++.++|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC--TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46899999999999999999965 5789999999976432 23357899999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeeecCCCceEEeccccccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHT-NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLK 857 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~ 857 (973)
|||+++|+|.+++.+. ..+++..+..++.|++.|++|||+ + +|+||||||+|||++.++.+||+|||+|+...
T Consensus 83 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 9999999999999754 368999999999999999999997 5 89999999999999999999999999998765
Q ss_pred CCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh--hhhh---------------
Q 002069 858 LGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL--SSNL--------------- 920 (973)
Q Consensus 858 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~--~~~~--------------- 920 (973)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.......... ....
T Consensus 157 ~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 157 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp HH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred CC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 42 2345689999999999999999999999999999999999999996432110000 0000
Q ss_pred ----------------hhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 921 ----------------NIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 921 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
............+.... ...+.++.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCB--TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCcc--ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000000000000000 0112457889999999999999999999873
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-47 Score=411.06 Aligned_cols=257 Identities=23% Similarity=0.352 Sum_probs=205.4
Q ss_pred hcCCcccccccCCCceeEEEEEcCC-C-----CEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeecc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPT-G-----EIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHA 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 772 (973)
.++|++.+.||+|+||+||+|++.. + ..||||++...... .....+.+|+.++.++ +|||||++++++.++
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--HHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 3679999999999999999996532 2 36999998754332 2357789999999998 899999999999999
Q ss_pred ceeEEEEEecCCCChHHHhccCcc--------------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecC
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAA--------------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDI 832 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dl 832 (973)
+..++||||+++|+|.++++.... ...+++.+++.++.||+.|++|||++ +|+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 999999999999999999975432 23589999999999999999999999 9999999
Q ss_pred CCCCeeecCCCceEEecccccccccCCCCc--ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcch
Q 002069 833 SSKNVLLNLEYEAHVSDFGISKFLKLGLSN--RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFI 909 (973)
Q Consensus 833 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~ 909 (973)
||+||+++.++.+||+|||+|+........ .....||+.|||||++.+..++.++|||||||++|||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876654332 234568999999999999999999999999999999998 89999743
Q ss_pred hhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 910 SSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.... ...........+..+.. .+..+.+++.+||+.||++|||++||+++|+
T Consensus 271 ~~~~-----~~~~~~~~~~~~~~p~~------~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVDA-----NFYKLIQNGFKMDQPFY------ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSH-----HHHHHHHTTCCCCCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHH-----HHHHHHhcCCCCCCCCc------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 3211 01111122122222221 2345789999999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=399.39 Aligned_cols=254 Identities=19% Similarity=0.271 Sum_probs=209.4
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCc---chhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPG---EMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
.++|++.+.||+|+||+||+|.. .+|+.||||++...... .....+.+.+|+.++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36799999999999999999965 58999999998643221 222367899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC----ceEEeccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY----EAHVSDFG 851 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~----~~kl~Dfg 851 (973)
|+||||+++|+|.++++.. ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++ .+|++|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999999654 3689999999999999999999999 999999999999998776 49999999
Q ss_pred ccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 852 ISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 852 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
+|+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+....
T Consensus 163 ~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---------~~~~~i~~~~ 232 (293)
T d1jksa_ 163 LAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---------ETLANVSAVN 232 (293)
T ss_dssp TCEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHTTC
T ss_pred hhhhcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH---------HHHHHHHhcC
Confidence 99877554 2334567999999999999999999999999999999999999999744321 1112222222
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
...........+..+.+++.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22222222233456789999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=395.46 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=195.8
Q ss_pred ccccCCCceeEEEEEcC---CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEecC
Q 002069 707 HCIGNGGQGSVYKAELP---TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEYLE 783 (973)
Q Consensus 707 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 783 (973)
++||+|+||+||+|.++ .++.||||+++.... .....++|.+|+.++++++|||||+++|+|..+ ..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 46999999999999653 356899999975433 233467899999999999999999999999654 5789999999
Q ss_pred CCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCCc-
Q 002069 784 MGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLSN- 862 (973)
Q Consensus 784 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 862 (973)
+|+|.++++.. ..+++.+++.++.|||.|++|||++ +|+||||||+||+++.++.+|++|||+|+........
T Consensus 91 ~g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 91 LGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp TEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999998754 3589999999999999999999999 9999999999999999999999999999876544322
Q ss_pred --ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 863 --RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 863 --~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
.....||+.|||||.+.+..++.++|||||||++|||+| |+.||....... ....+.....+..+.
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~------~~~~i~~~~~~~~p~----- 233 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGERMGCPA----- 233 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCCCCCT-----
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH------HHHHHHcCCCCCCCc-----
Confidence 233578999999999999999999999999999999998 899997543210 111111111222222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 940 QDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+..+.+++.+||+.||++|||+++|++.|+
T Consensus 234 -~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 234 -GCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp -TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred -ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 12345788999999999999999999988764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.6e-46 Score=408.96 Aligned_cols=253 Identities=20% Similarity=0.267 Sum_probs=208.6
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..|+|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35899999999999999999965 589999999997542 23457899999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC--CCceEEecccccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL--EYEAHVSDFGISKFL 856 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~--~~~~kl~Dfg~a~~~ 856 (973)
|||+++|+|.+++.+.. ..+++.++..++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||+|+..
T Consensus 102 mE~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 102 YEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp ECCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 99999999999986443 3589999999999999999999999 9999999999999964 578999999999877
Q ss_pred cCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 857 KLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 857 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
... .......||+.|||||++.+..++.++||||+||++|||++|+.||...... .....+.........
T Consensus 177 ~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---------~~~~~i~~~~~~~~~ 246 (350)
T d1koaa2 177 DPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---------ETLRNVKSCDWNMDD 246 (350)
T ss_dssp CTT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHTCCCSCC
T ss_pred ccc-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---------HHHHHHHhCCCCCCc
Confidence 644 3344578999999999999999999999999999999999999999743321 111111111111111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+..+.+++.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122234467889999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.4e-46 Score=407.52 Aligned_cols=253 Identities=18% Similarity=0.248 Sum_probs=208.1
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.+.|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..|+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35799999999999999999965 589999999987543 23356788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeec--CCCceEEecccccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLN--LEYEAHVSDFGISKFL 856 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~--~~~~~kl~Dfg~a~~~ 856 (973)
|||+++|+|.+++.... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+.+
T Consensus 105 mE~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 105 LEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEcCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceec
Confidence 99999999998876443 4589999999999999999999999 999999999999997 5689999999999987
Q ss_pred cCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 857 KLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 857 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
... .......||+.|+|||++.+..++.++||||+||++|||+||+.||....... ....+.......+.
T Consensus 180 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---------~~~~i~~~~~~~~~ 249 (352)
T d1koba_ 180 NPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---------TLQNVKRCDWEFDE 249 (352)
T ss_dssp CTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---------HHHHHHHCCCCCCS
T ss_pred CCC-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHhCCCCCCc
Confidence 654 33445679999999999999999999999999999999999999997543211 11111111111111
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
......+..+.+++.+||+.||.+|||++|+++.
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112233457889999999999999999999873
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-46 Score=395.73 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=197.4
Q ss_pred cCCcccccccCCCceeEEEEEcCCC-----CEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPTG-----EIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
..|+..+.||+|+||+||+|.+++. ..||||++...... ....+|.+|+.++++++|||||+++|++.+.+..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh--HHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 4688899999999999999966432 37999999754332 3356799999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+.++++.+++.... ..+++.++..++.|++.|++|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999999886543 4689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCC---cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 856 LKLGLS---NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 856 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
...... ......||+.|||||++.+..++.++|||||||++|||++|..|+......... ...+.....+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~-----~~~i~~~~~~~~ 234 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-----MKAINDGFRLPT 234 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----HHHHHTTCCCCC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH-----HHHHhccCCCCC
Confidence 654322 223356899999999999999999999999999999999976665422211110 111111122222
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+. ..+..+.+++.+||+.||++||||+||++.|+
T Consensus 235 ~~------~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~ 268 (283)
T d1mqba_ 235 PM------DCPSAIYQLMMQCWQQERARRPKFADIVSILD 268 (283)
T ss_dssp CT------TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred ch------hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHH
Confidence 21 12345789999999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=395.07 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=199.3
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
.++|++.+.||+|+||+||+|.+++++.||||+++..... .+.|.+|+.++++++|||||+++|++.+ +..++||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~ 90 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 90 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence 3679999999999999999999888889999999754322 4789999999999999999999999865 5678999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+++|++.+++.... ...+++.+++.++.|||.|++|||+. +|+||||||+||+++.++++||+|||+|+.....
T Consensus 91 Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 91 EYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 9999999999886543 24589999999999999999999999 9999999999999999999999999999876543
Q ss_pred C-CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 860 L-SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 860 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
. .......||+.|+|||++.++.++.++|||||||++|||+||..|+.......... ..+........+.
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~-----~~i~~~~~~~~~~---- 237 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-----DQVERGYRMPCPP---- 237 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-----HHHHTTCCCCCCT----
T ss_pred CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH-----HHHHhcCCCCCCc----
Confidence 2 23344678999999999999999999999999999999999766654222111110 1111111222222
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+..+.+++.+||+.||++|||+++|+++|+
T Consensus 238 --~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 269 (285)
T d1fmka3 238 --ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269 (285)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHh
Confidence 12345789999999999999999999998774
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=398.89 Aligned_cols=249 Identities=22% Similarity=0.257 Sum_probs=208.6
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|+. .+|+.||||++...........+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 35799999999999999999965 58999999998643222223357789999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++|+|.+++.+. ..+++..++.++.||+.|++|||++ +|+||||||+||+++.+|.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 9999999999998754 3688999999999999999999999 999999999999999999999999999997765
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcC--CCCCCCc
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLD--PRLPTPL 936 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 936 (973)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||...... ........ ..++..
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---------~~~~~i~~~~~~~p~~- 227 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---------RLFELILMEEIRFPRT- 227 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHCCCCCCTT-
T ss_pred CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---------HHHHHHhcCCCCCCcc-
Confidence 555556678999999999999999999999999999999999999999754321 11111111 122222
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPT-----MQKVSQ 969 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~ 969 (973)
.+..+.++|.+||++||.+||+ ++|+++
T Consensus 228 -----~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 228 -----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 2234678999999999999995 788876
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.4e-45 Score=387.08 Aligned_cols=255 Identities=22% Similarity=0.318 Sum_probs=207.8
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcc------hhhHHHHHHHHHHhhcCC-CCceeeeceeeec
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGE------MACQQEFLNEGNALTKIR-HRNIVKFYGFCSH 771 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~ 771 (973)
.++|++.+.||+|+||+||+|+. .+|+.||||++....... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999965 589999999987654322 223456889999999996 9999999999999
Q ss_pred cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccc
Q 002069 772 ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFG 851 (973)
Q Consensus 772 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg 851 (973)
++..|+||||+++|+|.++++.. ..+++.+++.++.||+.|++|||++ +|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999999753 3689999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCccccccccc------CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhh
Q 002069 852 ISKFLKLGLSNRTELAGTFGYIAPELAYT------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALD 925 (973)
Q Consensus 852 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 925 (973)
.++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ...
T Consensus 156 ~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---------~~~ 225 (277)
T d1phka_ 156 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---------MLR 225 (277)
T ss_dssp TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHH
T ss_pred heeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---------HHH
Confidence 999876543 3445689999999999863 346889999999999999999999998543211 111
Q ss_pred hhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 926 EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.................+..+.+++.+||+.||++|||++||++.
T Consensus 226 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 226 MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111111111111122334568899999999999999999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=391.04 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=195.0
Q ss_pred cCCcccccccCCCceeEEEEEcC--CC--CEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP--TG--EIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (973)
++|++.+.||+|+||+||+|++. ++ ..||||++...........++|.+|+.++++++|||||+++|++.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 57999999999999999999652 33 37899999866555555568899999999999999999999999764 678
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
+||||+++|++.+++.... ..+++..++.++.|||.|++|||++ +|+||||||+||+++.++.+|++|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence 9999999999999886433 4689999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCc---ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 857 KLGLSN---RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 857 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
...... .....|++.|+|||.+.+..++.++|||||||++|||+| |+.||....... ...........+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-----~~~~i~~~~~~~~~ 236 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-----ILHKIDKEGERLPR 236 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHTSCCCCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-----HHHHHHhCCCCCCC
Confidence 554322 233467889999999999999999999999999999998 899997443211 00111111111111
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+. ..+..+.+++.+||+.||++||||++|.+.|+
T Consensus 237 ~~------~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~ 270 (273)
T d1u46a_ 237 PE------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270 (273)
T ss_dssp CT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cc------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 11 12345789999999999999999999998874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.2e-45 Score=391.21 Aligned_cols=257 Identities=23% Similarity=0.336 Sum_probs=201.7
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc----e
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL----H 774 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~ 774 (973)
.++|++.+.||+|+||+||+|.. .+|+.||||+++..........+.|.+|+.++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36799999999999999999964 589999999998765555556778999999999999999999999987643 4
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.|+||||+++++|.+++... ..+++.+++.++.||+.|++|||++ +|+||||||+||+++.++.++++|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999988644 3689999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCC---CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 855 FLKLGL---SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 855 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
...... .......||+.|+|||++.+..++.++||||+||++|||+||+.||........ ....+...
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---------~~~~~~~~ 230 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV---------AYQHVRED 230 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---------HHHHHHCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH---------HHHHHhcC
Confidence 654332 233456799999999999999999999999999999999999999975432111 11111111
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCC-CHHHHHHHh
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRP-TMQKVSQLL 971 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ev~~~L 971 (973)
...........+..+.+++.+||+.||.+|| |++++.+.|
T Consensus 231 ~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l 271 (277)
T d1o6ya_ 231 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271 (277)
T ss_dssp CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHH
Confidence 1111111112334578899999999999999 899988765
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-45 Score=396.17 Aligned_cols=258 Identities=21% Similarity=0.383 Sum_probs=207.6
Q ss_pred HHhcCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec
Q 002069 698 RATKNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH 771 (973)
Q Consensus 698 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 771 (973)
...++|++.+.||+|+||+||+|+++ +++.||||+++.... ....++|.+|++++++++||||+++++++..
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC--hHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 34578999999999999999999753 457899999975432 3346789999999999999999999999999
Q ss_pred cceeEEEEEecCCCChHHHhccCc---------------------cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEee
Q 002069 772 ALHSFVVYEYLEMGSLAMILSNDA---------------------AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHR 830 (973)
Q Consensus 772 ~~~~~lv~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~ 830 (973)
.+..++||||+++|+|.++++... ....+++.+++.++.|+|.|++|||+. +|+||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEee
Confidence 999999999999999999996432 123488999999999999999999999 99999
Q ss_pred cCCCCCeeecCCCceEEecccccccccCCC--CcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCC-CCCc
Q 002069 831 DISSKNVLLNLEYEAHVSDFGISKFLKLGL--SNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGK-HPRD 907 (973)
Q Consensus 831 Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~-~p~~ 907 (973)
||||+||+++.++.+||+|||+|+...... .......|++.|+|||.+.+..++.++|||||||++|||++|. +||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999999999999999999998664432 2233467889999999999999999999999999999999985 5666
Q ss_pred chhhhhhhhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 908 FISSICSSLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..... +....+..+..+.... ..+.++.+++.+||+.||++||||.||+++|+
T Consensus 245 ~~~~~---------e~~~~v~~~~~~~~p~---~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 245 GMAHE---------EVIYYVRDGNILACPE---NCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp TSCHH---------HHHHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHH---------HHHHHHHcCCCCCCCc---cchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 43321 1111222222221111 12335789999999999999999999999885
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=385.06 Aligned_cols=248 Identities=28% Similarity=0.406 Sum_probs=196.0
Q ss_pred hcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec-cceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH-ALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv 778 (973)
.++|++.+.||+|+||.||+|++ .|+.||||+++... ..+.|.+|++++++++||||++++|++.+ .+..++|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 35788999999999999999988 57899999997532 24779999999999999999999999865 4568999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++|+|.+++.... ...+++..+++++.||+.|++|||+. +|+||||||+||+++.++.+|++|||+++....
T Consensus 80 ~ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp ECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC
Confidence 99999999999996543 23589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCch
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLR 937 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (973)
. .....+++.|+|||++.+..++.++|||||||++|||+| |++||...... .....+.....+..+..
T Consensus 156 ~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~------~~~~~i~~~~~~~~~~~-- 224 (262)
T d1byga_ 156 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVEKGYKMDAPDG-- 224 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG------GHHHHHTTTCCCCCCTT--
T ss_pred C---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH------HHHHHHHcCCCCCCCcc--
Confidence 2 334568899999999999999999999999999999998 78887643321 01111111222222222
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 938 NVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 938 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.+..+.+++.+||+.||++||||.+++++|+
T Consensus 225 ----~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~ 255 (262)
T d1byga_ 225 ----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255 (262)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----CCHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 2245789999999999999999999999885
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.5e-45 Score=393.30 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=205.0
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||+|+. .+|+.||||+++..........+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999965 579999999986432222333578999999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||++||++..++.... .+++..+..++.||+.|++|||++ +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999886544 578899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
.....||+.|||||++.+..++.++||||+||++|||+||+.||...... .............+.
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---------~~~~~i~~~~~~~p~--- 222 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---------KTYEKILNAELRFPP--- 222 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---------HHHHHHHHCCCCCCT---
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH---------HHHHHHHcCCCCCCC---
Confidence 34568999999999999999999999999999999999999999743321 111111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRP-----TMQKVSQL 970 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 970 (973)
..+.++.+++.+|++.||.+|| |+++++++
T Consensus 223 -~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 223 -FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1123477899999999999996 89998763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-45 Score=392.66 Aligned_cols=251 Identities=20% Similarity=0.238 Sum_probs=207.9
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 778 (973)
.++|++.+.||+|+||+||+|.. .+|+.||||+++... .....+.+|++++++++|||||++++++.+++..|+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 46899999999999999999965 478999999997542 2246788999999999999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC--CceEEecccccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE--YEAHVSDFGISKFL 856 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~--~~~kl~Dfg~a~~~ 856 (973)
|||+++|+|.++++... ..+++.+++.++.||+.|++|||++ +|+||||||+||+++.+ +.+|++|||.++..
T Consensus 80 mE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 99999999999997543 3589999999999999999999999 99999999999999854 58999999999877
Q ss_pred cCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 857 KLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 857 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
... .......+|+.|+|||...+..++.++||||+||++|+|++|+.||..... ......+.......+.
T Consensus 155 ~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---------~~~~~~i~~~~~~~~~ 224 (321)
T d1tkia_ 155 KPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---------QQIIENIMNAEYTFDE 224 (321)
T ss_dssp CTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---------HHHHHHHHHTCCCCCH
T ss_pred ccC-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHhCCCCCCh
Confidence 543 234456789999999999999999999999999999999999999974332 1112222222222222
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
......+..+.+++.+|++.||.+|||++|+++
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 222223456789999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=384.48 Aligned_cols=253 Identities=21% Similarity=0.354 Sum_probs=194.0
Q ss_pred hcCCcccccccCCCceeEEEEEcCC----CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELPT----GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
.++|++.+.||+|+||+||+|.+.. +..||||+++... .....+.|.+|+.++++++|||||+++|++.+ +..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeE
Confidence 4679999999999999999996542 3568999986543 33446789999999999999999999999964 578
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++||||+++|++.+++.... ..+++.+++.++.||+.|++|||+. +|+||||||+||+++.++.+|++|||+|+.
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhee
Confidence 99999999999999876443 4689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCC-cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCCC
Q 002069 856 LKLGLS-NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRLP 933 (973)
Q Consensus 856 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (973)
...... ......||+.|+|||++.+..++.++|||||||++|||+| |.+||....... ....+.....+..+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~------~~~~i~~~~~~~~~ 231 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPMP 231 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHHHTTCCCCCC
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCCCCCC
Confidence 654322 2344568999999999999999999999999999999998 899987443210 01111111111222
Q ss_pred CCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 934 TPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 934 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
. ..+..+.+++.+||+.||.+|||++||++.|+
T Consensus 232 ~------~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~ 264 (273)
T d1mp8a_ 232 P------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264 (273)
T ss_dssp T------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred C------CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 1 12345789999999999999999999998874
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=391.79 Aligned_cols=252 Identities=20% Similarity=0.243 Sum_probs=200.8
Q ss_pred hcCCcccc-cccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhc-CCCCceeeeceeeec----c
Q 002069 700 TKNFDDEH-CIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTK-IRHRNIVKFYGFCSH----A 772 (973)
Q Consensus 700 ~~~~~~~~-~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~ 772 (973)
.++|++.+ .||+|+||+||+|.. .+++.||||+++. ...+.+|+.++.+ .+|||||++++++.+ .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 36788875 599999999999955 5899999999863 2556789988665 489999999999865 4
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC---CCceEEec
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL---EYEAHVSD 849 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---~~~~kl~D 849 (973)
...|+|||||+||+|.++++... ...+++.+++.++.||+.|++|||+. +|+||||||+||+++. ++.+|++|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred CEEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccc
Confidence 56899999999999999997543 24689999999999999999999999 9999999999999985 46799999
Q ss_pred ccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcC
Q 002069 850 FGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLD 929 (973)
Q Consensus 850 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 929 (973)
||+|+..... .......||+.|+|||++.+..++.++||||+||++|+|+||+.||........ ..........
T Consensus 158 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-----~~~~~~~i~~ 231 (335)
T d2ozaa1 158 FGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----SPGMKTRIRM 231 (335)
T ss_dssp CTTCEECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCCS
T ss_pred cceeeeccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-----HHHHHHHHhc
Confidence 9999877654 334556899999999999999999999999999999999999999974432110 0011111112
Q ss_pred CCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 930 PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 930 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
.....+.......+.++.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 232 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2222222223344567889999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-45 Score=392.57 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=204.1
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhh-cCCCCceeeeceeeeccceeEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALT-KIRHRNIVKFYGFCSHALHSFVV 778 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv 778 (973)
++|++.+.||+|+||+||+|.. .+|+.||||+++..........+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999965 489999999986432222223456667776655 68999999999999999999999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccC
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKL 858 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 858 (973)
|||+++|+|.++++.. ..+++.+++.++.||+.|++|||++ +|+||||||+|||++.++.+|++|||.|+....
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 9999999999999754 3588999999999999999999999 999999999999999999999999999987766
Q ss_pred CCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchh
Q 002069 859 GLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRN 938 (973)
Q Consensus 859 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (973)
.........||+.|+|||++.+..++.++||||+||++|||+||+.||....... . ..... ...+.++..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--~---~~~i~--~~~~~~p~~--- 225 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--L---FHSIR--MDNPFYPRW--- 225 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---HHHHH--HCCCCCCTT---
T ss_pred ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--H---HHHHH--cCCCCCCcc---
Confidence 5556666789999999999999999999999999999999999999997543211 0 00010 112222221
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCHH-HHHH
Q 002069 939 VQDKLISIMEVSISCLDESPTSRPTMQ-KVSQ 969 (973)
Q Consensus 939 ~~~~~~~l~~li~~cl~~dP~~RPs~~-ev~~ 969 (973)
.+..+.+++.+||+.||.+||++. ++++
T Consensus 226 ---~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 226 ---LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 233477899999999999999995 6654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-44 Score=394.29 Aligned_cols=247 Identities=21% Similarity=0.261 Sum_probs=205.1
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++++.||+|+||+||+|.. .+|+.||||++...........+.+.+|+.++++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999965 589999999986432222233577899999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+.+|++.+++... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999998654 3689999999999999999999999 9999999999999999999999999999877533
Q ss_pred CCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCchhh
Q 002069 860 LSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPLRNV 939 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (973)
.....||+.|||||++.+..++.++||||+||++|||+||+.||...... .....+.......+.
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---------~~~~~i~~~~~~~p~--- 259 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---------QIYEKIVSGKVRFPS--- 259 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHCCCCCCT---
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---------HHHHHHhcCCCCCCc---
Confidence 34567999999999999999999999999999999999999999754321 111111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 002069 940 QDKLISIMEVSISCLDESPTSRP-----TMQKVSQ 969 (973)
Q Consensus 940 ~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~ 969 (973)
..+.++.+++.+||+.||.+|+ |++++++
T Consensus 260 -~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 260 -HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1233577899999999999994 8999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=389.83 Aligned_cols=252 Identities=22% Similarity=0.389 Sum_probs=198.7
Q ss_pred cCCcccccccCCCceeEEEEEcC-CCC----EEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecccee
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELP-TGE----IVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 775 (973)
.+|++.+.||+|+||+||+|.+. +|+ +||||+++..... ...++|.+|+.++++++|||||+++|+|.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 46999999999999999999654 454 6899998754322 2367899999999999999999999999875 56
Q ss_pred EEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccccc
Q 002069 776 FVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKF 855 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~ 855 (973)
++++||+.+|+|.+++.... ..+++..+++++.|||.||+|||++ +|+||||||+||+++.++.+||+|||+|+.
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred eEEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeecccccee
Confidence 78899999999999886543 4689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCc--ccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhhhhhhhhhhhhhhhcCCCC
Q 002069 856 LKLGLSN--RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICSSLSSNLNIALDEMLDPRL 932 (973)
Q Consensus 856 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (973)
....... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||+..... .....+.....+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~------~~~~~i~~~~~~~~ 234 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------EISSILEKGERLPQ 234 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG------GHHHHHHHTCCCCC
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH------HHHHHHHcCCCCCC
Confidence 7654332 233568999999999999999999999999999999998 88998744321 01111112122222
Q ss_pred CCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 933 PTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 933 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
+. ..+..+.+++.+||+.||.+|||+.|+++.|+
T Consensus 235 p~------~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 235 PP------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp CT------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred Cc------ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence 21 12345788999999999999999999998763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-44 Score=397.45 Aligned_cols=251 Identities=20% Similarity=0.213 Sum_probs=198.4
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHH---HHHHHhhcCCCCceeeeceeeeccceeE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFL---NEGNALTKIRHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (973)
++|++.+.||+|+||+||+|.. .+|+.||||++.............+. .|+.+++.++|||||++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999965 47999999998532211111123333 4467788889999999999999999999
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFL 856 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~ 856 (973)
+||||+++|+|.+++... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999999654 3578999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCC
Q 002069 857 KLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTP 935 (973)
Q Consensus 857 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (973)
... ......||+.|+|||++.. ..++.++||||+||++|||+||+.||...... ................+
T Consensus 158 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~~~~~~ 229 (364)
T d1omwa3 158 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK------DKHEIDRMTLTMAVELP 229 (364)
T ss_dssp SSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS------CHHHHHHHSSSCCCCCC
T ss_pred CCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcccCCCCCC
Confidence 543 3345679999999999864 56899999999999999999999999743211 00111111111111111
Q ss_pred chhhHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHH
Q 002069 936 LRNVQDKLISIMEVSISCLDESPTSRPT-----MQKVSQ 969 (973)
Q Consensus 936 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~ 969 (973)
. ..+..+.++|.+||+.||.+||| ++|+++
T Consensus 230 -~---~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 230 -D---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -S---SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -C---CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1 12335788999999999999999 688875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-44 Score=382.89 Aligned_cols=262 Identities=22% Similarity=0.306 Sum_probs=199.0
Q ss_pred cCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc----eeE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL----HSF 776 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~ 776 (973)
++|.+.+.||+|+||+||+|++ +|+.||||+++.. ......+..|+..+.+++|||||++++++.+++ ..|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 5688889999999999999987 7899999998632 221222334555666789999999999997653 579
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEeecCCCCCeeecCCCceEEeccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC-----FPPIVHRDISSKNVLLNLEYEAHVSDFG 851 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~Dlk~~Nill~~~~~~kl~Dfg 851 (973)
+||||+++|+|.+++++. .++|.++++++.|+|.|++|+|+.. .++|+||||||+|||++.++.+||+|||
T Consensus 78 lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 999999999999999753 4789999999999999999999731 1389999999999999999999999999
Q ss_pred ccccccCCCC----cccccccccCcccccccccCC------CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh-----
Q 002069 852 ISKFLKLGLS----NRTELAGTFGYIAPELAYTMK------VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL----- 916 (973)
Q Consensus 852 ~a~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~----- 916 (973)
+++....... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||...+......
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 9987755432 233567999999999987643 5678999999999999999998875432111000
Q ss_pred -hhhhh----hhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 917 -SSNLN----IALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 917 -~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..... .......++.++.... ..+....+.+++.+||+.||++|||+.||++.|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~ 293 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQ-SCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGG-GCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccC-ChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 01111 1122233343333322 2335566889999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-44 Score=385.50 Aligned_cols=258 Identities=22% Similarity=0.347 Sum_probs=195.9
Q ss_pred HhcCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeec
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSH 771 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 771 (973)
..++|++.+.||+|+||+||+|.+. +++.||||+++.... ....+.+.+|...+.++ +|+||+.+++++.+
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 3478999999999999999999642 346899999975433 23357788888888776 78999999998865
Q ss_pred c-ceeEEEEEecCCCChHHHhccCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCe
Q 002069 772 A-LHSFVVYEYLEMGSLAMILSNDAA-------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNV 837 (973)
Q Consensus 772 ~-~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni 837 (973)
+ ...++||||+++|+|.++++.... ...+++.+++.++.||++|++|||++ +|+||||||+||
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NI 165 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 165 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccce
Confidence 4 468999999999999999965432 23588999999999999999999999 999999999999
Q ss_pred eecCCCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhC-CCCCcchhhhhh
Q 002069 838 LLNLEYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKG-KHPRDFISSICS 914 (973)
Q Consensus 838 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg-~~p~~~~~~~~~ 914 (973)
|++.++.+||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||+|| ..||.......
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~- 244 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 244 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999999987654332 23456799999999999999999999999999999999986 45776432111
Q ss_pred hhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 915 SLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
...........+..+.. .+..+.+++.+||+.||.+|||++|++++|+
T Consensus 245 ----~~~~~~~~~~~~~~~~~------~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~ 292 (299)
T d1ywna1 245 ----EFCRRLKEGTRMRAPDY------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292 (299)
T ss_dssp ----HHHHHHHHTCCCCCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----HHHHHHhcCCCCCCCcc------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 01111222222222222 2235788999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=381.92 Aligned_cols=256 Identities=24% Similarity=0.347 Sum_probs=203.6
Q ss_pred hcCCcccccccCCCceeEEEEEcC--------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP--------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCS 770 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 770 (973)
.++|++.+.||+|+||.||+|+.. ++..||||+++.... .....++.+|...+.++ +|||||+++++|.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 468999999999999999999642 224799999986533 23357888998888888 8999999999999
Q ss_pred ccceeEEEEEecCCCChHHHhccCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCe
Q 002069 771 HALHSFVVYEYLEMGSLAMILSNDAA-------------AEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNV 837 (973)
Q Consensus 771 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni 837 (973)
+++..++||||+++|+|.+++..... ...+++.+++.++.|||.|++|||+. +|+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 99999999999999999999965532 24589999999999999999999999 999999999999
Q ss_pred eecCCCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhh
Q 002069 838 LLNLEYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICS 914 (973)
Q Consensus 838 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 914 (973)
|++.++.+||+|||.++....... ......|++.|+|||.+.+..++.++|||||||++|||++ |+.||.......
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~- 245 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 245 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-
Confidence 999999999999999987765432 2344678999999999999999999999999999999998 788886433210
Q ss_pred hhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 915 SLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
....+.....+..+.. .+..+.+++.+||+.||.+||||+||++.|+
T Consensus 246 -----~~~~i~~~~~~~~p~~------~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 292 (299)
T d1fgka_ 246 -----LFKLLKEGHRMDKPSN------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292 (299)
T ss_dssp -----HHHHHHTTCCCCCCSS------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -----HHHHHHcCCCCCCCcc------chHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 1111122222222222 2335789999999999999999999999885
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-44 Score=386.42 Aligned_cols=257 Identities=22% Similarity=0.343 Sum_probs=208.8
Q ss_pred HhcCCcccccccCCCceeEEEEEcC------CCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeecc
Q 002069 699 ATKNFDDEHCIGNGGQGSVYKAELP------TGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHA 772 (973)
Q Consensus 699 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 772 (973)
..++|++.+.||+|+||+||+|.+. +++.||||+++... .......|.+|+.++++++|||||+++|++..+
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 3578999999999999999999653 35789999997543 333457899999999999999999999999999
Q ss_pred ceeEEEEEecCCCChHHHhccCc-------cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCce
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDA-------AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEA 845 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~ 845 (973)
+..++||||+++|+|.+++.... ....+++..+.+++.|+|+|++|||++ +|+||||||+|||++.++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceE
Confidence 99999999999999999986432 123468999999999999999999999 99999999999999999999
Q ss_pred EEecccccccccCCCCc--ccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCC-CCCcchhhhhhhhhhhhhh
Q 002069 846 HVSDFGISKFLKLGLSN--RTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGK-HPRDFISSICSSLSSNLNI 922 (973)
Q Consensus 846 kl~Dfg~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~ 922 (973)
||+|||+|+........ .....||+.|+|||.+.+..++.++||||||+++|||+||. .||..... ..
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~---------~~ 243 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---------EQ 243 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---------HH
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH---------HH
Confidence 99999999876544322 23346899999999999999999999999999999999985 67653321 11
Q ss_pred hhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 923 ALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
....+.++..+.... ..+..+.+++.+||+.||.+|||+++|++.|+
T Consensus 244 ~~~~i~~~~~~~~p~---~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~ 290 (308)
T d1p4oa_ 244 VLRFVMEGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290 (308)
T ss_dssp HHHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred HHHHHHhCCCCCCcc---cchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 222222322222111 12345889999999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=380.32 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=198.1
Q ss_pred cccccCCCceeEEEEEcCCC----CEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec-cceeEEEEE
Q 002069 706 EHCIGNGGQGSVYKAELPTG----EIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH-ALHSFVVYE 780 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 780 (973)
.++||+|+||+||+|.+.++ ..||||+++... .....++|.+|++++++++||||++++|++.+ ++..++|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 57899999999999976432 268999997533 33446889999999999999999999999865 457899999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+++|++.+++.... ...++.++++++.|+|.|+.|+|+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 110 ~~~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EeecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 999999999987544 3567889999999999999999999 99999999999999999999999999998765432
Q ss_pred C----cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCCCCCCc
Q 002069 861 S----NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPRLPTPL 936 (973)
Q Consensus 861 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (973)
. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||......... ...+.....+..+.
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~-----~~~i~~g~~~~~p~-- 257 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-----TVYLLQGRRLLQPE-- 257 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C-----HHHHHTTCCCCCCT--
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH-----HHHHHcCCCCCCcc--
Confidence 2 223357899999999999999999999999999999999988887643221111 11111111222221
Q ss_pred hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 937 RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 937 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+..+.+++.+||+.||++||+|.||++.|+
T Consensus 258 ----~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~ 289 (311)
T d1r0pa_ 258 ----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289 (311)
T ss_dssp ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 12335788999999999999999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=381.45 Aligned_cols=264 Identities=23% Similarity=0.320 Sum_probs=201.8
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++.+.||+|+||+||+|.. .+|+.||||+++..... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 5799999999999999999965 68999999999754322 223578899999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
||+.++.+. ++.... ...+++.+++.++.||+.|++|||++ +||||||||+||+++.++.+|++|||.|+.....
T Consensus 81 e~~~~~~~~-~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 81 EFLHQDLKK-FMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp ECCSEEHHH-HHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred eecCCchhh-hhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 999765444 443222 34689999999999999999999999 9999999999999999999999999999888766
Q ss_pred CCcccccccccCcccccccccCC-CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh------hhhhhh---hhhhh--
Q 002069 860 LSNRTELAGTFGYIAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL------SSNLNI---ALDEM-- 927 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~------~~~~~~---~~~~~-- 927 (973)
........||+.|+|||.+.... ++.++||||+||++|+|++|+.||.......... ...... .....
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 66666778999999999877665 4789999999999999999999997543211100 000000 00000
Q ss_pred cCCCCCC----Cc-hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 928 LDPRLPT----PL-RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 928 ~~~~~~~----~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+. .. ......+..+.+++.+|++.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000000 00 0011223567889999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-44 Score=384.20 Aligned_cols=255 Identities=24% Similarity=0.362 Sum_probs=201.0
Q ss_pred hcCCcccccccCCCceeEEEEEcC-CCC--EEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeecccee
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAELP-TGE--IVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHS 775 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 775 (973)
.++|++.++||+|+||+||+|.+. +|. .||||++...... ...++|.+|+++++++ +|||||+++|++.+++..
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh--HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 368899999999999999999765 444 5788887643322 2356899999999998 799999999999999999
Q ss_pred EEEEEecCCCChHHHhccCc-------------cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC
Q 002069 776 FVVYEYLEMGSLAMILSNDA-------------AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE 842 (973)
Q Consensus 776 ~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~ 842 (973)
++||||+++|+|.++++... ....+++.++++++.|||.|++|+|+. +|+||||||+|||++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 163 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCC
Confidence 99999999999999997542 235689999999999999999999999 99999999999999999
Q ss_pred CceEEecccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCC-CCCcchhhhhhhhhhhhh
Q 002069 843 YEAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGK-HPRDFISSICSSLSSNLN 921 (973)
Q Consensus 843 ~~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~-~p~~~~~~~~~~~~~~~~ 921 (973)
+.+||+|||+|+...... ......||+.|+|||.+.+..++.++|||||||++|||++|. +||...... .+ .
T Consensus 164 ~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--~~----~ 236 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--EL----Y 236 (309)
T ss_dssp GCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HH----H
T ss_pred CceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--HH----H
Confidence 999999999998654432 223456899999999999999999999999999999999976 566533211 00 1
Q ss_pred hhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 922 IALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
..+.....+..+.. .+..+.++|.+||+.||++||||+||++.|+
T Consensus 237 ~~i~~~~~~~~~~~------~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 281 (309)
T d1fvra_ 237 EKLPQGYRLEKPLN------CDDEVYDLMRQCWREKPYERPSFAQILVSLN 281 (309)
T ss_dssp HHGGGTCCCCCCTT------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhcCCCCCCcc------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 11111112222221 2345788999999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-44 Score=386.03 Aligned_cols=257 Identities=22% Similarity=0.378 Sum_probs=208.2
Q ss_pred hcCCcccccccCCCceeEEEEEc------CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeecc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL------PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHA 772 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 772 (973)
.++|++.++||+|+||.||+|.+ .+++.||||+++.... .....+|.+|+.+++++ +|||||+++|++.++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 46899999999999999999964 3567899999986533 34467899999999999 699999999999999
Q ss_pred ceeEEEEEecCCCChHHHhccCc---------------cccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCe
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDA---------------AAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNV 837 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Ni 837 (973)
+..++||||+++|+|.++++... ....+++.++.+++.|||.|++|||++ +++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence 99999999999999999996543 123588999999999999999999999 999999999999
Q ss_pred eecCCCceEEecccccccccCCCC--cccccccccCcccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcchhhhhh
Q 002069 838 LLNLEYEAHVSDFGISKFLKLGLS--NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSICS 914 (973)
Q Consensus 838 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 914 (973)
+++.++.+|++|||.++....... ......||+.|+|||++.+..++.++|||||||++|||+| |.+||......
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-- 254 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999997765432 2234678999999999999999999999999999999999 55555432211
Q ss_pred hhhhhhhhhhhhhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 915 SLSSNLNIALDEMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
......+.....+..+.. .+..+.+++.+||+.||.+||||++|+++|+
T Consensus 255 ---~~~~~~i~~~~~~~~~~~------~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~ 303 (311)
T d1t46a_ 255 ---SKFYKMIKEGFRMLSPEH------APAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (311)
T ss_dssp ---HHHHHHHHHTCCCCCCTT------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---HHHHHHHhcCCCCCCccc------ccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 111122222233332222 2345789999999999999999999999885
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-44 Score=383.61 Aligned_cols=260 Identities=22% Similarity=0.247 Sum_probs=197.2
Q ss_pred ccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcch--hhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEEe
Q 002069 705 DEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEM--ACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYEY 781 (973)
Q Consensus 705 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 781 (973)
..++||+|+||+||+|.. .+|+.||||+++....... ...+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999976 4799999999875432211 1235688999999999999999999999999999999999
Q ss_pred cCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCCC
Q 002069 782 LEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGLS 861 (973)
Q Consensus 782 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 861 (973)
++++++..+.... ..+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||.|+.......
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9988777665433 4578899999999999999999999 999999999999999999999999999988776655
Q ss_pred cccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh------hhhhhhhhhhhh-------
Q 002069 862 NRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS------LSSNLNIALDEM------- 927 (973)
Q Consensus 862 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~------~~~~~~~~~~~~------- 927 (973)
......||+.|+|||++.+ ..++.++||||+||++|||+||+.||......... ............
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 5566789999999998865 45799999999999999999999999754322110 000000000000
Q ss_pred cCCCCCC-Cch-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 928 LDPRLPT-PLR-NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 928 ~~~~~~~-~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
.....+. ... ........+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000000 000 001123467899999999999999999999863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.5e-43 Score=376.50 Aligned_cols=262 Identities=23% Similarity=0.317 Sum_probs=201.1
Q ss_pred cCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVYE 780 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 780 (973)
++|++.++||+|+||+||+|+.++|+.||||++...... ....+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 589999999999999999998889999999999765432 2335789999999999999999999999999999999999
Q ss_pred ecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCCC
Q 002069 781 YLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLGL 860 (973)
Q Consensus 781 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 860 (973)
|+.++.+..+.+.. ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+|++|||.|.......
T Consensus 81 ~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred eehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 99887777766543 4689999999999999999999999 99999999999999999999999999998876655
Q ss_pred CcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh------hhh----hhhhh--h---
Q 002069 861 SNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS------LSS----NLNIA--L--- 924 (973)
Q Consensus 861 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~------~~~----~~~~~--~--- 924 (973)
.......|++.|+|||.+.+. .++.++||||+||++|||++|+.||......... ... .+... .
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 555566799999999998754 5689999999999999999999999754321100 000 00000 0
Q ss_pred hhhcCCCCCCCch-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 925 DEMLDPRLPTPLR-NVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 925 ~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
........+.+.. ........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000000 01112345778999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=371.71 Aligned_cols=242 Identities=21% Similarity=0.292 Sum_probs=196.5
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcc---hhhHHHHHHHHHHhhcCC--CCceeeeceeeeccce
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGE---MACQQEFLNEGNALTKIR--HRNIVKFYGFCSHALH 774 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~ 774 (973)
++|++.+.||+|+||+||+|.. .+|+.||||++....... .....++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999965 589999999986432211 111244678999999886 8999999999999999
Q ss_pred eEEEEEecCC-CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCC-CceEEecccc
Q 002069 775 SFVVYEYLEM-GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLE-YEAHVSDFGI 852 (973)
Q Consensus 775 ~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~-~~~kl~Dfg~ 852 (973)
.++||||+.+ +++.+++... ..+++.+++.++.||+.|++|||+. +|+||||||+||+++.+ +.+|++|||.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 5777877543 3689999999999999999999999 99999999999999855 7999999999
Q ss_pred cccccCCCCcccccccccCcccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
|+..... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||......... ...
T Consensus 158 a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~-------------~~~ 222 (273)
T d1xwsa_ 158 GALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG-------------QVF 222 (273)
T ss_dssp CEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHC-------------CCC
T ss_pred ceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhc-------------ccC
Confidence 9866433 3445789999999999987765 56789999999999999999999754321110 011
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
++.. .+.++.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~------~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 223 FRQR------VSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CSSC------CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCC------CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111 1235778999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=373.64 Aligned_cols=264 Identities=19% Similarity=0.289 Sum_probs=195.3
Q ss_pred hcCCcccccccCCCceeEEEEEc-CC-CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC---CCCceeeeceeeec---
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PT-GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI---RHRNIVKFYGFCSH--- 771 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~--- 771 (973)
.++|++.+.||+|+||+||+|.. ++ ++.||||+++...... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 47899999999999999999965 44 5679999986432221 1123455666665554 89999999999853
Q ss_pred --cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEec
Q 002069 772 --ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSD 849 (973)
Q Consensus 772 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~D 849 (973)
....+++|||++++.+....... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 34679999999988776554433 24578999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhhhhhh
Q 002069 850 FGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSNLNIA 923 (973)
Q Consensus 850 fg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~~ 923 (973)
||.++..... .......||+.|+|||++.+.+++.++||||+||++|||+||+.||........ .........
T Consensus 160 fg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 160 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 9999865443 334567899999999999999999999999999999999999999975432110 000000000
Q ss_pred -------hhhhcCCCCCCCc-hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 924 -------LDEMLDPRLPTPL-RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 924 -------~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
............. .........+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000101100 0111123456789999999999999999999863
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=366.57 Aligned_cols=262 Identities=19% Similarity=0.213 Sum_probs=196.2
Q ss_pred hcCCcccccccCCCceeEEEEE-cCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc----e
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAE-LPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL----H 774 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~ 774 (973)
..+|++++.||+|+||+||+|. ..+|+.||||++.... .....+.+.+|+.++++++||||+++++++.... .
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 4579999999999999999995 4689999999997543 2334678999999999999999999999986543 3
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.+++++|+.+|+|.++++.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 35666777899999999643 589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCC---cccccccccCcccccccc-cCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhh------hh----
Q 002069 855 FLKLGLS---NRTELAGTFGYIAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSS------NL---- 920 (973)
Q Consensus 855 ~~~~~~~---~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~------~~---- 920 (973)
....... ......||+.|+|||.+. +..++.++||||+||++|||++|+.||............ ..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 6644322 234467999999999985 456788999999999999999999999754321100000 00
Q ss_pred ------hhh-hhhhcCCCCCCCch-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 921 ------NIA-LDEMLDPRLPTPLR-NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 921 ------~~~-~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
... ...........++. ........+.+++.+|++.||.+|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00000011111111 011122357789999999999999999999873
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=366.41 Aligned_cols=259 Identities=21% Similarity=0.263 Sum_probs=194.6
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccc-----
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHAL----- 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 773 (973)
.++|++++.||+|+||+||+|.. .+|+.||||+++.... .....+.+.+|++++++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 46899999999999999999964 5799999999986543 3344678999999999999999999999997654
Q ss_pred -eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccc
Q 002069 774 -HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGI 852 (973)
Q Consensus 774 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~ 852 (973)
+.|+||||+ +.++..+.+. ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+|++|||.
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 569999999 5678777653 3589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhh---------------
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSL--------------- 916 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~--------------- 916 (973)
|+.... ..+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||..........
T Consensus 168 a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 168 ARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eeccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 987653 33456799999999998764 56899999999999999999999997543211100
Q ss_pred --hhhhhhhhhhhcCCCCCCCch-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 917 --SSNLNIALDEMLDPRLPTPLR-NVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 917 --~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
..................... ........+.+++.+||+.||.+|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000001111111111111 011123456789999999999999999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=358.42 Aligned_cols=262 Identities=19% Similarity=0.279 Sum_probs=206.1
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeeccceeEEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSHALHSFVVY 779 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 779 (973)
++|++++.||+|+||+||+|+. .+++.||||+++.... .....+.+.+|+.+++.++||||+++++++.++...++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 5799999999999999999965 5899999999976543 3344688999999999999999999999999999999999
Q ss_pred EecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccccccCC
Q 002069 780 EYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISKFLKLG 859 (973)
Q Consensus 780 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 859 (973)
|++.++++..+++.. ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.|+.....
T Consensus 81 ~~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 81 EFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp ECCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eeccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999998887654 3678999999999999999999999 9999999999999999999999999999988766
Q ss_pred CCcccccccccCcccccccccCC-CCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhh-------hhhhh---hhhhc
Q 002069 860 LSNRTELAGTFGYIAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSS-------NLNIA---LDEML 928 (973)
Q Consensus 860 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~-------~~~~~---~~~~~ 928 (973)
........+++.|+|||.+.+.. ++.++||||+||++|||++|+.||....+....... ..... .....
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 55556667889999999987665 689999999999999999999997422211110000 00000 00000
Q ss_pred C-------CCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 929 D-------PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 929 ~-------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
. +...............+.+++.+|++.||++||||+|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000001111122345778999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-41 Score=368.43 Aligned_cols=258 Identities=25% Similarity=0.299 Sum_probs=193.1
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec------cc
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH------AL 773 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~ 773 (973)
.+|+..++||+|+||+||+|+. .+|+.||||++..... .+.+|++++++++||||+++++++.. ..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 3688999999999999999965 4799999999975432 22369999999999999999999843 23
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC-ceEEecccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY-EAHVSDFGI 852 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-~~kl~Dfg~ 852 (973)
+.++||||++++....+.........+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccc
Confidence 4689999998765444433333345789999999999999999999999 999999999999999775 899999999
Q ss_pred cccccCCCCcccccccccCccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------hhhhhhhhhhh
Q 002069 853 SKFLKLGLSNRTELAGTFGYIAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------SLSSNLNIALD 925 (973)
Q Consensus 853 a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~~~~ 925 (973)
++..... .......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||........ ..+........
T Consensus 170 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 170 AKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CEECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred hhhccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 9877554 33445689999999998765 5689999999999999999999999975432111 00000001111
Q ss_pred ----hhcCCCCCC----Cc--hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 926 ----EMLDPRLPT----PL--RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 926 ----~~~~~~~~~----~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
...+..++. .+ .........+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111110 00 001112345778999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=359.79 Aligned_cols=263 Identities=21% Similarity=0.269 Sum_probs=195.2
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec-------
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH------- 771 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------- 771 (973)
.++|++++.||+|+||+||+|.. .+|+.||||++...... ....+++.+|+.++++++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 47899999999999999999965 58999999998654332 2235778899999999999999999998754
Q ss_pred -cceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecc
Q 002069 772 -ALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDF 850 (973)
Q Consensus 772 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Df 850 (973)
++..++||||++++.+..+... ...+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred cCceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 3467999999987776655432 24688999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCC----cccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh------hhhh
Q 002069 851 GISKFLKLGLS----NRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS------LSSN 919 (973)
Q Consensus 851 g~a~~~~~~~~----~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~------~~~~ 919 (973)
|+++.+..... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||......... ....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99987654321 22345799999999998765 6899999999999999999999999754321110 0000
Q ss_pred hhhhhh--------hhcCCCCCCCchhhH------HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 920 LNIALD--------EMLDPRLPTPLRNVQ------DKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 920 ~~~~~~--------~~~~~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
...... ..... ......... .....+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLEL-VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------C-CSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred Chhhccccchhhhhhhhcc-cccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000 00000 000000011 112356789999999999999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.2e-40 Score=353.44 Aligned_cols=257 Identities=18% Similarity=0.219 Sum_probs=198.9
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCC-CceeeeceeeeccceeEE
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRH-RNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~l 777 (973)
.++|++.+.||+|+||+||+|.+ .+|+.||||++...... ..+.+|++.++.++| +|++.+++++.+....++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 36799999999999999999965 47899999998654322 346678888888865 899999999999999999
Q ss_pred EEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC-----CCceEEecccc
Q 002069 778 VYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL-----EYEAHVSDFGI 852 (973)
Q Consensus 778 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~-----~~~~kl~Dfg~ 852 (973)
||||+ +++|.++++... ..+++.++..++.|++.|++|||+. +|+||||||+||+++. ++.+|++|||+
T Consensus 79 vme~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence 99998 689999886543 4689999999999999999999999 9999999999999974 57899999999
Q ss_pred cccccCCCC-------cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhh
Q 002069 853 SKFLKLGLS-------NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALD 925 (973)
Q Consensus 853 a~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 925 (973)
|+.+..... ......||+.|||||++.+..++.++|||||||++|||+||+.||.......... .......
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~--~~~~i~~ 230 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ--KYERIGE 230 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH--HHHHHHH
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH--HHHHHHh
Confidence 987754321 2334679999999999999999999999999999999999999997433211000 0000000
Q ss_pred hhcCCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 926 EMLDPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
....... .......+.++.+++..|++.+|++||+++.+.+.|+
T Consensus 231 ~~~~~~~---~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 231 KKQSTPL---RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp HHHHSCH---HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred ccCCCCh---HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 0000000 0000112245778889999999999999998877653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-40 Score=357.14 Aligned_cols=256 Identities=16% Similarity=0.205 Sum_probs=192.7
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeee-ceeeeccceeEEE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKF-YGFCSHALHSFVV 778 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~-~~~~~~~~~~~lv 778 (973)
++|++.+.||+|+||+||+|.+ .+|+.||||++..... .+++..|+++++.++|++++.. .+++.+.+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 5799999999999999999965 5789999999875432 2457789999999987765554 5555777888999
Q ss_pred EEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecC---CCceEEeccccccc
Q 002069 779 YEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNL---EYEAHVSDFGISKF 855 (973)
Q Consensus 779 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~---~~~~kl~Dfg~a~~ 855 (973)
|||++ +++.+.+.... ..+++..+..++.|++.|++|||++ +|+||||||+||+++. +..+|++|||+|+.
T Consensus 82 me~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 82 MELLG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EECCC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEcC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 99995 56666654332 4689999999999999999999999 9999999999998753 45799999999998
Q ss_pred ccCCCC-------cccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhc
Q 002069 856 LKLGLS-------NRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEML 928 (973)
Q Consensus 856 ~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 928 (973)
+..... ......||+.|||||.+.+..++.++|||||||++|||+||+.||........... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~--~~~~~~~~~ 233 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK--YERISEKKM 233 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---------HHHHHHHHH
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH--HHHhhcccC
Confidence 764322 22346799999999999999999999999999999999999999975432111000 000000000
Q ss_pred CCCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHhc
Q 002069 929 DPRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQLLK 972 (973)
Q Consensus 929 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 972 (973)
.... .......+.++.+++..||+.+|.+||+++++.+.|+
T Consensus 234 ~~~~---~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 274 (299)
T d1ckia_ 234 STPI---EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274 (299)
T ss_dssp HSCH---HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred CCCh---hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 0000 0000112345788999999999999999999887664
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=358.83 Aligned_cols=259 Identities=19% Similarity=0.249 Sum_probs=191.6
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec------cc
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH------AL 773 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~ 773 (973)
++|++.++||+|+||+||+|.+ .+|+.||||++...... .....++.+|+.++++++|||||++++++.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 6799999999999999999965 47999999999765433 3445779999999999999999999999853 36
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
+.|+||||+.++.+.. +. ..+++.+++.++.|++.|++|||+. ||+||||||+||+++.++.+|++|||.+
T Consensus 96 ~~~iv~Ey~~~~l~~~-~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQV-IQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHHH-HT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHHHh-hh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 7899999998665544 42 3578999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhhh-----------------h
Q 002069 854 KFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICSS-----------------L 916 (973)
Q Consensus 854 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~-----------------~ 916 (973)
+..... .......+|+.|+|||++.+..+++++||||+||++|||++|+.||......... .
T Consensus 167 ~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 167 RTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred hccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 866543 3344567899999999999999999999999999999999999999643311100 0
Q ss_pred hhhhhhhhhhh-----------cC-CCCCCCchhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 002069 917 SSNLNIALDEM-----------LD-PRLPTPLRNVQDKLISIMEVSISCLDESPTSRPTMQKVSQL 970 (973)
Q Consensus 917 ~~~~~~~~~~~-----------~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 970 (973)
........... .. ...+.........+..+.+++.+|++.||++||||+|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000000 00 00111112223456678899999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=365.08 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=200.0
Q ss_pred cCCcccccccCCCceeEEEEEc----CCCCEEEEEEcCCCCC-cchhhHHHHHHHHHHhhcCCC-Cceeeeceeeeccce
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL----PTGEIVAVKKFHSPLP-GEMACQQEFLNEGNALTKIRH-RNIVKFYGFCSHALH 774 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~ 774 (973)
++|++.+.||+|+||+||+|.. .+|+.||||+++.... ......+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999954 2588999999875321 112224678899999999966 899999999999999
Q ss_pred eEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 775 SFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 775 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
.++||||+.+|+|.+++.... .+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999986544 467889999999999999999999 99999999999999999999999999998
Q ss_pred cccCC-CCcccccccccCcccccccccC--CCCCccchHHHHHHHHHHHhCCCCCcchhhhhhhhhhhhhhhhhhhcCCC
Q 002069 855 FLKLG-LSNRTELAGTFGYIAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFISSICSSLSSNLNIALDEMLDPR 931 (973)
Q Consensus 855 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (973)
.+... ........|++.|+|||.+.+. .++.++||||+||++|||+||+.||........ ............
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-----~~~i~~~~~~~~ 252 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-----QAEISRRILKSE 252 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-----HHHHHHHHHHCC
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHhcccCC
Confidence 76433 2234456799999999998754 467899999999999999999999975432110 111111111111
Q ss_pred CCCCchhhHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 002069 932 LPTPLRNVQDKLISIMEVSISCLDESPTSRP-----TMQKVSQ 969 (973)
Q Consensus 932 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~ 969 (973)
.+.+ ...+..+.+++.+||++||++|| |++|+++
T Consensus 253 ~~~~----~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 PPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCc----ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1111 11234578899999999999999 4788876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.5e-39 Score=352.48 Aligned_cols=253 Identities=19% Similarity=0.237 Sum_probs=195.2
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeec--cceeE
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSH--ALHSF 776 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~ 776 (973)
++|++.++||+|+||+||+|+. .+|+.||||+++.. ..+++.+|++++++++ ||||+++++++.. ....+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 5799999999999999999965 58999999998642 1467889999999995 9999999999864 35689
Q ss_pred EEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC-ceEEeccccccc
Q 002069 777 VVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY-EAHVSDFGISKF 855 (973)
Q Consensus 777 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~-~~kl~Dfg~a~~ 855 (973)
+||||+++++|..+. +.+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+|++|||.|+.
T Consensus 109 ~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccccee
Confidence 999999999998764 3588999999999999999999999 999999999999998765 699999999987
Q ss_pred ccCCCCcccccccccCcccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcchhhhhh-------hhhhh-h------
Q 002069 856 LKLGLSNRTELAGTFGYIAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSICS-------SLSSN-L------ 920 (973)
Q Consensus 856 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-------~~~~~-~------ 920 (973)
.... .......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||........ ..+.. .
T Consensus 180 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 180 YHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp CCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred ccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 7654 234556789999999998765 478999999999999999999999864321110 00000 0
Q ss_pred -----hhhhhhhcCCCCCCCc------hhhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 921 -----NIALDEMLDPRLPTPL------RNVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 921 -----~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
................ ........++.+++.+|++.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000001110000000 011122345778999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-39 Score=356.51 Aligned_cols=259 Identities=20% Similarity=0.269 Sum_probs=195.6
Q ss_pred hcCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCceeeeceeeec-----cc
Q 002069 700 TKNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNIVKFYGFCSH-----AL 773 (973)
Q Consensus 700 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~ 773 (973)
.++|++.+.||+|+||+||+|.. .+|+.||||++...... ....+.+.+|++++++++|||+|++++++.. ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 46799999999999999999964 58999999999865433 3345778999999999999999999999853 23
Q ss_pred eeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEEeccccc
Q 002069 774 HSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHVSDFGIS 853 (973)
Q Consensus 774 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a 853 (973)
..++||+|+.+|+|.++++.. .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+|++|||.+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 456778888999999999643 589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCcccccccccCC-CCCccchHHHHHHHHHHHhCCCCCcchhhhhhh------hhhh-------
Q 002069 854 KFLKLGLSNRTELAGTFGYIAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSICSS------LSSN------- 919 (973)
Q Consensus 854 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~------~~~~------- 919 (973)
..... ......|++.|+|||...+.. ++.++||||+||++|+|++|+.||......... ....
T Consensus 169 ~~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 169 RHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp -CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 76542 334567999999999877654 688999999999999999999999754321100 0000
Q ss_pred -hhhhhhhhcC--CCCC-CCch-hhHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 002069 920 -LNIALDEMLD--PRLP-TPLR-NVQDKLISIMEVSISCLDESPTSRPTMQKVSQ 969 (973)
Q Consensus 920 -~~~~~~~~~~--~~~~-~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 969 (973)
.......... +..+ .... ........+.+++.+|++.||.+|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000000000 0111 0000 00112345778999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.5e-35 Score=324.51 Aligned_cols=261 Identities=19% Similarity=0.212 Sum_probs=189.1
Q ss_pred cCCcccccccCCCceeEEEEEc-CCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-----------CCceeeecee
Q 002069 701 KNFDDEHCIGNGGQGSVYKAEL-PTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-----------HRNIVKFYGF 768 (973)
Q Consensus 701 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~ 768 (973)
.+|+++++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.+++.++ |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 3599999999999999999965 58999999999743 223466778888887764 5789999998
Q ss_pred eecc--ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCC---
Q 002069 769 CSHA--LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEY--- 843 (973)
Q Consensus 769 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~--- 843 (973)
+... ...+++|+++..+..............+++..+..++.||+.|++|||+.. +|+||||||+||+++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCccc
Confidence 8643 455677777665544333333334457889999999999999999999832 899999999999998765
Q ss_pred ---ceEEecccccccccCCCCcccccccccCcccccccccCCCCCccchHHHHHHHHHHHhCCCCCcchhhhhh------
Q 002069 844 ---EAHVSDFGISKFLKLGLSNRTELAGTFGYIAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSICS------ 914 (973)
Q Consensus 844 ---~~kl~Dfg~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------ 914 (973)
.++++|||.|..... ......||+.|+|||++.+..++.++||||+||+++||++|+.||...+....
T Consensus 167 ~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp TEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ccceeeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 399999999986543 33456799999999999999999999999999999999999999974321100
Q ss_pred ------hhhhhhhhhh------hhhcC-----CCCCC------------CchhhHHHHHHHHHHHhcccCCCCCCCCCHH
Q 002069 915 ------SLSSNLNIAL------DEMLD-----PRLPT------------PLRNVQDKLISIMEVSISCLDESPTSRPTMQ 965 (973)
Q Consensus 915 ------~~~~~~~~~~------~~~~~-----~~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 965 (973)
..+....... ....+ ..+.. ...........+.+++.+|++.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 0000000000 00000 00000 0011234566788999999999999999999
Q ss_pred HHHHH
Q 002069 966 KVSQL 970 (973)
Q Consensus 966 ev~~~ 970 (973)
|++++
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99874
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=3.6e-29 Score=280.10 Aligned_cols=356 Identities=28% Similarity=0.337 Sum_probs=229.2
Q ss_pred eCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCc
Q 002069 6 GLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLS 85 (973)
Q Consensus 6 ~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~ 85 (973)
+++.+++++.++. ..+.+|++|++++|+|+.. +.+..|++|++|+|++|+|+ .+|+ |+++++|++|++++|+++
T Consensus 28 ~l~~~~~~~~~~~--~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~-~l~~-l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEECH--HHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccCH--HHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCC-CCcc-ccCCcccccccccccccc
Confidence 3455555544332 3566777777777777743 35777777777777777777 4443 777777777777777776
Q ss_pred ccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCcccc
Q 002069 86 GSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLG 165 (973)
Q Consensus 86 ~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~ 165 (973)
+ ++ .++.+++|+.|++++|.+++. + .......+..+....|.+....+................. ....+.
T Consensus 102 ~-i~-~l~~l~~L~~L~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 172 (384)
T d2omza2 102 D-IT-PLANLTNLTGLTLFNNQITDI-D-PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT-----DLKPLA 172 (384)
T ss_dssp C-CG-GGTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCC-----CCGGGT
T ss_pred c-cc-ccccccccccccccccccccc-c-cccccccccccccccccccccccccccccccccccccccc-----hhhhhc
Confidence 3 33 367777777777777777633 2 2344556666777666665333222222222111111111 112333
Q ss_pred CccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccce
Q 002069 166 NLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLAL 245 (973)
Q Consensus 166 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 245 (973)
..+.........|... .+..+..+++++.+++++|.++++.+ +..+++|+.|++++|.++.+ ..+..+++|+.|
T Consensus 173 ~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 246 (384)
T d2omza2 173 NLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDL 246 (384)
T ss_dssp TCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred cccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchh
Confidence 4444444444444443 34455666677777777777665443 44556677777777766653 356666666666
Q ss_pred ecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccC
Q 002069 246 QLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALS 325 (973)
Q Consensus 246 ~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 325 (973)
++++|.+++.. .+..+++|++|++++|++++.. .+..++.++.++++.|.++
T Consensus 247 ~l~~n~l~~~~--------------------------~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~ 298 (384)
T d2omza2 247 DLANNQISNLA--------------------------PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLE 298 (384)
T ss_dssp ECCSSCCCCCG--------------------------GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCS
T ss_pred ccccCccCCCC--------------------------cccccccCCEeeccCcccCCCC--ccccccccccccccccccc
Confidence 66666665322 2556677788888888877543 3667778888888888887
Q ss_pred CCCCccccCCCCCCcEEcCCCCCCCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcccC
Q 002069 326 GSIPNEITNLRSLSDLQLSENTLNGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIG 405 (973)
Q Consensus 326 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 405 (973)
+ +..+..+++++.|++++|++++.. .+..+++|++|++++|+|++ ++ .|.++++|++|++++|+|++..| +.
T Consensus 299 ~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~ 370 (384)
T d2omza2 299 D--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LA 370 (384)
T ss_dssp C--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GT
T ss_pred c--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hc
Confidence 4 235777888888888888888653 37778888888888888874 33 57888888888888888877543 78
Q ss_pred CCCCCCEEEccCC
Q 002069 406 DMKSLSILDLSSN 418 (973)
Q Consensus 406 ~l~~L~~L~Ls~N 418 (973)
++++|+.|+|++|
T Consensus 371 ~l~~L~~L~L~~N 383 (384)
T d2omza2 371 NLTRITQLGLNDQ 383 (384)
T ss_dssp TCTTCSEEECCCE
T ss_pred cCCCCCEeeCCCC
Confidence 8888888888887
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=6.1e-29 Score=278.26 Aligned_cols=357 Identities=29% Similarity=0.387 Sum_probs=249.9
Q ss_pred EECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcC
Q 002069 29 LSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSL 108 (973)
Q Consensus 29 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l 108 (973)
..+..+.+++.++ ...+.+|++|++++|.|+ .+ +.++.+++|++|+|++|+++ .+| .++++++|++|++++|++
T Consensus 27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~-~l~-~l~~L~~L~~L~L~~n~i 100 (384)
T d2omza2 27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLT-DIT-PLKNLTKLVDILMNNNQI 100 (384)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCC-CC-TTGGGCTTCCEEECCSSCCC-CCG-GGTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccC--HHHhCCCCEEECCCCCCC-Cc-cccccCCCCCEEeCcCCcCC-CCc-cccCCccccccccccccc
Confidence 3566666665433 356777888888888887 44 35777888888888888887 444 377788888888888888
Q ss_pred CCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccc
Q 002069 109 NGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEI 188 (973)
Q Consensus 109 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~ 188 (973)
++ ++ .++++++|+.|++++|.+++.. .......+..+....|.+....+................. ....+
T Consensus 101 ~~-i~-~l~~l~~L~~L~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 171 (384)
T d2omza2 101 AD-IT-PLANLTNLTGLTLFNNQITDID--PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT-----DLKPL 171 (384)
T ss_dssp CC-CG-GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCC-----CCGGG
T ss_pred cc-cc-cccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccc-----hhhhh
Confidence 74 33 3777788888888877776322 2344556666666666665333322222222222221111 12233
Q ss_pred cccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcchhhh
Q 002069 189 GNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVI 268 (973)
Q Consensus 189 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 268 (973)
...+.........|.... ...+..+++++.+++++|.++++.| +...++|+.|++++|.++
T Consensus 172 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~--------------- 232 (384)
T d2omza2 172 ANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK--------------- 232 (384)
T ss_dssp TTCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC---------------
T ss_pred cccccccccccccccccc--ccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCC---------------
Confidence 444444555555554432 3345566667777777776665532 445566666666666654
Q ss_pred ccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhcCCccceeeccccccCCCCCccccCCCCCCcEEcCCCCC
Q 002069 269 SCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGSLTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTL 348 (973)
Q Consensus 269 l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 348 (973)
.. +.+..+++|+.|++++|.+++.. .++.+++|++|++++|.+++.. .+..++.++.+.+++|.+
T Consensus 233 ---------~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l 297 (384)
T d2omza2 233 ---------DI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQL 297 (384)
T ss_dssp ---------CC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCC
T ss_pred ---------Cc--chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCC--cccccccccccccccccc
Confidence 22 24667889999999999998654 3888999999999999998543 488899999999999999
Q ss_pred CCcchhccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCCCCEEEccCCCCCCCcchhh
Q 002069 349 NGSIPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGSIPLSL 428 (973)
Q Consensus 349 ~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 428 (973)
++. ..+..+++++.|++++|++++.. .+..+++|++|++++|+|++. ..+.++++|++|++++|++++..| +
T Consensus 298 ~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l--~~l~~l~~L~~L~l~~N~l~~l~~--l 369 (384)
T d2omza2 298 EDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP--L 369 (384)
T ss_dssp SCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCBCGG--G
T ss_pred ccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCC--hhHcCCCCCCEEECCCCcCCCChh--h
Confidence 864 35788999999999999999754 388999999999999999863 368999999999999999995443 5
Q ss_pred hhhcccceEEEeeCc
Q 002069 429 ANLTNSLKVLYLSSN 443 (973)
Q Consensus 429 ~~~~~~L~~L~L~~n 443 (973)
.++. +|++|+|++|
T Consensus 370 ~~l~-~L~~L~L~~N 383 (384)
T d2omza2 370 ANLT-RITQLGLNDQ 383 (384)
T ss_dssp TTCT-TCSEEECCCE
T ss_pred ccCC-CCCEeeCCCC
Confidence 6654 8999999998
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=2.1e-30 Score=281.10 Aligned_cols=249 Identities=33% Similarity=0.496 Sum_probs=180.7
Q ss_pred CCCCEEECCCCcccc--cCCcCccCCCCCCeeeccC-CcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccce
Q 002069 24 THLKLLSFSKNQLSG--LIPHEIGRLSSLNGLSLYS-NFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSD 100 (973)
Q Consensus 24 ~~L~~L~l~~n~l~~--~~p~~~~~l~~L~~L~l~~-n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 100 (973)
.++++|||++|.+++ .+|++|++|++|++|+|++ |++.|.+|++|++|++|++|+|++|++++..|..+..+.+|++
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 357777777777766 3677777777777777775 6677777777777777777777777777666777777777777
Q ss_pred eeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCC-CceecccCCCCCCCCccccCccccceeeecccc
Q 002069 101 LRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFL-SDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINA 179 (973)
Q Consensus 101 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~ 179 (973)
+++++|++.+.+|..++++++|+++++++|.+++.+|+.+..+..+ +.+++++|++++..|..+..+..+ .++++.+.
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~ 208 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSE
T ss_pred cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 7777777777777777777777777777777777777777777665 667777777776667666666544 57777777
Q ss_pred cCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcc
Q 002069 180 LSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCS 259 (973)
Q Consensus 180 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 259 (973)
..+.+|..+..+++|+.+++++|.+.+.. ..++.+++|+.|+|++|++++..|..|+++++|++|+|++|++++.+| .
T Consensus 209 ~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP-~ 286 (313)
T d1ogqa_ 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-Q 286 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC-C
T ss_pred ccccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC-C
Confidence 77777777777777777777777776543 356777777777777777776667777777777777777777776666 3
Q ss_pred cCCcchhhhccCCCcc
Q 002069 260 FGNLTKLVISCLGTNA 275 (973)
Q Consensus 260 ~~~l~~L~~l~l~~n~ 275 (973)
++++++|+.+.+.+|+
T Consensus 287 ~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 287 GGNLQRFDVSAYANNK 302 (313)
T ss_dssp STTGGGSCGGGTCSSS
T ss_pred cccCCCCCHHHhCCCc
Confidence 5677777777777775
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=8.3e-30 Score=276.34 Aligned_cols=247 Identities=29% Similarity=0.467 Sum_probs=184.9
Q ss_pred CcEEeCCCCCCCC--CCCcccCCCCCCCEEECCC-CcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEE
Q 002069 2 LKVLGLSFNQFSG--SIPPEIGHLTHLKLLSFSK-NQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYID 78 (973)
Q Consensus 2 l~~L~l~~~~l~~--~~p~~~~~l~~L~~L~l~~-n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~ 78 (973)
++.|||++++++| .+|+++++|++|++|+|++ |+++|.+|.+|++|++|++|+|++|++.+..|..+..+.+|++++
T Consensus 52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~ 131 (313)
T d1ogqa_ 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccc
Confidence 4667777777776 4677777777777777775 677777777777777777777777777766777777777777777
Q ss_pred ccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCcc-ceeecccccccccCcccccccCCCCceecccCCCC
Q 002069 79 IGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNL-VTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLS 157 (973)
Q Consensus 79 l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~ 157 (973)
+++|.+.+.+|..++++++|+++++++|.+.+.+|..++.+.++ +.+++++|++++..|..++++..+ .++++.+...
T Consensus 132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~ 210 (313)
T d1ogqa_ 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE 210 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE
T ss_pred cccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence 77777777777777777777777777777777777777777665 677777777777777777766554 5777777777
Q ss_pred CCCCccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCcccc
Q 002069 158 GAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIG 237 (973)
Q Consensus 158 ~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~ 237 (973)
+.+|..+..+++|+.+++++|.+.+.+ ..++.+++|+.|+|++|++++..|..|+++++|++|+|++|++++.+| .++
T Consensus 211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP-~~~ 288 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGG 288 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC-CST
T ss_pred ccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC-Ccc
Confidence 777777777777777777777777543 357777777777777777777777777777777777777777776555 356
Q ss_pred ccccccceeccccc
Q 002069 238 NLKSLLALQLNYNT 251 (973)
Q Consensus 238 ~l~~L~~L~L~~N~ 251 (973)
++++|+.+++++|+
T Consensus 289 ~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 289 NLQRFDVSAYANNK 302 (313)
T ss_dssp TGGGSCGGGTCSSS
T ss_pred cCCCCCHHHhCCCc
Confidence 77777777777776
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=7.2e-27 Score=252.01 Aligned_cols=282 Identities=21% Similarity=0.287 Sum_probs=202.9
Q ss_pred cEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCC
Q 002069 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNN 82 (973)
Q Consensus 3 ~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n 82 (973)
+.+|=++++++ .+|+.+. +++++|+|++|+|+...+..|..+++|++|++++|++....|..|.++++|++|++++|
T Consensus 13 ~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 13 RVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp TEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 56677777887 7888764 67888888888888655557888888888888888888666777888888888888888
Q ss_pred cCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeeccccccc--ccCcccccccCCCCceecccCCCCCCC
Q 002069 83 LLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALS--GSIPDEIGNLKFLSDLQVSYNTLSGAI 160 (973)
Q Consensus 83 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~--~~~p~~~~~l~~L~~L~l~~N~l~~~~ 160 (973)
+++ .+|..+. ..++.|++++|.+.+..+..+.....++.++...|... ...+..|..+++|+.+++++|.++ .+
T Consensus 90 ~l~-~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l 165 (305)
T d1xkua_ 90 QLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TI 165 (305)
T ss_dssp CCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SC
T ss_pred ccC-cCccchh--hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-cc
Confidence 887 5665543 47888888888887554555666777777887777543 334566777888888888888877 34
Q ss_pred CccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccc
Q 002069 161 PFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLK 240 (973)
Q Consensus 161 p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~ 240 (973)
|..+ +++|+.|++++|..+...+..+.+++.+++|++++|.++++.+..|.++++|++|+|++|+|+.+ |.+|..++
T Consensus 166 ~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~l-p~~l~~l~ 242 (305)
T d1xkua_ 166 PQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHK 242 (305)
T ss_dssp CSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSC-CTTTTTCS
T ss_pred Cccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccccc-cccccccc
Confidence 4432 56778888888887777777777888888888888888877777777888888888888888765 56777788
Q ss_pred cccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEccccccc--CCcCchhhcCC
Q 002069 241 SLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLS--GSIPLSLGSLT 312 (973)
Q Consensus 241 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~--~~~~~~~~~l~ 312 (973)
+|++|+|++|+|+.+...+|... .....+.+|+.|++++|.++ ...|.+|..+.
T Consensus 243 ~L~~L~Ls~N~i~~i~~~~f~~~------------------~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~ 298 (305)
T d1xkua_ 243 YIQVVYLHNNNISAIGSNDFCPP------------------GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 298 (305)
T ss_dssp SCCEEECCSSCCCCCCTTSSSCS------------------SCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCC
T ss_pred CCCEEECCCCccCccChhhccCc------------------chhcccCCCCEEECCCCcCccCcCCHhHhcccc
Confidence 88888888888776655555432 12234456667777777654 23444444433
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=1.2e-25 Score=242.48 Aligned_cols=267 Identities=21% Similarity=0.254 Sum_probs=148.4
Q ss_pred CCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecc
Q 002069 73 SLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVS 152 (973)
Q Consensus 73 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~ 152 (973)
.++.+|.+++.++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.++...|..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 4677788888887 6777664 478888888888874333467788888888888888776667777777777777777
Q ss_pred cCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeecccccccc--ccccccCCCCcccEEecCCcccCC
Q 002069 153 YNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSG--SILYSFGNLTKLEILYLDVNALSG 230 (973)
Q Consensus 153 ~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~n~i~~ 230 (973)
+|+++ .+|..+ ...++.|++..|.+....+..+.....++.++...|.... .....|..+++|+.+++++|.++.
T Consensus 88 ~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~ 164 (305)
T d1xkua_ 88 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 164 (305)
T ss_dssp SSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc
Confidence 77776 333322 2355566666666654444444455555555555543321 223344444555555555554443
Q ss_pred CCCccccccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhhc
Q 002069 231 LIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLGS 310 (973)
Q Consensus 231 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 310 (973)
+... + .++|+.|++++|.++. ..+..|.+++.++.|++++|.+++..+..+.+
T Consensus 165 l~~~-~--~~~L~~L~l~~n~~~~------------------------~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~ 217 (305)
T d1xkua_ 165 IPQG-L--PPSLTELHLDGNKITK------------------------VDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 217 (305)
T ss_dssp CCSS-C--CTTCSEEECTTSCCCE------------------------ECTGGGTTCTTCCEEECCSSCCCEECTTTGGG
T ss_pred cCcc-c--CCccCEEECCCCcCCC------------------------CChhHhhccccccccccccccccccccccccc
Confidence 3111 1 2334444444444332 22333444445555555555555544555555
Q ss_pred CCccceeeccccccCCCCCccccCCCCCCcEEcCCCCCCCcchhcc------CCCCCCcEEEccCCccc
Q 002069 311 LTNLATLYFSTNALSGSIPNEITNLRSLSDLQLSENTLNGSIPLAL------GNLTKLVSLDLSINKLS 373 (973)
Q Consensus 311 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~------~~l~~L~~L~Ls~N~i~ 373 (973)
+++|++|+|++|+|+ .+|..|.++++|++|+|++|+|+.+....| ..+.+|+.|+|++|.+.
T Consensus 218 l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 218 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp STTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred cccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 555555555555554 334455555555555555555554332222 23445555555555543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.3e-25 Score=239.10 Aligned_cols=252 Identities=22% Similarity=0.192 Sum_probs=160.7
Q ss_pred EeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEcc-CCc
Q 002069 5 LGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIG-NNL 83 (973)
Q Consensus 5 L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~-~n~ 83 (973)
.+.++++++ .+|..+. +++++|+|++|+|++..|..|..+++|++|++++|++....+..+..+..+++++.. .|.
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 456666666 6666554 456777777777775555567777777777777777776566666666777776654 445
Q ss_pred CcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCcc
Q 002069 84 LSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFS 163 (973)
Q Consensus 84 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 163 (973)
++...|..+.++++|++|++++|.+....+..+..+++|+.+++++|.++++.+..|..+++|+.|++++|++++..+..
T Consensus 93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~ 172 (284)
T d1ozna_ 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred cccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhh
Confidence 55444566667777777777777766555556666677777777777776555566666777777777777776666666
Q ss_pred ccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCcccccccccc
Q 002069 164 LGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLL 243 (973)
Q Consensus 164 l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 243 (973)
|.++++|+.+++++|++++..|..|.++++|++|++++|++.++++..|+++++|+.|++++|.+....+ .-.-...++
T Consensus 173 f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~ 251 (284)
T d1ozna_ 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQ 251 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHHH
T ss_pred hccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHHHHH
Confidence 6677777777777777766666666767777777777777766666666666777777777766654322 111112344
Q ss_pred ceecccccccCCCCccc
Q 002069 244 ALQLNYNTLSGSIPCSF 260 (973)
Q Consensus 244 ~L~L~~N~l~~~~~~~~ 260 (973)
.+....+++....|..+
T Consensus 252 ~~~~~~~~~~C~~p~~l 268 (284)
T d1ozna_ 252 KFRGSSSEVPCSLPQRL 268 (284)
T ss_dssp HCCSEECCCBEEESGGG
T ss_pred hCcCCCCceEeCCchHH
Confidence 55555555544444433
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=6.2e-25 Score=233.79 Aligned_cols=225 Identities=26% Similarity=0.254 Sum_probs=194.8
Q ss_pred CEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeecc-C
Q 002069 27 KLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLS-N 105 (973)
Q Consensus 27 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~-~ 105 (973)
..++.++++++ .+|..+. +++++|+|++|+|++..|.+|.++++|++|++++|++....+..+..+..++.++.. .
T Consensus 14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 45678888888 6787665 678999999999985555679999999999999999987777778888888888765 5
Q ss_pred CcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCC
Q 002069 106 NSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIP 185 (973)
Q Consensus 106 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p 185 (973)
|.++...|..|.++++|++|++++|.+....+..+....+|+.+++++|+++++.+..|..+++|+.|++++|+++...+
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~ 170 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence 66776667889999999999999999987777788889999999999999997778889899999999999999997778
Q ss_pred ccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccC
Q 002069 186 NEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSG 254 (973)
Q Consensus 186 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 254 (973)
..|.++++|+++++++|+++++.+..|.++++|++|++++|++.++.+..|.++++|++|++++|++..
T Consensus 171 ~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred hhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence 888999999999999999998888999999999999999999999888889999999999999998864
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.4e-23 Score=220.48 Aligned_cols=202 Identities=23% Similarity=0.220 Sum_probs=132.4
Q ss_pred CCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCcccccee
Q 002069 22 HLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDL 101 (973)
Q Consensus 22 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L 101 (973)
..+.+.+.|.++++++ .+|+.|. ++|++|+|++|+|++..+.+|.++++|++|+|++|+++ .+| .++.+++|++|
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L 82 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTL 82 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEE
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccc
Confidence 3444555666666666 3565553 45666666666666433355666667777777777666 344 34566677777
Q ss_pred eccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccC
Q 002069 102 RLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALS 181 (973)
Q Consensus 102 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~ 181 (973)
+|++|+++ ..|..+.++++|++|++++|.+....+..+..+.++++|++++|.++...+..+..+++|+.|++++|+++
T Consensus 83 ~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred cccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence 77777766 45566666777777777777666555666667777777777777776666666667777777777777777
Q ss_pred CCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCC
Q 002069 182 GSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSG 230 (973)
Q Consensus 182 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~ 230 (973)
+..+..|..+++|++|+|++|+|+.+ +..+..+++|+.|+|++|.+..
T Consensus 162 ~~~~~~~~~l~~L~~L~Ls~N~L~~l-p~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 162 ELPAGLLNGLENLDTLLLQENSLYTI-PKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCC-CTTTTTTCCCSEEECCSCCBCC
T ss_pred ccCccccccccccceeecccCCCccc-ChhHCCCCCCCEEEecCCCCCC
Confidence 66666677777777777777777744 3345567777777777776654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=3.2e-23 Score=217.85 Aligned_cols=202 Identities=26% Similarity=0.250 Sum_probs=177.9
Q ss_pred cCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccce
Q 002069 45 GRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVT 124 (973)
Q Consensus 45 ~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 124 (973)
.+..++.+.+.++++++ .+|+.+. ++|++|+|++|++++..+..|.++++|++|+|++|+|+ .+| .++.+++|++
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCE
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccc
Confidence 45567778899999999 7898775 58999999999999655578999999999999999998 555 4678999999
Q ss_pred eecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeecccccc
Q 002069 125 LYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTL 204 (973)
Q Consensus 125 L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 204 (973)
|+|++|+++ ..+..+.++++|+.|++++|.+.+..+..+..+.+++.|++++|.++...+..+..+++|+.+++++|++
T Consensus 82 L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred ccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence 999999998 5788899999999999999999988888899999999999999999977777888899999999999999
Q ss_pred ccccccccCCCCcccEEecCCcccCCCCCccccccccccceeccccccc
Q 002069 205 SGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLS 253 (973)
Q Consensus 205 ~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (973)
+++++..|..+++|++|+|++|+|+.+ |..+..+++|+.|+|++|.+.
T Consensus 161 ~~~~~~~~~~l~~L~~L~Ls~N~L~~l-p~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDTLLLQENSLYTI-PKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCCCC-CTTTTTTCCCSEEECCSCCBC
T ss_pred cccCccccccccccceeecccCCCccc-ChhHCCCCCCCEEEecCCCCC
Confidence 999999999999999999999999965 667778899999999999875
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.87 E-value=2.3e-20 Score=204.98 Aligned_cols=198 Identities=29% Similarity=0.310 Sum_probs=92.6
Q ss_pred CCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccC
Q 002069 26 LKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSN 105 (973)
Q Consensus 26 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~ 105 (973)
+++|||++|+++ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .+++. .+.|++|++++
T Consensus 40 l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~ 107 (353)
T d1jl5a_ 40 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSN 107 (353)
T ss_dssp CSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCS
T ss_pred CCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccccc
Confidence 455555555554 34432 234555555555555 445432 34555555555554 33321 12355555555
Q ss_pred CcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCC
Q 002069 106 NSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIP 185 (973)
Q Consensus 106 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p 185 (973)
|+++ .+|. ++.+++|++|++++|.++ ..|.. ...+..+.+..+... .+..+..++.++.|+++.|.+. ..+
T Consensus 108 n~l~-~lp~-~~~l~~L~~L~l~~~~~~-~~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~-~~~ 178 (353)
T d1jl5a_ 108 NQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK-KLP 178 (353)
T ss_dssp SCCS-SCCC-CTTCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS-SCC
T ss_pred cccc-cccc-hhhhccceeecccccccc-ccccc---cccccchhhcccccc--ccccccccccceeccccccccc-ccc
Confidence 5555 3443 345555555555555554 22222 233334444443332 2234455555566666655554 222
Q ss_pred ccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceeccccccc
Q 002069 186 NEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLS 253 (973)
Q Consensus 186 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (973)
... ...+.+....+.+..+ ..+..++.|+.+++++|..... +. ...++..+++.++.+.
T Consensus 179 ~~~---~~~~~l~~~~~~~~~~--~~~~~l~~L~~l~l~~n~~~~~-~~---~~~~l~~~~~~~~~~~ 237 (353)
T d1jl5a_ 179 DLP---LSLESIVAGNNILEEL--PELQNLPFLTTIYADNNLLKTL-PD---LPPSLEALNVRDNYLT 237 (353)
T ss_dssp CCC---TTCCEEECCSSCCSSC--CCCTTCTTCCEEECCSSCCSSC-CS---CCTTCCEEECCSSCCS
T ss_pred ccc---cccccccccccccccc--cccccccccccccccccccccc-cc---cccccccccccccccc
Confidence 211 2233444444444422 2345566666666666665543 22 2334555555555554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=2.9e-22 Score=198.72 Aligned_cols=167 Identities=17% Similarity=0.114 Sum_probs=122.6
Q ss_pred CcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCc---------------chhhHHHHHHHHHHhhcCCCCceeeece
Q 002069 703 FDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPG---------------EMACQQEFLNEGNALTKIRHRNIVKFYG 767 (973)
Q Consensus 703 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~e~~~l~~l~h~niv~~~~ 767 (973)
+.+.++||+|+||+||+|...+|+.||||+++..... .......+..|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3467899999999999998788999999987532111 0112344567888899999999998876
Q ss_pred eeeccceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeecCCCCCeeecCCCceEE
Q 002069 768 FCSHALHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNCFPPIVHRDISSKNVLLNLEYEAHV 847 (973)
Q Consensus 768 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk~~Nill~~~~~~kl 847 (973)
+.. .++||||+++....+ ++......++.|++.|++|||+. +|+||||||+||+++++ .+++
T Consensus 82 ~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred ecC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 642 379999998765432 33455678999999999999999 99999999999999965 5899
Q ss_pred ecccccccccCCCCcccccccccCccc------ccccccCCCCCccchHHHHHHH
Q 002069 848 SDFGISKFLKLGLSNRTELAGTFGYIA------PELAYTMKVTEKCDVYSFGVLA 896 (973)
Q Consensus 848 ~Dfg~a~~~~~~~~~~~~~~g~~~y~a------PE~~~~~~~~~~~Dv~slG~~l 896 (973)
+|||.|+........ .|.. .+ +..+.|..++|+||..--+
T Consensus 144 iDFG~a~~~~~~~~~--------~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR--------EILERDVRNIIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH--------HHHHHHHHHHHH-HHHHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH--------HHHHHHHHHHHH-HHcCCCCCcccHHHHHHHH
Confidence 999999765432111 1111 11 1245678899999976443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.85 E-value=6.4e-20 Score=201.43 Aligned_cols=198 Identities=30% Similarity=0.340 Sum_probs=94.2
Q ss_pred CcEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccC
Q 002069 2 LKVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGN 81 (973)
Q Consensus 2 l~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~ 81 (973)
+++|||++++++ .+|+. +++|++|+|++|+|+ .+|+. +.+|+.|++++|+++ .++. + .+.|++|++++
T Consensus 40 l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~ 107 (353)
T d1jl5a_ 40 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSN 107 (353)
T ss_dssp CSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-C--CTTCCEEECCS
T ss_pred CCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-h--ccccccccccc
Confidence 345566666655 45542 345555566666655 34543 234555555555555 3332 1 12455666666
Q ss_pred CcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCC
Q 002069 82 NLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIP 161 (973)
Q Consensus 82 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 161 (973)
|.++ .+|. ++.+++|++|++++|.+. ..|... ..+..+.+..+... .+..++.++.++.|++++|.+.. .+
T Consensus 108 n~l~-~lp~-~~~l~~L~~L~l~~~~~~-~~~~~~---~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~-~~ 178 (353)
T d1jl5a_ 108 NQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKK-LP 178 (353)
T ss_dssp SCCS-SCCC-CTTCTTCCEEECCSSCCS-CCCCCC---TTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSS-CC
T ss_pred cccc-cccc-hhhhccceeecccccccc-cccccc---ccccchhhcccccc--ccccccccccceecccccccccc-cc
Confidence 6555 4442 345555666666555555 233322 33444444444332 23445555555555555555542 12
Q ss_pred ccccCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccC
Q 002069 162 FSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALS 229 (973)
Q Consensus 162 ~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~ 229 (973)
.. ....+.+....+.+. .+| .+..++.|+.+++++|....+. ....++..+.+..+.+.
T Consensus 179 ~~---~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~~~----~~~~~l~~~~~~~~~~~ 237 (353)
T d1jl5a_ 179 DL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLP----DLPPSLEALNVRDNYLT 237 (353)
T ss_dssp CC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCC----SCCTTCCEEECCSSCCS
T ss_pred cc---ccccccccccccccc-ccc-cccccccccccccccccccccc----ccccccccccccccccc
Confidence 11 122233444444333 222 2345555566666555544321 22344555555555554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=9.1e-23 Score=233.24 Aligned_cols=395 Identities=22% Similarity=0.148 Sum_probs=221.8
Q ss_pred cccceeeecccccCCCC-CccccccCccceeecccccccccc----ccccCCCCcccEEecCCcccCCCCC----cccc-
Q 002069 168 TNLVTLYIGINALSGSI-PNEIGNLKSLSDLRLDYNTLSGSI----LYSFGNLTKLEILYLDVNALSGLIP----NEIG- 237 (973)
Q Consensus 168 ~~L~~L~l~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~n~i~~~~~----~~~~- 237 (973)
.+|+.|+++.|++++.. .+.+..++++++|+|++|.++... ...+..+++|++|+|++|.|+.... ..+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 36788888888887421 234566778888888888776432 2345667788888888887753211 1111
Q ss_pred ccccccceecccccccCCCCcccCCcchhhhccCCCcccCchhhhhhccccccceEEcccccccCCcCchhh-----cCC
Q 002069 238 NLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCLGTNALSSSILEEIGNLKSLLHLQLNYNTLSGSIPLSLG-----SLT 312 (973)
Q Consensus 238 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-----~l~ 312 (973)
...+|+.|+|++|+++.... ......+..+++|++|++++|.++......+. ...
T Consensus 82 ~~~~L~~L~L~~n~it~~~~--------------------~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~ 141 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGC--------------------GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQC 141 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGH--------------------HHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred CCCCCCEEECCCCCcccccc--------------------ccccchhhccccccccccccccchhhhhhhhhhccccccc
Confidence 12357777777776653211 01233455566667777776666532222221 111
Q ss_pred ccceeeccccccCCC----CCccccCCCCCCcEEcCCCCCCCcchh----cc-CCCCCCcEEEccCCcccCCCC----cc
Q 002069 313 NLATLYFSTNALSGS----IPNEITNLRSLSDLQLSENTLNGSIPL----AL-GNLTKLVSLDLSINKLSGSIP----LS 379 (973)
Q Consensus 313 ~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~----~~-~~l~~L~~L~Ls~N~i~~~~~----~~ 379 (973)
...........+... ....+.....++.++++.+.+...... .+ ........+++..+.+..... ..
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 221 (460)
T d1z7xw1 142 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 221 (460)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred ccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhccccc
Confidence 122222222222210 011223345667777776665422111 11 122345667777766553211 22
Q ss_pred cccccccchhccccccccc-----CCCcccCCCCCCCEEEccCCCCCCCcchhhhh---hcccceEEEeeCcccccccCC
Q 002069 380 FASLTSLTTLYLYENSLCD-----SIPKEIGDMKSLSILDLSSNKLNGSIPLSLAN---LTNSLKVLYLSSNHIVGEIPL 451 (973)
Q Consensus 380 ~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~---~~~~L~~L~L~~n~l~~~~~~ 451 (973)
+...+.++.+++++|++.. .....+.....++.+++++|.+.......+.. ..+.++.+++++|.++.....
T Consensus 222 l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~ 301 (460)
T d1z7xw1 222 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 301 (460)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred ccccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 3345667777777776532 12333445677888888888776332222211 124688888888887643222
Q ss_pred CC-----CCCcccceeeccCCccCCCCCcc----ccccccccccccccccccccc----Ccccc-ccccccEEeecCccC
Q 002069 452 GH-----GKFSSLIQLILNNNELSGQLSPE----LGSLNQLEYLDLSANTFHNSI----PESLG-NLVKLHYLNLSNNQF 517 (973)
Q Consensus 452 ~~-----~~~~~L~~L~l~~N~l~~~~~~~----l~~l~~L~~L~Ls~N~i~~~~----~~~l~-~l~~L~~L~L~~N~l 517 (973)
.+ .....|+.+++++|.++...... +...++|++|||++|.|++.. ++.+. ..+.|++|+|++|+|
T Consensus 302 ~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i 381 (460)
T d1z7xw1 302 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 381 (460)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred hhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCC
Confidence 11 23356888888888876543333 334567888888888887532 23332 345688888888888
Q ss_pred CCCC----CcccccccccCeecccccccCCCcchhhcc-----cccccccccccccccCccchhhh----ccccccEE
Q 002069 518 SQKI----PNPIEKLIHLSELDLSYKIFGEEIPSQVCS-----MQSLEKLNLSHNNLSGSISRCFE----EMHWLSCI 582 (973)
Q Consensus 518 ~~~~----~~~~~~l~~L~~L~ls~n~i~~~~~~~~~~-----l~~L~~L~L~~N~l~~~~~~~~~----~l~~L~~l 582 (973)
++.. ++.+..+++|++||+++|.|++.+...+.. ...|+.|++.+|.+.......+. ..+.|++|
T Consensus 382 ~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l~~l~~~~~~l~~~ 459 (460)
T d1z7xw1 382 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459 (460)
T ss_dssp CHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHHHHHHHHCTTSEEE
T ss_pred ChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHHHHHHHHHhCCCCEEe
Confidence 7543 334556678888888888887766665542 23588888888887765544432 34555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=5.2e-20 Score=188.13 Aligned_cols=208 Identities=23% Similarity=0.351 Sum_probs=137.9
Q ss_pred CCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceee
Q 002069 23 LTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLR 102 (973)
Q Consensus 23 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ 102 (973)
++++..++++.+++++.. .+..+.+|++|++++|+|+ .++ .+..+++|++|++++|++++. + .+..+++|++++
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~-~-~l~~l~~l~~l~ 91 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDL-A-PLKNLTKITELE 91 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-G-GGTTCCSCCEEE
T ss_pred HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecc-c-cccccccccccc
Confidence 344445566666666542 3566777777777777777 453 477777777777777777633 2 367777777777
Q ss_pred ccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCC
Q 002069 103 LSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSG 182 (973)
Q Consensus 103 L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~ 182 (973)
+++|.++ .++ .++++++|+.+++++|...+ ...+...+.++.+.++.+.+... ..+..+++|+.|++++|.+..
T Consensus 92 ~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~ 165 (227)
T d1h6ua2 92 LSGNPLK-NVS-AIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSD 165 (227)
T ss_dssp CCSCCCS-CCG-GGTTCTTCCEEECTTSCCCC--CGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCC
T ss_pred ccccccc-ccc-cccccccccccccccccccc--cchhccccchhhhhchhhhhchh--hhhcccccccccccccccccc
Confidence 7777776 333 46677777777777776652 23456667777777777776533 235667777777777777663
Q ss_pred CCCccccccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccceecc
Q 002069 183 SIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLN 248 (973)
Q Consensus 183 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 248 (973)
. ..++++++|++|+|++|+++++. .|+++++|++|+|++|+++++. .++++++|+.|+++
T Consensus 166 ~--~~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 166 L--TPLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225 (227)
T ss_dssp C--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred c--hhhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence 2 23667777777777777776543 3677777777777777777653 36777777777775
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=2e-22 Score=230.37 Aligned_cols=212 Identities=20% Similarity=0.147 Sum_probs=106.4
Q ss_pred hccccccceEEcccccccCCcCc----hh-hcCCccceeeccccccCCC----CCccccCCCCCCcEEcCCCCCCCc---
Q 002069 284 IGNLKSLLHLQLNYNTLSGSIPL----SL-GSLTNLATLYFSTNALSGS----IPNEITNLRSLSDLQLSENTLNGS--- 351 (973)
Q Consensus 284 ~~~l~~L~~L~l~~n~l~~~~~~----~~-~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~--- 351 (973)
+.....++.++++++........ .+ ........+++..+.+... ....+...+.++.+++++|.+...
T Consensus 165 l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~ 244 (460)
T d1z7xw1 165 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMA 244 (460)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccc
Confidence 34445666666666655421111 11 1223445566666555422 112234456677777777765421
Q ss_pred --chhccCCCCCCcEEEccCCcccCCC----CcccccccccchhcccccccccCCCccc-----CCCCCCCEEEccCCCC
Q 002069 352 --IPLALGNLTKLVSLDLSINKLSGSI----PLSFASLTSLTTLYLYENSLCDSIPKEI-----GDMKSLSILDLSSNKL 420 (973)
Q Consensus 352 --~~~~~~~l~~L~~L~Ls~N~i~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l 420 (973)
..........++.+++++|.+.... ...+...+.++.+++++|.+++.....+ .....|+.+++++|.+
T Consensus 245 ~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l 324 (460)
T d1z7xw1 245 ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 324 (460)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred hhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccch
Confidence 2333445667777777777766322 1223345666667777776653222211 2235677888888877
Q ss_pred CCCcchhhhhhc---ccceEEEeeCcccccccCCC----C-CCCcccceeeccCCccCCC----CCcccccccccccccc
Q 002069 421 NGSIPLSLANLT---NSLKVLYLSSNHIVGEIPLG----H-GKFSSLIQLILNNNELSGQ----LSPELGSLNQLEYLDL 488 (973)
Q Consensus 421 ~~~~~~~~~~~~---~~L~~L~L~~n~l~~~~~~~----~-~~~~~L~~L~l~~N~l~~~----~~~~l~~l~~L~~L~L 488 (973)
+......+.... ++|++|+|++|++++..... + ...+.|++|+|++|.|++. +++.+..+++|++|||
T Consensus 325 ~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~L 404 (460)
T d1z7xw1 325 TAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDL 404 (460)
T ss_dssp BGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEEC
T ss_pred hhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEEC
Confidence 654444443322 35777777777665432111 1 1233455555555555431 2223334445555555
Q ss_pred ccccccc
Q 002069 489 SANTFHN 495 (973)
Q Consensus 489 s~N~i~~ 495 (973)
++|.|++
T Consensus 405 s~N~i~~ 411 (460)
T d1z7xw1 405 SNNCLGD 411 (460)
T ss_dssp CSSSCCH
T ss_pred CCCcCCH
Confidence 5555543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=1.9e-19 Score=186.09 Aligned_cols=218 Identities=20% Similarity=0.154 Sum_probs=117.8
Q ss_pred EEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCC-CCcccCCCCCcEEEccC-
Q 002069 4 VLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSI-PPSLGNLTSLIYIDIGN- 81 (973)
Q Consensus 4 ~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~-p~~~~~l~~L~~L~l~~- 81 (973)
+++.++++++ .+|+.+. +++++|||++|+|+...+..|.++++|++|++++|.+...+ +..|.++++++++++..
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 4455555555 5555443 35556666666655433334555555555555555554322 23455555555555442
Q ss_pred CcCcccCCccccCccccceeeccCCcCCCCCC-CccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCC
Q 002069 82 NLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIP-SSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAI 160 (973)
Q Consensus 82 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 160 (973)
|.+....+..|..+++|++|++++|++....+ ..+..+..+..+ ..+++.+....
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~------------------------~~~n~~l~~i~ 144 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLD------------------------IQDNINIHTIE 144 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEE------------------------EESCTTCCEEC
T ss_pred ccccccccccccccccccccccchhhhcccccccccccccccccc------------------------ccccccccccc
Confidence 34443444445555555555555555542111 112223333333 33444444333
Q ss_pred CccccCcc-ccceeeecccccCCCCCccccccCccce-eeccccccccccccccCCCCcccEEecCCcccCCCCCccccc
Q 002069 161 PFSLGNLT-NLVTLYIGINALSGSIPNEIGNLKSLSD-LRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGN 238 (973)
Q Consensus 161 p~~l~~l~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 238 (973)
+..|.+++ .++.|++++|+++. ++.......++.+ +++++|+++.++...|.++++|++|++++|+|+.+++..|.+
T Consensus 145 ~~~~~~~~~~l~~L~l~~n~l~~-i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~ 223 (242)
T d1xwdc1 145 RNSFVGLSFESVILWLNKNGIQE-IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 223 (242)
T ss_dssp TTSSTTSBSSCEEEECCSSCCCE-ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTT
T ss_pred ccccccccccceeeecccccccc-cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcC
Confidence 34444433 55666666666663 3333333344433 345667777777777777888888888888887776777788
Q ss_pred cccccceeccc
Q 002069 239 LKSLLALQLNY 249 (973)
Q Consensus 239 l~~L~~L~L~~ 249 (973)
+++|+.+++.+
T Consensus 224 l~~L~~l~~~~ 234 (242)
T d1xwdc1 224 LKKLRARSTYN 234 (242)
T ss_dssp CCEEESSSEES
T ss_pred CcccccCcCCC
Confidence 88887777654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=4.1e-19 Score=183.56 Aligned_cols=218 Identities=17% Similarity=0.123 Sum_probs=156.2
Q ss_pred CeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCC-CCccccCCccceeeccc
Q 002069 51 NGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSI-PSSLGNLTNLVTLYLHM 129 (973)
Q Consensus 51 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~ 129 (973)
++++.+++.++ .+|+.+. +++++|||++|+++...+..|.++++|++|++++|.+...+ +..|.+++++++|.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 46666666666 6666553 46777777777777433345777778888888887776433 34677778888777653
Q ss_pred -ccccccCcccccccCCCCceecccCCCCCCCC-ccccCccccceeeecccccCCCCCccccccC-ccceeecccccccc
Q 002069 130 -NALSGSIPDEIGNLKFLSDLQVSYNTLSGAIP-FSLGNLTNLVTLYIGINALSGSIPNEIGNLK-SLSDLRLDYNTLSG 206 (973)
Q Consensus 130 -n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~ 206 (973)
|.+....+..|.++++|++|++++|.++...+ ..+..++.+..+..+++.+....+..+.+++ .++.|++++|+++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 56665666778888888888888888764333 2344566677777777788765566777664 78889999999988
Q ss_pred ccccccCCCCcccEEecCCcccCCCCCccccccccccceecccccccCCCCcccCCcchhhhccC
Q 002069 207 SILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNYNTLSGSIPCSFGNLTKLVISCL 271 (973)
Q Consensus 207 ~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l 271 (973)
+....|.....++.+++++|+++.+.+..|.++++|++|+|++|+|+.+++..|.++++|+.+++
T Consensus 168 i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 168 IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 77777765555555677888898887778899999999999999998777777777766665543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=8.5e-19 Score=178.97 Aligned_cols=203 Identities=25% Similarity=0.363 Sum_probs=171.9
Q ss_pred EeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcC
Q 002069 5 LGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLL 84 (973)
Q Consensus 5 L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l 84 (973)
++++.+++++. ..+..+.+|++|++++|+|+. ++ .+.++++|++|++++|++++. + .+..+++|+++++++|.+
T Consensus 24 ~~l~~~~~~d~--~~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~-~-~l~~l~~l~~l~~~~n~~ 97 (227)
T d1h6ua2 24 IAAGKSNVTDT--VTQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDL-A-PLKNLTKITELELSGNPL 97 (227)
T ss_dssp HHTTCSSTTSE--ECHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-G-GGTTCCSCCEEECCSCCC
T ss_pred HHhCCCCcCCc--CCHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecc-c-cccccccccccccccccc
Confidence 46777777743 245678999999999999985 44 699999999999999999844 3 389999999999999999
Q ss_pred cccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccc
Q 002069 85 SGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSL 164 (973)
Q Consensus 85 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l 164 (973)
+ .++ .+..+++|+++++++++..+. ..+...+.++.+.++.+.+.. ...+.++++|++|++++|.+++.. .+
T Consensus 98 ~-~i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~~L~~L~l~~n~~~~~~--~l 169 (227)
T d1h6ua2 98 K-NVS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSDLT--PL 169 (227)
T ss_dssp S-CCG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCC--CGGGGGCTTCCEEECCSSCCCCCG--GG
T ss_pred c-ccc-ccccccccccccccccccccc--chhccccchhhhhchhhhhch--hhhhccccccccccccccccccch--hh
Confidence 8 554 688999999999999998743 457788999999999999863 345888999999999999997543 48
Q ss_pred cCccccceeeecccccCCCCCccccccCccceeeccccccccccccccCCCCcccEEecCC
Q 002069 165 GNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDV 225 (973)
Q Consensus 165 ~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 225 (973)
.++++|+.|++++|++++ ++ .++++++|++|+|++|+++++. .++++++|+.|++++
T Consensus 170 ~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 170 ANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTN 226 (227)
T ss_dssp TTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEE
T ss_pred cccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEeeC
Confidence 899999999999999985 44 4899999999999999999765 489999999999974
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=5.1e-19 Score=175.21 Aligned_cols=172 Identities=19% Similarity=0.242 Sum_probs=107.9
Q ss_pred cEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccC-CcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccC
Q 002069 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLI-PHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGN 81 (973)
Q Consensus 3 ~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~-p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~ 81 (973)
+++|.++++++ .+|+.+. +++++|+|++|+|++.+ +..|..+++|++|+|++|++.+..+..+..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 45677777777 7777654 67777777777776433 44567777777777777777766667777777777777777
Q ss_pred CcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCC
Q 002069 82 NLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIP 161 (973)
Q Consensus 82 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 161 (973)
|+++...|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+... ++...-...++.+.+..|.++...|
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~-~~~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN-CHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS-GGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc-cchHHHhhhhhhhcccCCCeEeCCC
Confidence 777755566677777777777777777755566677777777777777776532 2211112234444455555443333
Q ss_pred ccccCccccceeeecccccC
Q 002069 162 FSLGNLTNLVTLYIGINALS 181 (973)
Q Consensus 162 ~~l~~l~~L~~L~l~~n~l~ 181 (973)
.. +.+++.++++.|.+.
T Consensus 167 ~~---l~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 167 SK---VRDVQIKDLPHSEFK 183 (192)
T ss_dssp TT---TTTSBGGGSCTTTCC
T ss_pred hh---hcCCEeeecCHhhCc
Confidence 32 233344444444444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=1.5e-18 Score=174.42 Aligned_cols=183 Identities=25% Similarity=0.323 Sum_probs=123.3
Q ss_pred CEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCC
Q 002069 27 KLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNN 106 (973)
Q Consensus 27 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n 106 (973)
....+.++.+++.++ ...+.+|+.|++++|+++ .++ .+..+++|++|+|++|++++ ++ .++.+++|++|++++|
T Consensus 27 i~~~l~~~~~~~~~~--~~~L~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n 100 (210)
T d1h6ta2 27 IKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDEN 100 (210)
T ss_dssp HHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSS
T ss_pred HHHHhCcCccCCccC--HHHhcCccEEECcCCCCC-Cch-hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccc
Confidence 334556666654433 234667777777777776 343 36777777777777777763 43 3566777777777777
Q ss_pred cCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCc
Q 002069 107 SLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPN 186 (973)
Q Consensus 107 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~ 186 (973)
+++ .+| .+.++++|+.|++++|.+. . ...+..++.++.+++++|.+++. ..+..+++|+.+++++|++++ ++
T Consensus 101 ~i~-~l~-~l~~l~~L~~L~l~~~~~~-~-~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~-i~- 172 (210)
T d1h6ta2 101 KVK-DLS-SLKDLKKLKSLSLEHNGIS-D-INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-IV- 172 (210)
T ss_dssp CCC-CGG-GGTTCTTCCEEECTTSCCC-C-CGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC-CG-
T ss_pred ccc-ccc-ccccccccccccccccccc-c-ccccccccccccccccccccccc--ccccccccccccccccccccc-cc-
Confidence 776 344 4677777777777777765 2 23567777777777777777632 345667777788888777774 33
Q ss_pred cccccCccceeeccccccccccccccCCCCcccEEecCC
Q 002069 187 EIGNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDV 225 (973)
Q Consensus 187 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 225 (973)
.++++++|++|+|++|+++.++ .|.++++|++|+|++
T Consensus 173 ~l~~l~~L~~L~Ls~N~i~~l~--~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 173 PLAGLTKLQNLYLSKNHISDLR--ALAGLKNLDVLELFS 209 (210)
T ss_dssp GGTTCTTCCEEECCSSCCCBCG--GGTTCTTCSEEEEEE
T ss_pred cccCCCCCCEEECCCCCCCCCh--hhcCCCCCCEEEccC
Confidence 3777888888888888887643 577888888888764
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.4e-18 Score=172.84 Aligned_cols=184 Identities=30% Similarity=0.396 Sum_probs=129.2
Q ss_pred CCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeeccc
Q 002069 50 LNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHM 129 (973)
Q Consensus 50 L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 129 (973)
....++..+.+++.++. ..+.+|++|++++|.++ .++ .+..+++|++|+|++|++++ ++ .++.+++|++|++++
T Consensus 26 ~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~ 99 (210)
T d1h6ta2 26 TIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDE 99 (210)
T ss_dssp HHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCS
T ss_pred HHHHHhCcCccCCccCH--HHhcCccEEECcCCCCC-Cch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccc
Confidence 33445666666644332 35667788888888877 343 46777888888888888774 44 367778888888888
Q ss_pred ccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccccccCccceeeccccccccccc
Q 002069 130 NALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEIGNLKSLSDLRLDYNTLSGSIL 209 (973)
Q Consensus 130 n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 209 (973)
|+++ .+| .+.++++|+.|++++|.+.. + ..+..+++|+.++++.|.+++ +..+..+++|+++++++|+++++.
T Consensus 100 n~i~-~l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~- 172 (210)
T d1h6ta2 100 NKVK-DLS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV- 172 (210)
T ss_dssp SCCC-CGG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG-
T ss_pred cccc-ccc-cccccccccccccccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccccc-
Confidence 8877 344 47778888888888887763 2 357777788888888887763 345677788888888888877643
Q ss_pred cccCCCCcccEEecCCcccCCCCCccccccccccceeccc
Q 002069 210 YSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLALQLNY 249 (973)
Q Consensus 210 ~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 249 (973)
.++++++|++|++++|+|+++ + .+.++++|++|+|++
T Consensus 173 -~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 173 -PLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFS 209 (210)
T ss_dssp -GGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEE
T ss_pred -cccCCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEccC
Confidence 377788888888888887765 2 577788888887764
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=6.1e-18 Score=168.37 Aligned_cols=176 Identities=30% Similarity=0.403 Sum_probs=78.4
Q ss_pred EECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcC
Q 002069 29 LSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSL 108 (973)
Q Consensus 29 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l 108 (973)
+.++++.+++.++ ...+.++++|++++|.++ .++ .++.+++|++|++++|++++ ++ .++++++|++|++++|.+
T Consensus 23 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~-~~-~l~~l~~L~~L~l~~n~~ 96 (199)
T d2omxa2 23 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQI 96 (199)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccC--HHHhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccC-cc-cccCCccccccccccccc
Confidence 3444444443221 233445555555555554 332 24445555555555555542 22 144455555555555544
Q ss_pred CCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccceeeecccccCCCCCccc
Q 002069 109 NGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVTLYIGINALSGSIPNEI 188 (973)
Q Consensus 109 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~ 188 (973)
. .+| .+.++++|+.|++++|.+.. .+.+..++ +|+.|++++|++. .+ +.+
T Consensus 97 ~-~~~-~l~~l~~L~~L~l~~~~~~~--~~~~~~l~------------------------~L~~L~l~~n~l~-~~-~~l 146 (199)
T d2omxa2 97 A-DIT-PLANLTNLTGLTLFNNQITD--IDPLKNLT------------------------NLNRLELSSNTIS-DI-SAL 146 (199)
T ss_dssp C-CCG-GGTTCTTCSEEECCSSCCCC--CGGGTTCT------------------------TCSEEECCSSCCC-CC-GGG
T ss_pred c-ccc-cccccccccccccccccccc--ccccchhh------------------------hhHHhhhhhhhhc-cc-ccc
Confidence 4 222 24444444444444444431 12233444 4444444444443 11 134
Q ss_pred cccCccceeeccccccccccccccCCCCcccEEecCCcccCCCCCccccccccccc
Q 002069 189 GNLKSLSDLRLDYNTLSGSILYSFGNLTKLEILYLDVNALSGLIPNEIGNLKSLLA 244 (973)
Q Consensus 189 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 244 (973)
..+++|++|++++|+++++. .|+++++|++|++++|+++++ +.++++++|++
T Consensus 147 ~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~i--~~l~~L~~L~~ 198 (199)
T d2omxa2 147 SGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSDI--SVLAKLTNLES 198 (199)
T ss_dssp TTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSE
T ss_pred cccccccccccccccccCCc--cccCCCCCCEEECCCCCCCCC--ccccCCCCCCc
Confidence 44445555555555544332 245555555555555555543 23445555444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=6.9e-18 Score=167.96 Aligned_cols=177 Identities=31% Similarity=0.418 Sum_probs=141.5
Q ss_pred EeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcC
Q 002069 5 LGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLL 84 (973)
Q Consensus 5 L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l 84 (973)
++++.+++++.++ ...+.++++|++++|.++. + +.+..+++|++|++++|++++ +++ ++++++|++|++++|.+
T Consensus 23 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~ 96 (199)
T d2omxa2 23 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQI 96 (199)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccC-ccc-ccCCccccccccccccc
Confidence 3567777774333 3467899999999999985 4 358999999999999999994 554 99999999999999999
Q ss_pred cccCCccccCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccc
Q 002069 85 SGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSL 164 (973)
Q Consensus 85 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l 164 (973)
. .+| .++.+++|++|++++|.+.. . ..+..+++|+.|++++|++. .+ +.+..+++|++|++++|++++.. .+
T Consensus 97 ~-~~~-~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~l~~n~l~-~~-~~l~~~~~L~~L~l~~n~l~~l~--~l 168 (199)
T d2omxa2 97 A-DIT-PLANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLELSSNTIS-DI-SALSGLTSLQQLNFSSNQVTDLK--PL 168 (199)
T ss_dssp C-CCG-GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCC-CC-GGGTTCTTCSEEECCSSCCCCCG--GG
T ss_pred c-ccc-cccccccccccccccccccc-c-cccchhhhhHHhhhhhhhhc-cc-ccccccccccccccccccccCCc--cc
Confidence 8 555 58899999999999999874 3 45889999999999999997 33 46888999999999999988542 36
Q ss_pred cCccccceeeecccccCCCCCccccccCcccee
Q 002069 165 GNLTNLVTLYIGINALSGSIPNEIGNLKSLSDL 197 (973)
Q Consensus 165 ~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L 197 (973)
+++++|++|++++|+++. ++ .++++++|++|
T Consensus 169 ~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 169 ANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp TTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 777777777777777773 33 46666666654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=2.5e-18 Score=170.08 Aligned_cols=89 Identities=26% Similarity=0.346 Sum_probs=37.0
Q ss_pred cCccccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCCCccccCccccce
Q 002069 93 GSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIPFSLGNLTNLVT 172 (973)
Q Consensus 93 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~ 172 (973)
+.+++|++|+|++|++.+..+..+..+++|++|+|++|+|+...|+.|.++++|++|+|++|+|+++.|++|..+++|++
T Consensus 51 ~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~ 130 (192)
T d1w8aa_ 51 GRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTS 130 (192)
T ss_dssp GGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCE
T ss_pred CCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccc
Confidence 33444444444444444333334444444444444444444333333444444444444444444333334444444444
Q ss_pred eeecccccC
Q 002069 173 LYIGINALS 181 (973)
Q Consensus 173 L~l~~n~l~ 181 (973)
|+|++|.+.
T Consensus 131 l~L~~N~~~ 139 (192)
T d1w8aa_ 131 LNLASNPFN 139 (192)
T ss_dssp EECTTCCBC
T ss_pred ccccccccc
Confidence 444444433
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.60 E-value=3.1e-17 Score=178.89 Aligned_cols=252 Identities=18% Similarity=0.184 Sum_probs=153.1
Q ss_pred CCccccCCCCCCcEEcCCCCCCCcc----hhccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcc
Q 002069 328 IPNEITNLRSLSDLQLSENTLNGSI----PLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKE 403 (973)
Q Consensus 328 ~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 403 (973)
+...+.+...|++|+|++|.++... ...+...++|+.++++++............+ . .+...
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~---~-----------~l~~~ 88 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL---R-----------LLLQA 88 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHH---H-----------HHHHH
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHH---H-----------HHHHH
Confidence 4455677788889999988886432 3446677888888888776542211100000 0 01122
Q ss_pred cCCCCCCCEEEccCCCCCCCcchhhhhh---cccceEEEeeCcccccccCCC-------------CCCCcccceeeccCC
Q 002069 404 IGDMKSLSILDLSSNKLNGSIPLSLANL---TNSLKVLYLSSNHIVGEIPLG-------------HGKFSSLIQLILNNN 467 (973)
Q Consensus 404 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~---~~~L~~L~L~~n~l~~~~~~~-------------~~~~~~L~~L~l~~N 467 (973)
+..+++|+.|+|++|.+++.....+... .++|++|++++|.++...... ....+.|+.+++++|
T Consensus 89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n 168 (344)
T d2ca6a1 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 168 (344)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred HhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccc
Confidence 3334445555555555543322222211 124555555555443211000 123456777778777
Q ss_pred ccCCC----CCcccccccccccccccccccccc-----cCccccccccccEEeecCccCCCC----CCcccccccccCee
Q 002069 468 ELSGQ----LSPELGSLNQLEYLDLSANTFHNS-----IPESLGNLVKLHYLNLSNNQFSQK----IPNPIEKLIHLSEL 534 (973)
Q Consensus 468 ~l~~~----~~~~l~~l~~L~~L~Ls~N~i~~~-----~~~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L 534 (973)
+++.. +...+...++|++|+|++|.|+.. +...+..+++|+.|+|++|+++.. +...+..+++|++|
T Consensus 169 ~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L 248 (344)
T d2ca6a1 169 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248 (344)
T ss_dssp CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEE
T ss_pred cccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhh
Confidence 77643 233455667888888888888742 334566678888888888888654 33456677888899
Q ss_pred cccccccCCCcchhhcc------cccccccccccccccCccch----hhh-ccccccEEeCcCCCCCCCC
Q 002069 535 DLSYKIFGEEIPSQVCS------MQSLEKLNLSHNNLSGSISR----CFE-EMHWLSCIDISYNALQGLI 593 (973)
Q Consensus 535 ~ls~n~i~~~~~~~~~~------l~~L~~L~L~~N~l~~~~~~----~~~-~l~~L~~l~l~~N~l~~~~ 593 (973)
++++|.|++.+...++. .+.|++|++++|+|+..... ++. +.+.|+.|++++|++....
T Consensus 249 ~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~~ 318 (344)
T d2ca6a1 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 318 (344)
T ss_dssp ECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred hhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCcc
Confidence 99999888776666542 35689999999998765433 332 4678999999999886543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=7.6e-17 Score=169.92 Aligned_cols=60 Identities=20% Similarity=0.112 Sum_probs=29.8
Q ss_pred cccccEEeecCc-cCCCCCCcccccccccCeeccccc-ccCCCcchhhcccccccccccccc
Q 002069 504 LVKLHYLNLSNN-QFSQKIPNPIEKLIHLSELDLSYK-IFGEEIPSQVCSMQSLEKLNLSHN 563 (973)
Q Consensus 504 l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~ls~n-~i~~~~~~~~~~l~~L~~L~L~~N 563 (973)
+++|++|++++| .+++.....+.++++|++|++++| .|++.+...++.+++|+.|+++++
T Consensus 174 ~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 344444444443 233334444444445555555543 444444555555666666666665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.57 E-value=3.4e-15 Score=134.80 Aligned_cols=101 Identities=27% Similarity=0.334 Sum_probs=61.6
Q ss_pred cEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCC
Q 002069 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNN 82 (973)
Q Consensus 3 ~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n 82 (973)
|+|||++|+++ .+| .+.++++|++|++++|+|+ .+|+.++.+++|++|++++|+|+ .+| .++.+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 45667777766 554 3666666666666666666 34556666666666666666666 344 3666666666666666
Q ss_pred cCcccCC--ccccCccccceeeccCCcCC
Q 002069 83 LLSGSIP--NEVGSLKSLSDLRLSNNSLN 109 (973)
Q Consensus 83 ~l~~~~p--~~~~~l~~L~~L~L~~n~l~ 109 (973)
+++ .+| ..++.+++|++|++++|.++
T Consensus 76 ~i~-~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCC-SSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccC-CCCCchhhcCCCCCCEEECCCCcCC
Confidence 665 232 34555566666666666654
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.56 E-value=1.5e-16 Score=173.31 Aligned_cols=257 Identities=22% Similarity=0.190 Sum_probs=136.9
Q ss_pred hhhccccccceEEcccccccCCc----CchhhcCCccceeeccccccCCC----------CCccccCCCCCCcEEcCCCC
Q 002069 282 EEIGNLKSLLHLQLNYNTLSGSI----PLSLGSLTNLATLYFSTNALSGS----------IPNEITNLRSLSDLQLSENT 347 (973)
Q Consensus 282 ~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~L~~n~l~~~----------~~~~~~~l~~L~~L~L~~N~ 347 (973)
..+....+|+.|+|++|.+.... ...+...++|+.++++++..... +...+..+++|++|+|++|.
T Consensus 25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~ 104 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 104 (344)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccc
Confidence 34556777888888888775432 22344567777777776654321 11223445566666666666
Q ss_pred CCCc----chhccCCCCCCcEEEccCCcccCCCCcccccccccchhcccccccccCCCcccCCCCCCCEEEccCCCCCCC
Q 002069 348 LNGS----IPLALGNLTKLVSLDLSINKLSGSIPLSFASLTSLTTLYLYENSLCDSIPKEIGDMKSLSILDLSSNKLNGS 423 (973)
Q Consensus 348 l~~~----~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 423 (973)
++.. +...+...++|+.|++++|.+.......++ ..+..+.... .....+.|+.+++++|+++..
T Consensus 105 i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~--~~l~~~~~~~---------~~~~~~~L~~l~l~~n~i~~~ 173 (344)
T d2ca6a1 105 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA--RALQELAVNK---------KAKNAPPLRSIICGRNRLENG 173 (344)
T ss_dssp CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHH--HHHHHHHHHH---------HHHTCCCCCEEECCSSCCTGG
T ss_pred cccccccchhhhhcccccchheeccccccccccccccc--cccccccccc---------ccccCcccceeeccccccccc
Confidence 6543 222334456666666666665422222221 1122222111 112346788888888887744
Q ss_pred cchhhhhh---cccceEEEeeCcccccccCCCCCCCcccceeeccCCccCCCCCcccccccccccccccccccccc----
Q 002069 424 IPLSLANL---TNSLKVLYLSSNHIVGEIPLGHGKFSSLIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNS---- 496 (973)
Q Consensus 424 ~~~~~~~~---~~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~---- 496 (973)
....+... .+.|++|+|++|+++..... ..+...+..+++|++|+|++|.++..
T Consensus 174 ~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~-------------------~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~ 234 (344)
T d2ca6a1 174 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIE-------------------HLLLEGLAYCQELKVLDLQDNTFTHLGSSA 234 (344)
T ss_dssp GHHHHHHHHHHCTTCCEEECCSSCCCHHHHH-------------------HHHHTTGGGCTTCCEEECCSSCCHHHHHHH
T ss_pred ccccccchhhhhhhhcccccccccccccccc-------------------cchhhhhcchhhhccccccccccccccccc
Confidence 33333322 13566666666665532100 01123344455666666666665532
Q ss_pred cCccccccccccEEeecCccCCCCCCccc----cc--ccccCeecccccccCCCcchhhc-----ccccccccccccccc
Q 002069 497 IPESLGNLVKLHYLNLSNNQFSQKIPNPI----EK--LIHLSELDLSYKIFGEEIPSQVC-----SMQSLEKLNLSHNNL 565 (973)
Q Consensus 497 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~----~~--l~~L~~L~ls~n~i~~~~~~~~~-----~l~~L~~L~L~~N~l 565 (973)
+...+..+++|++|+|++|.|++.....+ .. ...|++||+++|.|++.+...+. +++.|++|+|++|++
T Consensus 235 L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~ 314 (344)
T d2ca6a1 235 LAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 314 (344)
T ss_dssp HHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred ccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcC
Confidence 23344555666666666666655433322 22 24577777777777655444333 356788888888887
Q ss_pred cCc
Q 002069 566 SGS 568 (973)
Q Consensus 566 ~~~ 568 (973)
...
T Consensus 315 ~~~ 317 (344)
T d2ca6a1 315 SEE 317 (344)
T ss_dssp CTT
T ss_pred CCc
Confidence 643
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.55 E-value=6.6e-15 Score=132.83 Aligned_cols=101 Identities=29% Similarity=0.441 Sum_probs=75.6
Q ss_pred CEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCC
Q 002069 27 KLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNN 106 (973)
Q Consensus 27 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n 106 (973)
|+|||++|+++ .+| .++.+++|++|++++|+|+ .+|++++.+++|++|++++|+++ .+| .++.+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 56888888887 344 4778888888888888887 67777888888888888888887 454 4777788888888888
Q ss_pred cCCCCCC--CccccCCccceeeccccccc
Q 002069 107 SLNGSIP--SSLGNLTNLVTLYLHMNALS 133 (973)
Q Consensus 107 ~l~~~~p--~~~~~l~~L~~L~L~~n~l~ 133 (973)
+|+. +| ..++.+++|++|++++|+++
T Consensus 76 ~i~~-~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQ-SAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCS-SSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCC-CCCchhhcCCCCCCEEECCCCcCC
Confidence 8773 33 45677777777777777776
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=2.9e-16 Score=165.44 Aligned_cols=254 Identities=17% Similarity=0.175 Sum_probs=169.3
Q ss_pred cEEeCCCCCCCCCCCcccCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCC-CCCcccCCCCCcEEEccC
Q 002069 3 KVLGLSFNQFSGSIPPEIGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGS-IPPSLGNLTSLIYIDIGN 81 (973)
Q Consensus 3 ~~L~l~~~~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~-~p~~~~~l~~L~~L~l~~ 81 (973)
+.|||+++.+.+.....+.. ..+..+.++...+.. .........+|++|++++|.+... ++..+..+++|++|+|++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~-~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQ-PLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECS-CCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeecccccccc-chhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 57899988775332222221 346677777777653 333455667899999999888633 455578889999999999
Q ss_pred CcCcccCCccccCccccceeeccCC-cCCCC-CCCccccCCccceeecccc-cccc-cCcccccc-cCCCCceecccC--
Q 002069 82 NLLSGSIPNEVGSLKSLSDLRLSNN-SLNGS-IPSSLGNLTNLVTLYLHMN-ALSG-SIPDEIGN-LKFLSDLQVSYN-- 154 (973)
Q Consensus 82 n~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~L~~n-~l~~-~~p~~~~~-l~~L~~L~l~~N-- 154 (973)
|.+++..+..++.+++|++|+++++ .++.. +.....++++|++|+++++ .++. .+...+.. .+.|+.|+++++
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~ 160 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK 160 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred cCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccc
Confidence 9888777788888899999999885 45421 1222456888999999886 3432 12223333 468888888864
Q ss_pred CCCCC-CCccccCccccceeeeccc-ccCCCCCccccccCccceeecccc-ccccccccccCCCCcccEEecCCcccCCC
Q 002069 155 TLSGA-IPFSLGNLTNLVTLYIGIN-ALSGSIPNEIGNLKSLSDLRLDYN-TLSGSILYSFGNLTKLEILYLDVNALSGL 231 (973)
Q Consensus 155 ~l~~~-~p~~l~~l~~L~~L~l~~n-~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~n~i~~~ 231 (973)
.++.. +...+.++++|++|++++| .+++..+..+.++++|++|++++| .+++.....++.+++|+.|+++++ ++
T Consensus 161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~-- 237 (284)
T d2astb2 161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP-- 237 (284)
T ss_dssp GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC--
T ss_pred ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CC--
Confidence 34321 2223356788888888875 466666677888888888888884 577666667788888888888877 33
Q ss_pred CCcccccc-ccccceecccccccCCCCcccCC
Q 002069 232 IPNEIGNL-KSLLALQLNYNTLSGSIPCSFGN 262 (973)
Q Consensus 232 ~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~ 262 (973)
...+..+ ..+..|.+..+.++...+..+++
T Consensus 238 -d~~l~~l~~~lp~L~i~~~~ls~~~~~~~~~ 268 (284)
T d2astb2 238 -DGTLQLLKEALPHLQINCSHFTTIARPTIGN 268 (284)
T ss_dssp -TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred -HHHHHHHHHhCccccccCccCCCCCCCccCc
Confidence 2233332 24555666777777665555543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=3.8e-15 Score=141.57 Aligned_cols=126 Identities=18% Similarity=0.195 Sum_probs=71.1
Q ss_pred cCCCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccc
Q 002069 20 IGHLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLS 99 (973)
Q Consensus 20 ~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 99 (973)
+.+...+++|||++|+|+. +|..+..+++|+.|+|++|+|+ .++ .|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 4455566666666666663 3544455666666666666666 443 366666666666666666633333344566666
Q ss_pred eeeccCCcCCCCCC--CccccCCccceeecccccccccCcc----cccccCCCCcee
Q 002069 100 DLRLSNNSLNGSIP--SSLGNLTNLVTLYLHMNALSGSIPD----EIGNLKFLSDLQ 150 (973)
Q Consensus 100 ~L~L~~n~l~~~~p--~~~~~l~~L~~L~L~~n~l~~~~p~----~~~~l~~L~~L~ 150 (973)
+|++++|+++ .++ ..+..+++|++|++++|.++ ..|. .+..+++|++||
T Consensus 91 ~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred cceecccccc-ccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 6666666665 333 24555666666666666654 2332 344455555444
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=3.9e-15 Score=141.50 Aligned_cols=86 Identities=21% Similarity=0.151 Sum_probs=36.7
Q ss_pred cCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccce
Q 002069 45 GRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVT 124 (973)
Q Consensus 45 ~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 124 (973)
.++.+|++|+|++|+|+ .+|..+..+++|++|||++|+++ .++ .+..+++|++|++++|+++...+..+..+++|++
T Consensus 15 ~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 91 (162)
T ss_dssp ECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred cCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccccc
Confidence 34444444444444444 33433344444444444444444 222 2444444444444444444222222233444444
Q ss_pred eeccccccc
Q 002069 125 LYLHMNALS 133 (973)
Q Consensus 125 L~L~~n~l~ 133 (973)
|++++|+|+
T Consensus 92 L~L~~N~i~ 100 (162)
T d1a9na_ 92 LILTNNSLV 100 (162)
T ss_dssp EECCSCCCC
T ss_pred ceecccccc
Confidence 444444443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.42 E-value=1.4e-15 Score=150.14 Aligned_cols=142 Identities=25% Similarity=0.359 Sum_probs=87.5
Q ss_pred CCEEECCCC--cccccCCcCccCCCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeec
Q 002069 26 LKLLSFSKN--QLSGLIPHEIGRLSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRL 103 (973)
Q Consensus 26 L~~L~l~~n--~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L 103 (973)
++.++++++ .++ .+|..+..+++|++|+|++|+|+ .++ .+..+++|++|+|++|+++ .+|..+..+++|++|++
T Consensus 25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l 100 (198)
T d1m9la_ 25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI 100 (198)
T ss_dssp CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred cceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence 445555543 233 34556666777777777777776 444 3666777777777777766 55555555566777777
Q ss_pred cCCcCCCCCCCccccCCccceeecccccccccCc--ccccccCCCCceecccCCCCCCCCcc----------ccCccccc
Q 002069 104 SNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIP--DEIGNLKFLSDLQVSYNTLSGAIPFS----------LGNLTNLV 171 (973)
Q Consensus 104 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p~~----------l~~l~~L~ 171 (973)
++|+++ .+ ..+..+++|++|++++|+|+. ++ ..++.+++|++|++++|.+....+.. +..+++|+
T Consensus 101 ~~N~i~-~l-~~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~ 177 (198)
T d1m9la_ 101 SYNQIA-SL-SGIEKLVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLK 177 (198)
T ss_dssp SEEECC-CH-HHHHHHHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCC
T ss_pred cccccc-cc-ccccccccccccccccchhcc-ccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcC
Confidence 777776 33 246666777777777777763 33 35667777777777777664322221 45677777
Q ss_pred eee
Q 002069 172 TLY 174 (973)
Q Consensus 172 ~L~ 174 (973)
.||
T Consensus 178 ~LD 180 (198)
T d1m9la_ 178 KLD 180 (198)
T ss_dssp EES
T ss_pred EeC
Confidence 765
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.40 E-value=3.2e-15 Score=147.41 Aligned_cols=126 Identities=20% Similarity=0.235 Sum_probs=71.1
Q ss_pred CCeeeccCC--cCCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccceeeccCCcCCCCCCCccccCCccceeec
Q 002069 50 LNGLSLYSN--FLKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTLYL 127 (973)
Q Consensus 50 L~~L~l~~n--~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 127 (973)
++.++++.+ .+. .+|.++..+++|++|+|++|+++ .++ .+..+++|++|+|++|+|+ .+|..+..+++|++|++
T Consensus 25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l 100 (198)
T d1m9la_ 25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI 100 (198)
T ss_dssp CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred cceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence 344445443 233 45556666667777777777666 443 4666666677777666666 45554455556666666
Q ss_pred ccccccccCcccccccCCCCceecccCCCCCCCC-ccccCccccceeeecccccC
Q 002069 128 HMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAIP-FSLGNLTNLVTLYIGINALS 181 (973)
Q Consensus 128 ~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~l~~n~l~ 181 (973)
++|+++. + +.+.++++|+.|++++|+++.... ..+..+++|+.|++++|.+.
T Consensus 101 ~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 101 SYNQIAS-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SEEECCC-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccc-c-ccccccccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 6666652 2 235556666666666666552211 23455555555555555544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=1.4e-12 Score=122.66 Aligned_cols=110 Identities=22% Similarity=0.097 Sum_probs=81.5
Q ss_pred CCCCCCEEECCCCcccccCCcCccCCCCCCeeeccCCc-CCCCCCCcccCCCCCcEEEccCCcCcccCCccccCccccce
Q 002069 22 HLTHLKLLSFSKNQLSGLIPHEIGRLSSLNGLSLYSNF-LKGSIPPSLGNLTSLIYIDIGNNLLSGSIPNEVGSLKSLSD 100 (973)
Q Consensus 22 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~-~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 100 (973)
.....+.++.+++.+. ..|..+..+++|++|++++|+ ++..-+.+|.++++|++|+|++|+++...|..|..+++|++
T Consensus 6 ~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~ 84 (156)
T d2ifga3 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84 (156)
T ss_dssp CCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred CcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence 3445567888888877 457778888888888887654 77444566888888888888888888666777888888888
Q ss_pred eeccCCcCCCCCCCccccCCccceeeccccccc
Q 002069 101 LRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALS 133 (973)
Q Consensus 101 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 133 (973)
|+|++|+|+ .+|.......+|++|+|++|.+.
T Consensus 85 L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 85 LNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp EECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred eeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 888888888 55555444457888888888775
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=4.8e-12 Score=118.91 Aligned_cols=109 Identities=22% Similarity=0.149 Sum_probs=69.4
Q ss_pred CCCCCeeeccCCcCCCCCCCcccCCCCCcEEEccCC-cCcccCCccccCccccceeeccCCcCCCCCCCccccCCcccee
Q 002069 47 LSSLNGLSLYSNFLKGSIPPSLGNLTSLIYIDIGNN-LLSGSIPNEVGSLKSLSDLRLSNNSLNGSIPSSLGNLTNLVTL 125 (973)
Q Consensus 47 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n-~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 125 (973)
+...++++.+++.+. ..|..+..+++|++|++++| .++...+..|..+++|+.|+|++|+|+...|..|.++++|++|
T Consensus 7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 344556777777766 56666777777777777654 3664444566777777777777777775556667777777777
Q ss_pred ecccccccccCcccccccCCCCceecccCCCC
Q 002069 126 YLHMNALSGSIPDEIGNLKFLSDLQVSYNTLS 157 (973)
Q Consensus 126 ~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~ 157 (973)
+|++|+|+ .+|........|+.|+|++|.+.
T Consensus 86 ~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 86 NLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp ECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred eccCCCCc-ccChhhhccccccccccCCCccc
Confidence 77777776 34333333335666666666663
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.61 E-value=4.4e-09 Score=99.04 Aligned_cols=120 Identities=25% Similarity=0.166 Sum_probs=82.0
Q ss_pred cceeeccCCccCCCCCcccccccccccccccccccccccCccccccccccEEeecCccCCCCC--CcccccccccCeecc
Q 002069 459 LIQLILNNNELSGQLSPELGSLNQLEYLDLSANTFHNSIPESLGNLVKLHYLNLSNNQFSQKI--PNPIEKLIHLSELDL 536 (973)
Q Consensus 459 L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~l 536 (973)
.+.|++++++.. ..+..+..+..++.+.|.+. .++..+..+++|++|+|++|+|+... +..+..+++|+.||+
T Consensus 24 ~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L 98 (162)
T d1koha1 24 QQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 98 (162)
T ss_dssp SCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred hCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence 445566555432 22344455556666666554 34444566788999999999988653 356778888999999
Q ss_pred cccccCCCcchhhcccccccccccccccccCccc-------hhhhccccccEEe
Q 002069 537 SYKIFGEEIPSQVCSMQSLEKLNLSHNNLSGSIS-------RCFEEMHWLSCID 583 (973)
Q Consensus 537 s~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-------~~~~~l~~L~~l~ 583 (973)
++|.|++..+-.+.....|+.|++++|+++.... ..+..+|+|+.||
T Consensus 99 s~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 99 SGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp TTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred ccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 9998887666555555678999999999876543 3356788888886
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.48 E-value=1.2e-08 Score=95.87 Aligned_cols=105 Identities=23% Similarity=0.094 Sum_probs=55.2
Q ss_pred ccceeeccCCcCCCCCCCccccCCccceeecccccccccCcccccccCCCCceecccCCCCCCC--CccccCccccceee
Q 002069 97 SLSDLRLSNNSLNGSIPSSLGNLTNLVTLYLHMNALSGSIPDEIGNLKFLSDLQVSYNTLSGAI--PFSLGNLTNLVTLY 174 (973)
Q Consensus 97 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~--p~~l~~l~~L~~L~ 174 (973)
..+.|+++++... ..+..+..+..++..++... .++..+..++.|++|+|++|+|+... +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 3455666554432 22444445555555555443 44555566777777777777776432 23344556666666
Q ss_pred ecccccCCCCCccccccCccceeecccccccc
Q 002069 175 IGINALSGSIPNEIGNLKSLSDLRLDYNTLSG 206 (973)
Q Consensus 175 l~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 206 (973)
+++|+|+...+-.+.+...|++|++++|.+..
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCc
Confidence 66666653222122233345555555555543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.36 E-value=5.6e-07 Score=92.06 Aligned_cols=149 Identities=15% Similarity=0.097 Sum_probs=101.8
Q ss_pred HHHHHHhcCCcccccccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-CCceeeeceeeecc
Q 002069 694 EEIIRATKNFDDEHCIGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-HRNIVKFYGFCSHA 772 (973)
Q Consensus 694 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 772 (973)
.++....+.|+.++..+-++.+.||+... +++.+++|+........ ...+.+|...+..+. +--+++++.++.++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~ 82 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence 34555667888777655555678999976 56677888875432222 234566777766552 44467788888888
Q ss_pred ceeEEEEEecCCCChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------
Q 002069 773 LHSFVVYEYLEMGSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTNC----------------------------- 823 (973)
Q Consensus 773 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------- 823 (973)
+..++||++++|.++.+..... .....++.++++.++.||+..
T Consensus 83 ~~~~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp TEEEEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred CceEEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 8899999999998886544211 122335566666677777531
Q ss_pred ---------------------------CCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 824 ---------------------------FPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 824 ---------------------------~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
...++|+|+.|.||++++++.+-++||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0237899999999999977667799999875
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.04 E-value=5e-07 Score=84.97 Aligned_cols=85 Identities=20% Similarity=0.215 Sum_probs=42.2
Q ss_pred ccccccEEeecCccCCCCCC----cccccccccCeecccccccCCCcchh----hcccccccccccccccccCc------
Q 002069 503 NLVKLHYLNLSNNQFSQKIP----NPIEKLIHLSELDLSYKIFGEEIPSQ----VCSMQSLEKLNLSHNNLSGS------ 568 (973)
Q Consensus 503 ~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~ls~n~i~~~~~~~----~~~l~~L~~L~L~~N~l~~~------ 568 (973)
..+.|++|+|++|.++.... +.+...+.|++|++++|.|++.+... +...+.|++|++++|.+...
T Consensus 42 ~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~ 121 (167)
T d1pgva_ 42 NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEM 121 (167)
T ss_dssp TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHH
T ss_pred hCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHH
Confidence 33445555555555543211 23333445555555555555444333 22345566666666654432
Q ss_pred -cchhhhccccccEEeCcCC
Q 002069 569 -ISRCFEEMHWLSCIDISYN 587 (973)
Q Consensus 569 -~~~~~~~l~~L~~l~l~~N 587 (973)
...++...+.|+.|+++++
T Consensus 122 ~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 122 DMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHHHHHHHCSSCCEEECCCC
T ss_pred HHHHHHHhCCCccEeeCcCC
Confidence 2333444566777776655
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.90 E-value=1.1e-06 Score=82.55 Aligned_cols=82 Identities=17% Similarity=0.129 Sum_probs=41.9
Q ss_pred ccceeeccCCccCC----CCCccccccccccccccccccccccc----CccccccccccEEeecCccCCCCC-------C
Q 002069 458 SLIQLILNNNELSG----QLSPELGSLNQLEYLDLSANTFHNSI----PESLGNLVKLHYLNLSNNQFSQKI-------P 522 (973)
Q Consensus 458 ~L~~L~l~~N~l~~----~~~~~l~~l~~L~~L~Ls~N~i~~~~----~~~l~~l~~L~~L~L~~N~l~~~~-------~ 522 (973)
+|++|+|++|.++. .+...+...++|++|+|++|.|++.. ..++...+.|++|+|++|.+.... .
T Consensus 45 ~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~ 124 (167)
T d1pgva_ 45 HIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMM 124 (167)
T ss_dssp CCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHH
T ss_pred ccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHH
Confidence 34444444444432 23344455566777777777776432 223444566777777776554321 2
Q ss_pred cccccccccCeeccccc
Q 002069 523 NPIEKLIHLSELDLSYK 539 (973)
Q Consensus 523 ~~~~~l~~L~~L~ls~n 539 (973)
..+...+.|+.|+++++
T Consensus 125 ~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 125 MAIEENESLLRVGISFA 141 (167)
T ss_dssp HHHHHCSSCCEEECCCC
T ss_pred HHHHhCCCccEeeCcCC
Confidence 23333445555555444
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.85 E-value=1.4e-05 Score=80.78 Aligned_cols=130 Identities=15% Similarity=0.087 Sum_probs=85.0
Q ss_pred cccCCCc-eeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC--CCceeeeceeeeccceeEEEEEecCC
Q 002069 708 CIGNGGQ-GSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR--HRNIVKFYGFCSHALHSFVVYEYLEM 784 (973)
Q Consensus 708 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~ 784 (973)
.+..|.. +.||+....++..+++|....... ..+..|...++.+. .-.++++++++.+++..++||+|++|
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 4555654 578999888888899998764432 23455666555442 33467788888888888999999998
Q ss_pred CChHHHhccCccccCCCHHHHHHHHHHHHHHHHHHhhC------------------------------------------
Q 002069 785 GSLAMILSNDAAAEEFGWTKRMNAIKGVADALLYMHTN------------------------------------------ 822 (973)
Q Consensus 785 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------------------------------------------ 822 (973)
.++.+.. ... ...+.+++..++-||+.
T Consensus 91 ~~~~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 91 QDLLSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp EETTTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred ccccccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence 7653211 111 11223333444444432
Q ss_pred ---------C----CCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 823 ---------C----FPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 823 ---------~----~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
. .+.++|+|+.|.||+++.+..+-|+||+.+.
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 1247999999999999987667899999875
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.51 E-value=8.8e-06 Score=76.19 Aligned_cols=63 Identities=19% Similarity=0.180 Sum_probs=27.9
Q ss_pred CcccceeeccC-CccCCC----CCccccccccccccccccccccccc----CccccccccccEEeecCccCC
Q 002069 456 FSSLIQLILNN-NELSGQ----LSPELGSLNQLEYLDLSANTFHNSI----PESLGNLVKLHYLNLSNNQFS 518 (973)
Q Consensus 456 ~~~L~~L~l~~-N~l~~~----~~~~l~~l~~L~~L~Ls~N~i~~~~----~~~l~~l~~L~~L~L~~N~l~ 518 (973)
.++|++|++++ +.++.. +..++...++|++|++++|.++... .+.+...+.++.|++++|.++
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 34555555554 334321 2233334455555555555554321 122233344555555555544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.48 E-value=5.3e-06 Score=77.75 Aligned_cols=110 Identities=12% Similarity=0.115 Sum_probs=55.9
Q ss_pred cccccccccccc-cccccc----cCccccccccccEEeecCccCCCCCC----cccccccccCeecccccccCCCcchh-
Q 002069 479 SLNQLEYLDLSA-NTFHNS----IPESLGNLVKLHYLNLSNNQFSQKIP----NPIEKLIHLSELDLSYKIFGEEIPSQ- 548 (973)
Q Consensus 479 ~l~~L~~L~Ls~-N~i~~~----~~~~l~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~ls~n~i~~~~~~~- 548 (973)
..++|++|+|++ +.|+.. +..++...+.|++|+|++|.++.... ..+.....++.+++++|.+++.+...
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l 94 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 94 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHH
Confidence 345666666665 345432 22333445566666666666654322 23444556666666666665444332
Q ss_pred ---hcccccccc--cccccccccCcc----chhhhccccccEEeCcCCC
Q 002069 549 ---VCSMQSLEK--LNLSHNNLSGSI----SRCFEEMHWLSCIDISYNA 588 (973)
Q Consensus 549 ---~~~l~~L~~--L~L~~N~l~~~~----~~~~~~l~~L~~l~l~~N~ 588 (973)
+...++|+. |++++|++...+ ...+...+.|+.|+++.+.
T Consensus 95 ~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 95 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 233455554 333455554332 2334445666666665553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.27 E-value=0.00029 Score=75.54 Aligned_cols=79 Identities=14% Similarity=0.032 Sum_probs=47.0
Q ss_pred cccccCCCceeEEEEEcC-CCCEEEEEEcCCCC---Ccc-hhhHHHHHHHHHHhhcC-C--CCceeeeceeeeccceeEE
Q 002069 706 EHCIGNGGQGSVYKAELP-TGEIVAVKKFHSPL---PGE-MACQQEFLNEGNALTKI-R--HRNIVKFYGFCSHALHSFV 777 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~-~~~~~~~~~e~~~l~~l-~--h~niv~~~~~~~~~~~~~l 777 (973)
.+.||.|....||++... +++.|+||...... ... .....+...|...++.+ . ...+++++.+. ++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 456899999999999765 46789999753210 000 00112344566666554 2 23466666554 445689
Q ss_pred EEEecCCCC
Q 002069 778 VYEYLEMGS 786 (973)
Q Consensus 778 v~e~~~~~~ 786 (973)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.80 E-value=0.0014 Score=68.10 Aligned_cols=69 Identities=13% Similarity=0.132 Sum_probs=44.4
Q ss_pred ceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCCCCce--eeece-----eeeccceeEEEEEecCCCC
Q 002069 714 QGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIRHRNI--VKFYG-----FCSHALHSFVVYEYLEMGS 786 (973)
Q Consensus 714 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~-----~~~~~~~~~lv~e~~~~~~ 786 (973)
--.||++..++|+.|++|+....... .+++..|...+..+....+ +..+. .....+..+.|+++++|..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 45799999999999999998654222 3566777777766632222 11111 2234556788999988653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.12 E-value=0.0048 Score=65.80 Aligned_cols=73 Identities=19% Similarity=0.262 Sum_probs=49.3
Q ss_pred cccccCCCceeEEEEEcCC--------CCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcC-CCCceeeeceeeeccceeE
Q 002069 706 EHCIGNGGQGSVYKAELPT--------GEIVAVKKFHSPLPGEMACQQEFLNEGNALTKI-RHRNIVKFYGFCSHALHSF 776 (973)
Q Consensus 706 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 776 (973)
++.|+.|-.-.+|++..++ .+.|.+++.... .. .....+|..+++.+ ++.-.+++++++.+ +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~----~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET----ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch----hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 4578889999999997643 356777776532 11 23345677777777 34445678887753 5
Q ss_pred EEEEecCCCCh
Q 002069 777 VVYEYLEMGSL 787 (973)
Q Consensus 777 lv~e~~~~~~L 787 (973)
+||||++|..+
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 89999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.94 E-value=0.033 Score=56.93 Aligned_cols=158 Identities=13% Similarity=0.084 Sum_probs=80.3
Q ss_pred ccHHHHHHHhcCCccccc-----ccCCCceeEEEEEcCCCCEEEEEEcCCCCCcchhhHHHHHHHHHHhhcCC-----CC
Q 002069 691 IVHEEIIRATKNFDDEHC-----IGNGGQGSVYKAELPTGEIVAVKKFHSPLPGEMACQQEFLNEGNALTKIR-----HR 760 (973)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~-----lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~ 760 (973)
++.+++.....+|.+.+. |..|.--+.|+.+..+|+ +++|++...... +++..|+.++..+. .|
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~-----~~l~~~~~~l~~L~~~g~pvp 76 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK-----NDLPFFLGLMQHLAAKGLSCP 76 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C-----CHHHHHHHHHHHHHHTTCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH-----HHHHHHHHHHHhhhhcccccc
Confidence 456778888888877544 346666889999876654 889998643211 23334444444442 22
Q ss_pred ceeeec-e--eeeccceeEEEEEecCCCChHHH-----------h-------ccCc--cccCCCH---------------
Q 002069 761 NIVKFY-G--FCSHALHSFVVYEYLEMGSLAMI-----------L-------SNDA--AAEEFGW--------------- 802 (973)
Q Consensus 761 niv~~~-~--~~~~~~~~~lv~e~~~~~~L~~~-----------l-------~~~~--~~~~~~~--------------- 802 (973)
..+... | +.......+.++.+..+...... + .... .......
T Consensus 77 ~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (316)
T d2ppqa1 77 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 156 (316)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred ccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence 222211 1 11223445666776665432110 0 0000 0000000
Q ss_pred ---HHHHHHHHHHHHHHHHHhh-CCCCCeEeecCCCCCeeecCCCceEEecccccc
Q 002069 803 ---TKRMNAIKGVADALLYMHT-NCFPPIVHRDISSKNVLLNLEYEAHVSDFGISK 854 (973)
Q Consensus 803 ---~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlk~~Nill~~~~~~kl~Dfg~a~ 854 (973)
......+......+...+. ....|+||+|+.+.||+++.+...-++||+.+.
T Consensus 157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0011112222222222222 122479999999999999988777899999875
|